Citrus Sinensis ID: 010626

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-----
Protein Sequence
MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSVI
Secondary Structure (PSIPRED)
cHHHHHHHHHHHHHHHHHHcccccccccccccccEEEEcccccEEEcccccHHHcccccccccccccccccHHHHHHccccHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHcccccccccccccHHHHHHHHHHcccccccccHHHHHccccccccccccccccccccccccHHHHcccccccccccccccccccccccccccccccccccHHHHcccccccEEEEcEEccccccEEEEEEcccccccccEEEEEEcccccHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHHHHHccccEEEEccccccEEEEccccEEEEccHHHHHHHHcccccEEcccHHHccHHHHHHcccHHHHHHHHHHHHHHHHHccccccccccHHHHHHHHccccccHHHHHcccHHHHHHHHHHHccccccccHHHHHccHHHccccccccccccccccccccccccccccccccccccccccEcccccccccccccccccHHHccccccccEEEEEEcccccEEEEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccEEEc
Coil and Loop (DISEMBL)
MKAIKNWARQILRGLHylhshnppiihrdlkcdnifvngnngevkiGDLGLAIVMqqptarsvigtpefmapelyeEEYNELVDIYSFGMCILEMVtceypynecknpaQIYKKVTsgikpaslskvtdpQVKQFIEKcivpaslrlpalellkdpflvtdnpkdlvcdplrlpnlvpevmnlahsephpmdidlnhkkvsadscaksntgtwfLTLELQRLtenneftlrgekndddtvSLTLRigdksghvsniHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKlvpswnpslgstasqqngllkgspvsqgnsislkcpgepgsnnaFAEAVSQQGVLSELAsgkyqynqessdsdisaefdvpvildahidkslvpdgysahyavydhgghevkadevslgesilfnestqnsetsfidscsgmsknlsfssisslsladkehsdGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLagsnvsvi
Flexible Loop (DISEMBL)
MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPaslskvtdpqvKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNeftlrgekndddtVSLTLRigdksghvsnIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARkrwlagsnvsvi
Low Complexity Region (SEG)
MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMsknlsfssisslslADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSVI
Disordered region (IsUnstruct)
***IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLA********************CAKSNTGTWFLTLELQRLTENNEFTLR******DTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWN*********************************************************************AEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILF********************************************LDAINSKYQQCFQEL************************
Disordered Region (DISOPRED)
MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL*KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNP******************************************************************************************SNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLV********************************************************************************************************************************************************************LELDAINSKYQQC****************KRWLAG**VSVI
Disordered Region (DISEMBL)
MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKY**********ISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNES**********SCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSVI
Disordered Region (DISPRO)
MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN************************************TWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWN****************************************************************************************************************************************************SLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSVI
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYxxxxxxxxxxxxxxxxxxxxxWLAGSNVSVI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	505	2.2.26 [Sep-21-2011]
Q944Q0	563	Serine/threonine-protein	yes	no	0.833	0.747	0.499	1e-117
Q6EU49	612	Probable serine/threonine	yes	no	0.926	0.764	0.461	1e-110
Q8S8Y8	567	Probable serine/threonine	no	no	0.592	0.527	0.584	2e-98
Q8RXE5	524	Probable serine/threonine	no	no	0.586	0.564	0.643	6e-98
Q8LST2	557	Probable serine/threonine	no	no	0.590	0.535	0.587	1e-96
Q0D598	704	Probable serine/threonine	no	no	0.639	0.458	0.526	6e-90
A2YMV6	704	Probable serine/threonine	N/A	no	0.639	0.458	0.526	6e-90
Q9CAV6	700	Serine/threonine-protein	no	no	0.603	0.435	0.486	2e-85
Q8S8Y9	568	Serine/threonine-protein	no	no	0.704	0.626	0.453	2e-85
Q65X23	621	Probable serine/threonine	no	no	0.586	0.476	0.514	2e-84

>sp|Q944Q0|WNK8_ARATH Serine/threonine-protein kinase WNK8 OS=Arabidopsis thaliana GN=WNK8 PE=1 SV=1

 Score =  422 bits (1084), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 256/513 (49%), Positives = 318/513 (61%), Gaps = 92/513 (17%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
           KAIKNWARQIL+GL+YLHS NPP+IHRDLKCDNIFVNGN GEVKIGDLGLA V+QQPTAR
Sbjct: 130 KAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVLQQPTAR 189

Query: 62  SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
           SVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPYNEC+N AQIYKKVTS IKP
Sbjct: 190 SVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTSNIKP 249

Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP--------LRL 173
            SL KV DPQV+QFIEKC++PAS R  ALEL KDPFL  D  KD             +R 
Sbjct: 250 QSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSALLASSSTSSKYVRP 309

Query: 174 PNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGE 233
           P L          E  PMD+D N  K    S + +    W  T+ELQR+ EN EF LRGE
Sbjct: 310 PQL----------EHLPMDVDHNENK----SVSSNEDYPWSQTIELQRIAENKEFRLRGE 355

Query: 234 KNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELID 293
           ++DD T S+ LRI D SG    +HF FYL +DTA +IAEEMVE+L L+ ++VV IA++ID
Sbjct: 356 RSDDVTASMVLRIADPSGKCRIVHFAFYLESDTATAIAEEMVEELHLTSQEVVVIADMID 415

Query: 294 NLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVL 353
           + IM+L+         T+S  N                     P   +   EA +QQ V 
Sbjct: 416 DFIMQLLSD------RTSSHHN------------------QNSPRLTHEDHEAANQQTVN 451

Query: 354 S--ELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKA 411
           S  E A+G      +S  SDISA++  P   +         DG +A  A  D        
Sbjct: 452 SKDEEAAG------QSMKSDISADYYFPYSAN---------DGNAAMEAGRD-------- 488

Query: 412 DEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAIN 471
                 ES+          +S++DSCS M      S+I +LS++D ++ + LK EL+ I 
Sbjct: 489 -----AESM----------SSYLDSCSMM------STIYNLSISDNDYPEDLKTELNLIE 527

Query: 472 SKYQQCFQELLRQREDEMENARKRWLAGSNVSV 504
           S++ Q FQ+LL+ +ED +ENA+++W+     +V
Sbjct: 528 SQFNQSFQDLLKLKEDAIENAKRKWITKKQKAV 560

Regulates flowering time by modulating the photoperiod pathway. Phosphorylates the vacuolar ATPase subunit C (VATC).
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q6EU49|WNK4_ORYSJ Probable serine/threonine-protein kinase WNK4 OS=Oryza sativa subsp. japonica GN=WNK4 PE=2 SV=1

 Score =  398 bits (1023), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 237/514 (46%), Positives = 318/514 (61%), Gaps = 46/514 (8%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           +KAIKNWARQ+LRGL YLH+H PPIIHRDLKCDNIFVNGN+GEVKIGDLGLA VM  P A
Sbjct: 125 LKAIKNWARQVLRGLDYLHTHQPPIIHRDLKCDNIFVNGNHGEVKIGDLGLATVMLTPRA 184

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           +SVIGTPEFMAPELY+E Y+ELVDIYSFGMC+LEM T EYPY+EC N AQI+KKV+ G+K
Sbjct: 185 KSVIGTPEFMAPELYDENYDELVDIYSFGMCMLEMFTLEYPYSECTNAAQIFKKVSKGVK 244

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 180
           PA+L+K+T+ Q KQFI+KC+VPAS RL A ELL+DPFL +DN   LV    + P+ +P+ 
Sbjct: 245 PAALAKITNIQAKQFIDKCLVPASERLSAKELLQDPFLCSDNSSVLV--GTKFPSSLPKS 302

Query: 181 MNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLT-LELQRLTENNEFTLRGEKNDDDT 239
           ++++    H MD+D N    ++ +C +++ G    + LE  R  +N E  L GEK DD++
Sbjct: 303 VDVSLEALH-MDVDTNESMCTS-TCKRNDLGGPHRSVLEFTRTNKNTELKLTGEKLDDNS 360

Query: 240 VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 299
           VSL LRI D  GH  NIHF+FYL++DTA+S+A EMVEQL+L+  DV  IA+ ID LI+ L
Sbjct: 361 VSLVLRIADLCGHARNIHFLFYLDSDTAMSVAAEMVEQLELADCDVTFIADFIDLLIVNL 420

Query: 300 VPS---WNPSLGSTASQQNGLLKGSPVSQGNSI--SLKCPGEPGSNNAFAEAVSQQG--- 351
           VP     N ++ ST+S+       S + +   +  S + P E   +    E +       
Sbjct: 421 VPGQQLMNDAVMSTSSE-------SKMGESEHVITSQQHPSELTHDYVLVEGMMHSKEAN 473

Query: 352 ------VLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHG 405
                 + S L +        S  SDIS + D          KSL      + Y V ++ 
Sbjct: 474 ASPSDYIDSLLNATNLGGPNSSEGSDISVQLDGS-------SKSL------SEYGVDEYR 520

Query: 406 GHEVKADEVS--LGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGL 463
             E  A + +  LG     +  + N     +D  S  S+ +  +S+S       E+ D L
Sbjct: 521 TLECGAYKGTDKLGCRHPLSNGSSNFAIFQMDQASHHSELVIGASVSI-----TENRDVL 575

Query: 464 KLELDAINSKYQQCFQELLRQREDEMENARKRWL 497
             EL  I ++Y+Q F+EL R RE+ +E ARK+WL
Sbjct: 576 NGELGLIEAQYEQWFRELTRMREEALEGARKKWL 609

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8S8Y8|WNK6_ARATH Probable serine/threonine-protein kinase WNK6 OS=Arabidopsis thaliana GN=WNK6 PE=2 SV=1

 Score =  360 bits (923), Expect = 2e-98,   Method: Compositional matrix adjust.
 Identities = 184/315 (58%), Positives = 230/315 (73%), Gaps = 16/315 (5%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           MKA+KNWARQIL GL YLH   PPIIHRDLKCDNIF+NGN+GEVKIGDLGLA VM+Q  A
Sbjct: 128 MKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANA 187

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           +SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVT +YPY ECKN AQIYKKV+SGIK
Sbjct: 188 KSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIK 247

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV-PE 179
           PASLS+V DP+VKQFIEKC++PAS RL A ELL DPFL  +     + +PL LP++V P+
Sbjct: 248 PASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLT--MNNPLPLPDIVMPK 305

Query: 180 --------VMNLAHSEPHP---MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEF 228
                   +M+       P   + IDL+            N+G+    +E++R    N F
Sbjct: 306 EGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSGS--RCIEVRRAKRGNFF 363

Query: 229 TLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSI 288
            L+GE+ND+ +VSL LRI D++G V NIHF+FY   DTA  ++ EMVEQL+L+ ++V  I
Sbjct: 364 VLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTFI 423

Query: 289 AELIDNLIMKLVPSW 303
           AELID L++ ++P+W
Sbjct: 424 AELIDILLVNMIPTW 438

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8RXE5|WNK10_ARATH Probable serine/threonine-protein kinase WNK10 OS=Arabidopsis thaliana GN=WNK10 PE=2 SV=1

 Score =  358 bits (919), Expect = 6e-98,   Method: Compositional matrix adjust.
 Identities = 193/300 (64%), Positives = 217/300 (72%), Gaps = 4/300 (1%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
           KAI NWARQIL+GLHYLHS  PP+IHRDLKCDNIFVNGN G+VKIGDLGLA VMQQPTAR
Sbjct: 117 KAIMNWARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTAR 176

Query: 62  SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
           SVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY EC+N AQIYKKVTSGIKP
Sbjct: 177 SVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKP 236

Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVM 181
            SLSKV DPQVKQFIEKC++PA  R  ALELLKD  L  D  KD            P + 
Sbjct: 237 QSLSKVDDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNTTFKPAMP 296

Query: 182 NLAHSEPHPMDIDL-NHKKVSADSCAKSNTGTWFL-TLELQRLTENNEFTLRGEKNDDDT 239
                E  PMD++   +  VS  S AKS+     L T+E+QR+ E+ EF L GE+ DD  
Sbjct: 297 --PQCEYRPMDVEYKKNTSVSICSSAKSSQECALLQTMEVQRVAESTEFKLSGERRDDVA 354

Query: 240 VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 299
            S+ LRI   SG    + F F L  DTA ++  EMVE+LDLS  +V  IAE+ID LIMKL
Sbjct: 355 ASMALRIAGSSGQARKVDFDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMIDELIMKL 414

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LST2|WNK7_ARATH Probable serine/threonine-protein kinase WNK7 OS=Arabidopsis thaliana GN=WNK7 PE=2 SV=1

 Score =  353 bits (907), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 185/315 (58%), Positives = 234/315 (74%), Gaps = 17/315 (5%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           MKA+K WARQIL GL YLHS +PPIIHRD+KCDNIF+NGN+GEVKIGDLGLA VM+Q  A
Sbjct: 128 MKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANA 187

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           +SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVT EYPY EC+N AQIYKKV+SGIK
Sbjct: 188 KSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIK 247

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVC-DPLRLPNLV-P 178
           PASLSKV DP+V +FIEKC++PAS RL A ELL D FL   N   LV  +PL LP++V P
Sbjct: 248 PASLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFL---NVNGLVMNNPLPLPDIVMP 304

Query: 179 EVMNLAH----SEPHP------MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEF 228
           +  +       SE  P      M ++L+         + +N+GT    +E++R    N F
Sbjct: 305 KEGSFGERCLMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSGTN--CIEVRRAKRGNFF 362

Query: 229 TLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSI 288
            L+GE+ND+++VSL LRI D++G V NIHF+F+   DTA +++ EMVEQL+L+ ++V  I
Sbjct: 363 VLKGEENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNVKFI 422

Query: 289 AELIDNLIMKLVPSW 303
           AELID L++ L+P+W
Sbjct: 423 AELIDVLLVNLIPNW 437

May regulate flowering time by modulating the photoperiod pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0D598|WNK1_ORYSJ Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. japonica GN=WNK1 PE=2 SV=1

 Score =  332 bits (850), Expect = 6e-90,   Method: Compositional matrix adjust.
 Identities = 181/344 (52%), Positives = 221/344 (64%), Gaps = 21/344 (6%)

Query: 3   AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 62
           A+K+W RQIL GL YLHSH+PPIIHRDLKCDNIFVNGN GEVKIGDLGLA ++++  A  
Sbjct: 129 AVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVH 188

Query: 63  VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 122
            +GTPEFMAPE+YEEEYNELVDIYSFGMC+LEMVT EYPY+EC +P QIYKKV SG KP 
Sbjct: 189 CVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPE 248

Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP----------LR 172
           +L KV DP V+QF+EKC+  AS RL A ELLKDPFL  D   DLV  P          LR
Sbjct: 249 ALYKVKDPMVRQFVEKCLATASRRLSARELLKDPFLQVD---DLVFCPGDGDYSLMNYLR 305

Query: 173 LPNLVPEVMNLAH-----SEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNE 227
            P L     N++      SE    D     +    D   K++    F   E + L  N +
Sbjct: 306 QPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLG-NVD 364

Query: 228 FTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVS 287
            T++G K++D ++ L LRI D  GHV NI+F F + ADTA+S+A EMV +LD++  +V  
Sbjct: 365 ITIKGRKSEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTR 424

Query: 288 IAELIDNLIMKLVPSWNPSLGSTASQQNGLLK--GSPVSQGNSI 329
           IAE+ID  +  LVP W P  G   SQ        GS VS   S+
Sbjct: 425 IAEMIDGEVSALVPDWRPGPGIEESQDTTYCHNCGSNVSSCGSL 468

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A2YMV6|WNK1_ORYSI Probable serine/threonine-protein kinase WNK1 OS=Oryza sativa subsp. indica GN=WNK1 PE=2 SV=2

 Score =  331 bits (849), Expect = 6e-90,   Method: Compositional matrix adjust.
 Identities = 181/344 (52%), Positives = 221/344 (64%), Gaps = 21/344 (6%)

Query: 3   AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 62
           A+K+W RQIL GL YLHSH+PPIIHRDLKCDNIFVNGN GEVKIGDLGLA ++++  A  
Sbjct: 129 AVKHWCRQILSGLLYLHSHDPPIIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHAVH 188

Query: 63  VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 122
            +GTPEFMAPE+YEEEYNELVDIYSFGMC+LEMVT EYPY+EC +P QIYKKV SG KP 
Sbjct: 189 CVGTPEFMAPEVYEEEYNELVDIYSFGMCVLEMVTFEYPYSECTHPVQIYKKVISGTKPE 248

Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP----------LR 172
           +L KV DP V+QF+EKC+  AS RL A ELLKDPFL  D   DLV  P          LR
Sbjct: 249 ALYKVKDPMVRQFVEKCLATASRRLSARELLKDPFLQVD---DLVFCPGDGDYSLMNYLR 305

Query: 173 LPNLVPEVMNLAH-----SEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNE 227
            P L     N++      SE    D     +    D   K++    F   E + L  N +
Sbjct: 306 QPYLEHAYSNVSMMSNGLSESIDEDTPTEDRWDCEDDDIKADGIDLFNGHEDEPLG-NVD 364

Query: 228 FTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVS 287
            T++G K++D ++ L LRI D  GHV NI+F F + ADTA+S+A EMV +LD++  +V  
Sbjct: 365 ITIKGRKSEDGSIFLRLRIADNDGHVRNIYFPFDIEADTALSVATEMVAELDITDHEVTR 424

Query: 288 IAELIDNLIMKLVPSWNPSLGSTASQQNGLLK--GSPVSQGNSI 329
           IAE+ID  +  LVP W P  G   SQ        GS VS   S+
Sbjct: 425 IAEMIDGEVSALVPDWRPGPGIEESQDTTYCHNCGSNVSSCGSL 468

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAV6|WNK1_ARATH Serine/threonine-protein kinase WNK1 OS=Arabidopsis thaliana GN=WNK1 PE=1 SV=1

 Score =  317 bits (811), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 168/345 (48%), Positives = 215/345 (62%), Gaps = 40/345 (11%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           ++A+K+W RQILRGLHYLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++++  A
Sbjct: 124 IRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
              +GTPEFMAPE+YEE YNELVDIYSFGMCILEMVT +YPY+EC +PAQIYKKV SG K
Sbjct: 184 AHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKK 243

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNP---------KDLVCDPL 171
           P +L KV DP+VK FIEKC+   SLR+ A ELL DPFL  D+          +D V    
Sbjct: 244 PDALYKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDLRSVDMEDSVGPLY 303

Query: 172 RLPNLVPEVMNLAHSEP----------HPMD-IDLNHKKVSADSCAKSNTGTWFLT---- 216
           R P+ +P+  N   +            +P +   LN +  +  +        W       
Sbjct: 304 RQPHHLPDYYNYPSNSSSLNRQYSNGNYPSNSSSLNRQYSNGYNSHHEYQNGWAYNPAET 363

Query: 217 -----LEL-----------QRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVF 260
                +EL           ++ + N + T++G++ DD  + L LRI DK G V NI+F F
Sbjct: 364 EETHGIELFESRNNDDQEEEKKSGNVDITIKGKRRDDGGLFLRLRIADKEGRVRNIYFPF 423

Query: 261 YLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNP 305
            +  DTA+S+A EMV +LD+    V  IA +ID  I  LVPSW P
Sbjct: 424 DIETDTALSVATEMVAELDMDDHGVTKIANMIDGEISSLVPSWRP 468

Regulates flowering time by modulating the photoperiod pathway. Phosphorylates APRR3.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8S8Y9|WNK2_ARATH Serine/threonine-protein kinase WNK2 OS=Arabidopsis thaliana GN=WNK2 PE=1 SV=1

 Score =  316 bits (810), Expect = 2e-85,   Method: Compositional matrix adjust.
 Identities = 171/377 (45%), Positives = 231/377 (61%), Gaps = 21/377 (5%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           ++A+K W +QIL+GL YLHS +PPIIHRDLKCDNIF+NGN GEVKIGDLGLA ++++  A
Sbjct: 124 IRAVKQWCKQILKGLLYLHSRSPPIIHRDLKCDNIFINGNQGEVKIGDLGLAAILRKSHA 183

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
              +GTPEFMAPE+Y+EEYNELVD+Y+FGMC+LEMVT +YPY+EC +PAQIYKKVTSG K
Sbjct: 184 VRCVGTPEFMAPEVYDEEYNELVDVYAFGMCVLEMVTFDYPYSECTHPAQIYKKVTSGKK 243

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 180
           P +   V DP+V++F+EKC+   + RL ALELL+DPFL  DN    V  P+   N   E 
Sbjct: 244 PEAFYLVKDPEVREFVEKCLANVTCRLTALELLQDPFLQDDNMDGFVMRPIDYYNGYDET 303

Query: 181 MNLAHSEPHPM-DIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDT 239
                   HP+ D  L H +  +    +       + L      ++ + +++G++N DD 
Sbjct: 304 GVFLR---HPLIDDPLYHDQFESSQICE-------IDLFANDDEDHVDISIKGKRNGDDG 353

Query: 240 VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 299
           + L LRI D  G + NI+F F    DTA S+A EMV +LD++++DV  IAE+ID  I  L
Sbjct: 354 IFLRLRISDAEGRIRNIYFPFETAIDTAWSVAVEMVSELDITNQDVAKIAEMIDAEIAAL 413

Query: 300 VPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASG 359
           VP W      T S QN     +  + G        GE  SN    E VS  G  S     
Sbjct: 414 VPDWK---NDTESSQNVNNNKNNNTAGFC------GECASNGYIQETVS-SGEKSHHNHH 463

Query: 360 KYQYNQESSDSDISAEF 376
           ++  +++ S S +   F
Sbjct: 464 EFDSSEDKSCSSVHGRF 480

Regulates flowering time by modulating the photoperiod pathway. Possesses kinase activity in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q65X23|WNK2_ORYSJ Probable serine/threonine-protein kinase WNK2 OS=Oryza sativa subsp. japonica GN=WNK2 PE=2 SV=1

 Score =  313 bits (802), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 161/313 (51%), Positives = 209/313 (66%), Gaps = 17/313 (5%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-T 59
           ++A+K W+RQIL GL YLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++    +
Sbjct: 128 VRALKKWSRQILSGLVYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLATILDNARS 187

Query: 60  ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
           A S+IGTPEFMAPELY+EEYNELVDIY+FGMC+LE+VT EYPY EC N AQIYKKV+ G 
Sbjct: 188 AHSIIGTPEFMAPELYDEEYNELVDIYAFGMCLLELVTFEYPYCECSNAAQIYKKVSDGE 247

Query: 120 KPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPE 179
           KP+SL+K+ DP+V+ FIEKCI  AS RL A ELL DPFL  D  K  +  PL+      +
Sbjct: 248 KPSSLAKIEDPEVRFFIEKCIAKASQRLSAQELLMDPFLRDDGEK--IFYPLQSNTKASD 305

Query: 180 VMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNE---------FTL 230
               ++S      +   + + ++    + +TG++       R   +            T+
Sbjct: 306 GAGSSNSS-----MGYKYDRDASSMAIREHTGSFAEEHPSDRYIHSTMDPQAAAGRIITV 360

Query: 231 RGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAE 290
             +  D +T+ L LRI D +GH  NIHF F + ADT+IS+A EMV QLDL+ +DV +IAE
Sbjct: 361 ESQMKDLNTIFLKLRIADSTGHAQNIHFPFDIEADTSISVATEMVVQLDLTDQDVTAIAE 420

Query: 291 LIDNLIMKLVPSW 303
           +ID  I   +P W
Sbjct: 421 MIDAEIRAHIPDW 433

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	505
224072272	596	predicted protein [Populus trichocarpa]	0.922	0.781	0.617	1e-152
359474135	645	PREDICTED: serine/threonine-protein kina	0.988	0.773	0.592	1e-148
255555709	585	kinase, putative [Ricinus communis] gi|2	0.912	0.788	0.591	1e-148
224058021	571	predicted protein [Populus trichocarpa]	0.873	0.772	0.598	1e-147
357462359	614	Serine/threonine protein kinase WNK8 [Me	0.976	0.802	0.570	1e-142
449452398	679	PREDICTED: serine/threonine-protein kina	0.964	0.717	0.544	1e-135
351724041	618	with no lysine kinase 8 [Glycine max] gi	0.968	0.791	0.548	1e-132
356547519	618	PREDICTED: serine/threonine-protein kina	0.972	0.794	0.548	1e-131
255564615	693	kinase, putative [Ricinus communis] gi|2	0.990	0.721	0.494	1e-123
225470964	625	PREDICTED: probable serine/threonine-pro	0.966	0.780	0.514	1e-121

>gi|224072272|ref|XP_002303683.1| predicted protein [Populus trichocarpa] gi|222841115|gb|EEE78662.1| predicted protein [Populus trichocarpa]

 Score =  546 bits (1407), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 308/499 (61%), Positives = 361/499 (72%), Gaps = 33/499 (6%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           MKAIKNWARQILRGLHYLH+H+PPIIHRDLKCDNIFVNGN GEVKIGDLGLAIVMQQP A
Sbjct: 124 MKAIKNWARQILRGLHYLHTHSPPIIHRDLKCDNIFVNGNTGEVKIGDLGLAIVMQQPIA 183

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           RSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY+ECKNPAQIYKKV+SGIK
Sbjct: 184 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYSECKNPAQIYKKVSSGIK 243

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 180
           PASL KV+D QVK FIEKC+VPAS RLPA+ELLKDPFL T+N K+LV   L+LPNL+   
Sbjct: 244 PASLGKVSDHQVKVFIEKCLVPASTRLPAIELLKDPFLATENSKELVSSSLQLPNLISRQ 303

Query: 181 MNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGEKNDDDT 239
           ++L  SE H MDID   KK+S  SC KS N    F TLEL R TENNEF LRG KN+D+T
Sbjct: 304 VHLLQSESHLMDIDC--KKLSVGSCTKSINESPQFSTLELSRFTENNEFRLRGAKNNDNT 361

Query: 240 VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 299
           VSLTLRI D  G   NIHF FYL++DTA+ IAEEMVEQLDL  EDV  IAELIDNLI KL
Sbjct: 362 VSLTLRIADPCGRARNIHFTFYLDSDTAVLIAEEMVEQLDLLTEDVAVIAELIDNLIAKL 421

Query: 300 VPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASG 359
           VPSWN                SP  +  S  L+       N++ +EAV +   L  L + 
Sbjct: 422 VPSWNT---------------SPSVRNGSSELE-------NHSTSEAVKKPDFLP-LTNM 458

Query: 360 KYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGES 419
                ++S +SDISAE+++ +  D+  +KSL          +YD    E    E  + + 
Sbjct: 459 TDLETKQSVNSDISAEYNMAIASDSGTNKSLGSSDCCLQSNMYD---LEFGMLEDGISK- 514

Query: 420 ILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQ 479
              N+ST+NS  S+I S SGMS+N S SSI SLSLADK+ S+ LK ELD+I+S Y QC Q
Sbjct: 515 --HNKSTRNSNDSYIGSFSGMSRNASMSSICSLSLADKDGSE-LKQELDSIDSHYNQCLQ 571

Query: 480 ELLRQREDEMENARKRWLA 498
           EL++ RE+ +ENA+KR + 
Sbjct: 572 ELMKMREEAIENAKKRGIT 590

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359474135|ref|XP_002273005.2| PREDICTED: serine/threonine-protein kinase WNK8-like [Vitis vinifera]

 Score =  531 bits (1368), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 307/518 (59%), Positives = 372/518 (71%), Gaps = 19/518 (3%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           +KAIKNWA+QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA
Sbjct: 123 LKAIKNWAKQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 182

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILE+VTCEYPYNECKNPAQIYKKV+SGIK
Sbjct: 183 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILELVTCEYPYNECKNPAQIYKKVSSGIK 242

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVC------DPLRLP 174
           PASL KV+DPQVKQFIEKC+VPASLRL A ELLKD F  T+N K+ V       D L+  
Sbjct: 243 PASLGKVSDPQVKQFIEKCLVPASLRLSAQELLKDAFFATENSKEPVYNHMHVDDSLQSS 302

Query: 175 NLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGT-WFLTLELQRLTENNEFTLRGE 233
           N +P +MNL   E  PMD+D N+KK+S  +  KS +GT  F  L+ +R  +NN F LRGE
Sbjct: 303 NFMPNLMNLPKPELQPMDMDPNYKKLSVSTHMKSISGTPHFRALQFERFNKNNLFKLRGE 362

Query: 234 KNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELID 293
           K DD+++S+TL I D  G   NIHF FYL++DTA+SIA EMVEQLDL +EDV  IAELID
Sbjct: 363 KIDDNSISMTLHIADPCGRAKNIHFAFYLDSDTALSIAGEMVEQLDLYNEDVAVIAELID 422

Query: 294 NLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVL 353
            +I +LVP+W P+  S     N   + S V      SL+ P + GS    ++AV++  ++
Sbjct: 423 VMISELVPTWKPAFESMLCGANSSCEDSLVLHNGGTSLRHPSDSGSAKGTSDAVTEH-LI 481

Query: 354 SELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSL-VPDG----------YSAHYAVY 402
           S  A+G+ Q   ES+ S +S + D  V  DA+  KSL  PD           ++    V 
Sbjct: 482 SLSANGEEQSTVESALSGMSTKDDATVASDANDIKSLECPDDECYEASDRCCFNGDRQVL 541

Query: 403 DHGGHEVKADEVSLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDG 462
           DH  H+      ++GE +  N  T++ E S I+SCSGMS +LS SSI SLSLADK+ SD 
Sbjct: 542 DHERHKEGRYNGNIGEPVAMNGFTKDWEISCIESCSGMSNSLSLSSICSLSLADKDPSDE 601

Query: 463 LKLELDAINSKYQQCFQELLRQREDEMENARKRWLAGS 500
           LKLE+D I+++Y QCFQELLR RE+ +E A+ RW+  S
Sbjct: 602 LKLEVDTIDTQYHQCFQELLRMREEAIEKAKNRWITKS 639

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255555709|ref|XP_002518890.1| kinase, putative [Ricinus communis] gi|223541877|gb|EEF43423.1| kinase, putative [Ricinus communis]

 Score =  530 bits (1365), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 300/507 (59%), Positives = 351/507 (69%), Gaps = 46/507 (9%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           +KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN+FVNGNNGEVKIGDLGLA VMQQPTA
Sbjct: 123 IKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNVFVNGNNGEVKIGDLGLATVMQQPTA 182

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPY+ECKNPAQIYKKVTSGIK
Sbjct: 183 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYSECKNPAQIYKKVTSGIK 242

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 180
           PASL KV DP VK+FIEKCIVPAS+RLPALELLKDPFL T+NPK+LV   L LP+L+ + 
Sbjct: 243 PASLCKVNDPLVKRFIEKCIVPASMRLPALELLKDPFLATENPKELVFASLHLPDLMLKQ 302

Query: 181 MNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGEKNDDDT 239
           ++   SE +PMDID NHKK+S  SC KS +    F T E QRLT  NEF LRGEKNDD+T
Sbjct: 303 VSRGQSESYPMDIDSNHKKLSVGSCTKSMDESLHFSTSEFQRLTVKNEFRLRGEKNDDNT 362

Query: 240 VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 299
           +SLTLRI D+ G V NIHF FYL++DT +SIAEEMVEQLDLS+EDV  IAELID LI+KL
Sbjct: 363 ISLTLRIVDRCGGVKNIHFTFYLDSDTTLSIAEEMVEQLDLSNEDVAIIAELIDALILKL 422

Query: 300 VPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASG 359
           VP  + S GST+S  NG                       N+A  +  S+   L  LA  
Sbjct: 423 VPHLSQS-GSTSSMPNGF------------------SELHNDATFKVASKHDFLP-LADL 462

Query: 360 KYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGES 419
           K Q  Q+S  S++S E  + V  DA  +K L    Y+  +  Y+ G     +D +  G+ 
Sbjct: 463 KGQETQDSLLSELSTELPLTVASDASTNKPLGSSDYTIDFNTYEFG-----SDFMMHGDG 517

Query: 420 IL-FNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCF 478
              + + T++SE                     L  A  E  D LKLELDAI+ +Y QCF
Sbjct: 518 TFKYGKYTKHSE-------------------KHLPSAKGEVQDDLKLELDAIDMQYNQCF 558

Query: 479 QELLRQREDEMENARKRWLAGSNVSVI 505
           +EL   RE+ +ENA+K+W+    V  I
Sbjct: 559 RELSMMREEAIENAKKKWITRKKVPAI 585

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224058021|ref|XP_002299436.1| predicted protein [Populus trichocarpa] gi|222846694|gb|EEE84241.1| predicted protein [Populus trichocarpa]

 Score =  528 bits (1361), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 299/500 (59%), Positives = 351/500 (70%), Gaps = 59/500 (11%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           MKAIKNWARQILRGL YLH+ +P IIHRDLKCDNI VNGNNGEVKIGDLGLAIVMQQP A
Sbjct: 124 MKAIKNWARQILRGLQYLHTRSPRIIHRDLKCDNILVNGNNGEVKIGDLGLAIVMQQPIA 183

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           RSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY+ECKNPAQIYKKVTSGIK
Sbjct: 184 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYSECKNPAQIYKKVTSGIK 243

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 180
           PASL KV D QVK+FIEKC+VPAS+RL A++LLKDPFL T+N K++V    +LPN++ + 
Sbjct: 244 PASLVKVNDLQVKEFIEKCLVPASVRLSAIDLLKDPFLATENSKEVVSSLSQLPNVICKQ 303

Query: 181 MNLAHSEPHPMDIDLNHKKVSADSCAKS-NTGTWFLTLELQRLTENNEFTLRGEKNDDDT 239
           ++L  SE H MDID   K +S  SC KS N    FLTLEL+R TENNEF LR EKNDD+T
Sbjct: 304 VHLPQSESHHMDIDC--KMLSLGSCPKSINESPQFLTLELRRFTENNEFRLRAEKNDDNT 361

Query: 240 VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 299
           VSLTLRI D  G   NIHF FYLN+DTA+SIAEEMVEQLDLS EDV  IAELID+LI+KL
Sbjct: 362 VSLTLRIADPCGRARNIHFTFYLNSDTAVSIAEEMVEQLDLSSEDVAVIAELIDSLIVKL 421

Query: 300 VPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPG-EPGSNNAFAEAVSQQGVLSELAS 358
           VP WN S    +S +NG       +   S + K P   P +N    EA+           
Sbjct: 422 VPCWNTS----SSVRNG--SSELENHATSETGKTPDFSPLTNITDHEAL----------- 464

Query: 359 GKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGE 418
                  +S +SDISAE+++ +  DA  +KSL     S    V+                
Sbjct: 465 -------QSVNSDISAEYNMAIASDASTNKSLGSSSCSLQSNVF---------------- 501

Query: 419 SILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCF 478
                          IDSCSGMS+N S S I SL LADK+ S+ LKLELD+I+S Y QCF
Sbjct: 502 --------------HIDSCSGMSRNASLSIICSLFLADKDGSE-LKLELDSIDSHYNQCF 546

Query: 479 QELLRQREDEMENARKRWLA 498
           QEL++ RE+ +ENA++RW++
Sbjct: 547 QELMKTREEAIENAKRRWIS 566

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357462359|ref|XP_003601461.1| Serine/threonine protein kinase WNK8 [Medicago truncatula] gi|355490509|gb|AES71712.1| Serine/threonine protein kinase WNK8 [Medicago truncatula]

 Score =  511 bits (1317), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 289/507 (57%), Positives = 355/507 (70%), Gaps = 14/507 (2%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           MKAIKNWARQILRGL +LHSHNPP+IHRDLKCDNIFVNGNNG+VKIGDLGLAIVMQQPTA
Sbjct: 120 MKAIKNWARQILRGLCFLHSHNPPVIHRDLKCDNIFVNGNNGQVKIGDLGLAIVMQQPTA 179

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           RSVIGTPEFMAPELYEEEYNELVD+YSFGMCILEM+TCEYPY+ECKNPAQIYKKVTSGIK
Sbjct: 180 RSVIGTPEFMAPELYEEEYNELVDVYSFGMCILEMITCEYPYSECKNPAQIYKKVTSGIK 239

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 180
           PASL++V DP+VKQFIEKC+VPAS+RLPA ELLKDPFL T N K++  D L LPN   + 
Sbjct: 240 PASLARVNDPEVKQFIEKCLVPASMRLPASELLKDPFLATGNTKEIYHDNLLLPNPPSKS 299

Query: 181 MNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTL--ELQRLTENNEFTLRGEKNDDD 238
           +N    EPHPM+ID N K  S  S  + +  T  ++   ++ R TENNEF LRGEKN D 
Sbjct: 300 LNPPTCEPHPMEIDSNVKHTSPASTVERDKETSQVSSNHDILRKTENNEFRLRGEKNADR 359

Query: 239 TVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMK 298
           T+SLTLRI D +G   NIHF FY+++DT ISIAEEMVE L+L  EDV  IAELI N+I K
Sbjct: 360 TISLTLRIADANGGARNIHFPFYIDSDTTISIAEEMVEHLELKDEDVAVIAELIHNMIFK 419

Query: 299 LVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELAS 358
           LVP W P L   +S  + L +  P+   N   L C    GSNN   +++ +    S+L  
Sbjct: 420 LVPDWKP-LCENSSGTDNLYR--PLEPQNE-QLNCHWTLGSNNFDMKSMYEDLGHSQL-D 474

Query: 359 GKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGE 418
           G+ Q  QES  SDISAE+   +  DA   K +  + +  H       G     D    G+
Sbjct: 475 GEDQDKQESVSSDISAEYGTVIATDA---KGVEQNCFILHECCKGSNGLNTNPDVRICGQ 531

Query: 419 SILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCF 478
               + ++  SE S +  CS  S+NL   S  SL+  D++H D L+LE++AI  +YQQ F
Sbjct: 532 E---DGNSNQSENSVVSCCSP-SENLDRLSKCSLTALDQDHLDELQLEIEAIEIQYQQSF 587

Query: 479 QELLRQREDEMENARKRWLAGSNVSVI 505
           +EL++ RE+ +EN +KRW +  N+SV+
Sbjct: 588 RELMKMREEAIENVKKRWTSKKNISVM 614

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452398|ref|XP_004143946.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Cucumis sativus] gi|449529646|ref|XP_004171809.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Cucumis sativus]

 Score =  488 bits (1257), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 284/522 (54%), Positives = 348/522 (66%), Gaps = 35/522 (6%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           +KA KNWARQILRGL YLH HNPPIIHRDLKCDNIFVNGN GEVKIGDLGLAIVMQQPTA
Sbjct: 176 LKAFKNWARQILRGLTYLHGHNPPIIHRDLKCDNIFVNGNTGEVKIGDLGLAIVMQQPTA 235

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           RSVIGTPEFMAPELY+E+YNELVDIYSFGMC+LE+VTCEYPYNECKN AQI+KKVTSGIK
Sbjct: 236 RSVIGTPEFMAPELYDEDYNELVDIYSFGMCMLEIVTCEYPYNECKNSAQIFKKVTSGIK 295

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 180
           PASL KV DPQVKQFIEKC+VPAS RLPA ELLKDPFL  ++PKD   +  R  N   + 
Sbjct: 296 PASLEKVLDPQVKQFIEKCLVPASTRLPASELLKDPFLAAESPKDNSSELSRSLNEHFKS 355

Query: 181 MNLAHSEPHPMDIDLNHKKVSAD--SCAKSNTG-TWFLTLELQRLTENNEFTLRGEKNDD 237
           +N      HPM+ D N  K+S    S  KSN G + F T ELQRLTENNE TL+G+  D 
Sbjct: 356 VNPPLLGSHPMETDHNCTKLSGSVASSVKSNNGISHFSTQELQRLTENNELTLKGDMTDH 415

Query: 238 DTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIM 297
           +T+S  LRI +  G   NIHF FYL++DT+++IA EMVEQL+LS+ED   IA+LID LI 
Sbjct: 416 NTMSFHLRIAELYGKSRNIHFAFYLDSDTSLAIALEMVEQLELSNEDATIIAKLIDELIA 475

Query: 298 KLVPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAV-------SQQ 350
           K VPSW P       QQ      SP +Q +   +        +  F+E V       + +
Sbjct: 476 KFVPSWKPCPNYCEEQQQN-TPHSPEAQEDKTFI--------SPFFSELVLSSPMVAAAR 526

Query: 351 GVLSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLV------PDGYSAHYAVYDH 404
             L+ LA  + Q NQ+S  S  S E+    + D  I K         PD   A+ +    
Sbjct: 527 NNLTGLAKVEDQENQQSIISCASVEYIYSTVSDYSIGKGSECGEFGHPDCEKAYIS---S 583

Query: 405 GGHEVKADEV-SLGESILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGL 463
           G  ++ A+ V SL  +I F      ++ S I SCS MSK LS SS S+LS+ +++H D L
Sbjct: 584 GTIDLDAEAVGSLSTTIDF------AKPSLISSCSEMSKELSLSSFSTLSMEERDHQDEL 637

Query: 464 KLELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSVI 505
           K+E+DAI+ +Y QC  EL R RE+ +E+A+KRW++    + I
Sbjct: 638 KMEIDAIDLQYHQCLCELSRMREEAIESAKKRWMSKKKATGI 679

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351724041|ref|NP_001236020.1| with no lysine kinase 8 [Glycine max] gi|225348645|gb|ACN87284.1| with no lysine kinase [Glycine max]

 Score =  479 bits (1234), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 272/496 (54%), Positives = 348/496 (70%), Gaps = 7/496 (1%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           MKAIKNWARQILRGL +LHS +PPI+HRDLKCDNIFVNGN+G VKIGDLGLAIVMQQPTA
Sbjct: 116 MKAIKNWARQILRGLCFLHSQSPPIVHRDLKCDNIFVNGNSGLVKIGDLGLAIVMQQPTA 175

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPY+ECKNPAQIYKKVTSGIK
Sbjct: 176 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYSECKNPAQIYKKVTSGIK 235

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 180
           PA+L+KV DP+VKQFIEKC+VPAS+RL A ELLKDPFL T+N K++  D L+LPN   ++
Sbjct: 236 PAALAKVNDPEVKQFIEKCLVPASMRLSASELLKDPFLATENTKEINHDTLQLPNPHIKL 295

Query: 181 MNLAHSEPHPMDIDLNHKKVS-ADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDT 239
           +NL   EPHPM+ID   ++ S   S  +    +     +L R+T+NN+  LRGEKN + T
Sbjct: 296 VNLPKCEPHPMEIDSYSRRTSPGSSMGRIEETSQVSFFDLVRMTDNNKLMLRGEKNAEST 355

Query: 240 VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 299
           +SLTLRI D  G   NIHF FY+++DTAISIAEEMVE L+L++EDV  IAELI+++I KL
Sbjct: 356 ISLTLRIPDACGGARNIHFPFYMDSDTAISIAEEMVEHLELTNEDVSVIAELINDMIAKL 415

Query: 300 VPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASG 359
           VP+  P     +S+ N L + S   Q N     C     S++   +A+ +  V S    G
Sbjct: 416 VPNSKPLCEKLSSETNLLYRPSSEVQ-NGEQFNCHWPLQSSDYDMKAMYKDLVHSRPVDG 474

Query: 360 KYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGES 419
             Q  QES  SDISA   + +  D+   K + PD +   +  +  G     +D    G+ 
Sbjct: 475 DDQEKQESVMSDISAACGITIASDS---KVVEPDIFI--FDEFWEGFFNSTSDIRFCGQE 529

Query: 420 ILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQ 479
                 ++NS  S I+SC    KN   SSI SL+LADK+ S+GL+L+++AI++ + + F 
Sbjct: 530 DGHKNQSENSVGSLINSCCCPFKNFDMSSICSLTLADKDPSEGLRLDIEAIDTYFDRRFL 589

Query: 480 ELLRQREDEMENARKR 495
           EL   R++ +++A++R
Sbjct: 590 ELEMMRQEAIKSAKRR 605

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356547519|ref|XP_003542159.1| PREDICTED: serine/threonine-protein kinase WNK8-like [Glycine max]

 Score =  475 bits (1222), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 272/496 (54%), Positives = 339/496 (68%), Gaps = 5/496 (1%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           MKAIKNWARQILRGL +LH H+PPI+HRDLKCDNIFVNGN+G VKIGDLGLAIVMQQPTA
Sbjct: 116 MKAIKNWARQILRGLCFLHCHSPPIVHRDLKCDNIFVNGNSGLVKIGDLGLAIVMQQPTA 175

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPY+EC NPAQIYKKVTSGIK
Sbjct: 176 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYSECNNPAQIYKKVTSGIK 235

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 180
           PA+L+KV DP+VKQFIEKC+VPAS+RL A ELLKDPFL T+N K++  D L LPN   ++
Sbjct: 236 PAALAKVNDPEVKQFIEKCLVPASMRLSASELLKDPFLATENTKEINHDILELPNPHTKL 295

Query: 181 MNLAHSEPHPMDIDLNHKKVS-ADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDT 239
           +N    EPHPM+ID   ++ S   S  +    +     +L R+TENN+F LRGEKN + T
Sbjct: 296 VNPPTCEPHPMEIDSKSRRTSPGSSMGRIEETSQVSFFDLVRMTENNKFMLRGEKNAEST 355

Query: 240 VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 299
           +SLTLRI +  G   NIHF FY+N+DTAISIAEEMVE L+L++EDV  IAELI+++I KL
Sbjct: 356 ISLTLRIANACGGARNIHFPFYINSDTAISIAEEMVEHLELTNEDVSVIAELINDMIAKL 415

Query: 300 VPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLSELASG 359
           VP+  P     +S  + L + S   Q N     C     S++   + V +  V S    G
Sbjct: 416 VPNLKPLSEKLSSGTDQLYRPSSEVQ-NGEQFNCHWPLQSSDYDMKPVFKDLVHSWPVDG 474

Query: 360 KYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGGHEVKADEVSLGES 419
                QES  SDIS E  + V  D+   K + PD +               +D    G+ 
Sbjct: 475 DDLEKQESVMSDISVECGITVASDS---KVVEPDIFIFDEFWEGFDAFNSTSDVRFCGQE 531

Query: 420 ILFNESTQNSETSFIDSCSGMSKNLSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQ 479
                 ++NS  S I+SC    KN   SSI SL+LADK+ S+GL+LE++AI++ ++Q F+
Sbjct: 532 DGHKNQSENSSGSLINSCCCPFKNFDISSICSLTLADKDPSEGLRLEIEAIDTYFEQRFR 591

Query: 480 ELLRQREDEMENARKR 495
           EL   R   +E+ ++R
Sbjct: 592 ELEMMRVAAIESLKRR 607

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255564615|ref|XP_002523302.1| kinase, putative [Ricinus communis] gi|223537390|gb|EEF39018.1| kinase, putative [Ricinus communis]

 Score =  448 bits (1152), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 272/550 (49%), Positives = 348/550 (63%), Gaps = 50/550 (9%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           MKAIKNWARQIL+GL YLH HNPPIIHRDLKCDNIFVNG+NG VKIGDLGLAI+MQQPTA
Sbjct: 141 MKAIKNWARQILQGLVYLHGHNPPIIHRDLKCDNIFVNGHNGVVKIGDLGLAIIMQQPTA 200

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
            SVIGTPEFMA ELYEEEYNEL+DIYSFGMC+LEMVT EYPY+EC+NPAQIYKKVTSGIK
Sbjct: 201 TSVIGTPEFMATELYEEEYNELIDIYSFGMCMLEMVTFEYPYSECRNPAQIYKKVTSGIK 260

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 180
           PASL  V+DPQVK+FI KC+VPAS RL A ELLKDPFL   N  + V DPL LPN  P+ 
Sbjct: 261 PASLGNVSDPQVKEFILKCLVPASERLSAKELLKDPFLQPQNLVEPVRDPLLLPNQYPKS 320

Query: 181 MNLAHSEPHPMDIDLNHKKVSADSCAKSNT-GTWFLTLELQRLTENNEFTLRGEKNDDDT 239
            +   S P  MDID ++K++S+ +C  SN  GT F   E QR  +N  F L+G+++DD++
Sbjct: 321 SSATKSGPLSMDIDADYKQISSSTCTGSNNEGTRFPVPEYQREHKNKVFKLKGKESDDNS 380

Query: 240 VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 299
           VSLTLRI D SG V NIHF+FYL++DTA+S+A EMV+QL+L+  DV  IAE ID+LIMKL
Sbjct: 381 VSLTLRIADSSGRVWNIHFLFYLDSDTALSVASEMVDQLELADHDVAFIAEFIDHLIMKL 440

Query: 300 VPSWNPSLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNAFAEAVSQQGVLS----- 354
            P W  S   + ++       S   +    S+ CP +       ++   +Q  LS     
Sbjct: 441 SPGWKLSSNYSLNELTSFYTASAALEN---SVACPWDSVLTTVLSQPAVEQEALSGMTTT 497

Query: 355 ----ELASGKYQYN--------------------QESSDSDISAEFDVPVILDAHIDKSL 390
                L +  + YN                     E  DS  S   ++ V   +  D  +
Sbjct: 498 PPEGSLQADDFNYNDNRDGAVFHINYHSSPSFGYMEDQDSQTSGVSEILVEDVSSKDDRI 557

Query: 391 --VPD-----------GYSAHYAVYD-HGGHEVKADEVSLGESILFNESTQNSETSFIDS 436
             +PD           GY++   + D +   +++ ++  +GE I  NE+ + SET F   
Sbjct: 558 SELPDYNTDGNCKYLNGYTSEPELRDSYSLRKLERNDSGVGECIPMNENAKVSETPF-PK 616

Query: 437 CSGMSKN--LSFSSISSLSLADKEHSDGLKLELDAINSKYQQCFQELLRQREDEMENARK 494
            SG   +  ++ SS SSL L  K     LKLELDAI ++YQ  F++L R+RE+ +E+ +K
Sbjct: 617 LSGAPNDMSMTSSSSSSLYLVGKSMDTELKLELDAIEAQYQNWFRDLSRRREEALESTKK 676

Query: 495 RWLAGSNVSV 504
           RW A   + V
Sbjct: 677 RWTAKKKLPV 686

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225470964|ref|XP_002266888.1| PREDICTED: probable serine/threonine-protein kinase WNK4-like [Vitis vinifera]

 Score =  441 bits (1135), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 267/519 (51%), Positives = 334/519 (64%), Gaps = 31/519 (5%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           MKAIKNWARQ+LRGL YLHSHNPPIIHRDLKCDNIFVNGN+GEVKIGDLGLAIVMQQPTA
Sbjct: 122 MKAIKNWARQVLRGLVYLHSHNPPIIHRDLKCDNIFVNGNHGEVKIGDLGLAIVMQQPTA 181

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           RSVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVT EYPYNECKNPAQIYKKVTSGIK
Sbjct: 182 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTFEYPYNECKNPAQIYKKVTSGIK 241

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 180
           PASL KVTD Q+K+FI KC+ PAS RLPA ELLKDPF  ++NPK+ +  PL+LP+  P+ 
Sbjct: 242 PASLCKVTDLQIKEFIVKCLAPASERLPAKELLKDPFFQSENPKEPIRVPLQLPSRSPKS 301

Query: 181 MNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTV 240
           + L+ S P  MDID +H ++S+ +  ++N    F  LE QR+ +++EF LR +K +D+++
Sbjct: 302 IILSKSGPFSMDIDPDHPQLSSSTSTENNGSPDFPVLEFQRMYKSSEFRLRAKKINDNSI 361

Query: 241 SLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLV 300
           SLTLR  D  G V NIHF F L+ DT  S+  EMVEQL+L+  +V  IA+ ID +IM+L+
Sbjct: 362 SLTLRTVDSYGPVKNIHFPFSLDTDTVHSVVGEMVEQLELAEHEVAFIADFIDYVIMRLL 421

Query: 301 PSWNP----SLGSTASQQNGLLKGSPVSQGNSISLKCPGEPGSNNA---FAEAVSQQGV- 352
           P W P     LG   S         P   GN  +  C    G  N+    A A  Q  + 
Sbjct: 422 PGWKPPRDDPLGGARSPN-----AEPPVLGNGNNHDCTISHGDGNSSPNLANAEDQDSLA 476

Query: 353 ------LSELASGKYQYNQESSDSDISAEFDVPVILDAHIDKSLVPDGYSAHYAVYDHGG 406
                 L+  AS K        D +I   +        H  +    D Y        H  
Sbjct: 477 SAGLVTLTVDASKKNDKTVGFGDYNIGGNYKGSN--GGHASEQESRDPY--------HED 526

Query: 407 HEVKADEVSLGESILFNESTQNSETSFIDSCSGMSK-NLSFSSISSLSLADKEHSDGLKL 465
           ++++ +  S+ E    N+  +++  SF D  SG+S       S SSLSLAD +   GLK 
Sbjct: 527 YKLQRNNSSIEEFTPMNKFQKSTVLSF-DDLSGLSNVRSLTCSCSSLSLADIDQDPGLKQ 585

Query: 466 ELDAINSKYQQCFQELLRQREDEMENARKRWLAGSNVSV 504
           ELDAI+ +YQ  FQEL R R + +E  +KRW+    ++V
Sbjct: 586 ELDAIDLQYQHWFQELSRMRVEALEATKKRWMTKKKLAV 624

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	505
TAIR|locus:2165790	563	WNK8 "with no lysine (K) kinas	0.580	0.520	0.662	5.7e-115
TAIR|locus:2019404	524	WNK10 "with no lysine (K) kina	0.732	0.706	0.549	4.2e-95
TAIR|locus:2093994	567	WNK6 "with no lysine (K) kinas	0.592	0.527	0.584	4.8e-95
TAIR|locus:2028521	557	WNK7 [Arabidopsis thaliana (ta	0.590	0.535	0.587	9.6e-89
TAIR|locus:2114845	700	WNK1 "with no lysine (K) kinas	0.328	0.237	0.712	1.4e-84
TAIR|locus:504955638	516	WNK3 "with no lysine (K) kinas	0.312	0.306	0.735	9.5e-80
TAIR|locus:2098242	549	WNK5 "with no lysine (K) kinas	0.358	0.329	0.645	1.1e-74
TAIR|locus:2182039	492	WNK9 [Arabidopsis thaliana (ta	0.607	0.623	0.485	1.2e-74
TAIR|locus:2161278	571	WNK4 "with no lysine (K) kinas	0.318	0.281	0.654	2.9e-68
MGI|MGI:2652875	1757	Wnk3 "WNK lysine deficient pro	0.316	0.091	0.645	6.4e-61

TAIR|locus:2165790 WNK8 "with no lysine (K) kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1002 (357.8 bits), Expect = 5.7e-115, Sum P(3) = 5.7e-115
 Identities = 198/299 (66%), Positives = 230/299 (76%)

Query:     2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
             KAIKNWARQIL+GL+YLHS NPP+IHRDLKCDNIFVNGN GEVKIGDLGLA V+QQPTAR
Sbjct:   130 KAIKNWARQILKGLNYLHSQNPPVIHRDLKCDNIFVNGNTGEVKIGDLGLATVLQQPTAR 189

Query:    62 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             SVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPYNEC+N AQIYKKVTS IKP
Sbjct:   190 SVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYNECRNQAQIYKKVTSNIKP 249

Query:   122 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVM 181
              SL KV DPQV+QFIEKC++PAS R  ALEL KDPFL  D  KD     L   +   + +
Sbjct:   250 QSLGKVDDPQVRQFIEKCLLPASSRPTALELSKDPFLARDGGKDSAL--LASSSTSSKYV 307

Query:   182 NLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDTVS 241
                  E  PMD+D N  K    S + +    W  T+ELQR+ EN EF LRGE++DD T S
Sbjct:   308 RPPQLEHLPMDVDHNENK----SVSSNEDYPWSQTIELQRIAENKEFRLRGERSDDVTAS 363

Query:   242 LTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLV 300
             + LRI D SG    +HF FYL +DTA +IAEEMVE+L L+ ++VV IA++ID+ IM+L+
Sbjct:   364 MVLRIADPSGKCRIVHFAFYLESDTATAIAEEMVEELHLTSQEVVVIADMIDDFIMQLL 422

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0006468 "protein phosphorylation" evidence=IDA;TAS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0048573 "photoperiodism, flowering" evidence=IMP

GO:0005634 "nucleus" evidence=IDA

GO:0009911 "positive regulation of flower development" evidence=IMP

GO:0010228 "vegetative to reproductive phase transition of meristem" evidence=RCA;IMP

GO:0009909 "regulation of flower development" evidence=IMP

GO:0006865 "amino acid transport" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0016926 "protein desumoylation" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0050665 "hydrogen peroxide biosynthetic process" evidence=RCA

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2019404 WNK10 "with no lysine (K) kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 946 (338.1 bits), Expect = 4.2e-95, P = 4.2e-95
 Identities = 211/384 (54%), Positives = 247/384 (64%)

Query:     2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
             KAI NWARQIL+GLHYLHS  PP+IHRDLKCDNIFVNGN G+VKIGDLGLA VMQQPTAR
Sbjct:   117 KAIMNWARQILKGLHYLHSQTPPVIHRDLKCDNIFVNGNTGKVKIGDLGLAAVMQQPTAR 176

Query:    62 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             SVIGTPEFMAPELYEEEYNELVDIYSFGMC+LEMVTCEYPY EC+N AQIYKKVTSGIKP
Sbjct:   177 SVIGTPEFMAPELYEEEYNELVDIYSFGMCMLEMVTCEYPYRECRNQAQIYKKVTSGIKP 236

Query:   122 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVM 181
              SLSKV DPQVKQFIEKC++PA  R  ALELLKD  L  D  KD            P + 
Sbjct:   237 QSLSKVDDPQVKQFIEKCLLPAPSRPTALELLKDQLLAVDGAKDSTLTASSNTTFKPAMP 296

Query:   182 NLAHSEPHPMDIDLN-HKKVSADSCAKSNTGTWFL-TLELQRLTENNEFTLRGEKNDDDT 239
                  E  PMD++   +  VS  S AKS+     L T+E+QR+ E+ EF L GE+ DD  
Sbjct:   297 --PQCEYRPMDVEYKKNTSVSICSSAKSSQECALLQTMEVQRVAESTEFKLSGERRDDVA 354

Query:   240 VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL 299
              S+ LRI   SG    + F F L  DTA ++  EMVE+LDLS  +V  IAE+ID LIMKL
Sbjct:   355 ASMALRIAGSSGQARKVDFDFNLKTDTARAVTGEMVEELDLSSHEVTVIAEMIDELIMKL 414

Query:   300 VPSWNPSLGSTASQQNGLLKGSPVSQGNSISL----KCPGEPGSN-NAFAEAVSQQGVLS 354
                 N SL +  S      + +  S  + IS     +     GS      EAV  + +LS
Sbjct:   415 KA--NRSLPNANSVYQSKDEEAGESMKSEISADYYHRVSSNEGSRLGCCCEAV--ESLLS 470

Query:   355 ELASGKYQYNQESSDSDISAEFDV 378
                      + + S+ D+  E +V
Sbjct:   471 SFLDSCSMVSNKQSE-DLKTELNV 493

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0003700 "sequence-specific DNA binding transcription factor activity" evidence=ISS

TAIR|locus:2093994 WNK6 "with no lysine (K) kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 899 (321.5 bits), Expect = 4.8e-95, Sum P(2) = 4.8e-95
 Identities = 184/315 (58%), Positives = 230/315 (73%)

Query:     1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
             MKA+KNWARQIL GL YLH   PPIIHRDLKCDNIF+NGN+GEVKIGDLGLA VM+Q  A
Sbjct:   128 MKAVKNWARQILMGLRYLHGQEPPIIHRDLKCDNIFINGNHGEVKIGDLGLATVMEQANA 187

Query:    61 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
             +SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVT +YPY ECKN AQIYKKV+SGIK
Sbjct:   188 KSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFDYPYCECKNSAQIYKKVSSGIK 247

Query:   121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV-PE 179
             PASLS+V DP+VKQFIEKC++PAS RL A ELL DPFL  +     + +PL LP++V P+
Sbjct:   248 PASLSRVKDPEVKQFIEKCLLPASERLSAKELLLDPFLQLNGLT--MNNPLPLPDIVMPK 305

Query:   180 --------VMNLAHSEPHP---MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEF 228
                     +M+       P   + IDL+            N+G+    +E++R    N F
Sbjct:   306 EGAFGDRCLMSEGPPTTRPSKTLSIDLDEDSNLPIVTFSDNSGS--RCIEVRRAKRGNFF 363

Query:   229 TLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSI 288
              L+GE+ND+ +VSL LRI D++G V NIHF+FY   DTA  ++ EMVEQL+L+ ++V  I
Sbjct:   364 VLKGEENDEQSVSLILRIVDENGRVRNIHFLFYQEGDTASKVSSEMVEQLELTDQNVTFI 423

Query:   289 AELIDNLIMKLVPSW 303
             AELID L++ ++P+W
Sbjct:   424 AELIDILLVNMIPTW 438

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2028521 WNK7 [Arabidopsis thaliana (taxid:3702)]

 Score = 886 (316.9 bits), Expect = 9.6e-89, P = 9.6e-89
 Identities = 185/315 (58%), Positives = 234/315 (74%)

Query:     1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
             MKA+K WARQIL GL YLHS +PPIIHRD+KCDNIF+NGN+GEVKIGDLGLA VM+Q  A
Sbjct:   128 MKAVKCWARQILTGLKYLHSQDPPIIHRDIKCDNIFINGNHGEVKIGDLGLATVMEQANA 187

Query:    61 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
             +SVIGTPEFMAPELY+E YNEL DIYSFGMC+LEMVT EYPY EC+N AQIYKKV+SGIK
Sbjct:   188 KSVIGTPEFMAPELYDENYNELADIYSFGMCMLEMVTFEYPYCECRNSAQIYKKVSSGIK 247

Query:   121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD-PLRLPNLV-P 178
             PASLSKV DP+V +FIEKC++PAS RL A ELL D FL   N   LV + PL LP++V P
Sbjct:   248 PASLSKVKDPEVMKFIEKCLLPASERLSAEELLLDSFL---NVNGLVMNNPLPLPDIVMP 304

Query:   179 EVMNLAH----SEPHP------MDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEF 228
             +  +       SE  P      M ++L+         + +N+GT    +E++R    N F
Sbjct:   305 KEGSFGERCLMSEGPPNARNRTMSMNLDEDNNLPIVISSNNSGT--NCIEVRRAKRGNFF 362

Query:   229 TLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSI 288
              L+GE+ND+++VSL LRI D++G V NIHF+F+   DTA +++ EMVEQL+L+ ++V  I
Sbjct:   363 VLKGEENDENSVSLILRIVDENGRVRNIHFLFFQEGDTASNVSSEMVEQLELTDKNVKFI 422

Query:   289 AELIDNLIMKLVPSW 303
             AELID L++ L+P+W
Sbjct:   423 AELIDVLLVNLIPNW 437

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2114845 WNK1 "with no lysine (K) kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 638 (229.6 bits), Expect = 1.4e-84, Sum P(3) = 1.4e-84
 Identities = 119/167 (71%), Positives = 139/167 (83%)

Query:     1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
             ++A+K+W RQILRGLHYLHSH+PP+IHRDLKCDNIFVNGN GEVKIGDLGLA ++++  A
Sbjct:   124 IRAMKHWCRQILRGLHYLHSHDPPVIHRDLKCDNIFVNGNQGEVKIGDLGLAAILRKSHA 183

Query:    61 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
                +GTPEFMAPE+YEE YNELVDIYSFGMCILEMVT +YPY+EC +PAQIYKKV SG K
Sbjct:   184 AHCVGTPEFMAPEVYEEAYNELVDIYSFGMCILEMVTFDYPYSECTHPAQIYKKVMSGKK 243

Query:   121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL-VTDNPKDL 166
             P +L KV DP+VK FIEKC+   SLR+ A ELL DPFL + D   DL
Sbjct:   244 PDALYKVKDPEVKCFIEKCLATVSLRVSARELLDDPFLRIDDGEFDL 290

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007623 "circadian rhythm" evidence=IEP

GO:0016020 "membrane" evidence=IDA

TAIR|locus:504955638 WNK3 "with no lysine (K) kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 632 (227.5 bits), Expect = 9.5e-80, Sum P(2) = 9.5e-80
 Identities = 117/159 (73%), Positives = 136/159 (85%)

Query:     1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-T 59
             ++A+K W+RQIL GL YLHSH+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA ++ +  +
Sbjct:   122 LRALKKWSRQILEGLVYLHSHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAAILHRARS 181

Query:    60 ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
             A SVIGTPEFMAPELYEE+YN LVDIY+FGMC+LE+VT EYPY+EC N AQIY+KVTSGI
Sbjct:   182 AHSVIGTPEFMAPELYEEDYNVLVDIYAFGMCLLELVTFEYPYSECTNAAQIYRKVTSGI 241

Query:   120 KPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 158
             KPA+L  VTDPQV+ FIEKCI   S RL A ELL DPFL
Sbjct:   242 KPAALLNVTDPQVRAFIEKCIAKVSQRLSAKELLDDPFL 280

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2098242 WNK5 "with no lysine (K) kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 614 (221.2 bits), Expect = 1.1e-74, Sum P(2) = 1.1e-74
 Identities = 120/186 (64%), Positives = 144/186 (77%)

Query:     1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPT 59
             ++AIK+WARQIL GL YLH H+PP+IHRDLKCDNIFVNG+ G+VKIGDLGLA +++    
Sbjct:   125 IRAIKSWARQILNGLAYLHGHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLAAILRGSQN 184

Query:    60 ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
             A SVIGTPEFMAPELYEE+YNELVDIYSFGMC+LEM+T EYPY+EC NPAQIYKKVTSG 
Sbjct:   185 AHSVIGTPEFMAPELYEEDYNELVDIYSFGMCVLEMLTGEYPYSECTNPAQIYKKVTSGK 244

Query:   120 KPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVP 178
              P S   +   + ++F+ KC+   S RLPA ELL DPFL   + +DL   PL RLP  + 
Sbjct:   245 LPDSFHLIQHTEAQRFVGKCLETVSRRLPAKELLADPFLAATDERDLA--PLFRLPQQLA 302

Query:   179 EVMNLA 184
              + NLA
Sbjct:   303 -IQNLA 307

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0043424 "protein histidine kinase binding" evidence=IPI

GO:0048573 "photoperiodism, flowering" evidence=IMP

TAIR|locus:2182039 WNK9 [Arabidopsis thaliana (taxid:3702)]

 Score = 753 (270.1 bits), Expect = 1.2e-74, P = 1.2e-74
 Identities = 163/336 (48%), Positives = 215/336 (63%)

Query:     1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
             ++A+KNW RQILRGL+YLH+H+PP+IHRDLKCDNIF+NGN GEVKIGDLGLA  +Q   A
Sbjct:   125 IRAVKNWCRQILRGLNYLHTHDPPVIHRDLKCDNIFINGNQGEVKIGDLGLAACLQHSHA 184

Query:    61 RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
                +GTPEFMAPE+Y+EEYN+LVDIYSFGMC+LEMVT +YPY+EC +PAQIYK+V SG K
Sbjct:   185 AHCVGTPEFMAPEVYKEEYNQLVDIYSFGMCVLEMVTFDYPYSECSHPAQIYKRVISGKK 244

Query:   121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTD--------NPKDLVCD--- 169
             P  L KV DP+V+ FIEKC+   SLRL A ELL D FL  D        + K L+ +   
Sbjct:   245 PDGLDKVKDPEVRGFIEKCLATVSLRLSACELLDDHFLCIDESDMRRVESEKGLIDEAGT 304

Query:   170 PLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNE-- 227
             PLR    +P   N  +S  +    D N      D   +S+       LE Q   +  E  
Sbjct:   305 PLRHSYHIPHYSNGYYSLYNQNQWDYN-----GDETVESHE---IDLLEFQNDDDEEEED 356

Query:   228 -------FTLRGEKNDD-DTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLD 279
                     +++G++ D+ D + L L+  +K G V NI+F F +  DTAIS+A EMVE+L+
Sbjct:   357 KRFGSVDISIKGKRRDNGDGLFLRLKTVNKEGCVRNIYFPFDIETDTAISVAREMVEELE 416

Query:   280 LSHEDVVSIAELIDNLIMKLVPSWNPSLGSTASQQN 315
             +   DV  IA +ID  I  LVP+W+    S +++ +
Sbjct:   417 MDDRDVTKIANMIDGEIASLVPNWSIFCSSESNRSS 452

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2161278 WNK4 "with no lysine (K) kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 580 (209.2 bits), Expect = 2.9e-68, Sum P(2) = 2.9e-68
 Identities = 106/162 (65%), Positives = 133/162 (82%)

Query:     1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PT 59
             ++AIK+WARQIL GL YLH H+PP+IHRDLKCDNIFVNG+ G+VKIGDLGLA +++   +
Sbjct:   119 IRAIKSWARQILEGLVYLHEHDPPVIHRDLKCDNIFVNGHLGQVKIGDLGLARMLRDCHS 178

Query:    60 ARSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
             A S+IGTPEFMAPELYEE YNEL+D+YSFGMC LEM+T E+PY+EC +PAQIYKKV  G 
Sbjct:   179 AHSIIGTPEFMAPELYEENYNELIDVYSFGMCFLEMITSEFPYSECNHPAQIYKKVVGGK 238

Query:   120 KPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTD 161
              P +  +V D + ++FI KC+V AS R+ A ELL+DPFL +D
Sbjct:   239 LPGAFYRVGDIEAQRFIGKCLVSASKRVSAKELLQDPFLASD 280

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0010260 "organ senescence" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

MGI|MGI:2652875 Wnk3 "WNK lysine deficient protein kinase 3" [Mus musculus (taxid:10090)]

 Score = 559 (201.8 bits), Expect = 6.4e-61, Sum P(3) = 6.4e-61
 Identities = 104/161 (64%), Positives = 126/161 (78%)

Query:     2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
             K +++W RQIL+GL +LH+  PPIIHRDLKCDNIF+ G  G VKIGDLGLA +M+   A+
Sbjct:   247 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLMRTSFAK 306

Query:    62 SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             SVIGTPEFMAPE+YEE Y+E VD+Y+FGMC+LEM T EYPY+EC+N AQIY+KVTSGIKP
Sbjct:   307 SVIGTPEFMAPEMYEEHYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRKVTSGIKP 366

Query:   122 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD 161
             AS +KVTDP+VK+ IE CI    S RL   +LL   F   D
Sbjct:   367 ASFNKVTDPEVKEIIEGCIRQNKSERLSIKDLLNHAFFAED 407

GO:0000166 "nucleotide binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISO

GO:0005912 "adherens junction" evidence=IDA

GO:0005923 "tight junction" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0010765 "positive regulation of sodium ion transport" evidence=ISO

GO:0010800 "positive regulation of peptidyl-threonine phosphorylation" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0032414 "positive regulation of ion transmembrane transporter activity" evidence=ISO

GO:0043066 "negative regulation of apoptotic process" evidence=ISO

GO:0046777 "protein autophosphorylation" evidence=ISO

GO:0051928 "positive regulation of calcium ion transport" evidence=ISO

GO:0090004 "positive regulation of establishment of protein localization to plasma membrane" evidence=ISO

GO:2000021 "regulation of ion homeostasis" evidence=ISO

GO:2000651 "positive regulation of sodium ion transmembrane transporter activity" evidence=ISO

GO:2000682 "positive regulation of rubidium ion transport" evidence=ISO

GO:2000688 "positive regulation of rubidium ion transmembrane transporter activity" evidence=ISO

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	505
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-44
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-43
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-36
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-36
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-34
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-32
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-32
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-30
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-26
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-25
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-25
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-22
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-22
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-22
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-22
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	9e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-21
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-20
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-20
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-20
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-19
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-19
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-19
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-19
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-19
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-18
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-18
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-17
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-17
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-16
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-16
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-16
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-16
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-15
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-15
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-13
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-12
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	5e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-09
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-08
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-08
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-08
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-07
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-07
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-07
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-06
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-06
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-06
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-06
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-05
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	2e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-05
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-05
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-05
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-05
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-04
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-04
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-04
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-04
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-04
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-04
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-04
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-04
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-04
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	9e-04
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	0.001
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	0.001
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.001
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	0.001
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  157 bits (399), Expect = 1e-44
 Identities = 59/162 (36%), Positives = 86/162 (53%), Gaps = 9/162 (5%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-A 60
              + + RQIL  L YLHS    I+HRDLK +NI ++  +G VK+ D GLA  +      
Sbjct: 97  DEARFYLRQILSALEYLHSKG--IVHRDLKPENILLD-EDGHVKLADFGLARQLDPGEKL 153

Query: 61  RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSG 118
            + +GTPE+MAPE L  + Y + VDI+S G  IL E++T + P+       +++KK+   
Sbjct: 154 TTFVGTPEYMAPEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFPGDDQLLELFKKIGKP 212

Query: 119 IKPASLSKVT-DPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
             P    +    P+ K  I K +V     RL A E L+ PF 
Sbjct: 213 KPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  154 bits (392), Expect = 1e-43
 Identities = 63/161 (39%), Positives = 88/161 (54%), Gaps = 9/161 (5%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--- 60
           I+ + RQIL GL YLHS+   I+HRD+K  NI V  ++G VK+ D G A  +        
Sbjct: 103 IRKYTRQILEGLAYLHSNG--IVHRDIKGANILV-DSDGVVKLADFGCAKRLGDIETGEG 159

Query: 61  -RSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
             SV GTP +MAPE+   EEY    DI+S G  ++EM T + P++E  NP     K+ S 
Sbjct: 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS 219

Query: 119 IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
            +P  + +    + K F+ KC+      R  A ELL+ PFL
Sbjct: 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  134 bits (340), Expect = 3e-36
 Identities = 64/162 (39%), Positives = 92/162 (56%), Gaps = 14/162 (8%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARS 62
           I+ + RQIL GL YLH  N   +HRD+K  NI V+  NG VK+ D G+A  V++   A+S
Sbjct: 104 IRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSFAKS 160

Query: 63  VIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
             G+P +MAPE+  ++  Y    DI+S G  +LEM T + P+++ +  A ++K   S   
Sbjct: 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL 220

Query: 121 PA---SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFL 158
           P     LS     + K FI KC+    SLR  A ELL+ PF+
Sbjct: 221 PPIPDHLS----DEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  134 bits (340), Expect = 3e-36
 Identities = 58/167 (34%), Positives = 86/167 (51%), Gaps = 12/167 (7%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QP 58
               K  A QILRGL YLHS+   IIHRDLK +NI ++  NG VKI D GLA  +     
Sbjct: 97  EDEAKKIALQILRGLEYLHSNG--IIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSS 153

Query: 59  TARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--K 114
           +  + +GTP +MAPE  L    Y   VD++S G+ + E++T + P++      Q+    +
Sbjct: 154 SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRR 213

Query: 115 VTSGIKPASLSKVTD--PQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
           +          K +    + K  I+KC+    S R  A E+L+ P+ 
Sbjct: 214 ILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  130 bits (329), Expect = 2e-34
 Identities = 64/162 (39%), Positives = 94/162 (58%), Gaps = 9/162 (5%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 65
            R++L+GL YLHS N  +IHRD+K DNI ++  +G VK+ D G A  +  ++    SV+G
Sbjct: 122 CREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVG 178

Query: 66  TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPAS 123
           TP +MAPE+ + ++Y   VDI+S G+  +EM   E PY   + P + ++   T GI P  
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIPPLK 237

Query: 124 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
             +   P+ K F+ KC+V     R  A ELL+ PFL    PK
Sbjct: 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  123 bits (311), Expect = 3e-32
 Identities = 56/154 (36%), Positives = 90/154 (58%), Gaps = 8/154 (5%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGT 66
            +++L+GL YLHS+   IIHRD+K  NI +  ++GEVK+ D GL+  +    AR +++GT
Sbjct: 104 CKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGT 160

Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASL 124
           P +MAPE +  + Y+   DI+S G+  +E+   + PY+E      ++K  T+G     + 
Sbjct: 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNP 220

Query: 125 SKVTDPQVKQFIEKCIVPA-SLRLPALELLKDPF 157
            K +D   K F++KC+      R  A +LLK PF
Sbjct: 221 EKWSDE-FKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  122 bits (308), Expect = 4e-32
 Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 41/158 (25%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           I     QIL GL YLHS+   IIHRDLK +NI ++ +NG+VK+ D GL+ ++       +
Sbjct: 94  ILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151

Query: 62  SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
           +++GTP +MAPE+      Y+E  DI+S G+ + E+                        
Sbjct: 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------ 187

Query: 120 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDP 156
                     P++K  I K +      R  A E+L+  
Sbjct: 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  119 bits (300), Expect = 2e-30
 Identities = 65/173 (37%), Positives = 95/173 (54%), Gaps = 21/173 (12%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
              I+ +  Q+L GL YLHSH   I+HRD+K  NIF+  +NG +K+GD G A+ ++  T 
Sbjct: 98  EHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFL-DHNGVIKLGDFGCAVKLKNNTT 154

Query: 61  R------SVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 110
                  S+ GTP +MAPE+      + +    DI+S G  +LEM T + P++E  N  Q
Sbjct: 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ 214

Query: 111 IYKKVTSGIKPA---SLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFL 158
           I   V +G KP    SL     P+ K F+++C+   P   R  A ELL+ PF+
Sbjct: 215 IMFHVGAGHKPPIPDSLQL--SPEGKDFLDRCLESDP-KKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (295), Expect = 7e-30
 Identities = 49/159 (30%), Positives = 88/159 (55%), Gaps = 9/159 (5%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--AR 61
           I +W  Q+   L YLHS    I+HRD+K  NIF+  +NG VK+GD G++ V+      A+
Sbjct: 105 ILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAK 161

Query: 62  SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           +V+GTP +++PEL + + YN   DI+S G  + E+ T ++P+ E +N  ++  K+  G +
Sbjct: 162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF-EGENLLELALKILKG-Q 219

Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
              +      +++  +   +      R    ++L+ PF+
Sbjct: 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  113 bits (284), Expect = 2e-28
 Identities = 53/158 (33%), Positives = 89/158 (56%), Gaps = 10/158 (6%)

Query: 8   ARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVI 64
           ARQIL+GL YLH+  +  IIHRD+K  N+ +N + GEVKI D G++ V++       + +
Sbjct: 105 ARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFV 161

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKKVTSGIKP 121
           GT  +M+PE +  E Y+   DI+S G+ +LE    ++P+      +  ++ + +  G  P
Sbjct: 162 GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP 221

Query: 122 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
           +  ++   P+ + FI  C+      R  A ELL+ PF+
Sbjct: 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  107 bits (270), Expect = 2e-26
 Identities = 57/159 (35%), Positives = 87/159 (54%), Gaps = 17/159 (10%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
            Q L+GL YLHS+    IHRD+K  NI +N   G+ K+ D G++  +    A+  +VIGT
Sbjct: 106 YQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGT 162

Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---PA 122
           P +MAPE+ +E  YN   DI+S G+  +EM   + PY++      I+      I    P 
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----IPNKPPP 217

Query: 123 SLSKVTD--PQVKQFIEKCIV-PASLRLPALELLKDPFL 158
           +LS      P+   F++KC+V     R  A++LL+ PF+
Sbjct: 218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 4e-26
 Identities = 57/160 (35%), Positives = 86/160 (53%), Gaps = 11/160 (6%)

Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPT 59
           + + RQIL G+ YLHS+   I+HRD+K  NI +  + G VK+GD G +     I      
Sbjct: 107 RKYTRQILEGVEYLHSNM--IVHRDIKGANI-LRDSAGNVKLGDFGASKRLQTICSSGTG 163

Query: 60  ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
            +SV GTP +M+PE+   E Y    D++S G  ++EM+T + P+ E +  A I+K  T  
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP 223

Query: 119 IKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPF 157
             P   S V  P  + F+ +  V  + + P A ELL+  F
Sbjct: 224 TNPQLPSHV-SPDARNFLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  104 bits (261), Expect = 4e-25
 Identities = 60/169 (35%), Positives = 94/169 (55%), Gaps = 15/169 (8%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
             +L+ L +LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  +S++GT
Sbjct: 122 LAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGT 178

Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKPAS- 123
           P +MAPE+     Y   VDI+S G+ ++EMV  E PY NE   P Q  K++   + P   
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE--PPLQAMKRIRDNLPPKLK 236

Query: 124 -LSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 169
            L KV+ P+++ F+++ +V  PA  R  A ELL  PFL    P   +  
Sbjct: 237 NLHKVS-PRLRSFLDRMLVRDPAQ-RATAAELLNHPFLAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  103 bits (259), Expect = 5e-25
 Identities = 65/169 (38%), Positives = 91/169 (53%), Gaps = 22/169 (13%)

Query: 3   AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG----LAIVMQQP 58
            I  + +QIL GL YLH +   I+HRD+K DN+ VN  +G VKI D G    LA +   P
Sbjct: 109 TIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NP 164

Query: 59  TARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYK- 113
              +  GT ++MAPE+ ++    Y    DI+S G  I+EM T + P+ E   P A ++K 
Sbjct: 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV 224

Query: 114 ---KVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 158
              K+   I P SLS     + K FI +C  P   +   A +LL+DPFL
Sbjct: 225 GMFKIHPEI-PESLSA----EAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  101 bits (254), Expect = 3e-24
 Identities = 52/161 (32%), Positives = 82/161 (50%), Gaps = 12/161 (7%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--- 62
           N+  Q+LRGL YLH +   IIHRD+K  N+ ++     ++I D G A  +      +   
Sbjct: 107 NYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF 164

Query: 63  ---VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYN--ECKNPAQIYKKVT 116
              ++GT  FMAPE L  E+Y    D++S G  I+EM T + P+N  +  N   +  K+ 
Sbjct: 165 QGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA 224

Query: 117 SGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDP 156
           S     S+ +   P ++    +C+ +    R P+ ELLK P
Sbjct: 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 5e-24
 Identities = 56/173 (32%), Positives = 88/173 (50%), Gaps = 24/173 (13%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           R++L GL YLH      IHRD+K  NI ++   G+VK+ D G++  +    ++  + +GT
Sbjct: 105 REVLLGLEYLHEEGK--IHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGT 161

Query: 67  PEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPA 122
           P +MAPE+  +  Y+E  DI+S G+  +E+   E P ++  +P     +V   I    P 
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD-LHPM----RVLFLIPKNNPP 216

Query: 123 SL--SKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFL----VTDNPKDLV 167
           SL  +K + P  K F+  C+   P   R  A ELLK  F+     T     L+
Sbjct: 217 SLEGNKFSKP-FKDFVSLCLNKDPKE-RPSAKELLKHKFIKKAKKTSYLTLLI 267

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (251), Expect = 7e-24
 Identities = 55/164 (33%), Positives = 85/164 (51%), Gaps = 21/164 (12%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS------ 62
           +++L+GL YLHS+    IHRD+K  NI + G +G VKI D G++  +     R+      
Sbjct: 109 KEVLKGLEYLHSNG--QIHRDIKAGNILL-GEDGSVKIADFGVSASLADGGDRTRKVRKT 165

Query: 63  VIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
            +GTP +MAPE+ E+   Y+   DI+SFG+  +E+ T   PY++   P ++         
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQN-D 223

Query: 121 PASLSKVTDPQV-----KQFIEKCIV--PASLRLPALELLKDPF 157
           P SL    D +      ++ I  C+   P+  R  A ELLK  F
Sbjct: 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSK-RPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 99.8 bits (249), Expect = 9e-24
 Identities = 54/158 (34%), Positives = 83/158 (52%), Gaps = 7/158 (4%)

Query: 3   AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 62
            I     Q+LRGL  LH     I+HRDLK  NI +   N  VKIGDLG++ V+++  A++
Sbjct: 104 EIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLV-ANDLVKIGDLGISKVLKKNMAKT 160

Query: 63  VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
            IGTP +MAPE+++   Y+   DI+S G  + EM T   P+ E ++   +  KV  G  P
Sbjct: 161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYP 219

Query: 122 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
             +  +    ++ FI   +     LR    ++L  P +
Sbjct: 220 P-IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 98.8 bits (246), Expect = 3e-23
 Identities = 59/165 (35%), Positives = 93/165 (56%), Gaps = 15/165 (9%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQ 56
           ++N+ RQIL+GL+YLH+    IIHRD+K  NI V+ N G +KI D G++       +  +
Sbjct: 108 VRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTK 164

Query: 57  QPTAR-SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 114
              AR S+ G+  +MAPE+ ++  Y    DI+S G  ++EM+T ++P+ +C     I+ K
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIF-K 223

Query: 115 VTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
           +     P   S ++  +   F+EK      + R  A ELLK PFL
Sbjct: 224 IGENASPEIPSNISS-EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 97.2 bits (243), Expect = 8e-23
 Identities = 44/143 (30%), Positives = 78/143 (54%), Gaps = 9/143 (6%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPT 59
           +  + +A +I+  L YLHS    II+RDLK +NI ++  +G +K+ D GLA  +  +   
Sbjct: 93  ERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSR 149

Query: 60  ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
             +  GTPE++APE L  + Y + VD +S G+ + EM+T + P+   ++  +IY+K+   
Sbjct: 150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDRKEIYEKILK- 207

Query: 119 IKPASLSKVTDPQVKQFIEKCIV 141
             P    +   P+ +  I   + 
Sbjct: 208 -DPLRFPEFLSPEARDLISGLLQ 229

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 96.8 bits (241), Expect = 1e-22
 Identities = 54/153 (35%), Positives = 95/153 (62%), Gaps = 9/153 (5%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTP 67
           QIL GL +LHS    I+HRD+K  N+F++  +  VKIGDLG+A ++   T  A +++GTP
Sbjct: 109 QILLGLAHLHSKK--ILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTP 165

Query: 68  EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 126
            +++PEL E++ YNE  D+++ G+ + E  T ++P+ +  N   +  K+  G+ P  +S+
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF-DANNQGALILKIIRGVFP-PVSQ 223

Query: 127 VTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 158
           +   Q+ Q I++C+     + P   +LL++P L
Sbjct: 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 14/159 (8%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           R+ L+GL YLH      IHRD+K  NI +   +G+VK+ D G++  +    A+  S IGT
Sbjct: 108 RETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGT 164

Query: 67  PEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKP 121
           P +MAPE+   E    Y+   DI++ G+  +E+   + P  +  +P + ++    S   P
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL-HPMRALFLISKSNFPP 223

Query: 122 ASLSKVT--DPQVKQFIEKCIVPASLRLP-ALELLKDPF 157
             L       P    FI+KC+     + P A +LL+ PF
Sbjct: 224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 10/157 (6%)

Query: 9   RQILRGLHYLHSHNPP---IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSV 63
            Q+L  L+  H+ + P   ++HRDLK  NIF++ NN  VK+GD GLA ++   +  A++ 
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKILGHDSSFAKTY 170

Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 122
           +GTP +M+PE L    Y+E  DI+S G  I E+     P+   +N  Q+  K+  G    
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-TARNQLQLASKIKEGKFR- 228

Query: 123 SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFL 158
            +      ++ + I+  + V    R    ELL+ P +
Sbjct: 229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 95.0 bits (237), Expect = 4e-22
 Identities = 53/154 (34%), Positives = 83/154 (53%), Gaps = 9/154 (5%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGT 66
            Q+L+GL YLH     +IHRD+K  NI     +G VK+ D G+A  +        SV+GT
Sbjct: 106 YQVLQGLAYLHEQG--VIHRDIKAANILTTK-DGVVKLADFGVATKLNDVSKDDASVVGT 162

Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           P +MAPE+ E    +   DI+S G  ++E++T   PY +    A +++ V     P  L 
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPP--LP 220

Query: 126 KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
           +   P++K F+ +C     +LR  A +LLK P++
Sbjct: 221 EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 95.1 bits (236), Expect = 6e-22
 Identities = 59/159 (37%), Positives = 87/159 (54%), Gaps = 10/159 (6%)

Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPT 59
           + + RQIL G+ YLHS+   I+HRD+K  NI  + + G VK+GD G +     I M    
Sbjct: 109 RKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTG 165

Query: 60  ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
            RSV GTP +M+PE+   E Y    D++S G  ++EM+T + P+ E +  A I+K  T  
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP 225

Query: 119 IKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPF 157
             P   S +++   + F+    V A  R  A ELL+ PF
Sbjct: 226 TNPQLPSHISE-HARDFLGCIFVEARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 94.7 bits (235), Expect = 7e-22
 Identities = 59/163 (36%), Positives = 89/163 (54%), Gaps = 10/163 (6%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQ 56
              + + RQIL G+ YLHS+   I+HRD+K  NI  + + G VK+GD G +     I + 
Sbjct: 106 NVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLS 162

Query: 57  QPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
               +SV GTP +M+PE+   E Y    DI+S G  ++EM+T + P+ E +  A I+K  
Sbjct: 163 GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA 222

Query: 116 TSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 158
           T    P     V+D   + F+++  V A LR  A ELL+  F+
Sbjct: 223 TQPTNPVLPPHVSD-HCRDFLKRIFVEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 94.6 bits (236), Expect = 9e-22
 Identities = 48/170 (28%), Positives = 83/170 (48%), Gaps = 19/170 (11%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL--------AIVM 55
            + +  +I+  L YLHS+   IIHRDLK DNI ++ +NG +K+ D GL         I +
Sbjct: 95  ARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINL 151

Query: 56  QQPTARS--VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
                    ++GTP+++APE +  + +++ VD +S G  + E +    P++  + P +I+
Sbjct: 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIF 210

Query: 113 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASL-RLPAL---ELLKDPFL 158
           + + +G            +    I K +VP    RL A    E+   PF 
Sbjct: 211 QNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 94.5 bits (236), Expect = 1e-21
 Identities = 64/191 (33%), Positives = 83/191 (43%), Gaps = 44/191 (23%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPT 59
           IK+   Q+LRGL Y HSH   I+HRDLK  NI +N  +G +K+ D GLA    I ++  T
Sbjct: 100 IKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYT 156

Query: 60  ARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT--------CE---------- 99
              V  T  + APE+    + Y+  VDI+S G    EM+T         E          
Sbjct: 157 HEVV--TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQI 214

Query: 100 --YPYNE-----CKNPAQIYKKVTSGIKPASLSKVT---DPQVKQFIEK--CIVPASLRL 147
              P  E      K P   YK       P  L KV    DP+    + K     PA  R+
Sbjct: 215 LGTPTEESWPGVTKLPD--YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAK-RI 271

Query: 148 PALELLKDPFL 158
            A E LK P+ 
Sbjct: 272 SAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 94.0 bits (234), Expect = 1e-21
 Identities = 61/176 (34%), Positives = 95/176 (53%), Gaps = 20/176 (11%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           RQ+L  L++LHSH   +IHRDLK  NI +   +G+VK+ D G++   +    +  + IGT
Sbjct: 110 RQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGT 166

Query: 67  PEFMAPELYEEE------YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           P +MAPE+   E      Y+   DI+S G+ ++E+   E P++E  NP ++  K+     
Sbjct: 167 PYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEP 225

Query: 121 PASL--SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL--VTDNP--KDLVCD 169
           P     SK +      F++ C+V     R  A ELLK PF+   +DN   KDL+ +
Sbjct: 226 PTLDQPSKWSS-SFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLLAE 280

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 95.6 bits (236), Expect = 2e-21
 Identities = 55/268 (20%), Positives = 92/268 (34%), Gaps = 28/268 (10%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------ 55
                   QIL  L YLHS    IIHRD+K +NI ++ +   VK+ D GLA ++      
Sbjct: 101 SEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158

Query: 56  --QQPTARSVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPY---NECK 106
                   + +GTP +MAPE+         +   DI+S G+ + E++T   P+       
Sbjct: 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS 218

Query: 107 NPAQIYKKVTSGIKPASLSKV-------TDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
             +Q  K +     P+  S +               ++K +      RL +   L    L
Sbjct: 219 ATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Query: 159 VTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLE 218
                  L    L       +   L  S P  ++  ++     A S +         + E
Sbjct: 279 ---AHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKE 335

Query: 219 LQRLTENNEFTLRGEKNDDDTVSLTLRI 246
           L     ++              S    +
Sbjct: 336 LAPNGVSSSPHNSSSLLLSTASSKRSSL 363

Length = 384

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 93.0 bits (232), Expect = 3e-21
 Identities = 49/167 (29%), Positives = 76/167 (45%), Gaps = 35/167 (20%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----- 55
            K  + +A +IL  L YLHS    IIHRDLK +NI ++  +  +KI D G A V+     
Sbjct: 101 EKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSS 157

Query: 56  -----------------QQPTARSVIGTPEFMAPELYEEEY-NELVDIYSFGMCIL-EMV 96
                             +    S +GT E+++PEL  E+   +  D+++ G CI+ +M+
Sbjct: 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALG-CIIYQML 216

Query: 97  TCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIV 141
           T + P+    N    ++K    I     S      P  K  IEK +V
Sbjct: 217 TGKPPFR-GSNEYLTFQK----ILKLEYSFPPNFPPDAKDLIEKLLV 258

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 91.3 bits (227), Expect = 1e-20
 Identities = 54/157 (34%), Positives = 81/157 (51%), Gaps = 13/157 (8%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           R++L  L Y+H     +IHRD+K  NI V  N G VK+ D G+A ++ Q +++  + +GT
Sbjct: 108 REVLVALKYIHKV--GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGT 164

Query: 67  PEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 124
           P +MAPE+  E   Y+   DI+S G+ I EM T   PY      A     +    KP  L
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY--SDVDAFRAMMLIPKSKPPRL 222

Query: 125 S-KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFL 158
                   +++F+  C+   P   RL A ELLK  ++
Sbjct: 223 EDNGYSKLLREFVAACLDEEPKE-RLSAEELLKSKWI 258

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.5 bits (224), Expect = 2e-20
 Identities = 57/162 (35%), Positives = 87/162 (53%), Gaps = 10/162 (6%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQ 56
              + + RQIL+G+ YLHS+   I+HRD+K  NI  + + G VK+GD G +     I M 
Sbjct: 106 NVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMS 162

Query: 57  QPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
               +SV GTP +M+PE+   E Y    D++S    ++EM+T + P+ E +  A I+K  
Sbjct: 163 GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA 222

Query: 116 TSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPF 157
           T   KP     V+D   + F+++  V    R  A  LL+ PF
Sbjct: 223 TQPTKPMLPDGVSD-ACRDFLKQIFVEEKRRPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 90.7 bits (225), Expect = 3e-20
 Identities = 59/161 (36%), Positives = 88/161 (54%), Gaps = 11/161 (6%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+ L+ L +LHS+   +IHRD+K DNI + G +G VK+ D G    I  +Q    +++GT
Sbjct: 122 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178

Query: 67  PEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGIKPAS 123
           P +MAPE+   + Y   VDI+S G+  +EMV  E PY NE  NP + +Y   T+G     
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQ 236

Query: 124 LSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 163
             +      + F+ +C+ +    R  A ELL+ PFL    P
Sbjct: 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 89.7 bits (222), Expect = 4e-20
 Identities = 50/159 (31%), Positives = 90/159 (56%), Gaps = 9/159 (5%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTAR 61
           +  W  QI   L YLH  +  I+HRDLK  N+F+   N  +K+GDLG+A V+  Q   A 
Sbjct: 104 VVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMAS 160

Query: 62  SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           ++IGTP +M+PEL+  + YN   D+++ G C+ EM T ++ +N     + +Y+ +   + 
Sbjct: 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP 220

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFL 158
           P  + K   P++ + I   +     + P+++ +L+ P++
Sbjct: 221 P--MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 90.1 bits (223), Expect = 5e-20
 Identities = 63/170 (37%), Positives = 95/170 (55%), Gaps = 15/170 (8%)

Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 68
           +L+ L  LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  +S++GTP 
Sbjct: 125 VLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 181

Query: 69  FMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP--ASL 124
           +MAPEL     Y   VDI+S G+ ++EMV  E PY NE   P +  K +   + P   +L
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPKLKNL 239

Query: 125 SKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLR 172
            KV+ P +K F+++ +V  PA  R  A ELLK PFL    P   +   +R
Sbjct: 240 HKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGPPSCIVPLMR 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 88.8 bits (221), Expect = 7e-20
 Identities = 40/132 (30%), Positives = 69/132 (52%), Gaps = 6/132 (4%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPE 68
            ++    YLH+    II+RDLK +N+ ++ +NG VK+ D G A  ++      +  GTPE
Sbjct: 101 CVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPE 157

Query: 69  FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSK 126
           ++APE+   + Y+  VD +S G+ + E++T   P+ E   +P +IY  +  G        
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN 217

Query: 127 VTDPQVKQFIEK 138
             D   K  I++
Sbjct: 218 YIDKAAKDLIKQ 229

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 88.6 bits (220), Expect = 9e-20
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 7/145 (4%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 59
           + I  +  Q+   L ++HS    I+HRD+K  N+F+    G VK+GDLGL       T  
Sbjct: 106 RTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTA 162

Query: 60  ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTS 117
           A S++GTP +M+PE ++E  YN   DI+S G  + EM   + P Y +  N   + KK+  
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222

Query: 118 GIKPASLSKVTDPQVKQFIEKCIVP 142
              P   +     +++  + +CI P
Sbjct: 223 CDYPPLPADHYSEELRDLVSRCINP 247

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 48/158 (30%), Positives = 83/158 (52%), Gaps = 8/158 (5%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A  +L+GL YLH     IIHRD+K  NI VN + G++K+ D G++  +    A++ +GT 
Sbjct: 106 AVAVLKGLTYLH-EKHKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFVGTS 163

Query: 68  EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPA 122
            +MAPE +   +Y+   DI+S G+ ++E+ T  +PY           ++ + + +   P 
Sbjct: 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR 223

Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLV 159
             S    P  + F+  C++      P+  ELL+ PF+ 
Sbjct: 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 11/140 (7%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVI 64
           ++A QI +G+ YL S     +HRDL   N  V G +  VKI D GL+  +      R   
Sbjct: 109 SFAIQIAKGMEYLASKK--FVHRDLAARNCLV-GEDLVVKISDFGLSRDVYDDDYYRKKT 165

Query: 65  GTPE---FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI 119
           G      +MAPE L +  +    D++SFG+ + E+ T    PY    N  ++ + +  G 
Sbjct: 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEYLRKGY 224

Query: 120 KPASLSKVTDPQVKQFIEKC 139
           +        D ++ + +  C
Sbjct: 225 RLPKPEYCPD-ELYELMLSC 243

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 87.9 bits (218), Expect = 3e-19
 Identities = 56/181 (30%), Positives = 90/181 (49%), Gaps = 14/181 (7%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
             L+GL YLHSH    IHRD+K  NI +    G VK+ D G A ++    A S +GTP +
Sbjct: 123 GALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVS--PANSFVGTPYW 177

Query: 70  MAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           MAPE+     E +Y+  VD++S G+  +E+   + P       + +Y    +     +LS
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPTLS 235

Query: 126 KVTDPQ-VKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMN 182
                   + F++ C+      R  + ELLK  F++ + P  ++ D + R  + V E+ N
Sbjct: 236 SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLIQRTKDAVRELDN 295

Query: 183 L 183
           L
Sbjct: 296 L 296

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 87.6 bits (218), Expect = 3e-19
 Identities = 40/104 (38%), Positives = 56/104 (53%), Gaps = 12/104 (11%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
              IK + +Q+L GL YLHS+   I+HRD+K  NI +N N+G +K+ D GLA    +  +
Sbjct: 99  ESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNS 155

Query: 61  RS----VIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 97
                 VI T  +  PEL      Y   VD++S G CIL E+  
Sbjct: 156 ADYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVG-CILAELFL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 86.8 bits (216), Expect = 3e-19
 Identities = 37/125 (29%), Positives = 57/125 (45%), Gaps = 12/125 (9%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           +K +   A QI +G+ YL S N   +HRDL   N  V   N  VKI D GL+  +     
Sbjct: 101 LKDLLQMALQIAKGMEYLESKN--FVHRDLAARNCLV-TENLVVKISDFGLSRDI-YEDD 156

Query: 61  RSVIGTPEF-----MAPELYEE-EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 113
                         MAPE  ++ ++    D++SFG+ + E+ T  E PY    N  ++ +
Sbjct: 157 YYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLE 215

Query: 114 KVTSG 118
            +  G
Sbjct: 216 LLEDG 220

Length = 258

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 87.0 bits (215), Expect = 5e-19
 Identities = 59/163 (36%), Positives = 87/163 (53%), Gaps = 10/163 (6%)

Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 68
           +L+ L YLHS    +IHRD+K D+I +   +G VK+ D G    I    P  +S++GTP 
Sbjct: 126 VLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPY 182

Query: 69  FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSK 126
           +MAPE+     Y   VDI+S G+ ++EMV  E PY    +P Q  K++     P    + 
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNAH 241

Query: 127 VTDPQVKQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 167
              P ++ F+E+ +      R  A ELL  PFL+ T  P+ LV
Sbjct: 242 KISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLV 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 86.0 bits (214), Expect = 7e-19
 Identities = 43/139 (30%), Positives = 65/139 (46%), Gaps = 10/139 (7%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 65
           ++A QI RG+ YL S N   IHRDL   N  V G N  VKI D GL+  +         G
Sbjct: 106 SFALQIARGMEYLESKN--FIHRDLAARNCLV-GENLVVKISDFGLSRDLYDDDYYRKRG 162

Query: 66  TPE---FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 120
                 +MAPE L E ++    D++SFG+ + E+ T  E PY    N  ++ + + +G +
Sbjct: 163 GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLKNGYR 221

Query: 121 PASLSKVTDPQVKQFIEKC 139
                      +   + +C
Sbjct: 222 LPQPPNCPPE-LYDLMLQC 239

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 86.3 bits (214), Expect = 7e-19
 Identities = 50/156 (32%), Positives = 82/156 (52%), Gaps = 9/156 (5%)

Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEF 69
           I++ L YLHS    +IHRD+K  N+ +N  NG+VK+ D G++  +    A+++  G   +
Sbjct: 112 IVKALEYLHS-KLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPY 169

Query: 70  MAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 124
           MAPE    E     Y+   D++S G+ ++E+ T  +PY+  K P Q  K+V     P   
Sbjct: 170 MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP 229

Query: 125 SKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLV 159
           ++   P+ + F+ KC+       P   ELL+ PF  
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 86.6 bits (214), Expect = 8e-19
 Identities = 57/169 (33%), Positives = 92/169 (54%), Gaps = 13/169 (7%)

Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 68
           +LR L YLH+    +IHRD+K D+I +  ++G +K+ D G    +  + P  +S++GTP 
Sbjct: 127 VLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY 183

Query: 69  FMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP--ASL 124
           +MAPE+     Y   VDI+S G+ ++EM+  E PY NE   P Q  +++   + P     
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE--PPLQAMRRIRDNLPPRVKDS 241

Query: 125 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPLR 172
            KV+   ++ F++  +V   S R  A ELL+ PFL    P   +   +R
Sbjct: 242 HKVSS-VLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIVPLMR 289

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 86.8 bits (216), Expect = 1e-18
 Identities = 42/101 (41%), Positives = 52/101 (51%), Gaps = 22/101 (21%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL YLHS N  +IHRDLK  NI VN N  ++KI D GLA  +             F
Sbjct: 111 QILRGLKYLHSAN--VIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDED-----EKGF 162

Query: 70  M----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 97
           +          APE  L    Y + +DI+S G CI  E++T
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVG-CIFAELLT 202

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 49/150 (32%), Positives = 84/150 (56%), Gaps = 7/150 (4%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTPE 68
           QIL  LH++H+    I+HRDLK  NI ++ +   VKIGD G++ I+  +  A +V+GTP 
Sbjct: 109 QILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPC 166

Query: 69  FMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 127
           +++PEL E + YN+  DI++ G  + E+ + +  +     PA +  K+ SG   A +S  
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-LVLKIMSG-TFAPISDR 224

Query: 128 TDPQVKQFIEKCI-VPASLRLPALELLKDP 156
             P ++Q I   + +  S R    +++  P
Sbjct: 225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 45/139 (32%), Positives = 67/139 (48%), Gaps = 10/139 (7%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 65
           ++A QI RG+ YL S N   IHRDL   N  V G N  VKI D GL+  +       V G
Sbjct: 107 SFALQIARGMEYLESKN--FIHRDLAARNCLV-GENLVVKISDFGLSRDLYDDDYYKVKG 163

Query: 66  TPE---FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 120
                 +MAPE L E ++    D++SFG+ + E+ T  E PY    N A++ + +  G +
Sbjct: 164 GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLKKGYR 222

Query: 121 PASLSKVTDPQVKQFIEKC 139
                      + + + +C
Sbjct: 223 LPKPPNCPPE-LYKLMLQC 240

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 84.5 bits (210), Expect = 4e-18
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 10/95 (10%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-- 61
           IK++    LRGL YLHS+   I+HRDLK +N+ +  ++G +K+ D GLA     P  +  
Sbjct: 104 IKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMT 160

Query: 62  -SVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL 93
             V+ T  + APEL      Y   VD++S G CI 
Sbjct: 161 HQVV-TRWYRAPELLFGARHYGVGVDMWSVG-CIF 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 84.1 bits (208), Expect = 5e-18
 Identities = 41/99 (41%), Positives = 63/99 (63%), Gaps = 6/99 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVI 64
           +  QI+ GL +LH     II+RDLK +N+ ++ N+G V+I DLGLA+ ++  Q   +   
Sbjct: 102 YTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYA 158

Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPY 102
           GTP FMAPEL + EEY+  VD ++ G+ + EM+    P+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 83.6 bits (206), Expect = 8e-18
 Identities = 58/161 (36%), Positives = 89/161 (55%), Gaps = 11/161 (6%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+ L+ L +LH++   +IHRD+K DN+ + G +G VK+ D G    I  +Q    +++GT
Sbjct: 122 RECLQALEFLHANQ--VIHRDIKSDNVLL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178

Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGIKPAS 123
           P +MAPE+   + Y   VDI+S G+  +EMV  E PY NE  NP + +Y   T+G     
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQ 236

Query: 124 LSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 163
             +   P  + F+ +C+ +    R  A ELL+ PFL    P
Sbjct: 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 51/165 (30%), Positives = 82/165 (49%), Gaps = 24/165 (14%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           R+ LRGL YLH +   +IHRD+K  NI +   N EVK+ D G++  +     R  + IGT
Sbjct: 120 RETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGT 176

Query: 67  PEFMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA-----QIYKKV 115
           P +MAPE+       +  Y+   D++S G+  +E+   + P   C         +I +  
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--CDMHPMRALFKIPRNP 234

Query: 116 TSGIK-PASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 158
              +K P + SK    +   FI +C++    + P   ELL+ PF+
Sbjct: 235 PPTLKSPENWSK----KFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 63/165 (38%), Positives = 91/165 (55%), Gaps = 19/165 (11%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+ L+ L +LHS+   +IHRD+K DNI + G +G VK+ D G    I  +Q    +++GT
Sbjct: 122 RECLQALDFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 178

Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI---- 119
           P +MAPE+   + Y   VDI+S G+  +EMV  E PY NE  NP + +Y   T+G     
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE--NPLRALYLIATNGTPELQ 236

Query: 120 KPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 163
            P  LS V     + F+ +C+ +    R  A ELL+ PFL    P
Sbjct: 237 NPERLSAV----FRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 51/149 (34%), Positives = 81/149 (54%), Gaps = 23/149 (15%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A Q++  L YLHS +  I++RDLK +N+ +  ++G +KI D G A  ++  T  ++ GTP
Sbjct: 107 AAQVVLALEYLHSLD--IVYRDLKPENLLL-DSDGYIKITDFGFAKRVKGRT-YTLCGTP 162

Query: 68  EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGIKPASL 124
           E++APE+   + Y + VD ++ G+ I EM+   YP  +++  NP QIY+K+  G      
Sbjct: 163 EYLAPEIILSKGYGKAVDWWALGILIYEML-AGYPPFFDD--NPIQIYEKILEG------ 213

Query: 125 SKVT-----DPQVKQFIEK-CIVPASLRL 147
            KV       P  K  I     V  + RL
Sbjct: 214 -KVRFPSFFSPDAKDLIRNLLQVDLTKRL 241

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 54/174 (31%), Positives = 94/174 (54%), Gaps = 16/174 (9%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-- 61
           I+   +Q L  L+YLH +   IIHRDLK  NI     +G++K+ D G++    +   R  
Sbjct: 105 IRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRD 161

Query: 62  SVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
           S IGTP +MAPE+       +  Y+   D++S G+ ++EM   E P++E  NP ++  K+
Sbjct: 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL-NPMRVLLKI 220

Query: 116 TSGIKPASLSKVT--DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 166
               +P +L++ +    + K F++KC+      R    +LL+ PF+  ++ K +
Sbjct: 221 AKS-EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPI 273

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 81.7 bits (201), Expect = 2e-17
 Identities = 56/160 (35%), Positives = 89/160 (55%), Gaps = 9/160 (5%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+IL+GL YLHS     IHRD+K  N+ ++  +GEVK+ D G+A  +   Q    + +GT
Sbjct: 108 REILKGLDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGT 164

Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           P +MAPE+ ++  Y+   DI+S G+  +E+   E P++E  +P ++   +     P    
Sbjct: 165 PFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNNPPTLEG 223

Query: 126 KVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 164
             + P +K+F+E C+    S R  A ELLK  F+V    K
Sbjct: 224 NYSKP-LKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 16/166 (9%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----AIVMQQPT 59
           ++ +  Q+L GL YLHS    I+HRDLK DN+ V+  +G  KI D G+      +     
Sbjct: 110 VRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQ 166

Query: 60  ARSVIGTPEFMAPE---LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--- 113
             S+ G+  +MAPE    Y + Y+  VDI+S G  +LEM     P+++ +  A ++K   
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN 226

Query: 114 -KVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPF 157
            +    I P     ++ P    F+  C        P A ELL+ PF
Sbjct: 227 KRSAPPIPPDVSMNLS-PVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 39/103 (37%), Positives = 54/103 (52%), Gaps = 5/103 (4%)

Query: 3   AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTAR 61
            +K W  +I+  L YLHS    IIHRD+K DNI ++   G V I D  +A  V       
Sbjct: 101 QVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTT 157

Query: 62  SVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYN 103
           S  GTP +MAPE+   + Y+  VD +S G+   E +  + PY 
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 81.1 bits (201), Expect = 4e-17
 Identities = 44/97 (45%), Positives = 60/97 (61%), Gaps = 7/97 (7%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
           + IK+  RQ+LRG+ +LHSH   I+HRDLK  NI V  ++G+VKI D GLA +     A 
Sbjct: 107 ETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMAL 163

Query: 62  -SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EM 95
            SV+ T  + APE L +  Y   VD++S G CI  E+
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVG-CIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 81.7 bits (202), Expect = 6e-17
 Identities = 40/99 (40%), Positives = 55/99 (55%), Gaps = 6/99 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VI 64
           +A  ++ GL YLH +   I++RDLK DN+ ++   G VKI D GL         R+    
Sbjct: 106 YAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFC 162

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 102
           GTPEF+APE L E  Y   VD +  G+ I EM+  E P+
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 9/153 (5%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTP 67
           QI+  + Y+H     I+HRD+K  NIF+    G +K+GD G++ ++      A +V+GTP
Sbjct: 109 QIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP 165

Query: 68  EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 126
            +M+PEL +  +YN   DI++ G  + E++T +  + +  NP  +  K+  G     +S 
Sbjct: 166 YYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNYTPVVSV 224

Query: 127 VTDPQVKQFIEKCI-VPASLRLPALELLKDPFL 158
            +  ++   +   +      R  A E+L  P L
Sbjct: 225 YSS-ELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 54/174 (31%), Positives = 85/174 (48%), Gaps = 25/174 (14%)

Query: 8   ARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
              +++GL +L   HN  IIHRD+K  N+ VNGN G+VK+ D G++  +    A++ IG 
Sbjct: 108 TYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGN-GQVKLCDFGVSGNLVASLAKTNIGC 164

Query: 67  PEFMAPELYEEE-------YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
             +MAPE  +         Y    D++S G+ ILEM    YPY     P + Y  + + +
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY-----PPETYANIFAQL 219

Query: 120 K------PASLSKVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKD 165
                  P +L        + F+ KC+  +P + R    +LL+ P+LV     D
Sbjct: 220 SAIVDGDPPTLPSGYSDDAQDFVAKCLNKIP-NRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 51/155 (32%), Positives = 84/155 (54%), Gaps = 9/155 (5%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+IL+GL YLHS     IHRD+K  N+ ++   G+VK+ D G+A  +   Q    + +GT
Sbjct: 108 REILKGLDYLHSERK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGT 164

Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           P +MAPE+ ++  Y+   DI+S G+  +E+   E P ++  +P ++   +     P    
Sbjct: 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL-HPMRVLFLIPKNSPPTLEG 223

Query: 126 KVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLV 159
           + + P  K+F+E C+      R  A ELLK  F+ 
Sbjct: 224 QYSKP-FKEFVEACLNKDPRFRPTAKELLKHKFIT 257

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 79.0 bits (194), Expect = 2e-16
 Identities = 52/159 (32%), Positives = 82/159 (51%), Gaps = 13/159 (8%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           R+ILRGL +LH H   +IHRD+K  N+ +   N EVK+ D G++  + +   R  + IGT
Sbjct: 118 REILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 174

Query: 67  PEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           P +MAPE+       +  Y+   D++S G+  +EM     P  +  +P +    +     
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPA 233

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFL 158
           P   SK    + + FIE C+V    + P  E L+K PF+
Sbjct: 234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 54/166 (32%), Positives = 90/166 (54%), Gaps = 16/166 (9%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-- 61
           I+   RQ+L  L YLHS    IIHRDLK  N+ +   +G++K+ D G++    +   R  
Sbjct: 112 IQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRD 168

Query: 62  SVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
           S IGTP +MAPE      + +  Y+   DI+S G+ ++EM   E P++E  NP ++  K+
Sbjct: 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKI 227

Query: 116 TSGIKPASLSKVT--DPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
               +P +LS+ +    + + F++  +      R  A +LL+ PF+
Sbjct: 228 AKS-EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV 272

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 9/165 (5%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           I    ++IL+GL YLHS     IHRD+K  N+ ++   G+VK+ D G+A  +   Q    
Sbjct: 103 IATMLKEILKGLDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRN 159

Query: 62  SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           + +GTP +MAPE+ ++  Y+   DI+S G+  +E+   E P N   +P ++   +     
Sbjct: 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE-PPNSDMHPMRVLFLIPKNNP 218

Query: 121 PASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 164
           P    + +    K+FI+ C+    S R  A ELLK  F+V +  K
Sbjct: 219 PTLTGEFSK-PFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 55/159 (34%), Positives = 83/159 (52%), Gaps = 13/159 (8%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           R+ILRGL +LH+H   +IHRD+K  N+ +   N EVK+ D G++  + +   R  + IGT
Sbjct: 128 REILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 184

Query: 67  PEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           P +MAPE+       +  Y+   DI+S G+  +EM     P  +  +P +    +     
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPP 243

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFL 158
           P   SK    +   FIE C+V   L  P+ E LLK PF+
Sbjct: 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 48/138 (34%), Positives = 82/138 (59%), Gaps = 12/138 (8%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A +I+  L YLHS    I++RDLK +NI ++   G +K+ D G A  ++  T  ++ GT
Sbjct: 106 YASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDRTW-TLCGT 161

Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PAS 123
           PE++APE+ + + +N+ VD ++ G+ I EM+    P+ +  NP  IY+K+ +G ++ P  
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKLEFPRH 220

Query: 124 LSKVTDPQVKQFIEKCIV 141
           L    D   K  I+K +V
Sbjct: 221 L----DLYAKDLIKKLLV 234

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 51/159 (32%), Positives = 83/159 (52%), Gaps = 8/159 (5%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--AR 61
           I +W  QI  GL   H H+  I+HRD+K  NIF++ N    K+GD G+A  +      A 
Sbjct: 103 ILSWFVQISLGLK--HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160

Query: 62  SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           + +GTP +++PE+ +   YN   DI+S G  + E+ T ++P+ E  N  Q+  K+  G  
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF-EGNNLHQLVLKICQG-Y 218

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFL 158
            A +S      ++  I +    +    P++  +LK PFL
Sbjct: 219 FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 33/101 (32%), Positives = 58/101 (57%), Gaps = 10/101 (9%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           +K++ R +L+G+ Y+H++   I+HRDLK  N+ +   +G +KI D GLA +  +   R  
Sbjct: 101 VKSYMRMLLKGVAYMHANG--IMHRDLKPANLLI-SADGVLKIADFGLARLFSEEEPRLY 157

Query: 64  ---IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTC 98
              + T  + APEL     +Y+  VD+++ G CI  E++  
Sbjct: 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVG-CIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 78.6 bits (193), Expect = 5e-16
 Identities = 60/165 (36%), Positives = 90/165 (54%), Gaps = 19/165 (11%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+ L+ L +LHS+   +IHRD+K DNI + G +G VK+ D G    I  +Q    +++GT
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179

Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI---- 119
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY NE  NP + +Y   T+G     
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQ 237

Query: 120 KPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 163
            P  LS +     + F+ +C+ +    R  A ELL+  FL    P
Sbjct: 238 NPEKLSAI----FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 41/166 (24%), Positives = 77/166 (46%), Gaps = 13/166 (7%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
            K +  +++ G+  LH     IIHRD+K +N+ ++   G +K+ D GL+    +   +  
Sbjct: 99  AKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLEN--KKF 153

Query: 64  IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-- 120
           +GTP+++APE       +++ D +S G  I E +   YP    + P  ++  + S     
Sbjct: 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF-GYPPFHAETPDAVFDNILSRRINW 212

Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPA---LELLKDPFLVTDN 162
           P  + +   P+    I + +    + RL A    E+   PF  + N
Sbjct: 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 52/156 (33%), Positives = 84/156 (53%), Gaps = 10/156 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVI 64
           W  Q+L G+HY+H     I+HRDLK  NIF+  N   +KIGD G++ ++      A +  
Sbjct: 111 WFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKNN--LLKIGDFGVSRLLMGSCDLATTFT 166

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 123
           GTP +M+PE L  + Y+   DI+S G  + EM    + + E +N   +  ++  G  P S
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTP-S 224

Query: 124 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
           L +    Q+   ++  +    SLR  A E+L++PF+
Sbjct: 225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 78.3 bits (193), Expect = 6e-16
 Identities = 37/102 (36%), Positives = 65/102 (63%), Gaps = 6/102 (5%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A +I+ GL +LH     II+RDLK DN+ ++  +G +KI D G+    +  +  A +  
Sbjct: 101 YAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFC 157

Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNEC 105
           GTP+++APE+ + ++YNE VD +SFG+ + EM+  + P++  
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 34/99 (34%), Positives = 58/99 (58%), Gaps = 6/99 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A +I+ GL +LH     II+RDLK DN+ ++   G +KI D G+    ++   T  +  
Sbjct: 101 YAAEIVLGLQFLHERG--IIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILGGVTTSTFC 157

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 102
           GTP+++APE L  + Y   VD ++ G+ + EM+  + P+
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 45/164 (27%), Positives = 83/164 (50%), Gaps = 12/164 (7%)

Query: 11  ILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPE 68
           I++ LHYL   H   +IHRD+K  NI ++  +G VK+ D G++  +    A++   G   
Sbjct: 123 IVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179

Query: 69  FMAPELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA- 122
           +MAPE  +      +Y+   D++S G+ ++E+ T ++PY  CK   ++  K+     P+ 
Sbjct: 180 YMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL 239

Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKD 165
             ++   P    F++ C+     + P   ELL+ PF+      +
Sbjct: 240 PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 59
           K +  +  Q+   L ++HS    ++HRD+K  N+F+    G VK+GDLGL       T  
Sbjct: 106 KTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTA 162

Query: 60  ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTS 117
           A S++GTP +M+PE ++E  YN   DI+S G  + EM   + P Y +  N   + KK+  
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 222

Query: 118 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 155
              P   S     +++Q +  CI P   + P +  + D
Sbjct: 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 38/103 (36%), Positives = 61/103 (59%), Gaps = 7/103 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVI 64
           +A QI+ GL +LH     I++RDLK +N+ ++ ++G V+I DLGLA+ +   +       
Sbjct: 100 YAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRA- 155

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 106
           GTP +MAPE L  E Y+  VD ++ G  + EM+    P+ + K
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 44/121 (36%), Positives = 67/121 (55%), Gaps = 7/121 (5%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--AR 61
           I +W  QI   L   H H+  I+HRD+K  NIF+   +G +K+GD G+A V+      AR
Sbjct: 103 ILDWFVQICLALK--HVHDRKILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELAR 159

Query: 62  SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           + IGTP +++PE+ E   YN   DI++ G  + EM T ++ + E  N   +  K+  G  
Sbjct: 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF-EAGNMKNLVLKIIRGSY 218

Query: 121 P 121
           P
Sbjct: 219 P 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 76.7 bits (188), Expect = 2e-15
 Identities = 58/181 (32%), Positives = 95/181 (52%), Gaps = 14/181 (7%)

Query: 12  LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMA 71
           L+GL YLHSHN  +IHRD+K  NI +    G+VK+ D G A +     A S +GTP +MA
Sbjct: 135 LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIAS--PANSFVGTPYWMA 189

Query: 72  PELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 127
           PE+     E +Y+  VD++S G+  +E+   + P       + +Y  +     P   S  
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPTLQSNE 248

Query: 128 TDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLA 184
                + F++ C+  +P   R  + ELLK  F++ + P+ ++ D + R  + V E+ NL 
Sbjct: 249 WSDYFRNFVDSCLQKIPQD-RPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRELDNLQ 307

Query: 185 H 185
           +
Sbjct: 308 Y 308

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 58/180 (32%), Positives = 90/180 (50%), Gaps = 12/180 (6%)

Query: 12  LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMA 71
           L+GL YLHSHN  +IHRD+K  NI +    G+VK+ D G A       A S +GTP +MA
Sbjct: 131 LQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSS--PANSFVGTPYWMA 185

Query: 72  PELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 127
           PE+     E +Y+  VD++S G+  +E+   + P       + +Y  +     P   S  
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQSNE 244

Query: 128 TDPQVKQFIEKCIVPASLRLPA-LELLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLAH 185
                + F++ C+       PA  ELL+  F+  D P  ++ D + R  + V E+ NL +
Sbjct: 245 WTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELDNLQY 304

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 76.2 bits (187), Expect = 3e-15
 Identities = 59/180 (32%), Positives = 93/180 (51%), Gaps = 12/180 (6%)

Query: 12  LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMA 71
           L+GL YLHSHN  +IHRD+K  NI ++   G VK+GD G A +M    A   +GTP +MA
Sbjct: 125 LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA--PANXFVGTPYWMA 179

Query: 72  PELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 127
           PE+     E +Y+  VD++S G+  +E+   + P       + +Y  +     PA  S  
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGH 238

Query: 128 TDPQVKQFIEKCIVPASLRLPALE-LLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLAH 185
                + F++ C+       P  E LLK  F++ + P  ++ D + R  + V E+ NL +
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQY 298

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 44/101 (43%), Positives = 57/101 (56%), Gaps = 14/101 (13%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQP-----TAR 61
           QIL G+HYLHS+   ++HRDLK  NI V G     G VKIGDLGLA +   P        
Sbjct: 116 QILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173

Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE 99
            V+ T  + APEL      Y + +DI++ G CI  E++T E
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIG-CIFAELLTLE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 74.5 bits (184), Expect = 8e-15
 Identities = 38/100 (38%), Positives = 55/100 (55%), Gaps = 8/100 (8%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS 62
           I++   QIL+GL ++H H     HRDLK +N+ V+G    VKI D GLA  +  +P    
Sbjct: 101 IRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSG-PEVVKIADFGLAREIRSRPPYTD 157

Query: 63  VIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTCE 99
            + T  + APE  L    Y+  VDI++ G CI+ E+ T  
Sbjct: 158 YVSTRWYRAPEILLRSTSYSSPVDIWALG-CIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 42/121 (34%), Positives = 64/121 (52%), Gaps = 6/121 (4%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I  W  Q+  G+   H H   ++HRD+K  NIF+   NG+VK+GD G A ++  P A + 
Sbjct: 102 ILQWFVQMCLGVQ--HIHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYAC 158

Query: 64  --IGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
             +GTP ++ PE++E   YN   DI+S G  + E+ T ++P+        I K      K
Sbjct: 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK 218

Query: 121 P 121
           P
Sbjct: 219 P 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 48/163 (29%), Positives = 81/163 (49%), Gaps = 14/163 (8%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A  +L+GL YLHS    IIHRD+K  NI +    G+VK+ D G++  +    A +  GT 
Sbjct: 111 AESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAGTFTGTS 167

Query: 68  EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 126
            +MAPE +  + Y+   D++S G+ +LE+    +P+     P     ++ S I      +
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227

Query: 127 VTD-PQV--------KQFIEKCIVPASLRLPA-LELLKDPFLV 159
           + D P          K FI++C+     R P   ++L+ P++ 
Sbjct: 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 11/163 (6%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A  +++GL YL S    I+HRD+K  N+ VN   G+VK+ D G++  +    A++ +GT 
Sbjct: 101 AVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTN 157

Query: 68  EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY-----NECK-NPAQIYKKVTSGIK 120
            +MAPE +  E+Y    D++S G+  +E+    +PY     N+    P Q+ + +     
Sbjct: 158 AYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP 217

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD-PFLVTDN 162
           P         +   FI +C+       PA E L D PF+V  N
Sbjct: 218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 40/96 (41%), Positives = 55/96 (57%), Gaps = 13/96 (13%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSV----- 63
           Q+LRGL Y+HS N  +IHRDLK  N+ VN  + E++IGD G+A  +   PT         
Sbjct: 115 QLLRGLKYIHSAN--VIHRDLKPSNLLVNE-DCELRIGDFGMARGLSSSPTEHKYFMTEY 171

Query: 64  IGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMV 96
           + T  + APEL     EY   +D++S G CI  EM+
Sbjct: 172 VATRWYRAPELLLSLPEYTTAIDMWSVG-CIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 3/92 (3%)

Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 70
           +LRGL YL      I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M
Sbjct: 108 VLRGLTYLRE-KHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 165

Query: 71  APE-LYEEEYNELVDIYSFGMCILEMVTCEYP 101
           +PE L    Y    DI+S G+ ++EM    YP
Sbjct: 166 SPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 5/134 (3%)

Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LY 75
           H H+  ++HRD+K  N+F+    G VK+GDLGL       T  A S++GTP +M+PE ++
Sbjct: 121 HMHSRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 76  EEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQ 134
           E  YN   DI+S G  + EM   + P Y +  N   + +K+     P   ++    ++++
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRE 239

Query: 135 FIEKCIVPASLRLP 148
            +  CI P   + P
Sbjct: 240 LVSMCIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 15/163 (9%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--------VMQQP 58
           + +QIL G+ YLH++   ++HRD+K +N+ +   NG +K+ D G A              
Sbjct: 107 YTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVGLHGTHSN 163

Query: 59  TARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVT 116
             +S+ GTP +MAPE+  E  Y    DI+S G  + EM T + P       A + Y    
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH 223

Query: 117 SGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 158
            G+ P  L          F+  C+       P AL+LL+  FL
Sbjct: 224 RGLMP-RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 45/94 (47%), Positives = 56/94 (59%), Gaps = 14/94 (14%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---T 66
           QILRGL Y+HS    IIHRDLK  NI VN +  E+KI D GLA    + T   + G   T
Sbjct: 126 QILRGLKYIHSAG--IIHRDLKPSNIAVNEDC-ELKILDFGLA----RHTDDEMTGYVAT 178

Query: 67  PEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 97
             + APE  L    YN+ VDI+S G CI+ E++T
Sbjct: 179 RWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLT 211

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 52/165 (31%), Positives = 83/165 (50%), Gaps = 19/165 (11%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---PTARSVI 64
           ARQIL G+ YLH  +  I+HRD+K  N+ +N     VKI D G++ ++ Q   P   SV 
Sbjct: 174 ARQILSGIAYLHRRH--IVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSV- 229

Query: 65  GTPEFMAPELYEEEYNELV------DIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVT 116
           GT  +M+PE    + N         DI+S G+ ILE     +P+   +    A +   + 
Sbjct: 230 GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC 289

Query: 117 SGIKPASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLV 159
               P + +  +  + + FI  C+   PA  R  A++LL+ PF++
Sbjct: 290 MSQPPEAPATAS-REFRHFISCCLQREPAK-RWSAMQLLQHPFIL 332

Length = 353

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 73.4 bits (180), Expect = 4e-14
 Identities = 43/95 (45%), Positives = 58/95 (61%), Gaps = 7/95 (7%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVIGTP 67
           +QIL GL YLH+    IIHRD+K +NIF+N  + +V IGDLG A   +  P    + GT 
Sbjct: 164 KQILEGLRYLHAQR--IIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTV 220

Query: 68  EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 101
           E  APE L  ++YN   DI+S G+ + EM+   YP
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLA--YP 253

Length = 357

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 11/153 (7%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           R+ L+GL YLHS     +HRD+K  NI +  +NG+VK+ D G+A  +    A+  S IGT
Sbjct: 113 RETLQGLAYLHSKGK--MHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGT 169

Query: 67  PEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 122
           P +MAPE+   E    YN+L DI++ G+  +E+   + P  +      ++    S  +P 
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPP 229

Query: 123 SLSKVT--DPQVKQFIEKCIVPASLRLPALELL 153
            L   T        F++  +     + P  E L
Sbjct: 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 50/160 (31%), Positives = 83/160 (51%), Gaps = 14/160 (8%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIG 65
           +R+ L+GL+YLHS     +HRD+K  NI +  +NG VK+ D G++  +    A+  S IG
Sbjct: 112 SRETLQGLYYLHSKGK--MHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIG 168

Query: 66  TPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
           TP +MAPE+   E    YN+L DI++ G+  +E+   + P  +      ++    S  +P
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP 228

Query: 122 ASLS---KVTDPQVKQFIEKCIVPASLRLPALE-LLKDPF 157
             L    K ++     F++  +     + P  E LL+ PF
Sbjct: 229 PKLKDKMKWSN-SFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 72.2 bits (177), Expect = 8e-14
 Identities = 40/95 (42%), Positives = 56/95 (58%), Gaps = 6/95 (6%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  QILRGL Y+HS    ++HRDLK  NI +N  N ++KI D GLA + Q P     
Sbjct: 110 IQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARI-QDPQMTGY 165

Query: 64  IGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMV 96
           + T  + APE  L  ++Y+  VDI+S G    EM+
Sbjct: 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 72.0 bits (177), Expect = 9e-14
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 43/222 (19%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+LRGL Y+HS N  ++HRDLK  N+ +N N  ++KI D GL        AR+     +F
Sbjct: 116 QLLRGLKYIHSAN--VLHRDLKPSNLLLNANC-DLKICDFGL--------ARTTSEKGDF 164

Query: 70  M----------APELY--EEEYNELVDIYSFGMCIL-EMVTCE--YPYNECKNPAQIYKK 114
           M          APEL     EY   +D++S G CI  E++  +  +P  +  +  ++  +
Sbjct: 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVG-CIFAELLGRKPLFPGKDYVHQLKLITE 223

Query: 115 VTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-----------ALELLKDPFLVTDNP 163
           +        L  + + + +++I    +P + R             A++LL +  LV D  
Sbjct: 224 LLGSPSEEDLGFIRNEKARRYIRS--LPYTPRQSFARLFPHANPLAIDLL-EKMLVFDPS 280

Query: 164 KDL-VCDPLRLPNLVP-EVMNLAHSEPHPMDIDLNHKKVSAD 203
           K + V + L  P L      +       P   D     ++ +
Sbjct: 281 KRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDALTEE 322

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 42/101 (41%), Positives = 60/101 (59%), Gaps = 12/101 (11%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPT 59
           IK++ +Q+L GL+Y H  N   +HRD+KC NI +N N G++K+ D GLA +      +P 
Sbjct: 118 IKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPY 174

Query: 60  ARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 97
              VI T  +  PEL   EE Y   +D++S G CIL E+ T
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCG-CILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 37/99 (37%), Positives = 56/99 (56%), Gaps = 9/99 (9%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-- 61
           +K    Q+L G+ +LH +   I+HRDLK  N+ +N N G +KI D GLA     P     
Sbjct: 108 VKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYT 164

Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 97
            ++ T  + APEL    +EY+  +D++S G CI  E++T
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVG-CIFAELLT 202

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 44/138 (31%), Positives = 77/138 (55%), Gaps = 11/138 (7%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A +I  GL +LHS    II+RDLK DN+ ++   G +KI D G+    +    T R+  
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFC 162

Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--SGIK 120
           GTP+++APE   Y + Y + VD ++FG+ + EM+  + P+ + ++  ++++ +   +   
Sbjct: 163 GTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSY 220

Query: 121 PASLSKVTDPQVKQFIEK 138
           P SLSK      K  + K
Sbjct: 221 PKSLSKEAVSICKGLLTK 238

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 44/174 (25%), Positives = 80/174 (45%), Gaps = 19/174 (10%)

Query: 8   ARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           A  ++ GL YL++ H   I+HRD+K  NI VN   G++K+ D G++  +    A + +GT
Sbjct: 109 AVAVVEGLTYLYNVHR--IMHRDIKPSNILVNS-RGQIKLCDFGVSGELINSIADTFVGT 165

Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI------ 119
             +M+PE +   +Y    D++S G+ I+E+   ++P+    N     +    GI      
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGILDLLQQ 224

Query: 120 ----KPASLSKVTDPQV-KQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDL 166
                P  L     P+  + F++ C++  P     P       PF+      ++
Sbjct: 225 IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 37/99 (37%), Positives = 57/99 (57%), Gaps = 9/99 (9%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTAR 61
           IK++  Q+L+GL + HSH   I+HRDLK +N+ +N   G +K+ D GLA           
Sbjct: 100 IKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYT 156

Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 97
             + T  + APEL   ++ Y+  VDI+S G CI  E+++
Sbjct: 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVG-CIFAELLS 194

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 68.8 bits (168), Expect = 8e-13
 Identities = 37/100 (37%), Positives = 63/100 (63%), Gaps = 6/100 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A +I+ GL +LHS    I++RDLK DNI ++  +G +KI D G+    ++      +  
Sbjct: 101 YAAEIICGLQFLHSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFC 157

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYN 103
           GTP+++APE L  ++YN  VD +SFG+ + EM+  + P++
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 37/100 (37%), Positives = 62/100 (62%), Gaps = 6/100 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A +I+ GL +LHS    II+RDLK DN+ ++  +G +KI D G+    V     A +  
Sbjct: 101 YAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFGDNRASTFC 157

Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN 103
           GTP+++APE+ +  +Y   VD +SFG+ + EM+  + P++
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 34/102 (33%), Positives = 61/102 (59%), Gaps = 7/102 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +  +I+  L YLHS +  +++RD+K +N+ ++  +G +KI D GL    +    T ++  
Sbjct: 100 YGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFC 156

Query: 65  GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYP-YNE 104
           GTPE++APE+ E+ +Y   VD +  G+ + EM+    P YN+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 39/94 (41%), Positives = 55/94 (58%), Gaps = 7/94 (7%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP 67
           QILRG+ + HSHN  IIHRD+K +NI V+  +G VK+ D G A  +  P       + T 
Sbjct: 108 QILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATR 164

Query: 68  EFMAPELY--EEEYNELVDIYSFGMCILEMVTCE 99
            + APEL   + +Y   VDI++ G  + EM+T E
Sbjct: 165 WYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 39/98 (39%), Positives = 56/98 (57%), Gaps = 12/98 (12%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N  N ++KI D GLA +       +      +
Sbjct: 114 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYV 170

Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTCE 99
            T  + APE  L  + Y + +DI+S G CIL EM++  
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVG-CILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 35/101 (34%), Positives = 60/101 (59%), Gaps = 10/101 (9%)

Query: 3   AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR- 61
           A++++  Q+L+ + Y HSHN  IIHRD+K +NI V+  +G +K+ D G A  ++   A  
Sbjct: 101 AVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASP 157

Query: 62  --SVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT 97
               + T  + APEL   +  Y + VD+++ G CI+ E++ 
Sbjct: 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIG-CIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 42/225 (18%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS- 62
            + +  Q+LRGL Y+HS N  ++HRDLK  N+F+N  +  +KIGD GLA ++    +   
Sbjct: 116 ARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG 173

Query: 63  ----VIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTC----------------- 98
                + T  + +P   L    Y + +D+++ G CI  EM+T                  
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKPLFAGAHELEQMQLIL 232

Query: 99  -------EYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIVPASL-RL 147
                  E   NE  N    + +   G     L  +    +P+   F+E+ +    + RL
Sbjct: 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292

Query: 148 PALELLKDPFL-VTDNPKD--LVCDPLRLPNLVPEVMNLAHSEPH 189
            A E L  P++     P D  +   P  + + + +++ +      
Sbjct: 293 TAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIHSI 337

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 7/136 (5%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTP 67
           Q++  L YLH     I+HRDL  +NI + G + +V I D GLA   +QP ++  SV+GT 
Sbjct: 121 QMVLALRYLHKEKR-IVHRDLTPNNIML-GEDDKVTITDFGLA-KQKQPESKLTSVVGTI 177

Query: 68  EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 126
            +  PE+ + E Y E  D+++FG  + +M T + P+    N   +  K+   +       
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEG 236

Query: 127 VTDPQVKQFIEKCIVP 142
           +    V   I  C+ P
Sbjct: 237 MYSEDVTDVITSCLTP 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 5/102 (4%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 65
           +A +I  GL  LH     I++RDLK +NI ++ + G ++I DLGLA+ + +  T R  +G
Sbjct: 107 YAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVG 163

Query: 66  TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK 106
           T  +MAPE+ + E Y    D +  G  I EM+  + P+ + K
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 38/97 (39%), Positives = 50/97 (51%), Gaps = 12/97 (12%)

Query: 3   AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---- 58
            +K    Q+LRGL YLH +   IIHRDLK  N+ +    G +KI D GLA     P    
Sbjct: 109 QVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPM 165

Query: 59  TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL 93
           T + V  T  + APEL      Y   +D+++ G CIL
Sbjct: 166 TPKVV--TLWYRAPELLLGCTTYTTAIDMWAVG-CIL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 66.3 bits (162), Expect = 9e-12
 Identities = 39/94 (41%), Positives = 54/94 (57%), Gaps = 9/94 (9%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           +K +  QILRGL YLHS    I+HRD+K  N+ VN +N  +KI D GLA V +   ++ +
Sbjct: 105 VKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDESKHM 161

Query: 64  ---IGTPEFMAPELY--EEEYNELVDIYSFGMCI 92
              + T  + APE+      Y   VDI+S G CI
Sbjct: 162 TQEVVTQYYRAPEILMGSRHYTSAVDIWSVG-CI 194

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 39/110 (35%), Positives = 54/110 (49%), Gaps = 20/110 (18%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPT 59
           IK +  Q+L G++YLH ++  I+HRD+K  NI ++ N G +KI D GLA         P 
Sbjct: 117 IKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPK 173

Query: 60  ARSVIGTPEFM---------APELY--EEEYNELVDIYSFGMCIL-EMVT 97
                GT ++           PEL   E  Y   VDI+  G C+  EM T
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG-CVFAEMFT 222

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 13/157 (8%)

Query: 11  ILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPE 68
            ++ L+YL       IIHRD+K  NI ++  NG +K+ D G++  +    A++   G   
Sbjct: 116 TVKALNYLKEELK--IIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDSIAKTRDAGCRP 172

Query: 69  FMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKP 121
           +MAPE  +      Y+   D++S G+ + E+ T ++PY +  +      +V  G   I  
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232

Query: 122 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPF 157
            S  +   P    FI  C++   S R    ELL+ PF
Sbjct: 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 38/95 (40%), Positives = 52/95 (54%), Gaps = 7/95 (7%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIG 65
           R +LR + YLH     IIHRD+K +NIF+N + G+V +GD G A   + +         G
Sbjct: 189 RSVLRAIQYLH--ENRIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYGWAG 245

Query: 66  TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCE 99
           T    APEL   + Y   VDI+S G+ + EM TC 
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 43/137 (31%), Positives = 73/137 (53%), Gaps = 9/137 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A ++   L +LH H   +I+RDLK DNI ++   G  K+ D G+    ++   T  +  
Sbjct: 101 YAAEVTLALMFLHRHG--VIYRDLKLDNILLDA-EGHCKLADFGMCKEGILNGVTTTTFC 157

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP 121
           GTP+++APE L E EY   VD ++ G+ + EM+  + P+ E  N   +++ +     + P
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYP 216

Query: 122 ASLSKVTDPQVKQFIEK 138
             LSK     +K F+ K
Sbjct: 217 VWLSKEAVSILKAFMTK 233

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 41/96 (42%), Positives = 57/96 (59%), Gaps = 5/96 (5%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTA 60
           + IK+   Q+LRGL +LHSH   ++HRDLK  NI V  ++G++K+ D GLA I   Q   
Sbjct: 110 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMAL 166

Query: 61  RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 95
            SV+ T  + APE L +  Y   VD++S G    EM
Sbjct: 167 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 35/84 (41%), Positives = 50/84 (59%), Gaps = 8/84 (9%)

Query: 21  HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPE-LYEE 77
           H    IHRDLK +N F+   +G +K+ D GL+  IV     A SV+G+P++MAPE L  +
Sbjct: 118 HELGYIHRDLKPEN-FLIDASGHIKLTDFGLSKGIVTY---ANSVVGSPDYMAPEVLRGK 173

Query: 78  EYNELVDIYSFGMCILEMVTCEYP 101
            Y+  VD +S G C+L    C +P
Sbjct: 174 GYDFTVDYWSLG-CMLYEFLCGFP 196

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 37/115 (32%), Positives = 69/115 (60%), Gaps = 6/115 (5%)

Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
           K +  +++    YLHS +  II+RDLK +N+ ++ N G VK+ D G A  +   T  ++ 
Sbjct: 121 KFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDRTF-TLC 176

Query: 65  GTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           GTPE++APE+ + + + + VD ++ G+ + E +    P+ +   P +IY+K+ +G
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAG 230

Length = 329

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 36/98 (36%), Positives = 52/98 (53%), Gaps = 12/98 (12%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA------IVMQQ 57
            +++  QIL GL Y+HS N  ++HRDLK  N+ VN  + E+KI D GLA           
Sbjct: 107 FQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNA-DCELKICDFGLARGFSENPGENA 163

Query: 58  PTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL 93
                 + T  + APE  L  + Y + +D++S G CIL
Sbjct: 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVG-CIL 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 39/101 (38%), Positives = 56/101 (55%), Gaps = 7/101 (6%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 58
           +  IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  
Sbjct: 99  LPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVR 155

Query: 59  TARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
           T    + T  + APE  L  + Y+  VDI+S G    EMVT
Sbjct: 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 56/176 (31%), Positives = 87/176 (49%), Gaps = 26/176 (14%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-----I 64
           Q+LR L Y+H+ N  + HRDLK  NI  N  + ++KI D GLA V    T  ++     +
Sbjct: 111 QLLRALKYIHTAN--VFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYV 167

Query: 65  GTPEFMAPEL---YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-- 119
            T  + APEL   +  +Y   +DI+S G CI   V    P    KN       +T  +  
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIG-CIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226

Query: 120 -KPASLSKVTDPQVKQFI----EKCIVPASLRLP-----ALELLKDPFLVTDNPKD 165
             P ++S+V + + ++++    +K  VP S + P     AL LL+   L+  +PKD
Sbjct: 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLER--LLAFDPKD 280

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 37/109 (33%), Positives = 65/109 (59%), Gaps = 7/109 (6%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QP 58
           M+ + +++ QI  G+  LH H+  I++RD+K +N+ ++ + G  ++ DLGLA+ ++  + 
Sbjct: 94  MERVIHYSAQITCGI--LHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKT 150

Query: 59  TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 106
             +   GT  +MAPE L EE Y+  VD ++ G  I EMV    P+ + K
Sbjct: 151 ITQRA-GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 39/101 (38%), Positives = 58/101 (57%), Gaps = 13/101 (12%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPT 59
           IK++  Q+L+G+ Y HSH   ++HRDLK  N+ ++   G +K+ D GLA    + ++  T
Sbjct: 101 IKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYT 157

Query: 60  ARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 97
              V  T  + APE  L   +Y+  VDI+S G CI  EMV 
Sbjct: 158 HEVV--TLWYRAPEILLGSRQYSTPVDIWSIG-CIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 34/100 (34%), Positives = 62/100 (62%), Gaps = 6/100 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A +I  GL +LH     II+RDLK DN+ ++ + G +KI D G+    ++   T R+  
Sbjct: 106 YAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFC 162

Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN 103
           GTP+++APE+   + Y + VD +++G+ + EM+  + P++
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 60/193 (31%), Positives = 94/193 (48%), Gaps = 18/193 (9%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A +I   L YLHS N  II+RDLK +NI ++ + G V + D GL    +    T  +  
Sbjct: 101 YAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFC 157

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 123
           GTPE++APE L ++ Y+  VD +  G  + EM+    P+   ++ A++Y  + +  KP  
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRDTAEMYDNILN--KPLR 214

Query: 124 LSKVTDPQVKQFIEKCIVP-ASLRLPA----LELLKDPFLVTDNPKDLVCDPLRLPNLVP 178
           L        +  +E  +    + RL A    LE+    F  + N  DLV   +  P   P
Sbjct: 215 LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPP-FNP 273

Query: 179 EV---MNLAHSEP 188
            V   M+L H +P
Sbjct: 274 NVSGPMDLKHFDP 286

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 36/92 (39%), Positives = 55/92 (59%), Gaps = 3/92 (3%)

Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 70
           +LRGL YL   +  I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M
Sbjct: 112 VLRGLAYLREKHQ-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 169

Query: 71  APE-LYEEEYNELVDIYSFGMCILEMVTCEYP 101
           +PE L    Y+   DI+S G+ ++E+    YP
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 40/125 (32%), Positives = 74/125 (59%), Gaps = 9/125 (7%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A +I  GL +LHS    II+RDLK DN+ ++ + G +KI D G+    +    T ++  
Sbjct: 106 YAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFC 162

Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP 121
           GTP+++APE+   + Y + VD ++FG+ + EM+  + P+ E ++  ++++ +       P
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYP 221

Query: 122 ASLSK 126
            S+SK
Sbjct: 222 KSMSK 226

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 22/169 (13%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVI 64
           ++ +I   L++LH     II+RDLK DN+ ++   G +K+ D G+     +P  T  +  
Sbjct: 101 YSAEISLALNFLHERG--IIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRPGDTTSTFC 157

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 123
           GTP ++APE L  E+Y   VD ++ G+ + EM+    P++              G+    
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD------------IVGMSDNP 205

Query: 124 LSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPKD-LVCDP 170
                D   +  +EK I +P SL + A  +LK  FL   +PK+ L C P
Sbjct: 206 DQNTEDYLFQVILEKQIRIPRSLSVKASSVLKG-FL-NKDPKERLGCHP 252

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 36/102 (35%), Positives = 48/102 (47%), Gaps = 22/102 (21%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----------IVMQQ 57
            QIL GL+ LH      +HRDL   NIF+N + G  KI D GLA           +   +
Sbjct: 126 LQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDE 182

Query: 58  PTARSVIGTPE-----FMAPELY--EEEYNELVDIYSFGMCI 92
              R    T +     + APEL    E+Y+  VD++S G CI
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG-CI 223

Length = 335

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 48/152 (31%), Positives = 81/152 (53%), Gaps = 16/152 (10%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 65
           +A +I  GL  LH     I++RDLK +NI ++ ++G ++I DLGLA+ V +  T +  +G
Sbjct: 107 YAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVG 163

Query: 66  TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 124
           T  +MAPE+ + E Y    D ++ G  + EM+  + P+ + K      KK    IK   +
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK------KK----IKREEV 213

Query: 125 SKVTDPQVKQFIEKCIVPASLRLPALELLKDP 156
            ++     +++ EK   P +  L  + L KDP
Sbjct: 214 ERLVKEVQEEYSEK-FSPDARSLCKMLLCKDP 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.5 bits (157), Expect = 5e-11
 Identities = 34/99 (34%), Positives = 62/99 (62%), Gaps = 8/99 (8%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----AIVMQQPTARSVIG 65
           Q+L  +H++HS +  +IHRD+K  NI +  +NG VK+GD G     A  +     R+  G
Sbjct: 151 QVLLAVHHVHSKH--MIHRDIKSANILL-CSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207

Query: 66  TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYN 103
           TP ++APE++  + Y++  D++S G+ + E++T + P++
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 64.3 bits (156), Expect = 5e-11
 Identities = 35/113 (30%), Positives = 65/113 (57%), Gaps = 9/113 (7%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSV--IG 65
           +Q+L  + Y+H     +IHRD+K +NIF+N  +G++ +GD G A+  ++   A     +G
Sbjct: 274 KQLLCAVEYIHDKK--LIHRDIKLENIFLNC-DGKIVLGDFGTAMPFEKEREAFDYGWVG 330

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY-PYNE-CKNPAQIYKKV 115
           T    +PE L  + Y E+ DI+S G+ +L+M++ ++ P  +    P +   K+
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383

Length = 501

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 45/135 (33%), Positives = 71/135 (52%), Gaps = 14/135 (10%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---T 66
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA    + T   + G   T
Sbjct: 128 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA----RHTDDEMTGYVAT 180

Query: 67  PEFMAPELYEE--EYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPA 122
             + APE+      YN+ VDI+S G  + E++T    +P  +  +  ++  ++       
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240

Query: 123 SLSKVTDPQVKQFIE 137
            L K++    + +I+
Sbjct: 241 LLKKISSESARNYIQ 255

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 63.2 bits (153), Expect = 8e-11
 Identities = 36/102 (35%), Positives = 60/102 (58%), Gaps = 7/102 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +  +I+  L YLHS    I++RDLK +N+ ++  +G +KI D GL    +    T ++  
Sbjct: 100 YGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTFC 156

Query: 65  GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYP-YNE 104
           GTPE++APE+ E+ +Y   VD +  G+ + EM+    P YN+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 62.5 bits (152), Expect = 9e-11
 Identities = 37/100 (37%), Positives = 51/100 (51%), Gaps = 6/100 (6%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
           K IK++  Q+L+G+ + H H   ++HRDLK  N+ V+   G +KI DLGL      P   
Sbjct: 110 KTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167

Query: 62  SV--IGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
               I T  + APE  L    Y+  VDI+S G    EM  
Sbjct: 168 YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 62.0 bits (151), Expect = 9e-11
 Identities = 41/125 (32%), Positives = 61/125 (48%), Gaps = 27/125 (21%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---------IVMQ 56
           ++A QI  G+ YL S     IHRDL   NI +  ++ +VKIGD GL           VM+
Sbjct: 101 DYAVQIANGMRYLESKR--FIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVME 157

Query: 57  Q----PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQ 110
           +    P A        + APE L    ++   D++ FG+ + EM T  E P+    + +Q
Sbjct: 158 EHLKVPFA--------WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQ 208

Query: 111 IYKKV 115
           I KK+
Sbjct: 209 ILKKI 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 41/97 (42%), Positives = 56/97 (57%), Gaps = 5/97 (5%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPT 59
            + IK+  RQ LRGL +LH++   I+HRDLK +NI V  + G+VK+ D GLA I   Q  
Sbjct: 107 AETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMA 163

Query: 60  ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 95
              V+ T  + APE L +  Y   VD++S G    EM
Sbjct: 164 LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 36/98 (36%), Positives = 57/98 (58%), Gaps = 5/98 (5%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 65
           +A +IL GL  LH  N   ++RDLK +NI ++ + G ++I DLGLA+ + +  + R  +G
Sbjct: 107 YAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVG 163

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 102
           T  +MAPE L  + Y    D +  G  I EM+  + P+
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 35/102 (34%), Positives = 60/102 (58%), Gaps = 6/102 (5%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +  +I+  L YLHS    +++RDLK +N+ ++  +G +KI D GL    +    T ++  
Sbjct: 100 YGAEIVSALDYLHSEKN-VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFC 157

Query: 65  GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYP-YNE 104
           GTPE++APE+ E+ +Y   VD +  G+ + EM+    P YN+
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 61.8 bits (151), Expect = 1e-10
 Identities = 33/146 (22%), Positives = 64/146 (43%), Gaps = 20/146 (13%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
             +K   RQ++  L+ LH HN  IIH D+K +N+  +     + + D GL  ++  P+  
Sbjct: 109 AEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY 166

Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY----NECKNPAQ----IY 112
              GT ++ +PE +    Y+   D ++ G+   E++T ++P+    +E  +         
Sbjct: 167 D--GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ 224

Query: 113 KKVTSGIKPASLSKVTDPQVKQFIEK 138
           KK+          K        F++ 
Sbjct: 225 KKLP-------FIKNVSKNANDFVQS 243

Length = 267

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 45/151 (29%), Positives = 79/151 (52%), Gaps = 12/151 (7%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A +I   L +LH     II+RDLK DN+ ++ + G  K+ D G+    +    T  +  
Sbjct: 101 YAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFC 157

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP 121
           GTP+++APE L E  Y   VD ++ G+ + EM+    P+ E +N   +++ + +   + P
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYP 216

Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPALEL 152
             LS+     +K F+ K     ++RL +L L
Sbjct: 217 TWLSQDAVDILKAFMTK---NPTMRLGSLTL 244

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 42/134 (31%), Positives = 71/134 (52%), Gaps = 9/134 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVI 64
           +A +I   L YLHS N  I++RDLK +NI ++ + G + + D GL     +   T  +  
Sbjct: 101 YAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFC 157

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 123
           GTPE++APE L+++ Y+  VD +  G  + EM+    P+   +N A++Y  + +  KP  
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILN--KPLQ 214

Query: 124 LSKVTDPQVKQFIE 137
           L        +  +E
Sbjct: 215 LKPNITNSARHLLE 228

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 20/157 (12%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIG 65
           A Q+  G+ YL + N   IHRDL   N+ V G N   K+ D GLA V+++    AR    
Sbjct: 109 AAQVASGMAYLEAQN--YIHRDLAARNVLV-GENNICKVADFGLARVIKEDIYEAREGAK 165

Query: 66  TP-EFMAPELYEEEYNELV---DIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 120
            P ++ APE     YN      D++SFG+ + E+VT    PY    N A++ ++V  G +
Sbjct: 166 FPIKWTAPE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQQVDQGYR 222

Query: 121 ---PASLSKVTDPQVKQFIEKCIVPASLRLPALELLK 154
              P         ++   +  C        P  E L+
Sbjct: 223 MPCPPG----CPKELYDIMLDCWKEDPDDRPTFETLQ 255

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 38/98 (38%), Positives = 51/98 (52%), Gaps = 6/98 (6%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK +  QILRG+ Y HSH   ++HRDLK  N+ ++     +K+ D GLA     P  T  
Sbjct: 104 IKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161

Query: 62  SVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
             + T  + APE  L    Y+  VDI+S G    EMV 
Sbjct: 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 3/92 (3%)

Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 70
           +++GL YL   +  I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M
Sbjct: 112 VIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 169

Query: 71  APE-LYEEEYNELVDIYSFGMCILEMVTCEYP 101
           +PE L    Y+   DI+S G+ ++EM    YP
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 38/114 (33%), Positives = 56/114 (49%), Gaps = 24/114 (21%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----------PT 59
           +I   + Y+HS    ++HRDLK DNI + G  GEV I D G AI  +             
Sbjct: 121 KICATIEYVHSKG--VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 60  ARS----------VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 102
                        ++GTP++MAPE L     +E  DIY+ G+ + +M+T  +PY
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 33/96 (34%), Positives = 58/96 (60%), Gaps = 6/96 (6%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTP 67
           +I+  L YLHS +  +++RDLK +N+ ++  +G +KI D GL    +    T ++  GTP
Sbjct: 103 EIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTP 159

Query: 68  EFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY 102
           E++APE+ E+ +Y   VD +  G+ + EM+    P+
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 68/218 (31%), Positives = 95/218 (43%), Gaps = 39/218 (17%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+L GL Y+HS    IIHRDLK  N+ VN  + E+KI D GLA          V+ T  +
Sbjct: 125 QMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGYVV-TRWY 180

Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + EM+T +  +       Q+ +  KVT    P  + 
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240

Query: 126 KVTDPQVKQFIEKCIVPA------SLRLP-----ALELLKDPFLVTDNPKDLVC------ 168
           K+ D   K +I+   +P       S   P     A++LL +  L  D  K L        
Sbjct: 241 KLEDKAAKSYIKS--LPKYPRKDFSTLFPKASPQAVDLL-EKMLELDVDKRLTATEALEH 297

Query: 169 ---DPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSAD 203
              D  R  +           E  P D  L ++K+S D
Sbjct: 298 PYFDSFRDADEET--------EQQPYDDSLENEKLSVD 327

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 61.8 bits (151), Expect = 2e-10
 Identities = 38/99 (38%), Positives = 53/99 (53%), Gaps = 14/99 (14%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQQPTARS 62
           Q+L+ L Y+HS N  +IHRDLK  NI +N ++  VK+ D GLA          + P    
Sbjct: 115 QLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEENPENPVLTD 171

Query: 63  VIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTC 98
            + T  + APE  L    Y + VD++S G CIL EM+  
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVG-CILGEMLLG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 7/98 (7%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-- 61
           IK    Q L+ +++ H HN   IHRD+K +NI +    G++K+ D G A ++  P     
Sbjct: 102 IKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYT 158

Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 97
             + T  + APEL   + +Y   VD+++ G    E++T
Sbjct: 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 29/100 (29%), Positives = 52/100 (52%), Gaps = 9/100 (9%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPT 59
           K +K++  Q+L+ L ++H +   I HRD+K +NI +  +   +K+ D G    I  + P 
Sbjct: 100 KRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPY 155

Query: 60  ARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
               I T  + APE  L +  Y   +DI++ G    E+++
Sbjct: 156 T-EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 52/171 (30%), Positives = 83/171 (48%), Gaps = 26/171 (15%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVI 64
           ++ +I   L+YLH     II+RDLK DN+ ++ + G +K+ D G+     +P  T  +  
Sbjct: 101 YSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFC 157

Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIK 120
           GTP ++APE+   E+Y   VD ++ G+ + EM+    P++      NP Q          
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ---------- 207

Query: 121 PASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 170
                   D   +  +EK I +P SL + A  +LK  FL  D  + L C P
Sbjct: 208 -----NTEDYLFQVILEKQIRIPRSLSVKAASVLKS-FLNKDPKERLGCHP 252

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 49/195 (25%), Positives = 77/195 (39%), Gaps = 51/195 (26%)

Query: 6   NWAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------ 55
             AR    +++  L  +H      IHRD+K DNI +   +G +K+ D GL   M      
Sbjct: 101 ETARFYIAELVLALDSVHKLG--FIHRDIKPDNILI-DADGHIKLADFGLCKKMNKAKDR 157

Query: 56  -----------------------QQPT--ARSVIGTPEFMAPE-LYEEEYNELVDIYSFG 89
                                  +Q    A S +GTP+++APE L    Y    D +S G
Sbjct: 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG 217

Query: 90  MCILEMVTCEYP--YNECKNPAQIYKKVTSGIKPASLSKVTDPQV----KQFIEKCIVPA 143
           + + EM+   +P  Y++     + Y K+ +  +  SL    DP V       I + +   
Sbjct: 218 VILYEMLY-GFPPFYSD--TLQETYNKIINWKE--SLRFPPDPPVSPEAIDLICRLLCDP 272

Query: 144 SLRL-PALELLKDPF 157
             RL    E+   PF
Sbjct: 273 EDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 35/99 (35%), Positives = 58/99 (58%), Gaps = 9/99 (9%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           +K++  Q+L+G+ + H +   ++HRDLK  N+ +N   GE+K+ D GLA     P  T  
Sbjct: 102 VKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFS 158

Query: 62  SVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 97
           + + T  + AP+  L    Y+  +DI+S G CI+ EM+T
Sbjct: 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVG-CIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 22/161 (13%)

Query: 12  LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEF 69
           L GL +LH  N  IIHRD+K +NI +    G VK+ D G++  +     R  + +GTP +
Sbjct: 138 LLGLQHLH--NNRIIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFW 194

Query: 70  MAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 123
           MAPE+      Y+  Y+   D++S G+  +E+   + P  +  +P +   K+     P  
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD-MHPVKTLFKIPRNPPPTL 253

Query: 124 LSKVTDPQ-----VKQFIEKCIVPASLRLPAL-ELLKDPFL 158
           L     P+        FI +C++      P++  LL+ PF+
Sbjct: 254 L----HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 60.5 bits (146), Expect = 5e-10
 Identities = 41/113 (36%), Positives = 59/113 (52%), Gaps = 13/113 (11%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA 60
           +K+   QIL G+HYLH++   ++HRDLK  NI V G     G VKI D+G A +   P  
Sbjct: 110 VKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167

Query: 61  -----RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECK 106
                  V+ T  + APEL      Y + +DI++ G    E++T E P   C+
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 60.5 bits (146), Expect = 5e-10
 Identities = 41/113 (36%), Positives = 59/113 (52%), Gaps = 13/113 (11%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA 60
           +K+   QIL G+HYLH++   ++HRDLK  NI V G     G VKI D+G A +   P  
Sbjct: 110 VKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167

Query: 61  -----RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECK 106
                  V+ T  + APEL      Y + +DI++ G    E++T E P   C+
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCR 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 39/114 (34%), Positives = 64/114 (56%), Gaps = 7/114 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVI 64
           +A ++   + YLHS N  II+RDLK +NI ++ + G V + D GL     +P  T  +  
Sbjct: 101 YAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFC 157

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
           GTPE++APE L +E Y+  VD +  G  + EM+    P+   ++ +Q+Y  +  
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILH 210

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.1 bits (148), Expect = 6e-10
 Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSV 63
           ARQ+L  + Y+H     IIHRD+K +N+ VNG   ++ +GD G A   +     P    +
Sbjct: 266 ARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGI 322

Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILE 94
            GT +  APE L  + Y   VDI+S G+ I E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 34/107 (31%), Positives = 61/107 (57%), Gaps = 5/107 (4%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
           K ++ +A +I+ GL   H HN  +++RDLK  NI ++  +G V+I DLGLA    +    
Sbjct: 97  KEMRFYATEIILGLE--HMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH 153

Query: 62  SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECK 106
           + +GT  +MAPE+ ++   Y+   D +S G  + +++    P+ + K
Sbjct: 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.3 bits (146), Expect = 7e-10
 Identities = 34/113 (30%), Positives = 63/113 (55%), Gaps = 8/113 (7%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL--AIVMQQPTARSVIGTP 67
           +++  L +LH ++  I++RDLK +NI ++   G + + D GL  A +    T  +  GT 
Sbjct: 104 ELVLALEHLHKYD--IVYRDLKPENILLDA-TGHIALCDFGLSKANLTDNKTTNTFCGTT 160

Query: 68  EFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           E++APE+  +E  Y + VD +S G+ + EM     P+   ++  Q+Y+ +  G
Sbjct: 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF-YAEDTQQMYRNIAFG 212

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 33/107 (30%), Positives = 60/107 (56%), Gaps = 5/107 (4%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
             ++ +A +I+ GL   H HN  +++RDLK  NI ++  +G V+I DLGLA    +    
Sbjct: 97  AEMRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH 153

Query: 62  SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECK 106
           + +GT  +MAPE+ ++   Y+   D +S G  + +++    P+ + K
Sbjct: 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 59.6 bits (144), Expect = 9e-10
 Identities = 39/114 (34%), Positives = 66/114 (57%), Gaps = 7/114 (6%)

Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +A +I   L YLHS N  I++RDLK +NI ++ + G V + D GL    + Q  T  +
Sbjct: 99  RFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTT 155

Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
             GTPE++APE + ++ Y+  VD +  G  + EM+    P+  C++ A++Y  +
Sbjct: 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPF-YCRDVAEMYDNI 208

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 45/137 (32%), Positives = 74/137 (54%), Gaps = 12/137 (8%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YL S N  I++RDLK +N+ ++  +G +K+ D G A V+   T  ++ GT
Sbjct: 136 YAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDTRT-YTLCGT 191

Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKKVTSGIKPAS 123
           PE++APE L    + +  D ++ G+ I E++    P+  NE   P  IY+K+  GI    
Sbjct: 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIYQKILEGI--IY 246

Query: 124 LSKVTDPQVKQFIEKCI 140
             K  D   K  ++K +
Sbjct: 247 FPKFLDNNCKHLMKKLL 263

Length = 340

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 37/129 (28%), Positives = 63/129 (48%), Gaps = 12/129 (9%)

Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY 75
           H H   II+RD+K +NI ++   G V + D GL+          A S  GT E+MAPE+ 
Sbjct: 120 HLHQLGIIYRDIKLENILLDS-EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178

Query: 76  ---EEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKPASLSKVTD 129
                 +++ VD +S G+   E++T   P+    E  + ++I +++     P    K   
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMS 236

Query: 130 PQVKQFIEK 138
            + + FI+K
Sbjct: 237 AEARDFIQK 245

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 35/114 (30%), Positives = 65/114 (57%), Gaps = 7/114 (6%)

Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-- 62
           + +  ++L  L  LH  N  +I+RDLK +NI ++   G + + D GL  +  +   ++  
Sbjct: 96  RFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNT 152

Query: 63  VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
             GTPE++APEL     Y + VD ++ G+ + EM+T   P+ + +N  ++Y+K+
Sbjct: 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKI 205

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 32/87 (36%), Positives = 51/87 (58%), Gaps = 4/87 (4%)

Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPEFMAPELYE 76
           H H+  II+RDLK +NI ++   G +K+ D GL+   +  +  A S  GT E+MAPE+  
Sbjct: 113 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 171

Query: 77  EE-YNELVDIYSFGMCILEMVTCEYPY 102
              + +  D +SFG+ + EM+T   P+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLPF 198

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 36/102 (35%), Positives = 60/102 (58%), Gaps = 13/102 (12%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQ 56
            + +K++  Q+L+GL + HSHN  ++HRDLK  N+ +N  NGE+K+ D GLA    I ++
Sbjct: 98  PEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVR 154

Query: 57  QPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCIL-EM 95
             +A  V  T  +  P+     + Y+  +D++S G CI  E+
Sbjct: 155 CYSAEVV--TLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 60.1 bits (145), Expect = 2e-09
 Identities = 43/141 (30%), Positives = 71/141 (50%), Gaps = 25/141 (17%)

Query: 3   AIKNWARQILRGLHYLHS-----HNPPIIHRDLKCDNIFV--------------NGNNGE 43
           AI +  RQ+L  L Y H+     +   ++HRDLK  NIF+              N  NG 
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178

Query: 44  --VKIGDLGLAI-VMQQPTARSVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVT 97
              KIGD GL+  +  +  A S +GTP + +PEL   E   Y++  D+++ G  I E+ +
Sbjct: 179 PIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238

Query: 98  CEYPYNECKNPAQIYKKVTSG 118
            + P+++  N +Q+  ++  G
Sbjct: 239 GKTPFHKANNFSQLISELKRG 259

Length = 1021

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 24/169 (14%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVI 64
           +A +I   L++LH     II+RDLK DN+ ++  +G +K+ D G+      P  T  +  
Sbjct: 101 YAAEICIALNFLHERG--IIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGPGDTTSTFC 157

Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN-ECKNPAQIYKKVTSGIKPA 122
           GTP ++APE+   EEY   VD ++ G+ + EM+    P++    NP              
Sbjct: 158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM------------ 205

Query: 123 SLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 170
                 D   +  +EK I +P  L + A  +LK  FL  D  + L C P
Sbjct: 206 ---NTEDYLFQVILEKPIRIPRFLSVKASHVLKG-FLNKDPKERLGCQP 250

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 41/116 (35%), Positives = 65/116 (56%), Gaps = 13/116 (11%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIG 65
           QI+  L  +HS    ++HRDLK  NIF+    G +K+GD G +           A S  G
Sbjct: 177 QIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFSKQYSDSVSLDVASSFCG 233

Query: 66  TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ--IYKKVTSG 118
           TP ++APEL+E + Y++  D++S G+ + E++T   P+   K P+Q  I ++V  G
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQVLYG 286

Length = 478

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 54/200 (27%), Positives = 80/200 (40%), Gaps = 57/200 (28%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----- 58
           IK   + +L GL+Y+H +   I+HRD+K  NI +   +G +K+ D GLA           
Sbjct: 121 IKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLADFGLARAFSLSKNSKP 177

Query: 59  ---TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVT--------------- 97
              T R V  T  +  PEL   E +Y   +D++  G CI+ EM T               
Sbjct: 178 NRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAG-CIMAEMWTRSPIMQGNTEQHQLT 234

Query: 98  -----C------------EYP-YNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 139
                C            +   + + + P    +KV   +KP     V DP     I+K 
Sbjct: 235 LISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP----YVKDPHALDLIDKL 290

Query: 140 IV--PASLRLPALELLKDPF 157
           +V  PA  R+ A   L   F
Sbjct: 291 LVLDPAK-RIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 44/132 (33%), Positives = 69/132 (52%), Gaps = 8/132 (6%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+LRGL Y+HS    IIHRDLK  N+ VN  + E++I D GLA           + T  +
Sbjct: 126 QLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQADDEMT-GYVATRWY 181

Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++  +  +P N+  +  +   +V     P  L 
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241

Query: 126 KVTDPQVKQFIE 137
           K++    +++I+
Sbjct: 242 KISSEHARKYIQ 253

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 30/102 (29%), Positives = 49/102 (48%), Gaps = 10/102 (9%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
           + + NW  QI +G+ YL      ++HRDL   N+ V      VKI D GLA  +     +
Sbjct: 109 QYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQ-HVKITDFGLA-KLLDVDEK 164

Query: 62  SVIGT----P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                    P ++MA E +    Y    D++S+G+ + E++T
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 38/90 (42%), Positives = 51/90 (56%), Gaps = 6/90 (6%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+L+GL Y+H+    IIHRDLK  N+ VN  + E+KI D GLA          V+ T  +
Sbjct: 126 QMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSEMTGYVV-TRWY 181

Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            APE  L    Y + VDI+S G  + EM+T
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 35/102 (34%), Positives = 58/102 (56%), Gaps = 5/102 (4%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 65
           +A ++  GL  L      I++RDLK +NI ++ + G ++I DLGLA+ + +  T R  +G
Sbjct: 107 YAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVG 163

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECK 106
           T  +MAPE +  E+Y    D +  G  I EM+  + P+ + K
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 32/122 (26%), Positives = 59/122 (48%), Gaps = 11/122 (9%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPT 59
           +K  A Q+  G+ YL S +   +HRDL   N+ +  N  + KI D G++  +        
Sbjct: 97  LKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYR 153

Query: 60  ARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVT 116
           A +    P ++ APE +   +++   D++S+G+ + E  +    PY E K   ++   + 
Sbjct: 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLE 212

Query: 117 SG 118
           SG
Sbjct: 213 SG 214

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 13/105 (12%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQ---QPTA 60
             A +I  G+ YL +     +HRDL   N  V  +   VKIGD G+   I      +   
Sbjct: 123 QMAAEIADGMAYLAAKK--FVHRDLAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGG 179

Query: 61  RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPY 102
           + ++  P  +MAPE L +  +    D++SFG+ + EM T  E PY
Sbjct: 180 KGLL--PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 34/103 (33%), Positives = 56/103 (54%), Gaps = 9/103 (8%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 58
           +K    +A QI +G+ YL S     +HRDL   N+ V  +  +VKIGD GL   ++    
Sbjct: 108 LKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKE 164

Query: 59  --TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 97
             T +  + +P F  APE L + ++    D++SFG+ + E++T
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 7/101 (6%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           M  +K +  Q+LRGL Y H     I+HRDLK  N+ +N   GE+K+ D GLA     PT 
Sbjct: 102 MHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTK 158

Query: 61  --RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
              + + T  +  P+  L   EY+  +D++  G  + EM T
Sbjct: 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 9/154 (5%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSV 63
           + A Q+  G+ YL   N   IHRDL   NI V G +   K+ D GLA ++++    +   
Sbjct: 108 DMACQVAEGMAYLEEQN--SIHRDLAARNILV-GEDLVCKVADFGLARLIKEDVYLSSDK 164

Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP 121
               ++ APE      ++   D++SFG+ + EM T  + PY    N  ++Y ++T+G + 
Sbjct: 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAGYRM 223

Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 155
              +K    ++ + + +C        P+ + L++
Sbjct: 224 PCPAKCP-QEIYKIMLECWAAEPEDRPSFKALRE 256

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 41/146 (28%), Positives = 77/146 (52%), Gaps = 21/146 (14%)

Query: 15  LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMA 71
           +H LH      +HRD+K DNI ++  NG +++ D G  + +M+  T +S   +GTP++++
Sbjct: 118 VHQLH-----YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 72  PELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----P 121
           PE+ +       +Y    D +S G+C+ EM+  E P+   ++  + Y K+ +  +    P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQFP 230

Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRL 147
           A ++ V++   K  I + I     RL
Sbjct: 231 AQVTDVSE-DAKDLIRRLICSREHRL 255

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 37/100 (37%), Positives = 53/100 (53%), Gaps = 11/100 (11%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----T 59
           +K++  QIL+G+ + HS    ++HRDLK  N+ ++ N G +K+ D GLA     P    T
Sbjct: 103 VKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYT 159

Query: 60  ARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
              V  T  + APE  L    Y+  VDI+S G    EM T
Sbjct: 160 HEVV--TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 18/171 (10%)

Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELY 75
           H H   II+RD+K +NI ++ +NG V + D GL+      +   A S  GT E+MAP++ 
Sbjct: 120 HLHKLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 76  ---EEEYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTD 129
              +  +++ VD +S G+ + E++T   P+    E  + A+I +++     P    +   
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMS 236

Query: 130 PQVKQFIEKCIVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLP 174
              K  I++ ++     RL      A E+ K PF    N  DL    +  P
Sbjct: 237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVPAP 287

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 40/144 (27%), Positives = 78/144 (54%), Gaps = 17/144 (11%)

Query: 18  LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARS--VIGTPEFMAPE 73
           +HS H    +HRD+K DN+ ++  NG +++ D G  + M Q  T +S   +GTP++++PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 74  LYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----PAS 123
           + +       +Y    D +S G+C+ EM+  E P+   ++  + Y K+ +  +    P+ 
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHEERFQFPSH 232

Query: 124 LSKVTDPQVKQFIEKCIVPASLRL 147
           ++ V++ + K  I++ I     RL
Sbjct: 233 ITDVSE-EAKDLIQRLICSRERRL 255

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 36/117 (30%), Positives = 54/117 (46%), Gaps = 15/117 (12%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGL---------AIVMQQP 58
           Q+L  L    +HN  I+HRDLK  NI V+        K+ D G+         A V    
Sbjct: 87  QVLDALA--CAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144

Query: 59  TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 114
               V+GTP + APE L  E      D+Y++G+  LE +T +    +  + A+I  +
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ-RVVQGASVAEILYQ 200

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 9/97 (9%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARS 62
           ++ QI +G+ YL S     IHRDL   NI V  +   VKI D GLA V+ +       + 
Sbjct: 114 FSSQICKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKE 170

Query: 63  VIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              +P F  APE L   +++   D++SFG+ + E+ T
Sbjct: 171 PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 34/101 (33%), Positives = 53/101 (52%), Gaps = 7/101 (6%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           M  +K +  Q+LRGL+Y H     ++HRDLK  N+ +N   GE+K+ D GLA     PT 
Sbjct: 103 MHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTK 159

Query: 61  --RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
              + + T  +  P+  L   +Y+  +D++  G    EM T
Sbjct: 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 42/135 (31%), Positives = 67/135 (49%), Gaps = 15/135 (11%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL---AIVMQQPTARSVIGT 66
           +I   L +LH     II+RDLK +NI ++   G VK+ D GL   +I     T  +  GT
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVT-HTFCGT 163

Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPAS 123
            E+MAPE L    + + VD +S G  + +M+T   P+   +N  +   K+  G    P  
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT-AENRKKTIDKILKGKLNLPPY 222

Query: 124 LSKVTDPQVKQFIEK 138
           L+    P+ +  ++K
Sbjct: 223 LT----PEARDLLKK 233

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 64/273 (23%), Positives = 94/273 (34%), Gaps = 79/273 (28%)

Query: 21  HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------------------------- 55
           H    IHRD+K DNI ++  +G +K+ D GL                             
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 56  --------------------QQPTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILE 94
                               Q+  A S++GTP ++APE+     Y +L D +S G+ + E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236

Query: 95  MVTCEYPYNECKNPAQIYKKV-----TSGIKP-ASLSKVTDPQVKQFIEKCIVPASLRL- 147
           M+  + P+     PA+   KV     T  I   A LS     +    I +    A  RL 
Sbjct: 237 MLVGQPPFLA-DTPAETQLKVINWETTLHIPSQAKLS----REASDLILRLCCGAEDRLG 291

Query: 148 --PALELLKDPFLVTDNPKDLVCDPLRLP-NLVPEVMNLAHSEPHPMDIDLNHKKVSADS 204
              A E+   PF       D      R     +P++        HP D   N   V  + 
Sbjct: 292 KNGADEIKAHPFFKG---IDFASLIRRQKAPYIPKIT-------HPTDTS-NFDPVDPEK 340

Query: 205 CAKSNTG---TWFLTLELQR-LTENN--EFTLR 231
               ++G            R  TE+   EFT R
Sbjct: 341 LRSDDSGESSPDRNVKPNNRKRTEHAFYEFTFR 373

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 53.6 bits (129), Expect = 7e-08
 Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 9/97 (9%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI +G+ YL S     +HRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 113 YASQICKGMEYLGSKR--YVHRDLATRNILVESEN-RVKIGDFGLTKVLPQDKEYYKVRE 169

Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 170 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 22/163 (13%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTP 67
           + L GL +LH      IHRD+K +NI +    G VK+ D G++  +     R  + +GTP
Sbjct: 132 EALMGLQHLH--VNKTIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTP 188

Query: 68  EFMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
            +MAPE+       +  Y+   D++S G+  +E+   + P  +  +P +   K+     P
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL-HPMRALFKIPRNPPP 247

Query: 122 ASLSKVTDPQV-----KQFIEKCIVPA-SLRLPALELLKDPFL 158
                +  P++       FI KC+      R    +LL+  F+
Sbjct: 248 ----TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 7/101 (6%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           M  +K +  QILRGL Y H     ++HRDLK  N+ +N   GE+K+ D GLA     PT 
Sbjct: 103 MHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTK 159

Query: 61  --RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
              + + T  +  P+  L   EY+  +D++  G    EM +
Sbjct: 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 35/142 (24%), Positives = 60/142 (42%), Gaps = 45/142 (31%)

Query: 15  LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----------------------- 51
           +  +H      IHRD+K DN+ ++   G +K+ D GL                       
Sbjct: 114 IDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170

Query: 52  -AIVMQQPT----------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCIL 93
               + +P                 A S +GTP+++APE++ +  YN+  D +S G+ + 
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230

Query: 94  EMVTCEYPYNECKNPAQIYKKV 115
           EM+   YP     NP + Y+K+
Sbjct: 231 EMLV-GYPPFCSDNPQETYRKI 251

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 35/123 (28%), Positives = 64/123 (52%), Gaps = 24/123 (19%)

Query: 15  LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV-----------------MQQ 57
           L YLH++   I+HRDLK DN+ +  + G +K+ D GL+ +                  ++
Sbjct: 114 LEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 58  PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKNPAQIYKKV 115
              + V GTPE++APE +  + Y + VD ++ G+ + E +V C   + +   P +++ +V
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--TPEELFGQV 228

Query: 116 TSG 118
            S 
Sbjct: 229 ISD 231

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 41/102 (40%), Positives = 53/102 (51%), Gaps = 12/102 (11%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIG 65
           A QI  G+ YL S N   IHRDL   NI V G N   KI D GLA +++    TAR    
Sbjct: 109 AAQIAEGMAYLESRN--YIHRDLAARNILV-GENLVCKIADFGLARLIEDDEYTAREGAK 165

Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT---CEYP 101
            P ++ APE   Y   +    D++SFG+ + E+VT     YP
Sbjct: 166 FPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYP 206

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 33/92 (35%), Positives = 46/92 (50%), Gaps = 8/92 (8%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARSVI 64
           R++L  L YLH     IIHRD+K +NIF++       +GD G A  +      P      
Sbjct: 192 RRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEM 95
           GT E  +PEL   + Y    DI+S G+ + EM
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 37/99 (37%), Positives = 56/99 (56%), Gaps = 13/99 (13%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------ 60
           +A+QI  G+ YLHS +   IHRDL   N+ ++ N+  VKIGD GLA  +  P        
Sbjct: 112 FAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAV--PEGHEYYRV 166

Query: 61  RSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           R    +P F  A E L E +++   D++SFG+ + E++T
Sbjct: 167 REDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 39/94 (41%), Positives = 52/94 (55%), Gaps = 15/94 (15%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE- 68
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 126 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 178

Query: 69  ----FMAPE-LYEEEYNELVDIYSFGMCIL-EMV 96
               + APE +    Y E VDI+S G CI+ EM+
Sbjct: 179 VTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 38/133 (28%), Positives = 62/133 (46%), Gaps = 40/133 (30%)

Query: 21  HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--------------PT------- 59
           H    IHRD+K DN+ ++ + G VK+ D GL   +++              P+       
Sbjct: 118 HQLGFIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 60  ----------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY 102
                           A S +GTP+++APE++ +  YN+L D +S G+ + EM+   YP 
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPP 235

Query: 103 NECKNPAQIYKKV 115
              + P + YKKV
Sbjct: 236 FCSETPQETYKKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 7/91 (7%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP 67
           Q+LRGL Y+H  +  I+HRDLK  N+ ++   GE+K+ D GLA     P  T  S + T 
Sbjct: 111 QLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTL 167

Query: 68  EFMAPE--LYEEEYNELVDIYSFGMCILEMV 96
            +  P+  L   +Y+  +DI+  G   +EM+
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEML 198

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 37/133 (27%), Positives = 61/133 (45%), Gaps = 40/133 (30%)

Query: 21  HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--------------PT------- 59
           H    IHRD+K DN+ ++   G VK+ D GL   +++              P+       
Sbjct: 118 HQLGFIHRDIKPDNLLLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 60  ----------------ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY 102
                           A S +GTP+++APE++ +  YN+L D +S G+ + EM+   YP 
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI-GYPP 235

Query: 103 NECKNPAQIYKKV 115
              + P + Y+KV
Sbjct: 236 FCSETPQETYRKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 51.5 bits (123), Expect = 5e-07
 Identities = 31/105 (29%), Positives = 60/105 (57%), Gaps = 8/105 (7%)

Query: 3   AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPT 59
            ++ ++ +I+  L +LH     I++RD+K +NI ++ + G V + D GL+   +  ++  
Sbjct: 106 EVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFLSEEKER 162

Query: 60  ARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPY 102
             S  GT E+MAPE+   +  + + VD +S G+ I E++T   P+
Sbjct: 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 7/92 (7%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTP 67
           Q+LRGL Y H     ++HRDLK  N+ ++   GE+K+ D GLA     P  T  + + T 
Sbjct: 111 QLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTL 167

Query: 68  EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            +  P+  L   EY+  +D++  G    EM T
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 51.1 bits (122), Expect = 6e-07
 Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 10/102 (9%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQ 56
           K + + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   
Sbjct: 134 KDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDN-VMKIADFGLARGVHDIDYY 190

Query: 57  QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           + T+   +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 191 KKTSNGRLPV-KWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 35/103 (33%), Positives = 56/103 (54%), Gaps = 12/103 (11%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQ 56
           K + ++A Q+ RG+ +L S     IHRDL   N+ V  ++  +KI D GLA     I   
Sbjct: 132 KDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDH-VMKIADFGLARDIHHIDYY 188

Query: 57  QPTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           + T    +  P ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 189 RKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 30/108 (27%), Positives = 56/108 (51%), Gaps = 15/108 (13%)

Query: 7   WAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ---QPT 59
           WAR    +++  L  +HS     IHRD+K DN+ ++  +G +K+ D G  + M       
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVR 199

Query: 60  ARSVIGTPEFMAPELYEE-----EYNELVDIYSFGMCILEMVTCEYPY 102
             + +GTP++++PE+ +       Y    D +S G+ + EM+  + P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 29/110 (26%), Positives = 60/110 (54%), Gaps = 15/110 (13%)

Query: 5   KNWAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 58
           + WA+    +++  L  +HS    +IHRD+K DN+ ++  +G +K+ D G  + M +   
Sbjct: 141 EKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGM 197

Query: 59  -TARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPY 102
               + +GTP++++PE+ + +     Y    D +S G+ + EM+  + P+
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 44/133 (33%), Positives = 68/133 (51%), Gaps = 18/133 (13%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A Q+  G+ Y+   N   IHRDL+  NI V G+    KI D GLA +++  + TAR    
Sbjct: 108 AAQVAAGMAYIERMN--YIHRDLRSANILV-GDGLVCKIADFGLARLIEDNEYTARQGAK 164

Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK- 120
            P ++ APE  LY   +    D++SFG+ + E+VT    PY    N  ++ ++V  G + 
Sbjct: 165 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYRM 222

Query: 121 ------PASLSKV 127
                 P SL ++
Sbjct: 223 PCPQDCPISLHEL 235

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 50.5 bits (120), Expect = 8e-07
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 7/97 (7%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           +K +  Q+LRGL Y+H     I+HRDLK  N+ ++ + GE+K+ D GLA     P  T  
Sbjct: 105 VKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYS 161

Query: 62  SVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMV 96
           + + T  +  P+  L   EY+  +D++  G   +EM+
Sbjct: 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 13/120 (10%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A QI   + YL   N   IHRDL   N  V G N  VK+ D GL+ +M   T  +  G  
Sbjct: 110 ATQISSAMEYLEKKN--FIHRDLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAGAK 166

Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVT---CEYPYNECKNPAQIYKKVTSGIK 120
              ++ APE L   +++   D+++FG+ + E+ T     YP  +    +Q+Y+ +  G +
Sbjct: 167 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKGYR 223

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 19/155 (12%)

Query: 18  LHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARSVIGTPEFMAPE 73
           +HS H    +HRD+K +N+ ++   G +K+ D G A  +   +   ++  +GTP+++APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPE 173

Query: 74  LYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 126
           +           Y    D +S G+   EM+    P++E    A+ Y  + +      L  
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE-GTSAKTYNNIMN--FQRFLKF 230

Query: 127 VTDPQV----KQFIEKCIVPASLRLPALELLKDPF 157
             DP+V       I+  +     RL    L   PF
Sbjct: 231 PEDPKVSSDFLDLIQSLLCGQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 62/236 (26%), Positives = 98/236 (41%), Gaps = 44/236 (18%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPT 59
           +  +K ++ Q+ R L Y+HS    I HRDLK  N+ ++ N   +K+ D G A  ++    
Sbjct: 169 LFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR 226

Query: 60  ARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKN---------- 107
           + S I +  + APEL      Y   +D++S G  I EM+   YP    ++          
Sbjct: 227 SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQ 285

Query: 108 ----PAQIYKKVTS---------GIKPASLSKV----TDPQVKQFIEKCIVPASL-RLPA 149
               P +   K  +          +KP  L KV    T      FI + +    L RL  
Sbjct: 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP 345

Query: 150 LELLKDPFLVTDNPKDLVCDP-LRLPNLV---PEVMNLAHSEPHPMDIDLNHKKVS 201
           +E L DPF       D + DP ++LP  +   P++ N   +E   M      K + 
Sbjct: 346 IEALADPFF------DDLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIP 395

Length = 440

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 10/94 (10%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVI 64
           Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T    +
Sbjct: 145 QVARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRL 201

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 202 PV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 43/136 (31%), Positives = 69/136 (50%), Gaps = 10/136 (7%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIGT-- 66
           Q+  G+ +L S N   +HRDL   N+ +      VKI D GLA  +M+     S   T  
Sbjct: 247 QVANGMEFLASKN--CVHRDLAARNVLI-CEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 67  P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 123
           P ++MAPE ++   Y  L D++SFG+ + E+ T    PY E     Q Y  +  G + A 
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAK 363

Query: 124 LSKVTDPQVKQFIEKC 139
            +  +D ++ + ++KC
Sbjct: 364 PAHASD-EIYEIMQKC 378

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 35/124 (28%), Positives = 63/124 (50%), Gaps = 11/124 (8%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV-KIGDLGLAIVMQQPTARSVIG 65
           ++ Q+ +G+ +L S N   IHRDL   N+ +   +G++ KI D GLA  +   +   V G
Sbjct: 146 FSYQVAKGMAFLASKN--CIHRDLAARNVLLT--HGKIVKICDFGLARDIMNDSNYVVKG 201

Query: 66  TP----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGI 119
                 ++MAPE ++   Y    D++S+G+ + E+ +    PY      ++ YK +  G 
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY 261

Query: 120 KPAS 123
           + A 
Sbjct: 262 RMAQ 265

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 30/108 (27%), Positives = 58/108 (53%), Gaps = 15/108 (13%)

Query: 7   WAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---T 59
           WAR    +++  L  +HS     IHRD+K DN+ ++  +G +K+ D G  + M +     
Sbjct: 143 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVR 199

Query: 60  ARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPY 102
             + +GTP++++PE+ + +     Y    D +S G+ + EM+  + P+
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 40/146 (27%), Positives = 71/146 (48%), Gaps = 21/146 (14%)

Query: 15  LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMA 71
           +H L       +HRD+K DN+ ++  NG +++ D G  + ++   T +S   +GTP++++
Sbjct: 118 VHQLG-----YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171

Query: 72  PELYEE------EYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTSGIKPASL 124
           PE+ +        Y    D +S G+C+ EM+  E P Y E  +  + Y K+ +  +    
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVETYGKIMNHKEHFQF 229

Query: 125 -SKVTD--PQVKQFIEKCIVPASLRL 147
              VTD   + K  I + I     RL
Sbjct: 230 PPDVTDVSEEAKDLIRRLICSPETRL 255

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 16/154 (10%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 65
              +   + YL S+    IHRDL   N  V G +  VK+ D GLA  ++  Q T+     
Sbjct: 106 CSDVCEAMEYLESNG--FIHRDLAARNCLV-GEDNVVKVSDFGLARYVLDDQYTSSQGTK 162

Query: 66  TP-EFMAPELYE-EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGI--- 119
            P ++  PE+++   ++   D++SFG+ + E+ +  + PY    N +++ + V++G    
Sbjct: 163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESVSAGYRLY 221

Query: 120 KPASLSKVTDPQVKQFIEKCIVPASLRLPALELL 153
           +P    K+   +V   +  C        PA + L
Sbjct: 222 RP----KLAPTEVYTIMYSCWHEKPEDRPAFKKL 251

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 48.0 bits (114), Expect = 4e-06
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 8/102 (7%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           M  + ++A QI RG+ YL      ++HRDL   N+ V     ++KI D GL+  + +  +
Sbjct: 126 MGDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEEDS 182

Query: 61  ---RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              RS    P ++MA E L++  Y    D++SFG+ + E+VT
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 24/101 (23%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+ RG+ +L S     IHRDL   NI ++ NN  VKI D GL        AR +   P++
Sbjct: 181 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 229

Query: 70  ------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                       MAPE ++++ Y    D++SFG+ + E+ +
Sbjct: 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 10/102 (9%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQ 56
           K + + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   
Sbjct: 140 KDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYY 196

Query: 57  QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           + T    +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 197 KKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 10/102 (9%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQ 56
           K + + A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   
Sbjct: 134 KDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDN-VMKIADFGLARDVHNIDYY 190

Query: 57  QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           + T    +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 191 KKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 47.4 bits (112), Expect = 6e-06
 Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 9/97 (9%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSV 63
           + A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR  
Sbjct: 106 DMAAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQG 162

Query: 64  IGTP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
              P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 163 AKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 47.2 bits (112), Expect = 7e-06
 Identities = 39/109 (35%), Positives = 54/109 (49%), Gaps = 8/109 (7%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+      KI D GLA  I   + TAR    
Sbjct: 108 AAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAK 164

Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 165 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 47.4 bits (112), Expect = 7e-06
 Identities = 38/95 (40%), Positives = 54/95 (56%), Gaps = 9/95 (9%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   IHRDL+  NI V G+N   KI D GLA +++  + TAR    
Sbjct: 108 AAQIADGMAYIERMN--YIHRDLRAANILV-GDNLVCKIADFGLARLIEDNEYTARQGAK 164

Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+VT
Sbjct: 165 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 10/152 (6%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+ RG+ +L S N   +HRDL   N+ +      VKI D GLA  +   +     G+   
Sbjct: 245 QVARGMEFLASKN--CVHRDLAARNVLL-AQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301

Query: 68  --EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPAS 123
             ++MAPE +++  Y  L D++S+G+ + E+ +    PY      +  Y K+ SG + A 
Sbjct: 302 PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK 361

Query: 124 LSKVTDPQVKQFIEKCIVPASLRLPALELLKD 155
               T  +V   + KC      + P+   L D
Sbjct: 362 PDHATQ-EVYDIMVKCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 46.8 bits (111), Expect = 9e-06
 Identities = 32/117 (27%), Positives = 60/117 (51%), Gaps = 9/117 (7%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP- 67
           + +  G+ YL S     IHRDL   N  V+ + G VK+ D GL+  +      S +G+  
Sbjct: 107 KDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSSVGSKF 163

Query: 68  --EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 120
              +  PE L   +++   D+++FG+ + E+ +  + PY    N ++  +KV+ G++
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETVEKVSQGLR 219

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 24/101 (23%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+ RG+ +L S     IHRDL   NI ++ NN  VKI D GL        AR +   P++
Sbjct: 182 QVARGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 230

Query: 70  ------------MAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                       MAPE ++++ Y    D++SFG+ + E+ +
Sbjct: 231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 8/97 (8%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---S 62
           NW  QI +G++YL  H   ++HR+L   NI +  ++  V+I D G+A ++     +   S
Sbjct: 113 NWCVQIAKGMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVADLLYPDDKKYFYS 169

Query: 63  VIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              TP ++MA E +    Y    D++S+G+ + EM++
Sbjct: 170 EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 37/124 (29%), Positives = 63/124 (50%), Gaps = 12/124 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP- 67
           R I  G+ YL   N   +HRDL   NI VN +N E K+ D GL+ V++     +   +  
Sbjct: 114 RGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGG 170

Query: 68  ----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK- 120
                + APE +   ++    D++SFG+ + E+++  E PY +  N  ++ K +  G + 
Sbjct: 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFRL 229

Query: 121 PASL 124
           PA +
Sbjct: 230 PAPM 233

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 26/144 (18%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+ +G+ +L S     IHRDL   NI ++ NN  VKI D GL        AR +   P++
Sbjct: 187 QVAKGMEFLASRK--CIHRDLAARNILLSENN-VVKICDFGL--------ARDIYKDPDY 235

Query: 70  ------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 115
                       MAPE +++  Y    D++SFG+ + E+ +    PY   K   +  +++
Sbjct: 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 295

Query: 116 TSGIKPASLSKVTDPQVKQFIEKC 139
             G +  +    T P++ Q +  C
Sbjct: 296 KEGTRMRA-PDYTTPEMYQTMLDC 318

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 8/97 (8%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTAR 61
           NW  QI +G+ YL      ++HRDL   N+ V   N  VKI D GLA +++    +  A 
Sbjct: 113 NWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNAD 169

Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E ++  ++    D++S+G+ I E++T
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 39/173 (22%), Positives = 62/173 (35%), Gaps = 22/173 (12%)

Query: 7   WA--RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
           WA   Q L  L  LH          L   +  +   +G V            +   +S  
Sbjct: 20  WAVCLQCLGALRELHRQAKS--GNILLTWDGLLK-LDGSV----------AFKTPEQS-R 65

Query: 65  GTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS 123
             P FMAPE+ +   Y E  DIYS G+ + E +  E PYNE +  + I + + +G    +
Sbjct: 66  PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG--MPA 123

Query: 124 LSKVTDPQVKQFIEKCIVPASLRLPALELLK---DPFLVTDNPKDLVCDPLRL 173
                   ++           +RL A  L +          + + L  + L L
Sbjct: 124 DDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRALFAETLEL 176

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 113 NWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAE 169

Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 36/118 (30%), Positives = 58/118 (49%), Gaps = 13/118 (11%)

Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIVMQQPTARSVIGT 66
           + +G  YL   +   IHRDL   N  V+    +    VKIGD GLA  + +       G 
Sbjct: 115 VAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 67  P----EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
                 +MAPE L + ++    D++SFG+ + E++T  + PY    N  ++ + VT+G
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQHVTAG 229

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 15/105 (14%)

Query: 12  LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLG--LAIVMQQPTARSVIGTPEF 69
           LRGL+YLH +    IHR++K  +I ++G+ G V +  L    ++V     A+ V   P+F
Sbjct: 111 LRGLNYLHQNG--YIHRNIKASHILISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQF 167

Query: 70  -------MAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNE 104
                  ++PEL  ++   YN   DIYS G+   E+ T   P+ +
Sbjct: 168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 17/143 (11%)

Query: 8   ARQILR-------GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           ++Q+L+       G+ YL       IHRDL   N+ V G N   KI D GL+   +    
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLV-GENLASKIADFGLSRGEEVYVK 174

Query: 61  RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVT 116
           +++   P  +MA E L    Y    D++SFG+ + E+V+    PY  C    A++Y+K+ 
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY--CGMTCAELYEKLP 232

Query: 117 SGIKPASLSKVTDPQVKQFIEKC 139
            G +     +  D +V + + +C
Sbjct: 233 QGYR-MEKPRNCDDEVYELMRQC 254

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 39/142 (27%), Positives = 63/142 (44%), Gaps = 16/142 (11%)

Query: 3   AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTA 60
           AI    + +L  L Y+HS     IHR +K  +I ++G+ G+V +  L  ++ M       
Sbjct: 102 AIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGD-GKVVLSGLRYSVSMIKHGKRQ 158

Query: 61  RSVIGTPEF-------MAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 110
           R V   P+        ++PE+ ++    YNE  DIYS G+   E+     P+ +     Q
Sbjct: 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP-ATQ 217

Query: 111 IYKKVTSGIKPASLSKVTDPQV 132
           +  +   G  P  L K T P  
Sbjct: 218 MLLEKVRGTVPCLLDKSTYPLY 239

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 49/163 (30%), Positives = 72/163 (44%), Gaps = 16/163 (9%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV-----MQQPTARSVI 64
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA       M  P     +
Sbjct: 131 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTACTNFMMTP----YV 183

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
            T  + APE +    Y E VDI+S G  + E+V     +    +  Q  K +   G   A
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243

Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKD 165
                  P V+ ++E    P    +   EL  D    +++ +D
Sbjct: 244 EFMNRLQPTVRNYVEN--RPQYPGISFEELFPDWIFPSESERD 284

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 37/93 (39%), Positives = 50/93 (53%), Gaps = 13/93 (13%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE- 68
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 186

Query: 69  ----FMAPE-LYEEEYNELVDIYSFGMCILEMV 96
               + APE +    Y E VDI+S G  + EM+
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.7 bits (105), Expect = 6e-05
 Identities = 49/149 (32%), Positives = 69/149 (46%), Gaps = 16/149 (10%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 127 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 179

Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKP 121
               + APE +    Y E VDI+S G  + EMV  +  +   ++    + KV    G   
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPC 238

Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL 150
               K   P V+ ++E     A L  P L
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKL 267

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 7/96 (7%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSV 63
           +++ QI  G+ Y+   N   IHRDL+  N+ V+  +   KI D GLA V++  + TAR  
Sbjct: 107 DFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREG 163

Query: 64  IGTP-EFMAPELYE-EEYNELVDIYSFGMCILEMVT 97
              P ++ APE      +    D++SFG+ + E+VT
Sbjct: 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 44.4 bits (105), Expect = 8e-05
 Identities = 29/105 (27%), Positives = 52/105 (49%), Gaps = 8/105 (7%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQP--TARSVI 64
             QI  G+ +L +     +HRDL   N  V+    EVK+  L L+  V        R+ +
Sbjct: 123 CTQIALGMDHLSNAR--FVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNAL 179

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKN 107
               ++APE + E++++   D++SFG+ + E+ T  E P+    +
Sbjct: 180 IPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD 224

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 38/111 (34%), Positives = 60/111 (54%), Gaps = 8/111 (7%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSV 63
           +++ QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA V++  + TAR  
Sbjct: 106 DFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREG 162

Query: 64  IGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 111
              P ++ APE +    +    D++SFG+ ++E+VT    PY    NP  I
Sbjct: 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 8/97 (8%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVI 64
           NW  QI +G+ YL      ++HRDL   N+ V   N  VKI D GLA ++    T     
Sbjct: 113 NWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLDIDETEYHAD 169

Query: 65  G--TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           G   P ++MA E +    +    D++S+G+ + E++T
Sbjct: 170 GGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 37/123 (30%), Positives = 52/123 (42%), Gaps = 32/123 (26%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----- 56
           K I+   RQIL  L  LHS    I+HRD+K  NI  +  +G  KI DLG A  ++     
Sbjct: 255 KIIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY 312

Query: 57  QPTARSVIGTPEFMAPE-----------------------LYEEEYNELVDIYSFGMCIL 93
            P  +  +  P + APE                       L++    +  DIYS G+  L
Sbjct: 313 IP--KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370

Query: 94  EMV 96
           +M 
Sbjct: 371 QMA 373

Length = 566

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 17/143 (11%)

Query: 8   ARQILR-------GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           ++Q+L        G+ YL       IHRDL   NI V G N   KI D GL+   +    
Sbjct: 111 SQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVK 167

Query: 61  RSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVT 116
           +++   P  +MA E L    Y    D++S+G+ + E+V+    PY  C    A++Y+K+ 
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLP 225

Query: 117 SGIKPASLSKVTDPQVKQFIEKC 139
            G +        D +V   + +C
Sbjct: 226 QGYR-LEKPLNCDDEVYDLMRQC 247

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 11/104 (10%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A QI  G+ YLH     +IH+D+   N  ++    +VKI D  L+  +  P     +G  
Sbjct: 123 AIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNALSRDLF-PMDYHCLGDN 178

Query: 68  E-----FMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNE 104
           E     +MA E L  +EY+   D++SFG+ + E++T  + PY E
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 35/108 (32%), Positives = 53/108 (49%), Gaps = 12/108 (11%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVI 64
           R I  G+ YL   N   +HRDL   NI VN +N   K+ D GL+  ++     PT  S +
Sbjct: 113 RGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSSL 169

Query: 65  GTP---EFMAPE-LYEEEYNELVDIYSFGMCILE-MVTCEYPYNECKN 107
           G      + APE +   ++    D++S+G+ + E M   E PY +  N
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 33/132 (25%), Positives = 51/132 (38%), Gaps = 51/132 (38%)

Query: 21  HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGL----------------------------- 51
           H    IHRD+K DNI ++  +G +K+ D GL                             
Sbjct: 118 HKMGFIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176

Query: 52  --------------------AIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 90
                               A   Q+  A S++GTP ++APE L    Y +L D +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236

Query: 91  CILEMVTCEYPY 102
            + EM+  + P+
Sbjct: 237 ILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 24/55 (43%), Positives = 33/55 (60%), Gaps = 3/55 (5%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 55
           +  IK   RQ+L GL  LH     I+HRD+K +N+ V   +G+VKI D G A+ M
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDM 359

Length = 507

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 8/95 (8%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A QI  G+ YL S +   +HRDL   N  V G N  VKIGD G++  +       V G  
Sbjct: 129 ASQIASGMVYLASQH--FVHRDLATRNCLV-GANLLVKIGDFGMSRDVYSTDYYRVGGHT 185

Query: 68  ----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                +M PE +   ++    D++SFG+ + E+ T
Sbjct: 186 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 30/127 (23%), Positives = 58/127 (45%), Gaps = 35/127 (27%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--------- 52
           +  + +A ++L  L YLH     I++RDLK +NI ++  +G + + D  L+         
Sbjct: 103 EVARFYAAEVLLALEYLH--LLGIVYRDLKPENILLHE-SGHIMLSDFDLSKQSDVEPPP 159

Query: 53  --------------------IVMQQPTAR--SVIGTPEFMAPELYEEE-YNELVDIYSFG 89
                                  ++P+ R  S +GT E++APE+   + +   VD ++ G
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLG 219

Query: 90  MCILEMV 96
           + + EM+
Sbjct: 220 ILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 21/40 (52%), Positives = 27/40 (67%), Gaps = 3/40 (7%)

Query: 15  LHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV 54
           L YLH H   IIHRDLK DN+ ++ N G +K+ D GL+ V
Sbjct: 117 LDYLHRHG--IIHRDLKPDNMLIS-NEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 16/140 (11%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A  + RG+ YL       IHRDL   NI V G N   KI D GL+   +    +++   
Sbjct: 129 FAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMGRL 185

Query: 67  P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGI--- 119
           P  +MA E L    Y    D++S+G+ + E+V+    PY  C    A++Y+K+  G    
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYRLE 243

Query: 120 KPASLSKVTDPQVKQFIEKC 139
           KP +     D +V   + +C
Sbjct: 244 KPLN----CDDEVYDLMRQC 259

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 31/113 (27%), Positives = 62/113 (54%), Gaps = 9/113 (7%)

Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP- 67
           +  G+ YL  ++   IHRDL   N  V+ + G VK+ D G+   ++  + T+ S    P 
Sbjct: 109 VCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPV 165

Query: 68  EFMAPELYE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 118
           ++  PE++   +Y+   D++SFG+ + E+ T  + P+ E K+  ++ + ++ G
Sbjct: 166 KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRG 217

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 34/94 (36%), Positives = 45/94 (47%), Gaps = 10/94 (10%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A QI  G+ YL SH+   +HRDL   N  V G    VKI D GL+  +       V    
Sbjct: 130 AIQIAAGMEYLSSHH--FVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 68  ----EFMAPE--LYEEEYNELVDIYSFGMCILEM 95
                +M PE  LY +   E  DI+SFG+ + E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 66/274 (24%), Positives = 103/274 (37%), Gaps = 76/274 (27%)

Query: 21  HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-------------------QPT-- 59
           H    IHRD+K DNI ++  +G +K+ D GL    +                   +P+  
Sbjct: 118 HKMGFIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176

Query: 60  ----------------------------ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGM 90
                                       A S++GTP ++APE L  + Y +L D +S G+
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236

Query: 91  CILEMVTCEYPYNECKNPAQIYKKVT---SGIKPASLSKVTDPQVKQFIEKCIVPASLRL 147
            + EM+  + P+     P +   KV    + +      K++ P+    I K    A  RL
Sbjct: 237 ILFEMLVGQPPF-LAPTPTETQLKVINWENTLHIPPQVKLS-PEAVDLITKLCCSAEERL 294

Query: 148 ---PALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADS 204
               A ++   PF    +  D   D    P   P V  ++    HPMD   N   V  +S
Sbjct: 295 GRNGADDIKAHPFF---SEVDFSSDIRTQP--APYVPKIS----HPMDTS-NFDPVEEES 344

Query: 205 ----CAKSNTGTW-FLTLELQRLTENN--EFTLR 231
                +  +T TW  L     +  E+   EFT R
Sbjct: 345 PWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFR 378

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 13/99 (13%)

Query: 14  GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP---EFM 70
           G+ YL S N  +IHRDL   N  V G N  VK+ D G+   +      S  GT    ++ 
Sbjct: 112 GMAYLESSN--VIHRDLAARNCLV-GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS 168

Query: 71  APELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP 108
           +PE++   +Y+   D++SFG+ + E+      ++E K P
Sbjct: 169 SPEVFSFSKYSSKSDVWSFGVLMWEV------FSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 37/119 (31%), Positives = 58/119 (48%), Gaps = 12/119 (10%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A QI  G+ YL S +   +HRDL   N  V G +  VKIGD G++  +       V G  
Sbjct: 128 AVQIASGMVYLASQH--FVHRDLATRNCLV-GYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184

Query: 68  ----EFMAPE--LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGI 119
                +M PE  +Y +   E  D++SFG+ + E+ T  + P+    N  ++ + +T G 
Sbjct: 185 MLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIECITQGR 241

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 36/159 (22%), Positives = 71/159 (44%), Gaps = 16/159 (10%)

Query: 3   AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTA 60
            +  ++  +   + YL ++N   +HRDL   N+ V+ +N   K+ D GL       Q T 
Sbjct: 103 CLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTG 159

Query: 61  RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
           +  +   ++ APE L E++++   D++SFG+ + E+    Y +     P    K V   +
Sbjct: 160 KLPV---KWTAPEALREKKFSTKSDVWSFGILLWEI----YSFGRVPYPRIPLKDVVPRV 212

Query: 120 KPASLSKVTD---PQVKQFIEKCIVPASLRLPALELLKD 155
           +        D   P V   +++C    +   P+   L++
Sbjct: 213 EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 26/94 (27%), Positives = 56/94 (59%), Gaps = 8/94 (8%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS- 62
           ++++  Q+++ +H+ H ++  I+HRD+K +N+ ++ N+  +K+ D G A  + + +  + 
Sbjct: 102 VRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANY 158

Query: 63  --VIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL 93
              + T  + +PE L    Y + VD++S G CIL
Sbjct: 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVG-CIL 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 41.4 bits (97), Expect = 6e-04
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 23/157 (14%)

Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------QQPTARSVI 64
           I  G+ YL S N   IHRDL   N  +N  N  V + D GL+  +      +Q  A  + 
Sbjct: 122 IASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVADFGLSKKIYSGDYYRQGCASKL- 177

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK-- 120
              +++A E L +  Y    D+++FG+ + E++T  + PY   +N ++IY  +  G +  
Sbjct: 178 -PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLIKGNRLK 235

Query: 121 --PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 155
             P  L  V +      + +C  P     P+ + L+D
Sbjct: 236 QPPDCLEDVYE-----LMCQCWSPEPKCRPSFQHLRD 267

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 41.2 bits (97), Expect = 9e-04
 Identities = 34/104 (32%), Positives = 51/104 (49%), Gaps = 10/104 (9%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A QI  G+ YL S N   +HRDL   N  V G N  +KI D G++  +       V G  
Sbjct: 136 ATQIASGMRYLESLN--FVHRDLATRNCLV-GKNYTIKIADFGMSRNLYSSDYYRVQGRA 192

Query: 68  ----EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-C-EYPYNE 104
                +MA E +   ++    D+++FG+ + E++T C E PY  
Sbjct: 193 PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 30/96 (31%), Positives = 43/96 (44%), Gaps = 11/96 (11%)

Query: 14  GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE----F 69
           G+ YL S N   IHRDL   N  V G N  +KI D G++   +        G  +    +
Sbjct: 105 GMEYLESKN--CIHRDLAARNCLV-GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW 161

Query: 70  MAPE-LYEEEYNELVDIYSFGMCILEMVT---CEYP 101
            APE L    Y    D++S+G+ + E  +     YP
Sbjct: 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 31/115 (26%), Positives = 57/115 (49%), Gaps = 9/115 (7%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           ++  +  G+ YL S    ++HRDL   NI V+  +G  K+ D GLA V       S +  
Sbjct: 105 FSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPV 161

Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
            ++ APE L  ++++   D++S+G+ + E+    + Y     P    K+V   ++
Sbjct: 162 -KWTAPEALKHKKFSSKSDVWSYGVLLWEV----FSYGRAPYPKMSLKEVKECVE 211

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 34/134 (25%), Positives = 57/134 (42%), Gaps = 27/134 (20%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQP 58
           MK +   AR + +G  YL  ++   IHRD+   N  +   G     KI D G+A      
Sbjct: 115 MKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMA------ 166

Query: 59  TARSVIGTP------------EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEY-PYNE 104
             R +                ++M PE + +  +    D++SFG+ + E+ +  Y PY  
Sbjct: 167 --RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224

Query: 105 CKNPAQIYKKVTSG 118
             N  ++ + VT G
Sbjct: 225 RTN-QEVMEFVTGG 237

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 35/144 (24%), Positives = 62/144 (43%), Gaps = 15/144 (10%)

Query: 14  GLHYLH-SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAP 72
           GL+ L+   N P  +++L   +  V   N ++KI   GL  ++  P  ++V     FM  
Sbjct: 134 GLYNLYKYTNKP--YKNLTSVSFLVT-ENYKLKIICHGLEKILSSPPFKNV----NFMVY 186

Query: 73  ELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 126
             Y+       EY    DIYS G+ + E+ T + P+       +IY  + +      L  
Sbjct: 187 FSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-TTKEIYDLIINKNNSLKLPL 245

Query: 127 VTDPQVKQFIEKCIVPASLRLPAL 150
               ++K  +E C    S++ P +
Sbjct: 246 DCPLEIKCIVEACTSHDSIKRPNI 269

Length = 283

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 31/145 (21%), Positives = 58/145 (40%), Gaps = 52/145 (35%)

Query: 21  HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-------------VMQQPTAR------ 61
           H    IHRD+K DNI ++   G +K+ D GL+              ++Q  + +      
Sbjct: 118 HKLGFIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 62  ------------------------------SVIGTPEFMAPELYEEE-YNELVDIYSFGM 90
                                         S +GTP+++APE++ ++ Y +  D +S G 
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236

Query: 91  CILEMVTCEYPYNECKNPAQIYKKV 115
            + E +   +P    +N  + Y+K+
Sbjct: 237 IMFECL-IGWPPFCSENSHETYRKI 260

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	505
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.97
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.97
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.97
KOG0578	550	consensus p21-activated serine/threonine protein k	99.97
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.97
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.97
KOG0198	313	consensus MEKK and related serine/threonine protei	99.97
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.96
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.96
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.96
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.96
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.96
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.96
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.96
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.95
KOG0605	550	consensus NDR and related serine/threonine kinases	99.95
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.95
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.95
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.95
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.95
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.95
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.95
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.95
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.95
PTZ00036	440	glycogen synthase kinase; Provisional	99.95
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.95
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.95
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.95
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.95
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.95
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.95
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.95
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.95
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.95
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.95
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.95
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.95
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.95
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.95
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.95
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.95
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.95
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.94
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.94
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.94
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.94
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.94
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.94
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.94
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.94
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.94
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.94
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.94
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.94
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.94
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.94
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.94
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.94
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.94
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.94
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.94
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.94
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.94
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.94
PTZ00284	467	protein kinase; Provisional	99.94
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.94
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.94
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.94
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.94
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.94
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.94
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.94
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.94
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.94
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.94
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.94
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.94
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.94
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.94
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.94
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.94
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.94
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.94
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.94
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.94
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.94
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.94
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.94
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.94
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.94
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.93
PHA03212	391	serine/threonine kinase US3; Provisional	99.93
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.93
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.93
PHA03207	392	serine/threonine kinase US3; Provisional	99.93
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.93
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.93
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.93
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.93
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.93
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.93
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.93
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.93
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.93
PTZ00283	496	serine/threonine protein kinase; Provisional	99.93
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.93
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.93
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.93
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.93
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.93
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.93
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.93
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.93
KOG0610	459	consensus Putative serine/threonine protein kinase	99.93
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.93
KOG0589	426	consensus Serine/threonine protein kinase [General	99.93
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.93
PHA03209	357	serine/threonine kinase US3; Provisional	99.93
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.93
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.93
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.93
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.93
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.93
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.93
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.93
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.93
PTZ00267	478	NIMA-related protein kinase; Provisional	99.93
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.93
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.93
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.93
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.92
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.92
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.92
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.92
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.92
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.92
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.92
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.92
PHA03211	461	serine/threonine kinase US3; Provisional	99.92
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.92
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.92
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.92
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.92
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.92
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.92
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.92
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.92
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.92
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.92
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.92
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.92
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.92
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.92
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.92
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.92
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.92
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.92
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.92
PHA02988	283	hypothetical protein; Provisional	99.92
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.92
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.92
PHA03210	501	serine/threonine kinase US3; Provisional	99.92
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.92
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.92
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.92
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.92
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.92
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.92
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.92
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.92
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.92
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.92
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.92
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.92
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.92
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.92
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.92
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.92
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.92
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.92
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.92
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.92
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.92
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.91
PHA02882	294	putative serine/threonine kinase; Provisional	99.91
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.91
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.91
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.91
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.91
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.91
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.91
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.91
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.91
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.91
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.91
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.91
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.91
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.91
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.91
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.91
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.91
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.91
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.91
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.91
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.91
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.91
PLN00009	294	cyclin-dependent kinase A; Provisional	99.91
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.91
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.91
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.91
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.91
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.91
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.91
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.91
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.91
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.91
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.91
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.91
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.91
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.91
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.91
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.91
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.91
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.91
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.91
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.91
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.91
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.9
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.9
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.9
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.9
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.9
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.9
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.9
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.9
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.9
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.9
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.9
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.9
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.9
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.9
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.9
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.9
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.9
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.9
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.9
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.9
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.9
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.9
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.9
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.9
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.9
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.9
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.9
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.9
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.9
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.9
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.9
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.9
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.9
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.9
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.9
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.9
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.9
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.9
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.9
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.9
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.9
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.9
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.9
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.9
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.9
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.9
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.9
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.9
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.9
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.9
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.9
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.9
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.9
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.89
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.89
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.89
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.89
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.89
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.89
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.89
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.89
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.89
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.89
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.89
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.89
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.89
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.89
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.89
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.89
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.89
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.89
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.89
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.89
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.89
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.89
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.89
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.89
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.89
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.89
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.89
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.89
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.89
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.89
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.89
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.89
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.89
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.89
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.89
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.89
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.89
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.88
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.88
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.88
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.88
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.88
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.88
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.88
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.88
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.88
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.88
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.88
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.88
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.88
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.88
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.88
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.88
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.88
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.88
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.88
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.88
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.88
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.88
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.88
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.88
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.88
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.88
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.88
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.88
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.88
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.88
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.87
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.87
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.87
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.87
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.87
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.87
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.87
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.87
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.87
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.87
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.86
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.86
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.86
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.86
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.86
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.86
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.85
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.85
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.85
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.85
KOG0586	596	consensus Serine/threonine protein kinase [General	99.85
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.85
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.85
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.85
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.85
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.84
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.83
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.83
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.83
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.82
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.82
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.8
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.8
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.79
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.79
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.77
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.74
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.74
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.73
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.73
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.73
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.72
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.72
KOG3653	534	consensus Transforming growth factor beta/activin	99.72
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.72
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.71
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.71
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.69
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.66
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.63
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.62
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.61
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.58
KOG1152	772	consensus Signal transduction serine/threonine kin	99.56
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.52
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.5
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.44
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.4
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.36
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.26
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.19
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.15
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.15
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.14
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.11
PRK12274	218	serine/threonine protein kinase; Provisional	99.05
PRK09188	365	serine/threonine protein kinase; Provisional	99.01
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	98.8
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	98.77
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	98.76
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	98.72
PF12202	38	OSR1_C: Oxidative-stress-responsive kinase 1 C ter	98.69
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.58
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.56
smart00090	237	RIO RIO-like kinase.	98.37
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	98.37
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	98.35
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	98.27
COG4248	637	Uncharacterized protein with protein kinase and he	98.25
PRK10345	210	hypothetical protein; Provisional	98.2
PRK14879	211	serine/threonine protein kinase; Provisional	98.14
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	98.11
PRK09605	535	bifunctional UGMP family protein/serine/threonine	98.03
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	97.91
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	97.8
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	97.73
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	97.57
KOG1243	690	consensus Protein kinase [General function predict	97.37
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	97.17
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	97.02
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	97.0
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	96.99
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	96.82
KOG3087	229	consensus Serine/threonine protein kinase [General	96.69
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.48
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	96.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	96.14
KOG0584	632	consensus Serine/threonine protein kinase [General	95.91
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	95.5
PRK09902	216	hypothetical protein; Provisional	94.88
KOG0576	829	consensus Mitogen-activated protein kinase kinase	94.8
COG0478	304	RIO-like serine/threonine protein kinase fused to	92.96
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	91.06
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	90.61
PF01636	239	APH: Phosphotransferase enzyme family This family	89.84
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	89.17
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	89.0
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	88.9
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	88.77
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	88.65
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	87.43
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	86.59
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	85.96
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	85.71
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	84.52
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	84.41
PLN02236	344	choline kinase	84.17
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	84.0
COG0661	517	AarF Predicted unusual protein kinase [General fun	83.51
PRK05231	319	homoserine kinase; Provisional	82.37
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	81.12
KOG1093	725	consensus Predicted protein kinase (contains TBC a	80.43

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-64  Score=535.43  Aligned_cols=307  Identities=56%  Similarity=0.903  Sum_probs=251.6

Q ss_pred             CHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccccCC
Q 010626            1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYN   80 (505)
Q Consensus         1 Lk~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~ys   80 (505)
                      +++++.|++|||+||.|||++.|||||||||++||||+|+.|.|||+|+|+|...+......++|||.|||||++...|+
T Consensus       142 ~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~Yn  221 (632)
T KOG0584|consen  142 IKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYEENYN  221 (632)
T ss_pred             HHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccceeccCccccChHHHhhhcc
Confidence            47899999999999999999999999999999999999999999999999999999888888999999999999999999


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcCCCCCCCCHHHHhcCCCCCC
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVT  160 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~dP~~RpSa~ElL~hpff~~  160 (505)
                      +.+||||||||++||+|+.+||..|.+++++|+++..|.+|..+.++.+|++++||++||...+.|+|+.|||+||||..
T Consensus       222 E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  222 ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLATKSERLSAKELLKDPFFDE  301 (632)
T ss_pred             hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcCchhccCHHHHhhChhhcc
Confidence            99999999999999999999999999999999999999999999999999999999999988999999999999999998


Q ss_pred             CCCCC-------cccCCC--CCCCCchhhcccCCCCCCCCCcccccccccc--ccccccCCCcchhhHHHhhhccCCcee
Q 010626          161 DNPKD-------LVCDPL--RLPNLVPEVMNLAHSEPHPMDIDLNHKKVSA--DSCAKSNTGTWFLTLELQRLTENNEFT  229 (505)
Q Consensus       161 ~~~~~-------l~~~~l--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~s~~~s~~~~~~~~~e~~~~~~~~~~~  229 (505)
                      +..-.       .....+  .+....+.....+......++.+.+......  +.......-.+-...++.|..+.+.+.
T Consensus       302 d~g~~~~~~e~d~~~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~  381 (632)
T KOG0584|consen  302 DGGIVELAPEDDMSDPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFS  381 (632)
T ss_pred             ccccccccchhhcccccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceee
Confidence            64311       100000  1111111111111111112222211111000  000001111122235667788889999


Q ss_pred             eecccCCCC-ceEEEEEecCCCCCcceeeeecccCCCCHHHHHHHHHHccCCCCcCHHHHHHHHHHHHHHhCCCCCCCC
Q 010626          230 LRGEKNDDD-TVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPSL  307 (505)
Q Consensus       230 ~~g~~~~~~-~i~L~Lri~d~~g~~r~I~F~F~~~~DTa~~VA~EmV~~~~l~~~d~~~iA~~i~~~i~~l~p~w~~~~  307 (505)
                      ++|+++++. .++|.|||++++|+.|||+|||++..|||.+||.|||+++.+++++|+.||+|||++|.+|+|.|+...
T Consensus       382 ikgkr~~~~~~~~l~l~i~~~~g~~r~i~fpf~~~~dta~~Va~eMv~el~~~dq~v~~ia~mid~~i~~L~p~~~~~~  460 (632)
T KOG0584|consen  382 IKGKRNDRQTEISLELRIADEDGLVRNIHFPFDLEGDTAPSVAHEMVEELEITDQPVVNIAEMIDGEISALVPNWKAST  460 (632)
T ss_pred             echhhhcccccceeEeeccCCCCCcccccCCCcCCCcchhHHHHHHHhhcCCcccchhhHHHHHhchhhhcCCccCCCC
Confidence            999999766 999999999999999999999999999999999999999999999999999999999999999998753

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-34  Score=292.71  Aligned_cols=284  Identities=24%  Similarity=0.392  Sum_probs=187.5

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----C-ccccCCCcccCcccc-
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----A-RSVIGTPEFMAPELY-   75 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~-~~~~Gt~~Y~APEll-   75 (505)
                      .|..+++++++||.|||.+|  .||||||+.|||++ .+|.|||+|||++..+....     . ++++|||+|||||++ 
T Consensus       127 ~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~-~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~  203 (516)
T KOG0582|consen  127 SIATILREVLKALDYLHQNG--HIHRDVKAGNILID-SDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLM  203 (516)
T ss_pred             HHHHHHHHHHHHHHHHHhcC--ceecccccccEEEc-CCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhh
Confidence            57899999999999999999  99999999999998 78999999999986653321     2 566899999999995 


Q ss_pred             c--ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC-------CCCCCCCCChHHHHHHHHhcC-CCCC
Q 010626           76 E--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-------PASLSKVTDPQVKQFIEKCIV-PASL  145 (505)
Q Consensus        76 ~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~-------p~~~~~~~s~~l~~LI~kcL~-dP~~  145 (505)
                      +  .+|+.|+||||||++..||.+|..||........+..++....+       +....+.++..++.+|..||+ ||.+
T Consensus       204 q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~k  283 (516)
T KOG0582|consen  204 QQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSK  283 (516)
T ss_pred             hcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCccc
Confidence            3  46999999999999999999999999986555555555544332       112223456789999999996 8999


Q ss_pred             CCCHHHHhcCCCCCCCCCCCcccCCC-C-CCCCchh---hcccC--------CC---CCCCCC----c-ccccccc----
Q 010626          146 RLPALELLKDPFLVTDNPKDLVCDPL-R-LPNLVPE---VMNLA--------HS---EPHPMD----I-DLNHKKV----  200 (505)
Q Consensus       146 RpSa~ElL~hpff~~~~~~~l~~~~l-~-~p~~~~~---~~~~~--------~~---~~~~~~----~-~~~~~~~----  200 (505)
                      |||+.++|+|+||+....+......+ . +|.....   .....        ..   +.....    . +......    
T Consensus       284 RptAskLlkh~FFk~~k~~~~~~~~~l~~l~~l~~r~~~~q~~~~~~~~~~~~~~~~e~~~~~W~f~~~~~~~~~~~~~~  363 (516)
T KOG0582|consen  284 RPTASKLLKHAFFKKAKSKEYLVKKLLQSLPPLGTRFKKSQSKEESQISGLSGNPLSEYQKGEWNFDYEDLDEEASLGDK  363 (516)
T ss_pred             CCCHHHHhccHHHhhccchhhcchhhhccCCcHHHHHHHHHhhhccccccccCCchhhhcCCCccccccchhcccccccc
Confidence            99999999999999877665332221 1 2222110   00000        00   000000    0 0000000    


Q ss_pred             c-cccc-------cccC--CCcchh-----hH-------HHhhhccCC------ceeeecc-c-CCCCceEEEEEecCCC
Q 010626          201 S-ADSC-------AKSN--TGTWFL-----TL-------ELQRLTENN------EFTLRGE-K-NDDDTVSLTLRIGDKS  250 (505)
Q Consensus       201 s-~~s~-------~~s~--~~~~~~-----~~-------e~~~~~~~~------~~~~~g~-~-~~~~~i~L~Lri~d~~  250 (505)
                      . ....       .+..  .+....     ..       .+.+-+...      +....|. . ....+++|++|++++.
T Consensus       364 ~~~~~s~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~l~~r~~~~~  443 (516)
T KOG0582|consen  364 SSSEDSPREEPQCENKETADSTTSSELPSSNSEHGALSAQLASGAPLAALSGAAEASESGSALNPTPEPLNLVLRLRNSK  443 (516)
T ss_pred             cccccccccchhhhcccccCccccccCCcccccccccccccccCCcccccccchhhhccccccCCCCchhhhhhhhcccc
Confidence            0 0000       0000  000000     00       000000000      0000011 1 1236799999999999


Q ss_pred             CCcceeeeecccCCCCHHHHHHHHHHccCCCCcCHHHHHHHHHHHHHHh
Q 010626          251 GHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKL  299 (505)
Q Consensus       251 g~~r~I~F~F~~~~DTa~~VA~EmV~~~~l~~~d~~~iA~~i~~~i~~l  299 (505)
                      .++++|+          ++|++|++.|++|..+|++++|.+.++++...
T Consensus       444 ~~~~~ir----------~~~~q~l~~~~~i~~~~~~~~a~~~~~~~~~~  482 (516)
T KOG0582|consen  444 AELNQIR----------EGILQELFSANLIQRDDLVITAGNLQKILDEP  482 (516)
T ss_pred             chhhhhh----------hHHHHHHHhcccccccceeeecchhcccccch
Confidence            9999999          99999999999999999999999988887765

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=285.11  Aligned_cols=158  Identities=32%  Similarity=0.577  Sum_probs=140.9

Q ss_pred             HHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccc-cCC
Q 010626            3 AIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-EYN   80 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~-~ys   80 (505)
                      .+.++++++++||.|||. ++  ||||||||+|||++ ..|+|||||||.+..+.+..+.+++||..|||||.+.+ .|+
T Consensus       179 ~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvN-skGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys  255 (364)
T KOG0581|consen  179 VLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVN-SKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYS  255 (364)
T ss_pred             HHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeec-cCCCEEeccccccHHhhhhhcccccccccccChhhhcCCcCC
Confidence            567899999999999995 88  99999999999998 68999999999999888888899999999999998854 699


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCC----CChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~----~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++||||||+.++|+++|++||...    .....++..|..+.+|......++++++.||..||+ +|.+|+++.|+|+|
T Consensus       256 ~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  256 VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            9999999999999999999999763    466778888888766654444699999999999996 79999999999999


Q ss_pred             CCCCCCCC
Q 010626          156 PFLVTDNP  163 (505)
Q Consensus       156 pff~~~~~  163 (505)
                      ||+++...
T Consensus       336 pfi~~~~~  343 (364)
T KOG0581|consen  336 PFIKKFED  343 (364)
T ss_pred             HHHhhccc
Confidence            99986543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=270.37  Aligned_cols=167  Identities=31%  Similarity=0.531  Sum_probs=145.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.|+.+|+.||.|||++|  ||||||||+|||+| .+|+++|+|||+++..-.  ....+++||+.|||||++ ...
T Consensus       125 ~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd-~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g  201 (357)
T KOG0598|consen  125 DRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLD-EQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKG  201 (357)
T ss_pred             hHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeec-CCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCC
Confidence            358999999999999999999  99999999999998 889999999999975433  345678999999999987 667


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC----CHHHHh
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL----PALELL  153 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp----Sa~ElL  153 (505)
                      |+..+|+||||+++|+|++|.+||.. .+...++++|..+..+ ..+...+.++++|+.++|. +|.+|.    .+.++-
T Consensus       202 y~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~~-~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik  279 (357)
T KOG0598|consen  202 YDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKLP-LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK  279 (357)
T ss_pred             CCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcCC-CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence            99999999999999999999999987 6778888888877533 4566679999999999995 899996    688999


Q ss_pred             cCCCCCCCCCCCcccCCCCC
Q 010626          154 KDPFLVTDNPKDLVCDPLRL  173 (505)
Q Consensus       154 ~hpff~~~~~~~l~~~~l~~  173 (505)
                      +||||...+|+.+....+..
T Consensus       280 ~HpfF~~inW~~l~~k~l~P  299 (357)
T KOG0598|consen  280 RHPFFKGINWEKLLAKKLSP  299 (357)
T ss_pred             cCcccccCCHHHHHhcCCCC
Confidence            99999999998877666544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.1e-32  Score=277.76  Aligned_cols=158  Identities=28%  Similarity=0.417  Sum_probs=135.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEeecCceeeccCC-CCccccCCCcccCcccccc--
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE--   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~--~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~~--   77 (505)
                      .-+.+++|++.||.|||++|  |+||||||+|||+..+  +-.+||+|||+|+..... ...+.+|||.|.|||++..  
T Consensus       277 ~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg  354 (475)
T KOG0615|consen  277 LGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKG  354 (475)
T ss_pred             hhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCC
Confidence            45779999999999999999  9999999999999632  256899999999887643 4678899999999999843  


Q ss_pred             --cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC--CCCCCCChHHHHHHHHhc-CCCCCCCCHHHH
Q 010626           78 --EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCI-VPASLRLPALEL  152 (505)
Q Consensus        78 --~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~LI~kcL-~dP~~RpSa~El  152 (505)
                        .|..++|+||+||+||-+++|.+||.+......+++.|..|..+.  ..+...+.++++||.+|| ++|++|||+.|+
T Consensus       355 ~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea  434 (475)
T KOG0615|consen  355 VEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEA  434 (475)
T ss_pred             eecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH
Confidence              255699999999999999999999998777776888898886543  345567899999999999 599999999999


Q ss_pred             hcCCCCCCCC
Q 010626          153 LKDPFLVTDN  162 (505)
Q Consensus       153 L~hpff~~~~  162 (505)
                      |+||||+...
T Consensus       435 L~hpW~~~~~  444 (475)
T KOG0615|consen  435 LNHPWFKDAP  444 (475)
T ss_pred             hcChhhhccc
Confidence            9999998543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-31  Score=261.56  Aligned_cols=169  Identities=30%  Similarity=0.533  Sum_probs=150.7

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCCc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNE   81 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys~   81 (505)
                      .++.|+.||+.||+|||+++  |++|||||+|||+| .+|.+||.|||+|+..... ..+.+|||.|+|||++ ..+|+.
T Consensus       145 ~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD-~~G~iKitDFGFAK~v~~r-T~TlCGTPeYLAPEii~sk~ynk  220 (355)
T KOG0616|consen  145 HARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLD-QNGHIKITDFGFAKRVSGR-TWTLCGTPEYLAPEIIQSKGYNK  220 (355)
T ss_pred             hHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeec-cCCcEEEEeccceEEecCc-EEEecCCccccChHHhhcCCCCc
Confidence            57899999999999999999  99999999999998 8899999999999888665 6778999999999988 567999


Q ss_pred             ccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHHHhcC
Q 010626           82 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLKD  155 (505)
Q Consensus        82 ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~ElL~h  155 (505)
                      ++|.|+||+++|||+.|..||.. .++.++|.+|..+..  .+|...++++++||.++|+ |-.+|.     ...++..|
T Consensus       221 avDWWalGVLIYEMlaG~pPF~~-~~~~~iY~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H  297 (355)
T KOG0616|consen  221 AVDWWALGVLIYEMLAGYPPFYD-DNPIQIYEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNH  297 (355)
T ss_pred             chhHHHHHHHHHHHHcCCCCCcC-CChHHHHHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccC
Confidence            99999999999999999999987 677999999998854  4677889999999999995 777773     57899999


Q ss_pred             CCCCCCCCCCcccCCCCCCCCch
Q 010626          156 PFLVTDNPKDLVCDPLRLPNLVP  178 (505)
Q Consensus       156 pff~~~~~~~l~~~~l~~p~~~~  178 (505)
                      |||+...|..+....+..|..+|
T Consensus       298 ~wF~~v~W~~i~~r~ie~P~~pp  320 (355)
T KOG0616|consen  298 PWFKGVDWEAILQRKIEPPFEPP  320 (355)
T ss_pred             cccccccHHHHhhccccCCCCCc
Confidence            99999999988887777776553

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.9e-31  Score=276.85  Aligned_cols=157  Identities=36%  Similarity=0.662  Sum_probs=139.9

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-cccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +|..++++++.||+|||.+|  |+|||||.+|||++ .+|.+||+|||++..+..  ..+.+.+|||.|||||++ +..|
T Consensus       370 qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~-~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~Y  446 (550)
T KOG0578|consen  370 QIAAICREILQGLKFLHARG--IIHRDIKSDNILLT-MDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPY  446 (550)
T ss_pred             HHHHHHHHHHHHHHHHHhcc--eeeeccccceeEec-cCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhccc
Confidence            68899999999999999999  99999999999997 789999999999987754  356778999999999998 5679


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      ++++||||||++++||+-|++||........+|.....+.+....+...++.+++|+.+||+ ++.+|++|.|||+||||
T Consensus       447 G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl  526 (550)
T KOG0578|consen  447 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL  526 (550)
T ss_pred             CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence            99999999999999999999999875555666666677777777788899999999999995 99999999999999999


Q ss_pred             CCCC
Q 010626          159 VTDN  162 (505)
Q Consensus       159 ~~~~  162 (505)
                      +...
T Consensus       527 ~~a~  530 (550)
T KOG0578|consen  527 KMAK  530 (550)
T ss_pred             hhcC
Confidence            6543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.6e-30  Score=276.94  Aligned_cols=152  Identities=35%  Similarity=0.582  Sum_probs=136.7

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccc-cccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +++.+++||+.||.|||+++  |+|||||..|+|++ .+.+|||+|||+|..+..+  ...+.+|||.|.|||++ ...+
T Consensus       119 Eary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~-~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gH  195 (592)
T KOG0575|consen  119 EARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLN-ENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGH  195 (592)
T ss_pred             HHHHHHHHHHHHHHHHHhcC--ceecccchhheeec-CcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCC
Confidence            68999999999999999999  99999999999998 6789999999999888644  45678999999999988 5669


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +..+||||+||++|-|++|++||.. .+....|.+|.....  .+|...+.++++||.++|. +|.+|||+.++|.|+||
T Consensus       196 sfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~Ik~~~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  196 SFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNKIKLNEY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             CCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHHHHhcCc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence            9999999999999999999999976 668889999987644  3566889999999999996 79999999999999999


Q ss_pred             CC
Q 010626          159 VT  160 (505)
Q Consensus       159 ~~  160 (505)
                      ++
T Consensus       273 ~~  274 (592)
T KOG0575|consen  273 KS  274 (592)
T ss_pred             hC
Confidence            54

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=273.31  Aligned_cols=159  Identities=29%  Similarity=0.509  Sum_probs=138.8

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC---------------CCccccCCC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---------------TARSVIGTP   67 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~---------------~~~~~~Gt~   67 (505)
                      ..+.|+.||+.||+|||++|  ||||||||+|||++ .+|++||.|||.|+.+...               ...+++||.
T Consensus       175 caR~YAAeIldAleylH~~G--IIHRDlKPENILLd-~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTA  251 (604)
T KOG0592|consen  175 CARFYAAEILDALEYLHSNG--IIHRDLKPENILLD-KDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTA  251 (604)
T ss_pred             HHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEc-CCCcEEEeeccccccCChhhccccCccCcccccCcccceeeee
Confidence            46889999999999999999  99999999999998 7899999999999876321               124589999


Q ss_pred             cccCccccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCC
Q 010626           68 EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASL  145 (505)
Q Consensus        68 ~Y~APEll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~  145 (505)
                      .|.+||++. +..++.+|+|+|||++|.|+.|++||.+ .+.-.++++|....  ..++...++.+++||+++|+ +|.+
T Consensus       252 eYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra-~NeyliFqkI~~l~--y~fp~~fp~~a~dLv~KLLv~dp~~  328 (604)
T KOG0592|consen  252 EYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA-ANEYLIFQKIQALD--YEFPEGFPEDARDLIKKLLVRDPSD  328 (604)
T ss_pred             cccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc-ccHHHHHHHHHHhc--ccCCCCCCHHHHHHHHHHHccCccc
Confidence            999999995 5578899999999999999999999987 56777778887653  34677778999999999996 8999


Q ss_pred             CCCHHHHhcCCCCCCCCCCCcc
Q 010626          146 RLPALELLKDPFLVTDNPKDLV  167 (505)
Q Consensus       146 RpSa~ElL~hpff~~~~~~~l~  167 (505)
                      |+|+.+|.+||||...+|+.+-
T Consensus       329 Rlt~~qIk~HpFF~~Vdw~nlw  350 (604)
T KOG0592|consen  329 RLTSQQIKAHPFFEGVDWENLW  350 (604)
T ss_pred             cccHHHHhhCcccccCChhhhh
Confidence            9999999999999999988853

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=265.40  Aligned_cols=159  Identities=35%  Similarity=0.589  Sum_probs=131.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC-----CCCccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-----PTARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~-----~~~~~~~Gt~~Y~APEll~   76 (505)
                      ..|+.+++||+.||+|||++|  |+||||||+|||++..++.+||+|||++.....     .......|||.|||||++.
T Consensus       117 ~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~  194 (313)
T KOG0198|consen  117 PLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIR  194 (313)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhc
Confidence            468999999999999999999  999999999999984368999999999976652     2244578999999999986


Q ss_pred             ccCC--cccchhhHHHHHHHHhhcCCCCCCC-CChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           77 EEYN--ELVDIYSFGMCILEMVTCEYPYNEC-KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        77 ~~ys--~ksDIWSLGviLyEmlTG~~Pf~~~-~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                      ..+.  .++|||||||++.||+||+.||... .....++........| .++...++++++||.+|+. +|.+||||.++
T Consensus       195 ~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eL  273 (313)
T KOG0198|consen  195 NGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLP-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEEL  273 (313)
T ss_pred             CCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCC-CCCcccCHHHHHHHHHHhhcCcccCcCHHHH
Confidence            4433  4999999999999999999999873 3334444444444333 7888899999999999995 89999999999


Q ss_pred             hcCCCCCCCCC
Q 010626          153 LKDPFLVTDNP  163 (505)
Q Consensus       153 L~hpff~~~~~  163 (505)
                      |.|||.+....
T Consensus       274 L~hpf~~~~~~  284 (313)
T KOG0198|consen  274 LEHPFLKQNSI  284 (313)
T ss_pred             hhChhhhcccc
Confidence            99999987543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-29  Score=263.61  Aligned_cols=154  Identities=29%  Similarity=0.660  Sum_probs=134.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeec--cCCCCccccCCCcccCcccccc-c-
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELYEE-E-   78 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~--~~~~~~~~~Gt~~Y~APEll~~-~-   78 (505)
                      .++++++||+.|++|||++|  |+||||||+||+++.+.+.+||+|||++...  ......+.+|||.|+|||++.+ . 
T Consensus       121 ~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~  198 (370)
T KOG0583|consen  121 EARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGT  198 (370)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCC
Confidence            68899999999999999999  9999999999999844389999999999887  3345677899999999999954 4 


Q ss_pred             CC-cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCC-ChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys-~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~-s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      |+ .++||||+|++||.|++|..||.. .+...++.++..+..  .++... +++++.|+++||. +|.+|+++.+++.|
T Consensus       199 Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  199 YSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             cCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence            64 789999999999999999999987 566777777776643  345555 9999999999996 89999999999999


Q ss_pred             CCCCCC
Q 010626          156 PFLVTD  161 (505)
Q Consensus       156 pff~~~  161 (505)
                      |||+..
T Consensus       276 ~w~~~~  281 (370)
T KOG0583|consen  276 PWFQKE  281 (370)
T ss_pred             hhhccC
Confidence            999874

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=9.5e-29  Score=239.18  Aligned_cols=155  Identities=29%  Similarity=0.577  Sum_probs=133.7

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-ccc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      .+-.+++||+.+|.|+|.+|  |+|||+||.|+++.+  ...-+||+|||+|..+... ....++|||.|||||++ ...
T Consensus       111 ~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdp  188 (355)
T KOG0033|consen  111 DASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDP  188 (355)
T ss_pred             HHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCC
Confidence            35678999999999999999  999999999999953  2335899999999887643 34567899999999998 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC--CCCCCCCCChHHHHHHHHhc-CCCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~LI~kcL-~dP~~RpSa~ElL~h  155 (505)
                      |+..+|||+.|++||-|+.|.+||.+ .....+|+.|..+..  +...+...++++++||++|| .+|.+|+|+.|+|+|
T Consensus       189 y~kpvDiW~cGViLfiLL~G~~PF~~-~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  189 YSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             CCCcchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            99999999999999999999999987 467788999988743  44456677899999999999 499999999999999


Q ss_pred             CCCCC
Q 010626          156 PFLVT  160 (505)
Q Consensus       156 pff~~  160 (505)
                      ||+..
T Consensus       268 pWi~~  272 (355)
T KOG0033|consen  268 PWICN  272 (355)
T ss_pred             chhcc
Confidence            99976

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.96  E-value=3.6e-29  Score=248.11  Aligned_cols=156  Identities=29%  Similarity=0.520  Sum_probs=130.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~--~   77 (505)
                      +.+++|++|++.|+.|||+++  +|||||||+|||++ .+|.+||||||+|+.+..+.  -+.++.|.+|+|||++-  .
T Consensus       101 ~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit-~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDt  177 (396)
T KOG0593|consen  101 ELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILIT-QNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDT  177 (396)
T ss_pred             HHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEe-cCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccC
Confidence            468999999999999999999  99999999999998 88999999999999887443  34568999999999883  5


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC-------------------CC-C-----CCCC---CCCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-------------------IK-P-----ASLS---KVTD  129 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~-------------------~~-p-----~~~~---~~~s  129 (505)
                      +|+..+|||++||++.||++|++-|.+..+.+++|.....-                   .. |     ..+.   ...+
T Consensus       178 qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s  257 (396)
T KOG0593|consen  178 QYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKIS  257 (396)
T ss_pred             cCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccch
Confidence            79999999999999999999999999988889987665421                   00 0     0111   1224


Q ss_pred             hHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          130 PQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       130 ~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      ..+.+|+.+||. ||.+|++.+++|.||||..
T Consensus       258 ~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  258 NVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             HHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence            578899999995 9999999999999999943

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.6e-29  Score=244.71  Aligned_cols=146  Identities=34%  Similarity=0.550  Sum_probs=131.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCC--eEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPP--IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~--IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll-~   76 (505)
                      +.||+++.|++.||..||.+-+.  |+||||||.|||++ .+|.|||+|||+++.+...  .+.+.+|||.||+||.+ .
T Consensus       124 ~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~-~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~  202 (375)
T KOG0591|consen  124 KTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT-ANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE  202 (375)
T ss_pred             HHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc-CCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc
Confidence            57999999999999999994333  99999999999998 7899999999999988654  35678999999999988 6


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA  149 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa  149 (505)
                      .+|+.++||||+||++|||+.-+.||.+ .+..++.++|..+..|+.+...++..+..||..|+. +|..||+.
T Consensus       203 ~~Y~~kSDiWslGCllyEMcaL~~PF~g-~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  203 SGYNFKSDIWSLGCLLYEMCALQSPFYG-DNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCCCcchhHHHHHHHHHHHHhcCCCccc-ccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            7799999999999999999999999988 588899999999977766668899999999999994 89999987

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.9e-29  Score=266.68  Aligned_cols=167  Identities=28%  Similarity=0.531  Sum_probs=146.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeec--cCCCCccccCCCcccCcccc-cccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~--~~~~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      .++.|+..|+.||.|||++|  |||||||.+|||+| ..|++||+|||+++..  ......+++|||.|||||++ ...|
T Consensus       469 rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD-~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Y  545 (694)
T KOG0694|consen  469 RARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLD-TEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSY  545 (694)
T ss_pred             HHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEc-ccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcc
Confidence            57889999999999999999  99999999999998 7899999999999754  34456788999999999988 5679


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHHHh
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELL  153 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~ElL  153 (505)
                      +.++|.|+|||+||||+.|+.||.+ ++.+++...|....  ..+|..++.++..+++++|. +|.+|..     +.++.
T Consensus       546 t~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~  622 (694)
T KOG0694|consen  546 TRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIK  622 (694)
T ss_pred             cchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCC--CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhh
Confidence            9999999999999999999999987 66778888877653  34677789999999999995 8999986     57899


Q ss_pred             cCCCCCCCCCCCcccCCCCCCC
Q 010626          154 KDPFLVTDNPKDLVCDPLRLPN  175 (505)
Q Consensus       154 ~hpff~~~~~~~l~~~~l~~p~  175 (505)
                      +||||+..+|+.+....++.|.
T Consensus       623 ~hpFFr~i~w~~L~~r~i~PPf  644 (694)
T KOG0694|consen  623 KHPFFRSIDWDDLLNRRIKPPF  644 (694)
T ss_pred             hCCccccCCHHHHhhccCCCCC
Confidence            9999999999988877665543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.1e-28  Score=264.27  Aligned_cols=155  Identities=28%  Similarity=0.557  Sum_probs=137.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC-CCCccccCCCcccCcccccc-cC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEE-EY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~-~~~~~~~Gt~~Y~APEll~~-~y   79 (505)
                      +++.++++||+.|+.|||..+  |+||||||+|+|++ ..+.+||+|||+|..-.. .-..+.+|+|.|.+||++.+ .|
T Consensus       112 ~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd-~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pY  188 (786)
T KOG0588|consen  112 REAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLD-VKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPY  188 (786)
T ss_pred             HHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhh-cccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCC
Confidence            467899999999999999999  99999999999998 556799999999976543 34667899999999998844 45


Q ss_pred             -CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhc-CCCCCCCCHHHHhcCCC
Q 010626           80 -NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPF  157 (505)
Q Consensus        80 -s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL-~dP~~RpSa~ElL~hpf  157 (505)
                       +.++||||+|||||.|+||++||++ +|...++.++..|...  ++..+++++++||.+|| +||.+|+|..|+++|||
T Consensus       189 dG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~G~f~--MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  189 DGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQRGVFE--MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             CCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHcCccc--CCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence             5799999999999999999999985 7899999999998654  56888999999999999 69999999999999999


Q ss_pred             CCCCC
Q 010626          158 LVTDN  162 (505)
Q Consensus       158 f~~~~  162 (505)
                      +....
T Consensus       266 l~g~~  270 (786)
T KOG0588|consen  266 LSGYT  270 (786)
T ss_pred             hhcCC
Confidence            98754

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-28  Score=255.79  Aligned_cols=159  Identities=29%  Similarity=0.450  Sum_probs=134.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc--ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY--EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll--~~~   78 (505)
                      ..|+.|+.||++||+|+|.+|  +.|||+||+|||+.+ +..+||+|||+|+..... .-+.++.|.+|+|||++  .+.
T Consensus       110 ~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~-~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~  186 (538)
T KOG0661|consen  110 SDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISG-NDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGY  186 (538)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecc-cceeEecccccccccccCCCcchhhhcccccchHHhhhccc
Confidence            579999999999999999999  999999999999974 568999999999887544 45567899999999977  456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC------------------------C---CCCCCCChH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP------------------------A---SLSKVTDPQ  131 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p------------------------~---~~~~~~s~~  131 (505)
                      |+.++|+|++|||++|+.+-++-|.+..+.+++++....-..|                        .   .+-...+++
T Consensus       187 Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~  266 (538)
T KOG0661|consen  187 YSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSE  266 (538)
T ss_pred             cCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHH
Confidence            9999999999999999999999999988888888765421111                        0   011225788


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                      +.++|.+|+. ||.+||||.++|+||||+....
T Consensus       267 ~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  267 AASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             HHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence            9999999997 9999999999999999987544

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.95  E-value=1.7e-28  Score=250.31  Aligned_cols=162  Identities=26%  Similarity=0.536  Sum_probs=133.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||+++....  .......||+.|+|||++ ...
T Consensus        95 ~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  171 (323)
T cd05571          95 DRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND  171 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCC
Confidence            357789999999999999999  99999999999998 678999999999865322  223345799999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~El  152 (505)
                      |+.++|||||||++|+|++|+.||.. .+.......+..+.  ..++...++.+++||.+||. +|.+||     ++.++
T Consensus       172 ~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l  248 (323)
T cd05571         172 YGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEI  248 (323)
T ss_pred             CCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHH
Confidence            89999999999999999999999976 44555555555442  23556678999999999996 899999     89999


Q ss_pred             hcCCCCCCCCCCCcccC
Q 010626          153 LKDPFLVTDNPKDLVCD  169 (505)
Q Consensus       153 L~hpff~~~~~~~l~~~  169 (505)
                      ++||||....+..+...
T Consensus       249 l~h~~f~~~~~~~~~~~  265 (323)
T cd05571         249 MEHRFFASINWQDVVQK  265 (323)
T ss_pred             HcCCCcCCCCHHHHHhC
Confidence            99999998776655433

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.95  E-value=1.8e-28  Score=257.97  Aligned_cols=165  Identities=26%  Similarity=0.476  Sum_probs=137.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC------------------------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ------------------------   57 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~------------------------   57 (505)
                      +.++.|+.+++.|++.||++|  +|||||||+|+||| ..|++||+|||++..+..                        
T Consensus       241 ~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD-~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (550)
T KOG0605|consen  241 DWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLID-AKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSD  317 (550)
T ss_pred             HHHHHHHHHHHHHHHHHHHcC--cccccCChhheeec-CCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCcc
Confidence            468899999999999999999  99999999999998 889999999999842200                        


Q ss_pred             -C------------------------CCccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHH
Q 010626           58 -P------------------------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI  111 (505)
Q Consensus        58 -~------------------------~~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i  111 (505)
                       .                        .+.+.+|||-|+|||++ ..+|+..+|+||||||+||||.|.+||.. .++.+.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s-~tp~~T  396 (550)
T KOG0605|consen  318 FPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCS-ETPQET  396 (550)
T ss_pred             ccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHH
Confidence             0                        01235799999999987 56799999999999999999999999987 678888


Q ss_pred             HHHHHcCCCCCCC--CCCCChHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCCCCCCcccCC
Q 010626          112 YKKVTSGIKPASL--SKVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDLVCDP  170 (505)
Q Consensus       112 ~~~i~~~~~p~~~--~~~~s~~l~~LI~kcL~dP~~RpS---a~ElL~hpff~~~~~~~l~~~~  170 (505)
                      +.+|........+  ....++++++||.+||.+|.+|..   +.||.+||||+...|..+...+
T Consensus       397 ~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~  460 (550)
T KOG0605|consen  397 YRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHLREMP  460 (550)
T ss_pred             HHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchhhcCC
Confidence            8888765322222  234568999999999999999985   8999999999999998876544

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.95  E-value=4.2e-28  Score=242.39  Aligned_cols=165  Identities=28%  Similarity=0.444  Sum_probs=132.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..+..++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++...... ......|++.|+|||++ ...|
T Consensus       102 ~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  178 (285)
T cd05631         102 QRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCC
Confidence            357789999999999999999  99999999999997 6789999999999765432 22345789999999988 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCCh---HHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----AL  150 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~---~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~  150 (505)
                      +.++|||||||++|+|++|+.||......   ..+...+..  .+..++...++.+.+||.+||. +|.+||+     +.
T Consensus       179 ~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~  256 (285)
T cd05631         179 TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAA  256 (285)
T ss_pred             CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc--ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHH
Confidence            99999999999999999999999764332   222222222  2233555678999999999996 8999997     89


Q ss_pred             HHhcCCCCCCCCCCCcccCCC
Q 010626          151 ELLKDPFLVTDNPKDLVCDPL  171 (505)
Q Consensus       151 ElL~hpff~~~~~~~l~~~~l  171 (505)
                      ++++||||...+++.+....+
T Consensus       257 ~~~~h~~~~~~~~~~~~~~~~  277 (285)
T cd05631         257 GVKQHPIFKNINFKRLEANML  277 (285)
T ss_pred             HHhcCHhhcCCCHHHHHhCcC
Confidence            999999999888776665443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.95  E-value=4.5e-28  Score=248.05  Aligned_cols=159  Identities=26%  Similarity=0.512  Sum_probs=134.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~ys   80 (505)
                      +.++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++...... .....||+.|+|||++. ..++
T Consensus       118 ~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~  193 (329)
T PTZ00263        118 DVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLD-NKGHVKVTDFGFAKKVPDR-TFTLCGTPEYLAPEVIQSKGHG  193 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEC-CCCCEEEeeccCceEcCCC-cceecCChhhcCHHHHcCCCCC
Confidence            356788999999999999999  99999999999998 7789999999999776443 23457999999999884 4588


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHHHhc
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~ElL~  154 (505)
                      .++|||||||++|+|++|..||.+ ......+..+..+..  .++...+..+++||.+||. +|.+|++     +.+++.
T Consensus       194 ~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        194 KAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            999999999999999999999976 456667777766543  3456678999999999995 8999997     799999


Q ss_pred             CCCCCCCCCCCcc
Q 010626          155 DPFLVTDNPKDLV  167 (505)
Q Consensus       155 hpff~~~~~~~l~  167 (505)
                      ||||....+..+.
T Consensus       271 hp~f~~~~~~~~~  283 (329)
T PTZ00263        271 HPYFHGANWDKLY  283 (329)
T ss_pred             CCccCCCCHHHHH
Confidence            9999987665543

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.95  E-value=1.4e-28  Score=240.89  Aligned_cols=155  Identities=28%  Similarity=0.521  Sum_probs=131.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCccccc----
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE----   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~----   76 (505)
                      +..+++++|++.|+.|||.++  |+||||||+|||++ ++..+||+|||+++.+.... ....+|||.|+|||.+.    
T Consensus       123 K~tR~iMrqlfegVeylHa~~--IVHRDLKpENILld-dn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~  199 (411)
T KOG0599|consen  123 KETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLD-DNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMY  199 (411)
T ss_pred             HHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeec-cccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecc
Confidence            467899999999999999999  99999999999998 77899999999998886553 45679999999999873    


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--CCCCCCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                         .+|+..+|+|++|+|+|-|+.|.+||... ....+...|..|...  .+.+..++..+++||.+||+ +|.+|.|++
T Consensus       200 e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-kQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritak  278 (411)
T KOG0599|consen  200 ENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-KQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAK  278 (411)
T ss_pred             cCCCCccchhhHHHHHHHHHHHHcCCCchhHH-HHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHH
Confidence               24888999999999999999999999763 233345667776543  23445678899999999995 999999999


Q ss_pred             HHhcCCCCCC
Q 010626          151 ELLKDPFLVT  160 (505)
Q Consensus       151 ElL~hpff~~  160 (505)
                      |+|.||||.+
T Consensus       279 e~LaHpff~q  288 (411)
T KOG0599|consen  279 EALAHPFFIQ  288 (411)
T ss_pred             HHhcChHHHH
Confidence            9999999965

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=5.5e-28  Score=242.50  Aligned_cols=158  Identities=31%  Similarity=0.530  Sum_probs=132.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~ys   80 (505)
                      ..++.++.||+.||+|||++|  ++||||||+|||++ .++.+||+|||++...... .....|++.|+|||++. ..++
T Consensus       101 ~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~-~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~  176 (291)
T cd05612         101 STGLFYASEIVCALEYLHSKE--IVYRDLKPENILLD-KEGHIKLTDFGFAKKLRDR-TWTLCGTPEYLAPEVIQSKGHN  176 (291)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEEecCcchhccCC-cccccCChhhcCHHHHcCCCCC
Confidence            356789999999999999999  99999999999997 6789999999999766432 33457999999999884 4588


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHHHhc
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~ElL~  154 (505)
                      .++|||||||++|+|++|+.||.. .+...++..+..+..  .++...++.+++||.+||. +|.+|++     +.+++.
T Consensus       177 ~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         177 KAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAGKL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence            999999999999999999999976 455666666665532  3555668999999999996 8999995     999999


Q ss_pred             CCCCCCCCCCCc
Q 010626          155 DPFLVTDNPKDL  166 (505)
Q Consensus       155 hpff~~~~~~~l  166 (505)
                      ||||....+...
T Consensus       254 h~~~~~~~~~~~  265 (291)
T cd05612         254 HRWFKSVDWDDV  265 (291)
T ss_pred             CccccCCCHHHH
Confidence            999987665443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-28  Score=247.16  Aligned_cols=156  Identities=32%  Similarity=0.471  Sum_probs=127.6

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc----CCCCccccCCCcccCcccc--c
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVIGTPEFMAPELY--E   76 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~----~~~~~~~~Gt~~Y~APEll--~   76 (505)
                      .++.+++||+.||.|+|+.|  |+||||||.|+|++ .+..+||+|||+|+...    ....+.++.|.+|+|||++  .
T Consensus       126 H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n-~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~  202 (359)
T KOG0660|consen  126 HAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLN-ADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNS  202 (359)
T ss_pred             HHHHHHHHHHHhcchhhccc--ccccccchhheeec-cCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhcc
Confidence            46788999999999999999  99999999999998 67899999999999885    3334567889999999977  4


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc-----------------------C--CCCCC---CCCCC
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-----------------------G--IKPAS---LSKVT  128 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~-----------------------~--~~p~~---~~~~~  128 (505)
                      ..|+.+.||||+|||+.||++|+.-|.+.....|+...+..                       .  .++..   .-...
T Consensus       203 ~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a  282 (359)
T KOG0660|consen  203 SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNA  282 (359)
T ss_pred             ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCC
Confidence            67999999999999999999999999876555544222211                       0  11111   12356


Q ss_pred             ChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          129 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       129 s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      ++.+.+|+++||+ +|.+|+|++|+|.||||...
T Consensus       283 ~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  283 NPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence            8899999999997 99999999999999999763

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.95  E-value=8.7e-28  Score=239.18  Aligned_cols=154  Identities=32%  Similarity=0.506  Sum_probs=122.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++....... .....|++.|+|||++ ...+
T Consensus       110 ~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  186 (290)
T cd07862         110 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY  186 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEc-CCCCEEEccccceEeccCCcccccccccccccChHHHhCCCC
Confidence            467889999999999999999  99999999999997 67899999999997664332 3345789999999987 5568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--C----------------------CCCCCCChHHHHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--A----------------------SLSKVTDPQVKQF  135 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--~----------------------~~~~~~s~~l~~L  135 (505)
                      +.++|||||||++|+|++|..||.+......+...+.....+  .                      .+....++.+++|
T Consensus       187 ~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  266 (290)
T cd07862         187 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL  266 (290)
T ss_pred             CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHH
Confidence            999999999999999999999998754433333222111000  0                      0112356788999


Q ss_pred             HHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          136 IEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       136 I~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      |.+||. +|.+|||+.++|+||||
T Consensus       267 i~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         267 LLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HHHHhccCchhcCCHHHHhcCCCC
Confidence            999996 89999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.95  E-value=7.9e-28  Score=249.46  Aligned_cols=165  Identities=25%  Similarity=0.462  Sum_probs=130.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----------------------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----------------------   59 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----------------------   59 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++......                      
T Consensus       101 ~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (363)
T cd05628         101 EETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN  177 (363)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCCEEEeeccCcccccccccccccccccccccccccccccc
Confidence            467889999999999999999  99999999999997 67899999999986542110                      


Q ss_pred             ---------------CccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC
Q 010626           60 ---------------ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS  123 (505)
Q Consensus        60 ---------------~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~  123 (505)
                                     ....+||+.|+|||++ ...|+.++|||||||++|+|++|..||.. ......+..+........
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~~~~  256 (363)
T cd05628         178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS-ETPQETYKKVMNWKETLI  256 (363)
T ss_pred             cccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCcCccc
Confidence                           1235799999999987 55689999999999999999999999976 455666666665322222


Q ss_pred             CC--CCCChHHHHHHHHhcCC---CCCCCCHHHHhcCCCCCCCCCCCcccCC
Q 010626          124 LS--KVTDPQVKQFIEKCIVP---ASLRLPALELLKDPFLVTDNPKDLVCDP  170 (505)
Q Consensus       124 ~~--~~~s~~l~~LI~kcL~d---P~~RpSa~ElL~hpff~~~~~~~l~~~~  170 (505)
                      ++  ...++++++||.+++.+   +..||++.|+++||||+...+..+...+
T Consensus       257 ~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~  308 (363)
T cd05628         257 FPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRERP  308 (363)
T ss_pred             CCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCC
Confidence            22  23578999999997754   3467899999999999988776654443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.95  E-value=9.1e-28  Score=250.39  Aligned_cols=150  Identities=38%  Similarity=0.615  Sum_probs=127.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC-cEEEeecCceeeccC--CCCccccCCCcccCcccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYEE-   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g-~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll~~-   77 (505)
                      +.+.+|+.||+.|++|||++++ ||||||||+|||++ .++ ++||+|||+++....  .......||+.|||||++.+ 
T Consensus       142 ~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~-~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~  219 (362)
T KOG0192|consen  142 KVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVD-LKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGE  219 (362)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEc-CCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCC
Confidence            4678899999999999999986 99999999999998 565 999999999987654  33444689999999999974 


Q ss_pred             --cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 --EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 --~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                        .|+.|+||||||+++|||+||+.||.+... .+....+..+...+.++..+++.+..||.+||. +|..||+..+++.
T Consensus       220 ~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  220 KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence              499999999999999999999999998666 555555554444556677789999999999995 8999999998774

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.95  E-value=5.9e-28  Score=257.98  Aligned_cols=159  Identities=28%  Similarity=0.384  Sum_probs=126.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc--cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~--~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++..++.+||+|||+++.+... ......||+.|+|||++.  ..
T Consensus       170 ~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  247 (440)
T PTZ00036        170 FLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATN  247 (440)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCC
Confidence            357889999999999999999  9999999999999855567999999999765432 233467899999999873  35


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--------------------------CCCCCCCChHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--------------------------ASLSKVTDPQV  132 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--------------------------~~~~~~~s~~l  132 (505)
                      |+.++|||||||++|+|++|.+||.+......+...+.....|                          ..++...++++
T Consensus       248 ~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~  327 (440)
T PTZ00036        248 YTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDA  327 (440)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHH
Confidence            8999999999999999999999998765554444333211000                          01223456789


Q ss_pred             HHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          133 KQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       133 ~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      ++||.+||. +|.+|||+.|+|+||||....
T Consensus       328 ~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        328 INFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence            999999996 899999999999999997643

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.1e-27  Score=242.95  Aligned_cols=158  Identities=28%  Similarity=0.510  Sum_probs=131.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.....  .......||+.|+|||++ ...
T Consensus        93 ~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  169 (312)
T cd05585          93 SRARFYTAELLCALENLHKFN--VIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG  169 (312)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEEC-CCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCC
Confidence            357789999999999999999  99999999999997 778999999999875422  223345799999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC---CHHHHhc
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL---PALELLK  154 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp---Sa~ElL~  154 (505)
                      ++.++|||||||++|+|++|+.||.. .+....+..+...  +..++...++.+++||.+||. +|.+||   ++.++|.
T Consensus       170 ~~~~~DvwslGvil~el~tg~~pf~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         170 YTKAVDWWTLGVLLYEMLTGLPPFYD-ENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CCCccceechhHHHHHHHhCCCCcCC-CCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            89999999999999999999999976 3455566665544  334566788999999999996 899997   5899999


Q ss_pred             CCCCCCCCCCC
Q 010626          155 DPFLVTDNPKD  165 (505)
Q Consensus       155 hpff~~~~~~~  165 (505)
                      ||||....+..
T Consensus       247 hp~~~~~~~~~  257 (312)
T cd05585         247 HPFFSQLSWKK  257 (312)
T ss_pred             CCCcCCCCHHH
Confidence            99998865543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.95  E-value=8.2e-28  Score=243.72  Aligned_cols=158  Identities=32%  Similarity=0.455  Sum_probs=133.0

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc--cccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY--EEEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll--~~~y   79 (505)
                      .|+-|+.||++||+|||++|  |+||||||.|+|+|...|.+||||||.|+.+... ...+++.|..|+|||++  ...|
T Consensus       126 ~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Y  203 (364)
T KOG0658|consen  126 EIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY  203 (364)
T ss_pred             eeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCcccc
Confidence            47889999999999999999  9999999999999988899999999999877543 34677899999999987  4579


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC----------------------CC----CCCCCCChHHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK----------------------PA----SLSKVTDPQVK  133 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~----------------------p~----~~~~~~s~~l~  133 (505)
                      +.+.||||.||++.||+.|++-|.+.....|+...+..-..                      +.    .+....++++.
T Consensus       204 t~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~  283 (364)
T KOG0658|consen  204 TTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDAL  283 (364)
T ss_pred             CceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHH
Confidence            99999999999999999999999987666666544432111                      11    13345689999


Q ss_pred             HHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          134 QFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       134 ~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      +|+.++|+ +|.+|.++.|+|.||||....
T Consensus       284 dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  284 DLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             HHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence            99999997 899999999999999997643

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.95  E-value=9.7e-28  Score=247.62  Aligned_cols=164  Identities=27%  Similarity=0.456  Sum_probs=136.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~ys   80 (505)
                      +.++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++...... .....||+.|+|||++. ..++
T Consensus       131 ~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~ikL~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~  206 (340)
T PTZ00426        131 DVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLD-KDGFIKMTDFGFAKVVDTR-TYTLCGTPEYIAPEILLNVGHG  206 (340)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEecCCCCeecCCC-cceecCChhhcCHHHHhCCCCC
Confidence            356789999999999999999  99999999999997 7789999999999766432 34567999999999884 4588


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHHHhc
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~ElL~  154 (505)
                      .++|||||||++|+|++|..||.. .+....+..+..+..  .++...++.++++|++||. +|.+|+     ++.++++
T Consensus       207 ~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        207 KAADWWTLGIFIYEILVGCPPFYA-NEPLLIYQKILEGII--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             ccccccchhhHHHHHhcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            999999999999999999999986 455666777766543  3456678899999999996 799995     8999999


Q ss_pred             CCCCCCCCCCCcccCCCC
Q 010626          155 DPFLVTDNPKDLVCDPLR  172 (505)
Q Consensus       155 hpff~~~~~~~l~~~~l~  172 (505)
                      ||||....+..+....+.
T Consensus       284 hp~f~~~~~~~~~~~~~~  301 (340)
T PTZ00426        284 HPWFGNIDWVSLLHKNVE  301 (340)
T ss_pred             CCCcCCCCHHHHHhCCCC
Confidence            999998776554444433

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.95  E-value=1.3e-27  Score=243.74  Aligned_cols=159  Identities=24%  Similarity=0.474  Sum_probs=132.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||.|||++|  ++||||||+|||++ .++.+||+|||++....  ........||+.|+|||++. ..
T Consensus        96 ~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  172 (320)
T cd05590          96 ARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML  172 (320)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCC
Confidence            356789999999999999999  99999999999997 67899999999986542  22234457999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH------HH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA------LE  151 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa------~E  151 (505)
                      ++.++|||||||++|+|++|+.||.. .+...++..+..+..  .++...++++++||.+||. +|.+|+++      .+
T Consensus       173 ~~~~~DiwslG~il~el~~g~~Pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~  249 (320)
T cd05590         173 YGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEA  249 (320)
T ss_pred             CCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHH
Confidence            89999999999999999999999976 455666666665432  3455678999999999996 89999998      89


Q ss_pred             HhcCCCCCCCCCCCc
Q 010626          152 LLKDPFLVTDNPKDL  166 (505)
Q Consensus       152 lL~hpff~~~~~~~l  166 (505)
                      +++||||....+..+
T Consensus       250 ~~~h~~f~~~~~~~~  264 (320)
T cd05590         250 ILRHPFFKELDWEKL  264 (320)
T ss_pred             HHcCCCcCCCCHHHH
Confidence            999999988766544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.95  E-value=1.4e-27  Score=240.38  Aligned_cols=158  Identities=25%  Similarity=0.405  Sum_probs=122.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~--~   77 (505)
                      +.++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++......  ......|++.|+|||++.  .
T Consensus       103 ~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  179 (303)
T cd07869         103 ENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST  179 (303)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCC
Confidence            467889999999999999999  99999999999997 6789999999998754322  223456899999999873  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC--CC---------------CCCCC-------------CC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IK---------------PASLS-------------KV  127 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~--~~---------------p~~~~-------------~~  127 (505)
                      .++.++|||||||++|+|++|..||.+..+.......+...  .+               +..+.             ..
T Consensus       180 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (303)
T cd07869         180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLS  259 (303)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccC
Confidence            58889999999999999999999998755543333322110  00               00000             01


Q ss_pred             CChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          128 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       128 ~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      .++.+++||.+||+ +|.+|||+.++|+||||+...
T Consensus       260 ~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         260 YVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             CChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            34678999999996 899999999999999997644

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=9.7e-28  Score=250.80  Aligned_cols=168  Identities=31%  Similarity=0.457  Sum_probs=135.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY--E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll--~   76 (505)
                      .+|+.|++||+.||+|||.+|  |+|||||+.||||| ++|.+||+|||+|+++....   .+..+.|.+|+|||++  .
T Consensus       218 ~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLid-n~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~  294 (560)
T KOG0600|consen  218 PQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILID-NNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGA  294 (560)
T ss_pred             HHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEc-CCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCC
Confidence            479999999999999999999  99999999999998 88999999999999775443   4456789999999987  4


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-CC------C-------------------CCCCCh
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-AS------L-------------------SKVTDP  130 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~------~-------------------~~~~s~  130 (505)
                      ..|+.++|+||.||||.||++|++.|.+..+.+|+........-| ..      +                   .+..++
T Consensus       295 t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~  374 (560)
T KOG0600|consen  295 TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPA  374 (560)
T ss_pred             cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCH
Confidence            569999999999999999999999999977777765544321111 00      0                   123467


Q ss_pred             HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCCCcccCCCCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN  175 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~~~l~~~~l~~p~  175 (505)
                      ...+|+.++|. +|.+|.||.++|+++||...   .+.+.+..+|.
T Consensus       375 ~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~---p~~~~p~~Lp~  417 (560)
T KOG0600|consen  375 SALDLLEKLLSLDPDKRGTASSALQSEYFTTE---PLPCDPSSLPK  417 (560)
T ss_pred             HHHHHHHHHhccCccccccHHHHhcCcccccC---CCCCCcccCCC
Confidence            88899999995 99999999999999999542   23444444554

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.2e-27  Score=245.11  Aligned_cols=160  Identities=25%  Similarity=0.451  Sum_probs=130.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----------------------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----------------------   59 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----------------------   59 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++.......                      
T Consensus       101 ~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (350)
T cd05573         101 ETARFYIAELVLALDSVHKLG--FIHRDIKPDNILID-ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR  177 (350)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEeecCCCCccCcccCcccccccccccccccccccccc
Confidence            467889999999999999999  99999999999997 77899999999997654322                      


Q ss_pred             ---------CccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCC--CCC
Q 010626           60 ---------ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKV  127 (505)
Q Consensus        60 ---------~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~  127 (505)
                               .....||+.|+|||++ ...++.++|||||||++|+|++|+.||.... ....+..+........+  ...
T Consensus       178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~  256 (350)
T cd05573         178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT-LQETYNKIINWKESLRFPPDPP  256 (350)
T ss_pred             cccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC-HHHHHHHHhccCCcccCCCCCC
Confidence                     2345699999999988 4568999999999999999999999998744 45555555542111122  223


Q ss_pred             CChHHHHHHHHhcCCCCCCCC-HHHHhcCCCCCCCCCCC
Q 010626          128 TDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDNPKD  165 (505)
Q Consensus       128 ~s~~l~~LI~kcL~dP~~RpS-a~ElL~hpff~~~~~~~  165 (505)
                      +++.+++||.+||.+|.+|++ +.++++||||+...+..
T Consensus       257 ~~~~~~~li~~ll~dp~~R~~s~~~ll~hp~~~~~~~~~  295 (350)
T cd05573         257 VSPEAIDLICRLLCDPEDRLGSFEEIKSHPFFKGIDWEN  295 (350)
T ss_pred             CCHHHHHHHHHHccChhhcCCCHHHHhcCCCcCCCCHHH
Confidence            589999999999999999999 99999999998765543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.95  E-value=1.9e-27  Score=242.11  Aligned_cols=158  Identities=28%  Similarity=0.509  Sum_probs=130.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++....  ........||+.|+|||++. ..
T Consensus        96 ~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  172 (316)
T cd05620          96 YRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLD-RDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK  172 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCC
Confidence            357789999999999999999  99999999999997 67899999999986432  22334567999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH-HHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA-LELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa-~ElL~hp  156 (505)
                      ++.++|||||||++|+|++|+.||.. .+...+...+....  ..++...++++++||.+||. +|.+|+++ .++++||
T Consensus       173 ~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~  249 (316)
T cd05620         173 YTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRVDT--PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHP  249 (316)
T ss_pred             CCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCC
Confidence            89999999999999999999999976 44555666655442  23455678999999999995 89999998 5888999


Q ss_pred             CCCCCCCCC
Q 010626          157 FLVTDNPKD  165 (505)
Q Consensus       157 ff~~~~~~~  165 (505)
                      ||....+..
T Consensus       250 ~f~~~~~~~  258 (316)
T cd05620         250 FFKTINWTA  258 (316)
T ss_pred             CcCCCCHHH
Confidence            998866543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.95  E-value=2.3e-27  Score=236.44  Aligned_cols=164  Identities=30%  Similarity=0.516  Sum_probs=130.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......  .....||+.|+|||++ ...
T Consensus        97 ~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~  173 (280)
T cd05608          97 PRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLD-NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE  173 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCC
Confidence            456789999999999999999  99999999999997 67899999999997654332  2345789999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCCh---HHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PA  149 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~---~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa  149 (505)
                      ++.++|||||||++|+|++|+.||......   ......+..  .+..++...++.+.+++.+||. +|.+||     ++
T Consensus       174 ~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~  251 (280)
T cd05608         174 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN--DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNC  251 (280)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc--cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCH
Confidence            889999999999999999999999754322   222222222  2334455678999999999995 899999     88


Q ss_pred             HHHhcCCCCCCCCCCCcccCC
Q 010626          150 LELLKDPFLVTDNPKDLVCDP  170 (505)
Q Consensus       150 ~ElL~hpff~~~~~~~l~~~~  170 (505)
                      .++++||||+...+..+....
T Consensus       252 ~~~l~h~~~~~~~~~~~~~~~  272 (280)
T cd05608         252 DGLRTHPLFRDLNWRQLEAGM  272 (280)
T ss_pred             HHHhcChhhhcCCHhHHhhcc
Confidence            999999999887666554433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.95  E-value=1.5e-27  Score=244.22  Aligned_cols=159  Identities=26%  Similarity=0.532  Sum_probs=130.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++.....  .......||+.|+|||++ ...
T Consensus        95 ~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  171 (328)
T cd05593          95 DRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLD-KDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND  171 (328)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEEC-CCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCC
Confidence            367889999999999999999  99999999999998 678999999999865322  223345799999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~El  152 (505)
                      ++.++|||||||++|+|++|+.||... +.......+....  ..++...++.+.+||.+||. +|.+|+     ++.++
T Consensus       172 ~~~~~DiwslGvil~elltG~~Pf~~~-~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~i  248 (328)
T cd05593         172 YGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILMED--IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEI  248 (328)
T ss_pred             CCccCCccccchHHHHHhhCCCCCCCC-CHHHHHHHhccCC--ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHH
Confidence            899999999999999999999999763 4444555544332  23566778999999999996 899997     89999


Q ss_pred             hcCCCCCCCCCCCc
Q 010626          153 LKDPFLVTDNPKDL  166 (505)
Q Consensus       153 L~hpff~~~~~~~l  166 (505)
                      ++||||....+..+
T Consensus       249 l~h~~~~~~~~~~~  262 (328)
T cd05593         249 MRHSFFTGVNWQDV  262 (328)
T ss_pred             hcCCCcCCCCHHHH
Confidence            99999987665543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.95  E-value=2.4e-27  Score=241.65  Aligned_cols=164  Identities=24%  Similarity=0.448  Sum_probs=134.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++.....  .......||+.|+|||++ ...
T Consensus       101 ~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  177 (323)
T cd05616         101 PHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP  177 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEEC-CCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCC
Confidence            367889999999999999999  99999999999998 778999999999975432  223455799999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~El  152 (505)
                      ++.++|||||||++|+|+||+.||.. .+...++..+.....  .++...++++.+|+.+||. +|.+|++     ..++
T Consensus       178 ~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i  254 (323)
T cd05616         178 YGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI  254 (323)
T ss_pred             CCCccchhchhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHH
Confidence            89999999999999999999999976 455666666665432  3556678999999999995 8999998     4899


Q ss_pred             hcCCCCCCCCCCCcccCCC
Q 010626          153 LKDPFLVTDNPKDLVCDPL  171 (505)
Q Consensus       153 L~hpff~~~~~~~l~~~~l  171 (505)
                      ++||||....+..+....+
T Consensus       255 ~~h~~~~~~~~~~~~~~~~  273 (323)
T cd05616         255 KEHAFFRYIDWEKLERKEV  273 (323)
T ss_pred             hcCCCcCCCCHHHHHhCCC
Confidence            9999999877665544433

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.95  E-value=3.2e-27  Score=240.81  Aligned_cols=160  Identities=26%  Similarity=0.484  Sum_probs=132.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++....  ........||+.|+|||++. ..
T Consensus       101 ~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  177 (324)
T cd05587         101 PHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-AEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP  177 (324)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEc-CCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCC
Confidence            356789999999999999999  99999999999997 67899999999986432  22233457999999999884 55


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH-----HHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA-----LEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa-----~El  152 (505)
                      ++.++|||||||++|+|+||+.||.. ......+..+....  ..++...++.+.+||.+||. +|.+|+++     .++
T Consensus       178 ~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~  254 (324)
T cd05587         178 YGKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQSIMEHN--VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDI  254 (324)
T ss_pred             CCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHH
Confidence            89999999999999999999999976 44556666665543  23556778999999999996 89999986     899


Q ss_pred             hcCCCCCCCCCCCcc
Q 010626          153 LKDPFLVTDNPKDLV  167 (505)
Q Consensus       153 L~hpff~~~~~~~l~  167 (505)
                      ++||||....+..+.
T Consensus       255 ~~hp~~~~~~~~~~~  269 (324)
T cd05587         255 REHAFFRRIDWEKLE  269 (324)
T ss_pred             hcCCCcCCCCHHHHH
Confidence            999999987665443

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.95  E-value=1.3e-27  Score=247.34  Aligned_cols=167  Identities=26%  Similarity=0.479  Sum_probs=132.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----------------------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----------------------   58 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----------------------   58 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+||+++ .+|.+||+|||++......                       
T Consensus       101 ~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~-~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (360)
T cd05627         101 EATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN  177 (360)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEEC-CCCCEEEeeccCCcccccccccccccccccCCcccccccccc
Confidence            367889999999999999999  99999999999997 6789999999998643211                       


Q ss_pred             --------------CCccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC
Q 010626           59 --------------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS  123 (505)
Q Consensus        59 --------------~~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~  123 (505)
                                    .....+||+.|+|||++ ...|+.++|||||||++|+|+||+.||.. ..+...+..+........
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~-~~~~~~~~~i~~~~~~~~  256 (360)
T cd05627         178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS-ETPQETYRKVMNWKETLV  256 (360)
T ss_pred             cccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC-CCHHHHHHHHHcCCCcee
Confidence                          01234799999999987 55689999999999999999999999976 455556666654322222


Q ss_pred             CC--CCCChHHHHHHHHhcCCCCCCC---CHHHHhcCCCCCCCCCCCcccCCCC
Q 010626          124 LS--KVTDPQVKQFIEKCIVPASLRL---PALELLKDPFLVTDNPKDLVCDPLR  172 (505)
Q Consensus       124 ~~--~~~s~~l~~LI~kcL~dP~~Rp---Sa~ElL~hpff~~~~~~~l~~~~l~  172 (505)
                      ++  ...++.+++||.+|+.+|.+|+   ++.++++||||...++..+...+..
T Consensus       257 ~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~  310 (360)
T cd05627         257 FPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAA  310 (360)
T ss_pred             cCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCC
Confidence            22  2357899999999888888888   5899999999998877665544433

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.95  E-value=3e-27  Score=236.62  Aligned_cols=154  Identities=25%  Similarity=0.411  Sum_probs=120.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~--~   77 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++......  ......+++.|+|||++.  .
T Consensus       103 ~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  179 (288)
T cd07871         103 HNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST  179 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCc
Confidence            467889999999999999999  99999999999997 6789999999999765332  223446899999999873  4


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC-C-------------------CC-------CCCCCCCh
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-K-------------------PA-------SLSKVTDP  130 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~-~-------------------p~-------~~~~~~s~  130 (505)
                      .++.++|||||||++|+|+||+.||........+........ +                   +.       ......++
T Consensus       180 ~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (288)
T cd07871         180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDT  259 (288)
T ss_pred             ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCH
Confidence            589999999999999999999999976443332222111100 0                   00       00123467


Q ss_pred             HHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      ++++||.+||. +|.+|||+.|+|+||||
T Consensus       260 ~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         260 DGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             HHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            89999999996 89999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.95  E-value=3e-27  Score=240.72  Aligned_cols=159  Identities=24%  Similarity=0.425  Sum_probs=132.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.....  .......||+.|+|||++. ..
T Consensus        96 ~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  172 (321)
T cd05591          96 PRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLD-AEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE  172 (321)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeecccceecccCCccccccccCccccCHHHHcCCC
Confidence            356789999999999999999  99999999999997 678999999999875422  2234457999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-------CHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-------PAL  150 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-------Sa~  150 (505)
                      ++.++|||||||++|+|++|+.||.. .+....+..+..+..  .++...++++.+||.+||. +|.+|+       ++.
T Consensus       173 ~~~~~DvwslG~il~el~tg~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~  249 (321)
T cd05591         173 YGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDLFESILHDDV--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGED  249 (321)
T ss_pred             CCCccceechhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHH
Confidence            89999999999999999999999986 455666666665432  2445578999999999996 799999       899


Q ss_pred             HHhcCCCCCCCCCCCc
Q 010626          151 ELLKDPFLVTDNPKDL  166 (505)
Q Consensus       151 ElL~hpff~~~~~~~l  166 (505)
                      ++++||||....+..+
T Consensus       250 ~~~~hp~~~~~~~~~~  265 (321)
T cd05591         250 AIKQHPFFKEIDWVLL  265 (321)
T ss_pred             HHhcCCccCCCCHHHH
Confidence            9999999987666544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.95  E-value=2.7e-27  Score=241.69  Aligned_cols=160  Identities=26%  Similarity=0.547  Sum_probs=131.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++.....  .......||+.|+|||++ ...
T Consensus        95 ~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  171 (323)
T cd05595          95 ERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND  171 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEc-CCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCC
Confidence            467889999999999999999  99999999999998 678999999999865322  223345799999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~El  152 (505)
                      ++.++|||||||++|+|++|+.||... +.......+....  ..++...++.+++||.+||. +|.+|+     ++.++
T Consensus       172 ~~~~~DiwSlGvil~ell~g~~Pf~~~-~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~  248 (323)
T cd05595         172 YGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHERLFELILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV  248 (323)
T ss_pred             CCchhchhhhHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHH
Confidence            899999999999999999999999763 4444555544332  23556778999999999995 899998     89999


Q ss_pred             hcCCCCCCCCCCCcc
Q 010626          153 LKDPFLVTDNPKDLV  167 (505)
Q Consensus       153 L~hpff~~~~~~~l~  167 (505)
                      ++||||....+....
T Consensus       249 l~h~~~~~~~~~~~~  263 (323)
T cd05595         249 MEHRFFLSINWQDVV  263 (323)
T ss_pred             HcCCCcCCCCHHHHH
Confidence            999999987665443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.95  E-value=4.2e-27  Score=233.92  Aligned_cols=154  Identities=19%  Similarity=0.374  Sum_probs=121.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      +.++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......   .....|++.|+|||++ ..
T Consensus       100 ~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  176 (287)
T cd07848         100 EKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA  176 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccCcccccccccccccccccccccCCcHHHcCC
Confidence            467889999999999999999  99999999999997 77899999999997654322   2235689999999987 45


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc--C------------------CCCC---------CCCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--G------------------IKPA---------SLSKVT  128 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~--~------------------~~p~---------~~~~~~  128 (505)
                      .++.++|||||||++|+|++|+.||...............  .                  ..+.         ......
T Consensus       177 ~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (287)
T cd07848         177 PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGIL  256 (287)
T ss_pred             CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhccc
Confidence            6899999999999999999999999764433322211110  0                  0000         011235


Q ss_pred             ChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          129 DPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       129 s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      ++.+.+||.+||. +|.+|||+.++|+||||
T Consensus       257 s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         257 SGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            7789999999996 89999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.94  E-value=2.9e-27  Score=241.36  Aligned_cols=160  Identities=25%  Similarity=0.444  Sum_probs=128.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC---CCccccCCCcccCcccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE-   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~---~~~~~~Gt~~Y~APEll~~-   77 (505)
                      +.++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++......   ......||+.|+|||++.+ 
T Consensus       105 ~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  181 (332)
T cd05614         105 DEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLD-SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK  181 (332)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEEC-CCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCC
Confidence            467889999999999999999  99999999999997 6789999999999754322   2234579999999998853 


Q ss_pred             -cCCcccchhhHHHHHHHHhhcCCCCCCC---CChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----
Q 010626           78 -EYNELVDIYSFGMCILEMVTCEYPYNEC---KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----  147 (505)
Q Consensus        78 -~ys~ksDIWSLGviLyEmlTG~~Pf~~~---~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----  147 (505)
                       .++.++|||||||++|+|+||+.||...   .....+...+....  ..++...++.+++||.+||. +|.+||     
T Consensus       182 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~  259 (332)
T cd05614         182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQ  259 (332)
T ss_pred             CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCC
Confidence             4788999999999999999999999642   22333444444322  23556678999999999996 799999     


Q ss_pred             CHHHHhcCCCCCCCCCCCc
Q 010626          148 PALELLKDPFLVTDNPKDL  166 (505)
Q Consensus       148 Sa~ElL~hpff~~~~~~~l  166 (505)
                      ++.++++||||+...+..+
T Consensus       260 ~~~~~l~h~~~~~~~~~~~  278 (332)
T cd05614         260 GASEIKEHPFFKGLDWEAL  278 (332)
T ss_pred             CHHHHHcCCCcCCCCHHHH
Confidence            8899999999987655443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.4e-28  Score=249.31  Aligned_cols=153  Identities=33%  Similarity=0.586  Sum_probs=130.3

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccccc-cCC
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE-EYN   80 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~~-~ys   80 (505)
                      +.-++++++.||.|||.++  .+|||||+.|||+. .+|.+||+|||++..+...  ...+++|||.|||||++.+ .|+
T Consensus       113 i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s-~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~  189 (467)
T KOG0201|consen  113 IAVILREVLKGLDYLHSEK--KIHRDIKAANILLS-ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYD  189 (467)
T ss_pred             eeeehHHHHHHhhhhhhcc--eecccccccceeEe-ccCcEEEEecceeeeeechhhccccccccccccchhhhcccccc
Confidence            4457899999999999999  99999999999998 5699999999999877543  3477899999999999855 799


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  159 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~  159 (505)
                      .++||||||++++||++|.+||..+....  +..+.....|+.+...+++.+++||..||. +|..||+|.+||+|+|++
T Consensus       190 ~KADIWSLGITaiEla~GePP~s~~hPmr--vlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk  267 (467)
T KOG0201|consen  190 TKADIWSLGITAIELAKGEPPHSKLHPMR--VLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIK  267 (467)
T ss_pred             chhhhhhhhHHHHHHhcCCCCCcccCcce--EEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHH
Confidence            99999999999999999999998754421  122223345666777889999999999996 799999999999999998


Q ss_pred             CC
Q 010626          160 TD  161 (505)
Q Consensus       160 ~~  161 (505)
                      ..
T Consensus       268 ~a  269 (467)
T KOG0201|consen  268 RA  269 (467)
T ss_pred             hc
Confidence            73

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.94  E-value=4.1e-27  Score=239.34  Aligned_cols=158  Identities=30%  Similarity=0.432  Sum_probs=121.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll~   76 (505)
                      +.++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.......     .....||+.|+|||++.
T Consensus       103 ~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  179 (338)
T cd07859         103 EHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILAN-ADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG  179 (338)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHh
Confidence            467889999999999999999  99999999999997 77899999999997543211     13357899999999874


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHH--------------HHHH--------c---CCCCCCC---C
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY--------------KKVT--------S---GIKPASL---S  125 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~--------------~~i~--------~---~~~p~~~---~  125 (505)
                         ..++.++|||||||++|+|+||+.||.+.....+..              ..+.        .   ...+..+   .
T Consensus       180 ~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  259 (338)
T cd07859         180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKF  259 (338)
T ss_pred             ccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc
Confidence               468999999999999999999999997643222110              1110        0   0011111   1


Q ss_pred             CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          126 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       126 ~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      ...++.+.++|.+||. +|.+||++.++|+||||+...
T Consensus       260 ~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         260 PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence            2356789999999996 899999999999999997643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.94  E-value=2.7e-27  Score=241.20  Aligned_cols=164  Identities=30%  Similarity=0.496  Sum_probs=133.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++.....  .......||+.|+|||++ ...
T Consensus        96 ~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  172 (323)
T cd05575          96 PRARFYAAEIASALGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP  172 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEEC-CCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCC
Confidence            356789999999999999999  99999999999997 678999999999865322  223345799999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH----HHHh
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LELL  153 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa----~ElL  153 (505)
                      ++.++|||||||++|+|++|..||.. .+..+++..+....  ..+....++.+.++|.+||. +|.+||++    .+++
T Consensus       173 ~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il  249 (323)
T cd05575         173 YDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILNKP--LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIK  249 (323)
T ss_pred             CCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHH
Confidence            89999999999999999999999976 45566666665542  23445568999999999996 89999987    6999


Q ss_pred             cCCCCCCCCCCCcccCCC
Q 010626          154 KDPFLVTDNPKDLVCDPL  171 (505)
Q Consensus       154 ~hpff~~~~~~~l~~~~l  171 (505)
                      .||||....+..+....+
T Consensus       250 ~~~~~~~~~~~~~~~~~~  267 (323)
T cd05575         250 NHVFFSSINWDDLVNKKI  267 (323)
T ss_pred             cCCCcCCCCHHHHhhccC
Confidence            999998877655544333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=3.4e-27  Score=243.82  Aligned_cols=160  Identities=26%  Similarity=0.510  Sum_probs=129.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----------------------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----------------------   58 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----------------------   58 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++..+...                       
T Consensus       101 ~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (364)
T cd05599         101 EETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLD-AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK  177 (364)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEeecccceeccccccccccccccccccccccccccc
Confidence            467889999999999999999  99999999999997 7889999999998654211                       


Q ss_pred             -----------------CCccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC
Q 010626           59 -----------------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK  120 (505)
Q Consensus        59 -----------------~~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~  120 (505)
                                       .....+||+.|+|||++ ...++.++|||||||++|+|++|..||... +....+..+.....
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~-~~~~~~~~i~~~~~  256 (364)
T cd05599         178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD-NPQETYRKIINWKE  256 (364)
T ss_pred             cccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCC-CHHHHHHHHHcCCC
Confidence                             01134699999999987 556899999999999999999999999864 45555555554332


Q ss_pred             CCCCC--CCCChHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCCCCCC
Q 010626          121 PASLS--KVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKD  165 (505)
Q Consensus       121 p~~~~--~~~s~~l~~LI~kcL~dP~~RpS---a~ElL~hpff~~~~~~~  165 (505)
                      ...++  ...++.+++||.+||.+|.+|++   +.+++.||||+...+..
T Consensus       257 ~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~  306 (364)
T cd05599         257 TLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEH  306 (364)
T ss_pred             ccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence            22222  24588999999999988999997   99999999998866543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.94  E-value=4.3e-27  Score=239.81  Aligned_cols=159  Identities=30%  Similarity=0.501  Sum_probs=130.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++.....  .......|++.|+|||++ ...
T Consensus       101 ~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~  177 (324)
T cd05589         101 PRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLD-TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS  177 (324)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEEC-CCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCC
Confidence            467889999999999999999  99999999999998 678999999999864322  223456799999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~El  152 (505)
                      ++.++|||||||++|+|++|+.||... +.......+..+..  .++...++.+.+||.+||. +|.+||     ++.++
T Consensus       178 ~~~~~DiwslG~il~el~~G~~pf~~~-~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l  254 (324)
T cd05589         178 YTRAVDWWGLGVLIYEMLVGESPFPGD-DEEEVFDSIVNDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDV  254 (324)
T ss_pred             CCcccchhhHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHH
Confidence            889999999999999999999999763 44555555555432  2455678999999999996 899999     69999


Q ss_pred             hcCCCCCCCCCCCc
Q 010626          153 LKDPFLVTDNPKDL  166 (505)
Q Consensus       153 L~hpff~~~~~~~l  166 (505)
                      ++||||....+...
T Consensus       255 ~~~~~f~~~~~~~~  268 (324)
T cd05589         255 KKQPFFRDINWDDL  268 (324)
T ss_pred             hhCCCcCCCCHHHH
Confidence            99999987665443

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=255.47  Aligned_cols=160  Identities=36%  Similarity=0.609  Sum_probs=139.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCccccc---c
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYE---E   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll~---~   77 (505)
                      ++..|.+||++||.|||.+.  |+|||||-+|+|++.-.|.+||+|||.++.+..  +...++.||..|||||++.   .
T Consensus       676 tm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~R  753 (1226)
T KOG4279|consen  676 TMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPR  753 (1226)
T ss_pred             HHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCc
Confidence            57789999999999999999  999999999999998899999999999987753  4567789999999999993   3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      +|+.++|||||||++.||.||++||.+..++....-++---...+.++...+.+++.||.+|+. +|..||+|.++|.+|
T Consensus       754 GYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~Dp  833 (1226)
T KOG4279|consen  754 GYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDP  833 (1226)
T ss_pred             CCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence            5999999999999999999999999987777665555544344556788889999999999996 699999999999999


Q ss_pred             CCCCCCCC
Q 010626          157 FLVTDNPK  164 (505)
Q Consensus       157 ff~~~~~~  164 (505)
                      |++..+.+
T Consensus       834 Flq~~~kk  841 (1226)
T KOG4279|consen  834 FLQHNNKK  841 (1226)
T ss_pred             ccccCCCC
Confidence            99876433

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.94  E-value=5.8e-27  Score=244.35  Aligned_cols=159  Identities=24%  Similarity=0.455  Sum_probs=129.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYEE-   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~~-   77 (505)
                      +.++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++.......   .....||+.|+|||++.. 
T Consensus       142 ~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~-~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  218 (370)
T cd05596         142 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ  218 (370)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEc-CCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccC
Confidence            356788999999999999999  99999999999997 78899999999997654322   234579999999998732 


Q ss_pred             ----cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCC--CCChHHHHHHHHhcC-CCCC--CCC
Q 010626           78 ----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIV-PASL--RLP  148 (505)
Q Consensus        78 ----~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~--~~s~~l~~LI~kcL~-dP~~--RpS  148 (505)
                          .++.++|||||||++|+|++|..||.. .+....+..+........++.  .++.++++||.+||. +|.+  |++
T Consensus       219 ~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s  297 (370)
T cd05596         219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNG  297 (370)
T ss_pred             CCCCCCCCceeeeehhHHHHHHHhCCCCcCC-CCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCC
Confidence                378999999999999999999999986 445566666665433333333  468999999999996 5766  999


Q ss_pred             HHHHhcCCCCCCCCCC
Q 010626          149 ALELLKDPFLVTDNPK  164 (505)
Q Consensus       149 a~ElL~hpff~~~~~~  164 (505)
                      +.++++||||+...+.
T Consensus       298 ~~ell~h~~~~~~~~~  313 (370)
T cd05596         298 VDEIKSHPFFKNDQWT  313 (370)
T ss_pred             HHHHhcCcccCCCChh
Confidence            9999999999876543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.94  E-value=5e-27  Score=239.02  Aligned_cols=159  Identities=28%  Similarity=0.548  Sum_probs=131.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++.....  .......||+.|+|||++. ..
T Consensus        96 ~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  172 (316)
T cd05592          96 ARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK  172 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEEC-CCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCC
Confidence            467889999999999999999  99999999999997 778999999999975432  2234457999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH-HHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA-LELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa-~ElL~hp  156 (505)
                      ++.++|||||||++|+|++|+.||.+ .+..+++..+....  ..++...++++.+||.+||. +|.+||++ .+++.||
T Consensus       173 ~~~~~DvwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~  249 (316)
T cd05592         173 YNESVDWWSFGVLLYEMLIGQSPFHG-EDEDELFDSILNDR--PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHP  249 (316)
T ss_pred             CCCcccchhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCc
Confidence            89999999999999999999999986 44555666655432  23556678999999999996 79999986 5888999


Q ss_pred             CCCCCCCCCc
Q 010626          157 FLVTDNPKDL  166 (505)
Q Consensus       157 ff~~~~~~~l  166 (505)
                      ||....+..+
T Consensus       250 ~~~~~~~~~~  259 (316)
T cd05592         250 FFRGIDWERL  259 (316)
T ss_pred             ccCCCCHHHH
Confidence            9987665443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.94  E-value=2.3e-27  Score=241.98  Aligned_cols=159  Identities=26%  Similarity=0.537  Sum_probs=130.5

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~   77 (505)
                      +.++.++.||+.||.|||+ +|  |+||||||+|||++ .++.+||+|||++.....  .......||+.|+|||++ ..
T Consensus        95 ~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  171 (325)
T cd05594          95 DRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN  171 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEEC-CCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccC
Confidence            4678899999999999997 78  99999999999997 778999999999875422  223345799999999988 45


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALE  151 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~E  151 (505)
                      .++.++|||||||++|+|+||..||... +.......+...  ...++...++++.+||.+||. +|.+|+     ++.+
T Consensus       172 ~~~~~~DiwslG~il~el~tG~~Pf~~~-~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~  248 (325)
T cd05594         172 DYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILME--EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKE  248 (325)
T ss_pred             CCCCccccccccceeeeeccCCCCCCCC-CHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHH
Confidence            6899999999999999999999999763 445555555443  223556678999999999995 899997     8999


Q ss_pred             HhcCCCCCCCCCCCc
Q 010626          152 LLKDPFLVTDNPKDL  166 (505)
Q Consensus       152 lL~hpff~~~~~~~l  166 (505)
                      +++||||....+...
T Consensus       249 il~h~~~~~~~~~~~  263 (325)
T cd05594         249 IMQHKFFAGIVWQDV  263 (325)
T ss_pred             HhcCCCcCCCCHHHH
Confidence            999999987655443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=5.5e-27  Score=239.15  Aligned_cols=158  Identities=30%  Similarity=0.456  Sum_probs=130.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccc-cccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      .++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+++.....  ......||+.|+|||++ ...+
T Consensus       101 ~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  177 (323)
T cd05584         101 TACFYLSEISLALEHLHQQG--IIYRDLKPENILLD-AQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH  177 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCC
Confidence            56778999999999999999  99999999999997 6789999999998654222  23345799999999988 4458


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHHHh
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELL  153 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~ElL  153 (505)
                      +.++|||||||++|+|++|+.||... +.......+..+..  .++...++.+++||.+||. +|.+||     ++.+++
T Consensus       178 ~~~~DiwslG~il~ell~G~~pf~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~  254 (323)
T cd05584         178 GKAVDWWSLGALMYDMLTGAPPFTAE-NRKKTIDKILKGKL--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQ  254 (323)
T ss_pred             CCcceecccHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHh
Confidence            89999999999999999999999864 44455555555432  3456678999999999996 799999     899999


Q ss_pred             cCCCCCCCCCCCc
Q 010626          154 KDPFLVTDNPKDL  166 (505)
Q Consensus       154 ~hpff~~~~~~~l  166 (505)
                      .||||....+..+
T Consensus       255 ~h~~~~~~~~~~~  267 (323)
T cd05584         255 SHPFFRHVNWDDL  267 (323)
T ss_pred             cCCCcCCCCHHHH
Confidence            9999987665443

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-27  Score=230.42  Aligned_cols=157  Identities=27%  Similarity=0.551  Sum_probs=132.0

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCcc-ccCCCcccCccccc----cc
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPELYE----EE   78 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~-~~Gt~~Y~APEll~----~~   78 (505)
                      +-++...++.||.||..+. +|+|||+||+|||+| ..|.+||||||++..+-...+.+ -.|.+.|||||.+.    ..
T Consensus       193 lGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlD-e~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~k  270 (391)
T KOG0983|consen  193 LGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLD-ERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPK  270 (391)
T ss_pred             hhhhHHHHHHHHHHHHHhc-ceeecccCccceEEc-cCCCEEeecccccceeecccccccccCCccccCccccCCCCCCc
Confidence            4456778899999998642 399999999999998 78999999999998776655444 47999999999883    35


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCC-CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-KVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~-~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      |+..+||||||++++||+||++||.++........++....+|.... ...++.+.+|+..||. |+.+||...+||+||
T Consensus       271 YDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  271 YDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             cchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence            99999999999999999999999999888888888887755543222 2379999999999995 899999999999999


Q ss_pred             CCCCCC
Q 010626          157 FLVTDN  162 (505)
Q Consensus       157 ff~~~~  162 (505)
                      |+....
T Consensus       351 Fi~~ye  356 (391)
T KOG0983|consen  351 FIKRYE  356 (391)
T ss_pred             ceeecc
Confidence            997644

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.94  E-value=4.5e-27  Score=239.79  Aligned_cols=161  Identities=21%  Similarity=0.419  Sum_probs=130.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE--   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~--   76 (505)
                      +.++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++..+....   .....||+.|+|||++.  
T Consensus       102 ~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  178 (330)
T cd05601         102 DMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLID-RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM  178 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEEC-CCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccc
Confidence            356789999999999999999  99999999999997 77899999999997764332   22346899999999873  


Q ss_pred             -----ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCC--CCCChHHHHHHHHhcCCCCCCCCH
Q 010626           77 -----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLPA  149 (505)
Q Consensus        77 -----~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~~l~~LI~kcL~dP~~RpSa  149 (505)
                           ..++.++|||||||++|+|++|+.||... .....+..+........++  ...++.+.+||.+||.+|.+||++
T Consensus       179 ~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~~p~~R~t~  257 (330)
T cd05601         179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG-TSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGY  257 (330)
T ss_pred             cccccCCCCCcceeecccceeeeeccCCCCCCCC-CHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccChhhCCCH
Confidence                 34788999999999999999999999764 3444555555433222222  246889999999999999999999


Q ss_pred             HHHhcCCCCCCCCCCCc
Q 010626          150 LELLKDPFLVTDNPKDL  166 (505)
Q Consensus       150 ~ElL~hpff~~~~~~~l  166 (505)
                      .++++||||....+..+
T Consensus       258 ~~l~~h~~~~~~~~~~~  274 (330)
T cd05601         258 EGLCCHPFFSKIDWNNI  274 (330)
T ss_pred             HHHhCCCCcCCCCHHHH
Confidence            99999999987665443

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=4.8e-27  Score=243.98  Aligned_cols=158  Identities=24%  Similarity=0.487  Sum_probs=130.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-------CccccCCCcccCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-------ARSVIGTPEFMAPEL   74 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-------~~~~~Gt~~Y~APEl   74 (505)
                      .++++|++.++.||+|||.+|  ||||||||+|+|++ .+|+|||+|||.+.......       ....+|||.|+|||+
T Consensus       210 ~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLLl~-~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~  286 (576)
T KOG0585|consen  210 QQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLLLS-SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL  286 (576)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC--eeccccchhheEEc-CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence            478999999999999999999  99999999999997 67999999999997663221       223589999999998


Q ss_pred             ccc---c--CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC
Q 010626           75 YEE---E--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP  148 (505)
Q Consensus        75 l~~---~--ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS  148 (505)
                      +.+   .  -+.+.||||+||+||.|+.|++||.+ .....++.+|..............+.+++||.+||. ||.+|++
T Consensus       287 c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~  365 (576)
T KOG0585|consen  287 CSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRIT  365 (576)
T ss_pred             hcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheee
Confidence            743   1  35789999999999999999999987 556677788776533222223457899999999995 8999999


Q ss_pred             HHHHhcCCCCCCCCC
Q 010626          149 ALELLKDPFLVTDNP  163 (505)
Q Consensus       149 a~ElL~hpff~~~~~  163 (505)
                      ..++..|||......
T Consensus       366 l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  366 LPDIKLHPWVTRDGD  380 (576)
T ss_pred             hhhheecceeccCCC
Confidence            999999999976543

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.94  E-value=7.7e-27  Score=235.91  Aligned_cols=155  Identities=29%  Similarity=0.471  Sum_probs=117.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe---CCCCcEEEeecCceeeccCC-----CCccccCCCcccCcc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPE   73 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld---~~~g~vKL~DFGlA~~~~~~-----~~~~~~Gt~~Y~APE   73 (505)
                      ..++.++.||+.||.|||++|  |+||||||+|||+.   ...+.+||+|||+++.....     ......||+.|+|||
T Consensus       108 ~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE  185 (317)
T cd07868         108 GMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE  185 (317)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCH
Confidence            357889999999999999999  99999999999994   24578999999999766432     123457899999999


Q ss_pred             ccc--ccCCcccchhhHHHHHHHHhhcCCCCCCCCCh---------HHHHHHHHcCCCC---------------------
Q 010626           74 LYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNP---------AQIYKKVTSGIKP---------------------  121 (505)
Q Consensus        74 ll~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~---------~~i~~~i~~~~~p---------------------  121 (505)
                      ++.  ..|+.++||||+||++|+|++|+.||......         .++...+.....+                     
T Consensus       186 ~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (317)
T cd07868         186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDF  265 (317)
T ss_pred             HHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhh
Confidence            874  34899999999999999999999999643211         1111111100000                     


Q ss_pred             --------------CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          122 --------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       122 --------------~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                                    .......+..+.+||.+||. +|.+|||+.|+|+||||
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         266 RRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                          00011235678899999996 89999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.94  E-value=5.3e-27  Score=239.04  Aligned_cols=159  Identities=28%  Similarity=0.530  Sum_probs=131.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++....  ........||+.|+|||++. ..
T Consensus        96 ~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  172 (316)
T cd05619          96 PRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLD-TDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK  172 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEEC-CCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCC
Confidence            467889999999999999999  99999999999997 67899999999986532  22334557999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHH-HHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL-ELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~-ElL~hp  156 (505)
                      ++.++|||||||++|+|++|..||.. .+.......+....  ..++...+..+++||.+||. +|.+||++. ++++||
T Consensus       173 ~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~  249 (316)
T cd05619         173 YNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRMDN--PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHP  249 (316)
T ss_pred             CCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCC--CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCc
Confidence            89999999999999999999999976 34555666555443  23455678899999999995 899999996 899999


Q ss_pred             CCCCCCCCCc
Q 010626          157 FLVTDNPKDL  166 (505)
Q Consensus       157 ff~~~~~~~l  166 (505)
                      ||....+..+
T Consensus       250 ~~~~~~~~~~  259 (316)
T cd05619         250 FFREIDWSAL  259 (316)
T ss_pred             ccCCCCHHHH
Confidence            9988765443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.94  E-value=6.8e-27  Score=232.21  Aligned_cols=154  Identities=31%  Similarity=0.468  Sum_probs=121.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +.++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++....... .....|++.|+|||++ ...+
T Consensus       108 ~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  184 (288)
T cd07863         108 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTY  184 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccCccccccCcccCCCccccccccCchHhhCCCC
Confidence            467889999999999999999  99999999999997 77899999999997664332 2345689999999987 5568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC------C------------------CCCCCCCChHHHHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------P------------------ASLSKVTDPQVKQF  135 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~------p------------------~~~~~~~s~~l~~L  135 (505)
                      +.++|||||||++|+|++|..||..........+.+.....      +                  .......+..+++|
T Consensus       185 ~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  264 (288)
T cd07863         185 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQL  264 (288)
T ss_pred             CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHH
Confidence            99999999999999999999999764433332222111000      0                  00112356788999


Q ss_pred             HHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          136 IEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       136 I~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      |.+||. +|.+|||+.+++.||||
T Consensus       265 i~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         265 LLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             HHHHhccCcccCCCHHHHhcCCCC
Confidence            999996 89999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.4e-27  Score=240.42  Aligned_cols=159  Identities=23%  Similarity=0.414  Sum_probs=128.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      +.++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++..... ......||+.|+|||++ ...++
T Consensus       101 ~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~  176 (333)
T cd05600         101 DHARFYMAEMFEAVDALHELG--YIHRDLKPENFLID-ASGHIKLTDFGLSKGIVT-YANSVVGSPDYMAPEVLRGKGYD  176 (333)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEEEeCcCCccccc-ccCCcccCccccChhHhcCCCCC
Confidence            457889999999999999999  99999999999997 678999999999976544 33456799999999988 45689


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC---CC---CCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SL---SKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~---~~---~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      .++|||||||++|+|++|..||.. .+....+..+.......   ..   ....++++.+||.+||. +|.+||++.+++
T Consensus       177 ~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll  255 (333)
T cd05600         177 FTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIK  255 (333)
T ss_pred             CccceecchHHHhhhhhCCCCCCC-CCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHH
Confidence            999999999999999999999976 44555555444321111   11   12457899999999996 689999999999


Q ss_pred             cCCCCCCCCCCC
Q 010626          154 KDPFLVTDNPKD  165 (505)
Q Consensus       154 ~hpff~~~~~~~  165 (505)
                      +||||....+..
T Consensus       256 ~h~~~~~~~~~~  267 (333)
T cd05600         256 NHPFFKEVDWNE  267 (333)
T ss_pred             hCcccCCCCHHH
Confidence            999998765443

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2e-27  Score=242.60  Aligned_cols=160  Identities=28%  Similarity=0.467  Sum_probs=130.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll~--~   77 (505)
                      +.++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++....  ........||+.|+|||++.  .
T Consensus        96 ~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  172 (330)
T cd05586          96 DRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLD-ATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK  172 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCC
Confidence            467889999999999999999  99999999999997 67899999999986532  22234567999999999874  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC----CHHHH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL----PALEL  152 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp----Sa~El  152 (505)
                      .++.++|||||||++|+|+||+.||.. .+..+.+..+..+.... .....++.+++||.+||. +|.+||    ++.++
T Consensus       173 ~~~~~~DvwslGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~l  250 (330)
T cd05586         173 GYTKHVDFWSLGVLVFEMCCGWSPFYA-EDTQQMYRNIAFGKVRF-PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVEL  250 (330)
T ss_pred             CCCCccceeccccEEEEeccCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHH
Confidence            488999999999999999999999976 45566666666553321 223468899999999996 799998    79999


Q ss_pred             hcCCCCCCCCCCCc
Q 010626          153 LKDPFLVTDNPKDL  166 (505)
Q Consensus       153 L~hpff~~~~~~~l  166 (505)
                      ++||||....+..+
T Consensus       251 l~h~~~~~~~~~~~  264 (330)
T cd05586         251 KEHPFFADIDWDLL  264 (330)
T ss_pred             hcCccccCCCHHHH
Confidence            99999987655443

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.94  E-value=9.7e-27  Score=242.97  Aligned_cols=158  Identities=24%  Similarity=0.467  Sum_probs=127.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYEE-   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~~-   77 (505)
                      +.++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++.......   .....||+.|+|||++.. 
T Consensus       142 ~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~  218 (370)
T cd05621         142 KWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ  218 (370)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhcc
Confidence            357889999999999999999  99999999999997 77899999999997764322   235679999999998842 


Q ss_pred             ----cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCC--CCChHHHHHHHHhcCCC---CCCCC
Q 010626           78 ----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIVPA---SLRLP  148 (505)
Q Consensus        78 ----~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~--~~s~~l~~LI~kcL~dP---~~RpS  148 (505)
                          .++.++|||||||++|+|++|+.||.. .+....+..+........++.  ..+..++++|.+||.++   ..|++
T Consensus       219 ~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~  297 (370)
T cd05621         219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYA-DSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNG  297 (370)
T ss_pred             CCCCCCCcccCEEeehHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCC
Confidence                278899999999999999999999976 345555666655433222332  45889999999999743   34889


Q ss_pred             HHHHhcCCCCCCCCC
Q 010626          149 ALELLKDPFLVTDNP  163 (505)
Q Consensus       149 a~ElL~hpff~~~~~  163 (505)
                      +.++++||||+...+
T Consensus       298 ~~e~l~hp~~~~~~~  312 (370)
T cd05621         298 VEEIKQHPFFKNDQW  312 (370)
T ss_pred             HHHHhcCcccCCCCc
Confidence            999999999987544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.94  E-value=6.6e-27  Score=233.35  Aligned_cols=162  Identities=27%  Similarity=0.466  Sum_probs=129.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc--ccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~--~~y   79 (505)
                      +.++.++.||+.||.|||+++  ++||||||+||+++ .++.++|+|||++............|++.|+|||.+.  ..+
T Consensus        97 ~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  173 (279)
T cd05633          97 KEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAY  173 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEEC-CCCCEEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCC
Confidence            467889999999999999999  99999999999997 6789999999999766544444457899999999874  358


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHH-HHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALEL  152 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~-i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~El  152 (505)
                      +.++|||||||++|+|++|..||........ ...... ...+..++...++.++++|.+||. +|.+|+     ++.++
T Consensus       174 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~  252 (279)
T cd05633         174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEV  252 (279)
T ss_pred             CchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHH
Confidence            8999999999999999999999965332211 111111 122334556678999999999995 899999     69999


Q ss_pred             hcCCCCCCCCCCCcc
Q 010626          153 LKDPFLVTDNPKDLV  167 (505)
Q Consensus       153 L~hpff~~~~~~~l~  167 (505)
                      ++||||+..++....
T Consensus       253 ~~h~~~~~~~~~~~~  267 (279)
T cd05633         253 KEHVFFKGIDWQQVY  267 (279)
T ss_pred             HhCccccCCCHhHHh
Confidence            999999987765543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.94  E-value=7.8e-27  Score=228.13  Aligned_cols=155  Identities=28%  Similarity=0.438  Sum_probs=127.8

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc--cccCCCcccCcccc--ccc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY--EEE   78 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~--~~~Gt~~Y~APEll--~~~   78 (505)
                      .|+.|+.++++||+|||++.  |+||||||.|+|++ .+|.+||+|||+|+.+..+...  ..+-|.+|+|||++  .+.
T Consensus       102 ~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis-~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~  178 (318)
T KOG0659|consen  102 DIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLIS-SDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQ  178 (318)
T ss_pred             HHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEc-CCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchh
Confidence            58999999999999999999  99999999999997 7899999999999988655432  23689999999977  457


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--CC-----------------------CCCCCChHHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--AS-----------------------LSKVTDPQVK  133 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~-----------------------~~~~~s~~l~  133 (505)
                      |+..+|+||.|||+.||+.|.+-|.+..+.+|+...+..-..|  ..                       +-...+.++.
T Consensus       179 Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~l  258 (318)
T KOG0659|consen  179 YGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDAL  258 (318)
T ss_pred             cCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHH
Confidence            9999999999999999999988888877777765544321111  11                       1122356779


Q ss_pred             HHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          134 QFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       134 ~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      +|+.+||. +|.+|+++.|+|+|+||+.
T Consensus       259 dLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  259 DLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             HHHHhhhccCchhcccHHHHhcchhhhc
Confidence            99999996 8999999999999999986

>PTZ00284 protein kinase; Provisional

Probab=99.94  E-value=8.2e-27  Score=250.40  Aligned_cols=158  Identities=22%  Similarity=0.339  Sum_probs=119.0

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCC---------------CcEEEeecCceeeccCCCCccccC
Q 010626            2 KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNN---------------GEVKIGDLGLAIVMQQPTARSVIG   65 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~---------------g~vKL~DFGlA~~~~~~~~~~~~G   65 (505)
                      ..++.|+.||+.||+|||+ .|  |+||||||+|||++..+               +.+||+|||.+..... .....+|
T Consensus       231 ~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-~~~~~~g  307 (467)
T PTZ00284        231 RHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-SRTAIVS  307 (467)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-ccccccC
Confidence            3678899999999999998 58  99999999999997322               1499999998754322 2345689


Q ss_pred             CCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc-CCCC----------------------
Q 010626           66 TPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP----------------------  121 (505)
Q Consensus        66 t~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~-~~~p----------------------  121 (505)
                      |+.|+|||++ ...|+.++|||||||++|||++|+.||....+...+...... +..|                      
T Consensus       308 t~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  387 (467)
T PTZ00284        308 TRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQL  387 (467)
T ss_pred             CccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccc
Confidence            9999999987 456999999999999999999999999765443322211110 0000                      


Q ss_pred             --CC--------------CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          122 --AS--------------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       122 --~~--------------~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                        ..              .....++.+.+||.+||+ +|.+|||+.|+|+||||....
T Consensus       388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~  445 (467)
T PTZ00284        388 RPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY  445 (467)
T ss_pred             cccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence              00              001124567899999996 899999999999999998643

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.94  E-value=7.5e-27  Score=241.35  Aligned_cols=156  Identities=29%  Similarity=0.416  Sum_probs=121.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +.++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++...... ......||+.|+|||++ ...+
T Consensus       123 ~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  199 (359)
T cd07876         123 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGY  199 (359)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCC
Confidence            457789999999999999999  99999999999997 6789999999999754332 23345789999999988 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHH---------------------cCCC--C---------------
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT---------------------SGIK--P---------------  121 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~---------------------~~~~--p---------------  121 (505)
                      +.++|||||||++|+|++|+.||.+..........+.                     ....  +               
T Consensus       200 ~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (359)
T cd07876         200 KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPS  279 (359)
T ss_pred             CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhcccccccc
Confidence            9999999999999999999999986543222111110                     0000  0               


Q ss_pred             -CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          122 -ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       122 -~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                       .......++.+++||.+||. +|.+|||+.|+|+||||..
T Consensus       280 ~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         280 ESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             ccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence             00112345789999999996 8999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.94  E-value=5.7e-27  Score=237.10  Aligned_cols=158  Identities=30%  Similarity=0.486  Sum_probs=129.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc--cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY--EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll--~~   77 (505)
                      +.|+.+++||+.||+|||+++  |+||||||+||+++ ..|.+||+|||+|+...-+.  ....++|.+|+|||++  ..
T Consensus       120 ~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~-~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~  196 (323)
T KOG0594|consen  120 RLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLIS-SSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGST  196 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEEC-CCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCC
Confidence            368999999999999999999  99999999999998 68999999999998665333  3455789999999977  34


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC---------------CCC------------CCCCh
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---------------SLS------------KVTDP  130 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~---------------~~~------------~~~s~  130 (505)
                      .|+..+||||+|||++||++++.-|.+..+..++......-..|.               .++            ...++
T Consensus       197 ~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~  276 (323)
T KOG0594|consen  197 SYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDP  276 (323)
T ss_pred             cCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCc
Confidence            699999999999999999999999988777776655544211110               011            11235


Q ss_pred             HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      ...+++.+||. +|.+|.|+..+|.||||....
T Consensus       277 ~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  277 DGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             cHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence            88999999996 899999999999999998654

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.94  E-value=1.2e-26  Score=237.38  Aligned_cols=157  Identities=28%  Similarity=0.537  Sum_probs=125.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccC
Q 010626            2 KAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~-g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~y   79 (505)
                      ..+..++.||+.||.|||+. +  |+||||||+||+++ .++.+||+|||++............|++.|+|||++. ..+
T Consensus       103 ~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  179 (331)
T cd06649         103 EILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY  179 (331)
T ss_pred             HHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEc-CCCcEEEccCcccccccccccccCCCCcCcCCHhHhcCCCC
Confidence            35778999999999999985 6  99999999999998 6789999999999776555555667999999999884 568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHH---------------------------------------------
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK---------------------------------------------  114 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~---------------------------------------------  114 (505)
                      +.++|||||||++|+|+||+.||.... ...+...                                             
T Consensus       180 ~~~~DiwslG~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T cd06649         180 SVQSDIWSMGLSLVELAIGRYPIPPPD-AKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLD  258 (331)
T ss_pred             CchHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHH
Confidence            999999999999999999999996532 2222111                                             


Q ss_pred             -HHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          115 -VTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       115 -i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                       +.....+......+++++++||.+||. +|.+|||+.++|+||||+...
T Consensus       259 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         259 YIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             HHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence             111111222223467899999999996 899999999999999998644

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.94  E-value=8.2e-27  Score=237.41  Aligned_cols=158  Identities=24%  Similarity=0.489  Sum_probs=131.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.....  .......|++.|+|||++ ...
T Consensus        96 ~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~  172 (318)
T cd05570          96 PRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLD-SEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP  172 (318)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEEC-CCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCC
Confidence            467889999999999999999  99999999999997 678999999999865322  223345789999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH-----HHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA-----LEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa-----~El  152 (505)
                      ++.++|||||||++|+|++|+.||.. .+.......+.....  .++...++.+.+||.+||. +|.+||++     .++
T Consensus       173 ~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~l  249 (318)
T cd05570         173 YGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILEDEV--RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDI  249 (318)
T ss_pred             CCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHH
Confidence            89999999999999999999999976 445555555554422  3456678999999999995 89999999     999


Q ss_pred             hcCCCCCCCCCCC
Q 010626          153 LKDPFLVTDNPKD  165 (505)
Q Consensus       153 L~hpff~~~~~~~  165 (505)
                      +.||||+...+..
T Consensus       250 l~~~~~~~~~~~~  262 (318)
T cd05570         250 KGHPFFREIDWDK  262 (318)
T ss_pred             hcCCCcCCCCHHH
Confidence            9999998866543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.94  E-value=8.8e-27  Score=238.48  Aligned_cols=159  Identities=22%  Similarity=0.421  Sum_probs=127.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      +.++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++....  ........||+.|+|||++. ..
T Consensus        96 ~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  172 (329)
T cd05588          96 EHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED  172 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCC
Confidence            467889999999999999999  99999999999997 67899999999986432  22234567999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCC--------ChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECK--------NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-  148 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~--------~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-  148 (505)
                      ++.++|+|||||++|+|+||+.||....        .....++.+....  ..++...++.+.++|.+||. +|.+|++ 
T Consensus       173 ~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            8999999999999999999999996311        1223344444432  23556678999999999996 8999987 


Q ss_pred             -----HHHHhcCCCCCCCCCCC
Q 010626          149 -----ALELLKDPFLVTDNPKD  165 (505)
Q Consensus       149 -----a~ElL~hpff~~~~~~~  165 (505)
                           +.++++||||....+..
T Consensus       251 ~~~~~~~~i~~hp~~~~~~~~~  272 (329)
T cd05588         251 HPQTGFRDIKSHPFFRNIDWDL  272 (329)
T ss_pred             CCCCCHHHHhcCCCCCCCCHHH
Confidence                 78999999998765543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.94  E-value=1.4e-26  Score=239.65  Aligned_cols=155  Identities=31%  Similarity=0.438  Sum_probs=121.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||+++...... .....||+.|+|||++ ...+
T Consensus       126 ~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  202 (364)
T cd07875         126 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY  202 (364)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEEC-CCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCC
Confidence            357789999999999999999  99999999999997 67899999999997654332 2345789999999988 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC---------------------C-----------------
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---------------------P-----------------  121 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~---------------------p-----------------  121 (505)
                      +.++|||||||++|+|++|+.||.+..... .+..+.....                     +                 
T Consensus       203 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (364)
T cd07875         203 KENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFP  281 (364)
T ss_pred             CchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccccc
Confidence            999999999999999999999997644322 2222221100                     0                 


Q ss_pred             --CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          122 --ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       122 --~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                        .......+..+++||.+||. +|.+|||+.++|+||||..
T Consensus       282 ~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         282 ADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             ccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence              00111234678999999996 8999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.94  E-value=2.9e-26  Score=236.64  Aligned_cols=156  Identities=30%  Similarity=0.566  Sum_probs=124.5

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccccc---
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE---   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~~---   77 (505)
                      .+..++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.......  .....||+.|+|||++..   
T Consensus       169 ~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  245 (353)
T PLN00034        169 FLADVARQILSGIAYLHRRH--IVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLN  245 (353)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEcccccceecccccccccccccCccccCccccccccc
Confidence            56789999999999999999  99999999999998 67899999999997764332  234579999999998732   


Q ss_pred             ---cCCcccchhhHHHHHHHHhhcCCCCCCCCC--hHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           78 ---EYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        78 ---~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                         .++.++|||||||++|+|++|+.||.....  .......+... .+...+...+.++++||.+||. +|.+||++.|
T Consensus       246 ~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~e  324 (353)
T PLN00034        246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS-QPPEAPATASREFRHFISCCLQREPAKRWSAMQ  324 (353)
T ss_pred             cCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence               234689999999999999999999974322  22222222222 2333455678899999999996 8999999999


Q ss_pred             HhcCCCCCCCC
Q 010626          152 LLKDPFLVTDN  162 (505)
Q Consensus       152 lL~hpff~~~~  162 (505)
                      +|+||||....
T Consensus       325 ll~hp~~~~~~  335 (353)
T PLN00034        325 LLQHPFILRAQ  335 (353)
T ss_pred             HhcCcccccCC
Confidence            99999998754

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.94  E-value=7.8e-27  Score=238.01  Aligned_cols=160  Identities=30%  Similarity=0.510  Sum_probs=131.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-cccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      .++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.....  .......||+.|+|||++ ...+
T Consensus        97 ~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~-~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  173 (325)
T cd05602          97 RARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY  173 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEC-CCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCC
Confidence            56779999999999999999  99999999999997 678999999999865422  223445799999999988 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHH----HHhc
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL----ELLK  154 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~----ElL~  154 (505)
                      +.++|||||||++|+|++|..||.. .+....+..+...  +..+....++.+.++|.+||+ +|.+|+++.    ++++
T Consensus       174 ~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~  250 (325)
T cd05602         174 DRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNK--PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN  250 (325)
T ss_pred             CCccccccccHHHHHHhcCCCCCCC-CCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence            8999999999999999999999986 4455555555543  223445678999999999996 799999875    8999


Q ss_pred             CCCCCCCCCCCccc
Q 010626          155 DPFLVTDNPKDLVC  168 (505)
Q Consensus       155 hpff~~~~~~~l~~  168 (505)
                      |+||....+..+..
T Consensus       251 ~~~~~~~~~~~~~~  264 (325)
T cd05602         251 HIFFSPINWDDLIN  264 (325)
T ss_pred             CcccCCCCHHHHHh
Confidence            99998877665543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.94  E-value=1.1e-26  Score=239.45  Aligned_cols=156  Identities=30%  Similarity=0.408  Sum_probs=121.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +.++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+++...... .....||+.|+|||++ ...+
T Consensus       119 ~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  195 (355)
T cd07874         119 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY  195 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEC-CCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCC
Confidence            357789999999999999999  99999999999997 67899999999997654332 3345789999999988 4468


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc---------------------CCC-------C----------
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---------------------GIK-------P----------  121 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~---------------------~~~-------p----------  121 (505)
                      +.++|||||||++|+|++|+.||.+..........+..                     ...       +          
T Consensus       196 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (355)
T cd07874         196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA  275 (355)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhcccccccc
Confidence            99999999999999999999999764322221111110                     000       0          


Q ss_pred             -CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          122 -ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       122 -~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                       .......+..+++||.+||. +|.+|||+.|+|+||||..
T Consensus       276 ~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         276 DSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             ccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence             00112235678999999996 8999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.94  E-value=1.2e-26  Score=237.35  Aligned_cols=161  Identities=24%  Similarity=0.438  Sum_probs=130.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++....  .......+||+.|+|||++ ...
T Consensus        96 ~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  172 (327)
T cd05617          96 EHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLD-ADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE  172 (327)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEe-CCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCC
Confidence            467889999999999999999  99999999999998 67899999999987532  2223456799999999987 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCC------CChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC---
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNEC------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP---  148 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~------~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS---  148 (505)
                      ++.++|||||||++|+|++|..||...      ......+..+...  +..++...+..+.++|.+||. +|.+|++   
T Consensus       173 ~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~  250 (327)
T cd05617         173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIPRFLSVKASHVLKGFLNKDPKERLGCQP  250 (327)
T ss_pred             CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCC
Confidence            899999999999999999999999532      1223344444433  334666778999999999996 8999998   


Q ss_pred             ---HHHHhcCCCCCCCCCCCcc
Q 010626          149 ---ALELLKDPFLVTDNPKDLV  167 (505)
Q Consensus       149 ---a~ElL~hpff~~~~~~~l~  167 (505)
                         +.+++.||||....+..+.
T Consensus       251 ~~~~~~i~~h~~f~~~~~~~~~  272 (327)
T cd05617         251 QTGFSDIKSHTFFRSIDWDLLE  272 (327)
T ss_pred             CCCHHHHHcCCCCCCCCHHHHH
Confidence               5799999999987665443

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.94  E-value=1.3e-26  Score=232.33  Aligned_cols=156  Identities=28%  Similarity=0.406  Sum_probs=130.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccc--cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY--EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll--~~   77 (505)
                      .+++.++.|++.||+|||.+.  |+|||||++|+|++ +.|.+||+|||+|+.+..+  .....+.|.+|+|||++  ..
T Consensus       177 ~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~-~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~  253 (419)
T KOG0663|consen  177 GEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLS-HKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAK  253 (419)
T ss_pred             HHHHHHHHHHHHHHHHHhhce--eEecccchhheeec-cCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCc
Confidence            478999999999999999999  99999999999997 8899999999999988765  24456789999999977  45


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC----------------C------------CCCC-C
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA----------------S------------LSKV-T  128 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~----------------~------------~~~~-~  128 (505)
                      .|+.++|+||+|||+.||+++++-|.+....+|+.+.+..-..|.                .            +... .
T Consensus       254 tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~l  333 (419)
T KOG0663|consen  254 TYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSL  333 (419)
T ss_pred             ccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhcccccc
Confidence            699999999999999999999999998888888766654311110                0            0111 3


Q ss_pred             ChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          129 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       129 s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      +....+|+..+|. +|.+|.||.+.|+|.||..
T Consensus       334 se~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e  366 (419)
T KOG0663|consen  334 SEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE  366 (419)
T ss_pred             chhHHHHHHHHhccCccccccHHHhhccccccc
Confidence            4677899999995 9999999999999999976

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.94  E-value=1.3e-26  Score=237.48  Aligned_cols=159  Identities=23%  Similarity=0.444  Sum_probs=127.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.....  .......||+.|+|||++ ...
T Consensus        96 ~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  172 (329)
T cd05618          96 EHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED  172 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCC
Confidence            357889999999999999999  99999999999997 778999999999865322  223345799999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCC--------CChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-  148 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~--------~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-  148 (505)
                      ++.++|||||||++|+|++|+.||...        .....+...+...  ...++...+..+.+||.+||. +|.+|++ 
T Consensus       173 ~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            889999999999999999999999521        1122233444433  223566778999999999996 8999998 


Q ss_pred             -----HHHHhcCCCCCCCCCCC
Q 010626          149 -----ALELLKDPFLVTDNPKD  165 (505)
Q Consensus       149 -----a~ElL~hpff~~~~~~~  165 (505)
                           +.++++||||....+..
T Consensus       251 ~~~~~~~~i~~hp~f~~~~~~~  272 (329)
T cd05618         251 HPQTGFADIQGHPFFRNVDWDL  272 (329)
T ss_pred             CCCCCHHHHhcCCCCCCCCHHH
Confidence                 57999999998766543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=6.9e-27  Score=248.22  Aligned_cols=158  Identities=34%  Similarity=0.619  Sum_probs=132.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCcccc----
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY----   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll----   75 (505)
                      .+|..+++|++.||.|||+++  |||||||..|||++ -+|.++|+|||++....  .....+++|||.|||||++    
T Consensus       130 ~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~T-ldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET  206 (1187)
T KOG0579|consen  130 DQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLT-LDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCET  206 (1187)
T ss_pred             HHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEE-ecCcEeeecccccccchhHHhhhccccCCcccccchheeecc
Confidence            368889999999999999999  99999999999998 78999999999986543  2346678999999999976    


Q ss_pred             --cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC-CCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           76 --EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        76 --~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                        ..+|+.++||||||++|.||.-+.+|... .++....-+|....+|. ..+...+..+.+|+.+||. +|..||++.+
T Consensus       207 ~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-lnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaq  285 (1187)
T KOG0579|consen  207 FKDQPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQ  285 (1187)
T ss_pred             ccCCCchhhhhHHhhhhHHHHHhccCCCccc-cchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHH
Confidence              24699999999999999999999999887 45555555555544443 3455678899999999996 7999999999


Q ss_pred             HhcCCCCCCCCC
Q 010626          152 LLKDPFLVTDNP  163 (505)
Q Consensus       152 lL~hpff~~~~~  163 (505)
                      +|+||||.....
T Consensus       286 ll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  286 LLKHPFVQNAPS  297 (1187)
T ss_pred             HhhCcccccCCc
Confidence            999999996544

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.94  E-value=1.4e-26  Score=241.55  Aligned_cols=159  Identities=27%  Similarity=0.440  Sum_probs=125.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----------------------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----------------------   58 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----------------------   58 (505)
                      +.++.++.||+.||+|||++|  |+||||||+|||++ .+|.+||+|||++..+...                       
T Consensus       101 ~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~-~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (382)
T cd05625         101 DLARFYIAELTCAVESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW  177 (382)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEeECCCCccccccccccccccccccccccccccccc
Confidence            357889999999999999999  99999999999997 7889999999997432100                       


Q ss_pred             --------------------------CCccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHH
Q 010626           59 --------------------------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI  111 (505)
Q Consensus        59 --------------------------~~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i  111 (505)
                                                .....+||+.|+|||++ ...|+.++|||||||++|||++|+.||... ++...
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~  256 (382)
T cd05625         178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQ-TPLET  256 (382)
T ss_pred             cccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCC-CHHHH
Confidence                                      01234699999999987 556999999999999999999999999864 34444


Q ss_pred             HHHHHcCCCCCC--CCCCCChHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCCCCC
Q 010626          112 YKKVTSGIKPAS--LSKVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPK  164 (505)
Q Consensus       112 ~~~i~~~~~p~~--~~~~~s~~l~~LI~kcL~dP~~RpS---a~ElL~hpff~~~~~~  164 (505)
                      ...+........  .....++++.++|.+|+.+|.+|++   +.++++||||+...+.
T Consensus       257 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~  314 (382)
T cd05625         257 QMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFS  314 (382)
T ss_pred             HHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChH
Confidence            444443222212  2235688999999998888999987   9999999999876543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.94  E-value=1.1e-26  Score=241.63  Aligned_cols=160  Identities=26%  Similarity=0.424  Sum_probs=125.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----------------------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----------------------   58 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----------------------   58 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++..+...                       
T Consensus       101 ~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (376)
T cd05598         101 DLARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW  177 (376)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEEC-CCCCEEEEeCCCCccccccccccccccccccccccccccccc
Confidence            357789999999999999999  99999999999997 7789999999997432100                       


Q ss_pred             ----------------------CCccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHH
Q 010626           59 ----------------------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV  115 (505)
Q Consensus        59 ----------------------~~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i  115 (505)
                                            .....+||+.|+|||++ ...++.++|||||||++|+|++|+.||.... .......+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i  256 (376)
T cd05598         178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADT-PAETQLKV  256 (376)
T ss_pred             cccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCC-HHHHHHHH
Confidence                                  01234799999999988 4568999999999999999999999998643 33333444


Q ss_pred             HcCCCCC--CCCCCCChHHHHHHHHhcCCCCCCC---CHHHHhcCCCCCCCCCCC
Q 010626          116 TSGIKPA--SLSKVTDPQVKQFIEKCIVPASLRL---PALELLKDPFLVTDNPKD  165 (505)
Q Consensus       116 ~~~~~p~--~~~~~~s~~l~~LI~kcL~dP~~Rp---Sa~ElL~hpff~~~~~~~  165 (505)
                      .......  ......++.+.+||.+|+.+|.+|+   ++.++++||||+...+..
T Consensus       257 ~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~  311 (376)
T cd05598         257 INWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFAS  311 (376)
T ss_pred             hccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHH
Confidence            3322111  1223568899999999888999999   999999999998755433

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.2e-26  Score=241.47  Aligned_cols=160  Identities=24%  Similarity=0.447  Sum_probs=125.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----------------------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----------------------   58 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----------------------   58 (505)
                      +.++.|+.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++.+...                       
T Consensus       101 ~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (377)
T cd05629         101 DVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILID-RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN  177 (377)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEEeeccccccccccccccccccccccccccccccccc
Confidence            357889999999999999999  99999999999997 7789999999998532110                       


Q ss_pred             --------------------------CCccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHH
Q 010626           59 --------------------------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI  111 (505)
Q Consensus        59 --------------------------~~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i  111 (505)
                                                .....+||+.|+|||++ ...|+.++|||||||++|||+||..||... .....
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~  256 (377)
T cd05629         178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSE-NSHET  256 (377)
T ss_pred             ccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCC-CHHHH
Confidence                                      00124699999999987 456899999999999999999999999763 44455


Q ss_pred             HHHHHcCCCCCCCCC--CCChHHHHHHHHhcCCCCC---CCCHHHHhcCCCCCCCCCCC
Q 010626          112 YKKVTSGIKPASLSK--VTDPQVKQFIEKCIVPASL---RLPALELLKDPFLVTDNPKD  165 (505)
Q Consensus       112 ~~~i~~~~~p~~~~~--~~s~~l~~LI~kcL~dP~~---RpSa~ElL~hpff~~~~~~~  165 (505)
                      +..+........++.  ..++++++||.+||.+|.+   |+++.+++.||||....+..
T Consensus       257 ~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~~  315 (377)
T cd05629         257 YRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDT  315 (377)
T ss_pred             HHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHHH
Confidence            555544322222222  4678999999999976554   56999999999998765543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.94  E-value=2.7e-26  Score=239.61  Aligned_cols=158  Identities=23%  Similarity=0.442  Sum_probs=128.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYEE-   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~~-   77 (505)
                      +.++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.......   .....||+.|+|||++.. 
T Consensus       142 ~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~-~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~  218 (371)
T cd05622         142 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ  218 (371)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEC-CCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhcc
Confidence            356788999999999999999  99999999999997 67899999999997764322   235579999999998842 


Q ss_pred             ----cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCC--CCCChHHHHHHHHhcCCCC---CCCC
Q 010626           78 ----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPAS---LRLP  148 (505)
Q Consensus        78 ----~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~~l~~LI~kcL~dP~---~RpS  148 (505)
                          .++.++|||||||++|+|++|..||.. .+....+..+........++  ...++.+++||.+||.+|.   .|++
T Consensus       219 ~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~  297 (371)
T cd05622         219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNG  297 (371)
T ss_pred             CCCccCCCccceeehhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCC
Confidence                278999999999999999999999976 45566667766543322222  3578899999999997543   3789


Q ss_pred             HHHHhcCCCCCCCCC
Q 010626          149 ALELLKDPFLVTDNP  163 (505)
Q Consensus       149 a~ElL~hpff~~~~~  163 (505)
                      +.++++||||+...+
T Consensus       298 ~~ei~~h~~~~~~~~  312 (371)
T cd05622         298 VEEIKRHLFFKNDQW  312 (371)
T ss_pred             HHHHhcCcccCCCCh
Confidence            999999999987544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.94  E-value=1.1e-26  Score=236.39  Aligned_cols=160  Identities=30%  Similarity=0.478  Sum_probs=131.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.....  .......||+.|+|||++. ..
T Consensus        96 ~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  172 (321)
T cd05603          96 PRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP  172 (321)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEEC-CCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCC
Confidence            357789999999999999999  99999999999997 678999999999865322  2233457999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH----HHHh
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LELL  153 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa----~ElL  153 (505)
                      ++.++|||||||++|+|++|..||.. .+..+.+..+...  +..++...+..+.++|.+||. +|.+|+++    .+++
T Consensus       173 ~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~  249 (321)
T cd05603         173 YDRTVDWWCLGAVLYEMLYGLPPFYS-RDVSQMYDNILHK--PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIK  249 (321)
T ss_pred             CCCcCcccccchhhhhhhcCCCCCCC-CCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHh
Confidence            89999999999999999999999976 4555666666554  334556678899999999996 79999875    5999


Q ss_pred             cCCCCCCCCCCCcc
Q 010626          154 KDPFLVTDNPKDLV  167 (505)
Q Consensus       154 ~hpff~~~~~~~l~  167 (505)
                      +|+||....+..+.
T Consensus       250 ~~~~~~~~~~~~~~  263 (321)
T cd05603         250 NHVFFSPINWDDLY  263 (321)
T ss_pred             CCCCcCCCCHHHHh
Confidence            99999876665443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.94  E-value=3.8e-26  Score=234.18  Aligned_cols=155  Identities=31%  Similarity=0.490  Sum_probs=122.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccc--cC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~--~y   79 (505)
                      +.++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++...... .....||+.|+|||++.+  .+
T Consensus       118 ~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~-~~~~~kl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~  193 (343)
T cd07878         118 EHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQADDE-MTGYVATRWYRAPEIMLNWMHY  193 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC-CCCCEEEcCCccceecCCC-cCCccccccccCchHhcCCccC
Confidence            467889999999999999999  99999999999997 6789999999999766443 344578999999998843  58


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC--CC--------------------C----C---CCCCCCCh
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IK--------------------P----A---SLSKVTDP  130 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~--~~--------------------p----~---~~~~~~s~  130 (505)
                      +.++|||||||++|+|++|+.||........+ ..+...  ..                    +    .   ......++
T Consensus       194 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (343)
T cd07878         194 NQTVDIWSVGCIMAELLKGKALFPGNDYIDQL-KRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANP  272 (343)
T ss_pred             CchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCH
Confidence            89999999999999999999999764322222 221110  00                    0    0   00123456


Q ss_pred             HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      .+.+||.+||. +|.+|||+.|+|.||||...
T Consensus       273 ~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         273 LAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence            78999999996 89999999999999999763

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.94  E-value=3.1e-26  Score=228.14  Aligned_cols=161  Identities=25%  Similarity=0.480  Sum_probs=130.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-c-cC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E-EY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~-~y   79 (505)
                      ..++.|+.|++.||+|||+++  ++||||||+||+++ .++.+||+|||++............|++.|+|||++. + .+
T Consensus        97 ~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  173 (278)
T cd05606          97 AEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY  173 (278)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEEC-CCCCEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCC
Confidence            467889999999999999999  99999999999997 6789999999998766544445567999999999884 3 58


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCC--hHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALE  151 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~E  151 (505)
                      +.++||||+|+++|+|++|+.||.....  .........  ..+..++...++.+.+++.+||. +|.+||     ++.+
T Consensus       174 ~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~  251 (278)
T cd05606         174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE  251 (278)
T ss_pred             CcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh--ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHH
Confidence            8999999999999999999999976422  222222222  12334555678999999999995 799999     9999


Q ss_pred             HhcCCCCCCCCCCCcc
Q 010626          152 LLKDPFLVTDNPKDLV  167 (505)
Q Consensus       152 lL~hpff~~~~~~~l~  167 (505)
                      +++||||+...+..+.
T Consensus       252 ll~~~~~~~~~~~~~~  267 (278)
T cd05606         252 VKEHPFFRSLDWQMVF  267 (278)
T ss_pred             HHhCccccCCCchHhh
Confidence            9999999987765543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.94  E-value=9.4e-27  Score=237.42  Aligned_cols=160  Identities=30%  Similarity=0.469  Sum_probs=129.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++....  ........||+.|+|||++ ...
T Consensus        96 ~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~-~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  172 (325)
T cd05604          96 PRARFYAAEIASALGYLHSIN--IVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP  172 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCC
Confidence            357889999999999999999  99999999999997 77899999999986532  2223445799999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH----HHHh
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LELL  153 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa----~ElL  153 (505)
                      ++.++|||||||++|+|++|..||.. .+...++..+....  ..+....+..+.++|.+||. +|.+||++    .+++
T Consensus       173 ~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~  249 (325)
T cd05604         173 YDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILHKP--LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQ  249 (325)
T ss_pred             CCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHcCC--ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence            89999999999999999999999976 44555666655442  22334568899999999995 79999876    5999


Q ss_pred             cCCCCCCCCCCCcc
Q 010626          154 KDPFLVTDNPKDLV  167 (505)
Q Consensus       154 ~hpff~~~~~~~l~  167 (505)
                      +||||....+..+.
T Consensus       250 ~h~~f~~~~~~~~~  263 (325)
T cd05604         250 EHPFFESLSWTDLE  263 (325)
T ss_pred             cCCCcCCCCHHHHH
Confidence            99999876655443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.94  E-value=2.7e-26  Score=234.27  Aligned_cols=162  Identities=25%  Similarity=0.466  Sum_probs=133.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      .+++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......  ......||+.|+|||++. ..
T Consensus       101 ~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~-~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  177 (323)
T cd05615         101 PQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP  177 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCC
Confidence            467889999999999999999  99999999999998 7789999999998754322  233456999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~El  152 (505)
                      ++.++|||||||++|+|++|+.||.. .+...++..+.....  .++...++.+.+++.+||. +|.+|++     ..++
T Consensus       178 ~~~~~DiwslGvil~elltG~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i  254 (323)
T cd05615         178 YGKSVDWWAYGVLLYEMLAGQPPFDG-EDEDELFQSIMEHNV--SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDI  254 (323)
T ss_pred             CCCccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHH
Confidence            89999999999999999999999976 445566666655432  3456678899999999996 7999997     5789


Q ss_pred             hcCCCCCCCCCCCcccC
Q 010626          153 LKDPFLVTDNPKDLVCD  169 (505)
Q Consensus       153 L~hpff~~~~~~~l~~~  169 (505)
                      ++||||....+..+...
T Consensus       255 ~~h~~f~~~~~~~~~~~  271 (323)
T cd05615         255 REHAFFRRIDWDKLENR  271 (323)
T ss_pred             hcCcccCCCCHHHHhcC
Confidence            99999998766554443

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=8.1e-27  Score=236.94  Aligned_cols=159  Identities=27%  Similarity=0.441  Sum_probs=131.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      +.++.|+.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......  ......|++.|+|||++. ..
T Consensus        98 ~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~  174 (318)
T cd05582          98 EDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG  174 (318)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEEC-CCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCC
Confidence            467889999999999999999  99999999999997 6789999999998765333  233457999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~El  152 (505)
                      ++.++|||||||++|+|++|+.||... ........+.....  .++...++.+++||.+||. +|.+||+     +.++
T Consensus       175 ~~~~~DiwslG~il~el~tg~~p~~~~-~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~  251 (318)
T cd05582         175 HTQSADWWSFGVLMFEMLTGSLPFQGK-DRKETMTMILKAKL--GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEI  251 (318)
T ss_pred             CCCccceeccceEeeeeccCCCCCCCC-CHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHH
Confidence            889999999999999999999999764 44555555554322  3455678999999999995 8999999     7789


Q ss_pred             hcCCCCCCCCCCCc
Q 010626          153 LKDPFLVTDNPKDL  166 (505)
Q Consensus       153 L~hpff~~~~~~~l  166 (505)
                      +.||||....+..+
T Consensus       252 ~~~~~~~~~~~~~~  265 (318)
T cd05582         252 KRHPFFSTIDWNKL  265 (318)
T ss_pred             hCCCCcCCCCHHHH
Confidence            99999987665443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.8e-26  Score=229.24  Aligned_cols=165  Identities=30%  Similarity=0.477  Sum_probs=131.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +.+..++.||+.||.|||++|  ++||||||+||+++ +++.++|+|||++....... .....|++.|+|||++ ...+
T Consensus       102 ~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  178 (285)
T cd05605         102 ERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEEC-CCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCC
Confidence            357889999999999999999  99999999999997 67899999999997654322 2345789999999988 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChH---HHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PAL  150 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~---~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~  150 (505)
                      +.++||||||+++|+|++|+.||.+.....   .+...+..  .+..++..+++.+++||.+||. +|.+||     ++.
T Consensus       179 ~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~  256 (285)
T cd05605         179 TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE--DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAE  256 (285)
T ss_pred             CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh--cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHH
Confidence            899999999999999999999998643322   12222222  1233455678899999999995 899999     899


Q ss_pred             HHhcCCCCCCCCCCCcccCCC
Q 010626          151 ELLKDPFLVTDNPKDLVCDPL  171 (505)
Q Consensus       151 ElL~hpff~~~~~~~l~~~~l  171 (505)
                      ++++||||....++.+...++
T Consensus       257 ~l~~~~~~~~~~~~~~~~~~~  277 (285)
T cd05605         257 EVKAHPFFRTANFKRLEAGML  277 (285)
T ss_pred             HHhcCcCccCCCHHHHhhCCC
Confidence            999999999877766544333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.94  E-value=3.7e-26  Score=227.45  Aligned_cols=161  Identities=27%  Similarity=0.423  Sum_probs=126.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..+..++.||+.||+|||++|  ++||||||+||+++ .++.++|+|||++....... .....|++.|+|||++ ...+
T Consensus        95 ~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  171 (277)
T cd05607          95 ERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY  171 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEc-CCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCC
Confidence            356778999999999999999  99999999999997 67899999999997664432 2334689999999987 4558


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCC---hHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH----HH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LE  151 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~---~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa----~E  151 (505)
                      +.++|||||||++|+|++|+.||.....   ...+.........+ .....+++++++||.+||. +|.+||++    .+
T Consensus       172 ~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            9999999999999999999999975332   22233333322221 1224568899999999996 89999999    67


Q ss_pred             HhcCCCCCCCCCCCc
Q 010626          152 LLKDPFLVTDNPKDL  166 (505)
Q Consensus       152 lL~hpff~~~~~~~l  166 (505)
                      +++||||+..++..+
T Consensus       251 ~~~h~~f~~~~~~~~  265 (277)
T cd05607         251 PRKHEFFKTINFPRL  265 (277)
T ss_pred             hhcChhhcCCCHHHH
Confidence            889999987655443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.93  E-value=4.9e-26  Score=229.46  Aligned_cols=154  Identities=31%  Similarity=0.487  Sum_probs=115.9

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe---CCCCcEEEeecCceeeccCCC-----CccccCCCcccCccc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPEL   74 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld---~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEl   74 (505)
                      .++.++.||+.||.|||++|  |+||||||+||++.   ..++.+||+|||+++......     .....||+.|+|||+
T Consensus       109 ~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~  186 (317)
T cd07867         109 MVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL  186 (317)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHH
Confidence            57889999999999999999  99999999999994   245789999999997664321     234568999999998


Q ss_pred             cc--ccCCcccchhhHHHHHHHHhhcCCCCCCCCCh---------HHHHHHHHcCCC------------C----------
Q 010626           75 YE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNP---------AQIYKKVTSGIK------------P----------  121 (505)
Q Consensus        75 l~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~---------~~i~~~i~~~~~------------p----------  121 (505)
                      +.  ..++.++|||||||++|+|+||+.||......         .+....+.....            +          
T Consensus       187 ~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (317)
T cd07867         187 LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFR  266 (317)
T ss_pred             hcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhc
Confidence            74  34889999999999999999999999643211         111111100000            0          


Q ss_pred             -------------CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          122 -------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       122 -------------~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                                   .......+..+.+||.+||. +|.+|||+.|+|+||||
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         267 RTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             ccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                         00011234578899999996 89999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=3.5e-26  Score=240.80  Aligned_cols=156  Identities=33%  Similarity=0.460  Sum_probs=118.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC---CCCccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---PTARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~---~~~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.....   .......||+.|+|||++ ..
T Consensus       182 ~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  258 (391)
T PHA03212        182 CDILAIERSVLRAIQYLHENR--IIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARD  258 (391)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEc-CCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCC
Confidence            357889999999999999999  99999999999997 678999999999965322   223345799999999988 45


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCC-------hHHHHHHHHc-CCC--------------------------CCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKN-------PAQIYKKVTS-GIK--------------------------PAS  123 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~-------~~~i~~~i~~-~~~--------------------------p~~  123 (505)
                      .|+.++|||||||++|+|++|..||.....       ..++...+.. +..                          +..
T Consensus       259 ~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (391)
T PHA03212        259 PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGS  338 (391)
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCC
Confidence            689999999999999999999988754211       1111111110 000                          000


Q ss_pred             CC-----CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          124 LS-----KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       124 ~~-----~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      .+     ...+.++.+||.+||. +|.+|||+.|+|+||||+.
T Consensus       339 ~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~  381 (391)
T PHA03212        339 RPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD  381 (391)
T ss_pred             CCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence            00     1235678999999996 8999999999999999975

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.93  E-value=6.6e-26  Score=225.31  Aligned_cols=157  Identities=29%  Similarity=0.557  Sum_probs=127.7

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCCc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNE   81 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys~   81 (505)
                      .+..++.||+.||.|||++|  ++|+||||+||+++ .++.++|+|||++............|++.|+|||++ ...++.
T Consensus        96 ~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  172 (279)
T cd06619          96 VLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGI  172 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEEC-CCCCEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCC
Confidence            56789999999999999999  99999999999997 788999999999987655555566899999999988 456899


Q ss_pred             ccchhhHHHHHHHHhhcCCCCCCCCC------hHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           82 LVDIYSFGMCILEMVTCEYPYNECKN------PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        82 ksDIWSLGviLyEmlTG~~Pf~~~~~------~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ++|+||||+++|+|++|+.||.....      .......+.....+.......++++++||.+||. +|.+||++.++++
T Consensus       173 ~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         173 HSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             cchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            99999999999999999999964221      1222333333333332334567899999999996 7999999999999


Q ss_pred             CCCCCCCC
Q 010626          155 DPFLVTDN  162 (505)
Q Consensus       155 hpff~~~~  162 (505)
                      ||||...+
T Consensus       253 ~~~~~~~~  260 (279)
T cd06619         253 HPFIVQYN  260 (279)
T ss_pred             Cccccccc
Confidence            99997653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=1.9e-26  Score=242.93  Aligned_cols=154  Identities=26%  Similarity=0.463  Sum_probs=125.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC----ccccCCCcccCccccc-c
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~----~~~~Gt~~Y~APEll~-~   77 (505)
                      -++.|.+|+|.|+.++|.+|  |||.||||.|+|+-  .|.+||+|||+|..+.....    .+.+||+.||+||.+. .
T Consensus       461 ~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV--kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~  536 (677)
T KOG0596|consen  461 FLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV--KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDM  536 (677)
T ss_pred             HHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE--eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhc
Confidence            46889999999999999999  99999999999985  68999999999988766543    3558999999999772 1


Q ss_pred             -----------cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChH-HHHHHHHhcC-CCC
Q 010626           78 -----------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQ-VKQFIEKCIV-PAS  144 (505)
Q Consensus        78 -----------~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~-l~~LI~kcL~-dP~  144 (505)
                                 +.+.++||||||||||+|+.|+.||....+.......|....-...++...... +.++++.||. +|.
T Consensus       537 ~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPk  616 (677)
T KOG0596|consen  537 SSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPK  616 (677)
T ss_pred             cccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcc
Confidence                       146789999999999999999999987555544445554432223455444444 9999999995 999


Q ss_pred             CCCCHHHHhcCCCCCC
Q 010626          145 LRLPALELLKDPFLVT  160 (505)
Q Consensus       145 ~RpSa~ElL~hpff~~  160 (505)
                      +||++.+||+|||++.
T Consensus       617 kR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  617 KRWSIPELLQHPFLQI  632 (677)
T ss_pred             cCCCcHHHhcCccccc
Confidence            9999999999999964

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=3.1e-26  Score=240.47  Aligned_cols=161  Identities=25%  Similarity=0.402  Sum_probs=123.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll~-   76 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+|||++ ..+.+||+|||++.......    .....||+.|+|||++. 
T Consensus       185 ~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~-~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  261 (392)
T PHA03207        185 EQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLD-EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL  261 (392)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEccCccccccCcccccccccccccccCccCHhHhcC
Confidence            467899999999999999999  99999999999998 67899999999997654322    23457999999999884 


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCCh---HHHHHHHHc-------------------------CCCC-CCCC--
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTS-------------------------GIKP-ASLS--  125 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~---~~i~~~i~~-------------------------~~~p-~~~~--  125 (505)
                      ..|+.++|||||||++|+|++|+.||.+....   .++...+..                         ...+ ...+  
T Consensus       262 ~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (392)
T PHA03207        262 DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPV  341 (392)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccch
Confidence            56899999999999999999999999764321   111111110                         0000 0011  


Q ss_pred             ---CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCCC
Q 010626          126 ---KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD  165 (505)
Q Consensus       126 ---~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~~~  165 (505)
                         ...+..+++||.+||. +|.+||++.++|.||||+...+..
T Consensus       342 ~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~  385 (392)
T PHA03207        342 IRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL  385 (392)
T ss_pred             hhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence               1245678999999996 899999999999999998755543

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.93  E-value=6e-26  Score=223.26  Aligned_cols=153  Identities=33%  Similarity=0.565  Sum_probs=123.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc---
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE---   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~---   76 (505)
                      +.++.++.||+.||+|||+++  ++||||||+||+++ .++.+||+|||++......  ......|++.|+|||++.   
T Consensus       111 ~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~  187 (272)
T cd06637         111 EWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE  187 (272)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEEC-CCCCEEEccCCCceecccccccCCcccccccccCHhHhcccc
Confidence            356789999999999999999  99999999999998 6789999999999765432  233457899999999873   


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                         ..|+.++|+|||||++|+|++|+.||..... ......+.....+.......+..+++||.+||. +|.+|||+.++
T Consensus       188 ~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  266 (272)
T cd06637         188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL  266 (272)
T ss_pred             CcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-HHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence               2478899999999999999999999976433 222233333323333344567899999999996 89999999999


Q ss_pred             hcCCCC
Q 010626          153 LKDPFL  158 (505)
Q Consensus       153 L~hpff  158 (505)
                      ++||||
T Consensus       267 l~~~~~  272 (272)
T cd06637         267 MKHPFI  272 (272)
T ss_pred             hhCCCC
Confidence            999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=9.7e-26  Score=220.37  Aligned_cols=152  Identities=36%  Similarity=0.637  Sum_probs=125.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC-----ccccCCCcccCccccc-
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELYE-   76 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~-----~~~~Gt~~Y~APEll~-   76 (505)
                      .++.++.||+.||.|||+.|  ++||||+|+||+++ .++.++|+|||++........     ....+++.|+|||++. 
T Consensus       105 ~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (263)
T cd06625         105 VTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG  181 (263)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceeccccccccccccCCCcCccccCcceecc
Confidence            56789999999999999999  99999999999998 778999999999876533211     2346788999999884 


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      ..++.++||||||+++|+|++|+.||.......... .+........++...+..+.++|.+||. +|.+||++.++++|
T Consensus       182 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         182 EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-HHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            458899999999999999999999997654443333 3333333445667788999999999996 79999999999999


Q ss_pred             CCC
Q 010626          156 PFL  158 (505)
Q Consensus       156 pff  158 (505)
                      |||
T Consensus       261 ~~~  263 (263)
T cd06625         261 FFV  263 (263)
T ss_pred             CCC
Confidence            997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-26  Score=237.56  Aligned_cols=170  Identities=30%  Similarity=0.497  Sum_probs=141.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +.++.|+.+|+.||++||..+  |++|||||+|||+| +.|+++|+|+|+|..+.... ....+||..|||||++ .+.|
T Consensus       287 ~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLD-d~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y  363 (591)
T KOG0986|consen  287 QRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLD-DHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVY  363 (591)
T ss_pred             HHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeec-cCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcc
Confidence            468899999999999999999  99999999999998 88999999999998876554 3444899999999998 4569


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCCh---HHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----AL  150 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~---~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~  150 (505)
                      +...|.|+|||++|||+.|+.||......   +++-+.+..  .+..++...++++++|.+.+|. +|.+|..     +.
T Consensus       364 ~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~  441 (591)
T KOG0986|consen  364 DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQ  441 (591)
T ss_pred             cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcc
Confidence            99999999999999999999999754322   222233332  3555677889999999999995 7999875     67


Q ss_pred             HHhcCCCCCCCCCCCcccCCCCCCCC
Q 010626          151 ELLKDPFLVTDNPKDLVCDPLRLPNL  176 (505)
Q Consensus       151 ElL~hpff~~~~~~~l~~~~l~~p~~  176 (505)
                      ++-+||||+..+|+.+....+..|..
T Consensus       442 evk~HpfFk~lnw~rleagml~PPfi  467 (591)
T KOG0986|consen  442 EVKEHPFFKDLNWRRLEAGMLEPPFI  467 (591)
T ss_pred             hhhhCcccccCCHhHHhccCCCCCCC
Confidence            99999999999999887776655544

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.93  E-value=5.1e-26  Score=237.63  Aligned_cols=160  Identities=25%  Similarity=0.408  Sum_probs=123.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----------------------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----------------------   58 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----------------------   58 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++..+...                       
T Consensus       101 ~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~-~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (381)
T cd05626         101 VLARFYIAELTLAIESVHKMG--FIHRDIKPDNILID-LDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW  177 (381)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEEC-CCCCEEEeeCcCCcccccccccccccccccccccccCccccc
Confidence            357889999999999999999  99999999999997 6789999999997532100                       


Q ss_pred             --------------------------CCccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHH
Q 010626           59 --------------------------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI  111 (505)
Q Consensus        59 --------------------------~~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i  111 (505)
                                                .....+||+.|+|||++ ...|+.++|||||||++|||+||..||.... ....
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~  256 (381)
T cd05626         178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPT-PTET  256 (381)
T ss_pred             ccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCC-HHHH
Confidence                                      01235799999999987 4568999999999999999999999998644 3333


Q ss_pred             HHHHHcCC--CCCCCCCCCChHHHHHHHHhcC---CCCCCCCHHHHhcCCCCCCCCCCC
Q 010626          112 YKKVTSGI--KPASLSKVTDPQVKQFIEKCIV---PASLRLPALELLKDPFLVTDNPKD  165 (505)
Q Consensus       112 ~~~i~~~~--~p~~~~~~~s~~l~~LI~kcL~---dP~~RpSa~ElL~hpff~~~~~~~  165 (505)
                      ...+....  .........++++++||.+|+.   ++..|+++.++++||||....+..
T Consensus       257 ~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~  315 (381)
T cd05626         257 QLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSS  315 (381)
T ss_pred             HHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhH
Confidence            33333221  1112223468999999999663   355699999999999998766543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.93  E-value=1.6e-26  Score=243.72  Aligned_cols=154  Identities=31%  Similarity=0.560  Sum_probs=133.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      +.++.++.|++.||.|||+++  |+|||+||.|||+. ..|.+|+||||+|+.+....  ..+..|||.|||||++ ++.
T Consensus       100 e~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~-~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~p  176 (808)
T KOG0597|consen  100 EQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLE-KGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQP  176 (808)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeec-CCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCC
Confidence            478999999999999999999  99999999999997 78999999999998876543  4566799999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      |+..+|+||+||++|||.+|++||.. ....++.+.|...  |..++...+..+..|+..+|. ||.+|.+..+++.|||
T Consensus       177 yd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF  253 (808)
T KOG0597|consen  177 YDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKD--PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF  253 (808)
T ss_pred             ccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcC--CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence            99999999999999999999999976 4455666666654  333455778999999999995 8999999999999999


Q ss_pred             CCCC
Q 010626          158 LVTD  161 (505)
Q Consensus       158 f~~~  161 (505)
                      ++..
T Consensus       254 ~k~~  257 (808)
T KOG0597|consen  254 WKGK  257 (808)
T ss_pred             Hhhh
Confidence            9863

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.93  E-value=6.9e-26  Score=235.46  Aligned_cols=157  Identities=32%  Similarity=0.472  Sum_probs=123.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYEE-   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~~-   77 (505)
                      ..++.++.||+.||.|||++|  ++||||||+|||++ .++.+||+|||++.......   .....+++.|+|||++.+ 
T Consensus       103 ~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  179 (372)
T cd07853         103 DHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVN-SNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS  179 (372)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEEC-CCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCC
Confidence            467889999999999999999  99999999999998 77899999999997654322   223467899999998743 


Q ss_pred             -cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc------------------------CCCCC------CCCC
Q 010626           78 -EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------------------GIKPA------SLSK  126 (505)
Q Consensus        78 -~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~------------------------~~~p~------~~~~  126 (505)
                       .|+.++|||||||++|+|++|+.||.+.... .....+..                        ...+.      .+..
T Consensus       180 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (372)
T cd07853         180 RHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSS  258 (372)
T ss_pred             CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCC
Confidence             4789999999999999999999999764332 22222211                        11111      1223


Q ss_pred             CCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          127 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       127 ~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      ..++++.+||.+||. +|.+|||+.++|+||||....
T Consensus       259 ~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         259 QATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             CCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            457889999999996 899999999999999998743

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.93  E-value=4.3e-26  Score=228.14  Aligned_cols=161  Identities=28%  Similarity=0.466  Sum_probs=127.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      .++..++.|++.||.|||++|  ++||||||+||+++ .++.++|+|||++...... ......|++.|+|||++ ...+
T Consensus       102 ~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  178 (285)
T cd05630         102 GRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEEC-CCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCC
Confidence            357789999999999999999  99999999999997 6789999999998765432 22345789999999988 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChH--HHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPA--QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALE  151 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~--~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~E  151 (505)
                      +.++||||||+++|+|++|+.||.......  .....+.... +...+...++.+++|+.+||+ +|.+|||     +.|
T Consensus       179 ~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~  257 (285)
T cd05630         179 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGARE  257 (285)
T ss_pred             CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHH
Confidence            999999999999999999999997643221  1122222211 223455678899999999996 8999999     999


Q ss_pred             HhcCCCCCCCCCCCc
Q 010626          152 LLKDPFLVTDNPKDL  166 (505)
Q Consensus       152 lL~hpff~~~~~~~l  166 (505)
                      +++||||+...++.+
T Consensus       258 ~~~h~~~~~~~~~~~  272 (285)
T cd05630         258 VKEHPLFKQINFKRL  272 (285)
T ss_pred             HHcChhhhccCHHHH
Confidence            999999987655443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.93  E-value=6.9e-26  Score=228.72  Aligned_cols=156  Identities=26%  Similarity=0.433  Sum_probs=121.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~--~   77 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++.......  .....+++.|+|||++.  .
T Consensus       104 ~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  180 (309)
T cd07872         104 HNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS  180 (309)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECccccceecCCCccccccccccccccCCHHHhCCC
Confidence            457789999999999999999  99999999999998 67899999999997653322  23346789999999873  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC---------------------CCC-------CCCCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---------------------KPA-------SLSKVTD  129 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~---------------------~p~-------~~~~~~s  129 (505)
                      .++.++|||||||++|+|+||+.||......... ..+....                     .+.       ......+
T Consensus       181 ~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (309)
T cd07872         181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL-HLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLD  259 (309)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCC
Confidence            5889999999999999999999999764332221 1111100                     000       0112357


Q ss_pred             hHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          130 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       130 ~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      +++++||.+||. +|.+|||+.|+|+||||+..
T Consensus       260 ~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         260 TEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             HHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            789999999996 89999999999999999764

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.1e-26  Score=244.52  Aligned_cols=149  Identities=25%  Similarity=0.496  Sum_probs=128.8

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCCc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNE   81 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys~   81 (505)
                      ++..|++||+.|+.|||.+|  ++||||||+|||+++..|+++|+|||.++..+.. ..+.+-|..|.|||++ ...|++
T Consensus       416 e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~~tp~~t~~y~APEvl~~~~yt~  492 (612)
T KOG0603|consen  416 EASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-CDTPALTLQYVAPEVLAIQEYTE  492 (612)
T ss_pred             HHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhhhCchh-hcccchhhcccChhhhccCCCCc
Confidence            45679999999999999999  9999999999999657889999999999877655 3333557789999988 556999


Q ss_pred             ccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           82 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        82 ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      ++|+||||++||+|++|+.||....+..+++.++..+    .+....+..+++||.+||+ +|.+|+++.+++.||||
T Consensus       493 acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  493 ACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             chhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC----ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            9999999999999999999998765555666666543    3447789999999999996 89999999999999999

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.1e-26  Score=239.12  Aligned_cols=169  Identities=25%  Similarity=0.445  Sum_probs=151.9

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cccCC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      +.+.++..+++|++|||++|  ||+|||||+|++++ .+|-+||.|||+|+.+... ...+++|||.|.|||++ ....+
T Consensus       521 tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd-~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD  597 (732)
T KOG0614|consen  521 TARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLD-NRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHD  597 (732)
T ss_pred             hhhhhHHHHHHHHHHHHhcC--ceeccCChhheeec-cCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcc
Confidence            46788899999999999999  99999999999998 8899999999999887554 56788999999999966 77789


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHHHhc
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~ElL~  154 (505)
                      .++|.|+||+++|||+||.+||.+ .++...|..|.+|.....+|+.....+.+||+++.. +|.+|..     +.++-+
T Consensus       598 ~avDyWaLGIli~ELL~G~pPFs~-~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  598 RAVDYWALGILIYELLTGSPPFSG-VDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             hhhHHHHHHHHHHHHHcCCCCCCC-CchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence            999999999999999999999987 678999999999999889999999999999999885 6999986     889999


Q ss_pred             CCCCCCCCCCCcccCCCCCCC
Q 010626          155 DPFLVTDNPKDLVCDPLRLPN  175 (505)
Q Consensus       155 hpff~~~~~~~l~~~~l~~p~  175 (505)
                      |.||..-+|..+....+..|-
T Consensus       677 H~Wf~gfdweglr~~~L~pPi  697 (732)
T KOG0614|consen  677 HRWFEGFDWEGLRSRTLPPPI  697 (732)
T ss_pred             hhhhhcCChhhhhhccCCCCc
Confidence            999999999888776665443

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.93  E-value=9e-26  Score=223.29  Aligned_cols=158  Identities=32%  Similarity=0.568  Sum_probs=127.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC-ccccCCCcccCccccc---
Q 010626            2 KAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELYE---   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~-g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~-~~~~Gt~~Y~APEll~---   76 (505)
                      +.++.++.||+.||.|||++ +  ++||||||+||+++ .++.+||+|||++........ ....++..|+|||.+.   
T Consensus       103 ~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  179 (283)
T cd06617         103 DILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL  179 (283)
T ss_pred             HHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecccccccccccccccccCCccccChhhcCCcc
Confidence            46789999999999999997 8  99999999999998 678999999999976543322 2346889999999873   


Q ss_pred             --ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 --~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                        ..++.++|+|||||++|+|++|+.||............+..+..+......++.++.+||.+||. +|.+||++.+++
T Consensus       180 ~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il  259 (283)
T cd06617         180 NQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELL  259 (283)
T ss_pred             cccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence              34788999999999999999999999764444333344444433333334568899999999995 899999999999


Q ss_pred             cCCCCCCCC
Q 010626          154 KDPFLVTDN  162 (505)
Q Consensus       154 ~hpff~~~~  162 (505)
                      .||||....
T Consensus       260 ~~~~~~~~~  268 (283)
T cd06617         260 QHPFFELHL  268 (283)
T ss_pred             cCchhhhcc
Confidence            999998754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=7.2e-26  Score=245.70  Aligned_cols=153  Identities=27%  Similarity=0.526  Sum_probs=129.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCccccc-c
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll~-~   77 (505)
                      .++.++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+++.+...    ......||+.|+|||++. .
T Consensus       144 ~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~-~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~  220 (496)
T PTZ00283        144 EAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLC-SNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK  220 (496)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEe-CCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCC
Confidence            56789999999999999999  99999999999998 6789999999999765432    234467999999999884 5


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      .|+.++|||||||++|+|++|+.||.. .+...++..+..+..+ .++...++++.+|+.+||. +|.+||++.++++||
T Consensus       221 ~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p  298 (496)
T PTZ00283        221 PYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP  298 (496)
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence            689999999999999999999999976 4555566666555433 3556678999999999996 899999999999999


Q ss_pred             CCCC
Q 010626          157 FLVT  160 (505)
Q Consensus       157 ff~~  160 (505)
                      |++.
T Consensus       299 ~~~~  302 (496)
T PTZ00283        299 ICKL  302 (496)
T ss_pred             HHHH
Confidence            9864

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.93  E-value=2.6e-25  Score=216.64  Aligned_cols=152  Identities=32%  Similarity=0.659  Sum_probs=125.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      .+++.++.|++.||+|||+.|  ++||||||+||+++ .++.++|+|||++......  ......+++.|+|||++ ...
T Consensus       102 ~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  178 (257)
T cd08223         102 NQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP  178 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEe-cCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCC
Confidence            357889999999999999999  99999999999997 6789999999999766432  22344688999999987 455


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++|+||||+++|+|++|+.||... +.......+..+..+ ..+...++.+.+||.+||. +|.+||++.++++|||
T Consensus       179 ~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  256 (257)
T cd08223         179 YNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIEGKLP-PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY  256 (257)
T ss_pred             CCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCCC-CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            889999999999999999999999764 334444444444333 3456678999999999996 7999999999999999


Q ss_pred             C
Q 010626          158 L  158 (505)
Q Consensus       158 f  158 (505)
                      |
T Consensus       257 ~  257 (257)
T cd08223         257 I  257 (257)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-26  Score=242.70  Aligned_cols=157  Identities=34%  Similarity=0.583  Sum_probs=134.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc----ccc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----EEE   78 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll----~~~   78 (505)
                      +|..|+.+.+.||+|||+++  .||||||..|||++ ..|.|||+|||.|....  .+++++|||.|||||++    .+.
T Consensus       127 EIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLs-e~g~VKLaDFGSAsi~~--PAnsFvGTPywMAPEVILAMDEGq  201 (948)
T KOG0577|consen  127 EIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLS-EPGLVKLADFGSASIMA--PANSFVGTPYWMAPEVILAMDEGQ  201 (948)
T ss_pred             HHHHHHHHHHHHHHHHHHhh--HHhhhccccceEec-CCCeeeeccccchhhcC--chhcccCCccccchhHheeccccc
Confidence            57789999999999999999  99999999999997 88999999999997654  46789999999999976    678


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      |+-++||||||++..||.-.++|++...-...+|.. ..+..|.......+..++.|+..||+ .|.+|||..++|+|+|
T Consensus       202 YdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI-AQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f  280 (948)
T KOG0577|consen  202 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-AQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF  280 (948)
T ss_pred             cCCccceeeccchhhhhhhcCCCccCchHHHHHHHH-HhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence            999999999999999999999999886555555544 44444444455678899999999997 5999999999999999


Q ss_pred             CCCCCCCC
Q 010626          158 LVTDNPKD  165 (505)
Q Consensus       158 f~~~~~~~  165 (505)
                      .....+..
T Consensus       281 v~R~Rp~t  288 (948)
T KOG0577|consen  281 VLRERPPT  288 (948)
T ss_pred             hccCCCch
Confidence            98765533

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.93  E-value=1.7e-25  Score=222.19  Aligned_cols=157  Identities=31%  Similarity=0.583  Sum_probs=125.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc---
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE---   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~---   76 (505)
                      ..+..++.||+.||.|||+.|  ++||||||+||+++ .++.+||+|||++......  ......+++.|+|||++.   
T Consensus       103 ~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  179 (282)
T cd06643         103 PQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET  179 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-cCCCEEEccccccccccccccccccccccccccCHhhccccC
Confidence            357889999999999999999  99999999999997 6789999999998654322  123456899999999872   


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                         ..++.++|+|||||++|+|++|+.||.... .......+..... ....+..++..+++||.+||. +|.+||++.+
T Consensus       180 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  258 (282)
T cd06643         180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQ  258 (282)
T ss_pred             CCCCCCCccchhhhHHHHHHHHccCCCCccccC-HHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence               237789999999999999999999997643 3333333333322 223345568899999999995 7999999999


Q ss_pred             HhcCCCCCCCC
Q 010626          152 LLKDPFLVTDN  162 (505)
Q Consensus       152 lL~hpff~~~~  162 (505)
                      +++||||....
T Consensus       259 il~~~~~~~~~  269 (282)
T cd06643         259 LLQHPFVTVNS  269 (282)
T ss_pred             HhcCCCEeccC
Confidence            99999998644

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.93  E-value=9.9e-26  Score=223.43  Aligned_cols=154  Identities=27%  Similarity=0.486  Sum_probs=120.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE--   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~~--   77 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......  .....+++.|+|||++.+  
T Consensus        99 ~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  175 (284)
T cd07839          99 EIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK  175 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEc-CCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCc
Confidence            467899999999999999999  99999999999998 67899999999997654322  223467889999998743  


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC-------------------C--------CCCCCCCCh
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-------------------P--------ASLSKVTDP  130 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~-------------------p--------~~~~~~~s~  130 (505)
                      .++.++|||||||++|+|+||..||....+.......+.....                   +        .......++
T Consensus       176 ~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (284)
T cd07839         176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNS  255 (284)
T ss_pred             ccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCH
Confidence            4789999999999999999999997554444333333221100                   0        001123568


Q ss_pred             HHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      .+++||.+||. +|.+|||+.+++.||||
T Consensus       256 ~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         256 TGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             HHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            89999999996 89999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.93  E-value=6.5e-26  Score=232.44  Aligned_cols=158  Identities=26%  Similarity=0.525  Sum_probs=132.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--C---CcEEEeecCceeeccCC-CCccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--N---GEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~--~---g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll   75 (505)
                      ..++.++.||+.||++||+++  ||||||||+|||++..  +   -.+||+|||+|+.+... ...+.+|+|.|||||++
T Consensus       109 ~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~  186 (429)
T KOG0595|consen  109 ATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVI  186 (429)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHH
Confidence            368899999999999999999  9999999999999743  1   45899999999988754 36678999999999988


Q ss_pred             -cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           76 -EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        76 -~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                       .++|+.|+|+||+|+++|+|++|+.||.. .+..++...+..+.. .+.++...++.+.+++...|. ++..|.+..+-
T Consensus       187 ~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a-~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~  265 (429)
T KOG0595|consen  187 MSQQYDAKADLWSIGTILYQCLTGKPPFDA-ETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDF  265 (429)
T ss_pred             HhccccchhhHHHHHHHHHHHHhCCCCccc-cCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence             78899999999999999999999999987 456666666666533 344555666777788888774 89999999999


Q ss_pred             hcCCCCCCCC
Q 010626          153 LKDPFLVTDN  162 (505)
Q Consensus       153 L~hpff~~~~  162 (505)
                      +.|+|+....
T Consensus       266 ~~~~~l~~~p  275 (429)
T KOG0595|consen  266 FDHPFLAANP  275 (429)
T ss_pred             hhhhhcccCc
Confidence            9999997654

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.93  E-value=8.5e-26  Score=224.65  Aligned_cols=158  Identities=28%  Similarity=0.508  Sum_probs=124.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEE--   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~-g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~~--   77 (505)
                      +.+..++.|++.||+|||+. +  ++||||||+||+++ .++.+||+|||++....... .....|++.|+|||++..  
T Consensus       107 ~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  183 (288)
T cd06616         107 EILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA  183 (288)
T ss_pred             HHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEc-cCCcEEEeecchhHHhccCCccccccCccCccCHHHhcccc
Confidence            35788999999999999974 8  99999999999997 67899999999987554332 233468899999998843  


Q ss_pred             --cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC---CCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           78 --EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---LSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        78 --~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~---~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                        .++.++|||||||++|+|++|+.||............+..+..+..   ....++..+.+||.+||. +|.+||++.+
T Consensus       184 ~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~  263 (288)
T cd06616         184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKE  263 (288)
T ss_pred             ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence              4889999999999999999999999765433333333333322221   123468899999999996 7999999999


Q ss_pred             HhcCCCCCCCC
Q 010626          152 LLKDPFLVTDN  162 (505)
Q Consensus       152 lL~hpff~~~~  162 (505)
                      +++||||....
T Consensus       264 i~~~~~~~~~~  274 (288)
T cd06616         264 LLEHPFIKDYE  274 (288)
T ss_pred             HhcChhhhchh
Confidence            99999997644

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.93  E-value=1.1e-25  Score=230.90  Aligned_cols=156  Identities=28%  Similarity=0.528  Sum_probs=122.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccC
Q 010626            2 KAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~-g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~y   79 (505)
                      +.++.++.||+.||.|||+. +  ++||||||+||+++ .++.+||+|||++............|++.|+|||++. ..+
T Consensus       103 ~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  179 (333)
T cd06650         103 QILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY  179 (333)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEc-CCCCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCC
Confidence            35678999999999999974 7  99999999999997 6789999999999766544445567999999999884 458


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHH--------------------------------------------HHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIY--------------------------------------------KKV  115 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~--------------------------------------------~~i  115 (505)
                      +.++|||||||++|+|++|+.||..... ..+.                                            ..+
T Consensus       180 ~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (333)
T cd06650         180 SVQSDIWSMGLSLVEMAIGRYPIPPPDA-KELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYI  258 (333)
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCcch-hHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHH
Confidence            8999999999999999999999965321 1111                                            111


Q ss_pred             HcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          116 TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       116 ~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      .....+.......+.++++||.+||+ +|.+|||+.|++.||||+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         259 VNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence            11111211222457889999999996 89999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.93  E-value=7.2e-26  Score=221.51  Aligned_cols=157  Identities=31%  Similarity=0.593  Sum_probs=127.0

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..+..++.||+.||+|||+ .|  ++||||||+||+++ .++.++|+|||.+............+++.|+|||.+ ...+
T Consensus       100 ~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  176 (265)
T cd06605         100 RILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDY  176 (265)
T ss_pred             HHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEEC-CCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCC
Confidence            3567899999999999999 88  99999999999998 678999999999876644333336788999999987 4468


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCC----ChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECK----NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~----~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      +.++||||||+++|+|++|..||....    ........+.....+.......++++++||.+||. +|.+||++.+++.
T Consensus       177 ~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            899999999999999999999997542    23333444444433333333378899999999995 8999999999999


Q ss_pred             CCCCCCC
Q 010626          155 DPFLVTD  161 (505)
Q Consensus       155 hpff~~~  161 (505)
                      ||||+..
T Consensus       257 ~~~~~~~  263 (265)
T cd06605         257 HPFIKKY  263 (265)
T ss_pred             Cchhhcc
Confidence            9999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=1.7e-25  Score=229.54  Aligned_cols=160  Identities=30%  Similarity=0.467  Sum_probs=132.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc-------------------------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-------------------------   56 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~-------------------------   56 (505)
                      +.++.|+.+++.||+|||-.|  ||+|||||+||||. ++|+|.|+||.++....                         
T Consensus       179 ~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvr-edGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~  255 (459)
T KOG0610|consen  179 SAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVR-EDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQP  255 (459)
T ss_pred             hhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEe-cCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccc
Confidence            478999999999999999999  99999999999997 88999999998863110                         


Q ss_pred             ---------C-C-----------------------CCccccCCCcccCccccc-ccCCcccchhhHHHHHHHHhhcCCCC
Q 010626           57 ---------Q-P-----------------------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPY  102 (505)
Q Consensus        57 ---------~-~-----------------------~~~~~~Gt~~Y~APEll~-~~ys~ksDIWSLGviLyEmlTG~~Pf  102 (505)
                               . .                       ...+++||-+|+|||++. .+.+.++|+|+||+++|||+.|..||
T Consensus       256 s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPF  335 (459)
T KOG0610|consen  256 SCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPF  335 (459)
T ss_pred             cccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence                     0 0                       012457999999999995 45889999999999999999999999


Q ss_pred             CCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC----HHHHhcCCCCCCCCCCC
Q 010626          103 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP----ALELLKDPFLVTDNPKD  165 (505)
Q Consensus       103 ~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS----a~ElL~hpff~~~~~~~  165 (505)
                      .+..+.+.+.+.+.+...-+.. ...+..+++||+++|+ ||.+|..    |.||-+||||+..+|.-
T Consensus       336 KG~~~~~Tl~NIv~~~l~Fp~~-~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaL  402 (459)
T KOG0610|consen  336 KGSNNKETLRNIVGQPLKFPEE-PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWAL  402 (459)
T ss_pred             CCCCchhhHHHHhcCCCcCCCC-CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhh
Confidence            9977776666666554332222 2457899999999996 7999998    99999999999999873

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.93  E-value=1.4e-25  Score=229.73  Aligned_cols=161  Identities=20%  Similarity=0.454  Sum_probs=127.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE--   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~--   76 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......   .....||+.|+|||++.  
T Consensus       102 ~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  178 (332)
T cd05623         102 DMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM  178 (332)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEC-CCCCEEEeecchheecccCCcceecccccCccccCHHHHhcc
Confidence            357889999999999999999  99999999999997 77899999999986543221   22347999999999873  


Q ss_pred             ----ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCC---CCCCChHHHHHHHHhcCC---CCCC
Q 010626           77 ----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL---SKVTDPQVKQFIEKCIVP---ASLR  146 (505)
Q Consensus        77 ----~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~---~~~~s~~l~~LI~kcL~d---P~~R  146 (505)
                          ..++.++|||||||++|+|++|+.||.. .+....+..+........+   ....++.+++||.+||..   +..|
T Consensus       179 ~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r  257 (332)
T cd05623         179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQ  257 (332)
T ss_pred             ccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCC
Confidence                3588999999999999999999999976 4455556666544322222   234688999999999953   3447


Q ss_pred             CCHHHHhcCCCCCCCCCCCc
Q 010626          147 LPALELLKDPFLVTDNPKDL  166 (505)
Q Consensus       147 pSa~ElL~hpff~~~~~~~l  166 (505)
                      +++.++++||||....+..+
T Consensus       258 ~~~~~~~~h~~f~~~~~~~~  277 (332)
T cd05623         258 NGIEDFKQHPFFTGIDWDNI  277 (332)
T ss_pred             CCHHHHhCCCCcCCCCHHHH
Confidence            89999999999988766543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=3.4e-26  Score=239.89  Aligned_cols=156  Identities=35%  Similarity=0.675  Sum_probs=137.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      +.|..|+.||+.||.|||++.  |+|||||+.|||++ .++.|||+|||+|+.+...  .+.+++|||.||.||++. ..
T Consensus       106 ~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Niflt-k~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~p  182 (426)
T KOG0589|consen  106 ERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLT-KDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIP  182 (426)
T ss_pred             HHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhcc-ccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCC
Confidence            468899999999999999988  99999999999998 6678899999999988766  567789999999999995 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      |+.|+|||||||++|||++-+.+|.. .+...+..++..+.. ..++..++.+++.+|+.||. +|..||++.++|.+|.
T Consensus       183 Yn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~ki~~~~~-~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~  260 (426)
T KOG0589|consen  183 YNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELILKINRGLY-SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPH  260 (426)
T ss_pred             CCccCcchhhcchHHHHHhcccccCc-cchHHHHHHHhhccC-CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChh
Confidence            99999999999999999999999987 567777777777652 34677789999999999995 7999999999999998


Q ss_pred             CCCCC
Q 010626          158 LVTDN  162 (505)
Q Consensus       158 f~~~~  162 (505)
                      +....
T Consensus       261 l~~~~  265 (426)
T KOG0589|consen  261 LLRYL  265 (426)
T ss_pred             hhhHH
Confidence            87543

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.93  E-value=1.4e-25  Score=222.42  Aligned_cols=152  Identities=34%  Similarity=0.551  Sum_probs=123.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc----
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE----   76 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~----   76 (505)
                      .++.++.||+.||.|||++|  ++||||+|+||+++ .++.++|+|||++......  ......|++.|+|||.+.    
T Consensus       122 ~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~  198 (282)
T cd06636         122 WIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN  198 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccC
Confidence            46788999999999999999  99999999999997 7789999999998655322  233456899999999873    


Q ss_pred             --ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 --~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                        ..++.++|+||||+++|+|++|..||......... ..+.....+......++..+.+||.+||. +|.+||++.++|
T Consensus       199 ~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell  277 (282)
T cd06636         199 PDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL  277 (282)
T ss_pred             cCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence              34788999999999999999999999764433333 23333333333445578899999999996 899999999999


Q ss_pred             cCCCC
Q 010626          154 KDPFL  158 (505)
Q Consensus       154 ~hpff  158 (505)
                      +||||
T Consensus       278 ~~~~~  282 (282)
T cd06636         278 KHPFI  282 (282)
T ss_pred             cCCCC
Confidence            99997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=1e-25  Score=233.49  Aligned_cols=156  Identities=32%  Similarity=0.502  Sum_probs=117.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC-CCCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~-~~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+|||++ ..+.+||+|||++..... .......||+.|+|||++ ...|
T Consensus       157 ~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  233 (357)
T PHA03209        157 DQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKY  233 (357)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEecCccccccccCcccccccccccccCCeecCCCCC
Confidence            467889999999999999999  99999999999997 678999999999965432 223445799999999988 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCCh----------HHHHHHHHc-CCCCCCCC-----------------------
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNP----------AQIYKKVTS-GIKPASLS-----------------------  125 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~----------~~i~~~i~~-~~~p~~~~-----------------------  125 (505)
                      +.++|||||||++|||+++..|+......          ..+...+.. +..+..++                       
T Consensus       234 ~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (357)
T PHA03209        234 NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYT  313 (357)
T ss_pred             CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCccc
Confidence            99999999999999999865554322111          111111111 11111111                       


Q ss_pred             -------CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          126 -------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       126 -------~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                             ...+..+.+||.+||. +|.+|||+.|+|+||||+.
T Consensus       314 ~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        314 RYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             ccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                   1235567789999996 8999999999999999974

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.93  E-value=1.9e-25  Score=221.16  Aligned_cols=154  Identities=29%  Similarity=0.468  Sum_probs=120.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~--~   77 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......  .....+++.|+|||.+.  .
T Consensus       101 ~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  177 (285)
T cd07861         101 ELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP  177 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEc-CCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCC
Confidence            357889999999999999999  99999999999997 78899999999997654322  22335788999999874  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--------------------------CCCCCCCChH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--------------------------ASLSKVTDPQ  131 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--------------------------~~~~~~~s~~  131 (505)
                      .++.++||||||+++|+|+||+.||.+................+                          .......+++
T Consensus       178 ~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (285)
T cd07861         178 RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDED  257 (285)
T ss_pred             CcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHH
Confidence            47889999999999999999999997654433332221110000                          0112345788


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +.+||.+||. +|.+|||+.+++.||||
T Consensus       258 ~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         258 GLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            9999999996 89999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.93  E-value=2.4e-25  Score=218.12  Aligned_cols=159  Identities=27%  Similarity=0.482  Sum_probs=131.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..++.++.||+.||+|||+++  ++|+||+|+||+++ .++.++|+|||++....... .....+++.|+|||.+ ...+
T Consensus        93 ~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~  169 (262)
T cd05572          93 YTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGY  169 (262)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEc-CCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCC
Confidence            467789999999999999999  99999999999997 67899999999997665432 2334688999999987 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCC-ChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALEL  152 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~El  152 (505)
                      +.++|+|+||+++|+|++|..||.... +....+..+..+......+...++.++++|.+||. +|.+||+     +.|+
T Consensus       170 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l  249 (262)
T cd05572         170 DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDI  249 (262)
T ss_pred             CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHH
Confidence            899999999999999999999997644 24555666654444444555568899999999995 8999999     9999


Q ss_pred             hcCCCCCCCCC
Q 010626          153 LKDPFLVTDNP  163 (505)
Q Consensus       153 L~hpff~~~~~  163 (505)
                      ++||||+...+
T Consensus       250 ~~~~~~~~~~~  260 (262)
T cd05572         250 KKHKWFNGFDW  260 (262)
T ss_pred             hcChhhhCCCC
Confidence            99999987554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.6e-25  Score=227.84  Aligned_cols=160  Identities=21%  Similarity=0.439  Sum_probs=125.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE--   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~--   76 (505)
                      +.++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++.......   .....||+.|+|||++.  
T Consensus       102 ~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  178 (331)
T cd05597         102 DMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM  178 (331)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEEC-CCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhc
Confidence            367889999999999999999  99999999999997 77899999999987654322   12246999999999884  


Q ss_pred             ----ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC---CCCCCCChHHHHHHHHhcCC---CCCC
Q 010626           77 ----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIEKCIVP---ASLR  146 (505)
Q Consensus        77 ----~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~---~~~~~~s~~l~~LI~kcL~d---P~~R  146 (505)
                          ..++.++|||||||++|+|++|+.||.. .+..+.+..+.......   ......++.+++||.+||..   +..|
T Consensus       179 ~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r  257 (331)
T cd05597         179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGR  257 (331)
T ss_pred             cccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCC
Confidence                3478899999999999999999999976 34455555554432211   12234688999999999853   3447


Q ss_pred             CCHHHHhcCCCCCCCCCCC
Q 010626          147 LPALELLKDPFLVTDNPKD  165 (505)
Q Consensus       147 pSa~ElL~hpff~~~~~~~  165 (505)
                      +++.++++||||....+..
T Consensus       258 ~~~~~~l~hp~~~~~~~~~  276 (331)
T cd05597         258 NGLQDFKDHPFFEGIDWDN  276 (331)
T ss_pred             CCHHHHhcCCCCCCCCHHH
Confidence            8999999999998766544

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.93  E-value=6.2e-26  Score=224.85  Aligned_cols=158  Identities=25%  Similarity=0.414  Sum_probs=131.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccC-CCCccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~-~~~~~~~Gt~~Y~APEll-~~   77 (505)
                      +++..|++||..|+.|||+.+  |.||||||+|+|..+  .+..+||+|||+|+.... ....+.+-||.|.|||++ ..
T Consensus       161 rea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~e  238 (400)
T KOG0604|consen  161 REASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPE  238 (400)
T ss_pred             HHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCch
Confidence            467889999999999999999  999999999999963  345789999999987653 345677889999999999 45


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCC---ChHHHHHHHHcCCC--CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~---~~~~i~~~i~~~~~--p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                      +|+..+|+||+|+++|-|++|.+||....   -...+..+|..+..  |..-+...+..++++|+++|. +|.+|.|+.+
T Consensus       239 KydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~  318 (400)
T KOG0604|consen  239 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEE  318 (400)
T ss_pred             hcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHH
Confidence            69999999999999999999999996432   22345566666633  444556678999999999995 8999999999


Q ss_pred             HhcCCCCCCC
Q 010626          152 LLKDPFLVTD  161 (505)
Q Consensus       152 lL~hpff~~~  161 (505)
                      ++.|||+...
T Consensus       319 ~m~hpwi~~~  328 (400)
T KOG0604|consen  319 VMDHPWINQY  328 (400)
T ss_pred             hhcCchhccc
Confidence            9999999764

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-25  Score=251.41  Aligned_cols=171  Identities=26%  Similarity=0.507  Sum_probs=143.5

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCccccc---
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE---   76 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~---   76 (505)
                      -++.|+..|+.||.-||+.|  +|||||||+|||+| ..|++||+|||.+..+....   ....+|||-|.+||+++   
T Consensus       176 ~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld-~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~  252 (1317)
T KOG0612|consen  176 WARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLD-KSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQG  252 (1317)
T ss_pred             HHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEec-ccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhc
Confidence            47889999999999999999  99999999999998 88999999999997775332   34558999999999882   


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCC--CCCChHHHHHHHHhcCCCCCCCC---
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIVPASLRLP---  148 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~~l~~LI~kcL~dP~~RpS---  148 (505)
                         +.|+..+|+||+||++|||+.|..||.. ......|.+|..-.....+|  ...++++++||.+++.+|..|..   
T Consensus       253 ~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa-dslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrng  331 (1317)
T KOG0612|consen  253 DGKGEYGRECDWWSLGVFMYEMLYGETPFYA-DSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLCDREVRLGRNG  331 (1317)
T ss_pred             CCccccCCccchhhhHHHHHHHHcCCCcchH-HHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhcChhhhccccc
Confidence               4599999999999999999999999976 56777888887654433444  44789999999999999999998   


Q ss_pred             HHHHhcCCCCCCCCCCCcccCCCCCCCCchhh
Q 010626          149 ALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV  180 (505)
Q Consensus       149 a~ElL~hpff~~~~~~~l~~~~l~~p~~~~~~  180 (505)
                      +.++-.||||....|..+...   .|+..|++
T Consensus       332 iedik~HpFF~g~~W~~iR~~---~pP~vPev  360 (1317)
T KOG0612|consen  332 IEDIKNHPFFEGIDWDNIRES---VPPVVPEV  360 (1317)
T ss_pred             HHHHHhCccccCCChhhhhhc---CCCCCCcC
Confidence            999999999999999665432   44445544

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.93  E-value=1.8e-25  Score=224.82  Aligned_cols=158  Identities=32%  Similarity=0.557  Sum_probs=127.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..+..++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++.......  .....|++.|+|||.+. ..
T Consensus       116 ~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  192 (296)
T cd06654         116 GQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA  192 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEECccccchhccccccccCcccCCccccCHHHHcCCC
Confidence            357789999999999999999  99999999999997 77899999999987553322  23346889999999874 45


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++|||||||++|+|++|+.||.........+.......++...+...++.+.+||.+||. +|.+||++.++++|||
T Consensus       193 ~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~  272 (296)
T cd06654         193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF  272 (296)
T ss_pred             CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence            789999999999999999999999765443444443333333333455677899999999996 8999999999999999


Q ss_pred             CCCCC
Q 010626          158 LVTDN  162 (505)
Q Consensus       158 f~~~~  162 (505)
                      |....
T Consensus       273 ~~~~~  277 (296)
T cd06654         273 LKIAK  277 (296)
T ss_pred             hhccC
Confidence            97643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.93  E-value=2.7e-25  Score=227.18  Aligned_cols=149  Identities=26%  Similarity=0.439  Sum_probs=120.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..+..++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||+++......    .....+++.|+|||++ .
T Consensus       174 ~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  250 (338)
T cd05102         174 EDLICYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD  250 (338)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEc-CCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc
Confidence            357789999999999999999  99999999999998 67899999999997653221    1223456789999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..|+.++|||||||++|||++ |..||............+..+..+ ..+...++.+.+||.+||. +|.+|||+.++++
T Consensus       251 ~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-RAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            568999999999999999997 999998755444455555544332 3456678899999999996 8999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.93  E-value=2.8e-25  Score=233.30  Aligned_cols=157  Identities=28%  Similarity=0.504  Sum_probs=133.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC---CCcEEEeecCceeeccCC-CCccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~---~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~-   76 (505)
                      +.+..+++||+.|++|||+.|  ++||||||+|+|+...   ++.+|++|||++...... .....+|||.|+|||++. 
T Consensus       135 ~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~  212 (382)
T KOG0032|consen  135 RDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG  212 (382)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC
Confidence            357789999999999999999  9999999999999644   347999999999887653 455679999999999996 


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC--CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ..|+..+||||+|+++|.|++|..||.+. ........+..+..  +...+..++..+++||.+||. +|.+|+|+.++|
T Consensus       213 ~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~-~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L  291 (382)
T KOG0032|consen  213 RPYGDEVDVWSIGVILYILLSGVPPFWGE-TEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQAL  291 (382)
T ss_pred             CCCCcccchhHHHHHHHHHhhCCCCCcCC-ChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHh
Confidence            78999999999999999999999999874 44455556666643  334455668999999999995 899999999999


Q ss_pred             cCCCCCCC
Q 010626          154 KDPFLVTD  161 (505)
Q Consensus       154 ~hpff~~~  161 (505)
                      +|||+...
T Consensus       292 ~HpWi~~~  299 (382)
T KOG0032|consen  292 QHPWIKSI  299 (382)
T ss_pred             cCccccCC
Confidence            99999864

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=1.9e-25  Score=241.09  Aligned_cols=153  Identities=29%  Similarity=0.507  Sum_probs=128.2

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++..+....    ....+||+.|+|||++ ..
T Consensus       170 ~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  246 (478)
T PTZ00267        170 EVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLM-PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK  246 (478)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEEC-CCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCC
Confidence            56779999999999999999  99999999999998 67899999999998764332    3345799999999988 45


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      .++.++|||||||++|+|++|+.||... ....+...+..+..+ .++..+++.+++||.+||. +|.+||++.+++.|+
T Consensus       247 ~~~~~~Dv~slG~~l~el~tg~~Pf~~~-~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~  324 (478)
T PTZ00267        247 RYSKKADMWSLGVILYELLTLHRPFKGP-SQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTE  324 (478)
T ss_pred             CCCcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCC-CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCH
Confidence            6899999999999999999999999763 445555555554333 2445678899999999996 899999999999999


Q ss_pred             CCCC
Q 010626          157 FLVT  160 (505)
Q Consensus       157 ff~~  160 (505)
                      |++.
T Consensus       325 ~~~~  328 (478)
T PTZ00267        325 FLKY  328 (478)
T ss_pred             HHHH
Confidence            9864

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.93  E-value=2.4e-25  Score=222.56  Aligned_cols=162  Identities=30%  Similarity=0.463  Sum_probs=128.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..+..++.|++.||.|||++|  |+||||||+||+++ .++.+||+|||++...... ......|++.|+|||++ ...+
T Consensus       102 ~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~  178 (285)
T cd05632         102 ERALFYAAEILCGLEDLHREN--TVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEC-CCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCC
Confidence            467889999999999999999  99999999999997 6689999999998665332 22345789999999987 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC--CCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALE  151 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~--~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~E  151 (505)
                      +.++|+||||+++|+|++|..||........ ...+....  ....++...++.+.+|+.+||. +|.+||+     +.+
T Consensus       179 ~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~  257 (285)
T cd05632         179 TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGE  257 (285)
T ss_pred             CcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHH
Confidence            9999999999999999999999986433222 22222111  1223445567899999999996 7999999     889


Q ss_pred             HhcCCCCCCCCCCCcc
Q 010626          152 LLKDPFLVTDNPKDLV  167 (505)
Q Consensus       152 lL~hpff~~~~~~~l~  167 (505)
                      ++.|+||.....+.+.
T Consensus       258 l~~~~~~~~~~~~~~~  273 (285)
T cd05632         258 VKRHPFFRNMNFKRLE  273 (285)
T ss_pred             HHcChhhhcCCHHHHh
Confidence            9999999987665443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.93  E-value=1.3e-25  Score=241.28  Aligned_cols=158  Identities=27%  Similarity=0.465  Sum_probs=127.3

Q ss_pred             CHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEeecCceeeccCCCCccccCCCcccCcccc-ccc
Q 010626            1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         1 Lk~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~-~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      |..++.++.||+.||.+||+.|  |||+||||+||||.. ....|||+|||.++...+... +++.+..|+|||++ ...
T Consensus       288 l~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-tYiQSRfYRAPEVILGlp  364 (586)
T KOG0667|consen  288 LPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-TYIQSRFYRAPEVILGLP  364 (586)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCceeEEecccccccCCcce-eeeeccccccchhhccCC
Confidence            4689999999999999999999  999999999999953 233799999999988766544 78899999999977 778


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC-CCC------------------------------------
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKP------------------------------------  121 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~-~~p------------------------------------  121 (505)
                      |+.+.||||||||++||++|.+.|.+....+++...+..- .+|                                    
T Consensus       365 Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~  444 (586)
T KOG0667|consen  365 YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSP  444 (586)
T ss_pred             CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccch
Confidence            9999999999999999999988888766666664443210 000                                    


Q ss_pred             ---------------C-C-------CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          122 ---------------A-S-------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       122 ---------------~-~-------~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                                     + .       +....+..+.+||.+||. +|.+|+|+.++|+||||...
T Consensus       445 ~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  445 EVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             hhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence                           0 0       001123467899999996 99999999999999999853

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.93  E-value=4.4e-25  Score=217.29  Aligned_cols=154  Identities=36%  Similarity=0.592  Sum_probs=123.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccccc---
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE---   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~~---   77 (505)
                      .+..++.||+.||+|||++|  |+||||||+||+++...+.++|+|||++......  ......|++.|+|||.+..   
T Consensus       109 ~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  186 (268)
T cd06624         109 TIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPR  186 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccc
Confidence            56778999999999999999  9999999999999755779999999998765322  1223458899999998732   


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      .++.++|+||||+++|+|++|..||.....................++...++++++|+.+||. +|.+||++.+++.||
T Consensus       187 ~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  266 (268)
T cd06624         187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP  266 (268)
T ss_pred             cCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence            3789999999999999999999999765443333222222222334566778999999999996 799999999999999


Q ss_pred             CC
Q 010626          157 FL  158 (505)
Q Consensus       157 ff  158 (505)
                      ||
T Consensus       267 ~~  268 (268)
T cd06624         267 FL  268 (268)
T ss_pred             CC
Confidence            97

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.92  E-value=5.6e-25  Score=219.79  Aligned_cols=158  Identities=33%  Similarity=0.564  Sum_probs=126.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc---
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE---   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~---   76 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++......  ......+++.|+|||++.   
T Consensus       110 ~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  186 (292)
T cd06644         110 PQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET  186 (292)
T ss_pred             HHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEc-CCCCEEEccCccceeccccccccceecCCccccCceeecccc
Confidence            467889999999999999999  99999999999997 6789999999998654322  123456889999999873   


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                         ..++.++|+|||||++|+|++|..||... +....+..+.....+ ...+...+..+.+||.+||. +|.+||++.+
T Consensus       187 ~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  265 (292)
T cd06644         187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQ  265 (292)
T ss_pred             ccCCCCCchhhhHhHHHHHHHHhcCCCCCccc-cHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence               23678999999999999999999999764 344444444443332 22344567899999999996 7999999999


Q ss_pred             HhcCCCCCCCCC
Q 010626          152 LLKDPFLVTDNP  163 (505)
Q Consensus       152 lL~hpff~~~~~  163 (505)
                      +++||||....+
T Consensus       266 il~~~~~~~~~~  277 (292)
T cd06644         266 LLEHPFVSSVTS  277 (292)
T ss_pred             HhcCcccccccc
Confidence            999999976544

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.92  E-value=6.4e-25  Score=213.37  Aligned_cols=152  Identities=35%  Similarity=0.659  Sum_probs=126.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..+..++.||+.||.|||+.|  ++||||||+||+++ .++.++|+|||++.......  .....|++.|+|||++ ...
T Consensus       101 ~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  177 (256)
T cd08529         101 DQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP  177 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEe-CCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCC
Confidence            356789999999999999999  99999999999998 67899999999987664332  2334688999999987 455


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++|+||||+++|+|++|+.||... +.......+..+..+ .++..++..+.++|.+||+ +|.+||++.++++|||
T Consensus       178 ~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  255 (256)
T cd08529         178 YNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGVFP-PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS  255 (256)
T ss_pred             CCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCC-CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence            889999999999999999999999764 455555555555433 2444678899999999996 7999999999999999


Q ss_pred             C
Q 010626          158 L  158 (505)
Q Consensus       158 f  158 (505)
                      +
T Consensus       256 ~  256 (256)
T cd08529         256 L  256 (256)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=2.9e-25  Score=217.38  Aligned_cols=153  Identities=31%  Similarity=0.555  Sum_probs=121.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc---
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE---   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~---   76 (505)
                      ..++.++.|++.||.|||++|  ++||||+|+||+++ .++.+||+|||++......  ......|++.|+|||++.   
T Consensus       113 ~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  189 (275)
T cd06608         113 EWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDE  189 (275)
T ss_pred             HHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEc-cCCeEEECCCccceecccchhhhcCccccccccCHhHhcccc
Confidence            357789999999999999999  99999999999998 6789999999998765332  223456889999999873   


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC-CCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                         ..++.++||||||+++|+|++|+.||......... ..+.....+. ..+...+..+++||.+||. +|.+|||+.+
T Consensus       190 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~  268 (275)
T cd06608         190 QPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL-FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEE  268 (275)
T ss_pred             cccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH-HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHH
Confidence               23678999999999999999999999764333333 3333332222 1222357789999999995 8999999999


Q ss_pred             HhcCCCC
Q 010626          152 LLKDPFL  158 (505)
Q Consensus       152 lL~hpff  158 (505)
                      +++|||+
T Consensus       269 ll~~~~~  275 (275)
T cd06608         269 LLEHPFI  275 (275)
T ss_pred             HhcCCCC
Confidence            9999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.92  E-value=3.8e-25  Score=217.76  Aligned_cols=154  Identities=36%  Similarity=0.604  Sum_probs=123.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----CCccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----~~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||+|||+++  ++||||+|+||+++ .++.+||+|||++......     ......++..|+|||.+.
T Consensus       106 ~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (266)
T cd06651         106 SVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS  182 (266)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCCCccccccccccCCccccCCccccccCHHHhC
Confidence            356789999999999999999  99999999999997 6789999999998755321     112345788999999884


Q ss_pred             -ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcCCCCCCCCHHHHhcC
Q 010626           77 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD  155 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~dP~~RpSa~ElL~h  155 (505)
                       ..++.++|+|||||++|+|++|+.||........+... ......+.++...++.++.||..|+.+|.+||++.++++|
T Consensus       183 ~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         183 GEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI-ATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             CCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHH-hcCCCCCCCchhcCHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             45889999999999999999999999875444444433 3333334556667889999995444689999999999999


Q ss_pred             CCCC
Q 010626          156 PFLV  159 (505)
Q Consensus       156 pff~  159 (505)
                      |||+
T Consensus       262 p~~~  265 (266)
T cd06651         262 PFAQ  265 (266)
T ss_pred             cccc
Confidence            9996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.92  E-value=3.1e-25  Score=215.58  Aligned_cols=153  Identities=35%  Similarity=0.610  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||.|||+.+  ++||||+|+||+++ .++.+||+|||++.......  .....++..|+|||.+. ..
T Consensus        99 ~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  175 (256)
T cd06612          99 EEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG  175 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEC-CCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCC
Confidence            467889999999999999999  99999999999998 67899999999997664432  23345888999999874 46


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC-CCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~-~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      ++.++||||||+++|+|++|+.||......... ..+... ......+..++..+.+||.+||. +|.+||++.++|.||
T Consensus       176 ~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~  254 (256)
T cd06612         176 YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-FMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP  254 (256)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-hhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCC
Confidence            889999999999999999999999764332222 222221 11222334567899999999995 899999999999999


Q ss_pred             CC
Q 010626          157 FL  158 (505)
Q Consensus       157 ff  158 (505)
                      ||
T Consensus       255 ~~  256 (256)
T cd06612         255 FI  256 (256)
T ss_pred             CC
Confidence            97

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.92  E-value=7.9e-26  Score=219.93  Aligned_cols=154  Identities=35%  Similarity=0.637  Sum_probs=121.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeec--cCCCCccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~--~~~~~~~~~Gt~~Y~APEll~--~   77 (505)
                      ..+..++.||+.||.|||++|  ++||||||+||+++ .++.++|+|||.+...  .........+++.|+|||++.  .
T Consensus        98 ~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  174 (260)
T PF00069_consen   98 EEILKIAYQILEALAYLHSKG--IVHRDIKPENILLD-ENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGK  174 (260)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEES-TTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTS
T ss_pred             ccccccccccccccccccccc--cccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc
Confidence            468899999999999999999  99999999999998 7889999999999763  222344557899999999986  5


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCC--ChHHHHHHHHcCCCCCCCC--CCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~--~~~~i~~~i~~~~~p~~~~--~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                      .++.++||||||+++|+|++|..||....  +.............+....  ....+.+.++|.+||. +|.+||++.++
T Consensus       175 ~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l  254 (260)
T PF00069_consen  175 KYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEEL  254 (260)
T ss_dssp             SBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHH
Confidence            68999999999999999999999998752  1222222222211111111  1123799999999996 89999999999


Q ss_pred             hcCCCC
Q 010626          153 LKDPFL  158 (505)
Q Consensus       153 L~hpff  158 (505)
                      ++||||
T Consensus       255 ~~~~~~  260 (260)
T PF00069_consen  255 LKHPWF  260 (260)
T ss_dssp             HTSGGG
T ss_pred             hcCCCC
Confidence            999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.92  E-value=4.2e-25  Score=220.26  Aligned_cols=154  Identities=27%  Similarity=0.472  Sum_probs=121.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE--   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~~--   77 (505)
                      ..++.++.|++.||+|||+++  ++||||||+||+++ .++.+||+|||++.......  .....|++.|+|||.+..  
T Consensus       128 ~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  204 (291)
T cd06639         128 AMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ  204 (291)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEeecccchhcccccccccCccCCccccChhhhcCCC
Confidence            357789999999999999999  99999999999997 67899999999987654322  233468899999998732  


Q ss_pred             ----cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           78 ----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        78 ----~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                          .++.++|||||||++|+|++|+.||......... ..+.....+ ...+......+.+||.+||. +|.+||++.+
T Consensus       205 ~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  283 (291)
T cd06639         205 QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-FKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTH  283 (291)
T ss_pred             CcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-HHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHH
Confidence                2678999999999999999999999864333333 333333222 12233456789999999996 7999999999


Q ss_pred             HhcCCCCC
Q 010626          152 LLKDPFLV  159 (505)
Q Consensus       152 lL~hpff~  159 (505)
                      +++||||+
T Consensus       284 il~~~~~~  291 (291)
T cd06639         284 LLEHPFIK  291 (291)
T ss_pred             HhcCcccC
Confidence            99999994

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.92  E-value=3.4e-25  Score=223.11  Aligned_cols=158  Identities=32%  Similarity=0.587  Sum_probs=127.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~-~~   78 (505)
                      .++..++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++.......  .....+++.|+|||.+. ..
T Consensus       115 ~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  191 (296)
T cd06655         115 AQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA  191 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCC
Confidence            467889999999999999999  99999999999997 67899999999987654322  23346889999999874 55


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++|+|||||++|+|++|+.||..................+...+..+++.+++||.+||. +|.+||++.++++|||
T Consensus       192 ~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~  271 (296)
T cd06655         192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF  271 (296)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence            889999999999999999999999775443333333223333333455678899999999995 8999999999999999


Q ss_pred             CCCCC
Q 010626          158 LVTDN  162 (505)
Q Consensus       158 f~~~~  162 (505)
                      |+...
T Consensus       272 ~~~~~  276 (296)
T cd06655         272 LKLAK  276 (296)
T ss_pred             hhhcc
Confidence            97644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=3.3e-25  Score=238.49  Aligned_cols=156  Identities=28%  Similarity=0.439  Sum_probs=120.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+++......    .....||+.|+|||++ .
T Consensus       260 ~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  336 (461)
T PHA03211        260 AQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVN-GPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG  336 (461)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEEC-CCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC
Confidence            467899999999999999999  99999999999997 67899999999997654321    2235699999999988 4


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCC-------ChHHHHHHHHcCCCC-CC-------------------------
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECK-------NPAQIYKKVTSGIKP-AS-------------------------  123 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~-------~~~~i~~~i~~~~~p-~~-------------------------  123 (505)
                      ..++.++|||||||++|||++|..|+....       ...++.+.+...... ..                         
T Consensus       337 ~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  416 (461)
T PHA03211        337 DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAY  416 (461)
T ss_pred             CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCcc
Confidence            568999999999999999999886653321       123344443322110 00                         


Q ss_pred             ----CC--CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          124 ----LS--KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       124 ----~~--~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                          +.  ...+..+.+||.+||. +|.+|||+.|+|+||||+.
T Consensus       417 ~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        417 TRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                00  1235689999999996 8999999999999999964

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.92  E-value=3.7e-25  Score=222.34  Aligned_cols=157  Identities=26%  Similarity=0.432  Sum_probs=121.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~--~   77 (505)
                      +.++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......  .....+++.|+|||++.  .
T Consensus       104 ~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  180 (301)
T cd07873         104 HNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST  180 (301)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEEC-CCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCC
Confidence            467889999999999999999  99999999999997 67899999999986543222  22345788999999874  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC---------------------CCC-------CCCCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---------------------KPA-------SLSKVTD  129 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~---------------------~p~-------~~~~~~s  129 (505)
                      .++.++||||||+++|+|+||+.||.......+ ...+....                     .+.       ......+
T Consensus       181 ~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (301)
T cd07873         181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLD  259 (301)
T ss_pred             CCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCC
Confidence            478899999999999999999999976443222 22111100                     000       0112457


Q ss_pred             hHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          130 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       130 ~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      +.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus       260 ~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         260 SDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            789999999996 899999999999999997543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=5e-25  Score=217.58  Aligned_cols=159  Identities=30%  Similarity=0.541  Sum_probs=129.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||+++  ++||||+|+||+++ .++.++|+|||++......  ......+++.|+|||.+ ...
T Consensus        98 ~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  174 (274)
T cd06609          98 TYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG  174 (274)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEcccccceeecccccccccccCCccccChhhhccCC
Confidence            467889999999999999999  99999999999998 6789999999999776543  23345788899999987 445


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++||||||+++|+|+||..||... ++......+.....+......+++.+.+++.+||. +|.+||++.++++|||
T Consensus       175 ~~~~sDv~slG~il~~l~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~  253 (274)
T cd06609         175 YDEKADIWSLGITAIELAKGEPPLSDL-HPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKF  253 (274)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcccC-chHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChh
Confidence            899999999999999999999999763 34444444444443332222278899999999995 8999999999999999


Q ss_pred             CCCCCCC
Q 010626          158 LVTDNPK  164 (505)
Q Consensus       158 f~~~~~~  164 (505)
                      |+.....
T Consensus       254 ~~~~~~~  260 (274)
T cd06609         254 IKKAKKT  260 (274)
T ss_pred             hcCCCcc
Confidence            9875543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=6e-25  Score=222.03  Aligned_cols=159  Identities=26%  Similarity=0.418  Sum_probs=125.4

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC------------------------
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------------------------   58 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~------------------------   58 (505)
                      .++.++.||+.||+|||+.|  ++||||||+||+++ .++.++|+|||++......                        
T Consensus       104 ~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (316)
T cd05574         104 VARFYAAEVLLALEYLHLLG--IVYRDLKPENILLH-ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET  180 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEc-CCCCEEEeecchhhcccccccccccccccccccccccccchhh
Confidence            56778999999999999999  99999999999997 6789999999998643211                        


Q ss_pred             -------CCccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCh
Q 010626           59 -------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDP  130 (505)
Q Consensus        59 -------~~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~  130 (505)
                             .....+|+..|+|||++ ...++.++||||||+++|+|++|..||........ +..+.............+.
T Consensus       181 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  259 (316)
T cd05574         181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET-FSNILKKEVTFPGSPPVSS  259 (316)
T ss_pred             hcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH-HHHHhcCCccCCCccccCH
Confidence                   11234688899999987 44588999999999999999999999976544433 3333332222222223688


Q ss_pred             HHHHHHHHhcC-CCCCCCC----HHHHhcCCCCCCCCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLP----ALELLKDPFLVTDNPKD  165 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpS----a~ElL~hpff~~~~~~~  165 (505)
                      .++++|.+||. +|.+||+    +.++|.||||+...+..
T Consensus       260 ~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~  299 (316)
T cd05574         260 SARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL  299 (316)
T ss_pred             HHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence            99999999995 8999999    99999999998766543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.92  E-value=5.4e-25  Score=219.97  Aligned_cols=162  Identities=29%  Similarity=0.523  Sum_probs=133.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      ..++.++.||+.||.|||++|  ++||||+|.||+++ .++.+||+|||++...... .....+++.|+|||.+ ...++
T Consensus       101 ~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  176 (290)
T cd05580         101 PVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGR-TYTLCGTPEYLAPEIILSKGYG  176 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEeeCCCccccCCC-CCCCCCCccccChhhhcCCCCC
Confidence            457789999999999999999  99999999999997 6789999999999776544 3445689999999977 45578


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHHHhc
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~ElL~  154 (505)
                      .++||||||+++|+|++|+.||.... .......+..+..  .++...++.++++|.+||. +|.+|+     ++.++++
T Consensus       177 ~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         177 KAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKILEGKV--RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCCc--cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            89999999999999999999997643 4555555554432  3455668999999999995 799999     8999999


Q ss_pred             CCCCCCCCCCCcccCC
Q 010626          155 DPFLVTDNPKDLVCDP  170 (505)
Q Consensus       155 hpff~~~~~~~l~~~~  170 (505)
                      ||||....+..+....
T Consensus       254 ~~~~~~~~~~~~~~~~  269 (290)
T cd05580         254 HPWFAGIDWIALLQRK  269 (290)
T ss_pred             CcccccCCHHHHhhcc
Confidence            9999887765554333

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.92  E-value=5.1e-25  Score=216.41  Aligned_cols=153  Identities=31%  Similarity=0.561  Sum_probs=121.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc----
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY----   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll----   75 (505)
                      ..++.++.||+.||.|||++|  ++|+||||+||+++ .++.+||+|||++.......  .....|++.|+|||++    
T Consensus       106 ~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  182 (267)
T cd06645         106 SQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER  182 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEECcceeeeEccCcccccccccCcccccChhhhcccc
Confidence            467889999999999999999  99999999999997 67899999999987654322  2344789999999986    


Q ss_pred             cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCC--CCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                      ...++.++|+|||||++|+|++|+.||..................+....  ..++..+.+||.+||. +|.+||++.++
T Consensus       183 ~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~l  262 (267)
T cd06645         183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKL  262 (267)
T ss_pred             CCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence            34588899999999999999999999976443333333222222222221  1356789999999996 79999999999


Q ss_pred             hcCCC
Q 010626          153 LKDPF  157 (505)
Q Consensus       153 L~hpf  157 (505)
                      ++|||
T Consensus       263 l~~~~  267 (267)
T cd06645         263 LQHPF  267 (267)
T ss_pred             hcCCC
Confidence            99998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.92  E-value=3.3e-25  Score=227.02  Aligned_cols=161  Identities=22%  Similarity=0.476  Sum_probs=126.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC---ccccCCCcccCccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYE--   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~---~~~~Gt~~Y~APEll~--   76 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++........   ....||+.|+|||++.  
T Consensus       102 ~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  178 (331)
T cd05624         102 DMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLD-MNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM  178 (331)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEc-CCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhcc
Confidence            357789999999999999999  99999999999997 678999999999976643321   2346999999999874  


Q ss_pred             ----ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCC---CCCChHHHHHHHHhcCCCCC---C
Q 010626           77 ----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS---KVTDPQVKQFIEKCIVPASL---R  146 (505)
Q Consensus        77 ----~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~---~~~s~~l~~LI~kcL~dP~~---R  146 (505)
                          +.++.++|||||||++|+|++|+.||.. .+....+..+........++   ...++.+++||.+||..+.+   |
T Consensus       179 ~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~  257 (331)
T cd05624         179 EDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQ  257 (331)
T ss_pred             ccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCC
Confidence                3578899999999999999999999976 34455555555432222222   23578999999999964333   5


Q ss_pred             CCHHHHhcCCCCCCCCCCCc
Q 010626          147 LPALELLKDPFLVTDNPKDL  166 (505)
Q Consensus       147 pSa~ElL~hpff~~~~~~~l  166 (505)
                      +++.++++||||+...+..+
T Consensus       258 ~~~~~~~~h~~f~~~~~~~~  277 (331)
T cd05624         258 NGIEDFKKHAFFEGIDWENI  277 (331)
T ss_pred             CCHHHHhcCCCcCCCCHHHH
Confidence            68999999999987666543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.92  E-value=4.6e-25  Score=216.50  Aligned_cols=154  Identities=30%  Similarity=0.494  Sum_probs=124.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--------CCCccccCCCcccCcc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--------PTARSVIGTPEFMAPE   73 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--------~~~~~~~Gt~~Y~APE   73 (505)
                      +.+..++.||+.||+|||+.+  ++|+||+|+||+++ .++.++|+|||++.....        .......|++.|+|||
T Consensus       102 ~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe  178 (265)
T cd06631         102 PVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLM-PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE  178 (265)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEEC-CCCeEEeccchhhHhhhhccccccccccccccCCCccccChh
Confidence            357789999999999999999  99999999999997 778999999999865421        1122346889999999


Q ss_pred             ccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           74 LYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        74 ll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                      .+. ..++.++|+||||+++|+|++|..||...................+..+..++..+.+||.+||. +|.+||++.+
T Consensus       179 ~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~  258 (265)
T cd06631         179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQ  258 (265)
T ss_pred             hhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHH
Confidence            884 45889999999999999999999999765444433333322223334566778999999999995 7999999999


Q ss_pred             HhcCCCC
Q 010626          152 LLKDPFL  158 (505)
Q Consensus       152 lL~hpff  158 (505)
                      ++.||||
T Consensus       259 ~l~~~~~  265 (265)
T cd06631         259 LLRHDFL  265 (265)
T ss_pred             HhcCCCC
Confidence            9999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.92  E-value=6.3e-25  Score=218.86  Aligned_cols=156  Identities=28%  Similarity=0.403  Sum_probs=121.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~--~   77 (505)
                      +.++.++.||+.||.|||++|  ++||||+|+||+++..++.+||+|||++.......  .....+++.|+|||.+.  .
T Consensus       110 ~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  187 (295)
T cd07837         110 KTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST  187 (295)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCC
Confidence            467889999999999999999  99999999999998547899999999987653321  22235788999999773  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC-------------------------CCCCCCChHH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-------------------------SLSKVTDPQV  132 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~-------------------------~~~~~~s~~l  132 (505)
                      .++.++|+||||+++|+|++|..||..................+.                         ......++.+
T Consensus       188 ~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (295)
T cd07837         188 HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEG  267 (295)
T ss_pred             CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHH
Confidence            478999999999999999999999987544443332222100000                         0112357889


Q ss_pred             HHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 010626          133 KQFIEKCIV-PASLRLPALELLKDPFLV  159 (505)
Q Consensus       133 ~~LI~kcL~-dP~~RpSa~ElL~hpff~  159 (505)
                      .+||.+||. +|.+||++.++|.||||+
T Consensus       268 ~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         268 LDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             HHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            999999996 799999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=5.1e-25  Score=215.57  Aligned_cols=156  Identities=25%  Similarity=0.487  Sum_probs=127.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~ys   80 (505)
                      +.+..++.||+.||.|||+.+  ++||||+|+||+++ .++.+||+|||++.....  .....+++.|+|||.+. ..++
T Consensus        97 ~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~  171 (260)
T cd05611          97 DWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLE--NKKFVGTPDYLAPETILGVGDD  171 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCcEEEeecccceeccc--cccCCCCcCccChhhhcCCCCc
Confidence            467889999999999999999  99999999999997 678999999999875543  23446889999999874 4478


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC--CCCCCCCCCChHHHHHHHHhcC-CCCCCCC---HHHHhc
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIV-PASLRLP---ALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~--~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS---a~ElL~  154 (505)
                      .++||||||+++|+|++|..||... +....+..+..+.  .+......+++.+.++|.+||. +|.+||+   +.|+|.
T Consensus       172 ~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         172 KMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             chhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            9999999999999999999999764 4455555554432  2333444578999999999995 8999995   579999


Q ss_pred             CCCCCCCCC
Q 010626          155 DPFLVTDNP  163 (505)
Q Consensus       155 hpff~~~~~  163 (505)
                      ||||+...|
T Consensus       251 ~~~~~~~~~  259 (260)
T cd05611         251 HPFFKSINW  259 (260)
T ss_pred             ChHhhcCCC
Confidence            999987554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-25  Score=224.49  Aligned_cols=166  Identities=27%  Similarity=0.528  Sum_probs=140.6

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeec--cCCCCccccCCCcccCccccc-ccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQPTARSVIGTPEFMAPELYE-EEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~--~~~~~~~~~Gt~~Y~APEll~-~~y   79 (505)
                      ..+.|..+|+.||.|||+++  |++||||.+|+++| .+|++||.|||+++.-  ......+++|||.|+|||++. ..|
T Consensus       269 RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLD-kDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDY  345 (516)
T KOG0690|consen  269 RTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLD-KDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDY  345 (516)
T ss_pred             hhhhhhHHHHHHhhhhhhCC--eeeeechhhhheec-cCCceEeeecccchhcccccceeccccCChhhcCchhhccccc
Confidence            45778899999999999999  99999999999998 8899999999999643  233467889999999999994 569


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHHHh
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELL  153 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~ElL  153 (505)
                      +.++|.|.+|+++|||++|+.||.. .+...++..|...  ...++...+++++.|+..+|. +|.+|..     +.|+.
T Consensus       346 graVDWWG~GVVMYEMmCGRLPFyn-~dh~kLFeLIl~e--d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~  422 (516)
T KOG0690|consen  346 GRAVDWWGVGVVMYEMMCGRLPFYN-KDHEKLFELILME--DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIM  422 (516)
T ss_pred             cceeehhhhhHHHHHHHhccCcccc-cchhHHHHHHHhh--hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHH
Confidence            9999999999999999999999987 4455566666544  234677889999999999995 8999985     89999


Q ss_pred             cCCCCCCCCCCCcccCCCCCC
Q 010626          154 KDPFLVTDNPKDLVCDPLRLP  174 (505)
Q Consensus       154 ~hpff~~~~~~~l~~~~l~~p  174 (505)
                      +|+||...+|.....+.+..|
T Consensus       423 ~h~FF~~v~W~~~~~Kki~PP  443 (516)
T KOG0690|consen  423 RHRFFASVDWEATYRKKIEPP  443 (516)
T ss_pred             hhhhhccCCHHHHHHhccCCC
Confidence            999999999988766555433

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.92  E-value=5.7e-25  Score=215.73  Aligned_cols=152  Identities=36%  Similarity=0.647  Sum_probs=124.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--------CccccCCCcccCcc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--------ARSVIGTPEFMAPE   73 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--------~~~~~Gt~~Y~APE   73 (505)
                      ..++.++.|++.||.|||++|  ++||||+|+||+++ .++.++|+|||.+.......        .....|++.|+|||
T Consensus       106 ~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe  182 (267)
T cd06628         106 TLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVD-NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE  182 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEc-CCCCEEecccCCCcccccccccCCccccccccCCCcCccChh
Confidence            357789999999999999999  99999999999997 77899999999987664211        12345788999999


Q ss_pred             cc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           74 LY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        74 ll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                      .+ ...++.++|+||||+++|+|++|+.||........+ ..+..... ..++...+..+.++|.+||. +|.+||++.+
T Consensus       183 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  260 (267)
T cd06628         183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-FKIGENAS-PEIPSNISSEAIDFLEKTFEIDHNKRPTAAE  260 (267)
T ss_pred             HhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-HHHhccCC-CcCCcccCHHHHHHHHHHccCCchhCcCHHH
Confidence            88 456888999999999999999999999875443333 33333322 33556678999999999996 7999999999


Q ss_pred             HhcCCCC
Q 010626          152 LLKDPFL  158 (505)
Q Consensus       152 lL~hpff  158 (505)
                      +++||||
T Consensus       261 il~~~~~  267 (267)
T cd06628         261 LLKHPFL  267 (267)
T ss_pred             HhhCCCC
Confidence            9999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.92  E-value=8e-25  Score=216.98  Aligned_cols=155  Identities=25%  Similarity=0.460  Sum_probs=122.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      ++++.++.||+.||.|||+.|  ++||||||+||+++...+.++|+|||++......  ....+++.|+|||++ ...++
T Consensus       109 ~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~  184 (267)
T PHA03390        109 AEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--SCYDGTLDYFSPEKIKGHNYD  184 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--ccCCCCCcccChhhhcCCCCC
Confidence            467889999999999999999  9999999999999844338999999998766433  234688999999988 45688


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHH-HcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-HHHHhcCCC
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV-TSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-ALELLKDPF  157 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i-~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-a~ElL~hpf  157 (505)
                      .++|+||||+++|+|++|..||............+ .....+.......++.+.+||.+||+ +|.+|++ ++++|+|||
T Consensus       185 ~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~  264 (267)
T PHA03390        185 VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF  264 (267)
T ss_pred             chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence            99999999999999999999997543221111111 11122334455688999999999996 7999996 599999999


Q ss_pred             CCC
Q 010626          158 LVT  160 (505)
Q Consensus       158 f~~  160 (505)
                      |+.
T Consensus       265 ~~~  267 (267)
T PHA03390        265 LKI  267 (267)
T ss_pred             ccC
Confidence            963

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.92  E-value=5.4e-25  Score=214.87  Aligned_cols=151  Identities=35%  Similarity=0.612  Sum_probs=121.8

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCCcccCccccc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~~Y~APEll~   76 (505)
                      .++.++.||+.||.|||++|  ++||||+|+||+++ .++.++|+|||++..+....      .....|++.|+|||.+.
T Consensus       103 ~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~  179 (267)
T cd06610         103 IIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME  179 (267)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHc
Confidence            57889999999999999999  99999999999998 67899999999986654322      12346889999999874


Q ss_pred             c--cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCC-----CCCChHHHHHHHHhcC-CCCCCCC
Q 010626           77 E--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS-----KVTDPQVKQFIEKCIV-PASLRLP  148 (505)
Q Consensus        77 ~--~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~-----~~~s~~l~~LI~kcL~-dP~~RpS  148 (505)
                      .  .++.++|+||||+++|+|++|+.||...... ..+..+.....+ .+.     ...++.+.+|+.+||. +|.+||+
T Consensus       180 ~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~  257 (267)
T cd06610         180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQNDPP-SLETGADYKKYSKSFRKMISLCLQKDPSKRPT  257 (267)
T ss_pred             cccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcCCCC-CcCCccccccccHHHHHHHHHHcCCChhhCcC
Confidence            3  5889999999999999999999999764433 333333333222 111     2457889999999996 7999999


Q ss_pred             HHHHhcCCCC
Q 010626          149 ALELLKDPFL  158 (505)
Q Consensus       149 a~ElL~hpff  158 (505)
                      +.++++||||
T Consensus       258 ~~~ll~~p~~  267 (267)
T cd06610         258 AEELLKHKFF  267 (267)
T ss_pred             HHHHhhCCCC
Confidence            9999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.92  E-value=3.2e-25  Score=223.18  Aligned_cols=158  Identities=33%  Similarity=0.576  Sum_probs=127.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..+..++.|++.||.|||+.|  ++||||||+||+++ .++.++|+|||++.......  .....+++.|+|||.+ ...
T Consensus       115 ~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  191 (297)
T cd06656         115 GQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA  191 (297)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCC
Confidence            357789999999999999999  99999999999997 77899999999987654332  2334688999999987 455


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++|+||||+++|+|++|..||...............+.++...+...++.+++||.+||. +|.+||++.++++|||
T Consensus       192 ~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  271 (297)
T cd06656         192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF  271 (297)
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence            889999999999999999999999764433333322222333333455677889999999996 7999999999999999


Q ss_pred             CCCCC
Q 010626          158 LVTDN  162 (505)
Q Consensus       158 f~~~~  162 (505)
                      |+...
T Consensus       272 ~~~~~  276 (297)
T cd06656         272 LKLAK  276 (297)
T ss_pred             hcccc
Confidence            98654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.92  E-value=9.4e-25  Score=220.16  Aligned_cols=155  Identities=25%  Similarity=0.370  Sum_probs=121.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~--~   77 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++......  ......+++.|+|||.+.  .
T Consensus       108 ~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  184 (309)
T cd07845         108 SQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCT  184 (309)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCC
Confidence            467889999999999999999  99999999999997 6789999999999776533  222334678899999874  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC--C---------------CCC-----------CCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P---------------ASL-----------SKVTD  129 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~--p---------------~~~-----------~~~~s  129 (505)
                      .++.++||||||+++|+|++|+.||..... ......+.....  .               ...           ....+
T Consensus       185 ~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T cd07845         185 TYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLS  263 (309)
T ss_pred             CcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccC
Confidence            578999999999999999999999976443 333333322100  0               000           01247


Q ss_pred             hHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          130 PQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       130 ~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      +.+.+||.+||. +|.+|||+.+++.||||+.
T Consensus       264 ~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~  295 (309)
T cd07845         264 EAGLRLLNFLLMYDPKKRATAEEALESSYFKE  295 (309)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence            888999999996 8999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.92  E-value=6.5e-25  Score=217.77  Aligned_cols=152  Identities=26%  Similarity=0.493  Sum_probs=121.7

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc----
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE----   76 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~----   76 (505)
                      .++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++......  ......|++.|+|||++.    
T Consensus       125 ~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  201 (286)
T cd06638         125 IIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQ  201 (286)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEEC-CCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhh
Confidence            46789999999999999999  99999999999997 6788999999999765432  223446899999999873    


Q ss_pred             --ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC-CCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           77 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-KPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        77 --~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~-~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                        ..++.++|||||||++|+|++|+.||.......... .+.... .....+...+..+.+||.+||. +|.+||++.++
T Consensus       202 ~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el  280 (286)
T cd06638         202 LDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL  280 (286)
T ss_pred             ccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-hccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHH
Confidence              347889999999999999999999997654333332 222222 1222344567889999999996 89999999999


Q ss_pred             hcCCCC
Q 010626          153 LKDPFL  158 (505)
Q Consensus       153 L~hpff  158 (505)
                      ++|+||
T Consensus       281 l~~~~~  286 (286)
T cd06638         281 LQHVFI  286 (286)
T ss_pred             hhcccC
Confidence            999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.92  E-value=8e-25  Score=212.70  Aligned_cols=157  Identities=30%  Similarity=0.522  Sum_probs=126.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----------CCccccCCCcccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----------TARSVIGTPEFMA   71 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----------~~~~~~Gt~~Y~A   71 (505)
                      ..+..++.||+.||.|||++|  ++||||+|+||+++ .++.++|+|||++......          ......+++.|+|
T Consensus        93 ~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (265)
T cd05579          93 DVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILID-SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA  169 (265)
T ss_pred             HHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEc-CCCCEEEEecccchhcccCcccccccccccccCcccCccccC
Confidence            357789999999999999999  99999999999998 6789999999998654322          2223467889999


Q ss_pred             cccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH
Q 010626           72 PELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA  149 (505)
Q Consensus        72 PEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa  149 (505)
                      ||.+ ...++.++|+||||+++|+|++|..||... ........+..+..+.......+..+.+|+.+||. +|.+|||+
T Consensus       170 Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~  248 (265)
T cd05579         170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE-TPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGA  248 (265)
T ss_pred             HHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCC
Confidence            9977 445888999999999999999999999764 45555555555433222222248899999999996 79999999


Q ss_pred             ---HHHhcCCCCCCCC
Q 010626          150 ---LELLKDPFLVTDN  162 (505)
Q Consensus       150 ---~ElL~hpff~~~~  162 (505)
                         .++|+||||+..+
T Consensus       249 ~~~~~~l~~~~~~~~~  264 (265)
T cd05579         249 KSIEEIKNHPFFKGID  264 (265)
T ss_pred             ccHHHHhcCccccCCC
Confidence               9999999997644

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.92  E-value=8.5e-25  Score=216.74  Aligned_cols=154  Identities=29%  Similarity=0.471  Sum_probs=120.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE--   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~~--   77 (505)
                      ..++.++.||+.||+|||.++  ++||||+|+||+++ .++.+||+|||++.......  .....+++.|+|||++.+  
T Consensus       100 ~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  176 (284)
T cd07860         100 PLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK  176 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEeeccchhhcccCccccccccccccccCCeEEecCC
Confidence            357889999999999999999  99999999999998 67899999999987553321  223356889999998743  


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC--------------------------CCCCCCChH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--------------------------SLSKVTDPQ  131 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~--------------------------~~~~~~s~~  131 (505)
                      .++.++||||||+++|+|+||+.||..........+.+.....+.                          ......++.
T Consensus       177 ~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (284)
T cd07860         177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDED  256 (284)
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHH
Confidence            368899999999999999999999976554443333222111110                          011235788


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      ++++|.+||. +|.+||++.++++||||
T Consensus       257 ~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         257 GRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            9999999996 89999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.92  E-value=6.1e-25  Score=220.81  Aligned_cols=157  Identities=33%  Similarity=0.624  Sum_probs=125.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..+..++.||+.||+|||++|  ++||||||+||+++ .++.++|+|||++.......  .....|++.|+|||.+ ...
T Consensus       118 ~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  194 (292)
T cd06658         118 EQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP  194 (292)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEc-CCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCC
Confidence            467889999999999999999  99999999999997 67899999999986543222  2345689999999987 446


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC-CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      ++.++|+||||+++|+|++|+.||... ........+.....+. ......+..+.+|+.+||. +|.+|||+.++++||
T Consensus       195 ~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~  273 (292)
T cd06658         195 YGTEVDIWSLGIMVIEMIDGEPPYFNE-PPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHP  273 (292)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence            889999999999999999999999764 3333344443332221 1223467889999999995 799999999999999


Q ss_pred             CCCCCC
Q 010626          157 FLVTDN  162 (505)
Q Consensus       157 ff~~~~  162 (505)
                      ||....
T Consensus       274 ~~~~~~  279 (292)
T cd06658         274 FLKLAG  279 (292)
T ss_pred             hhhccC
Confidence            998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PHA02988 hypothetical protein; Provisional

Probab=99.92  E-value=7.3e-25  Score=219.73  Aligned_cols=147  Identities=22%  Similarity=0.298  Sum_probs=122.9

Q ss_pred             HHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc---cc
Q 010626            3 AIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE---EE   78 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~-g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~---~~   78 (505)
                      ....++.|++.||.|||+. +  ++||||||+||+++ .++.+||+|||++...... .....|++.|+|||++.   ..
T Consensus       123 ~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~-~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  198 (283)
T PHA02988        123 TKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVT-ENYKLKIICHGLEKILSSP-PFKNVNFMVYFSYKMLNDIFSE  198 (283)
T ss_pred             HHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEEC-CCCcEEEcccchHhhhccc-cccccCcccccCHHHhhhcccc
Confidence            4678999999999999984 7  88999999999998 6789999999998765433 23456889999999884   46


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      |+.++|||||||++|||++|+.||... +...++..+........++...++.+++||.+||+ +|.+|||+.+++.
T Consensus       199 ~~~k~Di~SlGvil~el~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        199 YTIKDDIYSLGVVLWEIFTGKIPFENL-TTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             ccchhhhhHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            899999999999999999999999864 45566666655444445555678999999999996 8999999999985

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.92  E-value=1e-24  Score=215.73  Aligned_cols=155  Identities=26%  Similarity=0.476  Sum_probs=120.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE--   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~--   76 (505)
                      ..++.++.||+.||+|||++|  ++|+||||+||+++ .++.++|+|||++.......   .....|++.|+|||.+.  
T Consensus        99 ~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  175 (286)
T cd07832          99 AQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA  175 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEc-CCCcEEEeeeeecccccCCCCCccccccCcccccCceeeecc
Confidence            467889999999999999999  99999999999998 67899999999997665432   23346889999999873  


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--------------------C-------CCCCCCC
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--------------------A-------SLSKVTD  129 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--------------------~-------~~~~~~s  129 (505)
                      ..++.++||||||+++|+|+||..||....+.......+.....+                    .       ......+
T Consensus       176 ~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (286)
T cd07832         176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDAS  255 (286)
T ss_pred             ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCcc
Confidence            347899999999999999999988886544333222221110000                    0       0112346


Q ss_pred             hHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 010626          130 PQVKQFIEKCIV-PASLRLPALELLKDPFLV  159 (505)
Q Consensus       130 ~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~  159 (505)
                      ..+.+||.+||. +|.+||++.++|.||||.
T Consensus       256 ~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         256 PEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            789999999996 799999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.92  E-value=1.2e-24  Score=213.89  Aligned_cols=154  Identities=36%  Similarity=0.614  Sum_probs=124.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----CCccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----~~~~~~Gt~~Y~APEll-   75 (505)
                      ..+..++.|++.||+|||+++  ++|+||||+||+++ .++.++|+|||++......     ......|+..|+|||++ 
T Consensus       106 ~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (265)
T cd06652         106 NVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS  182 (265)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-CCCCEEECcCccccccccccccccccccCCCCccccChhhhc
Confidence            356789999999999999999  99999999999997 7789999999998755321     12334688899999987 


Q ss_pred             cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcCCCCCCCCHHHHhcC
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD  155 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~dP~~RpSa~ElL~h  155 (505)
                      ...++.++||||||+++|+|++|+.||.......... .+.........+...+..+.++|.+|+.+|.+||++.++++|
T Consensus       183 ~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~p~~Rp~~~~il~~  261 (265)
T cd06652         183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPVLPPHVSDHCRDFLKRIFVEAKLRPSADELLRH  261 (265)
T ss_pred             CCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH-HHhcCCCCCCCchhhCHHHHHHHHHHhcChhhCCCHHHHhcC
Confidence            4558899999999999999999999997654444333 333333333445566788999999999999999999999999


Q ss_pred             CCCC
Q 010626          156 PFLV  159 (505)
Q Consensus       156 pff~  159 (505)
                      ||+.
T Consensus       262 ~~~~  265 (265)
T cd06652         262 TFVH  265 (265)
T ss_pred             cccC
Confidence            9973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=4.1e-25  Score=239.96  Aligned_cols=159  Identities=27%  Similarity=0.475  Sum_probs=120.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      +.++.|+.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++..+....   .....||+.|+|||++ ..
T Consensus       267 ~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  343 (501)
T PHA03210        267 KQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENIFLN-CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD  343 (501)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC
Confidence            357789999999999999999  99999999999997 67899999999998764432   2345799999999988 45


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCC-CCCCC-Ch-HHHHHHHHcCC-CCCCC----------------------------C
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYP-YNECK-NP-AQIYKKVTSGI-KPASL----------------------------S  125 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~P-f~~~~-~~-~~i~~~i~~~~-~p~~~----------------------------~  125 (505)
                      .|+.++|||||||++|||++|..+ |.... .+ .++.+.+.... ....+                            .
T Consensus       344 ~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~  423 (501)
T PHA03210        344 GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRN  423 (501)
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHh
Confidence            699999999999999999998865 43221 22 22222221100 00000                            0


Q ss_pred             CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          126 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       126 ~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                      ...+..+.++|.+||. +|.+|||+.|+|.||||.....
T Consensus       424 ~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~  462 (501)
T PHA03210        424 LGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEE  462 (501)
T ss_pred             cCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCc
Confidence            1234567888999996 8999999999999999987543

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=8.8e-25  Score=216.49  Aligned_cols=156  Identities=35%  Similarity=0.625  Sum_probs=126.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc---
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE---   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~---   76 (505)
                      ..++.++.|++.||.|||++|  ++||||||+||+++ .++.++|+|||++......  ......+++.|+|||++.   
T Consensus       103 ~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  179 (280)
T cd06611         103 PQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLT-LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET  179 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEC-CCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcc
Confidence            467889999999999999999  99999999999997 6789999999998654322  223446899999999863   


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                         ..++.++|+||||+++|+|++|+.||... ........+..+..+ ...+..++..+.+||.+||. +|.+||++.+
T Consensus       180 ~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  258 (280)
T cd06611         180 FKDNPYDYKADIWSLGITLIELAQMEPPHHEL-NPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAE  258 (280)
T ss_pred             cCCCCCCccccHHHHHHHHHHHHhCCCCcccC-CHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHH
Confidence               23677999999999999999999999764 344444445444332 22345578899999999995 7999999999


Q ss_pred             HhcCCCCCCC
Q 010626          152 LLKDPFLVTD  161 (505)
Q Consensus       152 lL~hpff~~~  161 (505)
                      +|+||||...
T Consensus       259 il~~~~~~~~  268 (280)
T cd06611         259 LLKHPFVSDQ  268 (280)
T ss_pred             HhcChhhccc
Confidence            9999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.92  E-value=1.2e-24  Score=214.84  Aligned_cols=152  Identities=21%  Similarity=0.367  Sum_probs=118.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-c-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-E-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~-~~   78 (505)
                      ..++.++.||+.||+|||++|  ++||||+|+||+++ . +.+||+|||++....... .....+++.|+|||.+ . +.
T Consensus       100 ~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~-~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  175 (282)
T cd07831         100 KRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIK-D-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGY  175 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEc-C-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCC
Confidence            367889999999999999999  99999999999998 4 899999999997664332 2334688999999976 3 44


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC----------------CCCCC-----------CCCCChH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------------KPASL-----------SKVTDPQ  131 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~----------------~p~~~-----------~~~~s~~  131 (505)
                      ++.++|||||||++|+|++|..||..... ......+....                ....+           ....+..
T Consensus       176 ~~~~~Di~slGv~l~el~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (282)
T cd07831         176 YGPKMDIWAVGCVFFEILSLFPLFPGTNE-LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAE  254 (282)
T ss_pred             CCcchhHHHHHHHHHHHHcCCcCCCCCCH-HHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHH
Confidence            78899999999999999999999976432 22222221100                00001           1234689


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +.+||.+||. +|.+||++.++++||||
T Consensus       255 ~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         255 GLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             HHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            9999999996 79999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-25  Score=254.48  Aligned_cols=156  Identities=35%  Similarity=0.618  Sum_probs=136.6

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCCcccCccccc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~~Y~APEll~   76 (505)
                      ..+.|..|++.||+|||++|  |+||||||.|||++ .+|.+|++|||.|..+....      .+...|||.|||||++.
T Consensus      1335 vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld-~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit 1411 (1509)
T KOG4645|consen 1335 VTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLD-FNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVIT 1411 (1509)
T ss_pred             HHHHHHHHHHHHHHHHHhcC--ceecCCCccceeee-cCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhc
Confidence            34667899999999999999  99999999999998 77899999999998775442      34568999999999983


Q ss_pred             c----cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhc-CCCCCCCCHHH
Q 010626           77 E----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALE  151 (505)
Q Consensus        77 ~----~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL-~dP~~RpSa~E  151 (505)
                      +    +...+.||||+||++.||+||+.||...++.-++..++..|..|. +|...+++.++||++|| +||.+|.++.|
T Consensus      1412 ~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq-~P~~ls~~g~dFle~Cl~~dP~~Rw~~~q 1490 (1509)
T KOG4645|consen 1412 GTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQ-IPERLSSEGRDFLEHCLEQDPKMRWTASQ 1490 (1509)
T ss_pred             ccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCC-CchhhhHhHHHHHHHHHhcCchhhhHHHH
Confidence            2    356789999999999999999999999999999999999888775 55558999999999999 59999999999


Q ss_pred             HhcCCCCCCCC
Q 010626          152 LLKDPFLVTDN  162 (505)
Q Consensus       152 lL~hpff~~~~  162 (505)
                      ||.|.|-+...
T Consensus      1491 lle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1491 LLEHAFGKSCT 1501 (1509)
T ss_pred             HHHhhcccccc
Confidence            99999976544

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.92  E-value=1.4e-24  Score=209.22  Aligned_cols=154  Identities=41%  Similarity=0.681  Sum_probs=129.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll~-   76 (505)
                      ..+..++.|++.||+|||+.|  ++|+||+|+||+++ .++.++|+|||.+.......    .....++..|+|||.+. 
T Consensus       101 ~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~  177 (260)
T cd06606         101 PVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVD-SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG  177 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEc-CCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcC
Confidence            357789999999999999999  99999999999998 67899999999998775543    34456889999999884 


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      ..++.++||||||+++|+|++|..||....+.......+........++...+..+++||.+||. +|.+||++.++++|
T Consensus       178 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            44889999999999999999999999876545555555544344445666778999999999996 79999999999999


Q ss_pred             CCC
Q 010626          156 PFL  158 (505)
Q Consensus       156 pff  158 (505)
                      |||
T Consensus       258 ~~~  260 (260)
T cd06606         258 PFL  260 (260)
T ss_pred             CCC
Confidence            997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.92  E-value=1.6e-24  Score=210.54  Aligned_cols=152  Identities=30%  Similarity=0.502  Sum_probs=128.1

Q ss_pred             HHHHHHHHHHHHHHHHHH-----hCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccc
Q 010626            2 KAIKNWARQILRGLHYLH-----SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPEL   74 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLH-----s~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEl   74 (505)
                      +.++.++.||+.||.|||     +.+  ++||||+|+||+++ .++.+||+|||++.......  .....+++.|+|||.
T Consensus       105 ~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~  181 (265)
T cd08217         105 EFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQ  181 (265)
T ss_pred             HHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEe-cCCCEEEecccccccccCCcccccccccCCCccChhh
Confidence            467889999999999999     888  99999999999998 67899999999998765433  334578999999998


Q ss_pred             c-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           75 Y-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        75 l-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                      + ...++.++|+||||+++|+|++|..||.... .......+..+..+ .++...+..+.+++.+||. +|.+||++.++
T Consensus       182 ~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~i  259 (265)
T cd08217         182 LNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLASKIKEGKFR-RIPYRYSSELNEVIKSMLNVDPDKRPSTEEL  259 (265)
T ss_pred             hcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHHHHHhcCCCC-CCccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence            8 4458899999999999999999999998643 55555666555433 4556678999999999996 89999999999


Q ss_pred             hcCCCC
Q 010626          153 LKDPFL  158 (505)
Q Consensus       153 L~hpff  158 (505)
                      ++|||+
T Consensus       260 l~~~~~  265 (265)
T cd08217         260 LQLPLI  265 (265)
T ss_pred             hhCCCC
Confidence            999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.92  E-value=7.8e-25  Score=223.24  Aligned_cols=157  Identities=22%  Similarity=0.471  Sum_probs=118.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC---------CCccccCCCcccCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAP   72 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~---------~~~~~~Gt~~Y~AP   72 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++.+++.||+........         ......++..|+||
T Consensus       101 ~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  177 (327)
T cd08227         101 LAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP  177 (327)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEe-cCCcEEEcccchhhccccccccccccccccccccceecccCh
Confidence            357889999999999999999  99999999999998 6789999999865432111         01223467789999


Q ss_pred             cccc---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC-----------------------------
Q 010626           73 ELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-----------------------------  120 (505)
Q Consensus        73 Ell~---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~-----------------------------  120 (505)
                      |++.   ..|+.++|||||||++|+|++|+.||............+....+                             
T Consensus       178 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T cd08227         178 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGES  257 (327)
T ss_pred             HHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcc
Confidence            9884   35889999999999999999999999764333222222211100                             


Q ss_pred             -------C-------CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          121 -------P-------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       121 -------p-------~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                             +       .......++.+.+||.+||+ +|.+|||+.++++||||+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         258 TTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             cccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                   0       00112346789999999996 89999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.92  E-value=1.7e-25  Score=238.07  Aligned_cols=150  Identities=35%  Similarity=0.550  Sum_probs=126.9

Q ss_pred             CHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc----CCCCccccCCCcccCccccc
Q 010626            1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVIGTPEFMAPELYE   76 (505)
Q Consensus         1 Lk~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~----~~~~~~~~Gt~~Y~APEll~   76 (505)
                      |.+++.|++||++|+.|||.++  |||||||..|||+. +++.|||+|||++..-.    ........|...|||||+++
T Consensus       487 m~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~-~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIR  563 (678)
T KOG0193|consen  487 MNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLH-EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIR  563 (678)
T ss_pred             HHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEc-cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHh
Confidence            3467889999999999999999  99999999999997 66899999999995432    22334456788999999883


Q ss_pred             ----ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC---CCCCCCCChHHHHHHHHhcC-CCCCCCC
Q 010626           77 ----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---ASLSKVTDPQVKQFIEKCIV-PASLRLP  148 (505)
Q Consensus        77 ----~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p---~~~~~~~s~~l~~LI~kcL~-dP~~RpS  148 (505)
                          ..|++.+||||||+|+|||+||..||. ..+.+++.-++..|...   ......++.++++|+..||. ++++||.
T Consensus       564 mqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~  642 (678)
T KOG0193|consen  564 MQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPL  642 (678)
T ss_pred             hcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCcc
Confidence                359999999999999999999999999 68889988888888433   33444567799999999996 8999999


Q ss_pred             HHHHhc
Q 010626          149 ALELLK  154 (505)
Q Consensus       149 a~ElL~  154 (505)
                      +.+||.
T Consensus       643 F~~il~  648 (678)
T KOG0193|consen  643 FPQLLS  648 (678)
T ss_pred             HHHHHH
Confidence            999886

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=1.8e-24  Score=214.88  Aligned_cols=156  Identities=33%  Similarity=0.623  Sum_probs=126.0

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccc---
Q 010626            2 KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE---   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~---   77 (505)
                      ..++.++.||+.||.|||+ ++  ++||||||+||+++ .++.+||+|||++............+++.|+|||.+.+   
T Consensus       102 ~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  178 (286)
T cd06622         102 DVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGP  178 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEEC-CCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCC
Confidence            4678899999999999996 58  99999999999998 57899999999997665554555678899999998732   


Q ss_pred             ----cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHH---HHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH
Q 010626           78 ----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK---KVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA  149 (505)
Q Consensus        78 ----~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~---~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa  149 (505)
                          .++.++|+|||||++|+|++|+.||..... .....   .+..+ .+..++..+++.+.+||.+||. +|.+||++
T Consensus       179 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  256 (286)
T cd06622         179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-ANIFAQLSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTY  256 (286)
T ss_pred             CccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-hhHHHHHHHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCH
Confidence                257899999999999999999999965322 22222   23333 2334555688999999999996 79999999


Q ss_pred             HHHhcCCCCCCCC
Q 010626          150 LELLKDPFLVTDN  162 (505)
Q Consensus       150 ~ElL~hpff~~~~  162 (505)
                      .+++.||||....
T Consensus       257 ~~l~~~~~~~~~~  269 (286)
T cd06622         257 AQLLEHPWLVKYK  269 (286)
T ss_pred             HHHhcChhhhhcc
Confidence            9999999997644

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.92  E-value=1.6e-24  Score=214.40  Aligned_cols=154  Identities=27%  Similarity=0.487  Sum_probs=121.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~--~   77 (505)
                      +.++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......  .....++..|+|||.+.  .
T Consensus       100 ~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  176 (286)
T cd07847         100 HLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT  176 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEc-CCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCC
Confidence            467889999999999999999  99999999999997 67899999999997664432  22346788999999874  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC--C------------------CCCC--------CCCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I------------------KPAS--------LSKVTD  129 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~--~------------------~p~~--------~~~~~s  129 (505)
                      .++.++|+||||+++|+|++|+.||.+..............  .                  .+..        .....+
T Consensus       177 ~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (286)
T cd07847         177 QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNIS  256 (286)
T ss_pred             CcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCC
Confidence            47899999999999999999999998755444433221100  0                  0000        012346


Q ss_pred             hHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          130 PQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       130 ~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      ..+.+||.+||. +|.+||++.+++.||||
T Consensus       257 ~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         257 SPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             HHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            789999999996 79999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.92  E-value=1.7e-24  Score=218.99  Aligned_cols=156  Identities=31%  Similarity=0.542  Sum_probs=122.9

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccC
Q 010626            2 KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~y   79 (505)
                      +.++.++.||+.||.|||+ ++  ++||||||+||+++ .++.+||+|||++............|++.|+|||.+. ..+
T Consensus        99 ~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  175 (308)
T cd06615          99 NILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY  175 (308)
T ss_pred             HHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEe-cCCcEEEccCCCcccccccccccCCCCcCccChhHhcCCCC
Confidence            3578899999999999997 57  99999999999998 6789999999998766554455667899999999884 458


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHH------------------------------------cCCCCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT------------------------------------SGIKPAS  123 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~------------------------------------~~~~p~~  123 (505)
                      +.++|+||||+++|+|++|+.||.... .......+.                                    ....|..
T Consensus       176 ~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (308)
T cd06615         176 TVQSDIWSLGLSLVEMAIGRYPIPPPD-AKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKL  254 (308)
T ss_pred             CccchHHHHHHHHHHHHhCCCCCCCcc-hhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccC
Confidence            899999999999999999999986432 222211111                                    1111111


Q ss_pred             CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          124 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       124 ~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      ....++.++++||.+||. +|.+||++.++++||||...
T Consensus       255 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         255 PSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence            122357789999999995 89999999999999999763

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.92  E-value=1.8e-24  Score=212.06  Aligned_cols=156  Identities=33%  Similarity=0.597  Sum_probs=124.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~~Y~APEll   75 (505)
                      ..++.++.||+.||+|||++|  ++||||+|+||+++..+..+||+|||.+.......      .....++..|+|||.+
T Consensus       103 ~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~  180 (268)
T cd06630         103 AVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL  180 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHh
Confidence            457889999999999999999  99999999999997444469999999987654321      1234678899999987


Q ss_pred             -cccCCcccchhhHHHHHHHHhhcCCCCCCCCC--hHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           76 -EEEYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        76 -~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                       ...++.++|+||+|+++|+|++|..||.....  .......+.........+...++.+.+++.+||. +|.+||++.+
T Consensus       181 ~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~  260 (268)
T cd06630         181 RGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRE  260 (268)
T ss_pred             ccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHH
Confidence             45688999999999999999999999964332  2222223333333445666778999999999996 7999999999


Q ss_pred             HhcCCCCC
Q 010626          152 LLKDPFLV  159 (505)
Q Consensus       152 lL~hpff~  159 (505)
                      +++||||+
T Consensus       261 ll~~~~~~  268 (268)
T cd06630         261 LLKHPVFR  268 (268)
T ss_pred             HhcCcccC
Confidence            99999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.92  E-value=1.4e-24  Score=223.92  Aligned_cols=156  Identities=29%  Similarity=0.423  Sum_probs=121.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +.++.++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++....... .....+++.|+|||++ ...+
T Consensus       118 ~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  194 (353)
T cd07850         118 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY  194 (353)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCC
Confidence            357789999999999999999  99999999999998 67899999999997664432 2334688999999987 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC-C--------------------C----CC-----------
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-K--------------------P----AS-----------  123 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~-~--------------------p----~~-----------  123 (505)
                      +.++|||||||++|+|++|+.||........ +..+.... .                    +    ..           
T Consensus       195 ~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (353)
T cd07850         195 KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFP  273 (353)
T ss_pred             CCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccC
Confidence            9999999999999999999999976433222 22221100 0                    0    00           


Q ss_pred             -----CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          124 -----LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       124 -----~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                           .....++.+++||.+||. +|.+|||+.|+|.||||+..
T Consensus       274 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         274 PDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             cccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence                 011345678999999996 89999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.92  E-value=2.3e-24  Score=209.45  Aligned_cols=153  Identities=30%  Similarity=0.539  Sum_probs=125.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCccccc-ccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~-~~y   79 (505)
                      ..+..++.|++.||+|||++|  ++||||+|+||+++..++.+||+|||++....... .....+++.|+|||.+. ..+
T Consensus       101 ~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  178 (256)
T cd08220         101 DTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPY  178 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCC
Confidence            467889999999999999999  99999999999998556678999999997765432 23356889999999884 457


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +.++||||||+++|+|++|..||.... .......+...... .++...++.+++++.+||. +|.+|||+.++++||||
T Consensus       179 ~~~~Dv~slG~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         179 NQKSDIWALGCVLYELASLKRAFEAAN-LPALVLKIMSGTFA-PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             CcccchHHHHHHHHHHHhCCCCcccCc-hHHHHHHHHhcCCC-CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            889999999999999999999997644 33444444443322 3455678899999999995 89999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.4e-24  Score=211.77  Aligned_cols=153  Identities=32%  Similarity=0.581  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-c-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-E-   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~-   77 (505)
                      +.+..++.|++.||.|||++|  ++||||+|+||+++ .++.+||+|||++......  ......++..|+|||.+. . 
T Consensus       101 ~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~  177 (262)
T cd06613         101 LQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER  177 (262)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEEC-CCCCEEECccccchhhhhhhhccccccCCccccCchhhcccc
Confidence            457789999999999999999  99999999999998 7789999999998765432  223456888999999873 3 


Q ss_pred             --cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           78 --EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        78 --~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                        .++.++|+||||+++|+|+||+.||..................+..  .....+..+.+||.+||. +|..||++.++
T Consensus       178 ~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i  257 (262)
T cd06613         178 KGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKL  257 (262)
T ss_pred             cCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHH
Confidence              5888999999999999999999999875544443333333222221  223346789999999996 79999999999


Q ss_pred             hcCCC
Q 010626          153 LKDPF  157 (505)
Q Consensus       153 L~hpf  157 (505)
                      +.|+|
T Consensus       258 l~~~~  262 (262)
T cd06613         258 LQHPF  262 (262)
T ss_pred             hcCCC
Confidence            99998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.92  E-value=2.1e-24  Score=215.69  Aligned_cols=157  Identities=33%  Similarity=0.650  Sum_probs=127.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..+..++.||+.||+|||++|  ++||||+|+||+++ .++.++|+|||++......  ......|++.|+|||.+. ..
T Consensus       115 ~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  191 (285)
T cd06648         115 EQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP  191 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEc-CCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCC
Confidence            467889999999999999999  99999999999997 6789999999988654332  223346899999999874 45


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC-CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~-~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      ++.++|+||||+++|+|++|+.||.. .++......+.....+.. .....+..+.+||.+||. +|.+||++.+++.||
T Consensus       192 ~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  270 (285)
T cd06648         192 YGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHP  270 (285)
T ss_pred             CCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCc
Confidence            88999999999999999999999976 344555555555432221 122367899999999996 799999999999999


Q ss_pred             CCCCCC
Q 010626          157 FLVTDN  162 (505)
Q Consensus       157 ff~~~~  162 (505)
                      ||....
T Consensus       271 ~~~~~~  276 (285)
T cd06648         271 FLAKAG  276 (285)
T ss_pred             ccccCC
Confidence            998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=7.6e-25  Score=228.85  Aligned_cols=156  Identities=22%  Similarity=0.426  Sum_probs=133.9

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC-CCCccccCCCcccCcccc-cccCC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~-~~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      ..++|++||+.|+.|||+..  ++||||||+||.+-...|-|||.|||++..+.. ....+.+|+..|-|||++ ...|+
T Consensus       119 La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYD  196 (864)
T KOG4717|consen  119 LAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYD  196 (864)
T ss_pred             HHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccC
Confidence            57899999999999999998  999999999998877889999999999976644 456778999999999977 55565


Q ss_pred             -cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           81 -ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        81 -~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                       +++||||||+|||.|++|+.||.... ..+...+|.....  ..+...+.++++||..||+ +|.+|.+.+++..++|+
T Consensus       197 APAVDiWSLGVILyMLVCGq~PFqeAN-DSETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl  273 (864)
T KOG4717|consen  197 APAVDIWSLGVILYMLVCGQPPFQEAN-DSETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL  273 (864)
T ss_pred             CcchhhhHHHHHHHHHHhCCCcccccc-chhhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence             78999999999999999999998754 4455556665533  4677789999999999996 89999999999999999


Q ss_pred             CCCCC
Q 010626          159 VTDNP  163 (505)
Q Consensus       159 ~~~~~  163 (505)
                      +....
T Consensus       274 q~~D~  278 (864)
T KOG4717|consen  274 QAGDR  278 (864)
T ss_pred             cCCCC
Confidence            97554

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.92  E-value=2.7e-24  Score=216.87  Aligned_cols=155  Identities=31%  Similarity=0.536  Sum_probs=125.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc----cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll----~~   77 (505)
                      ..+..++.||+.||.|||+.|  ++||||+|+||+++ .++.+||+|||++......  ....+++.|+|||++    .+
T Consensus       115 ~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~-~~~~~kL~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~  189 (307)
T cd06607         115 VEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLT-EPGTVKLADFGSASLVSPA--NSFVGTPYWMAPEVILAMDEG  189 (307)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEC-CCCCEEEeecCcceecCCC--CCccCCccccCceeeeccCCC
Confidence            356789999999999999999  99999999999997 6789999999998655332  345688899999976    24


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      .++.++||||||+++|+|+||+.||.... .......+.....+......++..++++|.+||. +|.+||++.+++.||
T Consensus       190 ~~~~~sDv~s~G~il~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         190 QYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             CCCcccchHHHHHHHHHHHcCCCCCCCcc-HHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            58899999999999999999999997643 3333333333333333334467889999999996 799999999999999


Q ss_pred             CCCCCC
Q 010626          157 FLVTDN  162 (505)
Q Consensus       157 ff~~~~  162 (505)
                      ||....
T Consensus       269 ~~~~~~  274 (307)
T cd06607         269 FVLRER  274 (307)
T ss_pred             hhcccC
Confidence            997643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.92  E-value=1.4e-24  Score=215.35  Aligned_cols=160  Identities=29%  Similarity=0.500  Sum_probs=127.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..+..++.|++.||.|||++|  ++||||+|+||+++ .++.+||+|||++...... ......++..|+|||.+ .+.+
T Consensus        95 ~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  171 (277)
T cd05577          95 ARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVY  171 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEC-CCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCC
Confidence            356788999999999999999  99999999999997 6789999999998765432 22334678899999987 4458


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCC---hHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PAL  150 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~---~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~  150 (505)
                      +.++|+||||+++|+|++|+.||.....   ...+...+..  .+...+...++.+.++|.+||. +|.+||     ++.
T Consensus       172 ~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  249 (277)
T cd05577         172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSAD  249 (277)
T ss_pred             CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHH
Confidence            8999999999999999999999976432   2222222221  2334555678999999999995 799999     899


Q ss_pred             HHhcCCCCCCCCCCCc
Q 010626          151 ELLKDPFLVTDNPKDL  166 (505)
Q Consensus       151 ElL~hpff~~~~~~~l  166 (505)
                      +++.||||...++...
T Consensus       250 ~ll~h~~~~~~~~~~~  265 (277)
T cd05577         250 EVREHPLFKDLNWRRL  265 (277)
T ss_pred             HHHhChhhhcCChhhh
Confidence            9999999988776554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.92  E-value=1.6e-24  Score=211.25  Aligned_cols=156  Identities=35%  Similarity=0.653  Sum_probs=129.3

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc--cccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~--~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..++.||+.||.|||+ .+  ++||||+|+||+++ .++.++|+|||++.........  ...++..|+|||.+ ..
T Consensus        99 ~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~  175 (264)
T cd06623          99 PVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLIN-SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE  175 (264)
T ss_pred             HHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEEC-CCCCEEEccCccceecccCCCcccceeecccccCHhhhCCC
Confidence            3577899999999999999 99  99999999999997 6789999999999776543322  45688899999987 44


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCC--ChHHHHHHHHcCCCCCCCCCC-CChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPASLSKV-TDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~--~~~~i~~~i~~~~~p~~~~~~-~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      .++.++|+||||+++|+|+||+.||....  ...+....+.....+. .+.. ++..+.++|.+||. +|.+||++.+++
T Consensus       176 ~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll  254 (264)
T cd06623         176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS-LPAEEFSPEFRDFISACLQKDPKKRPSAAELL  254 (264)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC-CCcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence            58889999999999999999999997754  4555555555443333 3444 78899999999996 799999999999


Q ss_pred             cCCCCCCC
Q 010626          154 KDPFLVTD  161 (505)
Q Consensus       154 ~hpff~~~  161 (505)
                      .||||+..
T Consensus       255 ~~~~~~~~  262 (264)
T cd06623         255 QHPFIKKA  262 (264)
T ss_pred             hCHHHHhc
Confidence            99999754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.92  E-value=2e-24  Score=216.52  Aligned_cols=157  Identities=28%  Similarity=0.577  Sum_probs=124.5

Q ss_pred             HHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccccc---
Q 010626            3 AIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEE---   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~~---   77 (505)
                      .+..++.||+.||+|||+ +|  ++||||+|+||+++ .++.+||+|||++..+.... .....+++.|+|||.+.+   
T Consensus       115 ~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  191 (296)
T cd06618         115 ILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDP  191 (296)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEc-CCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCC
Confidence            467899999999999997 58  99999999999997 77899999999987654322 223357889999998843   


Q ss_pred             --cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC-CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           78 --EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        78 --~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                        .++.++||||||+++|+|++|+.||.......+....+.....+. .....++..+.+||.+||. +|.+||++.+++
T Consensus       192 ~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il  271 (296)
T cd06618         192 NPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELL  271 (296)
T ss_pred             ccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence              378899999999999999999999976444344444444433222 1223467899999999996 899999999999


Q ss_pred             cCCCCCCCC
Q 010626          154 KDPFLVTDN  162 (505)
Q Consensus       154 ~hpff~~~~  162 (505)
                      .||||....
T Consensus       272 ~~~~~~~~~  280 (296)
T cd06618         272 QHPFIRRYE  280 (296)
T ss_pred             cChhhhccc
Confidence            999998644

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.92  E-value=1.7e-24  Score=218.01  Aligned_cols=156  Identities=35%  Similarity=0.639  Sum_probs=125.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++......  ......|++.|+|||++. ..
T Consensus       117 ~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  193 (297)
T cd06659         117 EQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP  193 (297)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEc-cCCcEEEeechhHhhcccccccccceecCccccCHHHHccCC
Confidence            357889999999999999999  99999999999997 7789999999998654332  223456899999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      ++.++|||||||++|+|++|+.||.... .......+.....+ .......+..+.++|.+||. +|.+||++.++++||
T Consensus       194 ~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~  272 (297)
T cd06659         194 YGTEVDIWSLGIMVIEMVDGEPPYFSDS-PVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHP  272 (297)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence            8899999999999999999999997643 33444444333221 22233467889999999996 899999999999999


Q ss_pred             CCCCC
Q 010626          157 FLVTD  161 (505)
Q Consensus       157 ff~~~  161 (505)
                      ||...
T Consensus       273 ~~~~~  277 (297)
T cd06659         273 FLLQT  277 (297)
T ss_pred             hhccC
Confidence            99764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.91  E-value=2.6e-24  Score=206.57  Aligned_cols=152  Identities=35%  Similarity=0.629  Sum_probs=121.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCccccc-ccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~-~~y   79 (505)
                      ..+..++.|++.||.|||.+|  ++||||+|+||+++ .++.++|+|||.+....... .....++..|+|||.+. ..+
T Consensus        98 ~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~  174 (253)
T cd05122          98 SQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY  174 (253)
T ss_pred             HHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEc-cCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCC
Confidence            357789999999999999999  99999999999998 67899999999997665443 34557889999999874 457


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC-CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~-~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      +.++|+||||+++|+|++|+.||.............. ...+.. ....++..+.++|.+||. +|.+|||+.++|+|||
T Consensus       175 ~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            8899999999999999999999976533333333222 222221 222237899999999996 8999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.91  E-value=1.5e-24  Score=218.16  Aligned_cols=146  Identities=25%  Similarity=0.316  Sum_probs=115.6

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC---------CCccccCCCcccCcc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMAPE   73 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~---------~~~~~~Gt~~Y~APE   73 (505)
                      .++.++.||+.||+|||+++  ++||||||+||+++ .++.++|+|||+++.+...         ......||+.|+|||
T Consensus       127 ~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~-~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape  203 (294)
T PHA02882        127 LIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVD-GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLD  203 (294)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHH
Confidence            46789999999999999999  99999999999997 6789999999999765321         122346999999999


Q ss_pred             cc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHH--------HHHHcCCCCCCCCCCCChHHHHHHHHhcC-CC
Q 010626           74 LY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY--------KKVTSGIKPASLSKVTDPQVKQFIEKCIV-PA  143 (505)
Q Consensus        74 ll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~--------~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP  143 (505)
                      ++ ...++.++|||||||++|+|++|+.||..........        ..+..+.   ......++.+.+++..|+. +|
T Consensus       204 ~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  280 (294)
T PHA02882        204 AHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGK---IKIKNANKFIYDFIECVTKLSY  280 (294)
T ss_pred             HhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhh---hccCCCCHHHHHHHHHHHhCCC
Confidence            87 4568999999999999999999999998653322221        2222221   1223457889999999995 89


Q ss_pred             CCCCCHHHHhc
Q 010626          144 SLRLPALELLK  154 (505)
Q Consensus       144 ~~RpSa~ElL~  154 (505)
                      .+||++.++++
T Consensus       281 ~~rp~~~~l~~  291 (294)
T PHA02882        281 EEKPDYDALIK  291 (294)
T ss_pred             CCCCCHHHHHH
Confidence            99999999875

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.91  E-value=1.6e-25  Score=235.98  Aligned_cols=149  Identities=34%  Similarity=0.546  Sum_probs=124.5

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc-ccCC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEYN   80 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~-~~ys   80 (505)
                      .+..|..+|+.|++|||.+.  |||||||.-||||. .+..|||+|||.++..... ..-++.||..|||||+++ ...+
T Consensus       213 llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs-~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcs  289 (904)
T KOG4721|consen  213 LLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILIS-YDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCS  289 (904)
T ss_pred             HHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEee-ccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcc
Confidence            56789999999999999999  99999999999997 6679999999999776543 445789999999999995 4589


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      +|+|||||||+||||+||+.||.+-...+.+ .-+-.+......+..++..++-||++||. +|..||++.++|.|
T Consensus       290 EKVDIwSfGVVLWEmLT~EiPYkdVdssAII-wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  290 EKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             cccceehhHHHHHHHHhcCCCccccchheeE-EeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            9999999999999999999999764333222 22223334445677788999999999995 89999999999988

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.91  E-value=2.9e-24  Score=208.66  Aligned_cols=153  Identities=39%  Similarity=0.659  Sum_probs=124.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCccccc-cc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EE-   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~-~~-   78 (505)
                      ..+..++.||+.||+|||+.|  ++|+||+|+||+++ .++.+||+|||++....... .....|++.|+|||.+. .. 
T Consensus       102 ~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~  178 (258)
T cd06632         102 PVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVD-TNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGG  178 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCC
Confidence            356788999999999999999  99999999999997 67899999999987654433 34456889999999773 33 


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++|+||||+++|+|++|+.||.......... .+........++...++.+.+|+.+||. +|.+||++.+++.|||
T Consensus       179 ~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  257 (258)
T cd06632         179 YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF-KIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF  257 (258)
T ss_pred             CCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH-HHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence            8899999999999999999999997755333333 3333223334556678999999999996 8999999999999999


Q ss_pred             C
Q 010626          158 L  158 (505)
Q Consensus       158 f  158 (505)
                      +
T Consensus       258 ~  258 (258)
T cd06632         258 V  258 (258)
T ss_pred             C
Confidence            6

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=7.1e-25  Score=211.78  Aligned_cols=152  Identities=24%  Similarity=0.492  Sum_probs=135.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccCCc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYNE   81 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~ys~   81 (505)
                      ....|++|++.||.|||..+  +|||||||+|+|+. ..|.+||+|||.+.......+.+.+||.-|.|||+.+ ..++.
T Consensus       125 ~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg-~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~  201 (281)
T KOG0580|consen  125 RAATYIKQLANALLYCHLKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDK  201 (281)
T ss_pred             chhHHHHHHHHHHHHhccCC--cccCCCCHHHhccC-CCCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccc
Confidence            35689999999999999999  99999999999996 7789999999999887777788899999999999985 46899


Q ss_pred             ccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626           82 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus        82 ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      .+|+|++|++.||++.|..||... .....|++|.....  .++...+..++++|.+||. +|.+|++..|++.|||+..
T Consensus       202 ~Vd~w~lgvl~yeflvg~ppFes~-~~~etYkrI~k~~~--~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  202 FVDLWSLGVLCYEFLVGLPPFESQ-SHSETYKRIRKVDL--KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             hhhHHHHHHHHHHHHhcCCchhhh-hhHHHHHHHHHccc--cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            999999999999999999999764 47788888876532  3457778999999999996 7999999999999999864

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.91  E-value=3.8e-24  Score=208.93  Aligned_cols=153  Identities=39%  Similarity=0.707  Sum_probs=123.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC------ccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------RSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~------~~~~Gt~~Y~APEll   75 (505)
                      +.++.++.||+.||.|||++|  ++|+||+|+||+++ .++.+||+|||++........      ....+++.|+|||++
T Consensus        99 ~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~  175 (264)
T cd06626          99 HVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI  175 (264)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhc
Confidence            457789999999999999999  99999999999998 678999999999876643221      124578899999988


Q ss_pred             cc-c---CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCC--CChHHHHHHHHhcC-CCCCCCC
Q 010626           76 EE-E---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV--TDPQVKQFIEKCIV-PASLRLP  148 (505)
Q Consensus        76 ~~-~---ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~--~s~~l~~LI~kcL~-dP~~RpS  148 (505)
                      .. .   ++.++||||||+++|+|++|+.||....+.......+..+. +..++..  .++.+.+||.+||+ +|.+||+
T Consensus       176 ~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  254 (264)
T cd06626         176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-KPPIPDSLQLSPEGKDFLDRCLESDPKKRPT  254 (264)
T ss_pred             cCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCC-CCCCCcccccCHHHHHHHHHHccCCcccCCC
Confidence            43 3   78899999999999999999999976544444444444432 2233333  38899999999996 7999999


Q ss_pred             HHHHhcCCCC
Q 010626          149 ALELLKDPFL  158 (505)
Q Consensus       149 a~ElL~hpff  158 (505)
                      +.+++.|||+
T Consensus       255 ~~~i~~~~~~  264 (264)
T cd06626         255 ASELLQHPFV  264 (264)
T ss_pred             HHHHhcCCCC
Confidence            9999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=3e-24  Score=214.23  Aligned_cols=159  Identities=28%  Similarity=0.533  Sum_probs=125.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      ..+..++.||+.||.|||+.|  ++|+||+|+||+++ .++.++|+|||++............++..|+|||.+ ...++
T Consensus       105 ~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~  181 (287)
T cd06621         105 KVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYS  181 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEe-cCCeEEEeeccccccccccccccccCCccccCHHHhcCCCCC
Confidence            356789999999999999999  99999999999998 678899999999876544444445678899999987 45689


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCC----CChHHHHHHHHcCCCCCC---CC--CCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNEC----KNPAQIYKKVTSGIKPAS---LS--KVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~----~~~~~i~~~i~~~~~p~~---~~--~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                      .++||||||+++|+|++|..||...    .........+.....+..   ..  ...++.+.+||.+||. +|.+|||+.
T Consensus       182 ~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~  261 (287)
T cd06621         182 ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPW  261 (287)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHH
Confidence            9999999999999999999999764    223334444433222111   11  2245789999999996 899999999


Q ss_pred             HHhcCCCCCCCCC
Q 010626          151 ELLKDPFLVTDNP  163 (505)
Q Consensus       151 ElL~hpff~~~~~  163 (505)
                      |+++||||+....
T Consensus       262 eil~~~~~~~~~~  274 (287)
T cd06621         262 DMLEHPWIKAQMK  274 (287)
T ss_pred             HHHhCcccccccc
Confidence            9999999976443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.91  E-value=2.7e-24  Score=214.52  Aligned_cols=154  Identities=26%  Similarity=0.470  Sum_probs=118.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~~--   77 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++......  ......+++.|+|||.+.+  
T Consensus       103 ~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  179 (291)
T cd07870         103 YNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLIS-YLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT  179 (291)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEc-CCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCC
Confidence            357789999999999999999  99999999999997 7789999999998654322  1233457899999998743  


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC--CC-----------------------CCCC-----CCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IK-----------------------PASL-----SKV  127 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~--~~-----------------------p~~~-----~~~  127 (505)
                      .++.++||||||+++|+|++|..||............+...  .+                       +...     ...
T Consensus       180 ~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (291)
T cd07870         180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLS  259 (291)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccC
Confidence            47889999999999999999999997654433322222110  00                       0000     001


Q ss_pred             CChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          128 TDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       128 ~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      .++.+.+|+.+||. +|.+|||+.+++.||||
T Consensus       260 ~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         260 RPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             CChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            25688999999996 89999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.91  E-value=2.9e-24  Score=212.86  Aligned_cols=148  Identities=24%  Similarity=0.344  Sum_probs=122.5

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......    .....+++.|+|||.+ ..
T Consensus       125 ~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  201 (283)
T cd05048         125 DFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVG-EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG  201 (283)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--eeccccccceEEEc-CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC
Confidence            56789999999999999999  99999999999997 67899999999997653221    2233567889999977 56


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++|||||||++|||++ |..||.+ .....+...+..+..+ ..+..+++.+.+|+.+||. +|.+||++.+++++
T Consensus       202 ~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         202 KFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIEMIRSRQLL-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             cCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCcC-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            78999999999999999998 9999976 3455666666655443 3456678999999999996 79999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.91  E-value=3.4e-24  Score=213.97  Aligned_cols=153  Identities=27%  Similarity=0.426  Sum_probs=120.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~~--   77 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++......  ......+++.|+|||.+.+  
T Consensus       106 ~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  182 (293)
T cd07843         106 SEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAK  182 (293)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCcEEEeecCceeeccCCccccccccccccccCchhhcCCc
Confidence            467889999999999999999  99999999999998 6789999999999766543  2233467889999998743  


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC-----------------------------CCCCCCC-
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-----------------------------PASLSKV-  127 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~-----------------------------p~~~~~~-  127 (505)
                      .++.++|+||||+++|+|++|..||......... .++.....                             ...++.. 
T Consensus       183 ~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (293)
T cd07843         183 EYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL-NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALS  261 (293)
T ss_pred             cccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccC
Confidence            3688999999999999999999999764433222 22211000                             0112222 


Q ss_pred             CChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          128 TDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       128 ~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      .++.+.+||.+||+ +|.+|||+.|+|.||||
T Consensus       262 ~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         262 LSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             CChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            47789999999996 89999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.7e-24  Score=210.53  Aligned_cols=153  Identities=34%  Similarity=0.592  Sum_probs=126.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----CCccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----~~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.++|+|||++......     ......+++.|+|||++.
T Consensus       106 ~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (264)
T cd06653         106 NVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS  182 (264)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECccccccccccccccCccccccCCcccccCHhhhc
Confidence            357789999999999999999  99999999999997 6789999999999765321     122346889999999884


Q ss_pred             -ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcCCCCCCCCHHHHhcC
Q 010626           77 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD  155 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~dP~~RpSa~ElL~h  155 (505)
                       ..++.++|+|||||++|+|++|+.||........+. .+.....+..++...++.+.++|.+||++|..||++.+++.|
T Consensus       183 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~~i~~~l~~~~~r~~~~~~~~~  261 (264)
T cd06653         183 GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF-KIATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPTAEFLLRH  261 (264)
T ss_pred             CCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH-HHHcCCCCCCCCcccCHHHHHHHHHHhcCcccCccHHHHhcC
Confidence             458899999999999999999999998754444443 333333344567778899999999999989999999999999


Q ss_pred             CCC
Q 010626          156 PFL  158 (505)
Q Consensus       156 pff  158 (505)
                      ||.
T Consensus       262 ~~~  264 (264)
T cd06653         262 PFV  264 (264)
T ss_pred             CCC
Confidence            984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.91  E-value=2.5e-24  Score=237.05  Aligned_cols=157  Identities=27%  Similarity=0.399  Sum_probs=115.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC---CCccccCCCcccCccccc-c-
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYE-E-   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~---~~~~~~Gt~~Y~APEll~-~-   77 (505)
                      .++.++.||+.||.|||+++  |+||||||+|||++..++.+||+|||+++.+...   ......+++.|+|||.+. . 
T Consensus       256 ~i~~i~~qll~aL~yLH~~g--IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~  333 (566)
T PLN03225        256 IIQTIMRQILFALDGLHSTG--IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST  333 (566)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccC
Confidence            46789999999999999999  9999999999999855689999999999765332   234567899999999651 1 


Q ss_pred             ---------------------cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC----------CC---CC
Q 010626           78 ---------------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------KP---AS  123 (505)
Q Consensus        78 ---------------------~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~----------~p---~~  123 (505)
                                           .++.++|||||||++|||+++..|+..  ...+....+....          .+   ..
T Consensus       334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  411 (566)
T PLN03225        334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPD  411 (566)
T ss_pred             CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchh
Confidence                                 234567999999999999998776542  2222222221110          00   00


Q ss_pred             ------CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          124 ------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       124 ------~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                            .....+...++||.+||. +|.+|||+.++|+||||.....
T Consensus       412 ~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             hhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence                  011123345689999996 8999999999999999987554

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.91  E-value=2.1e-24  Score=217.53  Aligned_cols=157  Identities=25%  Similarity=0.482  Sum_probs=120.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---------CccccCCCcccCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---------ARSVIGTPEFMAP   72 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---------~~~~~Gt~~Y~AP   72 (505)
                      ..++.+++||+.||+|||+++  |+||||||+||+++ .++.+||+|||.+.......         .....++..|+||
T Consensus       101 ~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  177 (314)
T cd08216         101 LAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLS-GDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP  177 (314)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEe-cCCceEEecCccceeeccccccccccccccccccccccccCH
Confidence            356789999999999999999  99999999999998 67899999999886542211         1223567789999


Q ss_pred             ccccc---cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC----------------------------
Q 010626           73 ELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----------------------------  121 (505)
Q Consensus        73 Ell~~---~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p----------------------------  121 (505)
                      |++..   .|+.++|+|||||++|+|++|..||...........++......                            
T Consensus       178 E~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (314)
T cd08216         178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRD  257 (314)
T ss_pred             HHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhh
Confidence            98843   48899999999999999999999998754444433333211100                            


Q ss_pred             ---CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          122 ---ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       122 ---~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                         .......+..+.+|+.+||. +|.+|||+.++|+||||+..
T Consensus       258 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         258 SVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             hhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence               00111224578899999996 89999999999999999864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.91  E-value=2.2e-24  Score=220.70  Aligned_cols=157  Identities=31%  Similarity=0.471  Sum_probs=120.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++.......     .....|++.|+|||.+.
T Consensus       106 ~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  182 (336)
T cd07849         106 DHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML  182 (336)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEC-CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhh
Confidence            357889999999999999999  99999999999997 77899999999987653321     12346889999999763


Q ss_pred             --ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHH--------------HcCC-------CC--C--C---CCC
Q 010626           77 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV--------------TSGI-------KP--A--S---LSK  126 (505)
Q Consensus        77 --~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i--------------~~~~-------~p--~--~---~~~  126 (505)
                        ..++.++||||||+++|+|++|+.||.+...........              ....       .+  .  .   ...
T Consensus       183 ~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (336)
T cd07849         183 NSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFP  262 (336)
T ss_pred             CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhc
Confidence              458899999999999999999999997643222111110              0000       00  0  0   112


Q ss_pred             CCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          127 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       127 ~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      ..++.+.+||.+||. +|.+|||+.++++||||...
T Consensus       263 ~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         263 NADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             ccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            346789999999996 79999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.91  E-value=4.1e-24  Score=208.41  Aligned_cols=152  Identities=30%  Similarity=0.569  Sum_probs=125.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      .++..|+.|++.||.|||+++  ++|+||+|+||+++ .++.++|+|||++.......  .....|++.|+|||.+ ...
T Consensus       101 ~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~  177 (256)
T cd08218         101 DQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP  177 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCC
Confidence            356789999999999999999  99999999999997 67899999999997664332  2234688899999987 455


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++|+||||+++|+|++|..||... +.......+..+..+ ..+...+..+.++|.+||. +|.+||++.++++|||
T Consensus       178 ~~~~~Dv~slG~i~~~l~~g~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~  255 (256)
T cd08218         178 YNNKSDIWALGCVLYEMCTLKHAFEAG-NMKNLVLKIIRGSYP-PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF  255 (256)
T ss_pred             CCCccchhHHHHHHHHHHcCCCCccCC-CHHHHHHHHhcCCCC-CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence            788999999999999999999999764 444555555555433 2445678899999999995 7999999999999999


Q ss_pred             C
Q 010626          158 L  158 (505)
Q Consensus       158 f  158 (505)
                      |
T Consensus       256 ~  256 (256)
T cd08218         256 I  256 (256)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.91  E-value=3.3e-24  Score=214.66  Aligned_cols=153  Identities=29%  Similarity=0.447  Sum_probs=117.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-------------CccccCCCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-------------ARSVIGTPE   68 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-------------~~~~~Gt~~   68 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++.......             .....+++.
T Consensus       115 ~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (311)
T cd07866         115 SQIKCYMLQLLEGINYLHENH--ILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRW  191 (311)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEECcCccchhccCCCcccccCCcccccccccceeccC
Confidence            467889999999999999999  99999999999997 77899999999997553221             122356888


Q ss_pred             ccCccccc--ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC---CCCCC------------------C-
Q 010626           69 FMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPAS------------------L-  124 (505)
Q Consensus        69 Y~APEll~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~---~~p~~------------------~-  124 (505)
                      |+|||.+.  ..++.++||||||+++|+|++|+.||.+...... ...+...   ..+..                  . 
T Consensus       192 y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (311)
T cd07866         192 YRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP  270 (311)
T ss_pred             cCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhchhhhhcccccccccCCCCC
Confidence            99999773  3478999999999999999999999976443322 2222110   00000                  0 


Q ss_pred             ------CCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          125 ------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       125 ------~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                            .....+.+.+||.+||. +|.+|||+.+++.||||
T Consensus       271 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         271 RTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             ccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence                  01234678899999996 89999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.91  E-value=3.5e-24  Score=214.31  Aligned_cols=153  Identities=27%  Similarity=0.450  Sum_probs=117.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~~Y~APEll   75 (505)
                      .+++.++.||+.||+|||++|  ++|+||||+||+++ .++.+||+|||++.......      .....+++.|+|||.+
T Consensus       119 ~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  195 (310)
T cd07865         119 SEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILIT-KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELL  195 (310)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHh
Confidence            468899999999999999999  99999999999997 77899999999997653321      1234578899999977


Q ss_pred             cc--cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc---CCCCCC---------------------------
Q 010626           76 EE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKPAS---------------------------  123 (505)
Q Consensus        76 ~~--~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~---~~~p~~---------------------------  123 (505)
                      .+  .++.++||||||+++|+|++|..||..... ......+..   ...+..                           
T Consensus       196 ~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  274 (310)
T cd07865         196 LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERL  274 (310)
T ss_pred             cCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhc
Confidence            43  378899999999999999999999976432 222111111   111000                           


Q ss_pred             CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          124 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       124 ~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      .....++.+.+||.+||. +|.+||++.++|+||||
T Consensus       275 ~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         275 KPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            011235678899999996 89999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.91  E-value=4.1e-24  Score=215.38  Aligned_cols=160  Identities=25%  Similarity=0.455  Sum_probs=126.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----------------CCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----------------TARSVI   64 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----------------~~~~~~   64 (505)
                      ..+..++.|++.||.|||++|  ++||||||+||+++ .++.+||+|||+++.....                 ......
T Consensus       101 ~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (305)
T cd05609         101 DMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC  177 (305)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEEC-CCCCEEEeeCCCccccCcCccccccccccccchhhccccCCc
Confidence            356788999999999999999  99999999999997 7789999999988632100                 011235


Q ss_pred             CCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCChHHHHHHHHhcC-
Q 010626           65 GTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-  141 (505)
Q Consensus        65 Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~~LI~kcL~-  141 (505)
                      +++.|+|||.+ ...++.++|+||||+++|+|++|..||.+. ...++...+..+..+ +......++.+++||.+||. 
T Consensus       178 ~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  256 (305)
T cd05609         178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD-TPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQ  256 (305)
T ss_pred             cCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhcc
Confidence            78899999977 556899999999999999999999999764 445555555544222 22223568899999999996 


Q ss_pred             CCCCCCC---HHHHhcCCCCCCCCCCC
Q 010626          142 PASLRLP---ALELLKDPFLVTDNPKD  165 (505)
Q Consensus       142 dP~~RpS---a~ElL~hpff~~~~~~~  165 (505)
                      +|.+||+   +.++|.||||....+..
T Consensus       257 ~P~~R~~~~~~~~ll~~~~~~~~~~~~  283 (305)
T cd05609         257 NPLERLGTGGAFEVKQHRFFLGLDWNG  283 (305)
T ss_pred             ChhhccCccCHHHHHhCccccCCCHHH
Confidence            7999998   79999999998766544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.91  E-value=2.5e-24  Score=216.24  Aligned_cols=154  Identities=34%  Similarity=0.523  Sum_probs=117.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC----CCcEEEeecCceeeccCCC-----CccccCCCcccCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN----NGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAP   72 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~----~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~AP   72 (505)
                      ..++.++.||+.||+|||+++  ++||||||+||+++ .    ++.+||+|||++.......     .....+++.|+||
T Consensus       108 ~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~-~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  184 (316)
T cd07842         108 SMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVM-GEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAP  184 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEc-CCCCccceEEECCCccccccCCCcccccccCCccccccccCH
Confidence            367889999999999999999  99999999999997 5    7899999999987654322     2234678899999


Q ss_pred             cccc--ccCCcccchhhHHHHHHHHhhcCCCCCCCCChH--------HHHHHHHc------------------------C
Q 010626           73 ELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------QIYKKVTS------------------------G  118 (505)
Q Consensus        73 Ell~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~--------~i~~~i~~------------------------~  118 (505)
                      |++.  ..++.++||||||+++|+|++|+.||.......        .....+..                        .
T Consensus       185 E~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  264 (316)
T cd07842         185 ELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKD  264 (316)
T ss_pred             HHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhh
Confidence            9773  357899999999999999999999997533211        00000000                        0


Q ss_pred             CCCCCCC-----------CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          119 IKPASLS-----------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       119 ~~p~~~~-----------~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      ......+           ...+..+.++|.+||. +|.+|||+.|++.||||
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         265 FKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             ccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            0000011           1456789999999996 79999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.91  E-value=6.9e-24  Score=206.80  Aligned_cols=152  Identities=29%  Similarity=0.553  Sum_probs=126.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..+..++.|++.||.|||+.|  ++||||+|+||+++ .++.+||+|||++.......  .....+++.|+|||++. ..
T Consensus       101 ~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~-~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~  177 (256)
T cd08221         101 EMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK  177 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEe-CCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCC
Confidence            367889999999999999999  99999999999998 67899999999997664432  33457899999999874 45


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++|+||||+++|+|++|..||.. .+.......+..+..+. .+...+..+.++|.+||. +|.+||++.++|+|||
T Consensus       178 ~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         178 YNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP-VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             CCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence            78899999999999999999999976 44555555555544332 345668899999999996 7999999999999999


Q ss_pred             C
Q 010626          158 L  158 (505)
Q Consensus       158 f  158 (505)
                      +
T Consensus       256 l  256 (256)
T cd08221         256 L  256 (256)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.91  E-value=3.4e-24  Score=212.29  Aligned_cols=154  Identities=28%  Similarity=0.458  Sum_probs=119.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~--~   77 (505)
                      ..+..++.||+.||+|||+++  ++||||+|+||+++ .++.++|+|||++.......  .....+++.|+|||++.  .
T Consensus        99 ~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  175 (283)
T cd07835          99 PLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSR  175 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCcEEEeecccccccCCCccccCccccccCCCCCceeecCc
Confidence            357889999999999999999  99999999999998 58899999999986553221  12335688999999773  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC--------------------------CCCCCCCCChH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--------------------------PASLSKVTDPQ  131 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~--------------------------p~~~~~~~s~~  131 (505)
                      .++.++|+||||+++|+|++|+.||..................                          ........+..
T Consensus       176 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (283)
T cd07835         176 QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDED  255 (283)
T ss_pred             ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHH
Confidence            4788999999999999999999999764433333222211000                          00112345678


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +.++|.+||. +|.+||++.+++.||||
T Consensus       256 ~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         256 GLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            9999999996 79999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.91  E-value=5.3e-24  Score=205.79  Aligned_cols=152  Identities=32%  Similarity=0.612  Sum_probs=127.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..+..++.||+.||.|||++|  ++|+||+|+||+++ .++.++|+|||++.......  .....|++.|+|||.+ ...
T Consensus       103 ~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~  179 (258)
T cd08215         103 EQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP  179 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEc-CCCcEEECCccceeecccCcceecceeeeecccChhHhccCC
Confidence            367889999999999999999  99999999999998 67899999999997664432  3345688999999977 455


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++|+||+|+++|+|++|..||... +...+...+.... ...++...+..+.+++.+||. +|.+||++.++|+|||
T Consensus       180 ~~~~~Dv~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  257 (258)
T cd08215         180 YNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELALKILKGQ-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF  257 (258)
T ss_pred             CCccccHHHHHHHHHHHHcCCCCCCCC-cHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence            889999999999999999999999764 3455555554443 334555778999999999996 8999999999999999


Q ss_pred             C
Q 010626          158 L  158 (505)
Q Consensus       158 f  158 (505)
                      |
T Consensus       258 ~  258 (258)
T cd08215         258 I  258 (258)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.91  E-value=4.7e-24  Score=211.18  Aligned_cols=154  Identities=28%  Similarity=0.516  Sum_probs=121.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      +.++.++.||+.||.|||+++  ++||||+|+||+++ .++.+||+|||++.......   .....+++.|+|||++ ..
T Consensus       100 ~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~  176 (288)
T cd07833         100 DAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGD  176 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCC
Confidence            467889999999999999999  99999999999998 68899999999987664432   2345678899999987 34


Q ss_pred             -cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc--CCC-------------------C--------CCCCCC
Q 010626           78 -EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIK-------------------P--------ASLSKV  127 (505)
Q Consensus        78 -~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~--~~~-------------------p--------~~~~~~  127 (505)
                       .++.++|+||||+++|+|++|+.||...............  ...                   +        ..++..
T Consensus       177 ~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (288)
T cd07833         177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGK  256 (288)
T ss_pred             CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCc
Confidence             5789999999999999999999999765444333221110  000                   0        012233


Q ss_pred             CChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          128 TDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       128 ~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      .++++++||.+||. +|.+||++.++++||||
T Consensus       257 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         257 VSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            47889999999996 89999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.91  E-value=4.1e-24  Score=213.46  Aligned_cols=158  Identities=28%  Similarity=0.428  Sum_probs=122.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE--   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~~--   77 (505)
                      ..++.++.||+.||+|||+++  ++||||+|+||+++..++.+||+|||++.......  .....+++.|+|||.+.+  
T Consensus       102 ~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  179 (294)
T PLN00009        102 RLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR  179 (294)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCC
Confidence            356789999999999999999  99999999999998556689999999996543221  233467889999998743  


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-----------------------C---CCCCCCChH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-----------------------A---SLSKVTDPQ  131 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-----------------------~---~~~~~~s~~  131 (505)
                      .++.++||||||+++|+|+||..||........+.+.+.....+                       .   ......++.
T Consensus       180 ~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (294)
T PLN00009        180 HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPA  259 (294)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChH
Confidence            47889999999999999999999997644444333322110000                       0   011235778


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      +.++|.+||. +|.+||++.+++.||||...
T Consensus       260 ~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        260 GVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence            9999999996 79999999999999999764

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.91  E-value=4.9e-24  Score=210.22  Aligned_cols=154  Identities=30%  Similarity=0.489  Sum_probs=121.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc-c-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-E-   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~-~-   77 (505)
                      ..+..++.||+.||.|||+++  ++|+||||+||+++ .++.++|+|||.+.......  .....++..|+|||.+. . 
T Consensus        98 ~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~  174 (283)
T cd05118          98 SLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDK  174 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEEC-CCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCC
Confidence            467889999999999999999  99999999999998 67899999999997765432  22345788999999873 3 


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC---------------------------CCCCCCCCh
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---------------------------ASLSKVTDP  130 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p---------------------------~~~~~~~s~  130 (505)
                      .++.++|+||||+++|+|+||+.||.......+..........+                           .......+.
T Consensus       175 ~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (283)
T cd05118         175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASP  254 (283)
T ss_pred             CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCH
Confidence            58899999999999999999999997655444333322211110                           001123567


Q ss_pred             HHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      .+.+||.+||. +|.+||++.+++.||||
T Consensus       255 ~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         255 QALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             HHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            89999999996 89999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=4.6e-24  Score=212.38  Aligned_cols=157  Identities=25%  Similarity=0.502  Sum_probs=124.4

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..++.++.|++.||.|||+ ++  ++||||+|+||+++ .++.++|+|||++............|+..|+|||++ .+.+
T Consensus       103 ~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~-~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  179 (284)
T cd06620         103 EILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVN-SRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKY  179 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEEC-CCCcEEEccCCcccchhhhccCccccCcccCCHHHHccCCC
Confidence            4577899999999999997 57  99999999999997 778999999999876544444456789999999977 5568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCCh----------HHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNP----------AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP  148 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~----------~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS  148 (505)
                      +.++|+|||||++|+|+||..||......          ......+.....+.......+..+.+||.+||. +|.+||+
T Consensus       180 ~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt  259 (284)
T cd06620         180 TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPT  259 (284)
T ss_pred             CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcC
Confidence            89999999999999999999999753321          112223332222222222367889999999996 7999999


Q ss_pred             HHHHhcCCCCCCC
Q 010626          149 ALELLKDPFLVTD  161 (505)
Q Consensus       149 a~ElL~hpff~~~  161 (505)
                      +.|+++|+||...
T Consensus       260 ~~e~~~~~~~~~~  272 (284)
T cd06620         260 PQQLCAMPPFIQA  272 (284)
T ss_pred             HHHHhcCcccccc
Confidence            9999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.91  E-value=4e-24  Score=209.00  Aligned_cols=152  Identities=31%  Similarity=0.500  Sum_probs=125.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc-ccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~-~~y   79 (505)
                      +.+..|+.||+.||.|||++|  ++|+||+|+||+++ .++.++|+|||++...... ......|+..|+|||.+. ..+
T Consensus       100 ~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  176 (258)
T cd05578         100 EQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY  176 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEc-CCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCC
Confidence            467889999999999999999  99999999999998 6789999999998765443 223456888999999874 457


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCC--hHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH--HHHhc
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA--LELLK  154 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~--~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa--~ElL~  154 (505)
                      +.++|+||||+++|+|++|..||.....  ..........  .....+...+..+.++|.+||. +|.+||++  .++++
T Consensus       177 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         177 SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            8999999999999999999999986543  3333333332  2334555678999999999995 89999999  99999


Q ss_pred             CCCC
Q 010626          155 DPFL  158 (505)
Q Consensus       155 hpff  158 (505)
                      ||||
T Consensus       255 ~~~~  258 (258)
T cd05578         255 HPYF  258 (258)
T ss_pred             CCCC
Confidence            9998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.91  E-value=5.1e-24  Score=216.50  Aligned_cols=157  Identities=34%  Similarity=0.486  Sum_probs=123.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++ .++.++|+|||++.......     .....+++.|+|||.+.
T Consensus       103 ~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  179 (330)
T cd07834         103 DHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLL  179 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccCceEeecccccccccccccccccCcCCceeee
Confidence            356789999999999999999  99999999999998 66899999999998765442     33446889999999883


Q ss_pred             -c-cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC-CC----------------------------CCC
Q 010626           77 -E-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PA----------------------------SLS  125 (505)
Q Consensus        77 -~-~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~-p~----------------------------~~~  125 (505)
                       . .++.++|+||||+++|+|++|..||.... ....+..+..... +.                            ...
T Consensus       180 ~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (330)
T cd07834         180 SSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD-YIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLF  258 (330)
T ss_pred             cccCCCcchhHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhc
Confidence             3 58899999999999999999999997643 3333333322110 00                            011


Q ss_pred             CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          126 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       126 ~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      ...++.+.+||.+||. +|.+||++.+++.||||+...
T Consensus       259 ~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         259 PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            2246789999999996 899999999999999998643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=4.1e-24  Score=211.10  Aligned_cols=155  Identities=34%  Similarity=0.601  Sum_probs=124.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE--   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~~--   77 (505)
                      ..+..++.||+.||.|||+.|  ++||||+|+||+++ .++.++|+|||++.......  .....|++.|+|||.+..  
T Consensus       101 ~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  177 (277)
T cd06917         101 KYISVIIREVLVALKYIHKVG--VIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK  177 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEc-CCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCC
Confidence            457889999999999999999  99999999999998 67899999999997764432  233468899999998743  


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCC-CCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK-VTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~-~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++|+||||+++|+|++|..||.... .......+.... +..+.. ..+..+.+|+.+||. +|.+||++.+++.|
T Consensus       178 ~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         178 YYDTKADIWSLGITIYEMATGNPPYSDVD-AFRAMMLIPKSK-PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ccccchhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhccccCC-CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            47889999999999999999999997643 322222222222 223333 367899999999996 79999999999999


Q ss_pred             CCCCCC
Q 010626          156 PFLVTD  161 (505)
Q Consensus       156 pff~~~  161 (505)
                      +||+..
T Consensus       256 ~~~~~~  261 (277)
T cd06917         256 KWIKAH  261 (277)
T ss_pred             hHhhcc
Confidence            999763

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.91  E-value=2.8e-24  Score=215.89  Aligned_cols=158  Identities=33%  Similarity=0.577  Sum_probs=125.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..+..++.||+.||.|||++|  ++||||+|+||+++ .++.++|+|||++.......  .....|++.|+|||.+ .+.
T Consensus       115 ~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  191 (293)
T cd06647         115 GQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA  191 (293)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEc-CCCCEEEccCcceecccccccccccccCChhhcCchhhccCC
Confidence            356789999999999999999  99999999999997 67899999999986554322  2334688899999987 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++|+||||+++|++++|+.||...............+.+....+...+..++++|.+||. +|.+||++.+++.|+|
T Consensus       192 ~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~  271 (293)
T cd06647         192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF  271 (293)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence            889999999999999999999999764433333222222222222334457789999999996 7999999999999999


Q ss_pred             CCCCC
Q 010626          158 LVTDN  162 (505)
Q Consensus       158 f~~~~  162 (505)
                      |+...
T Consensus       272 ~~~~~  276 (293)
T cd06647         272 LKIAK  276 (293)
T ss_pred             HhcCc
Confidence            98654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.91  E-value=4.3e-24  Score=219.57  Aligned_cols=156  Identities=28%  Similarity=0.480  Sum_probs=120.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++..++.+||+|||++.......     .....++..|+|||.+.
T Consensus       114 ~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  191 (342)
T cd07854         114 EHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLL  191 (342)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHh
Confidence            467889999999999999999  99999999999997566789999999997653321     12235788999999763


Q ss_pred             --ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC-----------------------CCC-----CCCC
Q 010626           77 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-----------------------KPA-----SLSK  126 (505)
Q Consensus        77 --~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~-----------------------~p~-----~~~~  126 (505)
                        ..++.++|||||||++|+|++|+.||......... ..+....                       ...     ....
T Consensus       192 ~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (342)
T cd07854         192 SPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM-QLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLP  270 (342)
T ss_pred             CccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHcc
Confidence              45888999999999999999999999764332222 2211110                       000     0112


Q ss_pred             CCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          127 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       127 ~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      ..+.++.+||.+||. +|.+|||+.++|.||||+.
T Consensus       271 ~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         271 GVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             CCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence            457789999999996 7999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=1.7e-24  Score=200.53  Aligned_cols=145  Identities=27%  Similarity=0.377  Sum_probs=114.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      ++++.|+.||+.||.|||+++        ||+||+++ .++.+|+  ||++.......   ..||+.|+|||++ ...|+
T Consensus        17 ~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~-~~~~~~~--fG~~~~~~~~~---~~g~~~y~aPE~~~~~~~~   82 (176)
T smart00750       17 EEIWAVCLQCLRALRELHRQA--------KSGNILLT-WDGLLKL--DGSVAFKTPEQ---SRVDPYFMAPEVIQGQSYT   82 (176)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC--------CcccEeEc-Cccceee--ccceEeecccc---CCCcccccChHHhcCCCCc
Confidence            468899999999999999986        99999997 6788998  99997664432   2689999999988 55689


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC-----CCCCCCh--HHHHHHHHhcC-CCCCCCCHHHH
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-----LSKVTDP--QVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~-----~~~~~s~--~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                      .++|||||||++|||+||+.||............+.....+..     .....+.  .++++|.+||. +|.+||++.++
T Consensus        83 ~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~l  162 (176)
T smart00750       83 EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHY  162 (176)
T ss_pred             chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHH
Confidence            9999999999999999999999765444444444443322221     1111222  69999999995 89999999999


Q ss_pred             hcCCCCCC
Q 010626          153 LKDPFLVT  160 (505)
Q Consensus       153 L~hpff~~  160 (505)
                      ++|+|+..
T Consensus       163 l~~~~~~~  170 (176)
T smart00750      163 LAHCRALF  170 (176)
T ss_pred             HHHHHHHH
Confidence            99999753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.91  E-value=6.1e-24  Score=212.36  Aligned_cols=156  Identities=28%  Similarity=0.449  Sum_probs=120.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~--~   77 (505)
                      +.++.++.||+.||.|||++|  ++||||+|+||+++ .++.++|+|||++.......  .....+++.|+|||.+.  .
T Consensus       102 ~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  178 (298)
T cd07841         102 ADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGAR  178 (298)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEc-CCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCC
Confidence            467889999999999999999  99999999999998 67899999999997764432  22335678899999873  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC-CC-------------------------CCCCCCCChH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-KP-------------------------ASLSKVTDPQ  131 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~-~p-------------------------~~~~~~~s~~  131 (505)
                      .++.++|+|||||++|+|++|..||........ ..++.... .+                         .......+..
T Consensus       179 ~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (298)
T cd07841         179 HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ-LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDD  257 (298)
T ss_pred             CCCcHHHHHHHHHHHHHHHcCCccccCCccHHH-HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHH
Confidence            578999999999999999999777765443322 22222110 00                         0011234678


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      +.+||.+||. +|.+||++.++|.||||...
T Consensus       258 ~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~  288 (298)
T cd07841         258 ALDLLQRLLTLNPNKRITARQALEHPYFSND  288 (298)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence            9999999996 79999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.91  E-value=3.9e-24  Score=219.91  Aligned_cols=157  Identities=32%  Similarity=0.444  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccc--cC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~--~y   79 (505)
                      +.++.++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++..... ......+++.|+|||.+.+  .+
T Consensus       117 ~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~-~~~~~kL~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~  192 (342)
T cd07879         117 DKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVN-EDCELKILDFGLARHADA-EMTGYVVTRWYRAPEVILNWMHY  192 (342)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEeeCCCCcCCCC-CCCCceeeecccChhhhcCcccc
Confidence            467789999999999999999  99999999999998 678999999999865433 2234567889999998743  58


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC----------------------CC----CC---CCCCCCh
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------------------KP----AS---LSKVTDP  130 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~----------------------~p----~~---~~~~~s~  130 (505)
                      +.++|||||||++|+|++|+.||.+...... ...+....                      .+    ..   .....++
T Consensus       193 ~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (342)
T cd07879         193 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASP  271 (342)
T ss_pred             CchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCH
Confidence            8999999999999999999999986432222 22221100                      00    00   0123467


Q ss_pred             HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                      .+.+||.+||+ +|.+||++.+++.||||....+
T Consensus       272 ~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         272 QAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            89999999996 8999999999999999987543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.91  E-value=5.1e-24  Score=219.13  Aligned_cols=156  Identities=34%  Similarity=0.503  Sum_probs=123.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccc--cC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~--~y   79 (505)
                      ..++.++.||+.||+|||+.|  ++||||||+||+++ .++.+||+|||++...... .....+++.|+|||.+.+  .+
T Consensus       118 ~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  193 (343)
T cd07851         118 DHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN-EDCELKILDFGLARHTDDE-MTGYVATRWYRAPEIMLNWMHY  193 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC-CCCCEEEcccccccccccc-ccCCcccccccCHHHHhCCCCC
Confidence            467889999999999999999  99999999999997 6789999999999766433 334568889999998743  57


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC-CC----------------------------CCCCCCCh
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PA----------------------------SLSKVTDP  130 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~-p~----------------------------~~~~~~s~  130 (505)
                      +.++||||||+++|+|++|+.||...... ..+..+..... +.                            ......++
T Consensus       194 ~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  272 (343)
T cd07851         194 NQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANP  272 (343)
T ss_pred             CchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCH
Confidence            89999999999999999999999764433 32333222110 00                            01123478


Q ss_pred             HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      .+.+||.+||. +|.+|||+.++++||||....
T Consensus       273 ~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~  305 (343)
T cd07851         273 LAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH  305 (343)
T ss_pred             HHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence            89999999996 799999999999999998643

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.91  E-value=3.6e-24  Score=210.41  Aligned_cols=153  Identities=31%  Similarity=0.536  Sum_probs=118.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc---
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE---   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~---   76 (505)
                      ..+..++.|++.||.|||++|  |+||||+|+||+++ .++.+||+|||++.......  .....|++.|+|||.+.   
T Consensus       106 ~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  182 (267)
T cd06646         106 LQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEK  182 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCCEEECcCccceeecccccccCccccCccccCHhHccccc
Confidence            356789999999999999999  99999999999997 67899999999997654322  23456889999999772   


Q ss_pred             -ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           77 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                       ..++.++|+|||||++|+|++|+.||..................+..+  ....+..+.+||.+||. +|.+||++.++
T Consensus       183 ~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  262 (267)
T cd06646         183 NGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERL  262 (267)
T ss_pred             CCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHH
Confidence             347789999999999999999999996543222222111112222211  12357899999999995 79999999999


Q ss_pred             hcCCC
Q 010626          153 LKDPF  157 (505)
Q Consensus       153 L~hpf  157 (505)
                      |+|+|
T Consensus       263 l~~l~  267 (267)
T cd06646         263 LTHLF  267 (267)
T ss_pred             hcCCC
Confidence            99987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.91  E-value=7.6e-24  Score=210.96  Aligned_cols=154  Identities=26%  Similarity=0.467  Sum_probs=117.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~--~   77 (505)
                      +.++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......  .....+++.|+|||++.  .
T Consensus       103 ~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  179 (291)
T cd07844         103 HNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST  179 (291)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEc-CCCCEEECccccccccCCCCccccccccccccCCcHHhhcCc
Confidence            467889999999999999999  99999999999997 67899999999986543221  22235688999999874  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC---C----------------------CCC---CCCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---K----------------------PAS---LSKVTD  129 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~---~----------------------p~~---~~~~~s  129 (505)
                      .++.++||||||+++|+|++|+.||............+....   .                      +..   .....+
T Consensus       180 ~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (291)
T cd07844         180 EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLD  259 (291)
T ss_pred             ccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCC
Confidence            478999999999999999999999976543322222211100   0                      000   001123


Q ss_pred             --hHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          130 --PQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       130 --~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                        ..+.++|.+||. +|.+||++.++|.||||
T Consensus       260 ~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         260 RIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             CchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence              778899999996 79999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.91  E-value=9.4e-24  Score=213.54  Aligned_cols=154  Identities=32%  Similarity=0.569  Sum_probs=125.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc----c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE----E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~----~   77 (505)
                      ..+..++.|++.||.|||+++  ++||||+|+||+++ .++.++|+|||++......  ....+++.|+|||.+.    +
T Consensus       115 ~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~  189 (308)
T cd06634         115 VEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPA--NXFVGTPYWMAPEVILAMDEG  189 (308)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEEC-CCCcEEECCcccceeecCc--ccccCCccccCHHHHhhcccC
Confidence            357789999999999999999  99999999999997 6789999999998765432  3456889999999863    4


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      .++.++|||||||++|+|++|..||.......... .+..+..+.......+..+++||.+||. +|.+||++.++++||
T Consensus       190 ~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             CCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH-HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            57889999999999999999999997643333333 3333444444445678899999999996 799999999999999


Q ss_pred             CCCCC
Q 010626          157 FLVTD  161 (505)
Q Consensus       157 ff~~~  161 (505)
                      |+...
T Consensus       269 ~~~~~  273 (308)
T cd06634         269 FVLRE  273 (308)
T ss_pred             ccccc
Confidence            99763

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.91  E-value=1.3e-23  Score=213.27  Aligned_cols=154  Identities=32%  Similarity=0.566  Sum_probs=125.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc----cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE----EE   78 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~----~~   78 (505)
                      .+..++.||+.||.|||++|  ++||||+|+||+++ .++.+||+|||++.....  .....|++.|+|||++.    +.
T Consensus       122 ~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~-~~~~~kL~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~  196 (313)
T cd06633         122 EIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASKSSP--ANSFVGTPYWMAPEVILAMDEGQ  196 (313)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEEC-CCCCEEEeecCCCcccCC--CCCccccccccChhhccccCCCC
Confidence            56779999999999999999  99999999999997 678999999999854322  23457889999999873    45


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++||||||+++|+|++|..||.......... .+.....+......++..+++|+.+||. +|.+||++.+++.|||
T Consensus       197 ~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~  275 (313)
T cd06633         197 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDF  275 (313)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence            8889999999999999999999997754434443 3333333433444567789999999996 7999999999999999


Q ss_pred             CCCCC
Q 010626          158 LVTDN  162 (505)
Q Consensus       158 f~~~~  162 (505)
                      |....
T Consensus       276 ~~~~~  280 (313)
T cd06633         276 VRRDR  280 (313)
T ss_pred             cCCCc
Confidence            98644

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.91  E-value=7.1e-24  Score=206.16  Aligned_cols=152  Identities=32%  Similarity=0.560  Sum_probs=122.4

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-cccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      .+..++.||+.||.|||+++  ++|+||||+||+++.....+||+|||.+.......  .....|++.|+|||.+ ...+
T Consensus       102 ~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~  179 (257)
T cd08225         102 QILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY  179 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCC
Confidence            57789999999999999999  99999999999998544467999999987664332  2234688999999987 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +.++|+||||+++|+|++|+.||... +.......+..+..+ ......+..++++|.+||. +|.+|||+.++++||||
T Consensus       180 ~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         180 NNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFA-PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhcccCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            89999999999999999999999764 334444444433322 2344567899999999995 89999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.91  E-value=8.4e-24  Score=221.06  Aligned_cols=149  Identities=23%  Similarity=0.424  Sum_probs=119.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc----cccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR----SVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~----~~~Gt~~Y~APEll-~   76 (505)
                      +.+++++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||+++........    ...+++.|+|||++ .
T Consensus       212 ~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  288 (374)
T cd05106         212 DDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD  288 (374)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEe-CCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcC
Confidence            467899999999999999999  99999999999998 6789999999999765433221    22345679999977 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|||||||++|+|++ |..||............+..+.. ...+...++++.++|.+||. +|.+||++.++++
T Consensus       289 ~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         289 CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ-MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC-ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            569999999999999999997 99999765444444444444332 23445568999999999996 8999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.91  E-value=9.7e-24  Score=207.57  Aligned_cols=149  Identities=23%  Similarity=0.377  Sum_probs=120.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      +.+..++.||+.||+|||+++  |+||||||+||+++ .++.+||+|||++.......    .....+++.|+|||.+ .
T Consensus       112 ~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  188 (272)
T cd05075         112 QMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD  188 (272)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEc-CCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC
Confidence            357789999999999999999  99999999999997 67899999999997654322    1222456789999987 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|++ |+.||.. .....++..+..+..+. .+...+..++++|.+||. +|.+|||+.++++
T Consensus       189 ~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~  266 (272)
T cd05075         189 RVYTTKSDVWSFGVTMWEIATRGQTPYPG-VENSEIYDYLRQGNRLK-QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC  266 (272)
T ss_pred             CCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            568999999999999999999 8899976 44556666666654332 344567889999999996 8999999999986


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       267 ~  267 (272)
T cd05075         267 E  267 (272)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.91  E-value=8.2e-24  Score=210.49  Aligned_cols=158  Identities=40%  Similarity=0.694  Sum_probs=125.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..+..++.||+.||.|||+.|  ++|+||+|+||+++ .++.++|+|||++......  ......+++.|+|||.+. ..
T Consensus       116 ~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  192 (286)
T cd06614         116 PQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD  192 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEc-CCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCC
Confidence            356789999999999999999  99999999999998 6789999999988654332  123345788999999874 45


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC-CCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~-~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      ++.++|+||||+++|+|++|..||... +.......+... ..+......++..+++||.+||. +|.+||++.+++.|+
T Consensus       193 ~~~~~Dv~slGvil~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  271 (286)
T cd06614         193 YGPKVDIWSLGIMCIEMAEGEPPYLRE-PPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP  271 (286)
T ss_pred             CCCccccHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence            889999999999999999999999764 333333333332 22222233367899999999996 799999999999999


Q ss_pred             CCCCCCC
Q 010626          157 FLVTDNP  163 (505)
Q Consensus       157 ff~~~~~  163 (505)
                      ||+...+
T Consensus       272 ~~~~~~~  278 (286)
T cd06614         272 FLKKACP  278 (286)
T ss_pred             HhhccCc
Confidence            9987443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.91  E-value=1.5e-23  Score=203.33  Aligned_cols=152  Identities=35%  Similarity=0.582  Sum_probs=126.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      +.+..++.|++.||+|||+.|  ++||||+|+||+++ .++.+||+|||++............+++.|+|||.+ ...++
T Consensus       103 ~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~  179 (256)
T cd08530         103 QEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLV-ANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYS  179 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEe-cCCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCC
Confidence            357789999999999999999  99999999999998 578999999999977655544445688999999987 45588


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      .++|+||||+++|+|++|+.||... +.......+..+..+ ..+...+.++++++.+||. +|.+||++.++++||++
T Consensus       180 ~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         180 YKSDIWSLGCLLYEMATFAPPFEAR-SMQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCC-CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            8999999999999999999999764 344444444444333 3444678899999999996 79999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.91  E-value=4e-24  Score=241.07  Aligned_cols=153  Identities=36%  Similarity=0.611  Sum_probs=127.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--------------------CCCCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--------------------QPTAR   61 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--------------------~~~~~   61 (505)
                      ..++++++||+.||.|+|++|  ||||||||.|||++ .++.|||+|||+|....                    ....+
T Consensus       697 d~~wrLFreIlEGLaYIH~~g--iIHRDLKP~NIFLd-~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~T  773 (1351)
T KOG1035|consen  697 DEAWRLFREILEGLAYIHDQG--IIHRDLKPRNIFLD-SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLT  773 (1351)
T ss_pred             HHHHHHHHHHHHHHHHHHhCc--eeeccCCcceeEEc-CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccc
Confidence            468999999999999999999  99999999999998 67899999999997621                    01234


Q ss_pred             cccCCCcccCccccc--c--cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCChHHHHH
Q 010626           62 SVIGTPEFMAPELYE--E--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQF  135 (505)
Q Consensus        62 ~~~Gt~~Y~APEll~--~--~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l~~L  135 (505)
                      +.+||.-|+|||++.  .  .|+.|+|+||||++++||+   +||........+...+..+..|..  +....-+.-..+
T Consensus       774 s~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~sl  850 (1351)
T KOG1035|consen  774 SQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASL  850 (1351)
T ss_pred             cccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHH
Confidence            568999999999983  2  5999999999999999998   688877777777777777765544  222334567889


Q ss_pred             HHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          136 IEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       136 I~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      |+.||. +|.+||||.|+|++.||-.
T Consensus       851 I~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  851 IRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             HHHHhcCCCccCCCHHHHhhccCCCc
Confidence            999996 8999999999999999973

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.91  E-value=1.1e-23  Score=208.04  Aligned_cols=153  Identities=33%  Similarity=0.513  Sum_probs=119.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..++.++.||+.||.|||+++  ++|+||+|+||+++ .++.+||+|||++....... .....+++.|+|||.+ ...+
T Consensus       107 ~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~  183 (287)
T cd07838         107 ETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSY  183 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEc-cCCCEEEeccCcceeccCCcccccccccccccChHHhccCCC
Confidence            467889999999999999999  99999999999998 56899999999997764332 2334578899999987 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC-CCC------------------------CCCCCCCChHHHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKP------------------------ASLSKVTDPQVKQ  134 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~-~~p------------------------~~~~~~~s~~l~~  134 (505)
                      +.++|+|||||++|+|++|..||........ ..++... ..+                        .......++.+.+
T Consensus       184 ~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (287)
T cd07838         184 ATPVDMWSVGCIFAELFRRRPLFRGTSEADQ-LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLD  262 (287)
T ss_pred             CCcchhhhHHHHHHHHHhCCCcccCCChHHH-HHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHH
Confidence            8999999999999999999999876443333 2222211 000                        0001123567889


Q ss_pred             HHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          135 FIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       135 LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +|.+||. +|.+||++.+++.||||
T Consensus       263 li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         263 LLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             HHHHHhccCCccCCCHHHHhcCcCC
Confidence            9999995 89999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.90  E-value=9.6e-24  Score=208.21  Aligned_cols=153  Identities=29%  Similarity=0.487  Sum_probs=120.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE--   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~--   76 (505)
                      ..++.++.||+.||+|||.+|  ++|+||+|+||+++ .++.+||+|||++.......   .....++..|+|||.+.  
T Consensus       100 ~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  176 (287)
T cd07840         100 SQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGA  176 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEc-CCCCEEEccccceeeccCCCcccccccccccccCCceeeEcc
Confidence            467889999999999999999  99999999999998 68899999999997765443   23345688899999763  


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC-CC--C--------------------------CCCCC
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-KP--A--------------------------SLSKV  127 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~-~p--~--------------------------~~~~~  127 (505)
                      ..++.++||||||+++|+|+||+.||........ ...+.... .+  .                          .+...
T Consensus       177 ~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T cd07840         177 TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHL  255 (287)
T ss_pred             ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhccc
Confidence            3578999999999999999999999976443332 22222110 00  0                          01122


Q ss_pred             CChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          128 TDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       128 ~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      .++.+.++|.+||. +|.+||++.+++.||||
T Consensus       256 ~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         256 IDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            37789999999996 79999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.90  E-value=7.3e-24  Score=216.75  Aligned_cols=158  Identities=28%  Similarity=0.485  Sum_probs=122.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~~Y~APEll   75 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......      .....|+..|+|||.+
T Consensus       107 ~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~  183 (334)
T cd07855         107 EHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL  183 (334)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEecccccceeecccCcCCCcccccccccccccChHHh
Confidence            468899999999999999999  99999999999998 78899999999997653321      1234688999999987


Q ss_pred             c--ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc-CC----------------------CCCC-----CC
Q 010626           76 E--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GI----------------------KPAS-----LS  125 (505)
Q Consensus        76 ~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~-~~----------------------~p~~-----~~  125 (505)
                      .  ..++.++||||||+++|+|++|+.||.......++...... +.                      ....     ..
T Consensus       184 ~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (334)
T cd07855         184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIF  263 (334)
T ss_pred             cCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHc
Confidence            3  35889999999999999999999999764332221111100 00                      0000     11


Q ss_pred             CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          126 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       126 ~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      ...++.++++|.+||+ +|.+||++.+++.||||....
T Consensus       264 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~  301 (334)
T cd07855         264 PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH  301 (334)
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence            3357889999999996 899999999999999997543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.90  E-value=8.8e-24  Score=215.96  Aligned_cols=157  Identities=29%  Similarity=0.461  Sum_probs=120.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~~Y~APEll   75 (505)
                      ..++.++.||+.||.|||++|  ++||||||+|||++ .++.+||+|||++.......      .....|++.|+|||.+
T Consensus       105 ~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~  181 (332)
T cd07857         105 AHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVN-ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM  181 (332)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEc-CCCCEEeCcCCCceecccccccccccccCcccCccccCcHHH
Confidence            467889999999999999999  99999999999997 67899999999997654221      2234689999999976


Q ss_pred             c--ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHH--------------c-----------CCCCC---CCC
Q 010626           76 E--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--------------S-----------GIKPA---SLS  125 (505)
Q Consensus        76 ~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~--------------~-----------~~~p~---~~~  125 (505)
                      .  ..++.++||||||+++|+|++|..||............+.              .           .....   ...
T Consensus       182 ~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (332)
T cd07857         182 LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIF  261 (332)
T ss_pred             hCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhC
Confidence            3  3588999999999999999999999976432211111000              0           00001   112


Q ss_pred             CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          126 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       126 ~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      ...+..+.+|+.+||. +|.+|||+.+++.||||...
T Consensus       262 ~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         262 PNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             CCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence            2347889999999996 89999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.90  E-value=1.2e-23  Score=216.60  Aligned_cols=150  Identities=25%  Similarity=0.438  Sum_probs=121.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      +.+..++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++..+....    .....+++.|+|||++ .
T Consensus       173 ~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~-~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  249 (337)
T cd05054         173 EDLISYSFQVARGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD  249 (337)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEe-CCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC
Confidence            457889999999999999999  99999999999998 67899999999997653221    1223456789999977 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|||||||++|+|++ |..||.+..........+..+..+ ..+...++.+.+++.+||+ +|.+||++.++++
T Consensus       250 ~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~  328 (337)
T cd05054         250 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVE  328 (337)
T ss_pred             CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            669999999999999999998 999997644334444444444333 3445667899999999996 8999999999987


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      |
T Consensus       329 ~  329 (337)
T cd05054         329 I  329 (337)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.90  E-value=1.6e-23  Score=202.93  Aligned_cols=149  Identities=25%  Similarity=0.391  Sum_probs=124.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll~-   76 (505)
                      ..++.++.||+.||+|||++|  ++||||+|+||+++ .++.+||+|||.+.......    .....+++.|+|||.+. 
T Consensus       105 ~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (262)
T cd00192         105 KDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD  181 (262)
T ss_pred             HHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEEC-CCCcEEEcccccccccccccccccccCCCcCccccCHHHhcc
Confidence            467899999999999999999  99999999999998 67899999999997765432    33446788999999874 


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|++ |..||... ........+..+... ..+...++++.+++.+||. +|.+||++.++++
T Consensus       182 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~  259 (262)
T cd00192         182 GIFTSKSDVWSFGVLLWEIFTLGATPYPGL-SNEEVLEYLRKGYRL-PKPEYCPDELYELMLSCWQLDPEDRPTFSELVE  259 (262)
T ss_pred             CCcchhhccHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCccCChHHHHHHHHHccCCcccCcCHHHHHH
Confidence            468999999999999999999 69999774 556666666654333 3455668999999999996 7999999999987


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       260 ~  260 (262)
T cd00192         260 R  260 (262)
T ss_pred             h
Confidence            5

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.90  E-value=9.9e-24  Score=208.79  Aligned_cols=154  Identities=28%  Similarity=0.499  Sum_probs=119.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~--~   77 (505)
                      +.+..++.||+.||.|||++|  ++||||||+||+++ .++.++|+|||++.......  .....+++.|++||++.  .
T Consensus       100 ~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  176 (284)
T cd07836         100 NTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLIN-KRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR  176 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEC-CCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCC
Confidence            467889999999999999999  99999999999997 67899999999996553321  22345788999999873  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC---------------C-----------CCCCCCChH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---------------A-----------SLSKVTDPQ  131 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p---------------~-----------~~~~~~s~~  131 (505)
                      .++.++|+|+||+++|+|++|+.||.+..........+.....|               .           .+....++.
T Consensus       177 ~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (284)
T cd07836         177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPL  256 (284)
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcH
Confidence            47889999999999999999999998754433322221110000               0           011234678


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      ++++|.+||+ +|.+||++.++++||||
T Consensus       257 ~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         257 GIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            9999999995 89999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=5.8e-24  Score=224.24  Aligned_cols=147  Identities=27%  Similarity=0.436  Sum_probs=122.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccC---CCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~G---t~~Y~APEll-~~   77 (505)
                      .++..++.||++|++||++++  +|||||.+.||||+ ++..+||+|||+|+......-....|   ...|.|||.+ .+
T Consensus       303 ~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~-~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~  379 (468)
T KOG0197|consen  303 PQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVD-EDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYG  379 (468)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeec-cCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhC
Confidence            467889999999999999999  99999999999997 77899999999999544332211122   3479999988 67


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      .|+.++||||||++||||+| |+.||.+. ...+....+..|.+.+ -|..+++++.+++..||. +|.+|||+..+.
T Consensus       380 ~FS~kSDVWSFGVlL~E~fT~G~~py~~m-sn~ev~~~le~GyRlp-~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  380 KFSSKSDVWSFGVLLWELFTYGRVPYPGM-SNEEVLELLERGYRLP-RPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             CcccccceeehhhhHHHHhccCCCCCCCC-CHHHHHHHHhccCcCC-CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence            89999999999999999999 99999875 4556677888886654 456689999999999996 799999998654

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.90  E-value=1e-23  Score=210.12  Aligned_cols=160  Identities=29%  Similarity=0.466  Sum_probs=126.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE--   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~--   76 (505)
                      ..+..++.||+.||.|||++|  ++||||+|+||+++ .++.+||+|||++.......   .....|++.|+|||.+.  
T Consensus       105 ~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  181 (290)
T cd05613         105 QEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG  181 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEC-CCCCEEEeeCccceecccccccccccccCCcccCChhhccCC
Confidence            457788899999999999999  99999999999997 67899999999997654322   22356889999999874  


Q ss_pred             -ccCCcccchhhHHHHHHHHhhcCCCCCCCC---ChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC----
Q 010626           77 -EEYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL----  147 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp----  147 (505)
                       ..++.++||||||+++|+|++|..||....   ....+...+.....  .++...++.+.+++.+||. +|.+||    
T Consensus       182 ~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~  259 (290)
T cd05613         182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALAKDIIQRLLMKDPKKRLGCGP  259 (290)
T ss_pred             CCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCccCCHHHHHHHHHHhcCCHHHhcCCCC
Confidence             347789999999999999999999996422   12223333333322  3455678999999999996 799997    


Q ss_pred             -CHHHHhcCCCCCCCCCCCc
Q 010626          148 -PALELLKDPFLVTDNPKDL  166 (505)
Q Consensus       148 -Sa~ElL~hpff~~~~~~~l  166 (505)
                       ++.+++.||||...++..+
T Consensus       260 ~~~~~l~~~~~~~~~~~~~~  279 (290)
T cd05613         260 SDADEIKKHPFFQKINWDDL  279 (290)
T ss_pred             CCHHHHHcCcccccCCHHHH
Confidence             8999999999998776443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.90  E-value=2.3e-25  Score=220.62  Aligned_cols=160  Identities=32%  Similarity=0.581  Sum_probs=131.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ++|..+++..+.||+|||...  -||||||..|||++ .+|..||+|||+|..+...  .+++++|||.|||||+++ -.
T Consensus       129 ~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLN-T~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIG  205 (502)
T KOG0574|consen  129 QEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLN-TDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIG  205 (502)
T ss_pred             HHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEc-ccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhc
Confidence            468889999999999999987  89999999999998 7899999999999877554  467889999999999995 46


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      |+.++||||||++..||..|++||.+.. +......|-.. +|+.+  +...+.++-+||++||. +|.+|.|+.++++|
T Consensus       206 Y~~~ADIWSLGITaIEMAEG~PPYsDIH-PMRAIFMIPT~-PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  206 YDTKADIWSLGITAIEMAEGRPPYSDIH-PMRAIFMIPTK-PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             cchhhhHhhhcchhhhhhcCCCCccccc-ccceeEeccCC-CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            9999999999999999999999998743 32222222222 23333  34457889999999996 69999999999999


Q ss_pred             CCCCCCCCCCc
Q 010626          156 PFLVTDNPKDL  166 (505)
Q Consensus       156 pff~~~~~~~l  166 (505)
                      ||++......+
T Consensus       284 ~FiknA~g~~I  294 (502)
T KOG0574|consen  284 TFIKNAPGCDI  294 (502)
T ss_pred             hhhcCCCcccH
Confidence            99998766543

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.6e-23  Score=202.61  Aligned_cols=152  Identities=34%  Similarity=0.633  Sum_probs=124.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC--ccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~--~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.|++.||.|||++|  ++||||+|+||+++ .++.++|+|||++........  ....++..|+|||.+. ..
T Consensus        99 ~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~  175 (254)
T cd06627          99 SLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTT-KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG  175 (254)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEC-CCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCC
Confidence            356789999999999999999  99999999999998 678999999999977654332  3456888999999873 44


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++|+|+||+++|+|++|..||............ .... ...++...+..++++|.+||. +|.+||++.+++.|||
T Consensus       176 ~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~  253 (254)
T cd06627         176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI-VQDD-HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPW  253 (254)
T ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-hccC-CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCC
Confidence            788999999999999999999999765433333333 2222 234566678999999999996 8999999999999999


Q ss_pred             C
Q 010626          158 L  158 (505)
Q Consensus       158 f  158 (505)
                      |
T Consensus       254 ~  254 (254)
T cd06627         254 I  254 (254)
T ss_pred             C
Confidence            7

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.90  E-value=1.5e-23  Score=207.74  Aligned_cols=154  Identities=32%  Similarity=0.540  Sum_probs=119.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~--~   77 (505)
                      +.++.++.||+.||+|||++|  ++||||+|+||+++ .++.++|+|||++.......  .....++..|+|||.+.  .
T Consensus       100 ~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  176 (286)
T cd07846         100 SRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT  176 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEC-CCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhcccc
Confidence            467889999999999999999  99999999999997 67899999999997654322  22346788999999874  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc-------------------CCC-CC--------CCCCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------------GIK-PA--------SLSKVTD  129 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~-------------------~~~-p~--------~~~~~~s  129 (505)
                      .++.++||||||+++|+|++|+.||...............                   +.. +.        ......+
T Consensus       177 ~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (286)
T cd07846         177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLS  256 (286)
T ss_pred             ccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcC
Confidence            4788999999999999999999999754433222221110                   000 00        0112346


Q ss_pred             hHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          130 PQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       130 ~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      ..+.+|+.+||. +|.+||++.++++||||
T Consensus       257 ~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         257 GLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             HHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            789999999996 79999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.90  E-value=7.9e-24  Score=241.83  Aligned_cols=159  Identities=29%  Similarity=0.468  Sum_probs=127.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCC-----CCeEecCCCCCcEEEeC----------------CCCcEEEeecCceeeccCC-C
Q 010626            2 KAIKNWARQILRGLHYLHSHN-----PPIIHRDLKCDNIFVNG----------------NNGEVKIGDLGLAIVMQQP-T   59 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g-----~~IiHrDLKp~NILld~----------------~~g~vKL~DFGlA~~~~~~-~   59 (505)
                      ..++.|+.||+.||.|||+.+     .+|+||||||+||||+.                ..+.+||+|||++..+... .
T Consensus       118 ~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~  197 (1021)
T PTZ00266        118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM  197 (1021)
T ss_pred             HHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccccc
Confidence            367899999999999999843     23999999999999952                1235899999999766433 2


Q ss_pred             CccccCCCcccCccccc---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHH
Q 010626           60 ARSVIGTPEFMAPELYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI  136 (505)
Q Consensus        60 ~~~~~Gt~~Y~APEll~---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI  136 (505)
                      .....||+.|+|||++.   ..++.++|||||||++|+|+||..||.......++...+.....  ......++.+.+||
T Consensus       198 ~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~--lpi~~~S~eL~dLI  275 (1021)
T PTZ00266        198 AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPD--LPIKGKSKELNILI  275 (1021)
T ss_pred             ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCC--CCcCCCCHHHHHHH
Confidence            34457999999999873   34889999999999999999999999876666666665554422  22234578999999


Q ss_pred             HHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          137 EKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       137 ~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      .+||. +|.+||++.++|.||||+...
T Consensus       276 ~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        276 KNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             HHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            99996 899999999999999997543

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.90  E-value=2e-23  Score=205.61  Aligned_cols=154  Identities=34%  Similarity=0.593  Sum_probs=121.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCcccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll~~   77 (505)
                      ..++.++.||+.||.|||+++  ++||||+|+||+++ .++.++|+|||++......    ......|+..|+|||.+..
T Consensus       108 ~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  184 (272)
T cd06629         108 QLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS  184 (272)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEc-CCCeEEEeeccccccccccccccccccccCCccccCHHHhcc
Confidence            357788999999999999999  99999999999997 6789999999998755322    1223457889999998742


Q ss_pred             ---cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC---CCCCCCCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626           78 ---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---PASLSKVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus        78 ---~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~---p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                         .++.++|+||||+++|+|++|..||..................   +......++..++++|.+||. +|.+||++.
T Consensus       185 ~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  264 (272)
T cd06629         185 YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAR  264 (272)
T ss_pred             ccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHH
Confidence               3789999999999999999999999764443333322222211   222333457899999999995 899999999


Q ss_pred             HHhcCCCC
Q 010626          151 ELLKDPFL  158 (505)
Q Consensus       151 ElL~hpff  158 (505)
                      ++|+||||
T Consensus       265 ~il~~~~~  272 (272)
T cd06629         265 ELLQHPFI  272 (272)
T ss_pred             HHhhCCCC
Confidence            99999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=7.9e-24  Score=216.76  Aligned_cols=166  Identities=26%  Similarity=0.502  Sum_probs=142.4

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceee--ccCCCCccccCCCcccCcccc-cccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV--MQQPTARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~--~~~~~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      .+..|+.+|+-||-|||++|  ||+||||.+||+++ ..|++||+|||+++.  .......+++|||.|+|||++ .+.|
T Consensus       451 ~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd-~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPY  527 (683)
T KOG0696|consen  451 VAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPY  527 (683)
T ss_pred             hhhhhhHHHHHHhhhhhcCC--eeeeeccccceEec-cCCceEeeecccccccccCCcceeeecCCCcccccceEEeccc
Confidence            35678999999999999999  99999999999998 679999999999964  344556788999999999977 6789


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH-----HHHh
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA-----LELL  153 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa-----~ElL  153 (505)
                      +.++|.|++|++||||+.|+.||.+ .+..++++.|...  ...+++..+.++..++...|. .|.+|..+     .++-
T Consensus       528 gksvDWWa~GVLLyEmlaGQpPFdG-eDE~elF~aI~eh--nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~  604 (683)
T KOG0696|consen  528 GKSVDWWAFGVLLYEMLAGQPPFDG-EDEDELFQAIMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIR  604 (683)
T ss_pred             ccchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHc--cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchh
Confidence            9999999999999999999999987 5677777777764  345778889999999999995 69999864     5799


Q ss_pred             cCCCCCCCCCCCcccCCCCCC
Q 010626          154 KDPFLVTDNPKDLVCDPLRLP  174 (505)
Q Consensus       154 ~hpff~~~~~~~l~~~~l~~p  174 (505)
                      .||||+...|..+....++.|
T Consensus       605 ~H~FFR~iDWek~E~~eiqPP  625 (683)
T KOG0696|consen  605 EHPFFRRIDWEKLERREIQPP  625 (683)
T ss_pred             hCcchhhccHHHHhhccCCCC
Confidence            999999999988766665544

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.90  E-value=2.2e-23  Score=204.56  Aligned_cols=149  Identities=21%  Similarity=0.350  Sum_probs=120.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC----ccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~----~~~~Gt~~Y~APEll-~   76 (505)
                      ..+..++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||+++.......    ....++..|+|||.+ .
T Consensus       113 ~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  189 (273)
T cd05035         113 QTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLR-EDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD  189 (273)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccccchheEEEC-CCCeEEECCccceeeccccccccccccccCCccccCHhhccc
Confidence            356789999999999999999  99999999999997 678999999999976543321    112346689999987 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|||||||++|||++ |..||... ....+...+..+..+ ..+...++.+.+++.+||. +|.+||++.++++
T Consensus       190 ~~~~~~~Dv~SlG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~  267 (273)
T cd05035         190 RVYTSKSDVWAFGVTMWEIATRGQTPYPGV-ENHEIYDYLRHGNRL-KQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE  267 (273)
T ss_pred             CCCCcccchHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            568899999999999999999 88998764 445556666555433 3456678999999999996 7999999999986


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       268 ~  268 (273)
T cd05035         268 V  268 (273)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.90  E-value=2.3e-23  Score=211.47  Aligned_cols=156  Identities=33%  Similarity=0.569  Sum_probs=126.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc----cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll----~~   77 (505)
                      ..+..++.||+.||.|||++|  ++||||+|+||+++ .++.+||+|||++.....  .....|++.|+|||.+    .+
T Consensus       125 ~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~-~~~~~kl~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~  199 (317)
T cd06635         125 VEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLT-EPGQVKLADFGSASIASP--ANSFVGTPYWMAPEVILAMDEG  199 (317)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEEC-CCCCEEEecCCCccccCC--cccccCCccccChhhhhcCCCC
Confidence            356789999999999999999  99999999999997 678999999999865432  2345688999999986    24


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      .++.++|||||||++|+|++|+.||...... .....+.....+.......++.+++||.+||. +|.+||++.++++|+
T Consensus       200 ~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         200 QYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            5889999999999999999999999764333 33334444433433445567899999999996 799999999999999


Q ss_pred             CCCCCCC
Q 010626          157 FLVTDNP  163 (505)
Q Consensus       157 ff~~~~~  163 (505)
                      |+.....
T Consensus       279 ~~~~~~~  285 (317)
T cd06635         279 FVLRERP  285 (317)
T ss_pred             hhhccCc
Confidence            9976543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.90  E-value=1.6e-23  Score=210.69  Aligned_cols=157  Identities=34%  Similarity=0.625  Sum_probs=125.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      +.++.++.||+.||+|||++|  ++||||+|+||+++ .++.++|+|||++.......  .....|++.|+|||.+ ...
T Consensus       116 ~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~  192 (292)
T cd06657         116 EQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP  192 (292)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCCEEEcccccceecccccccccccccCccccCHHHhcCCC
Confidence            467889999999999999999  99999999999998 67899999999986553322  2334688999999987 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC-CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      ++.++|+||||+++|+|++|+.||... ........+....++. ......++.+.+++.+||. +|.+||++.+++.||
T Consensus       193 ~~~~~Dv~slGvil~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~  271 (292)
T cd06657         193 YGPEVDIWSLGIMVIEMVDGEPPYFNE-PPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP  271 (292)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcCh
Confidence            889999999999999999999999763 3333334443333221 1223467899999999995 799999999999999


Q ss_pred             CCCCCC
Q 010626          157 FLVTDN  162 (505)
Q Consensus       157 ff~~~~  162 (505)
                      ||....
T Consensus       272 ~~~~~~  277 (292)
T cd06657         272 FLAKAG  277 (292)
T ss_pred             HHhccC
Confidence            998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.90  E-value=2.5e-23  Score=205.44  Aligned_cols=147  Identities=23%  Similarity=0.380  Sum_probs=120.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......    .....+++.|+|||++ ..
T Consensus       123 ~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  199 (280)
T cd05049         123 QLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVG-YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR  199 (280)
T ss_pred             HHHHHHHHHHHHHHHHhhCC--eeccccccceEEEc-CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC
Confidence            56789999999999999999  99999999999997 67899999999987543221    1233457889999987 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++||||||+++|+|++ |..||... +.......+..+..+ ..+...+..+++++.+||. +|.+||++.|+++
T Consensus       200 ~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         200 KFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIECITQGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            68999999999999999998 99999764 445555666655433 3445678999999999996 7999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.90  E-value=3.5e-23  Score=204.75  Aligned_cols=154  Identities=29%  Similarity=0.440  Sum_probs=120.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCccccc--cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE--EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~--~~   78 (505)
                      ..+..++.||+.||.|||++|  ++|+||+|+||+++ .++.++|+|||++....... .....++..|+|||++.  ..
T Consensus        99 ~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  175 (283)
T cd07830          99 SVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS  175 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcC
Confidence            357889999999999999999  99999999999998 67899999999997664432 23456888999999873  34


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC---------------------------CCCCCCCChH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP---------------------------ASLSKVTDPQ  131 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p---------------------------~~~~~~~s~~  131 (505)
                      ++.++|+||||+++|+|++|+.||..........+.......+                           .......+..
T Consensus       176 ~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (283)
T cd07830         176 YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPE  255 (283)
T ss_pred             cCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHH
Confidence            7899999999999999999999997654444433222110000                           0001122578


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +.+||.+||. +|.+||++.|++.||||
T Consensus       256 ~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         256 AIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             HHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            9999999996 89999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.90  E-value=1.5e-23  Score=205.57  Aligned_cols=151  Identities=28%  Similarity=0.477  Sum_probs=123.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      +.+..++.||+.||.|||++|  ++||||||+||+++ .++.++|+|||++.......  .....|++.|+|||.+ ...
T Consensus       106 ~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  182 (267)
T cd08228         106 RTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG  182 (267)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEc-CCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCC
Confidence            457889999999999999999  99999999999997 67899999999987664322  2234688899999987 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCC-ChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      ++.++|+||||+++|+|++|+.||.... +.......+.....+.......+..++++|.+||. +|.+||++.++++.
T Consensus       183 ~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            8899999999999999999999996533 33445555555444444445667899999999996 89999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.90  E-value=1.1e-23  Score=208.61  Aligned_cols=156  Identities=33%  Similarity=0.597  Sum_probs=125.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||.|||++|  ++|+||+|+||+++ .++.++|+|||++.......  .....++..|+|||.+. ..
T Consensus       101 ~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  177 (277)
T cd06642         101 TYIATILREILKGLDYLHSER--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA  177 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEe-CCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCC
Confidence            357789999999999999999  99999999999997 67899999999987654322  22346788999999884 45


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++|+||||+++|+|++|..||.... +......+..+. +..+....+..+.++|.+||. +|.+||++.++++|||
T Consensus       178 ~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06642         178 YDFKADIWSLGITAIELAKGEPPNSDLH-PMRVLFLIPKNS-PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF  255 (277)
T ss_pred             CchhhhHHHHHHHHHHHHhCCCCCcccc-hhhHHhhhhcCC-CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence            8889999999999999999999997533 333333333332 233445567889999999996 8999999999999999


Q ss_pred             CCCCC
Q 010626          158 LVTDN  162 (505)
Q Consensus       158 f~~~~  162 (505)
                      |....
T Consensus       256 ~~~~~  260 (277)
T cd06642         256 ITRYT  260 (277)
T ss_pred             HHHHh
Confidence            97543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.90  E-value=1.7e-23  Score=206.17  Aligned_cols=149  Identities=24%  Similarity=0.365  Sum_probs=116.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCccccc--
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE--   76 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll~--   76 (505)
                      .+..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++.......    .....+++.|+|||++.  
T Consensus       101 ~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  177 (269)
T cd05042         101 VLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLT-ADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR  177 (269)
T ss_pred             HHHHHHHHHHHHHHHHHhcC--EecccccHhheEec-CCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhc
Confidence            46789999999999999999  99999999999998 67899999999986432211    12234567899999863  


Q ss_pred             ------ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCC---CCCCCCCCChHHHHHHHHhcCCCCCC
Q 010626           77 ------EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---PASLSKVTDPQVKQFIEKCIVPASLR  146 (505)
Q Consensus        77 ------~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~---p~~~~~~~s~~l~~LI~kcL~dP~~R  146 (505)
                            ..++.++|||||||++|+|++ |..||....+.......+.....   .+..+...++.+.+++..|+.+|.+|
T Consensus       178 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dp~~R  257 (269)
T cd05042         178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWLDPETR  257 (269)
T ss_pred             cccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHhcCcccc
Confidence                  246789999999999999999 78888765444444444443321   22344567888999999999999999


Q ss_pred             CCHHHHhc
Q 010626          147 LPALELLK  154 (505)
Q Consensus       147 pSa~ElL~  154 (505)
                      |++.+++.
T Consensus       258 pt~~~v~~  265 (269)
T cd05042         258 PTAEEVHE  265 (269)
T ss_pred             cCHHHHHH
Confidence            99999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.90  E-value=2.4e-23  Score=212.52  Aligned_cols=157  Identities=29%  Similarity=0.387  Sum_probs=121.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----------------CCccccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----------------TARSVIG   65 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----------------~~~~~~G   65 (505)
                      +.+..++.||+.||+|||++|  ++||||+|+||+++ .++.++|+|||++......                ......+
T Consensus       119 ~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (335)
T PTZ00024        119 SQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV  195 (335)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEEC-CCCCEEECCccceeeccccccccccccccccccccccccccc
Confidence            467789999999999999999  99999999999997 7789999999999765411                1112346


Q ss_pred             CCcccCcccccc--cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC-CCC--C------------------
Q 010626           66 TPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKP--A------------------  122 (505)
Q Consensus        66 t~~Y~APEll~~--~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~-~~p--~------------------  122 (505)
                      ++.|+|||.+.+  .++.++|+|||||++|+|++|..||......... ..+... ..+  .                  
T Consensus       196 ~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (335)
T PTZ00024        196 TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRK  274 (335)
T ss_pred             ccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCchhhCcchhhcccccccCcCC
Confidence            788999998743  4789999999999999999999999765443332 222110 000  0                  


Q ss_pred             -----CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          123 -----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       123 -----~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                           ......+..+.+||.+||. +|.+||++.++|.||||+...
T Consensus       275 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        275 PKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             cccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence                 0012346789999999996 799999999999999998654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.90  E-value=9e-24  Score=205.60  Aligned_cols=146  Identities=20%  Similarity=0.360  Sum_probs=117.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~ys   80 (505)
                      ..+..++.||+.||.|||++|  ++||||||+||+++ .++.++++|||.+....... ....++..|+|||.+. ..++
T Consensus        85 ~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~df~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~  160 (237)
T cd05576          85 ECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLD-DRGHIQLTYFSRWSEVEDSC-DGEAVENMYCAPEVGGISEET  160 (237)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEc-CCCCEEEecccchhcccccc-ccCCcCccccCCcccCCCCCC
Confidence            357889999999999999999  99999999999998 67899999999876554332 2345677899999884 5588


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH-----HHHhc
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA-----LELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa-----~ElL~  154 (505)
                      .++|+||+|+++|+|++|..|+....  ...     .......++...++.+++||.+||. +|.+|+++     .++++
T Consensus       161 ~~~DvwslG~il~el~~g~~~~~~~~--~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  233 (237)
T cd05576         161 EACDWWSLGAILFELLTGKTLVECHP--SGI-----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKS  233 (237)
T ss_pred             chhhHHHHHHHHHHHHHCcchhhcCc--hhc-----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHc
Confidence            99999999999999999998875421  111     1111123445678899999999995 79999985     99999


Q ss_pred             CCCC
Q 010626          155 DPFL  158 (505)
Q Consensus       155 hpff  158 (505)
                      ||||
T Consensus       234 h~~~  237 (237)
T cd05576         234 HPFF  237 (237)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.90  E-value=2.2e-23  Score=208.21  Aligned_cols=156  Identities=25%  Similarity=0.428  Sum_probs=124.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      +.+..++.||+.||.|||+++  ++||||||+||+++ .++.++|+|||+++......    .....++..|+|||.+ .
T Consensus       119 ~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~-~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~  195 (288)
T cd05061         119 QEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVA-HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD  195 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEc-CCCcEEECcCCccccccccccccccCCCcccccccCHHHhcc
Confidence            356789999999999999999  99999999999998 67899999999987543221    1122456789999987 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      +.++.++|+|||||++|+|++ |..||.. .........+..+..+ ..+...++.+++++.+||. +|.+||++.++++
T Consensus       196 ~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  273 (288)
T cd05061         196 GVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQVLKFVMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN  273 (288)
T ss_pred             CCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            568999999999999999998 7889876 3445555555544332 2344567899999999995 8999999999986


Q ss_pred             ------CCCCCCCC
Q 010626          155 ------DPFLVTDN  162 (505)
Q Consensus       155 ------hpff~~~~  162 (505)
                            ||||....
T Consensus       274 ~l~~~~~~~~~~~~  287 (288)
T cd05061         274 LLKDDLHPSFPEVS  287 (288)
T ss_pred             HHHhhcCCCCCCCC
Confidence                  89997654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.90  E-value=3e-23  Score=200.98  Aligned_cols=151  Identities=32%  Similarity=0.595  Sum_probs=125.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..+..++.||+.||.|||+.+  ++|+||+|+||+++ .++.++|+|||++......  ......++..|+|||.+. ..
T Consensus        93 ~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~  169 (250)
T cd05123          93 ERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG  169 (250)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEc-CCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCC
Confidence            457889999999999999999  99999999999997 6789999999999766443  234456888999999874 45


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH---HHHhc
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA---LELLK  154 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa---~ElL~  154 (505)
                      ++.++|+|+||+++|+|++|..||... ........+...  ...++...+..+.++|.+||. +|.+||++   .++++
T Consensus       170 ~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~~--~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         170 YGKAVDWWSLGVLLYEMLTGKPPFYAE-DRKEIYEKILKD--PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            788999999999999999999999763 345555555542  234556668899999999995 89999999   99999


Q ss_pred             CCCC
Q 010626          155 DPFL  158 (505)
Q Consensus       155 hpff  158 (505)
                      ||||
T Consensus       247 ~~~f  250 (250)
T cd05123         247 HPFF  250 (250)
T ss_pred             CCCC
Confidence            9998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.90  E-value=8.4e-24  Score=210.60  Aligned_cols=158  Identities=35%  Similarity=0.590  Sum_probs=121.9

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC---CCcEEEeecCceeeccCCC-----CccccCCCcccCccc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPEL   74 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~---~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEl   74 (505)
                      .++.++.||+.|+.|||++-  |+||||||.||++.++   .|.|||+|||+++.+..+-     ...++.|.+|+|||+
T Consensus       133 mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPEL  210 (438)
T KOG0666|consen  133 MVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPEL  210 (438)
T ss_pred             HHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHH
Confidence            58899999999999999999  9999999999999742   3899999999999886652     344578999999997


Q ss_pred             c--cccCCcccchhhHHHHHHHHhhcCCCCCCCC------Ch---HHHHHHHHc-CCC-----------CC---------
Q 010626           75 Y--EEEYNELVDIYSFGMCILEMVTCEYPYNECK------NP---AQIYKKVTS-GIK-----------PA---------  122 (505)
Q Consensus        75 l--~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~------~~---~~i~~~i~~-~~~-----------p~---------  122 (505)
                      +  ...|+.+.|||++|||+.||+|-++-|.+..      ++   .++.+.... |.+           |.         
T Consensus       211 LLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~  290 (438)
T KOG0666|consen  211 LLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFR  290 (438)
T ss_pred             hcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhH
Confidence            7  4579999999999999999999988775421      11   122111110 000           00         


Q ss_pred             -------------CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          123 -------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       123 -------------~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                                   ...+..++...+|+.++|. ||-+|.|++++|+|+||..+.
T Consensus       291 ~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~  344 (438)
T KOG0666|consen  291 RHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP  344 (438)
T ss_pred             HhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence                         0012235668899999995 999999999999999998754

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.90  E-value=2.6e-23  Score=206.19  Aligned_cols=149  Identities=26%  Similarity=0.449  Sum_probs=119.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC----ccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~----~~~~Gt~~Y~APEll-~   76 (505)
                      +.+..++.||+.||+|||+++  ++||||||+||+++ +++.+||+|||+++.......    ....+++.|+|||.+ .
T Consensus       109 ~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~-~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  185 (279)
T cd05109         109 QDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH  185 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc
Confidence            467889999999999999999  99999999999997 678999999999987643322    112346789999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|||||||++|||++ |..||.. .....+...+..+..+ ..+...++.+.++|.+||. +|.+||++.+++.
T Consensus       186 ~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         186 RRFTHQSDVWSYGVTVWELMTFGAKPYDG-IPAREIPDLLEKGERL-PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCCCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCcC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            568999999999999999998 8999865 3444455555554333 3345678899999999996 8999999999985


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      .
T Consensus       264 ~  264 (279)
T cd05109         264 E  264 (279)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.90  E-value=1.3e-23  Score=208.29  Aligned_cols=155  Identities=34%  Similarity=0.644  Sum_probs=125.5

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-cccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      .+..++.|++.||+|||+.+  ++|+||+|+||+++ .++.++|+|||++.......  .....++..|+|||.+ ...+
T Consensus       102 ~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~  178 (277)
T cd06640         102 QIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY  178 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEc-CCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCC
Confidence            56788999999999999999  99999999999998 67899999999997654322  2234678899999987 4458


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +.++|+||||+++|+|+||+.||.... +......+... .+..+....+..+.+||.+||. +|.+||++.++++||||
T Consensus       179 ~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  256 (277)
T cd06640         179 DSKADIWSLGITAIELAKGEPPNSDMH-PMRVLFLIPKN-NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI  256 (277)
T ss_pred             ccHHHHHHHHHHHHHHHHCCCCCCCcC-hHhHhhhhhcC-CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHh
Confidence            899999999999999999999997643 33333333332 2334555667899999999995 79999999999999999


Q ss_pred             CCCC
Q 010626          159 VTDN  162 (505)
Q Consensus       159 ~~~~  162 (505)
                      ....
T Consensus       257 ~~~~  260 (277)
T cd06640         257 VKNA  260 (277)
T ss_pred             hhcc
Confidence            7644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.90  E-value=2.8e-23  Score=203.51  Aligned_cols=148  Identities=22%  Similarity=0.368  Sum_probs=120.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC-----ccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~-----~~~~Gt~~Y~APEll~   76 (505)
                      ..+..++.||+.||+|||++|  ++||||||.||+++ .++.+||+|||++........     ....+++.|+|||.+.
T Consensus        95 ~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  171 (257)
T cd05116          95 KNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN  171 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEc-CCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhc
Confidence            467889999999999999999  99999999999998 678999999999976543321     1123457899999884


Q ss_pred             -ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 -EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                       ..++.++|+|||||++|||++ |..||.. .....+...+..+..+ ..+...++.+++||.+||. +|.+||++.++.
T Consensus       172 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~  249 (257)
T cd05116         172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYKG-MKGNEVTQMIESGERM-ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVE  249 (257)
T ss_pred             cCCcCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHhccCchhCcCHHHHH
Confidence             458889999999999999998 9999976 3455666666665443 3556678999999999996 899999999876


Q ss_pred             c
Q 010626          154 K  154 (505)
Q Consensus       154 ~  154 (505)
                      .
T Consensus       250 ~  250 (257)
T cd05116         250 L  250 (257)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.90  E-value=2.4e-23  Score=217.54  Aligned_cols=150  Identities=23%  Similarity=0.389  Sum_probs=121.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc----cccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR----SVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~----~~~Gt~~Y~APEll-~   76 (505)
                      +.+..++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.........    ...+++.|+|||++ .
T Consensus       214 ~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  290 (375)
T cd05104         214 EDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN  290 (375)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEE-CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC
Confidence            457889999999999999999  99999999999998 6789999999999765433221    12345679999987 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|||||||++|+|++ |..||..........+.+..+..+ ..+...+.++++||.+||. +|.+||++.++++
T Consensus       291 ~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~  369 (375)
T cd05104         291 CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM-LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ  369 (375)
T ss_pred             CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC-CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            568999999999999999998 889997755555666666655433 2345567899999999996 7999999999986


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      .
T Consensus       370 ~  370 (375)
T cd05104         370 L  370 (375)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.90  E-value=1.9e-23  Score=211.78  Aligned_cols=148  Identities=27%  Similarity=0.455  Sum_probs=119.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC----ccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~----~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||+++.......    ....++..|+|||.+ ..
T Consensus       110 ~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~  186 (316)
T cd05108         110 YLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR  186 (316)
T ss_pred             HHHHHHHHHHHHHHHHHhcC--eeccccchhheEec-CCCcEEEccccccccccCCCcceeccCCccceeecChHHhccC
Confidence            56789999999999999999  99999999999997 678999999999986643221    122345689999987 55


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|||++ |..||.+. ...++...+..+..+ ..+..++..+.+++.+||. +|.+||++.+++.+
T Consensus       187 ~~~~~~Di~slGv~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         187 IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERL-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCchhhhHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhCCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            68999999999999999998 99999763 444555544444333 2345667899999999995 89999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.90  E-value=2.1e-23  Score=206.99  Aligned_cols=148  Identities=22%  Similarity=0.313  Sum_probs=120.5

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..++.|++.||.|||++|  ++||||||+||+++ .++.+||+|||+++......    .....+++.|+|||.+ .+
T Consensus       125 ~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  201 (283)
T cd05091         125 DFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVF-DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG  201 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHcC--ccccccchhheEec-CCCceEecccccccccccchheeeccCccCCccccCHHHHhcC
Confidence            46789999999999999999  99999999999997 67899999999987653322    1223457799999977 56


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++|||||||++|||++ |..||.+ .....+...+..+..+ ..+..++..+.+|+.+||+ +|.+||++.+++..
T Consensus       202 ~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         202 KFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVIEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             CCCcchhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            68999999999999999998 8888876 4455666666655433 3455678899999999996 79999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.90  E-value=2.1e-23  Score=213.44  Aligned_cols=156  Identities=28%  Similarity=0.390  Sum_probs=121.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-------CCccccCCCcccCcccc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARSVIGTPEFMAPELY   75 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-------~~~~~~Gt~~Y~APEll   75 (505)
                      .++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++......       ......|++.|+|||.+
T Consensus       108 ~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  184 (337)
T cd07852         108 HKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLN-SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEIL  184 (337)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCcEEEeeccchhccccccccccCcchhcccccccccCceee
Confidence            45678999999999999999  99999999999998 7889999999999755322       12234689999999977


Q ss_pred             c--ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC----------------------------CCCCCC
Q 010626           76 E--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI----------------------------KPASLS  125 (505)
Q Consensus        76 ~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~----------------------------~p~~~~  125 (505)
                      .  ..++.++|+||||+++|+|+||+.||.................                            ......
T Consensus       185 ~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (337)
T cd07852         185 LGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL  264 (337)
T ss_pred             eccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhc
Confidence            3  4578899999999999999999999976443332221111100                            001112


Q ss_pred             CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          126 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       126 ~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      ...+..+.+||.+||+ +|.+||++.++++||||...
T Consensus       265 ~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         265 PKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             cCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            2357889999999996 89999999999999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.90  E-value=1.4e-23  Score=215.01  Aligned_cols=156  Identities=31%  Similarity=0.477  Sum_probs=121.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~--~   77 (505)
                      +.++.++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||++......  ......++..|+|||.+.  .
T Consensus       108 ~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  184 (337)
T cd07858         108 DHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCS  184 (337)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEc-CCCCEEECcCccccccCCCcccccccccccCccChHHHhcCC
Confidence            467889999999999999999  99999999999997 6789999999999765433  123446888999999773  4


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc-----------------------CC----CC--CCCCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-----------------------GI----KP--ASLSKVT  128 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~-----------------------~~----~p--~~~~~~~  128 (505)
                      .++.++|||||||++|+|++|+.||.+... ......+..                       ..    .+  .......
T Consensus       185 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (337)
T cd07858         185 EYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHA  263 (337)
T ss_pred             CCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccC
Confidence            588999999999999999999999965322 111111100                       00    00  0112346


Q ss_pred             ChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          129 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       129 s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      ++.+.+||.+||. +|.+|||+.++|+||||...
T Consensus       264 ~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         264 NPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             CHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            7889999999996 89999999999999999753

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.90  E-value=2.3e-23  Score=207.45  Aligned_cols=163  Identities=28%  Similarity=0.451  Sum_probs=126.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYEE-   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~~-   77 (505)
                      +.++.++.|++.||.|||+.+  ++||||+|+||+++ .++.++|+|||++.......   .....|++.|+|||.+.+ 
T Consensus       105 ~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  181 (288)
T cd05583         105 SEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLD-SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG  181 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEEC-CCCCEEEEECccccccccccccccccccCCccccCHHHhcCC
Confidence            467889999999999999999  99999999999997 67899999999987653322   223468899999998743 


Q ss_pred             --cCCcccchhhHHHHHHHHhhcCCCCCCCCC---hHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC---
Q 010626           78 --EYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP---  148 (505)
Q Consensus        78 --~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~---~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS---  148 (505)
                        .++.++|+||||+++|+|++|..||.....   ...+.+.+.....  ..+...++.++++|.+||. +|++|||   
T Consensus       182 ~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~t~~~  259 (288)
T cd05583         182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMSAEARDFIQKLLEKDPKKRLGANG  259 (288)
T ss_pred             CCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcccCHHHHHHHHHHhcCCHhhccCcch
Confidence              267899999999999999999999964221   2233333333322  3455578899999999996 7999998   


Q ss_pred             HHHHhcCCCCCCCCCCCcccC
Q 010626          149 ALELLKDPFLVTDNPKDLVCD  169 (505)
Q Consensus       149 a~ElL~hpff~~~~~~~l~~~  169 (505)
                      +.++|+||||+...+..+...
T Consensus       260 ~~~~l~~~~~~~~~~~~~~~~  280 (288)
T cd05583         260 ADEIKNHPFFQGIDWDDLAAK  280 (288)
T ss_pred             HHHHhcCcccccCCHHHHhhh
Confidence            567899999998776554433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.90  E-value=2.8e-23  Score=208.56  Aligned_cols=149  Identities=26%  Similarity=0.416  Sum_probs=118.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCcc-ccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~-~~Gt~~Y~APEll-~~~y   79 (505)
                      +.++.++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++.......... ...+..|+|||.+ ...+
T Consensus       119 ~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  195 (297)
T cd05089         119 QQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVG-ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVY  195 (297)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEEC-CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCC
Confidence            357889999999999999999  99999999999997 67899999999986432221111 1234579999987 4568


Q ss_pred             CcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           80 NELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      +.++|||||||++|+|++ |..||.. .........+..+..+ ..+..++..+++||.+||. +|.+||++.++++.
T Consensus       196 ~~~~DvwSlG~il~el~t~g~~pf~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         196 TTKSDVWSFGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRM-EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999997 9999976 3455556666554332 3455678999999999996 79999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.90  E-value=2.5e-23  Score=203.02  Aligned_cols=150  Identities=30%  Similarity=0.554  Sum_probs=123.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~-~~   78 (505)
                      +.++.|+.||+.||.|||++|  ++|+||||+||+++ .++.++|+|||.+.......  .....|++.|+|||++. ..
T Consensus       100 ~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  176 (255)
T cd08219         100 DTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP  176 (255)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEC-CCCcEEEcccCcceeecccccccccccCCccccCHHHHccCC
Confidence            357789999999999999999  99999999999997 67899999999997664332  23456889999999884 45


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      ++.++|+||||+++|+|++|..||.. .+.......+..+..+ ..+...+..+++||.+||. +|.+||++.+++..-
T Consensus       177 ~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         177 YNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             cCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence            88999999999999999999999976 4445555555554333 3455678899999999995 899999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.90  E-value=3.5e-23  Score=206.98  Aligned_cols=148  Identities=26%  Similarity=0.408  Sum_probs=119.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++ .++.++|+|||++.......    .....+++.|+|||.+ .
T Consensus       123 ~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  199 (291)
T cd05094         123 SQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY  199 (291)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc
Confidence            357889999999999999999  99999999999998 67899999999996553321    1233567889999977 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|+| |..||... ........+..+..+ ..+...+..+.+++.+||. +|.+||++.++++
T Consensus       200 ~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         200 RKFTTESDVWSFGVILWEIFTYGKQPWFQL-SNTEVIECITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            568899999999999999999 99998763 444455555554433 3445568899999999996 8999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.90  E-value=3.5e-23  Score=206.70  Aligned_cols=148  Identities=24%  Similarity=0.401  Sum_probs=119.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll~-   76 (505)
                      ..+..++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++.......    .....+++.|+|||.+. 
T Consensus       120 ~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  196 (288)
T cd05093         120 SQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY  196 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEc-cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc
Confidence            357889999999999999999  99999999999997 77899999999987553221    12234567899999874 


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|||||||++|+|++ |..||... ........+..+..+ ..+...++.+.+|+.+||. +|.+|||+.+++.
T Consensus       197 ~~~~~~sDiwslG~il~~l~t~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         197 RKFTTESDVWSLGVVLWEIFTYGKQPWYQL-SNNEVIECITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            568899999999999999998 89998764 445555666655433 3445678899999999996 7999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.90  E-value=2.4e-23  Score=209.49  Aligned_cols=148  Identities=22%  Similarity=0.322  Sum_probs=113.8

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+++......    .....+++.|+|||++ .+
T Consensus       139 ~~~~i~~~i~~al~~lH~~~--ivH~dlkp~Nill~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  215 (304)
T cd05096         139 SLLHVALQIASGMKYLSSLN--FVHRDLATRNCLVG-ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG  215 (304)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--ccccCcchhheEEc-CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC
Confidence            56789999999999999999  99999999999998 67899999999997654322    1223457789999987 56


Q ss_pred             cCCcccchhhHHHHHHHHhh--cCCCCCCCCChHHHHHHHHc----CC--CCCCCCCCCChHHHHHHHHhcC-CCCCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTS----GI--KPASLSKVTDPQVKQFIEKCIV-PASLRLP  148 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT--G~~Pf~~~~~~~~i~~~i~~----~~--~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS  148 (505)
                      .++.++||||||+++|+|++  +..||..... .+....+..    ..  .....+..++..+.+||.+||. +|.+|||
T Consensus       216 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs  294 (304)
T cd05096         216 KFTTASDVWAFGVTLWEILMLCKEQPYGELTD-EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS  294 (304)
T ss_pred             CCCchhhhHHHHHHHHHHHHccCCCCCCcCCH-HHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence            68999999999999999986  6678876433 332222211    11  1112234567899999999996 8999999


Q ss_pred             HHHHhc
Q 010626          149 ALELLK  154 (505)
Q Consensus       149 a~ElL~  154 (505)
                      +.++.+
T Consensus       295 ~~~i~~  300 (304)
T cd05096         295 FSDIHA  300 (304)
T ss_pred             HHHHHH
Confidence            999843

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.90  E-value=3.9e-23  Score=202.05  Aligned_cols=147  Identities=22%  Similarity=0.425  Sum_probs=120.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~ys   80 (505)
                      ..+..++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++....... ....++..|+|||++. ..++
T Consensus       102 ~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~  177 (256)
T cd05082         102 DCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKKFS  177 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEc-CCCcEEecCCccceeccccC-CCCccceeecCHHHHccCCCC
Confidence            356789999999999999999  99999999999997 77899999999987553322 2334556899999874 4588


Q ss_pred             cccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           81 ELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++|||||||++|+|++ |+.||.. .........+..+..+ ..+...++.++++|.+||. +|.+|||+.++++
T Consensus       178 ~~~Dv~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         178 TKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKM-DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             chhhhHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            99999999999999998 9999975 4455666666555433 4556678999999999995 8999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.90  E-value=4.1e-23  Score=202.01  Aligned_cols=148  Identities=22%  Similarity=0.370  Sum_probs=116.8

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCCcccCcccc-
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~~Y~APEll-   75 (505)
                      .+..++.||+.||+|||+.+  ++||||||+||+++ .++.+||+|||+++......      .....+++.|+|||.+ 
T Consensus        99 ~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  175 (262)
T cd05058          99 DLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ  175 (262)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCccccccccCCcceeecccccCcCCccccChhHhc
Confidence            46778899999999999999  99999999999997 67899999999987543221      1223456789999987 


Q ss_pred             cccCCcccchhhHHHHHHHHhhcC-CCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCE-YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~-~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ...++.++|||||||++|||++|. .||.. .+...+...+..+..+ ..+...++.+.+++.+||. +|.+||++.+++
T Consensus       176 ~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il  253 (262)
T cd05058         176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRL-LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELV  253 (262)
T ss_pred             cCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            456889999999999999999954 55544 4555555555554333 3345567899999999996 899999999998


Q ss_pred             cC
Q 010626          154 KD  155 (505)
Q Consensus       154 ~h  155 (505)
                      +.
T Consensus       254 ~~  255 (262)
T cd05058         254 SR  255 (262)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.90  E-value=6e-23  Score=204.31  Aligned_cols=149  Identities=25%  Similarity=0.459  Sum_probs=119.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..+..|+.||+.||.|||+++  ++||||||+||+++ .++.+||+|||+++......    .....++..|+|||.+ .
T Consensus       109 ~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~  185 (279)
T cd05111         109 QRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLK-SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF  185 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc
Confidence            357889999999999999999  99999999999998 67899999999997653221    1223466789999987 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      +.++.++||||||+++|||++ |..||.+. ........+..+..+ ..+..++..+..++.+||. +|.+||++.++++
T Consensus       186 ~~~~~~~Dv~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKGERL-AQPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCcCchhhHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            568999999999999999998 99999763 444444555544333 3445567889999999995 8999999999876


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      .
T Consensus       264 ~  264 (279)
T cd05111         264 E  264 (279)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.90  E-value=3.2e-23  Score=205.30  Aligned_cols=148  Identities=24%  Similarity=0.431  Sum_probs=118.4

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCccccc-c
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll~-~   77 (505)
                      .+..++.|++.||+|||+.|  ++||||||+||+++ .++.++|+|||++.......    .....+++.|+|||.+. +
T Consensus       120 ~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  196 (277)
T cd05062         120 KMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG  196 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEc-CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC
Confidence            56788999999999999999  99999999999998 67899999999986543221    11224567899999884 5


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|++ |..||.+. ........+..... ...+...+..+++++.+||. +|.+||++.+++++
T Consensus       197 ~~~~~~Di~slG~~l~el~~~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         197 VFTTYSDVWSFGVVLWEIATLAEQPYQGM-SNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CcCchhHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            68999999999999999999 78898763 44455555544433 23455677899999999996 79999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=9.9e-24  Score=240.80  Aligned_cols=153  Identities=16%  Similarity=0.198  Sum_probs=113.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC------------------CCCcEEEeecCceeeccCC-----
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------------------NNGEVKIGDLGLAIVMQQP-----   58 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~------------------~~g~vKL~DFGlA~~~~~~-----   58 (505)
                      ..++.|++||+.||+|||++|  |+||||||+||||+.                  .++.+|++|||+++.....     
T Consensus        80 ~~~~~i~~qi~~al~~lH~~g--IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~  157 (793)
T PLN00181         80 FECFHVFRQIVEIVNAAHSQG--IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRI  157 (793)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccch
Confidence            467899999999999999999  999999999999951                  2345677777777532110     


Q ss_pred             -------------CCccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCC
Q 010626           59 -------------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL  124 (505)
Q Consensus        59 -------------~~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~  124 (505)
                                   .....+||+.|||||++ ...|+.++|||||||++|||++|..|+...   ......+.....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~~~~~~  234 (793)
T PLN00181        158 EKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRVLPPQI  234 (793)
T ss_pred             hhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhhcChhh
Confidence                         00123588999999987 566999999999999999999998887532   1222222222222221


Q ss_pred             CCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          125 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       125 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      . ...+....++.+||. +|.+||++.|+|+||||..
T Consensus       235 ~-~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~  270 (793)
T PLN00181        235 L-LNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE  270 (793)
T ss_pred             h-hcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence            1 124567889999996 7999999999999999975

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.90  E-value=4e-23  Score=206.58  Aligned_cols=153  Identities=29%  Similarity=0.498  Sum_probs=119.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC---ccccCCCcccCccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYE--   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~---~~~~Gt~~Y~APEll~--   76 (505)
                      ..++.++.||+.||+|||+.|  |+||||||+||+++ .++.+||+|||++........   ....+++.|+|||.+.  
T Consensus       116 ~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  192 (302)
T cd07864         116 DHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGE  192 (302)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCcEEeCcccccccccCCcccccccceeccCccChHHhcCC
Confidence            467899999999999999999  99999999999997 778999999999976543321   2234677899999874  


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc---CCCCCC-------------------------CCCCC
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKPAS-------------------------LSKVT  128 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~---~~~p~~-------------------------~~~~~  128 (505)
                      ..++.++|||||||++|+|++|+.||....... ....+..   ...+..                         .....
T Consensus       193 ~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (302)
T cd07864         193 ERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFI  271 (302)
T ss_pred             CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCC
Confidence            347889999999999999999999997643322 2222221   111100                         11235


Q ss_pred             ChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          129 DPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       129 s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      ++.+.++|.+||. +|.+||++.+++.||||
T Consensus       272 ~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         272 PTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            7899999999996 89999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=3.9e-23  Score=203.82  Aligned_cols=147  Identities=27%  Similarity=0.455  Sum_probs=120.0

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..++.||+.||.|||+++  ++||||||+||+++ .++.+||+|||+++......    .....++..|+|||.+ .+
T Consensus       120 ~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  196 (277)
T cd05032         120 KFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVA-EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG  196 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--ccccccChheEEEc-CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC
Confidence            57789999999999999999  99999999999998 67899999999987653322    1223467889999987 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++|||||||++|+|+| |..||.. .......+.+..+.. ...+...+..+.++|.+||. +|.+|||+.+++.
T Consensus       197 ~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         197 VFTTKSDVWSFGVVLWEMATLAEQPYQG-LSNEEVLKFVIDGGH-LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCcccchHHHHHHHHHhhccCCCCCcc-CCHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            68899999999999999998 9999976 345555555554433 33455568999999999996 7999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.90  E-value=6e-23  Score=201.85  Aligned_cols=147  Identities=27%  Similarity=0.416  Sum_probs=120.2

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc---cccCCCcccCcccc-ccc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~---~~~Gt~~Y~APEll-~~~   78 (505)
                      .++.++.|++.||+|||++|  ++||||||+||+++ .++.+||+|||++.........   ...+++.|+|||.+ ...
T Consensus       105 ~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  181 (263)
T cd05052         105 VLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK  181 (263)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCC
Confidence            56788999999999999999  99999999999997 7789999999999766443211   12245679999977 456


Q ss_pred             CCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           79 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ++.++|||||||++|+|++ |..||.. ......+..+..+..+ ..+...++.+.++|.+||. +|.+||++.++++
T Consensus       182 ~~~~~Dv~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         182 FSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKGYRM-ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             CCchhHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            8899999999999999998 8999876 4555666666655433 4556678999999999996 8999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.90  E-value=5.2e-23  Score=201.38  Aligned_cols=151  Identities=33%  Similarity=0.629  Sum_probs=123.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.|++.||.|||++|  ++|+||+|+||+++  ++.+||+|||++.......  .....|++.|+|||.+. ..
T Consensus       106 ~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~--~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~  181 (260)
T cd08222         106 NQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG  181 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEee--cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCC
Confidence            356789999999999999999  99999999999997  3579999999987654322  23446888999999774 45


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++|+||||+++|+|++|..||... ........+..+..+ ..+..++..+.++|.+||. +|.+||++.++++|||
T Consensus       182 ~~~~~Dv~slG~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  259 (260)
T cd08222         182 YDSKSDIWSLGCILYEMCCLAHAFEGQ-NFLSVVLRIVEGPTP-SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF  259 (260)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHcCCCC-CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence            788999999999999999999999753 344444444444333 3556778899999999996 7999999999999999


Q ss_pred             C
Q 010626          158 L  158 (505)
Q Consensus       158 f  158 (505)
                      |
T Consensus       260 ~  260 (260)
T cd08222         260 I  260 (260)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.90  E-value=2.3e-23  Score=214.63  Aligned_cols=155  Identities=30%  Similarity=0.432  Sum_probs=120.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc--ccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~--~~y   79 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++...... .....+++.|+|||.+.  ..+
T Consensus       120 ~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~-~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  195 (345)
T cd07877         120 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDE-MTGYVATRWYRAPEIMLNWMHY  195 (345)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEc-CCCCEEEeccccccccccc-ccccccCCCccCHHHHhCccCC
Confidence            357789999999999999999  99999999999997 6789999999998765332 33456889999999874  357


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC--------------------------CCCC---CCCCCCCh
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--------------------------IKPA---SLSKVTDP  130 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~--------------------------~~p~---~~~~~~s~  130 (505)
                      +.++|||||||++|+|++|+.||....... ....+...                          ....   ......++
T Consensus       196 ~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (345)
T cd07877         196 NQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP  274 (345)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCH
Confidence            889999999999999999999996533222 21111110                          0000   01113577


Q ss_pred             HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      .+.+||.+||. +|.+||++.+++.||||+..
T Consensus       275 ~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         275 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             HHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence            89999999996 79999999999999999863

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.90  E-value=3.6e-23  Score=203.41  Aligned_cols=151  Identities=34%  Similarity=0.545  Sum_probs=123.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----------------------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----------------------   59 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----------------------   59 (505)
                      ..++.++.||+.||.|||++|  ++|+||+|+||+++ .++.++|+|||++.......                      
T Consensus       102 ~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (280)
T cd05581         102 KCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLD-KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR  178 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEEC-CCCCEEecCCccccccCCccccccCCCCCccccccccccccc
Confidence            467899999999999999999  99999999999997 77899999999987654322                      


Q ss_pred             CccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHH
Q 010626           60 ARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEK  138 (505)
Q Consensus        60 ~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~k  138 (505)
                      .....++..|+|||.+ ...++.++|+||||++++++++|+.||.... ....+..+...  ...++...++.+.+||.+
T Consensus       179 ~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~li~~  255 (280)
T cd05581         179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKILKL--EYSFPPNFPPDAKDLIEK  255 (280)
T ss_pred             cccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHHhc--CCCCCCccCHHHHHHHHH
Confidence            1233578899999977 4558889999999999999999999998644 33334444332  223445568899999999


Q ss_pred             hcC-CCCCCCCH----HHHhcCCCC
Q 010626          139 CIV-PASLRLPA----LELLKDPFL  158 (505)
Q Consensus       139 cL~-dP~~RpSa----~ElL~hpff  158 (505)
                      ||. +|.+||++    .++++||||
T Consensus       256 ~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         256 LLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HhcCCHhhCCCcccCHHHHhcCCCC
Confidence            995 79999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.90  E-value=3.9e-23  Score=204.93  Aligned_cols=150  Identities=23%  Similarity=0.383  Sum_probs=118.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEeecCceeeccCCCC----ccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~--~g~vKL~DFGlA~~~~~~~~----~~~~Gt~~Y~APEll   75 (505)
                      ..+..++.||+.||+|||+++  ++||||||+||+++..  ...+||+|||+++.......    .....++.|+|||++
T Consensus       116 ~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  193 (277)
T cd05036         116 KDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF  193 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHH
Confidence            457789999999999999999  9999999999999732  23699999999976532211    122335679999987


Q ss_pred             -cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           76 -EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        76 -~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                       ...++.++|||||||++|+|++ |..||.... ...+...+..... ...+...++.+.+|+.+||. +|.+||++.++
T Consensus       194 ~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~v  271 (277)
T cd05036         194 LDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT-NQEVMEFVTGGGR-LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATI  271 (277)
T ss_pred             hcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence             4569999999999999999997 999997643 3445555544433 33455678899999999996 79999999999


Q ss_pred             hcC
Q 010626          153 LKD  155 (505)
Q Consensus       153 L~h  155 (505)
                      ++|
T Consensus       272 l~~  274 (277)
T cd05036         272 LER  274 (277)
T ss_pred             HHH
Confidence            986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.90  E-value=4.3e-23  Score=202.09  Aligned_cols=149  Identities=23%  Similarity=0.412  Sum_probs=120.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccc---cCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV---IGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~---~Gt~~Y~APEll-~~   77 (505)
                      +.+..++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||+++..........   .++..|+|||.+ ..
T Consensus       100 ~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~  176 (256)
T cd05059         100 EWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYS  176 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEEC-CCCcEEECCcccceecccccccccCCCCCCccccCHHHhccC
Confidence            357889999999999999999  99999999999997 678999999999876543322222   234579999987 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++|+||||+++|+|++ |..||... ........+..+..+ ..+...++.+.+++.+||. +|.+||++.++++.
T Consensus       177 ~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         177 RFSSKSDVWSFGVLMWEVFSEGKMPYERF-SNSEVVESVSAGYRL-YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             CCCchhhHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            68899999999999999999 89999753 445556666555333 3455678999999999996 89999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.89  E-value=1.6e-23  Score=213.77  Aligned_cols=157  Identities=27%  Similarity=0.450  Sum_probs=117.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---------CccccCCCcccCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---------ARSVIGTPEFMAP   72 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---------~~~~~Gt~~Y~AP   72 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++ .++.++++||+.+.......         .....++..|+||
T Consensus       101 ~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  177 (328)
T cd08226         101 ALIGNILFGALRGLNYLHQNG--YIHRNIKASHILIS-GDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSP  177 (328)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEe-CCCcEEEechHHHhhhhccCccccccccccccccCccCccCh
Confidence            356789999999999999999  99999999999998 67899999998653221110         0112345679999


Q ss_pred             ccccc---cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC-C---------------------------
Q 010626           73 ELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-P---------------------------  121 (505)
Q Consensus        73 Ell~~---~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~-p---------------------------  121 (505)
                      |++.+   .++.++|||||||++|+|++|..||............+..... +                           
T Consensus       178 E~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (328)
T cd08226         178 ELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGES  257 (328)
T ss_pred             hhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccc
Confidence            98843   4789999999999999999999999775444433333221100 0                           


Q ss_pred             ----------------CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          122 ----------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       122 ----------------~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                                      .......++.+.+||.+||. +|.+|||+.++|+||||...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         258 VVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             hhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                            00112345678999999996 89999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.89  E-value=4.5e-23  Score=212.28  Aligned_cols=157  Identities=32%  Similarity=0.438  Sum_probs=123.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccc--cC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--EY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~--~y   79 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++...... .....+++.|+|||.+.+  .+
T Consensus       118 ~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  193 (343)
T cd07880         118 DRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQTDSE-MTGYVVTRWYRAPEVILNWMHY  193 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccccccccC-ccccccCCcccCHHHHhCCCCC
Confidence            467889999999999999999  99999999999997 6789999999998765432 234467899999998743  48


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC-------------------------C---CCCCCCCChH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-------------------------P---ASLSKVTDPQ  131 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~-------------------------p---~~~~~~~s~~  131 (505)
                      +.++|+||||+++|+|++|..||............+.....                         +   ..+....++.
T Consensus       194 ~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (343)
T cd07880         194 TQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPL  273 (343)
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChH
Confidence            89999999999999999999999865433222221111000                         0   0112345778


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      +.++|.+||. +|.+|||+.+++.||||+...
T Consensus       274 ~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~  305 (343)
T cd07880         274 AVNVLEKMLVLDAESRITAAEALAHPYFEEFH  305 (343)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence            9999999996 899999999999999998653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.89  E-value=6.3e-23  Score=202.35  Aligned_cols=149  Identities=24%  Similarity=0.340  Sum_probs=115.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccccc-
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll~~-   77 (505)
                      .++.++.|++.||+|||+++  ++||||||+||+++ .++.+||+|||++.......    .....+++.|+|||++.. 
T Consensus       101 ~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  177 (269)
T cd05087         101 TLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLT-ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV  177 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEc-CCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccc
Confidence            46678999999999999999  99999999999998 67899999999986543221    123456788999998742 


Q ss_pred             -------cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCC---CCCCCCCCChHHHHHHHHhcCCCCCC
Q 010626           78 -------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK---PASLSKVTDPQVKQFIEKCIVPASLR  146 (505)
Q Consensus        78 -------~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~---p~~~~~~~s~~l~~LI~kcL~dP~~R  146 (505)
                             .++.++|+||||+++|+|++ |..||............+.....   .+.+....+..+.+++.+|+.+|.+|
T Consensus       178 ~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~R  257 (269)
T cd05087         178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQR  257 (269)
T ss_pred             cccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHhcCcccC
Confidence                   35789999999999999996 99999765444433333332211   22233345778999999999889999


Q ss_pred             CCHHHHhc
Q 010626          147 LPALELLK  154 (505)
Q Consensus       147 pSa~ElL~  154 (505)
                      ||+.+++.
T Consensus       258 pt~~~l~~  265 (269)
T cd05087         258 PSAEEVHL  265 (269)
T ss_pred             CCHHHHHH
Confidence            99999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.89  E-value=4.5e-23  Score=205.61  Aligned_cols=149  Identities=27%  Similarity=0.458  Sum_probs=120.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..+..++.||+.||+|||+++  |+||||||+||+++ .++.+||+|||+++......    .....+++.|+|||.+ .
T Consensus       132 ~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  208 (293)
T cd05053         132 KDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVT-EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD  208 (293)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEc-CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc
Confidence            356789999999999999999  99999999999997 77899999999997654322    1112345679999977 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|||||||++|+|++ |..||.. ....+.+..+..+..+ ..+...+..+.+|+.+||. +|.+|||+.++++
T Consensus       209 ~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~  286 (293)
T cd05053         209 RVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLKEGYRM-EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE  286 (293)
T ss_pred             CCcCcccceeehhhHHHHHhcCCCCCCCC-CCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            568999999999999999997 9999976 4455566666555433 3445667899999999996 7999999999987


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       287 ~  287 (293)
T cd05053         287 D  287 (293)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.89  E-value=6e-23  Score=201.03  Aligned_cols=148  Identities=24%  Similarity=0.396  Sum_probs=118.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..++.||+.||+|||+++  ++||||||+||+++ .++.++|+|||++.......   .....++..|+|||.+ ..
T Consensus       103 ~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  179 (261)
T cd05072         103 PKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG  179 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEec-CCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccC
Confidence            356789999999999999999  99999999999998 67899999999997664322   1223456789999987 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++||||||+++|+|+| |..||... ........+..+... ......+..+.+++.+||. +|.+||++.++++
T Consensus       180 ~~~~~~Di~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         180 SFTIKSDVWSFGILLYEIVTYGKIPYPGM-SNSDVMSALQRGYRM-PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CCChhhhhhhhHHHHHHHHccCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            68889999999999999998 99999763 344455555544333 2334567899999999996 7999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.89  E-value=5.7e-23  Score=201.57  Aligned_cols=150  Identities=31%  Similarity=0.494  Sum_probs=120.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||++|  ++|+||||+||+++ .++.++|+|||++.......  .....|++.|+|||.+ ...
T Consensus       106 ~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~  182 (267)
T cd08229         106 KTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG  182 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCC
Confidence            357789999999999999999  99999999999998 67899999999987654322  2334688999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCC-hHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKN-PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~-~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ++.++|+||||+++|+|++|..||..... .....+.+.....+.......++.++++|.+||. +|.+|||+.++++
T Consensus       183 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            88899999999999999999999965332 2344444444444444445678899999999996 8999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.89  E-value=6.3e-23  Score=203.83  Aligned_cols=148  Identities=25%  Similarity=0.376  Sum_probs=119.9

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......    .....++..|+|||.+ ..
T Consensus       125 ~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  201 (283)
T cd05090         125 DFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIG-EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG  201 (283)
T ss_pred             HHHHHHHHHHHHHHHHHhcC--eehhccccceEEEc-CCCcEEeccccccccccCCcceecccCCCccceecChHHhccC
Confidence            45678999999999999999  99999999999998 67899999999997653221    2223456789999987 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|++ |..||.+. ....+...+.....+ ..+..+++.+++++.+||. +|.+||++.+++++
T Consensus       202 ~~~~~~Dv~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         202 KFSSDSDIWSFGVVLWEIFSFGLQPYYGF-SNQEVIEMVRKRQLL-PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             CCCchhhhHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            68999999999999999998 98999763 445555555554333 3556778999999999996 79999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.89  E-value=7.9e-23  Score=199.43  Aligned_cols=149  Identities=27%  Similarity=0.433  Sum_probs=119.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......     .....++..|+|||.+.
T Consensus        97 ~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~  173 (257)
T cd05040          97 STLCDYAVQIANGMRYLESKR--FIHRDLAARNILLA-SDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR  173 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEe-cCCEEEeccccccccccccccceecccCCCCCceecCHHHhc
Confidence            357889999999999999999  99999999999998 66899999999997664321     11234677899999874


Q ss_pred             -ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 -EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                       ..++.++|||||||++|+|++ |..||... +...+...+.........+...+..+.+++.+||. +|.+||++.+++
T Consensus       174 ~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~  252 (257)
T cd05040         174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALR  252 (257)
T ss_pred             ccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHH
Confidence             568999999999999999998 99999764 44445555543323333445567899999999996 799999999987


Q ss_pred             c
Q 010626          154 K  154 (505)
Q Consensus       154 ~  154 (505)
                      .
T Consensus       253 ~  253 (257)
T cd05040         253 E  253 (257)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.89  E-value=7.1e-23  Score=201.84  Aligned_cols=154  Identities=34%  Similarity=0.496  Sum_probs=118.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc-c-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-E-   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~-~-   77 (505)
                      ..++.++.||+.||.|||++|  ++||||+|+||+++ .++.++|+|||++.......  .....++..|+|||.+. . 
T Consensus        98 ~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  174 (282)
T cd07829          98 NLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILIN-RDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK  174 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEc-CCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCc
Confidence            467889999999999999999  99999999999997 67899999999987654332  22334677899999873 3 


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC-------------------CCCC-------CCCCCCChH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-------------------IKPA-------SLSKVTDPQ  131 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~-------------------~~p~-------~~~~~~s~~  131 (505)
                      .++.++|+||||+++|+|++|..||................                   ..+.       ......+..
T Consensus       175 ~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (282)
T cd07829         175 HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPE  254 (282)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHH
Confidence            68899999999999999999999997644332221111100                   0000       001123678


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +.++|.+||. +|.+||++.+++.||||
T Consensus       255 ~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         255 GIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            9999999996 89999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.89  E-value=5.2e-23  Score=204.05  Aligned_cols=155  Identities=35%  Similarity=0.629  Sum_probs=126.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      +.+..++.|++.||.|||++|  ++|+||+|+||+++ .++.++|+|||++.......  .....++..|+|||.+ ...
T Consensus       101 ~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  177 (277)
T cd06641         101 TQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA  177 (277)
T ss_pred             HHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEEC-CCCCEEEeecccceecccchhhhccccCCccccChhhhccCC
Confidence            457889999999999999999  99999999999997 67899999999987654322  2334688899999987 445


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++|+|||||++|+|++|..||... ........+.... +..+...++..+.++|.+||. +|.+||++.++++|||
T Consensus       178 ~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~  255 (277)
T cd06641         178 YDSKADIWSLGITAIELAKGEPPHSEL-HPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  255 (277)
T ss_pred             CCchhhHHHHHHHHHHHHcCCCCCCcc-chHHHHHHHhcCC-CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence            788999999999999999999999753 3444444443332 334556678899999999995 7999999999999999


Q ss_pred             CCCC
Q 010626          158 LVTD  161 (505)
Q Consensus       158 f~~~  161 (505)
                      |...
T Consensus       256 ~~~~  259 (277)
T cd06641         256 IVRF  259 (277)
T ss_pred             Hhhh
Confidence            9764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.89  E-value=7.7e-23  Score=200.82  Aligned_cols=149  Identities=23%  Similarity=0.431  Sum_probs=120.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCcc---ccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~---~~Gt~~Y~APEll~-~   77 (505)
                      ..++.++.||+.||.|||++|  ++|+||||+||+++ .++.+||+|||.++.........   ..++..|+|||.+. .
T Consensus       100 ~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~  176 (256)
T cd05113         100 SQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVD-DQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS  176 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcC
Confidence            467889999999999999999  99999999999997 67899999999987654332211   23456799999884 5


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|++ |..||.... .......+..+..+ ..+...+..+++++.+||. +|.+||++.+++.+
T Consensus       177 ~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFN-NSETVEKVSQGLRL-YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             cccchhHHHHHHHHHHHHhcCCCCCcCcCC-HHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            68999999999999999999 999997643 44555556555433 3345568899999999996 79999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.89  E-value=9.7e-24  Score=214.90  Aligned_cols=158  Identities=21%  Similarity=0.397  Sum_probs=123.1

Q ss_pred             CHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-------------------CCCcEEEeecCceeeccCCCCc
Q 010626            1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-------------------NNGEVKIGDLGLAIVMQQPTAR   61 (505)
Q Consensus         1 Lk~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~-------------------~~g~vKL~DFGlA~~~~~~~~~   61 (505)
                      |..|+.+++||+.+++|||+.+  ++|.||||+||++..                   .+-.|+++|||.|..-.+. ..
T Consensus       191 i~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-hs  267 (415)
T KOG0671|consen  191 IDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-HS  267 (415)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-cc
Confidence            4689999999999999999999  999999999999831                   1235899999999766544 36


Q ss_pred             cccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHH--HHHHHcCCCCC----------------
Q 010626           62 SVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI--YKKVTSGIKPA----------------  122 (505)
Q Consensus        62 ~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i--~~~i~~~~~p~----------------  122 (505)
                      +.+.|..|+|||++ .-+++.++||||+||||+|+.||...|..-.+.+.+  .+.|....+..                
T Consensus       268 ~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rl  347 (415)
T KOG0671|consen  268 TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRL  347 (415)
T ss_pred             eeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccc
Confidence            67889999999977 678999999999999999999999999875554432  23332211100                


Q ss_pred             CCCC-------------------------CCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          123 SLSK-------------------------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       123 ~~~~-------------------------~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      .++.                         ....++.+||++||. ||.+|+|+.|+|.||||+..
T Consensus       348 dw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  348 DWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             cCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence            0000                         011357899999995 99999999999999999764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.89  E-value=1e-22  Score=193.59  Aligned_cols=154  Identities=37%  Similarity=0.651  Sum_probs=128.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +.+..++.+++.+|.|||+.+  ++|+||+|.||+++ .++.++|+|||.+...... ......++..|++||.+ ...+
T Consensus        87 ~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~  163 (244)
T smart00220       87 DEARFYARQILSALEYLHSNG--IIHRDLKPENILLD-EDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGY  163 (244)
T ss_pred             HHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEEC-CCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCC
Confidence            467889999999999999999  99999999999998 5689999999999776543 33445688899999987 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCC-CChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV-TDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~-~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      +.++|||+||+++|+|++|..||........+...+............ .+..+.+++.+||. +|.+||++.++++|||
T Consensus       164 ~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~  243 (244)
T smart00220      164 GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPF  243 (244)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCC
Confidence            889999999999999999999997755666666666655443322222 67899999999996 8999999999999999


Q ss_pred             C
Q 010626          158 L  158 (505)
Q Consensus       158 f  158 (505)
                      |
T Consensus       244 ~  244 (244)
T smart00220      244 F  244 (244)
T ss_pred             C
Confidence            7

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.89  E-value=2.7e-23  Score=207.75  Aligned_cols=155  Identities=30%  Similarity=0.392  Sum_probs=124.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +.++.++.|++.|++|||+.|  |+||||||+||+++ .++.+||.|||+|+..... ....++.|..|.|||++ +.+|
T Consensus       118 ~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~-~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~  194 (369)
T KOG0665|consen  118 ETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVN-SDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGY  194 (369)
T ss_pred             HHHHHHHHHHHHHHHHHHhcc--eeecccCcccceec-chhheeeccchhhcccCcccccCchhheeeccCchheeccCC
Confidence            478999999999999999999  99999999999997 7789999999999776555 45566889999999977 5569


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC--------------------------------C-CCC--
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--------------------------------P-ASL--  124 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~--------------------------------p-~~~--  124 (505)
                      .+.+||||+||++.||++|+.-|.+....++..+.+..-..                                | ..+  
T Consensus       195 ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~  274 (369)
T KOG0665|consen  195 KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPV  274 (369)
T ss_pred             cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccc
Confidence            99999999999999999999999875544444333221000                                0 000  


Q ss_pred             ----CCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 010626          125 ----SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  159 (505)
Q Consensus       125 ----~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~  159 (505)
                          ++.....+++++.+||. +|++|.++.++|+||||+
T Consensus       275 ~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  275 VLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             cccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                11223468999999995 999999999999999997

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.89  E-value=7e-23  Score=203.69  Aligned_cols=148  Identities=24%  Similarity=0.399  Sum_probs=118.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      .++..++.||+.||+|||++|  ++||||||+|||++ .++.+||+|||++.......    .....+++.|+|||.+ .
T Consensus       122 ~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  198 (280)
T cd05092         122 GQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY  198 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEc-CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc
Confidence            467889999999999999999  99999999999997 67899999999997553322    1222356789999977 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|||||||++|+|++ |..||.... .......+..+..+ ..+..+++.+.+||.+||. +|.+||++.+++.
T Consensus       199 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         199 RKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-NTEAIECITQGREL-ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CCcCchhhHHHHHHHHHHHHcCCCCCCccCC-HHHHHHHHHcCccC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            568999999999999999998 899997643 34444555544333 3445678899999999996 8999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=1e-22  Score=199.22  Aligned_cols=148  Identities=23%  Similarity=0.381  Sum_probs=119.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc-----cccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-----SVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~-----~~~Gt~~Y~APEll-   75 (505)
                      ..+..++.|++.||.|||.++  ++||||||+||+++ .++.+||+|||+++........     ...++..|+|||.+ 
T Consensus        95 ~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~-~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  171 (257)
T cd05060          95 SDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN  171 (257)
T ss_pred             HHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEc-CCCcEEeccccccceeecCCcccccccCccccccccCHHHhc
Confidence            467889999999999999999  99999999999998 6789999999999765432211     11234579999987 


Q ss_pred             cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ...++.++||||||+++|+|++ |..||... +..+....+..... ...+...++.++++|.+||. +|.+||++.+++
T Consensus       172 ~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~  249 (257)
T cd05060         172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-KGAEVIAMLESGER-LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELE  249 (257)
T ss_pred             CCCCCccchHHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence            4568899999999999999998 99999764 44555556555433 34555678899999999996 799999999987


Q ss_pred             c
Q 010626          154 K  154 (505)
Q Consensus       154 ~  154 (505)
                      +
T Consensus       250 ~  250 (257)
T cd05060         250 S  250 (257)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.89  E-value=1.1e-22  Score=198.96  Aligned_cols=150  Identities=32%  Similarity=0.520  Sum_probs=121.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ++++.++.||+.||.|||++|  ++||||+|+||+++ .++.++|+|||++.......  .....+++.|+|||.+ ...
T Consensus       106 ~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~  182 (267)
T cd08224         106 RTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG  182 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEEC-CCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCC
Confidence            467889999999999999999  99999999999997 67899999999987654332  2334688899999977 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCC-ChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ++.++|+||||+++|+|++|+.||.... +.......+..+..+.......+..+.++|.+||. +|.+||++.++++
T Consensus       183 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            8899999999999999999999996533 33344455555544433333677899999999996 7999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.89  E-value=1e-22  Score=201.25  Aligned_cols=149  Identities=21%  Similarity=0.363  Sum_probs=114.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCcccccc-
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE-   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll~~-   77 (505)
                      .++.++.||+.||+|||+++  ++||||||+||+++ .++.+||+|||++......    ......+++.|+|||++.. 
T Consensus       100 ~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  176 (268)
T cd05086         100 LLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLT-SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF  176 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEc-CCccEEecccccccccCcchhhhcccCCcCcccccCchhcccc
Confidence            46788999999999999999  99999999999997 6789999999998542211    1233467889999998732 


Q ss_pred             -------cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCC---CCCCCCCCCChHHHHHHHHhcCCCCCC
Q 010626           78 -------EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVPASLR  146 (505)
Q Consensus        78 -------~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~---~p~~~~~~~s~~l~~LI~kcL~dP~~R  146 (505)
                             .++.++||||||+++|+|++ |..||............+....   ..+.+...+++.+.+++.+||.+|.+|
T Consensus       177 ~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~R  256 (268)
T cd05086         177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKR  256 (268)
T ss_pred             cCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHhhCcccC
Confidence                   35779999999999999997 5678876444333333232221   123344457889999999999889999


Q ss_pred             CCHHHHhc
Q 010626          147 LPALELLK  154 (505)
Q Consensus       147 pSa~ElL~  154 (505)
                      |++.++++
T Consensus       257 p~~~~i~~  264 (268)
T cd05086         257 ATAEEVHR  264 (268)
T ss_pred             CCHHHHHH
Confidence            99999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.89  E-value=3.1e-23  Score=212.04  Aligned_cols=151  Identities=23%  Similarity=0.494  Sum_probs=129.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCccccccc-C
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEE-Y   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~~~-y   79 (505)
                      ++.+++++||+.|+.|||.++  ++|||||.+|||+| .++.+||+|||++..+.... .++++|+|-|.+||++.+. |
T Consensus       153 rEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD-~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY  229 (668)
T KOG0611|consen  153 REARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLD-QNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPY  229 (668)
T ss_pred             HHHHHHHHHHHHHHHHHhhcc--ceecccchhheeec-CCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCC
Confidence            468999999999999999999  99999999999998 78899999999998776543 5788999999999999654 4


Q ss_pred             -CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhc-CCCCCCCCHHHHhcCCC
Q 010626           80 -NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPF  157 (505)
Q Consensus        80 -s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL-~dP~~RpSa~ElL~hpf  157 (505)
                       ++.+|.||||++||-|+.|..||++ .+...+.+.|..|....   ...+..+.-||+.|| ++|.+|.|+.++..|-|
T Consensus       230 ~GPEVDsWsLGvLLYtLVyGtMPFDG-~Dhk~lvrQIs~GaYrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  230 KGPEVDSWSLGVLLYTLVYGTMPFDG-RDHKRLVRQISRGAYRE---PETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             CCCccchhhHHHHHHHHhhcccccCC-chHHHHHHHhhcccccC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence             5789999999999999999999988 45566677777764432   122457889999999 69999999999999988


Q ss_pred             CC
Q 010626          158 LV  159 (505)
Q Consensus       158 f~  159 (505)
                      +.
T Consensus       306 vN  307 (668)
T KOG0611|consen  306 VN  307 (668)
T ss_pred             ee
Confidence            75

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.89  E-value=1e-22  Score=204.91  Aligned_cols=148  Identities=27%  Similarity=0.433  Sum_probs=120.7

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......    .....+++.|+|||++ ..
T Consensus       138 ~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nili~-~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  214 (304)
T cd05101         138 DLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR  214 (304)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--eeecccccceEEEc-CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC
Confidence            56788999999999999999  99999999999997 67899999999997664321    1122456789999987 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+..++..+++||.+||. +|.+||++.++++.
T Consensus       215 ~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         215 VYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             CCCchhhHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            68999999999999999998 7888866 4566666666655433 3445678899999999996 79999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=203.91  Aligned_cols=152  Identities=27%  Similarity=0.329  Sum_probs=115.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC-----------ccccCCCcccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----------RSVIGTPEFMA   71 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~-----------~~~~Gt~~Y~A   71 (505)
                      ++..|+.+|++||++||+..||++||||||.||++. ..+.++|.|||.+....-...           ..-..|..|+|
T Consensus       128 ~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls-~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRA  206 (302)
T KOG2345|consen  128 QILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS-DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRA  206 (302)
T ss_pred             HHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec-CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccC
Confidence            578899999999999999999999999999999997 578999999999865432110           11247899999


Q ss_pred             ccccc----ccCCcccchhhHHHHHHHHhhcCCCCCCCCC-hHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCC
Q 010626           72 PELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKN-PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASL  145 (505)
Q Consensus        72 PEll~----~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~-~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~  145 (505)
                      ||++.    ...++++|||||||++|.|+.|..||..... ...+.-.+..+....+-...++..+.+||+.||+ +|.+
T Consensus       207 PELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~q  286 (302)
T KOG2345|consen  207 PELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQ  286 (302)
T ss_pred             chheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCccc
Confidence            99984    3478999999999999999999999953110 0001111122211112223378999999999995 8999


Q ss_pred             CCCHHHHhcC
Q 010626          146 RLPALELLKD  155 (505)
Q Consensus       146 RpSa~ElL~h  155 (505)
                      ||++.+++.+
T Consensus       287 RP~i~~ll~~  296 (302)
T KOG2345|consen  287 RPTIPELLSK  296 (302)
T ss_pred             CCCHHHHHHH
Confidence            9999999864

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=4.3e-23  Score=200.74  Aligned_cols=158  Identities=27%  Similarity=0.426  Sum_probs=125.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~~Y~APEll   75 (505)
                      .+|++++++++.||.|+|...  |+|||+||.|+|++ .+|.+||+|||+++.+....      ....+.|.+|++||.+
T Consensus       124 s~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt-~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEll  200 (376)
T KOG0669|consen  124 SEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLIT-KDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELL  200 (376)
T ss_pred             HHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEc-CCceEEeeccccccceecccccCCCCcccceeeeecCCHHHh
Confidence            478999999999999999999  99999999999998 77999999999997764332      2233569999999977


Q ss_pred             --cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHH--HHcCCCCCC-----------------C----------
Q 010626           76 --EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK--VTSGIKPAS-----------------L----------  124 (505)
Q Consensus        76 --~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~--i~~~~~p~~-----------------~----------  124 (505)
                        ...|+++.|||..||++.||+|+.+-+.+..+..++...  +.....+..                 +          
T Consensus       201 LG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n  280 (376)
T KOG0669|consen  201 LGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKN  280 (376)
T ss_pred             hcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhh
Confidence              567999999999999999999999888876555443211  111111110                 0          


Q ss_pred             ---CCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          125 ---SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       125 ---~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                         +...++++.+|++++|. ||.+|+.+.++|+|.||..+.
T Consensus       281 ~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  281 RLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             hcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence               12235688899999996 999999999999999997643

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.89  E-value=1.2e-22  Score=199.86  Aligned_cols=148  Identities=20%  Similarity=0.387  Sum_probs=119.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC-----ccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~-----~~~~Gt~~Y~APEll~   76 (505)
                      +.+..++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++........     ....+++.|+|||.+.
T Consensus        95 ~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  171 (257)
T cd05115          95 SNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN  171 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEc-CCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHc
Confidence            467889999999999999999  99999999999997 678999999999875533211     1112356899999874


Q ss_pred             -ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 -EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                       ..++.++||||||+++|+|++ |..||... ........+..+..+ ..+...++++.++|.+||. +|.+||++.+++
T Consensus       172 ~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~  249 (257)
T cd05115         172 FRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-KGPEVMSFIEQGKRL-DCPAECPPEMYALMKDCWIYKWEDRPNFAKVE  249 (257)
T ss_pred             cCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence             568899999999999999996 99999764 344455566555443 4556678999999999996 799999999886


Q ss_pred             c
Q 010626          154 K  154 (505)
Q Consensus       154 ~  154 (505)
                      +
T Consensus       250 ~  250 (257)
T cd05115         250 E  250 (257)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.89  E-value=1e-22  Score=200.98  Aligned_cols=148  Identities=18%  Similarity=0.298  Sum_probs=118.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++ .++.+|++|||.+.......   .....+++.|+|||.+ ..
T Consensus       107 ~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  183 (266)
T cd05064         107 GQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVN-SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH  183 (266)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEc-CCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhC
Confidence            467899999999999999999  99999999999997 67899999999875432221   1122356789999987 56


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++|||||||++|++++ |+.||... ........+..+..+ ..+..++..+.+++.+||. +|.+||++.++++
T Consensus       184 ~~~~~~Di~slG~~l~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         184 HFSSASDVWSFGIVMWEVMSYGERPYWDM-SGQDVIKAVEDGFRL-PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CccchhHHHHHHHHHHHHhcCCCCCcCcC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            68999999999999999775 99999764 444455555555333 3456678899999999996 7999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.89  E-value=1.3e-22  Score=198.48  Aligned_cols=148  Identities=22%  Similarity=0.435  Sum_probs=119.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC---ccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~---~~~~Gt~~Y~APEll~-~   77 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||.+........   ....++..|+|||.+. .
T Consensus       100 ~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  176 (256)
T cd05114         100 DMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS  176 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEc-CCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccC
Confidence            357889999999999999999  99999999999998 678999999999875533221   1223456899999884 5


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++|+||||+++|+|++ |+.||... +.......+..+..+ ..+...+..+.+++.+||. +|.+||++.++++
T Consensus       177 ~~~~~~Di~s~G~~l~el~~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKK-SNYEVVEMISRGFRL-YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             ccchhhhhHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            68899999999999999999 89999763 445556666655433 2345567899999999996 7999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=2.1e-22  Score=197.47  Aligned_cols=148  Identities=26%  Similarity=0.419  Sum_probs=119.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccC---CCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~G---t~~Y~APEll~-~   77 (505)
                      ..+..++.|++.||.|||++|  ++||||||+||+++ .++.+||+|||++............|   +..|+|||.+. .
T Consensus       103 ~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  179 (261)
T cd05068         103 PQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVG-ENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN  179 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEc-CCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccC
Confidence            467889999999999999999  99999999999998 67899999999998765432222222   35799999874 5


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++||||||+++|+|+| |+.||.+. ........+...... ..+...+..+.+++.+||. +|.+||++.++++
T Consensus       180 ~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         180 RFSIKSDVWSFGILLTEIVTYGRMPYPGM-TNAEVLQQVDQGYRM-PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             CCCchhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            68899999999999999999 99999763 444555555544322 3445668899999999995 8999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.89  E-value=1.1e-22  Score=203.05  Aligned_cols=148  Identities=24%  Similarity=0.424  Sum_probs=120.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..+..++.|++.||.|||+++  ++||||||+||+++ .++.+||+|||++.......    .....++..|+|||.+ .
T Consensus       127 ~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~  203 (290)
T cd05045         127 GDLISFAWQISRGMQYLAEMK--LVHRDLAARNVLVA-EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD  203 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eehhhhhhheEEEc-CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc
Confidence            356789999999999999999  99999999999997 67899999999997543221    1222456789999976 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|+| |..||.+ ..+..+...+.....+ ..+..++..+.+|+.+||. +|.+||++.++++
T Consensus       204 ~~~~~~~Di~slG~~l~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         204 HIYTTQSDVWSFGVLLWEIVTLGGNPYPG-IAPERLFNLLKTGYRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCcchHhHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHhCCCCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            568899999999999999998 9999975 4566666666555433 3455678899999999996 7999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.89  E-value=1.7e-22  Score=198.22  Aligned_cols=148  Identities=25%  Similarity=0.389  Sum_probs=119.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC---ccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~---~~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..++.||+.||.|||+.|  ++||||||+||+++ .++.++|+|||++........   ....++..|+|||.+ ..
T Consensus       102 ~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~  178 (260)
T cd05069         102 PQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVG-DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG  178 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEc-CCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccC
Confidence            357789999999999999999  99999999999997 678999999999976643221   123456789999977 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++||||||+++|+|+| |..||.+. ........+..+..+ ..+...+..+++++.+||. +|.+||++.++++
T Consensus       179 ~~~~~~Di~slG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         179 RFTIKSDVWSFGILLTELVTKGRVPYPGM-VNREVLEQVERGYRM-PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             CcChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            68899999999999999999 89999764 344445555544332 3445678899999999996 8999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.89  E-value=1.2e-22  Score=202.49  Aligned_cols=149  Identities=23%  Similarity=0.311  Sum_probs=115.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++ .++.++|+|||++.......    .....+++.|+|||.+ .
T Consensus       130 ~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  206 (296)
T cd05051         130 STLLYMATQIASGMRYLESLN--FVHRDLATRNCLVG-KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL  206 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHHcC--ccccccchhceeec-CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc
Confidence            467889999999999999999  99999999999997 66899999999997653322    2233567789999987 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh--cCCCCCCCCChHHHHHHHHcC------CCCCCCCCCCChHHHHHHHHhcC-CCCCCC
Q 010626           77 EEYNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTSG------IKPASLSKVTDPQVKQFIEKCIV-PASLRL  147 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT--G~~Pf~~~~~~~~i~~~i~~~------~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp  147 (505)
                      ..++.++|||||||++|+|++  +..||..... ......+...      ......+...+.++.+++.+||. +|.+||
T Consensus       207 ~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp  285 (296)
T cd05051         207 GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP  285 (296)
T ss_pred             CCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCC
Confidence            578999999999999999998  7788866433 3333333321      11112234457899999999996 899999


Q ss_pred             CHHHHhc
Q 010626          148 PALELLK  154 (505)
Q Consensus       148 Sa~ElL~  154 (505)
                      ++.++++
T Consensus       286 t~~el~~  292 (296)
T cd05051         286 TFREIHL  292 (296)
T ss_pred             CHHHHHH
Confidence            9999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.89  E-value=1.6e-22  Score=204.86  Aligned_cols=148  Identities=26%  Similarity=0.436  Sum_probs=118.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      +.+..++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||+++......    .....+++.|+|||.+ .
T Consensus       134 ~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  210 (314)
T cd05099         134 KDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD  210 (314)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEEc-CCCcEEEccccccccccccccccccccCCCCccccCHHHHcc
Confidence            356788999999999999999  99999999999997 67899999999997654321    1112344679999987 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      +.++.++||||||+++|+|++ |..||.. ......+..+..+..+ ..+...+..++++|.+||. +|.+||++.++++
T Consensus       211 ~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         211 RVYTHQSDVWSFGILMWEIFTLGGSPYPG-IPVEELFKLLREGHRM-DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CCcCccchhhHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            568999999999999999999 8899965 4455666666555332 3445667899999999996 7999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.89  E-value=8e-23  Score=206.20  Aligned_cols=149  Identities=28%  Similarity=0.448  Sum_probs=120.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      .++..++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++.......    .....+++.|+|||.+ .
T Consensus       140 ~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~-~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  216 (307)
T cd05098         140 KDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD  216 (307)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccccccHHheEEc-CCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc
Confidence            457789999999999999999  99999999999997 67899999999987553221    1112345689999977 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|||||||++|+|++ |..||.. .....+...+..+.. ...+...+.++.+||.+||. +|.+||++.++++
T Consensus       217 ~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~  294 (307)
T cd05098         217 RIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLKEGHR-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  294 (307)
T ss_pred             CCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHcCCC-CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            568999999999999999998 8888865 455666666655543 23455678899999999996 7999999999986


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       295 ~  295 (307)
T cd05098         295 D  295 (307)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.89  E-value=1.4e-22  Score=204.75  Aligned_cols=149  Identities=23%  Similarity=0.407  Sum_probs=120.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC----ccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~----~~~~Gt~~Y~APEll-~   76 (505)
                      +++..++.||+.||.|||+++  ++|+||||+||+++ .++.++|+|||++........    ....+++.|+|||.+ .
T Consensus       141 ~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  217 (302)
T cd05055         141 EDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN  217 (302)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEc-CCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc
Confidence            467889999999999999999  99999999999997 678999999999976543221    123456789999977 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|||||||++|+|++ |..||............+..+..+ ..+...++.+.+|+.+||. +|.+||++.++++
T Consensus       218 ~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         218 CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM-AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            568999999999999999998 999997755444455555544333 3445568899999999996 7999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.89  E-value=1.4e-22  Score=197.50  Aligned_cols=148  Identities=23%  Similarity=0.385  Sum_probs=116.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCcc----ccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS----VIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~----~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.|++.||.|||++|  ++||||||+||+++ .++.+||+|||++..........    ..++..|+|||.+ .
T Consensus        94 ~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  170 (252)
T cd05084          94 KELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY  170 (252)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEc-CCCcEEECccccCcccccccccccCCCCCCceeecCchhhcC
Confidence            357889999999999999999  99999999999997 67899999999987543321111    1224569999987 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      +.++.++||||||+++|+|++ |..||... ........+..... ...+...+..+.+|+.+||. +|.+||++.++++
T Consensus       171 ~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         171 GRYSSESDVWSFGILLWEAFSLGAVPYANL-SNQQTREAIEQGVR-LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             CCCChHHHHHHHHHHHHHHHhCCCCCcccc-CHHHHHHHHHcCCC-CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            568899999999999999998 88888653 33444444444333 24556678899999999996 7999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.89  E-value=2e-22  Score=197.51  Aligned_cols=147  Identities=25%  Similarity=0.390  Sum_probs=118.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC---ccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~---~~~~Gt~~Y~APEll-~~   77 (505)
                      +.++.++.||+.||.|||++|  ++||||||+||+++ .++.++|+|||++........   ....++..|+|||.+ ..
T Consensus       102 ~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  178 (260)
T cd05070         102 PNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVG-DGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG  178 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEe-CCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcC
Confidence            467899999999999999999  99999999999998 678999999999976643321   122355679999977 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      .++.++|+||||+++|+|++ |..||... +.......+..+..+ ..+...+..+.+|+.+||. +|.+|||+.+++
T Consensus       179 ~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         179 RFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQVERGYRM-PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             CCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence            68899999999999999999 88999764 344445555544332 3455678899999999996 799999999886

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.89  E-value=1.6e-22  Score=197.74  Aligned_cols=148  Identities=26%  Similarity=0.440  Sum_probs=120.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......  .....+++.|+|||.+ ...
T Consensus       104 ~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~  180 (261)
T cd05148         104 ASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVG-EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT  180 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEc-CCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCC
Confidence            467889999999999999999  99999999999998 67899999999997654322  1122456789999987 456


Q ss_pred             CCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           79 YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ++.++||||||+++|+|++ |+.||.. .........+..+..+ ..+...++.+.++|.+||. +|.+|||+.++++
T Consensus       181 ~~~~~DiwslG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         181 FSTKSDVWSFGILLYEMFTYGQVPYPG-MNNHEVYDQITAGYRM-PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             CCchhhHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHHhCCcC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            8899999999999999998 8999976 3445555666554333 3455678899999999996 8999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.89  E-value=1.5e-22  Score=200.54  Aligned_cols=147  Identities=24%  Similarity=0.375  Sum_probs=119.6

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC----ccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~----~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..++.||+.||+|||+++  ++||||||+||+++ .++.+||+|||+++.+.....    ....++..|+|||.+ ..
T Consensus       118 ~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~  194 (280)
T cd05043         118 QLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVID-EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK  194 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEc-CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC
Confidence            56789999999999999999  99999999999997 678999999999976533211    123456689999987 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++||||||+++|++++ |+.||... ++..+...+..+..+. .+..+++.+.+++.+||. +|.+||++.+++.
T Consensus       195 ~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         195 EYSSASDVWSFGVLLWELMTLGQTPYVEI-DPFEMAAYLKDGYRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCchhhHHHhHHHHHHHhcCCCCCcCcC-CHHHHHHHHHcCCCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            68999999999999999999 99999763 5566666666554332 344567899999999996 8999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=3e-23  Score=229.05  Aligned_cols=148  Identities=21%  Similarity=0.362  Sum_probs=119.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc-----------cccCCCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-----------SVIGTPEFM   70 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~-----------~~~Gt~~Y~   70 (505)
                      .+|.+|+.|+++|+.+||...+||||||||-+||||+ .+|..||||||.|...-.....           ...-|+.|+
T Consensus       144 ~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls-~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YR  222 (738)
T KOG1989|consen  144 DEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS-ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYR  222 (738)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc-CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCcccc
Confidence            4789999999999999999999999999999999997 7889999999999643222111           124689999


Q ss_pred             Ccccc----cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCC
Q 010626           71 APELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASL  145 (505)
Q Consensus        71 APEll----~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~  145 (505)
                      |||++    ....++|+|||+|||+||-|+..+.||.+....     .|..+.........++..+++||+.||+ +|.+
T Consensus       223 sPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~  297 (738)
T KOG1989|consen  223 SPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDE  297 (738)
T ss_pred             ChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----eEEeccccCCCCccHHHHHHHHHHHHhccCccc
Confidence            99987    345899999999999999999999999764221     2334433333335678899999999996 7999


Q ss_pred             CCCHHHHhcC
Q 010626          146 RLPALELLKD  155 (505)
Q Consensus       146 RpSa~ElL~h  155 (505)
                      ||++-+++.+
T Consensus       298 RPnI~Qv~~~  307 (738)
T KOG1989|consen  298 RPNIYQVLEE  307 (738)
T ss_pred             CCCHHHHHHH
Confidence            9999998864

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.88  E-value=5.4e-23  Score=202.98  Aligned_cols=148  Identities=30%  Similarity=0.553  Sum_probs=117.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..+..|+.||+.||.|||+++  ++|++|+++||+++ .++.+||+|||++.......    .....+...|+|||.+ .
T Consensus       103 ~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~-~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  179 (259)
T PF07714_consen  103 QQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLD-SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD  179 (259)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEE-TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH
T ss_pred             ccccccccccccccccccccc--cccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc
Confidence            467889999999999999999  99999999999998 67899999999997763221    1223456789999988 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|||++ |+.||... ....+...+..+..+ ..+..++..+.++|.+||. +|.+||++.++++
T Consensus       180 ~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  180 GEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKLKQGQRL-PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             SEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHHHTTEET-TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             cccccccccccccccccccccccccccccc-ccccccccccccccc-eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            558999999999999999999 78999775 566666777655443 3556678999999999995 8999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.88  E-value=8.9e-23  Score=205.94  Aligned_cols=149  Identities=26%  Similarity=0.403  Sum_probs=117.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCccccc-ccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~-~~y   79 (505)
                      +.++.++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++....... .....+++.|+|||.+. ..+
T Consensus       124 ~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  200 (303)
T cd05088         124 QQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY  200 (303)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec-CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCC
Confidence            357889999999999999999  99999999999997 67899999999985432211 11122456799999874 457


Q ss_pred             CcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           80 NELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      +.++|||||||++|+|+| |..||... ........+..+..+ ..+...++.+.+||.+||. +|.+||++.+++.+
T Consensus       201 ~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         201 TTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLPQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cccccchhhhhHHHHHHhcCCCCcccC-ChHHHHHHHhcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899999999999999998 99999753 344555555443222 2344567899999999996 79999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.88  E-value=2e-22  Score=196.83  Aligned_cols=147  Identities=24%  Similarity=0.410  Sum_probs=120.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      ..++.++.|++.||.|||++|  ++||||||+||+++ .++.+||+|||.+........ ...++..|+|||.+ .+.++
T Consensus       102 ~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~-~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~ape~~~~~~~~  177 (256)
T cd05039         102 AQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQD-SGKLPVKWTAPEALREKKFS  177 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEe-CCCCEEEcccccccccccccc-cCCCcccccCchhhcCCcCC
Confidence            467889999999999999999  99999999999998 678999999999976643322 23345679999977 45688


Q ss_pred             cccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           81 ELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++||||||+++|+|++ |..||... ....+...+..+..+ ..+...++.+.++|.+||. +|.+||++.++++
T Consensus       178 ~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         178 TKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRM-EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             cHHHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHhcCCCC-CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            89999999999999997 99999763 455555555554333 3455678999999999996 8999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.88  E-value=1.6e-22  Score=199.76  Aligned_cols=148  Identities=26%  Similarity=0.396  Sum_probs=116.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC-ccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~-~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +.++.++.|++.||+|||++|  ++||||||+||+++ .++.+||+|||++........ .....++.|+|||.+ ...+
T Consensus       112 ~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~-~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~  188 (270)
T cd05047         112 QQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY  188 (270)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEc-CCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCC
Confidence            367889999999999999999  99999999999997 678999999999853322111 112235679999987 4568


Q ss_pred             CcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           80 NELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      +.++||||||+++|+|++ |..||.. .........+..+... ..+...+..+.+++.+||. +|.+||++.+++.
T Consensus       189 ~~~~Di~slG~il~el~~~g~~pf~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         189 TTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CchhhHHHHHHHHHHHHcCCCCCccc-cCHHHHHHHHhCCCCC-CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            899999999999999997 9999975 3444555555544332 2444567899999999996 7999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.88  E-value=1.8e-22  Score=200.47  Aligned_cols=149  Identities=26%  Similarity=0.401  Sum_probs=114.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC-----ccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~-----~~~~Gt~~Y~APEll-   75 (505)
                      ..++.++.|++.||.|||++|  ++||||||+||+++ .++.+||+|||++........     ....++..|+|||.+ 
T Consensus       107 ~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~  183 (283)
T cd05080         107 AQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK  183 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEc-CCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhc
Confidence            467889999999999999999  99999999999997 678999999999976543221     122356679999987 


Q ss_pred             cccCCcccchhhHHHHHHHHhhcCCCCCCCCChH--------------HHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA--------------QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV  141 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~--------------~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~  141 (505)
                      ...++.++||||||+++|+|+||..||.......              .....+..+. ....+...+..+.+++.+||.
T Consensus       184 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~  262 (283)
T cd05080         184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM-RLPCPKNCPQEVYILMKNCWE  262 (283)
T ss_pred             ccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC-CCCCCCCCCHHHHHHHHHHhc
Confidence            4568899999999999999999999986432110              0111111111 112345567899999999996


Q ss_pred             -CCCCCCCHHHHhc
Q 010626          142 -PASLRLPALELLK  154 (505)
Q Consensus       142 -dP~~RpSa~ElL~  154 (505)
                       +|.+||++.+++.
T Consensus       263 ~~p~~Rps~~~i~~  276 (283)
T cd05080         263 TEAKFRPTFRSLIP  276 (283)
T ss_pred             cChhhCCCHHHHHH
Confidence             7999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.88  E-value=1.5e-23  Score=219.50  Aligned_cols=158  Identities=23%  Similarity=0.403  Sum_probs=129.2

Q ss_pred             CHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccC
Q 010626            1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         1 Lk~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      |++|+.|+.|++.||..|...|  |+|.||||+|||++.....+||||||.|..........+..+..|.|||++ .-.|
T Consensus       535 ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~y  612 (752)
T KOG0670|consen  535 IKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPY  612 (752)
T ss_pred             ehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcceeeeccCccccccccccccHHHHHHhccCcceeecCcc
Confidence            5789999999999999999999  999999999999997777899999999988877777777778899999976 6679


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHH-HcCCCCC-----------CC-----------------------
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV-TSGIKPA-----------SL-----------------------  124 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i-~~~~~p~-----------~~-----------------------  124 (505)
                      +...|+||.||+||||.||+..|.+..|...+...+ ..|..|.           .|                       
T Consensus       613 d~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm  692 (752)
T KOG0670|consen  613 DYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVM  692 (752)
T ss_pred             cCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEe
Confidence            999999999999999999999999877765543221 1111110           00                       


Q ss_pred             -------------------CCC---CChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          125 -------------------SKV---TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       125 -------------------~~~---~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                                         +..   .-.++++|+.+||. +|.+|.|+.++|+||||+.
T Consensus       693 ~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  693 VNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             cccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence                               000   01267899999996 9999999999999999974

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.88  E-value=7.6e-24  Score=207.26  Aligned_cols=154  Identities=29%  Similarity=0.478  Sum_probs=125.2

Q ss_pred             HHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccc-cCCCcccCccccc---ccCCc
Q 010626            6 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFMAPELYE---EEYNE   81 (505)
Q Consensus         6 ~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~-~Gt~~Y~APEll~---~~ys~   81 (505)
                      +|..-.+.||.||...- .|||||+||+|||++ ..|.|||||||++..+....+.+. .|..+|||||.+.   .+|+-
T Consensus       171 ~ItvatV~AL~yLK~~l-kiIHRDvKPSNILld-r~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDi  248 (361)
T KOG1006|consen  171 HITVATVDALDYLKEEL-KIIHRDVKPSNILLD-RHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDI  248 (361)
T ss_pred             heeeeehhHHHHHHHHh-hhhhccCChhheEEe-cCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcch
Confidence            44455678999998642 399999999999998 789999999999977765544443 7899999999882   35999


Q ss_pred             ccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCC-CC---CCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           82 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-SK---VTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        82 ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~-~~---~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      ++||||||++|||+.||.+||.+..+.-.....+..+.+|... +.   .++..+..||..||. +.+.||...+|+++|
T Consensus       249 RSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~  328 (361)
T KOG1006|consen  249 RSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP  328 (361)
T ss_pred             hhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence            9999999999999999999998876665555666666555332 22   257899999999995 799999999999999


Q ss_pred             CCCCC
Q 010626          157 FLVTD  161 (505)
Q Consensus       157 ff~~~  161 (505)
                      |++..
T Consensus       329 fyr~y  333 (361)
T KOG1006|consen  329 FYRMY  333 (361)
T ss_pred             hhhhh
Confidence            99753

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.88  E-value=2.8e-22  Score=197.44  Aligned_cols=148  Identities=24%  Similarity=0.366  Sum_probs=118.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC---ccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~---~~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..++.|++.||+|||+.+  ++||||||+||+++ .++.++|+|||.+........   ....++..|+|||.+ ..
T Consensus       102 ~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~-~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  178 (262)
T cd05071         102 PQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG  178 (262)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEc-CCCcEEeccCCceeeccccccccccCCcccceecCHhHhccC
Confidence            467889999999999999999  99999999999997 678999999999976643322   123456789999977 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++||||||+++|+|+| |..||... ........+..+... ......+..+.++|.+||. +|.+||++.+++.
T Consensus       179 ~~~~~~DvwslG~~l~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         179 RFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             CCCchhhHHHHHHHHHHHHcCCCCCCCCC-ChHHHHHHHhcCCCC-CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            68999999999999999999 88888764 344555555544322 2345568899999999996 7999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.88  E-value=2.8e-22  Score=196.42  Aligned_cols=148  Identities=24%  Similarity=0.376  Sum_probs=119.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC---ccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~---~~~~Gt~~Y~APEll-~~   77 (505)
                      .++..++.||+.||+|||++|  ++||||||+||+++ .++.++|+|||++........   ....++..|+|||.+ ..
T Consensus       102 ~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~  178 (260)
T cd05067         102 NKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG  178 (260)
T ss_pred             HHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEc-CCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccC
Confidence            356789999999999999999  99999999999997 678999999999976653221   223456789999988 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++||||||+++|+|++ |+.||... +.......+..+..+ ..+...+.++.++|.+||. +|.+||++.+++.
T Consensus       179 ~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         179 TFTIKSDVWSFGILLTEIVTYGRIPYPGM-TNPEVIQNLERGYRM-PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CcCcccchHHHHHHHHHHHhCCCCCCCCC-ChHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            68899999999999999999 99999764 344455555544333 3445567899999999995 7999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.88  E-value=2.4e-22  Score=195.35  Aligned_cols=148  Identities=23%  Similarity=0.369  Sum_probs=117.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC----ccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~----~~~~Gt~~Y~APEll-~   76 (505)
                      +.+..++.|++.||.|||+++  ++||||||+||+++ .++.+||+|||++........    ....++..|+|||.+ .
T Consensus        93 ~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  169 (251)
T cd05041          93 KKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY  169 (251)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEc-CCCcEEEeeccccccccCCcceeccccCcceeccCChHhhcc
Confidence            457789999999999999999  99999999999997 678999999999875542211    112235679999987 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      +.++.++|+||||+++|+|+| |..||... ........+.... ....+...+..+.+++.+||. +|.+||++.++++
T Consensus       170 ~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         170 GRYTSESDVWSYGILLWETFSLGDTPYPGM-SNQQTRERIESGY-RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             CCCCcchhHHHHHHHHHHHHhccCCCCccC-CHHHHHHHHhcCC-CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            568899999999999999999 88888764 3444444554432 223455678899999999995 7999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.88  E-value=2.1e-22  Score=206.26  Aligned_cols=155  Identities=33%  Similarity=0.511  Sum_probs=119.8

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc--ccCC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEYN   80 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~--~~ys   80 (505)
                      .+..++.||+.||.|||++|  ++||||+|+||+++ .++.++|+|||.+...... .....+++.|+|||.+.  ..++
T Consensus       109 ~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~-~~~~~~l~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~  184 (328)
T cd07856         109 FIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILIN-ENCDLKICDFGLARIQDPQ-MTGYVSTRYYRAPEIMLTWQKYD  184 (328)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeEC-CCCCEEeCccccccccCCC-cCCCcccccccCceeeeccCCcC
Confidence            56778999999999999999  99999999999997 6789999999998755332 23456788999999874  3589


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc------------------------CC--CCC---CCCCCCChH
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------------------GI--KPA---SLSKVTDPQ  131 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~------------------------~~--~p~---~~~~~~s~~  131 (505)
                      .++|+||||+++|+|+||+.||..... ......+..                        ..  .+.   ......++.
T Consensus       185 ~~~Dv~slG~il~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (328)
T cd07856         185 VEVDIWSAGCIFAEMLEGKPLFPGKDH-VNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPS  263 (328)
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHH
Confidence            999999999999999999999975332 111111000                        00  000   111235688


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      ++++|.+||. +|.+||++.+++.||||....
T Consensus       264 ~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         264 AIDLLEKMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence            9999999996 899999999999999997543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.88  E-value=2.7e-22  Score=197.28  Aligned_cols=149  Identities=24%  Similarity=0.403  Sum_probs=119.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll~-   76 (505)
                      ..+..++.|++.||.|||+++  |+||||||+||+++ .++.++|+|||++.......    .....+++.|+|||.+. 
T Consensus       106 ~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~  182 (266)
T cd05033         106 GQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY  182 (266)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCCEEECccchhhcccccccceeccCCCCCccccChhhhcc
Confidence            467889999999999999999  99999999999998 67899999999997764211    11123456899999874 


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|++ |..||.... .......+..+... ..+...++.+.+|+.+||. +|.+||++.++++
T Consensus       183 ~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~  260 (266)
T cd05033         183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMS-NQDVIKAVEDGYRL-PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVS  260 (266)
T ss_pred             CCCccccchHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            568999999999999999998 999997643 44455555554332 2345678899999999996 8999999999986


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       261 ~  261 (266)
T cd05033         261 T  261 (266)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.88  E-value=2.5e-22  Score=205.44  Aligned_cols=150  Identities=27%  Similarity=0.433  Sum_probs=120.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..+..++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||+++......    .....++..|+|||++ .
T Consensus       134 ~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  210 (334)
T cd05100         134 KDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVT-EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD  210 (334)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc-CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc
Confidence            356778999999999999999  99999999999997 67899999999997654321    1112345679999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|++ |..||.. .........+..+..+ ..+...+..+.+||.+||. +|.+||++.+++.
T Consensus       211 ~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~  288 (334)
T cd05100         211 RVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IPVEELFKLLKEGHRM-DKPANCTHELYMIMRECWHAVPSQRPTFKQLVE  288 (334)
T ss_pred             CCcCchhhhHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            568899999999999999998 8888876 4455666666555433 3445567899999999996 7999999999998


Q ss_pred             CC
Q 010626          155 DP  156 (505)
Q Consensus       155 hp  156 (505)
                      +-
T Consensus       289 ~l  290 (334)
T cd05100         289 DL  290 (334)
T ss_pred             HH
Confidence            63

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.88  E-value=1.2e-23  Score=220.31  Aligned_cols=155  Identities=30%  Similarity=0.523  Sum_probs=131.7

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEeecCceeeccCC-CCccccCCCcccCcccc-ccc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~--g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      .-+.++.||+.||.|||-+|  |+|+||||+|||+....  .++||||||+|+.+... .+.+++|||.|+|||++ .++
T Consensus       665 ~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkG  742 (888)
T KOG4236|consen  665 ITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKG  742 (888)
T ss_pred             HHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhcc
Confidence            34667899999999999999  99999999999996432  36999999999988765 46778999999999998 567


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC--CCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~--~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      |+..-|+||.|+|+|--+.|..||.+..   .+...|+..  ..|+..++..++++.+||..+|+ +-.+|.++...|.|
T Consensus       743 yNrSLDMWSVGVIiYVsLSGTFPFNEdE---dIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  743 YNRSLDMWSVGVIIYVSLSGTFPFNEDE---DINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             ccccccceeeeEEEEEEecccccCCCcc---chhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            9999999999999999999999997643   344445443  45666778889999999999995 78999999999999


Q ss_pred             CCCCCCC
Q 010626          156 PFLVTDN  162 (505)
Q Consensus       156 pff~~~~  162 (505)
                      ||++...
T Consensus       820 ~Wlq~yq  826 (888)
T KOG4236|consen  820 PWLQDYQ  826 (888)
T ss_pred             hhhhcch
Confidence            9998754

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.88  E-value=4.7e-22  Score=192.82  Aligned_cols=148  Identities=28%  Similarity=0.449  Sum_probs=120.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc---cccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~---~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..++.||+.||+|||+++  ++||||||+||+++ .++.++|+|||++.........   ...+++.|+|||.+ ..
T Consensus       103 ~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~  179 (258)
T smart00219      103 SDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDG  179 (258)
T ss_pred             HHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEc-cCCeEEEcccCCceecccccccccccCCCcccccChHHhccC
Confidence            357889999999999999999  99999999999998 6789999999999766443111   12367899999987 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++|+||||+++|+|++ |..||.. .........+..+..+ ..+...+..+.+++.+||. +|.+|||+.++++
T Consensus       180 ~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      180 KFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLEYLKKGYRL-PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            68999999999999999998 7788865 4555666666655443 3445578899999999996 7999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.88  E-value=8.2e-23  Score=204.13  Aligned_cols=161  Identities=27%  Similarity=0.470  Sum_probs=127.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEeecCceeeccC---------CCCccccCCCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQQ---------PTARSVIGTPEFM   70 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~--g~vKL~DFGlA~~~~~---------~~~~~~~Gt~~Y~   70 (505)
                      .++.++.++|+.||.|||.+|  |.||||||+|||....+  .-|||+||.+......         +...+.+|+..||
T Consensus       176 ~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfM  253 (463)
T KOG0607|consen  176 REASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFM  253 (463)
T ss_pred             HHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhc
Confidence            367889999999999999999  99999999999996322  2489999988754321         2234567888999


Q ss_pred             Ccccc---c---ccCCcccchhhHHHHHHHHhhcCCCCCCCC--------------ChHHHHHHHHcCCC--CCCCCCCC
Q 010626           71 APELY---E---EEYNELVDIYSFGMCILEMVTCEYPYNECK--------------NPAQIYKKVTSGIK--PASLSKVT  128 (505)
Q Consensus        71 APEll---~---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~--------------~~~~i~~~i~~~~~--p~~~~~~~  128 (505)
                      |||+.   .   ..|+.++|.||||||+|-|+.|.+||.+.-              -...++..|+.|..  |..-+..+
T Consensus       254 APEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahI  333 (463)
T KOG0607|consen  254 APEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHI  333 (463)
T ss_pred             chhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHh
Confidence            99976   2   348999999999999999999999996411              12346677777754  33334557


Q ss_pred             ChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCCC
Q 010626          129 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPK  164 (505)
Q Consensus       129 s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~~  164 (505)
                      +.+.+++|..+|. ++.+|.++.++++|||++...+.
T Consensus       334 S~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  334 SSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             hHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            8899999999995 89999999999999999876554

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.88  E-value=3.3e-22  Score=196.61  Aligned_cols=150  Identities=29%  Similarity=0.463  Sum_probs=120.9

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.|++.||.|||+ .+  ++||||+|+||+++ .++.+||+|||++...... ......|+..|+|||.+ ...
T Consensus       113 ~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~  189 (269)
T cd08528         113 ERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP  189 (269)
T ss_pred             HHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEEC-CCCcEEEecccceeecccccccccccCcccCcChhhhcCCC
Confidence            3578899999999999996 67  99999999999997 6789999999999766543 23345688999999987 445


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      ++.++|+||||+++|+|++|+.||... +.......+......+......++.+.++|.+||. +|.+||++.|+..+
T Consensus       190 ~~~~~Dv~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         190 YGEKADVWAFGCILYQMCTLQPPFYST-NMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CchHHHHHHHHHHHHHHHhCCCccccc-CHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            889999999999999999999999753 34444445444443333344678899999999996 89999999998654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.88  E-value=4.1e-22  Score=194.64  Aligned_cols=147  Identities=22%  Similarity=0.401  Sum_probs=118.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      ..+..++.|++.||.|||++|  ++||||||+||+++ .++.+||+|||++...... ......+..|+|||.+ .+.++
T Consensus       100 ~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~-~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~  175 (254)
T cd05083         100 IQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVS-EDGVAKVSDFGLARVGSMG-VDNSKLPVKWTAPEALKHKKFS  175 (254)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEc-CCCcEEECCCccceecccc-CCCCCCCceecCHHHhccCCcC
Confidence            356789999999999999999  99999999999997 6789999999998765332 2223345689999987 45688


Q ss_pred             cccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           81 ELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++|+||||+++|+|++ |..||... ........+..+..+. .+..+++.+.+++.+||. +|.+||++.+++.
T Consensus       176 ~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         176 SKSDVWSYGVLLWEVFSYGRAPYPKM-SLKEVKECVEKGYRME-PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCccC-CHHHHHHHHhCCCCCC-CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999998 99999764 4445555555554332 345678899999999996 7999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.88  E-value=3.7e-22  Score=198.78  Aligned_cols=147  Identities=22%  Similarity=0.326  Sum_probs=117.8

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~~   77 (505)
                      ++..++.||+.||.|||.++  ++||||||+||+++ .++.++|+|||++.......    .....+++.|+|||.+ ..
T Consensus       131 ~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  207 (288)
T cd05050         131 EQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN  207 (288)
T ss_pred             HHHHHHHHHHHHHHHHHhCC--eecccccHhheEec-CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC
Confidence            46789999999999999999  99999999999997 67899999999987543221    1122346679999977 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++|||||||++|+|++ |..||.+ .........+..+..+ ..+...+..+.+||.+||. +|.+||++.|+++
T Consensus       208 ~~~~~~Dv~slG~il~el~~~~~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         208 RYTTESDVWAYGVVLWEIFSYGMQPYYG-MAHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            68999999999999999998 8889875 3455555555554433 2344567899999999996 8999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.88  E-value=5.6e-22  Score=192.64  Aligned_cols=149  Identities=26%  Similarity=0.384  Sum_probs=118.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC---ccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~---~~~~Gt~~Y~APEll~-~   77 (505)
                      +.+..++.|++.||.|||++|  ++||||||+||+++ .++.+||+|||++........   ....+++.|+|||++. +
T Consensus        93 ~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  169 (250)
T cd05085          93 KQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVG-ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG  169 (250)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEc-CCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccC
Confidence            457889999999999999999  99999999999997 778999999999865433211   1123456799999874 5


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|++ |..||... ........+..+... ..+...+..+.+|+.+||. +|.+||++.++++.
T Consensus       170 ~~~~~~Di~slG~ll~~~~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  247 (250)
T cd05085         170 RYSSESDVWSYGILLWETFSLGVCPYPGM-TNQQAREQVEKGYRM-SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE  247 (250)
T ss_pred             CCCchhHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            68899999999999999998 99999764 444555555544333 3445578899999999995 89999999998764

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.88  E-value=3.5e-22  Score=194.52  Aligned_cols=145  Identities=22%  Similarity=0.365  Sum_probs=111.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC-------cEEEeecCceeeccCCCCccccCCCcccCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL   74 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g-------~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEl   74 (505)
                      ..+..++.||+.||.|||++|  ++||||||+||+++ ..+       .+||+|||++.....  .....++..|+|||+
T Consensus       101 ~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~-~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~y~aPE~  175 (259)
T cd05037         101 HWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVA-RYGLNEGYVPFIKLSDPGIPITVLS--REERVERIPWIAPEC  175 (259)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEe-cCccccCCceeEEeCCCCccccccc--ccccccCCCccChhh
Confidence            356788999999999999999  99999999999997 444       699999999976543  223456788999998


Q ss_pred             ccc---cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH
Q 010626           75 YEE---EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA  149 (505)
Q Consensus        75 l~~---~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa  149 (505)
                      +..   .++.++||||||+++|+|++ |..||.... ...........   ...+......+.++|.+||. +|.+||++
T Consensus       176 ~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~  251 (259)
T cd05037         176 IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQDQ---HRLPMPDCAELANLINQCWTYDPTKRPSF  251 (259)
T ss_pred             hcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHhcC---CCCCCCCchHHHHHHHHHhccChhhCCCH
Confidence            843   58899999999999999999 578886643 22222222211   11222223789999999996 89999999


Q ss_pred             HHHhcC
Q 010626          150 LELLKD  155 (505)
Q Consensus       150 ~ElL~h  155 (505)
                      .++++.
T Consensus       252 ~~il~~  257 (259)
T cd05037         252 RAILRD  257 (259)
T ss_pred             HHHHHh
Confidence            999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.88  E-value=4.3e-22  Score=194.15  Aligned_cols=149  Identities=22%  Similarity=0.455  Sum_probs=119.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc---cccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~---~~~Gt~~Y~APEll~-~   77 (505)
                      +.++.++.|++.||+|||+++  ++||||||+||+++ .++.+||+|||++.........   ...++..|+|||.+. +
T Consensus       100 ~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~  176 (256)
T cd05112         100 ETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS  176 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEc-CCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccC
Confidence            467889999999999999999  99999999999997 6789999999998765433221   223456899999874 5


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|++ |..||.. .........+..+..+ ..+...+..+.+|+.+||. +|.+||++.+++++
T Consensus       177 ~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         177 KYSSKSDVWSFGVLMWEVFSEGKTPYEN-RSNSEVVETINAGFRL-YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             CcChHHHHHHHHHHHHHHHcCCCCCCCc-CCHHHHHHHHhCCCCC-CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            68899999999999999998 9999976 3445555565554333 2345568899999999996 79999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.88  E-value=3.2e-22  Score=205.99  Aligned_cols=150  Identities=27%  Similarity=0.443  Sum_probs=120.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..+..++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++.......    .....+++.|+|||.+ .
T Consensus       179 ~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  255 (343)
T cd05103         179 EDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  255 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEc-CCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcC
Confidence            356789999999999999999  99999999999997 67899999999987653221    1122356789999977 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|++ |..||............+..+..+ ..+...++.+.+++.+||. +|.+||++.++++
T Consensus       256 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~  334 (343)
T cd05103         256 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  334 (343)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            568999999999999999997 999997655444455555444332 3345567899999999996 7999999999997


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      |
T Consensus       335 ~  335 (343)
T cd05103         335 H  335 (343)
T ss_pred             H
Confidence            6

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.88  E-value=4.5e-22  Score=195.43  Aligned_cols=148  Identities=27%  Similarity=0.451  Sum_probs=116.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC-----cEEEeecCceeeccCCC----CccccCCCcccCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-----EVKIGDLGLAIVMQQPT----ARSVIGTPEFMAP   72 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g-----~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~AP   72 (505)
                      ..+..++.||+.||+|||+.+  ++|+||||+||+++ .++     .++|+|||++.......    .....++..|+||
T Consensus       106 ~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~-~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  182 (269)
T cd05044         106 KELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVS-EKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP  182 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEe-cCCCCCCcceEECCcccccccccccccccCcccCCCccccCH
Confidence            456789999999999999999  99999999999998 444     79999999987553221    1122456789999


Q ss_pred             ccc-cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH
Q 010626           73 ELY-EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA  149 (505)
Q Consensus        73 Ell-~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa  149 (505)
                      |.+ .+.++.++||||||+++|+|+| |..||... +.......+..+..+ ..+...+..+.+||.+||. +|.+||++
T Consensus       183 E~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~  260 (269)
T cd05044         183 ESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-NNQEVLQHVTAGGRL-QKPENCPDKIYQLMTNCWAQDPSERPTF  260 (269)
T ss_pred             HHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-CHHHHHHHHhcCCcc-CCcccchHHHHHHHHHHcCCCcccCCCH
Confidence            987 4568999999999999999998 99999764 344445555443322 3345567899999999996 79999999


Q ss_pred             HHHhc
Q 010626          150 LELLK  154 (505)
Q Consensus       150 ~ElL~  154 (505)
                      .++++
T Consensus       261 ~~i~~  265 (269)
T cd05044         261 DRIQE  265 (269)
T ss_pred             HHHHH
Confidence            99875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.88  E-value=3.7e-22  Score=197.11  Aligned_cols=145  Identities=21%  Similarity=0.357  Sum_probs=110.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc-------EEEeecCceeeccCCCCccccCCCcccCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-------VKIGDLGLAIVMQQPTARSVIGTPEFMAPEL   74 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~-------vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEl   74 (505)
                      ..+..++.||+.||+|||+++  |+||||||+||+++ .++.       ++++|||++.....  .....+++.|+|||.
T Consensus       105 ~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~-~~~~~~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~y~aPE~  179 (262)
T cd05077         105 PWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLA-REGIDGECGPFIKLSDPGIPITVLS--RQECVERIPWIAPEC  179 (262)
T ss_pred             HHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEe-cCCccCCCCceeEeCCCCCCccccC--cccccccccccChhh
Confidence            356789999999999999999  99999999999996 3343       89999999865432  233467889999998


Q ss_pred             cc--ccCCcccchhhHHHHHHHHh-hcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626           75 YE--EEYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus        75 l~--~~ys~ksDIWSLGviLyEml-TG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                      +.  ..++.++|||||||++|+|+ +|..||.... ..... ....+...  .....++.+.+||.+||. +|.+||++.
T Consensus       180 ~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~-~~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~  255 (262)
T cd05077         180 VEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-LAEKE-RFYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFR  255 (262)
T ss_pred             hcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-hhHHH-HHHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHH
Confidence            74  45889999999999999998 5888886532 22221 22222111  222335789999999996 899999999


Q ss_pred             HHhcC
Q 010626          151 ELLKD  155 (505)
Q Consensus       151 ElL~h  155 (505)
                      +++++
T Consensus       256 ~il~~  260 (262)
T cd05077         256 AIMRD  260 (262)
T ss_pred             HHHHh
Confidence            99875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.88  E-value=5.2e-22  Score=194.87  Aligned_cols=145  Identities=17%  Similarity=0.324  Sum_probs=110.9

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC-------cEEEeecCceeeccCCCCccccCCCcccCcccc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY   75 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g-------~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll   75 (505)
                      .+..++.||+.||+|||++|  |+||||||+||+++....       .++++|||++.....  .....+++.|+|||++
T Consensus       101 ~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~  176 (258)
T cd05078         101 WKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP--KEILLERIPWVPPECI  176 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccccccccCC--chhccccCCccCchhc
Confidence            56779999999999999999  999999999999973322       279999998865432  2334678899999988


Q ss_pred             cc--cCCcccchhhHHHHHHHHhhcC-CCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           76 EE--EYNELVDIYSFGMCILEMVTCE-YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        76 ~~--~ys~ksDIWSLGviLyEmlTG~-~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                      ..  .++.++||||||+++|+|++|. .||.. ............   ...++......+.+||.+||+ +|.+|||+.+
T Consensus       177 ~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  252 (258)
T cd05078         177 ENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA-LDSQKKLQFYED---RHQLPAPKWTELANLINQCMDYEPDFRPSFRA  252 (258)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHcCCCCChhh-ccHHHHHHHHHc---cccCCCCCcHHHHHHHHHHhccChhhCCCHHH
Confidence            53  4789999999999999999985 55544 333322222221   123444456789999999996 7999999999


Q ss_pred             HhcC
Q 010626          152 LLKD  155 (505)
Q Consensus       152 lL~h  155 (505)
                      +++.
T Consensus       253 il~~  256 (258)
T cd05078         253 IIRD  256 (258)
T ss_pred             HHHh
Confidence            9864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.88  E-value=4.8e-22  Score=195.59  Aligned_cols=149  Identities=23%  Similarity=0.384  Sum_probs=118.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      +.++.++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||+++......    .....+++.|++||.+ .
T Consensus       113 ~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~  189 (273)
T cd05074         113 QTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLN-ENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD  189 (273)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEc-CCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc
Confidence            357889999999999999999  99999999999997 67899999999987653221    1222456789999987 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|++ |..||.. .+...++..+..+... ..+...+..+.+++.+||. +|.+||++.+++.
T Consensus       190 ~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         190 NVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYNYLIKGNRL-KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             CccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            558889999999999999999 8888865 4445555555544332 2334567899999999996 7999999999876


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       268 ~  268 (273)
T cd05074         268 Q  268 (273)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.88  E-value=8.2e-22  Score=194.23  Aligned_cols=149  Identities=24%  Similarity=0.448  Sum_probs=118.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC---ccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~---~~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..++.||+.||+|||++|  ++||||||+||+++ ..+.+||+|||++........   ....+++.|+|||.+ ..
T Consensus       107 ~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  183 (270)
T cd05056         107 ASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVS-SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR  183 (270)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEe-cCCCeEEccCceeeecccccceecCCCCccccccChhhhccC
Confidence            357789999999999999999  99999999999998 678999999999976543321   122345689999987 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|++ |..||...... .....+..+..+ ..+...+..+.++|.+|+. +|.+|||+.+++..
T Consensus       184 ~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         184 RFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGRIENGERL-PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            68899999999999999996 99999875443 344445444333 3445678899999999995 79999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.88  E-value=5e-22  Score=200.26  Aligned_cols=148  Identities=28%  Similarity=0.455  Sum_probs=118.0

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCccccc-c
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll~-~   77 (505)
                      .+..++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......    .....++..|+|||.+. .
T Consensus       110 ~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  186 (303)
T cd05110         110 LLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVK-SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR  186 (303)
T ss_pred             HHHHHHHHHHHHHHHHhhcC--eeccccccceeeec-CCCceEEccccccccccCcccccccCCCccccccCCHHHhccC
Confidence            57789999999999999999  99999999999997 67899999999997654322    12234567899999874 5


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|++ |+.||.+. ........+..+..+ ..+...+..+.+++.+||. +|.+||++.++++.
T Consensus       187 ~~~~~~DiwslG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         187 KFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERL-PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCChHHHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            68899999999999999997 89999753 334444444444333 3345567899999999995 89999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.88  E-value=6.4e-22  Score=194.48  Aligned_cols=148  Identities=26%  Similarity=0.441  Sum_probs=117.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCcc-----ccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~-----~~Gt~~Y~APEll-   75 (505)
                      ..+..++.|++.||+|||+.|  ++||||||+||+++ .++.+||+|||++..........     ...++.|+|||++ 
T Consensus       107 ~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~  183 (268)
T cd05063         107 YQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA  183 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEc-CCCcEEECCCccceecccccccceeccCCCcCceecCHHHhh
Confidence            357789999999999999999  99999999999997 67899999999997654322111     1234579999987 


Q ss_pred             cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ...++.++|||||||++|+|++ |..||... ........+..+... ......+..+.+++.+||. +|.+||++.+++
T Consensus       184 ~~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~  261 (268)
T cd05063         184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGFRL-PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIV  261 (268)
T ss_pred             cCCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            4568899999999999999998 99999764 344555555544322 2334567899999999996 899999999987


Q ss_pred             c
Q 010626          154 K  154 (505)
Q Consensus       154 ~  154 (505)
                      +
T Consensus       262 ~  262 (268)
T cd05063         262 N  262 (268)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.87  E-value=6.8e-22  Score=198.17  Aligned_cols=148  Identities=23%  Similarity=0.344  Sum_probs=113.2

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~~   77 (505)
                      ++..++.||+.||+|||++|  ++||||||+||+++ .++.++|+|||++..+....    .....+++.|++||.. .+
T Consensus       131 ~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  207 (296)
T cd05095         131 TLIFMATQIASGMKYLSSLN--FVHRDLATRNCLVG-KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG  207 (296)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--eecccCChheEEEc-CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC
Confidence            57899999999999999999  99999999999997 67899999999987653322    1122346789999965 56


Q ss_pred             cCCcccchhhHHHHHHHHhh--cCCCCCCCCChHHHHHHHHc----C--CCCCCCCCCCChHHHHHHHHhcC-CCCCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTS----G--IKPASLSKVTDPQVKQFIEKCIV-PASLRLP  148 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT--G~~Pf~~~~~~~~i~~~i~~----~--~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS  148 (505)
                      .++.++|||||||++|||++  |..||..... .........    .  ......+..+++.+.+|+.+||. +|.+||+
T Consensus       208 ~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~  286 (296)
T cd05095         208 KFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS  286 (296)
T ss_pred             CccchhhhhHHHHHHHHHHHhCCCCCccccCh-HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCC
Confidence            78999999999999999998  7788865432 232222211    1  01112234467899999999996 8999999


Q ss_pred             HHHHhc
Q 010626          149 ALELLK  154 (505)
Q Consensus       149 a~ElL~  154 (505)
                      +.++++
T Consensus       287 ~~~i~~  292 (296)
T cd05095         287 FQEIHA  292 (296)
T ss_pred             HHHHHH
Confidence            999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.87  E-value=5.5e-22  Score=209.84  Aligned_cols=149  Identities=28%  Similarity=0.456  Sum_probs=120.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..+..++.||+.||+|||+++  ++||||||+||+++ .++.+||+|||++.......    .....+++.|+|||.+ .
T Consensus       237 ~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  313 (400)
T cd05105         237 LDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD  313 (400)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEe-CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC
Confidence            356789999999999999999  99999999999998 67899999999997653321    2233567889999987 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|||||||++|+|++ |..||.........+..+..+..+ ..+...+..+.+++.+||. +|.+||++.++.+
T Consensus       314 ~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         314 NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            568999999999999999997 999997655455555666555433 3445678899999999996 8999999988765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.87  E-value=7.5e-22  Score=192.97  Aligned_cols=148  Identities=27%  Similarity=0.398  Sum_probs=117.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~-~   77 (505)
                      ..+..++.||+.||.|||++|  ++|+||||+||+++ .++.+||+|||++.......   .....++..|+|||.+. .
T Consensus       103 ~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  179 (261)
T cd05034         103 PQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVG-ENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG  179 (261)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEc-CCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccC
Confidence            467889999999999999999  99999999999997 67899999999987664321   11223456899999874 5


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++|+||||+++|+|++ |+.||.+. ........+..+... ..+...+..+.+++.+||. +|.+||++.+++.
T Consensus       180 ~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         180 RFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQVERGYRM-PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            68899999999999999999 99999764 444555555554332 2334457899999999996 7999999998863

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.87  E-value=8.4e-22  Score=197.42  Aligned_cols=148  Identities=24%  Similarity=0.332  Sum_probs=113.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC----ccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~----~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++........    ....+++.|+|||.+ .+
T Consensus       130 ~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  206 (295)
T cd05097         130 NLLYMAVQIASGMKYLASLN--FVHRDLATRNCLVG-NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG  206 (295)
T ss_pred             HHHHHHHHHHHHHHHHHhcC--eeccccChhhEEEc-CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC
Confidence            56789999999999999999  99999999999997 678999999999875532221    122456789999977 56


Q ss_pred             cCCcccchhhHHHHHHHHhh--cCCCCCCCCChHHHHHHHHc------CCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTS------GIKPASLSKVTDPQVKQFIEKCIV-PASLRLP  148 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT--G~~Pf~~~~~~~~i~~~i~~------~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS  148 (505)
                      .++.++||||||+++|+|++  +..||..... ......+..      .......+...++.+.+||.+||. +|.+||+
T Consensus       207 ~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs  285 (295)
T cd05097         207 KFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT  285 (295)
T ss_pred             CcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcC
Confidence            68999999999999999988  6678875433 333222211      111122344567899999999996 8999999


Q ss_pred             HHHHhc
Q 010626          149 ALELLK  154 (505)
Q Consensus       149 a~ElL~  154 (505)
                      +.++++
T Consensus       286 ~~~i~~  291 (295)
T cd05097         286 FNKIHH  291 (295)
T ss_pred             HHHHHH
Confidence            999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.87  E-value=8.6e-22  Score=194.31  Aligned_cols=150  Identities=23%  Similarity=0.390  Sum_probs=119.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC---CCccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~---~~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..++.||+.||.|||+++  ++||||||+||+++ .++.++++|||++......   ......+++.|+|||.+ ..
T Consensus       117 ~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  193 (275)
T cd05046         117 KQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED  193 (275)
T ss_pred             HHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEe-CCCcEEEcccccccccCcccccccCCceeEEeecChhhhccC
Confidence            457889999999999999999  99999999999998 6789999999998644222   12233567789999977 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|++ |..||... ........+..+..+...+...+..+.+++.+||. +|.+||++.+++.+
T Consensus       194 ~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         194 DFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCcccc-chHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            57889999999999999998 88899653 34445555554444444455678899999999995 89999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.87  E-value=1.2e-21  Score=192.32  Aligned_cols=148  Identities=23%  Similarity=0.402  Sum_probs=117.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC---ccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~---~~~~Gt~~Y~APEll~-~   77 (505)
                      ..+..++.||+.||.|||++|  ++||||||+||+++ ..+.+||+|||.+........   ....++..|+|||++. +
T Consensus       102 ~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~  178 (260)
T cd05073         102 PKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG  178 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEc-CCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccC
Confidence            357789999999999999999  99999999999997 678999999999976543221   1223556799999884 4


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++|+||||+++|+++| |..||.... .......+..+... ......+.++.+++.+||. +|.+||++.+++.
T Consensus       179 ~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         179 SFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPEVIRALERGYRM-PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CcCccccchHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHhCCCCC-CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            58889999999999999999 899997643 44444555444332 3345667899999999996 7999999988764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.87  E-value=1.4e-21  Score=193.75  Aligned_cols=148  Identities=27%  Similarity=0.451  Sum_probs=119.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC----ccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~----~~~~Gt~~Y~APEll-~   76 (505)
                      ..+..++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||+++.......    ....++..|+|||.+ .
T Consensus       109 ~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~-~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  185 (279)
T cd05057         109 QYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH  185 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEc-CCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc
Confidence            367889999999999999999  99999999999997 678999999999976543221    111235679999977 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|+||||+++|++++ |..||... ....+...+..+.. ...+...+..+.+++.+||. +|..||++.++++
T Consensus       186 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         186 RIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGER-LPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCcCchhhHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            568899999999999999998 99999764 45566666665433 33455678899999999995 8999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.87  E-value=8.4e-22  Score=196.09  Aligned_cols=150  Identities=25%  Similarity=0.414  Sum_probs=114.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll-   75 (505)
                      ..+..++.||+.||+|||++|  ++||||||+||+++ .++.++|+|||++.......     .....++..|+|||.+ 
T Consensus       109 ~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  185 (284)
T cd05079         109 KQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI  185 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEc-CCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhc
Confidence            356789999999999999999  99999999999997 67899999999997654322     1234567789999977 


Q ss_pred             cccCCcccchhhHHHHHHHHhhcCCCCCCCC--------------ChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCEYPYNECK--------------NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV  141 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~--------------~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~  141 (505)
                      ...++.++||||||+++|+|+|+..|+....              ........+..+.. ...+..++..+.+|+.+||.
T Consensus       186 ~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~  264 (284)
T cd05079         186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR-LPRPPNCPEEVYQLMRKCWE  264 (284)
T ss_pred             cCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCcc-CCCCCCCCHHHHHHHHHHcc
Confidence            4568899999999999999999876643211              11112222222222 22345578899999999996


Q ss_pred             -CCCCCCCHHHHhcC
Q 010626          142 -PASLRLPALELLKD  155 (505)
Q Consensus       142 -dP~~RpSa~ElL~h  155 (505)
                       +|.+||++.+++++
T Consensus       265 ~~p~~Rpt~~~il~~  279 (284)
T cd05079         265 FQPSKRTTFQNLIEG  279 (284)
T ss_pred             CCcccCcCHHHHHHH
Confidence             89999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.87  E-value=7.4e-22  Score=189.95  Aligned_cols=156  Identities=24%  Similarity=0.439  Sum_probs=126.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCcc-ccCCCcccCcccc--cccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPELY--EEEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~-~~Gt~~Y~APEll--~~~y   79 (505)
                      .|+.++.||+.||.|||+.|  |+|||+||.|+++|.....++|+|+|+|.+........ .+.+..|--||++  -+.|
T Consensus       133 dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~Y  210 (338)
T KOG0668|consen  133 DIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMY  210 (338)
T ss_pred             hHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhc
Confidence            57899999999999999999  99999999999999888889999999998876654433 3567788899988  4569


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCC-CCChHHHHHHHHc---------------CCCC-------------------CCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNE-CKNPAQIYKKVTS---------------GIKP-------------------ASL  124 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~-~~~~~~i~~~i~~---------------~~~p-------------------~~~  124 (505)
                      +.+-|+|||||++..|+..+.||.. ..|.+|+.+....               ...|                   ..-
T Consensus       211 DYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n  290 (338)
T KOG0668|consen  211 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSEN  290 (338)
T ss_pred             cccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccc
Confidence            9999999999999999999999854 4566666443221               0000                   111


Q ss_pred             CCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          125 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       125 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      ....++++.+|+.++|. |..+|+||.|++.||||..
T Consensus       291 ~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  291 QHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             cccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence            22346899999999996 8999999999999999975

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.87  E-value=1.6e-21  Score=192.14  Aligned_cols=148  Identities=24%  Similarity=0.412  Sum_probs=117.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC-----ccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~-----~~~~Gt~~Y~APEll~   76 (505)
                      .++..++.||+.||+|||++|  ++||||||+||+++ .++.++|+|||++........     ....++..|+|||.+.
T Consensus       106 ~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~  182 (267)
T cd05066         106 IQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA  182 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEEC-CCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhc
Confidence            357889999999999999999  99999999999997 678999999999976543221     1112356799999884


Q ss_pred             -ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 -EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                       +.++.++|+||||+++|++++ |..||.... .......+..+..+ ..+...++.+.+++.+||. +|.+||++.+++
T Consensus       183 ~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~  260 (267)
T cd05066         183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMS-NQDVIKAIEEGYRL-PAPMDCPAALHQLMLDCWQKDRNERPKFEQIV  260 (267)
T ss_pred             cCccCchhhhHHHHHHHHHHhcCCCCCcccCC-HHHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCchhCCCHHHHH
Confidence             568999999999999999886 999997643 44455556555333 2344567899999999996 799999999987


Q ss_pred             c
Q 010626          154 K  154 (505)
Q Consensus       154 ~  154 (505)
                      +
T Consensus       261 ~  261 (267)
T cd05066         261 S  261 (267)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=6.2e-22  Score=211.04  Aligned_cols=161  Identities=25%  Similarity=0.438  Sum_probs=126.8

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc---------CC---------------
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ---------QP---------------   58 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~---------~~---------------   58 (505)
                      .++.|+.++..|+++.|..|  +|||||||+||||| .+|++||.|||++.-++         ..               
T Consensus       730 LARFYIAEltcAiesVHkmG--FIHRDiKPDNILID-rdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~  806 (1034)
T KOG0608|consen  730 LARFYIAELTCAIESVHKMG--FIHRDIKPDNILID-RDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWA  806 (1034)
T ss_pred             HHHHHHHHHHHHHHHHHhcc--ceecccCccceEEc-cCCceeeeeccccccceeccccccccCCCccccccCCCchhhc
Confidence            57889999999999999999  99999999999998 88999999999985331         00               


Q ss_pred             --------------------CCccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc
Q 010626           59 --------------------TARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS  117 (505)
Q Consensus        59 --------------------~~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~  117 (505)
                                          .....+||+.|+|||++ ..+|+..+|.||.|+|||||+.|+.||.........++.+.-
T Consensus       807 d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw  886 (1034)
T KOG0608|consen  807 DISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINW  886 (1034)
T ss_pred             cccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence                                01235799999999988 667999999999999999999999999764433322222211


Q ss_pred             -CCCCCCCCCCCChHHHHHHHHhcCCCCCCCC---HHHHhcCCCCCCCCCCCc
Q 010626          118 -GIKPASLSKVTDPQVKQFIEKCIVPASLRLP---ALELLKDPFLVTDNPKDL  166 (505)
Q Consensus       118 -~~~p~~~~~~~s~~l~~LI~kcL~dP~~RpS---a~ElL~hpff~~~~~~~l  166 (505)
                       ..........+++++.+||.++...++.|..   ++++-.||||+...+..+
T Consensus       887 ~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfssl  939 (1034)
T KOG0608|consen  887 RNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSL  939 (1034)
T ss_pred             hhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhh
Confidence             1112223456789999999999988888874   778999999998776554

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.86  E-value=1.8e-21  Score=206.07  Aligned_cols=149  Identities=27%  Similarity=0.455  Sum_probs=121.6

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..++.||+.||+|||+.+  ++||||||+||+++ ..+.+||+|||+++......    .....+++.|+|||.+ ..
T Consensus       240 ~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl~-~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  316 (401)
T cd05107         240 DLVGFSYQVANGMEFLASKN--CVHRDLAARNVLIC-EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN  316 (401)
T ss_pred             HHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEEe-CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC
Confidence            46789999999999999999  99999999999998 67899999999997653221    2233567889999987 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|||++ |..||............+..+..+ ..+...+..+.+|+.+||. +|.+||++.++++.
T Consensus       317 ~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         317 LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            58899999999999999998 899997755555556666655433 3455678999999999996 79999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.86  E-value=2.3e-21  Score=190.89  Aligned_cols=148  Identities=23%  Similarity=0.401  Sum_probs=116.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC----cccc---CCCcccCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVI---GTPEFMAPEL   74 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~----~~~~---Gt~~Y~APEl   74 (505)
                      ..++.++.|++.||+|||++|  ++||||||+||+++ .++.+||+|||++........    ....   .+..|+|||.
T Consensus       106 ~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~  182 (269)
T cd05065         106 IQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA  182 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEc-CCCcEEECCCccccccccCccccccccccCCCcceeecCHhH
Confidence            357889999999999999999  99999999999997 678999999999875533211    1111   2357999998


Q ss_pred             c-cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           75 Y-EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        75 l-~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                      + ...++.++|||||||++|||++ |..||... ........+..... ...+..++..+.+++.+||. +|.+||++.+
T Consensus       183 ~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-~~~~~~~~i~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~  260 (269)
T cd05065         183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQDVINAIEQDYR-LPPPMDCPTALHQLMLDCWQKDRNARPKFGQ  260 (269)
T ss_pred             hccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-CHHHHHHHHHcCCc-CCCcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            8 4568999999999999999886 99999764 34455555544322 23344567899999999996 7999999999


Q ss_pred             Hhc
Q 010626          152 LLK  154 (505)
Q Consensus       152 lL~  154 (505)
                      ++.
T Consensus       261 i~~  263 (269)
T cd05065         261 IVS  263 (269)
T ss_pred             HHH
Confidence            875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.86  E-value=2.4e-21  Score=192.23  Aligned_cols=150  Identities=25%  Similarity=0.365  Sum_probs=112.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC-----ccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~-----~~~~Gt~~Y~APEll~   76 (505)
                      ..+..++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++........     ....++..|+|||++.
T Consensus       108 ~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  184 (284)
T cd05081         108 RKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVE-SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT  184 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEEC-CCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhc
Confidence            356789999999999999999  99999999999997 678999999999976543221     1112344699999874


Q ss_pred             -ccCCcccchhhHHHHHHHHhhcCCCCCCCCCh---------------HHHHHHHHcCCCCCCCCCCCChHHHHHHHHhc
Q 010626           77 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNP---------------AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  140 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~---------------~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL  140 (505)
                       ..++.++||||||+++|||++|..|+......               ..+...+.... ....+...+..+.+||.+||
T Consensus       185 ~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl  263 (284)
T cd05081         185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG-RLPAPPGCPAEIYAIMKECW  263 (284)
T ss_pred             cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCC-cCCCCCCCCHHHHHHHHHHc
Confidence             56889999999999999999987765432110               01111122221 22234556789999999999


Q ss_pred             C-CCCCCCCHHHHhcC
Q 010626          141 V-PASLRLPALELLKD  155 (505)
Q Consensus       141 ~-dP~~RpSa~ElL~h  155 (505)
                      . +|.+|||+.++++.
T Consensus       264 ~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         264 NNDPSQRPSFSELALQ  279 (284)
T ss_pred             cCChhhCCCHHHHHHH
Confidence            6 89999999999763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.86  E-value=1.1e-21  Score=223.30  Aligned_cols=150  Identities=31%  Similarity=0.474  Sum_probs=113.8

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--------------------CCcc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--------------------TARS   62 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--------------------~~~~   62 (505)
                      .+..++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++......                    ....
T Consensus       114 ~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd-~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~  190 (932)
T PRK13184        114 AFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGK  190 (932)
T ss_pred             HHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEc-CCCCEEEEecCcceecccccccccccccccccccccccccCCC
Confidence            46778999999999999999  99999999999997 6789999999999765210                    0112


Q ss_pred             ccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC
Q 010626           63 VIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV  141 (505)
Q Consensus        63 ~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~  141 (505)
                      .+||+.|+|||++ ...++.++|||||||++|+|+||..||..........................++.+.+++.+||.
T Consensus       191 ~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~  270 (932)
T PRK13184        191 IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALA  270 (932)
T ss_pred             CCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHcc
Confidence            4699999999987 456899999999999999999999999764332222221111111111123567889999999996


Q ss_pred             -CCCCCCCHHHHhcC
Q 010626          142 -PASLRLPALELLKD  155 (505)
Q Consensus       142 -dP~~RpSa~ElL~h  155 (505)
                       +|.+|++..+.+.+
T Consensus       271 ~DP~kR~ss~eeLl~  285 (932)
T PRK13184        271 VDPAERYSSVQELKQ  285 (932)
T ss_pred             CChhhCcCHHHHHHH
Confidence             89999887665543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.86  E-value=5.1e-22  Score=217.64  Aligned_cols=152  Identities=28%  Similarity=0.395  Sum_probs=117.9

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC----CCcEEEeecCceeeccCCC-----CccccCCCcccCccc
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN----NGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPEL   74 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~----~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEl   74 (505)
                      .+.++.|++.||++||+.+  |+||||||.||||...    ...++|+|||+++.+....     .....||-.|+|||+
T Consensus       608 ~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~  685 (903)
T KOG1027|consen  608 PISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQ  685 (903)
T ss_pred             HHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHH
Confidence            4678899999999999999  9999999999999752    2468999999998775432     334579999999999


Q ss_pred             ccc-cCCcccchhhHHHHHHHHhhc-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           75 YEE-EYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        75 l~~-~ys~ksDIWSLGviLyEmlTG-~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                      +.. .-+.++||||+||++|+.++| ..||...  .......+........+....+.++.+||.+|+. +|..||+|.+
T Consensus       686 L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~  763 (903)
T KOG1027|consen  686 LREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATD  763 (903)
T ss_pred             HhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHH
Confidence            844 456799999999999999995 8999753  2222233332222222333333389999999996 7999999999


Q ss_pred             HhcCCCCC
Q 010626          152 LLKDPFLV  159 (505)
Q Consensus       152 lL~hpff~  159 (505)
                      +|.||||=
T Consensus       764 VL~HPlFW  771 (903)
T KOG1027|consen  764 VLNHPLFW  771 (903)
T ss_pred             HhCCCccC
Confidence            99999994

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.85  E-value=4e-21  Score=191.22  Aligned_cols=146  Identities=21%  Similarity=0.335  Sum_probs=110.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC------CCcEEEeecCceeeccCCCCccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~------~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll   75 (505)
                      ..+..++.||+.||+|||+++  |+||||||+||+++..      .+.+|++|||++......  ....+++.|+|||.+
T Consensus       117 ~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~  192 (274)
T cd05076         117 AWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECV  192 (274)
T ss_pred             HHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--cccccCCcccCchhh
Confidence            356789999999999999999  9999999999999631      224899999987543222  223578889999987


Q ss_pred             c--ccCCcccchhhHHHHHHHHh-hcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           76 E--EEYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        76 ~--~~ys~ksDIWSLGviLyEml-TG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                      .  ..++.++||||||+++|||+ +|+.||..... ..........   ...+....+.+.++|.+||. +|.+||++.+
T Consensus       193 ~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~  268 (274)
T cd05076         193 PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-SEKERFYEKK---HRLPEPSCKELATLISQCLTYEPTQRPSFRT  268 (274)
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-HHHHHHHHhc---cCCCCCCChHHHHHHHHHcccChhhCcCHHH
Confidence            4  35889999999999999995 69999976432 2222222221   12233346789999999996 7999999999


Q ss_pred             HhcC
Q 010626          152 LLKD  155 (505)
Q Consensus       152 lL~h  155 (505)
                      +|++
T Consensus       269 il~~  272 (274)
T cd05076         269 ILRD  272 (274)
T ss_pred             HHHh
Confidence            9875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.85  E-value=2.8e-21  Score=190.71  Aligned_cols=149  Identities=26%  Similarity=0.397  Sum_probs=114.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC-----ccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~-----~~~~Gt~~Y~APEll-   75 (505)
                      ..+..++.||+.||+|||++|  ++||||||+||+++ .++.++|+|||.+........     ....++..|+|||.+ 
T Consensus       109 ~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~  185 (284)
T cd05038         109 KRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR  185 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEc-CCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHc
Confidence            457889999999999999999  99999999999998 678999999999976653211     112345579999977 


Q ss_pred             cccCCcccchhhHHHHHHHHhhcCCCCCCCCCh--------------HHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNP--------------AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV  141 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~--------------~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~  141 (505)
                      ...++.++||||||+++|+|+||..|+......              ..+...+.... ....+..++..+.+++.+||.
T Consensus       186 ~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~  264 (284)
T cd05038         186 TSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGE-RLPRPPSCPDEVYDLMKLCWE  264 (284)
T ss_pred             cCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCC-cCCCCccCCHHHHHHHHHHhc
Confidence            456889999999999999999999998653211              11222222222 222344567899999999996


Q ss_pred             -CCCCCCCHHHHhc
Q 010626          142 -PASLRLPALELLK  154 (505)
Q Consensus       142 -dP~~RpSa~ElL~  154 (505)
                       +|.+||++.+++.
T Consensus       265 ~~p~~Rpt~~ei~~  278 (284)
T cd05038         265 AEPQDRPSFADLIL  278 (284)
T ss_pred             cChhhCCCHHHHHH
Confidence             7999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.85  E-value=4e-21  Score=215.75  Aligned_cols=99  Identities=24%  Similarity=0.438  Sum_probs=78.0

Q ss_pred             cCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC-CCCCCCCCCCChHHHHHHHHhcC
Q 010626           64 IGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKPASLSKVTDPQVKQFIEKCIV  141 (505)
Q Consensus        64 ~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~-~~p~~~~~~~s~~l~~LI~kcL~  141 (505)
                      +||+.|+|||++ ...|+.++|||||||++|||+||..||.+. ........+... ..........+..+.+++.+||.
T Consensus       541 vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~pf~~~-~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~  619 (669)
T cd05610         541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDE-TPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLT  619 (669)
T ss_pred             eeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcc
Confidence            468899999977 556899999999999999999999999764 444555555433 22222333567889999999995


Q ss_pred             -CCCCCCCHHHHhcCCCCCCCCC
Q 010626          142 -PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       142 -dP~~RpSa~ElL~hpff~~~~~  163 (505)
                       +|.+||++.++|+||||....+
T Consensus       620 ~dP~~R~ta~e~l~h~~~~~~~~  642 (669)
T cd05610         620 MDPTKRAGLKELKQHPLFHGVDW  642 (669)
T ss_pred             cChhHCcCHHHHHhCHhhcCCCH
Confidence             8999999999999999976544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.85  E-value=2.1e-21  Score=181.09  Aligned_cols=156  Identities=25%  Similarity=0.435  Sum_probs=120.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC--ccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~--~~~~Gt~~Y~APEll~--~   77 (505)
                      +.++.++.|+++||.|+|+++  +.||||||.|++++ .+|++|++|||+++.+.-+..  ...+.|.+|++|.++-  .
T Consensus       101 ~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin-~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgak  177 (292)
T KOG0662|consen  101 EIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK  177 (292)
T ss_pred             HHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEec-cCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeee
Confidence            568899999999999999999  99999999999998 789999999999988765542  2236789999999873  4


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCC--CCC---------------C---------CCCCh
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP--ASL---------------S---------KVTDP  130 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p--~~~---------------~---------~~~s~  130 (505)
                      -|+...|+||.||++.|+.. |.+.|.+..-.+++.+....-..|  ..+               +         .....
T Consensus       178 ly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns  257 (292)
T KOG0662|consen  178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNS  257 (292)
T ss_pred             hhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcc
Confidence            49999999999999999997 555566654445544333221110  000               0         11123


Q ss_pred             HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      .-++++.++|. +|.+|++++++|+||||..
T Consensus       258 ~grdllqkll~cnp~qrisaeaalqhpyf~d  288 (292)
T KOG0662|consen  258 TGRDLLQKLLKCNPAQRISAEAALQHPYFSD  288 (292)
T ss_pred             hhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence            56899999995 8999999999999999964

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.85  E-value=8.1e-22  Score=210.73  Aligned_cols=156  Identities=28%  Similarity=0.483  Sum_probs=130.2

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC-CCCccccCCCcccCccccccc--C
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELYEEE--Y   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~-~~~~~~~Gt~~Y~APEll~~~--y   79 (505)
                      .++.++.|++.|++|||+++  |+|||||++|||++ .+..+||+|||++..+.. ....+.+|++.|.|||++.+.  -
T Consensus       156 ~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~-~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~  232 (596)
T KOG0586|consen  156 EARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLD-ENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYD  232 (596)
T ss_pred             hhhhhhHHHHHHHHHHhhcc--eeccccchhhcccc-cccceeeeccccceeecccccccccCCCCCccChHhhcCcccC
Confidence            57889999999999999999  99999999999998 667899999999988764 346788999999999999543  4


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      ++.+|+||+|+++|-|+.|.+||.+ .+...+...+..+..  .++...+.++.++|+++|+ +|.+|++.++++.|.|.
T Consensus       233 gpe~D~Wslgvvly~LV~GsLPFDG-~~lk~Lr~rvl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~  309 (596)
T KOG0586|consen  233 GPEVDIWSLGVVLYALVEGSLPFDG-QNLKELRPRVLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR  309 (596)
T ss_pred             CcceehhhhhhhheeeeecccccCC-cccccccchheeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence            6899999999999999999999987 344444444444433  2445567899999999996 79999999999999998


Q ss_pred             CCCCCC
Q 010626          159 VTDNPK  164 (505)
Q Consensus       159 ~~~~~~  164 (505)
                      ......
T Consensus       310 n~~~~~  315 (596)
T KOG0586|consen  310 NDLLEA  315 (596)
T ss_pred             chhhhh
Confidence            765443

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.3e-21  Score=220.16  Aligned_cols=149  Identities=22%  Similarity=0.392  Sum_probs=122.2

Q ss_pred             CHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccc----cCCCcccCcccc-
Q 010626            1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV----IGTPEFMAPELY-   75 (505)
Q Consensus         1 Lk~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~----~Gt~~Y~APEll-   75 (505)
                      |+.+..++.||++|.+||++++  +|||||.++|+|++ ....|||+|||+|+-+........    .-...|||||.+ 
T Consensus       801 ~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~-~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~  877 (1025)
T KOG1095|consen  801 MRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLD-ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLK  877 (1025)
T ss_pred             HHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeec-ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHh
Confidence            4678889999999999999999  99999999999998 568999999999984422221111    123589999987 


Q ss_pred             cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      .+.|+.|+|||||||++||++| |..||.+..+.+.+......+  ....+..++..+.++|..||. +|.+||++..|+
T Consensus       878 d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~  955 (1025)
T KOG1095|consen  878 DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIV  955 (1025)
T ss_pred             hcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHH
Confidence            5789999999999999999999 999998866555444444555  445677888999999999996 899999999998


Q ss_pred             c
Q 010626          154 K  154 (505)
Q Consensus       154 ~  154 (505)
                      +
T Consensus       956 ~  956 (1025)
T KOG1095|consen  956 E  956 (1025)
T ss_pred             h
Confidence            7

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.85  E-value=8.2e-21  Score=206.08  Aligned_cols=156  Identities=28%  Similarity=0.379  Sum_probs=113.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-Cc--cccCCCcccCccccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-AR--SVIGTPEFMAPELYEEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~--~~~Gt~~Y~APEll~~~   78 (505)
                      ..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||++....... ..  ...+++.|+|||.+...
T Consensus       309 ~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~  385 (507)
T PLN03224        309 NVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVT-VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP  385 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEEC-CCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence            357889999999999999999  99999999999997 67899999999996553321 11  12357899999976321


Q ss_pred             ---------------------CC--cccchhhHHHHHHHHhhcCC-CCCCCC----------ChHHHHHHHHcCCCCCCC
Q 010626           79 ---------------------YN--ELVDIYSFGMCILEMVTCEY-PYNECK----------NPAQIYKKVTSGIKPASL  124 (505)
Q Consensus        79 ---------------------ys--~ksDIWSLGviLyEmlTG~~-Pf~~~~----------~~~~i~~~i~~~~~p~~~  124 (505)
                                           |+  .+.||||+||++|+|++|.. ||....          +....+..+.........
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~  465 (507)
T PLN03224        386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSL  465 (507)
T ss_pred             CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCccc
Confidence                                 12  34799999999999999886 664321          111112222222222223


Q ss_pred             CCCCChHHHHHHHHhcC-CC---CCCCCHHHHhcCCCCCC
Q 010626          125 SKVTDPQVKQFIEKCIV-PA---SLRLPALELLKDPFLVT  160 (505)
Q Consensus       125 ~~~~s~~l~~LI~kcL~-dP---~~RpSa~ElL~hpff~~  160 (505)
                      ....++..++|+.+||. +|   .+|+|+.|+|+||||..
T Consensus       466 ~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        466 LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            34567899999999995 33   68999999999999964

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.85  E-value=2.6e-21  Score=213.24  Aligned_cols=146  Identities=27%  Similarity=0.401  Sum_probs=122.5

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccc----cCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV----IGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~----~Gt~~Y~APEll-~~   77 (505)
                      +...|+.||+.|+.||-++.  ++||||-.+|+||. ++..|||+|||+++..-...-...    .-..+|||||.+ .+
T Consensus       604 q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVg-e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~  680 (774)
T KOG1026|consen  604 QFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVG-ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG  680 (774)
T ss_pred             HHHHHHHHHHHHHHHHHhCc--ccccchhhhhceec-cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC
Confidence            57889999999999999999  99999999999996 788999999999975432211111    224689999955 89


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      +|+.++|||||||+|||+++ |..||.+..+ ++..+.++.+.. ..-+..++.+++.|+..||+ .|++||++.||-
T Consensus       681 kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  681 KFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             cccchhhhhhhhhhhhhhhccccCcccccch-HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            99999999999999999998 9999988655 455566777655 56788899999999999996 799999999874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.85  E-value=1.6e-21  Score=185.25  Aligned_cols=117  Identities=32%  Similarity=0.595  Sum_probs=101.6

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCcc-ccCCCcccCccccc-----
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPEFMAPELYE-----   76 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~-~~Gt~~Y~APEll~-----   76 (505)
                      .+-+++..++.||.|||++ ..+||||+||+|||++ ..|+||+||||++..+.+..+.+ ..|...|||||.+.     
T Consensus       149 vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn-~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~  226 (282)
T KOG0984|consen  149 VLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILIN-YDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQ  226 (282)
T ss_pred             HhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEc-cCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCc
Confidence            3567899999999999987 3499999999999998 78999999999998887776665 57889999999873     


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP  121 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p  121 (505)
                      ..|+-++||||||+++.||.++++||.....+.+..+.+.....|
T Consensus       227 ~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P  271 (282)
T KOG0984|consen  227 KGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP  271 (282)
T ss_pred             ccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence            359999999999999999999999999888888887777766444

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=7.1e-21  Score=191.07  Aligned_cols=170  Identities=24%  Similarity=0.447  Sum_probs=133.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCcccccc-cC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELYEE-EY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll~~-~y   79 (505)
                      .++.|..+|..||+|||++|  ||+||||.+|+|++ ..|++||.|+|+++.--  .....+++|||.|.|||++++ .|
T Consensus       352 harfys~ei~lal~flh~rg--iiyrdlkldnvlld-aeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeey  428 (593)
T KOG0695|consen  352 HARFYSAEICLALNFLHERG--IIYRDLKLDNVLLD-AEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY  428 (593)
T ss_pred             HhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEc-cCCceeecccchhhcCCCCCcccccccCCCcccchhhhccccc
Confidence            56788999999999999999  99999999999998 67999999999997542  334667899999999999955 59


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCC--CCCCh-----HHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC---
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYN--ECKNP-----AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP---  148 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~--~~~~~-----~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS---  148 (505)
                      ...+|.|+||++++||+.|+.||.  +..++     +-+++.|...  ...++...+-.+..+++.-|. +|.+|..   
T Consensus       429 gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek--qiriprslsvkas~vlkgflnkdp~erlgc~~  506 (593)
T KOG0695|consen  429 GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK--QIRIPRSLSVKASHVLKGFLNKDPKERLGCRP  506 (593)
T ss_pred             CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh--cccccceeehhhHHHHHHhhcCCcHHhcCCCc
Confidence            999999999999999999999995  22222     3344555443  223555566677788888885 7998874   


Q ss_pred             ---HHHHhcCCCCCCCCCCCcccCCCCCCCCch
Q 010626          149 ---ALELLKDPFLVTDNPKDLVCDPLRLPNLVP  178 (505)
Q Consensus       149 ---a~ElL~hpff~~~~~~~l~~~~l~~p~~~~  178 (505)
                         ..++-.|+||....|..+..+.. +|+..|
T Consensus       507 ~~g~~dik~h~ffr~idwd~leqk~v-~ppf~p  538 (593)
T KOG0695|consen  507 QTGFSDIKSHAFFRSIDWDLLEQKQV-LPPFQP  538 (593)
T ss_pred             ccchhhhhcchhhhhCCHHHHhhccc-CCCCCC
Confidence               67899999999888876654433 444443

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.83  E-value=7.2e-21  Score=209.51  Aligned_cols=154  Identities=32%  Similarity=0.541  Sum_probs=127.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccccc---
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELYEE---   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll~~---   77 (505)
                      .|..|++.++.||.+||.+.  ++|||||-.|||++ .+|.|||+|||++..+..  ....+.+|||.|||||++.+   
T Consensus       124 ~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT-~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~  200 (953)
T KOG0587|consen  124 WIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDES  200 (953)
T ss_pred             HHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEe-ccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccC
Confidence            57789999999999999999  99999999999998 789999999999987643  35677899999999998832   


Q ss_pred             ---cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCC-CCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           78 ---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-SKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        78 ---~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~-~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                         .|+..+|+||||++..||.-|.+|+.+.. +....-.|....+|... ++..+.++.+||..||. +..+||+..++
T Consensus       201 ~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-PmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~l  279 (953)
T KOG0587|consen  201 PDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEEL  279 (953)
T ss_pred             CCCCcccccchhhccceeehhcCCCCCccCcc-hhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence               37789999999999999999999998743 33333333333333222 45667899999999995 79999999999


Q ss_pred             hcCCCCCC
Q 010626          153 LKDPFLVT  160 (505)
Q Consensus       153 L~hpff~~  160 (505)
                      |+|||++.
T Consensus       280 l~hpFi~e  287 (953)
T KOG0587|consen  280 LKHPFITE  287 (953)
T ss_pred             ccCCcccc
Confidence            99999984

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=7.3e-21  Score=186.88  Aligned_cols=156  Identities=29%  Similarity=0.504  Sum_probs=118.8

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc--cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY--EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll--~~   77 (505)
                      .|+-+++||++||.|||+.+  |+||||||.|+|++ .+..+||||||+++.-....   ....+.|..|+|||++  ..
T Consensus       157 HvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVN-SNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaR  233 (449)
T KOG0664|consen  157 HVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVN-SNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGAR  233 (449)
T ss_pred             hhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEec-cCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcch
Confidence            57788999999999999999  99999999999998 67789999999998764432   2233568899999987  45


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHH------------------------cCCCCCCCCCC------
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT------------------------SGIKPASLSKV------  127 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~------------------------~~~~p~~~~~~------  127 (505)
                      .|+.++||||.|||+.|++..+..|... ++.+....|.                        .+.+++.++..      
T Consensus       234 hYs~AvDiWSVGCIFaELLgRrILFQAq-~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~  312 (449)
T KOG0664|consen  234 RYTGAVDIWSVGCIFAELLQRKILFQAA-GPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASP  312 (449)
T ss_pred             hhcCccceehhhHHHHHHHhhhhhhhcc-ChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCC
Confidence            7999999999999999999988888763 3333322222                        12223332221      


Q ss_pred             --CChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          128 --TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       128 --~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                        ...+...++.++|. +|.+|.+..+++.|+|+.+..
T Consensus       313 ~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  313 DDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             cccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence              12355667777776 799999999999999987644

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.83  E-value=1.6e-20  Score=196.40  Aligned_cols=152  Identities=28%  Similarity=0.465  Sum_probs=110.4

Q ss_pred             HHHHHHHHHHHHHHHHHhCC-CCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC-CCC-ccc-cCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHN-PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTA-RSV-IGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g-~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~-~~~-~~~-~Gt~~Y~APEll-~~   77 (505)
                      .-.+|+.+++.||+|||... |+|||||||+.|||+| .+..+||+|||+|+.... ... ... .||..|+|||.+ .+
T Consensus       175 ~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD-~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g  253 (361)
T KOG1187|consen  175 TRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD-EDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTG  253 (361)
T ss_pred             HHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC-CCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccC
Confidence            34689999999999999854 5899999999999998 789999999999966553 222 222 799999999988 46


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCC--Ch---HHH-HHHHHcCCC----CCCCC-CCCC--hH---HHHHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECK--NP---AQI-YKKVTSGIK----PASLS-KVTD--PQ---VKQFIEKCIV  141 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~--~~---~~i-~~~i~~~~~----p~~~~-~~~s--~~---l~~LI~kcL~  141 (505)
                      ..+.++||||||++++|++||+.|.....  ..   ... ...+..+..    .+.+. ..++  ..   +..+..+|+.
T Consensus       254 ~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~  333 (361)
T KOG1187|consen  254 KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLR  333 (361)
T ss_pred             CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcC
Confidence            79999999999999999999998876432  11   111 112222211    11111 2222  23   4566778996


Q ss_pred             -CCCCCCCHHHHhcC
Q 010626          142 -PASLRLPALELLKD  155 (505)
Q Consensus       142 -dP~~RpSa~ElL~h  155 (505)
                       +|..||++.++++.
T Consensus       334 ~~~~~RP~m~~Vv~~  348 (361)
T KOG1187|consen  334 PDPKERPTMSQVVKE  348 (361)
T ss_pred             cCCCcCcCHHHHHHH
Confidence             68999999997543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=2.9e-20  Score=191.94  Aligned_cols=160  Identities=28%  Similarity=0.487  Sum_probs=125.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccCCCC---------ccccCCCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPTA---------RSVIGTPEFM   70 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~~~~---------~~~~Gt~~Y~   70 (505)
                      ++++.|+-||+.||.||....+||||-||||.|||+-.  ..|.+||.|||+++.+.....         ....||.+|+
T Consensus       568 KEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYL  647 (775)
T KOG1151|consen  568 KEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYL  647 (775)
T ss_pred             HHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeec
Confidence            57899999999999999999999999999999999842  346799999999988865432         2346899999


Q ss_pred             Ccccc-cc----cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHH--HHcC-CCCCCCCCCCChHHHHHHHHhcC-
Q 010626           71 APELY-EE----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK--VTSG-IKPASLSKVTDPQVKQFIEKCIV-  141 (505)
Q Consensus        71 APEll-~~----~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~--i~~~-~~p~~~~~~~s~~l~~LI~kcL~-  141 (505)
                      +||.+ .+    +.+.++||||+|||+|..+.|+.||........+...  |... ....+.....+++++.||++||. 
T Consensus       648 PPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaY  727 (775)
T KOG1151|consen  648 PPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAY  727 (775)
T ss_pred             CcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHh
Confidence            99977 22    3688999999999999999999999865443333222  2111 11112234568999999999997 


Q ss_pred             CCCCCCCHHHHhcCCCCCCC
Q 010626          142 PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       142 dP~~RpSa~ElL~hpff~~~  161 (505)
                      .-..|..+.+|..||||...
T Consensus       728 RKeDR~DV~qLA~dpyllPh  747 (775)
T KOG1151|consen  728 RKEDRIDVQQLACDPYLLPH  747 (775)
T ss_pred             hhhhhhhHHHHccCccccch
Confidence            57899999999999999753

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.82  E-value=4.7e-20  Score=204.97  Aligned_cols=149  Identities=26%  Similarity=0.402  Sum_probs=123.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCcc---ccCC--CcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS---VIGT--PEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~---~~Gt--~~Y~APEll~   76 (505)
                      ..+..++.||+.|++||++..  ++||||-++|||+. .+..+||+|||+|+.........   -.|+  ..|||||.+.
T Consensus       418 ~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~-~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~  494 (609)
T KOG0200|consen  418 KDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLIT-KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLF  494 (609)
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEec-CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhc
Confidence            467889999999999999998  99999999999997 66799999999998554332222   1222  3599999884


Q ss_pred             -ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 -EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                       ..|+.++||||||++|||++| |..||.+......+++.+..|.+.. .|..+++++.+++..||. +|.+||++.++.
T Consensus       495 ~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~-~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~  573 (609)
T KOG0200|consen  495 DRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRME-QPEHCSDEIYDLMKSCWNADPEDRPTFSECV  573 (609)
T ss_pred             cCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence             579999999999999999999 8999988554666788888876654 566679999999999996 799999998876


Q ss_pred             c
Q 010626          154 K  154 (505)
Q Consensus       154 ~  154 (505)
                      .
T Consensus       574 ~  574 (609)
T KOG0200|consen  574 E  574 (609)
T ss_pred             H
Confidence            4

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.80  E-value=5.2e-20  Score=196.39  Aligned_cols=148  Identities=24%  Similarity=0.362  Sum_probs=120.9

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc--cccCCCcccCcccc-cccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~--~~~Gt~~Y~APEll-~~~y   79 (505)
                      +...++.+.+.||+|||+++  +|||||-.+|+|+. .++.+||+|||+++.-......  ...-...|+|||.+ .+.|
T Consensus       263 ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~-~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~  339 (474)
T KOG0194|consen  263 EKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYS-KKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIF  339 (474)
T ss_pred             HHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheec-CCCeEEeCccccccCCcceeeccccccCcceecChhhhccCcc
Confidence            45678999999999999999  99999999999997 6677899999998655422111  11234689999988 4569


Q ss_pred             CcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           80 NELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ++++|||||||++||+.+ |..||.+. ...++..+|.....+...+...++.+..++.+|+. +|..||++.++.+
T Consensus       340 s~kTDV~sfGV~~~Eif~~g~~Py~g~-~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  340 SFKTDVWSFGVLLWEIFENGAEPYPGM-KNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             ccccchhheeeeEEeeeccCCCCCCCC-CHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            999999999999999999 88899884 55677777755555556667788999999999995 8999999998764

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.80  E-value=1.2e-19  Score=195.47  Aligned_cols=155  Identities=26%  Similarity=0.445  Sum_probs=128.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCcccc-----CCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-----GTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~-----Gt~~Y~APEll-   75 (505)
                      ..+..|+.||+.|+.||.+++  +|||||-..|+++- ....|||+|||+.+.+.........     -...|+|||.+ 
T Consensus       212 ~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNllla-sprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr  288 (1039)
T KOG0199|consen  212 SRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLA-SPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR  288 (1039)
T ss_pred             HHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheec-ccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhc
Confidence            357789999999999999999  99999999999997 4678999999999888655433222     24579999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ...|+.++|||+|||++|||+| |+.||.++ ...++.+.|..+.+ ..-++.++..+.+++..||. +|.+|||+..|.
T Consensus       289 h~kFShaSDvWmyGVTiWEMFtyGEePW~G~-~g~qIL~~iD~~er-LpRPk~csedIY~imk~cWah~paDRptFsair  366 (1039)
T KOG0199|consen  289 HRKFSHASDVWMYGVTIWEMFTYGEEPWVGC-RGIQILKNIDAGER-LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR  366 (1039)
T ss_pred             cccccccchhhhhhhhHHhhhccCCCCCCCC-CHHHHHHhcccccc-CCCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence            5779999999999999999998 89999985 56778888875433 34567889999999999996 799999999987


Q ss_pred             cCCCCCCC
Q 010626          154 KDPFLVTD  161 (505)
Q Consensus       154 ~hpff~~~  161 (505)
                      ..-++...
T Consensus       367 ~~~~l~ea  374 (1039)
T KOG0199|consen  367 EDLVLAEA  374 (1039)
T ss_pred             HhHHHHhc
Confidence            66555443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.79  E-value=1.5e-19  Score=186.25  Aligned_cols=158  Identities=28%  Similarity=0.488  Sum_probs=119.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc-----------------C-------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-----------------Q-------   57 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~-----------------~-------   57 (505)
                      ..++.|++.++.||.++|.+|  ||||||||.|++.+...+.-.|.|||+|....                 .       
T Consensus       132 ~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~  209 (418)
T KOG1167|consen  132 AEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVH  209 (418)
T ss_pred             HHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCccc
Confidence            578999999999999999999  99999999999999888889999999986110                 0       


Q ss_pred             ---------C-------------CCccccCCCcccCcccc--cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHH
Q 010626           58 ---------P-------------TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK  113 (505)
Q Consensus        58 ---------~-------------~~~~~~Gt~~Y~APEll--~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~  113 (505)
                               +             ......||+.|+|||++  ....+.++||||.|+|++.++++.+||....+......
T Consensus       210 ~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~  289 (418)
T KOG1167|consen  210 CQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALA  289 (418)
T ss_pred             ccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHH
Confidence                     0             00113489999999988  34578899999999999999999999975433211110


Q ss_pred             HHH--------------cCC-----------------------------------CCCCCCCCCChHHHHHHHHhcC-CC
Q 010626          114 KVT--------------SGI-----------------------------------KPASLSKVTDPQVKQFIEKCIV-PA  143 (505)
Q Consensus       114 ~i~--------------~~~-----------------------------------~p~~~~~~~s~~l~~LI~kcL~-dP  143 (505)
                      .+.              .+.                                   .+.......+..+.+|+.+||. +|
T Consensus       290 ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np  369 (418)
T KOG1167|consen  290 EIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNP  369 (418)
T ss_pred             HHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCCh
Confidence            000              000                                   0011122335588999999995 99


Q ss_pred             CCCCCHHHHhcCCCCCCC
Q 010626          144 SLRLPALELLKDPFLVTD  161 (505)
Q Consensus       144 ~~RpSa~ElL~hpff~~~  161 (505)
                      .+|.|++++|+||||...
T Consensus       370 ~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  370 QKRITAEDALKHPFFDEA  387 (418)
T ss_pred             hhcccHHHHhcCcCCcch
Confidence            999999999999999843

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.79  E-value=1.2e-19  Score=193.58  Aligned_cols=147  Identities=25%  Similarity=0.427  Sum_probs=119.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc---cccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~---~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..|+.||..||+|||+..  ++||||..+|||+. ....|||+|||+++.+......   ...-..-|||||-+ -.
T Consensus       491 ~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVs-Sp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfR  567 (974)
T KOG4257|consen  491 RTLTLYCYQICTALAYLESKR--FVHRDIAARNILVS-SPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFR  567 (974)
T ss_pred             HHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeec-CcceeeecccchhhhccccchhhccccccceeecCccccchh
Confidence            356779999999999999999  99999999999997 5568999999999988654322   11223479999987 57


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      .++.++|||-||+|+||++. |..||.+-.|.+.+. .+..|.++ +.+..+++.+..|+.+||. +|.+||++.++.
T Consensus       568 rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-~iEnGeRl-P~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  568 RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-HIENGERL-PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             cccchhhHHHHHHHHHHHHHhcCCccccccccceEE-EecCCCCC-CCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence            79999999999999999987 999999876655443 33444433 4677889999999999996 899999987654

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.77  E-value=9.4e-19  Score=186.50  Aligned_cols=145  Identities=28%  Similarity=0.434  Sum_probs=125.5

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccC---CCcccCcccc-cccC
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---TPEFMAPELY-EEEY   79 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~G---t~~Y~APEll-~~~y   79 (505)
                      +..++.||..|++||..++  +|||||...|+|+. .+..||++|||+++.+.........|   ..-|.|||-+ .+.+
T Consensus       367 LlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVg-EnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtF  443 (1157)
T KOG4278|consen  367 LLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTF  443 (1157)
T ss_pred             HHHHHHHHHHHHHHHHHhh--hhhhhhhhhhcccc-ccceEEeeccchhhhhcCCceecccCccCcccccCccccccccc
Confidence            5678899999999999999  99999999999995 77799999999999987765444444   3479999977 6789


Q ss_pred             CcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           80 NELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      +.|+|||+||++|||+.| |-.||.+ .+..+.|..+..+.+. .-+..+++.+.+|++.||+ .|+.||++.|+-
T Consensus       444 SiKSDVWAFGVLLWEIATYGMsPYPG-idlSqVY~LLEkgyRM-~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  444 SIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYGLLEKGYRM-DGPEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             ccchhhHHHHHHHHHHHhcCCCCCCC-ccHHHHHHHHhccccc-cCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence            999999999999999998 8899987 6788899888887665 3567789999999999998 899999988764

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.74  E-value=9.2e-19  Score=190.89  Aligned_cols=148  Identities=25%  Similarity=0.451  Sum_probs=122.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC--cccc-C--CCcccCcccc-c
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSVI-G--TPEFMAPELY-E   76 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~--~~~~-G--t~~Y~APEll-~   76 (505)
                      ++..+++.|+.|++||-..|  ++||||...|||++ .+-.+|++|||+++.+.....  .+.. |  ..+|.|||.+ .
T Consensus       732 QLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVN-snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~  808 (996)
T KOG0196|consen  732 QLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY  808 (996)
T ss_pred             hHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeec-cceEEEeccccceeecccCCCccccccCCccceeecChhHhhh
Confidence            45668899999999999999  99999999999998 667899999999998865432  1212 2  3589999988 6


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ++++.++||||||++|||.+. |+.||.+..|.+ ..+.|..+.+.+ .+-.++..+.+|+..||+ +..+||.+.+|+.
T Consensus       809 RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-VIkaIe~gyRLP-pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  809 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-VIKAIEQGYRLP-PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             cccCchhhccccceEEEEecccCCCcccccchHH-HHHHHHhccCCC-CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            889999999999999999886 999999876654 446666665432 455678999999999996 7899999999886


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       887 ~  887 (996)
T KOG0196|consen  887 T  887 (996)
T ss_pred             H
Confidence            4

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.74  E-value=8.4e-18  Score=172.05  Aligned_cols=147  Identities=20%  Similarity=0.330  Sum_probs=123.2

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCcc----ccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS----VIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~----~~Gt~~Y~APEll-~~   77 (505)
                      ++..++.|++.|++|||++|  +||.||..+|++++ +.-+|||+|=.+++-+-...-+.    ......||+||.+ ..
T Consensus       397 qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId-d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~  473 (563)
T KOG1024|consen  397 QLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID-DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS  473 (563)
T ss_pred             HHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh-hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh
Confidence            45678899999999999999  99999999999998 66799999998887553221111    1124579999988 56


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .|+.++|+||||+++|||+| |+.||.+ .++.+++..+..|.+. ..|-.++.++..++.-||. .|.+||+..++..
T Consensus       474 ~yssasDvWsfGVllWELmtlg~~Pyae-IDPfEm~~ylkdGyRl-aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  474 HYSSASDVWSFGVLLWELMTLGKLPYAE-IDPFEMEHYLKDGYRL-AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             hhcchhhhHHHHHHHHHHHhcCCCCccc-cCHHHHHHHHhcccee-cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            79999999999999999999 9999987 6788999999888665 4567789999999999995 8999999999764

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.73  E-value=5.2e-18  Score=184.07  Aligned_cols=104  Identities=35%  Similarity=0.634  Sum_probs=89.2

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe-CCCC--cEEEeecCceeeccCC-CCccccCCCcccCccccc--
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNG--EVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--   76 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld-~~~g--~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~--   76 (505)
                      ++..++..+..||.|||++|  |+||||||.||++- +.+|  ..||+|||.|+.+.+. ...+++||+.|++||+++  
T Consensus       121 e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q  198 (732)
T KOG4250|consen  121 EFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQ  198 (732)
T ss_pred             HHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhc
Confidence            57788999999999999999  99999999999873 2334  3699999999988654 467789999999999996  


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCCh
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNP  108 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~  108 (505)
                      +.|+..+|.|||||++|+.+||..||-....+
T Consensus       199 ~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  199 KKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             cCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            56999999999999999999999999643333

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.73  E-value=5.4e-18  Score=197.05  Aligned_cols=150  Identities=22%  Similarity=0.369  Sum_probs=103.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~-g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +.+.+++.||+.||+|||.+ .++|+||||||+||+++ .++..++. ||.......  .....+++.|+|||++ ...|
T Consensus       780 ~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~-~~~~~~~~-~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~  855 (968)
T PLN00113        780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID-GKDEPHLR-LSLPGLLCT--DTKCFISSAYVAPETRETKDI  855 (968)
T ss_pred             HHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC-CCCceEEE-ecccccccc--CCCccccccccCcccccCCCC
Confidence            35678999999999999943 22399999999999998 55666664 555433322  2233688999999988 4569


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCC----hHHHHHHHHcC------CCCC-----CCCCCCChHHHHHHHHhcC-CC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKN----PAQIYKKVTSG------IKPA-----SLSKVTDPQVKQFIEKCIV-PA  143 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~----~~~i~~~i~~~------~~p~-----~~~~~~s~~l~~LI~kcL~-dP  143 (505)
                      +.++|||||||++|||+||+.||.....    ...........      ..+.     ........++.+++.+||. +|
T Consensus       856 ~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P  935 (968)
T PLN00113        856 TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDP  935 (968)
T ss_pred             CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCc
Confidence            9999999999999999999999853211    11111111100      0010     0001112356789999996 89


Q ss_pred             CCCCCHHHHhcC
Q 010626          144 SLRLPALELLKD  155 (505)
Q Consensus       144 ~~RpSa~ElL~h  155 (505)
                      .+||++.|+++.
T Consensus       936 ~~RPt~~evl~~  947 (968)
T PLN00113        936 TARPCANDVLKT  947 (968)
T ss_pred             hhCcCHHHHHHH
Confidence            999999999875

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.73  E-value=8.9e-18  Score=178.54  Aligned_cols=148  Identities=22%  Similarity=0.295  Sum_probs=115.9

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc----cccCCCcccCcccc-ccc
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR----SVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~----~~~Gt~~Y~APEll-~~~   78 (505)
                      ..+++.||+.|++||.+.+  ++||||.+.|+|++ .++++||+|||+++.+-.....    ..+-..+|||||.+ .++
T Consensus       639 ~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~-~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk  715 (807)
T KOG1094|consen  639 GVSICTQIASGMAYLESLN--FVHRDLATRNCLVD-GEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK  715 (807)
T ss_pred             hHHHHHHHHHHHHHHHhhc--hhhccccccceeec-CcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcc
Confidence            3469999999999999999  99999999999998 6789999999999865433222    22345799999954 889


Q ss_pred             CCcccchhhHHHHHHHHhh--cCCCCCCCCChHHHHHHHHcCC---C---CCCCCCCCChHHHHHHHHhcC-CCCCCCCH
Q 010626           79 YNELVDIYSFGMCILEMVT--CEYPYNECKNPAQIYKKVTSGI---K---PASLSKVTDPQVKQFIEKCIV-PASLRLPA  149 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlT--G~~Pf~~~~~~~~i~~~i~~~~---~---p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa  149 (505)
                      ++.++|+|+||+++||+++  .+.||....+ +++......-.   .   -...+..++..+.++|.+||. +..+||++
T Consensus       716 FttaSDvWafgvTlwE~~~~C~e~Py~~lt~-e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsF  794 (807)
T KOG1094|consen  716 FTTASDVWAFGVTLWEVFMLCREQPYSQLTD-EQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSF  794 (807)
T ss_pred             ccchhhhhhhHHHHHHHHHHHhhCchhhhhH-HHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCH
Confidence            9999999999999999875  7899987543 34433332211   1   123466778899999999995 89999999


Q ss_pred             HHHhcC
Q 010626          150 LELLKD  155 (505)
Q Consensus       150 ~ElL~h  155 (505)
                      +++..+
T Consensus       795 e~lh~~  800 (807)
T KOG1094|consen  795 EQLHLF  800 (807)
T ss_pred             HHHHHH
Confidence            998543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.72  E-value=6.9e-18  Score=181.64  Aligned_cols=158  Identities=31%  Similarity=0.560  Sum_probs=131.9

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccc----c
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY----E   76 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll----~   76 (505)
                      +|..+++..+.||+|||+.|  -+|||||-.||+++ ..|.+|++|||.+..+...  ...+++|||.|||||+-    .
T Consensus       113 qiayvcRetl~gl~ylhs~g--k~hRdiKGanillt-d~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverk  189 (829)
T KOG0576|consen  113 QIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLT-DEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK  189 (829)
T ss_pred             HHHHHHhhhhccchhhhcCC--cccccccccceeec-ccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhc
Confidence            57788999999999999999  99999999999997 7899999999999766543  45678999999999976    4


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCC--CCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK--VTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~--~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      +.|+.++|||++|++..|+--.+.|..........+-.-..+..|+.+..  ..++.+.+|++.+|. +|.+||+++.+|
T Consensus       190 ggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  190 GGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             ccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            67999999999999999999999998764444445555556666654432  357889999999995 799999999999


Q ss_pred             cCCCCCCCCC
Q 010626          154 KDPFLVTDNP  163 (505)
Q Consensus       154 ~hpff~~~~~  163 (505)
                      .|||......
T Consensus       270 ~h~fvs~~l~  279 (829)
T KOG0576|consen  270 QHPFVSQTLS  279 (829)
T ss_pred             eceeeccchh
Confidence            9999876533

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.72  E-value=3.2e-17  Score=151.14  Aligned_cols=119  Identities=40%  Similarity=0.707  Sum_probs=104.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE--   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~~--   77 (505)
                      ..++.++.+++.+|.|||++|  ++|+||+|.||+++...+.++|+|||.+.......  .....+...|++||.+..  
T Consensus        92 ~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~  169 (215)
T cd00180          92 DEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKG  169 (215)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccC
Confidence            457889999999999999999  99999999999998326899999999998776543  344567889999998854  


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      .++.+.|+|++|+++++|                                  ..+.+++.+|+. +|.+||++.++++|+
T Consensus       170 ~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         170 YYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            688999999999999999                                  688999999995 899999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.72  E-value=2e-17  Score=172.73  Aligned_cols=148  Identities=29%  Similarity=0.488  Sum_probs=107.9

Q ss_pred             HHHHHHHHHHHHHHHHHhC-------CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccC
Q 010626            3 AIKNWARQILRGLHYLHSH-------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMA   71 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~-------g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~A   71 (505)
                      ...+++..+++||+|||+.       .|+|+|||||..||||. ++++.-|+|||+|..+....    ....+||.+|||
T Consensus       308 ~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK-~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMA  386 (534)
T KOG3653|consen  308 SLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK-NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMA  386 (534)
T ss_pred             HHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc-cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcC
Confidence            5678999999999999964       35799999999999997 88999999999998775332    334589999999


Q ss_pred             cccccccCC-------cccchhhHHHHHHHHhhcC------------CCCCC----CCChHHHHHHHHcCCCCCCCCCC-
Q 010626           72 PELYEEEYN-------ELVDIYSFGMCILEMVTCE------------YPYNE----CKNPAQIYKKVTSGIKPASLSKV-  127 (505)
Q Consensus        72 PEll~~~ys-------~ksDIWSLGviLyEmlTG~------------~Pf~~----~~~~~~i~~~i~~~~~p~~~~~~-  127 (505)
                      ||++++..+       .+.||||+|.++|||++.-            .||..    -...+++...+......+.++.. 
T Consensus       387 PEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W  466 (534)
T KOG3653|consen  387 PEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAW  466 (534)
T ss_pred             HHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhh
Confidence            999966433       3589999999999999742            22320    01123334444433333333321 


Q ss_pred             ----CChHHHHHHHHhc-CCCCCCCCHHH
Q 010626          128 ----TDPQVKQFIEKCI-VPASLRLPALE  151 (505)
Q Consensus       128 ----~s~~l~~LI~kcL-~dP~~RpSa~E  151 (505)
                          ....+++.++.|| .|+..|.|+.=
T Consensus       467 ~~h~~~~~l~et~EeCWDhDaeARLTA~C  495 (534)
T KOG3653|consen  467 RKHAGMAVLCETIEECWDHDAEARLTAGC  495 (534)
T ss_pred             hcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence                2356889999999 58999999753

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.72  E-value=2.1e-17  Score=180.94  Aligned_cols=148  Identities=29%  Similarity=0.464  Sum_probs=123.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCcc----ccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS----VIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~----~~Gt~~Y~APEll-~   76 (505)
                      +.+..|..||++|+.|||.+.  ++||||-.+||||. .-..+|+.|||+++.+.......    ..-.+.|||-|.+ .
T Consensus       798 q~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVk-sP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~  874 (1177)
T KOG1025|consen  798 QDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVK-SPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI  874 (1177)
T ss_pred             HHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeec-CCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhc
Confidence            577899999999999999999  99999999999997 55699999999998775443221    1224578888876 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..|+.++|||||||++||++| |..||.+ ....++-+.+..+.+ ...+..++.++..++.+||. |+..||+++++..
T Consensus       875 ~~~thqSDVWsfGVtiWElmTFGa~Py~g-i~~~eI~dlle~geR-LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  875 RKYTHQSDVWSFGVTIWELMTFGAKPYDG-IPAEEIPDLLEKGER-LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             cCCCchhhhhhhhhhHHHHHhcCCCccCC-CCHHHhhHHHhcccc-CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            679999999999999999999 9999987 556677777777766 55677889999999999995 8999999988754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=5.3e-18  Score=187.73  Aligned_cols=157  Identities=28%  Similarity=0.525  Sum_probs=124.2

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCCcccCcccc-
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~~Y~APEll-   75 (505)
                      .+..+++||+.||+|||+.|  +.|||||++|+++. .+|.+||+|||.+..+..+.      ....+|+.+|+|||++ 
T Consensus       421 e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~-~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~  497 (601)
T KOG0590|consen  421 EADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVT-ENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLT  497 (601)
T ss_pred             hhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEe-cCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccc
Confidence            56789999999999999999  99999999999998 77899999999997765432      3345799999999988 


Q ss_pred             cccCC-cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc------CCCCCCCCCCCChHHHHHHHHhcC-CCCCCC
Q 010626           76 EEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------GIKPASLSKVTDPQVKQFIEKCIV-PASLRL  147 (505)
Q Consensus        76 ~~~ys-~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~------~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp  147 (505)
                      ...|. ..+||||.|+++..|++|+.||.........+.....      ...+..+....+...+.+|.+||+ +|.+|.
T Consensus       498 ~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~  577 (601)
T KOG0590|consen  498 GKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI  577 (601)
T ss_pred             ccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhhee
Confidence            44565 4799999999999999999999754433322111110      111223344557788999999996 899999


Q ss_pred             CHHHHhcCCCCCCCC
Q 010626          148 PALELLKDPFLVTDN  162 (505)
Q Consensus       148 Sa~ElL~hpff~~~~  162 (505)
                      |+.+|++++||+...
T Consensus       578 ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  578 TIEQILNDEWIRSIE  592 (601)
T ss_pred             cHHHHhhChHhhhcc
Confidence            999999999998644

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=1.9e-17  Score=173.20  Aligned_cols=98  Identities=26%  Similarity=0.383  Sum_probs=69.4

Q ss_pred             cCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCC------CChHHHHHHHH-----------cCC------
Q 010626           64 IGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNEC------KNPAQIYKKVT-----------SGI------  119 (505)
Q Consensus        64 ~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~------~~~~~i~~~i~-----------~~~------  119 (505)
                      +.|..|+|||++ ..+|+..+||||++|+++||+||.+.|..-      .+.+.+...+.           .|.      
T Consensus       412 IQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFF  491 (590)
T KOG1290|consen  412 IQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFF  491 (590)
T ss_pred             hhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhh
Confidence            467889999977 778999999999999999999999988421      12222221111           111      


Q ss_pred             ------------CCCC----------CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          120 ------------KPAS----------LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       120 ------------~p~~----------~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                                  ++..          ++.....++.+|+.-||. +|.+||||.++|+|||+...
T Consensus       492 nr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~  556 (590)
T KOG1290|consen  492 NRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPV  556 (590)
T ss_pred             ccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCC
Confidence                        0111          111123567899999996 89999999999999999753

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=9.1e-17  Score=166.80  Aligned_cols=151  Identities=32%  Similarity=0.527  Sum_probs=109.4

Q ss_pred             HHHHHHHHHHHHHHHHHHh------CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC------CCccccCCCcc
Q 010626            2 KAIKNWARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEF   69 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs------~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~------~~~~~~Gt~~Y   69 (505)
                      +.+.+++..++.||++||.      ..|.|.|||||..||||. .+|.+-|+|+|+|......      ..+..+||.+|
T Consensus       308 ~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK-kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRY  386 (513)
T KOG2052|consen  308 EGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRY  386 (513)
T ss_pred             HHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc-cCCcEEEeeceeeEEecccCCcccCCCCCccceeec
Confidence            4577899999999999994      235699999999999997 8899999999999655433      24556899999


Q ss_pred             cCcccccccCC-------cccchhhHHHHHHHHhhc----------CCCCCCC----CChHHHHHHHHcCCCCCCCCCCC
Q 010626           70 MAPELYEEEYN-------ELVDIYSFGMCILEMVTC----------EYPYNEC----KNPAQIYKKVTSGIKPASLSKVT  128 (505)
Q Consensus        70 ~APEll~~~ys-------~ksDIWSLGviLyEmlTG----------~~Pf~~~----~~~~~i~~~i~~~~~p~~~~~~~  128 (505)
                      ||||++....+       ..+||||||.++||++..          ++||.+.    ...+++.+.+......+.++...
T Consensus       387 MAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW  466 (513)
T KOG2052|consen  387 MAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW  466 (513)
T ss_pred             cChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCccc
Confidence            99999954422       358999999999999852          4687542    22344444443332222222211


Q ss_pred             --C---hHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626          129 --D---PQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus       129 --s---~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                        +   ..+.++++.||. +|..|.||-.+-
T Consensus       467 ~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  467 KSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             ccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence              2   246688999995 899999987654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.66  E-value=1.2e-16  Score=179.57  Aligned_cols=153  Identities=30%  Similarity=0.533  Sum_probs=124.4

Q ss_pred             HHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC-----------------CCCccccCCCcccCc
Q 010626           10 QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-----------------PTARSVIGTPEFMAP   72 (505)
Q Consensus        10 QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~-----------------~~~~~~~Gt~~Y~AP   72 (505)
                      +++.+++|||+.|  |+|||+||+|.+++ .-|++|+.|||+.+..-.                 -....++|||.|.||
T Consensus       151 dmvla~Eylh~yg--ivhrdlkpdnllIT-~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP  227 (1205)
T KOG0606|consen  151 DMVLAVEYLHSYG--IVHRDLKPDNLLIT-SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP  227 (1205)
T ss_pred             hhhHHhHhhccCC--eecCCCCCCcceee-ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence            4578999999999  99999999999998 789999999999853211                 113456899999999


Q ss_pred             ccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC--CCCCCCCCCCChHHHHHHHHhcC-CCCCCC-
Q 010626           73 ELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQFIEKCIV-PASLRL-  147 (505)
Q Consensus        73 Ell-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~--~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-  147 (505)
                      |++ .++|+..+|+|++|+|+|+.+.|..||++ +.+++++..+...  ..|.. .....++++++|.++|+ +|..|. 
T Consensus       228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffG-dtpeelfg~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             hhhhhhccCCCccHHHHHHHHHHHheeeeeccC-CCHHHHHhhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcc
Confidence            977 67799999999999999999999999988 5567766666543  22333 55668999999999995 788776 


Q ss_pred             --CHHHHhcCCCCCCCCCCCcc
Q 010626          148 --PALELLKDPFLVTDNPKDLV  167 (505)
Q Consensus       148 --Sa~ElL~hpff~~~~~~~l~  167 (505)
                        .+.++.+|+||+...|+.+.
T Consensus       306 t~ga~evk~h~ff~~LDw~~ll  327 (1205)
T KOG0606|consen  306 TGGALEVKQHGFFQLLDWKSLL  327 (1205)
T ss_pred             cchhhhhhhccceeecccchhh
Confidence              47789999999998887543

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.63  E-value=1.3e-15  Score=144.17  Aligned_cols=116  Identities=35%  Similarity=0.608  Sum_probs=96.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC---CCccccCCCcccCcccc-c-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELY-E-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~---~~~~~~Gt~~Y~APEll-~-   76 (505)
                      ..+..++.|++.+|.|||+++  ++|+||+|.||+++ .++.++|+|||.+......   ......++..|++||.+ . 
T Consensus        98 ~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~-~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~  174 (225)
T smart00221       98 EEARFYLRQILEALEYLHSLG--IVHRDLKPENILLG-MDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGG  174 (225)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCC
Confidence            357789999999999999999  99999999999998 5689999999999876544   22345678899999987 2 


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCC-CCChHHHHHHHHcCCC
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNE-CKNPAQIYKKVTSGIK  120 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~-~~~~~~i~~~i~~~~~  120 (505)
                      ..++.++|+|+||+++++|++|+.||.. ..+...+.+.+..+.+
T Consensus       175 ~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  219 (225)
T smart00221      175 KGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP  219 (225)
T ss_pred             CCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence            3477799999999999999999999976 4555677777777653

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.62  E-value=2.9e-16  Score=154.73  Aligned_cols=152  Identities=24%  Similarity=0.363  Sum_probs=107.3

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe-CCCCcEEEeecCceeeccCCCCccccCCCcccCccccc----cc
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE----EE   78 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld-~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~----~~   78 (505)
                      .++++.|++.|+.|||+++  ++|||||.+|||+- .+...|||||||+.+..... ....--+..|.+||+..    +.
T Consensus       123 ~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-V~~~~~~~~y~~pe~~~~~~ne~  199 (378)
T KOG1345|consen  123 TKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-VKYLEYVNNYHAPELCDTVVNEK  199 (378)
T ss_pred             HHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecccccccCce-ehhhhhhcccCCcHHHhhccccc
Confidence            5789999999999999999  99999999999984 34457999999998654322 12222355789999762    22


Q ss_pred             --CCcccchhhHHHHHHHHhhcCCCCCCCCCh---HHHHHHHHcCCCCC--CCCCCCChHHHHHHHHhcC-CCCCC---C
Q 010626           79 --YNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLR---L  147 (505)
Q Consensus        79 --ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~---~~i~~~i~~~~~p~--~~~~~~s~~l~~LI~kcL~-dP~~R---p  147 (505)
                        .++..|+|.||+++|..+||.+||......   -..+.+...+..+.  ..-...++.+..+.++-|. .+.+|   .
T Consensus       200 ~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~  279 (378)
T KOG1345|consen  200 LVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIW  279 (378)
T ss_pred             eEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhH
Confidence              467899999999999999999999743222   22233333333321  1223457788888999886 57777   4


Q ss_pred             CHHHHhcCCCC
Q 010626          148 PALELLKDPFL  158 (505)
Q Consensus       148 Sa~ElL~hpff  158 (505)
                      ++....+.-|.
T Consensus       280 ~~kk~rk~~w~  290 (378)
T KOG1345|consen  280 TAKKMRKCLWK  290 (378)
T ss_pred             HHHHHHHHHHH
Confidence            55555566554

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.61  E-value=9.4e-15  Score=140.96  Aligned_cols=156  Identities=31%  Similarity=0.467  Sum_probs=122.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC-cEEEeecCceeeccCCC--------CccccCCCcccCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQPT--------ARSVIGTPEFMAP   72 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g-~vKL~DFGlA~~~~~~~--------~~~~~Gt~~Y~AP   72 (505)
                      ..+..++.|++.++.|+|+.+  ++|||+||+||+++ ..+ .++++|||.+.......        .....|++.|++|
T Consensus       101 ~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~p  177 (384)
T COG0515         101 SEALFILAQILSALEYLHSKG--IIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP  177 (384)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-CCCCeEEEeccCcceecCCCCccccccccccccccccccCCH
Confidence            367889999999999999999  99999999999998 445 79999999997654432        3456899999999


Q ss_pred             cccc----ccCCcccchhhHHHHHHHHhhcCCCCCCCCC---hHHHHHHHHcCCCC-CCCCCCC------ChHHHHHHHH
Q 010626           73 ELYE----EEYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKP-ASLSKVT------DPQVKQFIEK  138 (505)
Q Consensus        73 Ell~----~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~---~~~i~~~i~~~~~p-~~~~~~~------s~~l~~LI~k  138 (505)
                      |.+.    ..+....|+|++|++++++++|..||.....   .......+.....+ .......      ...+.+++.+
T Consensus       178 e~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (384)
T COG0515         178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKK  257 (384)
T ss_pred             HHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHH
Confidence            9884    3688899999999999999999999876543   45555555554433 1111111      1578999999


Q ss_pred             hcC-CCCCCCCHHHHhcCCCCCC
Q 010626          139 CIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       139 cL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      |+. +|..|.+..+...++|...
T Consensus       258 ~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         258 LLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             HHhcCchhcCCHHHHhhchHhhC
Confidence            995 7999999999988866654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.58  E-value=7.9e-16  Score=165.83  Aligned_cols=157  Identities=20%  Similarity=0.329  Sum_probs=128.8

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccccCCcc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNEL   82 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~ys~k   82 (505)
                      .++.+...++.+++++|+.+  ++|||+|++||+++ ..|++++.|||+++..-.....  +||..|||||++. .....
T Consensus        98 ~~~~~~aelaLald~lh~l~--iiyrd~k~enilld-~~Ghi~~tdfglske~v~~~~~--cgt~eymApEI~~-gh~~a  171 (612)
T KOG0603|consen   98 DVAFYLAELALALDHLHKLG--IAYRDYKLENVLLL-LEGHIKLTDFGLSKEAVKEKIA--CGTYEYRAPEIIN-GHLSA  171 (612)
T ss_pred             HHHHHHHHHHHHHhhcchhH--HHHhcccccceeec-ccCccccCCchhhhHhHhhhhc--ccchhhhhhHhhh-ccCCc
Confidence            46778899999999999999  99999999999998 7799999999999766443333  8999999999998 66789


Q ss_pred             cchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHHHhcCC
Q 010626           83 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLKDP  156 (505)
Q Consensus        83 sDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~ElL~hp  156 (505)
                      +|.||||+++++|+||..||..     .+...|....  ..++...++.+++++..++. +|.+|.-     +.|+++|+
T Consensus       172 ~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~  244 (612)
T KOG0603|consen  172 ADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAE--LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHE  244 (612)
T ss_pred             ccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhc--cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccc
Confidence            9999999999999999999976     4444554432  23556667899999999984 7888875     57999999


Q ss_pred             CCCCCCCCCcccCCCC
Q 010626          157 FLVTDNPKDLVCDPLR  172 (505)
Q Consensus       157 ff~~~~~~~l~~~~l~  172 (505)
                      ||....+..+.....+
T Consensus       245 f~~~i~~~~l~~r~~~  260 (612)
T KOG0603|consen  245 FFQSIDWNELEARSRP  260 (612)
T ss_pred             hheeeeHhhHhhcCCC
Confidence            9999888765544433

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.56  E-value=1.4e-15  Score=161.88  Aligned_cols=99  Identities=33%  Similarity=0.578  Sum_probs=90.7

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccccc-C-C
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE-Y-N   80 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~-y-s   80 (505)
                      +++.|++|++.|+++||++|  |+|||||-+|+.++ .+|.+||+|||.+..........++||..|.|||++++. | +
T Consensus       671 eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd-~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~g  747 (772)
T KOG1152|consen  671 EAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVD-SNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLG  747 (772)
T ss_pred             HHHHHHHHHHhccccccccC--ceecccccccEEEe-cCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCC
Confidence            67889999999999999999  99999999999998 679999999999988888888889999999999999653 4 5


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCC
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNE  104 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~  104 (505)
                      ..-|||++|++||.++..+.||.+
T Consensus       748 k~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  748 KPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             CcchhhhhhheeeEEEeccCCCcC
Confidence            778999999999999999999853

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.52  E-value=5e-15  Score=157.07  Aligned_cols=145  Identities=28%  Similarity=0.519  Sum_probs=112.8

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--------CccccCCCcccCccc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--------ARSVIGTPEFMAPEL   74 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--------~~~~~Gt~~Y~APEl   74 (505)
                      .+..|+.|+..|+.|   ++  .+|||+||.||++. .+..+||+|||+........        ....+||.+||+||.
T Consensus       360 ~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~-~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQ  433 (516)
T KOG1033|consen  360 LMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFS-DDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQ  433 (516)
T ss_pred             HHHHHHHhhccchhh---cc--chhhhccccccccc-cchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHH
Confidence            567899999999999   78  99999999999996 67789999999987654332        234579999999998


Q ss_pred             cc-ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           75 YE-EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        75 l~-~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                      +. ..|+.++|||+||++++|+++ -..++    ........+..+..|+.+... .|+-..|+.++|. .|.+||++.+
T Consensus       434 i~g~~y~~kvdIyaLGlil~EL~~~f~T~~----er~~t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  434 IRGQQYSEKVDIYALGLILAELLIQFSTQF----ERIATLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             HhhhhhhhhcchhhHHHHHHHHHHHhccHH----HHHHhhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHH
Confidence            85 679999999999999999996 33333    233344555666555444333 3566789999996 6999998888


Q ss_pred             HhcCCCC
Q 010626          152 LLKDPFL  158 (505)
Q Consensus       152 lL~hpff  158 (505)
                      .-.|+|.
T Consensus       509 ~~~~~~~  515 (516)
T KOG1033|consen  509 VALHEFL  515 (516)
T ss_pred             Hhhhhhc
Confidence            7777775

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.50  E-value=1.6e-14  Score=146.24  Aligned_cols=130  Identities=19%  Similarity=0.243  Sum_probs=87.4

Q ss_pred             HHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccc--------
Q 010626            6 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--------   77 (505)
Q Consensus         6 ~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~--------   77 (505)
                      .+..|+++.+++||.+|  ++|+||+|+|+|++ .+|.++|+||+.....+..... ...+..|.|||+...        
T Consensus       149 ~lT~Q~I~lvA~Lh~~G--lVHgdi~~~nfll~-~~G~v~Lg~F~~~~r~g~~~~~-~~~~~~~~PPe~~~~~~~~~~~~  224 (288)
T PF14531_consen  149 SLTVQMIRLVANLHSYG--LVHGDIKPENFLLD-QDGGVFLGDFSSLVRAGTRYRC-SEFPVAFTPPELESCAGQFGQNN  224 (288)
T ss_dssp             HHHHHHHHHHHHHHHTT--EEEST-SGGGEEE--TTS-EEE--GGGEEETTEEEEG-GGS-TTTS-HHHHHHHTSCHHSE
T ss_pred             HHHHHHHHHHHHHhhcc--eEecccceeeEEEc-CCCCEEEcChHHHeecCceeec-cCCCcccCChhhhhhhcccCccc
Confidence            45589999999999999  99999999999998 7899999999887655433222 334578999997622        


Q ss_pred             -cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCC
Q 010626           78 -EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLR  146 (505)
Q Consensus        78 -~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~R  146 (505)
                       .++.+.|.|+||+++|.|+++..||....... ....     .-.... ..+..++.||..+|+ +|.+|
T Consensus       225 ~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~-~~~~-----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  225 APYTFATDAWQLGITLYSLWCGRLPFGLSSPEA-DPEW-----DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             EEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGS-TSGG-----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ceeeeccCHHHHHHHHHHHHHccCCCCCCCccc-cccc-----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence             37889999999999999999999997532111 0000     011112 567889999999996 67776

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=4.1e-13  Score=138.34  Aligned_cols=150  Identities=21%  Similarity=0.315  Sum_probs=106.4

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-CC--cEEEeecCceeeccC-----CC---CccccCCCcccCc
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NG--EVKIGDLGLAIVMQQ-----PT---ARSVIGTPEFMAP   72 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~-~g--~vKL~DFGlA~~~~~-----~~---~~~~~Gt~~Y~AP   72 (505)
                      .+-++.|+++|+.|||++|  |.|||||.+|||+.-+ ++  .+.++|||.+---..     +.   .-..-|....|||
T Consensus       343 ~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAP  420 (598)
T KOG4158|consen  343 GRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAP  420 (598)
T ss_pred             HHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecch
Confidence            4567899999999999999  9999999999999432 22  478999998742211     11   1122477889999


Q ss_pred             cccccc-------CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCC
Q 010626           73 ELYEEE-------YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PAS  144 (505)
Q Consensus        73 Ell~~~-------ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~  144 (505)
                      |+....       .-.++|.|+.|.+.||+++...||.......--...... ...+.++..+++.+++++..+|+ +|+
T Consensus       421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe-~qLPalp~~vpp~~rqlV~~lL~r~ps  499 (598)
T KOG4158|consen  421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE-SQLPALPSRVPPVARQLVFDLLKRDPS  499 (598)
T ss_pred             hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh-hhCCCCcccCChHHHHHHHHHhcCCcc
Confidence            987422       235899999999999999999999752211100111111 22345777889999999999996 799


Q ss_pred             CCCCHH---HHhcCC
Q 010626          145 LRLPAL---ELLKDP  156 (505)
Q Consensus       145 ~RpSa~---ElL~hp  156 (505)
                      +|++..   .+|+-.
T Consensus       500 kRvsp~iAANvl~Ls  514 (598)
T KOG4158|consen  500 KRVSPNIAANVLNLS  514 (598)
T ss_pred             ccCCccHHHhHHHHH
Confidence            999843   455433

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.40  E-value=1.7e-12  Score=133.52  Aligned_cols=152  Identities=20%  Similarity=0.198  Sum_probs=106.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC----CcEEEeecCcee--eccCC-------C---CccccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN----GEVKIGDLGLAI--VMQQP-------T---ARSVIG   65 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~----g~vKL~DFGlA~--~~~~~-------~---~~~~~G   65 (505)
                      .++.+++.|++.+|++||+.|  ++||||||.|+++....    ..+.|.|||+++  .+...       .   ...+.|
T Consensus       122 ~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rG  199 (322)
T KOG1164|consen  122 KTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRG  199 (322)
T ss_pred             hHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCC
Confidence            467889999999999999999  99999999999996332    469999999998  32111       1   123459


Q ss_pred             CCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHH--HHHHHcCCCCCCCCCCCChHHHHHHHHhcC-
Q 010626           66 TPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI--YKKVTSGIKPASLSKVTDPQVKQFIEKCIV-  141 (505)
Q Consensus        66 t~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i--~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-  141 (505)
                      |..|+++... ....+.+.|+||++.++.+++.|..||.........  +................+.++..+...+-. 
T Consensus       200 T~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (322)
T KOG1164|consen  200 TLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSL  279 (322)
T ss_pred             ccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhcc
Confidence            9999999977 456889999999999999999999999765433222  222221111111223334556666555443 


Q ss_pred             CCCCCCCHHHHhcC
Q 010626          142 PASLRLPALELLKD  155 (505)
Q Consensus       142 dP~~RpSa~ElL~h  155 (505)
                      +...+|....+...
T Consensus       280 ~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  280 DYEDKPDYEKLAEL  293 (322)
T ss_pred             CCcCCCCHHHHHHH
Confidence            56778876665443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.36  E-value=5.7e-13  Score=150.54  Aligned_cols=145  Identities=23%  Similarity=0.309  Sum_probs=102.9

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeec--cC--CCCcc-c----cCCCcccCccc
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--QQ--PTARS-V----IGTPEFMAPEL   74 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~--~~--~~~~~-~----~Gt~~Y~APEl   74 (505)
                      -+-|+-||+.||..+|..|  |.|||||.+|||+++ -.-+.|.||..-+..  ..  +...+ +    ..-.+|.|||.
T Consensus       122 KkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTS-WNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPER  198 (1431)
T KOG1240|consen  122 KKWIAFQLLKALSQCHKLG--VCHGDIKSENILITS-WNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPER  198 (1431)
T ss_pred             HHHHHHHHHHHHHHHHHcC--ccccccccceEEEee-echhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHh
Confidence            3457899999999999999  999999999999984 457999999765422  11  11111 1    12348999997


Q ss_pred             ccc-----------c-CCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcC-CCC-CCCCCCCChHHHHHHHHh
Q 010626           75 YEE-----------E-YNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG-IKP-ASLSKVTDPQVKQFIEKC  139 (505)
Q Consensus        75 l~~-----------~-ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~-~~p-~~~~~~~s~~l~~LI~kc  139 (505)
                      +..           . .+++-||||+||+++|+++ |++||.    ..|+...-..+ ..+ ..+.+..+..++.||..|
T Consensus       199 Fv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~M  274 (1431)
T KOG1240|consen  199 FVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGNADDPEQLLEKIEDVSLRNLILSM  274 (1431)
T ss_pred             hhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccCccCHHHHHHhCcCccHHHHHHHH
Confidence            621           1 4578999999999999998 677774    23333222221 111 112344467899999999


Q ss_pred             cC-CCCCCCCHHHHhcC
Q 010626          140 IV-PASLRLPALELLKD  155 (505)
Q Consensus       140 L~-dP~~RpSa~ElL~h  155 (505)
                      ++ +|++|.+|++.|+.
T Consensus       275 i~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  275 IQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HccCchhccCHHHHHHh
Confidence            96 89999999999975

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.26  E-value=9.5e-12  Score=133.70  Aligned_cols=146  Identities=25%  Similarity=0.422  Sum_probs=107.4

Q ss_pred             HHHHHHHHHHHHHHHhCCCCe-EecCCCCCcEEEeCCCCcEEEeecCceeeccC----CCCccccCCCcccCccccccc-
Q 010626            5 KNWARQILRGLHYLHSHNPPI-IHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELYEEE-   78 (505)
Q Consensus         5 ~~ia~QIl~gL~yLHs~g~~I-iHrDLKp~NILld~~~g~vKL~DFGlA~~~~~----~~~~~~~Gt~~Y~APEll~~~-   78 (505)
                      ..++++|+.||+|||..-  | .|+.|++.|++++ ....+||.|||+......    .......-..-|.|||++... 
T Consensus        51 ~s~~rdi~~Gl~ylh~s~--i~~hg~l~s~nClvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~  127 (484)
T KOG1023|consen   51 LSFIRDISKGLAYLHNSP--IGYHGALKSSNCLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGAL  127 (484)
T ss_pred             HHHHHHHHHHHHHHhcCc--ceeeeeeccccceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccc
Confidence            357789999999999865  5 9999999999998 678999999999866632    111111233469999988442 


Q ss_pred             -------CCcccchhhHHHHHHHHhhcCCCCCCCC---ChHHHHHHHHcCCCCCC---CC-C-CCChHHHHHHHHhcC-C
Q 010626           79 -------YNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPAS---LS-K-VTDPQVKQFIEKCIV-P  142 (505)
Q Consensus        79 -------ys~ksDIWSLGviLyEmlTG~~Pf~~~~---~~~~i~~~i~~~~~p~~---~~-~-~~s~~l~~LI~kcL~-d  142 (505)
                             .+.+.||||||++++|+++.+.||....   .+.++..++..+..+..   +. . ...+.+..++..||. +
T Consensus       128 ~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~  207 (484)
T KOG1023|consen  128 SQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEI  207 (484)
T ss_pred             cccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccC
Confidence                   4678999999999999999999997532   23456666655222111   11 1 334579999999995 7


Q ss_pred             CCCCCCHHHHh
Q 010626          143 ASLRLPALELL  153 (505)
Q Consensus       143 P~~RpSa~ElL  153 (505)
                      |.+||++.++-
T Consensus       208 P~~rPs~~~i~  218 (484)
T KOG1023|consen  208 PEKRPSIEQIR  218 (484)
T ss_pred             hhhCccHHHHH
Confidence            99999998764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.19  E-value=4.1e-12  Score=141.07  Aligned_cols=154  Identities=27%  Similarity=0.410  Sum_probs=122.8

Q ss_pred             HHHHHHHHHHHHHHHH-hCCCCeEecCCCCCcEEEeCCCC-cEEEeecCceeeccC-CC----CccccC-CCcccCcccc
Q 010626            4 IKNWARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQ-PT----ARSVIG-TPEFMAPELY   75 (505)
Q Consensus         4 I~~ia~QIl~gL~yLH-s~g~~IiHrDLKp~NILld~~~g-~vKL~DFGlA~~~~~-~~----~~~~~G-t~~Y~APEll   75 (505)
                      ...++.|+..+|.|+| ..+  +.||||||+|.+++ ..+ .++++|||+|..+.. ..    ....+| ++.|+|||.+
T Consensus       125 ~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~-~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~  201 (601)
T KOG0590|consen  125 ASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLD-ESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHL  201 (601)
T ss_pred             hhhhhhhhccCccccCcccc--cccCCCCCccchhc-cCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccc
Confidence            4578999999999999 888  99999999999998 566 899999999987755 22    223468 9999999988


Q ss_pred             cc--cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC--CCCCCCCCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626           76 EE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus        76 ~~--~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~--~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                      .+  ...+..|+||.|+++.-+++|..|+.........+.......  .........+....+++.+++. +|..|.+.+
T Consensus       202 ~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~  281 (601)
T KOG0590|consen  202 SGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIE  281 (601)
T ss_pred             cchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccc
Confidence            54  467889999999999999999999976443333322222221  1234455667889999999994 899999999


Q ss_pred             HHhcCCCCCC
Q 010626          151 ELLKDPFLVT  160 (505)
Q Consensus       151 ElL~hpff~~  160 (505)
                      ++-.+||+..
T Consensus       282 ~~~~d~~~~~  291 (601)
T KOG0590|consen  282 ELKLDNWLSS  291 (601)
T ss_pred             cccccccccc
Confidence            9999999987

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.15  E-value=7.2e-11  Score=119.73  Aligned_cols=117  Identities=23%  Similarity=0.436  Sum_probs=95.8

Q ss_pred             CHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC----CCCcEEEeecCceeeccCCC---------CccccCCC
Q 010626            1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDLGLAIVMQQPT---------ARSVIGTP   67 (505)
Q Consensus         1 Lk~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~----~~g~vKL~DFGlA~~~~~~~---------~~~~~Gt~   67 (505)
                      +++|..+|.|++.-++|+|++.  +|+|||||+|+||..    ....+.++|||+|+.+..+.         ..+..||.
T Consensus       123 vKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTA  200 (449)
T KOG1165|consen  123 VKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTA  200 (449)
T ss_pred             HHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccce
Confidence            4788999999999999999999  999999999999942    22358999999998876543         34557999


Q ss_pred             cccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCC--ChHHHHHHHHcCC
Q 010626           68 EFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGI  119 (505)
Q Consensus        68 ~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~--~~~~i~~~i~~~~  119 (505)
                      +||+-... ....+...|+=+||-++.+.+.|.+||.+..  +..+.|++|-...
T Consensus       201 RYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K  255 (449)
T KOG1165|consen  201 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK  255 (449)
T ss_pred             eeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence            99998744 5667889999999999999999999998753  4566777776543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.15  E-value=1.2e-10  Score=115.29  Aligned_cols=143  Identities=20%  Similarity=0.340  Sum_probs=105.4

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEE--eecCceeeccCCCCccccCCCcccCccccccc--
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKI--GDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--   78 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL--~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~--   78 (505)
                      ++.+++.+|++|++|||+..|-|.---|....+++| ++-+.+|  +|--++  +..   ....-.|.||+||.++..  
T Consensus       290 qav~faldiargmaflhslep~ipr~~lns~hvmid-edltarismad~kfs--fqe---~gr~y~pawmspealqrkpe  363 (448)
T KOG0195|consen  290 QAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID-EDLTARISMADTKFS--FQE---VGRAYSPAWMSPEALQRKPE  363 (448)
T ss_pred             hHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec-chhhhheecccceee--eec---cccccCcccCCHHHHhcCch
Confidence            566799999999999999975455557888999998 5555554  332222  111   112346899999988543  


Q ss_pred             --CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           79 --YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        79 --ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                        .-.++|+|||++++||+.|.+.||.+....+--.+....+.++ .++...++.+-+|+.-|+. ||.+||.+..+
T Consensus       364 d~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv-~ippgis~hm~klm~icmnedpgkrpkfdmi  439 (448)
T KOG0195|consen  364 DLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV-HIPPGISRHMNKLMNICMNEDPGKRPKFDMI  439 (448)
T ss_pred             hcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc-cCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence              3368999999999999999999998865555444444555444 5667778999999999995 89999987654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.14  E-value=5e-11  Score=116.41  Aligned_cols=138  Identities=25%  Similarity=0.369  Sum_probs=104.4

Q ss_pred             CHHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEeecCceeeccCCC---------CccccCCCcc
Q 010626            1 MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPT---------ARSVIGTPEF   69 (505)
Q Consensus         1 Lk~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld--~~~g~vKL~DFGlA~~~~~~~---------~~~~~Gt~~Y   69 (505)
                      |+++.-++-|++.-++|+|.++  +|||||||+|+|..  .....+.|+|||+|+.+....         .....||.+|
T Consensus       110 mkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRY  187 (341)
T KOG1163|consen  110 MKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARY  187 (341)
T ss_pred             HHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeee
Confidence            4678889999999999999999  99999999999983  123368999999998664322         2345689999


Q ss_pred             cCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCC--ChHHHHHHHHcCCC---CCCCCCCCChHHHHHHHHhc
Q 010626           70 MAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIK---PASLSKVTDPQVKQFIEKCI  140 (505)
Q Consensus        70 ~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~--~~~~i~~~i~~~~~---p~~~~~~~s~~l~~LI~kcL  140 (505)
                      .+-... ....+...|+-|+|.++.+...|..||.+..  ...|.+.+|.....   +..+-+..+.++.-.+.-|-
T Consensus       188 ASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R  264 (341)
T KOG1163|consen  188 ASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCR  264 (341)
T ss_pred             hhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHh
Confidence            887654 3446778999999999999999999998753  34566777765432   22333455677777777775

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.11  E-value=9.4e-11  Score=118.82  Aligned_cols=155  Identities=34%  Similarity=0.550  Sum_probs=107.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeec------cCCCCccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM------QQPTARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~------~~~~~~~~~Gt~~Y~APEll   75 (505)
                      +..++|+-||+.||.|||+..|||+|+++.++-|++. .+|-+|++--.....-      .........+.+.|.+||.=
T Consensus       176 ~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq-~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg  254 (458)
T KOG1266|consen  176 KAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ-HNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG  254 (458)
T ss_pred             HHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec-CCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC
Confidence            5678999999999999999999999999999999997 8888887542211100      00011122456789999865


Q ss_pred             -cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 -EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 -~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                       ..+.+.++|||+||++.++|..++.--.+.......-..+...     ........-+.+|.+|+. .|..||++.++|
T Consensus       255 ~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~-----i~~len~lqr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  255 TTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV-----IIGLENGLQRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             cccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh-----eeeccCccccCcCcccccCCCCCCcchhhhh
Confidence             3456778999999999999999876543322111111111110     111112344678999997 699999999999


Q ss_pred             cCCCCCCCC
Q 010626          154 KDPFLVTDN  162 (505)
Q Consensus       154 ~hpff~~~~  162 (505)
                      .||.+....
T Consensus       330 fHpllfeVh  338 (458)
T KOG1266|consen  330 FHPLLFEVH  338 (458)
T ss_pred             cCceeeecc
Confidence            999876543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.05  E-value=2.8e-10  Score=110.65  Aligned_cols=97  Identities=23%  Similarity=0.208  Sum_probs=75.0

Q ss_pred             HHHHHHHHHHHHHHHhCCCCeEecCC-CCCcEEEeCCCCcEEEeecCceeeccCCCC------c---------cccCCCc
Q 010626            5 KNWARQILRGLHYLHSHNPPIIHRDL-KCDNIFVNGNNGEVKIGDLGLAIVMQQPTA------R---------SVIGTPE   68 (505)
Q Consensus         5 ~~ia~QIl~gL~yLHs~g~~IiHrDL-Kp~NILld~~~g~vKL~DFGlA~~~~~~~~------~---------~~~Gt~~   68 (505)
                      ..++.|++.+|.++|.+|  |+|||| ||.||+++ .+|.++|+|||++........      .         ....++.
T Consensus        94 ~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~-~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~  170 (218)
T PRK12274         94 LAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQ-EDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPA  170 (218)
T ss_pred             HHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEc-CCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCC
Confidence            357889999999999999  999999 79999997 678999999999975543321      0         0125777


Q ss_pred             ccCcccc--cccCC-cccchhhHHHHHHHHhhcCCCCCC
Q 010626           69 FMAPELY--EEEYN-ELVDIYSFGMCILEMVTCEYPYNE  104 (505)
Q Consensus        69 Y~APEll--~~~ys-~ksDIWSLGviLyEmlTG~~Pf~~  104 (505)
                      |+.|+..  -...+ ...+.++.|+-+|.++|+..|+..
T Consensus       171 ~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        171 ALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             CCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            8888743  22233 566788889999999999988754

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.01  E-value=4.4e-10  Score=117.91  Aligned_cols=69  Identities=30%  Similarity=0.467  Sum_probs=58.3

Q ss_pred             HHHHHHHHHHHHHHHhCCCCeEecCC-CCCcEEEeCCCCcEEEeecCceeeccCCC----------CccccCCCcccCcc
Q 010626            5 KNWARQILRGLHYLHSHNPPIIHRDL-KCDNIFVNGNNGEVKIGDLGLAIVMQQPT----------ARSVIGTPEFMAPE   73 (505)
Q Consensus         5 ~~ia~QIl~gL~yLHs~g~~IiHrDL-Kp~NILld~~~g~vKL~DFGlA~~~~~~~----------~~~~~Gt~~Y~APE   73 (505)
                      ..++.|++.||.|||++|  |+|||| ||+|||++ .++.+||+|||+++.+....          .....+++.|+|||
T Consensus       114 ~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~-~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe  190 (365)
T PRK09188        114 PAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMG-PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPD  190 (365)
T ss_pred             HHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEc-CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcc
Confidence            468899999999999999  999999 99999997 66899999999998664432          13446788899999


Q ss_pred             ccc
Q 010626           74 LYE   76 (505)
Q Consensus        74 ll~   76 (505)
                      .+.
T Consensus       191 ~~~  193 (365)
T PRK09188        191 ALT  193 (365)
T ss_pred             cCC
Confidence            883

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=98.80  E-value=2.1e-09  Score=105.99  Aligned_cols=78  Identities=24%  Similarity=0.302  Sum_probs=59.9

Q ss_pred             HHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccccCCcccch
Q 010626            6 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNELVDI   85 (505)
Q Consensus         6 ~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~ys~ksDI   85 (505)
                      ....+|+.+|..||.+|  ++|||+||+||+++ .+| ++|+|||.............         =+++..|+.++|+
T Consensus       139 ~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili~-~~g-i~liDfg~~~~~~e~~a~d~---------~vler~y~~~~di  205 (232)
T PRK10359        139 DVKAKIKASIESLHQHG--MVSGDPHKGNFIVS-KNG-LRIIDLSGKRCTAQRKAKDR---------IDLERHYGIKNEI  205 (232)
T ss_pred             HHHHHHHHHHHHHHHcC--CccCCCChHHEEEe-CCC-EEEEECCCcccccchhhHHH---------HHHHhHhcccccc
Confidence            34679999999999999  99999999999998 566 99999998765532221110         0235567889999


Q ss_pred             hhHHHHHHHHh
Q 010626           86 YSFGMCILEMV   96 (505)
Q Consensus        86 WSLGviLyEml   96 (505)
                      |+||+++....
T Consensus       206 ~~lg~~~~~~~  216 (232)
T PRK10359        206 KDLGYYLLIYK  216 (232)
T ss_pred             cceeEeehHHH
Confidence            99999876553

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=98.77  E-value=1.1e-08  Score=97.23  Aligned_cols=53  Identities=23%  Similarity=0.385  Sum_probs=47.4

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC
Q 010626            2 KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP   58 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~   58 (505)
                      +.+..++.|++.+|.+||. +|  |+||||||+||+++  ++.++|+|||++.....+
T Consensus       117 ~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~NIll~--~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         117 EEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYNILYH--DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC--EecCCCChhhEEEE--CCCEEEEEcccceecCCC
Confidence            4678899999999999999 99  99999999999997  579999999999776543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=98.76  E-value=1e-08  Score=98.10  Aligned_cols=53  Identities=19%  Similarity=0.370  Sum_probs=46.4

Q ss_pred             HHHHHHHHHHHHHHHHH-HhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC
Q 010626            2 KAIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP   58 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yL-Hs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~   58 (505)
                      +.+..++.||+.+|.|| |+.|  |+||||||+||+++  ++.++|+|||+|.....+
T Consensus       117 ~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~NIli~--~~~v~LiDFG~a~~~~~~  170 (190)
T cd05147         117 SKARELYLQVIQIMRILYQDCR--LVHADLSEYNLLYH--DGKLYIIDVSQSVEHDHP  170 (190)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEE--CCcEEEEEccccccCCCc
Confidence            46788999999999999 7999  99999999999997  378999999999755443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.74  E-value=1.2e-08  Score=115.96  Aligned_cols=161  Identities=25%  Similarity=0.420  Sum_probs=126.5

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc-------C-------------------
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-------Q-------------------   57 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~-------~-------------------   57 (505)
                      .+.++..+..+++|||...  +.|||++|.|++.. .+|..++.+||......       .                   
T Consensus       906 aRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~-~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~  982 (1205)
T KOG0606|consen  906 ARSPILERVQSLESLHSSL--RKHRDLKPDSLLIA-YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRP  982 (1205)
T ss_pred             ccchhHHHHhhhhccccch--hhcccccccchhhc-ccCCcccCccccccccccccCcCCcccccccCcccccccccccc
Confidence            3556778889999999987  89999999999996 78999999998432110       0                   


Q ss_pred             -------CCCccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC-CCCCCC
Q 010626           58 -------PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVT  128 (505)
Q Consensus        58 -------~~~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~  128 (505)
                             .......||+.|.+||.+ .......+|+|++|+++++.++|..||.. ..+.+++..+..+..+. .-+...
T Consensus       983 ~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na-~tpq~~f~ni~~~~~~~p~g~~~~ 1061 (1205)
T KOG0606|consen  983 QLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA-ETPQQIFENILNRDIPWPEGPEEG 1061 (1205)
T ss_pred             ccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC-cchhhhhhccccCCCCCCCCcccc
Confidence                   001234689999999976 55677889999999999999999999976 56677777666654443 334556


Q ss_pred             ChHHHHHHHHhcC-CCCCCCCHH---HHhcCCCCCCCCCCCccc
Q 010626          129 DPQVKQFIEKCIV-PASLRLPAL---ELLKDPFLVTDNPKDLVC  168 (505)
Q Consensus       129 s~~l~~LI~kcL~-dP~~RpSa~---ElL~hpff~~~~~~~l~~  168 (505)
                      ++.+++++.+.+. .|.+|..+.   ++-.|+||+...|..+..
T Consensus      1062 s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1062 SYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred             ChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccc
Confidence            8899999999995 799999988   899999999988876543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=98.72  E-value=1.5e-08  Score=116.50  Aligned_cols=97  Identities=25%  Similarity=0.356  Sum_probs=79.5

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC------CCCcEEEeecCceeecc---CC-CCccccCCCcccCc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------NNGEVKIGDLGLAIVMQ---QP-TARSVIGTPEFMAP   72 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~------~~g~vKL~DFGlA~~~~---~~-~~~~~~Gt~~Y~AP   72 (505)
                      .+..++.|++..++.||..+  |||+||||+|++|..      ....++|+|||.+.-+.   .. ......+|-.|-.+
T Consensus       795 lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~  872 (974)
T KOG1166|consen  795 LVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCI  872 (974)
T ss_pred             hhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhH
Confidence            46678999999999999999  999999999999941      23458999999995442   22 33445678889999


Q ss_pred             cccc-ccCCcccchhhHHHHHHHHhhcCCC
Q 010626           73 ELYE-EEYNELVDIYSFGMCILEMVTCEYP  101 (505)
Q Consensus        73 Ell~-~~ys~ksDIWSLGviLyEmlTG~~P  101 (505)
                      |+.. +.+++.+|.|.|+.+++-||.|++-
T Consensus       873 EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  873 EMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             HHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            9884 5699999999999999999999753

>PF12202 OSR1_C: Oxidative-stress-responsive kinase 1 C terminal; InterPro: IPR024678 Oxidative-stress-responsive kinase 1 (OSR1) is involved in the signalling cascade which activates Na/K/2Cl co-transporter during osmotic stress

Probab=98.69  E-value=1.8e-08  Score=70.54  Aligned_cols=32  Identities=38%  Similarity=0.523  Sum_probs=27.7

Q ss_pred             eEEEEEecCCCC------CcceeeeecccCCCCHHHHH
Q 010626          240 VSLTLRIGDKSG------HVSNIHFVFYLNADTAISIA  271 (505)
Q Consensus       240 i~L~Lri~d~~g------~~r~I~F~F~~~~DTa~~VA  271 (505)
                      |.|+||++|+++      +.++|+|+|++++|||++||
T Consensus         1 i~l~Lrv~d~kK~~~k~ken~aI~F~F~~~~D~~e~VA   38 (38)
T PF12202_consen    1 INLRLRVRDPKKRKGKHKENEAIEFEFDLGKDTAEEVA   38 (38)
T ss_dssp             EEEEEEEC-TTSSSSS--TCEEEEEEEETTT--HHHHH
T ss_pred             CcEEEEEeccccccCccccCccEEEEEecCCCcccccC
Confidence            689999999998      89999999999999999998

This entry represents the CCT domain found in OSR1, STE20/SPS1-related kinase and in WNK activators []. This domain is found in eukaryotes, and is approximately 40 amino acids in length. There is a single completely conserved residue F that may be functionally important. ; PDB: 2V3S_A 2LRU_A.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.58  E-value=4.7e-08  Score=105.86  Aligned_cols=154  Identities=26%  Similarity=0.308  Sum_probs=118.1

Q ss_pred             HHHHHHHHHHH----HHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc-------cccCCCcccC
Q 010626            3 AIKNWARQILR----GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-------SVIGTPEFMA   71 (505)
Q Consensus         3 ~I~~ia~QIl~----gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~-------~~~Gt~~Y~A   71 (505)
                      .++.++.+...    ||..+|+.+  ++|-|+||.||+...+....+++|||+...+......       ...|...|++
T Consensus       219 ~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~  296 (524)
T KOG0601|consen  219 LLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAA  296 (524)
T ss_pred             hhhhHHhhhhhcccccccccCCCc--ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeC
Confidence            46777888888    999999999  9999999999999743378999999999877654311       1246778999


Q ss_pred             cccccccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626           72 PELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus        72 PEll~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                      ||+.++-++...|+|++|.++.+..++..++....+..  +..+..+..+..+-...+..+...+..++. +|..|+++.
T Consensus       297 ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q  374 (524)
T KOG0601|consen  297 KELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS--WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQ  374 (524)
T ss_pred             hhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC--ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHH
Confidence            99999999999999999999999999887776542211  112222233444444445666677888885 699999999


Q ss_pred             HHhcCCCCCC
Q 010626          151 ELLKDPFLVT  160 (505)
Q Consensus       151 ElL~hpff~~  160 (505)
                      .+++|+++..
T Consensus       375 ~~~~l~~i~s  384 (524)
T KOG0601|consen  375 ILTALNVIHS  384 (524)
T ss_pred             HHhccccccc
Confidence            9999999874

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.56  E-value=4.8e-08  Score=107.49  Aligned_cols=150  Identities=19%  Similarity=0.315  Sum_probs=106.8

Q ss_pred             HHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc-----------cccCCCcccCcccc-c
Q 010626            9 RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-----------SVIGTPEFMAPELY-E   76 (505)
Q Consensus         9 ~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~-----------~~~Gt~~Y~APEll-~   76 (505)
                      .+.+.||.|+|.+ +.+||++|.|++|+++ .+|..||+.|+++.....+...           .......|.|||.+ .
T Consensus       106 ~~v~dgl~flh~s-Ak~VH~ni~p~~i~~n-a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS-AKVVHGNIQPEAIVVN-ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC-cceeecccchhheeec-cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3455889999987 3599999999999998 7889999999988554432111           11234579999977 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHH--cCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVT--SGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~--~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                      ...+.++|+||+|+++|.+.. |+.-+.. .+....+....  .+..........+.++++=+.+++. ++..||++.++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l  262 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAA-NGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL  262 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhc-cCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence            457789999999999999984 4444433 22222222111  1112223446678899999999995 89999999999


Q ss_pred             hcCCCCCCC
Q 010626          153 LKDPFLVTD  161 (505)
Q Consensus       153 L~hpff~~~  161 (505)
                      +..|||...
T Consensus       263 ~~~~ff~D~  271 (700)
T KOG2137|consen  263 LSIPFFSDP  271 (700)
T ss_pred             hcccccCCc
Confidence            999999764

>smart00090 RIO RIO-like kinase

Probab=98.37  E-value=5.2e-07  Score=89.35  Aligned_cols=52  Identities=25%  Similarity=0.358  Sum_probs=45.5

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ   57 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~   57 (505)
                      ++..++.||+.+|.+||.+| .++||||||+||+++  ++.++|+|||.+.....
T Consensus       149 ~~~~i~~qi~~~l~~LH~~g-~iiH~Dikp~NIli~--~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      149 EEFELYDDILEEMRKLYKEG-ELVHGDLSEYNILVH--DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             HHHHHHHHHHHHHHHHHhcC-CEEeCCCChhhEEEE--CCCEEEEEChhhhccCC
Confidence            45789999999999999987 499999999999997  57899999999865543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=98.37  E-value=5.2e-07  Score=86.03  Aligned_cols=52  Identities=25%  Similarity=0.289  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ   57 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~   57 (505)
                      ....++.+|+.++.++|.+|  ++||||||.||+++ .++.++|+|||.+.....
T Consensus       126 ~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~Nill~-~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         126 DPEEVLDEILEEIVKAYKHG--IIHGDLSEFNILVD-DDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cHHHHHHHHHHHHHHHHHCC--CCcCCCCcccEEEc-CCCcEEEEECCccccCCC
Confidence            35678999999999999999  99999999999998 678999999999965544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05119 RIO RIO kinase family, catalytic domain

Probab=98.35  E-value=5.3e-07  Score=84.45  Aligned_cols=51  Identities=29%  Similarity=0.373  Sum_probs=46.1

Q ss_pred             HHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC
Q 010626            3 AIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ   57 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~   57 (505)
                      .++.++.+++.++.++|. +|  ++||||||+||+++  ++.++|+|||.+.....
T Consensus       115 ~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~Nili~--~~~~~liDfg~a~~~~~  166 (187)
T cd05119         115 DPEELYDQILELMRKLYREAG--LVHGDLSEYNILVD--DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             cHHHHHHHHHHHHHHHhhccC--cCcCCCChhhEEEE--CCcEEEEECcccccccC
Confidence            567899999999999999 98  99999999999997  67999999999966544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=98.27  E-value=9.4e-07  Score=87.61  Aligned_cols=46  Identities=20%  Similarity=0.281  Sum_probs=41.2

Q ss_pred             HHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeec
Q 010626            7 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM   55 (505)
Q Consensus         7 ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~   55 (505)
                      .+.||+.+|.+||.+|  |+||||||.|||++ .++.++|+|||.+...
T Consensus       147 ~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~-~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        147 QWQAIGQLIARFHDAG--VYHADLNAHNILLD-PDGKFWLIDFDRGELR  192 (239)
T ss_pred             HHHHHHHHHHHHHHCC--CCCCCCCchhEEEc-CCCCEEEEECCCcccC
Confidence            4679999999999999  99999999999997 5678999999988553

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.25  E-value=8.9e-06  Score=85.68  Aligned_cols=144  Identities=23%  Similarity=0.379  Sum_probs=101.0

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceee-ccCCCCccccCCCcccCccccc------
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV-MQQPTARSVIGTPEFMAPELYE------   76 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~-~~~~~~~~~~Gt~~Y~APEll~------   76 (505)
                      +.+.++.|+.+.+-||.+|  ..-+|++++|+|+. +++.|.|.|-..-.. .+.......+|.+.|.+||+-.      
T Consensus       119 llrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVs-d~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g  195 (637)
T COG4248         119 LLRVARNLASAFATLHEHG--HVVGDVNQNSFLVS-DDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVG  195 (637)
T ss_pred             HHHHHHHHHHHHHHHHhcC--CcccccCccceeee-cCceEEEEcccceeeccCCceEecccCccccCCHHHhccccccc
Confidence            4678899999999999999  89999999999996 788999987432221 2222233457899999999653      


Q ss_pred             ccCCcccchhhHHHHHHHHhhc-CCCCCCCC------ChHH--H------H-HHHHcCCCCC--CC-CCCCChHHHHHHH
Q 010626           77 EEYNELVDIYSFGMCILEMVTC-EYPYNECK------NPAQ--I------Y-KKVTSGIKPA--SL-SKVTDPQVKQFIE  137 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG-~~Pf~~~~------~~~~--i------~-~~i~~~~~p~--~~-~~~~s~~l~~LI~  137 (505)
                      -.-+...|.|.||+++++++.| +.||.+..      ++-+  +      | .+-..+.+|.  .+ ....++.++.|..
T Consensus       196 ~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~  275 (637)
T COG4248         196 FERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQ  275 (637)
T ss_pred             cCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHH
Confidence            1346789999999999999986 99997531      1111  1      0 1111122221  11 2345789999999


Q ss_pred             HhcCC---CCCCCCHH
Q 010626          138 KCIVP---ASLRLPAL  150 (505)
Q Consensus       138 kcL~d---P~~RpSa~  150 (505)
                      +|+.+   +.-|||++
T Consensus       276 qaF~~~~~~~~RP~a~  291 (637)
T COG4248         276 QAFTESGVATPRPTAK  291 (637)
T ss_pred             HHhcccCCCCCCCCHH
Confidence            99964   56899965

>PRK10345 hypothetical protein; Provisional

Probab=98.20  E-value=1.9e-06  Score=83.94  Aligned_cols=46  Identities=26%  Similarity=0.255  Sum_probs=37.5

Q ss_pred             HHHHHHHHHHH-HHHHhCCCCeEecCCCCCcEEEeC---CCCcEEEeecCce
Q 010626            5 KNWARQILRGL-HYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGLA   52 (505)
Q Consensus         5 ~~ia~QIl~gL-~yLHs~g~~IiHrDLKp~NILld~---~~g~vKL~DFGlA   52 (505)
                      ..++.|++.++ +|||+++  |+||||||+||+++.   ..+.++|+||+.+
T Consensus       107 ~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        107 VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            35678888888 9999999  999999999999963   2347999995433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=98.14  E-value=3.4e-06  Score=80.53  Aligned_cols=47  Identities=36%  Similarity=0.492  Sum_probs=42.9

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceee
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV   54 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~   54 (505)
                      ...++.+++.+|.+||..|  ++|||++|.||+++  .+.++|+|||.+..
T Consensus        97 ~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~--~~~~~liDf~~a~~  143 (211)
T PRK14879         97 ELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS--GGKIYLIDFGLAEF  143 (211)
T ss_pred             HHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE--CCCEEEEECCcccC
Confidence            4588999999999999999  99999999999997  57899999998854

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=98.11  E-value=4.2e-06  Score=79.24  Aligned_cols=45  Identities=33%  Similarity=0.466  Sum_probs=41.7

Q ss_pred             HHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceee
Q 010626            6 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV   54 (505)
Q Consensus         6 ~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~   54 (505)
                      .++.|++.+|.+||+.|  ++|||++|.||+++  ++.+++.|||++..
T Consensus        94 ~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~--~~~~~liDfg~a~~  138 (199)
T TIGR03724        94 ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR--DDKLYLIDFGLGKY  138 (199)
T ss_pred             HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE--CCcEEEEECCCCcC
Confidence            68999999999999999  99999999999997  57899999998855

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=98.03  E-value=4.4e-06  Score=92.07  Aligned_cols=48  Identities=25%  Similarity=0.353  Sum_probs=43.3

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeec
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM   55 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~   55 (505)
                      ...++.||+.+|.|||++|  ++||||||+||+++  ++.++|+|||+++..
T Consensus       430 ~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl~--~~~~~liDFGla~~~  477 (535)
T PRK09605        430 NPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIVR--DDRLYLIDFGLGKYS  477 (535)
T ss_pred             HHHHHHHHHHHHHHHHhCC--CccCCCChHHEEEE--CCcEEEEeCcccccC
Confidence            4678899999999999999  99999999999994  578999999998653

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=97.91  E-value=4.4e-06  Score=90.76  Aligned_cols=149  Identities=22%  Similarity=0.241  Sum_probs=100.0

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCccc-Ccccc-c-ccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM-APELY-E-EEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~-APEll-~-~~y   79 (505)
                      ..++...|++.++.++|+..  ++|+|++|+||++....+..+++|||.+..+.-.... ..+.-+++ .+|++ . ..+
T Consensus       367 ~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~-~~~~~r~~p~~~~~~e~~~~  443 (524)
T KOG0601|consen  367 PRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGV-FHHIDRLYPIAEILLEDYPH  443 (524)
T ss_pred             hhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhccccccccccceeccc-ccccccccccchhhcccccc
Confidence            45678899999999999999  9999999999999733377899999998653222111 12233444 24544 3 347


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      ..+.|+++||..+.+.+++..--...    .....+..+..+. .+.. ..++..+.+.++. ++..|+.+.++..|.=|
T Consensus       444 ~~~~~~~sl~~~~~e~~~~~~ls~~~----~~~~~i~~~~~p~-~~~~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  444 LSKADIFSLGLSVDEAITGSPLSESG----VQSLTIRSGDTPN-LPGL-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             ccccccccccccccccccCcccCccc----ccceeeecccccC-CCch-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            78999999999999999986332211    1122333333322 2222 2566777777775 68889999998888766


Q ss_pred             CC
Q 010626          159 VT  160 (505)
Q Consensus       159 ~~  160 (505)
                      ..
T Consensus       518 ~~  519 (524)
T KOG0601|consen  518 YR  519 (524)
T ss_pred             hh
Confidence            43

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=97.80  E-value=3.9e-05  Score=67.25  Aligned_cols=51  Identities=27%  Similarity=0.227  Sum_probs=42.7

Q ss_pred             HHHHHHHHHHHHHHHHHhCC-CCeEecCCCCCcEEEeCCCCcEEEeecCceee
Q 010626            3 AIKNWARQILRGLHYLHSHN-PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV   54 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g-~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~   54 (505)
                      ....++.+++.+|++||... .+++|+|++|.||+++ ..+.+++.|||.+..
T Consensus        87 ~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~-~~~~~~l~Df~~~~~  138 (155)
T cd05120          87 EKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIIDWEYAGY  138 (155)
T ss_pred             HHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE-CCcEEEEEecccccC
Confidence            45678899999999999841 1299999999999998 568899999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=97.73  E-value=5.2e-05  Score=73.26  Aligned_cols=52  Identities=27%  Similarity=0.377  Sum_probs=44.7

Q ss_pred             HHHHHHHHHHHHHHHH-HhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC
Q 010626            3 AIKNWARQILRGLHYL-HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP   58 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yL-Hs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~   58 (505)
                      .+..+..|++.+|..| |..|  ++|+||++.||++.  ++.+.|+|||.+.....+
T Consensus       125 ~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~~NIL~~--~~~v~iIDF~qav~~~hp  177 (197)
T cd05146         125 EMKNAYYQVLSMMKQLYKECN--LVHADLSEYNMLWH--DGKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEE--CCcEEEEECCCceeCCCC
Confidence            4567789999999998 8999  99999999999996  468999999998766544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=97.57  E-value=0.00011  Score=67.23  Aligned_cols=47  Identities=26%  Similarity=0.228  Sum_probs=39.8

Q ss_pred             HHHHHHHHHHHHHHHhCCC---CeEecCCCCCcEEEeCCCCcEEEeecCcee
Q 010626            5 KNWARQILRGLHYLHSHNP---PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI   53 (505)
Q Consensus         5 ~~ia~QIl~gL~yLHs~g~---~IiHrDLKp~NILld~~~g~vKL~DFGlA~   53 (505)
                      ..++.+++.+|+.||..+.   .++|+|++|.||+++  ++.++++|||.+.
T Consensus        86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~  135 (170)
T cd05151          86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAG  135 (170)
T ss_pred             HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEeccccc
Confidence            4567899999999999871   149999999999997  4679999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=97.37  E-value=0.00051  Score=76.17  Aligned_cols=91  Identities=29%  Similarity=0.383  Sum_probs=66.5

Q ss_pred             HHHHHHHHHHHHHHHH-hCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccccccCC
Q 010626            4 IKNWARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEEYN   80 (505)
Q Consensus         4 I~~ia~QIl~gL~yLH-s~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~~~ys   80 (505)
                      +.--+.||+.||.||| ..+  ++|++|.-+.|||+ ..|..||++|-++.......  .....-.-.|..|+.+... .
T Consensus       106 v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn-~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s-~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVN-ESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS-E  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEc-CCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-c
Confidence            4556799999999998 455  99999999999998 78999999998875543322  1111122235555544211 1


Q ss_pred             cccchhhHHHHHHHHhhc
Q 010626           81 ELVDIYSFGMCILEMVTC   98 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG   98 (505)
                      -..|.|-|||++++++.|
T Consensus       182 ~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cchhhhhHHHHHHHHhCc
Confidence            457999999999999988

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=97.17  E-value=0.00066  Score=73.29  Aligned_cols=48  Identities=27%  Similarity=0.389  Sum_probs=40.5

Q ss_pred             HHHHHHHH-HHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc
Q 010626            6 NWARQILR-GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ   56 (505)
Q Consensus         6 ~ia~QIl~-gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~   56 (505)
                      .++.+++. .+..+|..|  ++|+|++|.||+++ .+|.++++|||++..+.
T Consensus       260 ~ia~~~~~~~l~ql~~~g--~~H~D~hPgNilv~-~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       260 ALAENLARSFLNQVLRDG--FFHADLHPGNIFVL-KDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHHHHHhCC--ceeCCCCcccEEEC-CCCcEEEEeCCCeeECC
Confidence            46666665 478899999  99999999999997 67899999999986654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=97.02  E-value=0.00098  Score=67.44  Aligned_cols=49  Identities=16%  Similarity=0.170  Sum_probs=42.6

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC------CCCcEEEeecCcee
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------NNGEVKIGDLGLAI   53 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~------~~g~vKL~DFGlA~   53 (505)
                      ....++.+++..+.-||..|  |+|+||++.|||++.      ..+.+.|+||+.+.
T Consensus       139 ~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        139 LKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            34578899999999999999  999999999999973      24679999999874

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=97.00  E-value=0.001  Score=64.23  Aligned_cols=51  Identities=25%  Similarity=0.286  Sum_probs=42.9

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEeecCceeec
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVM   55 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~--g~vKL~DFGlA~~~   55 (505)
                      ....++.+++..++-||..|  |+|+|+++.|||++...  ..+.++||+.+...
T Consensus       119 ~~~~ll~~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  119 QRRELLRALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hHHHHHHHHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            35678899999999999999  99999999999998432  26899999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=96.99  E-value=0.0012  Score=63.32  Aligned_cols=46  Identities=30%  Similarity=0.471  Sum_probs=38.3

Q ss_pred             HHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeec
Q 010626            6 NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM   55 (505)
Q Consensus         6 ~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~   55 (505)
                      .+++.+=.-+.-||..|  |+|+||.++||++.  .+.+.++|||++...
T Consensus        96 ~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~--~~~i~~IDfGLg~~s  141 (204)
T COG3642          96 DLLREVGRLVGKLHKAG--IVHGDLTTSNIILS--GGRIYFIDFGLGEFS  141 (204)
T ss_pred             HHHHHHHHHHHHHHhcC--eecCCCccceEEEe--CCcEEEEECCccccc
Confidence            35666667788899999  99999999999997  345999999998643

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=96.82  E-value=0.0025  Score=61.20  Aligned_cols=51  Identities=37%  Similarity=0.528  Sum_probs=38.6

Q ss_pred             HHHHHHHHHHHHHH-HHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC
Q 010626            4 IKNWARQILRGLHY-LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP   58 (505)
Q Consensus         4 I~~ia~QIl~gL~y-LHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~   58 (505)
                      ...++.+++..+.. +|..|  ++|+||.+.||+++ . +.+.|+|||.+.....+
T Consensus       108 ~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~-~-~~~~iIDf~qav~~~~p  159 (188)
T PF01163_consen  108 PKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVD-D-GKVYIIDFGQAVDSSHP  159 (188)
T ss_dssp             HHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEE-T-TCEEE--GTTEEETTST
T ss_pred             HHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEee-c-ceEEEEecCcceecCCc
Confidence            56778888886555 57999  99999999999997 3 48999999998766543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=96.69  E-value=0.0034  Score=60.26  Aligned_cols=49  Identities=33%  Similarity=0.470  Sum_probs=41.4

Q ss_pred             HHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc--EEEeecCceeec
Q 010626            5 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVM   55 (505)
Q Consensus         5 ~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~--vKL~DFGlA~~~   55 (505)
                      ..++++|=..+.-||..+  ++|+||..+||++...++.  +.++|||++...
T Consensus       116 ~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  116 AELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             HHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEeecchhcc
Confidence            567888889999999999  9999999999999755444  489999998544

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.48  E-value=0.0048  Score=72.42  Aligned_cols=145  Identities=26%  Similarity=0.368  Sum_probs=94.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCC---cEEEeCCCCcEEEe--ecCceeeccCCC-CccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCD---NIFVNGNNGEVKIG--DLGLAIVMQQPT-ARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~---NILld~~~g~vKL~--DFGlA~~~~~~~-~~~~~Gt~~Y~APEll   75 (505)
                      ..++.+..+++.||.|+|+..  ..|.-|...   +--.+ ..+.+.++  ||+....+.... ......+..+.+||..
T Consensus       286 ~~~r~~~~~~~~GL~~~h~~~--l~~v~L~~s~~~~~~~~-~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~  362 (1351)
T KOG1035|consen  286 ETLRILHQKLLEGLAYLHSLS--LEHVVLSASSSKESTVD-GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDL  362 (1351)
T ss_pred             HHHHHHHHHHhhhHHHHHHhc--cceeEEecccccccccC-ccceeecchhhhcccccCCCcccchhhcCcccccccccc
Confidence            467889999999999999986  666555544   22222 23345555  777766554332 2223445567788877


Q ss_pred             ccc-C--CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           76 EEE-Y--NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        76 ~~~-y--s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                      ... +  ....|+|++|.....+..|..+-.....+            ...++........++..+|+. ++++|+++.+
T Consensus       363 ~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~------------~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~  430 (1351)
T KOG1035|consen  363 KENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP------------VSLLDVLSTSELLDALPKCLDEDSEERLSALE  430 (1351)
T ss_pred             ccccchhhhhhHHHHHHHHHhhhhhcCcccccccch------------hhhhccccchhhhhhhhhhcchhhhhccchhh
Confidence            433 3  34469999999999998876553221110            111111122267888999995 7999999999


Q ss_pred             HhcCCCCCCC
Q 010626          152 LLKDPFLVTD  161 (505)
Q Consensus       152 lL~hpff~~~  161 (505)
                      ++.|+|....
T Consensus       431 ll~~~f~~~~  440 (1351)
T KOG1035|consen  431 LLTHPFLRFP  440 (1351)
T ss_pred             hhhchhcccc
Confidence            9999998753

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=96.40  E-value=0.023  Score=62.01  Aligned_cols=127  Identities=17%  Similarity=0.266  Sum_probs=88.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccccCCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNE   81 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~ys~   81 (505)
                      +.+|.|+.||..||.++|+.|  +.-+-|.+.+|++++. ..++|...|+...+.....            +.++.  ..
T Consensus       393 ~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~-~RIriS~C~i~Dvl~~d~~------------~~le~--~Q  455 (655)
T KOG3741|consen  393 EVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGK-MRIRISGCGIMDVLQEDPT------------EPLES--QQ  455 (655)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCc-ceEEEecccceeeecCCCC------------cchhH--Hh
Confidence            478999999999999999999  8889999999999854 4888888887766544321            11211  24


Q ss_pred             ccchhhHHHHHHHHhhcCCCCCCCCChHHH-HHHHHcCCCCCCCCCCCChHHHHHHHHhcCC-CCCCCCHHHHhcC
Q 010626           82 LVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD  155 (505)
Q Consensus        82 ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i-~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~d-P~~RpSa~ElL~h  155 (505)
                      +-|.=.||.+++.|.||..--.......+. ...         +...++.+++++|.-+..+ +.+ .++.+++.+
T Consensus       456 q~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~---------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  456 QNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR---------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hhhHHHHHHHHHHHhhcccccccccchHHHHHHH---------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            568889999999999996432221222221 122         2344577888898877753 443 778887765

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=96.14  E-value=0.0062  Score=67.41  Aligned_cols=38  Identities=21%  Similarity=0.344  Sum_probs=31.8

Q ss_pred             HHHhCCCCeEecCCCCCcEEEeCCCC----cEEEeecCceeeccC
Q 010626           17 YLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIVMQQ   57 (505)
Q Consensus        17 yLHs~g~~IiHrDLKp~NILld~~~g----~vKL~DFGlA~~~~~   57 (505)
                      .++..|  ++|+|+||.||+++ .+|    .+++.|||++..+..
T Consensus       275 Qif~~G--ffHaDpHPGNIlv~-~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVFRDG--FFHADMHPGNIFVS-YDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHhCC--eeeCCCChHHeEEe-cCCCCCCeEEEEecceEEECCH
Confidence            345688  99999999999997 555    899999999977643

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=95.91  E-value=0.0048  Score=67.97  Aligned_cols=70  Identities=30%  Similarity=0.443  Sum_probs=57.9

Q ss_pred             CCceEEEEEecCCCC----CcceeeeecccCCCCHHHHHHHHHHccCCCCcCHHHHHHHHHHHHHHhCCCCCCC
Q 010626          237 DDTVSLTLRIGDKSG----HVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLVPSWNPS  306 (505)
Q Consensus       237 ~~~i~L~Lri~d~~g----~~r~I~F~F~~~~DTa~~VA~EmV~~~~l~~~d~~~iA~~i~~~i~~l~p~w~~~  306 (505)
                      +..+.|.+|..+..+    ..|.|.|.|+++.|+++.||+|||+++.+++.|-..+|..|..-+.++--.....
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~n~i~~~~~~~~D~~e~v~~em~~~~~~~edd~~~v~r~~~~~~~~ikgkr~~~  389 (632)
T KOG0584|consen  316 DPALSLSLRDEDGKKNKRPKANAIQFDYNLNTDESEEVAQEMVEEEIVSEDDSREVARLLKDTVFSIKGKRNDR  389 (632)
T ss_pred             cccccccccccchhhcCCcccccccceeecCCCchhHHHHHHHHhccCCcchHHHHHHHhccceeeechhhhcc
Confidence            344556677776642    2457999999999999999999999999999999999999999998887766543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=95.50  E-value=0.021  Score=56.36  Aligned_cols=44  Identities=27%  Similarity=0.383  Sum_probs=37.4

Q ss_pred             HHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceee
Q 010626            7 WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV   54 (505)
Q Consensus         7 ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~   54 (505)
                      ++..|..++.-||..|  +.|+|.+|.|++++  ++.+++.||+..+.
T Consensus       140 ~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv~--~~~i~iID~~~k~~  183 (229)
T PF06176_consen  140 LAEKIVEAIKQLHKHG--FYHGDPHPGNFLVS--NNGIRIIDTQGKRM  183 (229)
T ss_pred             HHHHHHHHHHHHHHcC--CccCCCCcCcEEEE--CCcEEEEECccccc
Confidence            4467888999999999  99999999999997  35699999986643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=94.88  E-value=0.035  Score=54.46  Aligned_cols=46  Identities=20%  Similarity=0.236  Sum_probs=40.1

Q ss_pred             HHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc--EEEeecCcee
Q 010626            5 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAI   53 (505)
Q Consensus         5 ~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~--vKL~DFGlA~   53 (505)
                      ..++.+|+..++-||..|  +.|+|+.+.||+++ ..|.  ++++||--++
T Consensus       131 ~~il~~va~~ia~LH~~G--v~Hgdly~khIll~-~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        131 QAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVK-TEGKAEAGFLDLEKSR  178 (216)
T ss_pred             HHHHHHHHHHHHHHHHCC--CcCCCCCHhheeec-CCCCeeEEEEEhhccc
Confidence            478899999999999999  99999999999997 3445  9999997654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=94.80  E-value=0.0072  Score=67.18  Aligned_cols=146  Identities=23%  Similarity=0.261  Sum_probs=99.6

Q ss_pred             HHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cccCCcc
Q 010626            5 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEYNEL   82 (505)
Q Consensus         5 ~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~ys~k   82 (505)
                      ..+.+.-+++|+|+|+.-  -+|||    ||+..  .+..|.++|+....+... ..++..+++.++|||+. .+.+...
T Consensus       339 ~~~~r~et~~l~~l~~~~--~~~~d----~~l~s--~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~  410 (829)
T KOG0576|consen  339 AYPLRKETRPLAELHSSY--KVHRD----NILGS--EEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGC  410 (829)
T ss_pred             hhhhhhhccccccccccc--ccCcc----ccccc--ccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccC
Confidence            345566677899999874  48888    77764  478999999998766544 45667899999999976 5678999


Q ss_pred             cchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC---CCC-CCCChHHH-HHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           83 VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLS-KVTDPQVK-QFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        83 sDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~---~~~-~~~s~~l~-~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      .|.|++|.-..+|.-|..|-...   ......  .+..|.   ... ....+... ++...|+. .|..|+....++.|.
T Consensus       411 p~~~~~~~~~~~~ap~~pPr~~P---~~~~~~--~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsK  485 (829)
T KOG0576|consen  411 PDSGSLAVSAIQMAPGLPPRSSP---PAVLPM--IGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSK  485 (829)
T ss_pred             CCccCCCcchhhcCCCCCCCCCC---ccccCC--CCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHH
Confidence            99999998878888787775431   100000  011110   000 00111122 46778886 589999999999999


Q ss_pred             CCCCCCC
Q 010626          157 FLVTDNP  163 (505)
Q Consensus       157 ff~~~~~  163 (505)
                      +|.....
T Consensus       486 vfngCpl  492 (829)
T KOG0576|consen  486 VFNGCPL  492 (829)
T ss_pred             HhccCcc
Confidence            9987654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=92.96  E-value=0.17  Score=51.49  Aligned_cols=49  Identities=24%  Similarity=0.333  Sum_probs=39.2

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeec
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM   55 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~   55 (505)
                      +..++..|+.-+.-+-..|  ++|+|+++-||+++ .+|.+.++||--+...
T Consensus       204 ~~~il~~il~~~~~~~~~G--iVHGDlSefNIlV~-~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         204 PDEILDKILEEVRKAYRRG--IVHGDLSEFNILVT-EDGDIVVIDWPQAVPI  252 (304)
T ss_pred             HHHHHHHHHHHHHHHHHcC--ccccCCchheEEEe-cCCCEEEEeCcccccC
Confidence            4556677777776666788  99999999999998 7889999999766443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=91.06  E-value=0.2  Score=47.38  Aligned_cols=30  Identities=23%  Similarity=0.368  Sum_probs=25.0

Q ss_pred             CeEecCCCCCcEEEeCC-CCcEEEeecCcee
Q 010626           24 PIIHRDLKCDNIFVNGN-NGEVKIGDLGLAI   53 (505)
Q Consensus        24 ~IiHrDLKp~NILld~~-~g~vKL~DFGlA~   53 (505)
                      .++|+|++|.||+++.. .+.+.|+||+.+.
T Consensus       175 ~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         175 GLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             EEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence            38999999999999843 4568999998774

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=90.61  E-value=0.5  Score=47.57  Aligned_cols=52  Identities=25%  Similarity=0.404  Sum_probs=43.3

Q ss_pred             HHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC
Q 010626            3 AIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP   58 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~   58 (505)
                      +...+..+++..+.-|-. .+  ++|+||+.-|||+.  .+.+.|+|||-|....++
T Consensus       167 e~~~~~~~~v~~~~~l~~~a~--LVHgDLSEyNiL~~--~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         167 EAEGLYEDVVEYMRRLYKEAG--LVHGDLSEYNILVH--DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             hHHHHHHHHHHHHHHHHHhcC--cccccchhhheEEE--CCeEEEEECccccccCCC
Confidence            356677888888888776 77  99999999999996  678999999988666544

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=89.84  E-value=0.23  Score=47.05  Aligned_cols=31  Identities=35%  Similarity=0.419  Sum_probs=20.9

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEeecCceee
Q 010626           24 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV   54 (505)
Q Consensus        24 ~IiHrDLKp~NILld~~~g~vKL~DFGlA~~   54 (505)
                      .++|+|+.|.||+++..++.+-|+||+.+..
T Consensus       167 ~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  167 VLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             EEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             EEEEeccccccceeeeccceeEEEecccceE
Confidence            4999999999999984556678999987643

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=89.17  E-value=0.074  Score=64.54  Aligned_cols=145  Identities=12%  Similarity=0.038  Sum_probs=92.0

Q ss_pred             HHHHHHHHhC---CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-ccCCcccch
Q 010626           12 LRGLHYLHSH---NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEYNELVDI   85 (505)
Q Consensus        12 l~gL~yLHs~---g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~ys~ksDI   85 (505)
                      +.+..-+|+.   |-..+|++||+-|.++. .+..+|++++|+.+.....  .....++++.|+.|++.. -.++.++|+
T Consensus      1345 vl~~~~~ls~tnlg~T~v~~~Lkf~lpmIV-tny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdi 1423 (2724)
T KOG1826|consen 1345 VLNRNVILSLTNLGNTNVSKSLKFTLPMIV-TNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDI 1423 (2724)
T ss_pred             HhccchhhhcccCCccchhhhhhhhcccee-cCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHH
Confidence            5555555543   22368999999999997 4568999999999843322  234456788889998874 458888999


Q ss_pred             hhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhc-CCCCCCCCHHHHhcCCCCC
Q 010626           86 YSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLV  159 (505)
Q Consensus        86 WSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL-~dP~~RpSa~ElL~hpff~  159 (505)
                      |..|+-+|....|..+|...  .....+.+........++...+.+.-.....+| -+-..||.-...+..+.|.
T Consensus      1424 lr~s~~ly~rs~~n~~fi~f--lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1424 LRRSLSLYLRSDGNAYFIFF--LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HHHHHHHHHHhcccHHHHHH--HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            99999999998887776421  111112222222223344443333333333333 4566788888888777764

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=89.00  E-value=0.52  Score=45.64  Aligned_cols=29  Identities=34%  Similarity=0.387  Sum_probs=24.8

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEeecCce
Q 010626           24 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA   52 (505)
Q Consensus        24 ~IiHrDLKp~NILld~~~g~vKL~DFGlA   52 (505)
                      .++|+|+.+.||++++.++.+.++||-.|
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a  199 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYA  199 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccC
Confidence            38999999999999843568999999876

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=88.90  E-value=0.79  Score=46.31  Aligned_cols=27  Identities=26%  Similarity=0.417  Sum_probs=23.4

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEeecCce
Q 010626           24 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA   52 (505)
Q Consensus        24 ~IiHrDLKp~NILld~~~g~vKL~DFGlA   52 (505)
                      .++|+|+.+.||+++.  +.+.|.||+.+
T Consensus       188 ~liHgD~~~~Nil~~~--~~i~lIDfd~~  214 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD--NEVYVIDFDYC  214 (313)
T ss_pred             ceEcCCCCcccEEEeC--CcEEEEECccc
Confidence            3999999999999983  56899999865

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=88.77  E-value=0.84  Score=43.69  Aligned_cols=52  Identities=29%  Similarity=0.230  Sum_probs=42.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCC-CeEecCCCCCcEEEeCCCCcEEEeecCceee
Q 010626            2 KAIKNWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV   54 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~-~IiHrDLKp~NILld~~~g~vKL~DFGlA~~   54 (505)
                      +...+++.+++..+.+|+..-. .+.-.|++++|+-++ ++|.+|+.|...+..
T Consensus        59 ~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~-~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   59 EQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVN-DDGRLKLIDLDDVFV  111 (188)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEe-CCCcEEEEechhcch
Confidence            3567899999999999987311 288899999999998 778999999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=88.65  E-value=0.98  Score=45.69  Aligned_cols=29  Identities=24%  Similarity=0.313  Sum_probs=24.8

Q ss_pred             CeEecCCCCCcEEEeCC---CCcEEEeecCce
Q 010626           24 PIIHRDLKCDNIFVNGN---NGEVKIGDLGLA   52 (505)
Q Consensus        24 ~IiHrDLKp~NILld~~---~g~vKL~DFGlA   52 (505)
                      .++|+|+.+.||+++..   .+.+.++||..+
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya  211 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYA  211 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCC
Confidence            48999999999999832   368999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=87.43  E-value=1.5  Score=46.75  Aligned_cols=81  Identities=22%  Similarity=0.367  Sum_probs=53.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccccCCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNE   81 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~ys~   81 (505)
                      +++..++++.+..+.-+... .++-||++.-+||+++  .|.|.|+||-+++......   .+---.+--|-++.+.-+.
T Consensus       321 ~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId--~GnvtLIDfklsRl~~~q~---~isy~rldhp~lF~G~dd~  394 (488)
T COG5072         321 EEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID--EGNVTLIDFKLSRLSYSQG---IISYNRLDHPDLFNGVDDY  394 (488)
T ss_pred             HHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee--cCceEEEEeeeeecccCCc---eeeccccCchhhhcCccce
Confidence            46677888877766666554 5799999999999997  6899999999997332211   1111122334455554455


Q ss_pred             ccchhhH
Q 010626           82 LVDIYSF   88 (505)
Q Consensus        82 ksDIWSL   88 (505)
                      .-+||-+
T Consensus       395 QFeIYrl  401 (488)
T COG5072         395 QFEIYRL  401 (488)
T ss_pred             eeeHHHH
Confidence            6666654

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=86.59  E-value=1.1  Score=45.70  Aligned_cols=28  Identities=29%  Similarity=0.395  Sum_probs=23.9

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEeecCce
Q 010626           24 PIIHRDLKCDNIFVNGNNGEVKIGDLGLA   52 (505)
Q Consensus        24 ~IiHrDLKp~NILld~~~g~vKL~DFGlA   52 (505)
                      .++|+|+++.||+++ .++.+.|.||+.+
T Consensus       188 ~l~HgD~~~~Nvl~~-~~~~~~vIDfd~~  215 (307)
T TIGR00938       188 GVIHADLFPDNVLFD-GDSVKGVIDFYFA  215 (307)
T ss_pred             ccCCCCCCcCcEEEE-CCceEEEeecccc
Confidence            499999999999998 4555689999876

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=85.96  E-value=0.7  Score=46.07  Aligned_cols=40  Identities=30%  Similarity=0.376  Sum_probs=33.3

Q ss_pred             HHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCce
Q 010626           12 LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA   52 (505)
Q Consensus        12 l~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA   52 (505)
                      +.+|.-.|+.....+|+|-.|+||+-| ..|.+||.|-+..
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D-~~G~lKlVDP~~L  190 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCD-KFGYLKLVDPVCL  190 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeec-CCCCEEecChhhh
Confidence            456778896655699999999999998 7899999997643

The function of this family is unknown.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=85.71  E-value=0.77  Score=44.84  Aligned_cols=28  Identities=25%  Similarity=0.291  Sum_probs=23.2

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEeecCcee
Q 010626           25 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI   53 (505)
Q Consensus        25 IiHrDLKp~NILld~~~g~vKL~DFGlA~   53 (505)
                      ++|+|+.+.||+++ ..+..-|.||+.+.
T Consensus       166 l~HGD~~~~Nvlv~-~~~i~giIDw~~a~  193 (235)
T cd05155         166 WFHGDLAPGNLLVQ-DGRLSAVIDFGCLG  193 (235)
T ss_pred             EEeCCCCCCcEEEE-CCCEEEEEeCcccC
Confidence            89999999999997 44445699999763

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=84.52  E-value=1.4  Score=43.33  Aligned_cols=29  Identities=24%  Similarity=0.310  Sum_probs=24.4

Q ss_pred             CCeEecCCCCCcEEEeCCCCcEEEeecCcee
Q 010626           23 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI   53 (505)
Q Consensus        23 ~~IiHrDLKp~NILld~~~g~vKL~DFGlA~   53 (505)
                      +.++|+|+.|.||+++ ..+ +.++||+.+.
T Consensus       153 ~~~~HgD~~~~Nii~~-~~~-~~iIDwe~a~  181 (226)
T TIGR02172       153 STCLHGDFQIGNLITS-GKG-TYWIDLGDFG  181 (226)
T ss_pred             CceEecCCCCCcEEEc-CCC-cEEEechhcC
Confidence            3589999999999997 455 9999998774

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=84.41  E-value=0.82  Score=44.67  Aligned_cols=30  Identities=27%  Similarity=0.142  Sum_probs=24.8

Q ss_pred             CCeEecCCCCCcEEEeCCCCcEEEeecCcee
Q 010626           23 PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI   53 (505)
Q Consensus        23 ~~IiHrDLKp~NILld~~~g~vKL~DFGlA~   53 (505)
                      +.++|+|+.|.||+++ +++.+.|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~-~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVD-PGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEe-CCcEEEEEEccccc
Confidence            3489999999999998 45567899998763

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02236 choline kinase

Probab=84.17  E-value=1.2  Score=46.69  Aligned_cols=30  Identities=27%  Similarity=0.400  Sum_probs=25.5

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEeecCcee
Q 010626           24 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI   53 (505)
Q Consensus        24 ~IiHrDLKp~NILld~~~g~vKL~DFGlA~   53 (505)
                      .++|+|+++.||+++..++.+.++||..+.
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            389999999999998545789999998763

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=84.00  E-value=1.5  Score=44.03  Aligned_cols=28  Identities=29%  Similarity=0.395  Sum_probs=23.7

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEeecCcee
Q 010626           25 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI   53 (505)
Q Consensus        25 IiHrDLKp~NILld~~~g~vKL~DFGlA~   53 (505)
                      ++|+|+.|.||+++ .++.+.|.||+.+.
T Consensus       177 l~HgD~~~~Nil~~-~~~~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFD-GDELSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEe-CCceEEEeehhhhc
Confidence            99999999999998 45556899998763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=83.51  E-value=1.9  Score=47.74  Aligned_cols=38  Identities=24%  Similarity=0.396  Sum_probs=31.6

Q ss_pred             HHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC
Q 010626           17 YLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ   57 (505)
Q Consensus        17 yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~   57 (505)
                      .+-..|  ++|.|.+|.||+++ .+|.+.+.|||+...+..
T Consensus       280 q~~~dg--ffHaDpHpGNi~v~-~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         280 QLLRDG--FFHADPHPGNILVR-SDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHhcC--ccccCCCccceEEe-cCCcEEEEcCcceecCCH
Confidence            334467  99999999999998 678999999999866644

>PRK05231 homoserine kinase; Provisional

Probab=82.37  E-value=1  Score=46.00  Aligned_cols=28  Identities=29%  Similarity=0.353  Sum_probs=23.2

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEeecCcee
Q 010626           25 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI   53 (505)
Q Consensus        25 IiHrDLKp~NILld~~~g~vKL~DFGlA~   53 (505)
                      ++|+|+.|.||+++ .+...-|+||+.+.
T Consensus       189 liHgD~~~~Nil~~-~~~~~~iIDf~~~~  216 (319)
T PRK05231        189 VIHADLFRDNVLFE-GDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCCCCCCCcEEEE-CCceEEEEeccccc
Confidence            99999999999997 43345799998773

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=81.12  E-value=2.3  Score=43.12  Aligned_cols=49  Identities=18%  Similarity=0.270  Sum_probs=35.4

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCcee
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI   53 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~   53 (505)
                      +++.+..+-.++.-.|..-..++|+|+.|+|++.+ ..+.++|+||-.|.
T Consensus       134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t-~~~~l~LIDWEyAg  182 (269)
T COG0510         134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLT-DKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEc-CCCcEEEEecccCC
Confidence            44455555566665555411389999999999997 55899999997663

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=80.43  E-value=0.92  Score=50.08  Aligned_cols=81  Identities=17%  Similarity=0.213  Sum_probs=54.8

Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC---------CCCCCChHHHHHHHHhc-CCCCCCCCH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---------LSKVTDPQVKQFIEKCI-VPASLRLPA  149 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~---------~~~~~s~~l~~LI~kcL-~dP~~RpSa  149 (505)
                      .+|+|||++|.++.++.-|..-+....+..+......-...+..         +...++..+.++..+|+ ..|..||..
T Consensus       109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~  188 (725)
T KOG1093|consen  109 GPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP  188 (725)
T ss_pred             CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence            36999999999999999988776543333332222211111111         12234667788899999 579999999


Q ss_pred             HHHhcCCCCCC
Q 010626          150 LELLKDPFLVT  160 (505)
Q Consensus       150 ~ElL~hpff~~  160 (505)
                      .++++++-|..
T Consensus       189 ~~~~k~~i~~e  199 (725)
T KOG1093|consen  189 MELSKRCSFTE  199 (725)
T ss_pred             hHHhcCccHHH
Confidence            99999998865

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	505
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-53
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-21
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-16
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		8e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-14
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-14
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-13
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-13
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-13
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-13
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-13
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-13
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-13
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-13
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-13
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-13
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-13
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-12
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-12
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-12
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-12
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-12
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-12
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-12
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-12
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-12
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-12
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-12
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-12
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-12
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-12
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-12
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-12
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-12
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-12
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-12
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-12
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-12
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-12
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-12
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-12
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-12
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-12
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-12
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-12
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-12
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-12
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-12
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-12
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-12
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-12
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-12
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-12
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-12
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-12
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-12
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-12
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-11
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-11
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-11
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-10
3soa_A	444	Full-Length Human Camkii Length = 444		2e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-10
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-10
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-10
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		5e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-10
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		6e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		7e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		8e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		8e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-10
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-09
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-09
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-09
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-09
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-09
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-09
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-09
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-09
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-08
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		5e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		8e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-07
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-07
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-07
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-07
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-07
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-07
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-07
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-07
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-07
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-07
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-07
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-07
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-07
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		4e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		4e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		4e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		4e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		4e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-07
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		4e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		4e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-07
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		9e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-06
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-06
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-06
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-06
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-06
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-06
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		6e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		8e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		9e-06
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-06
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-06
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		9e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		9e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-05
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-05
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-05
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-05
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-05
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-05
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-05
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-05
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-05
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-05
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-05
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-05
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-05
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-05
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-05
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-05
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-05
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-05
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-05
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-05
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-05
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-05
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-05
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-05
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-05
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		5e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-05
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		7e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		7e-05
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		7e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-04
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-04
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-04
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-04
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-04
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-04
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-04
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-04
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-04
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-04
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-04
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-04
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-04
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		3e-04
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		3e-04
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-04
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		3e-04
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-04
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		3e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		3e-04
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		3e-04
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-04
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		3e-04
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-04
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-04
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-04
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		3e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-04
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		3e-04
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-04
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-04
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-04
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-04
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-04
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-04
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-04
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-04
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-04
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-04
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-04
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-04
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-04
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-04
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-04
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-04
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-04
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-04
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		6e-04
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-04
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-04
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		6e-04
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-04
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-04
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-04
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-04
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		8e-04
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		8e-04
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		8e-04
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		8e-04
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		8e-04
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		9e-04
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		9e-04
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		9e-04

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score =  206 bits (525), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 88/140 (62%), Positives = 111/140 (79%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           +K +++W RQIL+GL +LH+  PPIIHRDLKCDNIF+ G  G VKIGDLGLA + +   A
Sbjct: 128 IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 187
Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           ++VIGTPEF APE YEE+Y+E VD+Y+FG C LE  T EYPY+EC+N AQIY++VTSG+K
Sbjct: 188 KAVIGTPEFXAPEXYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVK 247
Query: 121 PASLSKVTDPQVKQFIEKCI 140
           PAS  KV  P+VK+ IE CI
Sbjct: 248 PASFDKVAIPEVKEIIEGCI 267

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 55/151 (36%), Positives = 85/151 (56%), Gaps = 5/151 (3%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIG 65
           A  + +G++YLH+ NPPI+HR+LK  N+ V+     VK+ D GL+ +      +++S  G
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAG 201
Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 124
           TPE+MAPE L +E  NE  D+YSFG+ + E+ T + P+    NPAQ+   V    K   +
Sbjct: 202 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKCKRLEI 260
Query: 125 SKVTDPQVKQFIEKCIVPASLRLPALELLKD 155
            +  +PQV   IE C      + P+   + D
Sbjct: 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 55/151 (36%), Positives = 83/151 (54%), Gaps = 5/151 (3%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIG 65
           A  + +G++YLH+ NPPI+HRDLK  N+ V+     VK+ D GL+ +       ++   G
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKASXFLXSKXAAG 201
Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 124
           TPE+MAPE L +E  NE  D+YSFG+ + E+ T + P+    NPAQ+   V    K   +
Sbjct: 202 TPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-NPAQVVAAVGFKCKRLEI 260
Query: 125 SKVTDPQVKQFIEKCIVPASLRLPALELLKD 155
            +  +PQV   IE C      + P+   + D
Sbjct: 261 PRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 58/170 (34%), Positives = 89/170 (52%), Gaps = 10/170 (5%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPT 59
           + I  + +QIL GL YLH +   I+HRD+K DN+ +N  +G +KI D G +  +    P 
Sbjct: 122 QTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179
Query: 60  ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYKKV 115
             +  GT ++MAPE+ ++    Y +  DI+S G  I+EM T + P+ E   P A ++K  
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG 239
Query: 116 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
              + P  + +    + K FI KC  P    R  A +LL D FL   + K
Sbjct: 240 MFKVHP-EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/161 (37%), Positives = 91/161 (56%), Gaps = 15/161 (9%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 68
           +L+ L  LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  + ++GTP 
Sbjct: 256 VLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 312
Query: 69  FMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP--ASL 124
           +MAPEL     Y   VDI+S G+ ++EMV  E PY NE   P +  K +   + P   +L
Sbjct: 313 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPRLKNL 370
Query: 125 SKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNP 163
            KV+ P +K F+++ +V  PA  R  A ELLK PFL    P
Sbjct: 371 HKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGP 409

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/151 (36%), Positives = 87/151 (57%), Gaps = 14/151 (9%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           MK + + ARQ  RG+ YLH+ +  IIHRDLK +NIF++ +N  VKIGD GLA V  + + 
Sbjct: 107 MKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDN-TVKIGDFGLATVKSRWSG 163
Query: 61  ----RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
                 + G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI 
Sbjct: 164 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 223
Query: 113 KKVTSGIKPASLSKVTD---PQVKQFIEKCI 140
           + V  G     LSKV      ++K+ + +C+
Sbjct: 224 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECL 254

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/161 (37%), Positives = 91/161 (56%), Gaps = 15/161 (9%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 68
           +L+ L  LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  + ++GTP 
Sbjct: 136 VLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 192
Query: 69  FMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP--ASL 124
           +MAPEL     Y   VDI+S G+ ++EMV  E PY NE   P +  K +   + P   +L
Sbjct: 193 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPRLKNL 250
Query: 125 SKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNP 163
            KV+ P +K F+++ +V  PA  R  A ELLK PFL    P
Sbjct: 251 HKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGP 289

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/170 (36%), Positives = 94/170 (55%), Gaps = 15/170 (8%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 68
           +L+ L  LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  + ++GTP 
Sbjct: 179 VLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 235
Query: 69  FMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP--ASL 124
           +MAPEL     Y   VDI+S G+ ++EMV  E PY NE   P +  K +   + P   +L
Sbjct: 236 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPRLKNL 293
Query: 125 SKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLR 172
            KV+ P +K F+++ +V  PA  R  A ELLK PFL    P   +   +R
Sbjct: 294 HKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGPPASIVPLMR 341

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/161 (37%), Positives = 91/161 (56%), Gaps = 15/161 (9%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 68
           +L+ L  LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  + ++GTP 
Sbjct: 125 VLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 181
Query: 69  FMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP--ASL 124
           +MAPEL     Y   VDI+S G+ ++EMV  E PY NE   P +  K +   + P   +L
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPRLKNL 239
Query: 125 SKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNP 163
            KV+ P +K F+++ +V  PA  R  A ELLK PFL    P
Sbjct: 240 HKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGP 278

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/161 (37%), Positives = 91/161 (56%), Gaps = 15/161 (9%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 68
           +L+ L  LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  + ++GTP 
Sbjct: 129 VLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 185
Query: 69  FMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP--ASL 124
           +MAPEL     Y   VDI+S G+ ++EMV  E PY NE   P +  K +   + P   +L
Sbjct: 186 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPRLKNL 243
Query: 125 SKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNP 163
            KV+ P +K F+++ +V  PA  R  A ELLK PFL    P
Sbjct: 244 HKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGP 282

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/161 (37%), Positives = 91/161 (56%), Gaps = 15/161 (9%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 68
           +L+ L  LH+    +IHRD+K D+I +  ++G VK+ D G    +  + P  + ++GTP 
Sbjct: 134 VLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 190
Query: 69  FMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP--ASL 124
           +MAPEL     Y   VDI+S G+ ++EMV  E PY NE   P +  K +   + P   +L
Sbjct: 191 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE--PPLKAMKMIRDNLPPRLKNL 248
Query: 125 SKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNP 163
            KV+ P +K F+++ +V  PA  R  A ELLK PFL    P
Sbjct: 249 HKVS-PSLKGFLDRLLVRDPAQ-RATAAELLKHPFLAKAGP 287

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/164 (34%), Positives = 87/164 (53%), Gaps = 10/164 (6%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPT 59
           + I  + +QIL GL YLH +   I+HRD+K DN+ +N  +G +KI D G +  +    P 
Sbjct: 108 QTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 165
Query: 60  ARSVIGTPEFMAPELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNP-AQIYKKV 115
             +  GT ++MAPE+ ++    Y +  DI+S G  I+EM T + P+ E   P A ++K  
Sbjct: 166 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG 225
Query: 116 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
              + P  + +    + K FI KC  P    R  A +LL D FL
Sbjct: 226 MFKVHP-EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 268

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 86/151 (56%), Gaps = 14/151 (9%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           MK + + ARQ  RG+ YLH+ +  IIHRDLK +NIF++ +N  VKIGD GLA    + + 
Sbjct: 119 MKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSG 175
Query: 61  ----RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
                 + G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI 
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235
Query: 113 KKVTSGIKPASLSKVTD---PQVKQFIEKCI 140
           + V  G     LSKV      ++K+ + +C+
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECL 266

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 86/151 (56%), Gaps = 14/151 (9%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           MK + + ARQ  RG+ YLH+ +  IIHRDLK +NIF++ +N  VKIGD GLA    + + 
Sbjct: 119 MKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSG 175
Query: 61  ----RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
                 + G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI 
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235
Query: 113 KKVTSGIKPASLSKVTD---PQVKQFIEKCI 140
           + V  G     LSKV      ++K+ + +C+
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECL 266

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 90/160 (56%), Gaps = 9/160 (5%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+IL+GL YLHS     IHRD+K  N+ ++  +GEVK+ D G+A  +   Q    + +GT
Sbjct: 111 REILKGLDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGT 167
Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           P +MAPE+ ++  Y+   DI+S G+  +E+   E P++E  +P ++   +     P    
Sbjct: 168 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNPPTLEG 226
Query: 126 KVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 164
             + P +K+F+E C+    S R  A ELLK  F++ +  K
Sbjct: 227 NYSKP-LKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 265

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 90/160 (56%), Gaps = 9/160 (5%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+IL+GL YLHS     IHRD+K  N+ ++  +GEVK+ D G+A  +   Q    + +GT
Sbjct: 131 REILKGLDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGT 187
Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           P +MAPE+ ++  Y+   DI+S G+  +E+   E P++E  +P ++   +     P    
Sbjct: 188 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNPPTLEG 246
Query: 126 KVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 164
             + P +K+F+E C+    S R  A ELLK  F++ +  K
Sbjct: 247 NYSKP-LKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 285

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 89/160 (55%), Gaps = 9/160 (5%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+IL+GL YLHS     IHRD+K  N+ ++  +GEVK+ D G+A  +   Q      +GT
Sbjct: 126 REILKGLDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGT 182
Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           P +MAPE+ ++  Y+   DI+S G+  +E+   E P++E  +P ++   +     P    
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNPPTLEG 241
Query: 126 KVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 164
             + P +K+F+E C+    S R  A ELLK  F++ +  K
Sbjct: 242 NYSKP-LKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 280

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 89/160 (55%), Gaps = 9/160 (5%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+IL+GL YLHS     IHRD+K  N+ ++  +GEVK+ D G+A  +   Q      +GT
Sbjct: 111 REILKGLDYLHSEKK--IHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNXFVGT 167
Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           P +MAPE+ ++  Y+   DI+S G+  +E+   E P++E  +P ++   +     P    
Sbjct: 168 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNPPTLEG 226
Query: 126 KVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 164
             + P +K+F+E C+    S R  A ELLK  F++ +  K
Sbjct: 227 NYSKP-LKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 265

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 91/169 (53%), Gaps = 13/169 (7%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 68
           +LR L YLH  N  +IHRD+K D+I +  ++G +K+ D G    +  + P  + ++GTP 
Sbjct: 150 VLRALSYLH--NQGVIHRDIKSDSILLT-SDGRIKLSDFGFCAQVSKEVPKRKXLVGTPY 206
Query: 69  FMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGIKP--ASL 124
           +MAPE+     Y   VDI+S G+ ++EM+  E PY NE   P Q  +++   + P    L
Sbjct: 207 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE--PPLQAMRRIRDSLPPRVKDL 264
Query: 125 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPLR 172
            KV+   ++ F++  +V   S R  A ELL  PFL    P   +   +R
Sbjct: 265 HKVSS-VLRGFLDLMLVREPSQRATAQELLGHPFLKLAGPPSCIVPLMR 312

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/165 (36%), Positives = 90/165 (54%), Gaps = 19/165 (11%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+ L+ L +LHS+   +IHRD+K DNI + G +G VK+ D G    I  +Q    +++GT
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 179
Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI---- 119
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY NE  NP + +Y   T+G     
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQ 237
Query: 120 KPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 163
            P  LS +     + F+ +C+ +    R  A ELL+  FL    P
Sbjct: 238 NPEKLSAI----FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/166 (33%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           R+ILRGL +LH H   +IHRD+K  N+ +   N EVK+ D G++  + +   R  + IGT
Sbjct: 136 REILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192
Query: 67  PEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           P +MAPE+       +  Y+   D++S G+  +EM     P  +  +P +    +     
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPA 251
Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFLVTDNPKD 165
           P   SK    + + FIE C+V    + PA E L+K PF + D P +
Sbjct: 252 PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPF-IRDQPNE 296

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/164 (35%), Positives = 89/164 (54%), Gaps = 12/164 (7%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPE 68
           +L+ L YLH+    +IHRD+K D+I +   +G VK+ D G    + +  P  + ++GTP 
Sbjct: 150 VLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKXLVGTPY 206
Query: 69  FMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSK 126
           +MAPE+     Y   VDI+S G+ ++EMV  E PY    +P Q  K++     P    S 
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSH 265
Query: 127 VTDPQVKQFIEKCIV--PASLRLPALELLKDPFLV-TDNPKDLV 167
              P ++ F+E+ +V  P   R  A ELL  PFL+ T  P+ LV
Sbjct: 266 KVSPVLRDFLERMLVRDPQE-RATAQELLDHPFLLQTGLPECLV 308

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/165 (36%), Positives = 89/165 (53%), Gaps = 19/165 (11%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+ L+ L +LHS+   +IHRD+K DNI + G +G VK+ D G    I  +Q     ++GT
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSEMVGT 179
Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI---- 119
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY NE  NP + +Y   T+G     
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQ 237
Query: 120 KPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 163
            P  LS +     + F+ +C+ +    R  A ELL+  FL    P
Sbjct: 238 NPEKLSAI----FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 88/165 (53%), Gaps = 9/165 (5%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           I    ++IL+GL YLHS     IHRD+K  N+ ++   G+VK+ D G+A  +   Q    
Sbjct: 122 IATMLKEILKGLDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRN 178
Query: 62  SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           + +GTP +MAPE+ ++  Y+   DI+S G+  +E+   E P N   +P ++   +     
Sbjct: 179 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE-PPNSDMHPMRVLFLIPKNNP 237
Query: 121 PASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 164
           P  +   T    K+FI+ C+    S R  A ELLK  F+V ++ K
Sbjct: 238 PTLVGDFTK-SFKEFIDACLNKDPSFRPTAKELLKHKFIVKNSKK 281

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 94/182 (51%), Gaps = 12/182 (6%)
Query: 12  LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMA 71
           L+GL YLHSHN  +IHRD+K  NI ++   G VK+GD G A +M    A   +GTP +MA
Sbjct: 164 LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMA--PANXFVGTPYWMA 218
Query: 72  PELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 127
           PE+     E +Y+  VD++S G+  +E+   + P       + +Y  +     PA  S  
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGH 277
Query: 128 TDPQVKQFIEKCIVPASLRLPALE-LLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLAH 185
                + F++ C+       P  E LLK  F++ + P  ++ D + R  + V E+ NL +
Sbjct: 278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQY 337
Query: 186 SE 187
            +
Sbjct: 338 RK 339

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/165 (36%), Positives = 89/165 (53%), Gaps = 19/165 (11%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+ L+ L +LHS+   +IHRD+K DNI + G +G VK+ D G    I  +Q     ++GT
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSXMVGT 179
Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI---- 119
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY NE  NP + +Y   T+G     
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQ 237
Query: 120 KPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 163
            P  LS +     + F+ +C+ +    R  A ELL+  FL    P
Sbjct: 238 NPEKLSAI----FRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 90/167 (53%), Gaps = 16/167 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           +Q L  L+YLH +   IIHRDLK  NI    + G++K+ D G++    +   R  S IGT
Sbjct: 142 KQTLDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGT 198
Query: 67  PEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           P +MAPE+       +  Y+   D++S G+ ++EM   E P++E  NP ++  K+    +
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKS-E 256
Query: 121 PASLSKVT--DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
           P +L++ +      K F++KC+      R    +LL+ PF+  D+ K
Sbjct: 257 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNK 303

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 94/182 (51%), Gaps = 12/182 (6%)
Query: 12  LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMA 71
           L+GL YLHSHN  +IHRD+K  NI ++   G VK+GD G A +M    A   +GTP +MA
Sbjct: 125 LQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIM--APANXFVGTPYWMA 179
Query: 72  PELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV 127
           PE+     E +Y+  VD++S G+  +E+   + P       + +Y  +     PA  S  
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGH 238
Query: 128 TDPQVKQFIEKCIVPASLRLPALE-LLKDPFLVTDNPKDLVCDPL-RLPNLVPEVMNLAH 185
                + F++ C+       P  E LLK  F++ + P  ++ D + R  + V E+ NL +
Sbjct: 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQY 298
Query: 186 SE 187
            +
Sbjct: 299 RK 300

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 90/167 (53%), Gaps = 16/167 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           +Q L  L+YLH +   IIHRDLK  NI    + G++K+ D G++    +   R  S IGT
Sbjct: 142 KQTLDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRXIQRRDSFIGT 198
Query: 67  PEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           P +MAPE+       +  Y+   D++S G+ ++EM   E P++E  NP ++  K+    +
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKS-E 256
Query: 121 PASLSKVT--DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
           P +L++ +      K F++KC+      R    +LL+ PF+  D+ K
Sbjct: 257 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNK 303

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/165 (35%), Positives = 89/165 (53%), Gaps = 19/165 (11%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+ L+ L +LHS+   +IHRD+K DNI + G +G VK+ D G    I  +Q     ++GT
Sbjct: 124 RECLQALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSXMVGT 180
Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI---- 119
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY NE  NP + +Y   T+G     
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQ 238
Query: 120 KPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 163
            P  LS +     + F+ +C+ +    R  A EL++  FL    P
Sbjct: 239 NPEKLSAI----FRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKP 279

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 79/149 (53%), Gaps = 24/149 (16%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV---------MQQP 58
           ARQ  +G+ YLH+ N  IIHRD+K +NIF++     VKIGD GLA V         ++QP
Sbjct: 138 ARQTAQGMDYLHAKN--IIHRDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSGSQQVEQP 194
Query: 59  TARSVIGTPEFMAPELYEEEYNELV----DIYSFGMCILEMVTCEYPYNECKNPAQIYKK 114
           T     G+  +MAPE+   + N       D+YS+G+ + E++T E PY+   N  QI   
Sbjct: 195 T-----GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM 249
Query: 115 VTSGIKPASLSKVTD---PQVKQFIEKCI 140
           V  G     LSK+       +K+ +  C+
Sbjct: 250 VGRGYASPDLSKLYKNCPKAMKRLVADCV 278

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 80/144 (55%), Gaps = 14/144 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSV 63
           ARQ  +G+ YLH+ +  IIHRDLK +NIF++  +  VKIGD GLA V  + +       +
Sbjct: 137 ARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQL 193
Query: 64  IGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G 
Sbjct: 194 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 253
Query: 120 KPASLSKVTD---PQVKQFIEKCI 140
               LSKV       +K+ + +C+
Sbjct: 254 LSPDLSKVRSNCPKAMKRLMAECL 277

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 80/144 (55%), Gaps = 14/144 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSV 63
           ARQ  +G+ YLH+ +  IIHRDLK +NIF++  +  VKIGD GLA V  + +       +
Sbjct: 138 ARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQL 194
Query: 64  IGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G 
Sbjct: 195 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 254
Query: 120 KPASLSKVTD---PQVKQFIEKCI 140
               LSKV       +K+ + +C+
Sbjct: 255 LSPDLSKVRSNCPKAMKRLMAECL 278

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 80/144 (55%), Gaps = 14/144 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSV 63
           ARQ  +G+ YLH+ +  IIHRDLK +NIF++  +  VKIGD GLA V  + +       +
Sbjct: 115 ARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 64  IGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G 
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 231
Query: 120 KPASLSKVTD---PQVKQFIEKCI 140
               LSKV       +K+ + +C+
Sbjct: 232 LSPDLSKVRSNCPKAMKRLMAECL 255

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 89/167 (53%), Gaps = 16/167 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGT 66
           +Q L  L+YLH +   IIHRDLK  NI    + G++K+ D G++    +   R    IGT
Sbjct: 142 KQTLDALNYLHDNK--IIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRXIQRRDXFIGT 198
Query: 67  PEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           P +MAPE+       +  Y+   D++S G+ ++EM   E P++E  NP ++  K+    +
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKS-E 256
Query: 121 PASLSKVT--DPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
           P +L++ +      K F++KC+      R    +LL+ PF+  D+ K
Sbjct: 257 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNK 303

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/165 (35%), Positives = 90/165 (54%), Gaps = 19/165 (11%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+ L+ L +LHS+   +IHR++K DNI + G +G VK+ D G    I  +Q    +++GT
Sbjct: 124 RECLQALEFLHSNQ--VIHRNIKSDNILL-GMDGSVKLTDFGFCAQITPEQSKRSTMVGT 180
Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY-NECKNPAQ-IYKKVTSGI---- 119
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY NE  NP + +Y   T+G     
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE--NPLRALYLIATNGTPELQ 238
Query: 120 KPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNP 163
            P  LS +     + F+ +C+ +    R  A EL++  FL    P
Sbjct: 239 NPEKLSAI----FRDFLNRCLEMDVEKRGSAKELIQHQFLKIAKP 279

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 80/144 (55%), Gaps = 14/144 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSV 63
           ARQ  +G+ YLH+ +  IIHRDLK +NIF++  +  VKIGD GLA V  + +       +
Sbjct: 115 ARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 64  IGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G 
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 231
Query: 120 KPASLSKVTD---PQVKQFIEKCI 140
               LSKV       +K+ + +C+
Sbjct: 232 LSPDLSKVRSNCPKAMKRLMAECL 255

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 80/144 (55%), Gaps = 14/144 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSV 63
           ARQ  +G+ YLH+ +  IIHRDLK +NIF++  +  VKIGD GLA V  + +       +
Sbjct: 112 ARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQL 168
Query: 64  IGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G 
Sbjct: 169 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 228
Query: 120 KPASLSKVTD---PQVKQFIEKCI 140
               LSKV       +K+ + +C+
Sbjct: 229 LSPDLSKVRSNCPKAMKRLMAECL 252

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 80/144 (55%), Gaps = 14/144 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSV 63
           ARQ  +G+ YLH+ +  IIHRDLK +NIF++  +  VKIGD GLA V  + +       +
Sbjct: 110 ARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 64  IGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G 
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 226
Query: 120 KPASLSKVTD---PQVKQFIEKCI 140
               LSKV       +K+ + +C+
Sbjct: 227 LSPDLSKVRSNCPKAMKRLMAECL 250

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 80/144 (55%), Gaps = 14/144 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSV 63
           ARQ  +G+ YLH+ +  IIHRDLK +NIF++  +  VKIGD GLA V  + +       +
Sbjct: 110 ARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 64  IGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G 
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 226
Query: 120 KPASLSKVTD---PQVKQFIEKCI 140
               LSKV       +K+ + +C+
Sbjct: 227 LSPDLSKVRSNCPKAMKRLMAECL 250

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 41/100 (41%), Positives = 63/100 (63%), Gaps = 6/100 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVI 64
           +  QI+ GL +LH  N  II+RDLK +N+ ++ ++G V+I DLGLA+ ++  Q   +   
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 65  GTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYN 103
           GTP FMAPEL   EEY+  VD ++ G+ + EM+    P+ 
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 41/100 (41%), Positives = 63/100 (63%), Gaps = 6/100 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVI 64
           +  QI+ GL +LH  N  II+RDLK +N+ ++ ++G V+I DLGLA+ ++  Q   +   
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 65  GTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYN 103
           GTP FMAPEL   EEY+  VD ++ G+ + EM+    P+ 
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 45/116 (38%), Positives = 68/116 (58%), Gaps = 6/116 (5%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQPTA-RS 62
           N  +QIL G+ YLH HN  I+HRD+K +NI +   N    +KI D GL+    +    R 
Sbjct: 150 NIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 63  VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
            +GT  ++APE+ +++YNE  D++S G+ I+ ++ C YP    +N   I KKV  G
Sbjct: 208 RLGTAYYIAPEVLKKKYNEKCDVWSCGV-IMYILLCGYPPFGGQNDQDIIKKVEKG 262

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 41/100 (41%), Positives = 63/100 (63%), Gaps = 6/100 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVI 64
           +  QI+ GL +LH  N  II+RDLK +N+ ++ ++G V+I DLGLA+ ++  Q   +   
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 65  GTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYN 103
           GTP FMAPEL   EEY+  VD ++ G+ + EM+    P+ 
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 7/151 (4%)
Query: 12  LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEF 69
           L+GL YLH      IHRD+K  NI +N   G  K+ D G+A  +    A+   VIGTP +
Sbjct: 135 LKGLEYLHFMRK--IHRDIKAGNILLN-TEGHAKLADFGVAGQLTDXMAKRNXVIGTPFW 191
Query: 70  MAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 128
           MAPE+ +E  YN + DI+S G+  +EM   + PY +      I+   T+        ++ 
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW 251
Query: 129 DPQVKQFIEKCIVPA-SLRLPALELLKDPFL 158
                 F+++C+V +   R  A +LL+ PF+
Sbjct: 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 9/156 (5%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPTA-RSVIG 65
           +Q+  G+ Y+H HN  I+HRDLK +NI +     + ++KI D GL+   QQ T  +  IG
Sbjct: 128 KQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           T  ++APE+    Y+E  D++S G+ +  +++   P+   KN   I K+V +G     L 
Sbjct: 186 TAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRVETGKYAFDLP 244
Query: 126 --KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 158
             +      K  I K +    SLR+ A + L+ P++
Sbjct: 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 79/144 (54%), Gaps = 14/144 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSV 63
           ARQ  +G+ YLH+ +  IIHRDLK +NIF++  +  VKIGD GLA    + +       +
Sbjct: 138 ARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATEKSRWSGSHQFEQL 194
Query: 64  IGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G 
Sbjct: 195 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 254
Query: 120 KPASLSKVTD---PQVKQFIEKCI 140
               LSKV       +K+ + +C+
Sbjct: 255 LSPDLSKVRSNCPKAMKRLMAECL 278

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 41/100 (41%), Positives = 63/100 (63%), Gaps = 6/100 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVI 64
           +  QI+ GL +LH  N  II+RDLK +N+ ++ ++G V+I DLGLA+ ++  Q   +   
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYA 350
Query: 65  GTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYN 103
           GTP FMAPEL   EEY+  VD ++ G+ + EM+    P+ 
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 6   NWARQILRGLHYLHSHN-PPIIHRDLKCDNIFV-----NGN--NGEVKIGDLGLAIVMQQ 57
           NWA QI RG++YLH     PIIHRDLK  NI +     NG+  N  +KI D GLA    +
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 58  PTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
            T  S  G   +MAPE+     +++  D++S+G+ + E++T E P+      A  Y    
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228
Query: 117 SGIKPASLSKVTDPQVKQFIEKCIVP 142
           + +     S   +P  K  +E C  P
Sbjct: 229 NKLALPIPSTCPEPFAK-LMEDCWNP 253

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 79/144 (54%), Gaps = 14/144 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSV 63
           ARQ  +G+ YLH+ +  IIHRDLK +NIF++  +  VKIGD GLA    + +       +
Sbjct: 130 ARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATEKSRWSGSHQFEQL 186
Query: 64  IGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G 
Sbjct: 187 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 246
Query: 120 KPASLSKVTD---PQVKQFIEKCI 140
               LSKV       +K+ + +C+
Sbjct: 247 LSPDLSKVRSNCPKAMKRLMAECL 270

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 59
           + +  +  Q+   L ++HS    ++HRD+K  N+F+    G VK+GDLGL       T  
Sbjct: 136 RTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTA 192
Query: 60  ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIYKKVTS 117
           A S++GTP +M+PE ++E  YN   DI+S G  + EM   + P Y +  N   + KK+  
Sbjct: 193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 252
Query: 118 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKD 155
              P   S     +++Q +  CI P   + P +  + D
Sbjct: 253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 88/158 (55%), Gaps = 11/158 (6%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQ-QPTARSVIG 65
           +Q+L G  YLH HN  I+HRDLK +N+ +   + +  +KI D GL+   +     +  +G
Sbjct: 111 KQVLSGTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLG 168
Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPA 122
           T  ++APE+  ++Y+E  D++S G+ IL ++ C YP    +   +I K+V  G     P 
Sbjct: 169 TAYYIAPEVLRKKYDEKCDVWSCGV-ILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPP 227
Query: 123 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 159
             ++V+D + KQ ++  +    S R+ A E L  P++V
Sbjct: 228 DWTQVSD-EAKQLVKLMLTYEPSKRISAEEALNHPWIV 264

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/144 (34%), Positives = 79/144 (54%), Gaps = 14/144 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSV 63
           ARQ  +G+ YLH+ +  IIHRDLK +NIF++  +  VKIGD GLA    + +       +
Sbjct: 110 ARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATEKSRWSGSHQFEQL 166
Query: 64  IGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI   V  G 
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGY 226
Query: 120 KPASLSKVTD---PQVKQFIEKCI 140
               LSKV       +K+ + +C+
Sbjct: 227 LSPDLSKVRSNCPKAMKRLMAECL 250

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 81/149 (54%), Gaps = 5/149 (3%)
Query: 6   NWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
           +W  Q  +G+ YLHS  P  +IHRDLK  N+ +      +KI D G A  +Q     +  
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK- 164
Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA-QIYKKVTSGIKPA 122
           G+  +MAPE++E   Y+E  D++S+G+ + E++T   P++E   PA +I   V +G +P 
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPALE 151
            +  +  P ++  + +C      + P++E
Sbjct: 225 LIKNLPKP-IESLMTRCWSKDPSQRPSME 252

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 81/149 (54%), Gaps = 5/149 (3%)
Query: 6   NWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
           +W  Q  +G+ YLHS  P  +IHRDLK  N+ +      +KI D G A  +Q     +  
Sbjct: 107 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK- 165
Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA-QIYKKVTSGIKPA 122
           G+  +MAPE++E   Y+E  D++S+G+ + E++T   P++E   PA +I   V +G +P 
Sbjct: 166 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 225
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPALE 151
            +  +  P ++  + +C      + P++E
Sbjct: 226 LIKNLPKP-IESLMTRCWSKDPSQRPSME 253

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 83/160 (51%), Gaps = 9/160 (5%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+IL+GL YLHS     IHRD+K  N+ ++   G+VK+ D G+A  +   Q      +GT
Sbjct: 123 REILKGLDYLHSERK--IHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNXFVGT 179
Query: 67  PEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           P +MAPE+ ++  Y+   DI+S G+  +E+   E P N   +P ++   +     P    
Sbjct: 180 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE-PPNSDLHPMRVLFLIPKNSPPTLEG 238
Query: 126 KVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPK 164
           + + P  K+F+E C+      R  A ELLK  F+     K
Sbjct: 239 QHSKP-FKEFVEACLNKDPRFRPTAKELLKHKFITRYTKK 277

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 9/156 (5%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPTA-RSVIG 65
           +Q+  G+ Y+H HN  I+HRDLK +NI +     + ++KI D GL+   QQ T  +  IG
Sbjct: 128 KQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           T  ++APE+    Y+E  D++S G+ +  +++   P+   KN   I K+V +G     L 
Sbjct: 186 TAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRVETGKYAFDLP 244
Query: 126 --KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 158
             +      K  I K +    SLR+ A + L+ P++
Sbjct: 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 83/156 (53%), Gaps = 9/156 (5%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPTA-RSVIG 65
           +Q+  G+ Y+H HN  I+HRDLK +NI +     + ++KI D GL+   QQ T  +  IG
Sbjct: 128 KQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           T  ++APE+    Y+E  D++S G+ +  +++   P+   KN   I K+V +G     L 
Sbjct: 186 TAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLP 244
Query: 126 --KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL 158
             +      K  I K +    SLR+ A + L+ P++
Sbjct: 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 88/158 (55%), Gaps = 11/158 (6%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQ-QPTARSVIG 65
           +Q+L G  YLH HN  I+HRDLK +N+ +   + +  +KI D GL+   +     +  +G
Sbjct: 128 KQVLSGTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLG 185
Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPA 122
           T  ++APE+  ++Y+E  D++S G+ IL ++ C YP    +   +I K+V  G     P 
Sbjct: 186 TAYYIAPEVLRKKYDEKCDVWSCGV-ILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPP 244
Query: 123 SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV 159
             ++V+D + KQ ++  +    S R+ A E L  P++V
Sbjct: 245 DWTQVSD-EAKQLVKLMLTYEPSKRISAEEALNHPWIV 281

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 42/124 (33%), Positives = 68/124 (54%), Gaps = 6/124 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--AR 61
           I +W  QI   L   H H+  I+HRD+K  NIF+   +G V++GD G+A V+      AR
Sbjct: 127 ILDWFVQICLALK--HVHDRKILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELAR 183
Query: 62  SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           + IGTP +++PE+ E + YN   DI++ G  + E+ T ++ +        + K ++    
Sbjct: 184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP 243
Query: 121 PASL 124
           P SL
Sbjct: 244 PVSL 247

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 87/178 (48%), Gaps = 24/178 (13%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-------VMQQPTAR 61
           R++L GL YLH +    IHRD+K  NI + G +G V+I D G++        + +    +
Sbjct: 128 REVLEGLEYLHKNGQ--IHRDVKAGNILL-GEDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 62  SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--- 116
           + +GTP +MAPE+ E+   Y+   DI+SFG+  +E+ T   PY+  K P      +T   
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH--KYPPMKVLMLTLQN 242
Query: 117 ------SGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDNPKDLV 167
                 +G++   + K      ++ I  C+     + P A ELL+  F      K+ +
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFL 300

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 97/188 (51%), Gaps = 19/188 (10%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP--TAR 61
           ++ RQIL  L Y H +N  IIHRD+K +N+ +    N+  VK+GD G+AI + +    A 
Sbjct: 134 HYMRQILEALRYCHDNN--IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAG 191
Query: 62  SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-- 118
             +GTP FMAPE+ + E Y + VD++  G+ +  +++   P+   K   ++++ +  G  
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKY 249
Query: 119 -IKPASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 175
            + P   S +++   K  + + ++  PA  R+   E L  P+L     +D     + LP 
Sbjct: 250 KMNPRQWSHISE-SAKDLVRRMLMLDPAE-RITVYEALNHPWL---KERDRYAYKIHLPE 304
Query: 176 LVPEVMNL 183
            V ++   
Sbjct: 305 TVEQLRKF 312

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/113 (38%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D GLA  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIKVTDFGLAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   + GT
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIKVADFGFAKRVKGRTW-XLCGT 202
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 84/169 (49%), Gaps = 24/169 (14%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-------VMQQPTAR 61
           R++L GL YLH +    IHRD+K  NI + G +G V+I D G++        + +    +
Sbjct: 123 REVLEGLEYLHKNGQ--IHRDVKAGNILL-GEDGSVQIADFGVSAFLATGGDITRNKVRK 179
Query: 62  SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--- 116
           + +GTP +MAPE+ E+   Y+   DI+SFG+  +E+ T   PY+  K P      +T   
Sbjct: 180 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH--KYPPMKVLMLTLQN 237
Query: 117 ------SGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 158
                 +G++   + K      ++ I  C+     + P A ELL+  F 
Sbjct: 238 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 286

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIKVADFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIKVADFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIKVADFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 91/175 (52%), Gaps = 16/175 (9%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARS 62
           + + RQ ++G+ YLH++   +IHRDLK  N+F+N ++ +VKIGD GLA  I       ++
Sbjct: 145 RYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKT 201
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
           + GTP ++APE L ++ ++  VDI+S G CIL  +    P  E     + Y ++      
Sbjct: 202 LCGTPNYIAPEVLCKKGHSFEVDIWSLG-CILYTLLVGKPPFETSCLKETYIRIKKN--E 258
Query: 122 ASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 175
            S+ +  +P     I + +    +LR    ELL D F  +         P+RLP 
Sbjct: 259 YSVPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGY------APMRLPT 307

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T  ++ GT
Sbjct: 167 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGATW-TLCGT 222
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 223 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 274

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   + GT
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW-XLCGT 202
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   + GT
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW-XLCGT 202
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/113 (35%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQ-QPTARSVIG 65
           +Q+L G+ YLH HN  I+HRDLK +N+ +     +  +KI D GL+ V + Q   +  +G
Sbjct: 143 KQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLG 200
Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           T  ++APE+  ++Y+E  D++S G+ IL ++   YP    +   +I +KV  G
Sbjct: 201 TAYYIAPEVLRKKYDEKCDVWSIGV-ILFILLAGYPPFGGQTDQEILRKVEKG 252

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   + GT
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW-XLCGT 202
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +K+ D G A  ++  T   + GT
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIKVTDFGFAKRVKGRTW-XLCGT 202
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 91/175 (52%), Gaps = 16/175 (9%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-- 62
           + + RQ ++G+ YLH++   +IHRDLK  N+F+N ++ +VKIGD GLA  ++    R   
Sbjct: 145 RYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKX 201
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
           + GTP ++APE L ++ ++  VDI+S G CIL  +    P  E     + Y ++      
Sbjct: 202 LCGTPNYIAPEVLCKKGHSFEVDIWSLG-CILYTLLVGKPPFETSCLKETYIRIKKN--E 258
Query: 122 ASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 175
            S+ +  +P     I + +    +LR    ELL D F  +         P+RLP 
Sbjct: 259 YSVPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGY------APMRLPT 307

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 91/175 (52%), Gaps = 16/175 (9%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-- 62
           + + RQ ++G+ YLH++   +IHRDLK  N+F+N ++ +VKIGD GLA  ++    R   
Sbjct: 145 RYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKD 201
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
           + GTP ++APE L ++ ++  VDI+S G CIL  +    P  E     + Y ++      
Sbjct: 202 LCGTPNYIAPEVLCKKGHSFEVDIWSLG-CILYTLLVGKPPFETSCLKETYIRIKKN--E 258
Query: 122 ASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 175
            S+ +  +P     I + +    +LR    ELL D F  +         P+RLP 
Sbjct: 259 YSVPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGY------APMRLPT 307

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 91/175 (52%), Gaps = 16/175 (9%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-- 62
           + + RQ ++G+ YLH++   +IHRDLK  N+F+N ++ +VKIGD GLA  ++    R   
Sbjct: 129 RYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKD 185
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
           + GTP ++APE L ++ ++  VDI+S G CIL  +    P  E     + Y ++      
Sbjct: 186 LCGTPNYIAPEVLCKKGHSFEVDIWSLG-CILYTLLVGKPPFETSCLKETYIRIKKN--E 242
Query: 122 ASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 175
            S+ +  +P     I + +    +LR    ELL D F  +         P+RLP 
Sbjct: 243 YSVPRHINPVASALIRRMLHADPTLRPSVAELLTDEFFTSGYA------PMRLPT 291

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D GLA  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIQVTDFGLAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 68/113 (60%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T  ++ GT
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-TLCGT 202
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLXGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLAGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/115 (36%), Positives = 69/115 (60%), Gaps = 6/115 (5%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
           + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T  ++ 
Sbjct: 130 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-TLC 185
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 186 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 239

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 202
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 167 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 222
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 223 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 274

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 202
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 167 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 222
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 223 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 274

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 202
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 202
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADEPIQIYEKIVSG 253

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/115 (36%), Positives = 68/115 (59%), Gaps = 6/115 (5%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
           + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + 
Sbjct: 137 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLC 192
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 193 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 246

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 141 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 196
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 197 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 248

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLIID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 202
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/115 (36%), Positives = 68/115 (59%), Gaps = 6/115 (5%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
           + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + 
Sbjct: 137 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLC 192
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 193 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 246

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 147 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 202
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 203 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 254

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLMID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/115 (36%), Positives = 68/115 (59%), Gaps = 6/115 (5%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
           + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + 
Sbjct: 131 RFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-EQGYIQVTDFGFAKRVKGRTW-XLC 186
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           GTPE++APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 187 GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 240

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 87/174 (50%), Gaps = 16/174 (9%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--S 62
           + + RQI+ G  YLH +   +IHRDLK  N+F+N  + EVKIGD GLA  ++    R  +
Sbjct: 120 RYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKT 176
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
           + GTP ++APE+  ++ +   VD++S G CI+  +    P  E     + Y ++      
Sbjct: 177 LCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--E 233
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLP 174
            S+ K  +P     I+K +       P + ELL D F  +         P RLP
Sbjct: 234 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY------IPARLP 281

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 87/174 (50%), Gaps = 16/174 (9%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--S 62
           + + RQI+ G  YLH +   +IHRDLK  N+F+N  + EVKIGD GLA  ++    R  +
Sbjct: 120 RYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKT 176
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
           + GTP ++APE+  ++ +   VD++S G CI+  +    P  E     + Y ++      
Sbjct: 177 LCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--E 233
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLP 174
            S+ K  +P     I+K +       P + ELL D F  +         P RLP
Sbjct: 234 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY------IPARLP 281

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 87/174 (50%), Gaps = 16/174 (9%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--S 62
           + + RQI+ G  YLH +   +IHRDLK  N+F+N  + EVKIGD GLA  ++    R  +
Sbjct: 124 RYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKT 180
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
           + GTP ++APE+  ++ +   VD++S G CI+  +    P  E     + Y ++      
Sbjct: 181 LCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--E 237
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLP 174
            S+ K  +P     I+K +       P + ELL D F  +         P RLP
Sbjct: 238 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY------IPARLP 285

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/174 (32%), Positives = 86/174 (49%), Gaps = 16/174 (9%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
           + + RQI+ G  YLH +   +IHRDLK  N+F+N  + EVKIGD GLA  ++    R  +
Sbjct: 118 RYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKV 174
Query: 65  --GTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             GTP ++APE+  ++ +   VD++S G CI+  +    P  E     + Y ++      
Sbjct: 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--E 231
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLP 174
            S+ K  +P     I+K +       P + ELL D F  +         P RLP
Sbjct: 232 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY------IPARLP 279

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 10/160 (6%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
           + + RQI+ G  YLH +   +IHRDLK  N+F+N  + EVKIGD GLA  ++    R  +
Sbjct: 144 RYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKV 200
Query: 65  --GTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             GTP ++APE+  ++ +   VD++S G CI+  +    P  E     + Y ++      
Sbjct: 201 LCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--E 257
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVT 160
            S+ K  +P     I+K +       P + ELL D F  +
Sbjct: 258 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 67/113 (59%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++APE +  + YN+ VD ++ G+ I +M    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 69/125 (55%), Gaps = 12/125 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           RQ+L  L++LHS    IIHRDLK  N+ +    G++++ D G++    +   +  S IGT
Sbjct: 124 RQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGT 180
Query: 67  PEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           P +MAPE      + +  Y+   DI+S G+ ++EM   E P++E  NP ++  K+     
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDP 239
Query: 121 PASLS 125
           P  L+
Sbjct: 240 PTLLT 244

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 69/125 (55%), Gaps = 12/125 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           RQ+L  L++LHS    IIHRDLK  N+ +    G++++ D G++    +   +  S IGT
Sbjct: 116 RQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGT 172
Query: 67  PEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           P +MAPE      + +  Y+   DI+S G+ ++EM   E P++E  NP ++  K+     
Sbjct: 173 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSDP 231
Query: 121 PASLS 125
           P  L+
Sbjct: 232 PTLLT 236

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 10/160 (6%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
           + + RQI+ G  YLH +   +IHRDLK  N+F+N  + EVKIGD GLA  ++    R  +
Sbjct: 142 RYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKV 198
Query: 65  --GTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             GTP ++APE+  ++ +   VD++S G CI+  +    P  E     + Y ++      
Sbjct: 199 LCGTPNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKN--E 255
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVT 160
            S+ K  +P     I+K +       P + ELL D F  +
Sbjct: 256 YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 295

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/112 (37%), Positives = 68/112 (60%), Gaps = 6/112 (5%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
           K +A ++   L YLHS +  II+RDLK +NI ++  NG +KI D G A  +   T   + 
Sbjct: 109 KFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVTY-XLC 164
Query: 65  GTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
           GTP+++APE+   + YN+ +D +SFG+ I EM+    P+ +  N  + Y+K+
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYEKI 215

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG-- 65
           A  I++ L +LHS    +IHRD+K  N+ +N   G+VK+ D G++  +    A+++    
Sbjct: 159 AVSIVKALEHLHSKLS-VIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDSVAKTIDAGC 216
Query: 66  ----TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
                PE + PEL ++ Y+   DI+S G+ ++E+    +PY+    P Q  K+V     P
Sbjct: 217 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 276
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFL 158
              +     +   F  +C+   S   P   EL++ PF 
Sbjct: 277 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 71/135 (52%), Gaps = 6/135 (4%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 70
           +++GL YL   +  I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M
Sbjct: 132 VIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 189
Query: 71  APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK---PASLSK 126
           +PE L    Y+   DI+S G+ ++EM    YP         I++ +   +    P   S 
Sbjct: 190 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSG 249
Query: 127 VTDPQVKQFIEKCIV 141
           V   + + F+ KC++
Sbjct: 250 VFSLEFQDFVNKCLI 264

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 66/113 (58%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE +APE +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 41/113 (36%), Positives = 66/113 (58%), Gaps = 6/113 (5%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T   + GT
Sbjct: 146 YAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRTW-XLCGT 201
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           PE++AP  +  + YN+ VD ++ G+ I EM    YP      P QIY+K+ SG
Sbjct: 202 PEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEKIVSG 253

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 25/145 (17%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEV--KIGDLGLAIVMQQP--TARSVI 64
           I  G+ Y+ + NPPI+HRDL+  NIF+     N  V  K+ D GL+   QQ   +   ++
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS---QQSVHSVSGLL 187
Query: 65  GTPEFMAPELY---EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT----- 116
           G  ++MAPE     EE Y E  D YSF M +  ++T E P++E       Y K+      
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-----YGKIKFINMI 242
Query: 117 --SGIKPASLSKVTDPQVKQFIEKC 139
              G++P ++ +   P+++  IE C
Sbjct: 243 REEGLRP-TIPEDCPPRLRNVIELC 266

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 62/100 (62%), Gaps = 6/100 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A +I+ GL +LHS    I++RDLK DNI ++  +G +KI D G+    ++         
Sbjct: 124 YAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNEFC 180
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYN 103
           GTP+++APE L  ++YN  VD +SFG+ + EM+  + P++
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 62/100 (62%), Gaps = 6/100 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A +I+ GL +LHS    I++RDLK DNI ++  +G +KI D G+    ++         
Sbjct: 123 YAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNXFC 179
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYN 103
           GTP+++APE L  ++YN  VD +SFG+ + EM+  + P++
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 219

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 9/164 (5%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG-- 65
           A  I++ L +LHS    +IHRD+K  N+ +N   G+VK+ D G++  +    A+ +    
Sbjct: 115 AVSIVKALEHLHS-KLSVIHRDVKPSNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGC 172
Query: 66  ----TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
                PE + PEL ++ Y+   DI+S G+ ++E+    +PY+    P Q  K+V     P
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 232
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPK 164
              +     +   F  +C+   S   P   EL++ PF      K
Sbjct: 233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESK 276

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/127 (37%), Positives = 64/127 (50%), Gaps = 24/127 (18%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---------- 58
           RQIL  L Y+HS    IIHRDLK  NIF++ +   VKIGD GLA  + +           
Sbjct: 123 RQILEALSYIHSQG--IIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 59  ------TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 110
                    S IGT  ++A E+ +    YNE +D+YS G+   EM+   YP++       
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVN 236
Query: 111 IYKKVTS 117
           I KK+ S
Sbjct: 237 ILKKLRS 243

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/127 (37%), Positives = 64/127 (50%), Gaps = 24/127 (18%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---------- 58
           RQIL  L Y+HS    IIHRDLK  NIF++ +   VKIGD GLA  + +           
Sbjct: 123 RQILEALSYIHSQG--IIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 59  ------TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 110
                    S IGT  ++A E+ +    YNE +D+YS G+   EM+   YP++       
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERVN 236
Query: 111 IYKKVTS 117
           I KK+ S
Sbjct: 237 ILKKLRS 243

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 94/188 (50%), Gaps = 19/188 (10%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLK--CDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           ++ RQIL  L Y H +N  IIHRD+K  C  +    N+  VK+G  G+AI + +    A 
Sbjct: 136 HYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 193
Query: 62  SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-- 118
             +GTP FMAPE+ + E Y + VD++  G+ +  +++   P+   K   ++++ +  G  
Sbjct: 194 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKY 251
Query: 119 -IKPASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 175
            + P   S +++   K  + + ++  PA  R+   E L  P+L     +D     + LP 
Sbjct: 252 KMNPRQWSHISE-SAKDLVRRMLMLDPAE-RITVYEALNHPWL---KERDRYAYKIHLPE 306
Query: 176 LVPEVMNL 183
            V ++   
Sbjct: 307 TVEQLRKF 314

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 85/159 (53%), Gaps = 13/159 (8%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQ--QPTARSVI 64
           +QIL  +  LH H   ++HRDLK +N+ +        VK+ D GLAI +Q  Q       
Sbjct: 110 QQILEAV--LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA 167
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P 121
           GTP +++PE L +E Y + VDI++ G+ IL ++   YP    ++  ++Y+++ +G    P
Sbjct: 168 GTPGYLSPEVLRKEAYGKPVDIWACGV-ILYILLVGYPPFWDEDQHKLYQQIKAGAYDFP 226
Query: 122 ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFL 158
           +       P+ K  I + +   PA  R+ A E LK P++
Sbjct: 227 SPEWDTVTPEAKNLINQMLTINPAK-RITAHEALKHPWV 264

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 9/157 (5%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           +  + R  L  L +LHS    ++H D+K  NIF+ G  G  K+GD GL + +    A  V
Sbjct: 159 VWGYLRDTLLALAHLHSQG--LVHLDVKPANIFL-GPRGRCKLGDFGLLVELGTAGAGEV 215
Query: 64  I-GTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 122
             G P +MAPEL +  Y    D++S G+ ILE V C     E  +  + ++++  G  P 
Sbjct: 216 QEGDPRYMAPELLQGSYGTAADVFSLGLTILE-VACNM---ELPHGGEGWQQLRQGYLPP 271
Query: 123 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
             +     +++  +   + P   LR  A  LL  P L
Sbjct: 272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 94/188 (50%), Gaps = 19/188 (10%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLK--CDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           ++ RQIL  L Y H +N  IIHRD+K  C  +    N+  VK+G  G+AI + +    A 
Sbjct: 134 HYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAG 191
Query: 62  SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-- 118
             +GTP FMAPE+ + E Y + VD++  G+ +  +++   P+   K   ++++ +  G  
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKY 249
Query: 119 -IKPASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 175
            + P   S +++   K  + + ++  PA  R+   E L  P+L     +D     + LP 
Sbjct: 250 KMNPRQWSHISE-SAKDLVRRMLMLDPAE-RITVYEALNHPWL---KERDRYAYKIHLPE 304
Query: 176 LVPEVMNL 183
            V ++   
Sbjct: 305 TVEQLRKF 312

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 91/175 (52%), Gaps = 18/175 (10%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLA---IVMQQPTA 60
           + + +Q+L G+ Y HS    I HRDLK +N  ++G+    +KI D G +   ++  QP  
Sbjct: 119 RFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 174
Query: 61  RSVIGTPEFMAPE-LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           +S +GTP ++APE L  +EY+ ++ D++S G+ +  M+   YP+ + + P   Y+K    
Sbjct: 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQR 233
Query: 119 IKPASLSKVTD----PQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLV 167
           I     S   D    P+    I +  V  PA+ R+   E+    + + + P DL+
Sbjct: 234 ILSVKYSIPDDIRISPECCHLISRIFVADPAT-RISIPEIKTHSWFLKNLPADLM 287

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 91/182 (50%), Gaps = 14/182 (7%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ-QPTARSVIG 65
           RQ+L G+ Y+H +   I+HRDLK +N+ +     +  ++I D GL+   +     +  IG
Sbjct: 157 RQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIG 214
Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           T  ++APE+    Y+E  D++S G+ +  +++   P+N   N   I KKV  G     L 
Sbjct: 215 TAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKVEKGKYTFELP 273
Query: 126 --KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVM 181
             K      K  I K +  VP S+R+ A + L   ++ T   + +  D   +P+L   ++
Sbjct: 274 QWKKVSESAKDLIRKMLTYVP-SMRISARDALDHEWIQTYTKEQISVD---VPSLDNAIL 329
Query: 182 NL 183
           N+
Sbjct: 330 NI 331

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTA 60
           + IK+   Q+LRGL +LHSH   ++HRDLK  NI V  ++G++K+ D GLA +   Q   
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMAL 176
Query: 61  RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 95
            SV+ T  + APE L +  Y   VD++S G    EM
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 91/182 (50%), Gaps = 14/182 (7%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ-QPTARSVIG 65
           RQ+L G+ Y+H +   I+HRDLK +N+ +     +  ++I D GL+   +     +  IG
Sbjct: 156 RQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIG 213
Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           T  ++APE+    Y+E  D++S G+ +  +++   P+N   N   I KKV  G     L 
Sbjct: 214 TAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKVEKGKYTFELP 272
Query: 126 --KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVM 181
             K      K  I K +  VP S+R+ A + L   ++ T   + +  D   +P+L   ++
Sbjct: 273 QWKKVSESAKDLIRKMLTYVP-SMRISARDALDHEWIQTYTKEQISVD---VPSLDNAIL 328
Query: 182 NL 183
           N+
Sbjct: 329 NI 330

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTA 60
           + IK+   Q+LRGL +LHSH   ++HRDLK  NI V  ++G++K+ D GLA +   Q   
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMAL 176
Query: 61  RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 95
            SV+ T  + APE L +  Y   VD++S G    EM
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTA 60
           + IK+   Q+LRGL +LHSH   ++HRDLK  NI V  ++G++K+ D GLA +   Q   
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMAL 176
Query: 61  RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 95
            SV+ T  + APE L +  Y   VD++S G    EM
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 74/145 (51%), Gaps = 25/145 (17%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEV--KIGDLGLAIVMQQP--TARSVI 64
           I  G+ Y+ + NPPI+HRDL+  NIF+     N  V  K+ D G +   QQ   +   ++
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS---QQSVHSVSGLL 187
Query: 65  GTPEFMAPELY---EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT----- 116
           G  ++MAPE     EE Y E  D YSF M +  ++T E P++E       Y K+      
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-----YGKIKFINMI 242
Query: 117 --SGIKPASLSKVTDPQVKQFIEKC 139
              G++P ++ +   P+++  IE C
Sbjct: 243 REEGLRP-TIPEDCPPRLRNVIELC 266

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 74/141 (52%), Gaps = 12/141 (8%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 70
           +++GL YL   +  I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M
Sbjct: 113 VIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170
Query: 71  APE-LYEEEYNELVDIYSFGMCILEMVTCEYPY------NECKNPAQIYK---KVTSGIK 120
           +PE L    Y+   DI+S G+ ++EM    YP        + + P  I++    + +   
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPP 230
Query: 121 PASLSKVTDPQVKQFIEKCIV 141
           P   S V   + + F+ KC++
Sbjct: 231 PKLPSGVFSLEFQDFVNKCLI 251

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 60/102 (58%), Gaps = 7/102 (6%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARS 62
           N+  QIL G+   H+H+  I+HRD+K  NI ++ N   +KI D G+A  + + +      
Sbjct: 115 NFTNQILDGIK--HAHDMRIVHRDIKPQNILIDSNKT-LKIFDFGIAKALSETSLTQTNH 171
Query: 63  VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN 103
           V+GT ++ +PE  + E  +E  DIYS G+ + EM+  E P+N
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 13/147 (8%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----- 55
           ++ ++ +  Q+LRGL Y+HS    +IHRDLK  N+ VN  N E+KIGD G+A  +     
Sbjct: 157 LEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPA 213
Query: 56  -QQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQ 110
             Q      + T  + APEL     EY + +D++S G    EM+     +P     +  Q
Sbjct: 214 EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ 273
Query: 111 IYKKVTSGIKPASLSKVTDPQVKQFIE 137
           +   V     PA +  V   +V+ +I+
Sbjct: 274 LIMMVLGTPSPAVIQAVGAERVRAYIQ 300

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 91/182 (50%), Gaps = 14/182 (7%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ-QPTARSVIG 65
           RQ+L G+ Y+H +   I+HRDLK +N+ +     +  ++I D GL+   +     +  IG
Sbjct: 133 RQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIG 190
Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           T  ++APE+    Y+E  D++S G+ +  +++   P+N   N   I KKV  G     L 
Sbjct: 191 TAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKVEKGKYTFELP 249
Query: 126 --KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVM 181
             K      K  I K +  VP S+R+ A + L   ++ T   + +  D   +P+L   ++
Sbjct: 250 QWKKVSESAKDLIRKMLTYVP-SMRISARDALDHEWIQTYTKEQISVD---VPSLDNAIL 305
Query: 182 NL 183
           N+
Sbjct: 306 NI 307

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 74/145 (51%), Gaps = 25/145 (17%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEV--KIGDLGLAIVMQQP--TARSVI 64
           I  G+ Y+ + NPPI+HRDL+  NIF+     N  V  K+ D  L+   QQ   +   ++
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS---QQSVHSVSGLL 187
Query: 65  GTPEFMAPELY---EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT----- 116
           G  ++MAPE     EE Y E  D YSF M +  ++T E P++E       Y K+      
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS-----YGKIKFINMI 242
Query: 117 --SGIKPASLSKVTDPQVKQFIEKC 139
              G++P ++ +   P+++  IE C
Sbjct: 243 REEGLRP-TIPEDCPPRLRNVIELC 266

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 85/158 (53%), Gaps = 11/158 (6%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVM--QQPTARSVI 64
           +QIL  +  LH H   ++HRDLK +N+ +        VK+ D GLAI +  +Q       
Sbjct: 128 QQILEAV--LHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 185
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P 121
           GTP +++PE L ++ Y + VD+++ G+ IL ++   YP    ++  ++Y+++ +G    P
Sbjct: 186 GTPGYLSPEVLRKDPYGKPVDLWACGV-ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP 244
Query: 122 ASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFL 158
           +       P+ K  I K + +  S R+ A E LK P++
Sbjct: 245 SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 13/147 (8%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----- 55
           ++ ++ +  Q+LRGL Y+HS    +IHRDLK  N+ VN  N E+KIGD G+A  +     
Sbjct: 158 LEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPA 214
Query: 56  -QQPTARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQ 110
             Q      + T  + APEL     EY + +D++S G    EM+     +P     +  Q
Sbjct: 215 EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQ 274
Query: 111 IYKKVTSGIKPASLSKVTDPQVKQFIE 137
           +   V     PA +  V   +V+ +I+
Sbjct: 275 LIMMVLGTPSPAVIQAVGAERVRAYIQ 301

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 72/135 (53%), Gaps = 10/135 (7%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 70
           +++GL YL   +  I+HRD+K  NI VN + GE+K+ D G++  +    A   +GT  +M
Sbjct: 116 VIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDEMANEFVGTRSYM 173
Query: 71  APE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK---KVTSGIKPASLSK 126
           +PE L    Y+   DI+S G+ ++EM    YP    + P  I++    + +   P   S 
Sbjct: 174 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP----RPPMAIFELLDYIVNEPPPKLPSA 229
Query: 127 VTDPQVKQFIEKCIV 141
           V   + + F+ KC++
Sbjct: 230 VFSLEFQDFVNKCLI 244

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 87/158 (55%), Gaps = 13/158 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           QIL  ++++H H+  I+HRDLK +N+ +        VK+ D GLAI +Q  Q       G
Sbjct: 138 QILESVNHIHQHD--IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAG 195
Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PA 122
           TP +++PE L ++ Y + VDI++ G+ IL ++   YP    ++  ++Y+++ +G    P+
Sbjct: 196 TPGYLSPEVLRKDPYGKPVDIWACGV-ILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPS 254
Query: 123 SLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFL 158
                  P+ K  I + +   PA  R+ A + LK P++
Sbjct: 255 PEWDTVTPEAKNLINQMLTINPAK-RITADQALKHPWV 291

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 9/158 (5%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV---- 63
           A  I++ L +LHS    +IHRD+K  N+ +N   G+VK  D G++  +    A+ +    
Sbjct: 142 AVSIVKALEHLHS-KLSVIHRDVKPSNVLINAL-GQVKXCDFGISGYLVDDVAKDIDAGC 199
Query: 64  --IGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
                PE + PEL ++ Y+   DI+S G+  +E+    +PY+    P Q  K+V     P
Sbjct: 200 KPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSP 259
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFL 158
              +     +   F  +C+   S   P   EL + PF 
Sbjct: 260 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 70
           +LRGL YL   +  I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M
Sbjct: 123 VLRGLAYLREKHQ-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 180
Query: 71  APE-LYEEEYNELVDIYSFGMCILEMVTCEYP 101
           APE L    Y+   DI+S G+ ++E+    YP
Sbjct: 181 APERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 61/100 (61%), Gaps = 6/100 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A +I  GL +LH     II+RDLK DN+ ++ + G +KI D G+    +M   T R   
Sbjct: 125 YAAEISIGLFFLHKRG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMMDGVTTREFC 181
Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN 103
           GTP+++APE+   + Y + VD +++G+ + EM+  + P++
Sbjct: 182 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 75/134 (55%), Gaps = 14/134 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-VIGTPE 68
           QI +G+ Y+HS    +IHRDLK  NIF+  +  +VKIGD GL   ++    R+   GT  
Sbjct: 144 QITKGVDYIHS--KKLIHRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLR 200
Query: 69  FMAPE-LYEEEYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQIYKKVTSGIKPASLSK 126
           +M+PE +  ++Y + VD+Y+ G+ + E++  C+  +      ++ +  +  GI    +S 
Sbjct: 201 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF----ETSKFFTDLRDGI----ISD 252
Query: 127 VTDPQVKQFIEKCI 140
           + D + K  ++K +
Sbjct: 253 IFDKKEKTLLQKLL 266

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 95/190 (50%), Gaps = 15/190 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPT-AR 61
           K +  Q+L  + YLH +   IIHRDLK +N+ ++    +  +KI D G + ++ + +  R
Sbjct: 256 KLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 313
Query: 62  SVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
           ++ GTP ++APE+        YN  VD +S G+ +   ++   P++E +    +  ++TS
Sbjct: 314 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 373
Query: 118 G---IKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 174
           G     P   ++V++  +    +  +V    R    E L+ P+L  ++ K    D L   
Sbjct: 374 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 433
Query: 175 N---LVPEVM 181
           N    +P+V+
Sbjct: 434 NESTALPQVL 443

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 84/173 (48%), Gaps = 26/173 (15%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARS 62
           + ++ +I   L+YLH     II+RDLK DN+ ++ + G +K+ D G+     +P  T  +
Sbjct: 156 RFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTST 212
Query: 63  VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSG 118
             GTP ++APE+   E+Y   VD ++ G+ + EM+    P++      NP Q        
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------- 264
Query: 119 IKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 170
                     D   +  +EK I +P SL + A  +LK  FL  D  + L C P
Sbjct: 265 -------NTEDYLFQVILEKQIRIPRSLSVKAASVLKS-FLNKDPKERLGCHP 309

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 95/190 (50%), Gaps = 15/190 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPT-AR 61
           K +  Q+L  + YLH +   IIHRDLK +N+ ++    +  +KI D G + ++ + +  R
Sbjct: 116 KLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 173
Query: 62  SVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
           ++ GTP ++APE+        YN  VD +S G+ +   ++   P++E +    +  ++TS
Sbjct: 174 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 233
Query: 118 G---IKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 174
           G     P   ++V++  +    +  +V    R    E L+ P+L  ++ K    D L   
Sbjct: 234 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 293
Query: 175 N---LVPEVM 181
           N    +P+V+
Sbjct: 294 NESTALPQVL 303

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 93/176 (52%), Gaps = 16/176 (9%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLA---IVMQQPTA 60
           + + +Q++ G+ Y H+    + HRDLK +N  ++G+    +KI D G +   ++  QP  
Sbjct: 118 RFFFQQLISGVSYAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQP-- 173
Query: 61  RSVIGTPEFMAPE-LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS- 117
           +S +GTP ++APE L ++EY+ ++ D++S G+ +  M+   YP+ + + P    K +   
Sbjct: 174 KSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233
Query: 118 -GIKPASLSKV-TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 169
             ++ A    V   P+ +  I +  V  PA  R+   E+    + + + P DL+ D
Sbjct: 234 LNVQYAIPDYVHISPECRHLISRIFVADPAK-RISIPEIRNHEWFLKNLPADLMND 288

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 85/159 (53%), Gaps = 13/159 (8%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ--QPTARSVI 64
           +QIL  ++  H H   I+HRDLK +N+ +        VK+ D GLAI +Q  Q       
Sbjct: 110 QQILESVN--HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA 167
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P 121
           GTP +++PE L ++ Y + VD+++ G+ IL ++   YP    ++  ++Y+++ +G    P
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGV-ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP 226
Query: 122 ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFL 158
           +       P+ K  I K +   PA  R+ A E LK P++
Sbjct: 227 SPEWDTVTPEAKDLINKMLTINPAK-RITASEALKHPWI 264

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 87/170 (51%), Gaps = 12/170 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPT-AR 61
           K +  Q+L  + YLH +   IIHRDLK +N+ ++    +  +KI D G + ++ + +  R
Sbjct: 117 KLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 62  SVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
           ++ GTP ++APE+        YN  VD +S G+ +   ++   P++E +    +  ++TS
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234
Query: 118 G---IKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPK 164
           G     P   ++V++  +    +  +V    R    E L+ P+L  ++ K
Sbjct: 235 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 284

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 95/190 (50%), Gaps = 15/190 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPT-AR 61
           K +  Q+L  + YLH +   IIHRDLK +N+ ++    +  +KI D G + ++ + +  R
Sbjct: 117 KLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 62  SVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
           ++ GTP ++APE+        YN  VD +S G+ +   ++   P++E +    +  ++TS
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234
Query: 118 G---IKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 174
           G     P   ++V++  +    +  +V    R    E L+ P+L  ++ K    D L   
Sbjct: 235 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 294
Query: 175 N---LVPEVM 181
           N    +P+V+
Sbjct: 295 NESTALPQVL 304

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 95/190 (50%), Gaps = 15/190 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPT-AR 61
           K +  Q+L  + YLH +   IIHRDLK +N+ ++    +  +KI D G + ++ + +  R
Sbjct: 123 KLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 180
Query: 62  SVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
           ++ GTP ++APE+        YN  VD +S G+ +   ++   P++E +    +  ++TS
Sbjct: 181 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 240
Query: 118 G---IKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 174
           G     P   ++V++  +    +  +V    R    E L+ P+L  ++ K    D L   
Sbjct: 241 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 300
Query: 175 N---LVPEVM 181
           N    +P+V+
Sbjct: 301 NESTALPQVL 310

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 87/170 (51%), Gaps = 12/170 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPT-AR 61
           K +  Q+L  + YLH +   IIHRDLK +N+ ++    +  +KI D G + ++ + +  R
Sbjct: 117 KLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174
Query: 62  SVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
           ++ GTP ++APE+        YN  VD +S G+ +   ++   P++E +    +  ++TS
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234
Query: 118 G---IKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPK 164
           G     P   ++V++  +    +  +V    R    E L+ P+L  ++ K
Sbjct: 235 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 284

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 96/185 (51%), Gaps = 16/185 (8%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +  +I+  L YLHS +  +++RD+K +N+ ++  +G +KI D GL    +    T ++
Sbjct: 108 RFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 164
Query: 63  VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             GTPE++APE+ E+ +Y   VD +  G+ + EM+    P+   ++  ++++ +   ++ 
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELIL--MEE 221
Query: 122 ASLSKVTDPQVKQFIEKCIVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPN 175
               +   P+ K  +   +      RL      A E+++  F ++ N +D+V   L LP 
Sbjct: 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-LPP 280
Query: 176 LVPEV 180
             P+V
Sbjct: 281 FKPQV 285

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 87/170 (51%), Gaps = 12/170 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPT-AR 61
           K +  Q+L  + YLH +   IIHRDLK +N+ ++    +  +KI D G + ++ + +  R
Sbjct: 242 KLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 299
Query: 62  SVIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
           ++ GTP ++APE+        YN  VD +S G+ +   ++   P++E +    +  ++TS
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359
Query: 118 G---IKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPK 164
           G     P   ++V++  +    +  +V    R    E L+ P+L  ++ K
Sbjct: 360 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 96/185 (51%), Gaps = 16/185 (8%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +  +I+  L YLHS +  +++RD+K +N+ ++  +G +KI D GL    +    T ++
Sbjct: 111 RFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 167
Query: 63  VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             GTPE++APE+ E+ +Y   VD +  G+ + EM+    P+   ++  ++++ +   ++ 
Sbjct: 168 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELIL--MEE 224
Query: 122 ASLSKVTDPQVKQFIEKCIVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPN 175
               +   P+ K  +   +      RL      A E+++  F ++ N +D+V   L LP 
Sbjct: 225 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-LPP 283
Query: 176 LVPEV 180
             P+V
Sbjct: 284 FKPQV 288

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 96/185 (51%), Gaps = 16/185 (8%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +  +I+  L YLHS +  +++RD+K +N+ ++  +G +KI D GL    +    T ++
Sbjct: 108 RFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKT 164
Query: 63  VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             GTPE++APE+ E+ +Y   VD +  G+ + EM+    P+   ++  ++++ +   ++ 
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELIL--MEE 221
Query: 122 ASLSKVTDPQVKQFIEKCIVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPN 175
               +   P+ K  +   +      RL      A E+++  F ++ N +D+V   L LP 
Sbjct: 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-LPP 280
Query: 176 LVPEV 180
             P+V
Sbjct: 281 FKPQV 285

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 85/158 (53%), Gaps = 11/158 (6%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVM--QQPTARSVI 64
           +QIL  +  LH H   ++HR+LK +N+ +        VK+ D GLAI +  +Q       
Sbjct: 117 QQILEAV--LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P 121
           GTP +++PE L ++ Y + VD+++ G+ IL ++   YP    ++  ++Y+++ +G    P
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGV-ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP 233
Query: 122 ASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFL 158
           +       P+ K  I K + +  S R+ A E LK P++
Sbjct: 234 SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/127 (35%), Positives = 62/127 (48%), Gaps = 24/127 (18%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---------- 58
           RQIL  L Y+HS    IIHR+LK  NIF++ +   VKIGD GLA  + +           
Sbjct: 123 RQILEALSYIHSQG--IIHRNLKPXNIFIDESRN-VKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 59  ------TARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 110
                    S IGT  ++A E+ +    YNE +D YS G+   E +   YP++       
Sbjct: 180 LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI---YPFSTGXERVN 236
Query: 111 IYKKVTS 117
           I KK+ S
Sbjct: 237 ILKKLRS 243

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 89/182 (48%), Gaps = 14/182 (7%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ-QPTARSVIG 65
           RQ+L G+ Y H +   I+HRDLK +N+ +     +  ++I D GL+   +     +  IG
Sbjct: 133 RQVLSGITYXHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIG 190
Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           T  ++APE+    Y+E  D++S G+ +  +++   P+N   N   I KKV  G     L 
Sbjct: 191 TAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKVEKGKYTFELP 249
Query: 126 --KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVM 181
             K      K  I K +  VP S R+ A + L   ++ T   + +  D   +P+L   ++
Sbjct: 250 QWKKVSESAKDLIRKXLTYVP-SXRISARDALDHEWIQTYTKEQISVD---VPSLDNAIL 305
Query: 182 NL 183
           N+
Sbjct: 306 NI 307

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 85/159 (53%), Gaps = 13/159 (8%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ--QPTARSVI 64
           +QIL  ++  H H   I+HRDLK +N+ +        VK+ D GLAI +Q  Q       
Sbjct: 110 QQILESVN--HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA 167
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--P 121
           GTP +++PE L ++ Y + VD+++ G+ IL ++   YP    ++  ++Y+++ +G    P
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGV-ILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP 226
Query: 122 ASLSKVTDPQVKQFIEKCIV--PASLRLPALELLKDPFL 158
           +       P+ K  I K +   PA  R+ A E LK P++
Sbjct: 227 SPEWDTVTPEAKDLINKMLTINPAK-RITASEALKHPWI 264

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 70
           +++GL YL   +  I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M
Sbjct: 175 VIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 232
Query: 71  APE-LYEEEYNELVDIYSFGMCILEMVTCEYP 101
           +PE L    Y+   DI+S G+ ++EM    YP
Sbjct: 233 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +  +I+  L YLHS +  +++RD+K +N+ ++  +G +KI D GL    +    T + 
Sbjct: 108 RFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKX 164
Query: 63  VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             GTPE++APE+ E+ +Y   VD +  G+ + EM+    P+   ++  ++++ +   ++ 
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELIL--MEE 221
Query: 122 ASLSKVTDPQVKQFIEKCIVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPN 175
               +   P+ K  +   +      RL      A E+++  F ++ N +D+V   L LP 
Sbjct: 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-LPP 280
Query: 176 LVPEV 180
             P+V
Sbjct: 281 FKPQV 285

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +  +I+  L YLHS +  +++RD+K +N+ ++  +G +KI D GL    +    T + 
Sbjct: 113 RFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKX 169
Query: 63  VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             GTPE++APE+ E+ +Y   VD +  G+ + EM+    P+   ++  ++++ +   ++ 
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELIL--MEE 226
Query: 122 ASLSKVTDPQVKQFIEKCIVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPN 175
               +   P+ K  +   +      RL      A E+++  F ++ N +D+V   L LP 
Sbjct: 227 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-LPP 285
Query: 176 LVPEV 180
             P+V
Sbjct: 286 FKPQV 290

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 70
           +++GL YL   +  I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M
Sbjct: 140 VIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 197
Query: 71  APE-LYEEEYNELVDIYSFGMCILEMVTCEYP 101
           +PE L    Y+   DI+S G+ ++EM    YP
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +  +I+  L YLHS +  +++RD+K +N+ ++  +G +KI D GL    +    T + 
Sbjct: 108 RFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKX 164
Query: 63  VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             GTPE++APE+ E+ +Y   VD +  G+ + EM+    P+   ++  ++++ +   ++ 
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELIL--MEE 221
Query: 122 ASLSKVTDPQVKQFIEKCIVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPN 175
               +   P+ K  +   +      RL      A E+++  F ++ N +D+V   L LP 
Sbjct: 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-LPP 280
Query: 176 LVPEV 180
             P+V
Sbjct: 281 FKPQV 285

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 55/96 (57%), Gaps = 5/96 (5%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTA 60
           + IK+  RQ LRGL +LH++   I+HRDLK +NI V  + G VK+ D GLA I   Q   
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL 176
Query: 61  RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 95
             V+ T  + APE L +  Y   VD++S G    EM
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +  +I+  L YLHS +  +++RD+K +N+ ++  +G +KI D GL    +    T + 
Sbjct: 108 RFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKX 164
Query: 63  VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             GTPE++APE+ E+ +Y   VD +  G+ + EM+    P+   ++  ++++ +   ++ 
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELIL--MEE 221
Query: 122 ASLSKVTDPQVKQFIEKCIVP-ASLRL-----PALELLKDPFLVTDNPKDLVCDPLRLPN 175
               +   P+ K  +   +      RL      A E+++  F ++ N +D+V   L LP 
Sbjct: 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL-LPP 280
Query: 176 LVPEV 180
             P+V
Sbjct: 281 FKPQV 285

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 26/173 (15%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARS 62
           + ++ +I   L+YLH     II+RDLK DN+ ++ + G +K+ D G+     +P  T   
Sbjct: 109 RFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSX 165
Query: 63  VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSG 118
             GTP ++APE+   E+Y   VD ++ G+ + EM+    P++      NP Q        
Sbjct: 166 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------- 217
Query: 119 IKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 170
                     D   +  +EK I +P SL + A  +LK  FL  D  + L C P
Sbjct: 218 -------NTEDYLFQVILEKQIRIPRSLSVKAASVLKS-FLNKDPKERLGCHP 262

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 70
           +++GL YL   +  I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M
Sbjct: 113 VIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170
Query: 71  APE-LYEEEYNELVDIYSFGMCILEMVTCEYP 101
           +PE L    Y+   DI+S G+ ++EM    YP
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 93/176 (52%), Gaps = 16/176 (9%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLA---IVMQQPTA 60
           + + +Q++ G+ Y H+    + HRDLK +N  ++G+    +KI D G +   ++  QP  
Sbjct: 117 RFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 172
Query: 61  RSVIGTPEFMAPE-LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS- 117
           +S +GTP ++APE L ++EY+ ++ D++S G+ +  M+   YP+ + + P    K +   
Sbjct: 173 KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 232
Query: 118 -GIKPASLSKV-TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 169
             ++ A    V   P+ +  I +  V  PA  R+   E+    + + + P DL+ D
Sbjct: 233 LNVQYAIPDYVHISPECRHLISRIFVADPAK-RISIPEIRNHEWFLKNLPADLMND 287

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +  +I+  L YLHS    +++RDLK +N+ ++  +G +KI D GL    +    T ++
Sbjct: 254 RFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKT 311
Query: 63  VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY 102
             GTPE++APE+ E+ +Y   VD +  G+ + EM+    P+
Sbjct: 312 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 59/101 (58%), Gaps = 5/101 (4%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +  +I+  L YLHS    +++RDLK +N+ ++  +G +KI D GL    +    T ++
Sbjct: 251 RFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKT 308
Query: 63  VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY 102
             GTPE++APE+ E+ +Y   VD +  G+ + EM+    P+
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 93/176 (52%), Gaps = 16/176 (9%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLA---IVMQQPTA 60
           + + +Q++ G+ Y H+    + HRDLK +N  ++G+    +KI D G +   ++  QP  
Sbjct: 118 RFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 173
Query: 61  RSVIGTPEFMAPE-LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS- 117
           +S +GTP ++APE L ++EY+ ++ D++S G+ +  M+   YP+ + + P    K +   
Sbjct: 174 KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233
Query: 118 -GIKPASLSKV-TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 169
             ++ A    V   P+ +  I +  V  PA  R+   E+    + + + P DL+ D
Sbjct: 234 LNVQYAIPDYVHISPECRHLISRIFVADPAK-RISIPEIRNHEWFLKNLPADLMND 288

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 70
           +++GL YL   +  I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M
Sbjct: 113 VIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170
Query: 71  APE-LYEEEYNELVDIYSFGMCILEMVTCEYP 101
           +PE L    Y+   DI+S G+ ++EM    YP
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 55/96 (57%), Gaps = 5/96 (5%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTA 60
           + IK+  RQ LRGL +LH++   I+HRDLK +NI V  + G VK+ D GLA I   Q   
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL 168
Query: 61  RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 95
             V+ T  + APE L +  Y   VD++S G    EM
Sbjct: 169 APVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 59/114 (51%), Gaps = 13/114 (11%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGLAIVMQQPTA 60
           +K+   QIL G+HYLH++   ++HRDLK  NI V G     G VKI D+G A +   P  
Sbjct: 130 VKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 61  -----RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKN 107
                  V+ T  + APEL      Y + +DI++ G    E++T E P   C+ 
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQ 240

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 70
           +++GL YL   +  I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M
Sbjct: 113 VIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170
Query: 71  APE-LYEEEYNELVDIYSFGMCILEMVTCEYP 101
           +PE L    Y+   DI+S G+ ++EM    YP
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 3/92 (3%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM 70
           +++GL YL   +  I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT  +M
Sbjct: 113 VIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYM 170
Query: 71  APE-LYEEEYNELVDIYSFGMCILEMVTCEYP 101
           +PE L    Y+   DI+S G+ ++EM    YP
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 26/173 (15%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARS 62
           + ++ +I   L+YLH     II+RDLK DN+ ++ + G +K+ D G+     +P  T   
Sbjct: 113 RFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSX 169
Query: 63  VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSG 118
             GTP ++APE+   E+Y   VD ++ G+ + EM+    P++      NP Q        
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------- 221
Query: 119 IKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 170
                     D   +  +EK I +P SL + A  +LK  FL  D  + L C P
Sbjct: 222 -------NTEDYLFQVILEKQIRIPRSLSVKAASVLKS-FLNKDPKERLGCHP 266

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 55/96 (57%), Gaps = 5/96 (5%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTA 60
           + IK+  RQ LRGL +LH++   I+HRDLK +NI V  + G VK+ D GLA I   Q   
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL 168
Query: 61  RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 95
             V+ T  + APE L +  Y   VD++S G    EM
Sbjct: 169 DPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 89/167 (53%), Gaps = 10/167 (5%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSV 63
           + + +QI+  + Y H H   I+HRDLK +N+ ++  +  VKI D GL+ +M      ++ 
Sbjct: 115 RRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTS 171
Query: 64  IGTPEFMAPELYEEEY--NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
            G+P + APE+   +      VD++S G+ +  M+    P+++   P  ++K +++G+  
Sbjct: 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGV-- 228
Query: 122 ASLSKVTDPQVKQFIEKCIVPASL-RLPALELLKDPFLVTDNPKDLV 167
            +L K   P     I++ ++   L R+   E+++D +   D P+ L+
Sbjct: 229 YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYLL 275

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 89/167 (53%), Gaps = 10/167 (5%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSV 63
           + + +QI+  + Y H H   I+HRDLK +N+ ++  +  VKI D GL+ +M      ++ 
Sbjct: 116 RRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTS 172
Query: 64  IGTPEFMAPELYEEEY--NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
            G+P + APE+   +      VD++S G+ +  M+    P+++   P  ++K +++G+  
Sbjct: 173 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGV-- 229
Query: 122 ASLSKVTDPQVKQFIEKCIVPASL-RLPALELLKDPFLVTDNPKDLV 167
            +L K   P     I++ ++   L R+   E+++D +   D P+ L+
Sbjct: 230 YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYLL 276

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 55/96 (57%), Gaps = 5/96 (5%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTA 60
           + IK+  RQ LRGL +LH++   I+HRDLK +NI V  + G VK+ D GLA I   Q   
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL 168
Query: 61  RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEM 95
             V+ T  + APE L +  Y   VD++S G    EM
Sbjct: 169 FPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 72/125 (57%), Gaps = 9/125 (7%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A +I  GL +L S    II+RDLK DN+ ++ + G +KI D G+    +    T +   
Sbjct: 447 YAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKXFC 503
Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP 121
           GTP+++APE+   + Y + VD ++FG+ + EM+  + P+ E ++  ++++ +       P
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYP 562
Query: 122 ASLSK 126
            S+SK
Sbjct: 563 KSMSK 567

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/98 (39%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 112 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT 168
Query: 62  SVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
             + T  + APE  L  + Y+  VDI+S G    EMVT
Sbjct: 169 HEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 89/167 (53%), Gaps = 10/167 (5%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSV 63
           + + +QI+  + Y H H   I+HRDLK +N+ ++  +  VKI D GL+ +M      ++ 
Sbjct: 110 RRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTS 166
Query: 64  IGTPEFMAPELYEEEY--NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
            G+P + APE+   +      VD++S G+ +  M+    P+++   P  ++K +++G+  
Sbjct: 167 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGV-- 223
Query: 122 ASLSKVTDPQVKQFIEKCIVPASL-RLPALELLKDPFLVTDNPKDLV 167
            +L K   P     I++ ++   L R+   E+++D +   D P+ L+
Sbjct: 224 YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYLL 270

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK +N+ +N   G +K+ D GLA     P  T  
Sbjct: 108 IKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYX 164
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 39/98 (39%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 105 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT 161
Query: 62  SVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
             + T  + APE  L  + Y+  VDI+S G    EMVT
Sbjct: 162 HEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 69/123 (56%), Gaps = 9/123 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +A +I   L YLHS N  I++RDLK +NI ++ + G + + D GL    +    T  +
Sbjct: 142 RFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTST 198
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             GTPE++APE L+++ Y+  VD +  G  + EM+    P+   +N A++Y  + +  KP
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILN--KP 255
Query: 122 ASL 124
             L
Sbjct: 256 LQL 258

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK +N+ +N   G +K+ D GLA     P  T  
Sbjct: 107 IKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYX 163
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 164 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK +N+ +N   G +K+ D GLA     P  T  
Sbjct: 106 IKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYX 162
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 163 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK +N+ +N   G +K+ D GLA     P  T  
Sbjct: 106 IKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYX 162
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 163 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 72/125 (57%), Gaps = 9/125 (7%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVI 64
           +A +I  GL +L S    II+RDLK DN+ ++ + G +KI D G+    +    T +   
Sbjct: 126 YAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKXFC 182
Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP 121
           GTP+++APE+   + Y + VD ++FG+ + EM+  + P+ E ++  ++++ +       P
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYP 241
Query: 122 ASLSK 126
            S+SK
Sbjct: 242 KSMSK 246

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 56/98 (57%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK +N+ +N   G +K+ D GLA     P  T  
Sbjct: 105 IKSYLFQLLQGLAFCHSHR--VLHRDLKPENLLIN-TEGAIKLADFGLARAFGVPVRTYX 161
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 58/101 (57%), Gaps = 5/101 (4%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +  +I+  L YLHS    +++RDLK +N+ ++  +G +KI D GL    +    T + 
Sbjct: 112 RFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKX 169
Query: 63  VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY 102
             GTPE++APE+ E+ +Y   VD +  G+ + EM+    P+
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 89/167 (53%), Gaps = 10/167 (5%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSV 63
           + + +QI+  + Y H H   I+HRDLK +N+ ++  +  VKI D GL+ +M      ++ 
Sbjct: 106 RRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTS 162
Query: 64  IGTPEFMAPELYEEEY--NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
            G+P + APE+   +      VD++S G+ +  M+    P+++   P  ++K +++G+  
Sbjct: 163 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGV-- 219
Query: 122 ASLSKVTDPQVKQFIEKCIVPASL-RLPALELLKDPFLVTDNPKDLV 167
            +L K   P     I++ ++   L R+   E+++D +   D P+ L+
Sbjct: 220 YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYLL 266

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 58/101 (57%), Gaps = 5/101 (4%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +  +I+  L YLHS    +++RDLK +N+ ++  +G +KI D GL    +    T + 
Sbjct: 113 RFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKX 170
Query: 63  VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY 102
             GTPE++APE+ E+ +Y   VD +  G+ + EM+    P+
Sbjct: 171 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 58/101 (57%), Gaps = 5/101 (4%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +  +I+  L YLHS    +++RDLK +N+ ++  +G +KI D GL    +    T + 
Sbjct: 111 RFYGAEIVSALDYLHSEKN-VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKX 168
Query: 63  VIGTPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPY 102
             GTPE++APE+ E+ +Y   VD +  G+ + EM+    P+
Sbjct: 169 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 32/82 (39%), Positives = 50/82 (60%), Gaps = 4/82 (4%)
Query: 25  IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYEEEYNE 81
           ++HRDLK  N+F++G    VK+GD GLA ++   T  A++ +GTP +M+PE +    YNE
Sbjct: 137 VLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNE 195
Query: 82  LVDIYSFGMCILEMVTCEYPYN 103
             DI+S G  + E+     P+ 
Sbjct: 196 KSDIWSLGCLLYELCALMPPFT 217

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 32/82 (39%), Positives = 50/82 (60%), Gaps = 4/82 (4%)
Query: 25  IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPE-LYEEEYNE 81
           ++HRDLK  N+F++G    VK+GD GLA ++   T  A++ +GTP +M+PE +    YNE
Sbjct: 137 VLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNE 195
Query: 82  LVDIYSFGMCILEMVTCEYPYN 103
             DI+S G  + E+     P+ 
Sbjct: 196 KSDIWSLGCLLYELCALMPPFT 217

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 26/173 (15%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARS 62
           + ++ +I   L+YLH     II+RDLK DN+ ++ + G +K+ D G+     +P  T   
Sbjct: 124 RFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSX 180
Query: 63  VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSG 118
             GTP ++APE+   E+Y   VD ++ G+ + EM+    P++      NP Q        
Sbjct: 181 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------- 232
Query: 119 IKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLVTDNPKDLVCDP 170
                     D   +  +EK I +P S+ + A  +LK  FL  D  + L C P
Sbjct: 233 -------NTEDYLFQVILEKQIRIPRSMSVKAASVLKS-FLNKDPKERLGCLP 277

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 70/132 (53%), Gaps = 8/132 (6%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+LRGL Y+HS    IIHRDLK  N+ VN  + E++I D GLA    +      + T  +
Sbjct: 139 QLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDSELRILDFGLARQADEEMT-GYVATRWY 194
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++  +  +P ++  +  +   +V     P  L+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLA 254
Query: 126 KVTDPQVKQFIE 137
           K++    + +I+
Sbjct: 255 KISSEHARTYIQ 266

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 87/168 (51%), Gaps = 14/168 (8%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSV 63
           + + +QI+  + Y H H   I+HRDLK +N+ ++ +N  VKI D GL+ +M      ++ 
Sbjct: 111 RRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTS 167
Query: 64  IGTPEFMAPELYEEEY--NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I 119
            G+P + APE+   +      VD++S G+ +  M+    P+++   P  ++KKV S   +
Sbjct: 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-NLFKKVNSCVYV 226
Query: 120 KPASLSKVTDPQVKQFIEKCIVPASL-RLPALELLKDPFLVTDNPKDL 166
            P  LS    P  +  I + IV   + R+   E+ +DP+   + P  L
Sbjct: 227 MPDFLS----PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYL 270

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 105 IKSYLFQLLQGLSFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT 161
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 108 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 164
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 107 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 163
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 164 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 105 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 161
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 108 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 164
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 105 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 161
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 106 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 162
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 163 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 108 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 164
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 107 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 163
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 164 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 107 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 163
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 164 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 104 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT 160
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 70/132 (53%), Gaps = 8/132 (6%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+LRGL Y+HS    IIHRDLK  N+ VN  + E++I D GLA    +      + T  +
Sbjct: 139 QLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDSELRILDFGLARQADEEMT-GYVATRWY 194
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++  +  +P ++  +  +   +V     P  L+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLA 254
Query: 126 KVTDPQVKQFIE 137
           K++    + +I+
Sbjct: 255 KISSEHARTYIQ 266

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 105 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 161
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 112 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT 168
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 169 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 109 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 165
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 166 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 106 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT 162
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 163 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 105 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT 161
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 108 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 164
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 108 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 164
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 165 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 104 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT 160
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 104 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT 160
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 104 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 160
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 105 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT 161
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 105 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 161
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 106 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 162
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 163 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 104 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYX 160
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 105 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT 161
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 104 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT 160
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA       A   + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMA-GFVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 74/134 (55%), Gaps = 14/134 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTPE 68
           QI +G+ Y+HS    +I+RDLK  NIF+  +  +VKIGD GL   ++    R    GT  
Sbjct: 130 QITKGVDYIHS--KKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRXRSKGTLR 186
Query: 69  FMAPE-LYEEEYNELVDIYSFGMCILEMV-TCEYPYNECKNPAQIYKKVTSGIKPASLSK 126
           +M+PE +  ++Y + VD+Y+ G+ + E++  C+  +      ++ +  +  GI    +S 
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF----ETSKFFTDLRDGI----ISD 238
Query: 127 VTDPQVKQFIEKCI 140
           + D + K  ++K +
Sbjct: 239 IFDKKEKTLLQKLL 252

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  T  
Sbjct: 109 IKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYT 165
Query: 62  SVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVT 97
             + T  + APE+    + Y+  VDI+S G    EMVT
Sbjct: 166 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 11/159 (6%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQ-QPTARSVIG 65
           RQ+L G+ Y+H +   I+HRDLK +N+ +     +  ++I D GL+   +     +  IG
Sbjct: 139 RQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIG 196
Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
           T  ++APE+    Y+E  D++S G+ +  +++   P+N   N   I KKV  G     L 
Sbjct: 197 TAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGA-NEYDILKKVEKGKYTFELP 255
Query: 126 --KVTDPQVKQFIEKCI--VPASLRLPALELLKDPFLVT 160
             K      K  I K +  VP S+R+ A + L   ++ T
Sbjct: 256 QWKKVSESAKDLIRKMLTYVP-SMRISARDALDHEWIQT 293

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 82/160 (51%), Gaps = 17/160 (10%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTPE 68
           I++ L+YL   +  +IHRD+K  NI ++   G++K+ D G++  +V  +   RS  G   
Sbjct: 133 IVKALYYLKEKHG-VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSA-GCAA 189
Query: 69  FMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GI 119
           +MAPE  +       +Y+   D++S G+ ++E+ T ++PY  CK   ++  KV      +
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL 249
Query: 120 KPASLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFL 158
            P  +    D Q   F++ C+     + P   +LL+  F+
Sbjct: 250 LPGHMGFSGDFQ--SFVKDCLTKDHRKRPKYNKLLEHSFI 287

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA       A   + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMA-GFVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 85/165 (51%), Gaps = 18/165 (10%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARS 62
           + +A +I+  L +LH     II+RDLK DN+ ++ + G  K+ D G+    +    T  +
Sbjct: 127 RFYAAEIISALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTAT 183
Query: 63  VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--I 119
             GTP+++APE+ +E  Y   VD ++ G+ + EM+    P+ E +N   +++ + +   +
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVV 242
Query: 120 KPASLSKVTDPQVKQFIEKCIVPASLRLPAL------ELLKDPFL 158
            P  L +     +K F+ K     ++RL +L       +L+ PF 
Sbjct: 243 YPTWLHEDATGILKSFMTK---NPTMRLGSLTQGGEHAILRHPFF 284

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/132 (37%), Positives = 71/132 (53%), Gaps = 10/132 (7%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 162 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 217
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPAS-L 124
            APE  L    YN  VDI+S G  + E++T    +P  +  N  Q   ++T G  PAS +
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLT-GTPPASVI 276
Query: 125 SKVTDPQVKQFI 136
           S++   + + +I
Sbjct: 277 SRMPSHEARNYI 288

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 14/167 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---T 66
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA    + TA  + G   T
Sbjct: 140 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA----RHTADEMTGYVAT 192
Query: 67  PEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPA 122
             + APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++       
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
            L K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 299

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA       A   + T  +
Sbjct: 129 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMA-GFVATRWY 184
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 245 KISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 288

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 14/167 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---T 66
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA    + TA  + G   T
Sbjct: 140 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA----RHTADEMTGYVAT 192
Query: 67  PEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPA 122
             + APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++       
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
            L K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 299

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 56/96 (58%), Gaps = 6/96 (6%)
Query: 13  RGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPE 68
           RGL YLH H +P IIHRD+K  NI ++    E  +GD GLA +M         +V GT  
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIG 208
Query: 69  FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYN 103
            +APE L   + +E  D++ +G+ +LE++T +  ++
Sbjct: 209 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 244

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 14/167 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG---T 66
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA    + TA  + G   T
Sbjct: 140 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA----RHTADEMTGYVAT 192
Query: 67  PEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPA 122
             + APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++       
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
            L K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 299

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 139 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDSELKILDFGLARHTDDEMT-GYVATRWY 194
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 254
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 255 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 298

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 135 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDSELKILDFGLARHTDDEMT-GYVATRWY 190
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 250
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 251 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 294

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--S 62
           +++  QI+ G+ YLHSH   I+HRDL   N+ +   N  +KI D GLA  ++ P  +  +
Sbjct: 115 RHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYT 171
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK- 120
           + GTP +++PE+     + L  D++S G     ++    P++       + K V +  + 
Sbjct: 172 LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM 231
Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 158
           P+ LS      + Q + +   PA  RL    +L  PF+
Sbjct: 232 PSFLSIEAKDLIHQLLRRN--PAD-RLSLSSVLDHPFM 266

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 59/108 (54%), Gaps = 20/108 (18%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---------- 55
           ++A+ I  G+ YLHS N  IIHRDL   N  V   N  V + D GLA +M          
Sbjct: 112 SFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 56  ---QQPTAR---SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMV 96
              ++P  +   +V+G P +MAPE+     Y+E VD++SFG+ + E++
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 70/132 (53%), Gaps = 8/132 (6%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+LRGL Y+HS    IIHRDLK  N+ VN  + E++I D GLA    +      + T  +
Sbjct: 131 QLLRGLKYIHSAG--IIHRDLKPSNVAVN-EDCELRILDFGLARQADEEMT-GYVATRWY 186
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++  +  +P ++  +  +   +V     P  L+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLA 246
Query: 126 KVTDPQVKQFIE 137
           K++    + +I+
Sbjct: 247 KISSEHARTYIQ 258

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDXELKILDFGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 144 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDXELKILDFGLARHTDDEMT-GYVATRWY 199
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 259
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 260 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 303

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 65/113 (57%), Gaps = 6/113 (5%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIF--VNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +Q+L  + YLH +   I+HRDLK +N+       N ++ I D GL+ + Q     +  GT
Sbjct: 113 QQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGT 170
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           P ++APE L ++ Y++ VD +S G+ I  ++ C YP    +  +++++K+  G
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGV-ITYILLCGYPPFYEETESKLFEKIKEG 222

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 138 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDXELKILDFGLARHTDDEMT-GYVATRWY 193
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 253
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 254 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 297

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 138 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDXELKILDFGLARHTDDEMT-GYVATRWY 193
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 253
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 254 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 297

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 92/176 (52%), Gaps = 16/176 (9%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLA---IVMQQPTA 60
           + + +Q++ G+ Y H+    + HRDLK +N  ++G+    +KI   G +   ++  QP  
Sbjct: 118 RFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP-- 173
Query: 61  RSVIGTPEFMAPE-LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS- 117
           +S +GTP ++APE L ++EY+ ++ D++S G+ +  M+   YP+ + + P    K +   
Sbjct: 174 KSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233
Query: 118 -GIKPASLSKV-TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 169
             ++ A    V   P+ +  I +  V  PA  R+   E+    + + + P DL+ D
Sbjct: 234 LNVQYAIPDYVHISPECRHLISRIFVADPAK-RISIPEIRNHEWFLKNLPADLMND 288

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 81/148 (54%), Gaps = 6/148 (4%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E 77
           + H+  +IHRD+K +N+ + G+NGE+KI D G ++        ++ GT +++ PE+ E  
Sbjct: 127 YCHSKRVIHRDIKPENLLL-GSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 78  EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIE 137
            ++E VD++S G+   E +    P+ E     + Y+++ S ++      VT+   +  I 
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPF-EAHTYQETYRRI-SRVEFTFPDFVTE-GARDLIS 242
Query: 138 KCIVP-ASLRLPALELLKDPFLVTDNPK 164
           + +   AS RL   E+L+ P++  ++ K
Sbjct: 243 RLLKHNASQRLTLAEVLEHPWIKANSSK 270

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 85/150 (56%), Gaps = 10/150 (6%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYE 76
           + H+  +IHRD+K +N+ + G+NGE+KI D G ++    P++R  ++ GT +++ PE+ E
Sbjct: 127 YCHSKRVIHRDIKPENLLL-GSNGELKIADFGWSV--HAPSSRRDTLCGTLDYLPPEMIE 183
Query: 77  -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQF 135
              ++E VD++S G+   E +    P+ E     + Y+++ S ++      VT+   +  
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPF-EAHTYQETYRRI-SRVEFTFPDFVTE-GARDL 240
Query: 136 IEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
           I + +   AS RL   E+L+ P++  ++ K
Sbjct: 241 ISRLLKHNASQRLTLAEVLEHPWIKANSSK 270

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 156 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA-RHTDDEMXGYVATRWY 211
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 271
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 272 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 315

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 145 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 200
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 260
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 261 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 304

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 145 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 200
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 260
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 261 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 304

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 145 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 200
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 201 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 260
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 261 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 304

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 60/106 (56%), Gaps = 5/106 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           ++ +A +I+ GL   H HN  +++RDLK  NI ++  +G V+I DLGLA    +    + 
Sbjct: 293 MRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS 349
Query: 64  IGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN 107
           +GT  +MAPE+ ++   Y+   D +S G  + +++    P+ + K 
Sbjct: 350 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 395

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 153 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 208
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 268
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 269 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 312

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 135 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 190
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 250
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 251 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 294

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 60/106 (56%), Gaps = 5/106 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           ++ +A +I+ GL   H HN  +++RDLK  NI ++  +G V+I DLGLA    +    + 
Sbjct: 294 MRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS 350
Query: 64  IGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN 107
           +GT  +MAPE+ ++   Y+   D +S G  + +++    P+ + K 
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 135 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 190
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 250
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 251 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 294

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 77/143 (53%), Gaps = 10/143 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 65
           +A +I  GL  LH     I++RDLK +NI ++ ++G ++I DLGLA+ V +  T +  +G
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVG 347
Query: 66  TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PA 122
           T  +MAPE+ + E Y    D ++ G  + EM+  + P+ + K   +  ++V   +K  P 
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKEVPE 406
Query: 123 SLSKVTDPQVKQFIEK--CIVPA 143
             S+   PQ +    +  C  PA
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPA 429

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 152 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 207
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 267
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 268 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 311

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 138 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 193
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 253
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 254 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 297

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 132 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 187
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 188 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 247
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 248 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 291

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 144 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 199
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 200 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 259
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 260 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 303

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 139 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 194
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 254
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 255 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 298

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 139 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 194
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 254
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 255 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 298

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 156 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 211
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 212 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 271
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 272 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 315

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 60/106 (56%), Gaps = 5/106 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           ++ +A +I+ GL   H HN  +++RDLK  NI ++  +G V+I DLGLA    +    + 
Sbjct: 294 MRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS 350
Query: 64  IGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN 107
           +GT  +MAPE+ ++   Y+   D +S G  + +++    P+ + K 
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 60/106 (56%), Gaps = 5/106 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           ++ +A +I+ GL   H HN  +++RDLK  NI ++  +G V+I DLGLA    +    + 
Sbjct: 294 MRFYAAEIILGLE--HMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHAS 350
Query: 64  IGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN 107
           +GT  +MAPE+ ++   Y+   D +S G  + +++    P+ + K 
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 60/103 (58%), Gaps = 6/103 (5%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  ++  GL +LHS    II+RDLK +NI ++   G +K+ D GL+   +  +  A 
Sbjct: 132 VKFYLAELALGLDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKEAIDHEKKAY 188
Query: 62  SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYN 103
           S  GT E+MAPE+   + ++   D +S+G+ + EM+T   P+ 
Sbjct: 189 SFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQ 231

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 140 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 195
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 196 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 299

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 131 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 186
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 246
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 247 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 290

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GXVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 135 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 190
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 191 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 250
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 251 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 294

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 152 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 207
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 208 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 267
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 268 KISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 311

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 74/142 (52%), Gaps = 13/142 (9%)
Query: 25  IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPE-LYEEEYNE 81
           ++HRDLK  N+F++G    VK+GD GLA ++   +  A+  +GTP +M+PE +    YNE
Sbjct: 137 VLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYNE 195
Query: 82  LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEK 138
             DI+S G  + E+     P+      A   K++   I+     ++      ++ + I +
Sbjct: 196 KSDIWSLGCLLYELCALMPPFT-----AFSQKELAGKIREGKFRRIPYRYSDELNEIITR 250
Query: 139 CIVPASLRLPAL-ELLKDPFLV 159
            +       P++ E+L++P ++
Sbjct: 251 MLNLKDYHRPSVEEILENPLIL 272

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 143 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 198
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 258
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 259 KISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 302

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 153 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 208
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 268
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 269 KISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 312

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 138 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 193
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 194 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 253
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 254 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 297

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 139 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 194
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 254
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 255 KISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 298

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 153 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLA-RHTDDEMXGXVATRWY 208
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 209 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 268
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 269 KISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 312

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 77/143 (53%), Gaps = 10/143 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARSVIG 65
           +A +I  GL  LH     I++RDLK +NI ++ ++G ++I DLGLA+ V +  T +  +G
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVG 347
Query: 66  TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PA 122
           T  +MAPE+ + E Y    D ++ G  + EM+  + P+ + K   +  ++V   +K  P 
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKEVPE 406
Query: 123 SLSKVTDPQVKQFIEK--CIVPA 143
             S+   PQ +    +  C  PA
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPA 429

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 129 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 184
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 288

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 130 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 185
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 245
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 246 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 289

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 130 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 185
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 186 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 245
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 246 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 289

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 129 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 184
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 245 KISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 288

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 129 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEMT-GYVATRWY 184
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 245 KISSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLD 288

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 6/96 (6%)
Query: 13  RGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPE 68
           RGL YLH H +P IIHRD+K  NI ++    E  +GD GLA +M         +V G   
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIG 200
Query: 69  FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYN 103
            +APE L   + +E  D++ +G+ +LE++T +  ++
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GL            + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDSELKILDFGLCRHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDYGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 54/105 (51%), Gaps = 5/105 (4%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           ++ IK   + +L    Y+H+    I HRD+K  NI ++ N G VK+ D G +  M     
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNE-KNICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDKKI 207
Query: 61  RSVIGTPEFMAPELYEEE--YN-ELVDIYSFGMCILEMVTCEYPY 102
           +   GT EFM PE +  E  YN   VDI+S G+C+  M     P+
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 14  GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV--KIGDLGLAIVMQQ-PTARSVIGTPEFM 70
            L YLH +   IIHRDLK +NI +      +  KI DLG A  + Q       +GT +++
Sbjct: 133 ALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 190
Query: 71  APELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
           APEL E++ Y   VD +SFG    E +T   P+     P Q + KV
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 14  GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEV--KIGDLGLAIVMQQ-PTARSVIGTPEFM 70
            L YLH +   IIHRDLK +NI +      +  KI DLG A  + Q       +GT +++
Sbjct: 134 ALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL 191
Query: 71  APELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
           APEL E++ Y   VD +SFG    E +T   P+     P Q + KV
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 237

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDAGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 78/154 (50%), Gaps = 14/154 (9%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--T 59
           + ++ +  QI+ G+ + HSHN  IIHRD+K +NI V+  +G VK+ D G A  +  P   
Sbjct: 124 QVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEV 180
Query: 60  ARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
               + T  + APEL   + +Y + VD+++ G  + EM   E  +    +  Q+Y  +  
Sbjct: 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM- 239
Query: 118 GIKPASLSKVTDPQVKQFIEKCIVPASLRLPALE 151
                 L  +  P+ ++   K  V A +RLP ++
Sbjct: 240 -----CLGNLI-PRHQELFNKNPVFAGVRLPEIK 267

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 53/104 (50%), Gaps = 20/104 (19%)
Query: 11  ILRGLHYLH------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--- 61
           I  GL +LH         P I HRDLK  NI V   NG+  I DLGLA++  Q T +   
Sbjct: 143 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDV 201
Query: 62  ---SVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEM 95
                +GT  +MAPE+ +E          + VDI++FG+ + E+
Sbjct: 202 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDRGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 51/88 (57%), Gaps = 4/88 (4%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE 76
           H H+  II+RDLK +NI ++   G +K+ D GL+   +  +  A S  GT E+MAPE+  
Sbjct: 142 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 200
Query: 77  EE-YNELVDIYSFGMCILEMVTCEYPYN 103
              + +  D +SFG+ + EM+T   P+ 
Sbjct: 201 RRGHTQSADWWSFGVLMFEMLTGTLPFQ 228

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 51/88 (57%), Gaps = 4/88 (4%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE 76
           H H+  II+RDLK +NI ++   G +K+ D GL+   +  +  A S  GT E+MAPE+  
Sbjct: 141 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 77  EE-YNELVDIYSFGMCILEMVTCEYPYN 103
              + +  D +SFG+ + EM+T   P+ 
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 53/104 (50%), Gaps = 20/104 (19%)
Query: 11  ILRGLHYLH------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--- 61
           I  GL +LH         P I HRDLK  NI V   NG+  I DLGLA++  Q T +   
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDV 172
Query: 62  ---SVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEM 95
                +GT  +MAPE+ +E          + VDI++FG+ + E+
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 91/176 (51%), Gaps = 16/176 (9%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLA---IVMQQPTA 60
           + + +Q++ G+ Y H+    + HRDLK +N  ++G+    +KI   G +   ++  QP  
Sbjct: 118 RFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP-- 173
Query: 61  RSVIGTPEFMAPE-LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS- 117
           +  +GTP ++APE L ++EY+ ++ D++S G+ +  M+   YP+ + + P    K +   
Sbjct: 174 KDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233
Query: 118 -GIKPASLSKV-TDPQVKQFIEKCIV--PASLRLPALELLKDPFLVTDNPKDLVCD 169
             ++ A    V   P+ +  I +  V  PA  R+   E+    + + + P DL+ D
Sbjct: 234 LNVQYAIPDYVHISPECRHLISRIFVADPAK-RISIPEIRNHEWFLKNLPADLMND 288

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/104 (36%), Positives = 53/104 (50%), Gaps = 20/104 (19%)
Query: 11  ILRGLHYLH------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--- 61
           I  GL +LH         P I HRDLK  NI V   NG+  I DLGLA++  Q T +   
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDV 172
Query: 62  ---SVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEM 95
                +GT  +MAPE+ +E          + VDI++FG+ + E+
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 51/88 (57%), Gaps = 4/88 (4%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPELYE 76
           H H+  II+RDLK +NI ++   G +K+ D GL+   +  +  A S  GT E+MAPE+  
Sbjct: 141 HLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 77  EE-YNELVDIYSFGMCILEMVTCEYPYN 103
              + +  D +SFG+ + EM+T   P+ 
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 61/108 (56%), Gaps = 5/108 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++        ++ GT ++
Sbjct: 142 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDY 198
Query: 70  MAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           + PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 199 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 245

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDGGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 84/161 (52%), Gaps = 8/161 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++        ++ GT ++
Sbjct: 133 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDY 189
Query: 70  MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 128
           + PE+ E   ++E VD++S G+   E +  + P+ E     + YK++ S ++      VT
Sbjct: 190 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVT 247
Query: 129 DPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKDLVC 168
           +   +  I + +     + P L E+L+ P++  ++ K   C
Sbjct: 248 E-GARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 287

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 73/142 (51%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 135 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 191
Query: 61  RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            S +GT ++++PEL  E+  ++  D+++ G CI+  +    P     N   I++K+    
Sbjct: 192 NSFVGTAQYVSPELLTEKSASKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 248
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLV 270

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 11/159 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIF-VNGNNGEVKIGDLGLAIVMQQPTARSV-I 64
           + +QI  G+   H H   I+H DLK +NI  VN +  ++KI D GLA   +      V  
Sbjct: 192 FMKQICEGIR--HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249
Query: 65  GTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIK 120
           GTPEF+APE+   ++     D++S G+    +++   P+    N A+    + +    ++
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF-LGDNDAETLNNILACRWDLE 308
Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
                 +++ + K+FI K ++   S R+ A E LK P+L
Sbjct: 309 DEEFQDISE-EAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 61/108 (56%), Gaps = 5/108 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++        ++ GT ++
Sbjct: 121 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDY 177
Query: 70  MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           + PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 224

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 61/108 (56%), Gaps = 5/108 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++        ++ GT ++
Sbjct: 121 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDY 177
Query: 70  MAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           + PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 224

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 61/108 (56%), Gaps = 5/108 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++        ++ GT ++
Sbjct: 119 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDY 175
Query: 70  MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           + PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 222

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 61/108 (56%), Gaps = 5/108 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++        ++ GT ++
Sbjct: 116 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDY 172
Query: 70  MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           + PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 219

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 64/110 (58%), Gaps = 9/110 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTP 67
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++    P++R   + GT 
Sbjct: 142 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRDDLCGTL 196
Query: 68  EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           +++ PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 245

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 65/110 (59%), Gaps = 9/110 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTP 67
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++    P++R  ++ GT 
Sbjct: 119 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRAALCGTL 173
Query: 68  EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           +++ PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 222

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTAR 61
           +  Q+LRGL Y+HS N  ++HRDLK  N+F+N  +  +KIGD GLA +M      +    
Sbjct: 125 FMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 97
             + T  + +P L      Y + +D+++ G    EM+T
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 65/110 (59%), Gaps = 9/110 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTP 67
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++    P++R  ++ GT 
Sbjct: 117 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRDTLCGTL 171
Query: 68  EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           +++ PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 220

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 57/101 (56%), Gaps = 7/101 (6%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 58
           +  +K +  Q+L+GL + H +   I+HRDLK  N+ +N   G++K+GD GLA     P  
Sbjct: 107 LNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVN 163
Query: 59  TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 97
           T  S + T  + AP++      Y+  +DI+S G  + EM+T
Sbjct: 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           IK +  Q+LRG+ + H H   I+HRDLK  N+ +N ++G +K+ D GLA     P     
Sbjct: 121 IKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYT 177
Query: 64  --IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 97
             + T  + AP++    ++Y+  VDI+S G    EM+T
Sbjct: 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 55/98 (56%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           IK +  Q+LRG+ + H H   I+HRDLK  N+ +N ++G +K+ D GLA     P     
Sbjct: 121 IKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYT 177
Query: 64  --IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 97
             + T  + AP++    ++Y+  VDI+S G    EM+T
Sbjct: 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 65/111 (58%), Gaps = 7/111 (6%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVK--IGDLGLAIVMQQPTARSV-IG 65
           RQ+L  ++YLH     I+HRDLK +N+     + E K  I D GL+ +  +    S   G
Sbjct: 127 RQVLDAVYYLHRMG--IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACG 184
Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
           TP ++APE L ++ Y++ VD +S G+ I  ++ C YP    +N +++++++
Sbjct: 185 TPGYVAPEVLAQKPYSKAVDCWSIGV-IAYILLCGYPPFYDENDSKLFEQI 234

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E 77
           + H+  +IHRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E  
Sbjct: 122 YCHSKRVIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 180
Query: 78  EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
            ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 181 MHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 218

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E 77
           + H+  +IHRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E  
Sbjct: 127 YCHSKRVIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 78  EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
            ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 223

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 62/101 (61%), Gaps = 7/101 (6%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYE 76
           + H+  +IHRD+K +N+ + G+ GE+KI D G ++    P++R  ++ GT +++ PE+ E
Sbjct: 126 YCHSKRVIHRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRTTLCGTLDYLPPEMIE 182
Query: 77  -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
              ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 222

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 83/161 (51%), Gaps = 8/161 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++        ++ GT ++
Sbjct: 121 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDY 177
Query: 70  MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVT 128
           + PE  E   ++E VD++S G+   E +  + P+ E     + YK++ S ++      VT
Sbjct: 178 LPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVT 235
Query: 129 DPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKDLVC 168
           +   +  I + +     + P L E+L+ P++  ++ K   C
Sbjct: 236 E-GARDLISRLLKHNPSQRPXLREVLEHPWITANSSKPSNC 275

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 60/108 (55%), Gaps = 5/108 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++         + GT ++
Sbjct: 121 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRXXLXGTLDY 177
Query: 70  MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           + PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 178 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 224

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 62/101 (61%), Gaps = 7/101 (6%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYE 76
           + H+  +IHRD+K +N+ + G+ GE+KI D G ++    P++R  ++ GT +++ PE+ E
Sbjct: 123 YCHSKRVIHRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRAALCGTLDYLPPEMIE 179
Query: 77  -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
              ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 219

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI   GLA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILGFGLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E 77
           + H+  +IHRD+K +N+ + G+ GE+KI D G ++        ++ GT +++ PE+ E  
Sbjct: 120 YCHSKRVIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 178
Query: 78  EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
            ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 179 MHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 216

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 60/108 (55%), Gaps = 5/108 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++         + GT ++
Sbjct: 118 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRXXLCGTLDY 174
Query: 70  MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           + PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 175 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 221

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 72/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 136 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 192
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            S +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 193 NSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 249
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 250 LEYDFPEKFFPKARDLVEKLLV 271

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 70/138 (50%), Gaps = 8/138 (5%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+    Q+L+GL Y+HS    ++HRDLK  N+ VN  + E+KI D GLA          V
Sbjct: 146 IQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGYV 202
Query: 64  IGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGI 119
           + T  + APE  L    YN+ VDI+S G  + EM+T +  +       Q+ +  KVT   
Sbjct: 203 V-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 261
Query: 120 KPASLSKVTDPQVKQFIE 137
               + K+ D   K +I+
Sbjct: 262 GTEFVQKLNDKAAKSYIQ 279

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           I + + YLH+    ++HRDLK  NI     +GN   ++I D G A   Q      ++ TP
Sbjct: 125 ITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFA--KQLRAENGLLMTP 180
Query: 68  ----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSG-- 118
                F+APE+ E + Y+   DI+S G+ +  M+T   P+    +  P +I  ++ SG  
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF 240
Query: 119 -IKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLV 159
            +     + V+D   K  + K + V    RL A  +L+ P++V
Sbjct: 241 SLSGGYWNSVSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 64/110 (58%), Gaps = 9/110 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTP 67
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++    P++R   + GT 
Sbjct: 121 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRTDLCGTL 175
Query: 68  EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           +++ PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 224

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 75/147 (51%), Gaps = 21/147 (14%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 138 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 194
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+   I
Sbjct: 195 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKI---I 250
Query: 120 K-----PASLSKVTDPQVKQFIEKCIV 141
           K     PA+      P+ +  +EK +V
Sbjct: 251 KLEYDFPAAFF----PKARDLVEKLLV 273

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 64/110 (58%), Gaps = 9/110 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTP 67
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++    P++R   + GT 
Sbjct: 117 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRTDLCGTL 171
Query: 68  EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           +++ PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 220

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 14  GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV----MQQPTARSVIGTPEF 69
           G+++LH ++   IHRD+K  NI ++      KI D GLA       Q      ++GT  +
Sbjct: 145 GINFLHENHH--IHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAY 201
Query: 70  MAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 108
           MAPE    E     DIYSFG+ +LE++T     +E + P
Sbjct: 202 MAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 60/108 (55%), Gaps = 5/108 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++         + GT ++
Sbjct: 116 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTELCGTLDY 172
Query: 70  MAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           + PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 219

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 70/138 (50%), Gaps = 8/138 (5%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+    Q+L+GL Y+HS    ++HRDLK  N+ VN  + E+KI D GLA          V
Sbjct: 128 IQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGYV 184
Query: 64  IGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGI 119
           + T  + APE  L    YN+ VDI+S G  + EM+T +  +       Q+ +  KVT   
Sbjct: 185 V-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243
Query: 120 KPASLSKVTDPQVKQFIE 137
               + K+ D   K +I+
Sbjct: 244 GTEFVQKLNDKAAKSYIQ 261

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 64/110 (58%), Gaps = 9/110 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTP 67
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++    P++R   + GT 
Sbjct: 116 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRTDLCGTL 170
Query: 68  EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           +++ PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 219

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 14  GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV----MQQPTARSVIGTPEF 69
           G+++LH ++   IHRD+K  NI ++      KI D GLA       Q      ++GT  +
Sbjct: 139 GINFLHENHH--IHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAY 195
Query: 70  MAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 108
           MAPE    E     DIYSFG+ +LE++T     +E + P
Sbjct: 196 MAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 234

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 57/99 (57%), Gaps = 3/99 (3%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E 77
           + H+  +IHRD+K +N+ + G+ GE+KI D G ++         + GT +++ PE+ E  
Sbjct: 126 YCHSKRVIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGR 184
Query: 78  EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
            ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 222

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 14  GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV----MQQPTARSVIGTPEF 69
           G+++LH ++   IHRD+K  NI ++      KI D GLA       Q      ++GT  +
Sbjct: 145 GINFLHENHH--IHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAY 201
Query: 70  MAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 108
           MAPE    E     DIYSFG+ +LE++T     +E + P
Sbjct: 202 MAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 240

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 61/101 (60%), Gaps = 7/101 (6%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPELYE 76
           + H+  +IHRD+K +N+ + G+ GE+KI D G ++    P++R   + GT +++ PE+ E
Sbjct: 126 YCHSKRVIHRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRDDLCGTLDYLPPEMIE 182
Query: 77  -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
              ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 222

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 61/101 (60%), Gaps = 7/101 (6%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGTPEFMAPELYE 76
           + H+  +IHRD+K +N+ + G+ GE+KI D G ++    P++R  ++ GT +++ PE+ E
Sbjct: 123 YCHSKKVIHRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRAALCGTLDYLPPEMIE 179
Query: 77  -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
              ++E VD++S G+   E +  + P+ E       YK+++
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQDTYKRIS 219

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 62/106 (58%), Gaps = 9/106 (8%)
Query: 14  GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMA 71
            L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++    P++R   + GT +++ 
Sbjct: 120 ALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRTDLCGTLDYLP 174
Query: 72  PELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 219

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 61/101 (60%), Gaps = 7/101 (6%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPELYE 76
           + H+  +IHRD+K +N+ + G+ GE+KI D G ++    P++R   + GT +++ PE+ E
Sbjct: 123 YCHSKRVIHRDIKPENLLL-GSAGELKIADFGWSV--HAPSSRRTXLCGTLDYLPPEMIE 179
Query: 77  -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
              ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 219

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 57/99 (57%), Gaps = 3/99 (3%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E 77
           + H+  +IHRD+K +N+ + G+ GE+KI D G ++         + GT +++ PE+ E  
Sbjct: 123 YCHSKRVIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGR 181
Query: 78  EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
            ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 219

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/119 (37%), Positives = 63/119 (52%), Gaps = 9/119 (7%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+L+GL Y+H+    IIHRDLK  N+ VN  + E+KI D GLA          V+ T  +
Sbjct: 136 QMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQADSEMXGXVV-TRWY 191
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK--KVTSGIKPASL 124
            APE  L    Y + VDI+S G  + EM+T +  +    +  Q+ +  KVT G  PA  
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT-GTPPAEF 249

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 72/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 132 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 188
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            S +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 189 NSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 245
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 246 LEYDFPEKFFPKARDLVEKLLV 267

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 12  LRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IGTPEFM 70
           ++ L++L   N  IIHRD+K  NI ++  +G +K+ D G++  +    A++   G   +M
Sbjct: 135 VKALNHL-KENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYM 192
Query: 71  APELYE-----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--- 122
           APE  +     + Y+   D++S G+ + E+ T  +PY +  +      +V  G  P    
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN 252
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLV 159
           S  +   P    F+  C+     + P   ELLK PF++
Sbjct: 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 8/164 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D  LA           + T  +
Sbjct: 133 QILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFYLARHTDDEMT-GYVATRWY 188
Query: 70  MAPE--LYEEEYNELVDIYSFGMCILEMVTCE--YPYNECKNPAQIYKKVTSGIKPASLS 125
            APE  L    YN+ VDI+S G  + E++T    +P  +  +  ++  ++        L 
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 248
Query: 126 KVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           K++    + +I+       +    + +  +P  V    K LV D
Sbjct: 249 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 292

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 135 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 191
Query: 61  RSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I+ K+    
Sbjct: 192 NXFVGTAQYVSPELLTEKSAXKSSDLWALG-CIIYQLVAGLPPFRAGNEGLIFAKIIK-- 248
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLV 270

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 9/104 (8%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RS 62
           + + + +++G+ YLH     IIHRD+K  N+ V G +G +KI D G++   +   A   +
Sbjct: 140 RFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLV-GEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 63  VIGTPEFMAPELYEEEY----NELVDIYSFGMCILEMVTCEYPY 102
            +GTP FMAPE   E       + +D+++ G+ +   V  + P+
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 63/112 (56%), Gaps = 8/112 (7%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLA-IVMQQPTARSVIG 65
           +QIL  + YLH +   I+HRDLK +N+       +  +KI D GL+ IV  Q   ++V G
Sbjct: 155 KQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG 212
Query: 66  TPEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKV 115
           TP + APE+     Y   VD++S G+ I  ++ C + P+ + +    +++++
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGI-ITYILLCGFEPFYDERGDQFMFRRI 263

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 72/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 133 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 189
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            + +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 190 NAFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 246
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 247 LEYDFPEKFFPKARDLVEKLLV 268

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 82/158 (51%), Gaps = 8/158 (5%)
Query: 14  GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE 73
            L Y HS    +IHRD+K +N+ + G+ GE+KI + G ++        ++ GT +++ PE
Sbjct: 122 ALSYCHSKR--VIHRDIKPENLLL-GSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPE 178
Query: 74  LYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQV 132
           + E   ++E VD++S G+   E +  + P+ E     + YK++ S ++      VT+   
Sbjct: 179 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRI-SRVEFTFPDFVTE-GA 235
Query: 133 KQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKDLVCD 169
           +  I + +     + P L E+L+ P++  ++ K   C 
Sbjct: 236 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQ 273

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 60/108 (55%), Gaps = 5/108 (4%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G +         ++ GT ++
Sbjct: 117 ELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSCHAPSSRRTTLSGTLDY 173
Query: 70  MAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           + PE+ E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 220

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 57/98 (58%), Gaps = 6/98 (6%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQQPTA-RSVIG 65
           +QIL G++YLH +N  I+H DLK  NI ++     G++KI D G++  +      R ++G
Sbjct: 138 KQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG 195
Query: 66  TPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY 102
           TPE++APE+   +      D+++ G+    ++T   P+
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 47/88 (53%), Gaps = 4/88 (4%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LY 75
           H H   II+RDLK +NI +N + G VK+ D GL    +       +  GT E+MAPE L 
Sbjct: 136 HLHQKGIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 76  EEEYNELVDIYSFGMCILEMVTCEYPYN 103
              +N  VD +S G  + +M+T   P+ 
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFT 222

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 63/121 (52%), Gaps = 7/121 (5%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTA 60
           K  +   +QIL G+ Y H H   ++HRDLK +N+ ++ +    KI D GL+ +M      
Sbjct: 116 KESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFL 172
Query: 61  RSVIGTPEFMAPELYEEEY--NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           R   G+P + APE+          VDI+S G+ +  ++    P+++   P  ++KK+  G
Sbjct: 173 RXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKKICDG 231
Query: 119 I 119
           I
Sbjct: 232 I 232

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 135 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 191
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I+ K+    
Sbjct: 192 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEGLIFAKIIK-- 248
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLV 270

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 59/104 (56%), Gaps = 5/104 (4%)
Query: 14  GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE 73
            L Y HS    +IHRD+K +N+ + G+ GE+KI + G ++        ++ GT +++ PE
Sbjct: 123 ALSYCHSKR--VIHRDIKPENLLL-GSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPE 179
Query: 74  LYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
           + E   ++E VD++S G+   E +  + P+ E     + YK+++
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRIS 222

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 71/139 (51%), Gaps = 14/139 (10%)
Query: 21  HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARS--VIGTPEFMAPELYEE 77
           H    +HRD+K DN+ ++  NG +++ D G  + M    T +S   +GTP++++PE+ + 
Sbjct: 208 HQLHYVHRDIKPDNVLLD-VNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 266
Query: 78  ------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-SKVTD- 129
                 +Y    D +S G+C+ EM+  E P+   ++  + Y K+ +  +     S VTD 
Sbjct: 267 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHEERFQFPSHVTDV 325
Query: 130 -PQVKQFIEKCIVPASLRL 147
             + K  I++ I     RL
Sbjct: 326 SEEAKDLIQRLICSRERRL 344

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 84/168 (50%), Gaps = 15/168 (8%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTA 60
           K  ++  R +L  + +LH++N  I+HRDLK +NI ++ +N ++++ D G +  ++     
Sbjct: 200 KETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKL 256
Query: 61  RSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 113
           R + GTP ++APE+ +         Y + VD+++ G+ +  ++    P+   +    + +
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLR 315
Query: 114 KVTSGIKPASLSKVTD--PQVKQFIEKCI-VPASLRLPALELLKDPFL 158
            +  G    S  +  D    VK  I + + V    RL A + L+ PF 
Sbjct: 316 MIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 54/113 (47%), Gaps = 20/113 (17%)
Query: 2   KAIKNWARQILRGLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 55
           K++   A   + GL +LH+        P I HRDLK  NI V   NG   I DLGLA+  
Sbjct: 134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKF 192
Query: 56  QQPT------ARSVIGTPEFMAPELYEEEYNE-------LVDIYSFGMCILEM 95
              T        + +GT  +M PE+ +E  N        + D+YSFG+ + E+
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 135 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 191
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 192 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 248
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLV 270

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 136 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 192
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 193 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 249
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 250 LEYDFPEKFFPKARDLVEKLLV 271

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 135 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 191
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 192 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 248
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLV 270

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 133 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 189
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 190 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 246
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 247 LEYDFPEKFFPKARDLVEKLLV 268

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 168
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 135 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 191
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 192 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 248
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 249 LEYDFPEKFFPKARDLVEKLLV 270

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 58/101 (57%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G+HYLHS    I H DLK +NI +   N  N  +K+ D G+A  ++     ++
Sbjct: 113 FLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 170
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 133 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 189
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 190 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 246
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 247 LEYDFPEKFFPKARDLVEKLLV 268

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 71/139 (51%), Gaps = 14/139 (10%)
Query: 21  HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQPTARS--VIGTPEFMAPELYEE 77
           H    +HRD+K DNI ++  NG +++ D G  + +M+  T +S   +GTP++++PE+ + 
Sbjct: 192 HQLHYVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 78  ------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-SKVTD- 129
                  Y    D +S G+C+ EM+  E P+   ++  + Y K+ +  +     ++VTD 
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKERFQFPTQVTDV 309
Query: 130 -PQVKQFIEKCIVPASLRL 147
               K  I + I     RL
Sbjct: 310 SENAKDLIRRLICSREHRL 328

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 58/101 (57%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G+HYLHS    I H DLK +NI +   N  N  +K+ D G+A  ++     ++
Sbjct: 120 FLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 177
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 133 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 189
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 190 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 246
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 247 LEYDFPEKFFPKARDLVEKLLV 268

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 169
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 140 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 196
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 197 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 253
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 254 LEYDFPEKFFPKARDLVEKLLV 275

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 71/139 (51%), Gaps = 14/139 (10%)
Query: 21  HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARS--VIGTPEFMAPELYEE 77
           H    +HRD+K DN+ ++  NG +++ D G  + M    T +S   +GTP++++PE+ + 
Sbjct: 192 HQLHYVHRDIKPDNVLLD-VNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQA 250
Query: 78  ------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-SKVTD- 129
                 +Y    D +S G+C+ EM+  E P+   ++  + Y K+ +  +     S VTD 
Sbjct: 251 MEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHEERFQFPSHVTDV 309
Query: 130 -PQVKQFIEKCIVPASLRL 147
             + K  I++ I     RL
Sbjct: 310 SEEAKDLIQRLICSRERRL 328

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 58/101 (57%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G+HYLHS    I H DLK +NI +   N  N  +K+ D G+A  ++     ++
Sbjct: 134 FLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN 191
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 192 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV- 63
           K++  Q+L G+ Y H     ++HRDLK  N+ +N   GE+KI D GLA     P  +   
Sbjct: 103 KSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTH 159
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
            I T  + AP++    ++Y+  +DI+S G    EMV
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXG 168
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/88 (37%), Positives = 46/88 (52%), Gaps = 4/88 (4%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI--VMQQPTARSVIGTPEFMAPE-LY 75
           H H   II+RDLK +NI +N + G VK+ D GL    +          GT E+MAPE L 
Sbjct: 136 HLHQKGIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 76  EEEYNELVDIYSFGMCILEMVTCEYPYN 103
              +N  VD +S G  + +M+T   P+ 
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFT 222

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 19/163 (11%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           I + + YLH+    ++HRDLK  NI     +GN   ++I D G A   Q      ++ TP
Sbjct: 125 ITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFA--KQLRAENGLLXTP 180
Query: 68  ----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSG-- 118
                F+APE+ E + Y+   DI+S G+ +   +T   P+    +  P +I  ++ SG  
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKF 240
Query: 119 -IKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLV 159
            +     + V+D   K  + K + V    RL A  +L+ P++V
Sbjct: 241 SLSGGYWNSVSD-TAKDLVSKXLHVDPHQRLTAALVLRHPWIV 282

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXG 168
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEY 217

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 168
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 117 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 173
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 174 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 230
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 231 LEYDFPEKFFPKARDLVEKLLV 252

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 169
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 169
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 169
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 168
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXG 168
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXG 169
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 65/111 (58%), Gaps = 9/111 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPTA--RSVIG 65
           Q+L  + YLH     I+HRDLK +N+       + ++ I D GL+  M+ P +   +  G
Sbjct: 124 QVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACG 180
Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
           TP ++APE L ++ Y++ VD +S G+ I  ++ C YP    +N A++++++
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGV-IAYILLCGYPPFYDENDAKLFEQI 230

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/113 (30%), Positives = 58/113 (51%), Gaps = 15/113 (13%)
Query: 19  HSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFM----AP 72
           H H+  ++HRDLK +N+      +N E+KI D G A +  +P     + TP F     AP
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTLHYAAP 178
Query: 73  ELYEEE-YNELVDIYSFGMCILEMVTCEYPYNE------CKNPAQIYKKVTSG 118
           EL  +  Y+E  D++S G+ +  M++ + P+        C +  +I KK+  G
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 132 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 188
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 189 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 245
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 246 LEYDFPEKFFPKARDLVEKLLV 267

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 66/111 (59%), Gaps = 9/111 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPTA--RSVIG 65
           Q+L  + YLH  +  I+HRDLK +N+       + ++ I D GL+  M+ P +   +  G
Sbjct: 124 QVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACG 180
Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
           TP ++APE L ++ Y++ VD +S G+ I  ++ C YP    +N A++++++
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGV-IAYILLCGYPPFYDENDAKLFEQI 230

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 110 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 166
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 167 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 223
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 224 LEYDFPEKFFPKARDLVEKLLV 245

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 111 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 167
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 168 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 224
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 225 LEYDFPEKFFPKARDLVEKLLV 246

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 66/111 (59%), Gaps = 9/111 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPTA--RSVIG 65
           Q+L  + YLH  +  I+HRDLK +N+       + ++ I D GL+  M+ P +   +  G
Sbjct: 124 QVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACG 180
Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
           TP ++APE L ++ Y++ VD +S G+ I  ++ C YP    +N A++++++
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGV-IAYILLCGYPPFYDENDAKLFEQI 230

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 59/107 (55%), Gaps = 8/107 (7%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
           + +K +  +++  L YL   N  IIHRD+K DNI ++  +G V I D  +A ++ + T  
Sbjct: 115 ETVKLFICELVMALDYLQ--NQRIIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQI 171
Query: 62  SVI-GTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYN 103
           + + GT  +MAPE++       Y+  VD +S G+   E++    PY+
Sbjct: 172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 111 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 167
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 134 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTSDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 168
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMXG 168
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 113 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 169
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 170 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 226
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 227 LEYDFPEKFFPKARDLVEKLLV 248

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-R 61
           ++ +QIL G++YLH+    I H DLK +NI +   N     +K+ D GLA  ++     +
Sbjct: 119 SFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 62  SVIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGI 119
           ++ GTPEF+APE+   E   L  D++S G+    +++   P+  + K          S  
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD 236
Query: 120 KPASLSKVTDPQVKQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 167
                   T    K FI K +V  +  RL   E L+ P++   DN + +V
Sbjct: 237 FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 168
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV- 63
           K++  Q+L G+ Y H     ++HRDLK  N+ +N   GE+KI D GLA     P  +   
Sbjct: 103 KSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTH 159
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
            + T  + AP++    ++Y+  +DI+S G    EMV
Sbjct: 160 EVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 7/96 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV- 63
           K++  Q+L G+ Y H     ++HRDLK  N+ +N   GE+KI D GLA     P  +   
Sbjct: 103 KSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTH 159
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
            + T  + AP++    ++Y+  +DI+S G    EMV
Sbjct: 160 EVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 21/109 (19%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ------------ 57
           QI   + +LHS    ++HRDLK  NIF   ++  VK+GD GL   M Q            
Sbjct: 126 QIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 58  PTARSV--IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYN 103
             AR    +GT  +M+PE ++   Y+  VDI+S G+ + E++   YP++
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFS 228

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/142 (28%), Positives = 71/142 (50%), Gaps = 11/142 (7%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTA 60
           + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q  A
Sbjct: 112 RFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARA 168
Query: 61  RSVIGTPEFMAPELYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              +GT ++++PEL  E+   +  D+++ G CI+  +    P     N   I++K+    
Sbjct: 169 NXFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPFRAGNEYLIFQKIIK-- 225
Query: 120 KPASLSKVTDPQVKQFIEKCIV 141
                 +   P+ +  +EK +V
Sbjct: 226 LEYDFPEKFFPKARDLVEKLLV 247

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA +       +      +
Sbjct: 152 QILRGLKYIHSAN--VLHRDLKPSNLLIN-TTCDLKICDFGLARIADPEHDHTGFLTEXV 208
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 82/170 (48%), Gaps = 10/170 (5%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-R 61
           ++ +QIL G++YLH+    I H DLK +NI +   N     +K+ D GLA  ++     +
Sbjct: 119 SFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 62  SVIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGI 119
           ++ GTPEF+APE+   E   L  D++S G+    +++   P+  + K          S  
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD 236
Query: 120 KPASLSKVTDPQVKQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 167
                   T    K FI K +V  +  RL   E L+ P++   DN + +V
Sbjct: 237 FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 169
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 53/105 (50%), Gaps = 7/105 (6%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV----MQQPTARSV 63
           A+    G+++LH ++   IHRD+K  NI ++      KI D GLA       Q      +
Sbjct: 130 AQGAANGINFLHENHH--IHRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRI 186
Query: 64  IGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 108
           +GT  + APE    E     DIYSFG+ +LE++T     +E + P
Sbjct: 187 VGTTAYXAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP 231

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/111 (32%), Positives = 65/111 (58%), Gaps = 9/111 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPTA--RSVIG 65
           Q+L  + YLH     I+HRDLK +N+       + ++ I D GL+  M+ P +   +  G
Sbjct: 124 QVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLS-KMEDPGSVLSTACG 180
Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
           TP ++APE L ++ Y++ VD +S G+ I  ++ C YP    +N A++++++
Sbjct: 181 TPGYVAPEVLAQKPYSKAVDCWSIGV-IAYILLCGYPPFYDENDAKLFEQI 230

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 14  GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE 73
            LHY H     +IHRD+K +N+ + G  GE+KI D G ++       R + GT +++ PE
Sbjct: 126 ALHYCHERK--VIHRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPE 182
Query: 74  LYE-EEYNELVDIYSFGMCILEMVTCEYPYN 103
           + E + ++E VD++  G+   E +    P++
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 168
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 169
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 168
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 169
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 52/102 (50%), Gaps = 18/102 (17%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ------------ 57
           QI   + +LHS    ++HRDLK  NIF   ++  VK+GD GL   M Q            
Sbjct: 172 QIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 58  --PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 96
              T    +GT  +M+PE ++   Y+  VDI+S G+ + E++
Sbjct: 229 AYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 14  GLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE 73
            LHY H     +IHRD+K +N+ + G  GE+KI D G ++       R + GT +++ PE
Sbjct: 127 ALHYCHERK--VIHRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPE 183
Query: 74  LYE-EEYNELVDIYSFGMCILEMVTCEYPYN 103
           + E + ++E VD++  G+   E +    P++
Sbjct: 184 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 61/109 (55%), Gaps = 9/109 (8%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI----G 65
           Q++ G+ YLH     I HRD+K +N+ ++  +  +KI D GLA V +      ++    G
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCG 168
Query: 66  TPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
           T  ++APEL +  E + E VD++S G+ +  M+  E P+++  +  Q Y
Sbjct: 169 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 217

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTXDLKIXDFGLARVADPDHDHTGFLTEYV 188
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 51/108 (47%), Gaps = 19/108 (17%)
Query: 8   ARQILRGLHYLH--------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 59
           A  + RGL YLH         H P I HRD+K  N+ +  NN    I D GLA+  +   
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGK 185
Query: 60  A----RSVIGTPEFMAPELYEEEYNE------LVDIYSFGMCILEMVT 97
           +       +GT  +MAPE+ E   N        +D+Y+ G+ + E+ +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 126 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKE 182
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 183 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 150 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKE 206
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 207 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 30/161 (18%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGTPEFMAPELY 75
           H H   II+RD+K +NI ++ +NG V + D GL+   +  +   A    GT E+MAP++ 
Sbjct: 174 HLHKLGIIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 76  ---EEEYNELVDIYSFGMCILEMVTCEYPYN---ECKNPAQIYKKVTSGIKPASLSKVTD 129
              +  +++ VD +S G+ + E++T   P+    E  + A+I +++     P        
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY------- 285
Query: 130 PQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDP 170
           PQ    + K ++    RL    L+KDP       K L C P
Sbjct: 286 PQEMSALAKDLIQ---RL----LMKDP------KKRLGCGP 313

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 124 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKE 180
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 181 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 117 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKE 173
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 174 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 122 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 152 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 119 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKE 175
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 122 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 86/172 (50%), Gaps = 14/172 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-R 61
           ++ +QIL G++YLH+    I H DLK +NI +   N     +K+ D GLA  ++     +
Sbjct: 119 SFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 62  SVIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTS 117
           ++ GTPEF+APE+   E   L  D++S G+    +++   P+    + +  A I   V+ 
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TSVSY 235
Query: 118 GIKPASLSKVTDPQVKQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 167
                  S  T    K FI K +V  +  RL   E L+ P++   DN + +V
Sbjct: 236 DFDEEFFSH-TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 122 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKE 178
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 179 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 118 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKE 174
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 175 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 134 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 125 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKE 181
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 182 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 53/103 (51%), Gaps = 8/103 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           IK +    L+GL YLH H   I+HRDLK +N+ ++  NG +K+ D GLA     P     
Sbjct: 114 IKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYX 170
Query: 64  --IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
             + T  + APEL      Y   VD+++ G CIL  +    P+
Sbjct: 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVG-CILAELLLRVPF 212

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 123 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKE 179
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 180 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 119 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKE 175
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 134 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLXEXV 192
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 137 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 193
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 138 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 194
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 229

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 129 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 185
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 220

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 137 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLXEXV 193
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 228

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 140 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 196
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 197 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 231

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 223

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 86/172 (50%), Gaps = 14/172 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-R 61
           ++ +QIL G++YLH+    I H DLK +NI +   N     +K+ D GLA  ++     +
Sbjct: 119 SFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 62  SVIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTS 117
           ++ GTPEF+APE+   E   L  D++S G+    +++   P+    + +  A I   V+ 
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TSVSY 235
Query: 118 GIKPASLSKVTDPQVKQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 167
                  S  T    K FI K +V  +  RL   E L+ P++   DN + +V
Sbjct: 236 DFDEEFFSH-TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 130 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 130 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 221

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 137 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKE 193
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 194 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 86/172 (50%), Gaps = 14/172 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-R 61
           ++ +QIL G++YLH+    I H DLK +NI +   N     +K+ D GLA  ++     +
Sbjct: 119 SFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 62  SVIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTS 117
           ++ GTPEF+APE+   E   L  D++S G+    +++   P+    + +  A I   V+ 
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-TSVSY 235
Query: 118 GIKPASLSKVTDPQVKQFIEKCIVPASL-RLPALELLKDPFLV-TDNPKDLV 167
                  S  T    K FI K +V  +  RL   E L+ P++   DN + +V
Sbjct: 236 DFDEEFFSH-TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 125 HCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/95 (37%), Positives = 52/95 (54%), Gaps = 10/95 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQPTARSVI 64
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V              +
Sbjct: 152 QILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 65  GTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            T  + APE  L  + Y + +DI+S G  + EM++
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 217
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 217
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 217
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 216
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 216
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 231
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 216
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 216
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 217 RYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 217
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 218 RYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 7/101 (6%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           M  +K +  Q+LRGL Y H     ++HRDLK  N+ +N   GE+K+ D GLA     PT 
Sbjct: 99  MHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTK 155
Query: 61  R--SVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
              + + T  +  P+  L   +Y+  +D++  G    EM T
Sbjct: 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 137 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEXXKVKE 193
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 194 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 55/102 (53%), Gaps = 7/102 (6%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--R 61
           +K++  Q+L+GL + HS N  ++HRDLK  N+ +N  NGE+K+ D GLA     P     
Sbjct: 103 VKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLADFGLARAFGIPVRCYS 159
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYP 101
           + + T  +  P++    + Y+  +D++S G    E+     P
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 231
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 6/96 (6%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPTARSVIGT 66
           R I   + +LHSHN  I HRD+K +N+       +  +K+ D G A    Q   ++   T
Sbjct: 135 RDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 192
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 101
           P ++APE L  E+Y++  D++S G+ I+ ++ C +P
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGV-IMYILLCGFP 227

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 188
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 177 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 236
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 237 RYHGRSAAVWSLGILLYDMVCGDIPF 262

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 203
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 189
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 204
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 6/96 (6%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPTARSVIGT 66
           R I   + +LHSHN  I HRD+K +N+       +  +K+ D G A    Q   ++   T
Sbjct: 116 RDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 173
Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP 101
           P ++APE L  E+Y++  D++S G+ I+ ++ C +P
Sbjct: 174 PYYVAPEVLGPEKYDKSCDMWSLGV-IMYILLCGFP 208

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 231
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 188
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 189
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 189
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 190 RYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 204
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 144 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 203
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 204 RYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 145 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 204
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 205 RYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 128 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 187
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 188 RYHGRSAAVWSLGILLYDMVCGDIPF 213

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 223
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 224 RYHGRSAAVWSLGILLYDMVCGDIPF 249

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 25/86 (29%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPEL--YE 76
           H HN  ++HRD+K +NI ++ N GE+K+ D G   +++        GT  +  PE   Y 
Sbjct: 152 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 211
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPY 102
             +     ++S G+ + +MV  + P+
Sbjct: 212 RYHGRSAAVWSLGILLYDMVCGDIPF 237

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 9/160 (5%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-R 61
           ++ +QIL G++YLH+    I H DLK +NI +   N     +K+ D GLA  ++     +
Sbjct: 119 SFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 62  SVIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY-NECKNPAQIYKKVTSGI 119
           ++ GTPEF+APE+   E   L  D++S G+    +++   P+  + K          S  
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYD 236
Query: 120 KPASLSKVTDPQVKQFIEKCIVPASL-RLPALELLKDPFL 158
                   T    K FI K +V  +  RL   E L+ P++
Sbjct: 237 FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHRDL   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 119 YTSQICKGMEYLGTKR--YIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEFFKVKE 175
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 62/116 (53%), Gaps = 11/116 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVIG 65
           Q++ GL YLHS    I+H+D+K  N+ +    G +KI  LG+A  +       T R+  G
Sbjct: 117 QLIDGLEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQG 173
Query: 66  TPEFMAPELYE--EEYNEL-VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           +P F  PE+    + ++   VDI+S G+ +  + T  YP+ E  N  ++++ +  G
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKG 228

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 7/118 (5%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSV 63
           +   +QIL  + Y H H   ++HRDLK +N+ ++ +    KI D GL+ +M      R+ 
Sbjct: 114 RRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTS 170
Query: 64  IGTPEFMAPELYEEEY--NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            G+P + APE+          VDI+S G+ +  ++    P+++   P  ++KK+  G+
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-LFKKIRGGV 227

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 53/113 (46%), Gaps = 26/113 (23%)
Query: 8   ARQILRGLHYLHS-------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----- 55
           A  + RGL YLH+       + P I HRDL   N+ V  N+G   I D GL++ +     
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRL 175
Query: 56  -----QQPTARSVIGTPEFMAPELYEEEYN--------ELVDIYSFGMCILEM 95
                +   A S +GT  +MAPE+ E   N        + VD+Y+ G+   E+
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 29/109 (26%), Positives = 59/109 (54%), Gaps = 11/109 (10%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-- 59
           K  K +  +++  L  +HS    +IHRD+K DN+ ++  +G +K+ D G  + M +    
Sbjct: 174 KWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMV 230
Query: 60  -ARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPY 102
              + +GTP++++PE+ + +     Y    D +S G+ + EM+  + P+
Sbjct: 231 HCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 56/97 (57%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARS 62
           +A+QI  G+ YLH+ +   IHRDL   N+ ++ N+  VKIGD GLA  +    +    R 
Sbjct: 139 FAQQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEXYRVRE 195
Query: 63  VIGTPEFM-APE-LYEEEYNELVDIYSFGMCILEMVT 97
              +P F  APE L E ++    D++SFG+ + E++T
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 53/111 (47%), Gaps = 12/111 (10%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQPT- 59
           K I N  RQI   LHYL  HN  I HRD+K +N   + N   E+K+ D GL+    +   
Sbjct: 168 KLISNIMRQIFSALHYL--HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN 225
Query: 60  -----ARSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEMVTCEYPY 102
                  +  GTP F+APE+     E Y    D +S G+ +  ++    P+
Sbjct: 226 GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 64/113 (56%), Gaps = 7/113 (6%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTP 67
           RQI+  + Y H     I+HRDLK +N+ ++G+   +KI D G +          +  G+P
Sbjct: 121 RQIVSAVQYCHQKY--IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSP 177
Query: 68  EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
            + APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRG 229

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVI 64
           Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T    +
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDXXKKTTNGRL 221
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 222 PV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +      ++
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 52/109 (47%), Gaps = 20/109 (18%)
Query: 8   ARQILRGLHYLH---------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-- 56
           A  + RGL YLH          H P I HRD K  N+ +  +   V + D GLA+  +  
Sbjct: 118 AETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAV-LADFGLAVRFEPG 176
Query: 57  QPTA--RSVIGTPEFMAPELYEEEYNE------LVDIYSFGMCILEMVT 97
           +P       +GT  +MAPE+ E   N        +D+Y+ G+ + E+V+
Sbjct: 177 KPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +      ++
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +      ++
Sbjct: 118 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 7/90 (7%)
Query: 20  SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-----PTARSVIGTPEFMAPEL 74
           SH   IIHRD+K  NI ++  N  VK+ D G+A  +           +VIGT ++++PE 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 75  YE-EEYNELVDIYSFGMCILEMVTCEYPYN 103
              +  +   D+YS G  + E++T E P+ 
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +      ++
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +      ++
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVI 64
           Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T    +
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDXXKKTTNGRL 221
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 222 PV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +      ++
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 7/90 (7%)
Query: 20  SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-----PTARSVIGTPEFMAPEL 74
           SH   IIHRD+K  NI ++  N  VK+ D G+A  +           +VIGT ++++PE 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 75  YE-EEYNELVDIYSFGMCILEMVTCEYPYN 103
              +  +   D+YS G  + E++T E P+ 
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 7/90 (7%)
Query: 20  SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-----PTARSVIGTPEFMAPEL 74
           SH   IIHRD+K  NI ++  N  VK+ D G+A  +           +VIGT ++++PE 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 75  YE-EEYNELVDIYSFGMCILEMVTCEYPYN 103
              +  +   D+YS G  + E++T E P+ 
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 7/90 (7%)
Query: 20  SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPEL 74
           SH   IIHRD+K  NI ++  N  VK+ D G+A  +           +VIGT ++++PE 
Sbjct: 132 SHQNGIIHRDVKPANILISATNA-VKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQ 190
Query: 75  YE-EEYNELVDIYSFGMCILEMVTCEYPYN 103
              +  +   D+YS G  + E++T E P+ 
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 58/108 (53%), Gaps = 15/108 (13%)
Query: 7   WAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---T 59
           WAR    +++  L  +HS     IHRD+K DN+ ++  +G +K+ D G  + M +     
Sbjct: 169 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVR 225
Query: 60  ARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPY 102
             + +GTP++++PE+ + +     Y    D +S G+ + EM+  + P+
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +      ++
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +      ++
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +      ++
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 7/90 (7%)
Query: 20  SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-----PTARSVIGTPEFMAPEL 74
           SH   IIHRD+K  NI ++  N  VK+ D G+A  +           +VIGT ++++PE 
Sbjct: 132 SHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 75  YE-EEYNELVDIYSFGMCILEMVTCEYPYN 103
              +  +   D+YS G  + E++T E P+ 
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 58/108 (53%), Gaps = 15/108 (13%)
Query: 7   WAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---T 59
           WAR    +++  L  +HS     IHRD+K DN+ ++  +G +K+ D G  + M +     
Sbjct: 174 WARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVR 230
Query: 60  ARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPY 102
             + +GTP++++PE+ + +     Y    D +S G+ + EM+  + P+
Sbjct: 231 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +      ++
Sbjct: 118 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +      ++
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 59/110 (53%), Gaps = 15/110 (13%)
Query: 5   KNWAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 58
           + WAR    +++  L  +HS     IHRD+K DN+ ++  +G +K+ D G  + M +   
Sbjct: 172 EKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGM 228
Query: 59  -TARSVIGTPEFMAPELYEEE-----YNELVDIYSFGMCILEMVTCEYPY 102
               + +GTP++++PE+ + +     Y    D +S G+ + EM+  + P+
Sbjct: 229 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVI 64
           Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T    +
Sbjct: 211 QLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRL 267
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 268 PV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 61/118 (51%), Gaps = 7/118 (5%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSV 63
           +   +QIL  + Y H H   ++HRDLK +N+ ++ +    KI D GL+ +M      R  
Sbjct: 114 RRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRDS 170
Query: 64  IGTPEFMAPELYEEEY--NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
            G+P + APE+          VDI+S G+ +  ++    P+++   P  ++KK+  G+
Sbjct: 171 CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-LFKKIRGGV 227

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVI 64
           Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T    +
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 222 PV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +      ++
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVI 64
           Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T    +
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 222 PV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +      ++
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTPEF+APE+   E   L  D++S G+    +++   P+
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVI 64
           Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T    +
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 222 PV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 7/90 (7%)
Query: 20  SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-----PTARSVIGTPEFMAPEL 74
           SH   IIHRD+K  NI ++  N  VK+ D G+A  +           +VIGT ++++PE 
Sbjct: 149 SHQNGIIHRDVKPANIMISATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 207
Query: 75  YE-EEYNELVDIYSFGMCILEMVTCEYPYN 103
              +  +   D+YS G  + E++T E P+ 
Sbjct: 208 ARGDSVDARSDVYSLGCVLYEVLTGEPPFT 237

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVI 64
           Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T    +
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 222 PV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVI 64
           Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T    +
Sbjct: 154 QLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRL 210
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 211 PV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVI 64
           Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T    +
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 222 PV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVI 64
           Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T    +
Sbjct: 157 QLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRL 213
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 214 PV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVI 64
           Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T    +
Sbjct: 152 QLARGMEYLASQK--CIHRDLTARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRL 208
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 209 PV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           I + + YLHS    ++HRDLK  NI     +GN   ++I D G A   Q      ++ TP
Sbjct: 130 IGKTVEYLHSQG--VVHRDLKPSNILYVDESGNPECLRICDFGFA--KQLRAENGLLMTP 185
Query: 68  ----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKKVTSG-- 118
                F+APE+ + + Y+E  DI+S G+ +  M+    P+       P +I  ++ SG  
Sbjct: 186 CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKF 245
Query: 119 -IKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLV 159
            +   + + V++   K  + K + V    RL A ++L+ P++ 
Sbjct: 246 TLSGGNWNTVSE-TAKDLVSKMLHVDPHQRLTAKQVLQHPWVT 287

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTA 60
           K  ++  RQI+  + Y H     I+HRDLK +N+ ++ +   +KI D G +         
Sbjct: 111 KEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKL 167
Query: 61  RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
            +  G+P + APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G
Sbjct: 168 DTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRG 226
Query: 119 IKPASLSKVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFLVTDNPKD 165
                    TD   +  +++ +V   ++   LE ++KD ++   + +D
Sbjct: 227 KYRIPFYMSTD--CENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED 272

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 46/101 (45%), Gaps = 20/101 (19%)
Query: 14  GLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------AR 61
           GL +LH         P I HRDLK  NI V   NG   I DLGLA+     T        
Sbjct: 113 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPN 171
Query: 62  SVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEM 95
             +GT  +MAPE+ ++  N       +  DIY+ G+   E+
Sbjct: 172 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 46/101 (45%), Gaps = 20/101 (19%)
Query: 14  GLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------AR 61
           GL +LH         P I HRDLK  NI V   NG   I DLGLA+     T        
Sbjct: 138 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPN 196
Query: 62  SVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEM 95
             +GT  +MAPE+ ++  N       +  DIY+ G+   E+
Sbjct: 197 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 46/101 (45%), Gaps = 20/101 (19%)
Query: 14  GLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------AR 61
           GL +LH         P I HRDLK  NI V   NG   I DLGLA+     T        
Sbjct: 118 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPN 176
Query: 62  SVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEM 95
             +GT  +MAPE+ ++  N       +  DIY+ G+   E+
Sbjct: 177 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 11  ILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           I + + YLHS    ++HRDLK  NI     +GN   ++I D G A   Q      ++ TP
Sbjct: 130 IGKTVEYLHSQG--VVHRDLKPSNILYVDESGNPECLRICDFGFA--KQLRAENGLLMTP 185
Query: 68  ----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKKVTSG-- 118
                F+APE+ + + Y+E  DI+S G+ +  M+    P+       P +I  ++ SG  
Sbjct: 186 CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKF 245
Query: 119 -IKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPFLV 159
            +   + + V++   K  + K + V    RL A ++L+ P++ 
Sbjct: 246 TLSGGNWNTVSE-TAKDLVSKMLHVDPHQRLTAKQVLQHPWVT 287

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 46/101 (45%), Gaps = 20/101 (19%)
Query: 14  GLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------AR 61
           GL +LH         P I HRDLK  NI V   NG   I DLGLA+     T        
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 62  SVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEM 95
             +GT  +MAPE+ ++  N       +  DIY+ G+   E+
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  QI +G+ YL +     IHR+L   NI V   N  VKIGD GL  V+ Q      +  
Sbjct: 120 YTSQICKGMEYLGTKR--YIHRNLATRNILVENEN-RVKIGDFGLTKVLPQDKEYYKVKE 176
Query: 67  PE-----FMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           P      + APE L E +++   D++SFG+ + E+ T
Sbjct: 177 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 46/101 (45%), Gaps = 20/101 (19%)
Query: 14  GLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------AR 61
           GL +LH         P I HRDLK  NI V   NG   I DLGLA+     T        
Sbjct: 115 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPN 173
Query: 62  SVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEM 95
             +GT  +MAPE+ ++  N       +  DIY+ G+   E+
Sbjct: 174 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 46/101 (45%), Gaps = 20/101 (19%)
Query: 14  GLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------AR 61
           GL +LH         P I HRDLK  NI V   NG   I DLGLA+     T        
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPN 170
Query: 62  SVIGTPEFMAPELYEEEYN-------ELVDIYSFGMCILEM 95
             +GT  +MAPE+ ++  N       +  DIY+ G+   E+
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 71/162 (43%), Gaps = 32/162 (19%)
Query: 13  RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI----VMQQPTARSVIGTPE 68
           RGLHYLH+    IIHRD+K  NI ++  N   KI D G++     + Q      V GT  
Sbjct: 150 RGLHYLHTR--AIIHRDVKSINILLD-ENFVPKITDFGISKKGTELGQTHLXXVVKGTLG 206
Query: 69  FMAPELY-EEEYNELVDIYSFGMCIL---------------EMVTCEYPYNECKNPAQIY 112
           ++ PE + +    E  D+YSFG+ +                EMV       E  N  Q+ 
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 113 KKV----TSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 150
           + V       I+P SL K  D  V     KC+  +S   P++
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAV-----KCLALSSEDRPSM 303

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARS 62
           A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T   
Sbjct: 156 AYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDXXKKTTNG 212
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
            +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 213 RLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 54/98 (55%), Gaps = 5/98 (5%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPT-ARSVIG 65
           +Q++  L Y HS +  ++H+DLK +NI       +  +KI D GLA + +    + +  G
Sbjct: 131 KQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG 188
Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYN 103
           T  +MAPE+++ +     DI+S G+ +  ++T   P+ 
Sbjct: 189 TALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFT 226

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 55/102 (53%), Gaps = 7/102 (6%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--R 61
           +K++  Q+L+GL + HS N  ++HRDLK  N+ +N  NGE+K+ + GLA     P     
Sbjct: 103 VKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYS 159
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYP 101
           + + T  +  P++    + Y+  +D++S G    E+     P
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/97 (37%), Positives = 56/97 (57%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARS 62
           +A+QI  G+ YLHS +   IHR+L   N+ ++ N+  VKIGD GLA  +    +    R 
Sbjct: 122 FAQQICEGMAYLHSQH--YIHRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 63  VIGTPEFM-APE-LYEEEYNELVDIYSFGMCILEMVT 97
              +P F  APE L E ++    D++SFG+ + E++T
Sbjct: 179 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARS 62
           A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T   
Sbjct: 145 AYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNG 201
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
            +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 202 RLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVI 64
           Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA     I   + T    +
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKNTTNGRL 221
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 222 PV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARS 62
           A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T   
Sbjct: 148 AYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNG 204
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
            +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 205 RLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARS 62
           A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T   
Sbjct: 156 AYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNG 212
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
            +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 213 RLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 71/162 (43%), Gaps = 32/162 (19%)
Query: 13  RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI----VMQQPTARSVIGTPE 68
           RGLHYLH+    IIHRD+K  NI ++  N   KI D G++     + Q      V GT  
Sbjct: 150 RGLHYLHTR--AIIHRDVKSINILLD-ENFVPKITDFGISKKGTELDQTHLXXVVKGTLG 206
Query: 69  FMAPELY-EEEYNELVDIYSFGMCIL---------------EMVTCEYPYNECKNPAQIY 112
           ++ PE + +    E  D+YSFG+ +                EMV       E  N  Q+ 
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 113 KKV----TSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPAL 150
           + V       I+P SL K  D  V     KC+  +S   P++
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAV-----KCLALSSEDRPSM 303

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARS 62
           A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T   
Sbjct: 156 AYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNG 212
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
            +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 213 RLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARS 62
           A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T   
Sbjct: 149 AYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNG 205
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
            +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 206 RLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARS 62
           A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T   
Sbjct: 141 AYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNG 197
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
            +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 198 RLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 83/155 (53%), Gaps = 12/155 (7%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTP 67
           RQI+  + Y   H   I+HRDLK +N+ ++ +   +KI D G +          +  G+P
Sbjct: 113 RQIVSAVQY--CHQKFIVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSP 169
Query: 68  EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PAS 123
            + APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G    P  
Sbjct: 170 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRGKYRIPFY 228
Query: 124 LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 158
           +S   +  +K+F+   I+  S R    +++KD ++
Sbjct: 229 MSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 260

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 10/94 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARSVI 64
           Q+ RG+ YL S     IHRDL   N+ V  NN  ++I D GLA     I   + T    +
Sbjct: 165 QLARGMEYLASQK--CIHRDLAARNVLVTENN-VMRIADFGLARDINNIDYYKKTTNGRL 221
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 222 PV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARS 62
           A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T   
Sbjct: 156 AYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNG 212
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
            +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 213 RLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 83/155 (53%), Gaps = 12/155 (7%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTP 67
           RQI+  + Y   H   I+HRDLK +N+ ++ +   +KI D G +          +  G+P
Sbjct: 120 RQIVSAVQY--CHQKFIVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSP 176
Query: 68  EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PAS 123
            + APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G    P  
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRGKYRIPFY 235
Query: 124 LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 158
           +S   +  +K+F+   I+  S R    +++KD ++
Sbjct: 236 MSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 83/155 (53%), Gaps = 12/155 (7%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTP 67
           RQI+  + Y   H   I+HRDLK +N+ ++ +   +KI D G +          +  G+P
Sbjct: 120 RQIVSAVQY--CHQKFIVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSP 176
Query: 68  EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PAS 123
            + APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G    P  
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRGKYRIPFY 235
Query: 124 LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 158
           +S   +  +K+F+   I+  S R    +++KD ++
Sbjct: 236 MSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 83/155 (53%), Gaps = 12/155 (7%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTP 67
           RQI+  + Y   H   I+HRDLK +N+ ++ +   +KI D G +          +  G+P
Sbjct: 120 RQIVSAVQY--CHQKFIVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSP 176
Query: 68  EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PAS 123
            + APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G    P  
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRGKYRIPFY 235
Query: 124 LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 158
           +S   +  +K+F+   I+  S R    +++KD ++
Sbjct: 236 MSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 267

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 83/163 (50%), Gaps = 11/163 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQ-QPTARSVI 64
           + RQ+ +GL ++H +N   +H DLK +NI F    + E+K+ D GL   +  + + +   
Sbjct: 154 YMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 211
Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIK 120
           GT EF APE+ E +      D++S G+    +++   P+   +N  +  + V S    + 
Sbjct: 212 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMD 270
Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 162
            ++ S +++   K FI K ++   + R+   + L+ P+L   N
Sbjct: 271 DSAFSGISE-DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 312

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 86/168 (51%), Gaps = 10/168 (5%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTA 60
           K  ++  RQI+  + Y H     I+HRDLK +N+ ++ +   +KI D G +         
Sbjct: 114 KEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKL 170
Query: 61  RSVIGTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
            +  G P + APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRG 229
Query: 119 IKPASLSKVTDPQVKQFIEKCIVPASLRLPALE-LLKDPFLVTDNPKD 165
                    TD   +  +++ +V   ++   LE ++KD ++   + +D
Sbjct: 230 KYRIPFYMSTD--CENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED 275

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 59/111 (53%), Gaps = 8/111 (7%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSV 63
           +++ QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA V++  + TAR  
Sbjct: 288 DFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREG 344
Query: 64  IGTP-EFMAPELYE-EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 111
              P ++ APE      +    D++SFG+ ++E+VT    PY    NP  I
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 395

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 10/96 (10%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-----IVMQQPTARS 62
           A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA     I   + T   
Sbjct: 197 AYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNG 253
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
            +   ++MAPE L++  Y    D++SFG+ + E+ T
Sbjct: 254 RLPV-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 83/163 (50%), Gaps = 11/163 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQ-QPTARSVI 64
           + RQ+ +GL ++H +N   +H DLK +NI F    + E+K+ D GL   +  + + +   
Sbjct: 260 YMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 317
Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIK 120
           GT EF APE+ E +      D++S G+    +++   P+   +N  +  + V S    + 
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMD 376
Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 162
            ++ S +++   K FI K ++   + R+   + L+ P+L   N
Sbjct: 377 DSAFSGISE-DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/119 (35%), Positives = 63/119 (52%), Gaps = 11/119 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A Q+  G+ Y+   N   IHRDL+  NI V GN    KI D GLA +++  + TAR    
Sbjct: 111 AAQVAAGMAYIERMN--YIHRDLRSANILV-GNGLICKIADFGLARLIEDNEXTARQGAK 167
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 120
            P ++ APE  LY   +    D++SFG+ + E+VT    PY    N  ++ ++V  G +
Sbjct: 168 FPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLEQVERGYR 224

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 56/112 (50%), Gaps = 18/112 (16%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------- 55
           I+ +  Q LR +  LH  N  +IHRDLK  N+ +N +N ++K+ D GLA ++        
Sbjct: 114 IQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNS 170
Query: 56  ----QQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYP 101
               QQ      + T  + APE  L   +Y+  +D++S G CIL  +    P
Sbjct: 171 EPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFLRRP 221

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 67/145 (46%), Gaps = 12/145 (8%)
Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEE 77
           H H+  ++HRD+K +NI ++   G  K+ D G   ++         GT  +  PE +   
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRH 213
Query: 78  EYNEL-VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFI 136
           +Y+ L   ++S G+ + +MV  + P+   +   +          PA +S    P     I
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHF-----PAHVS----PDCCALI 264
Query: 137 EKCIVPASLRLPAL-ELLKDPFLVT 160
            +C+ P     P+L E+L DP++ T
Sbjct: 265 RRCLAPKPSSRPSLEEILLDPWMQT 289

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 59/111 (53%), Gaps = 8/111 (7%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSV 63
           +++ QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA V++  + TAR  
Sbjct: 115 DFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLV-CKIADFGLARVIEDNEYTAREG 171
Query: 64  IGTP-EFMAPELYE-EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 111
              P ++ APE      +    D++SFG+ ++E+VT    PY    NP  I
Sbjct: 172 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 222

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 20/101 (19%)
Query: 14  GLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------AR 61
           GL +LH         P I HRD K  N+ V  +N +  I DLGLA++  Q +        
Sbjct: 117 GLAHLHVEIFGTQGKPAIAHRDFKSRNVLVK-SNLQCCIADLGLAVMHSQGSDYLDIGNN 175
Query: 62  SVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEM 95
             +GT  +MAPE+ +E       E  +  DI++FG+ + E+
Sbjct: 176 PRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 56/112 (50%), Gaps = 18/112 (16%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------- 55
           I+ +  Q LR +  LH  N  +IHRDLK  N+ +N +N ++K+ D GLA ++        
Sbjct: 114 IQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNS 170
Query: 56  ----QQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYP 101
               QQ      + T  + APE  L   +Y+  +D++S G CIL  +    P
Sbjct: 171 EPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFLRRP 221

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 81/155 (52%), Gaps = 12/155 (7%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-GTP 67
           RQI+  + Y   H   I+HRDLK +N+ ++ +   +KI D G +             G P
Sbjct: 120 RQIVSAVQY--CHQKFIVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCGAP 176
Query: 68  EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PAS 123
            + APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G    P  
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRGKYRIPFY 235
Query: 124 LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 158
           +S   +  +K+F+   I+  S R    +++KD ++
Sbjct: 236 MSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 267

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 9/97 (9%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTARS 62
           +A+QI  G+ YLH+ +   IHR+L   N+ ++ N+  VKIGD GLA  +    +    R 
Sbjct: 122 FAQQICEGMAYLHAQH--YIHRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 63  VIGTPEFM-APE-LYEEEYNELVDIYSFGMCILEMVT 97
              +P F  APE L E ++    D++SFG+ + E++T
Sbjct: 179 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 69/133 (51%), Gaps = 9/133 (6%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI-GTP 67
           RQI+  + Y H     I+HRDLK +N+ ++ +   +KI D G +             G P
Sbjct: 120 RQIVSAVQYCHQKF--IVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGAP 176
Query: 68  EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
            + APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G       
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRGKYRIPFY 235
Query: 126 KVTDPQ--VKQFI 136
             TD +  +K+F+
Sbjct: 236 XSTDCENLLKKFL 248

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 82/155 (52%), Gaps = 12/155 (7%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGTP 67
           RQI+  + Y   H   I+HRDLK +N+ ++ +   +KI D G +             G+P
Sbjct: 120 RQIVSAVQY--CHQKFIVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCGSP 176
Query: 68  EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PAS 123
            + APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G    P  
Sbjct: 177 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLRGKYRIPFY 235
Query: 124 LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 158
           +S   +  +K+F+   I+  S R    +++KD ++
Sbjct: 236 MSTDCENLLKKFL---ILNPSKRGTLEQIMKDRWM 267

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 7/101 (6%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQPTA-RS 62
           + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +      ++
Sbjct: 119 FLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 63  VIGTPEFMAPELYEEEYNEL-VDIYSFGMCILEMVTCEYPY 102
           + GTP F+APE+   E   L  D++S G+    +++   P+
Sbjct: 177 IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 56/112 (50%), Gaps = 18/112 (16%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------- 55
           I+ +  Q LR +  LH  N  +IHRDLK  N+ +N +N ++K+ D GLA ++        
Sbjct: 114 IQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNS 170
Query: 56  ----QQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYP 101
               QQ      + T  + APE  L   +Y+  +D++S G CIL  +    P
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFLRRP 221

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 77/145 (53%), Gaps = 10/145 (6%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI-VMQQP- 58
           M+ + +++ Q+ RG+ +L S     IHRDL   NI ++ NN  VKI D GLA  + + P 
Sbjct: 198 MEDLISYSFQVARGMEFLSSRK--CIHRDLAARNILLSENN-VVKICDFGLARDIYKNPD 254
Query: 59  -TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKK 114
              +     P ++MAPE ++++ Y+   D++S+G+ + E+ +    PY   +       +
Sbjct: 255 YVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSR 314
Query: 115 VTSGIKPASLSKVTDPQVKQFIEKC 139
           +  G++  +  + + P++ Q +  C
Sbjct: 315 LREGMRMRA-PEYSTPEIYQIMLDC 338

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 81/167 (48%), Gaps = 21/167 (12%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVK--IGDLG----LAIVMQQPTA 60
           +Q   GL +LHS N  I+HRDLK  NI ++  N  G++K  I D G    LA+     + 
Sbjct: 125 QQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 61  RS-VIGTPEFMAPELYEEEYNE----LVDIYSFGMCILEMVTCE--YPYNE-CKNPAQIY 112
           RS V GT  ++APE+  E+  E     VDI+S G C+   V  E  +P+ +  +  A I 
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGKSLQRQANIL 241
Query: 113 KKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFL 158
               S +      K  D   ++ IEK I     + P A  +LK PF 
Sbjct: 242 LGACS-LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 57/114 (50%), Gaps = 21/114 (18%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-------PTARS 62
           Q  R + ++H   PPIIHRDLK +N+ ++ N G +K+ D G A  +            R+
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRA 202
Query: 63  VI-------GTPEFMAPELYEEEYN----ELVDIYSFGMCILEMVTC-EYPYNE 104
           ++        TP +  PE+ +   N    E  DI++ G CIL ++   ++P+ +
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFED 255

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 61/119 (51%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVIGTP 67
           R I  G+ YL + N   +HRDL   NI VN +N   K+ D GL+ V++  P A       
Sbjct: 154 RGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 68  E----FMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 120
           +    + APE +   ++    D++SFG+ + E++T  E PY E  N  ++ K +  G +
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFR 268

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 19/170 (11%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTA 60
           K  +   R +L  +  LH  N  I+HRDLK +NI ++ ++  +K+ D G +  +      
Sbjct: 124 KETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKL 180
Query: 61  RSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 113
           RSV GTP ++APE+ E         Y + VD++S G+ +  ++    P+   K    +  
Sbjct: 181 RSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240
Query: 114 KVTSGIKPAS-----LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 158
            ++   +  S      S      V +F+   +V    R  A E L  PF 
Sbjct: 241 IMSGNYQFGSPEWDDYSDTVKDLVSRFL---VVQPQKRYTAEEALAHPFF 287

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 79/183 (43%), Gaps = 32/183 (17%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------------------GNNGEVK 45
           +K+   Q+ RGL Y+HS +  ++H D+K  NIF++                   N    K
Sbjct: 113 LKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 170
Query: 46  IGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNEL--VDIYSFGMCILEMVTCE-YPY 102
           IGDLG    +  P      G   F+A E+ +E Y  L   DI++  + ++     E  P 
Sbjct: 171 IGDLGHVTRISSPQVEE--GDSRFLANEVLQENYTHLPKADIFALALTVVXAAGAEPLPR 228
Query: 103 NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTD 161
           N        + ++  G  P  + +V   +  + ++  I P   R P A+ L+K   L++ 
Sbjct: 229 N-----GDQWHEIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 282
Query: 162 NPK 164
           + K
Sbjct: 283 SRK 285

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 158 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 214
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 215 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 160 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 216
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 217 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 10/103 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARS 62
           Q L GL YLHS    I+H D+K DN+ ++ +     + D G A+ +Q         T   
Sbjct: 193 QALEGLEYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY 250
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNE 104
           + GT   MAPE +     +  VD++S    +L M+   +P+ +
Sbjct: 251 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQ 293

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 152 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 208
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 209 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 162 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 218
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 219 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 158 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 214
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 71/137 (51%), Gaps = 23/137 (16%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV-------MQQPTA 60
           A++I++G+ YLH+    I+H+DLK  N+F   +NG+V I D GL  +        ++   
Sbjct: 136 AQEIVKGMGYLHAKG--ILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKL 191
Query: 61  RSVIGTPEFMAPELYEE----------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 110
           R   G    +APE+  +           +++  D+++ G    E+   E+P+      A 
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI 251
Query: 111 IYKKVTSGIKPASLSKV 127
           I+ ++ +G+KP +LS++
Sbjct: 252 IW-QMGTGMKP-NLSQI 266

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 10/103 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARS 62
           Q L GL YLHS    I+H D+K DN+ ++ +     + D G A+ +Q         T   
Sbjct: 174 QALEGLEYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY 231
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNE 104
           + GT   MAPE +     +  VD++S    +L M+   +P+ +
Sbjct: 232 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQ 274

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA +++  + TAR    
Sbjct: 123 AAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAK 179
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 180 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 228

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 203 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 259
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 260 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA +++  + TAR    
Sbjct: 115 AAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDAEXTAREGAK 171
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/135 (32%), Positives = 64/135 (47%), Gaps = 14/135 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLVGIKHLHSAG--IIHRDLKPSNIVVK-SDATLKILDFGLA----RTAGTSFMMTPYV 186
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G+ + EM+     +    +  Q  K +   G    
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 123 SLSKVTDPQVKQFIE 137
              K   P V+ ++E
Sbjct: 247 EFMKKLQPTVRTYVE 261

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 129 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 185
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 186 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 87/207 (42%), Gaps = 41/207 (19%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQP 58
           M  IK +  Q+LR L Y+HS    I HRD+K  N+ ++  +G +K+ D G A  ++  +P
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197
Query: 59  TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCE----------------- 99
              S I +  + APEL      Y   +DI+S G  + E++  +                 
Sbjct: 198 NV-SXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256
Query: 100 ---YPYNE---CKNPAQIYKKVTSGIKPASLSKV----TDPQVKQFIEKCI-VPASLRLP 148
               P  E     NP  +  K    I+P   SKV    T P     I + +    S RL 
Sbjct: 257 VLGTPSREQIKTMNPNYMEHKFPQ-IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315
Query: 149 ALELLKDPFLVTDNPKDLVCDPLRLPN 175
           A+E L  PF       +L     R+PN
Sbjct: 316 AIEALCHPFF-----DELRTGEARMPN 337

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 136 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 192
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 193 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA +++  + TAR    
Sbjct: 121 AAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAK 177
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 226

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA +++  + TAR    
Sbjct: 124 AAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAK 180
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 181 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 229

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA +++  + TAR    
Sbjct: 116 AAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAK 172
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 173 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 221

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA +++  + TAR    
Sbjct: 115 AAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA +++  + TAR    
Sbjct: 117 AAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAK 173
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 174 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 222

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 143 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 199
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 200 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 132 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 188
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 189 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 68/141 (48%), Gaps = 16/141 (11%)
Query: 21  HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSV--IGTPEFMAPELYEE 77
           H    +HRD+K DNI ++   G +++ D G  + ++   T RS+  +GTP++++PE+ + 
Sbjct: 179 HRLGYVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 78  EYNEL--------VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTD 129
                         D ++ G+   EM   + P+    + A+ Y K+    +  SL  V +
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY-ADSTAETYGKIVHYKEHLSLPLVDE 296
Query: 130 ---PQVKQFIEKCIVPASLRL 147
               + + FI++ + P   RL
Sbjct: 297 GVPEEARDFIQRLLCPPETRL 317

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 5/100 (5%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           IK +  Q++R +  LH  +  + HRD+K  N+ VN  +G +K+ D G A  +  P+  +V
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL-SPSEPNV 189
Query: 64  --IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCE 99
             I +  + APEL    + Y   VDI+S G    EM+  E
Sbjct: 190 AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 137 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 193
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 194 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA +++  + TAR    
Sbjct: 115 AAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEXTAREGAK 171
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 369 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAK 425
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 426 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 459

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 136 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 192
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 193 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/135 (32%), Positives = 64/135 (47%), Gaps = 14/135 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLVGIKHLHSAG--IIHRDLKPSNIVVK-SDATLKILDFGLA----RTAGTSFMMTPYV 186
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G+ + EM+     +    +  Q  K +   G    
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 123 SLSKVTDPQVKQFIE 137
              K   P V+ ++E
Sbjct: 247 EFMKKLQPTVRTYVE 261

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 125 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 181
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 182 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 124 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 180
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 124 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 180
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 124 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 180
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 124 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 180
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTAR 61
           NW  QI +G+ YL      ++HRDL   N+ V   N  VKI D GLA +++    +  A 
Sbjct: 121 NWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNAD 177
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E ++  ++    D++S+G+ I E++T
Sbjct: 178 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 124 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 180
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 124 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 180
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 124 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 180
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA +++  + TAR    
Sbjct: 121 AAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAK 177
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 178 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 226

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTAR 61
           NW  QI +G+ YL      ++HRDL   N+ V   N  VKI D GLA +++    +  A 
Sbjct: 144 NWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNAD 200
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E ++  ++    D++S+G+ I E++T
Sbjct: 201 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARS 62
           Q L GL YLH+    I+H D+K DN+ ++ +     + D G A+ +Q         T   
Sbjct: 158 QALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNE 104
           + GT   MAPE +  +  +  VDI+S    +L M+   +P+ +
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA +++  + TAR    
Sbjct: 120 AAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAK 176
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 177 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 225

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +V  +P   
Sbjct: 128 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV- 184
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           S I +  + APEL     +Y   +D++S G  + E++
Sbjct: 185 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLXGIKHLHSAG--IIHRDLKPSNIVVK-SDXTLKILDFGLA----RTAGTSFMMTPYV 186
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKP 121
               + APE +    Y E VDI+S G  + EMV  +  +   ++    + KV    G   
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPC 245
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL 150
               K   P V+ ++E     A L  P L
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA +++  + TAR    
Sbjct: 115 AAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAK 171
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLXGIKHLHSAG--IIHRDLKPSNIVVK-SDXTLKILDFGLA----RTAGTSFMMTPYV 186
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKP 121
               + APE +    Y E VDI+S G  + EMV  +  +   ++    + KV    G   
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPC 245
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL 150
               K   P V+ ++E     A L  P L
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA +++  + TAR    
Sbjct: 125 AAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAK 181
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 182 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 230

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 30/182 (16%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------------------GNNGEVK 45
           +K+   Q+ RGL Y+HS +  ++H D+K  NIF++                   N    K
Sbjct: 115 LKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172
Query: 46  IGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNEL--VDIYSFGMCILEMVTCEYPYN 103
           IGDLG    +  P      G   F+A E+ +E Y  L   DI++  +     V C     
Sbjct: 173 IGDLGHVTRISSPQVEE--GDSRFLANEVLQENYTHLPKADIFALALT----VVCAAGAE 226
Query: 104 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDN 162
                   + ++  G  P  + +V   +  + ++  I P   R P A+ L+K   L++ +
Sbjct: 227 PLPRNGDQWHEIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 285
Query: 163 PK 164
            K
Sbjct: 286 RK 287

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 286 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAK 342
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 343 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 376

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 127 QMLXGIKHLHSAG--IIHRDLKPSNIVVK-SDXTLKILDFGLA----RTAGTSFMMTPYV 179
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKP 121
               + APE +    Y E VDI+S G  + EMV  +  +   ++    + KV    G   
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPC 238
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL 150
               K   P V+ ++E     A L  P L
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKL 267

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 286 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAK 342
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 343 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 376

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 286 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAK 342
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 343 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 376

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARS 62
           Q L GL YLH+    I+H D+K DN+ ++ +     + D G A+ +Q         T   
Sbjct: 174 QALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 231
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNE 104
           + GT   MAPE +  +  +  VDI+S    +L M+   +P+ +
Sbjct: 232 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 274

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 30/182 (16%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------------------GNNGEVK 45
           +K+   Q+ RGL Y+HS +  ++H D+K  NIF++                   N    K
Sbjct: 115 LKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 172
Query: 46  IGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNEL--VDIYSFGMCILEMVTCEYPYN 103
           IGDLG    +  P      G   F+A E+ +E Y  L   DI++  +     V C     
Sbjct: 173 IGDLGHVTRISSPQVEE--GDSRFLANEVLQENYTHLPKADIFALALT----VVCAAGAE 226
Query: 104 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDN 162
                   + ++  G  P  + +V   +  + ++  I P   R P A+ L+K   L++ +
Sbjct: 227 PLPRNGDQWHEIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 285
Query: 163 PK 164
            K
Sbjct: 286 RK 287

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 110 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEXTARQGAK 166
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 167 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 200

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 30/182 (16%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------------------GNNGEVK 45
           +K+   Q+ RGL Y+HS +  ++H D+K  NIF++                   N    K
Sbjct: 117 LKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 46  IGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNEL--VDIYSFGMCILEMVTCEYPYN 103
           IGDLG    +  P      G   F+A E+ +E Y  L   DI++  +     V C     
Sbjct: 175 IGDLGHVTRISSPQVEE--GDSRFLANEVLQENYTHLPKADIFALALT----VVCAAGAE 228
Query: 104 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLP-ALELLKDPFLVTDN 162
                   + ++  G  P  + +V   +  + ++  I P   R P A+ L+K   L++ +
Sbjct: 229 PLPRNGDQWHEIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287
Query: 163 PK 164
            K
Sbjct: 288 RK 289

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 10/103 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARS 62
           Q L GL YLH+    I+H D+K DN+ ++ +     + D G A+ +Q         T   
Sbjct: 172 QALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 229
Query: 63  VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNE 104
           + GT   MAPE +  +  +  VDI+S    +L M+   +P+ +
Sbjct: 230 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 272

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 19/170 (11%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTA 60
           K  +   R +L  +  LH  N  I+HRDLK +NI ++ ++  +K+ D G +  +      
Sbjct: 124 KETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKL 180
Query: 61  RSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 113
           R V GTP ++APE+ E         Y + VD++S G+ +  ++    P+   K    +  
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240
Query: 114 KVTSGIKPAS-----LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 158
            ++   +  S      S      V +F+   +V    R  A E L  PF 
Sbjct: 241 IMSGNYQFGSPEWDDYSDTVKDLVSRFL---VVQPQKRYTAEEALAHPFF 287

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/93 (40%), Positives = 51/93 (54%), Gaps = 13/93 (13%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE- 68
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TPE 
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPEV 186
Query: 69  ----FMAPE-LYEEEYNELVDIYSFGMCILEMV 96
               + APE +    Y E VDI+S G  + EM+
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/137 (33%), Positives = 68/137 (49%), Gaps = 18/137 (13%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE- 68
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S +  PE 
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMEPEV 186
Query: 69  ----FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--- 120
               + APE +    Y E VDI+S G CI+  + C       ++    + KV   +    
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 121 PASLSKVTDPQVKQFIE 137
           PA + K+  P V+ ++E
Sbjct: 246 PAFMKKL-QPTVRNYVE 261

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA +++  + TAR    
Sbjct: 110 AAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAK 166
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 167 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 215

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----- 55
           +  IK   + +L GL+Y+H +   I+HRD+K  N+ +   +G +K+ D GLA        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKN 180
Query: 56  QQPTA-RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 97
            QP    + + T  +  PEL   E +Y   +D++  G  + EM T
Sbjct: 181 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 120 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEXTARQGAK 176
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 177 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 210

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARS 62
           NW  QI +G++YL  H   ++HR+L   N+ +  +  +V++ D G+A ++    +    S
Sbjct: 137 NWGVQIAKGMYYLEEHG--MVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYS 193
Query: 63  VIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              TP ++MA E ++  +Y    D++S+G+ + E++T
Sbjct: 194 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTARS 62
           NW  QI +G++YL  H   ++HR+L   N+ +  +  +V++ D G+A ++    +    S
Sbjct: 119 NWGVQIAKGMYYLEEHG--MVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYS 175
Query: 63  VIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              TP ++MA E ++  +Y    D++S+G+ + E++T
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 113 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAK 169
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 170 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 203

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 19/170 (11%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTA 60
           K  +   R +L  +  LH  N  I+HRDLK +NI ++ ++  +K+ D G +  +      
Sbjct: 111 KETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKL 167
Query: 61  RSVIGTPEFMAPELYE-------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 113
           R V GTP ++APE+ E         Y + VD++S G+ +  ++    P+   K    +  
Sbjct: 168 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 227
Query: 114 KVTSGIKPAS-----LSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 158
            ++   +  S      S      V +F+   +V    R  A E L  PF 
Sbjct: 228 IMSGNYQFGSPEWDDYSDTVKDLVSRFL---VVQPQKRYTAEEALAHPFF 274

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 67/135 (49%), Gaps = 18/135 (13%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIF-VNGNNGE--VKIGDLGLAIVMQQ-PTARSVI 64
           R ++ G+++L  +   I+HR++K  NI  V G +G+   K+ D G A  ++      S+ 
Sbjct: 119 RDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 65  GTPEFMAPELYE---------EEYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIY 112
           GT E++ P++YE         ++Y   VD++S G+      T   P+   + P    ++ 
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 113 KKVTSGIKPASLSKV 127
            K+ +G    ++S V
Sbjct: 237 YKIITGKPSGAISGV 251

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A Q+   L YL S     +HRD+   N+ V+ N+  VK+GD GL+  M+  T       
Sbjct: 116 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTXXKASKG 172
Query: 67  P---EFMAPE-LYEEEYNELVDIYSFGMCILEMV 96
               ++MAPE +    +    D++ FG+C+ E++
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/135 (32%), Positives = 63/135 (46%), Gaps = 14/135 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLVGIKHLHSAG--IIHRDLKPSNIVVK-SDATLKILDFGLA----RTAGTSFMMTPYV 186
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G  + EM+     +    +  Q  K +   G    
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 123 SLSKVTDPQVKQFIE 137
              K   P V+ ++E
Sbjct: 247 EFMKKLQPTVRTYVE 261

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 111 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAK 167
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 168 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 201

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----- 55
           +  IK   + +L GL+Y+H +   I+HRD+K  N+ +   +G +K+ D GLA        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKN 180
Query: 56  QQPTA-RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 97
            QP    + + T  +  PEL   E +Y   +D++  G  + EM T
Sbjct: 181 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 52/102 (50%), Gaps = 11/102 (10%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQP 58
           IK   + +L GL+Y+H +   I+HRD+K  N+ +   +G +K+ D GLA         QP
Sbjct: 126 IKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQP 182
Query: 59  TA-RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 97
               + + T  +  PEL   E +Y   +D++  G  + EM T
Sbjct: 183 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 53/105 (50%), Gaps = 11/105 (10%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----- 55
           +  IK   + +L GL+Y+H +   I+HRD+K  N+ +   +G +K+ D GLA        
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKN 180
Query: 56  QQPTA-RSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 97
            QP    + + T  +  PEL   E +Y   +D++  G  + EM T
Sbjct: 181 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDXTLKILDFGLA----RTAGTSFMMTPYV 186
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKP 121
               + APE +    Y E VDI+S G  + EMV  +  +   ++    + KV    G   
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPC 245
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL 150
               K   P V+ ++E     A L  P L
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 120 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 177 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 109 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAK 165
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 166 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 199

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A Q+   L YL S     +HRD+   N+ V+ N+  VK+GD GL+  M+  T       
Sbjct: 496 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKG 552
Query: 67  P---EFMAPE-LYEEEYNELVDIYSFGMCILEMV 96
               ++MAPE +    +    D++ FG+C+ E++
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 120 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 177 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 120 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 177 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 210

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 120 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 177 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 210

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 120 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 177 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 210

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 9/163 (5%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQ-QPTARSV 63
           N+ RQ   GL ++H H+  I+H D+K +NI         VKI D GLA  +      +  
Sbjct: 153 NYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT 210
Query: 64  IGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKKVTSGIK 120
             T EF APE+ + E      D+++ G+    +++   P+   +     Q  K+      
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270
Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 162
             + S V+ P+ K FI+  +      RL   + L+ P+L  D+
Sbjct: 271 EDAFSSVS-PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/168 (23%), Positives = 80/168 (47%), Gaps = 12/168 (7%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIF--VNGNNGEVKIGDLGLAIVMQQ-PTARSVIG 65
           + +L  + Y H  N  + HRDLK +N     +  +  +K+ D GLA   +     R+ +G
Sbjct: 130 KDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 187
Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPAS 123
           TP +++P++ E  Y    D +S G+ ++ ++ C YP        ++  K+  G    P  
Sbjct: 188 TPYYVSPQVLEGLYGPECDEWSAGV-MMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEK 246
Query: 124 LSKVTDPQVKQFIEKCIVPA-SLRLPALELLKDPFL---VTDNPKDLV 167
                 PQ +  I + +  +   R+ +L+ L+  +    ++ +P++L+
Sbjct: 247 DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNLL 294

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDXTLKILDFGLA----RTAGTSFMMTPYV 186
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKP 121
               + APE +    Y E VDI+S G  + EMV  +  +   ++    + KV    G   
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPC 245
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL 150
               K   P V+ ++E     A L  P L
Sbjct: 246 PEFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A Q+   L YL S     +HRD+   N+ V+ N+  VK+GD GL+  M+  T       
Sbjct: 118 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKG 174
Query: 67  P---EFMAPE-LYEEEYNELVDIYSFGMCILEMV 96
               ++MAPE +    +    D++ FG+C+ E++
Sbjct: 175 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/168 (23%), Positives = 80/168 (47%), Gaps = 12/168 (7%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIF--VNGNNGEVKIGDLGLAIVMQQ-PTARSVIG 65
           + +L  + Y H  N  + HRDLK +N     +  +  +K+ D GLA   +     R+ +G
Sbjct: 113 KDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 170
Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPAS 123
           TP +++P++ E  Y    D +S G+ ++ ++ C YP        ++  K+  G    P  
Sbjct: 171 TPYYVSPQVLEGLYGPECDEWSAGV-MMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEK 229
Query: 124 LSKVTDPQVKQFIEKCIVPA-SLRLPALELLKDPFL---VTDNPKDLV 167
                 PQ +  I + +  +   R+ +L+ L+  +    ++ +P++L+
Sbjct: 230 DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSSPRNLL 277

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 52/95 (54%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR    
Sbjct: 120 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAK 176
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 177 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 210

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A Q+   L YL S     +HRD+   N+ V+ N+  VK+GD GL+  M+  T       
Sbjct: 119 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKG 175
Query: 67  P---EFMAPE-LYEEEYNELVDIYSFGMCILEMV 96
               ++MAPE +    +    D++ FG+C+ E++
Sbjct: 176 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 52/100 (52%), Gaps = 7/100 (7%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQP 58
           M  I  +  Q+ R + ++HS    I HRD+K  N+ VN  +  +K+ D G A  ++  +P
Sbjct: 140 MNLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP 197
Query: 59  TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMV 96
           +  + I +  + APEL     EY   +D++S G    E++
Sbjct: 198 SV-AXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A Q+   L YL S     +HRD+   N+ V+ N+  VK+GD GL+  M+  T       
Sbjct: 144 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKG 200
Query: 67  P---EFMAPE-LYEEEYNELVDIYSFGMCILEMV 96
               ++MAPE +    +    D++ FG+C+ E++
Sbjct: 201 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +  + + + TP  
Sbjct: 132 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTASTNFMMTPYV 184
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G  + E+V     +    +  Q  K +   G   A
Sbjct: 185 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 244
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKD 165
                  P V+ ++E    PA   +   EL  D    +++ +D
Sbjct: 245 EFMAALQPTVRNYVEN--RPAYPGIAFEELFPDWIFPSESERD 285

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A Q+   L YL S     +HRD+   N+ V+ N+  VK+GD GL+  M+  T       
Sbjct: 113 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKG 169
Query: 67  P---EFMAPE-LYEEEYNELVDIYSFGMCILEMV 96
               ++MAPE +    +    D++ FG+C+ E++
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A Q+   L YL S     +HRD+   N+ V+ N+  VK+GD GL+  M+  T       
Sbjct: 121 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKG 177
Query: 67  P---EFMAPE-LYEEEYNELVDIYSFGMCILEMV 96
               ++MAPE +    +    D++ FG+C+ E++
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A Q+   L YL S     +HRD+   N+ V+ N+  VK+GD GL+  M+  T       
Sbjct: 116 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKG 172
Query: 67  P---EFMAPE-LYEEEYNELVDIYSFGMCILEMV 96
               ++MAPE +    +    D++ FG+C+ E++
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A Q+   L YL S     +HRD+   N+ V+ N+  VK+GD GL+  M+  T       
Sbjct: 116 YAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKG 172
Query: 67  P---EFMAPE-LYEEEYNELVDIYSFGMCILEMV 96
               ++MAPE +    +    D++ FG+C+ E++
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP 67
           QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P
Sbjct: 119 QIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEWTARQGAKFP 175
Query: 68  -EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 176 IKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 207

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 172 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 224
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKP 121
               + APE +    Y E VDI+S G  + EMV  +  +   ++    + KV    G   
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPC 283
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL 150
               K   P V+ ++E     A L  P L
Sbjct: 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKL 312

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/135 (32%), Positives = 63/135 (46%), Gaps = 14/135 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDATLKILDFGLA----RTAGTSFMMTPYV 186
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G  + EM+     +    +  Q  K +   G    
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 123 SLSKVTDPQVKQFIE 137
              K   P V+ ++E
Sbjct: 247 EFMKKLQPTVRTYVE 261

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/135 (32%), Positives = 63/135 (46%), Gaps = 14/135 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDATLKILDFGLA----RTAGTSFMMTPYV 186
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G  + EM+     +    +  Q  K +   G    
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 123 SLSKVTDPQVKQFIE 137
              K   P V+ ++E
Sbjct: 247 EFMKKLQPTVRTYVE 261

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 12/108 (11%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ----QPTARSVI 64
           R I  G+ YL   N   +HRDL   NI VN +N   K+ D GL+  ++     PT  S +
Sbjct: 142 RGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSAL 198
Query: 65  GTP---EFMAPELYE-EEYNELVDIYSFGMCILEMVTC-EYPYNECKN 107
           G      + APE  +  ++    D++S+G+ + E+++  E PY +  N
Sbjct: 199 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 246

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTP 67
           QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GLA +++  + TAR     P
Sbjct: 119 QIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLARLIEDNEYTARQGAKFP 175
Query: 68  -EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 176 IKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 207

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 67/148 (45%), Gaps = 14/148 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 186
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G    
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 246
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPAL 150
              K   P V+ ++E     A L  P L
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 67/148 (45%), Gaps = 14/148 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 186
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G    
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 246
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPAL 150
              K   P V+ ++E     A L  P L
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 67/148 (45%), Gaps = 14/148 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 187
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G    
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 247
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPAL 150
              K   P V+ ++E     A L  P L
Sbjct: 248 EFMKKLQPTVRNYVENRPKYAGLTFPKL 275

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ Y+   N   +HRDL+  NI V G N   K+ D GL  +++  + TAR    
Sbjct: 287 AAQIASGMAYVERMN--YVHRDLRAANILV-GENLVCKVADFGLGRLIEDNEYTARQGAK 343
Query: 66  TP-EFMAPE--LYEEEYNELVDIYSFGMCILEMVT 97
            P ++ APE  LY   +    D++SFG+ + E+ T
Sbjct: 344 FPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTT 377

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 67/148 (45%), Gaps = 14/148 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 133 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 185
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G    
Sbjct: 186 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 245
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPAL 150
              K   P V+ ++E     A L  P L
Sbjct: 246 EFMKKLQPTVRNYVENRPKYAGLTFPKL 273

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 67/148 (45%), Gaps = 14/148 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 187
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G    
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 247
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPAL 150
              K   P V+ ++E     A L  P L
Sbjct: 248 EFMKKLQPTVRNYVENRPKYAGLTFPKL 275

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 69/149 (46%), Gaps = 16/149 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 172 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 224
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKP 121
               + APE +    Y E VDI+S G  + EMV  +  +   ++    + KV    G   
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPC 283
Query: 122 ASLSKVTDPQVKQFIEKCIVPASLRLPAL 150
               K   P V+ ++E     A L  P L
Sbjct: 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKL 312

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 69/137 (50%), Gaps = 5/137 (3%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV-NGNNGEVKIGDLGLAIVMQQPTARSV 63
           + +A+Q+   L +L +    IIH DLK +NI + N     +KI D G +  + Q   +  
Sbjct: 141 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX- 199
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV-TSGIKP 121
           I +  + +PE L    Y+  +D++S G  ++EM T E  ++      Q+ K V   GI P
Sbjct: 200 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 259
Query: 122 ASLSKVTDPQVKQFIEK 138
           A +     P+ ++F EK
Sbjct: 260 AHILDQA-PKARKFFEK 275

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 67/148 (45%), Gaps = 14/148 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 128 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 180
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G    
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 240
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPAL 150
              K   P V+ ++E     A L  P L
Sbjct: 241 EFMKKLQPTVRNYVENRPKYAGLTFPKL 268

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 67/148 (45%), Gaps = 14/148 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 128 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 180
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G    
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 240
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPAL 150
              K   P V+ ++E     A L  P L
Sbjct: 241 EFMKKLQPTVRNYVENRPKYAGLTFPKL 268

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 69/137 (50%), Gaps = 5/137 (3%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV-NGNNGEVKIGDLGLAIVMQQPTARSV 63
           + +A+Q+   L +L +    IIH DLK +NI + N     +KI D G +  + Q   +  
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX- 218
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV-TSGIKP 121
           I +  + +PE L    Y+  +D++S G  ++EM T E  ++      Q+ K V   GI P
Sbjct: 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278
Query: 122 ASLSKVTDPQVKQFIEK 138
           A +     P+ ++F EK
Sbjct: 279 AHILDQA-PKARKFFEK 294

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/148 (33%), Positives = 67/148 (45%), Gaps = 14/148 (9%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 127 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 179
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G  + EMV  +  +       Q  K +   G    
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
Query: 123 SLSKVTDPQVKQFIEKCIVPASLRLPAL 150
              K   P V+ ++E     A L  P L
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKL 267

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ-QPTARSVI 64
           NW  QI +G+ YL      ++HRDL   N+ V   N  VKI D GLA ++    T     
Sbjct: 123 NWCMQIAKGMSYLEDVR--LVHRDLAARNVLVKSPN-HVKITDFGLARLLDIDETEYHAD 179
Query: 65  GTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
           G     ++MA E +    +    D++S+G+ + E++T
Sbjct: 180 GGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIG 65
           A QI  G+ ++   N   IHR+L+  NI V+ +    KI D GLA +++  + TAR    
Sbjct: 111 AAQIAEGMAFIEERN--YIHRNLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAK 167
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQI 111
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP  I
Sbjct: 168 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 216

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 16/136 (11%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE- 68
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S +  PE 
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMEPEV 186
Query: 69  ----FMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKP 121
               + APE +    Y E VD++S G CI+  + C       ++    + KV    G   
Sbjct: 187 VTRYYRAPEVILGMGYKENVDLWSVG-CIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 245
Query: 122 ASLSKVTDPQVKQFIE 137
               K   P V+ ++E
Sbjct: 246 PEFMKKLQPTVRTYVE 261

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 16/136 (11%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 139 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 191
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKP 121
               + APE +    Y E VD++S G CI+  + C       ++    + KV    G   
Sbjct: 192 VTRYYRAPEVILGMGYKENVDLWSVG-CIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 250
Query: 122 ASLSKVTDPQVKQFIE 137
               K   P V+ ++E
Sbjct: 251 PEFMKKLQPTVRTYVE 266

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 69/137 (50%), Gaps = 5/137 (3%)
Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV-NGNNGEVKIGDLGLAIVMQQPTARSV 63
           + +A+Q+   L +L +    IIH DLK +NI + N     +KI D G +  + Q   +  
Sbjct: 160 RKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQX- 218
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV-TSGIKP 121
           I +  + +PE L    Y+  +D++S G  ++EM T E  ++      Q+ K V   GI P
Sbjct: 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP 278
Query: 122 ASLSKVTDPQVKQFIEK 138
           A +     P+ ++F EK
Sbjct: 279 AHILDQA-PKARKFFEK 294

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 16/136 (11%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 128 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 180
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKP 121
               + APE +    Y E VD++S G CI+  + C       ++    + KV    G   
Sbjct: 181 VTRYYRAPEVILGMGYKENVDLWSVG-CIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPC 239
Query: 122 ASLSKVTDPQVKQFIE 137
               K   P V+ ++E
Sbjct: 240 PEFMKKLQPTVRTYVE 255

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/135 (32%), Positives = 63/135 (46%), Gaps = 14/135 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 186
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G  + EM+     +    +  Q  K +   G    
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 123 SLSKVTDPQVKQFIE 137
              K   P V+ ++E
Sbjct: 247 EFMKKLQPTVRTYVE 261

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 131 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 187
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 188 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 121 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 177
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 125 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 181
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 124 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 180
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 123 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 179
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/135 (32%), Positives = 63/135 (46%), Gaps = 14/135 (10%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 186
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA 122
               + APE +    Y E VDI+S G  + EM+     +    +  Q  K +   G    
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 123 SLSKVTDPQVKQFIE 137
              K   P V+ ++E
Sbjct: 247 EFMKKLQPTVRTYVE 261

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 127 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 183
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 184 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 122 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 178
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 179 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 124 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 180
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 123 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 179
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 122 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 178
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 179 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 121 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 177
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 146 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 202
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 203 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 124 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 180
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 115 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 171
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 121 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 177
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 124 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 180
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 181 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 128 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 184
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 50/93 (53%), Gaps = 13/93 (13%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 134 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 186
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMV 96
               + APE +    Y E VDI+S G  + EM+
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 128 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 184
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 128 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 184
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 50/93 (53%), Gaps = 13/93 (13%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP-- 67
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 187
Query: 68  ---EFMAPE-LYEEEYNELVDIYSFGMCILEMV 96
               + APE +    Y E VDI+S G  + EM+
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 121 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 177
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 121 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 177
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 155 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 211
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 212 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSV 63
           +++ QI  G+ Y+   N   IHRDL+  N+ V+  +   KI D GLA V++  + TAR  
Sbjct: 114 DFSAQIAEGMAYIERKN--YIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREG 170
Query: 64  IGTP-EFMAPELYEEE-YNELVDIYSFGMCILEMVT 97
              P ++ APE      +    D++SFG+ + E+VT
Sbjct: 171 AKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/98 (27%), Positives = 53/98 (54%), Gaps = 7/98 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--AR 61
           +K+   Q L+ +++ H HN   IHRD+K +NI +   +  +K+ D G A ++  P+    
Sbjct: 104 VKSITWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYD 160
Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT 97
             + T  + +PEL   + +Y   VD+++ G    E+++
Sbjct: 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/157 (21%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTA 60
           +A+K +A  + RG+ +LH+  P I    L   ++ ++ +    + + D+  +   Q P  
Sbjct: 112 QAVK-FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF--QSP-- 166
Query: 61  RSVIGTPEFMAPELYEEEYNEL----VDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
              +  P ++APE  +++  +      D++SF + + E+VT E P+ +  N     K   
Sbjct: 167 -GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL 225
Query: 117 SGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELL 153
            G++P ++     P V + ++ C+     + P  +++
Sbjct: 226 EGLRP-TIPPGISPHVSKLMKICMNEDPAKRPKFDMI 261

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 8/102 (7%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--- 57
           M  + ++A QI +G+ YL   +  ++HRDL   NI V     ++KI D GL+  + +   
Sbjct: 149 MGDLISFAWQISQGMQYLAEMS--LVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDS 205
Query: 58  PTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              RS    P ++MA E L++  Y    D++SFG+ + E+VT
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 57/119 (47%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 63
           R I  G+ YL       +HRDL   NI +N +N   K+ D GLA V++       T R  
Sbjct: 154 RGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLARVLEDDPEAAYTTRGG 210
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 120
                + +PE +   ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 12/108 (11%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 65
           +++ QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA V     A+  I 
Sbjct: 282 DFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARV----GAKFPI- 333
Query: 66  TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 111
             ++ APE      +    D++SFG+ ++E+VT    PY    NP  I
Sbjct: 334 --KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 379

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 8/102 (7%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--- 57
           M  + ++A QI +G+ YL      ++HRDL   NI V     ++KI D GL+  + +   
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDS 205
Query: 58  PTARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              RS    P ++MA E L++  Y    D++SFG+ + E+VT
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 55/102 (53%), Gaps = 8/102 (7%)
Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 58
           M  + ++A QI +G+ YL      ++HRDL   NI V     ++KI D GL+  + +   
Sbjct: 149 MGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDS 205
Query: 59  -TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
              RS    P ++MA E L++  Y    D++SFG+ + E+VT
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 52/102 (50%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  ++L+ L Y HS    I+HRD+K  N+ ++    ++++ D GLA         +V
Sbjct: 134 IRFYMYELLKALDYCHSKG--IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNV 191
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+    P+
Sbjct: 192 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 233

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 133 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 190
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 191 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 32/172 (18%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVI 64
           R I  G+ YL   +   +HRDL   NI VN +N   K+ D GL+  +++    PT  S +
Sbjct: 125 RGIASGMRYLAEMS--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEENSSDPTETSSL 181
Query: 65  GTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKN------------ 107
           G      + APE +   ++    D +S+G+ + E+++  E PY +  N            
Sbjct: 182 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYR 241
Query: 108 -------PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE 151
                  P  +++ +    +    ++   PQV   ++K I  PASL++ A E
Sbjct: 242 LPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARE 293

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI  G++YL      ++HRDL   N+ V      VKI D GLA ++    ++  A 
Sbjct: 118 NWCVQIAEGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAE 174
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 175 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 133 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNV 190
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 191 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 49/98 (50%), Gaps = 18/98 (18%)
Query: 21  HNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQ---------QPTARSVIGTPEF 69
           HN  I HRDLK +NI     N    VKI D GL   ++          P   +  G+ E+
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 70  MAPELYE---EE---YNELVDIYSFGMCILEMVTCEYP 101
           MAPE+ E   EE   Y++  D++S G+ IL ++   YP
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGV-ILYILLSGYP 224

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 60/119 (50%), Gaps = 9/119 (7%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 65
           ++A  + RG+ YL       IHRDL   NI V G N   KI D GL+   +    +++  
Sbjct: 136 HFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMGR 192
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGIK 120
            P  +MA E L    Y    D++S+G+ + E+V+    PY  C    A++Y+K+  G +
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYR 249

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 133 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 190
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 191 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 60/119 (50%), Gaps = 9/119 (7%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 65
           ++A  + RG+ YL       IHRDL   NI V G N   KI D GL+   +    +++  
Sbjct: 146 HFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADFGLSRGQEVYVKKTMGR 202
Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNEC-KNPAQIYKKVTSGIK 120
            P  +MA E L    Y    D++S+G+ + E+V+    PY  C    A++Y+K+  G +
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCAELYEKLPQGYR 259

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 133 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 190
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 191 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 133 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 190
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 191 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 32/172 (18%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ----PTARSVI 64
           R I  G+ YL   +   +HRDL   NI VN +N   K+ D GL+  +++    PT  S +
Sbjct: 123 RGIASGMRYLAEMS--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEENSSDPTYTSSL 179
Query: 65  GTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKN------------ 107
           G      + APE +   ++    D +S+G+ + E+++  E PY +  N            
Sbjct: 180 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYR 239
Query: 108 -------PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE 151
                  P  +++ +    +    ++   PQV   ++K I  PASL++ A E
Sbjct: 240 LPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPASLKIVARE 291

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 138 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 195
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 196 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 237

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 133 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 190
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 191 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 132 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 133 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 190
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 191 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 132 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 63
           R I  G+ YL       +HRDL   NI +N +N   K+ D GL+ V++       T R  
Sbjct: 154 RGIASGMKYLSDMG--FVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 120
                + +PE +   ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 133 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 190
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 191 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 52/102 (50%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  ++L+ L Y HS    I+HRD+K  N+ ++    ++++ D GLA         +V
Sbjct: 139 IRFYMYELLKALDYCHSKG--IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNV 196
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+    P+
Sbjct: 197 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRREPF 238

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 133 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 190
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 191 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 133 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 190
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 191 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 133 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 190
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 191 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/93 (39%), Positives = 49/93 (52%), Gaps = 13/93 (13%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV-----MQQPTARSVI 64
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA       M  P     +
Sbjct: 136 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMVP----FV 188
Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMV 96
            T  + APE +    Y E VDI+S G  + EM+
Sbjct: 189 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 221

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         +V
Sbjct: 131 IRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188
Query: 64  -IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    + Y+  +D++S G  +  M+  + P+
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 63
           R I  G+ YL       +HRDL   NI +N +N   K+ D GL+ V++       T R  
Sbjct: 154 RGIASGMKYLSDMGA--VHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 120
                + +PE +   ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 63
           R I  G+ YL       +HRDL   NI +N +N   K+ D GL+ V++       T R  
Sbjct: 125 RGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 120
                + +PE +   ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 239

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/119 (30%), Positives = 57/119 (47%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 63
           R I  G+ YL       +HRDL   NI +N +N   K+ D GL+ V++       T R  
Sbjct: 131 RGISAGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGG 187
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 120
                + APE +   ++    D++S+G+ + E+V+  E PY E  N   + K V  G +
Sbjct: 188 KIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTN-QDVIKAVEEGYR 245

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 51/117 (43%), Gaps = 29/117 (24%)
Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-------------- 55
           Q+++ + YLHS    ++HRD+K  NI +N     VK+ D GL+                 
Sbjct: 117 QLIKVIKYLHSGG--LLHRDMKPSNILLNA-ECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 56  ---------QQPTARSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYP 101
                     QP     + T  + APE  L   +Y + +D++S G CIL  + C  P
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILCGKP 229

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 63
           R I  G+ YL       +HRDL   NI +N +N   K+ D GL+ V++       T R  
Sbjct: 125 RGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 120
                + +PE +   ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 239

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 63
           R I  G+ YL       +HRDL   NI +N +N   K+ D GL+ V++       T R  
Sbjct: 154 RGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 120
                + +PE +   ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 63
           R I  G+ YL       +HRDL   NI +N +N   K+ D GL+ V++       T R  
Sbjct: 142 RGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGG 198
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 120
                + +PE +   ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 199 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 256

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 63
           R I  G+ YL       +HRDL   NI +N +N   K+ D GL+ V++       T R  
Sbjct: 154 RGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 120
                + +PE +   ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 63
           R I  G+ YL       +HRDL   NI +N +N   K+ D GL+ V++       T R  
Sbjct: 154 RGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 120
                + +PE +   ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 63
           R I  G+ YL       +HRDL   NI +N +N   K+ D GL+ V++       T R  
Sbjct: 154 RGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 120
                + +PE +   ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 63
           R I  G+ YL       +HRDL   NI +N +N   K+ D GL+ V++       T R  
Sbjct: 154 RGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 120
                + +PE +   ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 63
           R I  G+ YL       +HRDL   NI +N +N   K+ D GL  V++       T R  
Sbjct: 154 RGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIK 120
                + +PE +   ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 268

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D G A ++    ++  A 
Sbjct: 123 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAE 179
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 52/124 (41%), Gaps = 34/124 (27%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----- 58
           IK     +L G+ Y+HS    I+HRDLK  N  VN  +  VK+ D GLA  +  P     
Sbjct: 158 IKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNS 214
Query: 59  ---------------------TARSVIG---TPEFMAPE--LYEEEYNELVDIYSFGMCI 92
                                  R + G   T  + APE  L +E Y E +D++S G   
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274
Query: 93  LEMV 96
            E++
Sbjct: 275 AELL 278

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 11/119 (9%)
Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSV 63
           R I  G+ YL       +HRDL   NI +N +N   K+ D GL+ V++       T R  
Sbjct: 152 RGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLSRVLEDDPEAAYTTRGG 208
Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIK 120
                + +PE +   ++    D++S+G+ + E+++  E PY E  N   + K V  G +
Sbjct: 209 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEGYR 266

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D G A ++    ++  A 
Sbjct: 123 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAE 179
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 39/167 (23%), Positives = 80/167 (47%), Gaps = 17/167 (10%)
Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDN-IFVNGNNGEVKIGDLGLAIVMQ-QPT 59
           + I ++  Q+   L +LHSHN  I H D++ +N I+    +  +KI + G A  ++    
Sbjct: 102 REIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
Query: 60  ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
            R +   PE+ APE+++ +  +   D++S G  +  +++   P+      A+  +++   
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF-----LAETNQQIIEN 214
Query: 119 IKPASLS------KVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
           I  A  +      K    +   F+++ +V     R+ A E L+ P+L
Sbjct: 215 IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D G A ++    ++  A 
Sbjct: 128 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAE 184
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 185 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D G A ++    ++  A 
Sbjct: 121 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAE 177
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D G A ++    ++  A 
Sbjct: 123 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAE 179
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 180 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 8/97 (8%)
Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPTAR 61
           NW  QI +G++YL      ++HRDL   N+ V      VKI D G A ++    ++  A 
Sbjct: 125 NWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGRAKLLGAEEKEYHAE 181
Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVT 97
                 ++MA E +    Y    D++S+G+ + E++T
Sbjct: 182 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIG 65
           AR I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G
Sbjct: 153 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 210
Query: 66  TP----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
                 ++M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 211 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 268

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIG 65
           AR I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G
Sbjct: 147 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 204
Query: 66  TP----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
                 ++M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 205 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 54/105 (51%), Gaps = 8/105 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-----GNNGEVKIGDLGLAIVMQQP 58
           +K  ++Q+L GL Y+H     IIH D+K +N+ +       N  ++KI DLG A    + 
Sbjct: 133 VKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191
Query: 59  TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 102
              S I T E+ +PE L    +    DI+S    I E++T ++ +
Sbjct: 192 YTNS-IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIG 65
           AR I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G
Sbjct: 147 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 204
Query: 66  TP----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
                 ++M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 205 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIG 65
           AR I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G
Sbjct: 138 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 195
Query: 66  TP----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
                 ++M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 196 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 253

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIG 65
           AR I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G
Sbjct: 147 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGG 204
Query: 66  TP----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
                 ++M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 205 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 262

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIG 65
           AR I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G
Sbjct: 173 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 230
Query: 66  TP----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
                 ++M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 231 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 288

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 54/105 (51%), Gaps = 8/105 (7%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-----GNNGEVKIGDLGLAIVMQQP 58
           +K  ++Q+L GL Y+H     IIH D+K +N+ +       N  ++KI DLG A    + 
Sbjct: 133 VKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 191
Query: 59  TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY 102
              S I T E+ +PE L    +    DI+S    I E++T ++ +
Sbjct: 192 YTNS-IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIG 65
           AR I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G
Sbjct: 163 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 220
Query: 66  TP----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
                 ++M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 221 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 278

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIG 65
           AR I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G
Sbjct: 146 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 203
Query: 66  TP----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
                 ++M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIG 65
           AR I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G
Sbjct: 161 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 218
Query: 66  TP----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
                 ++M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 219 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 276

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 18  LHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE- 76
           ++ H   +IHRD+K +N+ + G  GE+KI D G ++       +++ GT +++ PE+ E 
Sbjct: 137 MYCHGKKVIHRDIKPENL-LLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 77  EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQF 135
             +NE VD++  G+   E++    P+    +     + V   +K PAS+       + + 
Sbjct: 196 RMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKL 255
Query: 136 IEKCIVPASLRLPALELLKDPFLVTDNPKDL 166
           +       S RLP  ++   P++  ++ + L
Sbjct: 256 LRHN---PSERLPLAQVSAHPWVRANSRRVL 283

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIG 65
           AR I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G
Sbjct: 161 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 218
Query: 66  TP----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
                 ++M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 219 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 276

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIG 65
           AR I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G
Sbjct: 146 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 203
Query: 66  TP----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
                 ++M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 261

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 55/118 (46%), Gaps = 9/118 (7%)
Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIG 65
           AR I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + +     G
Sbjct: 161 ARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 218
Query: 66  TP----EFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
                 ++M PE + E  +    D +SFG+ + E+ +  Y     K+  ++ + VTSG
Sbjct: 219 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG 276

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 53/102 (51%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  ++L+ L Y HS    I+HRD+K  N+ ++    ++++ D GLA         +V
Sbjct: 148 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 205
Query: 64  -IGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    ++Y+  +D++S G     M+  + P+
Sbjct: 206 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 247

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 53/102 (51%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  ++L+ L Y HS    I+HRD+K  N+ ++    ++++ D GLA         +V
Sbjct: 129 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 186
Query: 64  -IGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    ++Y+  +D++S G     M+  + P+
Sbjct: 187 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 228

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 53/102 (51%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  ++L+ L Y HS    I+HRD+K  N+ ++    ++++ D GLA         +V
Sbjct: 128 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 185
Query: 64  -IGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    ++Y+  +D++S G     M+  + P+
Sbjct: 186 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 53/102 (51%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  ++L+ L Y HS    I+HRD+K  N+ ++    ++++ D GLA         +V
Sbjct: 127 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 64  -IGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    ++Y+  +D++S G     M+  + P+
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 53/102 (51%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  ++L+ L Y HS    I+HRD+K  N+ ++    ++++ D GLA         +V
Sbjct: 127 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 64  -IGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    ++Y+  +D++S G     M+  + P+
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 53/102 (51%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  ++L+ L Y HS    I+HRD+K  N+ ++    ++++ D GLA         +V
Sbjct: 127 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 64  -IGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    ++Y+  +D++S G     M+  + P+
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 53/102 (51%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  ++L+ L Y HS    I+HRD+K  N+ ++    ++++ D GLA         +V
Sbjct: 128 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 185
Query: 64  -IGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    ++Y+  +D++S G     M+  + P+
Sbjct: 186 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 53/102 (51%), Gaps = 5/102 (4%)
Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+ +  ++L+ L Y HS    I+HRD+K  N+ ++    ++++ D GLA         +V
Sbjct: 127 IRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV 184
Query: 64  -IGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPY 102
            + +  F  PEL    ++Y+  +D++S G     M+  + P+
Sbjct: 185 RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	505
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-94
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-45
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-43
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-42
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-42
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-39
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-39
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-38
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-38
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-38
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-37
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-36
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-36
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-36
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-36
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-32
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-32
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-31
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-30
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-29
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-28
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-27
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-27
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-27
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-26
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-25
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-24
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-23
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-23
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-23
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-23
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-22
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-22
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-21
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-20
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-20
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-20
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	9e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-19
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-19
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-17
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-17
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-16
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-16
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-15
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-15
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-15
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-15
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-14
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-14
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-14
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-14
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-14
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-14
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-14
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-13
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-13
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-13
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-13
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-13
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-13
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-13
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-13
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-13
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-13
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-13
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-13
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-13
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-13
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-13
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-13
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-13
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-12
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-12
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-12
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-12
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-12
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-12
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-12
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-12
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-12
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-12
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-12
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-12
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-12
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	6e-12
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-12
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-12
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-12
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	9e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-11
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-11
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-11
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-11
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-11
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-11
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-11
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-08
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-08
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-07
2lru_A	98	Serine/threonine-protein kinase WNK1; autoinhibito	3e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-04

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  287 bits (737), Expect = 2e-94
 Identities = 95/162 (58%), Positives = 122/162 (75%), Gaps = 1/162 (0%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           +K +++W RQIL+GL +LH+  PPIIHRDLKCDNIF+ G  G VKIGDLGLA + +   A
Sbjct: 128 IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA 187

Query: 61  RSVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           ++VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+LEM T EYPY+EC+N AQIY++VTSG+K
Sbjct: 188 KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK 247

Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD 161
           PAS  KV  P+VK+ IE CI      R    +LL   F   +
Sbjct: 248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  159 bits (404), Expect = 5e-45
 Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 9/157 (5%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARS 62
           +  + R  L  L +LHS    ++H D+K  NIF+ G  G  K+GD GL + +        
Sbjct: 159 VWGYLRDTLLALAHLHSQG--LVHLDVKPANIFL-GPRGRCKLGDFGLLVELGTAGAGEV 215

Query: 63  VIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 122
             G P +MAPEL +  Y    D++S G+ ILE+       +  +   Q+ +        A
Sbjct: 216 QEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTA 275

Query: 123 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
            LS     +++  +   + P   LR  A  LL  P L
Sbjct: 276 GLS----SELRSVLVMMLEPDPKLRATAEALLALPVL 308

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  153 bits (390), Expect = 4e-43
 Identities = 60/172 (34%), Positives = 83/172 (48%), Gaps = 16/172 (9%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           I  + +QIL GL YLH +   I+HRD+K DN+ +N  +G +KI D G +  +    P   
Sbjct: 124 IGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181

Query: 62  SVIGTPEFMAPE---LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           +  GT ++MAPE        Y +  DI+S G  I+EM T + P+ E   P     KV   
Sbjct: 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF 241

Query: 119 IK----PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 165
                 P S+S     + K FI KC  P    R  A +LL D FL   + K 
Sbjct: 242 KVHPEIPESMS----AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKK 289

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  153 bits (388), Expect = 1e-42
 Identities = 46/137 (33%), Positives = 75/137 (54%), Gaps = 5/137 (3%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSV 63
           + A  + +G++YLH+ NPPI+HR+LK  N+ V+     VK+ D GL+ +      +++S 
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSA 199

Query: 64  IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 122
            GTPE+MAPE+   E  NE  D+YSFG+ + E+ T + P+        +        +  
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL- 258

Query: 123 SLSKVTDPQVKQFIEKC 139
            + +  +PQV   IE C
Sbjct: 259 EIPRNLNPQVAAIIEGC 275

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  151 bits (384), Expect = 4e-42
 Identities = 45/137 (32%), Positives = 74/137 (54%), Gaps = 5/137 (3%)

Query: 6   NWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
           +W  Q  +G+ YLHS  P  +IHRDLK  N+ +      +KI D G A  +Q     +  
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-HMTNNK 164

Query: 65  GTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGIKPA 122
           G+  +MAPE++E   Y+E  D++S+G+ + E++T   P++E   PA  I   V +G +P 
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP- 223

Query: 123 SLSKVTDPQVKQFIEKC 139
            L K     ++  + +C
Sbjct: 224 PLIKNLPKPIESLMTRC 240

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  145 bits (367), Expect = 6e-40
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 13/164 (7%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-S 62
                 QI +G+ Y+HS    +I+RDLK  NIF+  +  +VKIGD GL   ++    R  
Sbjct: 124 ALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 63  VIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
             GT  +M+PE    + Y + VD+Y+ G+ + E++       E       +  +  GI  
Sbjct: 181 SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK---FFTDLRDGIIS 237

Query: 122 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
                    + K  ++K +      R    E+L+   +   +P+
Sbjct: 238 DIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  146 bits (370), Expect = 7e-40
 Identities = 49/192 (25%), Positives = 89/192 (46%), Gaps = 10/192 (5%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--AR 61
           I +W  QI   L ++H     I+HRD+K  NIF+   +G V++GD G+A V+      AR
Sbjct: 127 ILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELAR 183

Query: 62  SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           + IGTP +++PE+ E + YN   DI++ G  + E+ T ++ + E  +   +  K+ SG  
Sbjct: 184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISG-S 241

Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPE 179
              +S      ++  + +        R     +L+  F +    +  +   L       +
Sbjct: 242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGF-IAKRIEKFLSPQLIAEEFCLK 300

Query: 180 VMNLAHSEPHPM 191
             +   S+P P 
Sbjct: 301 TFSKFGSQPIPA 312

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  143 bits (362), Expect = 3e-39
 Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 11/143 (7%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIVMQQPTAR 61
                I  G+ Y+ + NPPI+HRDL+  NIF+   +       K+ D GL+      +  
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-SVS 184

Query: 62  SVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVT 116
            ++G  ++MAPE    E   Y E  D YSF M +  ++T E P++E        I     
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244

Query: 117 SGIKPASLSKVTDPQVKQFIEKC 139
            G++P ++ +   P+++  IE C
Sbjct: 245 EGLRP-TIPEDCPPRLRNVIELC 266

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  142 bits (360), Expect = 4e-39
 Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 10/143 (6%)

Query: 6   NWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVN-------GNNGEVKIGDLGLAIVMQQ 57
           NWA QI RG++YLH     PIIHRDLK  NI +         +N  +KI D GLA    +
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168

Query: 58  PTARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
            T  S  G   +MAPE+     +++  D++S+G+ + E++T E P+      A  Y    
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAM 228

Query: 117 SGIKPASLSKVTDPQVKQFIEKC 139
           + +    +         + +E C
Sbjct: 229 NKLAL-PIPSTCPEPFAKLMEDC 250

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  140 bits (355), Expect = 2e-38
 Identities = 30/138 (21%), Positives = 62/138 (44%), Gaps = 9/138 (6%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 65
            +A  + RG+ +LH+  P I    L   ++ ++  +   +I    +    Q P     + 
Sbjct: 115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPG---RMY 170

Query: 66  TPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
            P ++APE  +++         D++SF + + E+VT E P+ +  N     K    G++P
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP 230

Query: 122 ASLSKVTDPQVKQFIEKC 139
            ++     P V + ++ C
Sbjct: 231 -TIPPGISPHVSKLMKIC 247

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  140 bits (354), Expect = 3e-38
 Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 12/164 (7%)

Query: 4   IKNWARQILRGLHYLHSHNPP---IIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 59
           +     Q+   L   H  +     ++HRDLK  N+F++G    VK+GD GLA ++   T 
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTS 171

Query: 60  -ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVT 116
            A++ +GTP +M+PE      YNE  DI+S G C+L E+     P+    +  ++  K+ 
Sbjct: 172 FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG-CLLYELCALMPPFTA-FSQKELAGKIR 229

Query: 117 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 159
            G K   +      ++ + I + +      R    E+L++P ++
Sbjct: 230 EG-KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  140 bits (355), Expect = 5e-38
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 8/161 (4%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--AR 61
           +  +  Q+   L ++HS    ++HRD+K  N+F+    G VK+GDLGL       T  A 
Sbjct: 138 VWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAH 194

Query: 62  SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYN-ECKNPAQIYKKVTSGI 119
           S++GTP +M+PE   E  YN   DI+S G  + EM   + P+  +  N   + KK+    
Sbjct: 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD 254

Query: 120 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 159
            P   S     +++Q +  CI P    R     +      +
Sbjct: 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  139 bits (353), Expect = 5e-38
 Identities = 53/151 (35%), Positives = 83/151 (54%), Gaps = 14/151 (9%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--- 57
           MK + + ARQ  RG+ YLH+ +  IIHRDLK +NIF+   +  VKIGD GLA    +   
Sbjct: 119 MKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFL-HEDNTVKIGDFGLATEKSRWSG 175

Query: 58  -PTARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
                 + G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI 
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235

Query: 113 KKVTSGIKPASLSKV---TDPQVKQFIEKCI 140
           + V  G     LSKV      ++K+ + +C+
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECL 266

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  141 bits (356), Expect = 5e-38
 Identities = 42/176 (23%), Positives = 70/176 (39%), Gaps = 19/176 (10%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ------ 57
              +  Q L GL YLH+    I+H D+K DN+ ++ +     + D G A+ +Q       
Sbjct: 152 ALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKS 209

Query: 58  -PTARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
             T   + GT   MAPE+   +  +  VDI+S    +L M+   +P+ +        K  
Sbjct: 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA 269

Query: 116 TSGI----KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 166
           +        P S +    P   Q I++ +      R  A+EL +           L
Sbjct: 270 SEPPPIREIPPSCA----PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  138 bits (349), Expect = 4e-37
 Identities = 35/156 (22%), Positives = 71/156 (45%), Gaps = 22/156 (14%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----- 55
           +   +  A++I++G+ YLH+    I+H+DLK  N+F +  NG+V I D GL  +      
Sbjct: 129 VNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQA 184

Query: 56  --QQPTARSVIGTPEFMAPEL----------YEEEYNELVDIYSFGMCILEMVTCEYPYN 103
             ++   R   G    +APE+           +  +++  D+++ G    E+   E+P+ 
Sbjct: 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK 244

Query: 104 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 139
             +    I  ++ +G+KP         ++   +  C
Sbjct: 245 T-QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFC 279

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  137 bits (346), Expect = 1e-36
 Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 23/173 (13%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
               +   QI   + +LHS    ++HRDLK  NIF    +  VK+GD GL   M Q    
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEE 220

Query: 62  --------------SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 106
                           +GT  +M+PE      Y+  VDI+S G+ + E++   Y ++   
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQM 277

Query: 107 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
              +I   V +   P   ++   PQ    ++  + P  + R  A +++++   
Sbjct: 278 ERVRIITDVRNLKFPLLFTQ-KYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  136 bits (344), Expect = 1e-36
 Identities = 42/173 (24%), Positives = 70/173 (40%), Gaps = 23/173 (13%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
               +   QI   + +LHS    ++HRDLK  NIF    +  VK+GD GL   M Q    
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEE 174

Query: 62  --------------SVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECK 106
                           +GT  +M+PE      Y+  VDI+S G+ + E++   YP++   
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPFSTQM 231

Query: 107 NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
              +    V +  K   L     P     ++  + P    R  A+ ++++   
Sbjct: 232 ERVRTLTDVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  135 bits (343), Expect = 2e-36
 Identities = 56/177 (31%), Positives = 76/177 (42%), Gaps = 27/177 (15%)

Query: 3   AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR- 61
                 RQIL  L Y+HS    IIHRDLK  NIF++  +  VKIGD GLA  + +     
Sbjct: 117 EYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDIL 173

Query: 62  ---------------SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNE 104
                          S IGT  ++A E+ +    YNE +D+YS G+   EM+   YP++ 
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFST 230

Query: 105 CKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
                 I KK+ S     P           K+ I   I    + R  A  LL   +L
Sbjct: 231 GMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  132 bits (333), Expect = 3e-35
 Identities = 39/177 (22%), Positives = 73/177 (41%), Gaps = 30/177 (16%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN------------------GEVK 45
           +K+   Q+ RGL Y+HS +  ++H D+K  NIF++  +                     K
Sbjct: 117 LKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174

Query: 46  IGDLGLAIVMQQPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYN 103
           IGDLG    +  P  +   G   F+A E+ +E   +    DI++  + ++     E    
Sbjct: 175 IGDLGHVTRISSP--QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232

Query: 104 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLV 159
                   + ++  G  P  + +V   +  + ++  I P    R  A+ L+K   L+
Sbjct: 233 N----GDQWHEIRQGRLP-RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  124 bits (314), Expect = 4e-32
 Identities = 37/178 (20%), Positives = 71/178 (39%), Gaps = 21/178 (11%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---- 59
            K++ + +L  +H +H H   I+H DLK  N  +   +G +K+ D G+A  MQ  T    
Sbjct: 110 RKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVV 165

Query: 60  ARSVIGTPEFMAPEL------------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKN 107
             S +GT  +M PE              + + +   D++S G  +  M   + P+ +  N
Sbjct: 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225

Query: 108 PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
                  +           + +  ++  ++ C+      R+   ELL  P++      
Sbjct: 226 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  123 bits (311), Expect = 8e-32
 Identities = 40/176 (22%), Positives = 73/176 (41%), Gaps = 23/176 (13%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 59
               K++ + +L  +H +H H   I+H DLK  N  +   +G +K+ D G+A  MQ  T 
Sbjct: 126 PWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTT 181

Query: 60  ---ARSVIGTPEFMAPELYEEE------------YNELVDIYSFGMCIL-EMVTCEYPYN 103
                S +GT  +M PE  ++              +   D++S G CIL  M   + P+ 
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQ 240

Query: 104 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
           +  N       +           + +  ++  ++ C+      R+   ELL  P++
Sbjct: 241 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  123 bits (310), Expect = 2e-31
 Identities = 47/188 (25%), Positives = 73/188 (38%), Gaps = 40/188 (21%)

Query: 6   NWARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 59
             A   + GL +LH+        P I HRDLK  NI V   NG   I DLGLA+     T
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDT 196

Query: 60  AR------SVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTC-------- 98
                   + +GT  +M PE+ +E       +   + D+YSFG+ + E+           
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256

Query: 99  --EYPYNECKNPAQIYKKVTSG---------IKPASLSKVTDPQVKQFIEKCIVP-ASLR 146
             + PY++       Y+ +                  S     Q+ + + +C     + R
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316

Query: 147 LPALELLK 154
           L AL + K
Sbjct: 317 LTALRVKK 324

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  123 bits (310), Expect = 4e-31
 Identities = 39/182 (21%), Positives = 72/182 (39%), Gaps = 23/182 (12%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT- 59
               K++ + +L  +H +H H   I+H DLK  N  +   +G +K+ D G+A  MQ  T 
Sbjct: 154 PWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTT 209

Query: 60  ---ARSVIGTPEFMAPELYEEE------------YNELVDIYSFGMCIL-EMVTCEYPYN 103
                S +G   +M PE  ++              +   D++S G CIL  M   + P+ 
Sbjct: 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQ 268

Query: 104 ECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 162
           +  N       +           + +  ++  ++ C+      R+   ELL  P++    
Sbjct: 269 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328

Query: 163 PK 164
             
Sbjct: 329 HP 330

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  120 bits (302), Expect = 1e-30
 Identities = 54/177 (30%), Positives = 85/177 (48%), Gaps = 21/177 (11%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           R+ILRGL +LH H   +IHRD+K  N+ +   N EVK+ D G++  + +   R  + IGT
Sbjct: 136 REILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192

Query: 67  PEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA----QIYKKVT 116
           P +MAPE        +  Y+   D++S G+  +EM     P  +  +P      I +   
Sbjct: 193 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPA 251

Query: 117 SGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPLR 172
             +K    SK    + + FIE C +   S R    +L+K PF+     +  V   L+
Sbjct: 252 PRLKSKKWSK----KFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLK 304

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  118 bits (299), Expect = 2e-30
 Identities = 49/188 (26%), Positives = 74/188 (39%), Gaps = 40/188 (21%)

Query: 6   NWARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 59
                I  GL +LH         P I HRDLK  NI V   NG+  I DLGLA++  Q T
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQST 167

Query: 60  AR------SVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNECK 106
            +        +GT  +MAPE+ +E       +  + VDI++FG+ + E+          +
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227

Query: 107 NPAQIYKKVTSG-------------------IKPASLSKVTDPQVKQFIEKCIVP-ASLR 146
           +    +  V                      I     S  T   + + +++C     S R
Sbjct: 228 DYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287

Query: 147 LPALELLK 154
           L AL + K
Sbjct: 288 LTALRIKK 295

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (299), Expect = 2e-30
 Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 17/159 (10%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           R+ L+ L +LHS+   +IHRD+K DNI +   +G VK+ D G    I  +Q    +++GT
Sbjct: 123 RECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGT 179

Query: 67  PEFMAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGI----K 120
           P +MAPE+   + Y   VDI+S G+  +EM+  E PY   +NP + +Y   T+G      
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTPELQN 238

Query: 121 PASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFL 158
           P  LS       + F+ +C  +    R  A ELL+  FL
Sbjct: 239 PEKLS----AIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  118 bits (299), Expect = 5e-30
 Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 22/203 (10%)

Query: 8   ARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV-IG 65
               ++ L++L       IIHRD+K  NI ++  +G +K+ D G++  +    A++   G
Sbjct: 131 TLATVKALNHLKENLK--IIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAG 187

Query: 66  TPEFMAPE-----LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
              +MAPE        + Y+   D++S G+ + E+ T  +PY +  +      +V  G  
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-D 246

Query: 121 PASLSKVTD----PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 175
           P  LS   +    P    F+  C+    S R    ELLK PF++    +      + +  
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA-----VEVAC 301

Query: 176 LVPEVMNLAHSEP-HPMDIDLNH 197
            V ++++   + P  PM +D +H
Sbjct: 302 YVCKILDQMPATPSSPMYVDHHH 324

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  118 bits (298), Expect = 5e-30
 Identities = 54/159 (33%), Positives = 81/159 (50%), Gaps = 17/159 (10%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
             +L+ L YLH+    +IHRD+K D+I +   +G VK+ D G    I    P  +S++GT
Sbjct: 148 EAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGT 204

Query: 67  PEFMAPEL-YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGI----K 120
           P +MAPE+     Y   VDI+S G+ ++EMV  E PY    +P Q + +   S       
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKN 263

Query: 121 PASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFL 158
              +S    P ++ F+E+  +     R  A ELL  PFL
Sbjct: 264 SHKVS----PVLRDFLERMLVRDPQERATAQELLDHPFL 298

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  118 bits (297), Expect = 1e-29
 Identities = 58/193 (30%), Positives = 95/193 (49%), Gaps = 20/193 (10%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 68
              L+GL YLHSHN  +IHRD+K  NI ++   G VK+GD G A +M    A S +GTP 
Sbjct: 161 HGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPY 215

Query: 69  FMAPE----LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ----IYKKVTSGIK 120
           +MAPE    + E +Y+  VD++S G+  +E+   + P     N       I +  +  ++
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQ 274

Query: 121 PASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLVP 178
               S       + F++ C       R  +  LLK  F++ + P  ++ D + R  + V 
Sbjct: 275 SGHWS----EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVR 330

Query: 179 EVMNLAHSEPHPM 191
           E+ NL + +   +
Sbjct: 331 ELDNLQYRKMKKI 343

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  117 bits (296), Expect = 1e-29
 Identities = 48/188 (25%), Positives = 69/188 (36%), Gaps = 40/188 (21%)

Query: 6   NWARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT 59
             A     GL +LH         P I HRDLK  NI V   NG   I DLGLA+     T
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSAT 201

Query: 60  ------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTC-------- 98
                     +GT  +MAPE+ ++       E  +  DIY+ G+   E+           
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261

Query: 99  --EYPYNECKNP----AQIYKKVTSG-----IKPASLSKVTDPQVKQFIEKCIVP-ASLR 146
             + PY +         ++ K V        I     S      + + + +C     + R
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 321

Query: 147 LPALELLK 154
           L AL + K
Sbjct: 322 LTALRIKK 329

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  116 bits (293), Expect = 2e-29
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 11/166 (6%)

Query: 8   ARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIG 65
           A  I++ L +LHS  +  +IHRD+K  N+ +N   G+VK+ D G++  +    A+    G
Sbjct: 115 AVSIVKALEHLHSKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAG 171

Query: 66  TPEFMAPE-----LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
              +MAPE     L ++ Y+   DI+S G+ ++E+    +PY+    P Q  K+V     
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231

Query: 121 PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 165
           P   +     +   F  +C+   +  R    EL++ PF      K 
Sbjct: 232 PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  116 bits (293), Expect = 2e-29
 Identities = 57/171 (33%), Positives = 89/171 (52%), Gaps = 17/171 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           R+IL+GL YLHS     IHRD+K  N+ ++  +GEVK+ D G+A  +     +  + +GT
Sbjct: 126 REILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGT 182

Query: 67  PEFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPA----QIYKKVTSGIKP 121
           P +MAPE+ ++  Y+   DI+S G+  +E+   E P++E  +P      I K       P
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE-LHPMKVLFLIPKN-----NP 236

Query: 122 ASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPL 171
            +L       +K+F+E C     S R  A ELLK  F++ +  K      L
Sbjct: 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTEL 287

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  118 bits (296), Expect = 2e-29
 Identities = 26/170 (15%), Positives = 52/170 (30%), Gaps = 25/170 (14%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
            A      Q++R L  LH +   ++H  L+  +I ++   G V +      +        
Sbjct: 206 HARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQ-RGGVFLTGFEHLVRDGARV-- 260

Query: 62  SVIGTPEFMAPELYEEE------------YNELVDIYSFGMCILEMVTCEYPYNECKNPA 109
               +  F  PEL                     D ++ G+ I  +   + P  +     
Sbjct: 261 VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK-DAAL 319

Query: 110 QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
              + +    K           V+  +E  +      RL  L+ ++ P  
Sbjct: 320 GGSEWIFRSCKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEY 363

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  115 bits (290), Expect = 5e-29
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 28/171 (16%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------IVMQQPTAR 61
           R++L GL YLH +    IHRD+K  NI +   +G V+I D G++        + +    +
Sbjct: 128 REVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRK 184

Query: 62  SVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNEC-----------KNP 108
           + +GTP +MAPE+ E+   Y+   DI+SFG+  +E+ T   PY++             +P
Sbjct: 185 TFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244

Query: 109 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFL 158
             +   V          K      ++ I  C       R  A ELL+  F 
Sbjct: 245 PSLETGVQDKEMLKKYGKS----FRKMISLCLQKDPEKRPTAAELLRHKFF 291

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  113 bits (286), Expect = 1e-28
 Identities = 41/172 (23%), Positives = 79/172 (45%), Gaps = 12/172 (6%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
             ++   L Y HS    +IHRD+K +N+ + G+ GE+KI D G ++         + GT 
Sbjct: 115 ITELANALSYCHSKR--VIHRDIKPENLLL-GSAGELKIADFGWSVHAPSSRRTDLCGTL 171

Query: 68  EFMAPELYEE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASL 124
           +++ PE+ E   ++E VD++S G+   E +    P  E     + YK+++      P  +
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKRISRVEFTFPDFV 230

Query: 125 SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 175
           +       +  I + +    S R    E+L+ P++  ++ K   C      +
Sbjct: 231 T----EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAS 278

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  113 bits (286), Expect = 2e-28
 Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 18/173 (10%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           RQ+L  L++LHS    IIHRDLK  N+ +    G++++ D G++   +       S IGT
Sbjct: 124 RQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGT 180

Query: 67  PEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKKVTSGI 119
           P +MAPE      + +  Y+   DI+S G+ ++EM   E P++E  NP + + K   S  
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSD- 238

Query: 120 KPASLSKVTD--PQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCD 169
            P +L   +    + + F++         R  A +LL+ PF+ +      + +
Sbjct: 239 -PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  116 bits (291), Expect = 2e-28
 Identities = 24/161 (14%), Positives = 49/161 (30%), Gaps = 20/161 (12%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVI 64
             Q++R L  LH +   ++H  L+  +I +    G V +      +              
Sbjct: 217 TLQVIRLLASLHHYG--LVHTYLRPVDIVL-DQRGGVFLTGFEHLVRDGASAVSPIGRGF 273

Query: 65  GTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
             PE  A  +               D ++ G+ I  +   + P  +        + +   
Sbjct: 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-DAALGGSEWIFRS 332

Query: 119 IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
            K           V+  +E  +      RL  L+ ++ P  
Sbjct: 333 CKNIP------QPVRALLEGFLRYPKEDRLLPLQAMETPEY 367

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  113 bits (284), Expect = 4e-28
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 17/170 (10%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGT 66
           +  L+GL YLH      IHRD+K  NI +N   G  K+ D G+A  +        +VIGT
Sbjct: 132 QSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGT 188

Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ----IYKKVTSGIK- 120
           P +MAPE + E  YN + DI+S G+  +EM   + PY +  +P +    I        + 
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTNPPPTFRK 247

Query: 121 PASLSKVTDPQVKQFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCD 169
           P   S         F+++C +     R  A +LL+ PF+ +     ++ D
Sbjct: 248 PELWS----DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRD 293

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  112 bits (281), Expect = 9e-28
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 13/168 (7%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-SVIGT 66
              I++ L+YL   +  +IHRD+K  NI ++   G++K+ D G++  +    A+    G 
Sbjct: 130 TVAIVKALYYLKEKHG-VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGC 187

Query: 67  PEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
             +MAPE        + +Y+   D++S G+ ++E+ T ++PY  CK   ++  KV    +
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-E 246

Query: 121 PASLSKVTD--PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNPKD 165
           P  L          + F++ C+      R    +LL+  F+      +
Sbjct: 247 PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  110 bits (278), Expect = 2e-27
 Identities = 56/172 (32%), Positives = 84/172 (48%), Gaps = 20/172 (11%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           RQI+ G  YLH +   +IHRDLK  N+F+N  + EVKIGD GLA  ++    R   + GT
Sbjct: 122 RQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGT 178

Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPAS 123
           P ++APE L ++ ++  VD++S G CI+  +    P  E     + Y ++       P  
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 237

Query: 124 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 174
           ++    P     I+K +    + R    ELL D F  +         P RLP
Sbjct: 238 IN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSG------YIPARLP 279

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  110 bits (277), Expect = 4e-27
 Identities = 41/186 (22%), Positives = 70/186 (37%), Gaps = 40/186 (21%)

Query: 8   ARQILRGLHYLHS--------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---- 55
           A  + RGL YLH         H P I HRD+K  N+ +  NN    I D GLA+      
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGK 185

Query: 56  QQPTARSVIGTPEFMAPEL------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA 109
                   +GT  +MAPE+      ++ +    +D+Y+ G+ + E+ +     +   +  
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245

Query: 110 QI--------------------YKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLP 148
            +                    +KK    ++           + + IE+C    A  RL 
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 149 ALELLK 154
           A  + +
Sbjct: 306 AGCVGE 311

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  109 bits (275), Expect = 5e-27
 Identities = 41/149 (27%), Positives = 59/149 (39%), Gaps = 20/149 (13%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---------- 57
           A+ I  G+ YLHS N  IIHRDL   N  V  N   V + D GLA +M            
Sbjct: 114 AKDIASGMAYLHSMN--IIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRS 170

Query: 58  ------PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 110
                     +V+G P +MAPE +    Y+E VD++SFG+ + E++       +      
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230

Query: 111 IYKKVTSGIKPASLSKVTDPQVKQFIEKC 139
            +     G           P       +C
Sbjct: 231 DFGLNVRGFLDRYCPPNCPPSFFPITVRC 259

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  110 bits (276), Expect = 9e-27
 Identities = 28/167 (16%), Positives = 56/167 (33%), Gaps = 16/167 (9%)

Query: 3   AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS 62
           A+     Q++R    L S    ++H     DN+F+   +G + +GD+      +  T   
Sbjct: 195 ALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFI-MPDGRLMLGDVSAL--WKVGTRGP 249

Query: 63  VIGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNEC-KNPAQIYKKVTS 117
               P   AP  +       +   ++ +  G+ I  +     P+          +K+ + 
Sbjct: 250 ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSL 309

Query: 118 GIK-----PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
            +                 VK  I + +      RL  LE ++ P  
Sbjct: 310 RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (272), Expect = 1e-26
 Identities = 40/161 (24%), Positives = 82/161 (50%), Gaps = 12/161 (7%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
             ++   LHY H     +IHRD+K +N+ + G  GE+KI D G ++       R++ GT 
Sbjct: 120 MEELADALHYCHERK--VIHRDIKPENLLM-GYKGELKIADFGWSVHAPSLRRRTMCGTL 176

Query: 68  EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASL 124
           +++ PE+ E + ++E VD++  G+   E +    P+ +  +  + ++++ +  +K P  L
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFL 235

Query: 125 SKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
           S       K  I K +      RLP   +++ P++  ++ +
Sbjct: 236 S----DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  108 bits (273), Expect = 2e-26
 Identities = 56/172 (32%), Positives = 84/172 (48%), Gaps = 20/172 (11%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
           RQI+ G  YLH +   +IHRDLK  N+F+N  + EVKIGD GLA  ++    R   + GT
Sbjct: 148 RQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGT 204

Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPAS 123
           P ++APE L ++ ++  VD++S G CI+  +    P  E     + Y ++       P  
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIG-CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 263

Query: 124 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 174
           ++    P     I+K +    + R    ELL D F  +         P RLP
Sbjct: 264 IN----PVAASLIQKMLQTDPTARPTINELLNDEFFTSG------YIPARLP 305

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  110 bits (276), Expect = 2e-26
 Identities = 45/171 (26%), Positives = 67/171 (39%), Gaps = 17/171 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLAIVMQQP-----T 59
           +Q   GL +LHS N  I+HRDLK  NI ++  N        I D GL   +         
Sbjct: 125 QQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182

Query: 60  ARSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKK 114
              V GT  ++APE+  E+        VDI+S G     +++    P+ +          
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242

Query: 115 VTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
               +      K  D   ++ IEK I      R  A  +LK PF  +   +
Sbjct: 243 GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  105 bits (263), Expect = 3e-25
 Identities = 38/171 (22%), Positives = 60/171 (35%), Gaps = 23/171 (13%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS- 62
           I      I RGL  +H+      HRDLK  NI +  + G+  + DLG           S 
Sbjct: 136 ILWLLLGICRGLEAIHA--KGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSR 192

Query: 63  ----------VIGTPEFMAPELYEEE----YNELVDIYSFGMCIL-EMVTCEYPYNECKN 107
                        T  + APEL+  +     +E  D++S G C+L  M+  E PY+    
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG-CVLYAMMFGEGPYDMVFQ 251

Query: 108 PAQIYK-KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDP 156
                   V + +      + +   + Q +   +      R     LL   
Sbjct: 252 KGDSVALAVQNQLSIPQSPRHS-SALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  105 bits (264), Expect = 4e-25
 Identities = 43/183 (23%), Positives = 75/183 (40%), Gaps = 23/183 (12%)

Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
           K   + +L    Y+H+    I HRD+K  NI +   NG VK+ D G +  M     +   
Sbjct: 154 KCIIKSVLNSFSYIHNEKN-ICHRDVKPSNILM-DKNGRVKLSDFGESEYMVDKKIKGSR 211

Query: 65  GTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--- 118
           GT EFM PE +  E       VDI+S G+C+  M     P++   +  +++  + +    
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271

Query: 119 --------------IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 163
                          K    +     +   F++  +    + R+ + + LK  +L   N 
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331

Query: 164 KDL 166
           +DL
Sbjct: 332 EDL 334

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  105 bits (263), Expect = 4e-25
 Identities = 43/202 (21%), Positives = 77/202 (38%), Gaps = 47/202 (23%)

Query: 8   ARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  +++GL YL   H   I+HRD+K  NI VN + GE+K+ D G++  +    A S +GT
Sbjct: 137 SIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGT 193

Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS 125
             +M+PE L    Y+   DI+S G+ ++EM    YP                    A+ +
Sbjct: 194 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253

Query: 126 KVTD-----------------------------------------PQVKQFIEKCIV-PA 143
                                                         + + F+ KC++   
Sbjct: 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 313

Query: 144 SLRLPALELLKDPFLVTDNPKD 165
           + R    +L+   F+   + ++
Sbjct: 314 AERADLKQLMVHAFIKRSDAEE 335

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  103 bits (259), Expect = 5e-25
 Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 16/163 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR--SVIGT 66
            QI+ G+ YLHSH   I+HRDL   N+ +   N  +KI D GLA  ++ P  +  ++ GT
Sbjct: 119 HQIITGMLYLHSHG--ILHRDLTLSNLLL-TRNMNIKIADFGLATQLKMPHEKHYTLCGT 175

Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGI--KPA 122
           P +++PE      +    D++S G C+   ++    P+ +         KV       P+
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLG-CMFYTLLIGRPPF-DTDTVKNTLNKVVLADYEMPS 233

Query: 123 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
            LS     + K  I + +    + RL    +L  PF+  ++  
Sbjct: 234 FLS----IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  105 bits (263), Expect = 7e-25
 Identities = 42/261 (16%), Positives = 79/261 (30%), Gaps = 64/261 (24%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR------- 61
           + +L+ L Y+H      +HR +K  +I ++  +G+V +  L   + M     R       
Sbjct: 135 QGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 62  --SVIGTPEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPY-------------- 102
               +    +++PE+ ++    Y+   DIYS G+   E+     P+              
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251

Query: 103 -------------NECKNPAQIYKKVTSGIKPASLSKVTDPQV----------------K 133
                         E    +       SG+  +  +    P                   
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311

Query: 134 QFIEKC-IVPASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMD 192
            F+E+C       R  A  LL   F      +        LP L+  V  + + E     
Sbjct: 312 HFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEA----LPELLRPVTPITNFEGSQSQ 367

Query: 193 IDLNHKKVSADSCAKSNTGTW 213
            D +       +  +     W
Sbjct: 368 -DHSGIFGLVTNLEELEVDDW 387

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  103 bits (259), Expect = 1e-24
 Identities = 40/207 (19%), Positives = 70/207 (33%), Gaps = 29/207 (14%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           +     Q  R + ++H   PPIIHRDLK +N+ +  N G +K+ D G A  +      S 
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL-SNQGTIKLCDFGSATTISHYPDYSW 196

Query: 64  --------------IGTPEFMAPELYE----EEYNELVDIYSFGMCIL-EMVTCEYPYNE 104
                           TP +  PE+ +        E  DI++ G CIL  +   ++P+ +
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLLCFRQHPFED 255

Query: 105 CKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 163
                +I     S     +            I   +      RL   E++     +    
Sbjct: 256 -GAKLRIVNGKYSIPPHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310

Query: 164 KDLVCDPLRLPNLVPEVMNLAHSEPHP 190
                 P  +  L+ +      +    
Sbjct: 311 NVNPKSP--ITELLEQNGGYGSATLSR 335

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  102 bits (256), Expect = 2e-24
 Identities = 45/177 (25%), Positives = 83/177 (46%), Gaps = 15/177 (8%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +Q+L  + YLH +   I+HRDLK +N+       N ++ I D GL+ + Q     +  GT
Sbjct: 113 QQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGT 170

Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---K 120
           P ++APE L ++ Y++ VD +S G  I  ++ C YP  Y E    +++++K+  G    +
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIG-VITYILLCGYPPFYEE--TESKLFEKIKEGYYEFE 227

Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 176
                 +++   K FI   +    + R    + L  P++  +        P     +
Sbjct: 228 SPFWDDISE-SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQI 283

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  105 bits (264), Expect = 2e-24
 Identities = 64/276 (23%), Positives = 95/276 (34%), Gaps = 24/276 (8%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI--FVNGNNGEVKIGDLGLAIVMQQPT-ARSVIG 65
             I   L YLH +   IIHRDLK +NI           KI DLG A  + Q       +G
Sbjct: 128 SDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185

Query: 66  TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 124
           T +++APEL E ++Y   VD +SFG    E +T   P+     P Q + KV        +
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245

Query: 125 SKVTDPQVKQFIEKCIVPASL---------RLPALELLKDP-----FLVTDNPKDLVCDP 170
                    +F      P  L         R     L+             N        
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305

Query: 171 LRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSADSCAKSNTGTWFLTLELQRLTENNEFTL 230
             L   +  VMN+     H   +  N    +  S  + +TG   +  E Q L + +   L
Sbjct: 306 SILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTG---IPEEEQELLQASGLAL 362

Query: 231 RGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADT 266
              +     V +   + D      ++ F+F      
Sbjct: 363 NSAQPLTQYV-IDCTVIDGRQGEGDLIFLFDNRKTV 397

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  102 bits (257), Expect = 2e-24
 Identities = 41/170 (24%), Positives = 71/170 (41%), Gaps = 18/170 (10%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA------R 61
           RQI   LHYLH+    I HRD+K +N  F    + E+K+ D GL+    +          
Sbjct: 175 RQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232

Query: 62  SVIGTPEFMAPEL---YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           +  GTP F+APE+     E Y    D +S G  +L ++          N A    +V + 
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAG-VLLHLLLMGAVPFPGVNDADTISQVLNK 291

Query: 119 ---IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
               +  + + ++    +  +   +      R  A+  L+ P++   + K
Sbjct: 292 KLCFENPNYNVLSP-LARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK 340

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  101 bits (255), Expect = 4e-24
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 17/186 (9%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQP 58
           +   ++ +QIL G++YLH+    I H DLK +NI +   N     +K+ D GLA  ++  
Sbjct: 115 EEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172

Query: 59  TA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKK 114
              +++ GTPEF+APE +  E      D++S G  I  ++         +     +    
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLAN 229

Query: 115 VTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDP 170
           +TS          S  ++   K FI K +V     RL   E L+ P++   + +  +   
Sbjct: 230 ITSVSYDFDEEFFSHTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRR 288

Query: 171 LRLPNL 176
             + NL
Sbjct: 289 ESVVNL 294

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  101 bits (253), Expect = 1e-23
 Identities = 30/170 (17%), Positives = 63/170 (37%), Gaps = 25/170 (14%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----------NNGEVKIGDLGLAI 53
           + ++A ++L  +  +H     IIH D+K DN  +             +  + + DLG +I
Sbjct: 174 VISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

Query: 54  VMQQP----TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNP 108
            M+         +   T  F   E L  + +N  +D +     +  M+   Y   + +  
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291

Query: 109 AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI-VPASLRLPALELLKDPF 157
               + +   +    +         +F    + +P    LP+L+LL+   
Sbjct: 292 ECKPEGLFRRLPHLDMW-------NEFFHVMLNIPDCHHLPSLDLLRQKL 334

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  102 bits (255), Expect = 1e-23
 Identities = 48/169 (28%), Positives = 85/169 (50%), Gaps = 16/169 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIG 65
            Q+L  + YLH +   IIHRDLK +N+ +     +  +KI D G + ++ + +  R++ G
Sbjct: 246 YQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 303

Query: 66  TPEFMAPE----LYEEEYNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSGI- 119
           TP ++APE    +    YN  VD +S G  IL +    Y P++E +    +  ++TSG  
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEHRTQVSLKDQITSGKY 362

Query: 120 --KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 165
              P   ++V++      ++K +V     R    E L+ P+L  ++ K 
Sbjct: 363 NFIPEVWAEVSEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 36/165 (21%), Positives = 71/165 (43%), Gaps = 15/165 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIG 65
           + +L  + Y H  N  + HRDLK +N     +  +  +K+ D GLA   +     R+ +G
Sbjct: 113 KDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 170

Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---K 120
           TP +++P++ E  Y    D +S G  ++ ++ C YP         +++  K+  G     
Sbjct: 171 TPYYVSPQVLEGLYGPECDEWSAG-VMMYVLLCGYPPFSAP--TDSEVMLKIREGTFTFP 227

Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
                 V+  Q +  I + +      R+ +L+ L+  +       
Sbjct: 228 EKDWLNVSP-QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  102 bits (256), Expect = 2e-23
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 11/176 (6%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIG 65
           RQ+L G+ Y+H +   I+HRDLK +N+   +   +  ++I D GL+   +     +  IG
Sbjct: 133 RQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIG 190

Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPA 122
           T  ++APE+    Y+E  D++S G  IL ++    P     N   I KKV  G    +  
Sbjct: 191 TAYYIAPEVLHGTYDEKCDVWSTG-VILYILLSGCPPFNGANEYDILKKVEKGKYTFELP 249

Query: 123 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 177
              KV++   K  I K +    S+R+ A + L   ++ T   + +  D   L N +
Sbjct: 250 QWKKVSE-SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAI 304

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  100 bits (251), Expect = 2e-23
 Identities = 47/194 (24%), Positives = 85/194 (43%), Gaps = 20/194 (10%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           R I   + +LHSHN  I HRD+K +N+ + +   +  +K+ D G A    Q   ++   T
Sbjct: 135 RDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 192

Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKN--PAQIYKKVTSG--- 118
           P ++APE L  E+Y++  D++S G  I+ ++ C +P  Y+         + +++  G   
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251

Query: 119 IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL-----VTDNPKDLVCDPLR 172
                 S+V++   KQ I   +    + RL   + +  P++     V   P         
Sbjct: 252 FPNPEWSEVSE-DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQE 310

Query: 173 LPNLVPEVMNLAHS 186
             +   EV     S
Sbjct: 311 DKDHWDEVKEEMTS 324

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  100 bits (252), Expect = 2e-23
 Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 17/179 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQPTA-RSVI 64
           +QIL G++YLH+    I H DLK +NI +   N     +K+ D GLA  ++     +++ 
Sbjct: 122 KQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI-- 119
           GTPEF+APE +  E      D++S G  I  ++         +     +    +T+    
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLANITAVSYD 236

Query: 120 -KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 176
                 S+ ++   K FI K +V     RL   E L+ P++   + +  +     + NL
Sbjct: 237 FDEEFFSQTSE-LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNL 294

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  100 bits (250), Expect = 2e-23
 Identities = 50/189 (26%), Positives = 87/189 (46%), Gaps = 18/189 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQPTA-RSVIG 65
            Q+L  + YLH +   IIHRDLK +N+ +     +  +KI D G + ++ + +  R++ G
Sbjct: 121 YQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 178

Query: 66  TPEFMAPE----LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI 119
           TP ++APE    +    YN  VD +S G  IL +    YP      +    +  ++TSG 
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLG-VILFICLSGYPPFSEH-RTQVSLKDQITSGK 236

Query: 120 ---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 175
               P   ++V++      ++K +V     R    E L+ P+L  ++ K    D L   N
Sbjct: 237 YNFIPEVWAEVSEK-ALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEEN 295

Query: 176 LVPEVMNLA 184
               +  + 
Sbjct: 296 ESTALPQVL 304

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 99.2 bits (248), Expect = 2e-23
 Identities = 36/159 (22%), Positives = 72/159 (45%), Gaps = 16/159 (10%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSVIG 65
           +Q++  L Y HS +  ++H+DLK +NI F +   +  +KI D GLA + +      +  G
Sbjct: 131 KQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG 188

Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-----K 120
           T  +MAPE+++ +     DI+S G  ++  +          +  ++ +K T        +
Sbjct: 189 TALYMAPEVFKRDVTFKCDIWSAG-VVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE 247

Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
              L+    PQ    +++ +      R  A ++L   + 
Sbjct: 248 CRPLT----PQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 99.2 bits (248), Expect = 2e-23
 Identities = 52/166 (31%), Positives = 86/166 (51%), Gaps = 15/166 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSVIG 65
           +Q+  G+ Y+H HN  I+HRDLK +NI   +   + ++KI D GL+   QQ T  +  IG
Sbjct: 128 KQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185

Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---K 120
           T  ++APE+    Y+E  D++S G  IL ++    P  Y +  N   I K+V +G     
Sbjct: 186 TAYYIAPEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYGK--NEYDILKRVETGKYAFD 242

Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 165
                 ++D   K  I K +    SLR+ A + L+ P++   + ++
Sbjct: 243 LPQWRTISD-DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSEE 287

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  100 bits (251), Expect = 2e-23
 Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 15/172 (8%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA 60
             + N+ RQ   GL ++H H+  I+H D+K +NI         VKI D GLA  +     
Sbjct: 149 AEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206

Query: 61  -RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVT 116
            +    T EF APE +  E      D+++ G  +  ++         E  +  +  + V 
Sbjct: 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGE--DDLETLQNVK 263

Query: 117 SGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
                    + S V+  + K FI+  +      RL   + L+ P+L  D+  
Sbjct: 264 RCDWEFDEDAFSSVSP-EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 99.1 bits (247), Expect = 3e-23
 Identities = 36/166 (21%), Positives = 67/166 (40%), Gaps = 22/166 (13%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVMQQPT-ARSVI 64
           R ++ G+++L  +   I+HR++K  NI            K+ D G A  ++      S+ 
Sbjct: 119 RDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176

Query: 65  GTPEFMAPELYE---------EEYNELVDIYSFGMCIL-EMVTCE---YPYNECKNPAQI 111
           GT E++ P++YE         ++Y   VD++S G        T      P+   +   ++
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRRNKEV 235

Query: 112 YKKVTSGIKPASLSKVTDPQ--VKQFIEKCIVPASLRLPALELLKD 155
             K+ +G    ++S V   +     +     V  SL      LL  
Sbjct: 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 98.0 bits (245), Expect = 4e-23
 Identities = 46/167 (27%), Positives = 82/167 (49%), Gaps = 16/167 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ-QPTARSVIG 65
           +QIL  + Y HS+   I+HR+LK +N+   +      VK+ D GLAI +          G
Sbjct: 112 QQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI--- 119
           TP +++PE L ++ Y++ VDI++ G  IL ++   YP  ++E  +  ++Y ++ +G    
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYAQIKAGAYDY 226

Query: 120 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 165
                  VT  + K  I+  +      R+ A + LK P++       
Sbjct: 227 PSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 97.6 bits (244), Expect = 5e-23
 Identities = 43/176 (24%), Positives = 78/176 (44%), Gaps = 17/176 (9%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQP 58
                + +QIL G+HYLHS    I H DLK +NI +   N  N  +K+ D G+A  ++  
Sbjct: 108 DEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165

Query: 59  TA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKK 114
              +++ GTPEF+APE +  E      D++S G  I  ++         E     +    
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGE--TKQETLTN 222

Query: 115 VTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 166
           +++          S  ++   K FI + +V     R+   + L+  ++     +++
Sbjct: 223 ISAVNYDFDEEYFSNTSE-LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 99.0 bits (247), Expect = 8e-23
 Identities = 46/173 (26%), Positives = 81/173 (46%), Gaps = 15/173 (8%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGT 66
           +QI  G+ ++H     I+H DLK +NI  VN +  ++KI D GLA   +     +   GT
Sbjct: 194 KQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGT 251

Query: 67  PEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI---K 120
           PEF+APE +  +  +   D++S G+ I  M+         +  N A+    + +     +
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGV-IAYMLLSGLSPFLGD--NDAETLNNILACRWDLE 308

Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLR 172
                 +++ + K+FI K ++   S R+ A E LK P+L        +    +
Sbjct: 309 DEEFQDISE-EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKK 360

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  100 bits (250), Expect = 9e-23
 Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 11/176 (6%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIG 65
           +Q+  G+ Y+H HN  I+HRDLK +NI   +   + ++KI D GL+   QQ    +  IG
Sbjct: 128 KQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185

Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPA 122
           T  ++APE+    Y+E  D++S G  IL ++    P    KN   I K+V +G       
Sbjct: 186 TAYYIAPEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244

Query: 123 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 177
               ++D   K  I K +    SLR+ A + L+ P++   + +      L      
Sbjct: 245 QWRTISD-DAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESA 299

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 36/117 (30%), Positives = 53/117 (45%), Gaps = 26/117 (22%)

Query: 6   NWARQILRGLHYLHS-------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM--- 55
             A  + RGL YLH+       + P I HRDL   N+ V  N+G   I D GL++ +   
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGN 173

Query: 56  -------QQPTARSVIGTPEFMAPELYE--------EEYNELVDIYSFGMCILEMVT 97
                  +   A S +GT  +MAPE+ E        E   + VD+Y+ G+   E+  
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 98.8 bits (246), Expect = 1e-22
 Identities = 40/182 (21%), Positives = 74/182 (40%), Gaps = 25/182 (13%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVMQQPT-ARSVI 64
           R ++ G+++L  +   I+HR++K  NI            K+ D G A  ++      S+ 
Sbjct: 119 RDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176

Query: 65  GTPEFMAPELYE---------EEYNELVDIYSFGMCIL-EMVTCE---YPYNECKNPAQI 111
           GT E++ P++YE         ++Y   VD++S G        T      P+   +   ++
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRRNKEV 235

Query: 112 YKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPA-LELLKDPFLVTDNPKDLVCDP 170
             K+ +G    ++S V   +         +P S  L   L++L  P L       L  D 
Sbjct: 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA----NILEADQ 291

Query: 171 LR 172
            +
Sbjct: 292 EK 293

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 37/172 (21%), Positives = 77/172 (44%), Gaps = 15/172 (8%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA 60
           + I ++  Q+   L +LHSHN  I H D++ +NI +    +  +KI + G A  ++    
Sbjct: 102 REIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159

Query: 61  -RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVT 116
            R +   PE+ APE    +  +   D++S G  ++ ++         E     QI + + 
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLG-TLVYVLLSGINPFLAE--TNQQIIENIM 216

Query: 117 SGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
           +        +  +++  +   F+++ +V     R+ A E L+ P+L     +
Sbjct: 217 NAEYTFDEEAFKEISI-EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 17/167 (10%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQ--QPTARSV 63
             I + + YLH+    ++HRDLK  NI     +GN   ++I D G A  ++       + 
Sbjct: 123 FTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP 180

Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECK-NPAQIYKKVTSG- 118
             T  F+APE L  + Y+   DI+S G  +L  +   Y    N     P +I  ++ SG 
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239

Query: 119 --IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 162
             +     + V+D   K  + K +      RL A  +L+ P++V  +
Sbjct: 240 FSLSGGYWNSVSD-TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 19/169 (11%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSVIG 65
           +QIL  + YLH +   I+HRDLK +N+ +     +  +KI D GL+ +++     ++V G
Sbjct: 155 KQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG 212

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFG--MCILEMVTCEYP--YNECKNPAQIYKKVTSGI- 119
           TP + APE L    Y   VD++S G    IL    C +   Y+E +    +++++ +   
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYIL---LCGFEPFYDE-RGDQFMFRRILNCEY 268

Query: 120 --KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 165
                   +V+    K  + K IV     RL   + L+ P++       
Sbjct: 269 YFISPWWDEVSL-NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANF 316

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 99.0 bits (247), Expect = 2e-22
 Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 11/176 (6%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIG 65
           +Q+L G+ YLH HN  I+HRDLK +N+   +   +  +KI D GL+ V +     +  +G
Sbjct: 143 KQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLG 200

Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPA 122
           T  ++APE+  ++Y+E  D++S G  IL ++   YP    +   +I +KV  G       
Sbjct: 201 TAYYIAPEVLRKKYDEKCDVWSIG-VILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP 259

Query: 123 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLV 177
               V++   K  I++ +   +  R+ A + L+ P++     K      L      
Sbjct: 260 EWKNVSE-GAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANA 314

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.0 bits (247), Expect = 3e-22
 Identities = 53/179 (29%), Positives = 85/179 (47%), Gaps = 15/179 (8%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQ-PTARSVIG 65
           +QIL G+ YLH HN  I+HRD+K +NI   N  +   +KI D GL+    +    R  +G
Sbjct: 153 KQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG 210

Query: 66  TPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPA 122
           T  ++APE+ +++YNE  D++S G  I+ ++ C YP    +N   I KKV  G       
Sbjct: 211 TAYYIAPEVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN 269

Query: 123 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK----DLVCDPLRLPNL 176
               ++  + K+ I+  +    + R  A E L   ++          D       L N+
Sbjct: 270 DWKNIS-DEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNM 327

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 19/180 (10%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQP--TARSVI 64
           RQIL  L Y H +N  IIHRD+K   +   +  N+  VK+G  G+AI + +    A   +
Sbjct: 137 RQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI-- 119
           GTP FMAPE +  E Y + VD++  G  IL ++       Y       ++++ +  G   
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCG-VILFILLSGCLPFYGT---KERLFEGIIKGKYK 250

Query: 120 -KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK-DLVCDPLRLPNL 176
             P   S +++   K  + + ++   + R+   E L  P+L   +     +  P  +  L
Sbjct: 251 MNPRQWSHISE-SAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQL 309

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 96.6 bits (241), Expect = 3e-22
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 17/175 (9%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV---NGNNGEVKIGDLGLAIVMQQP 58
           +    + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +   
Sbjct: 114 EEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171

Query: 59  TA-RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKK 114
              +++ GTPEF+APE +  E      D++S G  I  ++         +     +    
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG-VITYILLSGASPFLGD--TKQETLAN 228

Query: 115 VTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD 165
           V++     +    S  +    K FI + +V     R+   + L+ P++   + + 
Sbjct: 229 VSAVNYEFEDEYFSNTSA-LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 44/194 (22%), Positives = 84/194 (43%), Gaps = 22/194 (11%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ--QPTARSVI 64
           R+++  + ++H     ++HRDLK +N+ F +  +N E+KI D G A +        ++  
Sbjct: 113 RKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP-------YNECKNPAQIYKKVT 116
            T  + APE L +  Y+E  D++S G  IL  +               C +  +I KK+ 
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK 229

Query: 117 SG---IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLR 172
            G    +  +   V+  + K  I+  +    + RL    L  + +L   +      +PL 
Sbjct: 230 KGDFSFEGEAWKNVSQ-EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS--NPLM 286

Query: 173 LPNLVPEVMNLAHS 186
            P+++       H+
Sbjct: 287 TPDILGSSGAAVHT 300

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 95.8 bits (239), Expect = 7e-22
 Identities = 48/179 (26%), Positives = 86/179 (48%), Gaps = 17/179 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA-RSVIG 65
           +QIL  + Y HS+   I+HR+LK +N+   +      VK+ D GLAI +    A     G
Sbjct: 135 QQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI--- 119
           TP +++PE L ++ Y++ VDI++ G  IL ++   YP  ++E  +  ++Y ++ +G    
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACG-VILYILLVGYPPFWDE--DQHRLYAQIKAGAYDY 249

Query: 120 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK-DLVCDPLRLPNL 176
                  VT  + K  I+  +      R+ A + LK P++         +     +  L
Sbjct: 250 PSPEWDTVTP-EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCL 307

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 96.2 bits (240), Expect = 8e-22
 Identities = 40/163 (24%), Positives = 79/163 (48%), Gaps = 18/163 (11%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIG 65
           +  +++  L YL +    IIHRD+K DNI ++  +G V I D  +A ++ + T   ++ G
Sbjct: 120 FICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMAG 176

Query: 66  TPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKKVTSGI 119
           T  +MAPE++       Y+  VD +S G+   E++    PY      +  +I     + +
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV 236

Query: 120 K--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD-PFL 158
              P++ S     ++   ++K + P    R   L  +++ P++
Sbjct: 237 VTYPSAWS----QEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 96.4 bits (240), Expect = 1e-21
 Identities = 42/186 (22%), Positives = 70/186 (37%), Gaps = 32/186 (17%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVN------------GNNGEVKIGDLGLAIVMQ 56
           RQI  G+ +LHS    IIHRDLK  NI V+              N  + I D GL   + 
Sbjct: 122 RQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

Query: 57  ------QPTARSVIGTPEFMAPEL--------YEEEYNELVDIYSFGMCILEMVTCEYP- 101
                 +    +  GT  + APEL         +      +DI+S G     +++     
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

Query: 102 -YNECKNPAQIYKKVTSGIKPASLSKVT-DPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
             ++    + I + + S  +   L   +   +    I + I      R  A+++L+ P  
Sbjct: 240 FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

Query: 159 VTDNPK 164
              + K
Sbjct: 300 WPKSKK 305

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 43/144 (29%), Positives = 73/144 (50%), Gaps = 12/144 (8%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----IVMQQPTARSVIG 65
           +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A       +Q  A S +G
Sbjct: 138 EIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVG 194

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL 124
           T ++++PE L E+   +  D+++ G  I ++V    P+    N   I++K+         
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKL--EYDF 251

Query: 125 SKVTDPQVKQFIEKCIVP-ASLRL 147
            +   P+ +  +EK +V  A+ RL
Sbjct: 252 PEKFFPKARDLVEKLLVLDATKRL 275

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 97.2 bits (242), Expect = 1e-21
 Identities = 44/186 (23%), Positives = 80/186 (43%), Gaps = 17/186 (9%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPTA 60
                + RQ+ +GL ++H +N   +H DLK +NI F    + E+K+ D GL   +    +
Sbjct: 255 DEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312

Query: 61  -RSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVT 116
            +   GT EF APE    +      D++S G  +  ++         E  N  +  + V 
Sbjct: 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG-VLSYILLSGLSPFGGE--NDDETLRNVK 369

Query: 117 SGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN--PKDLVCDP 170
           S       ++ S +++   K FI K ++   + R+   + L+ P+L   N   +D     
Sbjct: 370 SCDWNMDDSAFSGISE-DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPS 428

Query: 171 LRLPNL 176
            R   +
Sbjct: 429 SRYTKI 434

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 16/169 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGN-NGEVKIGDLGLAIVMQQPTA-RSVIG 65
           +QIL G++YLH +N  I+H DLK  NI   +    G++KI D G++  +      R ++G
Sbjct: 138 KQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG 195

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI--- 119
           TPE++APE L  +      D+++ G+ I  M+         E  +  + Y  ++      
Sbjct: 196 TPEYLAPEILNYDPITTATDMWNIGI-IAYMLLTHTSPFVGE--DNQETYLNISQVNVDY 252

Query: 120 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLV 167
              + S V+      FI+  +V     R  A   L   +L   + ++L 
Sbjct: 253 SEETFSSVSQ-LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 43/172 (25%), Positives = 74/172 (43%), Gaps = 21/172 (12%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTP 67
           R +L  +  LH  N  I+HRDLK +NI ++ ++  +K+ D G +  +      R V GTP
Sbjct: 131 RALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTP 187

Query: 68  EFMAPE-------LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSG 118
            ++APE            Y + VD++S G  I+  +    P  ++       + + + SG
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTG-VIMYTLLAGSPPFWHR--KQMLMLRMIMSG 244

Query: 119 I---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 166
                       +D  VK  + + +V     R  A E L  PF      +++
Sbjct: 245 NYQFGSPEWDDYSDT-VKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 95.4 bits (238), Expect = 3e-21
 Identities = 46/180 (25%), Positives = 86/180 (47%), Gaps = 18/180 (10%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTA--RSVI 64
           +QIL  + + H     ++HR+LK +N+   +      VK+ D GLAI ++          
Sbjct: 117 QQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSGI-- 119
           GTP +++PE L ++ Y + VD+++ G  IL ++   YP  ++E  +  ++Y+++ +G   
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACG-VILYILLVGYPPFWDE--DQHRLYQQIKAGAYD 231

Query: 120 -KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP-KDLVCDPLRLPNL 176
                   VT  + K  I K +    S R+ A E LK P++   +     +     +  L
Sbjct: 232 FPSPEWDTVTP-EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCL 290

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 95.6 bits (238), Expect = 4e-21
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 11/138 (7%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVI 64
           +  QI+ GL +LH  N  II+RDLK +N+ ++ ++G V+I DLGLA  +   Q   +   
Sbjct: 294 YTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYA 350

Query: 65  GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIK 120
           GTP FMAPE L  EEY+  VD ++ G+ + EM+    P+    E     ++ ++V     
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-- 408

Query: 121 PASLSKVTDPQVKQFIEK 138
             +      P  K F E 
Sbjct: 409 AVTYPDKFSPASKDFCEA 426

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 95.7 bits (238), Expect = 5e-21
 Identities = 35/136 (25%), Positives = 69/136 (50%), Gaps = 9/136 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A +I+ GL ++H+    +++RDLK  NI ++  +G V+I DLGLA    +    + +GT
Sbjct: 297 YAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGT 353

Query: 67  PEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPY--NECKNPAQIYKKVTSGIKPA 122
             +MAPE       Y+   D +S G  + +++    P+  ++ K+  +I +   +     
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AV 411

Query: 123 SLSKVTDPQVKQFIEK 138
            L     P+++  +E 
Sbjct: 412 ELPDSFSPELRSLLEG 427

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 93.6 bits (233), Expect = 7e-21
 Identities = 42/166 (25%), Positives = 78/166 (46%), Gaps = 16/166 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ-QPTARSVIG 65
           + I   + YLHS N  I HRD+K +N+ + +   N  +K+ D G A       +  +   
Sbjct: 168 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 225

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQ--IYKKVTSGI- 119
           TP ++APE L  E+Y++  D++S G  I+ ++ C YP  Y+         +  ++  G  
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284

Query: 120 --KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 162
                  S+V++ +VK  I   +    + R+   E +  P+++   
Sbjct: 285 EFPNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 93.1 bits (232), Expect = 7e-21
 Identities = 38/124 (30%), Positives = 69/124 (55%), Gaps = 9/124 (7%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 65
           A +I   L YLHS N  I++RDLK +NI ++ + G + + D GL    +    T  +  G
Sbjct: 145 AAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCG 201

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PA 122
           TPE++APE L+++ Y+  VD +  G  + EM+    P+   +N A++Y  + +  ++   
Sbjct: 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKP 260

Query: 123 SLSK 126
           +++ 
Sbjct: 261 NITN 264

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 91.0 bits (227), Expect = 1e-20
 Identities = 34/107 (31%), Positives = 57/107 (53%), Gaps = 15/107 (14%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           +K++  Q+L+GL + HS N  ++HRDLK  N+ +N  NGE+K+ + GLA     P  R  
Sbjct: 103 VKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPV-RCY 158

Query: 64  IGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVTCEYPY 102
             + E +      P++    + Y+  +D++S G CI  E+     P 
Sbjct: 159 --SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG-CIFAELANAGRPL 202

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 93.3 bits (232), Expect = 1e-20
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 24/160 (15%)

Query: 6   NWAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQP 58
             AR    +++  +  +H  +   +HRD+K DNI ++  NG +++ D G     +     
Sbjct: 175 EMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTV 231

Query: 59  TARSVIGTPEFMAPELYEEE------YNELVDIYSFGMCILEMVTCEYP-YNECKNPAQI 111
            +   +GTP++++PE+ +        Y    D +S G+C+ EM+  E P Y E  +  + 
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE--SLVET 289

Query: 112 YKKVTSGIK----PASLSKVTDPQVKQFIEKCIVPASLRL 147
           Y K+ +  +    P  ++ V     K  I + I     RL
Sbjct: 290 YGKIMNHKERFQFPTQVTDV-SENAKDLIRRLICSREHRL 328

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 92.6 bits (230), Expect = 2e-20
 Identities = 39/105 (37%), Positives = 55/105 (52%), Gaps = 14/105 (13%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG---NNGEVKIGDLGLAIVMQQPTA 60
           +K+   QIL G+HYLH++   ++HRDLK  NI V G     G VKI D+G A +   P  
Sbjct: 130 VKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187

Query: 61  RSVIGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 97
                 P  +     APEL      Y + +DI++ G CI  E++T
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG-CIFAELLT 231

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 39/122 (31%), Positives = 61/122 (50%), Gaps = 9/122 (7%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 67
           +I   L +LH     II+RDLK +NI +N + G VK+ D GL    +       +  GT 
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTI 185

Query: 68  EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASL 124
           E+MAPE L    +N  VD +S G  + +M+T   P+   +N  +   K+    +  P  L
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKCKLNLPPYL 244

Query: 125 SK 126
           ++
Sbjct: 245 TQ 246

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 92.1 bits (229), Expect = 2e-20
 Identities = 38/157 (24%), Positives = 72/157 (45%), Gaps = 20/157 (12%)

Query: 6   NWAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 58
            WAR    +++  L  +HS     IHRD+K DN+ ++  +G +K+ D G  + M +    
Sbjct: 168 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMV 224

Query: 59  TARSVIGTPEFMAPEL-----YEEEYNELVDIYSFGMCILEMVTCEYP-YNECKNPAQIY 112
              + +GTP++++PE+      +  Y    D +S G+ + EM+  + P Y +  +    Y
Sbjct: 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD--SLVGTY 282

Query: 113 KKVTSGIKPASLSKVTD--PQVKQFIEKCIVPASLRL 147
            K+ +     +     D   + K  I   +    +RL
Sbjct: 283 SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRL 319

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 48/202 (23%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 67
           ++   L +LHS    II+RDLK +NI ++   G +K+ D GL+   +  +  A S  GT 
Sbjct: 134 ELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190

Query: 68  EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 126
           E+MAPE +    + +  D +SFG+ + EM+T   P+ + K+  +    +           
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILK--------- 240

Query: 127 VTDPQVKQFIEKCIVPASLRLPALELLKDPFLVTDNPKDLVCDPLRL---PNLVPEVMNL 183
                      K  +P  L   A  LL+   L   NP +      RL   P+ V E+   
Sbjct: 241 ----------AKLGMPQFLSPEAQSLLRM--LFKRNPAN------RLGAGPDGVEEIKR- 281

Query: 184 AHSEPHP--MDID---LNHKKV 200
                H     ID   L  +++
Sbjct: 282 -----HSFFSTIDWNKLYRREI 298

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 90.3 bits (225), Expect = 3e-20
 Identities = 38/102 (37%), Positives = 57/102 (55%), Gaps = 15/102 (14%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           IK +  Q+LRG+ + H H   I+HRDLK  N+ +N ++G +K+ D GLA     P     
Sbjct: 121 IKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSY- 176

Query: 64  IGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 97
             T E +     AP++    ++Y+  VDI+S G CI  EM+T
Sbjct: 177 --THEVVTLWYRAPDVLMGSKKYSTSVDIWSIG-CIFAEMIT 215

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 44/138 (31%), Positives = 75/138 (54%), Gaps = 12/138 (8%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T  ++ GTP
Sbjct: 147 AAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-WTLCGTP 202

Query: 68  EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASL 124
           E +APE +  + YN+ VD ++ G+ I EM     P+     P QIY+K+ SG ++ P+  
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHF 261

Query: 125 SKVTDPQVKQFIEKCIVP 142
           S      +K  +   +  
Sbjct: 262 S----SDLKDLLRNLLQV 275

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 36/128 (28%), Positives = 67/128 (52%), Gaps = 14/128 (10%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGT 66
           +I+  L +LH     II+RD+K +NI ++ +NG V + D GL+   +  +   A    GT
Sbjct: 167 EIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGT 223

Query: 67  PEFMAPELYEEE---YNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSG-I 119
            E+MAP++       +++ VD +S G+ + E++T   P+    E  + A+I +++     
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 283

Query: 120 K-PASLSK 126
             P  +S 
Sbjct: 284 PYPQEMSA 291

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 90.3 bits (225), Expect = 4e-20
 Identities = 44/136 (32%), Positives = 73/136 (53%), Gaps = 8/136 (5%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A ++   L YLHS +  II+RDLK +NI ++  NG +KI D G A  +   T  ++ GTP
Sbjct: 112 AAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVT-YTLCGTP 167

Query: 68  EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSK 126
           +++APE +  + YN+ +D +SFG+ I EM+    P+    N  + Y+K+ +         
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNA--ELRFPP 224

Query: 127 VTDPQVKQFIEKCIVP 142
             +  VK  + + I  
Sbjct: 225 FFNEDVKDLLSRLITR 240

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 90.0 bits (224), Expect = 6e-20
 Identities = 36/124 (29%), Positives = 70/124 (56%), Gaps = 9/124 (7%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 65
             +I+  L YLHS +  +++RD+K +N+ ++  +G +KI D GL    +    T ++  G
Sbjct: 111 GAEIVSALEYLHSRD--VVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCG 167

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PA 122
           TPE++APE L + +Y   VD +  G+ + EM+    P+   ++  ++++ +    I+ P 
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPR 226

Query: 123 SLSK 126
           +LS 
Sbjct: 227 TLSP 230

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 88.8 bits (221), Expect = 7e-20
 Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 17/161 (10%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARS 62
           N+  QIL G+ + H     I+HRD+K  NI +  +N  +KI D G+A  + + +      
Sbjct: 115 NFTNQILDGIKHAHDMR--IVHRDIKPQNILI-DSNKTLKIFDFGIAKALSETSLTQTNH 171

Query: 63  VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSGIK 120
           V+GT ++ +PE  + E  +E  DIYS G+ + EM+  E P+N  +    I  K +   + 
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHIQDSV- 229

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLP------ALELLKD 155
           P   + V    + Q +   I+ A+ +          E+  D
Sbjct: 230 PNVTTDV-RKDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 90.5 bits (225), Expect = 7e-20
 Identities = 33/160 (20%), Positives = 67/160 (41%), Gaps = 22/160 (13%)

Query: 6   NWAR----QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQP 58
             AR    +I+  +  +H      +HRD+K DNI ++   G +++ D G           
Sbjct: 162 EMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTV 218

Query: 59  TARSVIGTPEFMAPEL--------YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ 110
            +   +GTP++++PE+            Y    D ++ G+   EM   + P+    + A+
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTAE 277

Query: 111 IYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVPASLRL 147
            Y K+      +    + +    + + FI++ + P   RL
Sbjct: 278 TYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRL 317

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 90.2 bits (224), Expect = 7e-20
 Identities = 45/236 (19%), Positives = 88/236 (37%), Gaps = 60/236 (25%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+ R + ++HS    I HRD+K  N+ VN  +  +K+ D G         A+ +I + E 
Sbjct: 149 QLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGS--------AKKLIPS-EP 197

Query: 70  M----------APELY--EEEYNELVDIYSFGMCIL-EMVTCE--YPYNECKN------- 107
                      APEL     EY   +D++S G C+  E++  +  +      +       
Sbjct: 198 SVAYICSRFYRAPELMLGATEYTPSIDLWSIG-CVFGELILGKPLFSGETSIDQLVRIIQ 256

Query: 108 -----PAQIYKKVTSG--------IKPASLSKV----TDPQVKQFIEKCIV--PASLRLP 148
                  +   ++           +K     K+    T       +E+ +   P  LR+ 
Sbjct: 257 IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP-DLRIN 315

Query: 149 ALELLKDPFLVT-DNPKDL-VCDPLRLPNL----VPEVMNLAHSEPHPMDIDLNHK 198
             E +  PF     N  +  V +    P+     +P++ N +  E   +  ++ ++
Sbjct: 316 PYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNR 371

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 90.1 bits (224), Expect = 9e-20
 Identities = 61/233 (26%), Positives = 93/233 (39%), Gaps = 53/233 (22%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARS 62
           IK +  Q+LR L Y+HS    I HRD+K  N+ ++  +G +K+ D G A I++      S
Sbjct: 143 IKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200

Query: 63  VIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE-------------------- 99
            I +  + APEL      Y   +DI+S G C++ E++  +                    
Sbjct: 201 YICSRYYRAPELIFGATNYTTNIDIWSTG-CVMAELMQGQPLFPGESGIDQLVEIIKVLG 259

Query: 100 YPYNE---CKNPAQIYKKVTSGIKPASLSKV----TDPQVKQFIEKCIV--PASLRLPAL 150
            P  E     NP  +  K    I+P   SKV    T P     I + +   P S RL A+
Sbjct: 260 TPSREQIKTMNPNYMEHKFPQ-IRPHPFSKVFRPRTPPDAIDLISRLLEYTP-SARLTAI 317

Query: 151 ELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMNLAHSEPHPMDIDLNHKKVSAD 203
           E L  PF           D LR          + +    P   +   +++S  
Sbjct: 318 EALCHPFF----------DELRTGE-----ARMPNGRELPPLFNWTKEELSVR 355

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 32/103 (31%), Positives = 50/103 (48%), Gaps = 13/103 (12%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           IK   + +L GL+Y+H +   I+HRD+K  N+ +   +G +K+ D GLA           
Sbjct: 126 IKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQP 182

Query: 64  IG-TPE-----FMAPELY--EEEYNELVDIYSFGMCIL-EMVT 97
              T       +  PEL   E +Y   +D++  G CI+ EM T
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG-CIMAEMWT 224

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 91.0 bits (226), Expect = 1e-19
 Identities = 39/137 (28%), Positives = 70/137 (51%), Gaps = 10/137 (7%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIG 65
           +A +I  GL  LH     I++RDLK +NI ++ ++G ++I DLGLA+ + +  T +  +G
Sbjct: 291 YAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVG 347

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKKVTSGIKP 121
           T  +MAPE +  E Y    D ++ G  + EM+  + P+    +     ++ + V     P
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VP 405

Query: 122 ASLSKVTDPQVKQFIEK 138
              S+   PQ +    +
Sbjct: 406 EEYSERFSPQARSLCSQ 422

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 40/164 (24%), Positives = 75/164 (45%), Gaps = 21/164 (12%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTP 67
           R +L  + +LH++N  I+HRDLK +NI ++ +N ++++ D G +  ++     R + GTP
Sbjct: 207 RSLLEAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTP 263

Query: 68  EFMAPE-------LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECKNPAQIYKKVTSG 118
            ++APE            Y + VD+++ G  IL  +    P  ++       + + +  G
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACG-VILFTLLAGSPPFWHR--RQILMLRMIMEG 320

Query: 119 I---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
                       +   VK  I + +      RL A + L+ PF 
Sbjct: 321 QYQFSSPEWDDRSST-VKDLISRLLQVDPEARLTAEQALQHPFF 363

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 37/102 (36%), Positives = 54/102 (52%), Gaps = 15/102 (14%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
            K++  Q+L G+ Y H     ++HRDLK  N+ +N   GE+KI D GLA     P  R  
Sbjct: 102 AKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPV-RKY 157

Query: 64  IGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 97
             T E +     AP++    ++Y+  +DI+S G CI  EMV 
Sbjct: 158 --THEIVTLWYRAPDVLMGSKKYSTTIDIWSVG-CIFAEMVN 196

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 88.8 bits (221), Expect = 1e-19
 Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 6/110 (5%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 65
           + +I   L+YLH     II+RDLK DN+ ++   G +K+ D G+    +    T  +  G
Sbjct: 116 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 172

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 114
           TP ++APE L  E+Y   VD ++ G+ + EM+    P++   +     + 
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 41/186 (22%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE- 68
           Q+LRGL Y+HS N  ++HRDLK  N+F+N  +  +KIGD GLA +M    +     +   
Sbjct: 128 QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185

Query: 69  ----FMAPE--LYEEEYNELVDIYSFGMCIL-EMVT------------------------ 97
               + +P   L    Y + +D+++ G CI  EM+T                        
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAG-CIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244

Query: 98  CEYPYNECKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIV--PASLRLPALEL 152
            E    E  +   +Y +         L+++      +   F+E+ +   P   RL A E 
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD-RLTAEEA 303

Query: 153 LKDPFL 158
           L  P++
Sbjct: 304 LSHPYM 309

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 42/101 (41%), Positives = 55/101 (54%), Gaps = 15/101 (14%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           IK+  RQ LRGL +LH++   I+HRDLK +NI V  + G VK+ D GLA +     A   
Sbjct: 122 IKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMAL-- 176

Query: 64  IGTPEFM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 97
             TP  +     APE L +  Y   VD++S G CI  EM  
Sbjct: 177 --TPVVVTLWYRAPEVLLQSTYATPVDMWSVG-CIFAEMFR 214

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 13/154 (8%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 67
           +I+ GL +LHS    I++RDLK DNI ++  +G +KI D G+    ++      +  GTP
Sbjct: 126 EIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTP 182

Query: 68  EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 124
           +++APE L  ++YN  VD +SFG+ + EM+  + P+   ++  +++  +       P  L
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWL 241

Query: 125 SKVTDPQVKQFIEKCIVPASLRLPALELLKD-PF 157
            K     + +   +       RL     ++  P 
Sbjct: 242 EKEAKDLLVKLFVRE---PEKRLGVRGDIRQHPL 272

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 90.7 bits (225), Expect = 2e-19
 Identities = 28/97 (28%), Positives = 44/97 (45%), Gaps = 6/97 (6%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  +IL  L YLHS    +++ DLK +NI +     ++K+ DLG    +       + GT
Sbjct: 187 YLLEILPALSYLHSIG--LVYNDLKPENIMLTE--EQLKLIDLGAVSRINSFGY--LYGT 240

Query: 67  PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYN 103
           P F APE+         DIY+ G  +  +       N
Sbjct: 241 PGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRN 277

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 88.0 bits (219), Expect = 2e-19
 Identities = 40/101 (39%), Positives = 55/101 (54%), Gaps = 15/101 (14%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           IK+   Q+LRGL +LHSH   ++HRDLK  NI V  ++G++K+ D GLA +     A   
Sbjct: 122 IKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMAL-- 176

Query: 64  IGTPEFM-----APE-LYEEEYNELVDIYSFGMCIL-EMVT 97
             T   +     APE L +  Y   VD++S G CI  EM  
Sbjct: 177 --TSVVVTLWYRAPEVLLQSSYATPVDLWSVG-CIFAEMFR 214

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 36/122 (29%), Positives = 64/122 (52%), Gaps = 9/122 (7%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 67
           +I+  L +LH     II+RDLK DN+ ++   G  K+ D G+    +    T  +  GTP
Sbjct: 132 EIISALMFLHDKG--IIYRDLKLDNVLLDHE-GHCKLADFGMCKEGICNGVTTATFCGTP 188

Query: 68  EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 124
           +++APE L E  Y   VD ++ G+ + EM+    P+ E +N   +++ + +   + P  L
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWL 247

Query: 125 SK 126
            +
Sbjct: 248 HE 249

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 46/201 (22%), Positives = 80/201 (39%), Gaps = 40/201 (19%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQ---------Q 57
           + +   L +LH+    I HRDLK +NI   +      VKI D  L   ++          
Sbjct: 118 QDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175

Query: 58  PTARSVIGTPEFMAPE------LYEEEYNELVDIYSFGMCILEMVTCEYP--YNECK--- 106
           P   +  G+ E+MAPE           Y++  D++S G  IL ++   YP     C    
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYILLSGYPPFVGRCGSDC 234

Query: 107 ----------NPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALEL 152
                         +++ +  G         + ++    K  I K +V  A  RL A ++
Sbjct: 235 GWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISC-AAKDLISKLLVRDAKQRLSAAQV 293

Query: 153 LKDPFLVTDNPKDLVCDPLRL 173
           L+ P++    P++ +  P+ L
Sbjct: 294 LQHPWVQGCAPENTLPTPMVL 314

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 41/196 (20%), Positives = 80/196 (40%), Gaps = 18/196 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI---- 64
            Q++ GL YLHS    I+H+D+K  N+ +    G +KI  LG+A  +    A        
Sbjct: 116 CQLIDGLEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQ 172

Query: 65  GTPEFMAPELY--EEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-- 119
           G+P F  PE+    + ++   VDI+S G+ +  + T  YP+    N  ++++ +  G   
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSYA 231

Query: 120 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 178
            P        P +   ++  +    + R    ++ +  +    +P      P+       
Sbjct: 232 IPGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTK 287

Query: 179 EVMNLAHSEPHPMDID 194
           +        P+  D+ 
Sbjct: 288 DRWRSMTVVPYLEDLH 303

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 42/176 (23%), Positives = 85/176 (48%), Gaps = 15/176 (8%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTP 67
           RQI+  + Y H     I+HRDLK +N+ +   +  +KI D G +          +  G P
Sbjct: 121 RQIVSAVQYCHQKR--IVHRDLKAENLLL-DADMNIKIADFGFSNEFTVGGKLDAFCGAP 177

Query: 68  EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPAS 123
            + APEL++ ++Y+   VD++S G+ +  +V+   P++  +N  ++ ++V  G    P  
Sbjct: 178 PYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYRIPFY 236

Query: 124 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVP 178
           +S       +  +++ +V     R    +++KD ++   + +D +  P   P L  
Sbjct: 237 MS----TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL-KPFVEPELDI 287

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 87.3 bits (217), Expect = 4e-19
 Identities = 36/102 (35%), Positives = 56/102 (54%), Gaps = 15/102 (14%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           +K +  Q+L+GL + H +   I+HRDLK  N+ +N   G++K+GD GLA     P     
Sbjct: 110 VKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTF- 165

Query: 64  IGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 97
             + E +     AP++      Y+  +DI+S G CIL EM+T
Sbjct: 166 --SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCG-CILAEMIT 204

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 38/122 (31%), Positives = 71/122 (58%), Gaps = 9/122 (7%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 67
           +I  GL +L S    II+RDLK DN+ ++ + G +KI D G+    +    T ++  GTP
Sbjct: 129 EIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTP 185

Query: 68  EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASL 124
           +++APE +  + Y + VD ++FG+ + EM+  + P+ E ++  ++++ +       P S+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSM 244

Query: 125 SK 126
           SK
Sbjct: 245 SK 246

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 88.6 bits (220), Expect = 4e-19
 Identities = 52/206 (25%), Positives = 82/206 (39%), Gaps = 50/206 (24%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARS 62
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  +++     S
Sbjct: 158 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215

Query: 63  VIGTPEFMAPELY--EEEYNELVDIYSFGMCIL-EMVTCE-------------------- 99
            I +  + APEL     +Y   +D++S G C+L E++  +                    
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAG-CVLAELLLGQPIFPGDSGVDQLVEIIKVLG 274

Query: 100 YPYNE---CKNPAQIYKKVT-SGIKPASLSKV----TDPQVKQFIEKCIV--PASLRLPA 149
            P  E     NP   Y +     IK    +KV    T P+      + +   P + RL  
Sbjct: 275 TPTREQIREMNPN--YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP-TARLTP 331

Query: 150 LELLKDPFLVTDNPKDLVCDPLRLPN 175
           LE     F           D LR PN
Sbjct: 332 LEACAHSFF----------DELRDPN 347

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 87.8 bits (218), Expect = 5e-19
 Identities = 33/110 (30%), Positives = 57/110 (51%), Gaps = 6/110 (5%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 65
           + +I   L+YLH     II+RDLK DN+ ++   G +K+ D G+    +    T  +  G
Sbjct: 159 SAEISLALNYLHERG--IIYRDLKLDNVLLDSE-GHIKLTDYGMCKEGLRPGDTTSTFCG 215

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 114
           TP ++APE L  E+Y   VD ++ G+ + EM+    P++   +     + 
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 34/102 (33%), Positives = 51/102 (50%), Gaps = 15/102 (14%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           +K +  Q+LRGL Y H     ++HRDLK  N+ +N   GE+K+ D GLA     PT    
Sbjct: 102 VKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTY- 157

Query: 64  IGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 97
               E +      P++     +Y+  +D++  G CI  EM T
Sbjct: 158 --DNEVVTLWYRPPDILLGSTDYSTQIDMWGVG-CIFYEMAT 196

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 87.2 bits (217), Expect = 6e-19
 Identities = 38/102 (37%), Positives = 55/102 (53%), Gaps = 15/102 (14%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           IK +    L+GL YLH H   I+HRDLK +N+ ++  NG +K+ D GLA     P  R+ 
Sbjct: 114 IKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPN-RAY 169

Query: 64  IGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 97
             T + +     APEL      Y   VD+++ G CIL E++ 
Sbjct: 170 --THQVVTRWYRAPELLFGARMYGVGVDMWAVG-CILAELLL 208

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 86.5 bits (215), Expect = 7e-19
 Identities = 28/102 (27%), Positives = 53/102 (51%), Gaps = 15/102 (14%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           +K+   Q L+ +++ H HN   IHRD+K +NI +   +  +K+ D G A ++  P+    
Sbjct: 104 VKSITWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYY- 159

Query: 64  IGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 97
               E       +PEL   + +Y   VD+++ G C+  E+++
Sbjct: 160 --DDEVATRWYRSPELLVGDTQYGPPVDVWAIG-CVFAELLS 198

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 86.5 bits (215), Expect = 7e-19
 Identities = 53/211 (25%), Positives = 81/211 (38%), Gaps = 48/211 (22%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           ++ +  QI+ G+ + HSHN  IIHRD+K +NI V+  +G VK+ D G A  +  P     
Sbjct: 126 VQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVY- 181

Query: 64  IGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVTCEYPY------------- 102
               E       APEL   + +Y + VD+++ G C++ EM   E P              
Sbjct: 182 --DDEVATRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMGE-PLFPGDSDIDQLYHI 237

Query: 103 -------NE------CKNPAQIYKKVTSGIKPASLSKV---TDPQVKQFIEKCIV--PAS 144
                           KNP     ++    +   L +        V    +KC+   P  
Sbjct: 238 MMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDK 297

Query: 145 LRLPALELLKDPFLVTDNPKDLVCDPLRLPN 175
            R    ELL   F   D   +     L+L  
Sbjct: 298 -RPFCAELLHHDFFQMDGFAERFSQELQLKV 327

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 86.2 bits (214), Expect = 8e-19
 Identities = 33/119 (27%), Positives = 65/119 (54%), Gaps = 10/119 (8%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--RSV 63
            + + +++G+ YLH     IIHRD+K  N+ V G +G +KI D G++   +   A   + 
Sbjct: 141 FYFQDLIKGIEYLHYQK--IIHRDIKPSNLLV-GEDGHIKIADFGVSNEFKGSDALLSNT 197

Query: 64  IGTPEFMAPEL---YEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
           +GTP FMAPE      + ++ + +D+++ G+ +   V  + P+ + +    ++ K+ S 
Sbjct: 198 VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKIKSQ 255

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 86.1 bits (214), Expect = 9e-19
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 18/106 (16%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN----GNNGEVKIGDLGLAIVMQQPT 59
           IK++  Q++ G+++ HS     +HRDLK  N+ ++         +KIGD GLA     P 
Sbjct: 134 IKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191

Query: 60  ARSVIGTPEFM-----APELY--EEEYNELVDIYSFGMCIL-EMVT 97
            +    T E +      PE+      Y+  VDI+S   CI  EM+ 
Sbjct: 192 RQF---THEIITLWYRPPEILLGSRHYSTSVDIWSIA-CIWAEMLM 233

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 88.5 bits (219), Expect = 9e-19
 Identities = 39/124 (31%), Positives = 71/124 (57%), Gaps = 9/124 (7%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIG 65
           A +I  GL +L S    II+RDLK DN+ ++   G +KI D G+    +    T ++  G
Sbjct: 448 AAEIAIGLFFLQSKG--IIYRDLKLDNVMLDS-EGHIKIADFGMCKENIWDGVTTKTFCG 504

Query: 66  TPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPA 122
           TP+++APE +  + Y + VD ++FG+ + EM+  + P+ E ++  ++++ +       P 
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPK 563

Query: 123 SLSK 126
           S+SK
Sbjct: 564 SMSK 567

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 20/163 (12%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---- 61
                  + L++ H +   IIHRD+K  NI +      VK+ D G+A  +          
Sbjct: 120 EVIADACQALNFSHQNG--IIHRDVKPANIMI-SATNAVKVMDFGIARAIADSGNSVTQT 176

Query: 62  -SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI-YKKVTSG 118
            +VIGT ++++PE    +  +   D+YS G  + E++T E P+    +P  + Y+ V   
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVRED 235

Query: 119 IKPASLSKVTDPQVKQFIEKCIVPASLRLP------ALELLKD 155
             P S        +   ++  ++ A  + P      A E+  D
Sbjct: 236 PIPPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 38/134 (28%), Positives = 72/134 (53%), Gaps = 12/134 (8%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 67
           +I+  L YLHS    +++RDLK +N+ ++ + G +KI D GL    +    T ++  GTP
Sbjct: 256 EIVSALDYLHSEKN-VVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTP 313

Query: 68  EFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IK-PASL 124
           E++APE L + +Y   VD +  G+ + EM+    P+   ++  ++++ +    I+ P +L
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEKLFELILMEEIRFPRTL 372

Query: 125 SKVTDPQVKQFIEK 138
                P+ K  +  
Sbjct: 373 G----PEAKSLLSG 382

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 39/172 (22%), Positives = 72/172 (41%), Gaps = 20/172 (11%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 68
            Q++  + + HS    ++HRD+K +NI ++   G  K+ D G   ++         GT  
Sbjct: 146 GQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRV 203

Query: 69  FMAPELYE-EEYN-ELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGI--KPAS 123
           +  PE     +Y+     ++S G+ +L +MV  + P+          +++       PA 
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGI-LLYDMVCGDIPFER-------DQEILEAELHFPAH 255

Query: 124 LSKVTDPQVKQFIEKCIVPA-SLRLPALELLKDPFLVTDNPKDLVCDPLRLP 174
           +S    P     I +C+ P  S R    E+L DP++ T      +      P
Sbjct: 256 VS----PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGGP 303

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 35/103 (33%), Positives = 48/103 (46%), Gaps = 19/103 (18%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSVIGTP 67
           Q LR +  LH  N  +IHRDLK  N+ +N  N ++K+ D GLA  I           G  
Sbjct: 120 QTLRAVKVLHGSN--VIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 68  EFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 97
             M          APE  L   +Y+  +D++S G CIL E+  
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG-CILAELFL 218

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 29/98 (29%), Positives = 53/98 (54%), Gaps = 11/98 (11%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA---IVMQQPTARSVIGT 66
           +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA      Q+   R  + +
Sbjct: 138 EILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR--VAS 193

Query: 67  PEFMAPE--LYEEEYNELVDIYSFGMCIL-EMVTCEYP 101
             F  PE  +  + Y+  +D++S G C+L  M+  + P
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLG-CMLASMIFRKEP 230

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 83.0 bits (206), Expect = 6e-18
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 10/165 (6%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI---- 64
            Q++ G+ YLH     I HRD+K +N+ ++     +KI D GLA V +      ++    
Sbjct: 112 HQLMAGVVYLHGIG--ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMC 168

Query: 65  GTPEFMAPE-LYEEEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 122
           GT  ++APE L   E++ E VD++S G+ +  M+  E P+++  +  Q Y          
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228

Query: 123 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 166
           +  K  D      + K +V   S R+   ++ KD +      K  
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 35/176 (19%), Positives = 71/176 (40%), Gaps = 19/176 (10%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE 68
            Q+L  + + H+    ++HRD+K +NI ++ N GE+K+ D G   +++        GT  
Sbjct: 156 WQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 213

Query: 69  FMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASL 124
           +  PE      Y+     ++S G+ + +MV  + P+          +++  G       +
Sbjct: 214 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------DEEIIRGQVFFRQRV 266

Query: 125 SKVTDPQVKQFIEKCIVPASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLPNLVPE 179
           S     + +  I  C+       P   E+   P++            + L +L P 
Sbjct: 267 S----SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA-EIHLHSLSPG 317

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 45/194 (23%), Positives = 82/194 (42%), Gaps = 12/194 (6%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI---- 64
            Q++ G+ YLH     I HRD+K +N+ ++     +KI D GLA V +      ++    
Sbjct: 112 HQLMAGVVYLHGIG--ITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMC 168

Query: 65  GTPEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIY-KKVTSGIKP 121
           GT  ++APEL +  E++ E VD++S G+ +  M+  E P+++  +  Q Y          
Sbjct: 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228

Query: 122 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEV 180
               K+ D      + K +V   S R+   ++ KD +      K      +    +    
Sbjct: 229 NPWKKI-DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESP 287

Query: 181 MNLAHSEPHPMDID 194
              +      +D  
Sbjct: 288 SGFSKHIQSNLDFS 301

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 40/173 (23%), Positives = 69/173 (39%), Gaps = 44/173 (25%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
            IL GLH LH     ++HRDL   NI +  NN ++ I D  L        AR        
Sbjct: 142 HILLGLHVLHEAG--VVHRDLHPGNILLADNN-DITICDFNL--------ARE-DTADAN 189

Query: 70  M----------APE--LYEEEYNELVDIYSFGMCIL-EMVTCE--YPYNECKNPAQIYKK 114
                      APE  +  + + +LVD++S G C++ EM   +  +  +   N  Q+  K
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG-CVMAEMFNRKALFRGSTFYN--QL-NK 245

Query: 115 VTSGI---KPASLSKVTDPQVKQFIEKCI-----VPASLRLP-----ALELLK 154
           +   +   K   +   + P  + ++   +        +  +P     AL+L+ 
Sbjct: 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIA 298

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 39/96 (40%), Positives = 54/96 (56%), Gaps = 12/96 (12%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE- 68
           QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V       +   T   
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 69  ----FMAPE--LYEEEYNELVDIYSFGMCIL-EMVT 97
               + APE  L  + Y + +DI+S G CIL EM++
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVG-CILAEMLS 227

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 36/156 (23%), Positives = 57/156 (36%), Gaps = 21/156 (13%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARS 62
              RQI   L   H+      HRD+K +NI V   +    + D G+A            +
Sbjct: 138 AIVRQIGSALDAAHAAG--ATHRDVKPENILV-SADDFAYLVDFGIASATTDEKLTQLGN 194

Query: 63  VIGTPEFMAPELYE-EEYNELVDIYSFGMCIL-EMVTCEYPYNECKNPAQIYKKVTSGIK 120
            +GT  +MAPE +         DIY+   C+L E +T   PY +    + +   +   I 
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALT-CVLYECLTGSPPY-QGDQLSVMGAHINQAIP 252

Query: 121 PASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDP 156
             S      P +    +  I           + K+P
Sbjct: 253 RPS---TVRPGIPVAFDAVIARG--------MAKNP 277

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 81.7 bits (202), Expect = 6e-17
 Identities = 29/114 (25%), Positives = 49/114 (42%), Gaps = 30/114 (26%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-------------IVMQ 56
           Q+++ + YLHS    ++HRD+K  NI +N     VK+ D GL+              +  
Sbjct: 117 QLIKVIKYLHSGG--LLHRDMKPSNILLNA-ECHVKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 57  QPTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 97
                +       +          APE  L   +Y + +D++S G CIL E++ 
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG-CILGEILC 226

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 40/91 (43%), Positives = 54/91 (59%), Gaps = 8/91 (8%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+L+GL Y+HS    ++HRDLK  N+ VN  + E+KI D GLA          V+ T  +
Sbjct: 134 QMLKGLKYIHSAG--VVHRDLKPGNLAVNE-DCELKILDFGLARHADAEMTGYVV-TRWY 189

Query: 70  MAPE--LYEEEYNELVDIYSFGMCIL-EMVT 97
            APE  L    YN+ VDI+S G CI+ EM+T
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVG-CIMAEMLT 219

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 81.0 bits (200), Expect = 2e-16
 Identities = 35/124 (28%), Positives = 48/124 (38%), Gaps = 36/124 (29%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA----------------- 52
            +L G+ Y+HS    I+HRDLK  N  VN  +  VK+ D GLA                 
Sbjct: 164 NLLVGVKYVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISP 220

Query: 53  --IVMQQPTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 97
               M   T          +          APE  L +E Y E +D++S G CI  E++ 
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG-CIFAELLN 279

Query: 98  CEYP 101
               
Sbjct: 280 MIKE 283

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 29/204 (14%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTA-RSVIGT 66
           +Q+L G+ Y HS    I HRDLK +N  ++G+    +KI D G +      +  +S +GT
Sbjct: 123 QQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 180

Query: 67  PEFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS- 123
           P ++APE+   +EY+ ++ D++S G+ +  M+   YP+ E     + Y+K    I     
Sbjct: 181 PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPRDYRKTIQRILSVKY 239

Query: 124 -------LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPN 175
                  +S    P+    I +  V   + R+   E+    + + + P DL+ +      
Sbjct: 240 SIPDDIRIS----PECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQ 295

Query: 176 L---------VPEVMNLAHSEPHP 190
                     +  +M +      P
Sbjct: 296 FQEPEQPMQSLDTIMQIISEATIP 319

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 44/210 (20%), Positives = 71/210 (33%), Gaps = 65/210 (30%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q++R +  LH  +  + HRD+K  N+ VN  +G +K+ D G         A+ +  + E 
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS--------AKKLSPS-EP 187

Query: 70  M----------APELY--EEEYNELVDIYSFGMCIL-EMVTCE--YPYNECKN------- 107
                      APEL    + Y   VDI+S G CI  EM+  E  +  +           
Sbjct: 188 NVAYICSRYYRAPELIFGNQHYTTAVDIWSVG-CIFAEMMLGEPIFRGDNSAGQLHEIVR 246

Query: 108 -----PAQIYKKVTSG--------IKPASLSKV-------TDPQVKQFIEKCIV--PASL 145
                  ++ +K+            K    S V          +    +   +   P   
Sbjct: 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP-EE 305

Query: 146 RLPALELLKDPFLVTDNPKDLVCDPLRLPN 175
           R+   E L  P+           D L  P 
Sbjct: 306 RMKPYEALCHPYF----------DELHDPA 325

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 44/101 (43%), Positives = 55/101 (54%), Gaps = 28/101 (27%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           QILRGL Y+HS +  IIHRDLK  N+ VN +  E+KI D GL        AR    T + 
Sbjct: 140 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDFGL--------ARH---TADE 185

Query: 70  M----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 97
           M          APE  L    YN+ VDI+S G CI+ E++T
Sbjct: 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG-CIMAELLT 225

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 36/110 (32%), Positives = 56/110 (50%), Gaps = 20/110 (18%)

Query: 13  RGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS-----VIGT 66
           RGL YLH H +P IIHRD+K  NI ++    E  +GD GLA +M      +     V GT
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLM--DYKDTHVTTAVRGT 198

Query: 67  PEFMAPELYEEEY------NELVDIYSFGMCILEMVTCEYPYNECKNPAQ 110
              +AP     EY      +E  D++ +G+ +LE++T +  ++  +    
Sbjct: 199 IGHIAP-----EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 79.4 bits (196), Expect = 4e-16
 Identities = 31/115 (26%), Positives = 48/115 (41%), Gaps = 31/115 (26%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--------------IVM 55
            +L G +++H     IIHRDLK  N  +N  +  VK+ D GLA              +  
Sbjct: 137 NLLLGENFIHESG--IIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEE 193

Query: 56  QQPTARSVIGTPEFM----------APE--LYEEEYNELVDIYSFGMCIL-EMVT 97
            +          + +          APE  L +E Y + +DI+S G CI  E++ 
Sbjct: 194 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG-CIFAELLN 247

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 78.5 bits (194), Expect = 4e-16
 Identities = 58/227 (25%), Positives = 103/227 (45%), Gaps = 19/227 (8%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTP 67
           +QI+  + Y H H   I+HRDLK +N+ ++ +N  VKI D GL+ +M      ++  G+P
Sbjct: 115 QQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSP 171

Query: 68  EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPAS 123
            + APE+   + Y    VD++S G+ +  M+    P+++ +    ++KKV S +   P  
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYVMPDF 230

Query: 124 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 182
           LS    P  +  I + IV     R+   E+ +DP+   + P  L        +     + 
Sbjct: 231 LS----PGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIV 286

Query: 183 LAHSEPHPMDIDLNHKKVSADSCAKSN--TGTWFLTLELQRLTENNE 227
               E      D   + + +D   ++N     + L  E Q + E  E
Sbjct: 287 SKLGEAMGFSEDYIVEALRSD---ENNEVKEAYNLLHENQVIQEKLE 330

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 40/91 (43%), Positives = 53/91 (58%), Gaps = 8/91 (8%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+L+GL Y+H+    IIHRDLK  N+ VN  + E+KI D GLA          V+ T  +
Sbjct: 136 QMLKGLRYIHAAG--IIHRDLKPGNLAVNE-DCELKILDFGLARQADSEMTGYVV-TRWY 191

Query: 70  MAPE--LYEEEYNELVDIYSFGMCIL-EMVT 97
            APE  L    Y + VDI+S G CI+ EM+T
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVG-CIMAEMIT 221

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 39/95 (41%), Positives = 52/95 (54%), Gaps = 15/95 (15%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPE- 68
           Q+L G+ +LHS    IIHRDLK  NI V  ++  +KI D GLA    +    S + TP  
Sbjct: 135 QMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLA----RTAGTSFMMTPYV 187

Query: 69  ----FMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 97
               + APE +    Y E VDI+S G CI+ EM+ 
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMIK 221

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 16/165 (9%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RSVIGTP 67
           +QIL  + Y H H   ++HRDLK +N+ ++  +   KI D GL+ +M      R+  G+P
Sbjct: 118 QQILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSP 174

Query: 68  EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSGI--KPA 122
            + APE+     Y    VDI+S G+ IL  + C   P+++ ++   ++KK+  G+   P 
Sbjct: 175 NYAAPEVISGRLYAGPEVDIWSCGV-ILYALLCGTLPFDD-EHVPTLFKKIRGGVFYIPE 232

Query: 123 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 166
            L+      V   +   +      R    ++ +  +   D P  L
Sbjct: 233 YLN----RSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 35/124 (28%), Positives = 60/124 (48%), Gaps = 10/124 (8%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPT 59
            + + NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++  +  
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEK 172

Query: 60  ARSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKK 114
                G   P ++MA E +    Y    D++S+G+ + E++T    PY+     ++I   
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSI 231

Query: 115 VTSG 118
           +  G
Sbjct: 232 LEKG 235

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 41/100 (41%), Positives = 50/100 (50%), Gaps = 25/100 (25%)

Query: 10  QILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEF 69
           Q+L G+ +LHS    IIHRDLK  NI V  +   +KI D GL        AR+  GT   
Sbjct: 172 QMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC-TLKILDFGL--------ART-AGTSFM 219

Query: 70  M----------APE-LYEEEYNELVDIYSFGMCIL-EMVT 97
           M          APE +    Y E VDI+S G CI+ EMV 
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVG-CIMGEMVR 258

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 33/119 (27%), Positives = 46/119 (38%), Gaps = 10/119 (8%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 65
                   G+ YL S     IHRDL   N  V   N  +KI D G++         +  G
Sbjct: 217 QMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGG 273

Query: 66  TPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
             +      APE L    Y+   D++SFG+ + E  +    PY    N  Q  + V  G
Sbjct: 274 LRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-QQTREFVEKG 331

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 74.4 bits (183), Expect = 9e-15
 Identities = 39/178 (21%), Positives = 74/178 (41%), Gaps = 21/178 (11%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTP 67
           RQ++  + YL   +  IIHRD+K +NI +   +  +K+ D G A  +++     +  GT 
Sbjct: 137 RQLVSAVGYLRLKD--IIHRDIKDENIVIAE-DFTIKLIDFGSAAYLERGKLFYTFCGTI 193

Query: 68  EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPAS 123
           E+ APE+     Y    ++++S G+  L  +  E       NP    ++        P  
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGV-TLYTLVFEE------NPFCELEETVEAAIHPPYL 246

Query: 124 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTD-NPKDLVCDPLRLPNLVPE 179
           +S     ++   +   + P    R    +L+ DP++    N  D   + +   N    
Sbjct: 247 VS----KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPES 300

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 74.6 bits (183), Expect = 9e-15
 Identities = 33/119 (27%), Positives = 57/119 (47%), Gaps = 9/119 (7%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPTARSVI 64
            ++ Q+ +G+ +L S     IHRDL   NI +      VKI D GLA  + + P      
Sbjct: 197 CYSFQVAKGMEFLASRK--CIHRDLAARNILL-SEKNVVKICDFGLARDIYKDPDYVRKG 253

Query: 65  GTP---EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
                 ++MAPE +++  Y    D++SFG+ + E+ +    PY   K   +  +++  G
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 35/145 (24%), Positives = 62/145 (42%), Gaps = 18/145 (12%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 58
              +  ++ QI +G+ YL S     +HRDL   NI V  +   VKI D GLA ++     
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILV-ESEAHVKIADFGLAKLLPLDKD 182

Query: 59  --TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 113
               R    +P F  APE L +  ++   D++SFG+ + E+ T C+   +      ++  
Sbjct: 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242

Query: 114 KVTSGIKPASLSKVTDPQVKQFIEK 138
                            ++ + +E+
Sbjct: 243 CERDVP--------ALSRLLELLEE 259

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 14/168 (8%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTARSVIGTP 67
           +QIL G+ Y H H   ++HRDLK +N+ ++  +   KI D GL+ +M      R+  G+P
Sbjct: 123 QQILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSP 179

Query: 68  EFMAPELYE-EEYN-ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPAS 123
            + APE+     Y    VDI+S G+ +  ++    P+++  +   ++KK+  GI   P  
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGIFYTPQY 238

Query: 124 LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDP 170
           L+    P V   ++  +      R    ++ +  +   D PK L  + 
Sbjct: 239 LN----PSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPED 282

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 12/92 (13%)

Query: 13  RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGT 66
           RGLHYLH     IIHRD+K  NI ++ N    KI D G++    +       T   V GT
Sbjct: 150 RGLHYLH--TRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTV--VKGT 204

Query: 67  PEFMAPELYEEEY-NELVDIYSFGMCILEMVT 97
             ++ PE + +    E  D+YSFG+ + E++ 
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 74.8 bits (184), Expect = 2e-14
 Identities = 37/118 (31%), Positives = 57/118 (48%), Gaps = 9/118 (7%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSV 63
           + A QI  G+ Y+   N   +HRDL+  NI V  N    K+ D GLA +++    TAR  
Sbjct: 284 DMAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQG 340

Query: 64  IGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
              P ++ APE      +    D++SFG+ + E+ T    PY    N  ++  +V  G
Sbjct: 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG 397

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 37/118 (31%), Positives = 57/118 (48%), Gaps = 9/118 (7%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSV 63
           + A QI  G+ Y+   N   +HRDL+  NI V  N    K+ D GLA +++    TAR  
Sbjct: 367 DMAAQIASGMAYVERMN--YVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQG 423

Query: 64  IGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
              P ++ APE      +    D++SFG+ + E+ T    PY    N  ++  +V  G
Sbjct: 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG 480

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 36/164 (21%), Positives = 68/164 (41%), Gaps = 33/164 (20%)

Query: 9   RQILRGLHYLHSHNPPIIHRDLKCDNI-FVN-GNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           + I   + YLHS N  I HRD+K +N+ + +   N  +K+ D G                
Sbjct: 124 KSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGF--------------- 166

Query: 67  PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYP----YNECKNPAQIYKKVTSGI--- 119
               A E   E+Y++  D++S G  I+ ++ C YP     +       +  ++  G    
Sbjct: 167 ----AKETTGEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221

Query: 120 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 162
                S+V++ +VK  I   +    + R+   E +  P+++   
Sbjct: 222 PNPEWSEVSE-EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 36/118 (30%), Positives = 57/118 (48%), Gaps = 9/118 (7%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSV 63
             A QI   + YL   N   IHR+L   N  V G N  VK+ D GL+ +M     TA + 
Sbjct: 322 YMATQISSAMEYLEKKN--FIHRNLAARNCLV-GENHLVKVADFGLSRLMTGDTYTAHAG 378

Query: 64  IGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
              P ++ APE L   +++   D+++FG+ + E+ T    PY      +Q+Y+ +   
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 435

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 73.3 bits (180), Expect = 6e-14
 Identities = 34/123 (27%), Positives = 62/123 (50%), Gaps = 9/123 (7%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           + ++  +A Q+   L YL S     +HRD+   N+ V+ N+  VK+GD GL+  M+  T 
Sbjct: 490 LASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTY 546

Query: 61  RSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 115
                   P ++MAPE +    +    D++ FG+C+ E++     P+   KN   +  ++
Sbjct: 547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRI 605

Query: 116 TSG 118
            +G
Sbjct: 606 ENG 608

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 35/124 (28%), Positives = 61/124 (49%), Gaps = 10/124 (8%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQP 58
            + + NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA  +  ++ 
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEK 172

Query: 59  TARSVIG-TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKK 114
              +  G  P ++MA E +    Y    D++S+G+ + E++T    PY+     ++I   
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSI 231

Query: 115 VTSG 118
           +  G
Sbjct: 232 LEKG 235

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 33/127 (25%), Positives = 56/127 (44%), Gaps = 25/127 (19%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 65
           +++ Q+ +G+ +L S N   IHRDL   NI +  +    KI D GL        AR +  
Sbjct: 149 SFSYQVAKGMAFLASKN--CIHRDLAARNILL-THGRITKICDFGL--------ARDIKN 197

Query: 66  TPEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQI 111
              +            MAPE ++   Y    D++S+G+ + E+ +    PY      ++ 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 112 YKKVTSG 118
           YK +  G
Sbjct: 258 YKMIKEG 264

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 23/129 (17%), Positives = 49/129 (37%), Gaps = 27/129 (20%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-------GNNGEVKIGDLGLAIVMQQP 58
             A+Q+   +H+L  +   +IH ++   NI +        GN   +K+ D G+       
Sbjct: 117 EVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI------- 167

Query: 59  TARSVIGTPEF------MAPE--LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPA 109
            + +V+           + PE     +  N   D +SFG  + E+ +  + P +   +  
Sbjct: 168 -SITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-Q 225

Query: 110 QIYKKVTSG 118
           +  +     
Sbjct: 226 RKLQFYEDR 234

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 35/126 (27%), Positives = 56/126 (44%), Gaps = 25/126 (19%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A Q+ +G+ +L   +   +HRDL   N+ V      VKI D GL        AR ++  
Sbjct: 177 FAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGK-VVKICDFGL--------ARDIMSD 225

Query: 67  PEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 112
             +            MAPE L+E  Y    D++S+G+ + E+ +    PY      A  Y
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 285

Query: 113 KKVTSG 118
           K + +G
Sbjct: 286 KLIQNG 291

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 11/119 (9%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 65
                +  G+ YL      +IHRDL   N  V G N  +K+ D G+   +      S  G
Sbjct: 108 GMCLDVCEGMAYLEEAC--VIHRDLAARNCLV-GENQVIKVSDFGMTRFVLDDQYTSSTG 164

Query: 66  TPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
           T +F     +PE      Y+   D++SFG+ + E+ +  + PY    N +++ + +++G
Sbjct: 165 T-KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTG 221

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 30/123 (24%), Positives = 60/123 (48%), Gaps = 9/123 (7%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           +  +  ++ QI + + YL S N   +HRD+   NI V  +   VK+GD GL+  ++    
Sbjct: 112 VLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILV-ASPECVKLGDFGLSRYIEDEDY 168

Query: 61  RSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 115
                T  P ++M+PE +    +    D++ F +C+ E+++  + P+   +N   +   +
Sbjct: 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVL 227

Query: 116 TSG 118
             G
Sbjct: 228 EKG 230

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 33/89 (37%), Positives = 47/89 (52%), Gaps = 7/89 (7%)

Query: 13  RGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARS--VIGTPE 68
            G+++LH      IHRD+K  NI ++      KI D GLA        T  +  ++GT  
Sbjct: 144 NGINFLH--ENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTA 200

Query: 69  FMAPELYEEEYNELVDIYSFGMCILEMVT 97
           +MAPE    E     DIYSFG+ +LE++T
Sbjct: 201 YMAPEALRGEITPKSDIYSFGVVLLEIIT 229

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 33/119 (27%), Positives = 59/119 (49%), Gaps = 11/119 (9%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 65
                +  G+ +L SH    IHRDL   N  V+ +   VK+ D G+   +      S +G
Sbjct: 108 EMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVSSVG 164

Query: 66  TPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
           T +F     APE  +  +Y+   D+++FG+ + E+ +  + PY+   N +++  KV+ G
Sbjct: 165 T-KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-SEVVLKVSQG 221

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 30/117 (25%), Positives = 54/117 (46%), Gaps = 11/117 (9%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
            + +   + YL S     +HRDL   N  VN     VK+ D GL+  +      S +G+ 
Sbjct: 126 CKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGS- 181

Query: 68  EF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
           +F      PE L   +++   DI++FG+ + E+ +  + PY    N ++  + +  G
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQG 237

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 25/126 (19%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           ++ Q+ +G+ +L S N   IHRD+   N+ +  N    KIGD GL        AR ++  
Sbjct: 169 FSSQVAQGMAFLASKN--CIHRDVAARNVLL-TNGHVAKIGDFGL--------ARDIMND 217

Query: 67  PEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 112
             +            MAPE +++  Y    D++S+G+ + E+ +    PY      ++ Y
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277

Query: 113 KKVTSG 118
           K V  G
Sbjct: 278 KLVKDG 283

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 32/124 (25%), Positives = 65/124 (52%), Gaps = 10/124 (8%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 58
            + + NW  QI +G++YL  H   ++HR+L   N+ +   + +V++ D G+A ++     
Sbjct: 114 PQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDK 170

Query: 59  -TARSVIGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKK 114
               S   TP ++MA E ++  +Y    D++S+G+ + E++T    PY   +  A++   
Sbjct: 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-AEVPDL 229

Query: 115 VTSG 118
           +  G
Sbjct: 230 LEKG 233

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 34/123 (27%), Positives = 62/123 (50%), Gaps = 9/123 (7%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           + ++  +A Q+   L YL S     +HRD+   N+ V+ N+  VK+GD GL+  M+  T 
Sbjct: 115 LASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTY 171

Query: 61  RSVIGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 115
                   P ++MAPE +    +    D++ FG+C+ E++     P+   KN   +  ++
Sbjct: 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRI 230

Query: 116 TSG 118
            +G
Sbjct: 231 ENG 233

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 45/211 (21%), Positives = 78/211 (36%), Gaps = 56/211 (26%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV-----NGNNGEVKIGDLGLAIVM 55
           +  +K  ++Q+L GL Y+H     IIH D+K +N+ +       N  ++KI DLG A   
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRC-GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188

Query: 56  QQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEY------PYNECKNP 108
            +    + I T E+ +PE L    +    DI+S    I E++T ++       ++  K+ 
Sbjct: 189 DE-HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247

Query: 109 AQI-----------------------------YKKVTSGIKPASLSKV----------TD 129
             I                               +  S +K   L  V            
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307

Query: 130 PQVKQFIEKCIV--PASLRLPALELLKDPFL 158
            ++  F+   +   P   R  A  L+  P+L
Sbjct: 308 KEISDFLSPMLQLDP-RKRADAGGLVNHPWL 337

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 36/117 (30%), Positives = 56/117 (47%), Gaps = 11/117 (9%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A QI   + YL   N   IHRDL   N  V  N+  VK+ D GL+ +M   T  +  G  
Sbjct: 117 ATQISSAMEYLEKKN--FIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGA- 172

Query: 68  EF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
           +F     APE L   +++   D+++FG+ + E+ T    PY      +Q+Y+ +   
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKD 228

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 25/126 (19%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           ++ Q+ +G+ +L S     IHRDL   NI ++  N  VKI D GL        AR +   
Sbjct: 153 YSFQVAKGMEFLASRK--CIHRDLAARNILLSEKN-VVKICDFGL--------ARDIYKD 201

Query: 67  PEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 112
           P++            MAPE +++  Y    D++SFG+ + E+ +    PY   K   +  
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261

Query: 113 KKVTSG 118
           +++  G
Sbjct: 262 RRLKEG 267

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 15/139 (10%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSV 63
            +  QI +G+ YL +     IHRDL   NI V  N   VKIGD GL   +   +   +  
Sbjct: 118 QYTSQICKGMEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEFFKVK 174

Query: 64  IGT--PEF-MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
                P F  APE L E +++   D++SFG+ + E+ T    Y E             G 
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGN 230

Query: 120 KPASLSKVTDPQVKQFIEK 138
                 ++    + + ++ 
Sbjct: 231 DK--QGQMIVFHLIELLKN 247

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 15/139 (10%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSV 63
            +  QI +G+ YL +     IHRDL   NI V  N   VKIGD GL   +   +   +  
Sbjct: 149 QYTSQICKGMEYLGTKR--YIHRDLATRNILV-ENENRVKIGDFGLTKVLPQDKEYYKVK 205

Query: 64  IGT--PEF-MAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
                P F  APE L E +++   D++SFG+ + E+ T    Y E             G 
Sbjct: 206 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGN 261

Query: 120 KPASLSKVTDPQVKQFIEK 138
                 ++    + + ++ 
Sbjct: 262 DK--QGQMIVFHLIELLKN 278

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 68.4 bits (168), Expect = 6e-13
 Identities = 34/117 (29%), Positives = 51/117 (43%), Gaps = 11/117 (9%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSV 63
            +A Q+  G+ YL S     IHRDL   N+ +   +  VKIGD GL   +          
Sbjct: 125 RYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQ 181

Query: 64  IGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 115
                P  + APE L    ++   D + FG+ + EM T  + P+      +QI  K+
Sbjct: 182 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKI 237

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 68.1 bits (167), Expect = 9e-13
 Identities = 35/124 (28%), Positives = 57/124 (45%), Gaps = 10/124 (8%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           +  +   A +I  G+ YL+++    +HRDL   N  V  +   VKIGD G+   + +   
Sbjct: 137 LSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDY 193

Query: 61  RSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 114
               G        M+PE L +  +    D++SFG+ + E+ T  E PY    N  Q+ + 
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVLRF 252

Query: 115 VTSG 118
           V  G
Sbjct: 253 VMEG 256

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 67.7 bits (166), Expect = 9e-13
 Identities = 27/120 (22%), Positives = 54/120 (45%), Gaps = 11/120 (9%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSV 63
               Q+  G+ YL   N   +HRDL   N+ +   +   KI D GL+  +        + 
Sbjct: 114 ELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTAR 170

Query: 64  IGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
                P ++ APE +   +++   D++S+G+ + E ++  + PY + K   ++   +  G
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQG 229

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 28/120 (23%), Positives = 53/120 (44%), Gaps = 11/120 (9%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSV 63
               Q+  G+ YL   N   +HRDL   N+ +       KI D GL+  +   +   ++ 
Sbjct: 121 ELVHQVSMGMKYLEESN--FVHRDLAARNVLL-VTQHYAKISDFGLSKALRADENYYKAQ 177

Query: 64  IGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
                P ++ APE +   +++   D++SFG+ + E  +  + PY   K   ++   +  G
Sbjct: 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EVTAMLEKG 236

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 36/103 (34%), Positives = 57/103 (55%), Gaps = 9/103 (8%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 58
           +  +  +A+QI  G+ YLH+ +   IHRDL   N+ +  N+  VKIGD GLA  + +   
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLL-DNDRLVKIGDFGLAKAVPEGHE 189

Query: 59  --TARSVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 97
               R    +P F  APE L E ++    D++SFG+ + E++T
Sbjct: 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 33/98 (33%), Positives = 53/98 (54%), Gaps = 9/98 (9%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TAR 61
            +A QI +G+ YL S     +HRDL   N+ V  +  +VKIGD GL   ++      T +
Sbjct: 130 KYAVQICKGMDYLGSRQ--YVHRDLAARNVLV-ESEHQVKIGDFGLTKAIETDKEYYTVK 186

Query: 62  SVIGTPEF-MAPE-LYEEEYNELVDIYSFGMCILEMVT 97
               +P F  APE L + ++    D++SFG+ + E++T
Sbjct: 187 DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 36/125 (28%), Positives = 57/125 (45%), Gaps = 26/125 (20%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A QI  G+ YL S +   +HRDL   N  V  N   VKIGD G+        +R V  T 
Sbjct: 139 ASQIASGMVYLASQH--FVHRDLATRNCLVGANL-LVKIGDFGM--------SRDVYSTD 187

Query: 68  EF------------MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 113
            +            M PE +   ++    D++SFG+ + E+ T  + P+ +  N  ++ +
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-TEVIE 246

Query: 114 KVTSG 118
            +T G
Sbjct: 247 CITQG 251

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 5/100 (5%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPT 59
           +   + +A+Q+   L +L +    IIH DLK +NI   N     +KI D G +  + Q  
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI 215

Query: 60  ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 97
               I +  + +PE L    Y+  +D++S G CIL EM T
Sbjct: 216 Y-QYIQSRFYRSPEVLLGMPYDLAIDMWSLG-CILVEMHT 253

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 35/126 (27%), Positives = 56/126 (44%), Gaps = 26/126 (20%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +A QI +G+ YL      ++HRDL   NI V     ++KI D GL        +R V   
Sbjct: 155 FAWQISQGMQYLAEMK--LVHRDLAARNILVAEGR-KMKISDFGL--------SRDVYEE 203

Query: 67  PEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 112
             +            MA E L++  Y    D++SFG+ + E+VT    PY       +++
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP-ERLF 262

Query: 113 KKVTSG 118
             + +G
Sbjct: 263 NLLKTG 268

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 38/118 (32%), Positives = 63/118 (53%), Gaps = 9/118 (7%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSV 63
           +++ QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA V++    TAR  
Sbjct: 288 DFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREG 344

Query: 64  IGTP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 118
              P ++ APE +    +    D++SFG+ ++E+VT    PY    NP ++ + +  G
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVIRALERG 401

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 32/117 (27%), Positives = 55/117 (47%), Gaps = 10/117 (8%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
             QI  G+ YL SH+  ++H+DL   N+ V      VKI DLGL   +       ++G  
Sbjct: 134 VAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKL-NVKISDLGLFREVYAADYYKLLGNS 190

Query: 68  EF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 118
                 MAPE +   +++   DI+S+G+ + E+ +    PY    N   + + + + 
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDVVEMIRNR 246

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 30/126 (23%), Positives = 54/126 (42%), Gaps = 12/126 (9%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQP 58
           +K + ++  Q+ RG+ YL       +HRDL   N  ++ +   VK+ D GLA  I+ ++ 
Sbjct: 123 VKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESF-TVKVADFGLARDILDREY 179

Query: 59  TARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 112
            +              A E L    +    D++SFG+ + E++T    PY        + 
Sbjct: 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLT 238

Query: 113 KKVTSG 118
             +  G
Sbjct: 239 HFLAQG 244

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 38/116 (32%), Positives = 59/116 (50%), Gaps = 9/116 (7%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIG 65
           A QI  G+ ++   N   IHRDL+  NI V+      KI D GLA +++    TAR    
Sbjct: 115 AAQIAEGMAFIEERN--YIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYTAREGAK 171

Query: 66  TP-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
            P ++ APE +    +    D++SFG+ + E+VT    PY    NP ++ + +  G
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERG 226

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 32/120 (26%), Positives = 52/120 (43%), Gaps = 11/120 (9%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSV 63
              R +  G+ YL       +HRDL   N+ V+ N    K+ D GL+  +      A + 
Sbjct: 155 GMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTT 211

Query: 64  IGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
            G   P  + APE +    ++   D++SFG+ + E++   E PY    N   +   V  G
Sbjct: 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-RDVISSVEEG 270

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 31/125 (24%), Positives = 51/125 (40%), Gaps = 26/125 (20%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           ARQ+  G+ YL       +HRDL   N  V  N   VKI D GL+        R++    
Sbjct: 180 ARQVAAGMAYLSERK--FVHRDLATRNCLVGENM-VVKIADFGLS--------RNIYSAD 228

Query: 68  EF------------MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYK 113
            +            M PE ++   Y    D++++G+ + E+ +    PY    +  ++  
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH-EEVIY 287

Query: 114 KVTSG 118
            V  G
Sbjct: 288 YVRDG 292

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 35/120 (29%), Positives = 56/120 (46%), Gaps = 11/120 (9%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSV 63
              R I  G+ YL       +HRDL   NI +N N    K+ D GL  V++     A + 
Sbjct: 151 GMLRGIASGMKYLSDMG--YVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTT 207

Query: 64  IGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
            G   P  + +PE +   ++    D++S+G+ + E+++  E PY E  N   + K V  G
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVIKAVDEG 266

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 32/117 (27%), Positives = 52/117 (44%), Gaps = 10/117 (8%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A Q+  G+ YL   +   +HRDL   N  V      VKIGD G++  +       V G  
Sbjct: 164 ASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRT 220

Query: 68  EF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 118
                 M PE +   ++    D++SFG+ + E+ T  + P+ +  N  +    +T G
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEAIDCITQG 276

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 67.3 bits (164), Expect = 4e-12
 Identities = 28/120 (23%), Positives = 55/120 (45%), Gaps = 11/120 (9%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTARSV 63
               Q+  G+ YL   N   +HR+L   N+ +  N    KI D GL+  +        + 
Sbjct: 440 ELLHQVSMGMKYLEEKN--FVHRNLAARNVLL-VNRHYAKISDFGLSKALGADDSYYTAR 496

Query: 64  IGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
                P ++ APE +   +++   D++S+G+ + E ++  + PY + K P ++   +  G
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EVMAFIEQG 555

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 33/120 (27%), Positives = 52/120 (43%), Gaps = 12/120 (10%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
           +  Q+ +G+ YL S     +HRDL   N  ++     VK+ D GLA  M      SV   
Sbjct: 133 FGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNK 189

Query: 67  PEF------MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSG 118
                    MA E L  +++    D++SFG+ + E++T    PY +      I   +  G
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQG 248

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 31/100 (31%), Positives = 50/100 (50%), Gaps = 7/100 (7%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNI-FVNGNNGEVKIGDLGLAIVMQQPT 59
           +  ++ +A  IL+ L  LH +   IIH DLK +NI         +K+ D G +    Q  
Sbjct: 199 LPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV 256

Query: 60  ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 97
             + I +  + APE +    Y   +D++S G CIL E++T
Sbjct: 257 Y-TYIQSRFYRAPEVILGARYGMPIDMWSLG-CILAELLT 294

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 38/120 (31%), Positives = 59/120 (49%), Gaps = 11/120 (9%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSV 63
              R I  G+ YL + N   +HRDL   NI VN N    K+ D GL+ V++       + 
Sbjct: 151 GMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTT 207

Query: 64  IGT--P-EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
            G   P  + APE +   ++    D++SFG+ + E++T  E PY E  N  ++ K +  G
Sbjct: 208 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDG 266

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 65.4 bits (160), Expect = 8e-12
 Identities = 33/125 (26%), Positives = 53/125 (42%), Gaps = 26/125 (20%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
              I  G+ YL S N   IHRDL   N  +  +   V + D GL+        R +    
Sbjct: 143 MVDIACGMEYLSSRN--FIHRDLAARNCMLAEDM-TVCVADFGLS--------RKIYSGD 191

Query: 68  EF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 113
            +            +A E L +  Y    D+++FG+ + E++T  + PY   +N A+IY 
Sbjct: 192 YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYN 250

Query: 114 KVTSG 118
            +  G
Sbjct: 251 YLIGG 255

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 65.4 bits (160), Expect = 8e-12
 Identities = 36/126 (28%), Positives = 55/126 (43%), Gaps = 11/126 (8%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQP 58
           M  + + AR I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + 
Sbjct: 139 MLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196

Query: 59  TARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 112
           +     G        M PE   E  +    D +SFG+ + E+ +    PY    N  ++ 
Sbjct: 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVL 255

Query: 113 KKVTSG 118
           + VTSG
Sbjct: 256 EFVTSG 261

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 65.4 bits (160), Expect = 9e-12
 Identities = 38/126 (30%), Positives = 55/126 (43%), Gaps = 26/126 (20%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
              Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GL        AR +   
Sbjct: 162 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGL--------ARDINNI 210

Query: 67  PEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 112
             +            MAPE L++  Y    D++SFG+ + E+ T    PY       +++
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELF 269

Query: 113 KKVTSG 118
           K +  G
Sbjct: 270 KLLKEG 275

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 28/125 (22%), Positives = 50/125 (40%), Gaps = 26/125 (20%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
              I  G+ YL + N   +HRDL   N  +  +   V + D GL        ++ +    
Sbjct: 153 MVDIALGMEYLSNRN--FLHRDLAARNCMLRDDM-TVCVADFGL--------SKKIYSGD 201

Query: 68  EF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYK 113
            +            +A E L +  Y    D+++FG+ + E+ T    PY   +N  ++Y 
Sbjct: 202 YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYD 260

Query: 114 KVTSG 118
            +  G
Sbjct: 261 YLLHG 265

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 38/126 (30%), Positives = 55/126 (43%), Gaps = 26/126 (20%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
              Q+ RG+ YL S     IHRDL   N+ V  NN  +KI D GLA        R +   
Sbjct: 208 CTYQLARGMEYLASQK--CIHRDLAARNVLVTENN-VMKIADFGLA--------RDINNI 256

Query: 67  PEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 112
             +            MAPE L++  Y    D++SFG+ + E+ T    PY       +++
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELF 315

Query: 113 KKVTSG 118
           K +  G
Sbjct: 316 KLLKEG 321

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 12/126 (9%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           +K +  +  Q+ +G+ +L S     +HRDL   N  ++     VK+ D GLA  M     
Sbjct: 191 VKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEF 247

Query: 61  RSVIGTPE------FMAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 112
            SV           +MA E L  +++    D++SFG+ + E++T    PY +      I 
Sbjct: 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDIT 306

Query: 113 KKVTSG 118
             +  G
Sbjct: 307 VYLLQG 312

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 36/126 (28%), Positives = 54/126 (42%), Gaps = 11/126 (8%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQP 58
           M  + + AR I  G  YL  ++   IHRD+   N  +   G     KIGD G+A  + + 
Sbjct: 180 MLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237

Query: 59  TARSVIGTPEF----MAPE-LYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIY 112
                 G        M PE   E  +    D +SFG+ + E+ +    PY    N  ++ 
Sbjct: 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVL 296

Query: 113 KKVTSG 118
           + VTSG
Sbjct: 297 EFVTSG 302

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 7/114 (6%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           A  + RG+ YL       IHRDL   NI V  N    KI D GL+   +    +++   P
Sbjct: 148 AADVARGMDYLSQKQ--FIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLP 204

Query: 68  -EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
             +MA E L    Y    D++S+G+ + E+V+    PY      A++Y+K+  G
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG 257

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 29/114 (25%), Positives = 53/114 (46%), Gaps = 9/114 (7%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTP 67
           +  +   + YL  +N   +HRDL   N+ V+ +N   K+ D GL            +  P
Sbjct: 123 SLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQDTGKL--P 177

Query: 68  -EFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSG 118
            ++ APE L E++++   D++SFG+ + E+ +    PY        +  +V  G
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEKG 230

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 29/122 (23%), Positives = 54/122 (44%), Gaps = 21/122 (17%)

Query: 6   NWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIG 65
            ++  +   + YL  +N   +HRDL   N+ V+ +N   K+ D GL         +    
Sbjct: 293 KFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN-VAKVSDFGL--------TKEASS 341

Query: 66  TPE-------FMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVT 116
           T +       + APE L E++++   D++SFG+ + E+ +    PY        +  +V 
Sbjct: 342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVE 400

Query: 117 SG 118
            G
Sbjct: 401 KG 402

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 38/126 (30%), Positives = 56/126 (44%), Gaps = 26/126 (20%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
            A Q+ RG+ YL S     IHRDL   N+ V  +N  +KI D GLA        R +   
Sbjct: 196 CAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADFGLA--------RDIHHI 244

Query: 67  PEF------------MAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIY 112
             +            MAPE L++  Y    D++SFG+ + E+ T    PY       +++
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EELF 303

Query: 113 KKVTSG 118
           K +  G
Sbjct: 304 KLLKEG 309

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 50/251 (19%), Positives = 76/251 (30%), Gaps = 99/251 (39%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV-------------------------- 37
           +K   +Q+L+GL YLH+    IIH D+K +NI +                          
Sbjct: 148 VKKIIQQVLQGLDYLHTKC-RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206

Query: 38  ----------------------NGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-L 74
                                 N    +VKI DLG A  + +      I T ++ + E L
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-TEDIQTRQYRSLEVL 265

Query: 75  YEEEYNELVDIYSFGMCILEMVTCEYPYNECKNP---------AQIYK------------ 113
               YN   DI+S      E+ T +Y +               A I +            
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA 325

Query: 114 --------------KVTSGIKPASLSKVTDP----------QVKQFIEKCIV--PASLRL 147
                         K  + +KP  L +V                 F+   +   P   R 
Sbjct: 326 GKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK-RA 384

Query: 148 PALELLKDPFL 158
            A E L+ P+L
Sbjct: 385 TAAECLRHPWL 395

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 42/220 (19%), Positives = 80/220 (36%), Gaps = 66/220 (30%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------------------NG 42
           +  I+  A QI + +++LHS+   + H DLK +NI    +                  N 
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174

Query: 43  EVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-------- 93
           ++K+ D G A    +    +++ T  + APE +    +++  D++S G CIL        
Sbjct: 175 DIKVVDFGSATYDDE-HHSTLVSTRHYRAPEVILALGWSQPCDVWSIG-CILIEYYLGFT 232

Query: 94  --------EMVTC-------------------------EYPYNECKNPAQIYKKVTSGIK 120
                   E +                              ++E  +  +   +    +K
Sbjct: 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK 292

Query: 121 PASLSK-VTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
              LS+ V   ++   I+K +    + R+   E LK PF 
Sbjct: 293 EFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 26/117 (22%), Positives = 49/117 (41%), Gaps = 24/117 (20%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------------------NG 42
           +  +++ A Q+   L +LH +   + H DLK +NI    +                  N 
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179

Query: 43  EVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-EMVT 97
            +++ D G A    +    +++ T  +  PE + E  + +  D++S G CIL E   
Sbjct: 180 SIRVADFGSATFDHE-HHTTIVATRHYRPPEVILELGWAQPCDVWSIG-CILFEYYR 234

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 16/80 (20%), Positives = 35/80 (43%), Gaps = 12/80 (15%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA------- 52
            +++   A ++L  L +LH +    +H ++  +NIFV+  +  +V +   G A       
Sbjct: 158 ERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215

Query: 53  --IVMQQPTARSVIGTPEFM 70
             +   + +     G  EF+
Sbjct: 216 KHVAYVEGSRSPHEGDLEFI 235

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 31/123 (25%), Positives = 55/123 (44%), Gaps = 30/123 (24%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---------------------- 38
           ++ IK +  +IL+ L+YL   +  + H DLK +NI ++                      
Sbjct: 136 IEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193

Query: 39  --GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCIL-E 94
               +  +K+ D G A         S+I T ++ APE +    ++   D++SFG C+L E
Sbjct: 194 YRTKSTGIKLIDFGCATFKSD-YHGSIINTRQYRAPEVILNLGWDVSSDMWSFG-CVLAE 251

Query: 95  MVT 97
           + T
Sbjct: 252 LYT 254

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 14/154 (9%), Positives = 33/154 (21%), Gaps = 43/154 (27%)

Query: 7   WARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGT 66
             + +       H     +         + V   +G+V +        M     +     
Sbjct: 134 AMQSLAAAADAAHRAG--VALSIDHPSRVRV-SIDGDVVLAYPA---TMPDANPQD---- 183

Query: 67  PEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI---YKKVTSGIKPAS 123
                            DI   G  +  ++   +P  E    + +    +         +
Sbjct: 184 -----------------DIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA 226

Query: 124 LSKVTDPQVKQFIEKCIVPASLRLPALELL-KDP 156
                D           +P  +   A   +  D 
Sbjct: 227 ---DIDRD---------IPFQISAVAARSVQGDG 248

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.2 bits (124), Expect = 3e-07
 Identities = 89/630 (14%), Positives = 186/630 (29%), Gaps = 209/630 (33%)

Query: 15  LHY--LHSHNPPIIHRDLKCDNI--FVNG--NNGEVKIGDLGLAIVMQQPT----ARSVI 64
             Y  + S        +  C ++        +  E+         ++           + 
Sbjct: 16  YQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDH-------IIMSKDAVSGTLRLF 68

Query: 65  GTPEFMAPELYEEEYNELVDI-YSFGMCILEMVTCEY--P------YNECKNP----AQI 111
            T      E+ ++   E++ I Y F   ++  +  E   P      Y E ++      Q+
Sbjct: 69  WTLLSKQEEMVQKFVEEVLRINYKF---LMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125

Query: 112 YKK--VT------------SGIKPAS----------------LSKVTDPQVKQFIE---- 137
           + K  V+              ++PA                 L      +V+  ++    
Sbjct: 126 FAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF 185

Query: 138 -----KCIVPASLRLPALELLKDPFLVTDNPKDLVCD-----PLRLPNLVPEVMNLAHSE 187
                 C  P ++    LE+L+      D       D      LR+ ++  E+  L  S+
Sbjct: 186 WLNLKNCNSPETV----LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241

Query: 188 PHP-----MDIDLNHKKVSAD---SCAKSNTGTWFLTLELQRLTENNEFTLRGEKNDDDT 239
           P+      +  ++ + K       SC K         L           T R  K   D 
Sbjct: 242 PYENCLLVLL-NVQNAKAWNAFNLSC-K--------IL----------LTTR-FKQVTDF 280

Query: 240 VSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQ--LDLSHEDVVSIAELIDNLIM 297
           +S        + H+S  H    L  D   S+  + ++    DL  E V++      ++I 
Sbjct: 281 LS-----AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE-VLTTNPRRLSIIA 334

Query: 298 KLVPS----WNPSLGSTASQQNGLLKGSPVSQGNSISLKC--PGE------------PGS 339
           + +      W+        +   +++          SL    P E            P +
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLTTIIE---------SSLNVLEPAEYRKMFDRLSVFPPSA 385

Query: 340 N----------NAFAEAVSQQGVLSELAS----GKYQYNQESSDSDISAEFDVPVILDAH 385
           +              ++     V+++L       K       S   I  E  V +  +  
Sbjct: 386 HIPTILLSLIWFDVIKSDVMV-VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA 444

Query: 386 IDKSLV------------------PDGYSAHYAVYDHGGHEVKADEVSLGESILFNESTQ 427
           + +S+V                   D Y   +  + H  +    + ++L   +  +    
Sbjct: 445 LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-HLKNIEHPERMTLFRMVFLD---- 499

Query: 428 NSETSFIDS---CSGMSKNLSFSSISSLS--------LADKE-HSDGL---------KLE 466
                F++        + N S S +++L         + D +   + L         K+E
Sbjct: 500 ---FRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIE 556

Query: 467 LDAINSKYQQCFQELLRQREDEM--ENARK 494
            + I SKY    +  L   ++ +  E  ++
Sbjct: 557 ENLICSKYTDLLRIALMAEDEAIFEEAHKQ 586

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.2 bits (106), Expect = 5e-05
 Identities = 70/577 (12%), Positives = 157/577 (27%), Gaps = 173/577 (29%)

Query: 19  HSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS--VIGTPEFMAPELYE 76
           H H+    H D +          GE +     +  V +     +       +     L +
Sbjct: 2   HHHH----HMDFET---------GEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK 48

Query: 77  EEYNELVD-------IYSFGMCIL------------EMVTCEYPY------NECKNPAQI 111
           EE + ++               +L            E++   Y +       E + P+ +
Sbjct: 49  EEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMM 108

Query: 112 YKKVTSGIKPASLSKVTDPQV--KQFI--EKCIVPASLRLPALELLKDPFLVTDNPK--- 164
            +               D QV  K  +   +      LR   LEL     ++ D      
Sbjct: 109 TRMYIEQRDRLY----NDNQVFAKYNVSRLQPY--LKLRQALLELRPAKNVLIDGVLGSG 162

Query: 165 -----DLVCDPLRLPNLVP-EV--MNLAHSEPHPMDI-----DLNHKKVSADSCAKSNTG 211
                  VC   ++   +  ++  +NL +    P  +      L ++     +    ++ 
Sbjct: 163 KTWVALDVCLSYKVQCKMDFKIFWLNLKNCN-SPETVLEMLQKLLYQIDPNWTSRSDHSS 221

Query: 212 TWFLTLELQRLTENNEFTLRGEKNDDDTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIA 271
              L +   +         +  +N        L +     +V N                
Sbjct: 222 NIKLRIHSIQAELRRLLKSKPYEN-------CLLVLL---NVQN---------------- 255

Query: 272 EEMVEQLDLSHEDVV-----SIAELIDNLIMKLVPSWNPSLGSTASQQNGLLKGSPVSQG 326
            +     +LS + ++      + + +       +   + S+  T  +   LL        
Sbjct: 256 AKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL-------L 308

Query: 327 NSISLK--------CPGEPGSNNAFAEAVSQQGVLSELASGKY--QYNQESSDSDISAEF 376
             +  +            P   +  AE++        LA+       N +   + I +  
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRD-----GLATWDNWKHVNCDKLTTIIESSL 363

Query: 377 DVPVILDAHIDKSLVPDGYSAHY---AVYDHGGHEVKADEVSLGESILFNESTQNSETSF 433
           +V           L P  Y   +   +V+           + L  S+++ +  ++     
Sbjct: 364 NV-----------LEPAEYRKMFDRLSVFPPS---AHIPTILL--SLIWFDVIKSDVMVV 407

Query: 434 IDSCSGMS------KNLSFSSISSLSLADKEHSDGL----KLELDAINSKYQQCFQELLR 483
           ++     S      K  +  SI S+ L  K   +      +  +D  N        +L+ 
Sbjct: 408 VNKLHKYSLVEKQPKESTI-SIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIP 466

Query: 484 QRED------------EMENARK-----------RWL 497
              D             +E+  +           R+L
Sbjct: 467 PYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL 503

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 18/80 (22%), Positives = 32/80 (40%), Gaps = 12/80 (15%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA------- 52
              +     ++L  L Y+H +    +H D+K  N+ +   N  +V + D GL+       
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207

Query: 53  --IVMQQPTARSVIGTPEFM 70
                Q+   +   GT EF 
Sbjct: 208 NHKQYQENPRKGHNGTIEFT 227

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 22/73 (30%), Positives = 31/73 (42%), Gaps = 12/73 (16%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLA---------IVMQQ 57
           + +IL  L Y+H H    +H D+K  N+ +N  N  +V + D GLA              
Sbjct: 158 SLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215

Query: 58  PTARSVIGTPEFM 70
              R   GT EF 
Sbjct: 216 DPKRCHDGTIEFT 228

>2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus} Length = 98

 Score = 45.0 bits (106), Expect = 3e-06
 Identities = 20/73 (27%), Positives = 33/73 (45%), Gaps = 6/73 (8%)

Query: 233 EKNDDDTVSLTLRIGD----KSGHVSN--IHFVFYLNADTAISIAEEMVEQLDLSHEDVV 286
           +  +   + L LRI D    K  +  N  I F F L  D    +A+EMVE   +   D  
Sbjct: 19  DDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHK 78

Query: 287 SIAELIDNLIMKL 299
           ++A+ I + +  +
Sbjct: 79  TMAKAIKDRVSLI 91

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 22/81 (27%), Positives = 35/81 (43%), Gaps = 13/81 (16%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQP 58
           +K +   A Q++  + Y+HS N   IHRD+K DN  +        V I D GLA   +  
Sbjct: 104 LKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161

Query: 59  ---------TARSVIGTPEFM 70
                      +++ GT  + 
Sbjct: 162 RTHQHIPYRENKNLTGTARYA 182

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 45.3 bits (106), Expect = 3e-05
 Identities = 30/177 (16%), Positives = 51/177 (28%), Gaps = 27/177 (15%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN----------GNNGEVKIGDLGLAI 53
            K+   Q+   L      +    HRDL   N+ +            N     I   GL +
Sbjct: 163 AKSILHQLTASLAVAE-ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQV 221

Query: 54  VMQQPTAR--SVIGTPEFM----APELYEEEYNELVDIYSFGMCILEMVTCEY-PYNECK 106
            +   T       G   F       +L+  + +   DIY            EY PY+   
Sbjct: 222 SIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVL 281

Query: 107 -----NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVPASLRLPALELLKDPFL 158
                    + +            K    ++++F    +  +S    A +LL    L
Sbjct: 282 WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFSS----ATDLLCQHSL 334

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 16/49 (32%), Positives = 26/49 (53%), Gaps = 6/49 (12%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFV----NGNNGEVKIGDLGLA 52
           A Q++  + Y+HS N  +I+RD+K +N  +    N     + I D  LA
Sbjct: 111 AIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 16/47 (34%), Positives = 26/47 (55%), Gaps = 4/47 (8%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLA 52
           A Q++  + ++HS +   +HRD+K DN  +       +V I D GLA
Sbjct: 109 ADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 12/49 (24%), Positives = 26/49 (53%), Gaps = 6/49 (12%)

Query: 8   ARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE----VKIGDLGLA 52
           A+Q+L  +  +H  +  +++RD+K DN  +   N +    + + D G+ 
Sbjct: 112 AKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	505
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.98
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.98
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.97
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.97
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.97
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.97
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.97
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.96
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.96
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.96
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.96
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.96
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.96
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.96
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.96
3niz_A	311	Rhodanese family protein; structural genomics, str	99.96
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.96
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.96
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.96
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.96
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.96
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.96
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.96
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.96
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.96
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.96
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.96
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.96
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.96
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.96
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.96
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.96
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.96
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.96
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.96
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.96
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.95
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.95
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.95
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.95
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.95
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.95
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.95
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.95
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.95
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.95
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.95
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.95
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.95
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.95
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.95
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.95
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.95
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.95
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.95
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.95
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.95
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.95
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.95
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.95
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.95
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.95
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.95
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.95
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.95
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.95
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.95
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.95
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.95
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.95
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.95
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.95
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.95
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.95
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.95
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.95
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.95
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.95
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.95
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.95
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.95
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.95
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.95
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.95
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.95
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.95
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.95
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.95
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.95
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.95
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.95
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.95
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.95
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.95
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.95
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.95
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.95
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.95
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.95
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.95
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.95
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.95
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.95
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.95
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.95
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.94
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.94
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.94
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.94
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.94
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.94
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.94
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.94
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.94
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.94
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.94
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.94
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.94
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.94
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.94
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.94
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.94
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.94
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.94
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.94
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.94
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.94
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.94
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.94
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.94
3bhy_A	283	Death-associated protein kinase 3; death associate	99.94
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.94
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.94
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.94
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.93
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.93
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.93
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.93
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.93
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.93
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.93
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.93
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.93
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.93
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.93
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.93
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.93
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.93
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.93
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.93
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.93
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.93
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.92
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.92
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.92
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.92
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.92
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.92
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.92
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.92
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.92
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.92
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.92
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.92
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.92
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.92
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.92
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.92
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.92
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.92
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.92
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.92
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.92
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.92
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.92
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.92
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.92
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.92
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.92
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.92
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.92
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.92
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.92
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.92
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.92
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.92
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.92
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.92
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.92
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.92
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.92
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.92
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.92
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.91
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.91
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.91
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.91
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.91
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.91
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.91
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.91
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.91
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.91
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.91
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.91
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.91
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.91
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.91
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.91
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.91
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.9
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.9
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.9
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.9
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.9
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.9
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.9
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.9
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.9
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.89
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.89
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.89
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.86
3uqc_A	286	Probable conserved transmembrane protein; structur	99.8
2v3s_A	96	Serine/threonine-protein kinase OSR1; ATP-binding,	99.75
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.69
2lru_A	98	Serine/threonine-protein kinase WNK1; autoinhibito	99.25
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.38
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.07
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	98.72
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	98.04
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	97.0
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	96.28
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	96.2
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	95.89
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.07
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	94.06
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	91.67
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	90.51
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	84.1
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	84.08
3ats_A	357	Putative uncharacterized protein; hypothetical pro	84.06
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	83.95
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	82.76
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	81.88
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	81.07

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.6e-39  Score=324.92  Aligned_cols=159  Identities=60%  Similarity=1.102  Sum_probs=145.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccccCCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNE   81 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~ys~   81 (505)
                      +.++.|++||+.||+|||++|++|+||||||+|||+++.+|.+||+|||+|+........+.+|||.|||||++.+.|+.
T Consensus       129 ~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~~y~~  208 (290)
T 3fpq_A          129 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDE  208 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCT
T ss_pred             HHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCCCCCc
Confidence            46789999999999999999888999999999999986678999999999987666666778999999999999888999


Q ss_pred             ccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626           82 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus        82 ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      ++|||||||++|||+||+.||.+..+...++..+..+..|..++...++++++||.+||. +|.+|||+.|+|+||||+.
T Consensus       209 ~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          209 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            999999999999999999999888888889999988887777788889999999999996 8999999999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.1e-36  Score=304.60  Aligned_cols=166  Identities=26%  Similarity=0.412  Sum_probs=140.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      .+++.|++||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+|+....  ....+.+||+.|||||++ ...
T Consensus       126 ~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~  202 (304)
T 3ubd_A          126 EDVKFYLAELALALDHLHSLG--IIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG  202 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEc-CCCCEEecccccceeccCCCccccccccCcccCCHHHhccCC
Confidence            468899999999999999999  99999999999998 778999999999986533  334567899999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~El  152 (505)
                      |+.++|||||||++|||+||+.||.+ .+..+++..+..+..  .++..+++++++||.+||. +|.+|||     ++|+
T Consensus       203 y~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~ei  279 (304)
T 3ubd_A          203 HTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMILKAKL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEI  279 (304)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHH
T ss_pred             CCCCCcccchHHHHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHH
Confidence            99999999999999999999999986 566777777776643  3566789999999999996 8999998     5799


Q ss_pred             hcCCCCCCCCCCCcccCCCCC
Q 010626          153 LKDPFLVTDNPKDLVCDPLRL  173 (505)
Q Consensus       153 L~hpff~~~~~~~l~~~~l~~  173 (505)
                      ++||||+..+|..+....+..
T Consensus       280 l~Hp~f~~idw~~l~~~~~~p  300 (304)
T 3ubd_A          280 KRHSFFSTIDWNKLYRREIHP  300 (304)
T ss_dssp             HTSGGGTTCCHHHHHTTCSCC
T ss_pred             HcCccccCCCHHHHHhCCCCc
Confidence            999999988876665544443

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1e-35  Score=307.38  Aligned_cols=157  Identities=34%  Similarity=0.630  Sum_probs=135.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      +.++.|++||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+|+.+...  ...+.+||+.|||||++. ..
T Consensus       170 ~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~  246 (346)
T 4fih_A          170 EQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP  246 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEC-CCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCC
Confidence            468899999999999999999  99999999999998 7899999999999877543  345678999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC-CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      |+.++|||||||++|||++|+.||.+ .+....+..+.....+. ..+..+++++++||.+||. +|.+|||+.|+|+||
T Consensus       247 y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp  325 (346)
T 4fih_A          247 YGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP  325 (346)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence            99999999999999999999999987 55666777776654432 3345678999999999995 899999999999999


Q ss_pred             CCCCCC
Q 010626          157 FLVTDN  162 (505)
Q Consensus       157 ff~~~~  162 (505)
                      ||++..
T Consensus       326 ~~~~~~  331 (346)
T 4fih_A          326 FLAKAG  331 (346)
T ss_dssp             GGGGCC
T ss_pred             hhcCCC
Confidence            998644

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.2e-35  Score=302.80  Aligned_cols=161  Identities=29%  Similarity=0.488  Sum_probs=140.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll~-   76 (505)
                      +.++.|++||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+|+.+...    ...+.+||+.|||||++. 
T Consensus       132 ~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~  208 (311)
T 4aw0_A          132 TCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE  208 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEc-CCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC
Confidence            468899999999999999999  99999999999998 7899999999999876432    245678999999999984 


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH----
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE----  151 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E----  151 (505)
                      ..|+.++|||||||++|+|+||+.||.+ .+...++.++..+..  .++..+++++++||.+||. +|.+|||+.|    
T Consensus       209 ~~y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          209 KSACKSSDLWALGCIIYQLVAGLPPFRA-GNEGLIFAKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             SCBCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence            5699999999999999999999999976 567777778777643  3566789999999999996 8999999987    


Q ss_pred             --HhcCCCCCCCCCCCccc
Q 010626          152 --LLKDPFLVTDNPKDLVC  168 (505)
Q Consensus       152 --lL~hpff~~~~~~~l~~  168 (505)
                        +++||||+..+|..+..
T Consensus       286 ~~i~~Hp~F~~idw~~l~~  304 (311)
T 4aw0_A          286 GPLKAHPFFESVTWENLHQ  304 (311)
T ss_dssp             HHHHTSGGGTTCCCTTGGG
T ss_pred             HHHHCCCCcCCCCHHHhcC
Confidence              58999999988877643

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.5e-35  Score=297.17  Aligned_cols=156  Identities=27%  Similarity=0.583  Sum_probs=126.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccccc-cC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~~-~y   79 (505)
                      ..++.|++||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+..... ...+.+||+.|||||++.+ .|
T Consensus       112 ~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y  188 (275)
T 3hyh_A          112 QEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLD-EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY  188 (275)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTCCEEECCSSCC---------------CTTSCHHHHSSSSC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEEC-CCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCC
Confidence            468899999999999999999  99999999999998 7789999999999876543 3456789999999999854 44


Q ss_pred             -CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           80 -NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        80 -s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                       +.++|||||||++|+|+||+.||.+ .+...++..+..+..  .++...++++++||.+||. +|.+|||+.|+|+|||
T Consensus       189 ~~~~~DiwSlGvily~lltg~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw  265 (275)
T 3hyh_A          189 AGPEVDVWSCGVILYVMLCRRLPFDD-ESIPVLFKNISNGVY--TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDW  265 (275)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHH
T ss_pred             CCChhhhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcc
Confidence             6899999999999999999999976 567777788777643  3567789999999999996 8999999999999999


Q ss_pred             CCCCCC
Q 010626          158 LVTDNP  163 (505)
Q Consensus       158 f~~~~~  163 (505)
                      |+.+.+
T Consensus       266 ~k~~~p  271 (275)
T 3hyh_A          266 FKVDLP  271 (275)
T ss_dssp             HHTTCC
T ss_pred             cccCCC
Confidence            976443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7e-35  Score=308.45  Aligned_cols=157  Identities=34%  Similarity=0.629  Sum_probs=135.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.|++||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+|+.+...  ...+.+||+.|||||++. ..
T Consensus       247 ~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~  323 (423)
T 4fie_A          247 EQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP  323 (423)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEEC-TTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCC
Confidence            468899999999999999999  99999999999998 7899999999999876543  345678999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      |+.++|||||||++|||++|+.||.+ .+....+..+.....+ ......+++++++||.+||. +|.+|||+.|+|+||
T Consensus       324 y~~~~DiWSlGvilyeml~G~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp  402 (423)
T 4fie_A          324 YGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP  402 (423)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence            99999999999999999999999987 4566667777665443 23445678999999999995 899999999999999


Q ss_pred             CCCCCC
Q 010626          157 FLVTDN  162 (505)
Q Consensus       157 ff~~~~  162 (505)
                      ||+...
T Consensus       403 ~~~~~~  408 (423)
T 4fie_A          403 FLAKAG  408 (423)
T ss_dssp             GGGGCC
T ss_pred             HhcCCC
Confidence            998643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.6e-35  Score=303.74  Aligned_cols=154  Identities=29%  Similarity=0.549  Sum_probs=134.0

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-ccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~y   79 (505)
                      .++.|++||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+|+.....  ...+.+||+.|||||++. ..|
T Consensus       126 ~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y  202 (350)
T 4b9d_A          126 QILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY  202 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEEC-TTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEEC-CCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCC
Confidence            57889999999999999999  99999999999998 7899999999999876432  234568999999999885 469


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +.++|||||||++|||+||+.||.+ .+..+++.++..+..+ ..+..+++++++||.+||. +|.+|||+.|+|+||||
T Consensus       203 ~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~  280 (350)
T 4b9d_A          203 NNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI  280 (350)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHh
Confidence            9999999999999999999999987 5666777777776554 3556678999999999996 89999999999999999


Q ss_pred             CCC
Q 010626          159 VTD  161 (505)
Q Consensus       159 ~~~  161 (505)
                      ++.
T Consensus       281 ~~~  283 (350)
T 4b9d_A          281 AKR  283 (350)
T ss_dssp             HTT
T ss_pred             hcC
Confidence            753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.2e-34  Score=293.57  Aligned_cols=155  Identities=28%  Similarity=0.448  Sum_probs=126.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC-cEEEeecCceeeccCCC-------CccccCCCcccCcc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIVMQQPT-------ARSVIGTPEFMAPE   73 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g-~vKL~DFGlA~~~~~~~-------~~~~~Gt~~Y~APE   73 (505)
                      ..++.|++||+.||+|||++|  |+||||||+|||++ .+| .+||+|||+|+.+....       ....+||+.|||||
T Consensus       150 ~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~-~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE  226 (336)
T 4g3f_A          150 DRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE  226 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEC-TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEe-CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHH
Confidence            468899999999999999999  99999999999998 555 69999999998764321       23457999999999


Q ss_pred             ccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626           74 LYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus        74 ll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                      ++. ..|+.++|||||||++|||+||+.||.+.. ...+...+.....+ ..++..+++.+++||.+||. +|.+|||+.
T Consensus       227 ~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~  305 (336)
T 4g3f_A          227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF-RGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAM  305 (336)
T ss_dssp             HHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTC-CSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-HHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHH
Confidence            884 569999999999999999999999998643 33444555554333 34667789999999999995 899999999


Q ss_pred             HH-------------hcCCCCCC
Q 010626          151 EL-------------LKDPFLVT  160 (505)
Q Consensus       151 El-------------L~hpff~~  160 (505)
                      |+             |+|||+..
T Consensus       306 el~~~l~~~l~~~~~l~hPw~~~  328 (336)
T 4g3f_A          306 ELRRKVGKALQEVGGLKSPWKGE  328 (336)
T ss_dssp             HHHHHHHHHHHHTTSSCSCSSSS
T ss_pred             HHHHHHHHHHhhhhhccCCCcCC
Confidence            97             57899865

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-33  Score=293.05  Aligned_cols=158  Identities=21%  Similarity=0.382  Sum_probs=124.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----------------------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----------------------   59 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----------------------   59 (505)
                      ++++.|++||+.||+|||++|  |+||||||+|||++.+.+.+||+|||+|+......                      
T Consensus       117 ~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (361)
T 4f9c_A          117 QEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCS  194 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC---------------
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccccccccc
Confidence            478999999999999999999  99999999999998666899999999997553221                      


Q ss_pred             --------CccccCCCcccCcccccc--cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc------------
Q 010626           60 --------ARSVIGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS------------  117 (505)
Q Consensus        60 --------~~~~~Gt~~Y~APEll~~--~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~------------  117 (505)
                              ..+.+||+.|+|||++.+  .|+.++||||+||++|+|+||+.||....+.......+..            
T Consensus       195 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~  274 (361)
T 4f9c_A          195 ICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAK  274 (361)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             ccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhh
Confidence                    234579999999998843  4899999999999999999999999765554333222211            


Q ss_pred             --------------------------C--------------CCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626          118 --------------------------G--------------IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus       118 --------------------------~--------------~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                                                .              ..........++++++||.+||+ ||.+|+|+.|+|+||
T Consensus       275 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp  354 (361)
T 4f9c_A          275 TFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHP  354 (361)
T ss_dssp             HTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred             hccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCc
Confidence                                      0              00001223467899999999996 899999999999999


Q ss_pred             CCCCC
Q 010626          157 FLVTD  161 (505)
Q Consensus       157 ff~~~  161 (505)
                      ||+..
T Consensus       355 ~f~~i  359 (361)
T 4f9c_A          355 FFKDM  359 (361)
T ss_dssp             GGTTC
T ss_pred             ccCCC
Confidence            99753

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-33  Score=311.83  Aligned_cols=169  Identities=25%  Similarity=0.458  Sum_probs=144.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-c-cC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E-EY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~-~y   79 (505)
                      ..++.|++||+.||+|||++|  ||||||||+|||++ .+|.+||+|||+|+.+......+.+|||.|||||++. + .|
T Consensus       292 ~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld-~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y  368 (689)
T 3v5w_A          292 ADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY  368 (689)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEe-CCCCEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCC
Confidence            468899999999999999999  99999999999998 7899999999999988777777889999999999884 3 59


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCC--CChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALE  151 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~--~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~E  151 (505)
                      +.++|||||||++|||++|..||.+.  .+...+...+....  ..++..+++++++||.+||. +|.+|++     +.|
T Consensus       369 ~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~e  446 (689)
T 3v5w_A          369 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE  446 (689)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHH
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHH
Confidence            99999999999999999999999653  23445555555543  34567789999999999996 8999998     799


Q ss_pred             HhcCCCCCCCCCCCcccCCCCCCC
Q 010626          152 LLKDPFLVTDNPKDLVCDPLRLPN  175 (505)
Q Consensus       152 lL~hpff~~~~~~~l~~~~l~~p~  175 (505)
                      +++||||+..+|..+....+..|.
T Consensus       447 i~~HpfF~~idW~~l~~~~~~pP~  470 (689)
T 3v5w_A          447 VKESPFFRSLDWQMVFLQKYPPPL  470 (689)
T ss_dssp             HTTSGGGTTCCHHHHHTTCSCCSC
T ss_pred             HhcCccccCCCHHHHHcCCCCcCc
Confidence            999999999998887666554443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-33  Score=291.36  Aligned_cols=156  Identities=31%  Similarity=0.462  Sum_probs=125.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC------CCCccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ------PTARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~------~~~~~~~Gt~~Y~APEll   75 (505)
                      ..++.|++||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+|+.+..      ....+.+||+.|||||++
T Consensus       158 ~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~  234 (398)
T 4b99_A          158 EHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVN-ENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM  234 (398)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccC-CCCCEEEeecceeeecccCccccccccccceeChHhcCHHHh
Confidence            468999999999999999999  99999999999998 789999999999976532      234567899999999987


Q ss_pred             c--ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC-CCCC---------------------C-------C
Q 010626           76 E--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKPA---------------------S-------L  124 (505)
Q Consensus        76 ~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~-~~p~---------------------~-------~  124 (505)
                      .  ..|+.++||||+||++|||++|+.||.+.....+ ...+... ..|.                     .       .
T Consensus       235 ~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (398)
T 4b99_A          235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETV  313 (398)
T ss_dssp             TTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHH
T ss_pred             cCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHh
Confidence            4  3579999999999999999999999987544433 3333221 1110                     0       0


Q ss_pred             CCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          125 SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       125 ~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      ....++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus       314 ~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          314 YPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY  351 (398)
T ss_dssp             STTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred             CCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence            12357899999999996 89999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.98  E-value=2e-32  Score=278.53  Aligned_cols=150  Identities=34%  Similarity=0.550  Sum_probs=124.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll~-   76 (505)
                      ..+..|+.||+.||+|||+++  ||||||||+|||++ .++.+||+|||+|+.....    .....+||+.|||||++. 
T Consensus       132 ~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~  208 (307)
T 3omv_A          132 FQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLH-EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRM  208 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEE-TTEEEEECCCSSCBC------------CCCCTTSCCHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEEC-CCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhc
Confidence            367889999999999999999  99999999999998 7789999999999765432    234568999999999883 


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC---CCCCCCChHHHHHHHHhcC-CCCCCCCH
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPA  149 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~---~~~~~~s~~l~~LI~kcL~-dP~~RpSa  149 (505)
                         +.|+.++|||||||++|||+||+.||.+..+...+...+..+..++   ..+..+++.+++||.+||. +|.+|||+
T Consensus       209 ~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  288 (307)
T 3omv_A          209 QDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLF  288 (307)
T ss_dssp             CSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCH
T ss_pred             cCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCH
Confidence               3489999999999999999999999988777777777777665443   3455678999999999995 89999999


Q ss_pred             HHHhc
Q 010626          150 LELLK  154 (505)
Q Consensus       150 ~ElL~  154 (505)
                      .|+++
T Consensus       289 ~ei~~  293 (307)
T 3omv_A          289 PQILS  293 (307)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.98  E-value=3.1e-33  Score=283.04  Aligned_cols=153  Identities=25%  Similarity=0.431  Sum_probs=116.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--------------CccccCCCc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--------------ARSVIGTPE   68 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--------------~~~~~Gt~~   68 (505)
                      .++.|+.||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+|+.+....              ..+.+||+.
T Consensus       119 ~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~-~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~  195 (299)
T 4g31_A          119 VCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKL  195 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCCCC--------------------------CCCT
T ss_pred             HHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC-CCCcEEEccCccceecCCCccccccccccccccccCCcccCcc
Confidence            47889999999999999999  99999999999998 67899999999998764321              234579999


Q ss_pred             ccCccccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCC
Q 010626           69 FMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLR  146 (505)
Q Consensus        69 Y~APEll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~R  146 (505)
                      |||||++. ..|+.++|||||||++|||++   ||....+.......+.....|+. ....++.+.+||.+||. +|.+|
T Consensus       196 YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~-~~~~~~~~~~li~~~L~~dP~~R  271 (299)
T 4g31_A          196 YMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPL-FTQKYPCEYVMVQDMLSPSPMER  271 (299)
T ss_dssp             TSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHH-HHHHCHHHHHHHHHHTCSSGGGS
T ss_pred             ccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCC-CcccCHHHHHHHHHHcCCChhHC
Confidence            99999884 569999999999999999996   88653333333444444433322 22335678899999996 89999


Q ss_pred             CCHHHHhcCCCCCCCC
Q 010626          147 LPALELLKDPFLVTDN  162 (505)
Q Consensus       147 pSa~ElL~hpff~~~~  162 (505)
                      ||+.|+|+||||+..+
T Consensus       272 ps~~eil~h~~~~~~~  287 (299)
T 4g31_A          272 PEAINIIENAVFEDLD  287 (299)
T ss_dssp             CCHHHHHTSGGGCCC-
T ss_pred             cCHHHHhcCHhhCCCC
Confidence            9999999999997643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.97  E-value=8.2e-32  Score=278.90  Aligned_cols=150  Identities=27%  Similarity=0.436  Sum_probs=130.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      +.+..|+.||+.||+|||+++  ||||||||+|||++ .++.+||+|||+|+......    .....||+.|||||++ .
T Consensus       185 ~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~-~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~  261 (353)
T 4ase_A          185 EHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  261 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeC-CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc
Confidence            357789999999999999999  99999999999998 67899999999998764432    2345789999999988 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      +.|+.++|||||||++|||+| |+.||.+......+...+..+..+ ..+..+++++++||.+||. +|.+|||+.|+++
T Consensus       262 ~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~-~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~  340 (353)
T 4ase_A          262 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  340 (353)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            679999999999999999998 999998876667777777777654 3566789999999999995 8999999999998


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      |
T Consensus       341 ~  341 (353)
T 4ase_A          341 H  341 (353)
T ss_dssp             H
T ss_pred             H
Confidence            7

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.97  E-value=3.4e-31  Score=271.67  Aligned_cols=149  Identities=22%  Similarity=0.374  Sum_probs=121.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      .++..|+.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+++......    .....||+.|||||++ .
T Consensus       158 ~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~  234 (329)
T 4aoj_A          158 GQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVG-QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY  234 (329)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTEEEECCCC----------------CCCCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEEC-CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC
Confidence            357889999999999999999  99999999999998 77899999999998664322    2345799999999988 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..|+.++|||||||++|||+| |+.||.+. +..++...+..+..+ ..+..+++++.+||.+||. +|.+|||+.|++.
T Consensus       235 ~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~-~~~~~~~~i~~g~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~  312 (329)
T 4aoj_A          235 RKFTTESDVWSFGVVLWEIFTYGKQPWYQL-SNTEAIDCITQGREL-ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA  312 (329)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTCSS-CHHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred             CCCCccccccchHHHHHHHHcCCCCCCCCC-CHHHHHHHHHcCCCC-CCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            569999999999999999999 89999874 566677777776544 4567789999999999996 8999999999986


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       313 ~  313 (329)
T 4aoj_A          313 R  313 (329)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=3.5e-31  Score=290.24  Aligned_cols=159  Identities=26%  Similarity=0.417  Sum_probs=134.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-CCcEEEeecCceeeccCCC-CccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~-~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.|++||+.||.|||++|  |+||||||+|||++.. .+.+||+|||+|+.+.... ....+||+.|||||++. ..
T Consensus       255 ~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~  332 (573)
T 3uto_A          255 DEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP  332 (573)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCC
Confidence            468899999999999999999  9999999999999742 4789999999998875443 44568999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC--CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      |+.++|||||||++|+|++|..||.+ .+....+..+.....  +......+++++++||.+||. +|.+|||+.|+|+|
T Consensus       333 y~~~~DiWSlGvilyeml~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          333 VGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             BCHHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCC-cCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            99999999999999999999999987 456666677766533  233345678999999999996 89999999999999


Q ss_pred             CCCCCCCC
Q 010626          156 PFLVTDNP  163 (505)
Q Consensus       156 pff~~~~~  163 (505)
                      |||+...+
T Consensus       412 pw~~~~~~  419 (573)
T 3uto_A          412 PWLTPGNA  419 (573)
T ss_dssp             TTTSCCCC
T ss_pred             cCcCCCCC
Confidence            99987543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.97  E-value=3.1e-31  Score=269.62  Aligned_cols=148  Identities=23%  Similarity=0.322  Sum_probs=127.2

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..|+.||+.||+|||+++  ||||||||+|||++ .++.+||+|||+++.....    ......||+.|||||++ .+
T Consensus       146 ~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~-~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~  222 (308)
T 4gt4_A          146 DFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVY-DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG  222 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHhCC--CCCCCccccceEEC-CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC
Confidence            56789999999999999999  99999999999998 7789999999999765332    23345799999999987 56


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .|+.++|||||||++|||+| |..||.+ .+..++...+..+..+ ..+..+++.+.+||.+||. +|.+|||+.|++++
T Consensus       223 ~~s~ksDVwSfGvvl~El~t~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          223 KFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSNQDVVEMIRNRQVL-PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCTTTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCccchhhhHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            79999999999999999998 8999987 4566777777776554 3566789999999999995 89999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.97  E-value=6.4e-31  Score=259.93  Aligned_cols=160  Identities=59%  Similarity=1.100  Sum_probs=143.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccccCCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNE   81 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~ys~   81 (505)
                      ..++.|+.||+.||.|||++|++++||||||+||+++..++.+||+|||++............||+.|+|||++.+.++.
T Consensus       129 ~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  208 (290)
T 1t4h_A          129 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDE  208 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCT
T ss_pred             HHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHhccCCC
Confidence            46788999999999999998877999999999999976778999999999976666555667899999999999888999


Q ss_pred             ccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626           82 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus        82 ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      ++||||||+++|+|++|+.||....+....+..+..+..+..++...++.+.+||.+||. +|.+|||+.++|+||||+.
T Consensus       209 ~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          209 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             cchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            999999999999999999999988888888888888877777777888999999999996 8999999999999999975


Q ss_pred             C
Q 010626          161 D  161 (505)
Q Consensus       161 ~  161 (505)
                      .
T Consensus       289 ~  289 (290)
T 1t4h_A          289 E  289 (290)
T ss_dssp             -
T ss_pred             C
Confidence            3

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.97  E-value=2.1e-31  Score=269.76  Aligned_cols=150  Identities=23%  Similarity=0.382  Sum_probs=127.5

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..|+.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+|+......    .....||+.|||||++ .+
T Consensus       129 ~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~  205 (299)
T 4asz_A          129 QMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVG-ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR  205 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEEC-CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC
Confidence            57889999999999999999  99999999999998 67899999999997654322    2234689999999988 56


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .|+.++|||||||++|||+| |+.||.+ .+..++...+..+..+ ..+..+++++.+||.+||. +|.+|||+.+++  
T Consensus       206 ~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--  281 (299)
T 4asz_A          206 KFTTESDVWSLGVVLWEIFTYGKQPWYQ-LSNNEVIECITQGRVL-QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--  281 (299)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--
T ss_pred             CCCchhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHHH--
Confidence            79999999999999999999 8999987 4566777778777554 3566789999999999995 899999999984  


Q ss_pred             CCCC
Q 010626          156 PFLV  159 (505)
Q Consensus       156 pff~  159 (505)
                      +|++
T Consensus       282 ~~L~  285 (299)
T 4asz_A          282 TLLQ  285 (299)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            4553

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.97  E-value=4.7e-30  Score=256.50  Aligned_cols=158  Identities=32%  Similarity=0.560  Sum_probs=133.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......  ......||+.|+|||++ ...
T Consensus       116 ~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  192 (297)
T 3fxz_A          116 GQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA  192 (297)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEC-CCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCC
Confidence            467899999999999999999  99999999999997 6789999999999776543  23455799999999988 556


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      |+.++|||||||++|+|++|..||......................+...++.+++||.+||. +|.+|||+.|+|+|||
T Consensus       193 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  272 (297)
T 3fxz_A          193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF  272 (297)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence            999999999999999999999999875544555555555554555566778999999999996 8999999999999999


Q ss_pred             CCCCC
Q 010626          158 LVTDN  162 (505)
Q Consensus       158 f~~~~  162 (505)
                      |+...
T Consensus       273 ~~~~~  277 (297)
T 3fxz_A          273 LKIAK  277 (297)
T ss_dssp             GGGCC
T ss_pred             hcccC
Confidence            98643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=6e-30  Score=262.11  Aligned_cols=164  Identities=26%  Similarity=0.542  Sum_probs=138.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      +.++.++.||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+++....  ......+||+.|+|||++ ...
T Consensus       105 ~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  181 (337)
T 1o6l_A          105 ERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND  181 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEEC-CCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCC
Confidence            467889999999999999999  99999999999998 778999999999975422  234566899999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~El  152 (505)
                      |+.++|||||||++|+|++|+.||.. .+...++..+.....  .++...++++++||.+||. +|.+||     ++.++
T Consensus       182 ~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei  258 (337)
T 1o6l_A          182 YGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV  258 (337)
T ss_dssp             BCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH
T ss_pred             CCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH
Confidence            99999999999999999999999976 456666666665432  3566789999999999995 899999     89999


Q ss_pred             hcCCCCCCCCCCCcccCCC
Q 010626          153 LKDPFLVTDNPKDLVCDPL  171 (505)
Q Consensus       153 L~hpff~~~~~~~l~~~~l  171 (505)
                      ++||||...+|..+....+
T Consensus       259 ~~h~~f~~~~~~~~~~~~~  277 (337)
T 1o6l_A          259 MEHRFFLSINWQDVVQKKL  277 (337)
T ss_dssp             HTSGGGTTCCHHHHHTTCS
T ss_pred             HcCCCcCCCCHHHHHhCCC
Confidence            9999999888776654444

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.96  E-value=2e-30  Score=267.17  Aligned_cols=166  Identities=23%  Similarity=0.455  Sum_probs=136.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+++....  ......+||+.|+|||++ ...
T Consensus       124 ~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~-~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  200 (353)
T 3txo_A          124 ARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML  200 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEEC-CCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCC
Confidence            467889999999999999999  99999999999998 778999999999975432  234456899999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH------HH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA------LE  151 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa------~E  151 (505)
                      |+.++|||||||++|+|++|+.||.. .+...++..+..+..  .++...++.+++||.+||. +|.+||++      .+
T Consensus       201 ~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~  277 (353)
T 3txo_A          201 YGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAILNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHA  277 (353)
T ss_dssp             CTTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHH
T ss_pred             cCCccCCCcchHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHH
Confidence            99999999999999999999999986 566677777776543  3456678999999999996 89999998      89


Q ss_pred             HhcCCCCCCCCCCCcccCCCCC
Q 010626          152 LLKDPFLVTDNPKDLVCDPLRL  173 (505)
Q Consensus       152 lL~hpff~~~~~~~l~~~~l~~  173 (505)
                      +++||||+..+|..+....+..
T Consensus       278 il~hp~f~~~~w~~l~~~~~~~  299 (353)
T 3txo_A          278 ILRHPFFKEIDWAQLNHRQIEP  299 (353)
T ss_dssp             HHTSGGGTTCCHHHHHTTCSCC
T ss_pred             HhhCCcccCCCHHHHhcCcCCC
Confidence            9999999988877665544433

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.96  E-value=1.2e-29  Score=257.38  Aligned_cols=166  Identities=30%  Similarity=0.535  Sum_probs=139.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .+|.+||+|||++...... ....+||+.|+|||++ ...|+
T Consensus       106 ~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~  181 (318)
T 1fot_A          106 PVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV-TYTLCGTPDYIAPEVVSTKPYN  181 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC-BCCCCSCTTTCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEc-CCCCEEEeecCcceecCCc-cccccCCccccCHhHhcCCCCC
Confidence            357889999999999999999  99999999999997 7789999999999876543 3456899999999988 45689


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHHHhc
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~ElL~  154 (505)
                      .++|||||||++|+|++|+.||.. .+....+..+.....  .++...++++++||.+||. +|.+||     ++.++++
T Consensus       182 ~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          182 KSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             cccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            999999999999999999999976 455666666666532  3556678999999999996 899999     8999999


Q ss_pred             CCCCCCCCCCCcccCCCCCC
Q 010626          155 DPFLVTDNPKDLVCDPLRLP  174 (505)
Q Consensus       155 hpff~~~~~~~l~~~~l~~p  174 (505)
                      ||||+...+..+....+..|
T Consensus       259 hp~f~~~~~~~~~~~~~~~p  278 (318)
T 1fot_A          259 HPWFKEVVWEKLLSRNIETP  278 (318)
T ss_dssp             SGGGSSCCHHHHHTTCSCCS
T ss_pred             CccccCCCHHHHHhCCCCCC
Confidence            99999888776655544433

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.96  E-value=1.1e-29  Score=266.36  Aligned_cols=166  Identities=22%  Similarity=0.422  Sum_probs=136.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+++...  .......+||+.|+|||++ ...
T Consensus       153 ~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~  229 (396)
T 4dc2_A          153 EHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED  229 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEC-CCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCC
Confidence            467889999999999999999  99999999999998 77899999999997532  2334567899999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCC--------CChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA  149 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~--------~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa  149 (505)
                      |+.++|||||||++|+|++|+.||...        .....++..+....  ..++...++.+++||.+||. +|.+||++
T Consensus       230 ~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          230 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            999999999999999999999999632        12344555665543  34566789999999999996 89999985


Q ss_pred             ------HHHhcCCCCCCCCCCCcccCCCC
Q 010626          150 ------LELLKDPFLVTDNPKDLVCDPLR  172 (505)
Q Consensus       150 ------~ElL~hpff~~~~~~~l~~~~l~  172 (505)
                            .|+++||||+..+|..+....+.
T Consensus       308 ~~~~~~~ei~~Hpff~~i~w~~l~~~~~~  336 (396)
T 4dc2_A          308 HPQTGFADIQGHPFFRNVDWDMMEQKQVV  336 (396)
T ss_dssp             STTTHHHHHHHSTTTTTCCHHHHHTTCSC
T ss_pred             CCCCCHHHHhcCccccCCCHHHHHcCCCC
Confidence                  79999999999888766554443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=1.3e-29  Score=261.25  Aligned_cols=166  Identities=23%  Similarity=0.435  Sum_probs=139.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+++...  .......+||+.|+|||++ ...
T Consensus       121 ~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  197 (353)
T 2i0e_A          121 PHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP  197 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEc-CCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCC
Confidence            367889999999999999999  99999999999998 77899999999997542  2234566899999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~El  152 (505)
                      |+.++|||||||++|+|++|+.||.. .+...++..+.....  .++...++++++||.+||. +|.+||+     +.++
T Consensus       198 ~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i  274 (353)
T 2i0e_A          198 YGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI  274 (353)
T ss_dssp             BSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHH
T ss_pred             cCCcccccchHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHH
Confidence            99999999999999999999999976 566677777776533  3556789999999999996 8999994     6999


Q ss_pred             hcCCCCCCCCCCCcccCCCCC
Q 010626          153 LKDPFLVTDNPKDLVCDPLRL  173 (505)
Q Consensus       153 L~hpff~~~~~~~l~~~~l~~  173 (505)
                      ++||||+...|..+....+..
T Consensus       275 ~~h~~f~~~~w~~l~~~~~~~  295 (353)
T 2i0e_A          275 KEHAFFRYIDWEKLERKEIQP  295 (353)
T ss_dssp             HTSGGGTTCCHHHHHTTCSCC
T ss_pred             hcCccccCCCHHHHHhCCCCC
Confidence            999999988877665544443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.96  E-value=1.8e-29  Score=259.68  Aligned_cols=166  Identities=27%  Similarity=0.478  Sum_probs=141.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      ..++.++.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+++..... ....+||+.|+|||++ ...|+
T Consensus       141 ~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~  216 (350)
T 1rdq_E          141 PHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGR-TWTLCGTPEALAPEIILSKGYN  216 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC-BCCCEECGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccccCccceEEEC-CCCCEEEcccccceeccCC-cccccCCccccCHHHhcCCCCC
Confidence            467889999999999999999  99999999999997 7789999999999876543 3456899999999987 45689


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHHHhc
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~ElL~  154 (505)
                      .++|||||||++|+|++|..||.. .+...++..+..+..  .++..+++.+++||.+||. +|.+||+     +.++++
T Consensus       217 ~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          217 KAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CcCCEecccHhHhHHhhCCCCCCC-CCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            999999999999999999999986 466777777776643  3556789999999999996 8999998     999999


Q ss_pred             CCCCCCCCCCCcccCCCCCC
Q 010626          155 DPFLVTDNPKDLVCDPLRLP  174 (505)
Q Consensus       155 hpff~~~~~~~l~~~~l~~p  174 (505)
                      ||||....|..+....+..|
T Consensus       294 h~~f~~~~w~~~~~~~~~~p  313 (350)
T 1rdq_E          294 HKWFATTDWIAIYQRKVEAP  313 (350)
T ss_dssp             SGGGTTCCHHHHHTTCSCCS
T ss_pred             CcCcCCCCHHHHhhccCCCC
Confidence            99999887766554444433

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.96  E-value=7.1e-30  Score=262.54  Aligned_cols=165  Identities=27%  Similarity=0.522  Sum_probs=139.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .+|.+||+|||+++...  .......+||+.|+|||++ ...
T Consensus       118 ~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  194 (345)
T 1xjd_A          118 SRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK  194 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEEC-CCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCC
Confidence            467889999999999999999  99999999999998 77899999999997542  2334566899999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHH-HHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL-ELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~-ElL~hp  156 (505)
                      |+.++|||||||++|+|++|..||.+ .+...++..+..+..  .++...++.+++||.+||. +|.+||++. ++++||
T Consensus       195 ~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp  271 (345)
T 1xjd_A          195 YNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP  271 (345)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred             CCChhhhHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhCCC--CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCc
Confidence            89999999999999999999999976 456677777766533  3556688999999999996 899999998 999999


Q ss_pred             CCCCCCCCCcccCCCC
Q 010626          157 FLVTDNPKDLVCDPLR  172 (505)
Q Consensus       157 ff~~~~~~~l~~~~l~  172 (505)
                      ||+..+|..+....+.
T Consensus       272 ~f~~~~w~~l~~~~~~  287 (345)
T 1xjd_A          272 LFREINWEELERKEID  287 (345)
T ss_dssp             GGTTCCHHHHHTTCSC
T ss_pred             cccCCCHHHHhhCCCC
Confidence            9998887665544443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.96  E-value=3.7e-29  Score=254.93  Aligned_cols=155  Identities=24%  Similarity=0.502  Sum_probs=132.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccccc-cC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE-EY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~~-~y   79 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++...... .....+||+.|+|||++.+ .+
T Consensus       114 ~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  190 (328)
T 3fe3_A          114 KEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY  190 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEc-CCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCc
Confidence            367899999999999999999  99999999999998 7789999999999765433 3445689999999998843 44


Q ss_pred             -CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           80 -NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        80 -s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                       +.++|||||||++|+|++|+.||.+ .+...+...+..+...  ++...++.+.+||.+||. +|.+|||+.|+|+|||
T Consensus       191 ~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~  267 (328)
T 3fe3_A          191 DGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRGKYR--IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW  267 (328)
T ss_dssp             CSHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred             CCchhhhhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCC--CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence             4799999999999999999999986 5666777777766443  455678999999999996 8999999999999999


Q ss_pred             CCCCC
Q 010626          158 LVTDN  162 (505)
Q Consensus       158 f~~~~  162 (505)
                      |+...
T Consensus       268 ~~~~~  272 (328)
T 3fe3_A          268 INAGH  272 (328)
T ss_dssp             TTTTC
T ss_pred             hcCCC
Confidence            98644

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.96  E-value=2.6e-29  Score=249.69  Aligned_cols=154  Identities=24%  Similarity=0.473  Sum_probs=129.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEEE-   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~~~-   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......  .....||+.|+|||++.+. 
T Consensus       137 ~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  213 (298)
T 2zv2_A          137 DQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR  213 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEC-CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCC
Confidence            467889999999999999999  99999999999997 67899999999998765432  2345799999999988543 


Q ss_pred             ---CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           79 ---YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        79 ---ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                         ++.++|||||||++|+|++|+.||.. .........+.....+.......++.+++||.+||. +|.+||++.|+|+
T Consensus       214 ~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          214 KIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             CCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence               47789999999999999999999976 345555566665544433445678999999999996 8999999999999


Q ss_pred             CCCCC
Q 010626          155 DPFLV  159 (505)
Q Consensus       155 hpff~  159 (505)
                      ||||+
T Consensus       293 hp~~~  297 (298)
T 2zv2_A          293 HPWVT  297 (298)
T ss_dssp             CHHHH
T ss_pred             Ccccc
Confidence            99985

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.96  E-value=2.3e-29  Score=251.15  Aligned_cols=158  Identities=30%  Similarity=0.488  Sum_probs=124.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++...... ......||+.|+|||++ ...|
T Consensus       120 ~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  196 (308)
T 3g33_A          120 ETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTY  196 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEEC-TTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCC
Confidence            467899999999999999999  99999999999997 6789999999999766433 33456799999999988 5679


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc-CCCC-CC----------------------CCCCCChHHHHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKP-AS----------------------LSKVTDPQVKQF  135 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~-~~~p-~~----------------------~~~~~s~~l~~L  135 (505)
                      +.++|||||||++|+|++|+.||............+.. +..+ ..                      .....++.+.+|
T Consensus       197 ~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  276 (308)
T 3g33_A          197 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQL  276 (308)
T ss_dssp             CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHH
T ss_pred             CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHH
Confidence            99999999999999999999999875443333332221 1111 00                      112457889999


Q ss_pred             HHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          136 IEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       136 I~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      |.+||. +|.+|||+.|+|+||||+...
T Consensus       277 i~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          277 LLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             HHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            999996 899999999999999998643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.96  E-value=1.4e-29  Score=266.63  Aligned_cols=167  Identities=22%  Similarity=0.380  Sum_probs=136.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYEE-   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~~-   77 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+++......   ..+.+||+.|+|||++.. 
T Consensus       168 ~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~-~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~  244 (410)
T 3v8s_A          168 KWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ  244 (410)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeEC-CCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhcc
Confidence            357889999999999999999  99999999999998 77899999999998765442   346689999999998842 


Q ss_pred             c----CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC--CCCCCCCCChHHHHHHHHhcC-CCCC--CCC
Q 010626           78 E----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASL--RLP  148 (505)
Q Consensus        78 ~----ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~LI~kcL~-dP~~--RpS  148 (505)
                      .    |+.++|||||||++|+|++|+.||.. .+....+..+..+..  .......+++++++||.+||. +|.+  |++
T Consensus       245 ~~~~~~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~  323 (410)
T 3v8s_A          245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNG  323 (410)
T ss_dssp             TTTCEEETHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSC
T ss_pred             CCCcCCCCcceEecchHHHHHHHhCCCCCCC-CChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCC
Confidence            2    78999999999999999999999986 556666666665321  112234578999999999997 4677  999


Q ss_pred             HHHHhcCCCCCCCCCCCcccCCCC
Q 010626          149 ALELLKDPFLVTDNPKDLVCDPLR  172 (505)
Q Consensus       149 a~ElL~hpff~~~~~~~l~~~~l~  172 (505)
                      +.|+++||||+...|..+....+.
T Consensus       324 ~~ei~~Hp~f~~~~w~~~~~~~~~  347 (410)
T 3v8s_A          324 VEEIKRHLFFKNDQWAWETLRDTV  347 (410)
T ss_dssp             HHHHHTSGGGCCSSCCSTTGGGSC
T ss_pred             HHHHhcCccccCCCHHHHhhcccC
Confidence            999999999998877655444433

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.96  E-value=3.5e-29  Score=251.81  Aligned_cols=159  Identities=26%  Similarity=0.443  Sum_probs=126.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~--~   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......  ......||+.|+|||++.  .
T Consensus       119 ~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  195 (311)
T 3niz_A          119 SQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK  195 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEEC-CCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCC
Confidence            467889999999999999999  99999999999997 6789999999999876533  233457899999999874  4


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHH--cCCCCCC-------------------------CCCCCCh
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT--SGIKPAS-------------------------LSKVTDP  130 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~--~~~~p~~-------------------------~~~~~s~  130 (505)
                      .|+.++|||||||++|+|++|+.||.+............  ....+..                         .....++
T Consensus       196 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (311)
T 3niz_A          196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQ  275 (311)
T ss_dssp             SCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCH
T ss_pred             CCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCH
Confidence            589999999999999999999999987555444333222  1111111                         1123567


Q ss_pred             HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                      ++.+||.+||. +|.+|||+.|+|+||||+..++
T Consensus       276 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          276 EGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            89999999996 8999999999999999987543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.96  E-value=5.3e-29  Score=246.74  Aligned_cols=156  Identities=24%  Similarity=0.432  Sum_probs=126.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE-E   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~~-~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++......  ......||+.|+|||++.+ .
T Consensus       101 ~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  177 (292)
T 3o0g_A          101 EIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK  177 (292)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCC
Confidence            467899999999999999999  99999999999998 6789999999999876533  2344578999999998843 3


Q ss_pred             -CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC--CCC-------------------------CCCCCCCCh
Q 010626           79 -YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKP-------------------------ASLSKVTDP  130 (505)
Q Consensus        79 -ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~--~~p-------------------------~~~~~~~s~  130 (505)
                       ++.++|||||||++|+|++|..||....+.......+...  ..+                         .......++
T Consensus       178 ~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (292)
T 3o0g_A          178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA  257 (292)
T ss_dssp             CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCH
T ss_pred             CcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccCh
Confidence             8999999999999999999998876656665555544321  000                         011224678


Q ss_pred             HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      .+++||.+||. +|.+|||+.|+|+||||+.
T Consensus       258 ~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  288 (292)
T 3o0g_A          258 TGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHHHHHHhccChhhCCCHHHHhcCccccc
Confidence            99999999996 8999999999999999975

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.96  E-value=2.7e-29  Score=265.31  Aligned_cols=165  Identities=25%  Similarity=0.508  Sum_probs=136.8

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..++.++.||+.||+|||+ +|  |+||||||+|||++ .++.+||+|||+++....  ......+||+.|+|||++ ..
T Consensus       248 ~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~  324 (446)
T 4ejn_A          248 DRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLD-KDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN  324 (446)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEEC-SSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTS
T ss_pred             HHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEEC-CCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCC
Confidence            4678899999999999998 89  99999999999998 678999999999975432  234456899999999988 55


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALE  151 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~E  151 (505)
                      .|+.++|||||||++|+|++|+.||.. .+...+...+.....  .++...++.+++||.+||. +|.+||     ++.|
T Consensus       325 ~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~e  401 (446)
T 4ejn_A          325 DYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKE  401 (446)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH
T ss_pred             CCCCccchhhhHHHHHHHhhCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHH
Confidence            699999999999999999999999976 455566666655432  3556678999999999996 899999     9999


Q ss_pred             HhcCCCCCCCCCCCcccCCCC
Q 010626          152 LLKDPFLVTDNPKDLVCDPLR  172 (505)
Q Consensus       152 lL~hpff~~~~~~~l~~~~l~  172 (505)
                      +|+||||....+..+....+.
T Consensus       402 ll~hp~f~~~~~~~~~~~~~~  422 (446)
T 4ejn_A          402 IMQHRFFAGIVWQHVYEKKLS  422 (446)
T ss_dssp             HHTSGGGTTCCHHHHHTTCSC
T ss_pred             HHhCccccCCCHHHHhhCcCC
Confidence            999999998877665544443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.96  E-value=3e-29  Score=257.31  Aligned_cols=165  Identities=22%  Similarity=0.428  Sum_probs=135.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      +.++.++.||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+++...  .......+||+.|+|||++ ...
T Consensus       110 ~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  186 (345)
T 3a8x_A          110 EHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED  186 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCC
Confidence            467889999999999999999  99999999999998 77899999999997542  2234556899999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCC--------CChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNEC--------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA  149 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~--------~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa  149 (505)
                      |+.++|||||||++|+|++|+.||...        .....++..+....  ..++...++.+++||.+||. +|.+||++
T Consensus       187 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          187 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            899999999999999999999999642        22344555555543  23566788999999999996 89999995


Q ss_pred             ------HHHhcCCCCCCCCCCCcccCCC
Q 010626          150 ------LELLKDPFLVTDNPKDLVCDPL  171 (505)
Q Consensus       150 ------~ElL~hpff~~~~~~~l~~~~l  171 (505)
                            .++++||||+...|..+....+
T Consensus       265 ~~~~~~~~i~~hp~f~~~~w~~~~~~~~  292 (345)
T 3a8x_A          265 HPQTGFADIQGHPFFRNVDWDMMEQKQV  292 (345)
T ss_dssp             CTTTHHHHHHTSGGGTTCCHHHHHTTCS
T ss_pred             CCcCCHHHHhcCCccCCCCHHHHHhCCC
Confidence                  8999999999877765544333

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.96  E-value=2.2e-29  Score=252.93  Aligned_cols=152  Identities=27%  Similarity=0.459  Sum_probs=126.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccccccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~~~ys   80 (505)
                      ..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++....... .....||+.|+|||++.+.++
T Consensus       157 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  233 (311)
T 3p1a_A          157 AQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLG-PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYG  233 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-GGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGTCCS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEC-CCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcCCCC
Confidence            467889999999999999999  99999999999997 67899999999997765433 334569999999999988899


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  159 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~  159 (505)
                      .++|||||||++|+|++|..|+...    .....+..+..+..++...++.+.+||.+||. +|.+|||+.++|+||||+
T Consensus       234 ~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (311)
T 3p1a_A          234 TAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR  309 (311)
T ss_dssp             THHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence            9999999999999999997776542    23444555555545556678999999999996 899999999999999997


Q ss_pred             C
Q 010626          160 T  160 (505)
Q Consensus       160 ~  160 (505)
                      +
T Consensus       310 ~  310 (311)
T 3p1a_A          310 Q  310 (311)
T ss_dssp             C
T ss_pred             C
Confidence            5

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.96  E-value=3.1e-29  Score=264.22  Aligned_cols=162  Identities=21%  Similarity=0.448  Sum_probs=133.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE--   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~--   76 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+++......   ....+||+.|+|||++.  
T Consensus       162 ~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld-~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~  238 (412)
T 2vd5_A          162 EMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLD-RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV  238 (412)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeec-CCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhc
Confidence            367889999999999999999  99999999999998 77899999999998765432   23458999999999884  


Q ss_pred             ------ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC---CCCCCCCCCCChHHHHHHHHhcCCCCCC-
Q 010626           77 ------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVPASLR-  146 (505)
Q Consensus        77 ------~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~---~~p~~~~~~~s~~l~~LI~kcL~dP~~R-  146 (505)
                            ..|+.++|||||||++|||++|+.||.. .+....+..+...   ...+......++++++||.+||.+|.+| 
T Consensus       239 ~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~~p~~Rl  317 (412)
T 2vd5_A          239 GGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRL  317 (412)
T ss_dssp             HTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSSCGGGCT
T ss_pred             ccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcCChhhcC
Confidence                  3589999999999999999999999976 4556666666542   1222234567899999999999988877 


Q ss_pred             --CCHHHHhcCCCCCCCCCCCcc
Q 010626          147 --LPALELLKDPFLVTDNPKDLV  167 (505)
Q Consensus       147 --pSa~ElL~hpff~~~~~~~l~  167 (505)
                        +++.|+++||||+..+|..+.
T Consensus       318 gr~~~~ei~~Hpff~~i~w~~l~  340 (412)
T 2vd5_A          318 GRGGAGDFRTHPFFFGLDWDGLR  340 (412)
T ss_dssp             TTTTHHHHHTSGGGTTCCSTTST
T ss_pred             CCCCHHHHhcCCCcCCCCHHHHh
Confidence              599999999999998887763

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.96  E-value=3.1e-29  Score=255.26  Aligned_cols=156  Identities=24%  Similarity=0.447  Sum_probs=128.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll~-   76 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+|||++  ++.+||+|||++.......    .....||+.|+|||++. 
T Consensus       108 ~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  183 (343)
T 3dbq_A          108 WERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD  183 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSSCCC------------CCCCSSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE--CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhh
Confidence            367889999999999999999  99999999999997  5789999999997664332    23457999999999873 


Q ss_pred             -----------ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCC
Q 010626           77 -----------EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PAS  144 (505)
Q Consensus        77 -----------~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~  144 (505)
                                 ..|+.++|||||||++|+|++|+.||....+.......+........++...++.+.+||.+||. +|.
T Consensus       184 ~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~  263 (343)
T 3dbq_A          184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK  263 (343)
T ss_dssp             CC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTT
T ss_pred             ccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChh
Confidence                       45889999999999999999999999876666565666665555556777778899999999996 899


Q ss_pred             CCCCHHHHhcCCCCCCC
Q 010626          145 LRLPALELLKDPFLVTD  161 (505)
Q Consensus       145 ~RpSa~ElL~hpff~~~  161 (505)
                      +|||+.++|+||||+..
T Consensus       264 ~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          264 QRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             TSCCHHHHHTSHHHHSC
T ss_pred             HCCCHHHHHhCcccccc
Confidence            99999999999999753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.96  E-value=7e-29  Score=258.56  Aligned_cols=160  Identities=28%  Similarity=0.388  Sum_probs=129.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc--cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~--~~   78 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+|||++..++.+||+|||+++..... ......||+.|+|||++.  ..
T Consensus       141 ~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  218 (394)
T 4e7w_A          141 LLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATN  218 (394)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCC
Confidence            357889999999999999999  9999999999999866889999999999876433 344568999999999874  35


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--------------------------CCCCCCCChHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--------------------------ASLSKVTDPQV  132 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--------------------------~~~~~~~s~~l  132 (505)
                      |+.++|||||||++|+|++|+.||.+.....++...+.....|                          ..+....++++
T Consensus       219 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (394)
T 4e7w_A          219 YTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDA  298 (394)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHH
T ss_pred             CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHH
Confidence            8999999999999999999999998765554444433211000                          01223467899


Q ss_pred             HHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          133 KQFIEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       133 ~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                      .+||.+||. +|.+|||+.|+|+||||+...+
T Consensus       299 ~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          299 IDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             HHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            999999996 8999999999999999987544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.96  E-value=3.2e-29  Score=248.17  Aligned_cols=157  Identities=27%  Similarity=0.446  Sum_probs=122.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~--~   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......  ......||+.|+|||++.  .
T Consensus       100 ~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  176 (288)
T 1ob3_A          100 VTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK  176 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEeECccccccCccccccccccccccccCchheeCCC
Confidence            357889999999999999999  99999999999997 6789999999999765432  223457899999999884  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc-CCC-C------------------------CCCCCCCChH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-P------------------------ASLSKVTDPQ  131 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~-~~~-p------------------------~~~~~~~s~~  131 (505)
                      .++.++|||||||++|+|++|+.||.+............. +.. .                        ..+....++.
T Consensus       177 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (288)
T 1ob3_A          177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES  256 (288)
T ss_dssp             SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHH
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHH
Confidence            5899999999999999999999999875444433332221 000 0                        0112346789


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      +.+||.+||. +|.+|||+.|+|+||||+..
T Consensus       257 ~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          257 GIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             HHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            9999999996 89999999999999999753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.96  E-value=4e-29  Score=259.72  Aligned_cols=166  Identities=28%  Similarity=0.480  Sum_probs=139.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+++...  .......+||+.|+|||++ ...
T Consensus       139 ~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  215 (373)
T 2r5t_A          139 PRARFYAAEIASALGYLHSLN--IVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP  215 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEC-CCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCC
Confidence            357889999999999999999  99999999999998 77899999999997542  2234566899999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH----HHHh
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA----LELL  153 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa----~ElL  153 (505)
                      |+.++|||||||++|||++|..||.. .+...++..+....  ..++...++.+++||.+||. +|.+||++    .+++
T Consensus       216 ~~~~~DiwslG~il~ell~G~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~  292 (373)
T 2r5t_A          216 YDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNILNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK  292 (373)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCTTCC-SBHHHHHHHHHHSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred             CCchhhhHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHhcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence            89999999999999999999999976 45667777776653  33556778999999999996 89999986    6999


Q ss_pred             cCCCCCCCCCCCcccCCCCC
Q 010626          154 KDPFLVTDNPKDLVCDPLRL  173 (505)
Q Consensus       154 ~hpff~~~~~~~l~~~~l~~  173 (505)
                      +||||+..+|..+....+..
T Consensus       293 ~h~~f~~~~w~~l~~~~~~p  312 (373)
T 2r5t_A          293 SHVFFSLINWDDLINKKITP  312 (373)
T ss_dssp             TSGGGTTCCHHHHHTTCSCC
T ss_pred             CCccccCCCHHHHHhCCCCC
Confidence            99999998887766555443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=5.3e-29  Score=257.69  Aligned_cols=156  Identities=22%  Similarity=0.353  Sum_probs=123.5

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----------------------C
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----------------------T   59 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----------------------~   59 (505)
                      .++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++.....                       .
T Consensus       110 ~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (388)
T 3oz6_A          110 HKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI  186 (388)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEESSSCCCCCCCGGGCCC------------
T ss_pred             HHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEc-CCCCEEecCCccccccccccccccccccccccccccccccccc
Confidence            56789999999999999999  99999999999998 6789999999999765321                       1


Q ss_pred             CccccCCCcccCccccc--ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC---------------
Q 010626           60 ARSVIGTPEFMAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---------------  122 (505)
Q Consensus        60 ~~~~~Gt~~Y~APEll~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~---------------  122 (505)
                      ....+||+.|+|||++.  ..|+.++|||||||++|+|++|+.||.+.....++...+.....|.               
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~  266 (388)
T 3oz6_A          187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTM  266 (388)
T ss_dssp             ---CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHH
T ss_pred             ccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHH
Confidence            23457999999999884  4689999999999999999999999987554444333321111110               


Q ss_pred             -----------------------------CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          123 -----------------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       123 -----------------------------~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                                                   ......++++.+||.+||. +|.+|||+.|+|+||||...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          267 IESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF  335 (388)
T ss_dssp             HHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred             HHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence                                         0112557899999999996 89999999999999999763

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.96  E-value=3.3e-29  Score=260.93  Aligned_cols=155  Identities=23%  Similarity=0.459  Sum_probs=129.8

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccccc-
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE-   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll~~-   77 (505)
                      .++.++.||+.||.|||++|  |+||||||+|||++  ++.+||+|||++..+....    ....+||+.|+|||++.+ 
T Consensus       156 ~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  231 (390)
T 2zmd_A          156 ERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM  231 (390)
T ss_dssp             HHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES--SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE--CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhc
Confidence            57889999999999999999  99999999999995  4789999999997664332    235579999999998843 


Q ss_pred             -----------cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCC
Q 010626           78 -----------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASL  145 (505)
Q Consensus        78 -----------~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~  145 (505)
                                 .|+.++|||||||++|+|++|+.||....+.......+........++...++.+.+||.+||. +|.+
T Consensus       232 ~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  311 (390)
T 2zmd_A          232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ  311 (390)
T ss_dssp             ------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTT
T ss_pred             cccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhh
Confidence                       5889999999999999999999999876666556666666555555667778899999999996 8999


Q ss_pred             CCCHHHHhcCCCCCCC
Q 010626          146 RLPALELLKDPFLVTD  161 (505)
Q Consensus       146 RpSa~ElL~hpff~~~  161 (505)
                      ||++.|+|+||||+..
T Consensus       312 Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          312 RISIPELLAHPYVQIQ  327 (390)
T ss_dssp             SCCHHHHHTSHHHHSC
T ss_pred             CCCHHHHhhCcCcccc
Confidence            9999999999999753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.96  E-value=8.5e-29  Score=250.81  Aligned_cols=159  Identities=27%  Similarity=0.441  Sum_probs=131.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCcccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll~~   77 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||++..+...    ......||+.|+|||++.+
T Consensus       105 ~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  181 (323)
T 3tki_A          105 PDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  181 (323)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEe-CCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhcc
Confidence            468899999999999999999  99999999999998 6789999999999765322    2335679999999998843


Q ss_pred             -c-CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 -E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 -~-ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                       . ++.++|||||||++|+|++|+.||.........+................++.+.+||.+||. +|.+|||+.|+++
T Consensus       182 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence             3 477899999999999999999999876655455555554444333445678999999999996 8999999999999


Q ss_pred             CCCCCCCCC
Q 010626          155 DPFLVTDNP  163 (505)
Q Consensus       155 hpff~~~~~  163 (505)
                      ||||+....
T Consensus       262 h~~~~~~~~  270 (323)
T 3tki_A          262 DRWYNKPLK  270 (323)
T ss_dssp             CTTTTCCCC
T ss_pred             Chhhccccc
Confidence            999986543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.96  E-value=4.8e-29  Score=260.43  Aligned_cols=166  Identities=23%  Similarity=0.440  Sum_probs=138.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc----
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE----   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~----   76 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||++...... .....+||+.|+|||++.    
T Consensus       115 ~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~-~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~  191 (384)
T 4fr4_A          115 ETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG  191 (384)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEC-CCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCC
Confidence            467899999999999999999  99999999999998 7789999999999876443 345678999999999884    


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCC--CChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-HHHH
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-ALEL  152 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~--~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-a~El  152 (505)
                      ..|+.++|||||||++|+|++|+.||...  .....++..+....  ..++..+++.+.+||.+||. +|.+||+ +.++
T Consensus       192 ~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l  269 (384)
T 4fr4_A          192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV--VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDV  269 (384)
T ss_dssp             CCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHH
T ss_pred             CCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc--cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHH
Confidence            34899999999999999999999999743  33445555555443  23556678999999999996 8999998 8999


Q ss_pred             hcCCCCCCCCCCCcccCCCC
Q 010626          153 LKDPFLVTDNPKDLVCDPLR  172 (505)
Q Consensus       153 L~hpff~~~~~~~l~~~~l~  172 (505)
                      ++||||...+|..+....+.
T Consensus       270 ~~hp~f~~~~w~~~~~~~~~  289 (384)
T 4fr4_A          270 QNFPYMNDINWDAVFQKRLI  289 (384)
T ss_dssp             HTSGGGTTCCHHHHHTTCSC
T ss_pred             HcChhhhcCCHHHHHhCCCC
Confidence            99999999888776555443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.96  E-value=7.8e-29  Score=276.28  Aligned_cols=167  Identities=24%  Similarity=0.449  Sum_probs=142.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc--CCCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ--QPTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~--~~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+++...  .......+||+.|+|||++ ...
T Consensus       442 ~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~-~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~  518 (674)
T 3pfq_A          442 PHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP  518 (674)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEEC-SSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEc-CCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCC
Confidence            467889999999999999999  99999999999998 77899999999998643  2334567899999999988 467


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCH-----HHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPA-----LEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa-----~El  152 (505)
                      |+.++|||||||++|||++|+.||.+ .+...++..+.....  .++...++++++||.+||. +|.+||++     .++
T Consensus       519 ~~~~~DvwSlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei  595 (674)
T 3pfq_A          519 YGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDI  595 (674)
T ss_dssp             BSTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHH
T ss_pred             CCccceEechHHHHHHHHcCCCCCCC-CCHHHHHHHHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHH
Confidence            99999999999999999999999987 566777777776533  4566789999999999996 89999997     999


Q ss_pred             hcCCCCCCCCCCCcccCCCCCC
Q 010626          153 LKDPFLVTDNPKDLVCDPLRLP  174 (505)
Q Consensus       153 L~hpff~~~~~~~l~~~~l~~p  174 (505)
                      ++||||+..+|..+....+..|
T Consensus       596 ~~h~ff~~i~w~~l~~~~~~pp  617 (674)
T 3pfq_A          596 KEHAFFRYIDWEKLERKEIQPP  617 (674)
T ss_dssp             HSSGGGSSCCHHHHTTTCSCCS
T ss_pred             hcCccccCCCHHHHHhCCCCCC
Confidence            9999999988877665554433

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.96  E-value=6.9e-29  Score=251.60  Aligned_cols=163  Identities=29%  Similarity=0.416  Sum_probs=131.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++......  ......||+.|+|||++ ...
T Consensus       121 ~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  197 (327)
T 3a62_A          121 DTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG  197 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEEC-TTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEEC-CCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCC
Confidence            357889999999999999999  99999999999998 6789999999999754322  23456799999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~El  152 (505)
                      ++.++|||||||++|+|++|+.||.. .+.......+.....  .++...++.+++||.+||. +|.+||     ++.++
T Consensus       198 ~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~  274 (327)
T 3a62_A          198 HNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKILKCKL--NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEV  274 (327)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHH
T ss_pred             CCCcccchhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHH
Confidence            89999999999999999999999986 445555566655432  3455678999999999996 899999     89999


Q ss_pred             hcCCCCCCCCCCCcccCC
Q 010626          153 LKDPFLVTDNPKDLVCDP  170 (505)
Q Consensus       153 L~hpff~~~~~~~l~~~~  170 (505)
                      ++||||+...+..+....
T Consensus       275 l~hp~f~~~~~~~~~~~~  292 (327)
T 3a62_A          275 QAHPFFRHINWEELLARK  292 (327)
T ss_dssp             HHSGGGSSCCHHHHHTTC
T ss_pred             HcCCcccCCCHHHHhhcc
Confidence            999999987766554433

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.96  E-value=2.7e-29  Score=254.14  Aligned_cols=153  Identities=29%  Similarity=0.421  Sum_probs=113.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhC------CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCCcc
Q 010626            2 KAIKNWARQILRGLHYLHSH------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEF   69 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~------g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~~Y   69 (505)
                      +.+.+++.|++.||+|||++      .++|+||||||+|||++ .++.+||+|||+|+......      ....+||+.|
T Consensus       100 ~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~-~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~y  178 (303)
T 3hmm_A          100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY  178 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC-TTSCEEECCCTTCEEEETTTTEESCC-----CCGGG
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC-CCCCEEEEeCCCCccccCCCCceeeecccccccccc
Confidence            35678999999999999987      12399999999999998 77999999999998764432      2245799999


Q ss_pred             cCcccccc-------cCCcccchhhHHHHHHHHhhcCCCCCCC--------------CChHHHHHHHHcCCCCCCCCCC-
Q 010626           70 MAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNEC--------------KNPAQIYKKVTSGIKPASLSKV-  127 (505)
Q Consensus        70 ~APEll~~-------~ys~ksDIWSLGviLyEmlTG~~Pf~~~--------------~~~~~i~~~i~~~~~p~~~~~~-  127 (505)
                      ||||++.+       .|+.++|||||||++|||+||..||...              .....+...+......+.++.. 
T Consensus       179 mAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~  258 (303)
T 3hmm_A          179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW  258 (303)
T ss_dssp             CCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG
T ss_pred             cCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccc
Confidence            99998843       3678999999999999999997665321              1223444444444333333332 


Q ss_pred             ----CChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626          128 ----TDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus       128 ----~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                          ....+.+|+.+||. +|.+|||+.|+++.
T Consensus       259 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          259 QSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                12468899999995 89999999999864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.96  E-value=3.9e-29  Score=265.41  Aligned_cols=162  Identities=21%  Similarity=0.450  Sum_probs=133.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE--   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~--   76 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+++......   ....+||+.|+|||++.  
T Consensus       175 ~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~  251 (437)
T 4aw2_A          175 EMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM  251 (437)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEc-CCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhc
Confidence            467889999999999999999  99999999999998 77899999999997664432   23458999999999874  


Q ss_pred             ----ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC---CCCCCCCCCChHHHHHHHHhcC-CCCC--C
Q 010626           77 ----EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIV-PASL--R  146 (505)
Q Consensus        77 ----~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~---~p~~~~~~~s~~l~~LI~kcL~-dP~~--R  146 (505)
                          +.|+.++|||||||++|||++|+.||.+ .+....+..+....   ..+......++++++||.+||. +|.+  |
T Consensus       252 ~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r  330 (437)
T 4aw2_A          252 EGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQ  330 (437)
T ss_dssp             HTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTT
T ss_pred             ccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC-CChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCC
Confidence                3589999999999999999999999986 45666666665321   1122224478999999999996 4555  8


Q ss_pred             CCHHHHhcCCCCCCCCCCCcc
Q 010626          147 LPALELLKDPFLVTDNPKDLV  167 (505)
Q Consensus       147 pSa~ElL~hpff~~~~~~~l~  167 (505)
                      +++.|+++||||+..+|..+.
T Consensus       331 ~~~~eil~Hpff~~i~w~~l~  351 (437)
T 4aw2_A          331 NGIEDFKKHPFFSGIDWDNIR  351 (437)
T ss_dssp             TTTHHHHTSGGGTTCCTTTGG
T ss_pred             CCHHHHhCCCccCCCCHHHHh
Confidence            999999999999998888763

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.96  E-value=6.7e-29  Score=261.05  Aligned_cols=157  Identities=23%  Similarity=0.336  Sum_probs=127.2

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc--ccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~--~~y   79 (505)
                      .++.++.||+.||.|||++|  |+||||||+|||++.+.+.+||+|||+++..... .....+||+.|+|||++.  ..|
T Consensus       157 ~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  234 (420)
T 1j1b_A          157 YVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY  234 (420)
T ss_dssp             HHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCC
Confidence            57889999999999999999  9999999999999865677999999999876433 334568999999999874  368


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC--------------CCCC------------CCCCCChHHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--------------KPAS------------LSKVTDPQVK  133 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~--------------~p~~------------~~~~~s~~l~  133 (505)
                      +.++|||||||++|||++|+.||.+.....++...+....              ....            +....++++.
T Consensus       235 ~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  314 (420)
T 1j1b_A          235 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI  314 (420)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHH
T ss_pred             CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHH
Confidence            9999999999999999999999987655555444333100              0001            2234578999


Q ss_pred             HHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          134 QFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       134 ~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      +||.+||. +|.+||++.|+|+||||...
T Consensus       315 ~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          315 ALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             HHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence            99999996 89999999999999999754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.96  E-value=8.6e-29  Score=245.04  Aligned_cols=156  Identities=24%  Similarity=0.428  Sum_probs=124.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccCC-CCccccCCCcccCccccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++.  .++.+||+|||++...... ......||+.|+|||++.+.
T Consensus       124 ~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~  201 (285)
T 3is5_A          124 GYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD  201 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhccC
Confidence            357899999999999999999  999999999999952  3578999999999765433 23455799999999999888


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      ++.++||||||+++|+|++|+.||.+. ........+...... .......++.+.+||.+||. +|.+|||+.|+|+||
T Consensus       202 ~~~~~Di~slG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  280 (285)
T 3is5_A          202 VTFKCDIWSAGVVMYFLLTGCLPFTGT-SLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE  280 (285)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSG
T ss_pred             CCcccCeehHHHHHHHHHhCCCCCCCC-CHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence            999999999999999999999999874 444454444443322 22223468899999999996 899999999999999


Q ss_pred             CCCC
Q 010626          157 FLVT  160 (505)
Q Consensus       157 ff~~  160 (505)
                      ||++
T Consensus       281 ~f~~  284 (285)
T 3is5_A          281 WFKQ  284 (285)
T ss_dssp             GGGC
T ss_pred             Hhhc
Confidence            9975

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.96  E-value=1.6e-28  Score=253.85  Aligned_cols=159  Identities=28%  Similarity=0.469  Sum_probs=132.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC---cEEEeecCceeeccCC-CCccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---EVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g---~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~-   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++...+   .+||+|||++...... ......||+.|+|||++. 
T Consensus       115 ~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~  192 (361)
T 2yab_A          115 EEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY  192 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC
Confidence            467899999999999999999  999999999999973332   7999999999876543 334567999999999884 


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC--CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ..|+.++|||||||++|+|++|..||.+ .+.......+..+....  ......++.+++||.+||. +|.+|||+.|+|
T Consensus       193 ~~~~~~~DiwslGvil~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l  271 (361)
T 2yab_A          193 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL  271 (361)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHSCCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            4699999999999999999999999987 45566666666653321  2234568899999999996 899999999999


Q ss_pred             cCCCCCCCCC
Q 010626          154 KDPFLVTDNP  163 (505)
Q Consensus       154 ~hpff~~~~~  163 (505)
                      +||||+...+
T Consensus       272 ~hp~~~~~~~  281 (361)
T 2yab_A          272 RHPWITPVDT  281 (361)
T ss_dssp             TSTTTSCSSH
T ss_pred             cCcCcCCCch
Confidence            9999986443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.96  E-value=1.5e-28  Score=248.52  Aligned_cols=156  Identities=35%  Similarity=0.653  Sum_probs=130.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......  ......||+.|+|||++ ...
T Consensus       141 ~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  217 (321)
T 2c30_A          141 EQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL  217 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEC-CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCC
Confidence            467889999999999999999  99999999999997 6789999999999776543  23456799999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC-CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~-~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      ++.++||||||+++|+|++|+.||.. .........+.....+. ......++.+++||.+||. +|.+|||+.++|+||
T Consensus       218 ~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          218 YATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            89999999999999999999999976 44555556665554332 2334568899999999996 899999999999999


Q ss_pred             CCCCC
Q 010626          157 FLVTD  161 (505)
Q Consensus       157 ff~~~  161 (505)
                      ||...
T Consensus       297 ~~~~~  301 (321)
T 2c30_A          297 FLLQT  301 (321)
T ss_dssp             GGGGC
T ss_pred             hhccC
Confidence            99764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.96  E-value=3.4e-29  Score=246.42  Aligned_cols=156  Identities=28%  Similarity=0.494  Sum_probs=123.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc----
Q 010626            2 KAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY----   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~-g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll----   75 (505)
                      ..++.++.||+.||.|||++ |  ++||||||+||+++ .++.+||+|||++....... .....||+.|+|||++    
T Consensus       109 ~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  185 (290)
T 3fme_A          109 DILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL  185 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEEC-TTCCEEBCCC---------------CCCCCCSCHHHHSCCT
T ss_pred             HHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEEC-CCCCEEEeecCCcccccccccccccCCCccccChhhcChhh
Confidence            35788999999999999998 9  99999999999998 67899999999997664433 2334799999999985    


Q ss_pred             -cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 -EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 -~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                       ...++.++||||||+++|+|+||+.||..................+.......++.+.+||.+||. +|.+|||+.+++
T Consensus       186 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l  265 (290)
T 3fme_A          186 NQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELM  265 (290)
T ss_dssp             TC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             cCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHH
Confidence             345889999999999999999999999876666666655555555555556678999999999996 899999999999


Q ss_pred             cCCCCCC
Q 010626          154 KDPFLVT  160 (505)
Q Consensus       154 ~hpff~~  160 (505)
                      +||||+.
T Consensus       266 ~hp~f~~  272 (290)
T 3fme_A          266 QHPFFTL  272 (290)
T ss_dssp             TSHHHHH
T ss_pred             hCccccc
Confidence            9999975

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.96  E-value=1.4e-28  Score=247.82  Aligned_cols=157  Identities=28%  Similarity=0.479  Sum_probs=125.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~~--   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......  ......||+.|+|||++.+  
T Consensus       108 ~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  184 (317)
T 2pmi_A          108 NLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSR  184 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEc-CCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCC
Confidence            457889999999999999999  99999999999998 6789999999999876433  2344578999999998843  


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc--CCCCC------------------------------CCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPA------------------------------SLS  125 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~--~~~p~------------------------------~~~  125 (505)
                      .|+.++|||||||++|+|++|+.||.+..... ....+..  +.++.                              ...
T Consensus       185 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (317)
T 2pmi_A          185 TYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTK  263 (317)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCS
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhccccc
Confidence            58999999999999999999999998754333 3333321  11000                              011


Q ss_pred             CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          126 KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       126 ~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      ...++.+.+||.+||. +|.+|||+.|+|+||||+...
T Consensus       264 ~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          264 EPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             SCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence            2467899999999996 899999999999999998643

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.95  E-value=1.2e-28  Score=259.97  Aligned_cols=157  Identities=25%  Similarity=0.412  Sum_probs=123.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc--EEEeecCceeeccCCCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--VKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~--vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+|||++ .++.  +||+|||++...... ....+||+.|+|||++ ...
T Consensus       200 ~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~-~~~~~~vkL~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~  275 (429)
T 3kvw_A          200 PLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLK-QQGRSGIKVIDFGSSCYEHQR-VYTYIQSRFYRAPEVILGAR  275 (429)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEES-STTSCCEEECCCTTCEETTCC-CCSSCSCGGGCCHHHHHTBC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-cCCCcceEEeecccceecCCc-ccccCCCCCccChHHHhCCC
Confidence            467899999999999999999  99999999999997 5565  999999999765433 4456899999999987 556


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC------------------------------------
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA------------------------------------  122 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~------------------------------------  122 (505)
                      |+.++|||||||++|+|+||..||.+......+...+.....|.                                    
T Consensus       276 ~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (429)
T 3kvw_A          276 YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLN  355 (429)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEEC
T ss_pred             CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCccccccccccccccccc
Confidence            99999999999999999999999987554444333222100000                                    


Q ss_pred             --------------------CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          123 --------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       123 --------------------~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                                          .+....++.+.+||.+||. +|.+|||+.|+|+||||+...
T Consensus       356 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          356 GGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             CEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred             ccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence                                0112347889999999996 899999999999999998643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.95  E-value=1.8e-28  Score=247.96  Aligned_cols=162  Identities=25%  Similarity=0.439  Sum_probs=129.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccCCC-CccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~-~   77 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++.  .++.+||+|||++....... .....||+.|+|||++. .
T Consensus       131 ~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  208 (327)
T 3lm5_A          131 NDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD  208 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCC
Confidence            468899999999999999999  999999999999973  26799999999998765432 34457999999999884 5


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC--CCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI--KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~--~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++||||||+++|+|++|+.||.... ....+..+....  .+......+++.+++||.+||. +|.+|||+.++|+
T Consensus       209 ~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          209 PITTATDMWNIGIIAYMLLTHTSPFVGED-NQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            68999999999999999999999998744 444444444332  2333445678999999999996 8999999999999


Q ss_pred             CCCCCCCCCCCc
Q 010626          155 DPFLVTDNPKDL  166 (505)
Q Consensus       155 hpff~~~~~~~l  166 (505)
                      ||||+...+..+
T Consensus       288 h~~~~~~~~~~~  299 (327)
T 3lm5_A          288 HSWLQQWDFENL  299 (327)
T ss_dssp             CGGGCCCCTTCC
T ss_pred             CHhhcccccccc
Confidence            999998776554

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.95  E-value=2e-28  Score=241.46  Aligned_cols=160  Identities=34%  Similarity=0.550  Sum_probs=128.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~~--   77 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++..++.+||+|||++......  ......|++.|+|||++.+  
T Consensus       122 ~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  199 (295)
T 2clq_A          122 QTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP  199 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCC
Confidence            357789999999999999999  9999999999999855789999999999776432  2344578999999998843  


Q ss_pred             -cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 -EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 -~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                       .++.++||||||+++|+|++|+.||.....................++..+++.+.+||.+||. +|.+||++.++|+|
T Consensus       200 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             GGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             3889999999999999999999999765444433333222223344667788999999999996 89999999999999


Q ss_pred             CCCCCCCC
Q 010626          156 PFLVTDNP  163 (505)
Q Consensus       156 pff~~~~~  163 (505)
                      |||+....
T Consensus       280 ~~~~~~~~  287 (295)
T 2clq_A          280 EFLKVSSK  287 (295)
T ss_dssp             GGGCC---
T ss_pred             hhhhhccc
Confidence            99986543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.95  E-value=6.3e-29  Score=265.16  Aligned_cols=156  Identities=29%  Similarity=0.391  Sum_probs=118.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..++.+++||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++..... .....+||+.|+|||++ ...|
T Consensus       164 ~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  240 (464)
T 3ttj_A          164 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY  240 (464)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEe-CCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCC
Confidence            467889999999999999999  99999999999998 6789999999999876543 23456899999999987 5579


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--------------------C----C----CCCC----
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--------------------A----S----LSKV----  127 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--------------------~----~----~~~~----  127 (505)
                      +.++|||||||++|+|++|+.||.+.....++...+.....|                    .    .    ++..    
T Consensus       241 ~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (464)
T 3ttj_A          241 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA  320 (464)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCC
T ss_pred             CHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCccccccc
Confidence            999999999999999999999998754444433322211100                    0    0    0000    


Q ss_pred             -------CChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          128 -------TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       128 -------~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                             .++++++||.+||. +|.+|||+.|+|+||||..
T Consensus       321 ~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          321 DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             ccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence                   14578999999996 8999999999999999974

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.95  E-value=1.3e-28  Score=241.93  Aligned_cols=155  Identities=23%  Similarity=0.485  Sum_probs=127.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~ys   80 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++............|++.|+|||++. ..++
T Consensus       109 ~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  185 (279)
T 3fdn_A          109 QRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHD  185 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEEC-TTSCEEECSCCEESCC--------CCCCTTCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEc-CCCCEEEEeccccccCCcccccccCCCCCccCHhHhccCCCC
Confidence            467889999999999999999  99999999999997 7789999999998766555555668999999999884 4578


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  159 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~  159 (505)
                      .++||||||+++|+|++|..||.. .........+.....  .++...++.+++||.+||. +|.+|||+.|+|+||||+
T Consensus       186 ~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~  262 (279)
T 3fdn_A          186 EKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  262 (279)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred             ccchhHhHHHHHHHHHHCCCCCCC-CcHHHHHHHHHhCCC--CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence            999999999999999999999986 455555566555432  3456678999999999996 899999999999999997


Q ss_pred             CCC
Q 010626          160 TDN  162 (505)
Q Consensus       160 ~~~  162 (505)
                      ...
T Consensus       263 ~~~  265 (279)
T 3fdn_A          263 ANS  265 (279)
T ss_dssp             HHC
T ss_pred             CCc
Confidence            643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.95  E-value=1.5e-28  Score=250.64  Aligned_cols=154  Identities=27%  Similarity=0.420  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC------------------------CCCcEEEeecCceeeccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------------------------NNGEVKIGDLGLAIVMQQ   57 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~------------------------~~g~vKL~DFGlA~~~~~   57 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++.                        .++.+||+|||++.....
T Consensus       137 ~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~  214 (360)
T 3llt_A          137 EDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD  214 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence            468899999999999999999  999999999999962                        367899999999986544


Q ss_pred             CCCccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC-------------
Q 010626           58 PTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-------------  123 (505)
Q Consensus        58 ~~~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~-------------  123 (505)
                      . .....||+.|+|||++ ...|+.++|||||||++|+|++|+.||.... .......+.....+..             
T Consensus       215 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  292 (360)
T 3llt_A          215 Y-HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE-HMEHLAMMESIIQPIPKNMLYEATKTNGS  292 (360)
T ss_dssp             C-CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHTCCCCHHHHHHHTTSGGG
T ss_pred             C-CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc-HHHHHHHHHHhcCCCCHHHHhhhhhccCc
Confidence            3 3456799999999987 5569999999999999999999999998643 3333333322111100             


Q ss_pred             -----------CC--------------------CCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 010626          124 -----------LS--------------------KVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  159 (505)
Q Consensus       124 -----------~~--------------------~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~  159 (505)
                                 ++                    ...++.+.+||.+||. +|.+|||+.|+|+||||+
T Consensus       293 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          293 KYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             GGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             cccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence                       00                    1123678899999996 899999999999999995

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=2e-28  Score=253.27  Aligned_cols=157  Identities=24%  Similarity=0.385  Sum_probs=128.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc--cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~--~~   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++..++.+||+|||++...... ......||+.|+|||++.  ..
T Consensus       141 ~~~~~i~~qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  218 (383)
T 3eb0_A          141 NLISIYIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATE  218 (383)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSS
T ss_pred             HHHHHHHHHHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCC
Confidence            467889999999999999999  9999999999999866789999999999876433 344567899999999874  34


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--------------------------CCCCCCCChHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--------------------------ASLSKVTDPQV  132 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--------------------------~~~~~~~s~~l  132 (505)
                      |+.++|||||||++|+|++|+.||.+.....++...+.....|                          ..++...++.+
T Consensus       219 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (383)
T 3eb0_A          219 YTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA  298 (383)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHH
T ss_pred             CCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHH
Confidence            8999999999999999999999998765555544443311111                          01334567889


Q ss_pred             HHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          133 KQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       133 ~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      .+||.+||. +|.+|||+.|+|+||||+.
T Consensus       299 ~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          299 IDLLEQILRYEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence            999999996 8999999999999999975

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=3.3e-28  Score=251.21  Aligned_cols=157  Identities=32%  Similarity=0.461  Sum_probs=127.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc--ccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~--~~y   79 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||+++..... ....+||+.|+|||++.  ..|
T Consensus       128 ~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~  203 (367)
T 1cm8_A          128 DRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQADSE-MTGYVVTRWYRAPEVILNWMRY  203 (367)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCSS-CCSSCSCGGGCCTHHHHTTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEc-CCCCEEEEeeecccccccc-cCcCcCCCCcCCHHHHhCCCCC
Confidence            367889999999999999999  99999999999998 6789999999999876443 34567999999999874  469


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc-CCC------------------------C---CCCCCCCChH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK------------------------P---ASLSKVTDPQ  131 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~-~~~------------------------p---~~~~~~~s~~  131 (505)
                      +.++|||||||++|+|++|+.||.+.....++...+.. +.+                        .   .......++.
T Consensus       204 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (367)
T 1cm8_A          204 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL  283 (367)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHH
T ss_pred             ChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence            99999999999999999999999875444433322221 110                        0   1122345889


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      +.+||.+||. +|.+|||+.++|+||||+...
T Consensus       284 ~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          284 AVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            9999999996 899999999999999998643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.95  E-value=3.2e-28  Score=246.61  Aligned_cols=157  Identities=27%  Similarity=0.446  Sum_probs=128.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC----cEEEeecCceeeccCC-CCccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g----~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++    .+||+|||++...... ......||+.|+|||++.
T Consensus       114 ~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~-~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  190 (326)
T 2y0a_A          114 EEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLL-DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN  190 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEES-CSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEe-cCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeec
Confidence            467899999999999999999  99999999999997 444    7999999999876533 334567999999999884


Q ss_pred             -ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           77 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                       ..++.++|||||||++|+|++|..||.+. ........+......  .......++.+++||.+||. +|.+|||+.++
T Consensus       191 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  269 (326)
T 2y0a_A          191 YEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS  269 (326)
T ss_dssp             TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence             56899999999999999999999999764 444455555443222  11224568899999999996 89999999999


Q ss_pred             hcCCCCCCCC
Q 010626          153 LKDPFLVTDN  162 (505)
Q Consensus       153 L~hpff~~~~  162 (505)
                      |+||||+...
T Consensus       270 l~hp~~~~~~  279 (326)
T 2y0a_A          270 LQHPWIKPKD  279 (326)
T ss_dssp             HHSTTTSCCS
T ss_pred             hcCCCccCCc
Confidence            9999997643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.95  E-value=1.4e-28  Score=248.98  Aligned_cols=160  Identities=24%  Similarity=0.362  Sum_probs=121.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC----CCCcEEEeecCceeeccCC--CCccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~----~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll   75 (505)
                      +.++.++.||+.||.|||++|  |+||||||+|||++.    ..+.+||+|||++......  ......||+.|+|||++
T Consensus       132 ~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~  209 (329)
T 3gbz_A          132 RVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEIL  209 (329)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHh
Confidence            467899999999999999999  999999999999952    3456999999999766432  23345789999999988


Q ss_pred             cc--cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC--CC-------------------------CC
Q 010626           76 EE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SL-------------------------SK  126 (505)
Q Consensus        76 ~~--~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~~-------------------------~~  126 (505)
                      .+  .|+.++|||||||++|+|++|+.||........+...+.....+.  .+                         ..
T Consensus       210 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (329)
T 3gbz_A          210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGA  289 (329)
T ss_dssp             TTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGG
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhccc
Confidence            43  489999999999999999999999987555444444333211110  00                         11


Q ss_pred             CCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          127 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       127 ~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                      ..++++.+||.+||. +|.+|||+.|+|+||||+...+
T Consensus       290 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          290 LLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence            157889999999996 8999999999999999987654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.95  E-value=2.7e-28  Score=246.38  Aligned_cols=158  Identities=25%  Similarity=0.425  Sum_probs=121.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~--~   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......  ......||+.|+|||++.  .
T Consensus       100 ~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  176 (324)
T 3mtl_A          100 HNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGST  176 (324)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEEC-TTCCEEECSSSEEECC------------CGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEEC-CCCCEEEccCcccccccCCccccccccCcccccChhhhcCCC
Confidence            467889999999999999999  99999999999998 6789999999999765432  233457899999999874  4


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc---CCCCCCC-------------------------CCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKPASL-------------------------SKVTD  129 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~---~~~p~~~-------------------------~~~~s  129 (505)
                      .|+.++|||||||++|+|++|+.||.+...... ...+..   ...+..+                         ....+
T Consensus       177 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (324)
T 3mtl_A          177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLD  255 (324)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSC
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCC
Confidence            589999999999999999999999987543333 333222   1111111                         12357


Q ss_pred             hHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          130 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       130 ~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                      +.+.+||.+||. +|.+|||+.|+|+||||.....
T Consensus       256 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  290 (324)
T 3mtl_A          256 SDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE  290 (324)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred             HHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence            889999999996 8999999999999999987543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.95  E-value=4.5e-28  Score=236.76  Aligned_cols=158  Identities=27%  Similarity=0.446  Sum_probs=129.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCcccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll~~   77 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++......    ......|++.|+|||++.+
T Consensus       105 ~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  181 (276)
T 2yex_A          105 PDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  181 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEc-cCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhc
Confidence            467899999999999999999  99999999999997 6789999999999765322    2344578999999998843


Q ss_pred             -c-CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 -E-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 -~-ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                       . ++.++||||||+++|+|++|+.||.........+..+.............++.+.+||.+||. +|.+|||+.++++
T Consensus       182 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence             3 467899999999999999999999876554444555544433333345678999999999996 8999999999999


Q ss_pred             CCCCCCCC
Q 010626          155 DPFLVTDN  162 (505)
Q Consensus       155 hpff~~~~  162 (505)
                      ||||+...
T Consensus       262 ~~~~~~~~  269 (276)
T 2yex_A          262 DRWYNKPL  269 (276)
T ss_dssp             CTTTTCCC
T ss_pred             CccccChh
Confidence            99998643

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.95  E-value=3.1e-28  Score=247.77  Aligned_cols=157  Identities=27%  Similarity=0.453  Sum_probs=124.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC------CCccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~------~~~~~~Gt~~Y~APEll   75 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......      ......||+.|+|||++
T Consensus       124 ~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  200 (351)
T 3mi9_A          124 SEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL  200 (351)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEc-CCCCEEEccchhcccccccccccccccCCcccccCccCchhh
Confidence            468899999999999999999  99999999999997 6789999999999766422      22345789999999987


Q ss_pred             c--ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHH---cCCCCCCCCCC-----------------------
Q 010626           76 E--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT---SGIKPASLSKV-----------------------  127 (505)
Q Consensus        76 ~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~---~~~~p~~~~~~-----------------------  127 (505)
                      .  ..|+.++|||||||++|+|+||..||.+...... ...+.   ....+..++..                       
T Consensus       201 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (351)
T 3mi9_A          201 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ-LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL  279 (351)
T ss_dssp             TTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHH
T ss_pred             cCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHh
Confidence            4  3589999999999999999999999987443333 33222   22222211111                       


Q ss_pred             ----CChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          128 ----TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       128 ----~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                          .++.+.+||.+||. +|.+|||+.|+|+||||....
T Consensus       280 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          280 KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             HHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             hhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence                26779999999996 899999999999999997643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.95  E-value=3.2e-28  Score=244.60  Aligned_cols=159  Identities=23%  Similarity=0.388  Sum_probs=125.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc--cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~--~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++...+.+||+|||++...... ......|++.|+|||++.  ..
T Consensus       130 ~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  207 (330)
T 3nsz_A          130 YDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM  207 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCc
Confidence            367889999999999999999  9999999999999855458999999999876543 334557899999999874  45


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHH-------------cCCC----------------------CCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-------------SGIK----------------------PAS  123 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~-------------~~~~----------------------p~~  123 (505)
                      ++.++|||||||++|+|++|..||............+.             ....                      +..
T Consensus       208 ~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (330)
T 3nsz_A          208 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSE  287 (330)
T ss_dssp             CCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTT
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhcccc
Confidence            89999999999999999999999965444332222111             1100                      011


Q ss_pred             CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          124 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       124 ~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      .....++.+++||.+||. +|.+|||+.|+|+||||+...
T Consensus       288 ~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          288 NQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             TGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             ccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence            122368899999999996 899999999999999998654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.95  E-value=2.1e-28  Score=251.12  Aligned_cols=155  Identities=34%  Similarity=0.561  Sum_probs=130.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc----cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY----EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll----~~   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.....  .....||+.|+|||++    .+
T Consensus       154 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~--~~~~~gt~~y~aPE~~~~~~~~  228 (348)
T 1u5q_A          154 VEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEG  228 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS--BCCCCSCGGGCCHHHHHTTSSC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEC-CCCCEEEeeccCceecCC--CCcccCCcceeCHhhhccccCC
Confidence            357889999999999999999  99999999999998 778999999999976543  3456799999999987    35


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      .++.++|||||||++|+|++|+.||........ ...+..+..+......+++.+++||.+||. +|.+|||+.++|+||
T Consensus       229 ~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          229 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            689999999999999999999999987544444 344455545555566778999999999996 799999999999999


Q ss_pred             CCCCCC
Q 010626          157 FLVTDN  162 (505)
Q Consensus       157 ff~~~~  162 (505)
                      ||....
T Consensus       308 ~~~~~~  313 (348)
T 1u5q_A          308 FVLRER  313 (348)
T ss_dssp             HHHSCC
T ss_pred             hhhccC
Confidence            997643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.95  E-value=4.4e-28  Score=257.65  Aligned_cols=156  Identities=25%  Similarity=0.495  Sum_probs=131.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccCCC--CccccCCCcccCcccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~~   77 (505)
                      ..++.+++||+.||.|||++|  |+||||||+|||++.  .++.+||+|||++.......  .....||+.|+|||++.+
T Consensus       110 ~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~  187 (444)
T 3soa_A          110 ADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK  187 (444)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcC
Confidence            467889999999999999999  999999999999974  35789999999997665432  345689999999998854


Q ss_pred             -cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           78 -EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        78 -~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                       .|+.++|||||||++|+|++|..||.+ .+...++..+..+...  .......++.+++||.+||. +|.+|||+.|+|
T Consensus       188 ~~~~~~~DIwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L  266 (444)
T 3soa_A          188 DPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEAL  266 (444)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence             699999999999999999999999976 4566667777666432  22334678999999999996 899999999999


Q ss_pred             cCCCCCC
Q 010626          154 KDPFLVT  160 (505)
Q Consensus       154 ~hpff~~  160 (505)
                      +||||+.
T Consensus       267 ~hp~~~~  273 (444)
T 3soa_A          267 KHPWISH  273 (444)
T ss_dssp             HSCTTHH
T ss_pred             cCccccC
Confidence            9999964

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.95  E-value=3e-28  Score=257.70  Aligned_cols=161  Identities=28%  Similarity=0.427  Sum_probs=118.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----------------------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----------------------   58 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----------------------   58 (505)
                      ..++.|++||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++.....                       
T Consensus       156 ~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (458)
T 3rp9_A          156 LHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPH  232 (458)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTCCEEECCCTTCBCTTSCTTCCCCCC---------------
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEEC-CCCCEeecccccchhccCccccccccccCccccccccccccc
Confidence            468899999999999999999  99999999999998 7789999999999765421                       


Q ss_pred             ------CCccccCCCcccCcccc--cccCCcccchhhHHHHHHHHhh-----------cCCCCCCCCC------------
Q 010626           59 ------TARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVT-----------CEYPYNECKN------------  107 (505)
Q Consensus        59 ------~~~~~~Gt~~Y~APEll--~~~ys~ksDIWSLGviLyEmlT-----------G~~Pf~~~~~------------  107 (505)
                            .....+||+.|+|||++  ...|+.++|||||||++|||++           |+.+|.+...            
T Consensus       233 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~  312 (458)
T 3rp9_A          233 TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGND  312 (458)
T ss_dssp             ------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC----------------
T ss_pred             cccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccccccc
Confidence                  12345789999999975  4569999999999999999999           5666654221            


Q ss_pred             --------hHHHHHHHHc-CCC--------------------C-------CCCCCCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626          108 --------PAQIYKKVTS-GIK--------------------P-------ASLSKVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus       108 --------~~~i~~~i~~-~~~--------------------p-------~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                              ..++...+.. +.+                    +       .......++.+.+||.+||. +|.+|||+.
T Consensus       313 ~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~  392 (458)
T 3rp9_A          313 FKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITIN  392 (458)
T ss_dssp             ----CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             ccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHH
Confidence                    1111111000 000                    0       01123347899999999996 899999999


Q ss_pred             HHhcCCCCCCCCCCC
Q 010626          151 ELLKDPFLVTDNPKD  165 (505)
Q Consensus       151 ElL~hpff~~~~~~~  165 (505)
                      |+|+||||+...+..
T Consensus       393 e~L~Hp~f~~~~~~~  407 (458)
T 3rp9_A          393 ECLAHPFFKEVRIAE  407 (458)
T ss_dssp             HHHHSGGGTTTCCGG
T ss_pred             HHhcCHhhhhcCCCc
Confidence            999999998765433

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.95  E-value=2.9e-28  Score=249.71  Aligned_cols=157  Identities=26%  Similarity=0.455  Sum_probs=130.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC---CcEEEeecCceeeccCC--CCccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~---g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+|||+...+   +.+||+|||++......  .....+||+.|+|||++.
T Consensus       116 ~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~  193 (342)
T 2qr7_A          116 REASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLE  193 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhc
Confidence            467899999999999999999  99999999999995333   35999999999876443  234567999999999885


Q ss_pred             -ccCCcccchhhHHHHHHHHhhcCCCCCCC--CChHHHHHHHHcCCCCC--CCCCCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626           77 -EEYNELVDIYSFGMCILEMVTCEYPYNEC--KNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlTG~~Pf~~~--~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                       ..|+.++|||||||++|+|++|..||...  .....+...+..+..+.  ..+..+++.+++||.+||. +|.+||++.
T Consensus       194 ~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  273 (342)
T 2qr7_A          194 RQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA  273 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHH
Confidence             45899999999999999999999999753  35666777777664432  2345678999999999995 899999999


Q ss_pred             HHhcCCCCCC
Q 010626          151 ELLKDPFLVT  160 (505)
Q Consensus       151 ElL~hpff~~  160 (505)
                      ++|+||||..
T Consensus       274 ~il~hp~~~~  283 (342)
T 2qr7_A          274 LVLRHPWIVH  283 (342)
T ss_dssp             HHTTSHHHHT
T ss_pred             HHhcCCeecC
Confidence            9999999964

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.95  E-value=4.2e-28  Score=248.47  Aligned_cols=159  Identities=25%  Similarity=0.471  Sum_probs=124.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccCCC-CccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~-~   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++.  .++.+||+|||++....... .....||+.|+|||++. .
T Consensus       148 ~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  225 (349)
T 2w4o_A          148 RDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC  225 (349)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCC
Confidence            467899999999999999999  999999999999962  37899999999997664432 34567999999999884 4


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++|||||||++|+|++|..||.........+..+......  .......+..+++||.+||. +|.+|||+.++|+
T Consensus       226 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          226 AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            68999999999999999999999998766666666666665332  23345678899999999996 8999999999999


Q ss_pred             CCCCCCCC
Q 010626          155 DPFLVTDN  162 (505)
Q Consensus       155 hpff~~~~  162 (505)
                      ||||....
T Consensus       306 hp~~~~~~  313 (349)
T 2w4o_A          306 HPWVTGKA  313 (349)
T ss_dssp             STTTTSTT
T ss_pred             CcccCCCc
Confidence            99997643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.95  E-value=3.7e-28  Score=239.37  Aligned_cols=155  Identities=23%  Similarity=0.464  Sum_probs=131.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~ys   80 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++............|++.|+|||++. ..++
T Consensus       114 ~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  190 (284)
T 2vgo_A          114 QRSATFMEELADALHYCHERK--VIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHD  190 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEc-CCCCEEEecccccccCcccccccccCCCCcCCHHHhccCCCC
Confidence            467889999999999999999  99999999999997 6789999999999776655555678999999999884 4589


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  159 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~  159 (505)
                      .++||||||+++|+|++|..||... ........+.....  .++...++.+++||.+||. +|.+||++.++++||||+
T Consensus       191 ~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~  267 (284)
T 2vgo_A          191 EKVDLWCAGVLCYEFLVGMPPFDSP-SHTETHRRIVNVDL--KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK  267 (284)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred             cccchhhHHHHHHHHHHCCCCCCCC-CHhHHHHHHhcccc--CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence            9999999999999999999999764 34444555544322  3456678999999999996 899999999999999997


Q ss_pred             CCC
Q 010626          160 TDN  162 (505)
Q Consensus       160 ~~~  162 (505)
                      ...
T Consensus       268 ~~~  270 (284)
T 2vgo_A          268 ANS  270 (284)
T ss_dssp             HHC
T ss_pred             hhc
Confidence            643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=3.7e-28  Score=245.62  Aligned_cols=158  Identities=27%  Similarity=0.444  Sum_probs=125.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC--cEEEeecCceeeccCC------CCccccCCCcccCcc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQP------TARSVIGTPEFMAPE   73 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g--~vKL~DFGlA~~~~~~------~~~~~~Gt~~Y~APE   73 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++  .+||+|||++..+...      ......||+.|+|||
T Consensus       168 ~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  244 (345)
T 3hko_A          168 KLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFS-TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE  244 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEES-CSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEe-cCCCceEEEeeccccccccccCccccccccccCCCccccCch
Confidence            357789999999999999999  99999999999997 344  8999999999865332      123457999999999


Q ss_pred             ccc---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC--CCCCCCChHHHHHHHHhcC-CCCCCC
Q 010626           74 LYE---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRL  147 (505)
Q Consensus        74 ll~---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~LI~kcL~-dP~~Rp  147 (505)
                      ++.   ..++.++|||||||++|+|++|+.||....... ....+.......  .....+++.+++||.+||. +|.+||
T Consensus       245 ~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  323 (345)
T 3hko_A          245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD-TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF  323 (345)
T ss_dssp             HHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred             hhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCC
Confidence            884   568899999999999999999999998754444 444444433222  2223468899999999996 899999


Q ss_pred             CHHHHhcCCCCCCCCC
Q 010626          148 PALELLKDPFLVTDNP  163 (505)
Q Consensus       148 Sa~ElL~hpff~~~~~  163 (505)
                      ++.++|+||||+...+
T Consensus       324 s~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          324 DAMRALQHPWISQFSD  339 (345)
T ss_dssp             CHHHHHHSHHHHTTSS
T ss_pred             CHHHHhcChhhccChH
Confidence            9999999999986543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.95  E-value=2.3e-28  Score=246.51  Aligned_cols=159  Identities=21%  Similarity=0.373  Sum_probs=123.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe------------------CCCCcEEEeecCceeeccCCCCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN------------------GNNGEVKIGDLGLAIVMQQPTARSV   63 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld------------------~~~g~vKL~DFGlA~~~~~~~~~~~   63 (505)
                      ..++.++.||+.||.|||++|  |+||||||+|||++                  ..++.+||+|||++...... ....
T Consensus       123 ~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~  199 (355)
T 2eu9_A          123 PHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-HTTI  199 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-CCSS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-ccCC
Confidence            467899999999999999999  99999999999993                  15678999999999765433 3456


Q ss_pred             cCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc-CCCCC-------------------
Q 010626           64 IGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA-------------------  122 (505)
Q Consensus        64 ~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~-~~~p~-------------------  122 (505)
                      .||+.|+|||++ ...++.++|||||||++|+|++|..||............... +..|.                   
T Consensus       200 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  279 (355)
T 2eu9_A          200 VATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVW  279 (355)
T ss_dssp             CSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECC
T ss_pred             cCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhccccccc
Confidence            799999999988 556899999999999999999999999875433322211110 11110                   


Q ss_pred             ---------------------CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          123 ---------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       123 ---------------------~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                                           ......++.+.+||.+||. +|.+|||+.|+|+||||+...+
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          280 DENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP  342 (355)
T ss_dssp             CTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred             ccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCCh
Confidence                                 0011123578899999996 8999999999999999987554

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.3e-28  Score=249.53  Aligned_cols=157  Identities=24%  Similarity=0.418  Sum_probs=130.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-CCcEEEeecCceeeccCCC-CccccCCCcccCcccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEE-E   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~-~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~~-~   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++.. ++.+||+|||++....... .....||+.|+|||++.+ .
T Consensus       102 ~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  179 (321)
T 1tki_A          102 REIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV  179 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCC
Confidence            467899999999999999999  9999999999999742 6899999999998765432 334579999999998854 4


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      ++.++|||||||++|+|++|..||.. .+...+...+..+.....  .....++++++||.+||. +|.+|||+.|+|+|
T Consensus       180 ~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          180 VSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            79999999999999999999999987 445556666665543221  224568899999999996 89999999999999


Q ss_pred             CCCCCC
Q 010626          156 PFLVTD  161 (505)
Q Consensus       156 pff~~~  161 (505)
                      |||+..
T Consensus       259 p~~~~~  264 (321)
T 1tki_A          259 PWLKQK  264 (321)
T ss_dssp             HHHHSC
T ss_pred             hhhccC
Confidence            999764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.95  E-value=1.2e-27  Score=252.29  Aligned_cols=160  Identities=26%  Similarity=0.336  Sum_probs=118.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----------------------
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----------------------   59 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----------------------   59 (505)
                      ..++.+++||+.||.|||++|  |+||||||+|||++ .++.+||+|||+++......                      
T Consensus       129 ~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (432)
T 3n9x_A          129 EHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK  205 (432)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEEC--------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEEC-CCCCEEEccCCCcccccccccccccccccccccccccccchh
Confidence            468899999999999999999  99999999999998 77899999999998764321                      


Q ss_pred             --CccccCCCcccCcccc--cccCCcccchhhHHHHHHHHhhcCCCC-----------CCCCC-----------------
Q 010626           60 --ARSVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY-----------NECKN-----------------  107 (505)
Q Consensus        60 --~~~~~Gt~~Y~APEll--~~~ys~ksDIWSLGviLyEmlTG~~Pf-----------~~~~~-----------------  107 (505)
                        ....+||+.|+|||++  ...|+.++|||||||++|||++|..||           .+...                 
T Consensus       206 ~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~  285 (432)
T 3n9x_A          206 KQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSN  285 (432)
T ss_dssp             -----CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHH
T ss_pred             ccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccch
Confidence              2456899999999975  456999999999999999999854333           22110                 


Q ss_pred             hHHH-----------------------HHHHHcCCCCCC-----CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626          108 PAQI-----------------------YKKVTSGIKPAS-----LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus       108 ~~~i-----------------------~~~i~~~~~p~~-----~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      ..++                       ...+........     .....++.+.+||.+||. +|.+|||+.|+|+||||
T Consensus       286 ~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  365 (432)
T 3n9x_A          286 RDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL  365 (432)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGG
T ss_pred             HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhh
Confidence            1111                       111111100000     113468899999999996 89999999999999999


Q ss_pred             CCCCCC
Q 010626          159 VTDNPK  164 (505)
Q Consensus       159 ~~~~~~  164 (505)
                      +...+.
T Consensus       366 ~~~~~~  371 (432)
T 3n9x_A          366 KDVRKK  371 (432)
T ss_dssp             TTTCCT
T ss_pred             hhccCc
Confidence            876543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.95  E-value=3.4e-28  Score=238.45  Aligned_cols=156  Identities=22%  Similarity=0.390  Sum_probs=130.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEeecCceeeccCC-CCccccCCCcccCccccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld--~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~~~   78 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||++.  ..++.+||+|||++...... ......||+.|+|||++.+.
T Consensus       106 ~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  183 (277)
T 3f3z_A          106 SDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL  183 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc
Confidence            467899999999999999999  99999999999992  26688999999999876543 33455799999999999888


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      ++.++||||||+++|+|++|+.||... ........+..+.....  .....++.+.+||.+||. +|.+|||+.++|+|
T Consensus       184 ~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          184 YGPECDEWSAGVMMYVLLCGYPPFSAP-TDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             BCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCchhhehhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            999999999999999999999999874 45555555555533221  112568899999999996 89999999999999


Q ss_pred             CCCCC
Q 010626          156 PFLVT  160 (505)
Q Consensus       156 pff~~  160 (505)
                      |||+.
T Consensus       263 ~~~~~  267 (277)
T 3f3z_A          263 EWFEK  267 (277)
T ss_dssp             HHHHH
T ss_pred             HHHhc
Confidence            99975

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.95  E-value=6.7e-28  Score=236.85  Aligned_cols=158  Identities=26%  Similarity=0.539  Sum_probs=130.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccCCC-CccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~-~   77 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++.  ..+.+||+|||++....... .....||+.|+|||++. .
T Consensus       105 ~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  182 (284)
T 3kk8_A          105 ADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD  182 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCC
Confidence            467889999999999999999  999999999999963  23349999999997765433 34457999999999884 5


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC--CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++||||||+++|+|++|..||.. .........+..+..  +.......++.+.+||.+||. +|.+|||+.++|+
T Consensus       183 ~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          183 PYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCcccchHHHHHHHHHHHHCCCCCCC-CchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            589999999999999999999999987 445556666655533  222334678999999999996 8999999999999


Q ss_pred             CCCCCCCC
Q 010626          155 DPFLVTDN  162 (505)
Q Consensus       155 hpff~~~~  162 (505)
                      ||||+...
T Consensus       262 h~~~~~~~  269 (284)
T 3kk8_A          262 VPWICNRE  269 (284)
T ss_dssp             SHHHHSCC
T ss_pred             CccccCCh
Confidence            99998654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.95  E-value=2.9e-28  Score=243.40  Aligned_cols=159  Identities=25%  Similarity=0.402  Sum_probs=120.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc---EEEeecCceeeccCC---------CCccccCCCcc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE---VKIGDLGLAIVMQQP---------TARSVIGTPEF   69 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~---vKL~DFGlA~~~~~~---------~~~~~~Gt~~Y   69 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++.   +||+|||++......         ......||+.|
T Consensus       111 ~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y  187 (316)
T 2ac3_A          111 LEASVVVQDVASALDFLHNKG--IAHRDLKPENILCE-HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY  187 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEES-CSSSSCSEEECCTTCCC-------------------CCSGGG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEc-cCCCcCceEEEEccCccccccCCccccccccccccccCCcCc
Confidence            367889999999999999999  99999999999997 3343   999999998654321         12234699999


Q ss_pred             cCccccc------ccCCcccchhhHHHHHHHHhhcCCCCCCCCC--------------hHHHHHHHHcCCCCCC--CCCC
Q 010626           70 MAPELYE------EEYNELVDIYSFGMCILEMVTCEYPYNECKN--------------PAQIYKKVTSGIKPAS--LSKV  127 (505)
Q Consensus        70 ~APEll~------~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~--------------~~~i~~~i~~~~~p~~--~~~~  127 (505)
                      +|||++.      ..++.++|||||||++|+|++|+.||.....              ...+...+..+.....  ....
T Consensus       188 ~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  267 (316)
T 2ac3_A          188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAH  267 (316)
T ss_dssp             CCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTT
T ss_pred             cChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhccc
Confidence            9999884      4589999999999999999999999976432              2334555555533211  1134


Q ss_pred             CChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          128 TDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       128 ~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                      .++.+++||.+||. +|.+|||+.|+|+||||+...+
T Consensus       268 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          268 ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence            68899999999996 8999999999999999986543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.95  E-value=3.3e-28  Score=242.44  Aligned_cols=159  Identities=23%  Similarity=0.435  Sum_probs=120.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~--~   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......  .....||+.|+|||++.  .
T Consensus       102 ~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  178 (311)
T 4agu_A          102 HLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILIT-KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT  178 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECC------------GGGCCHHHHHTCS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEc-CCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCC
Confidence            467889999999999999999  99999999999997 67899999999998765332  33457899999999884  4


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc--C-----------------CC-C--CCC------CCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--G-----------------IK-P--ASL------SKVTD  129 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~--~-----------------~~-p--~~~------~~~~s  129 (505)
                      .++.++||||||+++|+|++|..||.+.............  .                 .. +  ...      ....+
T Consensus       179 ~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (311)
T 4agu_A          179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNIS  258 (311)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCC
T ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhccccc
Confidence            5899999999999999999999999875444333222111  0                 00 0  000      12457


Q ss_pred             hHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          130 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       130 ~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                      +.+.+||.+||. +|.+|||+.++|+||||+....
T Consensus       259 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          259 YPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             HHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             HHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence            789999999996 8999999999999999987554

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.95  E-value=3.5e-28  Score=253.22  Aligned_cols=158  Identities=29%  Similarity=0.498  Sum_probs=117.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe---CCCCcEEEeecCceeeccCC-----CCccccCCCcccCccc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN---GNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPEL   74 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld---~~~g~vKL~DFGlA~~~~~~-----~~~~~~Gt~~Y~APEl   74 (505)
                      .++.|++||+.||.|||++|  |+||||||+|||+.   ..++.+||+|||+++.....     .....+||+.|+|||+
T Consensus       129 ~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~  206 (405)
T 3rgf_A          129 MVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPEL  206 (405)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchh
Confidence            57899999999999999999  99999999999993   25689999999999766432     2344679999999998


Q ss_pred             ccc--cCCcccchhhHHHHHHHHhhcCCCCCCCCC---------hHHHHHHHHc-CCCCCC-C-----------------
Q 010626           75 YEE--EYNELVDIYSFGMCILEMVTCEYPYNECKN---------PAQIYKKVTS-GIKPAS-L-----------------  124 (505)
Q Consensus        75 l~~--~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~---------~~~i~~~i~~-~~~p~~-~-----------------  124 (505)
                      +.+  .|+.++|||||||++|+|++|+.||.....         ..++...+.. +.++.. +                 
T Consensus       207 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~  286 (405)
T 3rgf_A          207 LLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFR  286 (405)
T ss_dssp             HTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCC
T ss_pred             hcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhcc
Confidence            843  489999999999999999999999965332         1222222211 111110 0                 


Q ss_pred             ----------------CCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          125 ----------------SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       125 ----------------~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                                      ....++.+.+||.+||. +|.+|||+.|+|+||||....
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~  341 (405)
T 3rgf_A          287 RNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP  341 (405)
T ss_dssp             GGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred             ccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence                            01126788999999996 899999999999999998754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4.8e-28  Score=248.42  Aligned_cols=164  Identities=26%  Similarity=0.422  Sum_probs=132.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC---CCccccCCCcccCcccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE-   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~---~~~~~~Gt~~Y~APEll~~-   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+++.....   ......||+.|+|||++.+ 
T Consensus       159 ~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  235 (355)
T 1vzo_A          159 HEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG  235 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCC
Confidence            367889999999999999999  99999999999997 6789999999999765332   2234579999999998853 


Q ss_pred             --cCCcccchhhHHHHHHHHhhcCCCCCCC---CChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC----
Q 010626           78 --EYNELVDIYSFGMCILEMVTCEYPYNEC---KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL----  147 (505)
Q Consensus        78 --~ys~ksDIWSLGviLyEmlTG~~Pf~~~---~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp----  147 (505)
                        .++.++|||||||++|+|++|+.||...   .....+...+.....  .++...++.+++||.+||. +|.+||    
T Consensus       236 ~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~~  313 (355)
T 1vzo_A          236 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALAKDLIQRLLMKDPKKRLGCGP  313 (355)
T ss_dssp             C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSST
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCC--CCCcccCHHHHHHHHHHhhhCHHHhcCCCC
Confidence              4789999999999999999999999643   233445555544432  3456678999999999996 899999    


Q ss_pred             -CHHHHhcCCCCCCCCCCCcccCC
Q 010626          148 -PALELLKDPFLVTDNPKDLVCDP  170 (505)
Q Consensus       148 -Sa~ElL~hpff~~~~~~~l~~~~  170 (505)
                       ++.++++||||+..++..+....
T Consensus       314 ~s~~ell~h~~f~~~~~~~l~~~~  337 (355)
T 1vzo_A          314 RDADEIKEHLFFQKINWDDLAAKK  337 (355)
T ss_dssp             TTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred             CCHHHHHcCcchhcCChhHhhhcc
Confidence             99999999999987766554433

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.95  E-value=4.2e-28  Score=248.44  Aligned_cols=155  Identities=27%  Similarity=0.539  Sum_probs=127.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEeecCceeeccCCC--CccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~--~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~-   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+|||++..  .+.+||+|||++.......  .....||+.|+|||++. 
T Consensus       130 ~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  207 (351)
T 3c0i_A          130 AVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR  207 (351)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC
Confidence            357789999999999999999  9999999999999732  2349999999998765432  34457999999999884 


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ..|+.++|||||||++|+|++|..||.+.  ...+...+..+.....  ....+++.+++||.+||. +|.+|||+.++|
T Consensus       208 ~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l  285 (351)
T 3c0i_A          208 EPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEAL  285 (351)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             CCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            56899999999999999999999999763  4555566655533221  124568899999999996 899999999999


Q ss_pred             cCCCCCC
Q 010626          154 KDPFLVT  160 (505)
Q Consensus       154 ~hpff~~  160 (505)
                      +||||+.
T Consensus       286 ~hp~~~~  292 (351)
T 3c0i_A          286 NHPWLKE  292 (351)
T ss_dssp             TSHHHHT
T ss_pred             cChhhcC
Confidence            9999975

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.95  E-value=3.8e-28  Score=266.19  Aligned_cols=165  Identities=30%  Similarity=0.477  Sum_probs=138.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc-ccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~-~~y   79 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+|||++ .+|.+||+|||++...... .....+||+.|+|||++. ..|
T Consensus       286 ~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld-~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~  362 (576)
T 2acx_A          286 ARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY  362 (576)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEe-CCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCC
Confidence            367889999999999999999  99999999999998 7789999999999876543 234568999999999884 469


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCC---ChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PAL  150 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~  150 (505)
                      +.++|||||||++|+|++|+.||....   ....+...+...  +..++...++++++||.+||. +|.+||     ++.
T Consensus       363 ~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~--~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~  440 (576)
T 2acx_A          363 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV--PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAR  440 (576)
T ss_dssp             SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHH
T ss_pred             CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc--cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHH
Confidence            999999999999999999999997643   345566665543  334567789999999999996 899999     799


Q ss_pred             HHhcCCCCCCCCCCCcccCCC
Q 010626          151 ELLKDPFLVTDNPKDLVCDPL  171 (505)
Q Consensus       151 ElL~hpff~~~~~~~l~~~~l  171 (505)
                      |+++||||+..+|..+....+
T Consensus       441 eil~HpfF~~i~w~~l~~~~~  461 (576)
T 2acx_A          441 EVKEHPLFKKLNFKRLGAGML  461 (576)
T ss_dssp             HHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHHhChhhccCCHHHHhcCCC
Confidence            999999999888766654443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.95  E-value=3.8e-28  Score=250.49  Aligned_cols=156  Identities=26%  Similarity=0.527  Sum_probs=129.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEeecCceeeccCCC-CccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~--~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~-~   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+|||++..  ++.+||+|||++....... .....||+.|+|||++. .
T Consensus       128 ~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  205 (362)
T 2bdw_A          128 ADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD  205 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccC
Confidence            467889999999999999999  9999999999999732  3469999999997765432 34568999999999885 4


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .|+.++|||||||++|+|++|..||.. .+...++..+..+...  ......+++.+++||.+||. +|.+||++.++|+
T Consensus       206 ~~~~~~DiwslG~il~~ll~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          206 PYSKPVDIWACGVILYILLVGYPPFWD-EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            699999999999999999999999976 4556666666665432  22234568999999999996 8999999999999


Q ss_pred             CCCCCC
Q 010626          155 DPFLVT  160 (505)
Q Consensus       155 hpff~~  160 (505)
                      ||||..
T Consensus       285 hp~~~~  290 (362)
T 2bdw_A          285 VPWICN  290 (362)
T ss_dssp             SHHHHT
T ss_pred             CcccCC
Confidence            999964

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.95  E-value=3.2e-28  Score=251.59  Aligned_cols=159  Identities=21%  Similarity=0.448  Sum_probs=122.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC---------CCCccccCCCcccCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ---------PTARSVIGTPEFMAP   72 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~---------~~~~~~~Gt~~Y~AP   72 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||.+.....         .......||+.|+||
T Consensus       128 ~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  204 (389)
T 3gni_B          128 LAIAYILQGVLKALDYIHHMG--YVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP  204 (389)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEcccccceeeccccccccccccccccccccccccCH
Confidence            367899999999999999999  99999999999997 778999999998864321         112334789999999


Q ss_pred             ccccc---cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC------------------------------
Q 010626           73 ELYEE---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI------------------------------  119 (505)
Q Consensus        73 Ell~~---~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~------------------------------  119 (505)
                      |++.+   .|+.++|||||||++|+|++|+.||.+..........+....                              
T Consensus       205 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (389)
T 3gni_B          205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDS  284 (389)
T ss_dssp             HHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------------------------
T ss_pred             HHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccc
Confidence            98843   689999999999999999999999987554443332221110                              


Q ss_pred             -------------CCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          120 -------------KPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       120 -------------~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                                   .....+..+++.+++||.+||. +|.+|||+.|+|+||||+....
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~  342 (389)
T 3gni_B          285 LTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  342 (389)
T ss_dssp             ---------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred             cccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence                         0112344568899999999996 8999999999999999987543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.95  E-value=7.9e-28  Score=240.94  Aligned_cols=159  Identities=30%  Similarity=0.460  Sum_probs=127.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++...... ......||+.|+|||++ ...+
T Consensus       120 ~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  196 (326)
T 1blx_A          120 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY  196 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEc-CCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCC
Confidence            467889999999999999999  99999999999997 6789999999999765432 23445789999999987 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC------------------------CCCCCCCCChHHHHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------------------------PASLSKVTDPQVKQF  135 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~------------------------p~~~~~~~s~~l~~L  135 (505)
                      +.++||||||+++|+|++|+.||............+.....                        ...+...+++.+++|
T Consensus       197 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  276 (326)
T 1blx_A          197 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL  276 (326)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHH
T ss_pred             CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHH
Confidence            99999999999999999999999875444333332221000                        011234567899999


Q ss_pred             HHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          136 IEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       136 I~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                      |.+||. +|.+|||+.++|+||||+....
T Consensus       277 i~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          277 LLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             HHHHcCCCcccCCCHHHHhcCccccccch
Confidence            999996 8999999999999999986543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.95  E-value=1.1e-28  Score=252.93  Aligned_cols=155  Identities=28%  Similarity=0.554  Sum_probs=126.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCccccccc-C
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEE-Y   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~~~-y   79 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++....... ....+||+.|+|||++.+. +
T Consensus       108 ~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  184 (336)
T 3h4j_B          108 DEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY  184 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEEC-TTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGG
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEc-CCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCC
Confidence            467899999999999999999  99999999999998 67899999999997664432 3456799999999988543 3


Q ss_pred             -CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           80 -NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        80 -s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                       +.++|||||||++|+|++|+.||.+... ..+...+..+  ...++...++.+++||.+||. +|.+|||+.|+++|||
T Consensus       185 ~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  261 (336)
T 3h4j_B          185 AGPEVDVWSCGIVLYVMLVGRLPFDDEFI-PNLFKKVNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW  261 (336)
T ss_dssp             GCHHHHHHHHHHHHHHHHHSSCSSBCSSS-TTCBCCCCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred             CCCccchhHHHHHHHHHHhCCCCCCCccH-HHHHHHHHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence             7899999999999999999999976322 1122222111  223556678999999999996 8999999999999999


Q ss_pred             CCCCC
Q 010626          158 LVTDN  162 (505)
Q Consensus       158 f~~~~  162 (505)
                      |+...
T Consensus       262 ~~~~~  266 (336)
T 3h4j_B          262 FNVNL  266 (336)
T ss_dssp             HHTTC
T ss_pred             hccCC
Confidence            97643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.95  E-value=4.4e-28  Score=246.47  Aligned_cols=158  Identities=27%  Similarity=0.353  Sum_probs=125.2

Q ss_pred             HHHHHHHHHHHHHHHHH--hCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCccccc--c
Q 010626            3 AIKNWARQILRGLHYLH--SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLH--s~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~--~   77 (505)
                      .++.++.||+.||.|||  ++|  |+||||||+|||++..++.+||+|||++....... .....||+.|+|||++.  .
T Consensus       130 ~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  207 (360)
T 3e3p_A          130 LIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQ  207 (360)
T ss_dssp             HHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCC
Confidence            57889999999999999  888  99999999999998557899999999998765433 34557899999999873  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-----------------------------CCCCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-----------------------------ASLSKVT  128 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-----------------------------~~~~~~~  128 (505)
                      .++.++|||||||++|+|++|+.||............+.....+                             .......
T Consensus       208 ~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (360)
T 3e3p_A          208 HYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKD  287 (360)
T ss_dssp             SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTT
T ss_pred             CCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccc
Confidence            48999999999999999999999998754433333322211000                             0111224


Q ss_pred             ChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          129 DPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       129 s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      ++.+.+||.+||. +|.+|||+.|+|+||||+...
T Consensus       288 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          288 AKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             cHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence            6789999999996 899999999999999998643

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.95  E-value=9.5e-28  Score=246.23  Aligned_cols=157  Identities=29%  Similarity=0.435  Sum_probs=125.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll-   75 (505)
                      +.++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++.......     .....||+.|+|||++ 
T Consensus       128 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  204 (364)
T 3qyz_A          128 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML  204 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEEC-CCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhc
Confidence            467889999999999999999  99999999999997 67899999999997664321     2345799999999976 


Q ss_pred             c-ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-----------------------C-----CCCC
Q 010626           76 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-----------------------A-----SLSK  126 (505)
Q Consensus        76 ~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-----------------------~-----~~~~  126 (505)
                      . ..++.++|||||||++|+|++|+.||.+......+...+.....+                       .     ....
T Consensus       205 ~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (364)
T 3qyz_A          205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP  284 (364)
T ss_dssp             TBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCT
T ss_pred             CCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCC
Confidence            3 348999999999999999999999998755443333222110000                       0     0113


Q ss_pred             CCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          127 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       127 ~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      ..++.+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus       285 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          285 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             CCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            457899999999996 89999999999999999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.95  E-value=6.4e-28  Score=262.89  Aligned_cols=165  Identities=31%  Similarity=0.499  Sum_probs=137.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||++.......  ....+||+.|+|||++. ..
T Consensus       289 ~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~  365 (543)
T 3c4z_A          289 PRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE  365 (543)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEe-CCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCC
Confidence            357889999999999999999  99999999999998 78899999999998765432  33458999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCC---ChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----H
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----A  149 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a  149 (505)
                      |+.++|||||||++|||++|+.||....   ....+...+.....  .++..+++.+++||.+||. +|.+||+     +
T Consensus       366 ~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a  443 (543)
T 3c4z_A          366 YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV--TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSC  443 (543)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBS
T ss_pred             CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc--CCCcccCHHHHHHHHHhccCCHhHCCCCcccCH
Confidence            9999999999999999999999997643   34566666665432  3556778999999999996 8999996     5


Q ss_pred             HHHhcCCCCCCCCCCCcccCCC
Q 010626          150 LELLKDPFLVTDNPKDLVCDPL  171 (505)
Q Consensus       150 ~ElL~hpff~~~~~~~l~~~~l  171 (505)
                      .++++||||+...|..+....+
T Consensus       444 ~ei~~Hpff~~i~w~~l~~~~~  465 (543)
T 3c4z_A          444 DGLRTHPLFRDISWRQLEAGML  465 (543)
T ss_dssp             HHHHTSGGGTTCCHHHHHTTCS
T ss_pred             HHHHcCccccCCCHHHHHcCCC
Confidence            8999999999888766554443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=7e-28  Score=245.54  Aligned_cols=157  Identities=26%  Similarity=0.393  Sum_probs=125.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~--~   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......  ......||+.|+|||++.  .
T Consensus       112 ~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  188 (346)
T 1ua2_A          112 SHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR  188 (346)
T ss_dssp             SHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEc-CCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCC
Confidence            367899999999999999999  99999999999998 6789999999999766432  234457899999999884  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc-CCC-CCCC-----------------------CCCCChHH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-PASL-----------------------SKVTDPQV  132 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~-~~~-p~~~-----------------------~~~~s~~l  132 (505)
                      .|+.++|||||||++|+|++|..||.+..........+.. +.+ ...+                       ....++.+
T Consensus       189 ~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (346)
T 1ua2_A          189 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDL  268 (346)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHH
T ss_pred             CCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHH
Confidence            4889999999999999999999999875443333332221 111 1001                       13446889


Q ss_pred             HHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          133 KQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       133 ~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      ++||.+||. +|.+|||+.|+|+||||...
T Consensus       269 ~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          269 LDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             HHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             HHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence            999999996 89999999999999999764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.95  E-value=4e-28  Score=259.05  Aligned_cols=158  Identities=31%  Similarity=0.559  Sum_probs=132.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccCC-CCccccCCCcccCccccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~~~   78 (505)
                      ..++.+++||+.||.|||++|  |+||||||+||+++.  .++.+||+|||++...... .....+||+.|+|||++.+.
T Consensus       121 ~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  198 (486)
T 3mwu_A          121 HDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT  198 (486)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGSC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCCC
Confidence            467899999999999999999  999999999999953  4567999999999765433 23456799999999999888


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      |+.++|||||||++|+|++|..||.+ .+...+...+..+..+...  ...+++.+++||.+||. +|.+|||+.++|+|
T Consensus       199 ~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          199 YDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            99999999999999999999999987 4566666677666443322  34568999999999996 89999999999999


Q ss_pred             CCCCCCC
Q 010626          156 PFLVTDN  162 (505)
Q Consensus       156 pff~~~~  162 (505)
                      |||+...
T Consensus       278 p~~~~~~  284 (486)
T 3mwu_A          278 PWIQKYS  284 (486)
T ss_dssp             HHHHHTC
T ss_pred             HhhccCc
Confidence            9997643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.95  E-value=5.8e-28  Score=248.78  Aligned_cols=159  Identities=25%  Similarity=0.476  Sum_probs=117.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC--cEEEeecCceeeccC-CCCccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQ-PTARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g--~vKL~DFGlA~~~~~-~~~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++  .+||+|||+++.... .......||+.|+|||++ ..
T Consensus       116 ~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  192 (361)
T 3uc3_A          116 DEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQ  192 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEEC-SSSSCCEEECCCCCC---------------CTTSCHHHHHCS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEc-CCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCC
Confidence            468899999999999999999  99999999999997 334  499999999974432 233456799999999988 44


Q ss_pred             cCCcc-cchhhHHHHHHHHhhcCCCCCCCCC---hHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           78 EYNEL-VDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        78 ~ys~k-sDIWSLGviLyEmlTG~~Pf~~~~~---~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                      .++.+ +|||||||++|+|++|+.||.....   .......+.............++.+++||.+||. +|.+|||+.|+
T Consensus       193 ~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~el  272 (361)
T 3uc3_A          193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI  272 (361)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            55544 8999999999999999999976432   2344444444433333334568999999999996 89999999999


Q ss_pred             hcCCCCCCCCC
Q 010626          153 LKDPFLVTDNP  163 (505)
Q Consensus       153 L~hpff~~~~~  163 (505)
                      ++||||....+
T Consensus       273 l~hp~f~~~~~  283 (361)
T 3uc3_A          273 KTHSWFLKNLP  283 (361)
T ss_dssp             HTSHHHHTTCC
T ss_pred             HhCcchhcCCc
Confidence            99999976443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.95  E-value=5e-28  Score=253.03  Aligned_cols=158  Identities=23%  Similarity=0.420  Sum_probs=122.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~--~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+|||++..  ++.+||+|||+++..... .....+||+.|+|||++ ..
T Consensus       161 ~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  238 (400)
T 1nxk_A          161 REASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE  238 (400)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCC
Confidence            467899999999999999999  9999999999999742  688999999999876433 23456799999999988 45


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCCh---HHHHHHHHcCCC--CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNP---AQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~---~~i~~~i~~~~~--p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                      .|+.++|||||||++|+|++|..||......   ......+..+..  +......+++++++||.+||. +|.+|||+.+
T Consensus       239 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e  318 (400)
T 1nxk_A          239 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE  318 (400)
T ss_dssp             CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred             CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence            6999999999999999999999999754321   113334444322  222334578999999999996 8999999999


Q ss_pred             HhcCCCCCCC
Q 010626          152 LLKDPFLVTD  161 (505)
Q Consensus       152 lL~hpff~~~  161 (505)
                      +|+||||...
T Consensus       319 il~hp~~~~~  328 (400)
T 1nxk_A          319 FMNHPWIMQS  328 (400)
T ss_dssp             HHHSHHHHTT
T ss_pred             HhcCccccCC
Confidence            9999999753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.95  E-value=9.4e-28  Score=247.35  Aligned_cols=155  Identities=26%  Similarity=0.513  Sum_probs=128.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccccc---
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEE---   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~~---   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .+|.+||+|||++...... ......||+.|+|||++.+   
T Consensus       200 ~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~-~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  276 (365)
T 2y7j_A          200 KETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMD  276 (365)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC-CCCCEEEEecCcccccCCCcccccCCCCCCccChhhcccccc
Confidence            467889999999999999999  99999999999998 7789999999999876543 3345679999999998742   


Q ss_pred             ----cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626           78 ----EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus        78 ----~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                          .|+.++|||||||++|+|++|..||... ........+..+......  ....++.+.+||.+||. +|.+|||+.
T Consensus       277 ~~~~~~~~~~Di~slG~il~ell~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~  355 (365)
T 2y7j_A          277 ETHPGYGKEVDLWACGVILFTLLAGSPPFWHR-RQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAE  355 (365)
T ss_dssp             TTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             ccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence                4888999999999999999999999763 455555556555333221  23567889999999995 899999999


Q ss_pred             HHhcCCCCCC
Q 010626          151 ELLKDPFLVT  160 (505)
Q Consensus       151 ElL~hpff~~  160 (505)
                      ++|+||||++
T Consensus       356 ell~hp~f~r  365 (365)
T 2y7j_A          356 QALQHPFFER  365 (365)
T ss_dssp             HHHHSGGGCC
T ss_pred             HHhcCcccCC
Confidence            9999999963

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.95  E-value=6.9e-28  Score=244.35  Aligned_cols=158  Identities=26%  Similarity=0.420  Sum_probs=123.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------------CccccCCCcc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------------ARSVIGTPEF   69 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------------~~~~~Gt~~Y   69 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......            .....||+.|
T Consensus       112 ~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  188 (353)
T 2b9h_A          112 DHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY  188 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECC----------------CCCCCCGGG
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEc-CCCcEEEEecccccccccccccccCccccccchhhccccccc
Confidence            467889999999999999999  99999999999997 67899999999997664321            1234789999


Q ss_pred             cCccccc--ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC-------------------------
Q 010626           70 MAPELYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA-------------------------  122 (505)
Q Consensus        70 ~APEll~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~-------------------------  122 (505)
                      +|||++.  ..++.++|||||||++|+|++|..||.+................+.                         
T Consensus       189 ~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (353)
T 2b9h_A          189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA  268 (353)
T ss_dssp             CCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCC
T ss_pred             cCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCC
Confidence            9999773  5689999999999999999999999987543333222211100000                         


Q ss_pred             ----CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          123 ----SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       123 ----~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                          ......++.+.+||.+||. +|.+|||+.++|+||||+...
T Consensus       269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          269 APLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             CCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             cchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence                0113467899999999996 899999999999999998644

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.95  E-value=6.1e-28  Score=241.45  Aligned_cols=155  Identities=24%  Similarity=0.454  Sum_probs=126.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll~~   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++  ++.+||+|||++.......    .....|++.|+|||++..
T Consensus       127 ~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~--~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (313)
T 3cek_A          127 WERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD  202 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE--TTEEEECCCSSSCC--------------CCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEE--CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhh
Confidence            367889999999999999999  99999999999997  4799999999997654332    234568999999998743


Q ss_pred             ------------cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCC
Q 010626           78 ------------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PAS  144 (505)
Q Consensus        78 ------------~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~  144 (505)
                                  .++.++||||||+++|+|++|..||............+........++...++.+.+||.+||. +|.
T Consensus       203 ~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  282 (313)
T 3cek_A          203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK  282 (313)
T ss_dssp             CC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTT
T ss_pred             cccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcc
Confidence                        5888999999999999999999999876665555555555545555666778999999999996 899


Q ss_pred             CCCCHHHHhcCCCCCC
Q 010626          145 LRLPALELLKDPFLVT  160 (505)
Q Consensus       145 ~RpSa~ElL~hpff~~  160 (505)
                      +||++.++|+||||+.
T Consensus       283 ~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          283 QRISIPELLAHPYVQI  298 (313)
T ss_dssp             TSCCHHHHHTSHHHHC
T ss_pred             cCcCHHHHhcCccccC
Confidence            9999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.95  E-value=3.4e-28  Score=251.47  Aligned_cols=156  Identities=31%  Similarity=0.429  Sum_probs=115.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc--ccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~--~~y   79 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||+++..... .....||+.|+|||++.  ..|
T Consensus       132 ~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~-~~~~~kL~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~  207 (367)
T 2fst_X          132 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTADE-MTGYVATRWYRAPEIMLNWMHY  207 (367)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECC----------------CCCTTCCHHHHTTCCSC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEEC-CCCCEEEeecccccccccc-CCCcCcCcCccChHHHcCCcCC
Confidence            467889999999999999999  99999999999998 6789999999999765433 34567999999999874  468


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-------------------------CC---CCCCCChH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------------------------AS---LSKVTDPQ  131 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-------------------------~~---~~~~~s~~  131 (505)
                      +.++|||||||++|+|++|+.||.+.....++...+.....|                         ..   .....++.
T Consensus       208 ~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (367)
T 2fst_X          208 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL  287 (367)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHH
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHH
Confidence            999999999999999999999998754433332222110000                         00   11235788


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      +.+||.+||. +|.+|||+.++|+||||...
T Consensus       288 ~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~  318 (367)
T 2fst_X          288 AVDLLEKMLVLDSDKRITAAQALAHAYFAQY  318 (367)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHhCCCCcccCcCHHHHhcChhhhhc
Confidence            9999999996 89999999999999999864

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.95  E-value=2.9e-28  Score=249.97  Aligned_cols=154  Identities=29%  Similarity=0.433  Sum_probs=119.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCC--------------------------------------
Q 010626            2 KAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNG--------------------------------------   42 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~-g~~IiHrDLKp~NILld~~~g--------------------------------------   42 (505)
                      ..++.++.||+.||.|||++ |  |+||||||+|||++ .++                                      
T Consensus       146 ~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (397)
T 1wak_A          146 PCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLS-VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLV  222 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEEC-CCHHHHHHHHHHHC---------------------CCTTSC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEe-ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccc
Confidence            46889999999999999998 9  99999999999997 333                                      


Q ss_pred             -----------cEEEeecCceeeccCCCCccccCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCCh--
Q 010626           43 -----------EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNP--  108 (505)
Q Consensus        43 -----------~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~--  108 (505)
                                 .+||+|||++...... .....||+.|+|||++ ...|+.++|||||||++|+|+||+.||......  
T Consensus       223 ~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  301 (397)
T 1wak_A          223 NPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY  301 (397)
T ss_dssp             CTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSS
T ss_pred             cccccccccccceEecccccccccccc-CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCccccc
Confidence                       7999999999876543 3445799999999988 456999999999999999999999999754321  


Q ss_pred             ---HHHHHHHHc--CCCCC--------------------------------------CCCCCCChHHHHHHHHhcC-CCC
Q 010626          109 ---AQIYKKVTS--GIKPA--------------------------------------SLSKVTDPQVKQFIEKCIV-PAS  144 (505)
Q Consensus       109 ---~~i~~~i~~--~~~p~--------------------------------------~~~~~~s~~l~~LI~kcL~-dP~  144 (505)
                         ......+..  +..|.                                      .++...++.+.+||.+||. +|.
T Consensus       302 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  381 (397)
T 1wak_A          302 TRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPE  381 (397)
T ss_dssp             CHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGG
T ss_pred             CchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChh
Confidence               111111110  11000                                      0112224578899999996 899


Q ss_pred             CCCCHHHHhcCCCCC
Q 010626          145 LRLPALELLKDPFLV  159 (505)
Q Consensus       145 ~RpSa~ElL~hpff~  159 (505)
                      +|||+.|+|+||||+
T Consensus       382 ~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          382 KRATAAECLRHPWLN  396 (397)
T ss_dssp             GSCCHHHHHTSGGGG
T ss_pred             hcCCHHHHhhCcccc
Confidence            999999999999996

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.95  E-value=1.1e-27  Score=250.07  Aligned_cols=158  Identities=26%  Similarity=0.418  Sum_probs=130.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEeecCceeeccCCC-CccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~-~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++. ..+.+||+|||++....... .....||+.|+|||++. ..
T Consensus       149 ~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~  226 (387)
T 1kob_A          149 AEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP  226 (387)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCC
Confidence            467899999999999999999  999999999999973 34689999999998765432 33457999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC--CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      ++.++|||||||++|+|++|..||.+. +.......+.....  +.......++.+++||.+||. +|.+|||+.++|+|
T Consensus       227 ~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          227 VGFYTDMWAIGVLGYVLLSGLSPFAGE-DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             BCHHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCcccEeeHhHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            899999999999999999999999874 44455555554432  223344678999999999996 89999999999999


Q ss_pred             CCCCCCC
Q 010626          156 PFLVTDN  162 (505)
Q Consensus       156 pff~~~~  162 (505)
                      |||+...
T Consensus       306 p~~~~~~  312 (387)
T 1kob_A          306 PWLKGDH  312 (387)
T ss_dssp             TTTSSCC
T ss_pred             ccccCCc
Confidence            9998654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.95  E-value=1.2e-28  Score=253.64  Aligned_cols=153  Identities=16%  Similarity=0.275  Sum_probs=119.9

Q ss_pred             HHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc---ccCCc
Q 010626            5 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE---EEYNE   81 (505)
Q Consensus         5 ~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~---~~ys~   81 (505)
                      ..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++....... ...+|+.|+|||++.   ..|+.
T Consensus       197 ~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DFG~a~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~  272 (371)
T 3q60_A          197 HILTAQLIRLAANLQSKG--LVHGHFTPDNLFIM-PDGRLMLGDVSALWKVGTRGP-ASSVPVTYAPREFLNASTATFTH  272 (371)
T ss_dssp             HHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEC-TTSCEEECCGGGEEETTCEEE-GGGSCGGGCCHHHHTCSEEECCH
T ss_pred             HHHHHHHHHHHHHHHHCC--CccCcCCHHHEEEC-CCCCEEEEecceeeecCCCcc-CccCCcCCcChhhccCCCCCcCc
Confidence            455599999999999999  99999999999998 778999999999987654322 446779999999884   46999


Q ss_pred             ccchhhHHHHHHHHhhcCCCCCCCCChHH-HHHH---HHcCCCC--CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           82 LVDIYSFGMCILEMVTCEYPYNECKNPAQ-IYKK---VTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        82 ksDIWSLGviLyEmlTG~~Pf~~~~~~~~-i~~~---i~~~~~p--~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ++|||||||++|+|+||+.||........ .+..   .......  .......++.+++||.+||. +|.+|||+.++|+
T Consensus       273 ~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          273 ALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             cccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99999999999999999999976422100 0000   0001111  11224668999999999996 8999999999999


Q ss_pred             CCCCCCC
Q 010626          155 DPFLVTD  161 (505)
Q Consensus       155 hpff~~~  161 (505)
                      ||||+..
T Consensus       353 hp~f~~~  359 (371)
T 3q60_A          353 TPEFLQL  359 (371)
T ss_dssp             SHHHHHH
T ss_pred             CHHHHHH
Confidence            9999753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.95  E-value=4.2e-28  Score=250.72  Aligned_cols=159  Identities=26%  Similarity=0.390  Sum_probs=121.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~-~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..++.++.||+.||.|||.+..+|+||||||+|||++. .++.+||+|||++...... .....||+.|+|||++ ...|
T Consensus       157 ~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~  235 (382)
T 2vx3_A          157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-IYQYIQSRFYRSPEVLLGMPY  235 (382)
T ss_dssp             HHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-CCSSCSCGGGCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-cccccCCccccChHHHcCCCC
Confidence            46789999999999999953223999999999999952 4678999999999877543 3456899999999988 4569


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc-CCCCCC--------------CC------------------C
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPAS--------------LS------------------K  126 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~-~~~p~~--------------~~------------------~  126 (505)
                      +.++|||||||++|+|+||+.||.+......+...+.. +.++..              ++                  .
T Consensus       236 ~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (382)
T 2vx3_A          236 DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPP  315 (382)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCT
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCc
Confidence            99999999999999999999999875443333222221 110000              00                  0


Q ss_pred             ----------------------------CCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          127 ----------------------------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       127 ----------------------------~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                                                  ...+.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus       316 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          316 GTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             TCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             chhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence                                        001378999999996 89999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.95  E-value=1.2e-27  Score=242.12  Aligned_cols=159  Identities=28%  Similarity=0.498  Sum_probs=133.3

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE--E   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~--~   78 (505)
                      ..++.++.||+.||.|||+ +|  ++||||||+||+++ .++.+||+|||++............|++.|+|||++.+  .
T Consensus       151 ~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  227 (348)
T 2pml_X          151 QVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMD-KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESS  227 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEEC-TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCC
T ss_pred             HHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEEc-CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCC
Confidence            4678999999999999999 99  99999999999997 67899999999998776555556689999999998854  3


Q ss_pred             CCc-ccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCC-----------------CCCCChHHHHHHHHhc
Q 010626           79 YNE-LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL-----------------SKVTDPQVKQFIEKCI  140 (505)
Q Consensus        79 ys~-ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~-----------------~~~~s~~l~~LI~kcL  140 (505)
                      ++. ++||||||+++|+|++|..||............+..+......                 ....++.+.+||.+||
T Consensus       228 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  307 (348)
T 2pml_X          228 YNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFL  307 (348)
T ss_dssp             EEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHC
T ss_pred             CCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHc
Confidence            555 9999999999999999999998766656677777665332221                 1557899999999999


Q ss_pred             C-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          141 V-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       141 ~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                      . +|.+||++.++|+||||+...+
T Consensus       308 ~~dP~~Rps~~e~l~hp~f~~~~~  331 (348)
T 2pml_X          308 RKNPAERITSEDALKHEWLADTNI  331 (348)
T ss_dssp             CSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred             cCChhhCCCHHHHhcCccccCCCH
Confidence            6 8999999999999999986543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.95  E-value=9e-28  Score=257.11  Aligned_cols=156  Identities=28%  Similarity=0.522  Sum_probs=132.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEeecCceeeccCCC-CccccCCCcccCccccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~--~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~~~   78 (505)
                      ..++.+++||+.||.|||++|  |+||||||+|||++..  ++.+||+|||++....... ....+||+.|+|||++.+.
T Consensus       136 ~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~  213 (494)
T 3lij_A          136 VDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK  213 (494)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHccc
Confidence            357889999999999999999  9999999999999632  4569999999998765433 3456799999999999888


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      |+.++|||||||++|+|++|..||.+ .....+...+..+.....  .....++.+++||.+||. +|.+|||+.++|+|
T Consensus       214 ~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          214 YDEKCDVWSIGVILFILLAGYPPFGG-QTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            99999999999999999999999987 455666677766644322  234578999999999996 89999999999999


Q ss_pred             CCCCC
Q 010626          156 PFLVT  160 (505)
Q Consensus       156 pff~~  160 (505)
                      |||+.
T Consensus       293 p~~~~  297 (494)
T 3lij_A          293 PWIKE  297 (494)
T ss_dssp             HHHHH
T ss_pred             ccccc
Confidence            99975

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.95  E-value=7e-28  Score=241.08  Aligned_cols=156  Identities=24%  Similarity=0.369  Sum_probs=122.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC------------------CCcEEEeecCceeeccCCCCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN------------------NGEVKIGDLGLAIVMQQPTARSV   63 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~------------------~g~vKL~DFGlA~~~~~~~~~~~   63 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++..                  ++.+||+|||++...... ....
T Consensus       118 ~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~  194 (339)
T 1z57_A          118 DHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-HSTL  194 (339)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-CCSS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-cccc
Confidence            467899999999999999999  9999999999999732                  567999999999765433 3456


Q ss_pred             cCCCcccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc--CCCCC------------------
Q 010626           64 IGTPEFMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--GIKPA------------------  122 (505)
Q Consensus        64 ~Gt~~Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~--~~~p~------------------  122 (505)
                      .||+.|+|||++ ...++.++|||||||++|+|++|..||....... ....+..  +..|.                  
T Consensus       195 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  273 (339)
T 1z57_A          195 VSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLD  273 (339)
T ss_dssp             CSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEEC
T ss_pred             cCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhcccc
Confidence            799999999988 4568999999999999999999999998644332 2222211  10000                  


Q ss_pred             ----------------------CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          123 ----------------------SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       123 ----------------------~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                                            ......++.+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          274 WDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL  335 (339)
T ss_dssp             CCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred             ccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence                                  0111224678999999996 89999999999999999753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.95  E-value=1.2e-28  Score=254.43  Aligned_cols=147  Identities=19%  Similarity=0.223  Sum_probs=118.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-c---
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E---   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~---   77 (505)
                      ..+..|+.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++.... ......| +.|+|||++. .   
T Consensus       206 ~~~~~i~~qi~~aL~~LH~~~--ivHrDikp~NIll~-~~~~~kL~DFG~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~  280 (377)
T 3byv_A          206 HARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGA-RVVSSVS-RGFEPPELEARRATI  280 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCGGGCEETTC-EEECCCC-TTCCCHHHHHHHTST
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEc-CCCCEEEEechhheecCC-cccCCCC-cCccChhhhcccccc
Confidence            356679999999999999999  99999999999998 678999999999986443 3345567 9999999884 3   


Q ss_pred             --------cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC
Q 010626           78 --------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP  148 (505)
Q Consensus        78 --------~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS  148 (505)
                              .|+.++|||||||++|+|++|+.||..... ......+..      ....+++.+.+||.+||. +|.+|||
T Consensus       281 ~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~-~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt  353 (377)
T 3byv_A          281 SYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA-LGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLL  353 (377)
T ss_dssp             HHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred             cccccccccCChhhhHHHHHHHHHHHHHCCCCCccccc-ccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCC
Confidence                    599999999999999999999999975322 111111111      124568899999999996 8999999


Q ss_pred             HHHHhcCCCCCC
Q 010626          149 ALELLKDPFLVT  160 (505)
Q Consensus       149 a~ElL~hpff~~  160 (505)
                      +.++|+||||+.
T Consensus       354 ~~e~l~hp~f~~  365 (377)
T 3byv_A          354 PLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHHTSHHHHH
T ss_pred             HHHHhhChHHHH
Confidence            999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.95  E-value=2.7e-28  Score=259.76  Aligned_cols=158  Identities=29%  Similarity=0.510  Sum_probs=133.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEeecCceeeccCCC-CccccCCCcccCccccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld--~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~~~   78 (505)
                      ..++.+++||+.||.|||++|  |+||||||+||+++  ..++.+||+|||++....... ....+||+.|+|||++.+.
T Consensus       126 ~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  203 (484)
T 3nyv_A          126 VDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT  203 (484)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecCC
Confidence            367889999999999999999  99999999999995  256789999999997665432 3445799999999999888


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~--~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      |+.++|||||||++|+|++|..||.+ .+...+...+..+......  ...+++.+++||.+||. +|.+|||+.++|+|
T Consensus       204 ~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          204 YDEKCDVWSTGVILYILLSGCPPFNG-ANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCcceeHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            99999999999999999999999987 4566666777766443322  24578999999999996 89999999999999


Q ss_pred             CCCCCCC
Q 010626          156 PFLVTDN  162 (505)
Q Consensus       156 pff~~~~  162 (505)
                      |||+...
T Consensus       283 ~~~~~~~  289 (484)
T 3nyv_A          283 EWIQTYT  289 (484)
T ss_dssp             HHHHHHT
T ss_pred             hhhcccc
Confidence            9997643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.95  E-value=7.5e-28  Score=241.48  Aligned_cols=156  Identities=33%  Similarity=0.571  Sum_probs=124.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc---
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE---   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~---   76 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++......  ......|++.|+|||++.   
T Consensus       129 ~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  205 (326)
T 2x7f_A          129 EWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE  205 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEECCCTTTC-------------CCGGGCCHHHHC---
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEc-CCCCEEEeeCcCceecCcCccccccccCCccccChhhhcccc
Confidence            357889999999999999999  99999999999997 7789999999998765432  233457999999999873   


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                         ..++.++|||||||++|+|++|..||... +.......+.....+......+++.+++||.+||. +|.+||++.++
T Consensus       206 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  284 (326)
T 2x7f_A          206 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQL  284 (326)
T ss_dssp             -----CCTTHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             ccCcCCCccchHHHHHHHHHHHHhCCCCCCCC-cHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHH
Confidence               45889999999999999999999999764 34444445555545555566778999999999995 89999999999


Q ss_pred             hcCCCCCCC
Q 010626          153 LKDPFLVTD  161 (505)
Q Consensus       153 L~hpff~~~  161 (505)
                      ++||||+..
T Consensus       285 l~hp~~~~~  293 (326)
T 2x7f_A          285 MKHPFIRDQ  293 (326)
T ss_dssp             HTSHHHHCC
T ss_pred             hhChHHhhC
Confidence            999999753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.95  E-value=2.1e-27  Score=238.97  Aligned_cols=157  Identities=29%  Similarity=0.475  Sum_probs=129.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC----cEEEeecCceeeccCCC-CccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g----~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++    .+||+|||++....... .....||+.|+|||++.
T Consensus       115 ~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~-~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~  191 (321)
T 2a2a_A          115 EEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLL-DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN  191 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEES-CTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEe-cCCCCcCCEEEccCccceecCccccccccCCCCCccCccccc
Confidence            467899999999999999999  99999999999997 445    79999999998765432 34557999999999884


Q ss_pred             -ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC--CCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           77 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                       ..++.++||||||+++|+|++|..||... ........+.......  ......++.+++||.+||. +|.+|||+.++
T Consensus       192 ~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~  270 (321)
T 2a2a_A          192 YEPLGLEADMWSIGVITYILLSGASPFLGD-TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEA  270 (321)
T ss_dssp             TCCCCTHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHH
T ss_pred             CCCCCCccccHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence             56899999999999999999999999764 4455555555543221  1224568899999999996 89999999999


Q ss_pred             hcCCCCCCCC
Q 010626          153 LKDPFLVTDN  162 (505)
Q Consensus       153 L~hpff~~~~  162 (505)
                      |+||||....
T Consensus       271 l~hp~~~~~~  280 (321)
T 2a2a_A          271 LRHPWITPVD  280 (321)
T ss_dssp             HHSTTTSCSS
T ss_pred             hcCccccCCC
Confidence            9999997543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.95  E-value=8.5e-28  Score=243.63  Aligned_cols=158  Identities=24%  Similarity=0.388  Sum_probs=112.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEeecCceeeccCC--CCccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~--g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++..+  ..+||+|||++......  ......||+.|+|||++ .
T Consensus       106 ~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~  183 (325)
T 3kn6_A          106 TEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ  183 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcC
Confidence            467899999999999999999  99999999999997322  27999999999765433  23455789999999988 4


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCC------ChHHHHHHHHcCCCCCCC--CCCCChHHHHHHHHhcC-CCCCCC
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECK------NPAQIYKKVTSGIKPASL--SKVTDPQVKQFIEKCIV-PASLRL  147 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~------~~~~i~~~i~~~~~p~~~--~~~~s~~l~~LI~kcL~-dP~~Rp  147 (505)
                      ..|+.++|||||||++|+|++|+.||....      ....+...+..+..+...  ....++++++||.+||. +|.+||
T Consensus       184 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp  263 (325)
T 3kn6_A          184 NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL  263 (325)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCC
T ss_pred             CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCC
Confidence            568999999999999999999999997532      334566666655433211  13468899999999996 899999


Q ss_pred             CHHHHhcCCCCCCC
Q 010626          148 PALELLKDPFLVTD  161 (505)
Q Consensus       148 Sa~ElL~hpff~~~  161 (505)
                      |+.++++||||+..
T Consensus       264 t~~ell~h~w~~~~  277 (325)
T 3kn6_A          264 KMSGLRYNEWLQDG  277 (325)
T ss_dssp             CTTTSTTCGGGCTT
T ss_pred             CHHHHhcChhhccC
Confidence            99999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.95  E-value=7.1e-28  Score=238.70  Aligned_cols=158  Identities=30%  Similarity=0.543  Sum_probs=125.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc----
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY----   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll----   75 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.....  .......||+.|+|||++    
T Consensus       117 ~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  193 (302)
T 2j7t_A          117 PQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET  193 (302)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEC-CCCCEEEEECCCCccccccccccccccCChhhcCCeeecccc
Confidence            467889999999999999999  99999999999997 678999999998754321  122345789999999987    


Q ss_pred             --cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           76 --EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        76 --~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                        ...++.++||||||+++|+|++|..||.... .......+.....+ ...+..++..+.+||.+||. +|.+|||+.+
T Consensus       194 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  272 (302)
T 2j7t_A          194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQ  272 (302)
T ss_dssp             TTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred             CCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-HHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHH
Confidence              3458899999999999999999999998744 44444444444332 23455678899999999996 8999999999


Q ss_pred             HhcCCCCCCCCC
Q 010626          152 LLKDPFLVTDNP  163 (505)
Q Consensus       152 lL~hpff~~~~~  163 (505)
                      +++||||.....
T Consensus       273 ll~h~~~~~~~~  284 (302)
T 2j7t_A          273 LLEHPFVSSITS  284 (302)
T ss_dssp             HTTSTTTTTCCC
T ss_pred             HhcChHHhhhcc
Confidence            999999987543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.95  E-value=7.8e-28  Score=239.68  Aligned_cols=157  Identities=25%  Similarity=0.460  Sum_probs=131.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld--~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||++.  ..++.+||+|||++............||+.|+|||++. ..
T Consensus       106 ~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  183 (304)
T 2jam_A          106 KDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKP  183 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCC
Confidence            467889999999999999999  99999999999992  25678999999999765544444557999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      ++.++||||||+++|+|++|..||.. .....+...+..+..+  .......++.+.+||.+||. +|.+||++.++|+|
T Consensus       184 ~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          184 YSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            89999999999999999999999976 4455666666665432  23445678999999999996 89999999999999


Q ss_pred             CCCCCC
Q 010626          156 PFLVTD  161 (505)
Q Consensus       156 pff~~~  161 (505)
                      |||...
T Consensus       263 ~~~~~~  268 (304)
T 2jam_A          263 PWIDGN  268 (304)
T ss_dssp             HHHHSS
T ss_pred             ccccCC
Confidence            999754

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.95  E-value=1.6e-27  Score=237.90  Aligned_cols=158  Identities=31%  Similarity=0.542  Sum_probs=129.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......  .....|++.|+|||++ ...
T Consensus       125 ~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  201 (314)
T 3com_A          125 DEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG  201 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEEC-CCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCC
Confidence            467899999999999999999  99999999999997 67899999999997765432  3445789999999988 446


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      ++.++||||||+++|+|++|+.||....... ....+..... ....+..+++.+.+||.+||. +|.+|||+.++|+||
T Consensus       202 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~  280 (314)
T 3com_A          202 YNCVADIWSLGITAIEMAEGKPPYADIHPMR-AIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP  280 (314)
T ss_dssp             BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence            8999999999999999999999998744333 3333333322 223345568899999999996 899999999999999


Q ss_pred             CCCCCCC
Q 010626          157 FLVTDNP  163 (505)
Q Consensus       157 ff~~~~~  163 (505)
                      ||+....
T Consensus       281 ~~~~~~~  287 (314)
T 3com_A          281 FVRSAKG  287 (314)
T ss_dssp             HHHTCCC
T ss_pred             HHhcCCc
Confidence            9987543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.95  E-value=3.4e-28  Score=248.26  Aligned_cols=159  Identities=27%  Similarity=0.525  Sum_probs=126.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccC
Q 010626            2 KAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~-g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~y   79 (505)
                      ..++.++.||+.||.|||++ |  |+||||||+||+++ .++.+||+|||++............||+.|+|||++. ..+
T Consensus       131 ~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  207 (360)
T 3eqc_A          131 QILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY  207 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEEC-CCCCEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCC
Confidence            35788999999999999985 8  99999999999998 6789999999999766444455668999999999884 568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChH-----------------------------------------HHHHHHHcC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPA-----------------------------------------QIYKKVTSG  118 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~-----------------------------------------~i~~~i~~~  118 (505)
                      +.++|||||||++|+|++|+.||.......                                         .....+...
T Consensus       208 ~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (360)
T 3eqc_A          208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE  287 (360)
T ss_dssp             SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHS
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhcc
Confidence            999999999999999999999997532211                                         112223333


Q ss_pred             CCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          119 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       119 ~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                      ..+......+++.+++||.+||. +|.+|||+.++|+||||+...+
T Consensus       288 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          288 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             CCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             CCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence            33333445578899999999996 8999999999999999986443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.95  E-value=8.9e-28  Score=235.58  Aligned_cols=155  Identities=26%  Similarity=0.497  Sum_probs=106.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++......  ......||+.|+|||++. ..
T Consensus       112 ~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  188 (278)
T 3cok_A          112 NEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA  188 (278)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEEC-TTCCEEECCCTTCEECC-------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEc-CCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCC
Confidence            467899999999999999999  99999999999997 6789999999999776432  233457899999999884 45


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++||||||+++|+|++|+.||........ ...+..  .....+...++.+++||.+||. +|.+||++.++|+|||
T Consensus       189 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  265 (278)
T 3cok_A          189 HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKVVL--ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF  265 (278)
T ss_dssp             ---CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCS--SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTT
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHHhh--cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcc
Confidence            88999999999999999999999976443322 222211  1223455678999999999996 8999999999999999


Q ss_pred             CCCCC
Q 010626          158 LVTDN  162 (505)
Q Consensus       158 f~~~~  162 (505)
                      |....
T Consensus       266 ~~~~~  270 (278)
T 3cok_A          266 MSRNS  270 (278)
T ss_dssp             TC---
T ss_pred             ccCCC
Confidence            97643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.95  E-value=2.3e-27  Score=235.38  Aligned_cols=156  Identities=24%  Similarity=0.490  Sum_probs=130.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCcccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYEE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll~~   77 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++......    ......||+.|+|||++.+
T Consensus       109 ~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  185 (305)
T 2wtk_C          109 CQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG  185 (305)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEc-CCCcEEeeccccccccCccccccccccCCCCCCCcChhhccC
Confidence            367889999999999999999  99999999999997 6789999999999776432    1234568999999998853


Q ss_pred             ---cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           78 ---EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        78 ---~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                         .++.++||||||+++|+|++|..||.. .+.......+..+..  .++..+++.+.+||.+||. +|.+||++.+++
T Consensus       186 ~~~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~i~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  262 (305)
T 2wtk_C          186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKGSY--AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIR  262 (305)
T ss_dssp             CSCEESHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHCCC--CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             cccCCcchhhHHHHHHHHHHHHhCCCCCCC-chHHHHHHHHhcCCC--CCCCccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence               247899999999999999999999986 455666666666533  3456678999999999996 899999999999


Q ss_pred             cCCCCCCCCC
Q 010626          154 KDPFLVTDNP  163 (505)
Q Consensus       154 ~hpff~~~~~  163 (505)
                      +||||+...+
T Consensus       263 ~~~~~~~~~~  272 (305)
T 2wtk_C          263 QHSWFRKKHP  272 (305)
T ss_dssp             HSHHHHSCCC
T ss_pred             cCcccccCCC
Confidence            9999986543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.95  E-value=1.6e-27  Score=245.67  Aligned_cols=156  Identities=32%  Similarity=0.444  Sum_probs=121.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc--ccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~--~~y   79 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++...... .....||+.|+|||++.  ..+
T Consensus       144 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~  219 (371)
T 4exu_A          144 EKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARHADAE-MTGYVVTRWYRAPEVILSWMHY  219 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECSTTCC---------CTTCCCTTSCHHHHSCCSCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEEC-CCCCEEEEecCcccccccC-cCCcccCccccCHHHhcCCCCC
Confidence            467899999999999999999  99999999999997 7789999999999765433 34567899999999884  468


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC----------------------C------CCCCCCChH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----------------------A------SLSKVTDPQ  131 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p----------------------~------~~~~~~s~~  131 (505)
                      +.++|||||||++|+|++|+.||.+..........+.....+                      .      ......++.
T Consensus       220 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
T 4exu_A          220 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQ  299 (371)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHH
T ss_pred             CcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChH
Confidence            999999999999999999999998754333333222211110                      0      012345789


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      +.+||.+||. +|.+|||+.|+|+||||+..
T Consensus       300 ~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          300 AADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence            9999999996 89999999999999999754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.95  E-value=1.2e-27  Score=256.74  Aligned_cols=158  Identities=31%  Similarity=0.474  Sum_probs=133.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC--CcEEEeecCceeeccCC-CCccccCCCcccCccccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN--GEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~--g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~~~   78 (505)
                      ..++.+++||+.||.|||++|  |+||||||+||+++...  ..+||+|||++...... ......||+.|+|||++.+.
T Consensus       146 ~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  223 (504)
T 3q5i_A          146 CDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK  223 (504)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccC
Confidence            367899999999999999999  99999999999997432  26999999999876543 33456799999999999888


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      |+.++|||||||++|+|++|..||.+ .+...+...+..+.....  ....+++.+++||.+||. +|.+|||+.|+|+|
T Consensus       224 ~~~~~DiwslG~il~~ll~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          224 YNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCchHHHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            99999999999999999999999987 456667777776644322  224578999999999996 89999999999999


Q ss_pred             CCCCCCC
Q 010626          156 PFLVTDN  162 (505)
Q Consensus       156 pff~~~~  162 (505)
                      |||+...
T Consensus       303 ~~~~~~~  309 (504)
T 3q5i_A          303 RWIKKYA  309 (504)
T ss_dssp             HHHHHTC
T ss_pred             Hhhhhch
Confidence            9997643

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.95  E-value=9.3e-28  Score=237.23  Aligned_cols=161  Identities=30%  Similarity=0.553  Sum_probs=121.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-------CCccccCCCcccCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-------TARSVIGTPEFMAPEL   74 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-------~~~~~~Gt~~Y~APEl   74 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++......       ......||+.|+|||+
T Consensus       121 ~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (303)
T 2vwi_A          121 STIATILREVLEGLEYLHKNG--QIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV  197 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEC-TTCCEEECCCHHHHHCC---------------CCCTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEc-CCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHH
Confidence            367889999999999999999  99999999999997 6789999999998654322       1234578999999998


Q ss_pred             cc--ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-------CCCCCCCChHHHHHHHHhcC-CCC
Q 010626           75 YE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------ASLSKVTDPQVKQFIEKCIV-PAS  144 (505)
Q Consensus        75 l~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-------~~~~~~~s~~l~~LI~kcL~-dP~  144 (505)
                      +.  ..++.++||||||+++|+|++|+.||............+......       ......+++.+.+||.+||. +|.
T Consensus       198 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  277 (303)
T 2vwi_A          198 MEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPE  277 (303)
T ss_dssp             HHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGG
T ss_pred             hccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChh
Confidence            84  458999999999999999999999998755444433333222111       12234567899999999996 899


Q ss_pred             CCCCHHHHhcCCCCCCCCCCC
Q 010626          145 LRLPALELLKDPFLVTDNPKD  165 (505)
Q Consensus       145 ~RpSa~ElL~hpff~~~~~~~  165 (505)
                      +||++.++++||||+....+.
T Consensus       278 ~Rps~~~ll~h~~~~~~~~~~  298 (303)
T 2vwi_A          278 KRPTAAELLRHKFFQKAKNKE  298 (303)
T ss_dssp             GSCCHHHHHTSTTC-------
T ss_pred             hCcCHHHHhhChhhhcCCCCc
Confidence            999999999999998765543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.95  E-value=7.6e-28  Score=249.38  Aligned_cols=155  Identities=28%  Similarity=0.399  Sum_probs=127.2

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe-CCCCcEEEeecCceeeccCCC-CccccCCCcccCccccc-ccC
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EEY   79 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld-~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~-~~y   79 (505)
                      .++.++.||+.||.|||++|  |+||||||+|||+. ..++.+||+|||++....... .....||+.|+|||++. ..+
T Consensus       188 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  265 (373)
T 2x4f_A          188 DTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV  265 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBC
T ss_pred             HHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCC
Confidence            56789999999999999999  99999999999984 256789999999998765432 33457999999999884 568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      +.++|||||||++|+|++|..||.+. +.......+......  ......+++++++||.+||. +|.+|||+.|+|+||
T Consensus       266 ~~~~DiwslG~il~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp  344 (373)
T 2x4f_A          266 SFPTDMWSVGVIAYMLLSGLSPFLGD-NDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHP  344 (373)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             CcHHhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence            89999999999999999999999874 444444555443222  12234568999999999996 899999999999999


Q ss_pred             CCCC
Q 010626          157 FLVT  160 (505)
Q Consensus       157 ff~~  160 (505)
                      ||..
T Consensus       345 ~~~~  348 (373)
T 2x4f_A          345 WLSD  348 (373)
T ss_dssp             HHHC
T ss_pred             CcCC
Confidence            9975

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.95  E-value=5.2e-28  Score=241.75  Aligned_cols=151  Identities=28%  Similarity=0.444  Sum_probs=120.6

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--------------CccccCCCc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--------------ARSVIGTPE   68 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--------------~~~~~Gt~~   68 (505)
                      .++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++.......              .....||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEe-CCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            47889999999999999999  99999999999997 67899999999998765431              233469999


Q ss_pred             ccCcccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCC
Q 010626           69 FMAPELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLR  146 (505)
Q Consensus        69 Y~APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~R  146 (505)
                      |+|||++ ...++.++|||||||++|+|++|..|+..   .......+.....+. .....++.+.+||.+||. +|.+|
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R  317 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPL-LFTQKYPQEHMMVQDMLSPSPTER  317 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCH-HHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCc-ccccCChhHHHHHHHHccCCCCcC
Confidence            9999988 45689999999999999999998776532   333334444333221 222345788999999996 89999


Q ss_pred             CCHHHHhcCCCCCC
Q 010626          147 LPALELLKDPFLVT  160 (505)
Q Consensus       147 pSa~ElL~hpff~~  160 (505)
                      ||+.|+|+||||+.
T Consensus       318 ps~~~~l~~~~f~~  331 (332)
T 3qd2_B          318 PEATDIIENAIFEN  331 (332)
T ss_dssp             CCHHHHHHSTTCCC
T ss_pred             CCHHHHhhchhhhc
Confidence            99999999999974

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.95  E-value=3.6e-27  Score=233.22  Aligned_cols=158  Identities=27%  Similarity=0.451  Sum_probs=130.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc----
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE----   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~----   76 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++...... ......|++.|+|||++.    
T Consensus       124 ~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  200 (298)
T 1phk_A          124 KETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN  200 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEc-CCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccc
Confidence            467889999999999999999  99999999999997 7789999999999776543 234457999999999873    


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--LSKVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--~~~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                         ..++.++||||||+++|+|++|..||... +.......+..+.....  ....+++.+.+||.+||. +|.+|||+.
T Consensus       201 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  279 (298)
T 1phk_A          201 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE  279 (298)
T ss_dssp             TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             cccccCCcccccHhHHHHHHHHHHCCCCCcCc-cHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHH
Confidence               34788999999999999999999999764 45555555555533322  224568899999999996 899999999


Q ss_pred             HHhcCCCCCCCCC
Q 010626          151 ELLKDPFLVTDNP  163 (505)
Q Consensus       151 ElL~hpff~~~~~  163 (505)
                      ++|+||||+....
T Consensus       280 ~ll~h~~~~~~~~  292 (298)
T 1phk_A          280 EALAHPFFQQYVV  292 (298)
T ss_dssp             HHTTSGGGCTTC-
T ss_pred             HHHhChHhhhccc
Confidence            9999999986543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.95  E-value=2.3e-27  Score=231.64  Aligned_cols=152  Identities=26%  Similarity=0.435  Sum_probs=121.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC------------------CCCcEEEeecCceeeccCCCCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------------------NNGEVKIGDLGLAIVMQQPTARSV   63 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~------------------~~g~vKL~DFGlA~~~~~~~~~~~   63 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++.                  ....+||+|||.+.......  ..
T Consensus       115 ~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--~~  190 (289)
T 1x8b_A          115 AELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ--VE  190 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC--CC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc--cc
Confidence            467899999999999999999  999999999999962                  23479999999998765432  34


Q ss_pred             cCCCcccCcccccc--cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC
Q 010626           64 IGTPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV  141 (505)
Q Consensus        64 ~Gt~~Y~APEll~~--~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~  141 (505)
                      .||+.|+|||++.+  .++.++|||||||++|+|++|..|+...    .....+..+..+ .++..+++.+.+||.+||.
T Consensus       191 ~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~  265 (289)
T 1x8b_A          191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEIRQGRLP-RIPQVLSQEFTELLKVMIH  265 (289)
T ss_dssp             CCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHHHTTCCC-CCSSCCCHHHHHHHHHHTC
T ss_pred             CCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHHHcCCCC-CCCcccCHHHHHHHHHHhC
Confidence            69999999998854  3557999999999999999998777542    223344444333 4566788999999999996


Q ss_pred             -CCCCCCCHHHHhcCCCCCCCC
Q 010626          142 -PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       142 -dP~~RpSa~ElL~hpff~~~~  162 (505)
                       +|.+|||+.++|+||||+...
T Consensus       266 ~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          266 PDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             SSGGGSCCHHHHHTCTTC----
T ss_pred             CCcccCCCHHHHhhChHhhhhc
Confidence             899999999999999998643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.94  E-value=1.8e-27  Score=242.53  Aligned_cols=148  Identities=22%  Similarity=0.380  Sum_probs=123.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccccc-cC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEE-EY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~~-~y   79 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++....... .....||+.|+|||++.+ .+
T Consensus       130 ~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  206 (335)
T 3dls_A          130 PLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPY  206 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCB
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEc-CCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCC
Confidence            467889999999999999999  99999999999998 67899999999998765433 345679999999998843 44


Q ss_pred             -CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           80 -NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        80 -s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                       +.++|||||||++|+|++|..||.....       ..  ......+..+++.+.+||.+||. +|.+|||+.++|+|||
T Consensus       207 ~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~  277 (335)
T 3dls_A          207 RGPELEMWSLGVTLYTLVFEENPFCELEE-------TV--EAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW  277 (335)
T ss_dssp             CSHHHHHHHHHHHHHHHHHSSCSCSSGGG-------GT--TTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred             CCCcccchhHHHHHHHHHhCCCchhhHHH-------HH--hhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence             7899999999999999999999975211       11  11223345578999999999996 7999999999999999


Q ss_pred             CCCC
Q 010626          158 LVTD  161 (505)
Q Consensus       158 f~~~  161 (505)
                      |+..
T Consensus       278 ~~~~  281 (335)
T 3dls_A          278 VTQP  281 (335)
T ss_dssp             TTCC
T ss_pred             ccCC
Confidence            9763

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.94  E-value=2.6e-27  Score=254.06  Aligned_cols=154  Identities=27%  Similarity=0.517  Sum_probs=131.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccccc-C
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYEEE-Y   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~~~-y   79 (505)
                      +.++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++...... .....+||+.|+|||++.+. +
T Consensus       116 ~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~-~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  192 (476)
T 2y94_A          116 KESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY  192 (476)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCB
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEe-cCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCC
Confidence            467899999999999999999  99999999999998 6789999999999876543 34456899999999988543 3


Q ss_pred             -CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           80 -NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        80 -s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                       +.++|||||||++|+|++|+.||... +...++..+..+..  ..+...++.+++||.+||. +|.+|||+.++++|||
T Consensus       193 ~~~~~DiwSlGvil~elltG~~Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~  269 (476)
T 2y94_A          193 AGPEVDIWSSGVILYALLCGTLPFDDD-HVPTLFKKICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW  269 (476)
T ss_dssp             CSHHHHHHHHHHHHHHHHHSSCSSCCS-SSHHHHHHHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred             CCCcceehhhHHHHHHHhhCCCCCCCC-CHHHHHHHHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence             68999999999999999999999874 45566677766543  2455678999999999996 8999999999999999


Q ss_pred             CCCC
Q 010626          158 LVTD  161 (505)
Q Consensus       158 f~~~  161 (505)
                      |+..
T Consensus       270 ~~~~  273 (476)
T 2y94_A          270 FKQD  273 (476)
T ss_dssp             HHTT
T ss_pred             hhhc
Confidence            9864

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.94  E-value=1.1e-27  Score=244.21  Aligned_cols=158  Identities=26%  Similarity=0.402  Sum_probs=119.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeC-----CCCcEEEeecCceeeccCCCCccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNG-----NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~-g~~IiHrDLKp~NILld~-----~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll   75 (505)
                      ..++.++.||+.||+|||++ |  |+||||||+|||++.     ..+.+||+|||++...... .....||+.|+|||++
T Consensus       131 ~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~  207 (373)
T 1q8y_A          131 IYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVL  207 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-CCCCCCCccccCcHHH
Confidence            36788999999999999998 9  999999999999952     3347999999999876543 3345799999999988


Q ss_pred             -cccCCcccchhhHHHHHHHHhhcCCCCCCCCC-----hHHHHHHHHc--CCCC--------------------------
Q 010626           76 -EEEYNELVDIYSFGMCILEMVTCEYPYNECKN-----PAQIYKKVTS--GIKP--------------------------  121 (505)
Q Consensus        76 -~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~-----~~~i~~~i~~--~~~p--------------------------  121 (505)
                       ...++.++|||||||++|+|+||+.||.....     .......+..  +..|                          
T Consensus       208 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (373)
T 1q8y_A          208 LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL  287 (373)
T ss_dssp             HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCC
T ss_pred             hCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccc
Confidence             45689999999999999999999999975321     1111111111  0000                          


Q ss_pred             ------------CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          122 ------------ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       122 ------------~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                                  ..++...++.+.+||.+||. +|.+|||+.|+|+||||+...
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          288 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             CBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             cccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence                        01222345688999999996 899999999999999998643

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.94  E-value=2.9e-27  Score=241.01  Aligned_cols=156  Identities=31%  Similarity=0.443  Sum_probs=121.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc--ccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~--~~y   79 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++...... .....||+.|+|||++.  ..+
T Consensus       126 ~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~  201 (353)
T 3coi_A          126 EKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVN-EDCELKILDFGLARHADAE-MTGYVVTRWYRAPEVILSWMHY  201 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-TTCCEEECSTTCTTC---------CCSBCCSCHHHHSCCSCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeEC-CCCcEEEeecccccCCCCC-ccccccCcCcCCHHHHhCcCCC
Confidence            467899999999999999999  99999999999998 6789999999999765432 33457899999999874  468


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc----------------------CC------CCCCCCCCCChH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS----------------------GI------KPASLSKVTDPQ  131 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~----------------------~~------~p~~~~~~~s~~  131 (505)
                      +.++|||||||++|+|++|+.||.+......+...+..                      ..      .........++.
T Consensus       202 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (353)
T 3coi_A          202 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQ  281 (353)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHH
T ss_pred             CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHH
Confidence            99999999999999999999999874433322222110                      00      001123356889


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      +.+||.+||. +|.+|||+.++|+||||+..
T Consensus       282 ~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          282 AADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            9999999996 89999999999999999753

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.94  E-value=1.6e-27  Score=240.32  Aligned_cols=149  Identities=21%  Similarity=0.421  Sum_probs=125.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-cc-C
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EE-Y   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~-y   79 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++..++.+||+|||++............||+.|+|||++. .. +
T Consensus       149 ~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  226 (320)
T 3a99_A          149 ELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYH  226 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeCCCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCC
Confidence            367889999999999999999  9999999999999866789999999999887766556678999999999884 33 4


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +.++||||||+++|+|++|+.||...   ..    +...  ...++..+++.+.+||.+||. +|.+|||+.++++||||
T Consensus       227 ~~~~Di~slG~il~el~~g~~pf~~~---~~----~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~  297 (320)
T 3a99_A          227 GRSAAVWSLGILLYDMVCGDIPFEHD---EE----IIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM  297 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCSCCSH---HH----HHHC--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             CccchHHhHHHHHHHHHHCCCCCCCh---hh----hhcc--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence            68899999999999999999999652   21    2222  123455678999999999996 89999999999999999


Q ss_pred             CCC
Q 010626          159 VTD  161 (505)
Q Consensus       159 ~~~  161 (505)
                      +..
T Consensus       298 ~~~  300 (320)
T 3a99_A          298 QDV  300 (320)
T ss_dssp             SSC
T ss_pred             cCc
Confidence            764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.94  E-value=9.6e-28  Score=252.15  Aligned_cols=158  Identities=27%  Similarity=0.507  Sum_probs=123.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccCCC-CccccCCCcccCccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE--   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~--   76 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++.  .++.+||+|||+++...... .....||+.|+|||++.  
T Consensus       239 ~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  316 (419)
T 3i6u_A          239 ATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV  316 (419)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC--
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecC
Confidence            467889999999999999999  999999999999963  23459999999997765432 34567999999999873  


Q ss_pred             --ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC--CCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           77 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        77 --~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                        ..|+.++|||||||++|+|++|..||........+...+..+..+.  ......++.+.+||.+||. +|.+|||+.+
T Consensus       317 ~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  396 (419)
T 3i6u_A          317 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE  396 (419)
T ss_dssp             --CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHH
Confidence              4588899999999999999999999987555545555555553322  1224568899999999996 8999999999


Q ss_pred             HhcCCCCCCC
Q 010626          152 LLKDPFLVTD  161 (505)
Q Consensus       152 lL~hpff~~~  161 (505)
                      +|+||||+..
T Consensus       397 ~l~hp~~~~~  406 (419)
T 3i6u_A          397 ALRHPWLQDE  406 (419)
T ss_dssp             HHHSGGGCCH
T ss_pred             HhCCcccCCh
Confidence            9999999753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.94  E-value=2.2e-27  Score=236.56  Aligned_cols=156  Identities=25%  Similarity=0.513  Sum_probs=122.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc---
Q 010626            2 KAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE---   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~-g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~---   76 (505)
                      ..++.++.||+.||.|||++ |  ++||||||+||+++ .++.+||+|||++...... ......||+.|+|||++.   
T Consensus       124 ~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  200 (318)
T 2dyl_A          124 RILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD  200 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEEC-TTSCEEECCCTTC--------------CCTTCCHHHHC---
T ss_pred             HHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEEC-CCCCEEEEECCCchhccCCccccccCCCccccChhhccccc
Confidence            36788999999999999995 9  99999999999997 6789999999999765433 233457899999999873   


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC-CCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS-LSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~-~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                         ..++.++||||||+++|+|++|+.||............+.....+.. ....+++.+.+||.+||. +|.+||++.+
T Consensus       201 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  280 (318)
T 2dyl_A          201 PTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK  280 (318)
T ss_dssp             -----CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred             ccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence               35889999999999999999999999876666666666665544322 223578999999999995 8999999999


Q ss_pred             HhcCCCCCC
Q 010626          152 LLKDPFLVT  160 (505)
Q Consensus       152 lL~hpff~~  160 (505)
                      +++||||+.
T Consensus       281 ll~h~~~~~  289 (318)
T 2dyl_A          281 LLEHSFIKR  289 (318)
T ss_dssp             HTTSHHHHH
T ss_pred             HhhCHHHHh
Confidence            999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.94  E-value=1.4e-27  Score=237.30  Aligned_cols=157  Identities=28%  Similarity=0.454  Sum_probs=124.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----CCccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----~~~~~~Gt~~Y~APEll~   76 (505)
                      +.++.++.||+.||+|||++|  |+||||||+||+++..++.+||+|||++......     ......+++.|+|||++.
T Consensus       120 ~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (320)
T 2i6l_A          120 EHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL  197 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhc
Confidence            467889999999999999999  9999999999999866779999999999765322     223446799999999773


Q ss_pred             --ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC----------------------------CCCCC
Q 010626           77 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP----------------------------ASLSK  126 (505)
Q Consensus        77 --~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p----------------------------~~~~~  126 (505)
                        ..++.++||||||+++|+|++|+.||...... .....+......                            .....
T Consensus       198 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (320)
T 2i6l_A          198 SPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLP  276 (320)
T ss_dssp             CTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHST
T ss_pred             CcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcc
Confidence              56899999999999999999999999875433 333333221110                            01123


Q ss_pred             CCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          127 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       127 ~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      .+++.+++||.+||. +|.+|||+.++|+||||+..
T Consensus       277 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          277 GISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             TCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             hhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence            468899999999996 89999999999999999754

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.94  E-value=6e-28  Score=248.86  Aligned_cols=155  Identities=30%  Similarity=0.421  Sum_probs=114.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..++.++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++...... ......||+.|+|||++ ...|
T Consensus       127 ~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  203 (371)
T 2xrw_A          127 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY  203 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCC----------------CTTCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEc-CCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCC
Confidence            467889999999999999999  99999999999998 6789999999999766443 23445799999999988 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC--------------------CC--------------C
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--------------------SL--------------S  125 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~--------------------~~--------------~  125 (505)
                      +.++|||||||++|+|++|+.||.+.... ..+..+......+                    .+              +
T Consensus       204 ~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (371)
T 2xrw_A          204 KENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFP  282 (371)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSC
T ss_pred             CchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCc
Confidence            99999999999999999999999875433 3333333221100                    00              0


Q ss_pred             C------CCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          126 K------VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       126 ~------~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      .      ..++.+++||.+||. +|.+|||+.|+|+||||+.
T Consensus       283 ~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  324 (371)
T 2xrw_A          283 ADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  324 (371)
T ss_dssp             CSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence            0      014678999999996 8999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.94  E-value=1.9e-27  Score=239.13  Aligned_cols=159  Identities=27%  Similarity=0.512  Sum_probs=127.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEeecCceeeccCCC-CccccCCCcccCcccc---
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY---   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~--~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll---   75 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++..  .+.+||+|||++....... .....||+.|+|||++   
T Consensus       114 ~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  191 (322)
T 2ycf_A          114 ATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV  191 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccC
Confidence            367889999999999999999  9999999999999732  2349999999998765432 2345699999999987   


Q ss_pred             -cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC--CCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           76 -EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        76 -~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                       ...++.++|||||||++|+|++|..||........+...+..+....  ......++.+.+||.+||. +|.+||++.+
T Consensus       192 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~  271 (322)
T 2ycf_A          192 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEE  271 (322)
T ss_dssp             TTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHH
Confidence             34588999999999999999999999987554444455555443321  1224568899999999996 8999999999


Q ss_pred             HhcCCCCCCCC
Q 010626          152 LLKDPFLVTDN  162 (505)
Q Consensus       152 lL~hpff~~~~  162 (505)
                      +|+||||+...
T Consensus       272 ~l~h~~~~~~~  282 (322)
T 2ycf_A          272 ALRHPWLQDED  282 (322)
T ss_dssp             HHTSGGGCCHH
T ss_pred             HhhCcCcCCHH
Confidence            99999998643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.94  E-value=5.2e-27  Score=232.33  Aligned_cols=154  Identities=31%  Similarity=0.551  Sum_probs=129.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++......  ......||+.|+|||++. ..
T Consensus       115 ~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  191 (294)
T 2rku_A          115 PEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG  191 (294)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEc-CCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCC
Confidence            467889999999999999999  99999999999998 6789999999999776432  234457999999999884 45


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++||||||+++|+|++|+.||... .....+..+....  ..++...++.+.+||.+||. +|.+|||+.++++|||
T Consensus       192 ~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~  268 (294)
T 2rku_A          192 HSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF  268 (294)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhhcc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence            889999999999999999999999763 4444555555443  23456678999999999996 8999999999999999


Q ss_pred             CCCC
Q 010626          158 LVTD  161 (505)
Q Consensus       158 f~~~  161 (505)
                      |...
T Consensus       269 ~~~~  272 (294)
T 2rku_A          269 FTSG  272 (294)
T ss_dssp             HHTS
T ss_pred             eecC
Confidence            9753

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.94  E-value=2.6e-27  Score=241.56  Aligned_cols=157  Identities=26%  Similarity=0.403  Sum_probs=117.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc--cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~--~~   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++...... ......||+.|+|||++.  ..
T Consensus       134 ~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  210 (362)
T 3pg1_A          134 QHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKG  210 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCTTC---------------CGGGCCHHHHTTCTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEEEc-CCCCEEEEecCcccccccccccceecccceecCcHHhcCCCC
Confidence            467899999999999999999  99999999999997 6789999999999754333 234457899999999874  46


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-----------------------------CCCCCCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-----------------------------ASLSKVTD  129 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-----------------------------~~~~~~~s  129 (505)
                      ++.++|||||||++|+|++|+.||.+..........+.....+                             .......+
T Consensus       211 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (362)
T 3pg1_A          211 FTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTAD  290 (362)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSC
T ss_pred             CCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCC
Confidence            8999999999999999999999998754333322222110000                             00123457


Q ss_pred             hHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          130 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       130 ~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      +.+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus       291 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          291 PVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence            889999999996 89999999999999999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.94  E-value=3.9e-27  Score=232.03  Aligned_cols=155  Identities=35%  Similarity=0.524  Sum_probs=120.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----------------CCccccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----------------TARSVIG   65 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----------------~~~~~~G   65 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++......                ......|
T Consensus       116 ~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (303)
T 1zy4_A          116 DEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG  192 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCCCCCSCTTC------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEc-CCCCEEEeeCcchhhcccccchhccccccccccccccccCCC
Confidence            467889999999999999999  99999999999997 6789999999999765321                1234568


Q ss_pred             CCcccCcccccc--cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC--CCCCCCCCCCChHHHHHHHHhcC
Q 010626           66 TPEFMAPELYEE--EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG--IKPASLSKVTDPQVKQFIEKCIV  141 (505)
Q Consensus        66 t~~Y~APEll~~--~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~--~~p~~~~~~~s~~l~~LI~kcL~  141 (505)
                      ++.|+|||++.+  .++.++|||||||++|+|++   ||............+...  ..+..+....++.+++||.+||.
T Consensus       193 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  269 (303)
T 1zy4_A          193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLID  269 (303)
T ss_dssp             -CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTC
T ss_pred             cccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHh
Confidence            999999998843  58999999999999999998   665433344455555443  22444556667889999999996


Q ss_pred             -CCCCCCCHHHHhcCCCCCCCC
Q 010626          142 -PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       142 -dP~~RpSa~ElL~hpff~~~~  162 (505)
                       +|.+|||+.++++||||+...
T Consensus       270 ~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          270 HDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             SSGGGSCCHHHHHHSSCSCCCC
T ss_pred             cCcccCcCHHHHhCCCCcCCCC
Confidence             899999999999999997543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.94  E-value=9.4e-28  Score=242.55  Aligned_cols=157  Identities=29%  Similarity=0.473  Sum_probs=121.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEE--   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~~--   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......  ......||+.|+|||++.+  
T Consensus       124 ~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  200 (331)
T 4aaa_A          124 QVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV  200 (331)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCTTC------------CCCCCTTCCHHHHTTCT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEc-CCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCC
Confidence            467899999999999999999  99999999999997 6789999999999765432  2334578999999998854  


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC-------------------CCCCC---------CCCCCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-------------------IKPAS---------LSKVTD  129 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~-------------------~~p~~---------~~~~~s  129 (505)
                      .++.++|||||||++|+|++|+.||............+...                   .....         ....++
T Consensus       201 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (331)
T 4aaa_A          201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLS  280 (331)
T ss_dssp             TCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSC
T ss_pred             CcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchh
Confidence            58999999999999999999999998755444443332210                   00000         012457


Q ss_pred             hHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          130 PQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       130 ~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      +.+.+||.+||. +|.+|||+.|+|+||||+..
T Consensus       281 ~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          281 EVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             HHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            899999999996 89999999999999999764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.94  E-value=6.7e-27  Score=235.41  Aligned_cols=156  Identities=35%  Similarity=0.609  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.++.||+.||+|||++|++|+||||||+||+++ .++.+||+|||++......  ......||+.|+|||++. ..
T Consensus       137 ~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  215 (309)
T 3p86_A          137 RRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP  215 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC-TTCCEEECCCC-----------------CCTTSCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe-CCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCC
Confidence            3578899999999999999988899999999999997 6789999999999755433  234457999999999884 55


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc--C
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK--D  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~--h  155 (505)
                      ++.++|||||||++|+|++|+.||.. .+.......+........++..+++.+.+||.+||. +|.+|||+.++++  +
T Consensus       216 ~~~~~DiwslG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~  294 (309)
T 3p86_A          216 SNEKSDVYSFGVILWELATLQQPWGN-LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR  294 (309)
T ss_dssp             CCTTHHHHHHHHHHHHHHHCCCTTTT-SCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            89999999999999999999999986 455556666655555556777889999999999996 8999999999987  4


Q ss_pred             CCCC
Q 010626          156 PFLV  159 (505)
Q Consensus       156 pff~  159 (505)
                      ++++
T Consensus       295 ~~~~  298 (309)
T 3p86_A          295 PLIK  298 (309)
T ss_dssp             HHHC
T ss_pred             HHHH
Confidence            5543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.94  E-value=7.9e-27  Score=231.96  Aligned_cols=155  Identities=34%  Similarity=0.621  Sum_probs=130.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......  .....|++.|+|||++ ...
T Consensus       119 ~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  195 (303)
T 3a7i_A          119 TQIATILREILKGLDYLHSEK--KIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA  195 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEEC-CCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCC
Confidence            467889999999999999999  99999999999997 67899999999997765432  3445799999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++||||||+++|+|++|+.||... ........+..... ..+...+++.+.+||.+||. +|.+|||+.++++|||
T Consensus       196 ~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          196 YDSKADIWSLGITAIELARGEPPHSEL-HPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCC-CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             CCchhhhHHHHHHHHHHccCCCCCCCc-CHHHHHHHhhcCCC-CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence            889999999999999999999999764 44444455544433 34566788999999999996 8999999999999999


Q ss_pred             CCCC
Q 010626          158 LVTD  161 (505)
Q Consensus       158 f~~~  161 (505)
                      |...
T Consensus       274 ~~~~  277 (303)
T 3a7i_A          274 ILRN  277 (303)
T ss_dssp             HHHH
T ss_pred             hhcC
Confidence            9753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.94  E-value=5.6e-27  Score=237.84  Aligned_cols=154  Identities=31%  Similarity=0.554  Sum_probs=129.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......  ......||+.|+|||++ ...
T Consensus       141 ~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  217 (335)
T 2owb_A          141 PEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG  217 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEc-CCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCC
Confidence            467889999999999999999  99999999999998 6789999999999876432  23445799999999988 455


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      ++.++||||||+++|+|++|+.||... .....+..+.....  .++..+++.+.+||.+||. +|.+||++.++|+|||
T Consensus       218 ~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~  294 (335)
T 2owb_A          218 HSFEVDVWSIGCIMYTLLVGKPPFETS-CLKETYLRIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF  294 (335)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHHTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             CCchhhHHHHHHHHHHHHHCcCCCCCC-CHHHHHHHHhcCCC--CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            889999999999999999999999763 44455555554432  3456678999999999996 8999999999999999


Q ss_pred             CCCC
Q 010626          158 LVTD  161 (505)
Q Consensus       158 f~~~  161 (505)
                      |...
T Consensus       295 ~~~~  298 (335)
T 2owb_A          295 FTSG  298 (335)
T ss_dssp             HHTS
T ss_pred             ccCC
Confidence            9764

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.94  E-value=1.5e-27  Score=242.74  Aligned_cols=157  Identities=24%  Similarity=0.422  Sum_probs=105.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccCCCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++.  .++.+||+|||++............||+.|+|||++ ...
T Consensus       128 ~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  205 (336)
T 3fhr_A          128 REAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEK  205 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------CH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhhCCCC
Confidence            468899999999999999999  999999999999973  245699999999987766555667899999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHH---HHHHHHcC--CCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQ---IYKKVTSG--IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~---i~~~i~~~--~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                      ++.++||||||+++|+|++|..||........   ....+...  ..+......+++.+++||.+||. +|.+|||+.++
T Consensus       206 ~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  285 (336)
T 3fhr_A          206 YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF  285 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            88999999999999999999999975432211   11122211  11222334678999999999996 89999999999


Q ss_pred             hcCCCCCC
Q 010626          153 LKDPFLVT  160 (505)
Q Consensus       153 L~hpff~~  160 (505)
                      |+||||+.
T Consensus       286 l~hp~~~~  293 (336)
T 3fhr_A          286 MNHPWINQ  293 (336)
T ss_dssp             HHSHHHHT
T ss_pred             hcCccccc
Confidence            99999975

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.94  E-value=3.1e-27  Score=231.14  Aligned_cols=155  Identities=24%  Similarity=0.485  Sum_probs=122.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCccccccc-C
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEE-Y   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~~~-y   79 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++....... .....|++.|+|||++.+. +
T Consensus       111 ~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  187 (276)
T 2h6d_A          111 MEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY  187 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEEC-TTSCEEECCCCGGGCCCC-------------CCTGGGTTSCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEEC-CCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCC
Confidence            367889999999999999999  99999999999998 67899999999997664432 3345789999999988543 3


Q ss_pred             -CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           80 -NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        80 -s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                       +.++||||||+++|+|++|+.||.. .........+..+..+  ++...++.+.+||.+||. +|.+|||+.++++|||
T Consensus       188 ~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~  264 (276)
T 2h6d_A          188 AGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFY--IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW  264 (276)
T ss_dssp             CHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             CCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcCccc--CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence             5899999999999999999999976 4555666666665432  455678999999999996 8999999999999999


Q ss_pred             CCCCC
Q 010626          158 LVTDN  162 (505)
Q Consensus       158 f~~~~  162 (505)
                      |+...
T Consensus       265 ~~~~~  269 (276)
T 2h6d_A          265 FKQDL  269 (276)
T ss_dssp             HHTTC
T ss_pred             hccCc
Confidence            97643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.94  E-value=2.4e-27  Score=234.29  Aligned_cols=158  Identities=32%  Similarity=0.572  Sum_probs=130.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEeecCceeeccCCC-CccccCCCcccCccccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYEEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~--~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~~~   78 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++..  ++.+||+|||++....... .....|++.|+|||++.+.
T Consensus       121 ~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  198 (287)
T 2wei_A          121 HDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT  198 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcCC
Confidence            467899999999999999999  9999999999999642  3479999999997654432 3344688999999999888


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCC--CCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLS--KVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~--~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      ++.++||||||+++|+|++|..||.. .+...+...+..+..+...+  ..+++.+.+||.+||. +|.+|||+.++|+|
T Consensus       199 ~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          199 YDEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCCchhhHhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            99999999999999999999999987 45556666666664433322  4568899999999996 89999999999999


Q ss_pred             CCCCCCC
Q 010626          156 PFLVTDN  162 (505)
Q Consensus       156 pff~~~~  162 (505)
                      |||+...
T Consensus       278 p~~~~~~  284 (287)
T 2wei_A          278 PWIQKYS  284 (287)
T ss_dssp             HHHHHHC
T ss_pred             HHHhccc
Confidence            9997643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.94  E-value=1.2e-26  Score=231.59  Aligned_cols=150  Identities=22%  Similarity=0.435  Sum_probs=125.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccC-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEY-   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~y-   79 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++..++.+||+|||++............|++.|+|||++. ..+ 
T Consensus       139 ~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  216 (312)
T 2iwi_A          139 GPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYH  216 (312)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCC
Confidence            467889999999999999999  9999999999999866789999999999887766666678999999999884 334 


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +.++||||||+++|+|++|+.||...   ..    +...  ...++...++.+++||.+||. +|.+||++.++++||||
T Consensus       217 ~~~~Di~slG~il~~l~~g~~pf~~~---~~----~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~  287 (312)
T 2iwi_A          217 ALPATVWSLGILLYDMVCGDIPFERD---QE----ILEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM  287 (312)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCSCCSH---HH----HHHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred             CccchHHHHHHHHHHHHHCCCCCCCh---HH----Hhhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence            45899999999999999999999652   21    1222  223456678999999999996 89999999999999999


Q ss_pred             CCCC
Q 010626          159 VTDN  162 (505)
Q Consensus       159 ~~~~  162 (505)
                      +...
T Consensus       288 ~~~~  291 (312)
T 2iwi_A          288 QTPA  291 (312)
T ss_dssp             CC--
T ss_pred             cCch
Confidence            8643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.94  E-value=1.7e-27  Score=239.72  Aligned_cols=157  Identities=27%  Similarity=0.493  Sum_probs=107.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc----
Q 010626            2 KAIKNWARQILRGLHYLHSH-NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY----   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~-g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll----   75 (505)
                      ..++.++.||+.||.|||++ |  ++||||||+||+++ .++.+||+|||++....... .....||+.|+|||++    
T Consensus       125 ~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  201 (327)
T 3aln_A          125 EILGKITLATVKALNHLKENLK--IIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA  201 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEE-TTTEEEECCCSSSCC--------------------------
T ss_pred             HHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEc-CCCCEEEccCCCceecccccccccCCCCccccCceeecccc
Confidence            35788999999999999998 9  99999999999998 77899999999997664432 2334799999999987    


Q ss_pred             -cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC---CCCCCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626           76 -EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus        76 -~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~---~~~~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                       ...++.++||||||+++|+|++|+.||............+..+..+.   .....+++.+.+||.+||. +|.+||++.
T Consensus       202 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  281 (327)
T 3aln_A          202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYK  281 (327)
T ss_dssp             ----CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHH
Confidence             34588999999999999999999999976433322222222222221   1224578999999999996 899999999


Q ss_pred             HHhcCCCCCCC
Q 010626          151 ELLKDPFLVTD  161 (505)
Q Consensus       151 ElL~hpff~~~  161 (505)
                      ++++||||...
T Consensus       282 ell~hp~~~~~  292 (327)
T 3aln_A          282 ELLKHPFILMY  292 (327)
T ss_dssp             HHTTSHHHHHH
T ss_pred             HHHhChHHHHh
Confidence            99999999753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.94  E-value=6.7e-27  Score=234.58  Aligned_cols=159  Identities=21%  Similarity=0.355  Sum_probs=116.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......    .....+++.|+|||++ .
T Consensus       137 ~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  213 (323)
T 3qup_A          137 QTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLA-EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD  213 (323)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC-----------------CCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEc-CCCCEEEeeccccccccccccccccccccCcccccCchhhcC
Confidence            467899999999999999999  99999999999997 67899999999997654322    1233567889999988 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC------
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP------  148 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS------  148 (505)
                      ..++.++|||||||++|+|++ |..||... ....+...+..+..+ ..+...++.+.+||.+||. +|.+|||      
T Consensus       214 ~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  291 (323)
T 3qup_A          214 NLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-ENAEIYNYLIGGNRL-KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM  291 (323)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CCCCCccchhhHHHHHHHHHhCCCCCcccc-ChHHHHHHHhcCCCC-CCCCccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            568999999999999999999 89999874 444555555554433 3455678999999999996 8999999      


Q ss_pred             -HHHHhcCCCCCCCCCCC
Q 010626          149 -ALELLKDPFLVTDNPKD  165 (505)
Q Consensus       149 -a~ElL~hpff~~~~~~~  165 (505)
                       ..+++.|||+.......
T Consensus       292 ~l~~~l~~~~~~~~~~~p  309 (323)
T 3qup_A          292 ELENILGHLSVLSTSQDP  309 (323)
T ss_dssp             HHHHHHHC----------
T ss_pred             HHHHHHHHhhhcCCCCCC
Confidence             77888999998755443

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.94  E-value=1.4e-27  Score=250.36  Aligned_cols=146  Identities=21%  Similarity=0.243  Sum_probs=119.1

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-------
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-------   75 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-------   75 (505)
                      .+..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++..... ....+| +.|+|||++       
T Consensus       212 ~~~~i~~qi~~aL~~LH~~~--iiHrDiKp~NILl~-~~~~~kL~DFG~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~  286 (413)
T 3dzo_A          212 ARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLD-QRGGVFLTGFEHLVRDGAS-AVSPIG-RGFAPPETTAERMLPF  286 (413)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCGGGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTT
T ss_pred             HHHHHHHHHHHHHHHHHhCC--cccCCcccceEEEe-cCCeEEEEeccceeecCCc-cccCCC-CceeCchhhhcccccc
Confidence            56778899999999999999  99999999999998 6789999999999766443 344567 999999987       


Q ss_pred             ---cc-cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626           76 ---EE-EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus        76 ---~~-~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                         .. .|+.++|||||||++|+|+||+.||.... .......+..      ....+++.+++||.+||. +|.+||++.
T Consensus       287 ~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~-~~~~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~  359 (413)
T 3dzo_A          287 GQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA-ALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPL  359 (413)
T ss_dssp             GGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTG-GGSCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             ccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcc-hhhhHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHH
Confidence               22 37889999999999999999999997632 2111122211      112457899999999996 899999999


Q ss_pred             HHhcCCCCCC
Q 010626          151 ELLKDPFLVT  160 (505)
Q Consensus       151 ElL~hpff~~  160 (505)
                      ++++||||+.
T Consensus       360 ~~l~~~~~~~  369 (413)
T 3dzo_A          360 QAMETPEYEQ  369 (413)
T ss_dssp             HHTTSHHHHH
T ss_pred             HHHhCHHHHH
Confidence            9999999975

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.94  E-value=6.9e-27  Score=229.50  Aligned_cols=156  Identities=26%  Similarity=0.436  Sum_probs=124.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC----cEEEeecCceeeccCCC-CccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----EVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g----~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++    .+||+|||++....... .....|++.|+|||++.
T Consensus       108 ~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~-~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~  184 (283)
T 3bhy_A          108 DEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLL-DKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVN  184 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEES-CSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEe-cCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceec
Confidence            467899999999999999999  99999999999997 444    79999999997764432 33457899999999884


Q ss_pred             -ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC--CCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           77 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                       ..++.++||||||+++|+|++|..||... ........+.......  ......++.+.+||.+||. +|.+||++.++
T Consensus       185 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~  263 (283)
T 3bhy_A          185 YEPLGLEADMWSIGVITYILLSGASPFLGE-TKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS  263 (283)
T ss_dssp             TCCCCTHHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             CCCCCcchhhhhHHHHHHHHHHCCCCCCCc-chHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence             56899999999999999999999999864 4445555554443221  1224567899999999996 89999999999


Q ss_pred             hcCCCCCCC
Q 010626          153 LKDPFLVTD  161 (505)
Q Consensus       153 L~hpff~~~  161 (505)
                      |+||||+..
T Consensus       264 l~h~~~~~~  272 (283)
T 3bhy_A          264 LEHSWIKAI  272 (283)
T ss_dssp             HHCHHHHHH
T ss_pred             HhCHHHHHH
Confidence            999999763

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.94  E-value=7e-27  Score=229.00  Aligned_cols=157  Identities=26%  Similarity=0.481  Sum_probs=128.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCC---CCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g---~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-   75 (505)
                      ..++.++.||+.||.|||++|   .+++||||||+||+++ .++.+||+|||++.......  .....|++.|+|||++ 
T Consensus       111 ~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~  189 (279)
T 2w5a_A          111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN  189 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC-SSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc-CCCCEEEecCchheeeccccccccccCCCccccChHHhc
Confidence            367899999999999999976   3499999999999998 67899999999997654332  2234689999999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ...++.++||||||+++|+|++|..||... ....+...+..+..+ .++..+++.+.+||.+||. +|.+||++.++|+
T Consensus       190 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  267 (279)
T 2w5a_A          190 RMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  267 (279)
T ss_dssp             CC-CCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCCCchhhHHHHHHHHHHHHHCCCCCccc-CHHHHHHHHhhcccc-cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            446899999999999999999999999864 455666666666443 4556778999999999996 8999999999999


Q ss_pred             CCCCCCC
Q 010626          155 DPFLVTD  161 (505)
Q Consensus       155 hpff~~~  161 (505)
                      |+|+...
T Consensus       268 ~~~~~~~  274 (279)
T 2w5a_A          268 NPLILEH  274 (279)
T ss_dssp             STTCCGG
T ss_pred             Chhhhhh
Confidence            9999764

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.94  E-value=9.4e-27  Score=246.22  Aligned_cols=154  Identities=29%  Similarity=0.377  Sum_probs=115.6

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC----CCCcEEEeecCceeeccCC-----CCccccCCCcccCccc
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPEL   74 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~----~~g~vKL~DFGlA~~~~~~-----~~~~~~Gt~~Y~APEl   74 (505)
                      ++.++.||+.||.|||++|  |+||||||+|||++.    ....+||+|||++......     ......||+.|+|||+
T Consensus       120 ~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~  197 (432)
T 3p23_A          120 PITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM  197 (432)
T ss_dssp             HHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGG
T ss_pred             HHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhh
Confidence            5689999999999999999  999999999999952    1235889999999766432     2334579999999998


Q ss_pred             cc----ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCC--CCCCCCCChHHHHHHHHhcC-CCCCC
Q 010626           75 YE----EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLR  146 (505)
Q Consensus        75 l~----~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI~kcL~-dP~~R  146 (505)
                      +.    ..++.++|||||||++|+|+| |..||..... .+. ..+......  .......++.+++||.+||. +|.+|
T Consensus       198 l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  275 (432)
T 3p23_A          198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-RQA-NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKR  275 (432)
T ss_dssp             TSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-HHH-HHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGS
T ss_pred             hhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-HHH-HHHhccCCccccCccccccHHHHHHHHHHHhCCHhhC
Confidence            84    357789999999999999999 8999965332 222 222222111  11222335678999999996 89999


Q ss_pred             CCHHHHhcCCCCCCC
Q 010626          147 LPALELLKDPFLVTD  161 (505)
Q Consensus       147 pSa~ElL~hpff~~~  161 (505)
                      ||+.++|+||||...
T Consensus       276 ps~~evl~hp~f~~~  290 (432)
T 3p23_A          276 PSAKHVLKHPFFWSL  290 (432)
T ss_dssp             CCHHHHHTSTTTCCH
T ss_pred             CCHHHHHhCccccCh
Confidence            999999999999753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.94  E-value=3.3e-27  Score=236.48  Aligned_cols=156  Identities=22%  Similarity=0.393  Sum_probs=121.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----CCccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----~~~~~~Gt~~Y~APEll-   75 (505)
                      +.++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......     ......||+.|+|||++ 
T Consensus       116 ~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  192 (311)
T 3ork_A          116 KRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR  192 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTSCEEECCCSCC------------------CCTTCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEc-CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhc
Confidence            467899999999999999999  99999999999998 6789999999999765432     12335689999999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-ASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ...++.++||||||+++|+|++|+.||............+.....+ ......+++.+.+||.+||. +|.+||++.++|
T Consensus       193 ~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l  272 (311)
T 3ork_A          193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM  272 (311)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred             CCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHH
Confidence            4568999999999999999999999998754444444444443222 12234578899999999996 899999999999


Q ss_pred             cCCCCCC
Q 010626          154 KDPFLVT  160 (505)
Q Consensus       154 ~hpff~~  160 (505)
                      .|+|++.
T Consensus       273 ~~~l~~~  279 (311)
T 3ork_A          273 RADLVRV  279 (311)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.93  E-value=2e-26  Score=224.74  Aligned_cols=153  Identities=30%  Similarity=0.494  Sum_probs=118.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCC-CeEecCCCCCcEEEeC-------CCCcEEEeecCceeeccCCCCccccCCCcccCcc
Q 010626            2 KAIKNWARQILRGLHYLHSHNP-PIIHRDLKCDNIFVNG-------NNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPE   73 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~-~IiHrDLKp~NILld~-------~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APE   73 (505)
                      +.++.++.||+.||.|||++|. +++||||||+||+++.       .++.+||+|||++............||+.|+|||
T Consensus       105 ~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE  184 (271)
T 3dtc_A          105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPE  184 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHH
Confidence            4678899999999999999983 3889999999999973       2678999999999877655555668999999999


Q ss_pred             cc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           74 LY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        74 ll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                      ++ ...++.++||||||+++|+|++|+.||.... .......+.........+..+++.+.+||.+||. +|.+|||+.+
T Consensus       185 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  263 (271)
T 3dtc_A          185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-GLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTN  263 (271)
T ss_dssp             HHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-HHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence            88 4558999999999999999999999998744 4444444554544555667788999999999996 7999999999


Q ss_pred             HhcC
Q 010626          152 LLKD  155 (505)
Q Consensus       152 lL~h  155 (505)
                      ++++
T Consensus       264 ~l~~  267 (271)
T 3dtc_A          264 ILDQ  267 (271)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.93  E-value=3.3e-26  Score=226.57  Aligned_cols=150  Identities=33%  Similarity=0.577  Sum_probs=119.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll~-   76 (505)
                      +.++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......    ......||+.|+|||++. 
T Consensus       120 ~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  196 (289)
T 3og7_A          120 KKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM  196 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTTEEEECCCC------------------CCCTTCCHHHHC-
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CCCCEEEccceeccccccccccccccccCCCccccCchhhcc
Confidence            467889999999999999999  99999999999998 6789999999999755421    223457899999999873 


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC---CCCCCChHHHHHHHHhcC-CCCCCCCH
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS---LSKVTDPQVKQFIEKCIV-PASLRLPA  149 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~---~~~~~s~~l~~LI~kcL~-dP~~RpSa  149 (505)
                         ..++.++||||||+++|+|++|+.||........+...+..+..+..   ....+++.+.+||.+||. +|.+||++
T Consensus       197 ~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  276 (289)
T 3og7_A          197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSF  276 (289)
T ss_dssp             ---CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             cCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCH
Confidence               45788999999999999999999999987777777777776654433   334678999999999996 79999999


Q ss_pred             HHHhc
Q 010626          150 LELLK  154 (505)
Q Consensus       150 ~ElL~  154 (505)
                      .++++
T Consensus       277 ~ell~  281 (289)
T 3og7_A          277 PRILA  281 (289)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.93  E-value=3.2e-26  Score=236.56  Aligned_cols=149  Identities=28%  Similarity=0.443  Sum_probs=124.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..+..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++......    .....+|+.|+|||++ .
T Consensus       203 ~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  279 (370)
T 2psq_A          203 KDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD  279 (370)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEEC-CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC
Confidence            357789999999999999999  99999999999997 77899999999998664322    2234578899999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..|+.++|||||||++|||+| |..||.+. ....+...+..+..+ ..+..+++.+.+||.+||. +|.+||++.|+++
T Consensus       280 ~~~~~~~DvwslG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~  357 (370)
T 2psq_A          280 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  357 (370)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            569999999999999999999 99999764 455566666665443 4556778999999999996 8999999999986


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       358 ~  358 (370)
T 2psq_A          358 D  358 (370)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.93  E-value=1.6e-26  Score=234.88  Aligned_cols=150  Identities=27%  Similarity=0.436  Sum_probs=126.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.......    .....||+.|+|||++ .
T Consensus       193 ~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  269 (359)
T 3vhe_A          193 EHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  269 (359)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEc-CCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC
Confidence            467889999999999999999  99999999999997 67899999999997653322    2334678899999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..|+.++|||||||++|+|+| |..||.+..........+..+..+ ..+...++.+.++|.+||. +|.+|||+.++++
T Consensus       270 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  348 (359)
T 3vhe_A          270 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  348 (359)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            668999999999999999998 999998866666666666655433 4556678999999999996 8999999999997


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      |
T Consensus       349 ~  349 (359)
T 3vhe_A          349 H  349 (359)
T ss_dssp             H
T ss_pred             H
Confidence            6

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.93  E-value=3.7e-26  Score=241.12  Aligned_cols=153  Identities=26%  Similarity=0.389  Sum_probs=115.9

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC------------CCCcEEEeecCceeeccCCC------CccccC
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG------------NNGEVKIGDLGLAIVMQQPT------ARSVIG   65 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~------------~~g~vKL~DFGlA~~~~~~~------~~~~~G   65 (505)
                      ++.++.||+.||+|||++|  |+||||||+|||++.            .++.+||+|||++.......      .....|
T Consensus       117 ~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~g  194 (434)
T 2rio_A          117 PISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG  194 (434)
T ss_dssp             HHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------
T ss_pred             HHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCC
Confidence            4679999999999999999  999999999999973            23489999999998765432      224579


Q ss_pred             CCcccCccccc--------ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCC----CCCChHH
Q 010626           66 TPEFMAPELYE--------EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLS----KVTDPQV  132 (505)
Q Consensus        66 t~~Y~APEll~--------~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~----~~~s~~l  132 (505)
                      |+.|+|||++.        ..++.++|||||||++|+|+| |..||.......  ...+..........    ...++++
T Consensus       195 t~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~  272 (434)
T 2rio_A          195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEA  272 (434)
T ss_dssp             CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHH
T ss_pred             CCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHH
Confidence            99999999884        358899999999999999999 999997644332  12222221211111    1234789


Q ss_pred             HHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          133 KQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       133 ~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      ++||.+||. +|.+|||+.++++||||..
T Consensus       273 ~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          273 TDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            999999996 8999999999999999964

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.93  E-value=5.2e-26  Score=224.03  Aligned_cols=151  Identities=28%  Similarity=0.499  Sum_probs=124.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc-----EEEeecCceeeccCCCCccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-----VKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~-----vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-   75 (505)
                      ..++.++.||+.||+|||++|++|+||||||+||+++ .++.     +||+|||++..... ......||+.|+|||++ 
T Consensus       122 ~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~-~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~g~~~y~aPE~~~  199 (287)
T 4f0f_A          122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ-SLDENAPVCAKVADFGLSQQSVH-SVSGLLGNFQWMAPETIG  199 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES-CCCTTCSCCEEECCCTTCBCCSS-CEECCCCCCTTSCGGGSS
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe-ccCCCCceeEEeCCCCccccccc-cccccCCCccccCchhhc
Confidence            4678899999999999999987799999999999997 4454     99999999975443 23445799999999988 


Q ss_pred             --cccCCcccchhhHHHHHHHHhhcCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           76 --EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPA-QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        76 --~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~-~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                        ...++.++|||||||++|+|++|+.||....... .....+.....+..++..+++.+.+||.+||. +|.+|||+.+
T Consensus       200 ~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  279 (287)
T 4f0f_A          200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSY  279 (287)
T ss_dssp             CSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHH
Confidence              3347899999999999999999999997654433 33444444445556777889999999999996 8999999999


Q ss_pred             Hhc
Q 010626          152 LLK  154 (505)
Q Consensus       152 lL~  154 (505)
                      +++
T Consensus       280 ll~  282 (287)
T 4f0f_A          280 IVK  282 (287)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            985

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.93  E-value=1.3e-26  Score=232.71  Aligned_cols=153  Identities=21%  Similarity=0.381  Sum_probs=120.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE----eCCCCcEEEeecCceeeccCCC-CccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV----NGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILl----d~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||++    + ..+.+||+|||++....... .....||+.|+|||++.
T Consensus       112 ~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  188 (319)
T 4euu_A          112 SEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE  188 (319)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTT-SCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCC-CCceEEEccCCCceecCCCCceeecccCCCccCHHHhh
Confidence            467889999999999999999  9999999999998    4 45679999999998765433 34557999999999873


Q ss_pred             ---------ccCCcccchhhHHHHHHHHhhcCCCCCCCCC---hHHHHHHHHcCCCCC----------------------
Q 010626           77 ---------EEYNELVDIYSFGMCILEMVTCEYPYNECKN---PAQIYKKVTSGIKPA----------------------  122 (505)
Q Consensus        77 ---------~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~---~~~i~~~i~~~~~p~----------------------  122 (505)
                               ..++.++|||||||++|+|+||+.||.....   .......+..+.++.                      
T Consensus       189 ~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (319)
T 4euu_A          189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS  268 (319)
T ss_dssp             HHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTT
T ss_pred             hccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcc
Confidence                     5688999999999999999999999964332   233333443332211                      


Q ss_pred             -CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626          123 -SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus       123 -~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                       .+....++.+.+||.+||. +|.+|||+.|+|+||-
T Consensus       269 ~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          269 CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence             1122335678999999996 8999999999999973

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.93  E-value=4.4e-26  Score=224.86  Aligned_cols=151  Identities=23%  Similarity=0.310  Sum_probs=118.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEeecCceeeccCCC---------CccccCCCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPT---------ARSVIGTPEFM   70 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld--~~~g~vKL~DFGlA~~~~~~~---------~~~~~Gt~~Y~   70 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++  ..++.+||+|||++.......         .....||+.|+
T Consensus       105 ~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  182 (296)
T 3uzp_A          105 KTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA  182 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccC
Confidence            467899999999999999999  99999999999994  367899999999998765432         23457999999


Q ss_pred             Cccccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCCC--hHHHHHHHHcC---CCCCCCCCCCChHHHHHHHHhcC-CC
Q 010626           71 APELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIV-PA  143 (505)
Q Consensus        71 APEll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~--~~~i~~~i~~~---~~p~~~~~~~s~~l~~LI~kcL~-dP  143 (505)
                      |||++. ..++.++|||||||++|+|++|+.||.....  ....+..+...   .+.......+++.+.+||.+||. +|
T Consensus       183 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  262 (296)
T 3uzp_A          183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRF  262 (296)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCT
T ss_pred             ChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCc
Confidence            999884 4689999999999999999999999976322  11222222211   11112335568899999999996 89


Q ss_pred             CCCCCHHHHhc
Q 010626          144 SLRLPALELLK  154 (505)
Q Consensus       144 ~~RpSa~ElL~  154 (505)
                      .+||++.++++
T Consensus       263 ~~Rps~~~l~~  273 (296)
T 3uzp_A          263 DDKPDYSYLRQ  273 (296)
T ss_dssp             TCCCCHHHHHH
T ss_pred             CcCCCHHHHHH
Confidence            99999998875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.93  E-value=3.1e-26  Score=226.11  Aligned_cols=151  Identities=17%  Similarity=0.252  Sum_probs=119.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc-----EEEeecCceeeccCCC---------CccccCCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-----VKIGDLGLAIVMQQPT---------ARSVIGTP   67 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~-----vKL~DFGlA~~~~~~~---------~~~~~Gt~   67 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++.     +||+|||++.......         .....||+
T Consensus       106 ~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~  182 (298)
T 1csn_A          106 KTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIG-RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA  182 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-CSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEec-cCCCCCCCeEEEEECccccccccccccccccccCccCCCCCc
Confidence            467899999999999999999  99999999999997 4444     9999999998765432         23457999


Q ss_pred             cccCccccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCC--ChHHHHHHHHcCC---CCCCCCCCCChHHHHHHHHhcC
Q 010626           68 EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGI---KPASLSKVTDPQVKQFIEKCIV  141 (505)
Q Consensus        68 ~Y~APEll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~--~~~~i~~~i~~~~---~p~~~~~~~s~~l~~LI~kcL~  141 (505)
                      .|+|||++. ..++.++||||||+++|+|++|+.||....  .....+..+....   ........+++.+.+||.+||.
T Consensus       183 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  262 (298)
T 1csn_A          183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARN  262 (298)
T ss_dssp             TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHH
T ss_pred             ccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhc
Confidence            999999884 568999999999999999999999997643  3344444433321   1122334568899999999995


Q ss_pred             -CCCCCCCHHHHhcC
Q 010626          142 -PASLRLPALELLKD  155 (505)
Q Consensus       142 -dP~~RpSa~ElL~h  155 (505)
                       +|.+||++.++++.
T Consensus       263 ~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          263 LAFDATPDYDYLQGL  277 (298)
T ss_dssp             CCTTCCCCHHHHHHH
T ss_pred             CCcccCCCHHHHHHH
Confidence             89999999998754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.93  E-value=5.3e-26  Score=223.87  Aligned_cols=151  Identities=23%  Similarity=0.312  Sum_probs=118.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEeecCceeeccCCC---------CccccCCCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPT---------ARSVIGTPEFM   70 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld--~~~g~vKL~DFGlA~~~~~~~---------~~~~~Gt~~Y~   70 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++  ..++.+||+|||++.......         .....||+.|+
T Consensus       105 ~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~  182 (296)
T 4hgt_A          105 KTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA  182 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCcccc
Confidence            467899999999999999999  99999999999992  267899999999998764432         23457999999


Q ss_pred             Cccccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCCCh--HHHHHHHHcC---CCCCCCCCCCChHHHHHHHHhcC-CC
Q 010626           71 APELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIV-PA  143 (505)
Q Consensus        71 APEll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~--~~i~~~i~~~---~~p~~~~~~~s~~l~~LI~kcL~-dP  143 (505)
                      |||++. ..++.++|||||||++|+|++|+.||......  ...+..+...   .........+++.+.+||.+||. +|
T Consensus       183 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  262 (296)
T 4hgt_A          183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRF  262 (296)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCT
T ss_pred             chHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCC
Confidence            999884 56899999999999999999999999764321  1122222211   11112234567899999999996 89


Q ss_pred             CCCCCHHHHhc
Q 010626          144 SLRLPALELLK  154 (505)
Q Consensus       144 ~~RpSa~ElL~  154 (505)
                      .+||++.++++
T Consensus       263 ~~Rpt~~~l~~  273 (296)
T 4hgt_A          263 DDKPDYSYLRQ  273 (296)
T ss_dssp             TCCCCHHHHHH
T ss_pred             CCCCCHHHHHH
Confidence            99999999876

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=6.2e-26  Score=229.47  Aligned_cols=151  Identities=25%  Similarity=0.380  Sum_probs=126.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......    .....||+.|+|||++ .
T Consensus       172 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  248 (344)
T 1rjb_A          172 EDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE  248 (344)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEc-CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc
Confidence            357789999999999999999  99999999999998 67899999999997664332    2234578899999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|+| |..||............+..+..+ ..+...++.+.+||.+||. +|.+||++.++++
T Consensus       249 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  327 (344)
T 1rjb_A          249 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS  327 (344)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            668999999999999999998 999998866666666666555433 4556678999999999996 8999999999998


Q ss_pred             CC
Q 010626          155 DP  156 (505)
Q Consensus       155 hp  156 (505)
                      +.
T Consensus       328 ~l  329 (344)
T 1rjb_A          328 FL  329 (344)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.93  E-value=4e-26  Score=230.80  Aligned_cols=149  Identities=28%  Similarity=0.463  Sum_probs=122.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+++......    .....+|+.|+|||++ .
T Consensus       117 ~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  193 (327)
T 3poz_A          117 QYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH  193 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEEC-CCCCEEEccCcceeEccCCcccccccCCCccccccChHHhcc
Confidence            357889999999999999999  99999999999998 67899999999997664332    2233568899999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..|+.++|||||||++|+|+| |+.||... ....+...+..+... ..+...+..+.+|+.+||. +|.+||++.++++
T Consensus       194 ~~~~~~~Di~slG~il~ellt~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~  271 (327)
T 3poz_A          194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERL-PQPPICTIDVYMIMVKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred             CCCCchhhhhhhHHHHHHHHhcCCCCccCC-CHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            568999999999999999999 99999764 444555555555433 3455678899999999996 8999999999987


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       272 ~  272 (327)
T 3poz_A          272 E  272 (327)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.93  E-value=4.5e-26  Score=229.93  Aligned_cols=149  Identities=23%  Similarity=0.469  Sum_probs=121.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll~-   76 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+++......    .....|++.|+|||++. 
T Consensus       115 ~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  191 (325)
T 3kex_A          115 QLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF  191 (325)
T ss_dssp             THHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEES-SSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEEC-CCCeEEECCCCcccccCcccccccccCCCCcccccChHHhcc
Confidence            367889999999999999999  99999999999997 67899999999997664332    23346788999999884 


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|||||||++|+|+| |..||.... ...+...+..+.. ...+..+++.+.+||.+||. +|.+||++.++++
T Consensus       192 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~  269 (325)
T 3kex_A          192 GKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-LAEVPDLLEKGER-LAQPQICTIDVYMVMVKCWMIDENIRPTFKELAN  269 (325)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-TTHHHHHHHTTCB-CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHH
T ss_pred             CCCChhhHhHHhHHHHHHHHhCCCCCccccC-HHHHHHHHHcCCC-CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            669999999999999999999 999998743 4445555555433 33455678899999999996 8999999999998


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       270 ~  270 (325)
T 3kex_A          270 E  270 (325)
T ss_dssp             H
T ss_pred             H
Confidence            7

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.93  E-value=9.7e-26  Score=224.22  Aligned_cols=149  Identities=25%  Similarity=0.423  Sum_probs=124.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......    .....+++.|+|||++ .
T Consensus       150 ~~~~~i~~qi~~~l~~lH~~~--ivH~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  226 (314)
T 2ivs_A          150 GDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVA-EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD  226 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CcccccchheEEEc-CCCCEEEccccccccccccccceeccCCCCcccccChhhhcC
Confidence            367889999999999999999  99999999999998 67899999999998664332    2234578899999987 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|||||||++|+|+| |..||... ....+...+..+..+ ..+..+++.+.+||.+||. +|.+||++.++++
T Consensus       227 ~~~~~~~Di~slG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~  304 (314)
T 2ivs_A          227 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI-PPERLFNLLKTGHRM-ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK  304 (314)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHhhcCCcC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            568999999999999999999 99999763 445555666555433 4556778999999999996 8999999999987


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       305 ~  305 (314)
T 2ivs_A          305 D  305 (314)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.93  E-value=4.8e-26  Score=234.73  Aligned_cols=156  Identities=25%  Similarity=0.370  Sum_probs=128.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccC----CCCccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQ----PTARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~----~~~~~~~Gt~~Y~APEll   75 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++.  .+..+||+|||+++....    .......||+.|+|||++
T Consensus       181 ~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~  258 (367)
T 3l9p_A          181 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF  258 (367)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHh
Confidence            357889999999999999999  999999999999972  233599999999975421    223345689999999987


Q ss_pred             -cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           76 -EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        76 -~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                       ...|+.++|||||||++|+|++ |..||.. .....+...+..+..+ ..+..+++.+.+||.+||. +|.+||++.++
T Consensus       259 ~~~~~~~~~DvwslG~il~ellt~g~~pf~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ei  336 (367)
T 3l9p_A          259 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAII  336 (367)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence             5679999999999999999998 9999976 4556666666665443 3456678999999999996 89999999999


Q ss_pred             hcCCCCCCC
Q 010626          153 LKDPFLVTD  161 (505)
Q Consensus       153 L~hpff~~~  161 (505)
                      +++.++...
T Consensus       337 l~~l~~~~~  345 (367)
T 3l9p_A          337 LERIEYCTQ  345 (367)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHhh
Confidence            999877543

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.93  E-value=7.1e-26  Score=225.40  Aligned_cols=150  Identities=27%  Similarity=0.436  Sum_probs=126.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......    .....||+.|+|||++ .
T Consensus       148 ~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  224 (316)
T 2xir_A          148 EHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  224 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccccCccceEEEC-CCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc
Confidence            467889999999999999999  99999999999997 67899999999997664332    1234578899999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|+| |..||............+..+..+ ..+...++.+.++|.+||. +|.+|||+.++++
T Consensus       225 ~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  303 (316)
T 2xir_A          225 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  303 (316)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            568999999999999999998 999998766666666666655433 3456678999999999996 8999999999998


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      |
T Consensus       304 ~  304 (316)
T 2xir_A          304 H  304 (316)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.93  E-value=1.9e-25  Score=217.75  Aligned_cols=149  Identities=22%  Similarity=0.402  Sum_probs=122.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCc---cccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR---SVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~---~~~Gt~~Y~APEll~-~   77 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.........   ...+|+.|+|||++. .
T Consensus       104 ~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  180 (268)
T 3sxs_A          104 SQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVD-RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF  180 (268)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEEC-TTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEEC-CCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhcc
Confidence            467899999999999999999  99999999999997 6789999999999876544322   234567899999884 4


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|+| |..||... ........+..+.. ...+...++.+.+||.+||. +|.+|||+.+++++
T Consensus       181 ~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          181 KYSSKSDVWAFGILMWEVFSLGKMPYDLY-TNSEVVLKVSQGHR-LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             EEETTHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHHHHHTTCC-CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCchhhhhHHHHHHHHHHHcCCCCCcccc-ChHHHHHHHHcCCC-CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            68999999999999999999 99999764 44455555555433 23455678999999999996 79999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.93  E-value=9.8e-26  Score=220.30  Aligned_cols=149  Identities=21%  Similarity=0.465  Sum_probs=124.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC---CCccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~---~~~~~~Gt~~Y~APEll~-~   77 (505)
                      +.++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++......   ......+++.|+|||++. .
T Consensus       106 ~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  182 (269)
T 4hcu_A          106 ETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS  182 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEc-CCCCEEeccccccccccccccccccCcccccccCCHHHhcCC
Confidence            467889999999999999999  99999999999997 6789999999999765432   123345678899999884 6


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|++ |..||.. .........+..+..+ ..+...++.+.+||.+||. +|.+||++.++++|
T Consensus       183 ~~~~~~Di~slG~~l~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          183 RYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCchhhhHHHHHHHHHHhcCCCCCCCC-CCHHHHHHHHhcCccC-CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            69999999999999999999 9999976 4556666666665433 3456678999999999996 79999999999876

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.92  E-value=1.2e-25  Score=223.44  Aligned_cols=150  Identities=23%  Similarity=0.391  Sum_probs=125.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC----ccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~----~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++........    ....+|+.|+|||++ .
T Consensus       145 ~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  221 (313)
T 1t46_A          145 EDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN  221 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEc-CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC
Confidence            467889999999999999999  99999999999998 678999999999977654332    233567889999977 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|+| |..||............+..+..+ ..+...++.+.+||.+||. +|.+|||+.++++
T Consensus       222 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  300 (313)
T 1t46_A          222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (313)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC-CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            568999999999999999999 999998766666666666555433 3455678999999999996 8999999999987


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       301 ~  301 (313)
T 1t46_A          301 L  301 (313)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.92  E-value=7.2e-26  Score=230.54  Aligned_cols=151  Identities=18%  Similarity=0.295  Sum_probs=116.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC--cEEEeecCceeeccCC---------CCccccCCCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQP---------TARSVIGTPEFM   70 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g--~vKL~DFGlA~~~~~~---------~~~~~~Gt~~Y~   70 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++  .+||+|||+++.+...         ......||+.|+
T Consensus       151 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~  227 (345)
T 2v62_A          151 STVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLG-YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT  227 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEc-cCCCCcEEEEeCCCceecccccccccchhccccccCCCcccc
Confidence            468899999999999999999  99999999999998 445  9999999999765321         113457999999


Q ss_pred             Cccccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCC-ChHHHHHH---HHcCCCCC----CCCCCCChHHHHHHHHhcC
Q 010626           71 APELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKK---VTSGIKPA----SLSKVTDPQVKQFIEKCIV  141 (505)
Q Consensus        71 APEll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~-~~~~i~~~---i~~~~~p~----~~~~~~s~~l~~LI~kcL~  141 (505)
                      |||++. ..++.++|||||||++|+|+||+.||.... +.......   .....+..    .....+++.+.+||.+||.
T Consensus       228 aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  307 (345)
T 2v62_A          228 SLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHS  307 (345)
T ss_dssp             CHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHT
T ss_pred             CHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhh
Confidence            999884 458999999999999999999999995432 22222111   11111110    0112568899999999996


Q ss_pred             -CCCCCCCHHHHhcC
Q 010626          142 -PASLRLPALELLKD  155 (505)
Q Consensus       142 -dP~~RpSa~ElL~h  155 (505)
                       +|.+||++.++++.
T Consensus       308 ~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          308 LAYDEKPNYQALKKI  322 (345)
T ss_dssp             CCTTCCCCHHHHHHH
T ss_pred             cCcccCCCHHHHHHH
Confidence             89999999998764

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.92  E-value=1.5e-25  Score=220.51  Aligned_cols=150  Identities=25%  Similarity=0.369  Sum_probs=123.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll-   75 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......     .....+++.|+|||++ 
T Consensus       121 ~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  197 (291)
T 1u46_A          121 GTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK  197 (291)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEc-CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhc
Confidence            467889999999999999999  99999999999998 67899999999997764432     1233577889999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ...++.++||||||+++|+|++ |+.||... +.......+.........+..+++.+.++|.+||. +|.+||++.+++
T Consensus       198 ~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~  276 (291)
T 1u46_A          198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  276 (291)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCchhhHHHHHHHHHHHHhCCCCCcccC-CHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHH
Confidence            4558899999999999999999 99999864 55566666665544445566788999999999996 899999999998


Q ss_pred             cC
Q 010626          154 KD  155 (505)
Q Consensus       154 ~h  155 (505)
                      ++
T Consensus       277 ~~  278 (291)
T 1u46_A          277 DF  278 (291)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.92  E-value=1.5e-25  Score=231.75  Aligned_cols=149  Identities=28%  Similarity=0.444  Sum_probs=125.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++......    ......+|+.|+|||++ .
T Consensus       191 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  267 (382)
T 3tt0_A          191 KDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD  267 (382)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEEEc-CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC
Confidence            467899999999999999999  99999999999997 6789999999999766432    22334577899999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++|||||||++|+|++ |..||.. .....+...+..+..+ ..+..+++++.+||.+||. +|.+||++.++++
T Consensus       268 ~~~~~~~DiwslG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  345 (382)
T 3tt0_A          268 RIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  345 (382)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            568999999999999999999 9999976 4566666766665443 3456778999999999996 7999999999998


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       346 ~  346 (382)
T 3tt0_A          346 D  346 (382)
T ss_dssp             H
T ss_pred             H
Confidence            6

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.92  E-value=8.9e-26  Score=222.32  Aligned_cols=149  Identities=27%  Similarity=0.470  Sum_probs=113.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......   .....+++.|+|||++ ..
T Consensus       116 ~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  192 (281)
T 1mp8_A          116 ASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR  192 (281)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC-------------------CCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEEC-CCCCEEECccccccccCcccccccccCCCcccccChhhcccC
Confidence            467889999999999999999  99999999999998 67899999999997664332   2233567899999988 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|++ |..||.... .......+..+..+ ..+..+++.+.+||.+||. +|.+||++.+++++
T Consensus       193 ~~~~~~Di~slG~~l~ell~~g~~pf~~~~-~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          193 RFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVIGRIENGERL-PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCccCchHHHHHHHHHHhcCCCCCCcCC-HHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            68999999999999999997 999998744 34445555554333 3556778999999999996 89999999998864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.92  E-value=2.2e-26  Score=229.84  Aligned_cols=146  Identities=29%  Similarity=0.465  Sum_probs=115.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC----------------ccccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----------------RSVIG   65 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~----------------~~~~G   65 (505)
                      ..+..++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++........                ....|
T Consensus       108 ~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  184 (310)
T 3s95_A          108 SQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG  184 (310)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEC-TTSCEEECCCTTCEECC--------------------CCCCS
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEEC-CCCCEEEeecccceecccccccccccccccccccccccccCC
Confidence            467889999999999999999  99999999999998 678999999999976543221                14579


Q ss_pred             CCcccCccccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHH----HHHHHHcCCCCCCCCCCCChHHHHHHHHhc
Q 010626           66 TPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ----IYKKVTSGIKPASLSKVTDPQVKQFIEKCI  140 (505)
Q Consensus        66 t~~Y~APEll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~----i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL  140 (505)
                      |+.|+|||++. ..++.++||||||+++|+|++|..||........    .......    ...+..+++.+.+||.+||
T Consensus       185 t~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l  260 (310)
T 3s95_A          185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD----RYCPPNCPPSFFPITVRCC  260 (310)
T ss_dssp             CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----HTCCTTCCTTHHHHHHHHT
T ss_pred             CcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----ccCCCCCCHHHHHHHHHHc
Confidence            99999999884 5689999999999999999999999865322110    0111111    1134456789999999999


Q ss_pred             C-CCCCCCCHHHHhc
Q 010626          141 V-PASLRLPALELLK  154 (505)
Q Consensus       141 ~-dP~~RpSa~ElL~  154 (505)
                      . +|.+|||+.++++
T Consensus       261 ~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          261 DLDPEKRPSFVKLEH  275 (310)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             cCChhhCcCHHHHHH
Confidence            6 8999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.92  E-value=1.7e-25  Score=219.89  Aligned_cols=149  Identities=21%  Similarity=0.413  Sum_probs=123.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......   .....+|+.|+|||++ ..
T Consensus       120 ~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  196 (283)
T 3gen_A          120 QQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS  196 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEc-CCCCEEEccccccccccccccccccCCccCcccCCHHHhccC
Confidence            467899999999999999999  99999999999997 77899999999997654321   2233567889999988 46


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|+| |..||... ........+..+..+ ..+...++.+.+||.+||. +|.+|||+.++++|
T Consensus       197 ~~~~~~Dv~slG~~l~~l~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          197 KFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGLRL-YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             CCSHHHHHHHHHHHHHHHHTTTCCTTTTS-CHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCcccc-ChhHHHHHHhcccCC-CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            68999999999999999998 99999764 455566666655433 3456678999999999996 89999999999876

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.92  E-value=2.2e-25  Score=225.62  Aligned_cols=149  Identities=21%  Similarity=0.363  Sum_probs=121.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......     .....+|+.|+|||++.
T Consensus       151 ~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  227 (325)
T 3kul_A          151 MQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA  227 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEC-CCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhc
Confidence            467889999999999999999  99999999999997 67899999999998764432     12224577899999884


Q ss_pred             -ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 -EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                       ..++.++||||||+++|+|++ |..||.. .....+...+..+..+ ..+..+++.+.+||.+||. +|.+||++.+++
T Consensus       228 ~~~~~~~~Di~slG~il~ell~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil  305 (325)
T 3kul_A          228 FRTFSSASDVWSFGVVMWEVLAYGERPYWN-MTNRDVISSVEEGYRL-PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIV  305 (325)
T ss_dssp             HCEECHHHHHHHHHHHHHHHHTTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHcCCCC-CCCCCcCHHHHHHHHHHccCChhhCcCHHHHH
Confidence             568999999999999999999 9999977 4455566666655433 3456678999999999996 899999999988


Q ss_pred             cC
Q 010626          154 KD  155 (505)
Q Consensus       154 ~h  155 (505)
                      +.
T Consensus       306 ~~  307 (325)
T 3kul_A          306 SV  307 (325)
T ss_dssp             HH
T ss_pred             HH
Confidence            63

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.92  E-value=1.3e-25  Score=227.57  Aligned_cols=149  Identities=28%  Similarity=0.468  Sum_probs=117.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......    .....+|+.|+|||++ .
T Consensus       117 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  193 (327)
T 3lzb_A          117 QYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH  193 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCTTC----------------CCCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEc-CCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcC
Confidence            357889999999999999999  99999999999998 67899999999997664322    2233567899999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..|+.++|||||||++|+|++ |..||... ....+...+..+..+ ..+..+++.+.+||.+||. +|.+||++.++++
T Consensus       194 ~~~~~~~Di~slG~il~ell~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERL-PQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CGGGHHHHHHTTCCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCChHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            568999999999999999999 99999764 444555555554433 3456678999999999996 8999999999987


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      .
T Consensus       272 ~  272 (327)
T 3lzb_A          272 E  272 (327)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.92  E-value=6.7e-26  Score=232.43  Aligned_cols=151  Identities=20%  Similarity=0.295  Sum_probs=116.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEeecCceeeccCC---------CCccccCCCcccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQP---------TARSVIGTPEFMA   71 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~-~~g~vKL~DFGlA~~~~~~---------~~~~~~Gt~~Y~A   71 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+|||++. .++.+||+|||+++.+...         ......||+.|+|
T Consensus       152 ~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a  229 (364)
T 3op5_A          152 KTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTS  229 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccC
Confidence            467899999999999999999  999999999999972 4679999999999765322         1133459999999


Q ss_pred             ccccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC--------CCCCCCCCChHHHHHHHHhcC-
Q 010626           72 PELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--------PASLSKVTDPQVKQFIEKCIV-  141 (505)
Q Consensus        72 PEll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~--------p~~~~~~~s~~l~~LI~kcL~-  141 (505)
                      ||++. ..++.++|||||||++|+|+||+.||.+................        +......+++++.+||..||. 
T Consensus       230 PE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  309 (364)
T 3op5_A          230 IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLL  309 (364)
T ss_dssp             HHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTC
T ss_pred             HHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcC
Confidence            99884 45999999999999999999999999853332222211111100        001124567899999999996 


Q ss_pred             CCCCCCCHHHHhc
Q 010626          142 PASLRLPALELLK  154 (505)
Q Consensus       142 dP~~RpSa~ElL~  154 (505)
                      +|.+||++.++++
T Consensus       310 ~p~~RP~~~~l~~  322 (364)
T 3op5_A          310 DYTEKPLYENLRD  322 (364)
T ss_dssp             CTTCCCCHHHHHH
T ss_pred             CCCCCCCHHHHHH
Confidence            8999999998875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.92  E-value=2.2e-25  Score=216.38  Aligned_cols=148  Identities=20%  Similarity=0.358  Sum_probs=120.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccc-c--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEE-E--   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~-~--   78 (505)
                      ..++.++.||+.||.|||++|++++||||||+||+++ .++.++|+|||++....   .....||+.|+|||++.+ .  
T Consensus       111 ~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-~~~~~~l~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~  186 (271)
T 3kmu_A          111 SQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQ---SPGRMYAPAWVAPEALQKKPED  186 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC-TTSCEEEEGGGSCCTTS---CTTCBSCGGGSCHHHHHSCGGG
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc-CCcceeEEeccceeeec---ccCccCCccccChhhhccCCCC
Confidence            4678999999999999999888899999999999997 77899999988875432   234578999999998843 2  


Q ss_pred             -CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           79 -YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        79 -ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                       ++.++||||||+++|+|++|+.||.... .......+.........+..+++.+.++|.+||. +|.+|||+.++++
T Consensus       187 ~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          187 TNRRSADMWSFAVLLWELVTREVPFADLS-NMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHCSCTTTTSC-HHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCccccC-hHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             3347999999999999999999998754 4444444444444445677789999999999996 7999999999885

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=2.2e-25  Score=220.03  Aligned_cols=150  Identities=22%  Similarity=0.366  Sum_probs=123.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC------CCccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~------~~~~~~Gt~~Y~APEll   75 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++ .++.+||+|||++......      ......+++.|+|||.+
T Consensus       124 ~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  200 (298)
T 3pls_A          124 KDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL  200 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhh
Confidence            467889999999999999999  99999999999997 7789999999999754321      22344678899999988


Q ss_pred             c-ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 E-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 ~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      . ..++.++||||||+++|+|++|..|+....+.......+..+..+ ..+...++.+.+||.+||. +|.+|||+.+++
T Consensus       201 ~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll  279 (298)
T 3pls_A          201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL-PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLV  279 (298)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC-CCCccchHHHHHHHHHHccCChhhCcCHHHHH
Confidence            4 468999999999999999999776665556666666666655433 3456678999999999996 899999999988


Q ss_pred             cC
Q 010626          154 KD  155 (505)
Q Consensus       154 ~h  155 (505)
                      +.
T Consensus       280 ~~  281 (298)
T 3pls_A          280 GE  281 (298)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.92  E-value=1e-25  Score=227.37  Aligned_cols=151  Identities=27%  Similarity=0.391  Sum_probs=117.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhC----------CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCC
Q 010626            2 KAIKNWARQILRGLHYLHSH----------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTP   67 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~----------g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~   67 (505)
                      ..++.++.||+.||.|||++          |  |+||||||+|||++ .++.+||+|||+++......    .....||+
T Consensus       121 ~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~Dlkp~Nill~-~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~  197 (322)
T 3soc_A          121 NELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGKSAGDTHGQVGTR  197 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECSCCSGGGEEEC-TTCCEEECCCTTCEEECTTSCCCCCTTCCCCG
T ss_pred             HHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeCCCChHhEEEC-CCCeEEEccCCcccccccccCccccccCccCc
Confidence            46788999999999999999          8  99999999999997 67899999999997764332    23357999


Q ss_pred             cccCcccccc------cCCcccchhhHHHHHHHHhhcCCCCCCCC---------------ChHHHHHHHHcCCCCCCCCC
Q 010626           68 EFMAPELYEE------EYNELVDIYSFGMCILEMVTCEYPYNECK---------------NPAQIYKKVTSGIKPASLSK  126 (505)
Q Consensus        68 ~Y~APEll~~------~ys~ksDIWSLGviLyEmlTG~~Pf~~~~---------------~~~~i~~~i~~~~~p~~~~~  126 (505)
                      .|+|||++.+      .++.++|||||||++|+|+||+.||.+..               ....+...+......+.+..
T Consensus       198 ~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (322)
T 3soc_A          198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD  277 (322)
T ss_dssp             GGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred             cccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccc
Confidence            9999998853      46678999999999999999999996532               22333333333333332322


Q ss_pred             C-----CChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626          127 V-----TDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus       127 ~-----~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .     .++.+.+||.+||. +|.+|||+.++++.
T Consensus       278 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          278 YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2     13459999999996 89999999999863

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.92  E-value=1.2e-25  Score=224.98  Aligned_cols=149  Identities=24%  Similarity=0.426  Sum_probs=123.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..+..++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......    .....+|+.|+|||++ .
T Consensus       138 ~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  214 (322)
T 1p4o_A          138 SKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD  214 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEc-CCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc
Confidence            467789999999999999999  99999999999998 67899999999997553321    2233568899999988 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|++ |..||.. .........+..+..+ ..+..+++.+.+||.+||. +|.+|||+.++++
T Consensus       215 ~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~  292 (322)
T 1p4o_A          215 GVFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  292 (322)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCchhhHHHHHHHHHHHHhcCCCcccc-CCHHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            568999999999999999999 8899976 4555566666555433 3456678999999999996 8999999999997


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       293 ~  293 (322)
T 1p4o_A          293 S  293 (322)
T ss_dssp             H
T ss_pred             H
Confidence            6

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=2.7e-25  Score=219.47  Aligned_cols=150  Identities=21%  Similarity=0.386  Sum_probs=125.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......     .....+|+.|+|||++.
T Consensus       110 ~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  186 (287)
T 1u59_A          110 SNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  186 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEc-CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhc
Confidence            467899999999999999999  99999999999998 67899999999998764332     12335688999999884


Q ss_pred             -ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 -EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                       ..++.++||||||+++|+|+| |+.||.... .......+..+..+ ..+..+++.+.+||.+||. +|.+||++.+++
T Consensus       187 ~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~  264 (287)
T 1u59_A          187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRM-ECPPECPPELYALMSDCWIYKWEDRPDFLTVE  264 (287)
T ss_dssp             HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHHHHTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             cCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-HHHHHHHHhcCCcC-CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence             568999999999999999998 999998754 44555666655433 4556788999999999996 899999999999


Q ss_pred             cCC
Q 010626          154 KDP  156 (505)
Q Consensus       154 ~hp  156 (505)
                      ++.
T Consensus       265 ~~l  267 (287)
T 1u59_A          265 QRM  267 (287)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            874

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.92  E-value=1.2e-25  Score=222.33  Aligned_cols=150  Identities=32%  Similarity=0.507  Sum_probs=115.6

Q ss_pred             HHHHHHHHHHHHHHHHHH--------hCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCC
Q 010626            2 KAIKNWARQILRGLHYLH--------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTP   67 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLH--------s~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~   67 (505)
                      ..++.++.||+.||+|||        ++|  |+||||||+|||++ .++.+||+|||++.......      .....||+
T Consensus       105 ~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~  181 (301)
T 3q4u_A          105 VSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK  181 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEEC-TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCG
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEc-CCCCEEEeeCCCeeeccccccccccccccccccc
Confidence            357889999999999999        888  99999999999998 67899999999997664432      22347999


Q ss_pred             cccCcccccc-------cCCcccchhhHHHHHHHHhhc----------CCCCCCCC----ChHHHHHHHHcCCCCCCCCC
Q 010626           68 EFMAPELYEE-------EYNELVDIYSFGMCILEMVTC----------EYPYNECK----NPAQIYKKVTSGIKPASLSK  126 (505)
Q Consensus        68 ~Y~APEll~~-------~ys~ksDIWSLGviLyEmlTG----------~~Pf~~~~----~~~~i~~~i~~~~~p~~~~~  126 (505)
                      .|+|||++.+       .++.++|||||||++|+|+||          ..||....    ........+........++.
T Consensus       182 ~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (301)
T 3q4u_A          182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPN  261 (301)
T ss_dssp             GGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred             ceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCCh
Confidence            9999998844       345799999999999999999          88886432    22333333333222222222


Q ss_pred             -----CCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626          127 -----VTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus       127 -----~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                           ..++.+.+||.+||. +|.+|||+.++++
T Consensus       262 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          262 RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                 234679999999996 8999999999985

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.92  E-value=1e-25  Score=224.50  Aligned_cols=154  Identities=27%  Similarity=0.464  Sum_probs=117.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......   .....||+.|+|||++ ..
T Consensus       111 ~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  187 (294)
T 4eqm_A          111 DTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILID-SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE  187 (294)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCSSSTTC-------------CCSSCCHHHHHTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEC-CCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCC
Confidence            467889999999999999999  99999999999997 67899999999997654322   2345799999999988 45


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++||||||+++|+|+||+.||.+..........+....+.  ......+++.+.++|.+||. +|.+||+..+.+.
T Consensus       188 ~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~  267 (294)
T 4eqm_A          188 ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMK  267 (294)
T ss_dssp             CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHH
T ss_pred             CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHH
Confidence            68899999999999999999999998754444444444333221  12345678999999999996 8999996666666


Q ss_pred             CCCC
Q 010626          155 DPFL  158 (505)
Q Consensus       155 hpff  158 (505)
                      +.|.
T Consensus       268 ~~l~  271 (294)
T 4eqm_A          268 DDLS  271 (294)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6554

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.92  E-value=9.1e-26  Score=225.92  Aligned_cols=150  Identities=22%  Similarity=0.377  Sum_probs=104.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC--------------ccccCCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA--------------RSVIGTP   67 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~--------------~~~~Gt~   67 (505)
                      ..++.++.||+.||.|||++|++|+||||||+|||++ .++.+||+|||++........              ....||+
T Consensus       136 ~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~  214 (337)
T 3ll6_A          136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP  214 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC-TTSCEEBCCCTTCBCCSSCC----------------------
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC-CCCCEEEecCccceeccccCcccccccccccchhhccccCCC
Confidence            4678999999999999999987799999999999998 678999999999976643211              1345899


Q ss_pred             cccCcccc----cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-C
Q 010626           68 EFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-P  142 (505)
Q Consensus        68 ~Y~APEll----~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-d  142 (505)
                      .|+|||++    ...++.++|||||||++|+|++|+.||......     .+.............++.+.+||.+||. +
T Consensus       215 ~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  289 (337)
T 3ll6_A          215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-----RIVNGKYSIPPHDTQYTVFHSLIRAMLQVN  289 (337)
T ss_dssp             ---------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------------CCCCTTCCSSGGGHHHHHHHSCSS
T ss_pred             CcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----HhhcCcccCCcccccchHHHHHHHHHccCC
Confidence            99999987    335788999999999999999999999753221     1122222223345567889999999996 8


Q ss_pred             CCCCCCHHHHhcCCC
Q 010626          143 ASLRLPALELLKDPF  157 (505)
Q Consensus       143 P~~RpSa~ElL~hpf  157 (505)
                      |.+||++.++++|-.
T Consensus       290 p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          290 PEERLSIAEVVHQLQ  304 (337)
T ss_dssp             GGGSCCHHHHHHHHH
T ss_pred             hhhCcCHHHHHHHHH
Confidence            999999999998843

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.92  E-value=2.6e-25  Score=222.86  Aligned_cols=149  Identities=33%  Similarity=0.583  Sum_probs=114.1

Q ss_pred             HHHHHHHHHHHHHHHHHHh---CCCCeEecCCCCCcEEEeCCCCc-EEEeecCceeeccCCCCccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHS---HNPPIIHRDLKCDNIFVNGNNGE-VKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs---~g~~IiHrDLKp~NILld~~~g~-vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-   76 (505)
                      ..+..++.||+.||.|||+   +|  |+||||||+||+++ .++. +||+|||++...... .....||+.|+|||++. 
T Consensus       102 ~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~  177 (307)
T 2eva_A          102 AHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLV-AGGTVLKICDFGTACDIQTH-MTNNKGSAAWMAPEVFEG  177 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEE-TTTTEEEECCCCC-------------CCTTSSCHHHHTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEe-CCCCEEEEcccccccccccc-cccCCCCCceEChhhhCC
Confidence            3577899999999999999   77  99999999999998 4454 899999999765433 23346999999999884 


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPA-QIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~-~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|++|+.||....... .+...+..+..+ .....+++.+.+||.+||. +|.+|||+.++++
T Consensus       178 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-CcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            468999999999999999999999997644333 333344444333 4456678999999999996 8999999999987


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       257 ~  257 (307)
T 2eva_A          257 I  257 (307)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.92  E-value=1.7e-25  Score=225.98  Aligned_cols=149  Identities=21%  Similarity=0.307  Sum_probs=117.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc-----EEEeecCceeeccCCC---------CccccCCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE-----VKIGDLGLAIVMQQPT---------ARSVIGTP   67 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~-----vKL~DFGlA~~~~~~~---------~~~~~Gt~   67 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++.     +||+|||++.......         .....||+
T Consensus       105 ~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~-~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~  181 (330)
T 2izr_A          105 KTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIG-RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA  181 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeec-cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCc
Confidence            467899999999999999999  99999999999997 5555     9999999998764332         23567999


Q ss_pred             cccCccccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCC--ChHHHHHHHHcCCCCC---CCCCCCChHHHHHHHHhcC
Q 010626           68 EFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIEKCIV  141 (505)
Q Consensus        68 ~Y~APEll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~--~~~~i~~~i~~~~~p~---~~~~~~s~~l~~LI~kcL~  141 (505)
                      .|+|||++. ..++.++|||||||++|+|++|+.||.+..  .....+..+.....+.   ......+ ++.+||.+||.
T Consensus       182 ~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~  260 (330)
T 2izr_A          182 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRR  260 (330)
T ss_dssp             TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHH
T ss_pred             cccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHh
Confidence            999999884 568999999999999999999999997643  3334444443321111   1122233 99999999995


Q ss_pred             -CCCCCCCHHHHhc
Q 010626          142 -PASLRLPALELLK  154 (505)
Q Consensus       142 -dP~~RpSa~ElL~  154 (505)
                       +|.+||++.++++
T Consensus       261 ~~p~~RP~~~~l~~  274 (330)
T 2izr_A          261 LDFFEKPDYDYLRK  274 (330)
T ss_dssp             CCTTCCCCHHHHHH
T ss_pred             CCCCCCCCHHHHHH
Confidence             8999999988775

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.92  E-value=1.6e-25  Score=225.74  Aligned_cols=149  Identities=21%  Similarity=0.308  Sum_probs=122.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++......    ......+|+.|+|||++ .
T Consensus       174 ~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  250 (343)
T 1luf_A          174 AEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY  250 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEC-CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc
Confidence            357789999999999999999  99999999999997 6789999999999765322    12334678899999987 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|+| |..||.. .....+...+..+..+ ..+..+++.+.+||.+||. +|.+||++.++++
T Consensus       251 ~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          251 NRYTTESDVWAYGVVLWEIFSYGLQPYYG-MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcCcccccHHHHHHHHHHHhcCCCcCCC-CChHHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            569999999999999999999 9999976 4455666666655443 3556778999999999996 8999999999886


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       329 ~  329 (343)
T 1luf_A          329 I  329 (343)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.92  E-value=4.1e-25  Score=220.52  Aligned_cols=149  Identities=25%  Similarity=0.458  Sum_probs=121.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC-------CCCccccCCCcccCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-------PTARSVIGTPEFMAPEL   74 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~-------~~~~~~~Gt~~Y~APEl   74 (505)
                      ..++.++.||+.||+|||++|  ++||||||+||+++  ++.+||+|||++.....       .......|++.|+|||+
T Consensus       130 ~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~  205 (319)
T 2y4i_B          130 NKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI  205 (319)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe--CCCEEEeecCCccccccccccccccccccCCCcccccChHH
Confidence            468899999999999999999  99999999999997  57999999999865421       12233468999999998


Q ss_pred             ccc----------cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CC
Q 010626           75 YEE----------EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PA  143 (505)
Q Consensus        75 l~~----------~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP  143 (505)
                      +..          .++.++||||||+++|+|++|+.||.. .........+..+..+......+++.+.+||.+||. +|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p  284 (319)
T 2y4i_B          206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-QPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQ  284 (319)
T ss_dssp             HSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS-CCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSST
T ss_pred             hhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCCh
Confidence            742          478899999999999999999999976 455566666666666655555678899999999996 89


Q ss_pred             CCCCCHHHHhcC
Q 010626          144 SLRLPALELLKD  155 (505)
Q Consensus       144 ~~RpSa~ElL~h  155 (505)
                      .+|||+.++++.
T Consensus       285 ~~Rpt~~~l~~~  296 (319)
T 2y4i_B          285 EERPTFTKLMDM  296 (319)
T ss_dssp             TTSCCHHHHHHH
T ss_pred             hhCcCHHHHHHH
Confidence            999999999874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.92  E-value=1.8e-25  Score=225.02  Aligned_cols=150  Identities=23%  Similarity=0.414  Sum_probs=123.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......    .....+|+.|+|||++ .
T Consensus       164 ~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  240 (333)
T 2i1m_A          164 RDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD  240 (333)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEE-GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEEC-CCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc
Confidence            357889999999999999999  99999999999998 67899999999997654332    2234567889999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|+| |..||............+..+..+ ..+...++.+.+||.+||. +|.+|||+.++++
T Consensus       241 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          241 CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM-AQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            568999999999999999999 999998766656555555555333 3455678999999999996 8999999999986


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       320 ~  320 (333)
T 2i1m_A          320 F  320 (333)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.92  E-value=2.1e-25  Score=224.53  Aligned_cols=157  Identities=27%  Similarity=0.375  Sum_probs=116.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhC---------CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----------CCcc
Q 010626            2 KAIKNWARQILRGLHYLHSH---------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----------TARS   62 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~---------g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----------~~~~   62 (505)
                      ..++.++.||+.||.|||++         |  |+||||||+|||++ .++.+||+|||++..+...          ....
T Consensus       111 ~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~  187 (336)
T 3g2f_A          111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS  187 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSCSGGGEEEC-TTSCEEECCCTTCEECSSSSCC---------CC
T ss_pred             hHHHHHHHHHHHHHHHHHhhhccccccccc--eeecccccceEEEc-CCCcEEEeeccceeecccccccCcccccccccc
Confidence            35778999999999999999         8  99999999999998 6789999999999766432          1224


Q ss_pred             ccCCCcccCcccccc--------cCCcccchhhHHHHHHHHhhcCCCCCCCCC-----------------hHHHHHHHHc
Q 010626           63 VIGTPEFMAPELYEE--------EYNELVDIYSFGMCILEMVTCEYPYNECKN-----------------PAQIYKKVTS  117 (505)
Q Consensus        63 ~~Gt~~Y~APEll~~--------~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~-----------------~~~i~~~i~~  117 (505)
                      ..||+.|+|||++.+        .++.++|||||||++|+|++|..||.....                 .......+..
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (336)
T 3g2f_A          188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR  267 (336)
T ss_dssp             TTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTT
T ss_pred             CCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcc
Confidence            469999999998853        467789999999999999999877643221                 1122222222


Q ss_pred             CCCCCCCCCC------CChHHHHHHHHhcC-CCCCCCCHHHHh------cCCCCCCC
Q 010626          118 GIKPASLSKV------TDPQVKQFIEKCIV-PASLRLPALELL------KDPFLVTD  161 (505)
Q Consensus       118 ~~~p~~~~~~------~s~~l~~LI~kcL~-dP~~RpSa~ElL------~hpff~~~  161 (505)
                      ......++..      .++.+.+||.+||. +|.+|||+.|++      .++|-+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          268 EKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             SCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             cccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence            2222233332      23479999999996 899999999995      46776543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.92  E-value=2.4e-25  Score=218.86  Aligned_cols=149  Identities=23%  Similarity=0.407  Sum_probs=119.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~-~   77 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......   .....+++.|+|||++. .
T Consensus       113 ~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  189 (281)
T 3cc6_A          113 LTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVA-SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR  189 (281)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-ETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEC-CCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccC
Confidence            357889999999999999999  99999999999998 67899999999997654332   22345788999999884 5


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|+| |+.||..... ......+..+..+ ..+..+++.+.+||.+||. +|.+||++.+++++
T Consensus       190 ~~~~~~Di~slG~il~~llt~g~~p~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          190 RFTTASDVWMFAVCMWEILSFGKQPFFWLEN-KDVIGVLEKGDRL-PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-GGHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCchhccHHHHHHHHHHHhCCCCCcccCCh-HHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            68999999999999999998 9999976433 3344444444332 3455678999999999996 89999999999865

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.92  E-value=2.5e-25  Score=222.15  Aligned_cols=149  Identities=20%  Similarity=0.330  Sum_probs=117.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......    .....+++.|+|||.+ .
T Consensus       147 ~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  223 (313)
T 3brb_A          147 QTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLR-DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD  223 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEEC-TTSCEEECSCSCC----------------CCGGGSCHHHHHS
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc-CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC
Confidence            467899999999999999999  99999999999997 67899999999997654321    2233578899999988 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|++ |..||... ........+..+..+ ..+..+++.+.+||.+||. +|.+||++.++++
T Consensus       224 ~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  301 (313)
T 3brb_A          224 RVYTSKSDVWAFGVTMWEIATRGMTPYPGV-QNHEMYDYLLHGHRL-KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRL  301 (313)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCC-CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CCccchhhhHHHHHHHHHHHhcCCCCCccC-CHHHHHHHHHcCCCC-CCCccccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            568999999999999999999 88898764 444555555555433 3456678999999999995 8999999999986


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       302 ~  302 (313)
T 3brb_A          302 Q  302 (313)
T ss_dssp             H
T ss_pred             H
Confidence            5

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.92  E-value=6.5e-25  Score=217.23  Aligned_cols=148  Identities=20%  Similarity=0.328  Sum_probs=122.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC-----ccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~-----~~~~Gt~~Y~APEll-   75 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++........     ....+++.|+|||++ 
T Consensus       117 ~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  193 (291)
T 1xbb_A          117 KNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  193 (291)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEe-CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhc
Confidence            467889999999999999999  99999999999998 678999999999987644321     123467889999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ...++.++||||||+++|+|++ |+.||.. .....+...+..+..+ ..+..+++.+.++|.+||. +|.+||++.+++
T Consensus       194 ~~~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~  271 (291)
T 1xbb_A          194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDLMNLCWTYDVENRPGFAAVE  271 (291)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             cCCCChhhhHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            4468899999999999999999 9999986 4555666666665443 4556778999999999996 899999999987


Q ss_pred             c
Q 010626          154 K  154 (505)
Q Consensus       154 ~  154 (505)
                      +
T Consensus       272 ~  272 (291)
T 1xbb_A          272 L  272 (291)
T ss_dssp             H
T ss_pred             H
Confidence            5

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.92  E-value=2.5e-25  Score=224.11  Aligned_cols=149  Identities=26%  Similarity=0.402  Sum_probs=121.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc-ccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~-~~y   79 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++...... ......+++.|+|||++. ..+
T Consensus       142 ~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  218 (327)
T 1fvr_A          142 QQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY  218 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEE
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEc-CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccC
Confidence            467889999999999999999  99999999999997 6789999999999744322 122335788999999884 458


Q ss_pred             CcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           80 NELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      +.++||||||+++|+|+| |..||.. .....+...+..+..+ ..+..+++.+.+||.+||. +|.+||++.+++++
T Consensus       219 ~~~~Di~slG~il~ellt~g~~pf~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          219 TTNSDVWSYGVLLWEIVSLGGTPYCG-MTCAELYEKLPQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHGGGTCCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CchhcchHHHHHHHHHHcCCCCCCCC-CcHHHHHHHhhcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999998 9999976 4556666666665433 3455678999999999996 89999999999976

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.92  E-value=4.7e-25  Score=223.03  Aligned_cols=149  Identities=28%  Similarity=0.441  Sum_probs=124.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......    .....+++.|+|||++ .
T Consensus       157 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  233 (334)
T 2pvf_A          157 KDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT-ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD  233 (334)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEEEc-CCCCEEEccccccccccccccccccCCCCcccceeChHHhcC
Confidence            357889999999999999999  99999999999997 67899999999998765432    2233567899999987 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..++.++||||||+++|+|++ |..||.+ .....+...+..+..+ ..+..+++.+.+||.+||. +|.+||++.++++
T Consensus       234 ~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  311 (334)
T 2pvf_A          234 RVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE  311 (334)
T ss_dssp             CEECHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcChHHHHHHHHHHHHHHHhCCCCCcCc-CCHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            568999999999999999999 9999976 4556666666665433 3456678999999999996 8999999999987


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      +
T Consensus       312 ~  312 (334)
T 2pvf_A          312 D  312 (334)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=4.2e-25  Score=221.77  Aligned_cols=151  Identities=31%  Similarity=0.509  Sum_probs=114.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhC--------CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCC
Q 010626            2 KAIKNWARQILRGLHYLHSH--------NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTP   67 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~--------g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~   67 (505)
                      ..++.++.||+.||.|||++        |  |+||||||+||+++ .++.+||+|||++.......      .....||+
T Consensus       134 ~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~  210 (337)
T 3mdy_A          134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK  210 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEEC-TTSCEEECCCTTCEECC---------CCSSCSCG
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEEC-CCCCEEEEeCCCceeeccccccccCCCCCCccCc
Confidence            46788999999999999998        8  99999999999997 67899999999997664332      12457999


Q ss_pred             cccCccccccc-CCc------ccchhhHHHHHHHHhhc----------CCCCCCCC----ChHHHHHHHHcCCCCCCCCC
Q 010626           68 EFMAPELYEEE-YNE------LVDIYSFGMCILEMVTC----------EYPYNECK----NPAQIYKKVTSGIKPASLSK  126 (505)
Q Consensus        68 ~Y~APEll~~~-ys~------ksDIWSLGviLyEmlTG----------~~Pf~~~~----~~~~i~~~i~~~~~p~~~~~  126 (505)
                      .|+|||++.+. +..      ++|||||||++|+|+||          +.||....    ........+........++.
T Consensus       211 ~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (337)
T 3mdy_A          211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN  290 (337)
T ss_dssp             GGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred             ceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccc
Confidence            99999988543 333      38999999999999999          77775432    12233333333222222332


Q ss_pred             -----CCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626          127 -----VTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus       127 -----~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                           .+++.+.+||.+||. +|.+|||+.++++|
T Consensus       291 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          291 RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                 345679999999996 89999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.92  E-value=3.8e-25  Score=214.92  Aligned_cols=149  Identities=21%  Similarity=0.465  Sum_probs=123.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC---CCccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~---~~~~~~Gt~~Y~APEll~-~   77 (505)
                      +.+..++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++......   ......+++.|+|||++. .
T Consensus       104 ~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  180 (267)
T 3t9t_A          104 ETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS  180 (267)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEEC-GGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEC-CCCCEEEcccccccccccccccccccccccccccChhhhcCC
Confidence            467889999999999999999  99999999999997 6789999999999765332   122345778999999884 5


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|++ |..||.. .........+..+..+ ..+...++.+.+||.+||. +|.+||++.+++++
T Consensus       181 ~~~~~~Di~slG~il~~l~~~g~~p~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          181 RYSSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRL-YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccchhchhhhHHHHHHHhccCCCCCCC-CCHHHHHHHHhcCCcC-CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            68999999999999999999 8999976 4555666666665433 3455678999999999996 89999999999864

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.92  E-value=2.4e-25  Score=217.95  Aligned_cols=149  Identities=28%  Similarity=0.494  Sum_probs=123.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++....... .....|++.|+|||++ ...+
T Consensus       122 ~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  198 (284)
T 2a19_B          122 VLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY  198 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEEEc-CCCCEEECcchhheeccccccccccCCcccccChhhhccCCC
Confidence            357889999999999999999  99999999999998 67899999999998765432 3445799999999988 4568


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +.++||||||+++|+|++|..||..   .......+..+.    ++..+++.+++||.+||. +|.+||++.+++++.+.
T Consensus       199 ~~~~Di~slG~il~~l~~~~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~  271 (284)
T 2a19_B          199 GKEVDLYALGLILAELLHVCDTAFE---TSKFFTDLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV  271 (284)
T ss_dssp             CTHHHHHHHHHHHHHHHSCCSSHHH---HHHHHHHHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cchhhhHHHHHHHHHHHhcCCcchh---HHHHHHHhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            9999999999999999999988753   233344444332    345678899999999996 89999999999999876


Q ss_pred             CC
Q 010626          159 VT  160 (505)
Q Consensus       159 ~~  160 (505)
                      ..
T Consensus       272 ~~  273 (284)
T 2a19_B          272 WK  273 (284)
T ss_dssp             HT
T ss_pred             Hh
Confidence            54

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.92  E-value=9.6e-25  Score=214.08  Aligned_cols=148  Identities=24%  Similarity=0.391  Sum_probs=123.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~-~   77 (505)
                      ..+..++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......   .....+++.|+|||++. .
T Consensus       109 ~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  185 (279)
T 1qpc_A          109 NKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG  185 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEc-CCCCEEECCCcccccccCcccccccCCCCccCccChhhhccC
Confidence            467889999999999999999  99999999999997 77899999999998765432   22335678999999884 5


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++.++||||||+++|+|++ |..||... ........+..+..+ ..+..+++.+.+||.+||. +|.+|||+.++++
T Consensus       186 ~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          186 TFTIKSDVWSFGILLTEIVTHGRIPYPGM-TNPEVIQNLERGYRM-VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             EECHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCchhhhHHHHHHHHHHHhCCCCCCccc-CHHHHHHHHhcccCC-CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            68999999999999999999 99999764 455566666655433 3456678999999999996 8999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.92  E-value=4e-25  Score=228.45  Aligned_cols=148  Identities=23%  Similarity=0.341  Sum_probs=121.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC----ccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~----~~~~Gt~~Y~APEll-~   76 (505)
                      ..+..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++.......    ....+++.|+|||++ .
T Consensus       213 ~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~-~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  289 (377)
T 3cbl_A          213 KTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY  289 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEc-CCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc
Confidence            467889999999999999999  99999999999997 678999999999976543221    112346789999988 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      +.++.++|||||||++|||+| |..||... ...+....+..+..+ ..+..+++.+.+||.+||. +|.+|||+.++++
T Consensus       290 ~~~~~~~DvwslG~il~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          290 GRYSSESDVWSFGILLWETFSLGASPYPNL-SNQQTREFVEKGGRL-PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             CEEEHHHHHHHHHHHHHHHHTTSCCSSTTS-CHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            568999999999999999998 99999874 445555556555433 3556678999999999996 8999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.92  E-value=4.4e-25  Score=218.52  Aligned_cols=148  Identities=26%  Similarity=0.400  Sum_probs=118.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~~Y~APEll   75 (505)
                      +.++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......      .....+|+.|+|||.+
T Consensus       128 ~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  204 (298)
T 3f66_A          128 KDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL  204 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEC-CCCCEEECcccccccccccchhccccccCCCCCccccChHHh
Confidence            467889999999999999999  99999999999997 77899999999997654321      2334578899999988


Q ss_pred             -cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           76 -EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        76 -~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                       ...++.++||||||+++|+|++ |.+||.. .+.......+..+..+ ..+...++.+.++|.+||. +|.+||++.++
T Consensus       205 ~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~el  282 (298)
T 3f66_A          205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL  282 (298)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence             4568999999999999999999 5555554 4444444455544333 3455678899999999996 89999999998


Q ss_pred             hc
Q 010626          153 LK  154 (505)
Q Consensus       153 L~  154 (505)
                      ++
T Consensus       283 l~  284 (298)
T 3f66_A          283 VS  284 (298)
T ss_dssp             HH
T ss_pred             HH
Confidence            86

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.92  E-value=6e-25  Score=232.91  Aligned_cols=147  Identities=23%  Similarity=0.434  Sum_probs=121.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      ..+..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++..... .....+++.|+|||++ ...++
T Consensus       289 ~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  364 (450)
T 1k9a_A          289 DCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST-QDTGKLPVKWTAPEALREKKFS  364 (450)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTSCEEECCCTTCEECC-------CCCTTTSCHHHHHSSCCC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEC-CCCCEEEeeCCCccccccc-ccCCCCCcceeCHHHhcCCCCC
Confidence            357889999999999999999  99999999999997 6789999999999765433 2233678899999988 55699


Q ss_pred             cccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           81 ELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++||||||+++|||+| |+.||.... ..+....+..+..+ ..+..+++.+.+||.+||. +|.+|||+.+++.
T Consensus       365 ~~sDvwslG~~l~el~t~g~~P~~~~~-~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          365 TKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYKM-DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCSSTTSC-TTTHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999998 999998744 34455666665443 4566788999999999995 8999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.92  E-value=5.6e-25  Score=215.94  Aligned_cols=147  Identities=23%  Similarity=0.449  Sum_probs=116.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++...... .....+++.|+|||++ ...++
T Consensus       117 ~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~-~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  192 (278)
T 1byg_A          117 DCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST-QDTGKLPVKWTAPEALREKKFS  192 (278)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC-------------CCTTTSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEe-CCCcEEEeecccccccccc-ccCCCccccccCHHHhCCCCCC
Confidence            357889999999999999999  99999999999997 6789999999998765433 2234678899999988 45689


Q ss_pred             cccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           81 ELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .++||||||+++|+|+| |..||... ........+..+.. ...+..+++.+.++|.+||. +|.+||++.++++
T Consensus       193 ~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          193 TKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYK-MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCC-CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            99999999999999998 99999764 44455555555533 34556778999999999996 8999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.92  E-value=4.2e-25  Score=225.23  Aligned_cols=151  Identities=20%  Similarity=0.369  Sum_probs=118.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC--cEEEeecCceeeccCC---------CCccccCCCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG--EVKIGDLGLAIVMQQP---------TARSVIGTPEFM   70 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g--~vKL~DFGlA~~~~~~---------~~~~~~Gt~~Y~   70 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++  .+||+|||++..+...         ......||+.|+
T Consensus       159 ~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~~-~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~  235 (352)
T 2jii_A          159 RSVLQVACRLLDALEFLHENE--YVHGNVTAENIFVD-PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI  235 (352)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEEE-TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEc-CCCCceEEEecCcceeeccCCCccccccccccccccCCcccc
Confidence            467899999999999999999  99999999999998 566  8999999999765322         123347999999


Q ss_pred             Cccccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCC-ChHHHHHHHH---cCCCCC----CCCCCCChHHHHHHHHhcC
Q 010626           71 APELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVT---SGIKPA----SLSKVTDPQVKQFIEKCIV  141 (505)
Q Consensus        71 APEll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~-~~~~i~~~i~---~~~~p~----~~~~~~s~~l~~LI~kcL~  141 (505)
                      |||++. ..++.++|||||||++|+|++|+.||.... ....+.....   ....+.    .....+++.+.+||.+||.
T Consensus       236 aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  315 (352)
T 2jii_A          236 SMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMA  315 (352)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHT
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHh
Confidence            999884 468999999999999999999999998654 3333333322   111110    0112458999999999995


Q ss_pred             -CCCCCCCHHHHhcC
Q 010626          142 -PASLRLPALELLKD  155 (505)
Q Consensus       142 -dP~~RpSa~ElL~h  155 (505)
                       +|.+||++.++++.
T Consensus       316 ~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          316 LTYEEKPPYAMLRNN  330 (352)
T ss_dssp             CCTTCCCCHHHHHHH
T ss_pred             CChhhCCCHHHHHHH
Confidence             89999999998763

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.92  E-value=6.4e-25  Score=218.89  Aligned_cols=151  Identities=31%  Similarity=0.498  Sum_probs=114.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll-~~~   78 (505)
                      +.++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......  .....|++.|+|||++ ...
T Consensus       136 ~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  212 (310)
T 2wqm_A          136 RTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG  212 (310)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCC------------------CCSSCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEc-CCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCC
Confidence            357889999999999999999  99999999999997 67899999999997654332  2345789999999987 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCC-ChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      ++.++||||||+++|+|++|..||.+.. +.......+.....+......+++.+.+||.+||. +|.+||++.+++++
T Consensus       213 ~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          213 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            8999999999999999999999997543 34455566666555544456678999999999996 89999999999864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.92  E-value=4.6e-25  Score=221.49  Aligned_cols=153  Identities=27%  Similarity=0.399  Sum_probs=116.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhC---CCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSH---NPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~---g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll   75 (505)
                      ..++.++.||+.||.|||++   |  |+||||||+||+++ .++.+||+|||++.......   .....||+.|+|||++
T Consensus       131 ~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~  207 (326)
T 3uim_A          131 PKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLD-EEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL  207 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEEC-TTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEEC-CCCCEEeccCccccccCcccccccccccCCcCccCHHHh
Confidence            36788999999999999999   8  99999999999998 67899999999998764332   2334699999999988


Q ss_pred             -cccCCcccchhhHHHHHHHHhhcCCCCCC----CCChHHHHHHHHcCCCCC------------CCCCCCChHHHHHHHH
Q 010626           76 -EEEYNELVDIYSFGMCILEMVTCEYPYNE----CKNPAQIYKKVTSGIKPA------------SLSKVTDPQVKQFIEK  138 (505)
Q Consensus        76 -~~~ys~ksDIWSLGviLyEmlTG~~Pf~~----~~~~~~i~~~i~~~~~p~------------~~~~~~s~~l~~LI~k  138 (505)
                       ...++.++||||||+++|+|+||+.||..    ..........+.......            ......++.+.+|+.+
T Consensus       208 ~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  287 (326)
T 3uim_A          208 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALL  287 (326)
T ss_dssp             HHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHH
T ss_pred             ccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHH
Confidence             55689999999999999999999999952    111111111221111111            1111123678999999


Q ss_pred             hcC-CCCCCCCHHHHhcCCC
Q 010626          139 CIV-PASLRLPALELLKDPF  157 (505)
Q Consensus       139 cL~-dP~~RpSa~ElL~hpf  157 (505)
                      ||. +|.+|||+.++++|-.
T Consensus       288 cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          288 CTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             HTCSCGGGSCCHHHHHHHHH
T ss_pred             HhCcCCccCCCHHHHHHHhc
Confidence            996 8999999999998854

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.92  E-value=6.5e-25  Score=232.68  Aligned_cols=148  Identities=23%  Similarity=0.397  Sum_probs=122.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++......   .....+++.|+|||++ .+
T Consensus       284 ~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  360 (454)
T 1qcf_A          284 PKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVS-ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG  360 (454)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEEC-TTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEEC-CCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccC
Confidence            357789999999999999999  99999999999997 67899999999997654321   2233467889999988 46


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .|+.++|||||||++|||+| |+.||.+. ...++...+..+.... .+..+++.+.+||.+||. +|.+|||+.+++.
T Consensus       361 ~~~~~~DvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          361 SFTIKSDVWSFGILLMEIVTYGRIPYPGM-SNPEVIRALERGYRMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcHHHHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCCC-CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            79999999999999999999 99999874 4556666666664432 456678999999999996 8999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.91  E-value=4.7e-25  Score=218.36  Aligned_cols=149  Identities=24%  Similarity=0.359  Sum_probs=114.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll-   75 (505)
                      ..+..++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......     .....+++.|+|||++ 
T Consensus       114 ~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  190 (295)
T 3ugc_A          114 IKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT  190 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCSCC-------------CTTCGGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEc-CCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhc
Confidence            357889999999999999999  99999999999998 67899999999997664332     2233467789999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhhcCCCCCCCCCh---------------HHHHHHHHcCCCCCCCCCCCChHHHHHHHHhc
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNP---------------AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  140 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~---------------~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL  140 (505)
                      ...++.++||||||+++|+|+||..||......               ......+..+. ....+..+++.+.+||.+||
T Consensus       191 ~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l  269 (295)
T 3ugc_A          191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG-RLPRPDGCPDEIYMIMTECW  269 (295)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHS
T ss_pred             CCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccC-cCCCCcCcCHHHHHHHHHHc
Confidence            456899999999999999999999998642100               01222222332 33456677899999999999


Q ss_pred             C-CCCCCCCHHHHhc
Q 010626          141 V-PASLRLPALELLK  154 (505)
Q Consensus       141 ~-dP~~RpSa~ElL~  154 (505)
                      . +|.+|||+.++++
T Consensus       270 ~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          270 NNNVNQRPSFRDLAL  284 (295)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             CCChhhCCCHHHHHH
Confidence            6 8999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.91  E-value=3.6e-25  Score=222.91  Aligned_cols=155  Identities=25%  Similarity=0.374  Sum_probs=126.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccCC----CCccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll   75 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++.  ....+||+|||++......    ......|++.|+|||++
T Consensus       140 ~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  217 (327)
T 2yfx_A          140 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF  217 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHh
Confidence            357889999999999999999  999999999999972  3446999999999754322    12344678999999987


Q ss_pred             -cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           76 -EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        76 -~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                       ...++.++||||||+++|+|+| |..||.. .........+..+..+ ..+..+++.+.+||.+||. +|.+||++.++
T Consensus       218 ~~~~~~~~~Di~slG~il~ellt~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  295 (327)
T 2yfx_A          218 MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS-KSNQEVLEFVTSGGRM-DPPKNCPGPVYRIMTQCWQHQPEDRPNFAII  295 (327)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-cCHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence             5668999999999999999998 9999976 4555566666655433 3456678999999999996 89999999999


Q ss_pred             hcCCCCCC
Q 010626          153 LKDPFLVT  160 (505)
Q Consensus       153 L~hpff~~  160 (505)
                      +++.|+..
T Consensus       296 l~~l~~~~  303 (327)
T 2yfx_A          296 LERIEYCT  303 (327)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHh
Confidence            99988754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.91  E-value=3.9e-25  Score=219.84  Aligned_cols=151  Identities=26%  Similarity=0.414  Sum_probs=118.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELYEE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll~~   77 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......    .....||+.|+|||++.+
T Consensus       133 ~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~  209 (307)
T 2nru_A          133 HMRCKIAQGAANGINFLHENH--HIHRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG  209 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEc-CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC
Confidence            357789999999999999999  99999999999997 77899999999997664322    233578999999999988


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChH---HHHHHHHcCCC---------CCCCCCCCChHHHHHHHHhcC-CCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPA---QIYKKVTSGIK---------PASLSKVTDPQVKQFIEKCIV-PAS  144 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~---~i~~~i~~~~~---------p~~~~~~~s~~l~~LI~kcL~-dP~  144 (505)
                      .++.++||||||+++|+|++|..||.......   .+...+.....         ....+...+..+.+++.+||. +|.
T Consensus       210 ~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~  289 (307)
T 2nru_A          210 EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKN  289 (307)
T ss_dssp             EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTT
T ss_pred             CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcc
Confidence            89999999999999999999999997643321   22222222110         111222335678999999996 799


Q ss_pred             CCCCHHHHhcC
Q 010626          145 LRLPALELLKD  155 (505)
Q Consensus       145 ~RpSa~ElL~h  155 (505)
                      +||++.+++++
T Consensus       290 ~Rps~~~l~~~  300 (307)
T 2nru_A          290 KRPDIKKVQQL  300 (307)
T ss_dssp             TSCCHHHHHHH
T ss_pred             cCcCHHHHHHH
Confidence            99999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.91  E-value=3.4e-25  Score=218.03  Aligned_cols=146  Identities=18%  Similarity=0.305  Sum_probs=116.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCc--------EEEeecCceeeccCCCCccccCCCcccCcc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGE--------VKIGDLGLAIVMQQPTARSVIGTPEFMAPE   73 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~--------vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APE   73 (505)
                      ..++.++.||+.||.|||++|  |+||||||+|||++ .++.        +||+|||++.....  .....||+.|+|||
T Consensus       113 ~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~-~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~y~aPE  187 (289)
T 4fvq_A          113 LWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLI-REEDRKTGNPPFIKLSDPGISITVLP--KDILQERIPWVPPE  187 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-ECCBGGGTBCCEEEECCCCSCTTTSC--HHHHHHTTTTSCHH
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEe-cCCcccccccceeeeccCcccccccC--ccccCCcCcccCHH
Confidence            357889999999999999999  99999999999997 4555        99999999865432  23346889999999


Q ss_pred             ccc--ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626           74 LYE--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus        74 ll~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                      ++.  ..++.++||||||+++|+|++|..|+................   ..++...++.+.+||.+||. +|.+|||+.
T Consensus       188 ~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  264 (289)
T 4fvq_A          188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR---HQLPAPKAAELANLINNCMDYEPDHRPSFR  264 (289)
T ss_dssp             HHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHH
T ss_pred             HhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhcc---CCCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence            884  558999999999999999999665555445554444443332   23344557889999999996 899999999


Q ss_pred             HHhcC
Q 010626          151 ELLKD  155 (505)
Q Consensus       151 ElL~h  155 (505)
                      ++++|
T Consensus       265 ~ll~~  269 (289)
T 4fvq_A          265 AIIRD  269 (289)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.91  E-value=1.5e-25  Score=225.13  Aligned_cols=152  Identities=26%  Similarity=0.382  Sum_probs=116.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++.......    .....||+.|+|||++ .
T Consensus       139 ~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  215 (321)
T 2qkw_B          139 EQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLD-ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK  215 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEEC-TTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEEC-CCCCEEEeecccccccccccccccccccCCCccccCHHHhcC
Confidence            467889999999999999999  99999999999997 77899999999997653321    2334689999999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCCh-----HHH-HHHHHcCCC-----C---CCCCCCCChHHHHHHHHhcC-
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNP-----AQI-YKKVTSGIK-----P---ASLSKVTDPQVKQFIEKCIV-  141 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~-----~~i-~~~i~~~~~-----p---~~~~~~~s~~l~~LI~kcL~-  141 (505)
                      ..++.++||||||+++|+|+||+.||......     ... ......+..     +   .......+..+.+++.+||. 
T Consensus       216 ~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  295 (321)
T 2qkw_B          216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL  295 (321)
T ss_dssp             CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCS
T ss_pred             CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCC
Confidence            67999999999999999999999999753221     111 111111111     1   11122234678999999996 


Q ss_pred             CCCCCCCHHHHhcCC
Q 010626          142 PASLRLPALELLKDP  156 (505)
Q Consensus       142 dP~~RpSa~ElL~hp  156 (505)
                      +|.+|||+.+++++.
T Consensus       296 dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          296 SSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SGGGSCCHHHHHHHH
T ss_pred             CcccCcCHHHHHHHH
Confidence            899999999999764

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.91  E-value=5e-25  Score=236.72  Aligned_cols=162  Identities=20%  Similarity=0.275  Sum_probs=125.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEe--CCCCcEEEeecCceeeccCCCC---------ccccCCCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPTA---------RSVIGTPEFM   70 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld--~~~g~vKL~DFGlA~~~~~~~~---------~~~~Gt~~Y~   70 (505)
                      +.++.|+.||+.||.|||++|  |+||||||+|||++  ..++.+||+|||+++.+.....         ....||+.|+
T Consensus       103 ~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~  180 (483)
T 3sv0_A          103 KTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA  180 (483)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCcccc
Confidence            468899999999999999999  99999999999993  2678999999999987654321         2557999999


Q ss_pred             Ccccc-cccCCcccchhhHHHHHHHHhhcCCCCCCCCC--hHHHHHHHHcCCC---CCCCCCCCChHHHHHHHHhcC-CC
Q 010626           71 APELY-EEEYNELVDIYSFGMCILEMVTCEYPYNECKN--PAQIYKKVTSGIK---PASLSKVTDPQVKQFIEKCIV-PA  143 (505)
Q Consensus        71 APEll-~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~--~~~i~~~i~~~~~---p~~~~~~~s~~l~~LI~kcL~-dP  143 (505)
                      |||++ ...++.++|||||||++|+|++|+.||.+...  ..+.+..+.....   ...+...+++++.+||.+||. +|
T Consensus       181 aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP  260 (483)
T 3sv0_A          181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRF  260 (483)
T ss_dssp             CHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCT
T ss_pred             CHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCCh
Confidence            99988 45689999999999999999999999976433  3333333332211   112224567899999999996 89


Q ss_pred             CCCCCHHHHhc----------CCCCCCCCCCC
Q 010626          144 SLRLPALELLK----------DPFLVTDNPKD  165 (505)
Q Consensus       144 ~~RpSa~ElL~----------hpff~~~~~~~  165 (505)
                      .+||++.+|++          ++|+....|..
T Consensus       261 ~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~  292 (483)
T 3sv0_A          261 DDKPDYSYLKRLFRDLFIREGFQFDYVFDWTI  292 (483)
T ss_dssp             TCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHH
T ss_pred             hhCcCHHHHHHHHHHHHHHcCCCccCCcCchh
Confidence            99999987664          56665544443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.91  E-value=1.1e-24  Score=215.85  Aligned_cols=149  Identities=26%  Similarity=0.395  Sum_probs=119.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll-   75 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++.......     .....||+.|+|||++ 
T Consensus       126 ~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  202 (302)
T 4e5w_A          126 KQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM  202 (302)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEc-CCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeec
Confidence            467889999999999999999  99999999999998 67899999999998765432     2334678889999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhhcCCCCCCC--------------CChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCEYPYNEC--------------KNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV  141 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~--------------~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~  141 (505)
                      ...++.++||||||+++|+|+||..|+...              .........+..+. ....+..+++.+.+||.+||.
T Consensus       203 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~  281 (302)
T 4e5w_A          203 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGK-RLPCPPNCPDEVYQLMRKCWE  281 (302)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHTTC
T ss_pred             CCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccC-CCCCCCCCCHHHHHHHHHHcC
Confidence            556889999999999999999999876321              11222333333333 334566778999999999996


Q ss_pred             -CCCCCCCHHHHhc
Q 010626          142 -PASLRLPALELLK  154 (505)
Q Consensus       142 -dP~~RpSa~ElL~  154 (505)
                       +|.+|||+.++++
T Consensus       282 ~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          282 FQPSNRTSFQNLIE  295 (302)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHH
Confidence             8999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=1.9e-24  Score=219.29  Aligned_cols=149  Identities=26%  Similarity=0.414  Sum_probs=117.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll-   75 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......     .....+|+.|+|||++ 
T Consensus       147 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  223 (333)
T 1mqb_A          147 LQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS  223 (333)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC-----------------CCCGGGSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEEC-CCCcEEECCCCcchhhccccccccccCCCCccccccCchhcc
Confidence            467889999999999999999  99999999999997 67899999999997664322     1123467889999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ...++.++||||||+++|+|++ |..||... ....+...+..+..+ ..+..+++.+.+||.+||. +|.+||++.+++
T Consensus       224 ~~~~~~~~Di~slG~il~ellt~g~~pf~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~  301 (333)
T 1mqb_A          224 YRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKAINDGFRL-PTPMDCPSAIYQLMMQCWQQERARRPKFADIV  301 (333)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHTTCCC-CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             cCCCCchhhhHHHHHHHHHHHcCCCCCcccC-CHHHHHHHHHCCCcC-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            4568999999999999999999 99999764 455666666665433 2445678999999999996 899999999988


Q ss_pred             cC
Q 010626          154 KD  155 (505)
Q Consensus       154 ~h  155 (505)
                      ++
T Consensus       302 ~~  303 (333)
T 1mqb_A          302 SI  303 (333)
T ss_dssp             HH
T ss_pred             HH
Confidence            65

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.91  E-value=7.5e-25  Score=215.48  Aligned_cols=149  Identities=26%  Similarity=0.373  Sum_probs=122.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC---ccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~---~~~~Gt~~Y~APEll-~~   77 (505)
                      ..++.++.||+.||.|||++|  ++||||||+||+++ .++.+||+|||++........   ....+++.|+|||++ ..
T Consensus       111 ~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  187 (288)
T 3kfa_A          111 VVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN  187 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEEC-GGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHC
T ss_pred             hHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEc-CCCCEEEccCccceeccCCccccccCCccccCcCChhhhccC
Confidence            357889999999999999999  99999999999997 678999999999976644322   223567889999988 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++||||||+++|+|++ |..||.. .+.......+.....+ ..+..+++.+.+||.+||. +|.+||++.++++.
T Consensus       188 ~~~~~~Di~slG~il~~ll~~g~~p~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          188 KFSIKSDVWAFGVLLWEIATYGMSPYPG-IDLSQVYELLEKDYRM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHhccCCC-CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence            68999999999999999999 9999976 3445555555554333 3456678999999999996 89999999998763

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.91  E-value=7.1e-25  Score=220.79  Aligned_cols=150  Identities=23%  Similarity=0.355  Sum_probs=120.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll-   75 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+||+++ .++.+||+|||++.......     .....||+.|+|||++ 
T Consensus       127 ~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  203 (327)
T 3lxl_A          127 SRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS  203 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEEC-CCCCEEEcccccceecccCCccceeeccCCccccccCHHHhc
Confidence            467889999999999999999  99999999999998 67899999999998764432     2234578889999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhhcCCCCCCCCC--------------hHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCEYPYNECKN--------------PAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV  141 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~--------------~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~  141 (505)
                      ...++.++||||||+++|+|++|..||.....              .......+..+. ....+..+++.+.+||.+||.
T Consensus       204 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~  282 (327)
T 3lxl_A          204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ-RLPAPPACPAEVHELMKLCWA  282 (327)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTC
T ss_pred             cCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc-CCCCCCcccHHHHHHHHHHcC
Confidence            45589999999999999999999999854211              122233333333 334566778999999999996


Q ss_pred             -CCCCCCCHHHHhcC
Q 010626          142 -PASLRLPALELLKD  155 (505)
Q Consensus       142 -dP~~RpSa~ElL~h  155 (505)
                       +|.+|||+.+++++
T Consensus       283 ~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          283 PSPQDRPSFSALGPQ  297 (327)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCcCHHHHHHH
Confidence             89999999999654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.91  E-value=1.2e-24  Score=218.03  Aligned_cols=149  Identities=23%  Similarity=0.305  Sum_probs=111.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......   .....|++.|+|||++ ..
T Consensus       134 ~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  210 (309)
T 2h34_A          134 PRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVS-ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES  210 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSCCC----------------CCGGGCCGGGTCC-
T ss_pred             HHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEc-CCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCC
Confidence            467889999999999999999  99999999999997 67899999999997654332   2345789999999988 45


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCChHHHHHHHHhcC-CCCCCC-CHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRL-PALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-Sa~ElL~  154 (505)
                      .++.++||||||+++|+|++|+.||... ....+...+..... +......+++.+.+||.+||. +|.+|| ++.++++
T Consensus       211 ~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          211 HATYRADIYALTCVLYECLTGSPPYQGD-QLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             ---CCCHHHHHHHHHHHHHHSSCSSCSC-HHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCCchHhHHHHHHHHHHHHHCCCCCCCc-hHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            6889999999999999999999999763 33344444444332 334556678999999999996 899999 7887775

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.91  E-value=2.9e-25  Score=221.80  Aligned_cols=150  Identities=24%  Similarity=0.273  Sum_probs=115.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----------CccccCCCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----------ARSVIGTPEFM   70 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----------~~~~~Gt~~Y~   70 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......           .....||+.|+
T Consensus       134 ~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  210 (317)
T 2buj_A          134 DQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR  210 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEc-CCCCEEEEecCcchhcccccccccccccccccccccCCcccC
Confidence            467889999999999999999  99999999999997 67899999999986543211           11235799999


Q ss_pred             Ccccccc----cCCcccchhhHHHHHHHHhhcCCCCCCCC-ChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCC
Q 010626           71 APELYEE----EYNELVDIYSFGMCILEMVTCEYPYNECK-NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PAS  144 (505)
Q Consensus        71 APEll~~----~ys~ksDIWSLGviLyEmlTG~~Pf~~~~-~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~  144 (505)
                      |||++..    .++.++||||||+++|+|++|+.||.... ........+... ........+++.+.+||.+||. +|.
T Consensus       211 aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~  289 (317)
T 2buj_A          211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ-LSIPQSPRHSSALWQLLNSMMTVDPH  289 (317)
T ss_dssp             CGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC---CCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred             CHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc-CCCCccccCCHHHHHHHHHHhhcChh
Confidence            9998843    37899999999999999999999995310 001112222222 2223345668999999999996 899


Q ss_pred             CCCCHHHHhcC
Q 010626          145 LRLPALELLKD  155 (505)
Q Consensus       145 ~RpSa~ElL~h  155 (505)
                      +||++.+++++
T Consensus       290 ~Rps~~~ll~~  300 (317)
T 2buj_A          290 QRPHIPLLLSQ  300 (317)
T ss_dssp             GSCCHHHHHHH
T ss_pred             hCCCHHHHHHH
Confidence            99999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=8.4e-25  Score=226.69  Aligned_cols=149  Identities=24%  Similarity=0.388  Sum_probs=112.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~~Y~APEll   75 (505)
                      +.+..++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||+++......      .....+++.|+|||++
T Consensus       192 ~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  268 (373)
T 3c1x_A          192 KDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL  268 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC---------------------CCGGGSCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EecCccchheEEEC-CCCCEEEeeccccccccccccccccccCCCCCcccccChHHh
Confidence            467889999999999999999  99999999999997 67899999999997653321      1233577899999988


Q ss_pred             -cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           76 -EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        76 -~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                       ...++.++|||||||++|+|+| |..||.... .......+..+..+ ..+..+++.+.++|.+||. +|.+||++.++
T Consensus       269 ~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~-~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dp~~RPs~~el  346 (373)
T 3c1x_A          269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-TFDITVYLLQGRRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL  346 (373)
T ss_dssp             HHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-SSCHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC-HHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence             4568999999999999999999 677776543 33344445554433 3456678999999999996 89999999999


Q ss_pred             hcC
Q 010626          153 LKD  155 (505)
Q Consensus       153 L~h  155 (505)
                      +++
T Consensus       347 l~~  349 (373)
T 3c1x_A          347 VSR  349 (373)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.91  E-value=1.1e-24  Score=219.52  Aligned_cols=151  Identities=29%  Similarity=0.467  Sum_probs=118.5

Q ss_pred             HHHHHHHHHHHHHHHHHH--------hCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCC
Q 010626            2 KAIKNWARQILRGLHYLH--------SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTP   67 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLH--------s~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~   67 (505)
                      +.++.++.||+.||.|||        ++|  |+||||||+||+++ .++.+||+|||++.......      .....||+
T Consensus       139 ~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~  215 (342)
T 1b6c_B          139 EGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK  215 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEEC-TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCG
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEEC-CCCCEEEEECCCceeccccccccccccccCCcCc
Confidence            467889999999999999        888  99999999999997 67899999999997765432      23457999


Q ss_pred             cccCccccccc-------CCcccchhhHHHHHHHHhhc----------CCCCCCCC----ChHHHHHHHHcCCCCCCCCC
Q 010626           68 EFMAPELYEEE-------YNELVDIYSFGMCILEMVTC----------EYPYNECK----NPAQIYKKVTSGIKPASLSK  126 (505)
Q Consensus        68 ~Y~APEll~~~-------ys~ksDIWSLGviLyEmlTG----------~~Pf~~~~----~~~~i~~~i~~~~~p~~~~~  126 (505)
                      .|+|||++.+.       ++.++|||||||++|+|+||          +.||....    ....+...+........++.
T Consensus       216 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (342)
T 1b6c_B          216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN  295 (342)
T ss_dssp             GGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred             ccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcc
Confidence            99999988543       33689999999999999999          78886532    23444455544433333332


Q ss_pred             -----CCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626          127 -----VTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus       127 -----~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                           .....+.+||.+||. +|.+|||+.++++|
T Consensus       296 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          296 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                 223578999999995 89999999999876

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.91  E-value=2.1e-24  Score=231.70  Aligned_cols=148  Identities=25%  Similarity=0.372  Sum_probs=122.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC---ccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~---~~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++.......   ....+++.|+|||++ ..
T Consensus       318 ~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  394 (495)
T 1opk_A          318 VVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN  394 (495)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEEC-CCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcC
Confidence            356789999999999999999  99999999999997 678999999999987644321   223456789999988 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .|+.++|||||||++|||+| |..||.+. +..++...+..+... ..+..+++.+.+||.+||. +|.+|||+.++++
T Consensus       395 ~~~~~sDvwSlG~~l~el~t~g~~p~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          395 KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKDYRM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             EECHHHHHHHHHHHHHHHHTTSCCSSTTC-CGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcHHhHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            69999999999999999999 99999774 445566666655433 3556778999999999996 8999999999976

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.91  E-value=1.9e-24  Score=223.67  Aligned_cols=148  Identities=24%  Similarity=0.395  Sum_probs=111.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC-----ccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-----RSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~-----~~~~Gt~~Y~APEll-   75 (505)
                      ..+..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++.......     ....+++.|+|||++ 
T Consensus       147 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  223 (373)
T 2qol_A          147 IQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA  223 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC----------------------CTTSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEc-CCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhc
Confidence            357889999999999999999  99999999999997 678999999999976643321     122356789999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ...++.++||||||+++|||++ |+.||... ....+...+..+..+ ..+..+++.+.+||.+||. +|.+||++.+++
T Consensus       224 ~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~  301 (373)
T 2qol_A          224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEM-SNQDVIKAVDEGYRL-PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV  301 (373)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC-CHHHHHHHHHTTEEC-CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             cCCcCchhcHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCccccHHHHHHHHHHhCcChhhCcCHHHHH
Confidence            4569999999999999999998 99999764 455566666555332 2345678999999999996 899999999987


Q ss_pred             c
Q 010626          154 K  154 (505)
Q Consensus       154 ~  154 (505)
                      +
T Consensus       302 ~  302 (373)
T 2qol_A          302 S  302 (373)
T ss_dssp             H
T ss_pred             H
Confidence            6

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.91  E-value=1.9e-24  Score=229.19  Aligned_cols=154  Identities=23%  Similarity=0.378  Sum_probs=121.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++......   .....+++.|+|||++ .+
T Consensus       280 ~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  356 (452)
T 1fmk_A          280 PQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG  356 (452)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC--------------CCGGGSCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEC-CCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcC
Confidence            467889999999999999999  99999999999997 67899999999997664322   2233467889999987 56


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc-
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK-  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~-  154 (505)
                      .++.++||||||+++|||+| |..||.+. ...++...+..+..+ ..+..+++.+.+||.+||. +|.+|||+.++++ 
T Consensus       357 ~~~~~sDvwslG~~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~  434 (452)
T 1fmk_A          357 RFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF  434 (452)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHTTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCccccHHhHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            79999999999999999999 99999864 455666666666443 3455678999999999996 8999999999886 


Q ss_pred             -CCCCCC
Q 010626          155 -DPFLVT  160 (505)
Q Consensus       155 -hpff~~  160 (505)
                       +.++..
T Consensus       435 L~~~~~~  441 (452)
T 1fmk_A          435 LEDYFTS  441 (452)
T ss_dssp             HHTTTSC
T ss_pred             HHHHhcc
Confidence             355543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.90  E-value=2e-24  Score=217.24  Aligned_cols=149  Identities=26%  Similarity=0.403  Sum_probs=118.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......     .....+++.|+|||++.
T Consensus       134 ~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  210 (318)
T 3lxp_A          134 AQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK  210 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEc-CCCCEEECCccccccccccccccccccCCCCCceeeChHHhc
Confidence            467889999999999999999  99999999999997 67899999999998765432     22345788899999884


Q ss_pred             -ccCCcccchhhHHHHHHHHhhcCCCCCCCCCh--------------HHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC
Q 010626           77 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNP--------------AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV  141 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~--------------~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~  141 (505)
                       ..++.++||||||+++|+|+||..||......              ......+..+ .....+..+++.+.+||.+||.
T Consensus       211 ~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~  289 (318)
T 3lxp_A          211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG-ERLPRPDKCPAEVYHLMKNCWE  289 (318)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc-cCCCCCccccHHHHHHHHHHcC
Confidence             46889999999999999999999998642111              1112222233 3334566778999999999996


Q ss_pred             -CCCCCCCHHHHhc
Q 010626          142 -PASLRLPALELLK  154 (505)
Q Consensus       142 -dP~~RpSa~ElL~  154 (505)
                       +|.+|||+.++++
T Consensus       290 ~dP~~Rps~~ell~  303 (318)
T 3lxp_A          290 TEASFRPTFENLIP  303 (318)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CCcccCcCHHHHHH
Confidence             8999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.90  E-value=1e-24  Score=223.46  Aligned_cols=144  Identities=21%  Similarity=0.281  Sum_probs=109.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC-----------CCcEEEeecCceeeccC----CCCccccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-----------NGEVKIGDLGLAIVMQQ----PTARSVIGT   66 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~-----------~g~vKL~DFGlA~~~~~----~~~~~~~Gt   66 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+|||++ .           ++.+||+|||+++.+..    ......+||
T Consensus       172 ~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~-~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt  248 (365)
T 3e7e_A          172 GLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILG-NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET  248 (365)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEEC-GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCT
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEec-ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCC
Confidence            358899999999999999999  99999999999997 4           68999999999976542    123455799


Q ss_pred             CcccCccccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCC
Q 010626           67 PEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PAS  144 (505)
Q Consensus        67 ~~Y~APEll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~  144 (505)
                      +.|+|||++. ..|+.++|||||||++|+|+||+.||........       ...........++.+.+++.+||. +|.
T Consensus       249 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~~p~  321 (365)
T 3e7e_A          249 SGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-------KPEGLFRRLPHLDMWNEFFHVMLNIPDC  321 (365)
T ss_dssp             TSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-------EECSCCTTCSSHHHHHHHHHHHHCCCCT
T ss_pred             CCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-------eechhccccCcHHHHHHHHHHHcCCCCC
Confidence            9999999884 4589999999999999999999999964322100       000000111236788999999996 688


Q ss_pred             CCCCHHHHhcC
Q 010626          145 LRLPALELLKD  155 (505)
Q Consensus       145 ~RpSa~ElL~h  155 (505)
                      +|++..+.|.+
T Consensus       322 ~r~~~~~~l~~  332 (365)
T 3e7e_A          322 HHLPSLDLLRQ  332 (365)
T ss_dssp             TCCCCHHHHHH
T ss_pred             CcchHHHHHHH
Confidence            88665544443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.90  E-value=4.1e-24  Score=236.72  Aligned_cols=148  Identities=20%  Similarity=0.337  Sum_probs=121.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++.+....     .....+|+.|+|||++.
T Consensus       469 ~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~  545 (635)
T 4fl3_A          469 KNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  545 (635)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCTTHHHHTTC-------------CGGGSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEe-CCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhc
Confidence            467889999999999999999  99999999999998 67899999999997664322     12234678899999884


Q ss_pred             -ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 -EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                       ..|+.++|||||||++|||++ |+.||.+ .....+...+..+..+ ..+..+++++.+||.+||. +|.+||++.+++
T Consensus       546 ~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~  623 (635)
T 4fl3_A          546 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDLMNLCWTYDVENRPGFAAVE  623 (635)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence             579999999999999999998 9999987 4555666667666543 4556788999999999996 899999999987


Q ss_pred             c
Q 010626          154 K  154 (505)
Q Consensus       154 ~  154 (505)
                      +
T Consensus       624 ~  624 (635)
T 4fl3_A          624 L  624 (635)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.90  E-value=2.6e-24  Score=214.28  Aligned_cols=138  Identities=22%  Similarity=0.421  Sum_probs=106.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCC--CCcEEEeecCceeeccCCCCccccCCCcccCcccccccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN--NGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~--~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~y   79 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++..  ++.+||+|||++....                   ...|
T Consensus       117 ~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-------------------~~~~  175 (299)
T 3m2w_A          117 REASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-------------------GEKY  175 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-------------------TCGG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEeccccccccc-------------------cccC
Confidence            467899999999999999999  9999999999999742  6789999999986543                   2346


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--CCCC----CCCChHHHHHHHHhcC-CCCCCCCHHHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLS----KVTDPQVKQFIEKCIV-PASLRLPALEL  152 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~----~~~s~~l~~LI~kcL~-dP~~RpSa~El  152 (505)
                      +.++|||||||++|+|+||+.||...... .....+......  ..++    ..+++.+++||.+||. +|.+|||+.|+
T Consensus       176 ~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~  254 (299)
T 3m2w_A          176 DKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF  254 (299)
T ss_dssp             GGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCCCcch-hhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHH
Confidence            78999999999999999999999753221 111111111111  1111    4568899999999996 89999999999


Q ss_pred             hcCCCCCCC
Q 010626          153 LKDPFLVTD  161 (505)
Q Consensus       153 L~hpff~~~  161 (505)
                      |+||||+..
T Consensus       255 l~hp~~~~~  263 (299)
T 3m2w_A          255 MNHPWIMQS  263 (299)
T ss_dssp             HTSHHHHTG
T ss_pred             hcChhhccc
Confidence            999999753

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.90  E-value=5.1e-24  Score=234.89  Aligned_cols=147  Identities=20%  Similarity=0.380  Sum_probs=119.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll-   75 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++......     .....+++.|+|||++ 
T Consensus       436 ~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~  512 (613)
T 2ozo_A          436 SNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  512 (613)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCSTTTTCC--------------CCTTSCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEc-CCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhc
Confidence            467889999999999999999  99999999999998 67899999999997653321     1122456899999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ...|+.++|||||||++|||++ |+.||.... ...+...+..+..+ ..+..+++.+.+||.+||. +|.+||++.+++
T Consensus       513 ~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~-~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~  590 (613)
T 2ozo_A          513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRM-ECPPECPPELYALMSDCWIYKWEDRPDFLTVE  590 (613)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-SHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred             CCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC-HHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            4679999999999999999998 999998754 45566666666543 4556788999999999996 899999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.90  E-value=2.1e-24  Score=224.54  Aligned_cols=151  Identities=21%  Similarity=0.390  Sum_probs=118.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEE----eCCCCcEEEeecCceeeccCCC-CccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV----NGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILl----d~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||+    + ..+.+||+|||++....... .....||+.|+|||++.
T Consensus       112 ~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~-~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~  188 (396)
T 4eut_A          112 SEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGED-GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE  188 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTT-SCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCC-CceeEEEecCCCceEccCCCccccccCCccccCHHHhh
Confidence            467899999999999999999  9999999999998    4 45679999999998765432 34457999999999874


Q ss_pred             ---------ccCCcccchhhHHHHHHHHhhcCCCCCCCC---ChHHHHHHHHcCCCCCC---------------------
Q 010626           77 ---------EEYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPAS---------------------  123 (505)
Q Consensus        77 ---------~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~---~~~~i~~~i~~~~~p~~---------------------  123 (505)
                               ..|+.++|||||||++|+|++|+.||....   ........+..+.++..                     
T Consensus       189 ~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (396)
T 4eut_A          189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVS  268 (396)
T ss_dssp             HHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTT
T ss_pred             ccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcc
Confidence                     457889999999999999999999996422   23344444444433211                     


Q ss_pred             --CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626          124 --LSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus       124 --~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                        +....++.+.+||.+||. +|.+||++.+++++
T Consensus       269 ~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          269 CSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             cccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence              112235678999999996 89999999998654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.90  E-value=1.2e-24  Score=220.09  Aligned_cols=148  Identities=18%  Similarity=0.185  Sum_probs=115.1

Q ss_pred             HHHHHHHHHHHHHHHHHH-hCCCCeEecCCCCCcEEEeCCCC--------------------cEEEeecCceeeccCCCC
Q 010626            2 KAIKNWARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNG--------------------EVKIGDLGLAIVMQQPTA   60 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLH-s~g~~IiHrDLKp~NILld~~~g--------------------~vKL~DFGlA~~~~~~~~   60 (505)
                      ..++.|++||+.||+||| ++|  |+||||||+|||++ .++                    .+||+|||+++.....  
T Consensus       161 ~~~~~i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~-~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--  235 (336)
T 2vuw_A          161 ATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLK-KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--  235 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEE-ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC--EeECCCCHHHEEEe-ccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--
Confidence            478999999999999999 999  99999999999998 455                    8999999999876543  


Q ss_pred             ccccCCCcccCcccccccCCcccchhhHHHH-HHHHhhcCCCCCCCCChHHHHHHHHcCC-CCCC----CCCCCChHHHH
Q 010626           61 RSVIGTPEFMAPELYEEEYNELVDIYSFGMC-ILEMVTCEYPYNECKNPAQIYKKVTSGI-KPAS----LSKVTDPQVKQ  134 (505)
Q Consensus        61 ~~~~Gt~~Y~APEll~~~ys~ksDIWSLGvi-LyEmlTG~~Pf~~~~~~~~i~~~i~~~~-~p~~----~~~~~s~~l~~  134 (505)
                       ..+||+.|+|||++.+..+.++||||||++ .+++++|..||............+.... .+..    .....++++++
T Consensus       236 -~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          236 -IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             -EEECCCCTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHH
T ss_pred             -cEEEeecccChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHH
Confidence             457999999999997777899999998777 7788899999853211122333333221 1111    12235788999


Q ss_pred             HHHHhcCCCCCCCCHHHHh-cCCCCC
Q 010626          135 FIEKCIVPASLRLPALELL-KDPFLV  159 (505)
Q Consensus       135 LI~kcL~dP~~RpSa~ElL-~hpff~  159 (505)
                      ||.+||..+    |+.|+| +||||+
T Consensus       315 li~~~L~~d----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          315 FHRTMLNFS----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHGGGSS----SHHHHHHHCGGGC
T ss_pred             HHHHHhccC----CHHHHHhcCCCcC
Confidence            999999733    999999 999995

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.90  E-value=5.4e-24  Score=214.50  Aligned_cols=149  Identities=24%  Similarity=0.372  Sum_probs=117.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll-   75 (505)
                      ..++.++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||++.......     .....+++.|+|||++ 
T Consensus       145 ~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~-~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  221 (326)
T 2w1i_A          145 IKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT  221 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEc-CCCcEEEecCcchhhccccccccccccCCCCceeEECchhhc
Confidence            357889999999999999999  99999999999998 67899999999998765432     1233567789999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhhcCCCCCCCC-----------ChH----HHHHHHHcCCCCCCCCCCCChHHHHHHHHhc
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCEYPYNECK-----------NPA----QIYKKVTSGIKPASLSKVTDPQVKQFIEKCI  140 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~-----------~~~----~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL  140 (505)
                      ...++.++||||||+++|+|+||..||....           ...    .+...+..+.. ...+..+++.+.+||.+||
T Consensus       222 ~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl  300 (326)
T 2w1i_A          222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR-LPRPDGCPDEIYMIMTECW  300 (326)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHS
T ss_pred             CCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCC-CCCCCcccHHHHHHHHHHc
Confidence            4568899999999999999999999985321           000    11222333322 2345667899999999999


Q ss_pred             C-CCCCCCCHHHHhc
Q 010626          141 V-PASLRLPALELLK  154 (505)
Q Consensus       141 ~-dP~~RpSa~ElL~  154 (505)
                      . +|.+||++.++++
T Consensus       301 ~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          301 NNNVNQRPSFRDLAL  315 (326)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             CCChhhCcCHHHHHH
Confidence            6 8999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.90  E-value=7.3e-24  Score=229.76  Aligned_cols=153  Identities=23%  Similarity=0.362  Sum_probs=125.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++......   .....+++.|+|||++ ..
T Consensus       363 ~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  439 (535)
T 2h8h_A          363 PQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG  439 (535)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEc-CCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccC
Confidence            467889999999999999999  99999999999997 67899999999997654321   2233467889999987 56


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .|+.++|||||||++|||+| |+.||.+. ...++...+..+... ..+..+++.+.+||.+||. +|.+|||+.++++.
T Consensus       440 ~~~~~sDvwSlGv~l~el~t~g~~P~~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          440 RFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVERGYRM-PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             CCCHHHHHHHHHHHHHHHTTTTCCSSTTC-CHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            79999999999999999999 99999874 455666666665443 3455678999999999996 89999999998863


Q ss_pred             --CCCC
Q 010626          156 --PFLV  159 (505)
Q Consensus       156 --pff~  159 (505)
                        .+|.
T Consensus       518 L~~~~~  523 (535)
T 2h8h_A          518 LEDYFT  523 (535)
T ss_dssp             HHTSSC
T ss_pred             HHHHhh
Confidence              4544

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.89  E-value=2.1e-23  Score=231.86  Aligned_cols=149  Identities=26%  Similarity=0.464  Sum_probs=121.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..++.||+.||.|||++|  |+||||||+|||++ .++.+||+|||++.......   .....+++.|+|||++ ..
T Consensus       491 ~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  567 (656)
T 2j0j_A          491 ASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR  567 (656)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEe-CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCC
Confidence            357789999999999999999  99999999999998 67899999999997664332   2233567899999988 45


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++.++|||||||++|||++ |..||.+. ........+..+..+ ..+..+++.+.+||.+||. +|.+||++.++++.
T Consensus       568 ~~~~~~DiwSlG~il~ellt~g~~Pf~~~-~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          568 RFTSASDVWMFGVCMWEILMHGVKPFQGV-KNNDVIGRIENGERL-PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCchhhHHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHcCCCC-CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            69999999999999999997 99999864 455556666655433 3556778999999999996 89999999998753

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.89  E-value=8.1e-24  Score=235.25  Aligned_cols=155  Identities=30%  Similarity=0.429  Sum_probs=118.9

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC---cEEEeecCceeeccCCC-CccccCCCcccCccccc-c
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG---EVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g---~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~-~   77 (505)
                      .++.++.||+.||+|||++|  |+||||||+||+++. ++   .+||+|||++....... .....||+.|+|||++. .
T Consensus       122 ~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~-~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~  198 (676)
T 3qa8_A          122 PIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQP-GPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK  198 (676)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEEC-CSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCS
T ss_pred             HHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeec-CCCceeEEEcccccccccccccccccccCCcccCChHHhccC
Confidence            57889999999999999999  999999999999983 34   38999999998765433 34567999999999884 5


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHH-------------cC--------CCCCCCCCCCChHHHHHH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-------------SG--------IKPASLSKVTDPQVKQFI  136 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~-------------~~--------~~p~~~~~~~s~~l~~LI  136 (505)
                      .++.++||||||+++|+|++|..||.....+......+.             .+        ..+..+....++.+.+||
T Consensus       199 ~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI  278 (676)
T 3qa8_A          199 KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWL  278 (676)
T ss_dssp             CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHH
Confidence            689999999999999999999999976432222111000             00        011122334567899999


Q ss_pred             HHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          137 EKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       137 ~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      .+||. +|.+|||+.++|+||||+.
T Consensus       279 ~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          279 QCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             HHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             HHHccCCHhhCcCHHHHhcCHHHHH
Confidence            99996 8999999999999999975

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.86  E-value=6.4e-23  Score=228.20  Aligned_cols=143  Identities=23%  Similarity=0.294  Sum_probs=116.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccccCCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNE   81 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~ys~   81 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+|||++ . +.+||+|||++......  ....||+.|+|||++.+.++.
T Consensus       182 ~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~-~-~~~kl~DFG~a~~~~~~--~~~~gt~~y~aPE~~~~~~~~  255 (681)
T 2pzi_A          182 AEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLT-E-EQLKLIDLGAVSRINSF--GYLYGTPGFQAPEIVRTGPTV  255 (681)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-S-SCEEECCCTTCEETTCC--SCCCCCTTTSCTTHHHHCSCH
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEe-C-CcEEEEecccchhcccC--CccCCCccccCHHHHcCCCCC
Confidence            467899999999999999999  99999999999997 3 48999999999876544  456799999999999777899


Q ss_pred             ccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 010626           82 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  159 (505)
Q Consensus        82 ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~  159 (505)
                      ++|||||||++|+|++|..||.+...         ............++.+.+||.+||. +|.+||+..+.+.|+|+.
T Consensus       256 ~sDi~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          256 ATDIYTVGRTLAALTLDLPTRNGRYV---------DGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHHHHHHHHHHHSCCCEETTEEC---------SSCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ceehhhhHHHHHHHHhCCCCCccccc---------ccccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            99999999999999999988864210         0111000011124689999999996 899999999999998874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.80  E-value=1.7e-20  Score=186.95  Aligned_cols=125  Identities=14%  Similarity=0.166  Sum_probs=95.9

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccccCCcc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNEL   82 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~ys~k   82 (505)
                      .+..|+.||+.||+|||++|  |+||||||+||+++ .+|.+||+++|                  |++|      ++.+
T Consensus       130 ~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~-~~g~~kl~~~~------------------~~~~------~~~~  182 (286)
T 3uqc_A          130 GAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVS-IDGDVVLAYPA------------------TMPD------ANPQ  182 (286)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEE-TTSCEEECSCC------------------CCTT------CCHH
T ss_pred             HHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEc-CCCCEEEEecc------------------ccCC------CCch
Confidence            46789999999999999999  99999999999998 77899997443                  3333      7899


Q ss_pred             cchhhHHHHHHHHhhcCCCCCCCCChHHHH---HHHHcCCC-CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           83 VDIYSFGMCILEMVTCEYPYNECKNPAQIY---KKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        83 sDIWSLGviLyEmlTG~~Pf~~~~~~~~i~---~~i~~~~~-p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      +|||||||++|+|+||+.||.+......+.   ..+..... +......+++.+.+||.+||. +|.+| |+.++++.
T Consensus       183 ~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            999999999999999999998643321110   00111100 112234568899999999996 89999 99999874

>2v3s_A Serine/threonine-protein kinase OSR1; ATP-binding, magnesium, metal-binding, nucleotide-binding, phosphorylation, polymorphism, transferase; 1.70A {Homo sapiens}

Probab=99.75  E-value=2e-18  Score=141.99  Aligned_cols=60  Identities=23%  Similarity=0.409  Sum_probs=58.6

Q ss_pred             CceEEEEEecCCCCCcceeeeecccCCCCHHHHHHHHHHccCCCCcCHHHHHHHHHHHHH
Q 010626          238 DTVSLTLRIGDKSGHVSNIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIM  297 (505)
Q Consensus       238 ~~i~L~Lri~d~~g~~r~I~F~F~~~~DTa~~VA~EmV~~~~l~~~d~~~iA~~i~~~i~  297 (505)
                      .+|+|+||+||++++++||+|+|.+++|||++||+|||++|+|+++|+++||+||+++|.
T Consensus         1 ~pv~LvLRlRn~~rELnDIrFeF~~g~DTaegiA~ELv~AgLVDg~D~~vVAanL~klv~   60 (96)
T 2v3s_A            1 GPISLVLRLRNSKKELNDIRFEFTPGRDTAEGVSQELISAGLVDGRDLVIVAANLQKIVE   60 (96)
T ss_dssp             CCEEEEEEEECTTSCEEEEEEEECTTTCCHHHHHHHHHHTTSSCGGGHHHHHHHHHHHHH
T ss_pred             CCeeEEEEeccccchhcceEEEeecCCCcHHHHHHHHHHCCCcccccHHHHHHHHHHHHh
Confidence            379999999999999999999999999999999999999999999999999999999997

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.69  E-value=1.2e-18  Score=190.70  Aligned_cols=94  Identities=16%  Similarity=0.128  Sum_probs=65.4

Q ss_pred             HHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccccccCCcc
Q 010626            5 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYEEEYNEL   82 (505)
Q Consensus         5 ~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~~~ys~k   82 (505)
                      .+|++||+.||+|||++|  ||||||||+|||++ .+|.+||+|||+|+.....  ...+.+||+.|+|||++.+.+..+
T Consensus       342 ~~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~-~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~~~~~  418 (569)
T 4azs_A          342 EKILGSLLRSLAALEKQG--FWHDDVRPWNVMVD-ARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAENKSWN  418 (569)
T ss_dssp             HHHHHHHHHHHHHHHHTT--CEESCCCGGGEEEC-TTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------
T ss_pred             HHHHHHHHHHHHHHHHCC--ceeccCchHhEEEC-CCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCCCCCc
Confidence            468999999999999999  99999999999998 7899999999999876543  244568999999999998888899


Q ss_pred             cchhhHHHHHHHHhhcCCC
Q 010626           83 VDIYSFGMCILEMVTCEYP  101 (505)
Q Consensus        83 sDIWSLGviLyEmlTG~~P  101 (505)
                      +|+|++|++++++.++..|
T Consensus       419 ~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          419 GFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ----------CCCCTTHHH
T ss_pred             ccccccccchhhhccccch
Confidence            9999999998887665443

>2lru_A Serine/threonine-protein kinase WNK1; autoinhibitory domain, PF2 domain, transferase; NMR {Rattus norvegicus}

Probab=99.25  E-value=1.6e-15  Score=126.16  Aligned_cols=64  Identities=30%  Similarity=0.378  Sum_probs=59.5

Q ss_pred             CCceEEEEEecCCC---CCcc---eeeeecccCCCCHHHHHHHHHHccCCCCcCHHHHHHHHHHHHHHhC
Q 010626          237 DDTVSLTLRIGDKS---GHVS---NIHFVFYLNADTAISIAEEMVEQLDLSHEDVVSIAELIDNLIMKLV  300 (505)
Q Consensus       237 ~~~i~L~Lri~d~~---g~~r---~I~F~F~~~~DTa~~VA~EmV~~~~l~~~d~~~iA~~i~~~i~~l~  300 (505)
                      ..+|+|+|||.|++   |+.|   +|+|+|++++|||++||+|||++|+|.++|+..||++|+..|..+-
T Consensus        23 ~~~i~L~LRi~Dpkk~~gk~KeNeaIeF~Fdle~Dta~eVA~EMVe~~~l~e~D~~~VaklI~~~v~~~~   92 (98)
T 2lru_A           23 KIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLIK   92 (98)
Confidence            46899999999994   8889   9999999999999999999999999999999999999999877653

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.38  E-value=5.8e-14  Score=152.63  Aligned_cols=94  Identities=23%  Similarity=0.345  Sum_probs=81.3

Q ss_pred             HHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---------CccccCCCcccCcccc
Q 010626            5 KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---------ARSVIGTPEFMAPELY   75 (505)
Q Consensus         5 ~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---------~~~~~Gt~~Y~APEll   75 (505)
                      ..|+.||+.||.|||++|  |+||||||+|||++ .  .+||+|||+++......         .....||+.|+|||++
T Consensus       434 ~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~-~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~  508 (540)
T 3en9_A          434 LDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFD-K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIW  508 (540)
T ss_dssp             THHHHHHHHHHHHHHHTT--EECTTCCTTSEEES-S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCc--CccCCCCHHHEEEC-C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHH
Confidence            578999999999999999  99999999999997 3  99999999998875532         1356799999999998


Q ss_pred             c---ccCCcccchhhHHHHHHHHhhcCCCCC
Q 010626           76 E---EEYNELVDIYSFGMCILEMVTCEYPYN  103 (505)
Q Consensus        76 ~---~~ys~ksDIWSLGviLyEmlTG~~Pf~  103 (505)
                      .   ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       509 ~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          509 ERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             HHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            5   458889999999999988888877774

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.07  E-value=7.4e-11  Score=117.51  Aligned_cols=70  Identities=24%  Similarity=0.233  Sum_probs=57.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc------
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE------   76 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~------   76 (505)
                      ....++.||+.||.|||++|  |+||||||+|||++  ++.+||+|||+++..           ..++|||++.      
T Consensus       194 ~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~--~~~vkl~DFG~a~~~-----------~~~~a~e~l~rdv~~i  258 (282)
T 1zar_A          194 NPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS--EEGIWIIDFPQSVEV-----------GEEGWREILERDVRNI  258 (282)
T ss_dssp             CHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE--TTEEEECCCTTCEET-----------TSTTHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE--CCcEEEEECCCCeEC-----------CCCCHHHHHHHHHHHH
Confidence            35679999999999999999  99999999999998  789999999998643           3568888773      


Q ss_pred             -----ccCCcccchhh
Q 010626           77 -----EEYNELVDIYS   87 (505)
Q Consensus        77 -----~~ys~ksDIWS   87 (505)
                           ..|+..+|+|.
T Consensus       259 ~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          259 ITYFSRTYRTEKDINS  274 (282)
T ss_dssp             HHHHHHHHCCCCCHHH
T ss_pred             HHHHHHhcCCCCChHH
Confidence                 23555566654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=98.72  E-value=1.3e-08  Score=99.63  Aligned_cols=49  Identities=20%  Similarity=0.363  Sum_probs=44.3

Q ss_pred             HHHHHHHHHHHHHHHHH-hCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeecc
Q 010626            3 AIKNWARQILRGLHYLH-SHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ   56 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLH-s~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~   56 (505)
                      .+..++.||+.||.||| ++|  |+||||||+|||++ .  .++|+|||+|....
T Consensus       171 ~~~~i~~qi~~~l~~lH~~~g--ivHrDlkp~NILl~-~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          171 DVEGIFNDVVENVKRLYQEAE--LVHADLSEYNIMYI-D--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             CHHHHHHHHHHHHHHHHHTSC--EECSSCSTTSEEES-S--SEEECCCTTCEETT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEEc-C--cEEEEECcccccCC
Confidence            46789999999999999 999  99999999999997 3  89999999997653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=98.04  E-value=3.6e-06  Score=88.03  Aligned_cols=51  Identities=18%  Similarity=0.217  Sum_probs=43.3

Q ss_pred             HHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCC----------cEEEeecCceeeccC
Q 010626            4 IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNG----------EVKIGDLGLAIVMQQ   57 (505)
Q Consensus         4 I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g----------~vKL~DFGlA~~~~~   57 (505)
                      ...++.||+.+|.|||++|  ||||||||.|||++ .+|          .+.|+||+-+.....
T Consensus       207 ~~~l~~qll~~l~~lH~~g--IVHrDLKp~NILl~-~dgd~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          207 PASLYADLIALILRLAKHG--LIHGDFNEFNILIR-EEKDAEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             HHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-EEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred             HHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEe-CCCCcccccccccceEEEEeCCcccCCC
Confidence            5678999999999999999  99999999999997 444          388999998755443

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=97.00  E-value=0.00052  Score=67.86  Aligned_cols=78  Identities=22%  Similarity=0.233  Sum_probs=49.3

Q ss_pred             CeEecCCCCCcEEEeCC-CCcEEEeecCceeeccCCCCccccCCCcc---cCccccc---ccCC------------cccc
Q 010626           24 PIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQPTARSVIGTPEF---MAPELYE---EEYN------------ELVD   84 (505)
Q Consensus        24 ~IiHrDLKp~NILld~~-~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y---~APEll~---~~ys------------~ksD   84 (505)
                      .++|+|++|.||+++.. .+.+.|+||+.+.......  .......+   ..|+...   ..|.            ...+
T Consensus       192 ~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~  269 (304)
T 3sg8_A          192 CLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEK  269 (304)
T ss_dssp             EEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHH
T ss_pred             eeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHH
Confidence            38999999999999843 4467899999986542211  00001111   2333221   1121            2258


Q ss_pred             hhhHHHHHHHHhhcCCCCC
Q 010626           85 IYSFGMCILEMVTCEYPYN  103 (505)
Q Consensus        85 IWSLGviLyEmlTG~~Pf~  103 (505)
                      .|++|.++|.+.+|..+|.
T Consensus       270 ~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          270 YWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHHHHHHcCCHHHH
Confidence            8999999999999987763

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=96.28  E-value=0.0036  Score=59.90  Aligned_cols=28  Identities=36%  Similarity=0.380  Sum_probs=23.2

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEeecCcee
Q 010626           25 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI   53 (505)
Q Consensus        25 IiHrDLKp~NILld~~~g~vKL~DFGlA~   53 (505)
                      ++|+|++|.||+++ ..+.+.|+||+.+.
T Consensus       185 l~HgDl~~~Nil~~-~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          185 FSHGDLGDSNIFVK-DGKVSGFIDLGRSG  212 (263)
T ss_dssp             EECSSCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred             EECCCCCcCcEEEE-CCcEEEEEEchhcc
Confidence            89999999999997 44445799998763

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=96.20  E-value=0.0031  Score=59.56  Aligned_cols=29  Identities=31%  Similarity=0.217  Sum_probs=24.1

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEeecCceee
Q 010626           25 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIV   54 (505)
Q Consensus        25 IiHrDLKp~NILld~~~g~vKL~DFGlA~~   54 (505)
                      ++|+|++|.||+++ .++.+.|+||+.+..
T Consensus       186 l~HgDl~~~Nil~~-~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          186 VTHGDACLPNIMVE-NGRFSGFIDCGRLGV  214 (264)
T ss_dssp             EECSSCCGGGEEEE-TTEEEEECCCTTCEE
T ss_pred             EECCCCCCCcEEEE-CCcEEEEEcchhccc
Confidence            99999999999997 444567999998743

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=95.89  E-value=0.0088  Score=60.26  Aligned_cols=31  Identities=23%  Similarity=0.415  Sum_probs=25.0

Q ss_pred             CeEecCCCCCcEEEeCCCC-cEEEeecCceee
Q 010626           24 PIIHRDLKCDNIFVNGNNG-EVKIGDLGLAIV   54 (505)
Q Consensus        24 ~IiHrDLKp~NILld~~~g-~vKL~DFGlA~~   54 (505)
                      .++|+|+++.||+++.+.+ .+.|+||+.+..
T Consensus       217 ~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          217 SIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             EEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             eEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            4999999999999974332 368999998864

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.07  E-value=0.13  Score=49.56  Aligned_cols=107  Identities=19%  Similarity=0.142  Sum_probs=66.6

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccccCC
Q 010626            2 KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~ys   80 (505)
                      +++|.++.|.+.+|.-+-. ..  -..+=+.|..|++. .+|.|.+.+ +.+.          .....|.|||......+
T Consensus        49 EqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~-~dG~V~f~~-~~s~----------~~~~~~~~pe~~~~~~t  114 (229)
T 2yle_A           49 EQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVW-RDGAVTLAP-AADD----------AGEPPPVAGKLGYSQCM  114 (229)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEE-TTSCEEECC-C----------------------CCSSSSSC
T ss_pred             HHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEe-cCCceeccc-cccc----------ccccCCCChhhccccch
Confidence            5789999999998877622 22  11223346888987 778877653 1110          12235678887755567


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcCC
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP  142 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~d  142 (505)
                      .+.=|||||+++|..+--..|-                    ..+...++.+.+||..|..+
T Consensus       115 e~~~IysLG~tLY~ALDygL~e--------------------~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          115 ETEVIESLGIIIYKALDYGLKE--------------------NEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCT--------------------TEEECCCHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHhhcCCCc--------------------ccchhhCHHHHHHHHHHHhc
Confidence            7888999999999988543332                    23445688999999998743

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=94.06  E-value=0.055  Score=53.14  Aligned_cols=44  Identities=23%  Similarity=0.285  Sum_probs=32.2

Q ss_pred             HHHHHHHHHHHh-----------CCCCeEecCCCCCcEEEeCCCCcEEEeecCcee
Q 010626            9 RQILRGLHYLHS-----------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAI   53 (505)
Q Consensus         9 ~QIl~gL~yLHs-----------~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~   53 (505)
                      .++..++.+|+.           ..+.++|+|+++.||+++ .++.+.|+||+.+.
T Consensus       197 ~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~-~~~~~~lIDfe~a~  251 (346)
T 2q83_A          197 EDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLG-ENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEEC-GGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEe-CCCcEEEEehhhcc
Confidence            344456666653           123499999999999996 45689999999764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=90.51  E-value=0.21  Score=51.54  Aligned_cols=29  Identities=21%  Similarity=0.444  Sum_probs=24.5

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEeecCceee
Q 010626           24 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV   54 (505)
Q Consensus        24 ~IiHrDLKp~NILld~~~g~vKL~DFGlA~~   54 (505)
                      .++|+|++|.||+++ .++ ++++||+.+..
T Consensus       233 ~liHGDl~~~Nil~~-~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVT-QDS-TQVIDPEFSFY  261 (420)
T ss_dssp             EEECSCCSGGGEEEC-SSC-EEECCCTTCEE
T ss_pred             eEEecCCCCCcEEEe-CCC-CEEEeCccccc
Confidence            399999999999997 444 99999998753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=84.10  E-value=0.58  Score=44.40  Aligned_cols=29  Identities=21%  Similarity=0.355  Sum_probs=24.0

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEeecCceee
Q 010626           25 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIV   54 (505)
Q Consensus        25 IiHrDLKp~NILld~~~g~vKL~DFGlA~~   54 (505)
                      ++|+|+.+.||+++ ..+.+-|+||+.+..
T Consensus       195 l~HGDl~~~Nil~~-~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          195 VTHGDFSLDNLIFD-EGKLIGCIDVGRVGI  223 (272)
T ss_dssp             EECSCCCTTSEEEE-TTEEEEECCCTTCEE
T ss_pred             EEcCCCCCCeEEEE-CCeEEEEEECccccc
Confidence            79999999999998 445567999988743

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=84.08  E-value=0.79  Score=45.06  Aligned_cols=32  Identities=31%  Similarity=0.369  Sum_probs=25.1

Q ss_pred             CeEecCCCCCcEEEeC--CCCc-EEEeecCceeec
Q 010626           24 PIIHRDLKCDNIFVNG--NNGE-VKIGDLGLAIVM   55 (505)
Q Consensus        24 ~IiHrDLKp~NILld~--~~g~-vKL~DFGlA~~~   55 (505)
                      .++|+|++|.||+++.  .++. +.|+||+.+...
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence            4899999999999974  1345 589999987543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=84.06  E-value=0.59  Score=46.50  Aligned_cols=30  Identities=13%  Similarity=0.255  Sum_probs=24.8

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEeecCceee
Q 010626           24 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV   54 (505)
Q Consensus        24 ~IiHrDLKp~NILld~~~g~vKL~DFGlA~~   54 (505)
                      .++|+|+.+.||+++ ..+.+.|+||+.+..
T Consensus       223 ~l~HgDl~~~Nil~~-~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          223 VLLWGDARVGNVLYR-DFQPVAVLDWEMVAL  252 (357)
T ss_dssp             EEECSSCSGGGEEEE-TTEEEEECCGGGCEE
T ss_pred             eEEeCCCCCCeEEEe-CCcEEEEEccccccc
Confidence            499999999999998 444578999998743

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=83.95  E-value=0.6  Score=45.62  Aligned_cols=29  Identities=31%  Similarity=0.355  Sum_probs=23.6

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEeecCcee
Q 010626           24 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAI   53 (505)
Q Consensus        24 ~IiHrDLKp~NILld~~~g~vKL~DFGlA~   53 (505)
                      .++|+|+++.||+++ .++.+.|+||+.+.
T Consensus       188 ~liHgDl~~~Nil~~-~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          188 GVIHADLFQDNVFFL-GDELSGLIDFYFAC  216 (322)
T ss_dssp             EEECSCCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred             ccCCCCCCccCEEEe-CCceEEEecchhcc
Confidence            389999999999998 34445799998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=82.76  E-value=0.64  Score=45.86  Aligned_cols=32  Identities=22%  Similarity=0.242  Sum_probs=26.0

Q ss_pred             CeEecCCCCCcEEEeCC---CCcEEEeecCceeec
Q 010626           24 PIIHRDLKCDNIFVNGN---NGEVKIGDLGLAIVM   55 (505)
Q Consensus        24 ~IiHrDLKp~NILld~~---~g~vKL~DFGlA~~~   55 (505)
                      .++|||+.+.||+++..   .+.+.|+||+.+...
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            49999999999999732   257899999988543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=81.07  E-value=1.2  Score=43.66  Aligned_cols=28  Identities=25%  Similarity=0.163  Sum_probs=23.8

Q ss_pred             CeEecCCCCCcEEEeCCCCcEEEeecCceee
Q 010626           24 PIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV   54 (505)
Q Consensus        24 ~IiHrDLKp~NILld~~~g~vKL~DFGlA~~   54 (505)
                      .++|+|+++.||+++ +  .+.|+||+.+..
T Consensus       196 ~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~  223 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D--GPMFVDLDDARN  223 (328)
T ss_dssp             EECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred             eeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence            389999999999997 3  789999987743

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	505
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-38
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-36
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-36
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-35
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-35
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-35
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-34
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-32
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-30
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-30
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-29
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-29
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-29
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-29
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-28
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-28
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-28
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-28
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-28
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-27
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-27
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-27
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-26
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-26
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-26
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-26
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-26
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-26
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-26
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-25
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-25
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-25
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-25
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-25
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-25
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-25
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-25
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-25
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-25
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-24
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-24
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-24
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-24
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-23
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-23
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-23
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-23
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	7e-23
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-22
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-22
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-22
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-22
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-22
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-21
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-21
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-19
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-17
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-16
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-14
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-11

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 9e-55
 Identities = 95/158 (60%), Positives = 120/158 (75%), Gaps = 1/158 (0%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
           K +++W RQIL+GL +LH+  PPIIHRDLKCDNIF+ G  G VKIGDLGLA + +   A+
Sbjct: 112 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK 171

Query: 62  SVIGTPEFMAPELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
           +VIGTPEFMAPE+YEE+Y+E VD+Y+FGMC+LEM T EYPY+EC+N AQIY++VTSG+KP
Sbjct: 172 AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 231

Query: 122 ASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
           AS  KV  P+VK+ IE CI      R    +LL   F 
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 5e-38
 Identities = 36/161 (22%), Positives = 76/161 (47%), Gaps = 8/161 (4%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
              +  ++   L Y HS    +IHRD+K +N+ +  + GE+KI D G ++        ++
Sbjct: 108 TATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTL 164

Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 122
            GT +++ PE +    ++E VD++S G+   E +  + P+ E     + YK+++      
Sbjct: 165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRV--EF 221

Query: 123 SLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDN 162
           +         +  I + +    S R    E+L+ P++  ++
Sbjct: 222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 262

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-36
 Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 10/164 (6%)

Query: 2   KAIKNWARQILRGLHYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP 58
           + +     Q+   L   H  +     ++HRDLK  N+F++G    VK+GD GLA ++   
Sbjct: 109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHD 167

Query: 59  T--ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
           T  A++ +GTP +M+PE      YNE  DI+S G  + E+     P+    +  ++  K+
Sbjct: 168 TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKI 226

Query: 116 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
             G K   +      ++ + I + +      R    E+L++P +
Sbjct: 227 REG-KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (338), Expect = 3e-36
 Identities = 60/190 (31%), Positives = 94/190 (49%), Gaps = 12/190 (6%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I       L+GL YLHSHN  +IHRD+K  NI ++   G VK+GD G A +M    A S 
Sbjct: 117 IAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSF 171

Query: 64  IGTPEFMAPELY----EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
           +GTP +MAPE+     E +Y+  VD++S G+  +E+   + P     N       +    
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNE 230

Query: 120 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPL-RLPNLV 177
            PA  S       + F++ C+      R  +  LLK  F++ + P  ++ D + R  + V
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV 290

Query: 178 PEVMNLAHSE 187
            E+ NL + +
Sbjct: 291 RELDNLQYRK 300

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-35
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 12/174 (6%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
             I+   +Q L  L+YLH +   IIHRDLK  NI     +G++K+ D G++    +   R
Sbjct: 110 SQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQR 166

Query: 62  --SVIGTPEFMAPELY------EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 113
             S IGTP +MAPE+       +  Y+   D++S G+ ++EM   E P++E      + K
Sbjct: 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK 226

Query: 114 KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDL 166
              S     +         K F++KC+      R    +LL+ PF+  D+ K +
Sbjct: 227 IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 3e-35
 Identities = 56/182 (30%), Positives = 86/182 (47%), Gaps = 16/182 (8%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
           I    R+ L+ L +LHS+   +IHRD+K DNI +   +G VK+ D G    I  +Q    
Sbjct: 118 IAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRS 174

Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           +++GTP +MAPE +  + Y   VDI+S G+  +EM+  E PY        +Y   T+G  
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP 234

Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPE 179
                +      + F+ +C+      R  A ELL+  FL    P         L +L P 
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP---------LSSLTPL 285

Query: 180 VM 181
           + 
Sbjct: 286 IA 287

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 4e-35
 Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 10/168 (5%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQPT 59
            + +  Q++ G+ YLH     I HRD+K +N+ ++     +KI D GLA V     ++  
Sbjct: 105 AQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERL 161

Query: 60  ARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
              + GT  ++APEL +    + E VD++S G+ +  M+  E P+++  +  Q Y     
Sbjct: 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE 221

Query: 118 GIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
                +  K  D      + K +V   S R+   ++ KD +      K
Sbjct: 222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 269

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 3e-34
 Identities = 54/166 (32%), Positives = 87/166 (52%), Gaps = 15/166 (9%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           M  + + ARQ  +G+ YLH+ +  IIHRDLK +NIF++  +  VKIGD GLA V  + + 
Sbjct: 103 MIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSG 159

Query: 61  ----RSVIGTPEFMAPELYEEE----YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
                 + G+  +MAPE+   +    Y+   D+Y+FG+ + E++T + PY+   N  QI 
Sbjct: 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 219

Query: 113 KKVTSGIKPASLSKVTD---PQVKQFIEKCIVP-ASLRLPALELLK 154
             V  G     LSKV       +K+ + +C+      R    ++L 
Sbjct: 220 FMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 4e-32
 Identities = 44/207 (21%), Positives = 83/207 (40%), Gaps = 45/207 (21%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
           + +   +  +++GL YL   +  I+HRD+K  NI VN + GE+K+ D G++  +    A 
Sbjct: 104 QILGKVSIAVIKGLTYLREKHK-IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN 161

Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY------------------ 102
           S +GT  +M+PE L    Y+   DI+S G+ ++EM    YP                   
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

Query: 103 -----------------------NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKC 139
                                         ++   + +   P   S V   + + F+ KC
Sbjct: 222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281

Query: 140 IVP-ASLRLPALELLKDPFLVTDNPKD 165
           ++   + R    +L+   F+   + ++
Sbjct: 282 LIKNPAERADLKQLMVHAFIKRSDAEE 308

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  120 bits (301), Expect = 1e-30
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 11/198 (5%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN-GNNGEVKIGDLGLAIVMQ-QPT 59
                + RQ+ +GL ++H +N   +H DLK +NI      + E+K+ D GL   +  + +
Sbjct: 124 DEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181

Query: 60  ARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
            +   GT EF APE+ E +      D++S G+    +++   P+   +N  +  + V S 
Sbjct: 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSC 240

Query: 119 I--KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP--KDLVCDPLRL 173
                 S         K FI K ++   + R+   + L+ P+L   N   +D      R 
Sbjct: 241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRY 300

Query: 174 PNLVPEVMNLAHSEPHPM 191
             +   +     + P P+
Sbjct: 301 TKIRDSIKTKYDAWPEPL 318

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  116 bits (292), Expect = 3e-30
 Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 15/168 (8%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTA 60
           K  +   R +L  +  LH  N  I+HRDLK +NI ++ ++  +K+ D G +  +      
Sbjct: 110 KETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKL 166

Query: 61  RSVIGTPEFMAPELYEEE-------YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK 113
           R V GTP ++APE+ E         Y + VD++S G+ +  ++    P+   +    + +
Sbjct: 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLR 225

Query: 114 KVTSGIKPASLSKVTD--PQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
            + SG       +  D    VK  + + +V     R  A E L  PF 
Sbjct: 226 MIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  117 bits (293), Expect = 1e-29
 Identities = 40/166 (24%), Positives = 70/166 (42%), Gaps = 7/166 (4%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGN-NGEVKIGDLGLAIVMQQP-TAR 61
           + N+ RQ   GL ++H H+  I+H D+K +NI         VKI D GLA  +      +
Sbjct: 129 VINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186

Query: 62  SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
               T EF APE+ + E      D+++ G+    +++   P+    +   +        +
Sbjct: 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE 246

Query: 121 -PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPK 164
                     P+ K FI+  +      RL   + L+ P+L  D+  
Sbjct: 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  114 bits (287), Expect = 5e-29
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 15/186 (8%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
            K +A ++   L YLHS +  II+RDLK +NI ++  NG +KI D G A  +   T  ++
Sbjct: 106 AKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDVT-YTL 161

Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 122
            GTP+++APE +  + YN+ +D +SFG+ I EM+    P+ +  N  + Y+K+ +     
Sbjct: 162 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA--EL 218

Query: 123 SLSKVTDPQVKQFIEKCIV------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 176
                 +  VK  + + I         +L+    ++   P+      + L+   +  P  
Sbjct: 219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETP-Y 277

Query: 177 VPEVMN 182
            P +  
Sbjct: 278 EPPIQQ 283

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 8e-29
 Identities = 30/160 (18%), Positives = 67/160 (41%), Gaps = 14/160 (8%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
           +  +++  Q+L  + + H+    ++HRD+K +NI ++ N GE+K+ D G   +++     
Sbjct: 110 ELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 167

Query: 62  SVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
              GT  +  PE       +     ++S G+ + +MV  + P+   +   +        +
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 227

Query: 120 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
                      + +  I  C+    S R    E+   P++
Sbjct: 228 ---------SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 9e-29
 Identities = 46/163 (28%), Positives = 80/163 (49%), Gaps = 12/163 (7%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQ 57
              + +  +I+  L YLH     IIHRDLK +NI +N  +  ++I D G A V+    +Q
Sbjct: 108 TCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQ 164

Query: 58  PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
             A S +GT ++++PE L E+   +  D+++ G  I ++V    P+    N   I++K+ 
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKII 223

Query: 117 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
                    +   P+ +  +EK +V  A+ RL   E+     L
Sbjct: 224 KL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 2e-28
 Identities = 38/163 (23%), Positives = 77/163 (47%), Gaps = 9/163 (5%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV-NGNNGEVKIGDLGLAIVMQQP-T 59
           + I ++  Q+   L +LHSHN  I H D++ +NI      +  +KI + G A  ++    
Sbjct: 102 REIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159

Query: 60  ARSVIGTPEFMAPELYEEE-YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
            R +   PE+ APE+++ +  +   D++S G  +  +++   P+   +   QI + + + 
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNA 218

Query: 119 --IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
                    K    +   F+++ +V     R+ A E L+ P+L
Sbjct: 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 3e-28
 Identities = 36/166 (21%), Positives = 67/166 (40%), Gaps = 12/166 (7%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM---QQPTA 60
           + + A QI  G+ ++   N   IHRDL+  NI V+ +    KI D GLA ++   +    
Sbjct: 111 LLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAR 167

Query: 61  RSVIGTPEFMAP-ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
                  ++ AP  +    +    D++SFG+ + E+VT            ++ + +  G 
Sbjct: 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY 227

Query: 120 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPA---LELLKDPFLVTD 161
           +          ++ Q +  C       R        +L+D F  T+
Sbjct: 228 RMVRPDNC-PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 5e-28
 Identities = 34/155 (21%), Positives = 68/155 (43%), Gaps = 7/155 (4%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
             +  ++  +   + YL  +N   +HRDL   N+ V+  +   K+ D GL       T  
Sbjct: 103 DCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS-STQD 158

Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           +     ++ APE L E++++   D++SFG+ + E+ +             +  +V  G K
Sbjct: 159 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK 218

Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 154
             +      P V + ++ C    A++R   L+L +
Sbjct: 219 MDAPDGC-PPAVYEVMKNCWHLDAAMRPSFLQLRE 252

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 6e-28
 Identities = 34/171 (19%), Positives = 66/171 (38%), Gaps = 11/171 (6%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 58
           +  + + A QI  G+ Y+   N   +HRDL+  NI V   N   K+ D GLA +++    
Sbjct: 112 LPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEY 168

Query: 59  -TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
              +      ++ APE      +    D++SFG+ + E+ T            ++  +V 
Sbjct: 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228

Query: 117 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK--DPFLVTDNPK 164
            G +     +     +   + +C       R     L    + +  +  P+
Sbjct: 229 RGYRMPCPPEC-PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  110 bits (277), Expect = 8e-28
 Identities = 38/182 (20%), Positives = 77/182 (42%), Gaps = 10/182 (5%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLAIVMQQPT 59
           +       Q+L  + YLH     I+HRDLK +N+       + ++ I D GL+ +    +
Sbjct: 107 RDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164

Query: 60  -ARSVIGTPEFMAP-ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
              +  GTP ++AP  L ++ Y++ VD +S G+    ++    P+ + +N A++++++  
Sbjct: 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILK 223

Query: 118 GIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 174
                 +          K FI   +      R    + L+ P++  D   D         
Sbjct: 224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSE 283

Query: 175 NL 176
            +
Sbjct: 284 QI 285

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-27
 Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 11/182 (6%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM----QQ 57
           + + NW  QI +G++YL      ++HRDL   N+ V      VKI D GLA ++    ++
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKE 167

Query: 58  PTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
             A       ++MA E +    Y    D++S+G+ + E++T      +    ++I   + 
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 227

Query: 117 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDP-FLVTDNPKDLVCDPLRLP 174
            G +      +    V   + KC +  A  R    EL+ +   +  D  + LV       
Sbjct: 228 KGERL-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 286

Query: 175 NL 176
           +L
Sbjct: 287 HL 288

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 3e-27
 Identities = 44/186 (23%), Positives = 90/186 (48%), Gaps = 16/186 (8%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA--IVMQQPTAR 61
            + +  +I+  L YLHS +  +++RD+K +N+ ++  +G +KI D GL    +    T +
Sbjct: 107 ARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMK 163

Query: 62  SVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           +  GTPE++APE+ E  +Y   VD +  G+ + EM+    P+   ++  ++++ +     
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILME-- 220

Query: 121 PASLSKVTDPQVKQFIEKCIV------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLP 174
                +   P+ K  +   +              A E+++  F ++ N +D+V   L  P
Sbjct: 221 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280

Query: 175 NLVPEV 180
              P+V
Sbjct: 281 -FKPQV 285

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 5e-27
 Identities = 30/158 (18%), Positives = 63/158 (39%), Gaps = 9/158 (5%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
           + +      +  G+ YL      +IHRDL   N  V   N  +K+ D G+   +      
Sbjct: 101 ETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYT 157

Query: 62  ---SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
                    ++ +PE      Y+   D++SFG+ + E+ +      E ++ +++ + +++
Sbjct: 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 217

Query: 118 GIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 154
           G +     ++    V Q +  C       R     LL+
Sbjct: 218 GFRL-YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLR 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 1e-26
 Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 11/160 (6%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 58
           + +  +A Q+ +G+ +L   +   +HRDL   N+ V  +   VKI D GLA  +      
Sbjct: 164 EDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNY 220

Query: 59  -TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKV 115
               +     ++MAPE L+E  Y    D++S+G+ + E+ +    PY      A  YK +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280

Query: 116 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 154
            +G K       T  ++   ++ C    +  R     L  
Sbjct: 281 QNGFKMDQPFYAT-EEIYIIMQSCWAFDSRKRPSFPNLTS 319

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-26
 Identities = 38/156 (24%), Positives = 67/156 (42%), Gaps = 7/156 (4%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
           + + ++A  + RG+ YL       IHRDL   NI V   N   KI D GL+   +    +
Sbjct: 127 QQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKK 183

Query: 62  SVI-GTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
           ++      +MA E L    Y    D++S+G+ + E+V+           A++Y+K+  G 
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243

Query: 120 KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 154
           +        D +V   + +C       R    ++L 
Sbjct: 244 RLEKPLNC-DDEVYDLMRQCWREKPYERPSFAQILV 278

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 4e-26
 Identities = 29/166 (17%), Positives = 60/166 (36%), Gaps = 14/166 (8%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 58
           K I     Q+  G+ YL   N   +HRDL   N+ +       KI D GL+  ++     
Sbjct: 107 KNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENY 163

Query: 59  --TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
                      ++ APE +   +++   D++SFG+ + E  +           +++   +
Sbjct: 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223

Query: 116 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPA---LELLKDPF 157
             G +    +     ++   +  C       R         L++ +
Sbjct: 224 EKGERMGCPAGC-PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 5e-26
 Identities = 37/173 (21%), Positives = 72/173 (41%), Gaps = 14/173 (8%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN--GNNGEVKIGDLGLA-IVMQQP 58
           +      + I   + YLHS N  I HRD+K +N+       N  +K+ D G A       
Sbjct: 111 REASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168

Query: 59  TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
           +  +   TP ++APE+   E+Y++  D++S G+ +  ++    P+    +   I   + +
Sbjct: 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS-NHGLAISPGMKT 227

Query: 118 GIK------PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNP 163
            I+      P         +VK  I   +    + R+   E +  P+++    
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  106 bits (266), Expect = 5e-26
 Identities = 42/185 (22%), Positives = 83/185 (44%), Gaps = 16/185 (8%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
             ++ +A +I+ GL ++H+    +++RDLK  NI ++  +G V+I DLGLA    +    
Sbjct: 107 ADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH 163

Query: 62  SVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
           + +GT  +MAPE+ ++   Y+   D +S G  + +++    P+ + K   +      +  
Sbjct: 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223

Query: 120 KPASLSKVTDPQVKQFIEKCIV------PASLRLPALELLKDPFLVTDNPKDLVCDPLRL 173
               L     P+++  +E  +          L   A E+ + PF      + L    + L
Sbjct: 224 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF-----RSLDWQMVFL 278

Query: 174 PNLVP 178
               P
Sbjct: 279 QKYPP 283

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  104 bits (261), Expect = 8e-26
 Identities = 30/160 (18%), Positives = 60/160 (37%), Gaps = 13/160 (8%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           +    R I  G+ YL   N   +HRDL   NI VN +N   K+ D GL+  ++  T+   
Sbjct: 130 LVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPT 186

Query: 64  -------IGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
                       + APE  +  ++    D++S+G+ + E+++             +   +
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 246

Query: 116 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 154
               +           + Q +  C     + R    +++ 
Sbjct: 247 EQDYRLPPPMDC-PSALHQLMLDCWQKDRNHRPKFGQIVN 285

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 9e-26
 Identities = 45/184 (24%), Positives = 77/184 (41%), Gaps = 11/184 (5%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQ 57
            +    + +QIL G++YLHS    I H DLK +NI +   N     +KI D GLA  +  
Sbjct: 112 EEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169

Query: 58  PTARS-VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
                 + GTPEF+APE+   E      D++S G+    +++   P+       +    V
Sbjct: 170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANV 228

Query: 116 TSGIK--PASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKDLVCDPLR 172
           ++            T    K FI + +V     R+   + L+ P++   + +  +     
Sbjct: 229 SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWS 288

Query: 173 LPNL 176
            P  
Sbjct: 289 HPQF 292

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 1e-25
 Identities = 52/185 (28%), Positives = 78/185 (42%), Gaps = 30/185 (16%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLA-IVMQQPT 59
            + IK+   Q+LRGL +LHSH   ++HRDLK  NI V  ++G++K+ D GLA I   Q  
Sbjct: 115 TETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMA 171

Query: 60  ARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
             SV+ T  + APE L +  Y   VD++S G    EM   +  +    +  Q+ K +   
Sbjct: 172 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231

Query: 119 IKPAS------------------------LSKVTDPQVKQFIEKCIVP-ASLRLPALELL 153
             P                               D   K  + KC+    + R+ A   L
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

Query: 154 KDPFL 158
             P+ 
Sbjct: 292 SHPYF 296

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  104 bits (259), Expect = 2e-25
 Identities = 30/157 (19%), Positives = 57/157 (36%), Gaps = 10/157 (6%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-- 61
               ARQ+  G+ YL       +HRDL   N  V   N  VKI D GL+  +        
Sbjct: 142 QLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKA 198

Query: 62  --SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG 118
             +      +M PE ++   Y    D++++G+ + E+ +            ++   V  G
Sbjct: 199 DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG 258

Query: 119 IKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 154
               +  +    ++   +  C     + R     + +
Sbjct: 259 -NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 2e-25
 Identities = 37/160 (23%), Positives = 68/160 (42%), Gaps = 9/160 (5%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           + ++  +A Q+   L YL S     +HRD+   N+ V+ N   VK+GD GL+  M+  T 
Sbjct: 107 LASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTY 163

Query: 61  R---SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
                     ++MAPE +    +    D++ FG+C+ E++       +      +  ++ 
Sbjct: 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 223

Query: 117 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD 155
           +G +   +     P +   + KC     S R    EL   
Sbjct: 224 NGERL-PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 2e-25
 Identities = 27/164 (16%), Positives = 62/164 (37%), Gaps = 14/164 (8%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----QQP 58
           +     Q+  G+ YL   N   +HRDL   N+ +  N    KI D GL+  +        
Sbjct: 111 VAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYT 167

Query: 59  TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
              +     ++ APE +   +++   D++S+G+ + E ++      +     ++   +  
Sbjct: 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227

Query: 118 GIKPASLSKVTDPQVKQFIEKCIVPASLRLP----ALELLKDPF 157
           G +         P++   +  C +      P      + ++  +
Sbjct: 228 GKRM-ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 2e-25
 Identities = 47/216 (21%), Positives = 83/216 (38%), Gaps = 39/216 (18%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA-RS 62
           +K +  Q+ R L Y+HS    I HRD+K  N+ ++ +   +K+ D G A  + +     S
Sbjct: 124 VKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 181

Query: 63  VIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT---- 116
            I +  + APEL     +Y   +D++S G  + E++  +  +       Q+ + +     
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241

Query: 117 ------------------SGIKPASLSKV----TDPQVKQFIEKCIVP-ASLRLPALELL 153
                               IK    +KV    T P+      + +    + RL  LE  
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301

Query: 154 KDPFLVTDNPKDLVCDPLRLPNL--VPEVMNLAHSE 187
              F       +L    ++LPN    P + N    E
Sbjct: 302 AHSFF-----DELRDPNVKLPNGRDTPALFNFTTQE 332

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 2e-25
 Identities = 32/160 (20%), Positives = 63/160 (39%), Gaps = 9/160 (5%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
            + +    + +   + YL S     +HRDL   N  VN + G VK+ D GL+  +     
Sbjct: 99  TQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY 155

Query: 61  RS---VIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
            S         +  PE+    +++   DI++FG+ + E+ +      E    ++  + + 
Sbjct: 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 215

Query: 117 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD 155
            G++      +   +V   +  C    A  R     LL +
Sbjct: 216 QGLRL-YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  104 bits (260), Expect = 3e-25
 Identities = 46/186 (24%), Positives = 86/186 (46%), Gaps = 15/186 (8%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
            + +A QI+    YLHS +  +I+RDLK +N+ ++   G +++ D G A  ++  T  ++
Sbjct: 143 ARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGRT-WTL 198

Query: 64  IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA 122
            GTPE +APE +  + YN+ VD ++ G+ I EM     P+     P QIY+K+ SG    
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSGKVR- 256

Query: 123 SLSKVTDPQVKQFIEKCIV------PASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNL 176
                    +K  +   +         +L+    ++    +  T +   +    +  P  
Sbjct: 257 -FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAP-F 314

Query: 177 VPEVMN 182
           +P+   
Sbjct: 315 IPKFKG 320

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 4e-25
 Identities = 35/158 (22%), Positives = 67/158 (42%), Gaps = 11/158 (6%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----- 58
           +    R I  G+ YL + N   +HRDL   NI VN +N   K+ D GL+ V++       
Sbjct: 112 LVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATY 168

Query: 59  TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
           T         + APE +   ++    D++SFG+ + E++T         +  ++ K +  
Sbjct: 169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228

Query: 118 GIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 154
           G +  +        + Q + +C     + R    +++ 
Sbjct: 229 GFRLPTPMDC-PSAIYQLMMQCWQQERARRPKFADIVS 265

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 4e-25
 Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 10/160 (6%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 58
           K + + A Q+ RG+ YL S     IHRDL   N+ V  +   +KI D GLA  +      
Sbjct: 135 KDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYY 191

Query: 59  -TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
               +     ++MAPE L++  Y    D++SFG+ + E+ T            +++K + 
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

Query: 117 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLKD 155
            G +    S  T  ++   +  C     S R    +L++D
Sbjct: 252 EGHRMDKPSNCT-NELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (256), Expect = 6e-25
 Identities = 49/182 (26%), Positives = 90/182 (49%), Gaps = 12/182 (6%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-- 61
              +A +I+ GL +LHS    I++RDLK DNI ++  +G +KI D G+        A+  
Sbjct: 105 ATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTN 161

Query: 62  SVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK 120
           +  GTP+++APE L  ++YN  VD +SFG+ + EM+  + P+   ++  +++  +     
Sbjct: 162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNP 220

Query: 121 PASLSKVTDPQVKQFIEKCIVP-ASLRLPAL-ELLKDPFLVTDNPKDLVCDPLRLPNLVP 178
                +  + + K  + K  V     RL    ++ + P     N ++L    +  P   P
Sbjct: 221 F--YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEID-PPFRP 277

Query: 179 EV 180
           +V
Sbjct: 278 KV 279

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 8e-25
 Identities = 47/201 (23%), Positives = 76/201 (37%), Gaps = 36/201 (17%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TAR 61
           IK +    L+GL YLH H   I+HRDLK +N+ ++  NG +K+ D GLA     P     
Sbjct: 102 IKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYT 158

Query: 62  SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPY----------------- 102
             + T  + APEL      Y   VD+++ G  + E++                       
Sbjct: 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 218

Query: 103 --------NECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELL 153
                   + C  P  +  K   GI    +       +   I+   +     R+ A + L
Sbjct: 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

Query: 154 KDPFLVTDNPKDLVCDPLRLP 174
           K  +  ++ P        +LP
Sbjct: 279 KMKYF-SNRPGP--TPGCQLP 296

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 4e-24
 Identities = 38/159 (23%), Positives = 66/159 (41%), Gaps = 12/159 (7%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS- 62
           +  +  Q+ +G+      +   +HRDL   N  ++     VK+ D GLA  M      S 
Sbjct: 132 LIGFGLQVAKGMK--FLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSV 188

Query: 63  -----VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
                     ++MA E L  +++    D++SFG+ + E++T   P     N   I   + 
Sbjct: 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 248

Query: 117 SGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 154
            G +        DP + + + KC  P A +R    EL+ 
Sbjct: 249 QGRRLLQPEYCPDP-LYEVMLKCWHPKAEMRPSFSELVS 286

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.4 bits (247), Expect = 5e-24
 Identities = 37/161 (22%), Positives = 59/161 (36%), Gaps = 10/161 (6%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 58
           +  +  +A Q+  G+ YL S     IHRDL   N+ +      VKIGD GL   + Q   
Sbjct: 110 LGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDD 166

Query: 59  ---TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 114
                        + APE L    ++   D + FG+ + EM T         N +QI  K
Sbjct: 167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK 226

Query: 115 VTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 154
           +    +     +     +   + +C       R   + L  
Sbjct: 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 99.0 bits (246), Expect = 8e-24
 Identities = 37/158 (23%), Positives = 65/158 (41%), Gaps = 9/158 (5%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
             +   A QI   + YL   N   IHRDL   N  V   N  VK+ D GL+ +M   T  
Sbjct: 115 VVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYT 171

Query: 62  SVIGT---PEFMAP-ELYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS 117
           +  G     ++ AP  L   +++   D+++FG+ + E+ T         + +Q+Y+ +  
Sbjct: 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231

Query: 118 GIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 154
             +          +V + +  C     S R    E+ +
Sbjct: 232 DYRMERPEGCP-EKVYELMRACWQWNPSDRPSFAEIHQ 268

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 8e-24
 Identities = 46/205 (22%), Positives = 77/205 (37%), Gaps = 42/205 (20%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           +  IK   + +L GL+Y+H +   I+HRD+K  N+ +   +G +K+ D GLA        
Sbjct: 116 LSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKN 172

Query: 61  ------RSVIGTPEFMAPE--LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIY 112
                  + + T  +  PE  L E +Y   +D++  G  + EM T            Q+ 
Sbjct: 173 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 232

Query: 113 -----------------------------KKVTSGIKPASLSKVTDPQVKQFIEKCIVP- 142
                                        K     +K    + V DP     I+K +V  
Sbjct: 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292

Query: 143 ASLRLPALELLKDPFLVTD-NPKDL 166
            + R+ + + L   F  +D  P DL
Sbjct: 293 PAQRIDSDDALNHDFFWSDPMPSDL 317

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.2 bits (246), Expect = 9e-24
 Identities = 38/161 (23%), Positives = 72/161 (44%), Gaps = 11/161 (6%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 58
           ++ +  ++ Q+ +G+ +L S     IHRDL   NI ++     VKI D GLA  + +   
Sbjct: 133 LEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 189

Query: 59  --TARSVIGTPEFMA-PELYEEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKK 114
                      ++MA   +++  Y    D++SFG+ + E+ +    PY   K   +  ++
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 115 VTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 154
           +  G +       T P++ Q +  C     S R    EL++
Sbjct: 250 LKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 98.7 bits (245), Expect = 1e-23
 Identities = 23/158 (14%), Positives = 62/158 (39%), Gaps = 21/158 (13%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVN----GNNGEVKIGDLGLAIVMQ 56
           +K +   A+Q+L  +  +H  +  +++RD+K DN  +      N   + + D G+    +
Sbjct: 100 VKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157

Query: 57  QP---------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVT--CEYPYNE 104
            P           +++ GT  +M+   +   E +   D+ + G   +  +     +   +
Sbjct: 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217

Query: 105 CKNPAQIYKKVTSGIKPASLSKVTD---PQVKQFIEKC 139
                Q Y+++    +   L ++      +  +++   
Sbjct: 218 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYA 255

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 97.6 bits (242), Expect = 3e-23
 Identities = 34/178 (19%), Positives = 65/178 (36%), Gaps = 23/178 (12%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFV--NGNNGEVKIGDLGLAIVMQQP 58
           +K +   A Q++  + Y+HS N   IHRD+K DN  +        V I D GLA   +  
Sbjct: 102 LKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159

Query: 59  ---------TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCE--YPYNECK 106
                      +++ GT  + +   +   E +   D+ S G  ++        +   +  
Sbjct: 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219

Query: 107 NPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIVPASLRLP----ALELLKDPF 157
              Q Y++++          L K    +   ++  C        P      +L ++ F
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.2 bits (241), Expect = 5e-23
 Identities = 45/189 (23%), Positives = 76/189 (40%), Gaps = 34/189 (17%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           +  IK++  Q+L+GL + HSH   ++HRDLK  N+ +N   G +K+ D GLA     P  
Sbjct: 101 LPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVR 157

Query: 61  R--SVIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT 116
                + T  + APE+    + Y+  VDI+S G    EMVT    +       Q+++   
Sbjct: 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217

Query: 117 SGIKP--------------------------ASLSKVTDPQVKQFIEKCIVP-ASLRLPA 149
           +   P                          + +    D   +  + + +    + R+ A
Sbjct: 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277

Query: 150 LELLKDPFL 158
              L  PF 
Sbjct: 278 KAALAHPFF 286

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 96.4 bits (239), Expect = 5e-23
 Identities = 37/165 (22%), Positives = 68/165 (41%), Gaps = 11/165 (6%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--- 58
           K          + L++ H +   IIHRD+K  NI ++  N  VK+ D G+A  +      
Sbjct: 111 KRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNS 167

Query: 59  --TARSVIGTPEFMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
                +VIGT ++++PE    +  +   D+YS G  + E++T E P+      +  Y+ V
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227

Query: 116 TSGIKPAS-LSKVTDPQVKQFIEKCIVP-ASLRLPALELLKDPFL 158
                P S   +     +   + K +      R      ++   +
Sbjct: 228 REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 96.5 bits (239), Expect = 7e-23
 Identities = 43/186 (23%), Positives = 70/186 (37%), Gaps = 34/186 (18%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR-- 61
            K++  Q+L G+ Y H     ++HRDLK  N+ +N   GE+KI D GLA     P  +  
Sbjct: 102 AKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYT 158

Query: 62  SVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYK------ 113
             I T  + AP++      Y+  +DI+S G    EMV     +       Q+ +      
Sbjct: 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG 218

Query: 114 --------------------KVTSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALEL 152
                                V   +   S  K  D      + K +    + R+ A + 
Sbjct: 219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

Query: 153 LKDPFL 158
           L+  + 
Sbjct: 279 LEHAYF 284

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.1 bits (238), Expect = 1e-22
 Identities = 45/192 (23%), Positives = 87/192 (45%), Gaps = 21/192 (10%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIV---MQQPTA 60
           ++ +  +I+  L +LH     II+RD+K +NI ++ +NG V + D GL+      +   A
Sbjct: 131 VQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERA 187

Query: 61  RSVIGTPEFMAPELY---EEEYNELVDIYSFGMCILEMVTCEYPY---NECKNPAQIYKK 114
               GT E+MAP++    +  +++ VD +S G+ + E++T   P+    E  + A+I ++
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 247

Query: 115 VTSGIKPASLSKVTDPQVKQFIEKCIV------PASLRLPALELLKDPFLVTDNPKDLVC 168
           +     P    +      K  I++ ++             A E+ +  F    N  DL  
Sbjct: 248 ILKSEPP--YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA 305

Query: 169 DPLRLPNLVPEV 180
             +  P   P +
Sbjct: 306 KKVPAP-FKPVI 316

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.4 bits (236), Expect = 2e-22
 Identities = 40/199 (20%), Positives = 77/199 (38%), Gaps = 41/199 (20%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARS- 62
           +K++  Q+L+GL + HS N  ++HRDLK  N+ +N  NGE+K+ + GLA     P     
Sbjct: 103 VKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYS 159

Query: 63  -VIGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
             + T  +  P++    + Y+  +D++S G    E+     P     +     K++   +
Sbjct: 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219

Query: 120 ---------------------------KPASLSKVTDPQVKQFIEKCIVP-ASLRLPALE 151
                                         ++    +   +  ++  +      R+ A E
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279

Query: 152 LLKDPFLVTDNPKDLVCDP 170
            L+ P+       D  C P
Sbjct: 280 ALQHPYF-----SDF-CPP 292

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.5 bits (234), Expect = 4e-22
 Identities = 35/160 (21%), Positives = 67/160 (41%), Gaps = 10/160 (6%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-- 58
           +  +   A +I  G+ YL+++    +HRDL   N  V   +  VKIGD G+   + +   
Sbjct: 132 LSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDY 188

Query: 59  --TARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
                  +    +M+PE L +  +    D++SFG+ + E+ T      +  +  Q+ + V
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248

Query: 116 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 154
             G          D  + + +  C      +R   LE++ 
Sbjct: 249 MEGGLLDKPDNCPD-MLFELMRMCWQYNPKMRPSFLEIIS 287

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 4e-22
 Identities = 45/193 (23%), Positives = 72/193 (37%), Gaps = 39/193 (20%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM-----Q 56
             I  +  QILRGL Y+HS N  ++HRDLK  N+ +N    ++KI D GLA V       
Sbjct: 109 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDH 165

Query: 57  QPTARSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKK 114
                  + T  + APE+      Y + +DI+S G  + EM++    +       Q+   
Sbjct: 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225

Query: 115 VTSGIKP----------------------------ASLSKVTDPQVKQFIEKCIVP-ASL 145
           +     P                              L    D +    ++K +      
Sbjct: 226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285

Query: 146 RLPALELLKDPFL 158
           R+   + L  P+L
Sbjct: 286 RIEVEQALAHPYL 298

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.1 bits (233), Expect = 6e-22
 Identities = 31/160 (19%), Positives = 68/160 (42%), Gaps = 9/160 (5%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA 60
           ++ + +++ Q+ +G+ +L S N   IHRDL   NI +  +    KI D GLA  ++  + 
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIKNDSN 200

Query: 61  RSV----IGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKV 115
             V        ++MAPE ++   Y    D++S+G+ + E+ +              + K+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 116 TSGIKPASLSKVTDPQVKQFIEKCIVP-ASLRLPALELLK 154
                     +    ++   ++ C       R    ++++
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.6 bits (229), Expect = 2e-21
 Identities = 44/192 (22%), Positives = 69/192 (35%), Gaps = 40/192 (20%)

Query: 2   KAIKNWARQILRGLHYLHS------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVM 55
           + +   A     GL +LH         P I HRDLK  NI V   NG   I DLGLA+  
Sbjct: 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRH 158

Query: 56  QQPT------ARSVIGTPEFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPY 102
              T          +GT  +MAPE+ ++       E  +  DIY+ G+   E+       
Sbjct: 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 218

Query: 103 NECK--------------NPAQIYKKVTSGIKPASLSKVTDP-----QVKQFIEKCIVP- 142
              +              +  ++ K V       ++            + + + +C    
Sbjct: 219 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 278

Query: 143 ASLRLPALELLK 154
            + RL AL + K
Sbjct: 279 GAARLTALRIKK 290

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 92.2 bits (228), Expect = 3e-21
 Identities = 37/203 (18%), Positives = 74/203 (36%), Gaps = 42/203 (20%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ-PTA 60
             I+ +  +IL+ L Y HS    I+HRD+K  N+ ++  + ++++ D GLA         
Sbjct: 129 YDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186

Query: 61  RSVIGTPEFMAPELYEEE--YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT-- 116
              + +  F  PEL  +   Y+  +D++S G  +  M+  + P+    +      ++   
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246

Query: 117 ---------------------------------SGIKPASLSKVTDPQVKQFIEKCIVP- 142
                                                 +    +  P+   F++K +   
Sbjct: 247 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306

Query: 143 ASLRLPALELLKDPFLVTDNPKD 165
              RL A E ++ P+      KD
Sbjct: 307 HQSRLTAREAMEHPYF-YTVVKD 328

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (215), Expect = 2e-19
 Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 35/186 (18%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           I+    Q+L+GL Y+H+      HRDLK  N+ VN  + E+KI D GLA           
Sbjct: 123 IQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVN-EDCELKILDFGLARQADSEM-TGY 178

Query: 64  IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
           + T  + APE+      Y + VDI+S G  + EM+T +  +    +  Q+ + +     P
Sbjct: 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238

Query: 122 ----------------------------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALEL 152
                                       AS+     P     +EK +V  A  R+ A E 
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

Query: 153 LKDPFL 158
           L  P+ 
Sbjct: 299 LAHPYF 304

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.4 bits (197), Expect = 4e-17
 Identities = 48/223 (21%), Positives = 83/223 (37%), Gaps = 51/223 (22%)

Query: 2   KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTAR 61
           + +     Q+L G+ +LHS     IHRDLK  NI V  ++  +KI D GLA         
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGI--IHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMM 175

Query: 62  S-VIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI 119
           +  + T  + APE +    Y E VDI+S G  + EMV  +  +       Q  K +    
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235

Query: 120 KP---------------------------------------ASLSKVTDPQVKQFIEKCI 140
            P                                       +  +K+   Q +  + K +
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295

Query: 141 VP-ASLRLPALELLKDPFLVTDNPKDLVCDPLRLPNLVPEVMN 182
           V   + R+   + L+ P++      ++  DP  +    P++ +
Sbjct: 296 VIDPAKRISVDDALQHPYI------NVWYDPAEVEAPPPQIYD 332

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.4 bits (192), Expect = 2e-16
 Identities = 54/201 (26%), Positives = 83/201 (41%), Gaps = 37/201 (18%)

Query: 4   IKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSV 63
           ++    QILRGL Y+HS +  IIHRDLK  N+ VN  + E+KI D GLA           
Sbjct: 123 VQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDDEM-TGY 178

Query: 64  IGTPEFMAPELY--EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP 121
           + T  + APE+      YN+ VDI+S G  + E++T    +    +  Q+   +     P
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 238

Query: 122 ----------------------------ASLSKVTDPQVKQFIEKCIVP-ASLRLPALEL 152
                                       A++    +P     +EK +V  +  R+ A + 
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

Query: 153 LKDPFLVT-DNPKDL-VCDPL 171
           L   +     +P D  V DP 
Sbjct: 299 LAHAYFAQYHDPDDEPVADPY 319

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 72.8 bits (177), Expect = 1e-14
 Identities = 42/227 (18%), Positives = 82/227 (36%), Gaps = 58/227 (25%)

Query: 1   MKAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQ---- 56
           +  +K  ++Q+L GL Y+H     IIH D+K +N+ +   +    +  + +A +      
Sbjct: 124 LIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182

Query: 57  QPTARSVIGTPEFMAPE-LYEEEYNELVDIYSFGMCILEMVTCEYPY------NECKNPA 109
                + I T E+ +PE L    +    DI+S    I E++T ++ +      +  K+  
Sbjct: 183 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242

Query: 110 QIYKKVTSGIKPAS---------------------------------------LSKVTDP 130
            I + +    +  S                                        SK    
Sbjct: 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 302

Query: 131 QVKQFIEKCIVP-ASLRLPALELLKDPFLVTDNPKD-LVCDPLRLPN 175
           ++  F+   +      R  A  L+  P+L     KD L  + +R+P+
Sbjct: 303 EISDFLSPMLQLDPRKRADAGGLVNHPWL-----KDTLGMEEIRVPD 344

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 61.3 bits (148), Expect = 1e-11
 Identities = 17/90 (18%), Positives = 31/90 (34%), Gaps = 4/90 (4%)

Query: 5   KNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVI 64
                 IL  +   +     I+H DL   N+ V+     + I D   ++ + +   R ++
Sbjct: 106 DEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEEGWREIL 161

Query: 65  GTPEFMAPELYEEEYNELVDIYSFGMCILE 94
                     +   Y    DI S    IL+
Sbjct: 162 ERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	505
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.98
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.98
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.98
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.97
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.97
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.97
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.97
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.97
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.97
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.97
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.97
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.97
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.97
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.96
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.96
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.96
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.96
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.96
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.96
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.96
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.96
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.96
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.96
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.96
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.95
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.95
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.95
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.95
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.95
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.95
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.95
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.95
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.94
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.94
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.94
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.93
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.93
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.24
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	85.6
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	82.88
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	80.91

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-38  Score=309.14  Aligned_cols=158  Identities=60%  Similarity=1.109  Sum_probs=145.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccccCCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNE   81 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~ys~   81 (505)
                      +.++.|++||+.||+|||+++++|+||||||+|||+++.++.+||+|||+++..........+||+.|+|||++.+.|+.
T Consensus       112 ~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~~~~~  191 (270)
T d1t4ha_         112 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDE  191 (270)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTCCCT
T ss_pred             HHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCccCCcccCccccCHHHhCCCCCC
Confidence            46789999999999999999888999999999999975678999999999987666666677899999999999888999


Q ss_pred             ccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 010626           82 LVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  159 (505)
Q Consensus        82 ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~  159 (505)
                      ++|||||||++|+|++|+.||.+..+...++..+..+..+..++...++++++||.+||. +|.+|||+.|+|+||||+
T Consensus       192 ~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         192 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             cCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999988888889999988888777888889999999999996 799999999999999995

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-35  Score=294.50  Aligned_cols=157  Identities=32%  Similarity=0.559  Sum_probs=135.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.|++||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+++.+...  .....+||+.|+|||++. +.
T Consensus       116 ~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~  192 (293)
T d1yhwa1         116 GQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA  192 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEEC-CCCcEeeccchhheeeccccccccccccCCCccChhhhcCCC
Confidence            468899999999999999999  99999999999997 6789999999999876433  345568999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPF  157 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpf  157 (505)
                      |+.++|||||||++|+|+||+.||.+......+...+..+.++...+..+++.+++||.+||. +|.+|||+.|+|+|||
T Consensus       193 ~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~  272 (293)
T d1yhwa1         193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF  272 (293)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred             CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            899999999999999999999999876555556666666555555667789999999999996 8999999999999999


Q ss_pred             CCCC
Q 010626          158 LVTD  161 (505)
Q Consensus       158 f~~~  161 (505)
                      |+..
T Consensus       273 ~~~~  276 (293)
T d1yhwa1         273 LKIA  276 (293)
T ss_dssp             GGGC
T ss_pred             hCCC
Confidence            9753

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-35  Score=290.69  Aligned_cols=157  Identities=27%  Similarity=0.470  Sum_probs=132.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll~-   76 (505)
                      ..++.+++||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+.....    .....+||+.|+|||++. 
T Consensus       103 ~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~-~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  179 (271)
T d1nvra_         103 PDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR  179 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC-TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEEC-CCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcC
Confidence            468899999999999999999  99999999999997 6789999999999876432    234568999999999884 


Q ss_pred             ccC-CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEY-NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~y-s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ..| +.++|||||||++|+|+||+.||.........+..+.............++++++||.+||. +|.+|||+.|+|+
T Consensus       180 ~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            344 67899999999999999999999876666666666655544444456678999999999996 8999999999999


Q ss_pred             CCCCCCC
Q 010626          155 DPFLVTD  161 (505)
Q Consensus       155 hpff~~~  161 (505)
                      ||||++.
T Consensus       260 hpwf~~~  266 (271)
T d1nvra_         260 DRWYNKP  266 (271)
T ss_dssp             CTTTTCC
T ss_pred             CHhhCcC
Confidence            9999753

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-35  Score=289.31  Aligned_cols=153  Identities=24%  Similarity=0.487  Sum_probs=135.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~ys   80 (505)
                      ..++.|++||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|............||+.|+|||++. ..|+
T Consensus       106 ~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~  182 (263)
T d2j4za1         106 QRTATYITELANALSYCHSKR--VIHRDIKPENLLLG-SAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHD  182 (263)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceec-CCCCEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCC
Confidence            468899999999999999999  99999999999998 6789999999999877666666778999999999885 4589


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCC
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLV  159 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~  159 (505)
                      .++|||||||++|+|+||+.||.+ .+...++..+.....  .++...++++++||.+||. +|.+|||+.|+|+||||.
T Consensus       183 ~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         183 EKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHTTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             chhhhhhHhHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence            999999999999999999999976 566777777766533  3566789999999999996 899999999999999996


Q ss_pred             C
Q 010626          160 T  160 (505)
Q Consensus       160 ~  160 (505)
                      .
T Consensus       260 ~  260 (263)
T d2j4za1         260 A  260 (263)
T ss_dssp             H
T ss_pred             C
Confidence            4

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.1e-34  Score=296.63  Aligned_cols=165  Identities=25%  Similarity=0.462  Sum_probs=138.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-c-cC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E-EY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~-~y   79 (505)
                      ..++.|++||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+|+...........||+.|+|||++. + .|
T Consensus       107 ~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~-~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~  183 (364)
T d1omwa3         107 ADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY  183 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-SSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEc-CCCcEEEeeeceeeecCCCcccccccccccchhHHhhcCCCC
Confidence            468899999999999999999  99999999999998 7789999999999988776667778999999999884 3 58


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCCh--HHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNP--AQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALE  151 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~--~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~E  151 (505)
                      +.++|||||||++|+|+||+.||......  ..+...  ....+..++..+++++++||.+||. +|.+|||     +.|
T Consensus       184 ~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~e  261 (364)
T d1omwa3         184 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE  261 (364)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH--SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHH
T ss_pred             CcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHH
Confidence            99999999999999999999999764332  222222  2233445667789999999999996 8999999     799


Q ss_pred             HhcCCCCCCCCCCCcccCCC
Q 010626          152 LLKDPFLVTDNPKDLVCDPL  171 (505)
Q Consensus       152 lL~hpff~~~~~~~l~~~~l  171 (505)
                      +++||||+..+|..+....+
T Consensus       262 il~Hp~f~~i~~~~~~~~~~  281 (364)
T d1omwa3         262 VKESPFFRSLDWQMVFLQKY  281 (364)
T ss_dssp             HHTSGGGTTCCHHHHHTTCS
T ss_pred             HHcCccccCCCHHHHhcCCC
Confidence            99999999887766544443

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-34  Score=289.03  Aligned_cols=158  Identities=32%  Similarity=0.587  Sum_probs=131.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccc----
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY----   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll----   75 (505)
                      +.++.|++||+.||.|||++|  |+||||||+|||++ .++.+||+|||+|+.....  ......||+.|+|||++    
T Consensus       110 ~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~  186 (288)
T d2jfla1         110 SQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFT-LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET  186 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeEC-CCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcc
Confidence            468899999999999999999  99999999999998 6789999999999765432  23456899999999987    


Q ss_pred             --cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           76 --EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        76 --~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                        ...|+.++|||||||++|+|+||+.||.+.. ..++...+..+.. ....+...++++++||.+||+ +|.+|||+.|
T Consensus       187 ~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e  265 (288)
T d2jfla1         187 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELN-PMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ  265 (288)
T ss_dssp             TTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC-GGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             cCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence              2348899999999999999999999998754 4444555555433 334456778999999999996 8999999999


Q ss_pred             HhcCCCCCCCCC
Q 010626          152 LLKDPFLVTDNP  163 (505)
Q Consensus       152 lL~hpff~~~~~  163 (505)
                      +|+||||+....
T Consensus       266 ll~hp~~~~~~~  277 (288)
T d2jfla1         266 LLQHPFVTVDSN  277 (288)
T ss_dssp             HTTSGGGCCCCC
T ss_pred             HhcCcccCCCCC
Confidence            999999976443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.4e-34  Score=292.10  Aligned_cols=166  Identities=27%  Similarity=0.472  Sum_probs=141.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~ys   80 (505)
                      ..++.|+.||+.||.|||++|  |+||||||+|||++ .+|.+||+|||+|+..... .....||+.|||||++. ..|+
T Consensus       141 ~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~-~~g~ikL~DFG~a~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~  216 (350)
T d1rdqe_         141 PHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLID-QQGYIQVTDFGFAKRVKGR-TWTLCGTPEALAPEIILSKGYN  216 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTSCEEECCCTTCEECSSC-BCCCEECGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccC-CCCCEEeeeceeeeecccc-cccccCccccCCHHHHcCCCCC
Confidence            468899999999999999999  99999999999998 6789999999999887543 44568999999999884 5699


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHHHhc
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~ElL~  154 (505)
                      .++|||||||++|+|+||+.||.+ .+...++..+..+..  .++..+++++.+||.+||. +|.+|+     |+.++++
T Consensus       217 ~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         217 KAVDWWALGVLIYEMAAGYPPFFA-DQPIQIYEKIVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ccccccchhHHHHHHHhCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            999999999999999999999976 567777777776643  3456788999999999995 798884     8999999


Q ss_pred             CCCCCCCCCCCcccCCCCCC
Q 010626          155 DPFLVTDNPKDLVCDPLRLP  174 (505)
Q Consensus       155 hpff~~~~~~~l~~~~l~~p  174 (505)
                      ||||+..++..+....+..|
T Consensus       294 Hp~f~~~~~~~~~~~~~~~p  313 (350)
T d1rdqe_         294 HKWFATTDWIAIYQRKVEAP  313 (350)
T ss_dssp             SGGGTTCCHHHHHTTCSCCS
T ss_pred             CccccCCCHHHHHhcCCCcC
Confidence            99999887766655554444

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-35  Score=293.74  Aligned_cols=158  Identities=28%  Similarity=0.527  Sum_probs=126.2

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +.++.++.||+.||.|||+ +|  |+||||||+|||++ .+|.+||+|||+|+........+.+||+.|+|||++ ...|
T Consensus       104 ~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~-~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y  180 (322)
T d1s9ja_         104 QILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY  180 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEEC-TTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeEC-CCCCEEEeeCCCccccCCCccccccCCccccCchHHcCCCC
Confidence            4688999999999999997 58  99999999999997 778999999999987765556677999999999988 4579


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHH-----------------------------------------HHHHHHcC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQ-----------------------------------------IYKKVTSG  118 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~-----------------------------------------i~~~i~~~  118 (505)
                      +.++||||+||++|||++|+.||........                                         ....+...
T Consensus       181 ~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (322)
T d1s9ja_         181 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE  260 (322)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTS
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhcc
Confidence            9999999999999999999999976432211                                         11111122


Q ss_pred             CCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCC
Q 010626          119 IKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDN  162 (505)
Q Consensus       119 ~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~  162 (505)
                      .++.......++++++||.+||+ +|.+|||+.|+|+||||++..
T Consensus       261 ~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         261 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence            22222333467899999999996 899999999999999998643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.9e-34  Score=286.48  Aligned_cols=166  Identities=30%  Similarity=0.536  Sum_probs=141.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-ccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~ys   80 (505)
                      ..++.+++||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+|+..... ..+.+||+.|+|||++. ..|+
T Consensus       104 ~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~-~~g~vkL~DFG~a~~~~~~-~~~~~Gt~~Y~APE~l~~~~y~  179 (316)
T d1fota_         104 PVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLD-KNGHIKITDFGFAKYVPDV-TYTLCGTPDYIAPEVVSTKPYN  179 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEEC-TTSCEEECCCSSCEECSSC-BCCCCSCTTTCCHHHHTTCCBC
T ss_pred             cHHHHHHHHHHHhhhhhccCc--EEccccCchheeEc-CCCCEEEecCccceEeccc-cccccCcccccCHHHHcCCCCC
Confidence            357889999999999999999  99999999999998 6889999999999877543 44578999999999985 4599


Q ss_pred             cccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC-----CHHHHhc
Q 010626           81 ELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL-----PALELLK  154 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp-----Sa~ElL~  154 (505)
                      .++|||||||++|+|+||+.||.+ .+...++..+..+..  .++...+++++++|.+||. +|.+|+     |++++|+
T Consensus       180 ~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         180 KSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             chhhccccchhHHHHHhCCCCCCC-cCHHHHHHHHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            999999999999999999999986 566677777776643  3556678999999999995 799986     8999999


Q ss_pred             CCCCCCCCCCCcccCCCCCC
Q 010626          155 DPFLVTDNPKDLVCDPLRLP  174 (505)
Q Consensus       155 hpff~~~~~~~l~~~~l~~p  174 (505)
                      ||||+...+..+....+..|
T Consensus       257 Hp~f~~i~~~~l~~~~~~~p  276 (316)
T d1fota_         257 HPWFKEVVWEKLLSRNIETP  276 (316)
T ss_dssp             SGGGSSCCHHHHHTTCSCCS
T ss_pred             CcccccCCHHHHHhCCCCcC
Confidence            99999988776655554443

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-34  Score=289.67  Aligned_cols=165  Identities=25%  Similarity=0.532  Sum_probs=141.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      +.++.+++||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+|+....  ......+||+.|+|||++ ...
T Consensus       105 ~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~-~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~  181 (337)
T d1o6la_         105 ERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND  181 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC
T ss_pred             HHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEec-CCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCC
Confidence            468899999999999999999  99999999999998 678999999999986543  234567899999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCC-----HHHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLP-----ALEL  152 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpS-----a~El  152 (505)
                      |+.++|||||||++|||++|+.||.+ .+...++..+..+..  .++...++++++||.+||+ +|.+|++     +.|+
T Consensus       182 y~~~~DiwSlGvilyeml~G~~pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~ei  258 (337)
T d1o6la_         182 YGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV  258 (337)
T ss_dssp             BCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH
T ss_pred             CChhhcccchhhHHHHHHHCCCCCCC-cCHHHHHHHHhcCCC--CCCccCCHHHHHHHHhhccCCchhhcccccccHHHH
Confidence            99999999999999999999999987 566777777776643  4567789999999999996 8999994     9999


Q ss_pred             hcCCCCCCCCCCCcccCCCC
Q 010626          153 LKDPFLVTDNPKDLVCDPLR  172 (505)
Q Consensus       153 L~hpff~~~~~~~l~~~~l~  172 (505)
                      ++||||+..++..+....+.
T Consensus       259 l~Hp~f~~i~~~~l~~~~~~  278 (337)
T d1o6la_         259 MEHRFFLSINWQDVVQKKLL  278 (337)
T ss_dssp             HTSGGGTTCCHHHHHTTCSC
T ss_pred             HcCcccccCCHHHHHhCCCC
Confidence            99999998777665544443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-34  Score=283.90  Aligned_cols=161  Identities=30%  Similarity=0.494  Sum_probs=136.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.++.||+.||+|||++|  |+||||||+|||++ .+|.+||+|||+|+.+...    .....+||+.|+|||++ .
T Consensus       108 ~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  184 (288)
T d1uu3a_         108 TCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE  184 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccC-CCceEEecccccceecccCCcccccccccCCccccCceeecc
Confidence            468899999999999999999  99999999999998 7789999999999876432    23456799999999988 4


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH----
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE----  151 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E----  151 (505)
                      ..|+.++|||||||++|+|+||+.||.+ .+...++..+..+..  .++...++++++||.+||. +|.+|||+.|    
T Consensus       185 ~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         185 KSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCC--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CCCCcccceehhhHHHHHHhhCCCCCCC-cCHHHHHHHHHcCCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            5699999999999999999999999986 567777777776533  3566789999999999996 8999999988    


Q ss_pred             --HhcCCCCCCCCCCCccc
Q 010626          152 --LLKDPFLVTDNPKDLVC  168 (505)
Q Consensus       152 --lL~hpff~~~~~~~l~~  168 (505)
                        +++||||+..+|..+..
T Consensus       262 ~~i~~Hpff~~i~w~~l~~  280 (288)
T d1uu3a_         262 GPLKAHPFFESVTWENLHQ  280 (288)
T ss_dssp             HHHHTSGGGTTCCCTTGGG
T ss_pred             HHHHcCCccCCCCHHHhhc
Confidence              58899999888776543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.1e-34  Score=288.23  Aligned_cols=154  Identities=34%  Similarity=0.558  Sum_probs=132.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc----c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE----E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~----~   77 (505)
                      ..++.|++||+.||.|||++|  |+||||||+|||++ .++.+||+|||+|.....  .....||+.|+|||++.    +
T Consensus       115 ~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~-~~~~~Kl~DFG~a~~~~~--~~~~~GT~~Y~APE~~~~~~~~  189 (309)
T d1u5ra_         115 VEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEG  189 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEE-TTTEEEECCCTTCBSSSS--BCCCCSCGGGCCHHHHTTTTSC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEC-CCCCEEEeecccccccCC--CCccccCccccCHHHHhccCCC
Confidence            468899999999999999999  99999999999998 778999999999976543  34568999999999873    3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDP  156 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hp  156 (505)
                      .|+.++|||||||++|||++|..||.+. +.......+..+..+...+..+++++++||.+||. +|.+|||+.|+|+||
T Consensus       190 ~y~~~~DiwSlGvilyel~~g~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp  268 (309)
T d1u5ra_         190 QYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (309)
T ss_dssp             CBCTHHHHHHHHHHHHHHHHSSCTTTTS-CHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             CcCchhhhhhHHHHHHHHHHCCCCCCCC-CHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence            5899999999999999999999999874 44455555666655555566789999999999996 899999999999999


Q ss_pred             CCCCC
Q 010626          157 FLVTD  161 (505)
Q Consensus       157 ff~~~  161 (505)
                      ||.+.
T Consensus       269 ~~~~~  273 (309)
T d1u5ra_         269 FVLRE  273 (309)
T ss_dssp             HHHSC
T ss_pred             HhcCC
Confidence            99754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-34  Score=282.09  Aligned_cols=154  Identities=26%  Similarity=0.469  Sum_probs=122.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCC---CCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHN---PPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g---~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll-   75 (505)
                      ..++.|+.||+.||+|||++|   .+|+||||||+|||++ .++.+||+|||+++.....  ......||+.|+|||++ 
T Consensus       109 ~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~-~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~  187 (269)
T d2java1         109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN  187 (269)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC-TTSCEEECCHHHHHHC-----------CCCSCCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC-CCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHc
Confidence            368899999999999999864   2499999999999998 6789999999999876443  23456899999999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      ...|+.++|||||||++|||+||+.||.+ .+..++...+..+..+ .++..+++++++||.+||. +|.+|||+.|+|+
T Consensus       188 ~~~~~~~~DIwSlGvilyel~tg~~Pf~~-~~~~~~~~~i~~~~~~-~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         188 RMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFR-RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCChHHHHHhhCHHHHHHhhCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            45699999999999999999999999976 5667777777776544 4566789999999999996 8999999999999


Q ss_pred             CCCC
Q 010626          155 DPFL  158 (505)
Q Consensus       155 hpff  158 (505)
                      |||+
T Consensus       266 hp~i  269 (269)
T d2java1         266 NPLI  269 (269)
T ss_dssp             STTC
T ss_pred             CCcC
Confidence            9996

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-33  Score=277.02  Aligned_cols=156  Identities=27%  Similarity=0.409  Sum_probs=125.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~--~   77 (505)
                      ..++.|++||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++.....  .....+||+.|+|||++.  .
T Consensus       100 ~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~-~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  176 (299)
T d1ua2a_         100 SHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR  176 (299)
T ss_dssp             SHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHHHhhccc--eecccCCcceEEec-CCCccccccCccccccCCCcccccceecChhhccHHHHccCC
Confidence            368899999999999999999  99999999999998 7789999999999766443  234567999999999873  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc-CCCCC----------------C--------CCCCCChHH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIKPA----------------S--------LSKVTDPQV  132 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~-~~~p~----------------~--------~~~~~s~~l  132 (505)
                      .|+.++|||||||++|||+||..||.+.....++...... +.++.                .        .....++++
T Consensus       177 ~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  256 (299)
T d1ua2a_         177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDL  256 (299)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHH
T ss_pred             CCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHH
Confidence            5899999999999999999999999875544443332221 00000                0        012357899


Q ss_pred             HHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          133 KQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       133 ~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      ++||.+||+ +|.+|||+.|+|+||||+.
T Consensus       257 ~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         257 LDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             HHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             HHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence            999999996 8999999999999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-33  Score=275.72  Aligned_cols=148  Identities=21%  Similarity=0.425  Sum_probs=127.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-cc-C
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-EE-Y   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~~-y   79 (505)
                      ++++.|++||+.||+|||++|  |+||||||+|||++.+++.+||+|||+++........+..||+.|+|||++. .. +
T Consensus       110 ~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~  187 (273)
T d1xwsa_         110 ELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYH  187 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEECccccceecccccccccccCCCcCCHHHHcCCCCC
Confidence            468899999999999999999  9999999999999866689999999999887766667788999999999884 33 4


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFL  158 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff  158 (505)
                      +.++|||||||++|+|+||+.||...   .    .+..+.  ..++..+++++++||.+||. +|.+|||+.|+|+||||
T Consensus       188 ~~~~DiwSlGvilyell~g~~Pf~~~---~----~i~~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~  258 (273)
T d1xwsa_         188 GRSAAVWSLGILLYDMVCGDIPFEHD---E----EIIRGQ--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM  258 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCSCCSH---H----HHHHCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             CcccccccceeeehhHhhCCCCCCCc---h----HHhhcc--cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence            67899999999999999999999752   2    222322  23556789999999999996 89999999999999999


Q ss_pred             CC
Q 010626          159 VT  160 (505)
Q Consensus       159 ~~  160 (505)
                      +.
T Consensus       259 ~~  260 (273)
T d1xwsa_         259 QD  260 (273)
T ss_dssp             SS
T ss_pred             CC
Confidence            75

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.98  E-value=5e-33  Score=279.85  Aligned_cols=157  Identities=24%  Similarity=0.459  Sum_probs=121.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccCC-CCccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~-~   77 (505)
                      ..++.++.||+.||+|||++|  |+||||||+||++..  .++.+||+|||+++..... ...+.+||+.|+|||++. .
T Consensus       107 ~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~  184 (307)
T d1a06a_         107 RDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK  184 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCC
Confidence            468899999999999999999  999999999999952  4678999999999866443 344568999999999884 5


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .|+.++|||||||++|+|+||+.||.+ .....+...+..+..+  ......+++++++||.+||. +|.+|||+.|+|+
T Consensus       185 ~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         185 PYSKAVDCWSIGVIAYILLCGYPPFYD-ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCC-SSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCcHHHhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            699999999999999999999999987 4556666777665433  23445678999999999996 8999999999999


Q ss_pred             CCCCCCC
Q 010626          155 DPFLVTD  161 (505)
Q Consensus       155 hpff~~~  161 (505)
                      ||||+..
T Consensus       264 hp~~~~~  270 (307)
T d1a06a_         264 HPWIAGD  270 (307)
T ss_dssp             STTTTSS
T ss_pred             CHhhCCC
Confidence            9999753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=7.1e-33  Score=275.93  Aligned_cols=157  Identities=31%  Similarity=0.466  Sum_probs=127.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +.++.+++||+.||+|||++|  |+||||||+|||++ ..+.+||+|||++...... ......||+.|+|||++ ...|
T Consensus       116 ~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~-~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y  192 (305)
T d1blxa_         116 ETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY  192 (305)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEc-CCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCC
Confidence            467899999999999999999  99999999999997 6789999999998765332 34556899999999987 5679


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC------------------------CCCCCCCCChHHHHH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK------------------------PASLSKVTDPQVKQF  135 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~------------------------p~~~~~~~s~~l~~L  135 (505)
                      +.++||||+||++|||+||+.||.+......+...+.....                        ...+....++.+++|
T Consensus       193 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl  272 (305)
T d1blxa_         193 ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL  272 (305)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHH
T ss_pred             ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHH
Confidence            99999999999999999999999875444333332221000                        011234567899999


Q ss_pred             HHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          136 IEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       136 I~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      |.+||. +|.+|||+.|+|+||||+..
T Consensus       273 i~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         273 LLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            999996 89999999999999999864

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.1e-32  Score=274.42  Aligned_cols=162  Identities=27%  Similarity=0.442  Sum_probs=131.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCC---CcEEEeecCceeeccCC-CCccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNN---GEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~---g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~-   76 (505)
                      ..++.+++||+.||+|||++|  |+||||||+||+++..+   ..+||+|||++...... ......||+.|+|||++. 
T Consensus       113 ~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~  190 (293)
T d1jksa_         113 EEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY  190 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT
T ss_pred             hHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC
Confidence            468899999999999999999  99999999999997332   25999999999877543 344568999999999885 


Q ss_pred             ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ..|+.++|||||||++|+|+||+.||.+ .+..+.+..+..+...  ...+...++.+++||.+||. +|.+|||+.|+|
T Consensus       191 ~~~~~~~DiwSlGvilyell~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil  269 (293)
T d1jksa_         191 EPLGLEADMWSIGVITYILLSGASPFLG-DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL  269 (293)
T ss_dssp             CCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             CCCCCcccchhhhHHHHHHHcCCCCCCC-CCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            4699999999999999999999999986 4566666666665432  22335678999999999996 799999999999


Q ss_pred             cCCCCCCCCCCCc
Q 010626          154 KDPFLVTDNPKDL  166 (505)
Q Consensus       154 ~hpff~~~~~~~l  166 (505)
                      +||||+...+...
T Consensus       270 ~hp~~~~~~~~~~  282 (293)
T d1jksa_         270 QHPWIKPKDTQQA  282 (293)
T ss_dssp             HSTTTCC------
T ss_pred             cCcccCCCChhHh
Confidence            9999987655443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.97  E-value=1.7e-32  Score=280.95  Aligned_cols=159  Identities=26%  Similarity=0.415  Sum_probs=133.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEeecCceeeccCCC-CccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~-~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~-~~   78 (505)
                      ..++.|++||+.||+|||++|  |+||||||+|||++. .++.+||+|||+++.+.... .....||+.|+|||++. ..
T Consensus       124 ~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~  201 (350)
T d1koaa2         124 DEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP  201 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCC
T ss_pred             HHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCC
Confidence            468899999999999999999  999999999999963 35789999999998775443 34568999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC--CCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP--ASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p--~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      |+.++|||||||++|+|+||+.||.+ .+.......+..+...  ......+++++++||.+||. +|.+|||+.|+|+|
T Consensus       202 ~~~~~DiwSlGvilyell~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         202 VGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             BCHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CChhHhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            89999999999999999999999976 4566666666655332  22334578999999999996 89999999999999


Q ss_pred             CCCCCCCC
Q 010626          156 PFLVTDNP  163 (505)
Q Consensus       156 pff~~~~~  163 (505)
                      |||+....
T Consensus       281 p~~~~~~~  288 (350)
T d1koaa2         281 PWLTPGNA  288 (350)
T ss_dssp             TTTSCTTC
T ss_pred             cccCCCCC
Confidence            99987543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.97  E-value=2.8e-32  Score=279.58  Aligned_cols=158  Identities=26%  Similarity=0.418  Sum_probs=133.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEeecCceeeccCCC-CccccCCCcccCccccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELYE-EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~-~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll~-~~   78 (505)
                      .+++.|++||+.||+|||++|  |+||||||+|||++. .++.+||+|||+|....... .....||+.|+|||++. ..
T Consensus       127 ~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~  204 (352)
T d1koba_         127 AEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP  204 (352)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCC
Confidence            468899999999999999999  999999999999963 46899999999998876543 44568999999999884 56


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC--CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      |+.++|||||||++|+|+||+.||.+. +.......+..+..  +.......++++++||.+||. +|.+|||+.|+|+|
T Consensus       205 ~~~~~DiwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         205 VGFYTDMWAIGVLGYVLLSGLSPFAGE-DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             BCHHHHHHHHHHHHHHHHHSCCSSCCS-SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            999999999999999999999999874 45555566665533  333445678999999999996 89999999999999


Q ss_pred             CCCCCCC
Q 010626          156 PFLVTDN  162 (505)
Q Consensus       156 pff~~~~  162 (505)
                      |||+...
T Consensus       284 p~~~~~~  290 (352)
T d1koba_         284 PWLKGDH  290 (352)
T ss_dssp             TTTSSCC
T ss_pred             HhhCCCc
Confidence            9998643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.4e-33  Score=279.40  Aligned_cols=162  Identities=27%  Similarity=0.522  Sum_probs=138.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccC--CCCccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQ--PTARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~--~~~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ..++.+++||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++....  .......||+.|+|||++ ...
T Consensus       103 ~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~-~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  179 (320)
T d1xjda_         103 SRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLD-KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK  179 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC-TTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeec-CCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCC
Confidence            468899999999999999999  99999999999998 778999999999976543  233446899999999988 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHH-HHhcCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPAL-ELLKDP  156 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~-ElL~hp  156 (505)
                      |+.++|||||||++|+|+||+.||.+ .+..+++..+..+.+  .++..+++++++||.+||. +|.+||++. ++++||
T Consensus       180 ~~~~~DiwSlGvilyemltG~~PF~~-~~~~~~~~~i~~~~~--~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hp  256 (320)
T d1xjda_         180 YNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHP  256 (320)
T ss_dssp             BCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred             CCchhhhhhhhHHHHHHHhCCCCCCC-CCHHHHHHHHHcCCC--CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCc
Confidence            99999999999999999999999986 567777777776543  4567789999999999996 899999996 899999


Q ss_pred             CCCCCCCCCcccC
Q 010626          157 FLVTDNPKDLVCD  169 (505)
Q Consensus       157 ff~~~~~~~l~~~  169 (505)
                      ||+..++..+...
T Consensus       257 ff~~~~~~~l~~~  269 (320)
T d1xjda_         257 LFREINWEELERK  269 (320)
T ss_dssp             GGTTCCHHHHHTT
T ss_pred             hhccCCHHHHHhc
Confidence            9988665544333

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.97  E-value=7.4e-32  Score=267.50  Aligned_cols=155  Identities=28%  Similarity=0.489  Sum_probs=131.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc----
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE----   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~----   76 (505)
                      +.++.|+.||+.||+|||++|  |+||||||+||+++ .++.+||+|||+++..... ......||+.|+|||.+.    
T Consensus       110 ~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~-~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~  186 (277)
T d1phka_         110 KETRKIMRALLEVICALHKLN--IVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN  186 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEc-CCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhcccc
Confidence            478999999999999999999  99999999999997 7889999999999877543 344567999999999873    


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC--CCCCCCCCChHHHHHHHHhcC-CCCCCCCHH
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPAL  150 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~--p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~  150 (505)
                         ..|+.++||||+||++|+|+||+.||.+ .+.......+..+..  +......+++++++||.+||. +|.+|||+.
T Consensus       187 ~~~~~~~~~~DiwslGvilyeml~g~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~  265 (277)
T d1phka_         187 DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE  265 (277)
T ss_dssp             TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             ccCCCCCchheEcccchhhhhhccCCCCCCC-CCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHH
Confidence               2378899999999999999999999987 455666666665533  223344678999999999996 899999999


Q ss_pred             HHhcCCCCCC
Q 010626          151 ELLKDPFLVT  160 (505)
Q Consensus       151 ElL~hpff~~  160 (505)
                      |+|+||||++
T Consensus       266 eil~h~~~~~  275 (277)
T d1phka_         266 EALAHPFFQQ  275 (277)
T ss_dssp             HHTTSGGGCT
T ss_pred             HHHcCHHHHH
Confidence            9999999975

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.9e-32  Score=267.01  Aligned_cols=151  Identities=32%  Similarity=0.542  Sum_probs=126.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELYE-   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll~-   76 (505)
                      ..+..|+.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+.....    ......||+.|+|||++. 
T Consensus       104 ~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~  180 (276)
T d1uwha_         104 IKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLH-EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM  180 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-TTSSEEECCCCCSCC------------CCCCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEc-CCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhc
Confidence            467889999999999999999  99999999999998 6789999999999765432    234567999999999883 


Q ss_pred             ---ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC---CCCCCCChHHHHHHHHhcC-CCCCCCCH
Q 010626           77 ---EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA---SLSKVTDPQVKQFIEKCIV-PASLRLPA  149 (505)
Q Consensus        77 ---~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~---~~~~~~s~~l~~LI~kcL~-dP~~RpSa  149 (505)
                         +.|+.++|||||||++|||+||+.||.+......+...+..+..++   ..+..+++.+++||.+||. +|.+|||+
T Consensus       181 ~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~  260 (276)
T d1uwha_         181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLF  260 (276)
T ss_dssp             CSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCH
Confidence               3489999999999999999999999998777777777777765443   3455678999999999995 89999999


Q ss_pred             HHHhcC
Q 010626          150 LELLKD  155 (505)
Q Consensus       150 ~ElL~h  155 (505)
                      .+++++
T Consensus       261 ~~il~~  266 (276)
T d1uwha_         261 PQILAS  266 (276)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.7e-31  Score=266.26  Aligned_cols=157  Identities=29%  Similarity=0.461  Sum_probs=126.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC--CCccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP--TARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~--~~~~~~Gt~~Y~APEll~--~   77 (505)
                      +.++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+.....  ......||+.|+|||++.  .
T Consensus       102 ~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~-~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~  178 (298)
T d1gz8a_         102 PLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK  178 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHHHhhcCC--EEccccCchheeec-ccCcceeccCCcceeccCCcccceeecccceeeehhhhcccc
Confidence            478999999999999999999  99999999999998 6789999999999776543  234458999999999773  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCC--------------------------CCCCCChH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPAS--------------------------LSKVTDPQ  131 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~--------------------------~~~~~s~~  131 (505)
                      .++.++|||||||++|+|++|+.||.+......++..+.....+..                          .....+++
T Consensus       179 ~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  258 (298)
T d1gz8a_         179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDED  258 (298)
T ss_dssp             SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHH
T ss_pred             CCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHH
Confidence            3688999999999999999999999875555555444332111100                          01234678


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      +++||.+||+ +|.+|||+.|+|+||||+..
T Consensus       259 ~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         259 GRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            9999999996 89999999999999999753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-31  Score=272.77  Aligned_cols=158  Identities=23%  Similarity=0.418  Sum_probs=124.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccCC-CCccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~-~   77 (505)
                      .+++.|++||+.||+|||++|  |+||||||+|||++.  ..+.+||+|||+|+..... ......||+.|+|||++. .
T Consensus       111 ~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  188 (335)
T d2ozaa1         111 REASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE  188 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGG
T ss_pred             HHHHHHHHHHHHHHHHHHHcC--CccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCC
Confidence            468999999999999999999  999999999999974  3467999999999876543 345568999999999985 4


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHH---HHHHHHcCCC--CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQ---IYKKVTSGIK--PASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~---i~~~i~~~~~--p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                      .|+.++|||||||++|+|+||+.||.+......   +...+..+..  |......+++++++||.+||+ +|.+|||+.|
T Consensus       189 ~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e  268 (335)
T d2ozaa1         189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE  268 (335)
T ss_dssp             GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence            699999999999999999999999976433222   1122222211  111112468899999999996 8999999999


Q ss_pred             HhcCCCCCCC
Q 010626          152 LLKDPFLVTD  161 (505)
Q Consensus       152 lL~hpff~~~  161 (505)
                      +|+||||+..
T Consensus       269 il~hp~~~~~  278 (335)
T d2ozaa1         269 FMNHPWIMQS  278 (335)
T ss_dssp             HHHSHHHHTT
T ss_pred             HHcCHHhhCC
Confidence            9999999653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.7e-31  Score=269.97  Aligned_cols=150  Identities=25%  Similarity=0.388  Sum_probs=128.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC----ccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA----RSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~----~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+||+++ .++.+||+|||+|+.......    ....||+.|||||++ .
T Consensus       164 ~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  240 (325)
T d1rjba_         164 EDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVT-HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE  240 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EEETTCSGGGEEEE-TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeeccCchhccccc-cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC
Confidence            357889999999999999999  99999999999998 778999999999977644332    244679999999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      +.|+.++|||||||++|||+| |+.||.+......+.+.+..+..+ ..+..+++++++||.+||. +|.+|||+.||++
T Consensus       241 ~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  319 (325)
T d1rjba_         241 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS  319 (325)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            679999999999999999998 899998766666666666665443 4667789999999999996 8999999999987


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      |
T Consensus       320 ~  320 (325)
T d1rjba_         320 F  320 (325)
T ss_dssp             H
T ss_pred             H
Confidence            6

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=2.1e-31  Score=263.37  Aligned_cols=156  Identities=28%  Similarity=0.432  Sum_probs=122.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCccccc--c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYE--E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~--~   77 (505)
                      ..++.+++||+.||+|||++|  |+||||||+|||++ .++.+||+|||.+.......  .....|++.|+|||.+.  .
T Consensus       100 ~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~  176 (286)
T d1ob3a_         100 VTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK  176 (286)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCC
T ss_pred             hhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEc-CCCCEEecccccceecccCccccceecccchhhhHHHHhCCC
Confidence            468899999999999999999  99999999999998 67899999999997765432  34457899999999874  3


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc-CCC-------------------------CCCCCCCCChH
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-GIK-------------------------PASLSKVTDPQ  131 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~-~~~-------------------------p~~~~~~~s~~  131 (505)
                      .++.++|||||||++|||++|+.||.+.....++.+.... +.+                         ........++.
T Consensus       177 ~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  256 (286)
T d1ob3a_         177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDES  256 (286)
T ss_dssp             SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHH
T ss_pred             CCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHH
Confidence            4789999999999999999999999875444443332211 000                         01123445789


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      +++||.+||+ +|.+|||+.|+|+||||++
T Consensus       257 ~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         257 GIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            9999999996 8999999999999999973

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.8e-31  Score=269.67  Aligned_cols=158  Identities=23%  Similarity=0.364  Sum_probs=127.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCcccc--ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELY--EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll--~~~   78 (505)
                      ..++.|++||+.||+|||++|  |+||||||+|||++.+...+||+|||++...... ...+.+||+.|+|||.+  ...
T Consensus       122 ~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  199 (350)
T d1q5ka_         122 IYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD  199 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSS
T ss_pred             HHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccC
Confidence            468899999999999999999  9999999999999855558999999999876443 34556899999999976  346


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc--------------C----CCC--------CCCCCCCChHH
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS--------------G----IKP--------ASLSKVTDPQV  132 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~--------------~----~~p--------~~~~~~~s~~l  132 (505)
                      |+.++||||+||++|||++|+.||.......++...+..              .    ..+        .......++++
T Consensus       200 ~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  279 (350)
T d1q5ka_         200 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEA  279 (350)
T ss_dssp             CCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHH
T ss_pred             CCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHH
Confidence            899999999999999999999999875544444333221              0    000        01123467899


Q ss_pred             HHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          133 KQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       133 ~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      .+||.+||. +|.+|||+.|+|+||||+..
T Consensus       280 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         280 IALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            999999996 89999999999999999753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.97  E-value=6.8e-31  Score=264.61  Aligned_cols=160  Identities=23%  Similarity=0.400  Sum_probs=127.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-CCccccCCCcccCccccc--cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-TARSVIGTPEFMAPELYE--EE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-~~~~~~Gt~~Y~APEll~--~~   78 (505)
                      ..++.+++||+.||+|||++|  |+||||||+|||++..++.+||+|||+|...... .....+||+.|+|||.+.  ..
T Consensus       129 ~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  206 (328)
T d3bqca1         129 YDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM  206 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCC
Confidence            468999999999999999999  9999999999999866667999999999876543 345567999999999873  35


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc-------------C-C---------------------CCCC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS-------------G-I---------------------KPAS  123 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~-------------~-~---------------------~p~~  123 (505)
                      |+.++||||+||++|+|++|..||............+..             . .                     .+..
T Consensus       207 ~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (328)
T d3bqca1         207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSE  286 (328)
T ss_dssp             CCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTT
T ss_pred             CCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhccccc
Confidence            899999999999999999999999775544332222110             0 0                     0111


Q ss_pred             CCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCCCC
Q 010626          124 LSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTDNP  163 (505)
Q Consensus       124 ~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~~~  163 (505)
                      .....++++++||.+||+ +|.+|||++|+|+||||+...+
T Consensus       287 ~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         287 NQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             TGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            123357899999999996 8999999999999999987543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8e-31  Score=262.71  Aligned_cols=155  Identities=26%  Similarity=0.442  Sum_probs=122.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC------CCccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP------TARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~------~~~~~~Gt~~Y~APEll   75 (505)
                      ..++.+++||+.||.|||++|  |+||||||+|||++ .++.+||+|||++......      .....+||+.|+|||++
T Consensus       117 ~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~  193 (318)
T d3blha1         117 SEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL  193 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHhccCC--EEecCcCchheeec-CCCcEEeeecceeeecccccccccccccceecCHHHhhHHHH
Confidence            468899999999999999999  99999999999998 6789999999999765422      23345799999999987


Q ss_pred             c--ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHc---CCCCCCCCC------------------------
Q 010626           76 E--EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTS---GIKPASLSK------------------------  126 (505)
Q Consensus        76 ~--~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~---~~~p~~~~~------------------------  126 (505)
                      .  ..|+.++|||||||++|+|++|+.||.+.. .......+..   ...+.....                        
T Consensus       194 ~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (318)
T d3blha1         194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL  272 (318)
T ss_dssp             TTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHH
T ss_pred             cCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-HHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhh
Confidence            3  458999999999999999999999997643 3333222221   111111000                        


Q ss_pred             ---CCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          127 ---VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       127 ---~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                         ..++.+++||.+||+ +|.+|||+.|+|+||||+.
T Consensus       273 ~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         273 KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             HHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             ccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence               125678899999996 8999999999999999975

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.8e-31  Score=260.99  Aligned_cols=154  Identities=23%  Similarity=0.340  Sum_probs=131.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..|+.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+|+......   .....||+.|+|||++ .+
T Consensus       109 ~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~  185 (272)
T d1qpca_         109 NKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVS-DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG  185 (272)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-TTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--cccCccchhheeee-cccceeeccccceEEccCCccccccccCCcccccChHHHhCC
Confidence            467899999999999999999  99999999999998 77899999999998775432   2345689999999988 46


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc--
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK--  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~--  154 (505)
                      .|+.++|||||||++|||+||..|+.......++...+..+..+. .+..+++++.+||.+||. +|.+|||+.++++  
T Consensus       186 ~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L  264 (272)
T d1qpca_         186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL  264 (272)
T ss_dssp             EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHh
Confidence            699999999999999999997777666677777888887775543 456788999999999996 7999999999998  


Q ss_pred             CCCCC
Q 010626          155 DPFLV  159 (505)
Q Consensus       155 hpff~  159 (505)
                      |+||.
T Consensus       265 ~~~ft  269 (272)
T d1qpca_         265 EDFFT  269 (272)
T ss_dssp             HHHHH
T ss_pred             hhhhh
Confidence            77874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.2e-31  Score=263.96  Aligned_cols=150  Identities=27%  Similarity=0.437  Sum_probs=122.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.|+.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+|+......    .....||+.|+|||++ .
T Consensus       134 ~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~  210 (299)
T d1ywna1         134 EHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD  210 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--CcCCcCCccceeEC-CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc
Confidence            367899999999999999999  99999999999998 67899999999997654322    3345799999999988 5


Q ss_pred             ccCCcccchhhHHHHHHHHhhc-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVTC-EYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlTG-~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      +.|+.++|||||||++|||+|| ..||.+......+...+..+..+ ..+..+++++++||.+||. +|.+|||+.|+++
T Consensus       211 ~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~  289 (299)
T d1ywna1         211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  289 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            5699999999999999999986 56787766666777777776554 4566788999999999996 8999999999998


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      |
T Consensus       290 ~  290 (299)
T d1ywna1         290 H  290 (299)
T ss_dssp             H
T ss_pred             H
Confidence            7

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-30  Score=264.34  Aligned_cols=156  Identities=32%  Similarity=0.434  Sum_probs=126.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc--ccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE--EEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~--~~y   79 (505)
                      ..++.+++||+.||+|||++|  |+||||||+|||++ .++.+|++|||+++..... .....||+.|+|||++.  ..+
T Consensus       121 ~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~-~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~~~~~~  196 (346)
T d1cm8a_         121 DRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVN-EDCELKILDFGLARQADSE-MTGYVVTRWYRAPEVILNWMRY  196 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCSS-CCSSCSCGGGCCTHHHHTTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcc-cccccccccccceeccCCc-cccccccccccCHHHHcCCCCC
Confidence            468899999999999999999  99999999999998 7889999999999876543 44568999999999873  347


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC-------------------------C---CCCCCCCCChH
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI-------------------------K---PASLSKVTDPQ  131 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~-------------------------~---p~~~~~~~s~~  131 (505)
                      +.++||||+||++|+|++|++||.+......+........                         .   ........++.
T Consensus       197 ~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  276 (346)
T d1cm8a_         197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL  276 (346)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHH
T ss_pred             CccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHH
Confidence            8999999999999999999999987543333322211100                         0   01123446789


Q ss_pred             HHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          132 VKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       132 l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      +.+||.+||. +|.+|||+.|+|+||||+..
T Consensus       277 ~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         277 AVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            9999999996 89999999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.7e-31  Score=260.78  Aligned_cols=152  Identities=20%  Similarity=0.354  Sum_probs=127.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll-   75 (505)
                      +.+..|+.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++......     .....||+.|+|||++ 
T Consensus       107 ~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~  183 (277)
T d1xbba_         107 KNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN  183 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE-ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhccc-ccCcccccchhhhhhccccccccccccccCCCceecCchhhc
Confidence            467899999999999999999  99999999999998 77899999999998764432     2234689999999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH-
Q 010626           76 EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL-  152 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El-  152 (505)
                      ...|+.++|||||||++|||+| |+.||.+ ....++...+..+.++ ..+..+++++++||.+||. +|.+|||+.++ 
T Consensus       184 ~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~-~~~~~~~~~i~~~~~~-~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~  261 (277)
T d1xbba_         184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-MKGSEVTAMLEKGERM-GCPAGCPREMYDLMNLCWTYDVENRPGFAAVE  261 (277)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTTCCSSTT-CCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             CCCCCchhhhccchhhhhHHhhCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            5669999999999999999998 8999987 4566777777776554 4566789999999999996 89999999988 


Q ss_pred             --hcCCCC
Q 010626          153 --LKDPFL  158 (505)
Q Consensus       153 --L~hpff  158 (505)
                        |+|+|+
T Consensus       262 ~~L~~~~~  269 (277)
T d1xbba_         262 LRLRNYYY  269 (277)
T ss_dssp             HHHHHHHH
T ss_pred             HHhhCHHh
Confidence              567665

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.5e-30  Score=263.06  Aligned_cols=157  Identities=29%  Similarity=0.424  Sum_probs=124.5

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----CCccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----~~~~~~Gt~~Y~APEll~   76 (505)
                      ..++.+++||+.||+|||++|  |+||||||+|||++ .++.+||+|||++......     .....+||+.|+|||++.
T Consensus       109 ~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~  185 (345)
T d1pmea_         109 DHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML  185 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEC-TTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEEC-CCCCEEEcccCceeeccCCCccceeeccccccceechHHHhh
Confidence            468899999999999999999  99999999999998 7789999999999765332     234557999999999873


Q ss_pred             --ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCC-------------------------C---CCCC
Q 010626           77 --EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKP-------------------------A---SLSK  126 (505)
Q Consensus        77 --~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p-------------------------~---~~~~  126 (505)
                        ..|+.++||||+||++|+|++|+.||............+.....+                         .   ....
T Consensus       186 ~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (345)
T d1pmea_         186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP  265 (345)
T ss_dssp             TBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCT
T ss_pred             cCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCC
Confidence              357899999999999999999999997654333332222110000                         0   0123


Q ss_pred             CCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          127 VTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       127 ~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      ..++++++||.+||. +|.+|||+.|+|+||||+..
T Consensus       266 ~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         266 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            457889999999996 89999999999999999754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.1e-31  Score=267.22  Aligned_cols=157  Identities=24%  Similarity=0.419  Sum_probs=131.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC-CCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-ccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG-NNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~-~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~~~   78 (505)
                      ++++.|++||+.||+|||++|  |+||||||+|||++. ..+.+||+|||+++...... .....||+.|+|||.+ ...
T Consensus       102 ~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~  179 (321)
T d1tkia_         102 REIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDV  179 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCC
Confidence            468899999999999999999  999999999999963 24579999999998765432 4456799999999987 456


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCC--CCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPA--SLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~--~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      |+.++|||||||++|+|++|..||.. .+....+..+..+....  .....+++++++||.+||. +|.+|||+.|+|+|
T Consensus       180 ~~~~~DiWSlGvily~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         180 VSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ECHHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCchhhcccHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            89999999999999999999999986 45666677776654321  2223568999999999996 89999999999999


Q ss_pred             CCCCCC
Q 010626          156 PFLVTD  161 (505)
Q Consensus       156 pff~~~  161 (505)
                      |||++.
T Consensus       259 p~~~~~  264 (321)
T d1tkia_         259 PWLKQK  264 (321)
T ss_dssp             HHHHSC
T ss_pred             HhhccC
Confidence            999753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-30  Score=259.51  Aligned_cols=153  Identities=20%  Similarity=0.390  Sum_probs=129.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll-   75 (505)
                      ..+..++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||+++.+....     .....||+.|+|||++ 
T Consensus       109 ~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  185 (285)
T d1u59a_         109 SNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN  185 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeec-cCCceeeccchhhhcccccccccccccccccCccccChHHHh
Confidence            467899999999999999999  99999999999998 67899999999998765432     2234688999999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHH-
Q 010626           76 EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALEL-  152 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~El-  152 (505)
                      .+.|+.++|||||||++|||+| |+.||.+.. ..++...+..+..+ ..+..+++++.+||.+||. +|.+|||+.++ 
T Consensus       186 ~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~-~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~  263 (285)
T d1u59a_         186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-GPEVMAFIEQGKRM-ECPPECPPELYALMSDCWIYKWEDRPDFLTVE  263 (285)
T ss_dssp             HCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-THHHHHHHHTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             CCCCCccchhhcchHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCCC-CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence            4679999999999999999998 899998754 55667777777654 4566789999999999996 89999999877 


Q ss_pred             --hcCCCCC
Q 010626          153 --LKDPFLV  159 (505)
Q Consensus       153 --L~hpff~  159 (505)
                        |+|+|+.
T Consensus       264 ~~L~~~~~~  272 (285)
T d1u59a_         264 QRMRACYYS  272 (285)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHH
Confidence              6778764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-30  Score=255.41  Aligned_cols=150  Identities=20%  Similarity=0.400  Sum_probs=118.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCccccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELYE-E   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll~-~   77 (505)
                      +.+..|+.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+++......   .....||+.|+|||++. .
T Consensus       101 ~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~  177 (263)
T d1sm2a_         101 ETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS  177 (263)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEEC-GGGCEEECSCC------------------CTTSCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHhhhccc--eeecccchhheeec-CCCCeEecccchheeccCCCceeecceecCcccCChHHhcCC
Confidence            457789999999999999999  99999999999998 67899999999997764432   22356899999999884 5


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .|+.++|||||||++|||+|+..|+....+..++...+..+..+ ..+..+++++.+||.+||. +|.+|||+.++++|
T Consensus       178 ~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC-CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            69999999999999999999655555556777788888777554 3566778999999999996 79999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.9e-31  Score=264.50  Aligned_cols=166  Identities=26%  Similarity=0.421  Sum_probs=132.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC---CCccccCCCcccCcccccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELYEE-   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~---~~~~~~Gt~~Y~APEll~~-   77 (505)
                      ..++.+++||+.||.|||++|  |+||||||+||+++ .+|.+||+|||+++.+...   ......|++.|+|||.+.. 
T Consensus       129 ~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~-~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~  205 (322)
T d1vzoa_         129 HEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLD-SNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG  205 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeec-CCCCEEEeeccchhhhcccccccccccccccccchhHHhhcC
Confidence            367889999999999999999  99999999999998 6789999999999876432   2345679999999998732 


Q ss_pred             --cCCcccchhhHHHHHHHHhhcCCCCCCCC---ChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCC----
Q 010626           78 --EYNELVDIYSFGMCILEMVTCEYPYNECK---NPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRL----  147 (505)
Q Consensus        78 --~ys~ksDIWSLGviLyEmlTG~~Pf~~~~---~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~Rp----  147 (505)
                        .++.++|||||||++|+|+||+.||....   ....+.......  ...++..+++++++||.+||. +|.+||    
T Consensus       206 ~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~  283 (322)
T d1vzoa_         206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP  283 (322)
T ss_dssp             C---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSST
T ss_pred             CcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCc
Confidence              47889999999999999999999996643   223334433333  233556789999999999996 799999    


Q ss_pred             -CHHHHhcCCCCCCCCCCCcccCCCC
Q 010626          148 -PALELLKDPFLVTDNPKDLVCDPLR  172 (505)
Q Consensus       148 -Sa~ElL~hpff~~~~~~~l~~~~l~  172 (505)
                       |++|+|+||||+..++..+....+.
T Consensus       284 ~t~~eil~Hpff~~i~~~~l~~~~~~  309 (322)
T d1vzoa_         284 RDADEIKEHLFFQKINWDDLAAKKVP  309 (322)
T ss_dssp             TTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred             ccHHHHHcCHhhcCCCHHHHHhCCCC
Confidence             5899999999998776665554444

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.3e-30  Score=252.03  Aligned_cols=156  Identities=24%  Similarity=0.428  Sum_probs=127.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC--CccccCCCcccCcccccc--
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT--ARSVIGTPEFMAPELYEE--   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~--~~~~~Gt~~Y~APEll~~--   77 (505)
                      ..++.+++|++.||+|||++|  |+||||||+|||++ .++.+||+|||.+.......  .....+++.|+|||++..  
T Consensus       101 ~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~  177 (292)
T d1unla_         101 EIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK  177 (292)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEC-TTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCS
T ss_pred             hHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccc-cCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCC
Confidence            468899999999999999999  99999999999998 67899999999998765432  233467889999998743  


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCC---------------------------CCCCCCCCCCh
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGI---------------------------KPASLSKVTDP  130 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~---------------------------~p~~~~~~~s~  130 (505)
                      .++.++|||||||++|+|++|+.||....+..+....+....                           .........++
T Consensus       178 ~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  257 (292)
T d1unla_         178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNA  257 (292)
T ss_dssp             CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCH
T ss_pred             CCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCH
Confidence            378999999999999999999999877677666655543210                           01112234578


Q ss_pred             HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                      .+++||.+||+ +|.+|||++|+|+||||+.
T Consensus       258 ~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~  288 (292)
T d1unla_         258 TGRDLLQNLLKCNPVQRISAEEALQHPYFSD  288 (292)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence            99999999996 8999999999999999975

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.9e-30  Score=254.93  Aligned_cols=149  Identities=23%  Similarity=0.350  Sum_probs=121.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll-   75 (505)
                      ..+..++.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+++......     .....||+.|+|||++ 
T Consensus       110 ~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~  186 (283)
T d1mqba_         110 LQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS  186 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC-----------------CCCGGGSCHHHHH
T ss_pred             HHHHHHHHHHHHhhhhccccc--cccCccccceEEEC-CCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHc
Confidence            357889999999999999999  99999999999998 78899999999998764322     2234689999999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .+.|+.++|||||||++|||++|..||.......++...+..+..++ .+..+++.+.+||.+||. +|.+|||+.|+++
T Consensus       187 ~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         187 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP-TPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC-CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            55799999999999999999997777766677888888888776554 456678999999999995 7999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=4.8e-30  Score=256.72  Aligned_cols=149  Identities=23%  Similarity=0.372  Sum_probs=116.7

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-------CccccCCCcccCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-------ARSVIGTPEFMAPEL   74 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-------~~~~~Gt~~Y~APEl   74 (505)
                      ..+..|+.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++......       .....||+.|+|||+
T Consensus       128 ~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~  204 (299)
T d1jpaa_         128 IQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVN-SNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA  204 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCC-----------------------CGGGSCHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhCC--CccCccccceEEEC-CCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHH
Confidence            357889999999999999999  99999999999998 77899999999998764322       112357899999998


Q ss_pred             c-cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHH
Q 010626           75 Y-EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALE  151 (505)
Q Consensus        75 l-~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~E  151 (505)
                      + .+.|+.++|||||||++|||+| |+.||.+ ....++...+..+..++ .+..+++.+.+||.+||. +|.+|||+.|
T Consensus       205 ~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~-~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~e  282 (299)
T d1jpaa_         205 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-MTNQDVINAIEQDYRLP-PPMDCPSALHQLMLDCWQKDRNHRPKFGQ  282 (299)
T ss_dssp             HHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTTCCCC-CCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             HhcCCCCcccccccchHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence            8 4679999999999999999998 8999987 45566777777765443 456678999999999995 8999999999


Q ss_pred             HhcC
Q 010626          152 LLKD  155 (505)
Q Consensus       152 lL~h  155 (505)
                      ++++
T Consensus       283 i~~~  286 (299)
T d1jpaa_         283 IVNT  286 (299)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8765

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.96  E-value=2.5e-30  Score=257.31  Aligned_cols=148  Identities=24%  Similarity=0.344  Sum_probs=127.3

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCC---ccccCCCcccCcccc-ccc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTA---RSVIGTPEFMAPELY-EEE   78 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~---~~~~Gt~~Y~APEll-~~~   78 (505)
                      .++.++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++.......   ....|++.|+|||++ .+.
T Consensus       116 ~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~-~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~  192 (287)
T d1opja_         116 VLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK  192 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHHHCC--cccCccccCeEEEC-CCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCC
Confidence            57889999999999999999  99999999999998 678999999999987654332   223578999999987 567


Q ss_pred             CCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           79 YNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        79 ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      |+.++|||||||++|||++|..||....+..+++..+..+..+ ..+..+++.+++||.+||. +|.+|||+.++++
T Consensus       193 ~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC-CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999888877767788888877776554 4566788999999999996 8999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.6e-30  Score=254.99  Aligned_cols=156  Identities=21%  Similarity=0.319  Sum_probs=128.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..+..++.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++......   .....||+.|+|||.+ .+
T Consensus       113 ~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  189 (285)
T d1fmka3         113 PQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG  189 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCCTTC--------------CCGGGSCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHhhhh--eecccccceEEEEC-CCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCC
Confidence            467899999999999999999  99999999999998 67899999999997664332   2335689999999988 56


Q ss_pred             cCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc--
Q 010626           78 EYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK--  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~--  154 (505)
                      .++.++|||||||++|||+||..||.......++...+..+..+. .+..+++++++||.+||. +|.+||++.+++.  
T Consensus       190 ~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L  268 (285)
T d1fmka3         190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL  268 (285)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence            799999999999999999998777766677788888887765543 566788999999999996 8999999999988  


Q ss_pred             CCCCCCC
Q 010626          155 DPFLVTD  161 (505)
Q Consensus       155 hpff~~~  161 (505)
                      ++||...
T Consensus       269 ~~~~~~~  275 (285)
T d1fmka3         269 EDYFTST  275 (285)
T ss_dssp             HTTTSCS
T ss_pred             hhhhcCC
Confidence            8888653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.5e-30  Score=249.93  Aligned_cols=149  Identities=21%  Similarity=0.413  Sum_probs=128.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC---CccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT---ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~---~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..+++++.||+.||+|||++|  |+||||||+||+++ .++.+||+|||+++......   .....||+.|+|||++ ..
T Consensus       100 ~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  176 (258)
T d1k2pa_         100 QQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS  176 (258)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEEC-TTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEc-CCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCC
Confidence            357889999999999999999  99999999999998 77899999999997664432   2234689999999988 46


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .|+.++|||||||++|||+| |+.||... +..++...+..+.++ ..+...++++++||.+||. +|.+|||+.++|+|
T Consensus       177 ~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         177 KFSSKSDIWAFGVLMWEIYSLGKMPYERF-TNSETAEHIAQGLRL-YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCcceeecccchhhHhHHhcCCCCCCCC-CHHHHHHHHHhCCCC-CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            79999999999999999998 89999874 566777778776544 4667788999999999996 79999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.1e-30  Score=253.07  Aligned_cols=149  Identities=26%  Similarity=0.455  Sum_probs=117.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC---CCccccCCCcccCcccc-cc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP---TARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~---~~~~~~Gt~~Y~APEll-~~   77 (505)
                      ..++.++.||+.||.|||+++  |+||||||+||+++ .++.+||+|||+++.....   ......||+.|+|||++ .+
T Consensus       108 ~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~-~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~  184 (273)
T d1mp8a_         108 ASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR  184 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-ETTEEEECC-------------------CCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHhhhhcccC--eeccccchhheeec-CCCcEEEccchhheeccCCcceeccceecCcccchhhHhccC
Confidence            467889999999999999999  99999999999998 6789999999999876432   22344689999999988 46


Q ss_pred             cCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           78 EYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .|+.++|||||||++|||+| |.+||.. .+..+++..+..+..+ .++..+++.+++||.+||. +|.+|||+.|+++|
T Consensus       185 ~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         185 RFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRIENGERL-PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            79999999999999999998 8888876 4556677777776554 4566789999999999996 89999999999876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.2e-30  Score=258.72  Aligned_cols=150  Identities=27%  Similarity=0.449  Sum_probs=125.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      +.++.|+.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++......    .....||+.|+|||++ .
T Consensus       111 ~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~  187 (317)
T d1xkka_         111 QYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH  187 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEE-ETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeC-CCCCeEeeccccceecccccccccccccccCccccChHHHhc
Confidence            357889999999999999999  99999999999998 67899999999998764322    2234689999999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      +.|+.++|||||||++|||+| |+.||.+ ....++...+..+..+ ..+..+++.+.+||.+||. +|.+|||+.|++.
T Consensus       188 ~~~~~~sDvwS~Gvil~el~t~g~~p~~~-~~~~~~~~~i~~~~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~  265 (317)
T d1xkka_         188 RIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERL-PQPPICTIDVYMIMVKCWMIDADSRPKFRELII  265 (317)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCGGGHHHHHHHTCCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCChhhhhhhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCC-CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHH
Confidence            679999999999999999998 7888876 4556677777776554 3456678999999999996 8999999999998


Q ss_pred             CC
Q 010626          155 DP  156 (505)
Q Consensus       155 hp  156 (505)
                      |.
T Consensus       266 ~l  267 (317)
T d1xkka_         266 EF  267 (317)
T ss_dssp             HH
T ss_pred             HH
Confidence            83

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.96  E-value=1.2e-29  Score=250.12  Aligned_cols=154  Identities=23%  Similarity=0.405  Sum_probs=116.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC-----CCccccCCCcccCccccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP-----TARSVIGTPEFMAPELYE   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~-----~~~~~~Gt~~Y~APEll~   76 (505)
                      ++++.|++||+.||+|||++|  |+||||||+|||++ .++.++++|||.+......     .....+||+.|+|||++.
T Consensus       111 ~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~  187 (277)
T d1o6ya_         111 KRAIEVIADACQALNFSHQNG--IIHRDVKPANIMIS-ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR  187 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE-TTSCEEECCCTTCEECC----------------TTCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccC-ccccceeehhhhhhhhccccccccccccccCcccccCHHHHc
Confidence            468899999999999999999  99999999999998 6789999999998765332     234557999999999885


Q ss_pred             -ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           77 -EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIK-PASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        77 -~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~-p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                       ..|+.++|||||||++|+|+||+.||.+..........+..... +......+++.+++||.+||. +|.+||+..+.|
T Consensus       188 ~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l  267 (277)
T d1o6ya_         188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM  267 (277)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred             CCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHH
Confidence             45999999999999999999999999875444444444444433 234456678999999999996 799999444444


Q ss_pred             cCCCC
Q 010626          154 KDPFL  158 (505)
Q Consensus       154 ~hpff  158 (505)
                      .|+|.
T Consensus       268 ~~~l~  272 (277)
T d1o6ya_         268 RADLV  272 (277)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            45554

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4e-29  Score=246.87  Aligned_cols=149  Identities=25%  Similarity=0.380  Sum_probs=122.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-----CccccCCCcccCcccc-
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-----ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-----~~~~~Gt~~Y~APEll-   75 (505)
                      ..+..++.||+.||.|||++|  |+||||||+||+++ .++.+||+|||+++......     .....|++.|+|||++ 
T Consensus       111 ~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~-~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  187 (273)
T d1u46a_         111 GTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK  187 (273)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEE-ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccc-cccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHh
Confidence            467899999999999999999  99999999999998 67899999999998764432     2233578899999988 


Q ss_pred             cccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHh
Q 010626           76 EEEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELL  153 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL  153 (505)
                      ...|+.++|||||||++|||+| |+.||.+ .+.......+.........+..+++.+++||.+||. +|.+|||+.+++
T Consensus       188 ~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             HCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            4568999999999999999998 8999987 455566666655544445667788999999999996 899999999986


Q ss_pred             c
Q 010626          154 K  154 (505)
Q Consensus       154 ~  154 (505)
                      +
T Consensus       267 ~  267 (273)
T d1u46a_         267 D  267 (273)
T ss_dssp             H
T ss_pred             H
Confidence            3

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=2.9e-29  Score=250.53  Aligned_cols=147  Identities=22%  Similarity=0.333  Sum_probs=123.5

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCC----CCccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQP----TARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~----~~~~~~Gt~~Y~APEll-~~   77 (505)
                      .+..+++||+.||+|||+++  ++||||||+|||++ .++.+||+|||+++.....    ...+..|++.|+|||++ ..
T Consensus       141 ~~~~i~~qi~~gl~ylH~~~--ivHrDlKp~NILld-~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  217 (301)
T d1lufa_         141 EQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVG-ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN  217 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHhhhcccCC--eEeeEEcccceEEC-CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC
Confidence            57889999999999999999  99999999999998 6789999999999765332    22345688999999988 55


Q ss_pred             cCCcccchhhHHHHHHHHhhcCC-CCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVTCEY-PYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~~-Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .|+.++|||||||++|||++|.. ||.+ .+..++...+..+..+ ..+..+++++.+||.+||. +|.+|||+.|+++
T Consensus       218 ~~t~ksDVwS~Gvvl~ell~~~~~p~~~-~~~~e~~~~v~~~~~~-~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         218 RYTTESDVWAYGVVLWEIFSYGLQPYYG-MAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             CCCHHHHHHHHHHHHHHHHTTTCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCChhhhhccchhhHHHHHccCCCCCCC-CCHHHHHHHHHcCCCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            79999999999999999999865 5554 6777778888877654 4566778999999999996 8999999999865

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.4e-29  Score=256.48  Aligned_cols=155  Identities=31%  Similarity=0.436  Sum_probs=120.3

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCccccc-c-cC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYE-E-EY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~-~-~y   79 (505)
                      ..++.+++||+.||+|||++|  |+||||||+|||++ .+|.+|++|||++..... ......|++.|+|||++. . .+
T Consensus       121 ~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~-~~~~~kl~dfg~a~~~~~-~~~~~~g~~~y~apE~~~~~~~~  196 (348)
T d2gfsa1         121 DHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN-EDCELKILDFGLARHTDD-EMTGYVATRWYRAPEIMLNWMHY  196 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC-TTCCEEECCC----CCTG-GGSSSCHHHHTSCHHHHTTCSCC
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--CcccccCCcccccc-ccccccccccchhcccCc-ccccccccccccCchhhcCCccC
Confidence            478999999999999999999  99999999999998 778999999999966543 234567899999999763 3 46


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcC-CCC--------------------CC--------CCCCCCh
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSG-IKP--------------------AS--------LSKVTDP  130 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~-~~p--------------------~~--------~~~~~s~  130 (505)
                      +.++|||||||++|+|++|+.||.+.... .....+... ..+                    ..        .....++
T Consensus       197 ~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  275 (348)
T d2gfsa1         197 NQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP  275 (348)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCH
T ss_pred             CcccchhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCH
Confidence            89999999999999999999999874333 322222211 000                    00        1124578


Q ss_pred             HHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          131 QVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       131 ~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                      ++++||.+||. +|.+|||+.|+|+||||+..
T Consensus       276 ~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         276 LAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            99999999996 89999999999999999863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.2e-28  Score=246.08  Aligned_cols=148  Identities=27%  Similarity=0.436  Sum_probs=127.2

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..++.|+.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+++......    .....|++.|+|||.+ .
T Consensus       135 ~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~  211 (299)
T d1fgka_         135 KDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD  211 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeec-CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC
Confidence            467899999999999999999  99999999999998 77899999999998764432    2345789999999987 5


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      +.|+.++|||||||++|||++ |..||.+ .+..+++..+..+..+ ..+...++.+++||.+||. +|.+|||+.|+++
T Consensus       212 ~~y~~k~DiwS~Gvvl~ell~~g~~p~~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTSCCSSTT-CCHHHHHHHHHTTCCC-CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCchhhhHHhHHHHHHhccCCCCCCCC-CCHHHHHHHHHcCCCC-CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            679999999999999999998 6777765 6677788888776554 4567788999999999996 8999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.8e-29  Score=247.73  Aligned_cols=150  Identities=25%  Similarity=0.339  Sum_probs=125.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      ..+.+++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+++...... .....||+.|+|||.+ .+.|
T Consensus       127 ~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~-~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~  203 (309)
T d1fvra_         127 QQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY  203 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEE
T ss_pred             HHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEc-CCCceEEccccccccccccccccceecCCcccchHHhccCCC
Confidence            357889999999999999999  99999999999998 67899999999997654332 2345689999999988 5679


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      +.++|||||||++|||++|..|+....+..+++..+..+..+ ..+..+++++++||.+||. +|.+|||+.|++++
T Consensus       204 ~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         204 TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC-CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999765444446788888888877655 3556778999999999996 89999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.2e-29  Score=253.64  Aligned_cols=156  Identities=29%  Similarity=0.392  Sum_probs=115.0

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC-CccccCCCcccCcccc-cccC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT-ARSVIGTPEFMAPELY-EEEY   79 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~-~~~~~Gt~~Y~APEll-~~~y   79 (505)
                      +.++.+++||+.||+|||++|  |+||||||+|||++ .++.+|++|||+++...... .....||+.|+|||++ ...|
T Consensus       119 ~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~-~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~  195 (355)
T d2b1pa1         119 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY  195 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC-TTCCEEECCCCC---------------CCTTCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHhhhcc--cccccCCccccccc-cccceeeechhhhhccccccccccccccccccChhhhcCCCC
Confidence            578999999999999999999  99999999999998 67899999999987665433 3455799999999988 4569


Q ss_pred             CcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHH---------------------cCCCCCC------------C--
Q 010626           80 NELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVT---------------------SGIKPAS------------L--  124 (505)
Q Consensus        80 s~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~---------------------~~~~p~~------------~--  124 (505)
                      +.++||||+||++|+|++|+.||.+..........+.                     ....+..            .  
T Consensus       196 ~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (355)
T d2b1pa1         196 KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPA  275 (355)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCC
T ss_pred             CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccc
Confidence            9999999999999999999999976443332222211                     1100000            0  


Q ss_pred             ----CCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCC
Q 010626          125 ----SKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVT  160 (505)
Q Consensus       125 ----~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~  160 (505)
                          ....++++++||.+||. +|.+||||+|+|+||||+.
T Consensus       276 ~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~  316 (355)
T d2b1pa1         276 DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  316 (355)
T ss_dssp             SSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             cccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                00124678999999996 8999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.1e-28  Score=246.18  Aligned_cols=149  Identities=23%  Similarity=0.344  Sum_probs=123.6

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCCcccCcccc-
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTPEFMAPELY-   75 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~~Y~APEll-   75 (505)
                      .+..++.||+.||.|||+.+  |+||||||+|||++ .++.+||+|||+++......      .....||+.|+|||.+ 
T Consensus       131 ~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~-~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  207 (311)
T d1r0pa_         131 DLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ  207 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHH
T ss_pred             HHHHHHHHHHHhhhhhcccC--cccCCccHHhEeEC-CCCCEEEecccchhhccccccccceecccccccccccChHHHh
Confidence            56789999999999999999  99999999999998 77899999999998764322      2234689999999987 


Q ss_pred             cccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           76 EEEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        76 ~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .+.++.++||||||+++|||+||..||....+..++...+..+..+ ..+..+++.+.+||.+||. +|.+||++.|+++
T Consensus       208 ~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~-~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  286 (311)
T d1r0pa_         208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  286 (311)
T ss_dssp             HCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC-CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            5679999999999999999999888887766666777777777555 3566778999999999996 8999999999998


Q ss_pred             C
Q 010626          155 D  155 (505)
Q Consensus       155 h  155 (505)
                      |
T Consensus       287 ~  287 (311)
T d1r0pa_         287 R  287 (311)
T ss_dssp             H
T ss_pred             H
Confidence            7

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.4e-28  Score=239.08  Aligned_cols=148  Identities=23%  Similarity=0.440  Sum_probs=120.1

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccc-cccCC
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY-EEEYN   80 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll-~~~ys   80 (505)
                      ..+++|+.||+.||.|||+++  |+||||||+||+++ .++.+||+|||+++..... .....+++.|+|||++ .+.|+
T Consensus       103 ~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~-~~~~~kl~dfg~s~~~~~~-~~~~~~~~~y~aPE~l~~~~~t  178 (262)
T d1byga_         103 DCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVS-EDNVAKVSDFGLTKEASST-QDTGKLPVKWTAPEALREKKFS  178 (262)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC-TTSCEEECCCCC-------------CCTTTSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHhhccccccCc--eeccccchHhheec-CCCCEeecccccceecCCC-CccccccccCCChHHHhCCCCC
Confidence            357899999999999999999  99999999999998 7889999999999765443 3445689999999987 56799


Q ss_pred             cccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626           81 ELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus        81 ~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      .++|||||||++|||+| |..||.. ....++...+..+..+. ++...++++++||.+||. +|.+|||+.+++++
T Consensus       179 ~~sDIwSfG~il~el~t~~~~p~~~-~~~~~~~~~i~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         179 TKSDVWSFGILLWEIYSFGRVPYPR-IPLKDVVPRVEKGYKMD-APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSCTT-SCGGGHHHHHTTTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHhHHHHHHHHHHCCCCCCCC-CCHHHHHHHHHcCCCCC-CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            99999999999999998 6777765 56677788887776654 566788999999999996 79999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.3e-28  Score=243.99  Aligned_cols=147  Identities=24%  Similarity=0.418  Sum_probs=124.6

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-cc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-EE   77 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~~   77 (505)
                      .+.+++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||+++......    .....||+.|+|||.+ .+
T Consensus       134 ~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld-~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~  210 (308)
T d1p4oa_         134 KMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVA-EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG  210 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEEC-TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeec-CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccC
Confidence            56789999999999999999  99999999999998 77899999999997664322    2334689999999988 55


Q ss_pred             cCCcccchhhHHHHHHHHhhcC-CCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           78 EYNELVDIYSFGMCILEMVTCE-YPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        78 ~ys~ksDIWSLGviLyEmlTG~-~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      .|+.++||||||+++|||+||. .||.+ .+..+++..+..+..+ ..+..+++.+.+||.+||. +|.+|||+.++++
T Consensus       211 ~~~~~~Dv~S~G~il~El~t~~~~p~~~-~~~~~~~~~i~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         211 VFTTYSDVWSFGVVLWEIATLAEQPYQG-LSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHTSCCTTTT-SCHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccccccHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHhCCCC-CCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6899999999999999999985 56654 6777777777776554 3556778999999999996 8999999999997

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=5e-28  Score=242.75  Aligned_cols=149  Identities=23%  Similarity=0.402  Sum_probs=123.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC----CccccCCCcccCcccc-c
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT----ARSVIGTPEFMAPELY-E   76 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~----~~~~~Gt~~Y~APEll-~   76 (505)
                      ..+..|+.||+.||+|||+++  ++||||||+||+++ .++.+|++|||+++......    .....||+.|+|||++ .
T Consensus       145 ~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~~-~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  221 (311)
T d1t46a_         145 EDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN  221 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE-TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCC--eeeccccccccccc-ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC
Confidence            367889999999999999999  99999999999998 67899999999998765432    2335789999999988 4


Q ss_pred             ccCCcccchhhHHHHHHHHhh-cCCCCCCCCChHHHHHHHHcCCCCCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhc
Q 010626           77 EEYNELVDIYSFGMCILEMVT-CEYPYNECKNPAQIYKKVTSGIKPASLSKVTDPQVKQFIEKCIV-PASLRLPALELLK  154 (505)
Q Consensus        77 ~~ys~ksDIWSLGviLyEmlT-G~~Pf~~~~~~~~i~~~i~~~~~p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~  154 (505)
                      +.++.++|||||||++|||+| |.+||........+.+.+..+.++ ..+...++.+.+||.+||. +|.+|||+.++++
T Consensus       222 ~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            668999999999999999999 555565555555566666666544 4556678999999999996 8999999999885

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=1e-27  Score=238.23  Aligned_cols=156  Identities=22%  Similarity=0.325  Sum_probs=119.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC--CCCcEEEeecCceeeccCCC---------CccccCCCccc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG--NNGEVKIGDLGLAIVMQQPT---------ARSVIGTPEFM   70 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~--~~g~vKL~DFGlA~~~~~~~---------~~~~~Gt~~Y~   70 (505)
                      ..+..++.||+.||+|||++|  |+||||||+|||++.  .+..+||+|||+|+.+....         .....||+.|+
T Consensus       103 ~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~  180 (299)
T d1ckia_         103 KTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA  180 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSC
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCcccc
Confidence            468899999999999999999  999999999999853  34579999999998764322         23457999999


Q ss_pred             Cccccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCCChHHH--HHHHHc---CCCCCCCCCCCChHHHHHHHHhcC-CC
Q 010626           71 APELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECKNPAQI--YKKVTS---GIKPASLSKVTDPQVKQFIEKCIV-PA  143 (505)
Q Consensus        71 APEll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~~~i--~~~i~~---~~~p~~~~~~~s~~l~~LI~kcL~-dP  143 (505)
                      |||++. ..|+.++|||||||++|||+||+.||.........  +.....   ..+.......+++++.+||.+||. +|
T Consensus       181 aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p  260 (299)
T d1ckia_         181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRF  260 (299)
T ss_dssp             CHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCT
T ss_pred             CHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCCh
Confidence            999884 45999999999999999999999999764432221  111111   112223345678999999999994 89


Q ss_pred             CCCCCHH---HHhcCCCCC
Q 010626          144 SLRLPAL---ELLKDPFLV  159 (505)
Q Consensus       144 ~~RpSa~---ElL~hpff~  159 (505)
                      .+||++.   ++|+|+|.+
T Consensus       261 ~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         261 DDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             TCCCCHHHHHHHHHHHHHH
T ss_pred             hHCcCHHHHHHHHHHHHHH
Confidence            9999986   557777654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.94  E-value=1e-27  Score=243.08  Aligned_cols=157  Identities=25%  Similarity=0.400  Sum_probs=117.8

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCCCeEecCCCCCcEEEeCCCC-----cEEEeecCceeeccCCCCccccCCCcccCcccc
Q 010626            2 KAIKNWARQILRGLHYLHS-HNPPIIHRDLKCDNIFVNGNNG-----EVKIGDLGLAIVMQQPTARSVIGTPEFMAPELY   75 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs-~g~~IiHrDLKp~NILld~~~g-----~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll   75 (505)
                      ..++.+++||+.||+|||+ +|  |+||||||+|||++....     .++++|||.+...... ....+||+.|+|||++
T Consensus       125 ~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-~~~~~gt~~y~aPE~~  201 (362)
T d1q8ya_         125 IYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-YTNSIQTREYRSPEVL  201 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-CCSCCSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccCcccccceeeEeecccccccccc-cccccccccccChhhc
Confidence            4689999999999999998 88  999999999999973221     4899999999776543 3556899999999977


Q ss_pred             -cccCCcccchhhHHHHHHHHhhcCCCCCCCCCh------HHHHHHHHc-CC--------------------C-------
Q 010626           76 -EEEYNELVDIYSFGMCILEMVTCEYPYNECKNP------AQIYKKVTS-GI--------------------K-------  120 (505)
Q Consensus        76 -~~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~~~------~~i~~~i~~-~~--------------------~-------  120 (505)
                       ...|+.++||||+||++++|++|+.||......      ..+...+.. +.                    .       
T Consensus       202 ~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (362)
T d1q8ya_         202 LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL  281 (362)
T ss_dssp             HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCC
T ss_pred             cccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccc
Confidence             566999999999999999999999999643211      111111100 00                    0       


Q ss_pred             -----------CCCCCCCCChHHHHHHHHhcC-CCCCCCCHHHHhcCCCCCCC
Q 010626          121 -----------PASLSKVTDPQVKQFIEKCIV-PASLRLPALELLKDPFLVTD  161 (505)
Q Consensus       121 -----------p~~~~~~~s~~l~~LI~kcL~-dP~~RpSa~ElL~hpff~~~  161 (505)
                                 ...+....++.+++||.+||. +|.+|||+.|+|+||||+..
T Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~  334 (362)
T d1q8ya_         282 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT  334 (362)
T ss_dssp             CBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred             cCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence                       001112235689999999996 89999999999999999853

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.93  E-value=2e-26  Score=229.05  Aligned_cols=150  Identities=17%  Similarity=0.270  Sum_probs=117.8

Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeC----CCCcEEEeecCceeeccCC---------CCccccCCCc
Q 010626            2 KAIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNG----NNGEVKIGDLGLAIVMQQP---------TARSVIGTPE   68 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~----~~g~vKL~DFGlA~~~~~~---------~~~~~~Gt~~   68 (505)
                      ..+..++.|++.||+|||++|  |+||||||+||+++.    ..+.+||+|||+|+.....         .....+||+.
T Consensus       101 ~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~  178 (293)
T d1csna_         101 KTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR  178 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTT
T ss_pred             HHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchh
Confidence            467889999999999999999  999999999999963    2568999999999876432         2334579999


Q ss_pred             ccCccccc-ccCCcccchhhHHHHHHHHhhcCCCCCCCC--ChHHHHHHHHcC---CCCCCCCCCCChHHHHHHHHhcC-
Q 010626           69 FMAPELYE-EEYNELVDIYSFGMCILEMVTCEYPYNECK--NPAQIYKKVTSG---IKPASLSKVTDPQVKQFIEKCIV-  141 (505)
Q Consensus        69 Y~APEll~-~~ys~ksDIWSLGviLyEmlTG~~Pf~~~~--~~~~i~~~i~~~---~~p~~~~~~~s~~l~~LI~kcL~-  141 (505)
                      |||||++. ..|+.++|||||||++|||+||+.||.+..  .....+..+...   ..+..+...+++++.+|+..|+. 
T Consensus       179 y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~  258 (293)
T d1csna_         179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNL  258 (293)
T ss_dssp             TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHC
T ss_pred             hcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcC
Confidence            99999884 459999999999999999999999997533  233333333322   12222345567899999999994 


Q ss_pred             CCCCCCCHHHHh
Q 010626          142 PASLRLPALELL  153 (505)
Q Consensus       142 dP~~RpSa~ElL  153 (505)
                      +|.+||+...+.
T Consensus       259 ~~~~rP~y~~l~  270 (293)
T d1csna_         259 AFDATPDYDYLQ  270 (293)
T ss_dssp             CTTCCCCHHHHH
T ss_pred             CcccCcCHHHHH
Confidence            899999876654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.2e-26  Score=232.00  Aligned_cols=151  Identities=28%  Similarity=0.394  Sum_probs=113.2

Q ss_pred             HHHHHHHHHHHHHHHHHHh--------CCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCC------CccccCCC
Q 010626            2 KAIKNWARQILRGLHYLHS--------HNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPT------ARSVIGTP   67 (505)
Q Consensus         2 k~I~~ia~QIl~gL~yLHs--------~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~------~~~~~Gt~   67 (505)
                      +.+..++.|++.||+|||+        +|  |+||||||+|||++ .++.+||+|||+++......      .....||+
T Consensus       100 ~~~~~~~~~ia~gl~~lH~~~~~~~~~~~--IvHrDlKp~NILl~-~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~  176 (303)
T d1vjya_         100 EGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK  176 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCCGGGEEEC-TTSCEEECCCTTCEEEETTTTEECC----CCSCG
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhhhccCCC--eeccccCccceEEc-CCCCeEEEecCccccccCCCcceeccccceeccc
Confidence            3567899999999999997        46  99999999999998 77899999999998764322      23457999


Q ss_pred             cccCcccccc-------cCCcccchhhHHHHHHHHhhcCCCCCCC--------------CChHHHHHHHHcCCCCCCCCC
Q 010626           68 EFMAPELYEE-------EYNELVDIYSFGMCILEMVTCEYPYNEC--------------KNPAQIYKKVTSGIKPASLSK  126 (505)
Q Consensus        68 ~Y~APEll~~-------~ys~ksDIWSLGviLyEmlTG~~Pf~~~--------------~~~~~i~~~i~~~~~p~~~~~  126 (505)
                      .|+|||++..       .++.++|||||||++|||+||..||...              .....+...+......+.++.
T Consensus       177 ~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~  256 (303)
T d1vjya_         177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN  256 (303)
T ss_dssp             GGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred             CcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCc
Confidence            9999998843       2577899999999999999998776321              122333444433332222322


Q ss_pred             CC-----ChHHHHHHHHhcC-CCCCCCCHHHHhcC
Q 010626          127 VT-----DPQVKQFIEKCIV-PASLRLPALELLKD  155 (505)
Q Consensus       127 ~~-----s~~l~~LI~kcL~-dP~~RpSa~ElL~h  155 (505)
                      ..     ...+.+|+.+||+ +|.+|||+.|++++
T Consensus       257 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         257 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            21     2358899999996 79999999999764

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.24  E-value=8e-13  Score=121.51  Aligned_cols=84  Identities=18%  Similarity=0.152  Sum_probs=61.2

Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCeEecCCCCCcEEEeCCCCcEEEeecCceeeccCCCCccccCCCcccCcccccccCCcc
Q 010626            3 AIKNWARQILRGLHYLHSHNPPIIHRDLKCDNIFVNGNNGEVKIGDLGLAIVMQQPTARSVIGTPEFMAPELYEEEYNEL   82 (505)
Q Consensus         3 ~I~~ia~QIl~gL~yLHs~g~~IiHrDLKp~NILld~~~g~vKL~DFGlA~~~~~~~~~~~~Gt~~Y~APEll~~~ys~k   82 (505)
                      .+..++.||+.||.|||++|  |+||||||+|||++ + +.++|+|||.|.....+........-.-.-.+.+.+.|+.+
T Consensus       104 ~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~-~-~~~~liDFG~a~~~~~~~~~~~l~rd~~~~~~~f~r~y~~~  179 (191)
T d1zara2         104 NPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS-E-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTE  179 (191)
T ss_dssp             CHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE-T-TEEEECCCTTCEETTSTTHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHHhhCC--EEEccCChhheeee-C-CCEEEEECCCcccCCCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence            45689999999999999999  99999999999998 4 46999999999776544332211000000012345678999


Q ss_pred             cchhhHHH
Q 010626           83 VDIYSFGM   90 (505)
Q Consensus        83 sDIWSLGv   90 (505)
                      +|+||+.-
T Consensus       180 ~d~~s~~~  187 (191)
T d1zara2         180 KDINSAID  187 (191)
T ss_dssp             CCHHHHHH
T ss_pred             ccHHHHHH
Confidence            99999754

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=85.60  E-value=0.15  Score=47.68  Aligned_cols=28  Identities=32%  Similarity=0.387  Sum_probs=23.8

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEeecCcee
Q 010626           25 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI   53 (505)
Q Consensus        25 IiHrDLKp~NILld~~~g~vKL~DFGlA~   53 (505)
                      +||+|+.++||+++ .+...-+.||+.+.
T Consensus       185 iIHgDl~~dNvl~~-~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         185 VIHADLFQDNVFFL-GDELSGLIDFYFAC  212 (316)
T ss_dssp             EECSCCCGGGEEEE-TTEEEEECCCTTCE
T ss_pred             cccCCcchhhhhcc-cccceeEecccccc
Confidence            99999999999998 44455799999874

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=82.88  E-value=0.33  Score=43.58  Aligned_cols=28  Identities=36%  Similarity=0.380  Sum_probs=23.1

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEeecCcee
Q 010626           25 IIHRDLKCDNIFVNGNNGEVKIGDLGLAI   53 (505)
Q Consensus        25 IiHrDLKp~NILld~~~g~vKL~DFGlA~   53 (505)
                      ++|+|+.|.||+++ .++.+-|.||+.+.
T Consensus       185 l~HgD~~~~Nil~~-~~~~~~lIDwe~a~  212 (263)
T d1j7la_         185 FSHGDLGDSNIFVK-DGKVSGFIDLGRSG  212 (263)
T ss_dssp             EECSCCCTTSEEEE-TTEEEEECCCTTCE
T ss_pred             EEEeeccCcceeec-CCceEEEeechhcc
Confidence            79999999999998 44445699998774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=80.91  E-value=0.36  Score=43.10  Aligned_cols=29  Identities=31%  Similarity=0.217  Sum_probs=23.6

Q ss_pred             eEecCCCCCcEEEeCCCCcEEEeecCceee
Q 010626           25 IIHRDLKCDNIFVNGNNGEVKIGDLGLAIV   54 (505)
Q Consensus        25 IiHrDLKp~NILld~~~g~vKL~DFGlA~~   54 (505)
                      ++|+|+.|.||+++ .++.+-|+||+.+..
T Consensus       177 liHgD~~~~Nvl~~-~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         177 VTHGDACLPNIMVE-NGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EECSSCCGGGEEEE-TTEEEEECCCTTCEE
T ss_pred             EEeCCCCCcceEEe-CCceEEEEEchhccc
Confidence            79999999999997 444467999987643